Citrus Sinensis ID: 038118

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370------
Protein Sequence
RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSSAASSSASRSNMP
Secondary Structure (PSIPRED)
ccccccccccccccccHHHHHHHHcccccEEcHHHHHHHHccccccccccccccccccEEEEcccccEEEEEEcccccHHHHHHHHHHHHHHHccccccccccccEEccccEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccEEEEEccccccccccccccccccccccccEEEcccccccccEEccccccccHHHHcccccccccccEEHHHHHHHHHcccccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccHcccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEccccccEEEEEEEEccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHcHccEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
rkrnvddgednqgfneyiddefekgagpkrftYKELAQAtndfnddqklgqggfggvykGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEympngsldshlfkennLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRdikssnimldlnfnakigDFGLARLVEHakgsqttvlagtmgymapecattgraskesdvySFGIVALEIAcgrkpisltaKEEVQVYLVQWVWDLygngklleavdprlcrdFDEQQMECLMIVGLwcahpdenlrpSIRQVIHVLnseaplpalppkmpvptyfsppanmravngagpdkgpnknsssysnftsssaasssasrsnmp
Flexible Loop (DISEMBL)
rkrnvddgednqgfneyiddefekgaGPKRFTYKELAQATNdfnddqklgqGGFGGVYKGFFRETSSYIAvkrvskgskqgiKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSysnftsssaasssasrsnmp
Low Complexity Region (SEG)
RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLgqggfggvykgffRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEaplpalppKMPVPTYFSPPANMRAVNGAGPDKGPNKnsssysnftsssaasssasrsnMP
Disordered region (IsUnstruct)
******************************FTYKELAQA**DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN**************************************************************
Disordered Region (DISOPRED)
******************DDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG****IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI******EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTY*********************************************
Disordered Region (DISEMBL)
*********DNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVNGAG*******************************
Disordered Region (DISPRO)
*************************AGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALP*****************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSSAASSSASRSNMP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	376	2.2.26 [Sep-21-2011]
Q9LXA5	651	L-type lectin-domain cont	yes	no	0.877	0.506	0.606	1e-119
Q9LSL5	675	L-type lectin-domain cont	no	no	0.837	0.466	0.575	1e-108
Q9M2S4	684	L-type lectin-domain cont	no	no	0.808	0.444	0.498	2e-90
Q9FHG4	681	Probable L-type lectin-do	no	no	0.800	0.441	0.519	2e-90
Q9LFH9	715	L-type lectin-domain cont	no	no	0.811	0.426	0.509	9e-87
O80939	675	L-type lectin-domain cont	no	no	0.898	0.500	0.459	5e-86
Q9M345	677	L-type lectin-domain cont	no	no	0.811	0.450	0.482	2e-84
O81292	674	L-type lectin-domain cont	no	no	0.893	0.498	0.441	4e-84
O81291	669	L-type lectin-domain cont	no	no	0.906	0.509	0.434	6e-84
Q9FG33	652	Probable L-type lectin-do	no	no	0.877	0.506	0.454	2e-83

>sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1

 Score =  427 bits (1099), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 202/333 (60%), Positives = 249/333 (74%), Gaps = 3/333 (0%)

Query: 1   RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKG 60
           RK+     E+ +     I+++ E+GAGP++FTYK+LA A N+F DD+KLG+GGFG VY+G
Sbjct: 294 RKQQKKKAEETENLTS-INEDLERGAGPRKFTYKDLASAANNFADDRKLGEGGFGAVYRG 352

Query: 61  FFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           +       +A+K+ + GSKQG +E+ +EV IIS LRHRNLVQL+GWCHEK E L++YE+M
Sbjct: 353 YLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWCHEKDEFLMIYEFM 412

Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           PNGSLD+HLF +   L W  R KI   LAS LLYL E WEQCVVHRDIK+SN+MLD NFN
Sbjct: 413 PNGSLDAHLFGKKPHLAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVMLDSNFN 472

Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
           AK+GDFGLARL++H  G QTT LAGT GYMAPE  +TGRASKESDVYSFG+V LEI  GR
Sbjct: 473 AKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRASKESDVYSFGVVTLEIVTGR 532

Query: 241 KPIS-LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL-CRDFDEQQMECLMIVGLWCAHP 298
           K +     + E    LV+ +WDLYG G+++ A+D +L    FDE+Q ECLMIVGLWCAHP
Sbjct: 533 KSVDRRQGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIGGFDEKQAECLMIVGLWCAHP 592

Query: 299 DENLRPSIRQVIHVLNSEAPLPALPPKMPVPTY 331
           D N RPSI+Q I VLN EAP+P LP KMPV TY
Sbjct: 593 DVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATY 625

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LSL5|LRK92_ARATH L-type lectin-domain containing receptor kinase IX.2 OS=Arabidopsis thaliana GN=LECRK92 PE=2 SV=1

 Score =  390 bits (1002), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 186/323 (57%), Positives = 241/323 (74%), Gaps = 8/323 (2%)

Query: 18  IDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG 77
           I+ + E+ AGP++F+YK+L  ATN F+  +KLG+GGFG VY+G  +E ++ +AVK++S  
Sbjct: 325 INKDLEREAGPRKFSYKDLVSATNRFSSHRKLGEGGFGAVYEGNLKEINTMVAVKKLSGD 384

Query: 78  SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF-KENNLL 136
           S+QG  E+ +EV IIS+LRHRNLVQL+GWC+EK E LL+YE +PNGSL+SHLF K  NLL
Sbjct: 385 SRQGKNEFLNEVKIISKLRHRNLVQLIGWCNEKNEFLLIYELVPNGSLNSHLFGKRPNLL 444

Query: 137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           +W+ R+KI   LAS LLYL E W+QCV+HRDIK+SNIMLD  FN K+GDFGLARL+ H  
Sbjct: 445 SWDIRYKIGLGLASALLYLHEEWDQCVLHRDIKASNIMLDSEFNVKLGDFGLARLMNHEL 504

Query: 197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV--- 253
           GS TT LAGT GYMAPE    G ASKESD+YSFGIV LEI  GRK +  T ++       
Sbjct: 505 GSHTTGLAGTFGYMAPEYVMKGSASKESDIYSFGIVLLEIVTGRKSLERTQEDNSDTESD 564

Query: 254 ---YLVQWVWDLYGNGKLLEA-VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
               LV+ VW+LYG  +L+ + VD +L  DFD+++ ECL+++GLWCAHPD+N RPSI+Q 
Sbjct: 565 DEKSLVEKVWELYGKQELITSCVDDKLGEDFDKKEAECLLVLGLWCAHPDKNSRPSIKQG 624

Query: 310 IHVLNSEAPLPALPPKMPVPTYF 332
           I V+N E+PLP LP K PV  Y+
Sbjct: 625 IQVMNFESPLPDLPLKRPVAMYY 647

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  332 bits (852), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 153/307 (49%), Positives = 217/307 (70%), Gaps = 3/307 (0%)

Query: 20  DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK 79
           +E+E   GP RF+Y+EL +ATN F D + LG GGFG VYKG    +  ++AVKR+S  S+
Sbjct: 323 EEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESR 382

Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENN--LLT 137
           QG++E+ SEV+ I  LRHRNLVQLLGWC  + +LLLVY++MPNGSLD +LF EN   +LT
Sbjct: 383 QGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILT 442

Query: 138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG 197
           W+ RFKI + +ASGLLYL EGWEQ V+HRDIK++N++LD   N ++GDFGLA+L EH   
Sbjct: 443 WKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSD 502

Query: 198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
              T + GT GY+APE   +G+ +  +DVY+FG V LE+ACGR+PI  +A  E ++ +V 
Sbjct: 503 PGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPE-ELVMVD 561

Query: 258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA 317
           WVW  + +G + + VD RL  +FDE+++  ++ +GL C++    +RP++RQV+  L  + 
Sbjct: 562 WVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQF 621

Query: 318 PLPALPP 324
           P P + P
Sbjct: 622 PSPEVVP 628

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1

 Score =  332 bits (852), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 160/308 (51%), Positives = 216/308 (70%), Gaps = 7/308 (2%)

Query: 26  AGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEY 85
            G + F+YKEL  AT  F+  + +G+G FG VY+  F  + +  AVKR    S +G  E+
Sbjct: 348 TGLREFSYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEF 407

Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL----LTWEFR 141
            +E++II+ LRH+NLVQL GWC+EK ELLLVYE+MPNGSLD  L++E+      L W  R
Sbjct: 408 LAELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHR 467

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT 201
             IA  LAS L YL    EQ VVHRDIK+SNIMLD+NFNA++GDFGLARL EH K   +T
Sbjct: 468 LNIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVST 527

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD 261
           + AGTMGY+APE    G A++++D +S+G+V LE+ACGR+PI    + +  V LV WVW 
Sbjct: 528 LTAGTMGYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWR 587

Query: 262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE---AP 318
           L+  G++LEAVD RL  +FDE+ M+ L++VGL CAHPD N RPS+R+V+ +LN+E   +P
Sbjct: 588 LHSEGRVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSP 647

Query: 319 LPALPPKM 326
           +P + P +
Sbjct: 648 VPKMKPTL 655

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFH9|LRK81_ARATH L-type lectin-domain containing receptor kinase VIII.1 OS=Arabidopsis thaliana GN=LECRK81 PE=1 SV=1

 Score =  320 bits (821), Expect = 9e-87,   Method: Compositional matrix adjust.
 Identities = 158/310 (50%), Positives = 205/310 (66%), Gaps = 5/310 (1%)

Query: 27  GPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA 86
            PK F+YKEL   T +FN+ + +G G FG VY+G   ET   +AVKR S  S+    E+ 
Sbjct: 360 APKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFL 419

Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           SE++II  LRHRNLV+L GWCHEK E+LLVY+ MPNGSLD  LF+    L W+ R KI  
Sbjct: 420 SELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDHRKKILL 479

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
            +AS L YL    E  V+HRD+KSSNIMLD +FNAK+GDFGLAR +EH K  + TV AGT
Sbjct: 480 GVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAGT 539

Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI--SLTAKEE---VQVYLVQWVWD 261
           MGY+APE   TGRAS+++DV+S+G V LE+  GR+PI   L  +     V   LV+WVW 
Sbjct: 540 MGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWG 599

Query: 262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPA 321
           LY  GK+  A D RL   FDE +M  +++VGL C+HPD   RP++R V+ +L  EA +P 
Sbjct: 600 LYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIGEADVPV 659

Query: 322 LPPKMPVPTY 331
           +P   P  ++
Sbjct: 660 VPKSRPTMSF 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  318 bits (814), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 158/344 (45%), Positives = 217/344 (63%), Gaps = 6/344 (1%)

Query: 27  GPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA 86
           G  RF +K+L  AT  F +   LG GGFG VYKG    T   IAVKRVS  S+QG+KE+ 
Sbjct: 331 GKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFV 390

Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIA 145
           +E+  I R+ HRNLV LLG+C  + ELLLVY+YMPNGSLD +L+    + L W+ R K+ 
Sbjct: 391 AEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVI 450

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
             +ASGL YL E WEQ V+HRD+K+SN++LD   N ++GDFGLARL +H    QTT + G
Sbjct: 451 LGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVG 510

Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T+GY+APE   TGRA+  +DV++FG   LE+ACGR+PI    + +    LV WV+ L+  
Sbjct: 511 TLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNK 570

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPK 325
           G +L A DP +  + DE+++E ++ +GL C+H D   RPS+RQV+H L  +A LP L   
Sbjct: 571 GDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPELS-- 628

Query: 326 MPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSSAASSS 369
              P   S    M  V+    + G + +SS +  FT  S+ + S
Sbjct: 629 ---PLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGSSIADS 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  313 bits (801), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 148/307 (48%), Positives = 204/307 (66%), Gaps = 2/307 (0%)

Query: 20  DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK 79
           D++E   G  RF +KEL  AT  F +   LG GGFG VY+G    T   +AVKRVS  SK
Sbjct: 324 DDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSK 383

Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKE-NNLLTW 138
           QG+KE+ +E+  I R+ HRNLV LLG+C  + ELLLVY+YMPNGSLD +L+      L W
Sbjct: 384 QGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPETTLDW 443

Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
           + R  I + +ASGL YL E WEQ V+HRD+K+SN++LD +FN ++GDFGLARL +H    
Sbjct: 444 KQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDP 503

Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
           QTT + GT+GY+APE + TGRA+  +DVY+FG   LE+  GR+PI   +  +    LV+W
Sbjct: 504 QTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEW 563

Query: 259 VWDLYGNGKLLEAVDPRL-CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA 317
           V+ L+  G ++EA DP+L    +D +++E ++ +GL C+H D   RPS+RQV+  L  + 
Sbjct: 564 VFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDM 623

Query: 318 PLPALPP 324
            LP L P
Sbjct: 624 ALPELTP 630

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  311 bits (798), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 155/351 (44%), Positives = 221/351 (62%), Gaps = 15/351 (4%)

Query: 20  DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK 79
           +++E   G  R  +K+L  AT  F D   LG GGFG VY+G    T   IAVKRVS  S+
Sbjct: 332 EDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESR 391

Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL-LTW 138
           QG+KE+ +E+  I R+ HRNLV LLG+C  + ELLLVY+YMPNGSLD +L+    + L W
Sbjct: 392 QGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEVTLDW 451

Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
           + RF +   +ASGL YL E WEQ V+HRDIK+SN++LD  +N ++GDFGLARL +H    
Sbjct: 452 KQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDP 511

Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
           QTT + GT GY+AP+   TGRA+  +DV++FG++ LE+ACGR+PI +  + +  V LV  
Sbjct: 512 QTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDS 571

Query: 259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP 318
           V+  +  G +L+A DP L   +D++++E ++ +GL C+H D  +RP++RQV+  L  +A 
Sbjct: 572 VFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDAT 631

Query: 319 LPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSSAASSS 369
           LP L            P + R   G+G   G N   S    F+S S+ + S
Sbjct: 632 LPDL-----------SPLDFR---GSGKMLGMNHRFSESCTFSSGSSIAYS 668

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  311 bits (796), Expect = 6e-84,   Method: Compositional matrix adjust.
 Identities = 155/357 (43%), Positives = 226/357 (63%), Gaps = 16/357 (4%)

Query: 14  FNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKR 73
           F E ++D +E   G  R  +K+L  AT  F D   LG GGFG VYKG   +T   IAVKR
Sbjct: 322 FAEEVED-WETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKR 380

Query: 74  VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN 133
           VS  S+QG+KE+ +E+  I ++ HRNLV L+G+C  + ELLLVY+YMPNGSLD +L+   
Sbjct: 381 VSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSP 440

Query: 134 NL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
            + L W+ RFK+   +AS L YL E WEQ V+HRD+K+SN++LD   N ++GDFGLA+L 
Sbjct: 441 EVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLC 500

Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
           +H    QTT + GT GY+AP+   TGRA+  +DV++FG++ LE+ACGR+PI +  +   +
Sbjct: 501 DHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGER 560

Query: 253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
           V LV WV+  +    +L+A DP L  ++D++++E ++ +GL C+H D   RP++RQV+  
Sbjct: 561 VVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQY 620

Query: 313 LNSEAPLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSSAASSS 369
           L  +A LP L            P ++R   G+G   G +  S+    FTS S+ + S
Sbjct: 621 LRGDAMLPDL-----------SPLDLR---GSGIMLGTHNGSNESGMFTSGSSVAYS 663

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FG33|LRKS5_ARATH Probable L-type lectin-domain containing receptor kinase S.5 OS=Arabidopsis thaliana GN=LECRKS5 PE=2 SV=1

 Score =  309 bits (792), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 156/343 (45%), Positives = 226/343 (65%), Gaps = 13/343 (3%)

Query: 8   GEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSS 67
           GE N      +D+     A P++F  +EL +AT +F  + KLGQGGFG V+KG ++    
Sbjct: 298 GETNPDIEAELDN---CAANPQKFKLRELKRATGNFGAENKLGQGGFGMVFKGKWQGRD- 353

Query: 68  YIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
            IAVKRVS+ S QG +E+ +E+T I  L HRNLV+LLGWC+E+KE LLVYEYMPNGSLD 
Sbjct: 354 -IAVKRVSEKSHQGKQEFIAEITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDK 412

Query: 128 HLFKENNL---LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
           +LF E+     LTWE R  I   L+  L YL  G E+ ++HRDIK+SN+MLD +FNAK+G
Sbjct: 413 YLFLEDKSRSNLTWETRKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLG 472

Query: 185 DFGLARLVEHAKGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           DFGLAR+++ ++ +   T  +AGT GYMAPE    GRA+ E+DVY+FG++ LE+  G+KP
Sbjct: 473 DFGLARMIQQSEMTHHSTKEIAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKP 532

Query: 243 ISLTAKEEVQVY---LVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPD 299
             +  K+    Y   +V W+W+LY NG + +A DP +   FD+++M+ ++++GL C HP+
Sbjct: 533 SYVLVKDNQNNYNNSIVNWLWELYRNGTITDAADPGMGNLFDKEEMKSVLLLGLACCHPN 592

Query: 300 ENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVN 342
            N RPS++ V+ VL  E   P +P + P   + + P +   ++
Sbjct: 593 PNQRPSMKTVLKVLTGETSPPDVPTERPAFVWPAMPPSFSDID 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
224096774	713	predicted protein [Populus trichocarpa]	0.906	0.478	0.751	1e-155
224092745	681	predicted protein [Populus trichocarpa]	0.896	0.494	0.753	1e-154
224056341	610	predicted protein [Populus trichocarpa]	0.906	0.559	0.751	1e-154
255562072	606	kinase, putative [Ricinus communis] gi|2	0.885	0.549	0.757	1e-154
224059892	613	predicted protein [Populus trichocarpa]	0.896	0.549	0.744	1e-152
255554595	718	kinase, putative [Ricinus communis] gi|2	0.869	0.455	0.746	1e-147
147765964	692	hypothetical protein VITISV_007747 [Viti	0.856	0.465	0.774	1e-146
225470605	720	PREDICTED: L-type lectin-domain containi	0.856	0.447	0.768	1e-145
357476157	782	Class I heat shock protein [Medicago tru	0.933	0.448	0.665	1e-142
359475577	675	PREDICTED: L-type lectin-domain containi	0.965	0.537	0.670	1e-142

>gi|224096774|ref|XP_002334671.1| predicted protein [Populus trichocarpa] gi|222874064|gb|EEF11195.1| predicted protein [Populus trichocarpa]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 257/342 (75%), Positives = 297/342 (86%), Gaps = 1/342 (0%)

Query: 1   RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKG 60
           R    D+G D     EY+DDEFE+G GPK+F+Y+ELA+ATN+F D++KLG+GGFGGVYKG
Sbjct: 328 RGHEEDEG-DGHVLEEYMDDEFERGTGPKKFSYQELARATNNFKDEEKLGEGGFGGVYKG 386

Query: 61  FFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           F +   S++AVKRVS+GSKQGIKEYA+EV IISRLRHRNLVQL+GWCHE+KELLLVYE+M
Sbjct: 387 FLKGIDSFVAVKRVSRGSKQGIKEYAAEVKIISRLRHRNLVQLIGWCHERKELLLVYEFM 446

Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P+GSLDSHLFKE +LLTWE R+KI Q LASGLLYL E WEQCVVHRDIKSSNIMLD  FN
Sbjct: 447 PHGSLDSHLFKETSLLTWEVRYKIVQGLASGLLYLHEEWEQCVVHRDIKSSNIMLDSEFN 506

Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
           AK+GDFGLARLV+H KGSQTTVLAGTMGYMAPECA TG+AS+ESDVYSFGIVALEIACGR
Sbjct: 507 AKLGDFGLARLVDHGKGSQTTVLAGTMGYMAPECAMTGKASRESDVYSFGIVALEIACGR 566

Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE 300
           KPI+  A  E QV +VQWVW+LYG GKLLEAVDPRLC DF++ QME LMIVGL CAHPDE
Sbjct: 567 KPINPKASNEDQVSMVQWVWELYGEGKLLEAVDPRLCGDFNKTQMERLMIVGLSCAHPDE 626

Query: 301 NLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVN 342
           +LRPSIRQ +HVLN +APLP LP KMPVP+YF+PP +  +++
Sbjct: 627 HLRPSIRQALHVLNFDAPLPILPSKMPVPSYFAPPISASSLS 668

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224092745|ref|XP_002334872.1| predicted protein [Populus trichocarpa] gi|222831889|gb|EEE70366.1| predicted protein [Populus trichocarpa]

 Score =  552 bits (1422), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 254/337 (75%), Positives = 296/337 (87%)

Query: 6   DDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRET 65
           +D E      EY+DDEFE+G GPK+F+Y+ELA+AT++F D++KLG+GGFGGVYKGF +E 
Sbjct: 300 EDEEGGHVLEEYMDDEFERGTGPKKFSYQELARATSNFKDEEKLGEGGFGGVYKGFLKEI 359

Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
            S++AVKRVS+GSKQGIKEYA+EV IISRLRHRNLVQL+GWCHE+KELLLVYE+MP+GSL
Sbjct: 360 DSFVAVKRVSRGSKQGIKEYAAEVKIISRLRHRNLVQLIGWCHERKELLLVYEFMPHGSL 419

Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
           DSHLFKE +LLTWE R+KI Q LASGLLYL E WEQCVVHRDIKSSNIMLD  FNAK+GD
Sbjct: 420 DSHLFKETSLLTWEVRYKIVQGLASGLLYLHEEWEQCVVHRDIKSSNIMLDSEFNAKLGD 479

Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLARLV+H KGSQTTVLAGTMGYMAPECA TG+AS+ESDVYSFGIVALEIACGRKPI+ 
Sbjct: 480 FGLARLVDHGKGSQTTVLAGTMGYMAPECAMTGKASRESDVYSFGIVALEIACGRKPINP 539

Query: 246 TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS 305
            A  E QV +VQWVW+LYG GKLLEAVDPRLC DF++ QME LMIVGL CAHPDE+LRPS
Sbjct: 540 KASNEDQVSMVQWVWELYGEGKLLEAVDPRLCGDFNKTQMERLMIVGLSCAHPDEHLRPS 599

Query: 306 IRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVN 342
           IRQ +H+LN +APLP LP KMPVP+YF+PP +  +++
Sbjct: 600 IRQALHILNFDAPLPILPSKMPVPSYFAPPISASSLS 636

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224056341|ref|XP_002298811.1| predicted protein [Populus trichocarpa] gi|222846069|gb|EEE83616.1| predicted protein [Populus trichocarpa]

 Score =  551 bits (1420), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 257/342 (75%), Positives = 297/342 (86%), Gaps = 1/342 (0%)

Query: 1   RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKG 60
           R    D+G D     EY+DDEFE+G GPK+F+Y+ELA+ATN+F D++KLG+GGFGGVYKG
Sbjct: 225 RGHEEDEG-DGHVLEEYMDDEFERGTGPKKFSYQELARATNNFKDEEKLGEGGFGGVYKG 283

Query: 61  FFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           F +   S++AVKRVS+GSKQGIKEYA+EV IISRLRHRNLVQL+GWCHE+KELLLVYE+M
Sbjct: 284 FLKGIDSFVAVKRVSRGSKQGIKEYAAEVKIISRLRHRNLVQLIGWCHERKELLLVYEFM 343

Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P+GSLDSHLFKE +LLTWE R+KI Q LASGLLYL E WEQCVVHRDIKSSNIMLD  FN
Sbjct: 344 PHGSLDSHLFKETSLLTWEVRYKIVQGLASGLLYLHEEWEQCVVHRDIKSSNIMLDSEFN 403

Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
           AK+GDFGLARLV+H KGSQTTVLAGTMGYMAPECA TG+AS+ESDVYSFGIVALEIACGR
Sbjct: 404 AKLGDFGLARLVDHGKGSQTTVLAGTMGYMAPECAMTGKASRESDVYSFGIVALEIACGR 463

Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE 300
           KPI+  A  E QV +VQWVW+LYG GKLLEAVDPRLC DF++ QME LMIVGL CAHPDE
Sbjct: 464 KPINPKASNEDQVSMVQWVWELYGEGKLLEAVDPRLCGDFNKTQMERLMIVGLSCAHPDE 523

Query: 301 NLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVN 342
           +LRPSIRQ +HVLN +APLP LP KMPVP+YF+PP +  +++
Sbjct: 524 HLRPSIRQALHVLNFDAPLPILPSKMPVPSYFAPPISASSLS 565

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562072|ref|XP_002522044.1| kinase, putative [Ricinus communis] gi|223538643|gb|EEF40244.1| kinase, putative [Ricinus communis]

 Score =  549 bits (1415), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 253/334 (75%), Positives = 295/334 (88%), Gaps = 1/334 (0%)

Query: 2   KRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGF 61
           K+N DD E+    ++ +DD+FEKG GPKRF Y ELA+AT++F D++KLG GGFG VYKGF
Sbjct: 239 KKNADDEEEAHVLDDCMDDDFEKGTGPKRFLYHELARATSNFKDEEKLGVGGFGEVYKGF 298

Query: 62  FRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
            +  +SY+AVK+VS+GS+QG+KEYA+EV IISRLRH+NLVQL+GWCHE+KELLLVYE++P
Sbjct: 299 LKNLNSYVAVKKVSRGSQQGVKEYAAEVKIISRLRHQNLVQLIGWCHERKELLLVYEFLP 358

Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           N SLDSHLFKE +LLTWE R+KIAQ LASGLLYL E  EQCVVHRDIK+SNIMLD NFNA
Sbjct: 359 NVSLDSHLFKEKSLLTWELRYKIAQGLASGLLYLHEECEQCVVHRDIKASNIMLDSNFNA 418

Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           K+GDFGLARLVEH KGSQTTVLAGTMGYMAPEC TTG+AS+ESDVY FGIVALEIACGRK
Sbjct: 419 KLGDFGLARLVEHGKGSQTTVLAGTMGYMAPECVTTGKASRESDVYRFGIVALEIACGRK 478

Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           PI+  A +E +VY+V+WVWDLYG GKLL+A DPRLC DFD+QQME LMI+GLWCAHPDEN
Sbjct: 479 PINPKA-DETEVYMVKWVWDLYGKGKLLKAGDPRLCGDFDKQQMERLMIIGLWCAHPDEN 537

Query: 302 LRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPP 335
           LRPSIRQ IHVL+ EAPLP LPP+MP+PTYF+PP
Sbjct: 538 LRPSIRQAIHVLHFEAPLPILPPEMPIPTYFAPP 571

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224059892|ref|XP_002300009.1| predicted protein [Populus trichocarpa] gi|222847267|gb|EEE84814.1| predicted protein [Populus trichocarpa]

 Score =  544 bits (1402), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 251/337 (74%), Positives = 295/337 (87%)

Query: 6   DDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRET 65
           +D E      EY+D+EFE+G GPK+F+Y+ELA+AT++F D++KLG+GGFGGVYKGF +E 
Sbjct: 268 EDEEGGHVVEEYMDEEFERGTGPKKFSYQELARATSNFKDEEKLGEGGFGGVYKGFLKEI 327

Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
            S++AVKRVS+GSKQGIKEYA+EV IISRLRHRNLVQL+GWCHE+KELLLVYE+M +GSL
Sbjct: 328 DSFVAVKRVSRGSKQGIKEYAAEVKIISRLRHRNLVQLIGWCHERKELLLVYEFMSHGSL 387

Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
           DSHLFKE +LLTWE R+KI Q LASGLLYL E WEQCVVHRDIKSSNI+LD  FNAK+GD
Sbjct: 388 DSHLFKETSLLTWEVRYKIVQGLASGLLYLHEEWEQCVVHRDIKSSNIILDSEFNAKLGD 447

Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLARLV+H KGSQTTVLAGTMGYMAPECA TG+AS+ESDVYSFGIVALEIACGRKPI+ 
Sbjct: 448 FGLARLVDHGKGSQTTVLAGTMGYMAPECAMTGKASRESDVYSFGIVALEIACGRKPINP 507

Query: 246 TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS 305
            A  E +V +VQWVW+LYG GKLLEAVDPRLC DF++ QME LMIVGL CAHPDE+LRPS
Sbjct: 508 KASNEDRVSMVQWVWELYGEGKLLEAVDPRLCGDFNKTQMERLMIVGLSCAHPDEHLRPS 567

Query: 306 IRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVN 342
           IRQ +HVLN +APLP LP KMPVP+YF+PP +  +++
Sbjct: 568 IRQALHVLNFDAPLPILPSKMPVPSYFAPPISASSLS 604

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255554595|ref|XP_002518336.1| kinase, putative [Ricinus communis] gi|223542556|gb|EEF44096.1| kinase, putative [Ricinus communis]

 Score =  527 bits (1358), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 247/331 (74%), Positives = 288/331 (87%), Gaps = 4/331 (1%)

Query: 4   NVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFR 63
           NVDD E    F+  +D++FEKG GP++F+Y +L +ATN+F++ +KLG+GGFG VYKGF R
Sbjct: 337 NVDDEEVVDHFDMSMDEDFEKGTGPRKFSYNDLVRATNNFSEQEKLGEGGFGAVYKGFLR 396

Query: 64  E-TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  +SY+AVKR+SKGSKQG+KEYASEV IISRLRHRNLVQL+GWCHE+K+LLLVYE+MPN
Sbjct: 397 EFMNSYVAVKRISKGSKQGMKEYASEVKIISRLRHRNLVQLIGWCHEEKKLLLVYEFMPN 456

Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDSHLFK+++LLTW+ R+KIAQ LASGLLYLQE WEQCV+HRDIKSSNIMLD NFNAK
Sbjct: 457 GSLDSHLFKQDSLLTWDIRYKIAQGLASGLLYLQEEWEQCVLHRDIKSSNIMLDSNFNAK 516

Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           +GDFGLARLV+H KG +TT+LAGTMGYMAPECA TG+AS+ESDVYSFG+VALEIACGRKP
Sbjct: 517 LGDFGLARLVDHGKGPETTILAGTMGYMAPECAITGKASRESDVYSFGVVALEIACGRKP 576

Query: 243 ISLTAKEEVQVYLVQWVWDLYGNG--KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE 300
           I+  A E+ QVYL+QWVW+LYG G  KLLEA DPRL  DFDEQQM+CL+IVGLWC HPDE
Sbjct: 577 INYKAGED-QVYLIQWVWNLYGGGPSKLLEAADPRLNGDFDEQQMKCLIIVGLWCVHPDE 635

Query: 301 NLRPSIRQVIHVLNSEAPLPALPPKMPVPTY 331
             R SIRQ I VL  EAPLP LP KMPVPTY
Sbjct: 636 KCRASIRQAIQVLKFEAPLPILPAKMPVPTY 666

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765964|emb|CAN70210.1| hypothetical protein VITISV_007747 [Vitis vinifera]

 Score =  522 bits (1345), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 251/324 (77%), Positives = 286/324 (88%), Gaps = 2/324 (0%)

Query: 18  IDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG 77
           ++D+FEKG GPK+F Y ELA +TN+F ++ KLG+GGFGGVYKGF +E  SYIAVKRVS G
Sbjct: 325 MEDDFEKGTGPKKFRYNELASSTNNFAEEGKLGEGGFGGVYKGFLKELDSYIAVKRVSSG 384

Query: 78  SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLT 137
           SKQGIKEY SEV IISRLRHRNLVQL+GWCHEK++LLLVYE+MPNGSL+SHLF E +LLT
Sbjct: 385 SKQGIKEYVSEVKIISRLRHRNLVQLIGWCHEKRDLLLVYEFMPNGSLESHLFSERSLLT 444

Query: 138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG 197
           WE R+KIAQ LAS LLYL EGWEQCV+HRDIKSSNIMLD  FNAK+GDFGLARLV+H KG
Sbjct: 445 WEMRYKIAQGLASALLYLHEGWEQCVLHRDIKSSNIMLDSGFNAKLGDFGLARLVDHGKG 504

Query: 198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
           SQTTVLAGTMGYMAPECATTG+ASK+SD+YSFG+VALEIACGRKPI+L AKE+ Q+ +++
Sbjct: 505 SQTTVLAGTMGYMAPECATTGKASKQSDIYSFGVVALEIACGRKPINLKAKED-QIMMLE 563

Query: 258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA 317
           WVWDLYG G +LEA DPRLC +FD QQM+CLM VGLWCAHPD NLRPS+R+VIHVLN EA
Sbjct: 564 WVWDLYGKGNILEAADPRLCAEFDAQQMQCLMTVGLWCAHPDRNLRPSVREVIHVLNFEA 623

Query: 318 PLPALPPKMPVPTYFSPPANMRAV 341
           PLP LPPKMPVPTY S P  M AV
Sbjct: 624 PLPILPPKMPVPTY-SIPGAMSAV 646

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225470605|ref|XP_002262748.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Vitis vinifera]

 Score =  521 bits (1341), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 249/324 (76%), Positives = 285/324 (87%), Gaps = 2/324 (0%)

Query: 18  IDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG 77
           ++D+FEKG GPK+F Y ELA +TN+F ++ KLG+GGFGGVYKGF +E  SYIAVKRVS G
Sbjct: 353 MEDDFEKGTGPKKFRYNELASSTNNFAEEGKLGEGGFGGVYKGFLKELDSYIAVKRVSSG 412

Query: 78  SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLT 137
           SKQGIKEY SEV IISRLRHRNLVQL+GWCHEK++LLLVYE+MPNGSL+SH+F E +LLT
Sbjct: 413 SKQGIKEYVSEVKIISRLRHRNLVQLIGWCHEKRDLLLVYEFMPNGSLESHIFSERSLLT 472

Query: 138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG 197
           WE R+KIAQ LAS LLYL EGWEQCV+HRDIKSSNIMLD  FNAK+GDFGLARLV+H KG
Sbjct: 473 WEMRYKIAQGLASALLYLHEGWEQCVLHRDIKSSNIMLDSGFNAKLGDFGLARLVDHGKG 532

Query: 198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
           SQTTVLAGTMGYMAPECATTG+ASK+SD+YSFG+VALEIACGRKPI+L AKE+ Q+ +++
Sbjct: 533 SQTTVLAGTMGYMAPECATTGKASKQSDIYSFGVVALEIACGRKPINLKAKED-QIMMLE 591

Query: 258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA 317
           WVWDLYG G +LEA DPRLC +FD QQM+CLM VGLWCAHPD NLRPS+R+VIHVLN EA
Sbjct: 592 WVWDLYGKGNILEAADPRLCAEFDAQQMQCLMTVGLWCAHPDRNLRPSVREVIHVLNFEA 651

Query: 318 PLPALPPKMPVPTYFSPPANMRAV 341
           PLP LPPKMPVPTY S P  M  V
Sbjct: 652 PLPILPPKMPVPTY-SIPGAMSTV 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357476157|ref|XP_003608364.1| Class I heat shock protein [Medicago truncatula] gi|355509419|gb|AES90561.1| Class I heat shock protein [Medicago truncatula]

 Score =  512 bits (1318), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 239/359 (66%), Positives = 287/359 (79%), Gaps = 8/359 (2%)

Query: 1   RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKG 60
           ++R  +DGE    F EY+ ++F +G GPK++TY ELA A N+F D+ KLGQGGFGGVY+G
Sbjct: 313 KRREQEDGE----FQEYMGEDFGRGTGPKKYTYAELANAANNFKDEHKLGQGGFGGVYRG 368

Query: 61  FFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           F ++T SY+A+K VS+ S QGIKE+ASEVTIIS+LRHRNLVQL+GWCH++K+LLLVYEYM
Sbjct: 369 FLKDTKSYVAIKSVSEDSHQGIKEFASEVTIISKLRHRNLVQLIGWCHQRKKLLLVYEYM 428

Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           PNGSLD HLFK+ +LL W  R+ IA+ LAS LLYL E WEQCVVHRDIK+SNIMLD  FN
Sbjct: 429 PNGSLDIHLFKKQSLLKWGVRYTIAKGLASALLYLHEEWEQCVVHRDIKASNIMLDSEFN 488

Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
           AK+GDFGLAR V+HAKG QTT LAGTMGYMAPECATTGRASKE+DVYSFGIVALEIACGR
Sbjct: 489 AKLGDFGLARFVDHAKGGQTTALAGTMGYMAPECATTGRASKETDVYSFGIVALEIACGR 548

Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE 300
           KPI     +E ++ +V+WVW LYG G+++EAVDPRL  D++E+Q++C+MIVGLWCAHPD 
Sbjct: 549 KPI--INAQENEINIVEWVWGLYGRGRIVEAVDPRLDGDYEEEQIKCMMIVGLWCAHPDP 606

Query: 301 NLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPAN--MRAVNGAGPDKGPNKNSSSY 357
           N RPSIRQ I VLN E PLP LP  MPVPTY   P N      N  G ++GPN N   +
Sbjct: 607 NNRPSIRQAIQVLNFEVPLPNLPSSMPVPTYLDGPLNSFTAPFNTNGSEEGPNMNIEKF 665

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475577|ref|XP_003631707.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Vitis vinifera]

 Score =  509 bits (1311), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/364 (67%), Positives = 293/364 (80%), Gaps = 1/364 (0%)

Query: 1   RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKG 60
           +KRN    E+    +  +D++FEKG GP++F++ ELA AT++F +++KLG+GGFGGVY+G
Sbjct: 313 KKRNSGGEENGTDSDLVMDEDFEKGTGPRKFSFDELALATSNFAEEEKLGEGGFGGVYRG 372

Query: 61  FFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           F RE +SY+AVKRVS+GSKQG+KEYA+EV IISRLRHRNLV+L+GWCH+K ELLLVYE+M
Sbjct: 373 FLRELNSYVAVKRVSRGSKQGMKEYAAEVKIISRLRHRNLVRLMGWCHKKGELLLVYEFM 432

Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           PNG+L S L +E  LLTW  R+KIA  LAS LLYL E WEQCVV RDIKSSN+MLD +FN
Sbjct: 433 PNGNLSSCLLEEKTLLTWAMRYKIALGLASSLLYLHEEWEQCVVRRDIKSSNVMLDSDFN 492

Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
           AK+GDFGLARLV+H+KGSQTTVLAGTMGYM PEC  TG+ASKE+DVYSFGIVALEI CGR
Sbjct: 493 AKLGDFGLARLVDHSKGSQTTVLAGTMGYMDPECLLTGKASKETDVYSFGIVALEICCGR 552

Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE 300
           +P+   AKE+ QV LV+WVW LYG GKL++A DPRL  DFDE+QME LMIVGLWCAHPD 
Sbjct: 553 RPVEPKAKEK-QVRLVEWVWHLYGVGKLVDAADPRLSNDFDEEQMERLMIVGLWCAHPDC 611

Query: 301 NLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNF 360
           +LRPSIRQ I+VLNSEA LP LP KMPVP Y SPP       GA   +  +   S +SN 
Sbjct: 612 DLRPSIRQAINVLNSEASLPLLPLKMPVPMYCSPPVLQTISRGAPISESSHTQYSDFSNS 671

Query: 361 TSSS 364
           T+SS
Sbjct: 672 TTSS 675

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
TAIR|locus:2142499	651	AT5G10530 [Arabidopsis thalian	0.914	0.528	0.553	3.9e-99
TAIR|locus:2155685	675	AT5G65600 [Arabidopsis thalian	0.837	0.466	0.535	1.2e-88
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.787	0.432	0.471	2.1e-75
TAIR|locus:2162212	681	AT5G55830 [Arabidopsis thalian	0.771	0.425	0.510	7.3e-75
TAIR|locus:2083986	715	AT3G53380 [Arabidopsis thalian	0.768	0.404	0.5	1.8e-71
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.789	0.44	0.459	9.9e-71
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.803	0.446	0.452	8.9e-70
TAIR|locus:2170224	652	AT5G06740 [Arabidopsis thalian	0.797	0.460	0.456	2.4e-69
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.803	0.448	0.444	6.3e-69
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.803	0.451	0.430	8e-69

TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)]

 Score = 984 (351.4 bits), Expect = 3.9e-99, P = 3.9e-99
 Identities = 192/347 (55%), Positives = 238/347 (68%)

Query:     1 RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXX 60
             RK+     E+ +     I+++ E+GAGP++FTYK+LA A N+F DD+KL           
Sbjct:   294 RKQQKKKAEETENLTS-INEDLERGAGPRKFTYKDLASAANNFADDRKLGEGGFGAVYRG 352

Query:    61 XXRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
                     +A+K+ + GSKQG +E+ +EV IIS LRHRNLVQL+GWCHEK E L++YE+M
Sbjct:   353 YLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWCHEKDEFLMIYEFM 412

Query:   121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
             PNGSLD+HLF +   L W  R KI   LAS LLYL E WEQCVVHRDIK+SN+MLD NFN
Sbjct:   413 PNGSLDAHLFGKKPHLAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVMLDSNFN 472

Query:   181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
             AK+GDFGLARL++H  G QTT LAGT GYMAPE  +TGRASKESDVYSFG+V LEI  GR
Sbjct:   473 AKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRASKESDVYSFGVVTLEIVTGR 532

Query:   241 KPISLT-AKEEVQVYLVQWVWDLYGNGKLLEAVDPRL-CRDFDEQQMECLMIVGLWCAHP 298
             K +     + E    LV+ +WDLYG G+++ A+D +L    FDE+Q ECLMIVGLWCAHP
Sbjct:   533 KSVDRRQGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIGGFDEKQAECLMIVGLWCAHP 592

Query:   299 DENLRPSIRQVIHVLNSEXXXXXXXXKMPVPTYFSPPANMRAVNGAG 345
             D N RPSI+Q I VLN E        KMPV TY    +N  +V+  G
Sbjct:   593 DVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATYHVSSSNTTSVSSGG 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2155685 AT5G65600 [Arabidopsis thaliana (taxid:3702)]

 Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
 Identities = 173/323 (53%), Positives = 227/323 (70%)

Query:    18 IDDEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG 77
             I+ + E+ AGP++F+YK+L  ATN F+  +KL             +E ++ +AVK++S  
Sbjct:   325 INKDLEREAGPRKFSYKDLVSATNRFSSHRKLGEGGFGAVYEGNLKEINTMVAVKKLSGD 384

Query:    78 SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF-KENNLL 136
             S+QG  E+ +EV IIS+LRHRNLVQL+GWC+EK E LL+YE +PNGSL+SHLF K  NLL
Sbjct:   385 SRQGKNEFLNEVKIISKLRHRNLVQLIGWCNEKNEFLLIYELVPNGSLNSHLFGKRPNLL 444

Query:   137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
             +W+ R+KI   LAS LLYL E W+QCV+HRDIK+SNIMLD  FN K+GDFGLARL+ H  
Sbjct:   445 SWDIRYKIGLGLASALLYLHEEWDQCVLHRDIKASNIMLDSEFNVKLGDFGLARLMNHEL 504

Query:   197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKE------E 250
             GS TT LAGT GYMAPE    G ASKESD+YSFGIV LEI  GRK +  T ++      +
Sbjct:   505 GSHTTGLAGTFGYMAPEYVMKGSASKESDIYSFGIVLLEIVTGRKSLERTQEDNSDTESD 564

Query:   251 VQVYLVQWVWDLYGNGKLLEA-VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
              +  LV+ VW+LYG  +L+ + VD +L  DFD+++ ECL+++GLWCAHPD+N RPSI+Q 
Sbjct:   565 DEKSLVEKVWELYGKQELITSCVDDKLGEDFDKKEAECLLVLGLWCAHPDKNSRPSIKQG 624

Query:   310 IHVLNSEXXXXXXXXKMPVPTYF 332
             I V+N E        K PV  Y+
Sbjct:   625 IQVMNFESPLPDLPLKRPVAMYY 647

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 760 (272.6 bits), Expect = 2.1e-75, P = 2.1e-75
 Identities = 141/299 (47%), Positives = 204/299 (68%)

Query:    20 DEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSK 79
             +E+E   GP RF+Y+EL +ATN F D + L               +  ++AVKR+S  S+
Sbjct:   323 EEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESR 382

Query:    80 QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENN--LLT 137
             QG++E+ SEV+ I  LRHRNLVQLLGWC  + +LLLVY++MPNGSLD +LF EN   +LT
Sbjct:   383 QGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILT 442

Query:   138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG 197
             W+ RFKI + +ASGLLYL EGWEQ V+HRDIK++N++LD   N ++GDFGLA+L EH   
Sbjct:   443 WKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSD 502

Query:   198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
                T + GT GY+APE   +G+ +  +DVY+FG V LE+ACGR+PI  +A  E ++ +V 
Sbjct:   503 PGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPE-ELVMVD 561

Query:   258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
             WVW  + +G + + VD RL  +FDE+++  ++ +GL C++    +RP++RQV+  L  +
Sbjct:   562 WVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQ 620

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)]

 Score = 755 (270.8 bits), Expect = 7.3e-75, P = 7.3e-75
 Identities = 150/294 (51%), Positives = 200/294 (68%)

Query:    27 GPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIKEYA 86
             G + F+YKEL  AT  F+  + +               + +  AVKR    S +G  E+ 
Sbjct:   349 GLREFSYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFL 408

Query:    87 SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL----LTWEFRF 142
             +E++II+ LRH+NLVQL GWC+EK ELLLVYE+MPNGSLD  L++E+      L W  R 
Sbjct:   409 AELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRL 468

Query:   143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
              IA  LAS L YL    EQ VVHRDIK+SNIMLD+NFNA++GDFGLARL EH K   +T+
Sbjct:   469 NIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTL 528

Query:   203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL 262
              AGTMGY+APE    G A++++D +S+G+V LE+ACGR+PI    + +  V LV WVW L
Sbjct:   529 TAGTMGYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRL 588

Query:   263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
             +  G++LEAVD RL  +FDE+ M+ L++VGL CAHPD N RPS+R+V+ +LN+E
Sbjct:   589 HSEGRVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNE 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)]

 Score = 723 (259.6 bits), Expect = 1.8e-71, P = 1.8e-71
 Identities = 147/294 (50%), Positives = 189/294 (64%)

Query:    28 PKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIKEYAS 87
             PK F+YKEL   T +FN+ + +              ET   +AVKR S  S+    E+ S
Sbjct:   361 PKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLS 420

Query:    88 EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
             E++II  LRHRNLV+L GWCHEK E+LLVY+ MPNGSLD  LF+    L W+ R KI   
Sbjct:   421 ELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDHRKKILLG 480

Query:   148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
             +AS L YL    E  V+HRD+KSSNIMLD +FNAK+GDFGLAR +EH K  + TV AGTM
Sbjct:   481 VASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAGTM 540

Query:   208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS--LTAKEE---VQVYLVQWVWDL 262
             GY+APE   TGRAS+++DV+S+G V LE+  GR+PI   L  +     V   LV+WVW L
Sbjct:   541 GYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWGL 600

Query:   263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
             Y  GK+  A D RL   FDE +M  +++VGL C+HPD   RP++R V+ +L  E
Sbjct:   601 YKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIGE 654

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 716 (257.1 bits), Expect = 9.9e-71, P = 9.9e-71
 Identities = 137/298 (45%), Positives = 191/298 (64%)

Query:    20 DEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSK 79
             +E+EK  G  RF +K+L  AT  F +   L               T   IAVKRVS  S+
Sbjct:   324 EEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESR 383

Query:    80 QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL-LTW 138
             QG+KE+ +E+  I R+ HRNLV LLG+C  + ELLLVY+YMPNGSLD +L+    + L W
Sbjct:   384 QGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNW 443

Query:   139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
             + R K+   +ASGL YL E WEQ V+HRD+K+SN++LD   N ++GDFGLARL +H    
Sbjct:   444 KQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDP 503

Query:   199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
             QTT + GT+GY+APE   TGRA+  +DV++FG   LE+ACGR+PI    + +    LV W
Sbjct:   504 QTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDW 563

Query:   259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
             V+ L+  G +L A DP +  + DE+++E ++ +GL C+H D   RPS+RQV+H L  +
Sbjct:   564 VFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGD 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 707 (253.9 bits), Expect = 8.9e-70, P = 8.9e-70
 Identities = 138/305 (45%), Positives = 194/305 (63%)

Query:    14 FNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKR 73
             + E +DD +E   G  RF +KEL  AT  F +   L               T   +AVKR
Sbjct:   319 YEEELDD-WETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKR 377

Query:    74 VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKE- 132
             VS  SKQG+KE+ +E+  I R+ HRNLV LLG+C  + ELLLVY+YMPNGSLD +L+   
Sbjct:   378 VSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNP 437

Query:   133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
                L W+ R  I + +ASGL YL E WEQ V+HRD+K+SN++LD +FN ++GDFGLARL 
Sbjct:   438 ETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLY 497

Query:   193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
             +H    QTT + GT+GY+APE + TGRA+  +DVY+FG   LE+  GR+PI   +  +  
Sbjct:   498 DHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDT 557

Query:   253 VYLVQWVWDLYGNGKLLEAVDPRL-CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
               LV+WV+ L+  G ++EA DP+L    +D +++E ++ +GL C+H D   RPS+RQV+ 
Sbjct:   558 FLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQ 617

Query:   312 VLNSE 316
              L  +
Sbjct:   618 YLRGD 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2170224 AT5G06740 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 2.4e-69, P = 2.4e-69
 Identities = 142/311 (45%), Positives = 203/311 (65%)

Query:    15 NEYIDDEFEK-GAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKR 73
             N  I+ E +   A P++F  +EL +AT +F  + KL             +     IAVKR
Sbjct:   301 NPDIEAELDNCAANPQKFKLRELKRATGNFGAENKLGQGGFGMVFKGKWQGRD--IAVKR 358

Query:    74 VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF--- 130
             VS+ S QG +E+ +E+T I  L HRNLV+LLGWC+E+KE LLVYEYMPNGSLD +LF   
Sbjct:   359 VSEKSHQGKQEFIAEITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFLED 418

Query:   131 KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
             K  + LTWE R  I   L+  L YL  G E+ ++HRDIK+SN+MLD +FNAK+GDFGLAR
Sbjct:   419 KSRSNLTWETRKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLGDFGLAR 478

Query:   191 LVEHAKGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAK 248
             +++ ++ +   T  +AGT GYMAPE    GRA+ E+DVY+FG++ LE+  G+KP  +  K
Sbjct:   479 MIQQSEMTHHSTKEIAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKPSYVLVK 538

Query:   249 EEVQVY---LVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS 305
             +    Y   +V W+W+LY NG + +A DP +   FD+++M+ ++++GL C HP+ N RPS
Sbjct:   539 DNQNNYNNSIVNWLWELYRNGTITDAADPGMGNLFDKEEMKSVLLLGLACCHPNPNQRPS 598

Query:   306 IRQVIHVLNSE 316
             ++ V+ VL  E
Sbjct:   599 MKTVLKVLTGE 609

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

GO:0000041 "transition metal ion transport" evidence=RCA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 699 (251.1 bits), Expect = 6.3e-69, P = 6.3e-69
 Identities = 135/304 (44%), Positives = 194/304 (63%)

Query:    14 FNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKR 73
             F E  +D +E   G  R  +K+L  AT  F D   L               T   IAVKR
Sbjct:   327 FAEEFED-WETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKR 385

Query:    74 VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN 133
             VS  S+QG+KE+ +E+  I R+ HRNLV LLG+C  + ELLLVY+YMPNGSLD +L+   
Sbjct:   386 VSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCP 445

Query:   134 NL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
              + L W+ RF +   +ASGL YL E WEQ V+HRDIK+SN++LD  +N ++GDFGLARL 
Sbjct:   446 EVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLC 505

Query:   193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
             +H    QTT + GT GY+AP+   TGRA+  +DV++FG++ LE+ACGR+PI +  + +  
Sbjct:   506 DHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDES 565

Query:   253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
             V LV  V+  +  G +L+A DP L   +D++++E ++ +GL C+H D  +RP++RQV+  
Sbjct:   566 VLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQY 625

Query:   313 LNSE 316
             L  +
Sbjct:   626 LRGD 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 698 (250.8 bits), Expect = 8.0e-69, P = 8.0e-69
 Identities = 131/304 (43%), Positives = 195/304 (64%)

Query:    14 FNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKR 73
             F E ++D +E   G  R  +K+L  AT  F D   L              +T   IAVKR
Sbjct:   322 FAEEVED-WETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKR 380

Query:    74 VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN 133
             VS  S+QG+KE+ +E+  I ++ HRNLV L+G+C  + ELLLVY+YMPNGSLD +L+   
Sbjct:   381 VSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSP 440

Query:   134 NL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
              + L W+ RFK+   +AS L YL E WEQ V+HRD+K+SN++LD   N ++GDFGLA+L 
Sbjct:   441 EVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLC 500

Query:   193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
             +H    QTT + GT GY+AP+   TGRA+  +DV++FG++ LE+ACGR+PI +  +   +
Sbjct:   501 DHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGER 560

Query:   253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
             V LV WV+  +    +L+A DP L  ++D++++E ++ +GL C+H D   RP++RQV+  
Sbjct:   561 VVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQY 620

Query:   313 LNSE 316
             L  +
Sbjct:   621 LRGD 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.10.2	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	376
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-59
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-58
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-54
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-53
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-50
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-35
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-34
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-29
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-28
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-28
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-27
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-26
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-25
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-22
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-22
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-21
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-20
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-20
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-19
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-19
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-16
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-16
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-16
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  189 bits (483), Expect = 6e-59
 Identities = 66/191 (34%), Positives = 101/191 (52%), Gaps = 7/191 (3%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWC 107
           LG+GGFG VY    ++T   +A+K + K     + E    E+ I+ +L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
            ++  L LV EY   GSL   L +    L+ +   +I   +  GL YL       ++HRD
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 168 IKSSNIMLD-LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-TGRASKESD 225
           +K  NI+LD  N   K+ DFGL++L+     S    + GT  YMAPE     G  S++SD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 226 VYSFGIVALEI 236
           ++S G++  E+
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  188 bits (479), Expect = 8e-58
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 7/201 (3%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLV 101
           +   +KLG+G FG VY    ++T   +A+K + K   +  +E    E+ I+ +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +L     ++ +L LV EY   G L   L K   L   E RF   + + S L YL     +
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLHS---K 116

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS 221
            +VHRD+K  NI+LD + + K+ DFGLAR ++   G + T   GT  YMAPE        
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 222 KESDVYSFGIVALEIACGRKP 242
           K  D++S G++  E+  G+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  180 bits (458), Expect = 1e-54
 Identities = 84/280 (30%), Positives = 124/280 (44%), Gaps = 35/280 (12%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEY--ASEVTIISRLRHRNL 100
           +   +KLG G FG VYK   + T   +AVK + K S++  K+     E+ I+ RL H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V+L+    +K  L LV EY   G L  +L +    L+ +   KIA  +  GL YL     
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLH---S 116

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATTGR 219
             ++HRD+K  NI+LD N   KI DFGLA+ +     S  T   GT  YMAPE       
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 220 ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL--LEAVDPRLC 277
              + DV+S G++  E+  G+ P                     G   L  L+ +   L 
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP-------------------FSGENILDQLQLIRRILG 216

Query: 278 RD--FDEQQMECLMIVGL----WCAHPDENLRPSIRQVIH 311
               FDE +              C + D + RP+  +++ 
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  178 bits (455), Expect = 4e-54
 Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 35/279 (12%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
            +KLG+G FG VYKG  +         +AVK + +  S+Q I+E+  E  I+ +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           V+LLG C E++ L++V EYMP G L  +L       L+       A  +A G+ YL+   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECAT 216
            +  +HRD+ + N ++  N   KI DFGL+R +          + G      +MAPE   
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYKVKGGKLPIRWMAPESLK 177

Query: 217 TGRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP 274
            G+ + +SDV+SFG++  EI   G +P   ++  E     +++++      G  L    P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-----VLEYL----KKGYRLPK--P 226

Query: 275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
             C       +  LM   L C   D   RP+  +++ +L
Sbjct: 227 PNCPPE----LYKLM---LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  176 bits (449), Expect = 4e-53
 Identities = 88/277 (31%), Positives = 135/277 (48%), Gaps = 31/277 (11%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
            +KLG+G FG VYKG  +         +AVK + +G S++  +E+  E +I+ +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V+LLG C + + L +V EYMP G L   L K    LT +   ++A  +A G+ YL+    
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATT 217
           +  VHRD+ + N ++  N   KI DFGL+R +   +        G      +MAPE    
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIY--EDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 218 GRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL 276
           G+ + +SDV+SFG++  EI   G +P    + EEV   L          G  L    P  
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED--------GYRLPR--PEN 228

Query: 277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           C      ++  LM   L C   D   RP+  +++  L
Sbjct: 229 C----PDELYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  175 bits (447), Expect = 7e-53
 Identities = 84/278 (30%), Positives = 135/278 (48%), Gaps = 34/278 (12%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
            +KLG+G FG VYKG  +         +AVK + +  S+Q I+E+  E  I+ +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V+LLG C E++ L +V EYM  G L S+L K    L+       A  +A G+ YL+    
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATT 217
           +  +HRD+ + N ++  N   KI DFGL+R +            G      +MAPE    
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYRKRGGKLPIRWMAPESLKE 177

Query: 218 GRASKESDVYSFGIVALEIA--CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
           G+ + +SDV+SFG++  EI     +    ++ +E     +++++     NG  L    P 
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLEYL----KNGYRLPQ--PP 226

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
            C       +  LM   L C   D   RP+  +++ +L
Sbjct: 227 NCPPE----LYDLM---LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  170 bits (432), Expect = 1e-50
 Identities = 85/286 (29%), Positives = 137/286 (47%), Gaps = 46/286 (16%)

Query: 48  KLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQL 103
           KLG+G FG VYKG  +     ++ +AVK + +  S++  K++  E  ++ +L H N+V+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHL--------FKENNLLTWEFRFKIAQDLASGLLYL 155
           LG C E++ L LV EYM  G L  +L          E + L+ +     A  +A G+ YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YM 210
                +  VHRD+ + N ++  +   KI DFGL+R V      +      T G     +M
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRWM 174

Query: 211 APECATTGRASKESDVYSFGIVALEIAC-GRKPIS-LTAKEEVQVYLVQWVWDLYGNGKL 268
           APE    G  + +SDV+SFG++  EI   G  P   L+ +E     +++++      G  
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----VLEYL----RKGYR 225

Query: 269 LEAVDPRLCRDFDEQQME-CLMIVGLWCAHPDENLRPSIRQVIHVL 313
           L    P  C D   + M  C      W   P++  RP+  +++  L
Sbjct: 226 LPK--PEYCPDELYELMLSC------WQLDPED--RPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  167 bits (426), Expect = 8e-50
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 19/206 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLL 104
           + LG+G FG VY    ++T   +AVK   +S  S++ ++    E+ I+S L+H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 105 GWCH--EKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQE 157
           G     EK  L +  EY+  GSL S L       E  +  +       + +  GL YL  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY------TRQILEGLAYLHS 119

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECAT 216
                +VHRDIK +NI++D +   K+ DFG A+ + +   G  T  + GT  +MAPE   
Sbjct: 120 ---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
                + +D++S G   +E+A G+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  150 bits (381), Expect = 3e-43
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 17/209 (8%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
            F   +K+G+GGFG VYK   + T   +A+K +   SK+  ++  +E+ I+ + +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDS------HLFKENNLLTWEFRFKIAQDLASGLLYL 155
           +  G   +K EL +V E+   GSL            E+ +        + ++L  GL YL
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY------VCKELLKGLEYL 114

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
                  ++HRDIK++NI+L  +   K+ DFGL+  +   K   T V  GT  +MAPE  
Sbjct: 115 H---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVI 169

Query: 216 TTGRASKESDVYSFGIVALEIACGRKPIS 244
                  ++D++S GI A+E+A G+ P S
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 4e-36
 Identities = 84/279 (30%), Positives = 125/279 (44%), Gaps = 54/279 (19%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRNLVQLL 104
             +G+G FG VYKG   ET  ++A+K++S  K  ++ +K    E+ ++  L+H N+V+ +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 105 GWCHEKKELLLVYEYMPNGSLDS-----HLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           G       L ++ EY  NGSL         F E+ +  +     + Q L  GL YL    
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY-----VYQVL-QGLAYLH--- 116

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
           EQ V+HRDIK++NI+   +   K+ DFG+A  +        +V  GT  +MAPE      
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSG 175

Query: 220 ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV---DPRL 276
           AS  SD++S G   +E+  G  P           Y     +DL     L   V    P L
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP-----------Y-----YDLNPMAALFRIVQDDHPPL 219

Query: 277 -------CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQ 308
                   +DF  Q           C   D NLRP+ +Q
Sbjct: 220 PEGISPELKDFLMQ-----------CFQKDPNLRPTAKQ 247

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (326), Expect = 3e-35
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +++G+G FG VY    +       +K +      +  +E A +EV I+ +L H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63

Query: 105 GWCHE----KKELLLVYEYMPNGSLDSHL---------FKENNLLTWEFRFKIAQDLASG 151
              +E    K +L +V EY   G L   +         F E  +L W       Q L   
Sbjct: 64  --YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLA 115

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           L YL     + ++HRDIK  NI L  N   K+GDFG+++++        TV+ GT  Y++
Sbjct: 116 LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKP 242
           PE       + +SD++S G V  E+   + P
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  127 bits (322), Expect = 2e-34
 Identities = 82/287 (28%), Positives = 138/287 (48%), Gaps = 52/287 (18%)

Query: 46  DQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLV 101
           ++ +G G FG V +G  +        +A+K +  GS    + ++ +E +I+ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +L G   + + ++++ EYM NGSLD  L + +   T      + + +ASG+ YL    E 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EM 125

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG------YMAPECA 215
             VHRD+ + NI+++ N   K+ DFGL+R +E ++ + T     T G      + APE  
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-----TKGGKIPIRWTAPEAI 180

Query: 216 TTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP 274
              + +  SDV+SFGIV  E+ + G +P           Y   W      N  +++AV+ 
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERP-----------Y---WDMS---NQDVIKAVED 223

Query: 275 --RLCRDFDEQQMEC------LMIVGLWCAHPDENLRPSIRQVIHVL 313
             RL        M+C      LM   L C   D N RP+  Q++  L
Sbjct: 224 GYRL-----PPPMDCPSALYQLM---LDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  125 bits (317), Expect = 7e-34
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 28/270 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVS-----KGSKQGIKEYASEVTIISRLRHRNLV 101
           + LG G FG VY+G   +   + AVK VS     +  ++ +K+   E+ ++S+L+H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           Q LG   E+  L +  E +P GSL   L K+             + +  GL YL    ++
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DR 121

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATTGRA 220
             VHRDIK +NI++D N   K+ DFG+A+ V   + S      G+  +MAPE  A  G  
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQQGGY 179

Query: 221 SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF 280
              +D++S G   LE+A G+ P S       Q+  V  V+ + G  K L  +   L  + 
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWS-------QLEGVAAVFKI-GRSKELPPIPDHLSDEA 231

Query: 281 DEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            +  ++CL          D +LRP+  +++
Sbjct: 232 KDFILKCL--------QRDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  122 bits (308), Expect = 1e-32
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQL 103
           + +G+G FG V     R+T    A+K ++K     K  ++   +E  I+  L H  LV L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQEG 158
                +++ + LV + +  G L  HL     F E  +     +F I + +   L YL   
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-----KFWICE-IVLALEYLHS- 118

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
             + ++HRDIK  NI+LD   +  I DF +A  V     + TT  +GT GYMAPE     
Sbjct: 119 --KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLCRQ 174

Query: 219 RASKESDVYSFGIVALEIACGRKP---ISLTAKEEVQ 252
             S   D +S G+ A E   G++P    S T +++++
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (309), Expect = 2e-32
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 47  QKLGQGGFGGVYKGFFR----ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLV 101
           ++LG+G FG V    +      T   +AVK ++  G +Q   ++  E+ I+  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 102 QLLGWCHE--KKELLLVYEYMPNGSLDSHL--FKENNLLTWEFRFKIAQDLASGLLYLQE 157
           +  G C +   + L L+ EY+P+GSL  +L   ++   L     F  +  +  G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLGS 127

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECA 215
              Q  +HRD+ + NI+++     KI DFGLA+++   K        G   + + APEC 
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 216 TTGRASKESDVYSFGIVALEI 236
            T + S  SDV+SFG+   E+
Sbjct: 185 RTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  121 bits (307), Expect = 2e-32
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+G FG V     ++T    A+K + K     ++ ++   +E  I+SR+ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 106 WC--HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
                 +++L LV EY P G L SHL KE        RF  A+ +   L YL       +
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE-IVLALEYLHS---LGI 114

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           ++RD+K  NI+LD + + K+ DFGLA+ +   +GS+T    GT  Y+APE        K 
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 224 SDVYSFGIVALEIACGRKP 242
            D +S G++  E+  G+ P
Sbjct: 174 VDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  125 bits (313), Expect = 2e-32
 Identities = 80/314 (25%), Positives = 128/314 (40%), Gaps = 27/314 (8%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH- 97
            +   +KLG+G FG VY    R+    +A+K ++K      + ++ +  E+ I++ L H 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTWEFRFKIAQDLASGLLYL 155
            N+V+L  +  ++  L LV EY+  GSL+  L        L+      I   + S L YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 156 QEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQ-----TTVLAGTMGY 209
                + ++HRDIK  NI+LD +    K+ DFGLA+L+     +       +   GT GY
Sbjct: 118 ---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 210 MAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
           MAPE         AS  SD++S GI   E+  G  P             ++ + +L    
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-PTP 233

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLNSEAPLPALPPK 325
            L   + P       +   + L          D   R S    + H L +   L      
Sbjct: 234 SLASPLSPSNPELISKAASDLLK----KLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Query: 326 MPVPTYFSPPANMR 339
             +    S P  + 
Sbjct: 290 DLLKPDDSAPLRLS 303

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  121 bits (307), Expect = 4e-32
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHRNL 100
           + + +K+G+G  G VYK   R T   +A+K  R+ K +K+ I    +E+ I+   +H N+
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNI 77

Query: 101 VQLLGWCHE-KKELLLVYEYMPNGSLDSHLFKENNLLTW-EFRFK------IAQDLASGL 152
           V      +    EL +V EYM  GSL        +++T    R        + +++  GL
Sbjct: 78  VDYYD-SYLVGDELWVVMEYMDGGSL-------TDIITQNFVRMNEPQIAYVCREVLQGL 129

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
            YL     Q V+HRDIKS NI+L  + + K+ DFG A  +   K  + +V+ GT  +MAP
Sbjct: 130 EYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKP 242
           E         + D++S GI+ +E+A G  P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (304), Expect = 6e-32
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 5/205 (2%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRHRN 99
           +D    + LGQG  G VYK   + T    A+K++   G ++  K+   E+  +       
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V+  G  +++ E+ +V EYM  GSL   L K+   +       IA+ +  GL YL    
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHT-- 117

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
           ++ ++HRDIK SN++++     KI DFG+++++E+      T + GT+ YM+PE      
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176

Query: 220 ASKESDVYSFGIVALEIACGRKPIS 244
            S  +D++S G+  LE A G+ P  
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFL 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 14/196 (7%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLL 104
           +K+G+G FG VYKG  +  +  +AVK  R +       K +  E  I+ +  H N+V+L+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLI 58

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
           G C +K+ + +V E +P GSL + L K+ N LT +   +++ D A+G+ YL+    +  +
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRA 220
           HRD+ + N ++  N   KI DFG++R  E   G   TV  G     + + APE    GR 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-EEE--GGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 221 SKESDVYSFGIVALEI 236
           + ESDV+S+GI+  E 
Sbjct: 173 TSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 75/202 (37%), Positives = 109/202 (53%), Gaps = 13/202 (6%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG 105
           ++KLG G FG V+ G +  T+  +AVK +  G+    + +  E  I+ +LRH  LVQL  
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
            C E++ + +V EYM  GSL   L   E   L       +A  +A G+ YL+    +  +
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYI 125

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRAS 221
           HRD+ + NI++  N   KI DFGLARL+E     + T   G    + + APE A  GR +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPEAANYGRFT 182

Query: 222 KESDVYSFGIVALEIAC-GRKP 242
            +SDV+SFGI+  EI   GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 3e-31
 Identities = 81/274 (29%), Positives = 128/274 (46%), Gaps = 33/274 (12%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
             +G+G FG V  G +R     +AVK   K      + + +E ++++ LRH NLVQLLG 
Sbjct: 12  ATIGKGEFGDVMLGDYRGQK--VAVK-CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 107 CHEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
             +   L +V EYM  GSL  +L  +   ++T   +   A D+  G+ YL+   E+  VH
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM--GYMAPECATTGRASKE 223
           RD+ + N+++  +  AK+ DFGL      AK +     +G +   + APE     + S +
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGL------AKEASQGQDSGKLPVKWTAPEALREKKFSTK 179

Query: 224 SDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE 282
           SDV+SFGI+  EI + GR P      ++V  ++          G  +EA  P  C     
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE--------KGYRMEA--PEGCPPEVY 229

Query: 283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
           + M         C   D   RP+ +Q+   L   
Sbjct: 230 KVM-------KDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 5e-31
 Identities = 79/292 (27%), Positives = 138/292 (47%), Gaps = 54/292 (18%)

Query: 49  LGQGGFGGVYKGFFR---ETSSY-IAVKRV-SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LG G FG VYKG +    E     +A+K +  + S +  KE   E  +++ + H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENN-------LLTWEFRFKIAQDLASGLLYLQ 156
           LG C   + + L+ + MP G L  ++ + +        LL W         +A G+ YL+
Sbjct: 75  LGICLSSQ-VQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNW------CVQIAKGMSYLE 126

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE------HAKGSQTTVLAGTMGYM 210
           E   + +VHRD+ + N+++    + KI DFGLA+L++      HA+G +  +      +M
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI-----KWM 178

Query: 211 APECATTGRASKESDVYSFGIVALEIAC-GRKPI-SLTAKEEVQVYLVQWVWDLYGNGKL 268
           A E       + +SDV+S+G+   E+   G KP   + A E         + DL   G+ 
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---------IPDLLEKGER 229

Query: 269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLP 320
           L    P +C   D   +  +++    C   D   RP+ +++I+  +  A  P
Sbjct: 230 LP--QPPIC-TID---VYMVLVK---CWMIDAESRPTFKELINEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (297), Expect = 5e-31
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
           +F  ++KLG G FG V++G ++     +A+K +        +++  EV  + RLRH++L+
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            L   C   + + ++ E M  GSL + L   E  +L       +A  +A G+ YL+   E
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---E 122

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECATTGR 219
           Q  +HRD+ + NI++  +   K+ DFGLARL+ E    S    +     + APE A+ G 
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGT 180

Query: 220 ASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
            S +SDV+SFGI+  E+   G+ P       E        V+D    G  +    P  C 
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------VYDQITAGYRMPC--PAKCP 230

Query: 279 DFDEQQM-ECLMIVGLWCAHPDENLRPSIR 307
               + M EC      W A P++  RPS +
Sbjct: 231 QEIYKIMLEC------WAAEPED--RPSFK 252

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  117 bits (295), Expect = 1e-30
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 45/291 (15%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNL 100
           ++LG+G FG V+ G             +AVK + + +    ++ +  E  +++  +H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFK-------------ENNLLTWEFRFKIAQD 147
           V+  G C E    ++V+EYM +G L+  L                   LT     +IA  
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLA 204
           +ASG++YL     Q  VHRD+ + N ++  +   KIGDFG++R V   ++ +    T+L 
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLY 263
             + +M PE     + + ESDV+SFG+V  EI   G++P    + EEV   + Q      
Sbjct: 188 --IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ------ 239

Query: 264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
             G+LL+   PR C       M       L C   D   R +I+ +   L 
Sbjct: 240 --GRLLQR--PRTCPSEVYDIM-------LGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  116 bits (293), Expect = 1e-30
 Identities = 72/268 (26%), Positives = 130/268 (48%), Gaps = 23/268 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           Q++G G FG V+ G++ E    +A+K + +G+    +++  E  ++ +L H  LVQL G 
Sbjct: 10  QEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C E+  + LV+E+M +G L  +L  +    + E    +  D+  G+ YL+      V+HR
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDV 226
           D+ + N ++  N   K+ DFG+ R V   + + +T     + + +PE  +  + S +SDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 227 YSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQM 285
           +SFG++  E+ + G+ P    +  EV       V  +    +L +   PRL      + M
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEV-------VETINAGFRLYK---PRLASQSVYELM 234

Query: 286 ECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           +        C       RPS   ++H L
Sbjct: 235 Q-------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  117 bits (295), Expect = 2e-30
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 33/228 (14%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKE----YAS-EVTIISRL 95
           +DF   + +G+G F  V     +ET+   A+K + K  +Q IKE    Y   E  +++RL
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58

Query: 96  -RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
             H  +++L     +++ L  V EY PNG L  ++ K  +L     RF  A+ +   L Y
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE-ILLALEY 117

Query: 155 L-QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-------------------EH 194
           L  +G    ++HRD+K  NI+LD + + KI DFG A+++                     
Sbjct: 118 LHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
               +     GT  Y++PE      A K SD+++ G +  ++  G+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  116 bits (292), Expect = 3e-30
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 6/204 (2%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
             F+  +KLG+G +G VYK   +ET   +A+K V    ++ ++E   E++I+ +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI 60

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V+  G   +  +L +V EY   GS+   +   N  LT E    I      GL YL     
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS--- 117

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
              +HRDIK+ NI+L+    AK+ DFG++  +      + TV+ GT  +MAPE       
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176

Query: 221 SKESDVYSFGIVALEIACGRKPIS 244
           + ++D++S GI A+E+A G+ P S
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYS 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 2e-29
 Identities = 71/209 (33%), Positives = 111/209 (53%), Gaps = 8/209 (3%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +KLG G FG V++G +  T+  +AVK +  G+    K++ +E  I+ +LRH  L+QL   
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
           C  ++ + +V E M  GSL  +L       L       +A  +ASG+ YL+    Q  +H
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+ + N+++  N   K+ DFGLAR+++             + + APE A   R S +SD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 226 VYSFGIVALEIAC-GRKPIS-LTAKEEVQ 252
           V+SFGI+  EI   GR P   +T  E +Q
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQ 215

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  113 bits (286), Expect = 2e-29
 Identities = 74/206 (35%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLL 104
            K+G G FG VY     +T   +AVK  R+     + IKE A E+ ++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
           G    ++++ +  EY   G+L+  L +   +L           L  GL YL       +V
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIV 121

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAK--GSQTTVLAGTMGYMAPECATTGRAS 221
           HRDIK +NI LD N   K+GDFG A +L  +    G +   LAGT  YMAPE  T G+  
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 222 ---KESDVYSFGIVALEIACGRKPIS 244
              + +D++S G V LE+A G++P S
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWS 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 4e-29
 Identities = 75/278 (26%), Positives = 132/278 (47%), Gaps = 43/278 (15%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           ++LG G FG V+ G +R     +A+K + +G+     ++  E  ++ +L H NLVQL G 
Sbjct: 10  KELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C +++ + +V EYM NG L ++L +    L  E+   +  D+   + YL+       +HR
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHR 124

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKE 223
           D+ + N ++  +   K+ DFGLAR V      Q T   GT   + +  PE     R S +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 224 SDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV-------DPR 275
           SDV+SFG++  E+ + G+ P                 ++ + N +++E+V        P+
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP-----------------YERFSNSEVVESVSAGYRLYRPK 224

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           L         E   I+   C H     RP+ ++++  L
Sbjct: 225 LA------PTEVYTIMYS-CWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  111 bits (279), Expect = 2e-28
 Identities = 72/272 (26%), Positives = 117/272 (43%), Gaps = 27/272 (9%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEY-ASEVTIISRLRHRNLVQLLG 105
            +G+G FG V K   +     +  K +  G+  +  K+   SEV I+  L+H N+V+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 106 WCH--EKKELLLVYEYMPNGSLDS---HLFKENNLLTWEFRFKIAQDLASGLLYLQEGW- 159
                  + L +V EY   G L        KE   +  EF ++I   L   L        
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 160 -EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
               V+HRD+K +NI LD N N K+GDFGLA+++ H   S      GT  YM+PE     
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPEQLNHM 185

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
              ++SD++S G +  E+     P +   + ++   + +        GK    +  R   
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE--------GKFRR-IPYRYSS 236

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
           + +E     L +       PD+  RPS  +++
Sbjct: 237 ELNEVIKSMLNV------DPDK--RPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (275), Expect = 7e-28
 Identities = 63/195 (32%), Positives = 108/195 (55%), Gaps = 13/195 (6%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           KLG G +G VY+G +++ S  +AVK + K     ++E+  E  ++  ++H NLVQLLG C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENN--LLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
             +    ++ E+M  G+L  +L +E N   +       +A  ++S + YL+   ++  +H
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASK 222
           RD+ + N ++  N   K+ DFGL+RL+    G   T  AG    + + APE     + S 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 223 ESDVYSFGIVALEIA 237
           +SDV++FG++  EIA
Sbjct: 185 KSDVWAFGVLLWEIA 199

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  109 bits (274), Expect = 1e-27
 Identities = 84/273 (30%), Positives = 129/273 (47%), Gaps = 31/273 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI---KEYA---SEVTIISRLRHRNLVQ 102
           LG+G +G VY G        IAVK+V   +   +   KEY     EV ++  L+H N+VQ
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
            LG C +   + +  E++P GS+ S L +   L    F  K  + +  G+ YL      C
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLHN---NC 122

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVE--HAKGSQTTVLA---GTMGYMAPECATT 217
           VVHRDIK +N+ML  N   K+ DFG AR +      G+ + +L    GT  +MAPE    
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
               ++SD++S G    E+A G+ P++   +     Y+        G  + L    PRL 
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--------GAHRGLM---PRLP 231

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
             F    ++ +      C   D++ RPS  Q++
Sbjct: 232 DSFSAAAIDFVTS----CLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 3e-27
 Identities = 80/290 (27%), Positives = 136/290 (46%), Gaps = 47/290 (16%)

Query: 46  DQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRN 99
            ++LGQG FG VY+G  +     E  + +A+K V++ +      E+ +E +++      +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK------ENNLL---TWEFRFKIAQDLAS 150
           +V+LLG     +  L+V E M  G L S+L         N  L   T +   ++A ++A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EH---AKGSQTTVLAGT 206
           G+ YL     +  VHRD+ + N M+  +   KIGDFG+ R + E     KG +     G 
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK-----GL 182

Query: 207 MG--YMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLY 263
           +   +MAPE    G  + +SDV+SFG+V  E+A    +P    + EEV  ++        
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-------- 234

Query: 264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
            +G  L+   P  C      ++  LM     C   +  +RP+  +++  L
Sbjct: 235 IDGGHLDL--PENC----PDKLLELM---RMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 1e-26
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 9/199 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH 108
           LG G FG VYK   +ET  + A K +   S++ ++++  E+ I+S  +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 109 EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
            + +L ++ E+   G+LDS + +    LT      + + +   L +L       V+HRD+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 169 KSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CATTGRASKE-- 223
           K+ NI+L L+ + K+ DFG++   +     + T + GT  +MAPE   C T      +  
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDYK 188

Query: 224 SDVYSFGIVALEIACGRKP 242
           +D++S GI  +E+A    P
Sbjct: 189 ADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 1e-26
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 11/201 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV-----SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LGQG FG VY  +  +T   +AVK+V     S  +K+ +     E+ ++  L+H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
            G   + + L +  EYMP GS+   L K    LT     K  + +  G+ YL       +
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHS---NMI 125

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVE--HAKGSQTTVLAGTMGYMAPECATTGRAS 221
           VHRDIK +NI+ D   N K+GDFG ++ ++   + G+    + GT  +M+PE  +     
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 222 KESDVYSFGIVALEIACGRKP 242
           +++DV+S G   +E+   + P
Sbjct: 186 RKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  106 bits (265), Expect = 1e-26
 Identities = 64/188 (34%), Positives = 107/188 (56%), Gaps = 5/188 (2%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWC 107
           LG+G FG V+KG  ++ +  +AVK   +   Q +K ++ SE  I+ +  H N+V+L+G C
Sbjct: 3   LGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
            +++ + +V E +P G   S L K+ + L  +   K A D A+G+ YL+   + C +HRD
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES--KNC-IHRD 118

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVY 227
           + + N ++  N   KI DFG++R  +    S + +    + + APE    GR S ESDV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178

Query: 228 SFGIVALE 235
           S+GI+  E
Sbjct: 179 SYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  106 bits (266), Expect = 2e-26
 Identities = 80/283 (28%), Positives = 123/283 (43%), Gaps = 39/283 (13%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI-KEYASEVTIISRLRHRN 99
           +D     +LG G  G V K   R T   +AVK +     + I K+   E+ I+ +     
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRF-KIAQDLASGLLYLQEG 158
           +V   G  +   ++ +  EYM  GSLD  + KE      E    KIA  +  GL YL E 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATT 217
            +  ++HRD+K SNI+++     K+ DFG++ +LV     +      GT  YMAPE    
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT----FVGTSSYMAPERIQG 173

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG--KLLEAV--- 272
              S +SD++S G+  +E+A GR P                  +   +G  +LL+ +   
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPY--------------PPENDPPDGIFELLQYIVNE 219

Query: 273 -DPRLCRD-FDE--QQMECLMIVGLWCAHPDENLRPSIRQVIH 311
             PRL    F    Q    L      C   D   RPS ++++ 
Sbjct: 220 PPPRLPSGKFSPDFQDFVNL------CLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  106 bits (265), Expect = 2e-26
 Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 39/283 (13%)

Query: 46  DQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           ++ +G G FG V +G  +   +   ++A+K +  G +++  +++ SE +I+ +  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            L G   + + ++++ E+M NG+LDS L + +   T      + + +A+G+ YL    E 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EM 125

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG--SQTTVLAGTMG--YMAPECATT 217
             VHRD+ + NI+++ N   K+ DFGL+R +E      + T+ L G +   + APE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 218 GRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV--DP 274
            + +  SDV+S+GIV  E+ + G +P                 WD+  N  ++ A+  D 
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP----------------YWDM-SNQDVINAIEQDY 228

Query: 275 RLCRDFDEQQMEC---LMIVGLWCAHPDENLRPSIRQVIHVLN 314
           RL        M+C   L  + L C   D N RP   Q++  L+
Sbjct: 229 RL-----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  105 bits (262), Expect = 4e-26
 Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 8/206 (3%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           KLGQG FG V+ G +  T+  +A+K +  G+    + +  E  ++ +LRH  LVQL    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            E+  + +V EYM  GSL   L  E    L       +A  +ASG+ Y++       VHR
Sbjct: 71  SEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDV 226
           D++++NI++  N   K+ DFGLARL+E  + +        + + APE A  GR + +SDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 227 YSFGIVALEIAC-GRKPISLTAKEEV 251
           +SFGI+  E+   GR P       EV
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREV 212

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  105 bits (263), Expect = 5e-26
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 11/198 (5%)

Query: 47  QKLGQGGFGGV----YKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           Q+LG+G FG V    Y      T   +AVK++   + + ++++  E+ I+  L+H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 103 LLGWCHE--KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
             G C+   ++ L LV EY+P GSL  +L K    L        A  +  G+ YL     
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS--- 126

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTG 218
           +  VHRD+ + NI+++     KIGDFGL +++   K        G   + + APE  T  
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 219 RASKESDVYSFGIVALEI 236
           + S  SDV+SFG+V  E+
Sbjct: 187 KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 7e-26
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 9/206 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRN 99
             F   + +G+G FG VYK   + T+  +A+K +  + ++  I++   E+  +S+ R   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           + +  G   +  +L ++ EY   GS    L K   L      F I +++  GL YL E  
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAF-ILREVLLGLEYLHE-- 116

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTG 218
            +  +HRDIK++NI+L    + K+ DFG++ +L        T V  GT  +MAPE     
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIKQS 173

Query: 219 RASKESDVYSFGIVALEIACGRKPIS 244
              +++D++S GI A+E+A G  P+S
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 68/221 (30%), Positives = 106/221 (47%), Gaps = 33/221 (14%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIK-EYASEVTIISRLRHRNLVQLLG 105
           ++G+G +G VYK   ++T   +A+K++  +  K+G       E+ ++ +LRH N+V+L  
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 106 WCHEKK--ELLLVYEYMP---NGSLDSHLFKENNLLTWEFRFKIAQ------DLASGLLY 154
               K    + +V+EYM     G LDS           E +F  +Q       L  GL Y
Sbjct: 66  IVTSKGKGSIYMVFEYMDHDLTGLLDSP----------EVKFTESQIKCYMKQLLEGLQY 115

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 214
           L       ++HRDIK SNI+++ +   K+ DFGLAR       +  T    T+ Y  PE 
Sbjct: 116 LHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 215 ---ATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
              AT  R   E D++S G +  E+  G KPI      E++
Sbjct: 173 LLGAT--RYGPEVDMWSVGCILAELFLG-KPI-FQGSTELE 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  104 bits (260), Expect = 1e-25
 Identities = 88/288 (30%), Positives = 144/288 (50%), Gaps = 44/288 (15%)

Query: 47  QKLGQGGFGGV-----YKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
           ++LG+G FG V     Y     +    +AVK +   S    K++  E  +++ L+H ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 102 QLLGWCHEKKELLLVYEYMPNGSL---------DSHLFKENN---LLTWEFRFKIAQDLA 149
           +  G C E   L++V+EYM +G L         D+ L  E N    LT      IAQ +A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGT 206
           +G++YL     Q  VHRD+ + N ++  N   KIGDFG++R V   ++ +    T+L   
Sbjct: 131 AGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-- 185

Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           + +M PE     + + ESDV+S G+V  EI   G++P    +  EV   + Q        
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-------- 237

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           G++L+   PR C     +++  LM+ G W   P  ++R +I++ IH L
Sbjct: 238 GRVLQR--PRTC----PKEVYDLML-GCWQREP--HMRLNIKE-IHSL 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 19/212 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRV----------SKGSKQGIKEYASEVTIISRLR 96
           + +G+G +G VY      T   +AVK+V              K  +K   SE+  +  L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 97  HRNLVQLLGWCHEKKELLLVY-EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
           H N+VQ LG     +E L ++ EY+P GS+ S L           RF   Q L  GL YL
Sbjct: 67  HLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-EGLAYL 124

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPEC 214
                + ++HRD+K+ N+++D +   KI DFG+++  +    + Q   + G++ +MAPE 
Sbjct: 125 HS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 215 ATTGRA--SKESDVYSFGIVALEIACGRKPIS 244
             +     S + D++S G V LE+  GR+P S
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  103 bits (259), Expect = 2e-25
 Identities = 62/215 (28%), Positives = 113/215 (52%), Gaps = 31/215 (14%)

Query: 47  QKLGQGGFGGVYKGFF-----RETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNL 100
           ++LG+G FG VYKG       R +++ +A+K + +    +  +E+  E  ++S L+H N+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFK----------------ENNLLTWEFRFKI 144
           V LLG C +++   +++EY+ +G L   L +                +++L   +F   I
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF-LHI 129

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTT 201
           A  +A+G+ YL        VHRD+ + N ++      KI DFGL+R +   ++ +    +
Sbjct: 130 AIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
           +L   + +M PE    G+ + ESD++SFG+V  EI
Sbjct: 187 LLP--VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-25
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 30/210 (14%)

Query: 49  LGQGGFGGVYKGFFRETSSY---IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLL 104
           LG G FG V KG +   S     +AVK + +     G KE+  E +++++L H  +V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           G C + + L+LV E  P G L  +L        ++L         A  +A G+ YL+   
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG------YMAPE 213
            +  VHRD+ + N++L     AKI DFG++R    A G+ +     T        + APE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSR----ALGAGSDYYRATTAGRWPLKWYAPE 168

Query: 214 CATTGRASKESDVYSFGIVALEI-ACGRKP 242
           C   G+ S +SDV+S+G+   E  + G KP
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 7/169 (4%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +KLG+G +G VYK   ++T   +A+K++     ++GI   A  E++++  L+H N+V+LL
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
              H +++L LV+EY     L  +L K    L+      I   L  GL Y        ++
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRIL 120

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
           HRD+K  NI+++ +   K+ DFGLAR       + T  +  T+ Y APE
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  103 bits (257), Expect = 3e-25
 Identities = 79/281 (28%), Positives = 140/281 (49%), Gaps = 37/281 (13%)

Query: 46  DQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           ++ +G G FG V  G  +        +A+K +  G +++  +++ SE +I+ +  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            L G   + K +++V EYM NGSLD+ L K +   T      + + +ASG+ YL    + 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DM 125

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGR 219
             VHRD+ + NI+++ N   K+ DFGL+R++E    +  T   G +   + APE     +
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 220 ASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RL 276
            +  SDV+S+GIV  E+ + G +P                 W++  N  +++A++   RL
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERP----------------YWEM-SNQDVIKAIEEGYRL 228

Query: 277 CRDFDEQQMEC---LMIVGLWCAHPDENLRPSIRQVIHVLN 314
                   M+C   L  + L C   D N RP   Q++ +L+
Sbjct: 229 -----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (256), Expect = 5e-25
 Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 14/203 (6%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI-KEYASEVTIISRLRHRNLVQLLGW 106
           +LG+G  G V K   + T    A+K ++      + K+   E+ I    +   +V+  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 107 CHEKKE--LLLVYEYMPNGSLDSHL--FKENNLLTWEFRF-KIAQDLASGLLYLQEGWEQ 161
             ++    + +  EY   GSLDS     K+      E    KIA+ +  GL YL     +
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---R 124

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
            ++HRDIK SNI+L      K+ DFG++  LV     S      GT  YMAPE       
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN----SLAGTFTGTSFYMAPERIQGKPY 180

Query: 221 SKESDVYSFGIVALEIACGRKPI 243
           S  SDV+S G+  LE+A  R P 
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (253), Expect = 1e-24
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 10/210 (4%)

Query: 49  LGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLL 104
           +G G FG V++G  +        +A+K +  G +++  +++ SE +I+ +  H N+++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
           G   + K  +++ EYM NG+LD +L   +   +      + + +A+G+ YL    +   V
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYV 129

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASK 222
           HRD+ + NI+++ N   K+ DFGL+R++E       T   G +   + APE     + + 
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189

Query: 223 ESDVYSFGIVALEI-ACGRKPISLTAKEEV 251
            SDV+SFGIV  E+ + G +P    +  EV
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  101 bits (252), Expect = 1e-24
 Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 20/213 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +KLG G FG V+ G +   +  +AVK +  G+    + +  E  I+ +LRH  LVQL   
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 107 CHEKKELLLVYEYMPNGSL-------DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
             E+  + +V EYM  GSL       +    K  NL+       +A  +A+G+ Y++   
Sbjct: 70  VSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLV------DMAAQVAAGMAYIER-- 120

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
               +HRD++S+NI++      KI DFGLARL+E  + +        + + APE A  GR
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 220 ASKESDVYSFGIVALEIAC-GRKPISLTAKEEV 251
            + +SDV+SFGI+  E+   GR P       EV
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  101 bits (253), Expect = 1e-24
 Identities = 82/298 (27%), Positives = 142/298 (47%), Gaps = 45/298 (15%)

Query: 47  QKLGQGGFGGVYKGFFRETSS-----YIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
           ++LG+G FG V+       S       +AVK +   +    K++  E  +++ L+H ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFRFKIAQ 146
           +  G C +   L++V+EYM +G L+  L                +    L       IA 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVL 203
            +ASG++YL     Q  VHRD+ + N ++  N   KIGDFG++R V   ++ +    T+L
Sbjct: 131 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDL 262
              + +M PE     + + ESDV+SFG++  EI   G++P    +  EV   + Q     
Sbjct: 188 P--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ----- 240

Query: 263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLR-PSIRQVIHVLNSEAPL 319
              G++LE   PR+C     +++  +M+ G W   P + L    I +++H L    P+
Sbjct: 241 ---GRVLER--PRVC----PKEVYDIML-GCWQREPQQRLNIKEIYKILHALGKATPI 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 7/201 (3%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           Q++G G +G VYK     T   +A+K +        +    E++++   RH N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
              + +L +V EY   GSL          L+      + ++   GL YL    E   +HR
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHR 125

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA---TTGRASKE 223
           DIK +NI+L  + + K+ DFG++  +      + + + GT  +MAPE A     G    +
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGK 184

Query: 224 SDVYSFGIVALEIACGRKPIS 244
            D+++ GI A+E+A  + P+ 
Sbjct: 185 CDIWALGITAIELAELQPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 99.2 bits (247), Expect = 6e-24
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 8/198 (4%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +KLG G FG V+ G++   +  +A+K + +GS    + + +E  ++ +L+H  LV+L   
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
              ++ + ++ EYM NGSL   L     + LT      +A  +A G+ +++    +  +H
Sbjct: 70  V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD++++NI++      KI DFGLARL+E  + +        + + APE    G  + +SD
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 226 VYSFGIVALEIAC-GRKP 242
           V+SFGI+  EI   GR P
Sbjct: 186 VWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 99.5 bits (248), Expect = 8e-24
 Identities = 84/296 (28%), Positives = 136/296 (45%), Gaps = 53/296 (17%)

Query: 49  LGQGGFGGVYKG-----FFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQ 102
           +GQG FG V++         E  + +AVK + +  S     ++  E  +++   H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHL--------------------FKENNL-LTWEFR 141
           LLG C   K + L++EYM  G L+  L                       N L L+   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR---LVEHAKGS 198
             IA+ +A+G+ YL E   +  VHRD+ + N ++  N   KI DFGL+R     ++ K S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQ 257
           +   +   + +M PE     R + ESDV+++G+V  EI + G +P    A EEV +Y V+
Sbjct: 190 ENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-IYYVR 246

Query: 258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
                  +G +L       C D    ++  LM    W   P +  RPS   +  +L
Sbjct: 247 -------DGNVLS------CPDNCPLELYNLM-RLCWSKLPSD--RPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.8 bits (246), Expect = 9e-24
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN 99
            ++  +   LG+G +G VY      T   IA+K + +   + ++    E+ + S L+HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHL--------FKENNLLTWEFRFKIAQDLASG 151
           +VQ LG   E     +  E +P GSL + L          E  ++ +       + +  G
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY------TKQILEG 120

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFG----LARLVEHAKGSQTTVLAGT 206
           L YL    +  +VHRDIK  N++++      KI DFG    LA +        T    GT
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-----NPCTETFTGT 172

Query: 207 MGYMAPECATTGRA--SKESDVYSFGIVALEIACGRKP 242
           + YMAPE    G       +D++S G   +E+A G+ P
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 10/197 (5%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLG 105
           K+G+G +G VYK   + T   +A+K++    + +GI + A  E+ ++  L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK-IAQDLASGLLYLQEGWEQCVV 164
               K +L LV+E+M        L K+      E   K     L  GL +        ++
Sbjct: 66  VFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           HRD+K  N++++     K+ DFGLAR         T  +  T  Y APE     +     
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTP 179

Query: 225 -DVYSFGIVALEIACGR 240
            D++S G +  E+   R
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 97.0 bits (241), Expect = 3e-23
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 17/197 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLG 105
           +++G+G FG V+ G  R  ++ +AVK   +     +K ++  E  I+ +  H N+V+L+G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
            C +K+ + +V E +  G   + L  E   L  +   ++ ++ A+G+ YL+    +  +H
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIH 117

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-------YMAPECATTG 218
           RD+ + N ++      KI DFG++R  E   G    V A T G       + APE    G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR--EEEDG----VYASTGGMKQIPVKWTAPEALNYG 171

Query: 219 RASKESDVYSFGIVALE 235
           R S ESDV+SFGI+  E
Sbjct: 172 RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 98.0 bits (245), Expect = 3e-23
 Identities = 72/209 (34%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG----SKQGIKEYASEVTIISRLR 96
           +DF   + LG G FG V     + +  Y A+K +SK      KQ ++   +E  I+  +R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  LV L G   +   L LV EY+P G L SHL K         RF  AQ +   L YL 
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-VVLALEYLH 118

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE--- 213
                 +V+RD+K  N++LD +   KI DFG A+ V+    + T  L GT  Y+APE   
Sbjct: 119 S---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK--GRTYT--LCGTPEYLAPEIIL 171

Query: 214 CATTGRASKESDVYSFGIVALEIACGRKP 242
               G+A    D ++ GI+  E+  G  P
Sbjct: 172 SKGYGKA---VDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 4e-23
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYAS-------EVTIISRLRHRN 99
           +G G FG VY G    +   +AVK+V     S        S       E+ ++  L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE---FRFKIAQDLASGLLYLQ 156
           +VQ LG   +   L +  EY+P GS+ + L   NN   +E    R  + Q L  GL YL 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQIL-KGLNYLH 123

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMA 211
               + ++HRDIK +NI++D     KI DFG+++ +E              L G++ +MA
Sbjct: 124 N---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKP 242
           PE       ++++D++S G + +E+  G+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.8 bits (241), Expect = 5e-23
 Identities = 86/290 (29%), Positives = 133/290 (45%), Gaps = 48/290 (16%)

Query: 49  LGQGGFGGVYKGFFR------ETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLV 101
           LG G FG VY+G              +AVK + KG+  Q  KE+  E  ++S   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFK------ENNLLTWEFRFKIAQDLASGLLYL 155
           +LLG C   +   ++ E M  G L S+L           LLT +    I  D+A G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 156 QEGWEQCVVHRDIKSSNIML-----DLNFNAKIGDFGLARLV----EHAKGSQTTVLAGT 206
           +   +   +HRD+ + N ++     D +   KIGDFGLAR +     + K  +  +    
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL---P 176

Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           + +MAPE    G+ + +SDV+SFG++  EI   G++P      +EV  ++          
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-------G 229

Query: 266 GKLLEAVDPRLCRDFDEQQM-ECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
           G+L +   P  C D   Q M  C      W   P E  RP+  ++  +L 
Sbjct: 230 GRLQK---PENCPDKIYQLMTNC------WAQDPSE--RPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.9 bits (241), Expect = 6e-23
 Identities = 86/280 (30%), Positives = 123/280 (43%), Gaps = 20/280 (7%)

Query: 47  QKLGQGGFGGV----YKGFFRETSSYIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLV 101
           + LG+G FG V    Y      T   +AVK + +   Q     +  E+ I+  L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 102 QLLGWCHEK--KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +  G C E+  K L L+ EY+P GSL  +L K    L     F  AQ +  G+ YL    
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHS-- 125

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATT 217
            Q  +HRD+ + N++LD +   KIGDFGLA+ V            G   + + A EC   
Sbjct: 126 -QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 218 GRASKESDVYSFGIVALEIA--CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
            + S  SDV+SFG+   E+   C  K  S   K E  +   Q    +    +LLE     
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSK-QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
            C     Q++  LM    W        RP+ R +I +L  
Sbjct: 244 PCPKNCPQEVYILM-KNCWETEA--KFRPTFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 96.3 bits (239), Expect = 6e-23
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 8/208 (3%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG 105
           D KLGQG FG V+ G +  T+  +A+K +  G+    + +  E  I+ +LRH  LV L  
Sbjct: 11  DVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYA 68

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
              E+  + +V E+M  GSL   L + +   L       +A  +A G+ Y++       +
Sbjct: 69  VVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYI 124

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           HRD++++NI++  N   KI DFGLARL+E  + +        + + APE A  GR + +S
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 225 DVYSFGIVALEIAC-GRKPISLTAKEEV 251
           DV+SFGI+  E+   GR P       EV
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREV 212

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 96.2 bits (239), Expect = 6e-23
 Identities = 84/268 (31%), Positives = 132/268 (49%), Gaps = 35/268 (13%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG- 105
           Q +G+G FG V  G +R     +AVK +   +    + + +E +++++LRH NLVQLLG 
Sbjct: 12  QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67

Query: 106 WCHEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
              EK  L +V EYM  GSL  +L  +  ++L  +   K + D+   + YL+       V
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           HRD+ + N+++  +  AK+ DFGL +  E +    T  L   + + APE     + S +S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKS 180

Query: 225 DVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD--PRLCRDFD 281
           DV+SFGI+  EI + GR P      ++V V  V+        G  ++A D  P +  D  
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRVE-------KGYKMDAPDGCPPVVYDVM 232

Query: 282 EQQMECLMIVGLWCAHPDENLRPSIRQV 309
           +Q           C H D   RPS  Q+
Sbjct: 233 KQ-----------CWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 9/202 (4%)

Query: 46  DQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLV 101
            + +G+G FG VY+G +    +    +AVK     +   ++E +  E  I+ +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +L+G    +  + +V E  P G L S+L      L        +  L++ L YL+    +
Sbjct: 71  KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS 221
             VHRDI + N+++      K+GDFGL+R +E     + +     + +MAPE     R +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 222 KESDVYSFGIVALEI-ACGRKP 242
             SDV+ FG+   EI   G KP
Sbjct: 187 SASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 72/229 (31%), Positives = 112/229 (48%), Gaps = 28/229 (12%)

Query: 49  LGQGGFGGVYKGFFR-----ETSSYIAVK-RVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           LG G FG VY+G +R          +AVK      S+Q   ++  E  I+S+  H+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKEN-------NLLTWEFRFKIAQDLASGLLYL 155
           L+G   E+    ++ E M  G L S L +EN       + LT +     A+D+A G  YL
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLVEHA----KGSQTTVLAGTMG 208
           +   E   +HRDI + N +L        AKI DFG+AR +  A    KG +  +    + 
Sbjct: 133 E---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML---PIK 186

Query: 209 YMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLV 256
           +M PE    G  + ++DV+SFG++  EI + G  P      +EV  ++ 
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 15/204 (7%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYAS---EVTIISRLRHRNLVQL 103
           LG+G FG VY  +  +T   +AVK+V     S++  KE  +   E+ ++  LRH  +VQ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 104 LGWC---HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            G C    E+K+L +  EYMP GS+   L K    LT     +  + +  G+ YL     
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHS--- 124

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE--HAKGSQTTVLAGTMGYMAPECATTG 218
             +VHRDIK +NI+ D   N K+GDFG ++ ++     G+    + GT  +M+PE  +  
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184

Query: 219 RASKESDVYSFGIVALEIACGRKP 242
              +++DV+S     +E+   + P
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 11/199 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+GGFG V     + T    A K++ K     ++G +   +E  I+ ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR--FKIAQDLASGLLYLQEGWEQCV 163
               K +L LV   M  G L  H++        E R  F  AQ +  GL +L +   + +
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---RRI 116

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           V+RD+K  N++LD + N +I D GLA  VE   G +    AGT GYMAPE          
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 224 SDVYSFGIVALEIACGRKP 242
            D ++ G    E+  GR P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 95.0 bits (236), Expect = 3e-22
 Identities = 77/269 (28%), Positives = 127/269 (47%), Gaps = 30/269 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYI----AVKRV-SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LG G FG V+KG +      I    A+K +  +  +Q  +E    +  +  L H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
           LG C     L LV +  P GSL  H+ +  + L  +        +A G+ YL+E     +
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRM 130

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           VHR++ + NI+L  +   +I DFG+A L+    K    +     + +MA E    GR + 
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190

Query: 223 ESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DF 280
           +SDV+S+G+   E+ + G +P +     EV         DL   G+ L    P++C  D 
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP--------DLLEKGERLA--QPQICTIDV 240

Query: 281 DEQQMECLMIVGLWCAHPDENLRPSIRQV 309
               ++C MI        DEN+RP+ +++
Sbjct: 241 YMVMVKCWMI--------DENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 78/271 (28%), Positives = 130/271 (47%), Gaps = 29/271 (10%)

Query: 49  LGQGGFGGVYKGFFRETSS---YIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLL 104
           +G+G FG VY G   ++     + AVK +++ +  + ++++  E  I+    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 105 GWCHEKKEL-LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
           G C   +   L+V  YM +G L + +  E +  T +        +A G+ YL     +  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKF 119

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRA 220
           VHRD+ + N MLD +F  K+ DFGLAR +   E+      T     + +MA E   T + 
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 221 SKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD 279
           + +SDV+SFG++  E+   G  P       ++ VYL+Q        G+ L  + P  C D
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--------GRRL--LQPEYCPD 229

Query: 280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
                   L  V L C HP   +RP+  +++
Sbjct: 230 -------PLYEVMLSCWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 68/236 (28%), Positives = 117/236 (49%), Gaps = 36/236 (15%)

Query: 47  QKLGQGGFGGVY-------KGFFRETSS-------YIAVKRV-SKGSKQGIKEYASEVTI 91
           +KLG+G FG V+         F  E +         +AVK + +  +K    ++  E+ I
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 92  ISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD---------SHLFKENNL--LTWEF 140
           +SRL++ N+++LLG C     L ++ EYM NG L+         S     NN+  ++   
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 141 RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKG 197
              +A  +ASG+ YL        VHRD+ + N ++  ++  KI DFG++R +   ++ + 
Sbjct: 131 LLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI--ACGRKPISLTAKEEV 251
               VL   + +MA E    G+ +  SDV++FG+   E+   C  +P SL + E+V
Sbjct: 188 QGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.7 bits (233), Expect = 4e-22
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLRHRN 99
           DF    K+G+G FG V+K   +      A+K++  SK +++  +E   E  ++++L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK-------ENNLLTWEFRFKIAQDLASGL 152
           +++      +K +L +V EY  NG L   L         E+ +  W F  +I      GL
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV--WRFFIQILL----GL 114

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
            +L     + ++HRDIKS N+ LD   N KIGD G+A+L+        T++ GT  Y++P
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSP 170

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKP 242
           E       +++SDV++ G+V  E   G+ P
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 93.0 bits (231), Expect = 8e-22
 Identities = 59/206 (28%), Positives = 109/206 (52%), Gaps = 6/206 (2%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           ++LG G FG V+ G +R     +A+K +++G+    +++  E  ++ +L H  LVQL G 
Sbjct: 10  KELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C ++K L +V E+M NG L ++L +    L+ +    + QD+  G+ YL+       +HR
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDV 226
           D+ + N ++      K+ DFG+ R V   + + ++     + +  PE     + S +SDV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 227 YSFGIVALEIAC-GRKPISLTAKEEV 251
           +SFG++  E+   G+ P    +  EV
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEV 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 93.6 bits (232), Expect = 9e-22
 Identities = 79/284 (27%), Positives = 137/284 (48%), Gaps = 43/284 (15%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNL 100
           ++LGQG FG VY+G  +     E  + +A+K V++ +    + E+ +E +++      ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFK-----ENN----LLTWEFRFKIAQDLASG 151
           V+LLG   + +  L++ E M  G L S+L       ENN      + +   ++A ++A G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA----KGSQTTVLAGTM 207
           + YL        VHRD+ + N M+  +F  KIGDFG+ R +       KG +  +    +
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PV 185

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNG 266
            +M+PE    G  +  SDV+SFG+V  EIA    +P    + E+V  ++++        G
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME--------G 237

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            LL+   P  C D   + M         C   +  +RPS  ++I
Sbjct: 238 GLLD--KPDNCPDMLFELMRM-------CWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 9e-22
 Identities = 73/225 (32%), Positives = 107/225 (47%), Gaps = 22/225 (9%)

Query: 36  LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL 95
           L   T  F   + +G+G +G VYK   ++T   +A+K +    +   +E   E  I+ + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59

Query: 96  -RHRNLVQLLGWCHEKK-------ELLLVYEYMPNGS---LDSHLFKENNLLTWEFRFKI 144
             H N+    G    KK       +L LV E    GS   L   L K+   L  E+   I
Sbjct: 60  SNHPNIATFYG-AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA 204
            ++   GL YL E     V+HRDIK  NI+L  N   K+ DFG++  ++   G + T + 
Sbjct: 119 LRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI- 174

Query: 205 GTMGYMAPE---CATTGRAS--KESDVYSFGIVALEIACGRKPIS 244
           GT  +MAPE   C     AS    SDV+S GI A+E+A G+ P+ 
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV-----SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LGQG FG VY  +  +T   +AVK+V     S  + + +     E+ ++  L H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 104 LGWCHEKKE--LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            G   +  E  L +  E+MP GS+   L K    LT     K  + +  G+ YL      
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHS---N 125

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA--KGSQTTVLAGTMGYMAPECATTGR 219
            +VHRDIK +NI+ D   N K+GDFG ++ ++     G+    + GT  +M+PE  +   
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 220 ASKESDVYSFGIVALEIACGRKP 242
             +++D++S G   +E+   + P
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 93.1 bits (231), Expect = 1e-21
 Identities = 63/218 (28%), Positives = 111/218 (50%), Gaps = 28/218 (12%)

Query: 48  KLGQGGFGGVYKG-----FFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           +LG+G FG V+          +    +AVK + + S+   +++  E  +++ L+H+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 103 LLGWCHEKKELLLVYEYMPNGSL---------DSHLFKENNL-----LTWEFRFKIAQDL 148
             G C E + LL+V+EYM +G L         D+ +           LT      IA  +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAG 205
           ASG++YL        VHRD+ + N ++      KIGDFG++R +   ++ +    T+L  
Sbjct: 132 ASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 187

Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
            + +M PE     + + ESD++SFG+V  EI   G++P
Sbjct: 188 -IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 15/204 (7%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV-----SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LGQG FG VY  +  +T   +A K+V     S  + + +     E+ ++  L+H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 104 LGWC---HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            G C     +K L +  EYMP GS+   L K    LT     K  + +  G+ YL     
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS--- 124

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH--AKGSQTTVLAGTMGYMAPECATTG 218
             +VHRDIK +NI+ D   N K+GDFG ++ ++     G+    + GT  +M+PE  +  
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 219 RASKESDVYSFGIVALEIACGRKP 242
              +++DV+S G   +E+   + P
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 60/213 (28%), Positives = 111/213 (52%), Gaps = 7/213 (3%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +KLG G FG V+ G++   S+ +AVK +  G+   ++ +  E  ++  L+H  LV+L   
Sbjct: 12  KKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 107 CHEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
             +++ + ++ EYM  GSL   L   E   +        +  +A G+ Y++    +  +H
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD++++N+++  +   KI DFGLAR++E  + +        + + APE    G  + +SD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 226 VYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ 257
           V+SFGI+  EI   G+ P    +  +V   L +
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 20/214 (9%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRH-R 98
            D  D  ++G+G FG V K   + + + +AVKR+ S   ++  K    ++ ++ R     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK-----ENNLLTWEFRFKIAQDLASGLL 153
            +V+  G    + +  +  E M + SLD   +K       +++  E   KIA      L 
Sbjct: 64  YIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEH-AKGSQTTVLAGTMGYMA 211
           YL+E  E  ++HRD+K SNI+LD N N K+ DFG++ +LV+  AK    T  AG   YMA
Sbjct: 122 YLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMA 175

Query: 212 PECATTGRASK---ESDVYSFGIVALEIACGRKP 242
           PE             SDV+S GI   E+A G+ P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 73/252 (28%), Positives = 114/252 (45%), Gaps = 22/252 (8%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYA-SEVTIISRLRHRNLVQLLG 105
           LG GGFG V     +  +   A+K V K    + G +E+  SE  I+    H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
              +KK + ++ EY   G L + L        +  RF IA  +     YL     + +++
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHN---RGIIY 116

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+K  N++LD N   K+ DFG A+ ++   G +T    GT  Y+APE           D
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174

Query: 226 VYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL-------LEAVD--PRL 276
            +S GI+  E+  GR P     ++ +++Y       L GNGKL         A D   +L
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDI----LKGNGKLEFPNYIDKAAKDLIKQL 230

Query: 277 CRDFDEQQMECL 288
            R   E+++  L
Sbjct: 231 LRRNPEERLGNL 242

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.8 bits (228), Expect = 2e-21
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 26/212 (12%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVS----KGSKQG--IKEYASEVTIISRLRHRNL 100
           Q+LG G F   Y+    +T + +AVK+V+      S+Q   ++    E+ +++RL H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYL 155
           +++LG   E     L  E+M  GS+   L     FKE  ++         + L  GL YL
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII------NYTEQLLRGLSYL 119

Query: 156 QEGWEQCVVHRDIKSSNIMLD-LNFNAKIGDFGLA-RLVEHAKGS---QTTVLAGTMGYM 210
            E     ++HRD+K +N+++D      +I DFG A RL     G+   Q  +L GT+ +M
Sbjct: 120 HE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL-GTIAFM 175

Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKP 242
           APE     +  +  DV+S G V +E+A  + P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 74/278 (26%), Positives = 124/278 (44%), Gaps = 36/278 (12%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYA-SEVTIISRLRHRN 99
           DF   +KLG+G +G VYK      + + A+K V  GS  Q  +E A +E+ I++ + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 100 LVQLLGWCHEK----KELLLVYEYMPNGSLDSHLFKEN---NLLTWEFRFKIAQDLASGL 152
           ++       E      +L +V EY P G L   + K      L+  +  ++I   L  GL
Sbjct: 61  IISY----KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
             L E   Q ++HRD+KS+NI+L  N   KIGD G++++    K +      GT  YMAP
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQIGTPHYMAP 170

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV 272
           E       S +SD++S G +  E+A    P    + ++++              K+    
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-------------KVQRGK 217

Query: 273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            P +   + +     +             LRP+  +++
Sbjct: 218 YPPIPPIYSQDLQNFIR----SMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 40/287 (13%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-------SKGSKQGIKEYASEVTII 92
             +F  ++K+G+G F  VYK         +A+K+V       +K  +  +KE    + ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56

Query: 93  SRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD---SHLFKENNLLTWEFRFKIAQDLA 149
            +L H N+++ L    E  EL +V E    G L     H  K+  L+     +K    L 
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV---LAGT 206
           S L ++     + ++HRDIK +N+ +      K+GD GL R       S+TT    L GT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHSLVGT 169

Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
             YM+PE       + +SD++S G +  E+A  + P      +++ +Y       L    
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLY------SLC--- 217

Query: 267 KLLEAVD-PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
           K +E  D P L  D   +++  L+     C +PD   RP I  V+ V
Sbjct: 218 KKIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 91.6 bits (227), Expect = 5e-21
 Identities = 83/290 (28%), Positives = 146/290 (50%), Gaps = 43/290 (14%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNL 100
           ++LGQG FG VY+G  R     E  + +AVK V++  S +   E+ +E +++      ++
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLF-----KENN----LLTWEFRFKIAQDLASG 151
           V+LLG   + +  L+V E M +G L S+L       ENN      T +   ++A ++A G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTM 207
           + YL     +  VHRD+ + N M+  +F  KIGDFG+ R +     + KG +  +    +
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PV 185

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNG 266
            +MAPE    G  +  SD++SFG+V  EI     +P    + E+V    +++V D    G
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV----LKFVMD----G 237

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
             L+   P  C     +++  LM +   C   +  +RP+  +++++L  +
Sbjct: 238 GYLD--QPDNC----PERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDD 278

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 30/278 (10%)

Query: 44  NDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI-KEYASEVTIISRLRHR 98
           N+D      LG G  G V K     T + +A K V  G+K  + K+   E+ I+   R  
Sbjct: 4   NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
            +V   G    +  + +  E+M  GSLD  ++K+   +  E   KIA  +  GL YL   
Sbjct: 64  YIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYN- 121

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATT 217
               ++HRDIK SNI+++     K+ DFG++  L+     + T V  GT  YM+PE    
Sbjct: 122 -VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFV--GTSTYMSPERIQG 176

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN------GKLLEA 271
           G+ + +SDV+S GI  +E+A G+ P + +  ++        + DL          +L  +
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236

Query: 272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
             P   RDF +            C   D   RP+ +Q+
Sbjct: 237 DFPEDLRDFVDA-----------CLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 33/210 (15%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLG 105
           +KLG+G +  VYKG  R T   +A+K +   +++G    A  E++++  L+H N+V+L  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 106 WCHEKKELLLVYEYMPN------------GSLDSHLFKENNLLTWEFRFKIAQDLASGLL 153
             H + +L+LV+EYM              G+LD +  K        F +++ +    G+ 
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKS-------FTYQLLK----GIA 114

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL--VEHAKGSQTTVLAGTMGYMA 211
           +  E     V+HRD+K  N++++     K+ DFGLAR   +     S   V   T+ Y A
Sbjct: 115 FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRA 168

Query: 212 PECATTGRASKES-DVYSFGIVALEIACGR 240
           P+     R    S D++S G +  E+  GR
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.5 bits (225), Expect = 6e-21
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 20/208 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSY---IAVKRVSKGSKQGI-KEYASEVTIISRLRHRNLVQ 102
           +KLG G FG V +G +  +      +AVK +       I  ++  E  I+  L H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENN---LLT--WEFRFKIAQDLASGLLYLQE 157
           L G       L++V E  P GSL   L K+     L++   ++  +IA    +G+ YL+ 
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLES 115

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR--LVEHAKGSQTTVLAGTMGYMAPECA 215
              +  +HRD+ + NI+L  +   KIGDFGL R              L     + APE  
Sbjct: 116 ---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 216 TTGRASKESDVYSFGIVALEI-ACGRKP 242
            T   S  SDV+ FG+   E+   G +P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 34/220 (15%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYI--AVKRVSK-GSKQGIKEYASEVTIISRL-R 96
           ND      +G+G FG V K   ++    +  A+KR+ +  SK   +++A E+ ++ +L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL---------------LTWEFR 141
           H N++ LLG C  +  L L  EY P+G+L   L K   L               L+ +  
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT 201
              A D+A G+ YL +   +  +HRD+ + NI++  N+ AKI DFGL+R        Q  
Sbjct: 127 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEV 176

Query: 202 VLAGTMG-----YMAPECATTGRASKESDVYSFGIVALEI 236
            +  TMG     +MA E       +  SDV+S+G++  EI
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 12/197 (6%)

Query: 49  LGQGGFGGV----YKGFFRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL 103
           LG+G FG V    Y      T   +AVK +   S    I +   E+ I+  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 104 LGWCHEK--KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            G C E     + L+ E++P+GSL  +L +  N +  + + K A  +  G+ YL  G  Q
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSRQ 129

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPECATTGR 219
             VHRD+ + N++++     KIGDFGL + +E  K   T    L   + + APEC    +
Sbjct: 130 -YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 220 ASKESDVYSFGIVALEI 236
               SDV+SFG+   E+
Sbjct: 189 FYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 6/212 (2%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           ++LG G FG V  G +R     +A+K + +GS     E+  E  ++ +L H  LVQL G 
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C +++ + +V EYM NG L ++L +           ++ +D+  G+ YL+    +  +HR
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDV 226
           D+ + N ++D     K+ DFGL+R V   + + +      + +  PE     + S +SDV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 227 YSFGIVALEI-ACGRKPISLTAKEEVQVYLVQ 257
           ++FG++  E+ + G+ P       E    + Q
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 17/199 (8%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           +LG G FG VYK   +ET +  A K +   S++ +++Y  E+ I++   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
           +   +L ++ E+ P G++D+ + + +  LT      I + +   L YL       ++HRD
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRD 135

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT----TVLAGTMGYMAPE---CATTGRA 220
           +K+ N++L L+ + K+ DFG++     AK  +T        GT  +MAPE   C T    
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 221 SKE--SDVYSFGIVALEIA 237
             +  +D++S GI  +E+A
Sbjct: 191 PYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 34/271 (12%)

Query: 49  LGQGGFGGVYKGFF---RETSSY-IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQ 102
           LG G FG VYKG +    ET    +A+K +++  G K  + E+  E  I++ + H +LV+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALIMASMDHPHLVR 73

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           LLG C     + LV + MP+G L  ++ +  + +  +        +A G++YL+E   + 
Sbjct: 74  LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RR 129

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM--GYMAPECATTGRA 220
           +VHRD+ + N+++    + KI DFGLARL+E     +     G M   +MA EC    + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 221 SKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR- 278
           + +SDV+S+G+   E+   G KP       E+         DL   G+ L    P +C  
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIP--------DLLEKGERLP--QPPICTI 238

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
           D     ++C MI        D + RP  +++
Sbjct: 239 DVYMVMVKCWMI--------DADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 14/208 (6%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           + +G+G FG V +G +  T   +AVK +        + +  E  ++++L H+NLV+LLG 
Sbjct: 12  EIIGEGEFGAVLQGEY--TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRF-KIAQDLASGLLYLQEGWEQCVVH 165
                 L +V E M  G+L + L      L    +  + + D+A G+ YL+    + +VH
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+ + NI++  +  AK+ DFGLAR+   + G   + L   + + APE     + S +SD
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKSD 179

Query: 226 VYSFGIVALEI-ACGRKPISLTAKEEVQ 252
           V+S+G++  E+ + GR P    + +EV+
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVK 207

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 10/216 (4%)

Query: 48  KLGQGGFGGVYKGFFRETSSYI--AVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLL 104
           +LG G FG V KG ++     I  A+K +   +++ ++ E   E  I+ +L +  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
           G C E + L+LV E    G L+  L  + + +T     ++   ++ G+ YL+    +  V
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFV 117

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASK 222
           HRD+ + N++L     AKI DFGL++ +           AG   + + APEC    + S 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 223 ESDVYSFGIVALE-IACGRKPISLTAKEEVQVYLVQ 257
            SDV+S+GI   E  + G+KP       EV  ++ Q
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.6 bits (220), Expect = 4e-20
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 14/213 (6%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRN 99
           +D+   + +G G    VY       +  +A+KR+  +  +  + E   EV  +S+  H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS---GLLYLQ 156
           +V+         EL LV  Y+  GSL   + K +          IA  L     GL YL 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG----LARLVEHAKGSQTTVLAGTMGYMAP 212
                  +HRDIK+ NI+L  + + KI DFG    LA   +  +  + T   GT  +MAP
Sbjct: 120 S---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAP 175

Query: 213 ECATTGRASKE-SDVYSFGIVALEIACGRKPIS 244
           E           +D++SFGI A+E+A G  P S
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISRLRHRNLVQL 103
           +K+G+G FG +Y    +  S +  +K +   +K  +KE  +   EV ++++++H N+V  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSH-------LFKENNLLTWEFRFKIAQDLASGLLYLQ 156
                E   L +V EY   G L          LF E+ +L+W  +      ++ GL ++ 
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIH 118

Query: 157 EGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
              ++ ++HRDIKS NI L  N   AK+GDFG+AR +  +     T   GT  Y++PE  
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEIC 174

Query: 216 TTGRASKESDVYSFGIVALEIACGRKP 242
                + ++D++S G V  E+   + P
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 88.4 bits (219), Expect = 5e-20
 Identities = 63/223 (28%), Positives = 115/223 (51%), Gaps = 20/223 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSY-------IAVKRVSKGSKQGIKEYASEVTIISRLRHRN 99
           + LGQG F  ++KG  RE   Y       + +K + K  +   + +    +++S+L H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           LV   G C    E ++V EY+  GSLD++L K  NL+   ++ ++A+ LA  L +L+   
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE--- 117

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM-----GYMAPEC 214
           ++ + H ++ + N++L    + K G+    +L +   G   TVL   +      ++ PEC
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD--PGISITVLPKEILLERIPWVPPEC 175

Query: 215 ATTGRA-SKESDVYSFGIVALEIACG-RKPIS-LTAKEEVQVY 254
               +  S  +D +SFG    EI  G  KP+S L +++++Q Y
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY 218

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 30/170 (17%)

Query: 39  ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLR 96
              D+    KLG+G FG VYK    +T   +A+K++     K G    A  E+ I+ +L+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 97  HRNLVQLL--------GWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTWEFRFKIAQ 146
           H N+V L+            ++  + +V  YM     D  L    EN       +   +Q
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-----DHDLSGLLENP----SVKLTESQ 116

Query: 147 ------DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
                  L  G+ YL E     ++HRDIK++NI++D     KI DFGLAR
Sbjct: 117 IKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 87.8 bits (217), Expect = 9e-20
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 17/199 (8%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           +LG G FG VYK   +ET    A K +   S++ +++Y  E+ I++   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
           + +  L ++ E+   G++D+ + +    LT      + +     L YL    E  ++HRD
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT----VLAGTMGYMAPE---CATTGRA 220
           +K+ NI+  L+ + K+ DFG++     AK ++T        GT  +MAPE   C T+   
Sbjct: 129 LKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183

Query: 221 SKE--SDVYSFGIVALEIA 237
             +  +DV+S GI  +E+A
Sbjct: 184 PYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.2 bits (219), Expect = 9e-20
 Identities = 78/303 (25%), Positives = 134/303 (44%), Gaps = 51/303 (16%)

Query: 47  QKLGQGGFGGVY---------------KGFFRETSS-YIAVKRVSKG-SKQGIKEYASEV 89
           +KLG+G FG V+                      +   +AVK +    S    +++  EV
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD----SHLFKENNL------LTWE 139
            I+SRL   N+ +LLG C     L ++ EYM NG L+     H+ + + L      L++ 
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAK 196
               +A  +ASG+ YL+       VHRD+ + N ++  N+  KI DFG++R +   ++ +
Sbjct: 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187

Query: 197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA--CGRKPISLTAKEEVQVY 254
                 L   + +MA E    G+ + +SDV++FG+   EI   C  +P      ++V   
Sbjct: 188 VQGRAPLP--IRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV--- 242

Query: 255 LVQWVWDLYGNGKLLEAVD-PRLC-RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
            ++     + +      +  P  C +D  E  +EC      W    DE  RP+ R++   
Sbjct: 243 -IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLEC------W--RRDEEDRPTFREIHLF 293

Query: 313 LNS 315
           L  
Sbjct: 294 LQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 11/201 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRH---RNLVQLL 104
           +G+G +G VY+G    T   +A+K ++  +    + +   EV ++S+LR     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
           G   +   L ++ EY   GS+ + +  +   +  ++   I +++   L Y+ +     V+
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYIHK---VGVI 123

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKE 223
           HRDIK++NI++    N K+ DFG+A L+      ++T   GT  +MAPE  T G+    +
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKYYDTK 182

Query: 224 SDVYSFGIVALEIACGRKPIS 244
           +D++S GI   E+A G  P S
Sbjct: 183 ADIWSLGITIYEMATGNPPYS 203

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 25/229 (10%)

Query: 49  LGQGGFGGVYKGFFRE---TSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LG+G FG V +G   +   +   +AVK  ++   +   I+E+ SE   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 104 LGWCHEKKEL------LLVYEYMPNGSLDSHLFKEN-----NLLTWEFRFKIAQDLASGL 152
           +G C E   L      +++  +M +G L S L           L  +   K   D+A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGY 209
            YL     +  +HRD+ + N ML  +    + DFGL++ +    G    Q  +    + +
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPVKW 181

Query: 210 MAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ 257
           +A E       + +SDV++FG+   EIA  G+ P       E+  YL  
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 86.5 bits (214), Expect = 2e-19
 Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 47/282 (16%)

Query: 49  LGQGGFGGVYKGFF-----RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LG G FG + +G       RE    I   R     KQ  + + +E   + +  H N+V+L
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIVRL 71

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE-GWEQC 162
            G       +++V EYM NG+LDS L K    L       +   LASG+ YL E G+   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRA 220
            VH+ + +  ++++ +   KI  F   RL E    +  T ++G   + + APE       
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185

Query: 221 SKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD------ 273
           S  SDV+SFGIV  E+ + G +P                 WD+     +++AV+      
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERP----------------YWDM-SGQDVIKAVEDGFRLP 228

Query: 274 -PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
            PR C +   Q M       L C   +   RP   Q+  +L+
Sbjct: 229 APRNCPNLLHQLM-------LDCWQKERGERPRFSQIHSILS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 39/216 (18%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGW 106
           ++G G  G VYK   R T    A+K +    +  ++ +   E+ I+  + H N+V+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK---- 136

Query: 107 CHE----KKELLLVYEYMPNGSLD-SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           CH+      E+ ++ E+M  GSL+ +H+  E  L        +A+ + SG+ YL     +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA------DVARQILSGIAYLHR---R 187

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT----TVLAGTMGYMAPECATT 217
            +VHRDIK SN++++   N KI DFG++R++     +QT        GT+ YM+PE   T
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSVGTIAYMSPERINT 242

Query: 218 --------GRASKESDVYSFGIVALEIACGRKPISL 245
                   G A    D++S G+  LE   GR P  +
Sbjct: 243 DLNHGAYDGYA---GDIWSLGVSILEFYLGRFPFGV 275

Length = 353

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 18/207 (8%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRN 99
           F D +++G G FG VY      T+  +A+K++S   KQ  +++     EV  + +LRH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 100 LVQLLGWCHEKKELL-LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
            ++  G C+ ++    LV EY    + D     +  L   E    I      GL YL   
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-AICHGALQGLAYLHS- 133

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CA 215
                +HRDIK+ NI+L      K+ DFG A LV  A         GT  +MAPE     
Sbjct: 134 --HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAM 186

Query: 216 TTGRASKESDVYSFGIVALEIACGRKP 242
             G+   + DV+S GI  +E+A  RKP
Sbjct: 187 DEGQYDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 37/220 (16%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRN 99
           D+   +K+G+G +G VYKG  ++T   +A+K++   S+ +G+   A  E++++  L+H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 100 LVQLLGWCHEKKELLLVYEYM------------PNGSLDSHLFKENNLLTWEFRFKIAQD 147
           +V L     ++  L L++E++                +D+ L K        + ++I Q 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS-------YLYQILQ- 112

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG-- 205
              G+L+      + V+HRD+K  N+++D     K+ DFGLAR    A G    V     
Sbjct: 113 ---GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR----AFGIPVRVYTHEV 162

Query: 206 -TMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPI 243
            T+ Y APE      R S   D++S G +  E+A  +KP+
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 85.8 bits (212), Expect = 4e-19
 Identities = 60/208 (28%), Positives = 110/208 (52%), Gaps = 8/208 (3%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG 105
           ++KLG G FG V+   + + +  +AVK +  GS   ++ + +E  ++  L+H  LV+L  
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 68

Query: 106 WCHEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
               K+ + ++ E+M  GSL   L   E +          +  +A G+ ++++   +  +
Sbjct: 69  VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYI 124

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           HRD++++NI++  +   KI DFGLAR++E  + +        + + APE    G  + +S
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 225 DVYSFGIVALEIAC-GRKPISLTAKEEV 251
           DV+SFGI+ +EI   GR P    +  EV
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEV 212

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.9 bits (212), Expect = 4e-19
 Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 15/207 (7%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLV 101
           F   +++G+G FG V+KG    T   +A+K +  + ++  I++   E+T++S+     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 102 QLLGWCHEKKELLLVYEYMPNGS----LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
           +  G   +  +L ++ EY+  GS    L +  F E  + T      + +++  GL YL  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLHS 119

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              +  +HRDIK++N++L    + K+ DFG+A  +   +  + T   GT  +MAPE    
Sbjct: 120 ---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQ 175

Query: 218 GRASKESDVYSFGIVALEIACGRKPIS 244
                ++D++S GI A+E+A G  P S
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 14/214 (6%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK---GSKQGIKEYASEVTIISRLRH 97
            DF+    +G+G FG V     + T    A+K + K    +++ +  +  E  I+S    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ-DLASGLLYLQ 156
             + QL     +K  L LV EY P G L S L +  +    +F   +AQ  LA  +L + 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIH 116

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
              +   VHRDIK  N+++D   + K+ DFG A  +   K   + +  GT  Y+APE  T
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 217 T------GRASKESDVYSFGIVALEIACGRKPIS 244
           T      G    E D +S G++A E+  GR P  
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 8/197 (4%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLG 105
           +K+GQG  G VY      T   +A+K+++   +Q  KE   +E+ ++   +H N+V  L 
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
                 EL +V EY+  GSL + +  E  +   +    + ++    L +L       V+H
Sbjct: 84  SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIA-AVCRECLQALEFLHS---NQVIH 138

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RDIKS NI+L ++ + K+ DFG    +   +  ++T + GT  +MAPE  T      + D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 226 VYSFGIVALEIACGRKP 242
           ++S GI+A+E+  G  P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 5e-19
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 19/221 (8%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           LG+G FG        E  S +  K V  ++ S++  ++  +E+ I+S L+H N++     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 107 CHEKKELLLVYEYMPNGSL-------DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
             +   LL+  EY   G+L          LF+E  +L + F+      + S + Y+ +  
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ------IVSAVSYIHK-- 119

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
              ++HRDIK+ NI L      K+GDFG+++++        TV+ GT  YM+PE     +
Sbjct: 120 -AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVK 177

Query: 220 ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW 260
            + +SD+++ G V  E+   ++    T    + V +VQ  +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 34/226 (15%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG 105
            +G+G +G V K   + T   +A+K  + S+  +   K    EV ++ +LRH N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 106 WCHEKKELLLVYEY-----------MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
               K  L LV+EY            P G L     +      W+        L   + Y
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVR---SYIWQ--------LLQAIAY 115

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE- 213
                   ++HRDIK  NI++  +   K+ DFG AR +     S  T    T  Y APE 
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Query: 214 --CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
               T     K  DV++ G +  E+  G  P+     +  Q+YL+Q
Sbjct: 173 LVGDTN--YGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQ 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.8 bits (220), Expect = 5e-19
 Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 21/289 (7%)

Query: 29  KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASE 88
           K  T  ++  +  + N    + +G  G  YKG   +      VK ++      I    SE
Sbjct: 681 KSITINDILSSLKEEN---VISRGKKGASYKGKSIKNGMQFVVKEIND--VNSIPS--SE 733

Query: 89  VTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDL 148
           +  + +L+H N+V+L+G C  +K   L++EY+   +L   L      L+WE R KIA  +
Sbjct: 734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGI 789

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 208
           A  L +L       VV  ++    I++D      +    L  L+        T    +  
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLL-----CTDTKCFISSA 843

Query: 209 YMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL 268
           Y+APE   T   +++SD+Y FG++ +E+  G+ P    A+  V   +V+W    Y +  L
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD--AEFGVHGSIVEWARYCYSDCHL 901

Query: 269 LEAVDPRLCRD--FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
              +DP +  D   ++ ++  +M + L C   D   RP    V+  L S
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 85.5 bits (212), Expect = 9e-19
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 15/210 (7%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHR- 98
           ND  +  ++G G  G VYK  F++T   +AVK++ + G+K+  K    ++ ++    H  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVL-KSHDC 73

Query: 99  -NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             +V+  G+     ++ +  E M    LD  L +    +  +   K+   +   L YL+E
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECAT 216
             +  V+HRD+K SNI+LD + N K+ DFG++ RLV+    +++   AG   YMAPE   
Sbjct: 133 --KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERID 187

Query: 217 TGRASKE----SDVYSFGIVALEIACGRKP 242
               + +    +DV+S GI  +E+A G+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 85.9 bits (213), Expect = 9e-19
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 13/222 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
            DF    ++GQGG+G V+    ++T   +A+KR+ K        ++   +E  I++  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             LV+LL    + + L L  EY+P G   + L     L     RF +A+   +     + 
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECAT 216
           G+    +HRD+K  N ++D + + K+ DFGL++ +V +A       + G+  YMAPE   
Sbjct: 121 GY----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLR 171

Query: 217 TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
                   D +S G +  E  CG  P S +   E    L  W
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 85.3 bits (211), Expect = 9e-19
 Identities = 87/320 (27%), Positives = 139/320 (43%), Gaps = 60/320 (18%)

Query: 29  KRFTYKELAQATNDFNDDQKLGQGGFGGVY------------KGFFRETSS----YIAVK 72
           KR T+KE            KLG+G FG V+            K F  + S      +AVK
Sbjct: 5   KRLTFKE------------KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK 52

Query: 73  RV-SKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK 131
            +    +K    ++  E+ I+SRL+  N+++LL  C     L ++ EYM NG L+  L +
Sbjct: 53  MLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSR 112

Query: 132 ---ENNLLTWEFRF-------KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
              +      +           +A  +ASG+ YL        VHRD+ + N ++  N+  
Sbjct: 113 HEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTI 169

Query: 182 KIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA- 237
           KI DFG++R +   ++ +     VL   + +M+ E    G+ +  SDV++FG+   EI  
Sbjct: 170 KIADFGMSRNLYSGDYYRIQGRAVLP--IRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Query: 238 -CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
            C  +P S  + E+V     ++  D    G+ +    P LC D   + M       L C 
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRD---QGRQVYLPKPALCPDSLYKLM-------LSCW 277

Query: 297 HPDENLRPSIRQVIHVLNSE 316
             +   RPS  Q IH    E
Sbjct: 278 RRNAKERPSF-QEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 9/204 (4%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLV 101
           F   +++G+G FG VYKG    T   +A+K +  + ++  I++   E+T++S+     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 102 QLLGWCHEKKELLLVYEYMPNGS-LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           +  G   +  +L ++ EY+  GS LD  L K   L    +   I +++  GL YL     
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPL-EETYIATILREILKGLDYLHS--- 119

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
           +  +HRDIK++N++L    + K+ DFG+A  +   +  + T   GT  +MAPE       
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 178

Query: 221 SKESDVYSFGIVALEIACGRKPIS 244
             ++D++S GI A+E+A G  P S
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 87/314 (27%), Positives = 136/314 (43%), Gaps = 64/314 (20%)

Query: 47  QKLGQGGFGGVY--------------------KGFFRETSSYIAVKRV-SKGSKQGIKEY 85
           +KLG+G FG V+                    KG        +AVK +    +K    ++
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG----RPLLVAVKILRPDANKNARNDF 66

Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF------KENN----- 134
             EV I+SRL+  N+++LLG C ++  L ++ EYM NG L+  L       KE N     
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 135 -------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
                   +++     +A  +ASG+ YL        VHRD+ + N ++  N   KI DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFG 183

Query: 188 LARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI--ACGRKP 242
           ++R +   ++ +     VL   + +MA EC   G+ +  SDV++FG+   EI   C  +P
Sbjct: 184 MSRNLYAGDYYRIQGRAVLP--IRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Query: 243 ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL 302
                 E+V     ++  D    G+ +    P  C     Q +  LM   L C   D   
Sbjct: 242 YGELTDEQVIENAGEFFRD---QGRQVYLFRPPPC----PQGLYELM---LQCWSRDCRE 291

Query: 303 RPSIRQVIHVLNSE 316
           RPS    IH   +E
Sbjct: 292 RPSFSD-IHAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 49  LGQGGFGGVYK----GFFRETSSY-IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLV 101
           LG G FG V +    G  +  +   +AVK +   +    +E   SE+ I+S L  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            LLG C     +L++ EY   G L + L  K  + LT E     +  +A G+ +L    +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--K 160

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECA 215
            C+ HRD+ + N++L      KI DFGLAR + +      KG+    +     +MAPE  
Sbjct: 161 NCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK----WMAPESI 215

Query: 216 TTGRASKESDVYSFGIVALEI 236
                + ESDV+S+GI+  EI
Sbjct: 216 FNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 26/156 (16%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +K+G+G +G V+K   RET   +A+KRV      +G+   A  E+ ++  L+H+N+V+L 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 105 GWCHEKKELLLVYEYMP----------NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
              H  K+L LV+EY            NG +D  + K        F F++ +    GL +
Sbjct: 66  DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS-------FMFQLLK----GLAF 114

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
                   V+HRD+K  N++++ N   K+ DFGLAR
Sbjct: 115 CHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 15/207 (7%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLV 101
           F   +K+G+G FG V+KG    T   +A+K +  + ++  I++   E+T++S+     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 102 QLLGWCHEKKELLLVYEYMPNGS----LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
           +  G   +  +L ++ EY+  GS    L+     E  + T      I +++  GL YL  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLHS 119

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              +  +HRDIK++N++L  +   K+ DFG+A  +   +  +     GT  +MAPE    
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ 175

Query: 218 GRASKESDVYSFGIVALEIACGRKPIS 244
                ++D++S GI A+E+A G  P S
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRH-R 98
           +D    ++LG+G +G V K     T + +AVKR+ +  + Q  K    ++ I  R     
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDS---HLFKENNLLTWEFRFKIAQDLASGLLYL 155
             V   G    + ++ +  E M + SLD     ++ +   +  +   KIA  +   L YL
Sbjct: 61  YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEH-AKGSQTTVLAGTMGYMAPE 213
                  V+HRD+K SN++++ N   K+ DFG++  LV+  AK    T+ AG   YMAPE
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----TIDAGCKPYMAPE 173

Query: 214 CATTGRASK----ESDVYSFGIVALEIACGRKP 242
                   K    +SDV+S GI  +E+A GR P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 11/237 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRN 99
           +DF    +LG G  G V K   + +   +A K +    K  I+ +   E+ ++       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V   G  +   E+ +  E+M  GSLD  + KE   +  E   K++  +  GL YL+E  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSIAVLRGLAYLRE-- 121

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTG 218
           +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT  YM+PE     
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGT 177

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
             S +SD++S G+  +E+A GR PI     +E++    + V D  G      ++ PR
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVD--GEEGEPHSISPR 232

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 79/294 (26%), Positives = 134/294 (45%), Gaps = 52/294 (17%)

Query: 49  LGQGGFGGVYKGFFRET-----SSYIAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLV 101
           LG+G FG V K           +S +AVK +    +++ + +  SE+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHL-------FKENNLLTWEFRFKIAQ-DLAS--- 150
            LLG C ++  L +V EY  +G+L   L          +          + Q DL S   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 151 ----GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
               G+ +L    ++C+ HRD+ + N+++  +   KI DFGLAR + H    + T    T
Sbjct: 140 QVARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT----T 192

Query: 207 MG-----YMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVW 260
            G     +MAPE       + +SDV+SFG++  EI   G  P      EE        ++
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------LF 244

Query: 261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
            L   G  +E   P+ C     Q++  LM     C H   + RP+ +Q++  L+
Sbjct: 245 KLLKEGYRMEK--PQNC----TQELYHLM---RDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.0 bits (205), Expect = 4e-18
 Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+GGFG V     R T    A K+++K     ++G +    E  I++++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFR--FKIAQDLASGLLYLQEGWEQ 161
               K +L LV   M  G L  H++   E N    E R  F  AQ + SGL +L +   +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-IISGLEHLHQ---R 116

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRA 220
            +++RD+K  N++LD + N +I D GLA  VE   G S+T   AGT G+MAPE       
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174

Query: 221 SKESDVYSFGIVALEIACGRKP 242
               D ++ G+   E+   R P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 69/213 (32%), Positives = 94/213 (44%), Gaps = 15/213 (7%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+GGFG V     + T    A K++ K     K G K    E  I+ ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
               K  L LV   M  G L  H++   E  L         AQ +  G+L+L       +
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ-ITCGILHLHS---MDI 116

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           V+RD+K  N++LD   N ++ D GLA  VE   G   T  AGT GYMAPE       S  
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 224 SDVYSFGIVALEIACGRKPI----SLTAKEEVQ 252
            D ++ G    E+  GR P        AKEE++
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 57/298 (19%)

Query: 46  DQKLGQGGFGGVYKGFFRETS-----SYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRN 99
            + LG+G FG V K            + +AVK + + +    +++  SE  ++ ++ H +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL-----------------------L 136
           +++L G C +   LLL+ EY   GSL S L +   +                       L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---- 192
           T       A  ++ G+ YL    E  +VHRD+ + N+++      KI DFGL+R V    
Sbjct: 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEV 251
            + K S+  +    + +MA E       + +SDV+SFG++  EI   G  P    A E  
Sbjct: 182 SYVKRSKGRI---PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER- 237

Query: 252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
                  +++L   G  +E   P  C     ++M  LM+   W   PD+  RP+   +
Sbjct: 238 -------LFNLLKTGYRMER--PENC----SEEMYNLMLT-CWKQEPDK--RPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 81.9 bits (202), Expect = 7e-18
 Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 39/274 (14%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRNLVQLL-G 105
           +G+G +G V     R       +K+++    S++  K    E  ++S+L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 106 WCHEKKELLLVYEYMPNGSL-------DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           W  E   L +V  +   G L          L  EN ++ W  +  +A      L YL E 
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLHE- 120

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
             + ++HRD+K+ N+ L      K+GD G+AR++E+     +T L GT  YM+PE  +  
Sbjct: 121 --KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNK 177

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKE-EVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
             + +SDV++ G    E+A  +   +  AK+    VY            +++E   P + 
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKH--AFNAKDMNSLVY------------RIIEGKLPPMP 223

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
           +D+  +  E  +I  +    P++  RPS++ ++ 
Sbjct: 224 KDYSPELGE--LIATMLSKRPEK--RPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 6/168 (3%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-GI-KEYASEVTIISRLRHRNLVQLLG 105
           ++G+G  G V+K   RET   +A+K+V+    + GI  +   E+  +   +H  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
                   +LV EYMP   L   L  E   L         + L  G+ Y+       ++H
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMH 122

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
           RD+K +N+++  +   KI DFGLARL    +    +    T  Y APE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 14/198 (7%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLRHRNLVQLLG 105
            +G+G +G V K   +ET   +A+K+   S+  K   K    E+ ++ +LRH NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
               KK L LV+E++ +  LD  L K  N L      K    +  G+ +        ++H
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC----ATTGRAS 221
           RDIK  NI++  +   K+ DFG AR +  A G   T    T  Y APE        GRA 
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRA- 181

Query: 222 KESDVYSFGIVALEIACG 239
              D+++ G +  E+  G
Sbjct: 182 --VDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 34/219 (15%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYI--AVKRVSK-GSKQGIKEYASEVTIISRL-RH 97
           D   +  +G+G FG V +   ++    +  A+K + +  S+   +++A E+ ++ +L  H
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL---------------LTWEFRF 142
            N++ LLG C  +  L +  EY P G+L   L K   L               LT +   
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
           + A D+A+G+ YL E   +  +HRD+ + N+++  N  +KI DFGL+R        +   
Sbjct: 123 QFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVY 172

Query: 203 LAGTMG-----YMAPECATTGRASKESDVYSFGIVALEI 236
           +  TMG     +MA E       + +SDV+SFG++  EI
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 9/204 (4%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNL 100
           DF    +LG G  G V K   R +   +A K +    K  I+ +   E+ ++       +
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V   G  +   E+ +  E+M  GSLD  L K+   +      KI+  +  GL YL+E  +
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLRE--K 118

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
             ++HRD+K SNI+++     K+ DFG++ +L++    S      GT  YM+PE      
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTH 174

Query: 220 ASKESDVYSFGIVALEIACGRKPI 243
            + +SD++S G+  +E+A GR PI
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 36/211 (17%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS--------EVTIISRL-RH 97
           ++LG G FG VY    +ET   +A+K++        K++ S        EV  + +L  H
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENN--LLTWEFRFKIAQDLASGLLYL 155
            N+V+L     E  EL  V+EYM  G+L   L K+      +      I   +  GL ++
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 156 -QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT--TVLAGTMGYMAP 212
            + G+     HRD+K  N+++      KI DFGLAR +     S+   T    T  Y AP
Sbjct: 116 HKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIR----SRPPYTDYVSTRWYRAP 167

Query: 213 ECATTGRASKES---DVYSFGIVALEIACGR 240
           E     R++  S   D+++ G +  E+   R
Sbjct: 168 EILL--RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 11/149 (7%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----KQGIKEYA-SEVTIISRLRHRNLVQ 102
           KLG+G +  VYK   +ET   +A+K++  G     K GI   A  E+ ++  L+H N++ 
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK-IAQDLASGLLYLQEGWEQ 161
           LL     K  + LV+E+M    L   + K+ +++      K        GL YL   W  
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
            ++HRD+K +N+++  +   K+ DFGLAR
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 27/203 (13%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLRHRNLVQLL 104
           +K+G+G FG       +E      +K +  SK S +  +E   EV ++S ++H N+VQ  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 105 GWCHEKKELLLVYEYMPNGSLDSH-------LFKENNLLTWEFRFKIAQDLASGLLYLQE 157
               E   L +V +Y   G L          LF E+ +L W  +  +A         L+ 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LKH 116

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA----GTMGYMAPE 213
             ++ ++HRDIKS NI L  +   K+GDFG+AR++     + T  LA    GT  Y++PE
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYLSPE 171

Query: 214 CATTGRASKESDVYSFGIVALEI 236
                  + +SD+++ G V  E+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 28/226 (12%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQL--- 103
           +G+G +G VYK   ++T   +A+K+V     K+G    A  E+ I+ +L HRN+V L   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 104 -------LGWCHEKKELLLVYEYMPN---GSLDSHL--FKENNLLTWEFRFKIAQDLASG 151
                  L +  +K    LV+EYM +   G L+S L  F E+++ +        + L  G
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS------FMKQLLEG 128

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           L Y  +   +  +HRDIK SNI+L+     K+ DFGLARL    +    T    T+ Y  
Sbjct: 129 LNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 212 PECAT-TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
           PE      R     DV+S G +  E+   +KPI    +E  Q+ L+
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELI 230

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 15/206 (7%)

Query: 51  QGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           +G FG VY    R T  Y A+K + K    +K  +    +E  I+        V  L + 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 108 HEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL-QEGWEQCVVH 165
            + K+ L LV EY+  G   S L K    L  ++  +   ++  G+  L Q G    ++H
Sbjct: 66  FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG----IIH 120

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RDIK  N+++D   + K+ DFGL+R     K        GT  Y+APE        K SD
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDDKMSD 175

Query: 226 VYSFGIVALEIACGRKPISLTAKEEV 251
            +S G V  E   G  P      + V
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAV 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 24/215 (11%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNL 100
           +   + +G G +G V     + T   +A+K++S      I  K    E+ ++  LRH N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 101 VQLL-----GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWE-FRFKIAQDLASGLL 153
           + LL         +  ++ +V E M     D H + K    LT +  ++ + Q L  GL 
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQYFLYQIL-RGLK 117

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYM 210
           YL       V+HRD+K SNI+++ N + KI DFGLAR V+     +   L     T  Y 
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP-DEDEKGFLTEYVVTRWYR 173

Query: 211 APE-CATTGRASKESDVYSFG-IVALEIACGRKPI 243
           APE   ++ R +K  D++S G I A E+   RKP+
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFA-ELL-TRKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 14/198 (7%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           + LG G  G VYK +   T   +AVK +    + +  K+  SE+ I+ +     ++   G
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
               +  + +  E+M  GSLD +     ++L      +IA  +  GL YL   W   ++H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILH 118

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           RD+K SN++++     K+ DFG++  LV     S      GT  YMAPE  +  +    S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S GI  +E+A GR P
Sbjct: 175 DVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 61/231 (26%), Positives = 117/231 (50%), Gaps = 32/231 (13%)

Query: 47  QKLGQGGFGGVYKGFF----RETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLV 101
           ++LG+  FG +YKG       + +  +A+K +    + Q   E+  E ++++ L H N+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFK-----------------ENNLLTWEFRFKI 144
            LLG   +++ + +++EY+  G L   L                   +++L   +F   I
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF-LHI 129

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTT 201
           A  +A+G+ YL   +    VH+D+ + NI++    + KI D GL+R +   ++ +    +
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEV 251
           +L   + +M PE    G+ S +SD++SFG+V  EI + G +P    + +EV
Sbjct: 187 LLP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV-----SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           +G+G FG V+    +     + +K++     +K  +   +   +E  ++  L H N+++ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
                E K L++V EY P G+L  ++ K  N L  E    I       LL L     + +
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE--DTILHFFVQILLALHHVHTKLI 122

Query: 164 VHRDIKSSNIMLDLNFN-AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           +HRD+K+ NI+LD +    KIGDFG+++++     + T V  GT  Y++PE       ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCEGKPYNQ 180

Query: 223 ESDVYSFGIVALEIA 237
           +SD+++ G V  E+A
Sbjct: 181 KSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 63/197 (31%), Positives = 88/197 (44%), Gaps = 8/197 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+G FG V     + T  Y A+K + K    +K  +    +E  ++   RH  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
                  L  V EY   G L  HL +E        RF  A+ + S L YL       VV+
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-IVSALGYLHS---CDVVY 118

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+K  N+MLD + + KI DFGL +    + G+      GT  Y+APE        +  D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 226 VYSFGIVALEIACGRKP 242
            +  G+V  E+ CGR P
Sbjct: 178 WWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 20/213 (9%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTI---ISRLRHRNLVQ 102
           LG+G FG V    +++T    A+K + KG   ++  ++    E  I    +  RH  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS----GLLYLQEG 158
           L      +  +  V EY   G L  H+  +       F    A   A+    GL YL E 
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHE- 119

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
               +V+RD+K  N++LD     KI DFGL +      G +T+   GT  ++APE  T  
Sbjct: 120 --NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTET 176

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
             ++  D +  G++  E+  G  P     +EEV
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 20/228 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSY--IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           + LG+G FG V +G   +  S   +AVK  +++  ++  ++++ SE   +    H N+++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 103 LLGWCHEKKEL------LLVYEYMPNGSLDSHLFKEN-----NLLTWEFRFKIAQDLASG 151
           L+G C +  E       +++  +M +G L S L           L  +   K   D+ASG
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYM 210
           + YL     +  +HRD+ + N ML+ N N  + DFGL++ + +     Q  +    + ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 211 APECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ 257
           A E       + +SDV+SFG+   EIA  G+ P       E+  YL Q
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 9/214 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRN 99
           +DF    +LG G  G V+K   + +   +A K +    K  I+ +   E+ ++       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  +  GL YL+E  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIAVIKGLTYLRE-- 121

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTG 218
           +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT  YM+PE     
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGT 177

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
             S +SD++S G+  +E+A GR PI     +E++
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRN 99
           F D +++G G FG VY      T+  +A+K++S   KQ  +++     EV  + R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
            ++  G    +    LV EY    + D     +  L   E    I      GL YL    
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH--- 142

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 216
              ++HRDIK+ NI+L      K+ DFG A +   A         GT  +MAPE      
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMD 197

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
            G+   + DV+S GI  +E+A  RKP
Sbjct: 198 EGQYDGKVDVWSLGITCIELA-ERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 77/270 (28%), Positives = 132/270 (48%), Gaps = 31/270 (11%)

Query: 48  KLGQGGFGGVYKGFFR--ETSSYIAVKRV-SKGSKQGIK-EYASEVTIISRLRHRNLVQL 103
           +LG G FG V KG ++  ++   +AVK + +  +   +K E   E  ++ +L +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
           +G C E +  +LV E    G L+  L K N  +T +   ++   ++ G+ YL+E      
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEE---TNF 116

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRA 220
           VHRD+ + N++L     AKI DFGL++ +   E+   ++T      + + APEC    + 
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPVKWYAPECMNYYKF 175

Query: 221 SKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD 279
           S +SDV+SFG++  E  + G+KP       EV   +         +G+ +E   P+ C  
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI--------ESGERMEC--PQRC-- 223

Query: 280 FDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
               +M  LM +  W    DE  RP    V
Sbjct: 224 --PPEMYDLMKL-CWTYGVDE--RPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 40/286 (13%)

Query: 49  LGQGGFGGVYKGFFRETSSYI----AVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQL 103
           LG G FG VYKG +      +    A+K + +  S +  KE   E  +++ +    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
           LG C     + LV + MP G L  ++ +  + +  +        +A G+ YL+E     +
Sbjct: 75  LGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVE------HAKGSQTTVLAGTMGYMAPECATT 217
           VHRD+ + N+++    + KI DFGLARL++      HA G +  +      +MA E    
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI-----KWMALESILH 185

Query: 218 GRASKESDVYSFGIVALEIAC-GRKPI-SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
            R + +SDV+S+G+   E+   G KP   + A+E         + DL   G+ L    P 
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKGERLP--QPP 234

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPA 321
           +C       ++  MI+ + C   D   RP  R+++   +  A  P+
Sbjct: 235 IC------TIDVYMIM-VKCWMIDSECRPRFRELVDEFSRMARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 16/205 (7%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG---IKEYASEVTIISRLRHRNLVQLLG 105
           + +G +G V+    + T    A+K + K        + +  +E  I+S+ +   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL-QEGWEQCVV 164
               KK L LV EY+P G L S L    +L     R  IA+ +   L YL   G    ++
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-IVLALEYLHSNG----II 115

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLAR--LVEHAKG-----SQTTVLAGTMGYMAPECATT 217
           HRD+K  NI++D N + K+ DFGL++  LV           +   + GT  Y+APE    
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
              SK  D +S G +  E   G  P
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 34/282 (12%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-------SKGSKQGIKEYASEVTIISR 94
           +F  ++K+G+G F  VY+         +A+K+V       +K     IKE    + ++ +
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLKQ 58

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS---HLFKENNLLTWEFRFKIAQDLASG 151
           L H N+++      E  EL +V E    G L     H  K+  L+  +  +K    L S 
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           L ++     + V+HRDIK +N+ +      K+GD GL R    +K +    L GT  YM+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA 271
           PE       + +SD++S G +  E+A  + P                  +LY   K +E 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------------NLYSLCKKIEQ 222

Query: 272 VD-PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
            D P L  D   +++  L+ +   C +PD   RP I  V  V
Sbjct: 223 CDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 78/278 (28%), Positives = 123/278 (44%), Gaps = 39/278 (14%)

Query: 49  LGQGGFGGVYKGFFRETS---SYIAVKRVS----------KGSKQGIKEYASEVTII-SR 94
           LG G FG VYK   R+ +   + +A+K ++          +   + I +  SEVTII  +
Sbjct: 8   LGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTWEFR-FKIAQDLASG 151
           LRH N+V+      E   L +V + +    L  H    KE      E R + I   +   
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           L YL +  E+ +VHRD+  +NIML  +    I DFGLA+  +    S+ T + GT+ Y  
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA 271
           PE        +++DV++FG +  ++   + P   T    +   +V+ V++      L E 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-----PLPEG 236

Query: 272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
           +      D         +I    C  PD   RP I QV
Sbjct: 237 MYSEDVTD---------VIT--SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 31/215 (14%)

Query: 47  QKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNL 100
           ++LG+  FG VYKG        E +  +A+K +   ++  ++E +  E  + SRL+H N+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 101 VQLLGWCHEKKELLLVYEYMPN----------------GSLDSHLFKENNLLTWEFRFKI 144
           V LLG   +++ L +++ Y  +                GS D     ++ L   +F   I
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-VHI 129

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTT 201
              +A+G+ +L       VVH+D+ + N+++    N KI D GL R V   ++ K    +
Sbjct: 130 VTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
           +L   + +M+PE    G+ S +SD++S+G+V  E+
Sbjct: 187 LLP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 20/231 (8%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRH 97
           TN + D Q +G G FG V     + T   +A+K++ K     +  K    E+ ++  LRH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 98  RNLVQLLG-WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
            N++ L   +    +++  V E +     D H    +  L  +F       +  GL Y+ 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
                 VVHRD+K SNI+++ N + KI DFGLAR+ +     Q T    T  Y APE   
Sbjct: 126 SAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIML 178

Query: 217 T-GRASKESDVYSFGIVALEIACGRKPISLTAKEEV-QVYLVQWVWDLYGN 265
           T  +   E D++S G +  E+  G KP+    K+ V Q  ++    DL G 
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEG-KPL-FPGKDHVNQFSIIT---DLLGT 224

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 34/212 (16%)

Query: 49  LGQGGFGGVYKGFFRETSSYI--AVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLL 104
           +G+G FG V K   ++    +  A+KR+ +  SK   +++A E+ ++ +L  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNL---------------LTWEFRFKIAQDLA 149
           G C  +  L L  EY P+G+L   L K   L               L+ +     A D+A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG- 208
            G+ YL +   +  +HRD+ + NI++  N+ AKI DFGL+R        Q   +  TMG 
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 172

Query: 209 ----YMAPECATTGRASKESDVYSFGIVALEI 236
               +MA E       +  SDV+S+G++  EI
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 24/208 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +K+G+G +G VYK   + T   +A+K++  +   +G+   A  E++++  L H N+V+LL
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC- 162
              H + +L LV+E+     LD  L K  +         +   L    LY L +G   C 
Sbjct: 65  DVVHSENKLYLVFEF-----LDLDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 163 ---VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG---SQTTVLAGTMGYMAPECAT 216
              V+HRD+K  N+++D     K+ DFGLAR    A G      T    T+ Y APE   
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLAR----AFGVPVRTYTHEVVTLWYRAPEILL 172

Query: 217 TGRA-SKESDVYSFGIVALEIACGRKPI 243
             R  S   D++S G +  E+   R+P+
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEM-VNRRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLL 104
           LG+G FG V     + T    AVK + K        ++   +E  +++   +H  L QL 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
                K  L  V EY+  G L  H+     F E        RF  A ++  GL +L E  
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-----RF-YAAEIVLGLQFLHE-- 114

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTG 218
            + +++RD+K  N++LD   + KI DFG+ +  E   G  TT    GT  Y+APE  +  
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQ 171

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                 D ++ G++  E+  G+ P     ++E+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRN 99
           F    ++G G FG VY      T+  +AVK++S   KQ  +++     EV  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
            ++  G   ++    LV EY    + D     +  L   E    I      GL YL    
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS-- 139

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 216
              ++HRDIK+ NI+L      K+ DFG A     +K S      GT  +MAPE      
Sbjct: 140 -HNMIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMD 193

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
            G+   + DV+S GI  +E+A  RKP
Sbjct: 194 EGQYDGKVDVWSLGITCIELA-ERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 79.0 bits (194), Expect = 1e-16
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 6/196 (3%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +K+GQG  G VY      T   +A+K+++   +   +   +E+ ++   ++ N+V  L  
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
                EL +V EY+  GSL + +  E  +   +    + ++    L +L       V+HR
Sbjct: 85  YLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIA-AVCRECLQALDFLHSNQ---VIHR 139

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDV 226
           DIKS NI+L ++ + K+ DFG    +   +  ++T + GT  +MAPE  T      + D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 227 YSFGIVALEIACGRKP 242
           +S GI+A+E+  G  P
Sbjct: 199 WSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 8/197 (4%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEY-ASEVTIISRLRHRNLVQLLG 105
           +K+GQG  G V+      T   +A+K+++   KQ  KE   +E+ ++  L++ N+V  L 
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
                 EL +V EY+  GSL + +  E  +   +    + ++    L +L       V+H
Sbjct: 84  SFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIA-AVCRECLQALEFLHANQ---VIH 138

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RDIKS N++L ++ + K+ DFG    +   +  ++T + GT  +MAPE  T      + D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 226 VYSFGIVALEIACGRKP 242
           ++S GI+A+E+  G  P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 16/206 (7%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRN 99
           F+D +++G G FG VY       S  +A+K++S   KQ  +++     EV  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
            +Q  G    +    LV EY    + D     +  L   E    +      GL YL    
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS-- 133

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 216
              ++HRD+K+ NI+L      K+GDFG A ++  A         GT  +MAPE      
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMD 187

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
            G+   + DV+S GI  +E+A  RKP
Sbjct: 188 EGQYDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 49/288 (17%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSK--------GSKQGIKEYASE-VTIISRLRH 97
           + LGQG F  +YKG  R  S    V    +        GS         E  +++S+L H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
           ++LV+L G C  + E ++V EY+  G LD  L +E N ++  ++  +A+ LAS L YL++
Sbjct: 61  KHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 158 GWEQCVVHRDIKSSNIML---DLNFN----AKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
             ++  VH ++   NI++    LN       K+ D G+   V   +     +      ++
Sbjct: 120 --KKL-VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PWI 171

Query: 211 APECATTGRASKES--DVYSFGIVALEIAC-GRKPIS-LTAKEEVQVYLVQWVWDLYGNG 266
           APEC   G+AS     D +SFG   LEI   G +P+S L++ E+ +          Y + 
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---------FYQDQ 222

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
             L   D   C +      +C           D   RPS R ++  LN
Sbjct: 223 HRLPMPD---CAELANLINQCW--------TYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 19/206 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +K+G+G +G VYK   R T+  IA+K++  +   +G+   A  E++++  ++H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
              H +K L LV+EY+ +  L  H+     F +N  L   + ++I      G+ Y     
Sbjct: 68  DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIAYCH--- 119

Query: 160 EQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
              V+HRD+K  N+++D   NA K+ DFGLAR       + T  +  T+ Y APE     
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGS 178

Query: 219 RA-SKESDVYSFGIVALEIACGRKPI 243
           R  S   D++S G +  E+   +KP+
Sbjct: 179 RHYSTPVDIWSVGCIFAEMV-NQKPL 203

Length = 294

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 64/197 (32%), Positives = 89/197 (45%), Gaps = 8/197 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+G FG V     + T  Y A+K + K    +K  +    +E  ++   RH  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
                  L  V EY   G L  HL +E        RF  A+ + S L YL     + VV+
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS---RDVVY 118

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE        +  D
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 226 VYSFGIVALEIACGRKP 242
            +  G+V  E+ CGR P
Sbjct: 178 WWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 24/215 (11%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA----SEVTIISRLRH 97
            + +   +G+G +G V     + T   +A+K++S    Q    +      E+ I+ R +H
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKH 62

Query: 98  RNLVQLL-----GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLASG 151
            N++ +L            ++ +V E M     D + L K  +L     ++ + Q L  G
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYFLYQIL-RG 118

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGY 209
           L Y+       V+HRD+K SN++L+ N + KI DFGLAR+   EH      T    T  Y
Sbjct: 119 LKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 210 MAPECATTGRA-SKESDVYSFGIVALEIACGRKPI 243
            APE     +  +K  D++S G +  E+   R P+
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 63/197 (31%), Positives = 90/197 (45%), Gaps = 8/197 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+G FG V     + +  Y A+K + K    +K  +    +E  ++   RH  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
               K  L  V EY+  G L  HL +E        RF  A+ + S L YL  G    +V+
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE-IVSALDYLHSGK---IVY 118

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+K  N+MLD + + KI DFGL +       +  T   GT  Y+APE        +  D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAVD 177

Query: 226 VYSFGIVALEIACGRKP 242
            +  G+V  E+ CGR P
Sbjct: 178 WWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 66/198 (33%), Positives = 91/198 (45%), Gaps = 9/198 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+G FG V     + T  Y A+K + K    +K  +    +E  ++   RH  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
                  L  V EY   G L  HL +E        RF  A+ + S L YL    E+ VV+
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVY 119

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKES 224
           RD+K  N+MLD + + KI DFGL +  E  K G+      GT  Y+APE        +  
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 177

Query: 225 DVYSFGIVALEIACGRKP 242
           D +  G+V  E+ CGR P
Sbjct: 178 DWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 24/211 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLG 105
           +G G +G VYKG   +T    A+K   V+   ++ IK+   E+ ++ +   HRN+    G
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYG 70

Query: 106 WCHEKK------ELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQE 157
              +K       +L LV E+   GS+ + L K  + N L  E+   I +++  GL +L +
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---C 214
                V+HRDIK  N++L  N   K+ DFG++  ++   G + T + GT  +MAPE   C
Sbjct: 130 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 185

Query: 215 ATTGRASKE--SDVYSFGIVALEIACGRKPI 243
                A+ +  SD++S GI A+E+A G  P+
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 17/186 (9%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYA-SEVTIISRLRHR 98
           + +    K+GQG FG V+K   ++T   +A+K+V   + K+G    A  E+ I+  L+H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 99  NLVQLLGWCHEKK--------ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS 150
           N+V L+  C  K            LV+E+  +  L   L  +N   T     K+ + L +
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN 130

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TM 207
           GL Y+       ++HRD+K++NI++  +   K+ DFGLAR    +K S+         T+
Sbjct: 131 GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 208 GYMAPE 213
            Y  PE
Sbjct: 188 WYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 38/281 (13%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYI----AVKRVSKG-SKQGIKEYASEVTIISRLR 96
           +F   + LG G FG VYKG +      +    A+K + +  S +  KE   E  +++ + 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           + ++ +LLG C     + L+ + MP G L  ++ +  + +  ++       +A G+ YL+
Sbjct: 68  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE------HAKGSQTTVLAGTMGYM 210
           E   + +VHRD+ + N+++    + KI DFGLA+L+       HA+G +  +      +M
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI-----KWM 178

Query: 211 APECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLL 269
           A E       + +SDV+S+G+   E+   G KP       E+   L          G+ L
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERL 230

Query: 270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
               P +C       ++  MI+ + C   D + RP  R++I
Sbjct: 231 P--QPPIC------TIDVYMIM-VKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 20/214 (9%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIK-EYASEVTIISRLRHRNLVQLLG 105
           ++G+G +G VY+     +   +A+K+V     + GI      E+T++  LRH N+V+L  
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 106 WCHEKK--ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK-IAQDLASGLLYLQEGWEQC 162
               K    + LV EY     L S L       + E + K +   L  GL YL E     
Sbjct: 74  VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS-ESQVKCLMLQLLRGLQYLHE---NF 128

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE----CATTG 218
           ++HRD+K SN++L      KI DFGLAR         T  +  T+ Y APE    C T  
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYT 187

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
            A    D+++ G +  E+    KP+ L  K E++
Sbjct: 188 TA---IDMWAVGCILAELLAH-KPL-LPGKSEIE 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRN---LVQ 102
           +G+G FG VY+   ++T    A+K +SK      KE A    E  I+ R        +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L        +L LV +YM  G L  HL KE        +F IA+ +    L L+   +  
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELV----LALEHLHKYD 116

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-S 221
           +V+RD+K  NI+LD   +  + DFGL++         T    GT  Y+APE     +  +
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 222 KESDVYSFGIVALEIACGRKPISLTAKEEVQVY 254
           K  D +S G++  E+ CG  P    A++  Q+Y
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSP--FYAEDTQQMY 206

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.2 bits (190), Expect = 3e-16
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 27/231 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRV------SKGSKQGIKEYASEVTIISRLRHRNL 100
            ++G G FG V  G   E    ++  RV      +  +      +  EV     L H N+
Sbjct: 1   DEIGNGWFGKVLLG---EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV 57

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTW----EFRFKIAQDLASGLLYLQ 156
           +Q LG C E    LLV E+ P G L ++L     ++      +   ++A ++ASGLL+L 
Sbjct: 58  LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPEC 214
           +      +H D+   N  L  + + KIGD+GLA L ++ +    T    A  + ++APE 
Sbjct: 118 QA---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPEL 173

Query: 215 AT-------TGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQ 257
                        +K+S+++S G+   E+     +P    + E+V   +V+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 24/217 (11%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGW 106
           KLG+G +  V+KG  + T + +A+K +    ++G    A  EV+++  L+H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE----FRFKIAQDLASGLLYLQEGWEQC 162
            H ++ L LV+EY+ +  L  +L    NL++      F F+    L  GL Y  +   + 
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ----LLRGLSYCHK---RK 123

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECAT-TG 218
           ++HRD+K  N++++     K+ DFGLAR    AK   T   +    T+ Y  P+    + 
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 219 RASKESDVYSFGIVALEIACGRK--PISLTAKEEVQV 253
             S   D++  G +  E+A GR   P S T KEE+ +
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGS-TVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 8/197 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           +G+G FG V +   R+T    A+K + K    S+  +    +E T+++++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
                ++L LV  ++  G L  HL +E        RF  A+ L      L+   +  V++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL----CALENLHKFNVIY 116

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+K  NI+LD   +  + DFGL +L       +T    GT  Y+APE       +K  D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 226 VYSFGIVALEIACGRKP 242
            ++ G++  E+  G  P
Sbjct: 176 WWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 29/179 (16%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKR-VSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLG 105
           K+G+G +G V+K   RET   +A+K+ V       IK+ A  E+ ++ +L+H NLV L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 106 WCHEKKELLLVYEYM-----------PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
               K++L LV+EY            P G +  HL K+   + W+            L  
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKK---IIWQT-----------LQA 112

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
           +    +   +HRD+K  NI++      K+ DFG AR++       T  +A T  Y APE
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 20/211 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLG 105
           + +G G +G VYKG   +T    A+K V   ++   +E   E+ ++ +   HRN+    G
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 106 WCHEKK------ELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQE 157
              +K       +L LV E+   GS+ + L K  + N L  ++   I +++  GL +L  
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---C 214
                V+HRDIK  N++L  N   K+ DFG++  ++   G + T + GT  +MAPE   C
Sbjct: 140 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 195

Query: 215 ATTGRASKE--SDVYSFGIVALEIACGRKPI 243
                A+ +  SD++S GI A+E+A G  P+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 6/195 (3%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           K+G+G  G V     + +   +AVK +    +Q  +   +EV I+   +H+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
              +EL ++ E++  G+L   + +    L  E    + + +   L YL     Q V+HRD
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHS---QGVIHRD 142

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVY 227
           IKS +I+L L+   K+ DFG    +      + + L GT  +MAPE  +      E D++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRTPYGTEVDIW 201

Query: 228 SFGIVALEIACGRKP 242
           S GI+ +E+  G  P
Sbjct: 202 SLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 41/289 (14%)

Query: 47  QKLGQGGFGGVYKG--FFRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           +++G G FG V  G      T + + VK +    S Q   ++  E      L+H NL+Q 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTWEFRF--KIAQDLASGLLYLQEGW 159
           LG C E    LLV E+ P G L  +L   ++  L+T +     ++A ++A GLL+L    
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT-----MGYMAPEC 214
           +   +H D+   N +L  +   KIGD+GL+    H K  +   +        + ++APE 
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 215 A-------TTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
                        +KES+V+S G+   E+   G +P    + E+V  Y V+         
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------E 225

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           + L+   PRL     ++  E +    L    P++  RPS  +V H+L S
Sbjct: 226 QQLKLPKPRLKLPLSDRWYEVMQFCWL---QPEQ--RPSAEEV-HLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 76.2 bits (187), Expect = 8e-16
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 8/206 (3%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
           +D+   Q++G G +G VYK     T    AVK +             E+ ++   +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V   G    +++L +  EY   GSL         L   +  + + ++   GL YL     
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHS--- 124

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT---T 217
           +  +HRDIK +NI+L  N + K+ DFG+A  +      + + + GT  +MAPE A     
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKN 183

Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
           G  ++  D+++ GI A+E+A  + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 9e-16
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 13/205 (6%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----KQGIKEYASEVTIISRLRH 97
           D    + +G G FG V+    R +  Y A+K ++       KQ  +   +E  ++  + H
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             +++L    H+++ L ++ EY+P G L S+L            F  A ++   L YL  
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLHS 119

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + +V+RD+K  NI+LD   + K+ DFG A+ +      +T  L GT  Y+APE   +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEYLAPEVIQS 172

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
              +K  D ++ GI+  E+  G  P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 73/239 (30%), Positives = 108/239 (45%), Gaps = 28/239 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+GGFG V     R T    A K++ K     ++G     +E  I+ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 106 WCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKI-AQDLASGLLYLQEGWEQCV 163
           + +E K+ L LV   M  G L  H++   N    E R    A +L  GL  LQ    + +
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERI 123

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           V+RD+K  NI+LD   + +I D GLA  V+  +G       GT+GYMAPE     + +  
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 224 SDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE 282
            D +  G +  E+  G+ P     KE V+                 E VD R+  D +E
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFR-KRKERVK----------------REEVDRRVKEDQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 22/219 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLG 105
           +KLG+G +  V+KG  + T + +A+K +    ++G    A  EV+++  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE----FRFKIAQDLASGLLYLQEGWEQ 161
             H  K L LV+EY+ +  L  ++    N+++      F ++I +    GL Y      +
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR----GLAYCHR---R 123

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECAT-T 217
            V+HRD+K  N++++     K+ DFGLAR    AK   T   +    T+ Y  P+    +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGS 179

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
              S + D++  G +  E+A GR P+   +  E +++L+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 8/205 (3%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
           DF   Q++G G +G VYK     T    A+K +     +       E+ ++   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
              G    + +L +  E+   GSL         L   +  + ++++   GL YL    + 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHSKGK- 127

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA- 220
             +HRDIK +NI+L  N + K+ DFG++  +      + + + GT  +MAPE A   R  
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKG 184

Query: 221 --SKESDVYSFGIVALEIACGRKPI 243
             ++  D+++ GI A+E+A  + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 26/210 (12%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +LG+G +G VYK   R T   +A+K +  +  +    +   E+ I+ +     +V   G 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 107 CHEKKELLLVYEYMPNGSLDS-------HLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
              +  + +  EYM  GSLD              ++L      +I   +  GL +L+E  
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFLKE-- 120

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTG 218
           E  ++HRD+K +N++++ N   K+ DFG++  LV  A  ++T +  G   YMAPE   +G
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--ASLAKTNI--GCQSYMAPERIKSG 176

Query: 219 RASK------ESDVYSFGIVALEIACGRKP 242
             ++      +SDV+S G+  LE+A GR P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 12/215 (5%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRN 99
           F   + LG+GGFG V     R T    A KR+ K     ++G     +E  I+ ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKI-AQDLASGLLYL-QE 157
           +V L      K  L LV   M  G L  H++   N    E R    A ++  GL  L +E
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
                 V+RD+K  NI+LD   + +I D GLA  V+  +G       GT+GYMAPE    
Sbjct: 122 N----TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
            R +   D +  G +  E+  G+ P     KE+V+
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFR-GRKEKVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 10/198 (5%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +K+GQG  G VY      T   +A+++++   +   +   +E+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
                EL +V EY+  GSL + +  E  +   +    + ++    L +L       V+HR
Sbjct: 86  YLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIHR 140

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           DIKS NI+L ++ + K+ DFG    +  E +K S    + GT  +MAPE  T      + 
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKV 197

Query: 225 DVYSFGIVALEIACGRKP 242
           D++S GI+A+E+  G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 28/212 (13%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
             ++  K+G+G  G V     + T   +AVK++    +Q  +   +EV I+   +H N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLD---SHL-FKENNLLTWEFRFKIAQDLASGLLYLQE 157
           ++        EL +V E++  G+L    +H    E  + T      +   +   L +L  
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLHA 133

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV-------LAGTMGYM 210
              Q V+HRDIKS +I+L  +   K+ DFG          +Q +        L GT  +M
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFC--------AQVSKEVPRRKSLVGTPYWM 182

Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKP 242
           APE  +      E D++S GI+ +E+  G  P
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNL 100
            +N  + +G+G FG         +    A+K +    S   +++   E  ++++++H N+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSL-------DSHLFKENNLLTWEFRFKIAQDLASGLL 153
           V           L +V EY   G L          LF E+ +L W              L
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---------FVQMCL 111

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
            +Q   E+ V+HRDIKS NI L  N   K+GDFG ARL+    G+      GT  Y+ PE
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAYACTYVGTPYYVPPE 170

Query: 214 CATTGRASKESDVYSFGIVALEIACGRKP 242
                  + +SD++S G +  E+   + P
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 13/218 (5%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRN 99
           F   + LG+GGFG V     R T    A K++ K     ++G     +E  I+ ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKI-AQDLASGLLYLQEG 158
           +V L      K  L LV   M  G L  H++        E R    A ++  GL  L + 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ- 120

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
             + +V+RD+K  NI+LD + + +I D GLA  V   +G       GT+GYMAPE     
Sbjct: 121 --ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE 176

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAK----EEVQ 252
           R +   D ++ G +  E+  G+ P     K    EEV+
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 37/212 (17%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNL 100
           F   +K+G+G +G VYK   + T   +A+K++   ++ +G+   A  E++++  L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 101 VQLLGWCHEKKELLLVYEYM-----------PNGSLDSHLFKENNLLTWEFRFKIAQDLA 149
           V+LL   H + +L LV+E++           P   +   L K                  
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK------------------ 103

Query: 150 SGLLYLQEGWEQC----VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           S L  L +G   C    V+HRD+K  N++++     K+ DFGLAR       + T  +  
Sbjct: 104 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 162

Query: 206 TMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
           T+ Y APE     +  S   D++S G +  E+
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 14/214 (6%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGW 106
           KLG+G +  VYKG  + T + +A+K +    ++G    A  EV+++  L+H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            H +K L LV+EY+ +  L  +L    N +           L  GL Y      + V+HR
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHR 128

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECAT-TGRASK 222
           D+K  N++++     K+ DFGLAR    AK   T   +    T+ Y  P+    +   S 
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 223 ESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
           + D++  G +  E++ GR P+   +  E Q++ +
Sbjct: 185 QIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 13/209 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR------LRHRNLVQ 102
           LG+G FG V     + T+ + A+K + K     +++   E T++ R        H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L      K+ L  V EY+  G L  H+           RF  A ++  GL +L +     
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG--- 116

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           +++RD+K  N++LD + + KI DFG+ +   + +G  +T   GT  Y+APE     + ++
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNE 175

Query: 223 ESDVYSFGIVALEIACGRKPISLTAKEEV 251
             D +SFG++  E+  G+ P     ++E+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-------SKGSKQGIKEYASEVTIISR 94
           +F  ++K+G+G F  VY+         +A+K+V       +K  +  +KE    + ++ +
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLKQ 58

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS---HLFKENNLLTWEFRFKIAQDLASG 151
           L H N+++ L    E  EL +V E    G L     +  K+  L+     +K    L S 
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           + ++     + V+HRDIK +N+ +      K+GD GL R    +K +    L GT  YM+
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMS 174

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKP 242
           PE       + +SD++S G +  E+A  + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 12/209 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           LG+GGFG V     R T    A K++ K     ++G     +E  I+ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 106 WCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKI-AQDLASGLLYLQEGWEQCV 163
           + +E K+ L LV   M  G L  H++   N    E R    A ++  GL  L     + +
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERI 123

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           V+RD+K  NI+LD   + +I D GLA  VE  +G       GT+GYMAPE     R +  
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 224 SDVYSFGIVALEIACGRKPISLTAKEEVQ 252
            D +  G +  E+  G+ P     KE+V+
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFR-QRKEKVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 13/205 (6%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----KQGIKEYASEVTIISRLRH 97
           DF   + LG G FG V     + T  Y A+K + K      KQ ++  A E +I+  L H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSH 77

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             +V ++    ++  +  + E++  G L +HL K         +F  A+ L     YL  
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-LVLAFEYLHS 136

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + +++RD+K  N++LD   + K+ DFG A+ V      +T  L GT  Y+APE   +
Sbjct: 137 ---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----DRTFTLCGTPEYLAPEVIQS 189

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
               K  D ++ G++  E   G  P
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 15/210 (7%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR------LRHRNLVQ 102
           LG+G FG V+    + T+ + A+K + K     + +   E T++ +        H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L      K+ L  V EY+  G L  H+   +        F  A ++  GL +L     + 
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-YAAEIICGLQFLHS---KG 116

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRAS 221
           +V+RD+K  NI+LD + + KI DFG+ +  E+  G ++T    GT  Y+APE     + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174

Query: 222 KESDVYSFGIVALEIACGRKPISLTAKEEV 251
              D +SFG++  E+  G+ P     +EE+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 26/214 (12%)

Query: 47  QKLGQGGFG--------GVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRL-R 96
           + LG+G FG        G+ K   +E  + +AVK +    +++ + +  SE+ ++  + +
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVT-VAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA---------QD 147
           H+N++ LLG C +   L ++ EY   G+L  +L +       E+ + IA         +D
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 148 LASGLLYLQEGWE----QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTV 202
           L S    +  G E    Q  +HRD+ + N+++  N   KI DFGLAR V +     +TT 
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
               + +MAPE       + +SDV+SFG++  EI
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 65/237 (27%), Positives = 101/237 (42%), Gaps = 39/237 (16%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG----SKQGIKEYASEVTIISRLR 96
           +DF   + +G+G FG V+    ++T    A+K + K       Q I    +E  I++   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL- 155
              +V+L     +++ L LV EYMP G L + L +++       RF IA+ L   L  + 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE-LVLALDSVH 118

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA------------------------RL 191
           + G+    +HRDIK  NI++D + + K+ DFGL                          L
Sbjct: 119 KLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 192 VEHAKGSQTTVLA----GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
           V      Q  V A    GT  Y+APE         E D +S G++  E+  G  P  
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 49  LGQGGFGGVY---KGFFRETSSYIAVKRVSKGS-KQGIKEYA---SEVTIISRLRHRNLV 101
           LG+GG+G V+   K    +T    A+K + K +  +  K+ A   +E  I+  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            L+       +L L+ EY+  G L  HL +E   +     F     L+   L L+   +Q
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY----LSEISLALEHLHQQ 119

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-AKGSQTTVLAGTMGYMAPECATTGRA 220
            +++RD+K  NI+LD   + K+ DFGL +  E   +G+ T    GT+ YMAPE       
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 221 SKESDVYSFGIVALEIACGRKPIS 244
            K  D +S G +  ++  G  P +
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 50/294 (17%)

Query: 49  LGQGGFGGVYK----GFFR---ETSSYIAVKRVS-KGSKQGIKEYASEVTIISRL-RHRN 99
           LG+G FG V +    G  +   + +  +AVK +    + + + +  SE+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKE---------------NNLLTWEFRFKI 144
           ++ LLG C ++  L ++ EY   G+L   L                     L+++     
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA 204
           A  +A G+ YL+    +C+ HRD+ + N+++  +   KI DFGLAR V      + T   
Sbjct: 140 AYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS-N 195

Query: 205 GTM--GYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWD 261
           G +   +MAPE       + +SDV+SFGI+  EI   G  P      EE        ++ 
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--------LFK 247

Query: 262 LYGNGKLLEAVDPRLCRDFDEQQM-ECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
           L   G  ++   P  C       M EC      W A P +  RP+ +Q++  L+
Sbjct: 248 LLREGHRMDK--PSNCTHELYMLMREC------WHAVPTQ--RPTFKQLVEALD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 11/199 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKE----YASEVTIISRLRHRNLVQLL 104
           +G+G FG V     +    + AVK + K +    KE     A    ++  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
                  +L  V +Y+  G L  HL +E +      RF  A ++AS L YL       ++
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNII 118

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTGRASKE 223
           +RD+K  NI+LD   +  + DFGL +  E  + S+TT    GT  Y+APE        + 
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176

Query: 224 SDVYSFGIVALEIACGRKP 242
            D +  G V  E+  G  P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 6/195 (3%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           K+G+G  G V     + +   +AVK++    +Q  +   +EV I+   +H N+V++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
               EL +V E++  G+L       +  +  E   +IA    + L  L     Q V+HRD
Sbjct: 87  LVGDELWVVMEFLEGGALTD--IVTHTRMNEE---QIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVY 227
           IKS +I+L  +   K+ DFG    V      + + L GT  +MAPE  +      E D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIW 200

Query: 228 SFGIVALEIACGRKP 242
           S GI+ +E+  G  P
Sbjct: 201 SLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 53/299 (17%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           + D + LG G  G V+     +    +AVK++     Q +K    E+ II RL H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 103 L--------------LGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQ 146
           +              +G   E   + +V EYM     ++ L    E   L+ E       
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLV----EHAKG--SQ 199
            L  GL Y+       V+HRD+K +N+ ++  +   KIGDFGLAR+V     H KG  S+
Sbjct: 122 QLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH-KGYLSE 177

Query: 200 TTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
             V   T  Y +P    +    +K  D+++ G +  E+  G KP+   A E  Q+ L+  
Sbjct: 178 GLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLI-- 231

Query: 259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA 317
                     LE+V   + R+ D  ++  ++   +      E  RP +R ++  +N EA
Sbjct: 232 ----------LESV--PVVREEDRNELLNVIPSFV-RNDGGEPRRP-LRDLLPGVNPEA 276

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLG 105
           +KLG+G +  VYKG  R     +A+K +S  +++G+   A  E +++  L+H N+V L  
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
             H K+ L  V+EYM        +     L  +  R  + Q L  GL Y+     Q ++H
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHG---QHILH 126

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG--SQT-TVLAGTMGYMAPECATTGRA-- 220
           RD+K  N+++      K+ DFGLAR    AK   SQT +    T+ Y  P+    G    
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSEVVTLWYRPPD-VLLGATDY 181

Query: 221 SKESDVYSFGIVALEIACGR 240
           S   D++  G + +E+  G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 24/221 (10%)

Query: 49  LGQGGFGGVYKGFFRETSS-----YIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQ 102
           LG+G FG V+    +          + VK + K   + ++ E+  E+ +  +L H+N+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLF----KENNL----LTWEFRFKIAQDLASGLLY 154
           LLG C E +   ++ EY   G L   L     K+  L    L+ + +  +   +A G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMA 211
           L        VHRD+ + N ++      K+    L++ V   E+ K     +    + ++A
Sbjct: 133 LSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI---PLRWLA 186

Query: 212 PECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEV 251
           PE       S +SDV+SFG++  E+   G  P    + EEV
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 14/236 (5%)

Query: 23  EKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFR-ETSSYIAVKRVSKGS--- 78
           +K +   +   ++      DFN  + LG G FG V    ++ E    +A+KR  K     
Sbjct: 12  KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71

Query: 79  KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTW 138
           ++ +    SE  I++ + H   V L G   ++  L LV E++  G   + L + N     
Sbjct: 72  QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPN 130

Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
           +     A  +     YLQ      +V+RD+K  N++LD +   K+ DFG A++V+    +
Sbjct: 131 DVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----T 183

Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY 254
           +T  L GT  Y+APE        K +D ++ GI   EI  G  P    A E + +Y
Sbjct: 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP--FYANEPLLIY 237

Length = 340

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 78/294 (26%), Positives = 137/294 (46%), Gaps = 46/294 (15%)

Query: 47  QKLGQGGFGGVYK----GFFRETSSYI---AVKRV-SKGSKQGIKEYASEVTIISRL-RH 97
           + LG+G FG V      G  +E  + +   AVK + S  +++ + +  SE+ ++  + +H
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKE---------------NNLLTWEFRF 142
           +N++ LLG C +   L ++ EY   G+L  +L                     L+++   
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTT 201
             A  +A G+ YL    ++C+ HRD+ + N+++  +   KI DFGLAR + H     +TT
Sbjct: 144 SCAYQVARGMEYLAS--KKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVW 260
                + +MAPE       + +SDV+SFG++  EI   G  P      EE        ++
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------LF 252

Query: 261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
            L   G  ++   P  C   +E  M   M+   W A P +  RP+ +Q++  L+
Sbjct: 253 KLLKEGHRMDK--PSNCT--NELYM---MMRDCWHAVPSQ--RPTFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQL--- 103
           +G+G +G V      ET+  +A+K+++      I  K    E+ ++  L H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 104 LGWCHEK--KELLLVYEYMPNGSLDSH-LFKENNLLTWEF-RFKIAQDLASGLLYLQEGW 159
           +   H +   ++ +VYE M     D H + + +  L+ +  ++ + Q L  GL Y+    
Sbjct: 73  MPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHCQYFLYQ-LLRGLKYIHSA- 127

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE----CA 215
              V+HRD+K SN++L+ N + KI DFGLAR     KG   T    T  Y APE    C+
Sbjct: 128 --NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 216 TTGRASKESDVYSFGIVALEIACGRKPI 243
               A    DV+S G +  E+  GRKP+
Sbjct: 185 EYTTA---IDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 37/197 (18%)

Query: 33  YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTI 91
           Y+ELA+          +G+G +G VYK     T  ++A+K+V    S++GI    S +  
Sbjct: 1   YEELAE----------IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLRE 48

Query: 92  ISRLR------HRNLVQLLGWCH-----EKKELLLVYEYMPNGSLDSHLFKEN----NLL 136
           I+ L+      H N+V+LL  CH      + +L LV+E++     D   +        L 
Sbjct: 49  IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLP 105

Query: 137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
               +  + Q L  G+ +L       +VHRD+K  NI++  +   KI DFGLAR+     
Sbjct: 106 PETIKDLMRQ-LLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161

Query: 197 GSQTTVLAGTMGYMAPE 213
            + T+V+  T+ Y APE
Sbjct: 162 -ALTSVVV-TLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 27/207 (13%)

Query: 47  QKLGQGGFGGVY----KGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNL 100
           Q+LG+G FG VY    K    E    + +K +  G  +     +   E  ++S+L H  +
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL---------FKENNLLTWEFRFKIAQDLASG 151
           V+      E+    ++ EY     LD  L           EN +  W  +      L  G
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ------LLLG 118

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           + Y+ +   + ++HRD+K+ NI L  N   KIGDFG++RL+  +    TT   GT  YM+
Sbjct: 119 VHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMS 173

Query: 212 PECATTGRASKESDVYSFGIVALEIAC 238
           PE         +SD++S G +  E+ C
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 25/222 (11%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL------ 95
           DFN    LG+G FG V     + T    A+K + K     I++   E T++ +       
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPG 58

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           +   L QL         L  V EY+  G L  H+     FKE + + +      A ++A 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAI 112

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGY 209
           GL +L     + +++RD+K  N+MLD   + KI DFG+ +  E+  G +TT    GT  Y
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDY 167

Query: 210 MAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           +APE        K  D ++FG++  E+  G+ P     ++E+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR----LRHRN--LVQ 102
           LG+G FG V     +    Y AVK + K     + +   E T++ +    L   N  L  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L      K+ L  V E++  G L  H+  +     +   F  A ++  GL +L       
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSKG--- 116

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRAS 221
           +++RD+K  N+MLD + + KI DFG+ +  E+  G ++ +   GT  Y+APE     + +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYT 174

Query: 222 KESDVYSFGIVALEIACGRKP 242
              D +SFG++  E+  G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 15/149 (10%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGW 106
           KLG+G +  VYKG  + T   +A+K +    ++G    A  E +++  L+H N+V L   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 107 CHEKKELLLVYEYMPNG---SLDSH--LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            H KK L LV+EY+       +D        +N+  + F+      L  GL Y     ++
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ------LLRGLAYCH---QR 122

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
            V+HRD+K  N+++      K+ DFGLAR
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 15/269 (5%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC 107
           K+G+G  G V     + T   +AVK++    +Q  +   +EV I+    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
               EL +V E++  G+L       +  +  E    +   +   L YL     Q V+HRD
Sbjct: 89  LVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRD 143

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVY 227
           IKS +I+L  +   K+ DFG    V      + + L GT  +MAPE  +      E D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 228 SFGIVALEIACGRKPI----SLTAKEEVQVYLVQWVWDLYGNGKLLEA-VDPRLCRDFDE 282
           S GI+ +E+  G  P      L A   ++  L   V D +    +L   +D  L R+   
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE-PS 261

Query: 283 QQMECLMIVG---LWCAHPDENLRPSIRQ 308
           Q+     ++    L  A P   + P +RQ
Sbjct: 262 QRATAQELLQHPFLKLAGPPSCIVPLMRQ 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRLR---HRNLVQ 102
           ++G G +G VYK     +  ++A+K  RV             EV ++ RL    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 103 LLGWC-----HEKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQ 156
           L+  C       + ++ LV+E++ +  L ++L K     L  E    + +    GL +L 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
                C+VHRD+K  NI++      K+ DFGLAR+          V+  T+ Y APE   
Sbjct: 126 A---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLL 180

Query: 217 TGRASKESDVYSFGIVALEIACGRKPI 243
               +   D++S G +  E+   RKP+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMF-RRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 25/222 (11%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL------ 95
           DFN    LG+G FG V     + T    A+K + K     I++   E T++ +       
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSG 58

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           +   L QL         L  V EY+  G L   +     FKE + + +      A ++A 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIAI 112

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGY 209
           GL +L     + +++RD+K  N+MLD   + KI DFG+ +  E+   G  T    GT  Y
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167

Query: 210 MAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           +APE        K  D ++FG++  E+  G+ P     ++E+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLR-HRNLVQL 103
           QKLG+G +G V+K   R T   +A+K++  +  +    +    E+  +  L  H N+V+L
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 104 LGWCHEK--KELLLVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           L     +  K++ LV+EYM     D H + + N L     R+ + Q L   L Y+  G  
Sbjct: 73  LNVIKAENDKDIYLVFEYMET---DLHAVIRANILEDVHKRYIMYQ-LLKALKYIHSG-- 126

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT----TVLAGTMGYMAPEC-- 214
             V+HRD+K SNI+L+ +   K+ DFGLAR +   + +      T    T  Y APE   
Sbjct: 127 -NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL 185

Query: 215 ATTGRASKESDVYSFGIVALEIACGR 240
            +T R +K  D++S G +  E+  G+
Sbjct: 186 GST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 9/209 (4%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQL 103
           + LG+G FG V     +E+    AVK + K        ++   +E  I+S  R+   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 104 LGWCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L  C +  + L  V E++  G L  H+ K         RF  A ++ S L++L +   + 
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHD---KG 116

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           +++RD+K  N++LD   + K+ DFG+ +      G  T+   GT  Y+APE         
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 223 ESDVYSFGIVALEIACGRKPISLTAKEEV 251
             D ++ G++  E+ CG  P     ++++
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 25/222 (11%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR----LRH 97
           DFN    LG+G FG V     + T    A+K + K     I++   E T++ +    L+ 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQD 58

Query: 98  RN--LVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           +   L QL         L  V EY+  G L  H+     FKE   + +      A +++ 
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISV 112

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-AKGSQTTVLAGTMGY 209
           GL +L     + +++RD+K  N+MLD   + KI DFG+ +  EH   G  T    GT  Y
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDY 167

Query: 210 MAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           +APE        K  D +++G++  E+  G+ P     ++E+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 19/224 (8%)

Query: 34  KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIIS 93
           + L   T+ +   + +G+G +G VYK   ++  S  AVK +   S    +E  +E  I+ 
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQ 73

Query: 94  RL-RHRNLVQLLGWCHEKK-----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK---I 144
            L  H N+V+  G  ++       +L LV E    GS+ + L K   LL    R     I
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVK--GLLICGQRLDEAMI 130

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA 204
           +  L   LL LQ      ++HRD+K +NI+L      K+ DFG++  +   +  + T + 
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 189

Query: 205 GTMGYMAPE---CATTGRASKES--DVYSFGIVALEIACGRKPI 243
           GT  +MAPE   C      S ++  DV+S GI A+E+  G  P+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 9/198 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKE----YASEVTIISRLRHRNLVQLL 104
           +G+G FG V     +   S+ AVK + K +    KE     A    ++  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
                 ++L  V +Y+  G L  HL +E   L    RF  A ++AS + YL       ++
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNII 118

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           +RD+K  NI+LD   +  + DFGL +     + + T+   GT  Y+APE        +  
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFCGTPEYLAPEVLRKEPYDRTV 177

Query: 225 DVYSFGIVALEIACGRKP 242
           D +  G V  E+  G  P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRN---LVQ 102
           +G+GGFG VY     +T    A+K + K     KQG     +E  ++S +   +   +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           +    H   +L  + + M  G L  HL +       E RF  A ++  GL ++   +   
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF--- 117

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           VV+RD+K +NI+LD + + +I D GLA      K   +    GT GYMAPE    G A  
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174

Query: 223 ES-DVYSFGIVALEIACGRKP 242
            S D +S G +  ++  G  P
Sbjct: 175 SSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 14/214 (6%)

Query: 49  LGQGGFGGVY---KGFFRETSSYIAVKRVSKGS---KQGIKEYA-SEVTIISRLRHRNLV 101
           LG G +G V+   K    +     A+K + K +   K    E+  +E  ++  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 102 QLLGWCHE-KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
             L +  +   +L L+ +Y+  G L +HL++  +    E R  IA+ +    L L    +
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV----LALDHLHQ 123

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
             +++RDIK  NI+LD   +  + DFGL++     +  +     GT+ YMAPE    G  
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183

Query: 221 --SKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
              K  D +S G++  E+  G  P ++  ++  Q
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 47  QKLGQGGFGGVYK----GFFRETSS---YIAVKRVSK-GSKQGIKEYASEVTIISRL-RH 97
           + LG+G FG V      G  ++  +    +AVK +    + + + +  SE+ ++  + +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKE---------------NNLLTWEFRF 142
           +N++ LLG C +   L ++ EY   G+L  +L                     LT++   
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTT 201
             A  +A G+ YL    ++C+ HRD+ + N+++  +   KI DFGLAR V +     +TT
Sbjct: 138 SCAYQVARGMEYLAS--QKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
                + +MAPE       + +SDV+SFG++  EI
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 11/199 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISR-LRHRNLVQLL 104
           +G+G FG V     +    + AVK + K +   K+  K   SE  ++ + ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
                  +L  V +Y+  G L  HL +E   L    RF  A ++AS L YL       +V
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIV 118

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARL-VEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           +RD+K  NI+LD   +  + DFGL +  +EH     T+   GT  Y+APE        + 
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRT 176

Query: 224 SDVYSFGIVALEIACGRKP 242
            D +  G V  E+  G  P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.5 bits (170), Expect = 9e-13
 Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 19/191 (9%)

Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLL--GWCHEKKELLLVYE 118
            T   +A+K +   + +   + A    E  + +RL H N+V LL  G       L  V+E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59

Query: 119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML--- 175
           Y+P  +L   L  +  L   E    + Q L +    L     Q +VHRD+K  NIM+   
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDA----LACAHNQGIVHRDLKPQNIMVSQT 115

Query: 176 DLNFNAKIGDFGLARL------VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
            +  +AK+ DFG+  L       + A  ++TT + GT  Y APE       +  SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 230 GIVALEIACGR 240
           G++ LE   G+
Sbjct: 176 GLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 37/228 (16%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +G+G +G V K   +ET   +A+K+   S+ +++  +    E+ ++  L+  N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 107 CHEKKELLLVYEY-----------MPNGSL----DSHLFKENNLLTWEFRFKIAQDLASG 151
              + +L LV+EY           MPNG       S++++    + W  +  I       
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI------- 121

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
                       VHRDIK  N+++  N   K+ DFG AR +     +  T    T  Y +
Sbjct: 122 ------------VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV 259
           PE        K  D++S G +  E++ G +P+     E  Q++ +Q V
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESEIDQLFTIQKV 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 24/195 (12%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQ 102
           ++ +G +G VY+   ++T   +A+K++ K  K+  KE        E+ I+ +L+H N+V 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKL-KMEKE--KEGFPITSLREINILLKLQHPNIVT 68

Query: 103 L----LGWCHEKKELLLVYEYMPNG--SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           +    +G   +K  + +V EY+ +   SL      +   L  E +  + Q L SG+ +L 
Sbjct: 69  VKEVVVGSNLDK--IYMVMEYVEHDLKSLMET--MKQPFLQSEVKCLMLQ-LLSGVAHLH 123

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
           + W   ++HRD+K+SN++L+     KI DFGLAR         T ++  T+ Y APE   
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLL 179

Query: 217 -TGRASKESDVYSFG 230
                S   D++S G
Sbjct: 180 GAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 32/204 (15%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLR-HRNLVQLL 104
           K+G+G F  V K   R+T  Y A+K + K   S + +     E+  + RL  H N+++L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLI 64

Query: 105 GWCHEKK--------ELL--LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
               ++K        EL+   +YE +           E  + ++ ++      L   L +
Sbjct: 65  EVLFDRKTGRLALVFELMDMNLYELIKG---RKRPLPEKRVKSYMYQ------LLKSLDH 115

Query: 155 L-QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
           + + G    + HRDIK  NI++  +   K+ DFG  R + ++K   T  ++ T  Y APE
Sbjct: 116 MHRNG----IFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPPYTEYIS-TRWYRAPE 168

Query: 214 CA-TTGRASKESDVYSFGIVALEI 236
           C  T G    + D+++ G V  EI
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW 106
           +G G +G V   F  +T   +A+K++S+  +  I  K    E+ ++  + H N++ LL  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 107 CHEKKEL------LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
                 L       LV   M  G+  +++ K   L     +F + Q L  GL Y+     
Sbjct: 83  FTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQIL-RGLKYIHSA-- 137

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GR 219
             ++HRD+K SNI ++ +   KI DFGLAR  +     + T    T  Y APE       
Sbjct: 138 -GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH 192

Query: 220 ASKESDVYSFGIVALEIACGR 240
            ++  D++S G +  E+  G+
Sbjct: 193 YNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 12/200 (6%)

Query: 49  LGQGGFGGVY--KGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISRLRHRNLVQL 103
           LGQG FG V+  +      +  +   +V K +   +++      E  I++ + H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
                 + +L L+ +++  G L + L KE      + +F +A+ LA  L +L       +
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---LGI 119

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           ++RD+K  NI+LD   + K+ DFGL++  ++H K  +     GT+ YMAPE       ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQ 177

Query: 223 ESDVYSFGIVALEIACGRKP 242
            +D +SFG++  E+  G  P
Sbjct: 178 SADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 15/221 (6%)

Query: 42  DFNDDQKLGQGGFGGVY---KGFFRETSSYIAVKRVSKGS---KQGIKEYA-SEVTIISR 94
           +F   + LG G +G V+   K    +T    A+K + K +   K    E+  +E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 95  LRHRNLVQLLGWCHEKK-ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLL 153
           +R    +  L +  + + +L L+ +Y+  G + +HL++ +N    E RF   + +    L
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEII----L 116

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
            L+   +  +V+RDIK  NI+LD   +  + DFGL++     +  +T    GT+ YMAPE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176

Query: 214 C--ATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
                 G   K  D +S GI+  E+  G  P +L  +   Q
Sbjct: 177 IIRGKGGHG-KAVDWWSLGILIFELLTGASPFTLEGERNTQ 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 72/291 (24%), Positives = 128/291 (43%), Gaps = 54/291 (18%)

Query: 49  LGQGGFGGVYKGFFR-ETSSY--IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQL 103
           LG+G FG V +   + E  S+  +AVK  +    S   I+E+  E   +    H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 104 LGWC---HEKKEL---LLVYEYMPNGSLDSHLF-----KENNLLTWEFRFKIAQDLASGL 152
           +G       K  L   +++  +M +G L + L      +E   L  +   +   D+ASG+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMG 208
            YL     +  +HRD+ + N ML+ N    + DFGL++ +     + +G  + +    + 
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL---PVK 180

Query: 209 YMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGK 267
           ++A E       +  SDV++FG+   EI   G+ P +     E+  YL++      GN  
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------GN-- 232

Query: 268 LLEAVDPRLCRDFDEQQMECL-----MIVGLWCAHPDENLRPSIRQVIHVL 313
                  RL     +Q  +CL     ++   W   P+   RPS + +   L
Sbjct: 233 -------RL-----KQPPDCLEDVYELMCQCW--SPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 13/182 (7%)

Query: 64  ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG 123
           E    + VK V+ G   G      E+ I+  + HR ++ L+   H  +    V   MP  
Sbjct: 117 EQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLI---HAYRWKSTVCMVMPKY 168

Query: 124 SLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
             D   + + +  L  E    I + L   L YL     + ++HRD+K+ NI LD   NA 
Sbjct: 169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAV 225

Query: 183 IGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           +GDFG A +L  H    Q    +GT+   +PE         ++D++S G+V  E++    
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285

Query: 242 PI 243
            +
Sbjct: 286 TL 287

Length = 392

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRN---LVQ 102
           +G+GGFG VY     +T    A+K + K     KQG     +E  ++S +   +   +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           +    H   +L  + + M  G L  HL +       E RF  A+ +    L L+    + 
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII----LGLEHMHNRF 117

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           VV+RD+K +NI+LD + + +I D GLA      K   +    GT GYMAPE    G A  
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 174

Query: 223 ES-DVYSFGIVALEIACGRKP 242
            S D +S G +  ++  G  P
Sbjct: 175 SSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 51/176 (28%)

Query: 48  KLGQGGFGGVYKGFFRETSS--YIAVKRVSKGSK---QGIKEYA-SEVTIISRLRHRNLV 101
            +G+G +G VYK   +        A+K+  KG K    GI + A  E+ ++  L+H N+V
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 102 QLLGWC--HEKKELLLVYEY-------------------MPNGSLDSHLFKENNLLTWEF 140
            L+     H  K + L+++Y                   +P   + S        L W+ 
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS--------LLWQ- 116

Query: 141 RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA----KIGDFGLARLV 192
                  + +G+ YL   W   V+HRD+K +NI++          KIGD GLARL 
Sbjct: 117 -------ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 35/237 (14%)

Query: 85  YA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           YA SE+  ++   H  +V+         +LLL+ EY   G L+  + +    L     F 
Sbjct: 111 YARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR---LKEHLPF- 166

Query: 144 IAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAK 196
             Q+   GLL+ Q      E   + ++HRD+KS+NI L      K+GDFG ++   +   
Sbjct: 167 --QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224

Query: 197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
               +   GT  Y+APE     R SK++D++S G++  E+    +P    ++ E+    +
Sbjct: 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI----M 280

Query: 257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQ--MECLMIVGLWCAHPDENLRPSIRQVIH 311
           Q V  LYG        DP  C      +  ++ L+         +  LRP+ +Q++H
Sbjct: 281 QQV--LYGK------YDPFPCPVSSGMKALLDPLL-------SKNPALRPTTQQLLH 322

Length = 478

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETS--SYIAVKRVSK--GSKQGIKEYASEVTIISRLR-HRNLV 101
           ++LGQG +G V      ETS    +A+K+++     K   K    E+ ++   R H+N+ 
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 102 QLLG----WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
            L      +     EL L YE +    L   +     L    F+  I Q L  GL Y+  
Sbjct: 66  CLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQILC-GLKYIHS 123

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPEC 214
                V+HRD+K  N++++ +   KI DFGLAR      G     +     T  Y APE 
Sbjct: 124 A---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Query: 215 ATTGRA-SKESDVYSFGIVALEIACGRKPI 243
             + ++ +K  DV+S G +  E+  GRKP+
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 41/254 (16%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHR 98
           DF   + +G+G FG V     ++T    A+K + K     K+ +    +E  I+      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
            +V++     +K  L L+ E++P G + + L K++ L   E +F IA+ + +     Q G
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA------------RLVEHAKGSQTTV---- 202
           +    +HRDIK  N++LD   + K+ DFGL             R + H+  S  T     
Sbjct: 122 F----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 203 ------------------LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
                               GT  Y+APE       +K  D +S G++  E+  G  P  
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 245 LTAKEEVQVYLVQW 258
               +E    ++ W
Sbjct: 238 SETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 17/151 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLG 105
           +KLG+G +  VYKG  +     +A+K +    ++G    A  E +++  L+H N+V L  
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 106 WCHEKKELLLVYEYMPNG---SLDSH---LFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
             H K+ L LV+EY+       +D H   L  EN  L   F F+    L  GL Y+ + +
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL---FLFQ----LLRGLSYIHQRY 123

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
              ++HRD+K  N+++      K+ DFGLAR
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 41/255 (16%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           +DF   + +G+G FG V     ++T    A+K + K     K+ +    +E  I+     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             +V++     +K+ L L+ E++P G + + L K++ L     +F IA+ + +     Q 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA---------------------------- 189
           G+    +HRDIK  N++LD   + K+ DFGL                             
Sbjct: 121 GF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 190 ---RLVEHAKGSQTTVLAGTMG---YMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
              R  E  K ++  +   T+G   Y+APE       +K  D +S G++  E+  G  P 
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 244 SLTAKEEVQVYLVQW 258
                +E    ++ W
Sbjct: 237 CSETPQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR-------LRHRNLV 101
           +G+G +G V       T   +A+K++       + E+ S+ T I R       LRH ++V
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKI-----NDVFEHVSDATRILREIKLLRLLRHPDIV 62

Query: 102 QLLGWCH--------EKKELLLVYEYMPNGSLDSH-LFKENNLLTWE-FRFKIAQDLASG 151
           ++    H        E K++ +V+E M +   D H + K N+ LT E  +F + Q L   
Sbjct: 63  EIK---HIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQ-LLRA 115

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT--TVLAGTMGY 209
           L Y+       V HRD+K  NI+ + +   KI DFGLAR+  +   +    T    T  Y
Sbjct: 116 LKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 210 MAPE-CAT-TGRASKESDVYSFGIVALEIACGR 240
            APE C +   + +   D++S G +  E+  G+
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 42/221 (19%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQL 103
            + +G G +G V       +   +A+K++          K    E+ I+   +H N++ +
Sbjct: 10  IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLF-----KENNL---------LTWE-FRFKIAQDL 148
                  +++L      P G+    ++      E++L         LT E  R+ + Q L
Sbjct: 70  -------RDIL-----RPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ-L 116

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL-----VEHAKGSQTTVL 203
             GL Y+       V+HRD+K SN++++ +   +IGDFG+AR       EH K   T  +
Sbjct: 117 LRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH-KYFMTEYV 172

Query: 204 AGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKPI 243
           A T  Y APE   +    +   D++S G +  E+  GR+ +
Sbjct: 173 A-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 21/209 (10%)

Query: 48  KLGQGGFGGVYKGF-FRETSSYIAVKRVS-KGSKQGIK-EYASEVTIISRLR---HRNLV 101
           ++G+G +G V+K    +    ++A+KRV  +  ++G+      EV ++  L    H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 102 QLLGWC-----HEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLY 154
           +L   C       + +L LV+E++ +  L ++L K  E  + T   +  + Q L  GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 214
           L       VVHRD+K  NI++  +   K+ DFGLAR+  ++     T +  T+ Y APE 
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEV 180

Query: 215 ATTGRASKESDVYSFGIVALEIACGRKPI 243
                 +   D++S G +  E+   RKP+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF-RRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 19/216 (8%)

Query: 34  KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI--KEYASEVTI 91
           K + +    + +   +G G +G V   F  +T   +AVK++S+  +  I  K    E+ +
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 92  ISRLRHRNLVQLLG------WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           +  ++H N++ LL          E  ++ LV   M  G+  +++ K   L     +F I 
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIY 127

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q L  GL Y+       ++HRD+K SN+ ++ +   KI DFGLAR   H     T  +A 
Sbjct: 128 QIL-RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVA- 179

Query: 206 TMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           T  Y APE         ++ D++S G +  E+  GR
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 11/207 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSK---GSKQGIKEYASEVTIISRL-RHRNLVQLL 104
           +G+G +  V     ++T    A+K V K      + I    +E  +  +   H  LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
                +  L  V EY+  G L  H+ ++  L     RF  A+ ++  L YL E   + ++
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RGII 118

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKE 223
           +RD+K  N++LD   + K+ D+G+ +  E  + G  T+   GT  Y+APE          
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176

Query: 224 SDVYSFGIVALEIACGRKPISLTAKEE 250
            D ++ G++  E+  GR P  +    +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 13/200 (6%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR------LRHRNLVQ 102
           LG+G FG V     + T    A+K + K     +++   + T+  +       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L      K  L  V EY+  G L   + +         RF  A ++   L++L       
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHR---HG 116

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           V++RD+K  NI+LD   + K+ DFG+ +      G  TT   GT  Y+APE         
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 223 ESDVYSFGIVALEIACGRKP 242
             D ++ G++  E+  G+ P
Sbjct: 176 SVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 14/214 (6%)

Query: 49  LGQGGFGGVY---KGFFRETSSYIAVKRVSKGS---KQGIKEYA-SEVTIISRLRHRNLV 101
           LG G +G V+   K    ++    A+K + K +   K    E+  +E  ++  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 102 QLLGWCHEKK-ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
             L +  +   +L L+ +Y+  G L +HL +       E +    + +    L L+   +
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIV----LALEHLHK 123

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
             +++RDIK  NI+LD N +  + DFGL++     +  +     GT+ YMAP+    G  
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183

Query: 221 --SKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
              K  D +S G++  E+  G  P ++  ++  Q
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 16/218 (7%)

Query: 34  KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS-----E 88
            +L     DF+  + +G+G FG V     + +    A+K +SK   + IK   S     E
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK--FEMIKRSDSAFFWEE 93

Query: 89  VTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDL 148
             I++      +VQL     + K L +V EYMP G L + +   +    W  RF  A+ +
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA-RFYTAEVV 152

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 208
               L L        +HRD+K  N++LD + + K+ DFG    ++     +     GT  
Sbjct: 153 ----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208

Query: 209 YMAPEC----ATTGRASKESDVYSFGIVALEIACGRKP 242
           Y++PE        G   +E D +S G+   E+  G  P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
                   + K   + T++ +AVK+++    SK+ +K    E+    +L+H N++  +  
Sbjct: 10  FEDLMIVHLAK--HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67

Query: 107 CHEKKELLLVYEYMPNGS----LDSHLFKE--NNLLTWEFRFKIAQDLASGLLYLQEGWE 160
                EL +V   M  GS    L +H F E    L      F I +D+ + L Y+    +
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPELA---IAF-ILKDVLNALDYIHS--K 120

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGT-----MGYMAPEC 214
             + HR +K+S+I+L  +    +     +  +++H K  +            + +++PE 
Sbjct: 121 GFI-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 215 ---ATTGRASKESDVYSFGIVALEIACGRKPIS 244
                 G   K SD+YS GI A E+A G  P  
Sbjct: 180 LQQNLQGYNEK-SDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 46/243 (18%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA----SEVTIISRLR 96
           +DF   + +G+G FG V     ++T    A+K++ K S+   KE      +E  I++   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEAD 59

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           +  +V+L     ++  L L+ EY+P G + + L K++     E RF IA+ +    L + 
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI----LAID 115

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL------------ARLVEHAKGSQTT--- 201
              +   +HRDIK  N++LD   + K+ DFGL             R++ HA  S      
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 202 ------------------VLA----GTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
                              LA    GT  Y+APE       +KE D +S G++  E+  G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Query: 240 RKP 242
             P
Sbjct: 236 YPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 9/198 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKE----YASEVTIISRLRHRNLVQLL 104
           +G+G FG V     +      AVK + K      KE     A    ++  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
                 ++L  V +++  G L  HL +E +      RF  A+ +AS L YL       +V
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-IASALGYLHS---INIV 118

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           +RD+K  NI+LD   +  + DFGL +    A+   TT   GT  Y+APE           
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177

Query: 225 DVYSFGIVALEIACGRKP 242
           D +  G V  E+  G  P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 49/223 (21%)

Query: 48  KLGQGGFGGVYKGFFRETSSYIAVKRVSK---GSKQGIKEYASEVTIISRLRHRNLVQLL 104
            +G+GG G VY  +    S  +A+K++ +    +    K +  E  I + L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 105 GWCHEKKELLLVYEYMP--NGSLDSHLFKENNLLTWEFRFKIAQDLA------------- 149
             C +      VY  MP   G     L K      W+ +  ++++LA             
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKS----VWQ-KESLSKELAEKTSVGAFLSIFH 120

Query: 150 ---SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV---- 202
              + + Y+     + V+HRD+K  NI+L L     I D+G A   +  +     +    
Sbjct: 121 KICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 203 -------------LAGTMGYMAPECATTGRASKESDVYSFGIV 232
                        + GT  YMAPE      AS+ +D+Y+ G++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLG 105
           + +G+G +G V+K   ++  S  AVK +        +E  +E  I+  L  H N+V+  G
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYG 82

Query: 106 WCHEKK-----ELLLVYEYMPNGS---LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             ++K      +L LV E    GS   L     K    +       IA  L   L+ LQ 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME---EPIIAYILHEALMGLQH 139

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---C 214
                 +HRD+K +NI+L      K+ DFG++  +   +  + T + GT  +MAPE   C
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 198

Query: 215 ATTGRASKES--DVYSFGIVALEIACGRKPIS 244
                ++ ++  DV+S GI A+E+  G  P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 21/206 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRV-SKGSKQGIKEYA-SEVTIISRLRHRN-LVQL 103
           +K+G+G +G VYK   + T   +A+K+   +  ++GI   A  E++++  L     +V+L
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 104 LGWCHE-----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
           L   H      K  L LV+EY     LDS L K  +         +        +Y L +
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
           G   C    V+HRD+K  N+++D      KI D GL R       S T  +  T+ Y AP
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAP 180

Query: 213 ECATTGRA-SKESDVYSFGIVALEIA 237
           E        S   D++S G +  E++
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 12/216 (5%)

Query: 34  KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVT 90
           ++L     D++  + +G+G FG V     + +    A+K +SK       + A    E  
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 91  IISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS 150
           I++      +VQL     + K L +V EYMP G L + +   +    W  +F  A+ +  
Sbjct: 96  IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA-KFYTAEVV-- 152

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
             L L       ++HRD+K  N++LD + + K+ DFG    ++     +     GT  Y+
Sbjct: 153 --LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210

Query: 211 APECATT----GRASKESDVYSFGIVALEIACGRKP 242
           +PE   +    G   +E D +S G+   E+  G  P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 5/146 (3%)

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           LV L         L LV EY+  G L  H+ ++  L     RF  A ++   L +L E  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE-- 114

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
            + +++RD+K  N++LD + + K+ D+G+ +      G  T+   GT  Y+APE      
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 220 ASKESDVYSFGIVALEIACGRKPISL 245
                D ++ G++  E+  GR P  +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 29/230 (12%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
           +DF   + +G+G FG V     + T    A+K ++K       E A         R    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC-------FREERN 53

Query: 101 VQLLGWCH----------EKKELLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLA 149
           V + G C           ++  L LV +Y   G L + L K E+ L     RF IA+   
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAE--- 110

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY 209
             +L +    +   VHRDIK  N++LD+N + ++ DFG    +      Q++V  GT  Y
Sbjct: 111 -MVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169

Query: 210 MAPECATT-----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY 254
           ++PE         G+   E D +S G+   E+  G  P    A+  V+ Y
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP--FYAESLVETY 217

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 12/216 (5%)

Query: 34  KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVT 90
           ++L     D+   + +G+G FG V     + T    A+K +SK       + A    E  
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 91  IISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS 150
           I++      +VQL     + + L +V EYMP G L + +   +    W  RF  A+ +  
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVV-- 152

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
             L L        +HRD+K  N++LD + + K+ DFG    +      +     GT  Y+
Sbjct: 153 --LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210

Query: 211 APECATT----GRASKESDVYSFGIVALEIACGRKP 242
           +PE   +    G   +E D +S G+   E+  G  P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 15/222 (6%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHR 98
           DF   + +G+G FG V     +      A+K ++K       E A    E  ++    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQE 157
            +  L     ++  L LV +Y   G L + L K E+ L     RF     LA  ++ +  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY----LAEMVIAIDS 117

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
             +   VHRDIK  NI++D+N + ++ DFG    +      Q++V  GT  Y++PE    
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 218 -----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY 254
                G+   E D +S G+   E+  G  P    A+  V+ Y
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP--FYAESLVETY 217

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 57/232 (24%), Positives = 105/232 (45%), Gaps = 30/232 (12%)

Query: 47  QKLGQGGFGGVYKG-FFRETSSYIAVKR---VSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           Q++G G FG V     + +T     V +    +  SK+   E+  +      L+H N++Q
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR-------FKIAQDLASGLLYL 155
            LG C E    LLV+EY   G L S+L +E     W  R        ++A ++A+G+ ++
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ----WHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL--ARLVEHAKGSQTTVLAGTMGYMAPE 213
               +   +H D+   N  L  +   K+GD+G+  +R  E    ++       + ++APE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171

Query: 214 CAT-------TGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQ 257
                     T   +K S+V++ G+   E+     +P S  +  EV  ++++
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 45/154 (29%), Positives = 86/154 (55%), Gaps = 14/154 (9%)

Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA 149
           +++ ++ H+++V L G C    E ++V E++  G LD  + +++++LT  ++FK+A+ LA
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQTTVLA---- 204
           S L YL+   ++ +VH ++ + NI+L     + + G F   +L +   G   TVL+    
Sbjct: 116 SALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSD--PGIPITVLSRQEC 168

Query: 205 -GTMGYMAPECATTGRA-SKESDVYSFGIVALEI 236
              + ++APEC    +  S  +D +SFG    EI
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 60/261 (22%), Positives = 101/261 (38%), Gaps = 53/261 (20%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQL 103
           + LG G FG V      +T +  A+K + K    ++  +    +E  I++   +  +V+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
                +K  L  V +Y+P G + S L +         RF IA+      L ++   +   
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT----LAIESVHKMGF 122

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLA---------------------------------- 189
           +HRDIK  NI++DL+ + K+ DFGL                                   
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 190 --------RLVEHAKGSQTTVLA----GTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
                    L + A       LA    GT  Y+APE       ++  D +S G++  E+ 
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 238 CGRKPISLTAKEEVQVYLVQW 258
            G+ P       E Q+ ++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 62/270 (22%), Positives = 113/270 (41%), Gaps = 42/270 (15%)

Query: 57  VYKGFFRETSSYI-AVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW----CHEKK 111
           +YKG F      I   K+  KG K  I    +E+  + R+   N++++ G+      +  
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL--LYLQEGWEQCVVHRDIK 169
            L L+ EY   G L   L KE +L +++ +  +A D   GL  LY          ++++ 
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKDL-SFKTKLDMAIDCCKGLYNLYKYTN----KPYKNLT 150

Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GRASKESDVY 227
           S + ++  N+  KI   GL +++              M Y + +         + + D+Y
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVN----FMVYFSYKMLNDIFSEYTIKDDIY 206

Query: 228 SFGIVALEIACGRKPI-SLTAKEEVQVYLVQWVWDLYGNGKLLEAVD---PRLCRDFDEQ 283
           S G+V  EI  G+ P  +LT KE         ++DL  N      +    P         
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKE---------IYDLIINKNNSLKLPLDCPLE------- 250

Query: 284 QMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
            ++C++     C   D   RP+I+++++ L
Sbjct: 251 -IKCIVEA---CTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRHRNL 100
           + D +++G G +G V     R T + +A+K++ +   S+   K    E+ ++  ++H N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 101 VQLLGWCHEKKEL------LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
           + LL        L       LV  +M  G+    L K   L     +F + Q L  GL Y
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML-KGLKY 133

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 214
           +       ++HRD+K  N+ ++ +   KI DFGLAR  +    S+ T    T  Y APE 
Sbjct: 134 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEV 186

Query: 215 ATTG-RASKESDVYSFGIVALEIACGR 240
                  ++  D++S G +  E+  G+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 16/155 (10%)

Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA 149
           +++S++ H +L  + G C    E ++V E++ +G LD  L KE   +   ++  +AQ LA
Sbjct: 68  SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG--DFGLARLVEHAKGSQTTVLA--- 204
           S L YL+   ++ +VH ++ + NI+L     A++G  +     +     G   T L+   
Sbjct: 128 SALSYLE---DKNLVHGNVCAKNILL-----ARLGLAEGTSPFIKLSDPGVSFTALSREE 179

Query: 205 --GTMGYMAPECATTGRA-SKESDVYSFGIVALEI 236
               + ++APEC   G + S  +D +SFG   LEI
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 24/203 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLG- 105
           +G G +G V     + T   +A+K++S+  +  I  K    E+T++  ++H N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 106 -----WCHEKKELLLVYEYMPN--GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
                   E ++  LV  YM      +  H   E+ +     ++ + Q L  GL Y+   
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV-----QYLVYQML-CGLKYIHSA 136

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
               ++HRD+K  N+ ++ +   KI DFGLAR   HA    T  +  T  Y APE     
Sbjct: 137 G---IIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPEVILNW 189

Query: 219 -RASKESDVYSFGIVALEIACGR 240
              ++  D++S G +  E+  G+
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLL-- 104
           +G G +G V   +       +AVK++S+  +  I  +    E+ ++  ++H N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 105 ----GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
                      E+ LV   M  G+  +++ K   L     +F I Q L  GL Y+     
Sbjct: 83  FTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSAG- 138

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
             ++HRD+K SN+ ++ +   +I DFGLAR  +     + T    T  Y APE       
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAPEIMLNWMH 192

Query: 221 SKES-DVYSFGIVALEIACGR 240
             ++ D++S G +  E+  G+
Sbjct: 193 YNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 64/290 (22%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLG 105
           +G G FG V      +T++  A+K + K     +       +E  I++   +  +V+L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFK----ENNLLTWEFRFKIAQDLASGLLYLQE-GWE 160
              +K  L  V +Y+P G + S L +    E +L     RF IA+ L   +  + + G+ 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA----RFYIAE-LTCAIESVHKMGF- 122

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGL------------------AR------------ 190
              +HRDIK  NI++D + + K+ DFGL                   R            
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 191 --------LVEHAKGSQTTVLA----GTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
                   L    K      LA    GT  Y+APE       ++  D +S G++  E+  
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239

Query: 239 GRKPISLTAKEEVQVYLVQWVWDLY--GNGKL-LEAVD--PRLCRDFDEQ 283
           G+ P       E Q+ ++ W   L+     KL  EA D   RLC   +++
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDR 289

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 7/134 (5%)

Query: 113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
           L  V E++  G L  H+ ++  L     RF  + +++  L +L E     +++RD+K  N
Sbjct: 71  LFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNFLHERG---IIYRDLKLDN 126

Query: 173 IMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGI 231
           ++LD   + K+ D+G+ +  E  + G  T+   GT  Y+APE           D ++ G+
Sbjct: 127 VLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184

Query: 232 VALEIACGRKPISL 245
           +  E+  GR P  +
Sbjct: 185 LMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 60/235 (25%), Positives = 91/235 (38%), Gaps = 39/235 (16%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHR 98
            F   + LG+G  G V+    + T    A+K + K       +     +E  I++ L H 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWE-FRFKIAQDLASGLLYLQ 156
            L  L      +  L LV +Y P G L   L ++    L+ E  RF  A+ L   L YL 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLH 120

Query: 157 -EGWEQCVVHRDIKSSNIML-----------DLNFNA--------KIGDFGLARLVEHAK 196
             G    +V+RD+K  NI+L           DL+  +        K    G  R   ++ 
Sbjct: 121 LLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 197 GSQTTV---------LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            S+T             GT  Y+APE  +        D ++ GI+  E+  G  P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 7/109 (6%)

Query: 150 SGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA-KGSQTTV 202
           +GLL++Q          + ++HRDIKS+NI+L  N   K+GDFG +++            
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
             GT  Y+APE       SK++D++S G++  E+   ++P      EEV
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253

Length = 496

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 32/232 (13%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIK-EYASEVTIISRLRHR 98
           N++   +K+G G FG V+    + T  +   K +S +G K+  K +   EV ++  L+H+
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 99  NLVQLLGWCHEK--KELLLVYEYMPNGSLDSHL---FKENNLLTWEFRFKIAQDLASGLL 153
           N+V+ +     K  ++L ++ E+   G L  ++   +K    +       I + L   L 
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 154 Y---LQEGWE-QCVVHRDIKSSNIMLDL-------------NFN----AKIGDFGLARLV 192
           Y   L++G   + V+HRD+K  NI L               N N    AKIGDFGL++ +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 193 EHAKGSQTTVLAGTMGYMAPECA--TTGRASKESDVYSFGIVALEIACGRKP 242
                + + V  GT  Y +PE     T     +SD+++ G +  E+  G+ P
Sbjct: 193 GIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 10/168 (5%)

Query: 74  VSKGSKQGIKEYASEVTIISRLRHRNLVQLLG-WCHEKKELLLVYEYMPNGSLDSHLFKE 132
           +  G + G    A+E  I+  + H +++QL G + + K   L++  Y  +  L  +L  +
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAK 176

Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
            N+   +    I + +   + YL E     ++HRDIK+ NI ++   +  +GDFG A   
Sbjct: 177 RNIAICDI-LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFP 232

Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
                ++    AGT+   APE           D++S GIV  E+A   
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 58/295 (19%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRN 99
           F   + LG G FG V      +T +  A+K + K     +  +    +E  I++   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V+L     +K  L  V +Y+P G + S L +         RF IA+   +    ++   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA----VESVH 118

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLA---RLVEHAKGSQTT--------------- 201
           +   +HRDIK  NI++D + + K+ DFGL    R    +K  Q+                
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 202 ----------------------------VLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
                                        L GT  Y+APE       ++  D +S G++ 
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 234 LEIACGRKPISLTAKEEVQVYLVQWVWDLY--GNGKLL-EAVD--PRLCRDFDEQ 283
            E+  G+ P       E Q+ ++ W   L+     KL  EA D   +LCR  +++
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDR 293

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 35/222 (15%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRH 97
           +DF   + +G+G FG V     + T    A+K ++K       E A    E  ++     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
           R +  L     ++  L LV +Y   G L + L K        F  ++ +D+A    YL E
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK--------FEDRLPEDMAR--FYLAE 110

Query: 158 -----------GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAG 205
                      G+    VHRDIK  N++LD N + ++ DFG + L   A G+ Q+ V  G
Sbjct: 111 MVLAIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVG 165

Query: 206 TMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKP 242
           T  Y++PE         GR   E D +S G+   E+  G  P
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 25/159 (15%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRV--------SKGSKQGIKEYA------SEVTIISR 94
           LG+G +G V K +   T   +A+K+V            +Q +           E+ I++ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFK-IAQDLASG 151
           ++H N++ L+    E   + LV + M      S L K  +  +   E + K I   + +G
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
           L  L + +    +HRD+  +NI ++     KI DFGLAR
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 6/149 (4%)

Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E  ++  + H +++++           +V  +  +  L ++L K +  L  +    I + 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           +  GL YL     Q ++HRD+K+ NI ++      IGD G A+    A       LAGT+
Sbjct: 166 ILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTV 220

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEI 236
              APE     + + ++D++S GIV  E+
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 25/240 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRH 97
            DF   + +  G +G VY    +ET    A+K+++K +   +  I++   E  I++   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEF-RFKIAQDLASGLLYLQ 156
             +V +      K+ L +V EY+  G   + L K    L  +  R   A+ + + L YL 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFAETVLA-LEYLH 118

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR---------LVEH-----AKGSQTTV 202
                 +VHRD+K  N+++    + K+ DFGL++         L E       +      
Sbjct: 119 N---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV--QVYLVQWVW 260
           + GT  Y+APE        K  D ++ GI+  E   G  P      EE+  QV      W
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 76/304 (25%), Positives = 117/304 (38%), Gaps = 53/304 (17%)

Query: 28  PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRE----TSSYIAVKRVSKGSKQ-GI 82
             R T  +L Q            +G FG ++ G   +        + VK V   + +  +
Sbjct: 5   RDRVTLSDLLQ------------EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV 52

Query: 83  KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV-YEYMPNGSLDSHLFK-----ENNLL 136
                E  ++  L H+N++ +L  C E  E   V Y YM  G+L   L +      NN  
Sbjct: 53  TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112

Query: 137 TWEFR--FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-- 192
               +    +A  +A G+ YL +   + V+H+DI + N ++D     KI D  L+R +  
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169

Query: 193 --EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKE 249
              H  G         + +MA E       S  SDV+SFG++  E+   G+ P       
Sbjct: 170 MDYHCLGDNEN---RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226

Query: 250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
           E+  YL         +G  L    P  C D     M C       C   D   RPS  Q+
Sbjct: 227 EMAAYLK--------DGYRLA--QPINCPDELFAVMAC-------CWALDPEERPSFSQL 269

Query: 310 IHVL 313
           +  L
Sbjct: 270 VQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 17/173 (9%)

Query: 72  KRVSKGSKQGIKEYASEVTIISRLRHRNLVQL--------LGWCHEKKELLLVYEYMPNG 123
           KRV  GS+  I +  +E+  + RL H N++++          +   +K    +Y +M + 
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE 256

Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI 183
           + D   +K+  LL  + R  I + L   + Y+ +   + ++HRDIK  NI L+ +    +
Sbjct: 257 AFD---WKDRPLL-KQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVL 308

Query: 184 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
           GDFG A   E  + +      GT+   +PE        + +D++S G++ L++
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)

Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ 199
           F  ++AQ    G+ +L    + C+ HRD+ + N++L     AKI DFGLAR + +     
Sbjct: 217 FSSQVAQ----GMDFLAS--KNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMN---DS 266

Query: 200 TTVLAGT----MGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
             V+ G     + +MAPE       + +SDV+S+GI+  EI + G+ P
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 39/121 (32%), Positives = 61/121 (50%), Gaps = 12/121 (9%)

Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P  +    L  E+  L++      +  +A+G+ +L    + CV HRD+ + N+++     
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCV-HRDLAARNVLICEGKL 277

Query: 181 AKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE 235
            KI DFGLAR +       +KGS  T L   + +MAPE       +  SDV+SFGI+  E
Sbjct: 278 VKICDFGLARDIMRDSNYISKGS--TFLP--LKWMAPESIFNNLYTTLSDVWSFGILLWE 333

Query: 236 I 236
           I
Sbjct: 334 I 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRHRNL 100
           + + + +G G  G V   +       +A+K++S+   ++   K    E+ ++  + H+N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 101 VQLLG------WCHEKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLL 153
           + LL          E +++ +V E M     D++L +   + L  E    +   +  G+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIK 140

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
           +L       ++HRD+K SNI++  +   KI DFGLAR    +      V+  T  Y APE
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 195

Query: 214 CATTGRASKES-DVYSFGIVALEIACGR 240
               G   KE+ D++S G +  E+  G 
Sbjct: 196 -VILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 4/91 (4%)

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
           GL YL       ++HRDIK  N++++ N   KI DFGLAR+ E  +    T    T  Y 
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171

Query: 211 APECATTGRASKES-DVYSFGIVALEIACGR 240
           APE     R    + D++S G +  E+   R
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 12/94 (12%)

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTV 202
           +A G+ +L     +C+ HRD+ + NI+L  N   KI DFGLAR +        KGS    
Sbjct: 183 VARGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
           L     +MAPE       + +SDV+SFG++  EI
Sbjct: 240 LK----WMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW-- 106
           +G G FG VY+    +TS  +A+K+V     Q  +    E+ I+  L H N++ L  +  
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129

Query: 107 --CHEKKE----LLLVYEYMPNGSLDSHL--FKENNLLTWEFRFKI-AQDLASGLLYLQE 157
             C +K E    L +V E++P  ++  ++  +  NN     F  K+ +  L   L Y+  
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
            +   + HRD+K  N+++D N +  K+ DFG A+ +    G ++     +  Y APE   
Sbjct: 189 KF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSRFYRAPELML 243

Query: 217 -TGRASKESDVYSFGIVALEIACG 239
                +   D++S G +  E+  G
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 18/109 (16%)

Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
            +LL++ ++      +A G+ +L    + CV HRD+ + N++L      KI DFGLAR +
Sbjct: 237 LDLLSFTYQ------VARGMEFLAS--KNCV-HRDLAARNVLLAQGKIVKICDFGLARDI 287

Query: 193 EH-----AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
            H     +KGS  T L   + +MAPE       +  SDV+S+GI+  EI
Sbjct: 288 MHDSNYVSKGS--TFLP--VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 12/108 (11%)

Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE 193
            +LT E     +  +A G+ +L     +C+ HRD+ + NI+L  N   KI DFGLAR + 
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIY 230

Query: 194 H-----AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
                  KG     L     +MAPE       + +SDV+SFG++  EI
Sbjct: 231 KDPDYVRKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLL 104
           + +G G  G V   F       +AVK++S+   ++   K    E+ ++  + H+N++ LL
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 105 G------WCHEKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQE 157
                     E +++ LV E M     D++L +  ++ L  E    +   +  G+ +L  
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 141

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
                ++HRD+K SNI++  +   KI DFGLAR          T    T  Y APE    
Sbjct: 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYRAPEVILG 196

Query: 218 GRASKESDVYSFGIVALEIACG 239
               +  D++S G +  E+  G
Sbjct: 197 MGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 14/101 (13%)

Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ 199
           F +++A+    G+ +L    + C+ HRD+ + NI+L      KI DFGLAR +   +   
Sbjct: 219 FSYQVAK----GMSFLAS--KNCI-HRDLAARNILLTHGRITKICDFGLARDI---RNDS 268

Query: 200 TTVLAGT----MGYMAPECATTGRASKESDVYSFGIVALEI 236
             V+ G     + +MAPE       + ESDV+S+GI+  EI
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 23/224 (10%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRHRNL 100
           + + + +G G  G V   +       +A+K++S+   ++   K    E+ ++  + H+N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-----L 155
           + LL     +K L    E   +  L   L   N  L    + ++  +  S LLY     +
Sbjct: 79  ISLLNVFTPQKSL----EEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI 132

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
           +      ++HRD+K SNI++  +   KI DFGLAR          T    T  Y APE  
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE-V 189

Query: 216 TTGRASKES-DVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
             G   KE+ D++S G +  E+   R  I    ++    Y+ QW
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRD----YIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 8e-06
 Identities = 30/78 (38%), Positives = 41/78 (52%), Gaps = 9/78 (11%)

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTG 218
           +HRD+ + NI+L  N   KI DFGLAR +        KG     L     +MAPE     
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPESIFDK 250

Query: 219 RASKESDVYSFGIVALEI 236
             + +SDV+SFG++  EI
Sbjct: 251 VYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 58/272 (21%), Positives = 102/272 (37%), Gaps = 53/272 (19%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRH 97
            DF+  + +G+G FG V     ++T    A+K + K     K  +    +E  +++    
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             +V L     + + L L+ E++P G L + L K +       RF +A+     +L ++ 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE----CVLAIEA 116

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-------------RLVE------HAKGS 198
             +   +HRDIK  NI++D   + K+ DFGL+             +L++           
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 199 QTTVL---------------------------AGTMGYMAPECATTGRASKESDVYSFGI 231
            +  +                            GT  Y+APE        +E D +S G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 232 VALEIACGRKPISLTAKEEVQVYLVQWVWDLY 263
           +  E   G  P       E    ++ W   LY
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKIINWRETLY 268

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 12/159 (7%)

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           + N ++L       K  +L+ +Y+ +G L   L KE  L   E +  I Q L   L  L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ-LVEALNDLH 126

Query: 157 EGWEQCVVHRDIKSSNIMLD-LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
           +     ++H DIK  N++ D       + D+GL + +            GT+ Y +PE  
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPS----CYDGTLDYFSPE-K 177

Query: 216 TTGRASKES-DVYSFGIVALEIACGRKPISLTAKEEVQV 253
             G     S D ++ G++  E+  G+ P      EE+ +
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216

Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 26/224 (11%)

Query: 48  KLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQL- 103
           K+G+G +G VYK   ++       A+K++      GI   A  E+ ++  L+H N++ L 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG---TGISMSACREIALLRELKHPNVIALQ 64

Query: 104 -LGWCHEKKELLLVYEYMPNG---SLDSHLFKENNLLTWEFRFKIAQDLA----SGLLYL 155
            +   H  +++ L+++Y  +     +  H   + N    +    + + L      G+ YL
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 156 QEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGY 209
              W   V+HRD+K +NI++          KI D G ARL          +  +  T  Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 210 MAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
            APE     R  +K  D+++ G +  E+    +PI    +E+++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 12/99 (12%)

Query: 144 IAQDLASGLLYLQ-EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
           +A+ L S + Y+  EG    ++HRDIK+ N++++   +  +GDFG A     A+GS +T 
Sbjct: 265 VARQLLSAIDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACF---ARGSWSTP 317

Query: 203 ----LAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
               +AGT+   APE       +   D++S G+V  E A
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 58/240 (24%)

Query: 48  KLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQL- 103
           K+G+G +G VYK   ++       A+K++      GI   A  E+ ++  L+H N++ L 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG---TGISMSACREIALLRELKHPNVISLQ 64

Query: 104 -LGWCHEKKELLLVYEY-----------------------MPNGSLDSHLFKENNLLTWE 139
            +   H  +++ L+++Y                       +P G + S L++        
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 116

Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHA 195
                   +  G+ YL   W   V+HRD+K +NI++          KI D G ARL    
Sbjct: 117 --------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 196 KGSQTTV--LAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
                 +  +  T  Y APE     R  +K  D+++ G +  E+    +PI    +E+++
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 17/158 (10%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHR 98
           +F   + + +G FG VY G  +  S   AVK V K    +K  + +  +E   ++  +  
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLL 153
            +V L         + LV EY+  G + S L     F E      E   K   ++A  L 
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------EMAVKYISEVALALD 118

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL 191
           YL       ++HRD+K  N+++    + K+ DFGL+++
Sbjct: 119 YLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 30/81 (37%), Positives = 42/81 (51%), Gaps = 8/81 (9%)

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT--TVLAGTMGYMAPECATTGRA 220
           ++HRD+K SNI++  +   KI DFGLAR      G+    T    T  Y APE    G  
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAPE-VILGMG 193

Query: 221 SKES-DVYSFGIVALEIACGR 240
            KE+ D++S G +  E+  G 
Sbjct: 194 YKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 33/142 (23%), Positives = 61/142 (42%), Gaps = 8/142 (5%)

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           N+V L  +   +  + LV ++   G L SH+ K  N+        + +  A  ++ L   
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP----EECVKRWAAEMVVALDAL 101

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
             + +V RD+  +NI+LD   + ++  F     VE +   +    A    Y APE     
Sbjct: 102 HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE----AVENMYCAPEVGGIS 157

Query: 219 RASKESDVYSFGIVALEIACGR 240
             ++  D +S G +  E+  G+
Sbjct: 158 EETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 42/161 (26%), Positives = 58/161 (36%), Gaps = 30/161 (18%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEY-ASEVTIISRLRHRNL 100
           DF   +KLG+G FG VYK       S    K V K +     EY A E+ +  R+R    
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA----TEYGAVEIWMNERVRRACP 188

Query: 101 VQLLGWCH---------EKKELLLVYEYMPNGSL-DSHLFKENNLLTWEFRFKIAQDLAS 150
                + +         ++ E  LV+ Y    +L D    KE       +     QDL  
Sbjct: 189 NSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248

Query: 151 G---------------LLYLQEGWEQCVVHRDIKSSNIMLD 176
           G               L  L       +VHRD+K  NI+  
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	376
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
smart00090	237	RIO RIO-like kinase.	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.29
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.23
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.03
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.96
COG4248	637	Uncharacterized protein with protein kinase and he	98.95
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
PRK09902	216	hypothetical protein; Provisional	98.77
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.7
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.62
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.57
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.54
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
PLN02876	822	acyl-CoA dehydrogenase	98.34
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.25
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.24
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.19
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.11
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.1
PRK10593	297	hypothetical protein; Provisional	98.08
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.07
PRK05231	319	homoserine kinase; Provisional	98.07
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.0
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.96
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.85
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.83
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.81
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.8
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.75
PLN02236	344	choline kinase	97.55
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.33
KOG2270	520	consensus Serine/threonine protein kinase involved	97.32
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.3
PLN02756	418	S-methyl-5-thioribose kinase	97.3
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.25
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.23
PRK12396	409	5-methylribose kinase; Reviewed	97.15
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.09
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.01
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.91
PRK11768	325	serine/threonine protein kinase; Provisional	96.61
COG2334	331	Putative homoserine kinase type II (protein kinase	96.54
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.47
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.45
PTZ00296	442	choline kinase; Provisional	96.42
PTZ00384	383	choline kinase; Provisional	96.41
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.17
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.65
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.95

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-52  Score=384.88  Aligned_cols=288  Identities=48%  Similarity=0.814  Sum_probs=250.0

Q ss_pred             CCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeE
Q 038118           27 GPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW  106 (376)
Q Consensus        27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  106 (376)
                      ..+.|+++++..++++|.-...||+||||.||+|...++ ..||||++........++|..|+.++.+++|||+++++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            678899999999999999999999999999999998874 7899998876543214569999999999999999999999


Q ss_pred             EeeCC-eEEEEEecCCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          107 CHEKK-ELLLVYEYMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       107 ~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                      |.+.+ ..+||+||+++|+|.++++.... .++|..+++|+.++|+||.|||......|+|||||+.|||||++.++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99988 59999999999999999987666 89999999999999999999998656679999999999999999999999


Q ss_pred             eCCCccccccCCCcceeee-ccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          185 DFGLARLVEHAKGSQTTVL-AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       185 Dfg~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      |||+++..... ....... .||.+|+|||++..+..+.|+||||||++|.||+||+.+.+... ......+..|++...
T Consensus       220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence            99999654331 2222222 79999999999998999999999999999999999998887554 222233788888888


Q ss_pred             cCCccccccCCcCC-CCCcH-HHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          264 GNGKLLEAVDPRLC-RDFDE-QQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       264 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .++.+.+.+|+.+. ..... .....+..++.+|++.+|..||+|.+|+++|+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            88999999999987 55554 67888999999999999999999999999995433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-51  Score=384.03  Aligned_cols=248  Identities=29%  Similarity=0.417  Sum_probs=218.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .+|...++||+|||+.||.+++..+|..||+|++.+.   .....+...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999999999999999999873   3444677889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+|..++|..++. +.+.+++.+++.+++||+.||.|||   +++|+|||||.+|+|++++.++||+|||+|+.+... .
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-G  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc-c
Confidence            9999999988775 7788999999999999999999999   899999999999999999999999999999887543 3


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ....+..||+.|+|||++.....+..+||||+||++|.||.|++||...+-.+....+...              +-.+ 
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--------------~Y~~-  237 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--------------EYSM-  237 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------Cccc-
Confidence            4556778999999999999999999999999999999999999999988777776665531              1111 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         +........+||..+|++||.+|||+++|+.
T Consensus       238 ---P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  238 ---PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               1133345788899999999999999999994

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7e-51  Score=362.56  Aligned_cols=251  Identities=27%  Similarity=0.457  Sum_probs=211.5

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++|.+.+.||.|.||+||+|+++.++..||||.+...  .++..+.+..|+.+|+.++|||||.+++++..++.+|||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            357899999999999999999999999999999999877  677778889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC------ceEEEeeCCCcc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN------FNAKIGDFGLAR  190 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~------~~~kl~Dfg~~~  190 (376)
                      ||||.||+|.+++.+ .+.+++..+..++.||+.||++||   +++|+||||||+||||+..      -.+||+|||+++
T Consensus        88 MEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999954 457999999999999999999999   8999999999999999875      458999999999


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .+.  .+....+..|++.|||||+++.+.|+.|+|+||+|+|||+|++|+.||...+..+....+..        +    
T Consensus       164 ~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k--------~----  229 (429)
T KOG0595|consen  164 FLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK--------G----  229 (429)
T ss_pred             hCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------c----
Confidence            875  33445677899999999999999999999999999999999999999998887776654332        1    


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                         ..+...+.......+++++...++.++.+|-++.+-.
T Consensus       230 ---~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  230 ---NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             ---ccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence               1111222222223344555666777777777766655

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-51  Score=360.35  Aligned_cols=251  Identities=29%  Similarity=0.397  Sum_probs=210.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-eEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-ELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~  119 (376)
                      +++..+.||+|..|+||++.++.+++.+|+|++... .....+++.+|+++++..+||+||++|+.|.... ..+|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            455678999999999999999999999999999654 4555678999999999999999999999999988 59999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      |++|+|.+.+.. .+.+++..+-+++.+|++||.|||+  +.+|+||||||+|||+...|.+||||||.+..+-..   .
T Consensus       160 MDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~  233 (364)
T KOG0581|consen  160 MDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I  233 (364)
T ss_pred             cCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence            999999888854 4779999999999999999999995  599999999999999999999999999999865433   5


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCcc--chhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTA--KEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ..+++||..|||||.+++..|+.++||||||++++|+++|+.||....  ...... +..+..         ....|.+.
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-Ll~~Iv---------~~ppP~lP  303 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-LLCAIV---------DEPPPRLP  303 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-HHHHHh---------cCCCCCCC
Confidence            567789999999999999999999999999999999999999997641  111111 111111         01123333


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..   ....+++.++..||++||.+||++.++++
T Consensus       304 ~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  304 EG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            32   24456888899999999999999999985

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-52  Score=352.42  Aligned_cols=258  Identities=28%  Similarity=0.387  Sum_probs=215.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceee-EEeeCCe-EEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLG-WCHEKKE-LLLV  116 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv  116 (376)
                      ..|++.++||.|.||.||++.+..+|..||.|.+...  +.+..+....|+.+|++|+||||+++++ .|.+++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4578889999999999999999999999999998754  4555678899999999999999999998 4555555 8999


Q ss_pred             EecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          117 YEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQ-CVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      ||+|.+|+|...+..   ..+.+++..+|+++.|++.||..+|+.+.+ -|+||||||.|||++.+|.+||+|||+++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999988753   567899999999999999999999964333 3999999999999999999999999999987


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ... .......+||+.||+||.+.+.+|+.||||||+||++|||+.-+.||.+.+-.+....|.+        +..    
T Consensus       179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q--------gd~----  245 (375)
T KOG0591|consen  179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ--------GDY----  245 (375)
T ss_pred             cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc--------CCC----
Confidence            543 3345567899999999999999999999999999999999999999998865555555543        111    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       +.+   ...-....+..+|..|+..||+.||+...+++.+..
T Consensus       246 -~~~---p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 -PPL---PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -CCC---cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence             111   124556678889999999999999997666655543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-51  Score=363.87  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=210.5

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-------hHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-------GIKEYASEVTIISRLRHRNLVQLLGWCHEKK  111 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  111 (376)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+....       ......+|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            468899999999999999999999999999999999764211       1233579999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC---ceEEEeeCCC
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGL  188 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~  188 (376)
                      ..||||||++||.|.+.+.. .+.+.+..-..++.|++.|+.|||   ++||+||||||+|||+..+   -.+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999999854 456777778889999999999999   8999999999999999776   6799999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccCC---CCCCCceeechhhHHHHHhCCCCCCCccchh-hHHHHHHHHHHHhc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGR---ASKESDVYSFGIVALEIACGRKPISLTAKEE-VQVYLVQWVWDLYG  264 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~  264 (376)
                      +++.+  ......+..||+.|.|||++.+..   +..+.|+|||||+||-+|+|.+||....... ....+.+       
T Consensus       326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~-------  396 (475)
T KOG0615|consen  326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK-------  396 (475)
T ss_pred             hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-------
Confidence            99875  345567788999999999997764   3457899999999999999999998765443 3333332       


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ++...  -|    ..-....+...++|.+||..||++|||+.|+|+
T Consensus       397 -G~y~f--~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 -GRYAF--GP----LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -Ccccc--cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             11111  11    222345567889999999999999999999995

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-49  Score=365.79  Aligned_cols=258  Identities=37%  Similarity=0.555  Sum_probs=212.6

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-eEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-ELL  114 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~  114 (376)
                      .......+.+.||.|+||+||+|.|+++. .||+|++....  ....+.|.+|+.+|.+++||||++|+|++.+.. .++
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            33455556667999999999999999643 29999998653  222568999999999999999999999999987 799


Q ss_pred             EEEecCCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc-eEeecccCCCeeecCCc-eEEEeeCCCccc
Q 038118          115 LVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQC-VVHRDIKSSNIMLDLNF-NAKIGDFGLARL  191 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~-i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~  191 (376)
                      +||||+++|+|.+++.. ....++...++.|+.+|++||.|||   +++ |||||||++|||++.++ ++||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999999999999977 4788999999999999999999999   677 99999999999999998 999999999986


Q ss_pred             cccCCCcceeeeccCCCCCchhhhc--cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECAT--TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ..... ...+...||+.|||||++.  ...++.|+||||||+++|||+||+.||...........+..            
T Consensus       194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~------------  260 (362)
T KOG0192|consen  194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV------------  260 (362)
T ss_pred             ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------------
Confidence            54322 2333367999999999999  56899999999999999999999999988775333222211            


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                          ...+..++......+..++.+||..||..||++.+++..|+..
T Consensus       261 ----~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  261 ----GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             ----cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                1112222233455678888899999999999999999998753

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-48  Score=358.40  Aligned_cols=262  Identities=31%  Similarity=0.477  Sum_probs=222.4

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      .+.++.-...+++.+.||+|.||.||.|.++++ ..||+|.+...... .+.|.+|++++++|+|+|||+++++|..+..
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            344445555667789999999999999999974 35999999876443 3678899999999999999999999999989


Q ss_pred             EEEEEecCCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          113 LLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      +||||||++.|+|.++|.. .+..+....++.++.|||+||+||+   ++++|||||...||||++++.+||+|||+++.
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccc
Confidence            9999999999999999976 5677999999999999999999999   89999999999999999999999999999996


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ..+...........+..|.|||.+..+.++.||||||||++||||+| |+.|+.+.++.+....+.+             
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-------------  419 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-------------  419 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-------------
Confidence            55544444444456789999999999999999999999999999998 9999999887776554432             


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                          ..+-..+..+...+.+++..||..+|++|||++.+...|+..
T Consensus       420 ----GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  420 ----GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             ----cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence                222333344556688899999999999999999999888753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.6e-49  Score=336.23  Aligned_cols=266  Identities=25%  Similarity=0.320  Sum_probs=216.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|+...++|+|+||+||+++++.||+.||||+|....  +...+-.++|+++|++|+|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888999999999999999999999999999997653  3334456899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ||+..-|. .+.....-++...+..++.|++.|+.|+|   +++++||||||+|||++.+|.+||||||+|+.+.. .+.
T Consensus        82 ~~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd  156 (396)
T KOG0593|consen   82 YCDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD  156 (396)
T ss_pred             ecchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence            99886654 45455556899999999999999999999   89999999999999999999999999999987754 344


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh--------cCCccc
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY--------GNGKLL  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~  269 (376)
                      ..+..+.|..|.|||.+-+ ..|+...|||++||++.||++|.+.|.+.+.-+....|......+.        .+....
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            4555668999999999877 6799999999999999999999999999887776666655433221        111111


Q ss_pred             -----cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 -----EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           +.-++.-.....+.....+.+++..||+.||++|++.++++.
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                 111111112222344457889999999999999999999873

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=344.00  Aligned_cols=245  Identities=26%  Similarity=0.354  Sum_probs=210.4

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ...++|++.+.||+|+||+||.++.+.+++.+|+|++++.   .....+....|..+|..++||+||+++-.|++...+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            3467899999999999999999999999999999999875   3345677889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +|+||+.||.|..+| ++.+.+++..+.-++.+|+.||.|||   ++||+||||||+|||++.+|.++|+|||+++..- 
T Consensus       102 lVld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-  176 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-  176 (357)
T ss_pred             EEEeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc-
Confidence            999999999999988 45567899999999999999999999   8999999999999999999999999999998532 


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ..+....+..||+.|||||++.+..|+..+|.||||+++|+|++|.+||.+.+.......+..        +++      
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~--------~k~------  242 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK--------GKL------  242 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc--------CcC------
Confidence            233345557899999999999999999999999999999999999999999887766665543        110      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRP  304 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  304 (376)
                         ...+.-......+++.++|+.||++|.
T Consensus       243 ---~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence               111111224467888889999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=352.35  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=216.9

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCe
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  112 (376)
                      ....++|.+.+.||+|+|++|++|+.+.+++.||||++.+.-   ..-.+....|-..|.+| .||.|++++-.|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            456789999999999999999999999999999999997641   12234566788999999 69999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|+|+||+++|.|.++|.+ .+.+++.....++.+|+.||+|||   ++|||||||||+||||+.+++++|+|||.++.+
T Consensus       149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999955 478999999999999999999999   899999999999999999999999999999877


Q ss_pred             ccCCCc------------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH
Q 038118          193 EHAKGS------------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       193 ~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      ......            ....++||..|.+||++.++..+..+|+|+||||||+|+.|.+||.+.+.--+...|...  
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--  302 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--  302 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--
Confidence            432211            125588999999999999999999999999999999999999999988765555555542  


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                                  +-.+...+.    +.+.+|+.+.|..||.+|+|+.+|-+
T Consensus       303 ------------~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  303 ------------DYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ------------cccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence                        222333333    55788888999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=346.69  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=213.4

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC----Ch-hhHHHHHHHHHHHHhCC-CCCccceeeEEeeC
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG----SK-QGIKEYASEVTIISRLR-HRNLVQLLGWCHEK  110 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~  110 (376)
                      ....++|.+.+.||+|.||+|+.|.+..++..||+|++...    .. ...+.+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            34578999999999999999999999999999999987654    12 23456778999999999 99999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCCc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLA  189 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~  189 (376)
                      ..+|+||||+.||.|.+++.. .+++.+..+..+++||+.|+.|+|   ++||+||||||+|||++.+ +++||+|||++
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999999977 778999999999999999999999   8999999999999999999 99999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCC-C-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGR-A-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .... .......+..|++.|+|||++.+.. | +.++||||+|++||.|++|..||...+.......+..        +.
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--------~~  239 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--------GE  239 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--------CC
Confidence            8764 2334556677999999999998866 6 4889999999999999999999998654444333221        11


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                            -.+...+.   ...+..++.+||..||.+|+|+.+|+.
T Consensus       240 ------~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 ------FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ------ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                  11112221   445788899999999999999999993

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=336.07  Aligned_cols=255  Identities=30%  Similarity=0.466  Sum_probs=206.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC--eEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK--ELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~  117 (376)
                      ..+|...+.||+|.||.||++.+.++|...|||.+........+.+.+|+.+|..++|||||++++......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            567888999999999999999999999999999998764333677899999999999999999999744433  799999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCCCcccccc--
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEH--  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~--  194 (376)
                      ||+++|+|.+++...++.+++..+..+.+||++||.|||   ++||+|+||||+|||++. ++.+||+|||++.....  
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999776668999999999999999999999   899999999999999999 79999999999886653  


Q ss_pred             CCCcceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCCCCc-cchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPISLT-AKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..........||+.|||||++.++. ...++|||||||++.||+||..||... ........       .....     .
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~-------ig~~~-----~  240 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL-------IGRED-----S  240 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH-------HhccC-----C
Confidence            1222344577999999999998643 345999999999999999999999763 11111111       11111     1


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      .|.+...    ......+++..|+..||+.|||+.++|+..
T Consensus       241 ~P~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  241 LPEIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            1333333    334567788889999999999999999643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-46  Score=344.56  Aligned_cols=251  Identities=29%  Similarity=0.433  Sum_probs=214.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ...|....+||+|..|.||.|....+++.||||.+........+-+.+|+.+++.++|+|||.+++.|...+.+|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            35788889999999999999999999999999999876555556789999999999999999999999888999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      ++||+|.+.+..  ..+++.++..+++++++||.|||   .+||+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus       352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K  425 (550)
T KOG0578|consen  352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K  425 (550)
T ss_pred             cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence            999999888843  45899999999999999999999   89999999999999999999999999999987654433 4


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ..+.+||++|||||++....|+.|.||||||++++||+-|++||-..+.......+..       ++.      |.+  .
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-------ng~------P~l--k  490 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------NGT------PKL--K  490 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-------cCC------CCc--C
Confidence            4566799999999999999999999999999999999999999976554444333332       111      221  1


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........+.+++.+||+.|+++|+++.++|+
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            12344456888899999999999999999995

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=329.95  Aligned_cols=267  Identities=25%  Similarity=0.336  Sum_probs=217.7

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      .++....+.|++.+.||.|..++||+|+...++..||||++... .......+.+|+..++.++||||++++..|..+..
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            34445568999999999999999999999999999999999865 33346889999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      +|+||.||.+|++.+.+...- .-+++..+..+++++++||.|||   .+|.+|||||+.||||+.+|.|||+|||.+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeee
Confidence            999999999999999886532 34899999999999999999999   89999999999999999999999999998765


Q ss_pred             cccCCCcc---eeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          192 VEHAKGSQ---TTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       192 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      +.......   ...+.||++|||||++..  ..|+.|+||||||++..||.+|..||.............+        +
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--------n  247 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--------N  247 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--------C
Confidence            54332221   145689999999999643  4699999999999999999999999987765444322221        1


Q ss_pred             ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .........+..+........+..++..||+.||++|||++++++
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111112233334445567888888999999999999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=338.12  Aligned_cols=269  Identities=24%  Similarity=0.278  Sum_probs=220.7

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHH-HHHHHHHHHHhCC-CCCccceeeEEeeCC-eEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLR-HRNLVQLLGWCHEKK-ELL  114 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~  114 (376)
                      ..-++|++.++||.|.||.||+|+...++..||||.++.....+.+ .-++|+..|++|+ ||||+++.+++.+.+ .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3468999999999999999999999999999999999876433222 2358999999999 999999999998887 999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +|||||+. +|++++..+++.+++..+..|+.||++||+|+|   ++|+.|||+||+|||+..+..+||+|||+|+.+..
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence            99999955 999999988899999999999999999999999   89999999999999999888999999999987643


Q ss_pred             CCCcceeeeccCCCCCchhhh-ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC-----Ccc
Q 038118          195 AKGSQTTVLAGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN-----GKL  268 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~  268 (376)
                      .  ...+..+.|..|.|||++ +.+.|+.+.|||++|||++|+++-++.|.+.+..+....+..........     ..+
T Consensus       163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            2  345566789999999987 55679999999999999999999999999988777777776543221111     000


Q ss_pred             cc-------ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          269 LE-------AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       269 ~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ..       ...+.-...+.+......++++..|+..||.+|||+.+.++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11       111111122333456778999999999999999999999964

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-45  Score=336.27  Aligned_cols=269  Identities=26%  Similarity=0.299  Sum_probs=217.1

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~  114 (376)
                      ..+.|+..++||+|.||.||+|++..+|+.||+|+++...  .....-..+||.+|++|.||||+++.++..+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            3467788899999999999999999999999999998764  33334456899999999999999999998876  6899


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||+|||++ +|.-++....-.+++.++..++.||+.||+|+|   .+||+|||||..||||+.+|.+||+|||+++++..
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99999987 777777666678999999999999999999999   89999999999999999999999999999998876


Q ss_pred             CCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH----hcCCccc
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL----YGNGKLL  269 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~  269 (376)
                      ......+..+-|..|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+.+..+....|.......    |...++.
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            666666777789999999998775 59999999999999999999999999988777766666543221    1111111


Q ss_pred             --cccCCcC-----CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 --EAVDPRL-----CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 --~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ..+.+..     ..+..........+|+..+|..||.+|.|+.++|+
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              0111100     00111122244677788899999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=337.81  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=214.0

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      ....++|++.+.||+|+||.||+|+-+.||..+|+|++++.   .....+..+.|-.+|....++.||+++-.|.+..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            44678999999999999999999999999999999999876   344567788999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ||||||++||.+..+|. ..+.+++..+..++.+++-|+..||   +.|++||||||+|+|||..|++||+|||++.-+.
T Consensus       217 YLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999998884 4567999999999999999999999   8999999999999999999999999999985321


Q ss_pred             c------------------------CCC----cc------------------eeeeccCCCCCchhhhccCCCCCCCcee
Q 038118          194 H------------------------AKG----SQ------------------TTVLAGTMGYMAPECATTGRASKESDVY  227 (376)
Q Consensus       194 ~------------------------~~~----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvw  227 (376)
                      .                        ...    ..                  ....+|||.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                        000    00                  0124699999999999999999999999


Q ss_pred             echhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 038118          228 SFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS  305 (376)
Q Consensus       228 slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  305 (376)
                      |||||+||||.|.+||...+..+....+.+|...+......              .......++|.+|+. ||++|..
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999999999999999999886543221110              111457888999999 9999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=313.65  Aligned_cols=238  Identities=27%  Similarity=0.363  Sum_probs=207.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|+..+.||.|+||+|.+++.+.+|..+|+|++.+.   ..+..+...+|..+|+.+.||+++++++.|.+.+.+|||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            35677889999999999999999999999999999865   344566778999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||++||.|..++. ..+++++..++.++.||+.||+|||   +++|++|||||+|||+|.+|.+||+|||+++.+.   
T Consensus       123 meyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---  195 (355)
T ss_pred             EeccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence            99999999999994 4567999999999999999999999   8999999999999999999999999999998653   


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       ..+.+..||+.|+|||++....++.++|.|+||+++|||+.|.+||...+...+...|..        ++      -  
T Consensus       196 -~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~--------~~------v--  258 (355)
T KOG0616|consen  196 -GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE--------GK------V--  258 (355)
T ss_pred             -CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh--------Cc------c--
Confidence             236678899999999999999999999999999999999999999998887666655543        11      1  


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCC
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLR  303 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~R  303 (376)
                        .++.-....+.+|+...|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              1222233447778888999999988

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-46  Score=343.96  Aligned_cols=271  Identities=28%  Similarity=0.489  Sum_probs=222.1

Q ss_pred             CcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceee
Q 038118           28 PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLG  105 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~  105 (376)
                      ....+..++++-.+...+...||+|.||+||+|+|-++   ||||++...  ..+.++.|..|+..+++-+|-||+-|.|
T Consensus       379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cCCccccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            45666788888899999999999999999999999754   999999765  5567889999999999999999999999


Q ss_pred             EEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEee
Q 038118          106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       106 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                      +|..... .||+.||+|.+|+.+++.....+.....+.|++||++|+.|||   .++|+|||||..|||+.+++.|||+|
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEec
Confidence            9999887 9999999999999999888888999999999999999999999   79999999999999999999999999


Q ss_pred             CCCccccccCCCc-ceeeeccCCCCCchhhhccC---CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH
Q 038118          186 FGLARLVEHAKGS-QTTVLAGTMGYMAPECATTG---RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       186 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      ||++......... ......|...|||||+++.+   +|++.+||||||+++|||++|..||.... .+....++     
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dqIifmV-----  605 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQIIFMV-----  605 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhheEEEe-----
Confidence            9999765443222 22334477899999999654   68999999999999999999999999443 33222111     


Q ss_pred             HhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCC
Q 038118          262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP  318 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~  318 (376)
                        +.+.+.  .|..   .......+.+.+|+..||..++++||.+.+|+..|+...+
T Consensus       606 --GrG~l~--pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  606 --GRGYLM--PDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --cccccC--ccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              112111  1111   1122344567778888999999999999999998887665

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-44  Score=305.73  Aligned_cols=266  Identities=21%  Similarity=0.269  Sum_probs=217.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh--hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ--GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .+|...++||+|.||.||+|++..+|+.||||++......  ......+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5788899999999999999999999999999999876332  13456789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |++. +|...+......+....+..|+.++++|++|+|   .+.|+||||||.|+|++.+|.+||+|||+++.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9965 898888888888999999999999999999999   899999999999999999999999999999987654433


Q ss_pred             ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC--cccc-----
Q 038118          199 QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG--KLLE-----  270 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----  270 (376)
                      .. ..+-|..|.|||.+.|. .|+...||||.|||+.||+-|.+-|.+.+.-+....+.+.......+.  .+..     
T Consensus       158 ~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 QT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             cc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            32 23578899999988775 599999999999999999999999999887777666655432211110  0000     


Q ss_pred             ---ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 ---AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .........+-......+.+++..|+..||.+|.|+.|.++
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence               11111112233344556788999999999999999999985

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-46  Score=334.88  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=213.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ...|+..++||+|.||.||+|.++.+++.||+|++... ....+..+++|+.+|.+++++||.++|+.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            45677889999999999999999999999999999876 44457889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ||.||++.+.+. .+..+.+..+.-++++++.||.|||   ..+.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus        92 y~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   92 YCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            999999999884 4445588888889999999999999   899999999999999999999999999999876554443


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      . .+++||+.|||||++....|+.|+||||||++.+||++|.+|+...........|.             +.-.|.+..
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------k~~PP~L~~  233 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------KSAPPRLDG  233 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------CCCCCcccc
Confidence            3 67889999999999998899999999999999999999999998765433222111             122233333


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          .....+.+++..||+.||+.||++.++++
T Consensus       234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                44556888888999999999999999884

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=338.88  Aligned_cols=247  Identities=28%  Similarity=0.402  Sum_probs=212.6

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|-+.+.||+|.||.||+|+.+.+.+.||+|.+.+.  ..+.++.+.+|+++++.++||||+.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4788899999999999999999999999999999875  44567889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+.| +|..++ ...+.++++.+..++.+++.||.|||   +++|+|||+||.|||+..+|.+|+||||+++.... +..
T Consensus        82 ~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~  155 (808)
T KOG0597|consen   82 YAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS  155 (808)
T ss_pred             hhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence            9977 998888 45677999999999999999999999   89999999999999999999999999999987643 334


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ..+...||+.|||||++.++.|+..+|+||||||+|||++|++||....-......|..       +        +... 
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~-------d--------~v~~-  219 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK-------D--------PVKP-  219 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-------C--------CCCC-
Confidence            55677899999999999999999999999999999999999999986553333222221       1        1111 


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        +......+..++...|.+||..|.|..+++.
T Consensus       220 --p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  220 --PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             --cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence              1244556788888899999999999999984

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-45  Score=324.64  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=215.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...+|++.+.||+|.||.|-+|+....|+.||||.+++.   +...+-.+.+|++++..|+||||+.+|.+|+..+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            357899999999999999999999999999999999875   44556678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||..+|.|++++. ..+.+++..+..+++||..|+.|+|   +++++|||||.+|||+|.++++||+|||++..+.. 
T Consensus       131 vMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-  205 (668)
T ss_pred             EEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence            999999999999994 5567999999999999999999999   89999999999999999999999999999976543 


Q ss_pred             CCcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                       .....++.|++-|.+||.+++.+| ++..|-||||++||.|+.|.+||++.+...+...|.+        +...+.   
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~--------GaYrEP---  273 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR--------GAYREP---  273 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--------ccccCC---
Confidence             234567789999999999998876 6789999999999999999999999886665444443        222221   


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      ...        ....-||.|||..||++|.|+++|...+
T Consensus       274 ~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  274 ETP--------SDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             CCC--------chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            111        1245688999999999999999999644

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-44  Score=335.69  Aligned_cols=259  Identities=27%  Similarity=0.393  Sum_probs=202.4

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGS-KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      ...++|++.++||.|+||.||+|.+.     .++..||+|++.... ......+.+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            34578999999999999999999853     345679999987543 33456789999999999 899999999988754


Q ss_pred             -CeEEEEEecCCCCChhhhhhhcC--------------------------------------------------------
Q 038118          111 -KELLLVYEYMPNGSLDSHLFKEN--------------------------------------------------------  133 (376)
Q Consensus       111 -~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------------------------  133 (376)
                       ..+++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             46899999999999998885421                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCC
Q 038118          134 -----NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTM  207 (376)
Q Consensus       134 -----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~  207 (376)
                           ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........ .......++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 23677888899999999999999   79999999999999999999999999999875432211 1122234567


Q ss_pred             CCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHH
Q 038118          208 GYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQME  286 (376)
Q Consensus       208 ~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (376)
                      .|+|||++.+..++.++|||||||++|+|++ |..||............       ...+..     ...    ......
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~~~-----~~~----~~~~~~  304 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR-------LKDGTR-----MRA----PENATP  304 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-------HhcCCC-----CCC----CCCCCH
Confidence            8999999998889999999999999999997 99999765432221111       111111     111    112234


Q ss_pred             HHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          287 CLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       287 ~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            57889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.5e-44  Score=331.39  Aligned_cols=246  Identities=24%  Similarity=0.354  Sum_probs=204.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            46789999999999999999999999999999998753   223356788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+.+++|.+++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... 
T Consensus        97 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            999999999988854 456889999999999999999999   799999999999999999999999999998754322 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                         .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.        .+.      ..+
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--------~~~------~~~  234 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--------AGR------LKF  234 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--------cCC------cCC
Confidence               223568999999999998889999999999999999999999997655433222221        111      011


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ...+    ...+.+++.+||+.||.+||+     +.+++.
T Consensus       235 p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        235 PNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1112    234678899999999999997     677764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-44  Score=339.33  Aligned_cols=248  Identities=24%  Similarity=0.355  Sum_probs=211.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .+-|++.+.||.|+.|.|.+|++..||+.+|||++...   .......+.+|+-+++.+.|||++++|+++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            46689999999999999999999999999999999765   223345678999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      .||++||.|++++... +.+++..+.+++.||+.|+.|+|   ..+|+||||||+|+||+..+++||+|||+|..-  ..
T Consensus        91 lEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe--~~  164 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE--VP  164 (786)
T ss_pred             EEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc--cC
Confidence            9999999999999654 56888888999999999999999   799999999999999999999999999999753  23


Q ss_pred             CcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      +....+..|++.|.+||++.+.+| +.++||||.|||||.||+|++||++.+...+...+.+..+               
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f---------------  229 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF---------------  229 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc---------------
Confidence            344556779999999999998876 6899999999999999999999997664444333332111               


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         +++........+|+.+||..||.+|.|+++|++
T Consensus       230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence               112233345788899999999999999999996

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=332.42  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=219.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe-EEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE-LLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~  117 (376)
                      ++|...+++|+|+||.+++++++..+..+++|.+...  .....+...+|+.++.+++||||+.+.+.|.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            6799999999999999999999999999999999764  23334467889999999999999999999998887 99999


Q ss_pred             ecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          118 EYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      +||+||++.+.+.... ..++++.++.|+.|++.|+.|||   ++.|+|||||+.|||++.++.++|+|||+++..+...
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997655 67999999999999999999999   8999999999999999999999999999999875443


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       ....+..||+.|+.||.+.+.+|+.|+|||||||++|||++-+.+|...+.......+.+                 ..
T Consensus       161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~-----------------~~  222 (426)
T KOG0589|consen  161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR-----------------GL  222 (426)
T ss_pred             -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-----------------cc
Confidence             245567799999999999999999999999999999999999999998886666555543                 12


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ...++......+..++..||+.+|+.||++.++|.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            233444556678889999999999999999999964

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=330.66  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=209.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+..|+.++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987542   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.. .+.+++..++.++.||+.||.|||   +.|++||||||+|||++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            99999999998854 456889999999999999999999   79999999999999999999999999999875432   


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                       ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..+...      . .  .+.. 
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------~-~--~~~~-  222 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET------L-Q--RPVY-  222 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc------c-c--CCCC-
Confidence             223456899999999999889999999999999999999999999877655544333322110      0 0  0111 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ..........+.+++.+||+.+|.+||++.++++.
T Consensus       223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            10011234457888899999999999999999963

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.7e-43  Score=326.79  Aligned_cols=242  Identities=28%  Similarity=0.363  Sum_probs=198.4

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.||+|+||.||++.+..++..||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4799999999999999999999999998753   2334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeee
Q 038118          124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL  203 (376)
Q Consensus       124 sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  203 (376)
                      +|..++.. .+.+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||++...... .......
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~  155 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF  155 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccc
Confidence            99887744 457899999999999999999999   799999999999999999999999999998643211 1122345


Q ss_pred             ccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       204 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      .|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+..      ..        ..+...    
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~------~~--------~~~p~~----  217 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EE--------IRFPRT----  217 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CC--------CCCCCC----
Confidence            689999999999988999999999999999999999999976554333222211      00        111122    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          284 QMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ....+.+++.+||+.||++|+     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            234577888999999999998     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.2e-43  Score=326.34  Aligned_cols=242  Identities=26%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999998753   2334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeee
Q 038118          124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL  203 (376)
Q Consensus       124 sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  203 (376)
                      +|.+.+.. .+.+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++..... ........
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~  155 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF  155 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccce
Confidence            99888854 457899999999999999999999   79999999999999999999999999999864321 12223345


Q ss_pred             ccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       204 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        .      +..+..    .
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------~------~~~~p~----~  217 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------E------EIRFPR----T  217 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------C------CCCCCC----C
Confidence            689999999999988999999999999999999999999976554333222211        0      011112    2


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          284 QMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ....+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            234578889999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-44  Score=327.00  Aligned_cols=245  Identities=24%  Similarity=0.312  Sum_probs=204.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999999999999999986532   233566889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999999998854 456889999999999999999999   799999999999999999999999999998754321  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                        .....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..        +.      ..+.
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--------~~------~~~~  218 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--------GK------LEFP  218 (291)
T ss_pred             --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC------cCCC
Confidence              2234589999999999988899999999999999999999999987654443332221        10      1111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ..    ....+.+++.+||+.||.+||+     +.++++
T Consensus       219 ~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         219 RH----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             cc----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            11    2345788999999999999995     888874

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6e-44  Score=325.69  Aligned_cols=267  Identities=21%  Similarity=0.258  Sum_probs=207.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....  ....+.+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999987542  3335677899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |++++.+.. +......+++..++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~~l~~-~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLEL-LEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            999876654 4344567899999999999999999999   799999999999999999999999999999765433222


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH--------HHHhcCCcccc
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV--------WDLYGNGKLLE  270 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  270 (376)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....        ...........
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            3334568999999999998889999999999999999999999998765433322222110        00011111100


Q ss_pred             ccCCcCCC------CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCR------DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+....      .........+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00011100      011123356889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-43  Score=328.17  Aligned_cols=253  Identities=25%  Similarity=0.322  Sum_probs=206.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999997542   234566888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++......+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999998766578999999999999999999999   79999999999999999999999999999976543333


Q ss_pred             cceeeeccCCCCCchhhhc------cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          198 SQTTVLAGTMGYMAPECAT------TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .......||..|+|||++.      ...++.++|||||||++|+|++|..||...........+..       .......
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~  230 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN-------FQRFLKF  230 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc-------CCCccCC
Confidence            2333456899999999986      45678999999999999999999999976654433222221       0100000


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        +   .  .......+.+++..||+ +|.+||++.+++.
T Consensus       231 --~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         231 --P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              0   0  11123446778888998 9999999999984

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=322.64  Aligned_cols=258  Identities=24%  Similarity=0.306  Sum_probs=209.5

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--------------hhHHHHHHHHHHHHhCCCCCc
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--------------QGIKEYASEVTIISRLRHRNL  100 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i  100 (376)
                      +-....++|++...||+|.||.|-+|++..+++.||||++.+...              ..++...+|+.+|+++.|+||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            334557899999999999999999999999999999999975321              124578899999999999999


Q ss_pred             cceeeEEee--CCeEEEEEecCCCCChhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC
Q 038118          101 VQLLGWCHE--KKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL  177 (376)
Q Consensus       101 ~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~  177 (376)
                      |+++.+..+  .+.+|||+|||..|.+.+.-  ..+. +.+.+++.+++.++.||+|||   .+||+||||||.|+||++
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence            999999875  46899999999988875432  3344 899999999999999999999   799999999999999999


Q ss_pred             CceEEEeeCCCccccccCC----CcceeeeccCCCCCchhhhccCC----CCCCCceeechhhHHHHHhCCCCCCCccch
Q 038118          178 NFNAKIGDFGLARLVEHAK----GSQTTVLAGTMGYMAPECATTGR----ASKESDVYSFGIVALEIACGRKPISLTAKE  249 (376)
Q Consensus       178 ~~~~kl~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~~lltg~~pf~~~~~~  249 (376)
                      +|++||+|||.+..+....    ........||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+....
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            9999999999997652221    11233467999999999886632    467889999999999999999999887766


Q ss_pred             hhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      +....|.+                ..+.-...++..+.+.+||+++|++||+.|.++.+|....
T Consensus       326 ~l~~KIvn----------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 ELFDKIVN----------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHHHHhc----------------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            66555543                1121122224556789999999999999999999987543

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=343.87  Aligned_cols=259  Identities=22%  Similarity=0.274  Sum_probs=213.6

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEE-ee----
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWC-HE----  109 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~----  109 (376)
                      +.....++++.+.|.+|||+.||+|.+.+.|..||+|++-..+...++.+.+|++++++|+ |+|||.+++.. ..    
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            3445678899999999999999999999988999999998888888999999999999998 99999999932 11    


Q ss_pred             --CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          110 --KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       110 --~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                        .-.++|.||||.||.|-+++..+ ...+.+.++++|+.++++|+.+||.+ +..|+|||||-+||||..+|+.|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence              23678999999999999999753 34599999999999999999999975 567999999999999999999999999


Q ss_pred             CCccccccCCCc-c-------eeeeccCCCCCchhhh---ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH
Q 038118          187 GLARLVEHAKGS-Q-------TTVLAGTMGYMAPECA---TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL  255 (376)
Q Consensus       187 g~~~~~~~~~~~-~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~  255 (376)
                      |.++-.-..... .       ......|+.|++||.+   .+...+.|+|||+|||+||-|+....||+.....      
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------  264 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------  264 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence            998643222211 1       1123468999999976   6778999999999999999999999999865322      


Q ss_pred             HHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                                    .+++..+.-...+.+...|..||..||+.||++||++-+|+..+-.
T Consensus       265 --------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 --------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             --------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                          2233333333345778889999999999999999999999976643

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.3e-43  Score=318.43  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=206.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+.   ..+..||+|.+... .......|.+|+..+++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            467999999999999999999875   45678999998765 33445678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.||+.||.|||   +++++||||||+||+++.++.++++|||........
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999988765667899999999999999999999   799999999999999999999999999987543221


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.        .+..     .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~--------~~~~-----~  227 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE--------DGFR-----L  227 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH--------CCCC-----C
Confidence            1111112234678999999998999999999999999999775 999997665443322221        1110     0


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..    .......+.+++..||+.+|.+||++.+|++.|..
T Consensus       228 ~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         228 PA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            11    12233457888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.9e-43  Score=330.28  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            688999999999999999999999999999999753   23345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  197 (376)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999988854 456889999999999999999999   79999999999999999999999999999753311000 


Q ss_pred             ---------------------------------------------cceeeeccCCCCCchhhhccCCCCCCCceeechhh
Q 038118          198 ---------------------------------------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIV  232 (376)
Q Consensus       198 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~i  232 (376)
                                                                   .......||..|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123468999999999998889999999999999


Q ss_pred             HHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHH--ccCCCCCCCCChHHHH
Q 038118          233 ALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLW--CAHPDENLRPSIRQVI  310 (376)
Q Consensus       233 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPs~~~vl  310 (376)
                      +|+|++|..||......+....+..+..      .. . + +. ...+.    ..+.+++.+  |+..++..||++.+++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~------~~-~-~-~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWEN------TL-H-I-PP-QVKLS----PEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHcccc------cc-C-C-CC-CCCCC----HHHHHHHHHHccCcccccCCCCHHHHh
Confidence            9999999999987654443333322100      00 0 0 00 01122    335556655  5566777799999998


Q ss_pred             H
Q 038118          311 H  311 (376)
Q Consensus       311 ~  311 (376)
                      .
T Consensus       304 ~  304 (381)
T cd05626         304 A  304 (381)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.2e-43  Score=320.74  Aligned_cols=251  Identities=26%  Similarity=0.336  Sum_probs=202.7

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.++|+|++++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4788899999999999999999999999999987542   2223467889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|...+... ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++......  
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--  155 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence            99999998877543 346899999999999999999999   799999999999999999999999999998764321  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+....    ...          .
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~----------~  221 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV----KED----------Q  221 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh----hcc----------c
Confidence            12233468999999999999999999999999999999999999998654322221111110    000          0


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ..+.......+..++.+||+.||.+||+     ++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1112223345788899999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-43  Score=323.15  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=206.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.++||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            367999999999999999999999999999999987543 2223467789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++ +|.+++......+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........ 
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            9975 888888666667899999999999999999999   79999999999999999999999999999875432221 


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH----h----cCCccc
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL----Y----GNGKLL  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~----~~~~~~  269 (376)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......    +    ......
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            1223457889999998865 468899999999999999999999998766554433333221100    0    000000


Q ss_pred             cccCCcCCC----CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCR----DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+.+....    .........+.+++.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            001111100    000112245788999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.9e-43  Score=325.23  Aligned_cols=266  Identities=23%  Similarity=0.298  Sum_probs=207.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||++.+..++..||+|.+... .......+.+|+++++.++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            47899999999999999999999999999999998765 33445679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++.. ...+++..++.++.|++.+|.|||+  ..+|+||||||+|||++.++.++|+|||++......   
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          84 HMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            9999999988854 4568999999999999999999994  347999999999999999999999999998654321   


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc--c--------
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK--L--------  268 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~--------  268 (376)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+..-.........  .        
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            123345899999999999888999999999999999999999999765443322111100000000000  0        


Q ss_pred             -------------------ccccCCcCCCC-CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 -------------------LEAVDPRLCRD-FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 -------------------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                                         ...+....... ........+.+++.+||+.||++|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                               00000000000 01123456889999999999999999999985

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-42  Score=316.53  Aligned_cols=259  Identities=20%  Similarity=0.306  Sum_probs=204.7

Q ss_pred             CCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhHHHHHHHHHHHHhCCCCCccce
Q 038118           27 GPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGIKEYASEVTIISRLRHRNLVQL  103 (376)
Q Consensus        27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~  103 (376)
                      +.+.++.+++     +..-...||+|++|.||+|.+.  |+.||||.+.....   ...+.|.+|+.++++++||||+++
T Consensus        11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~   83 (283)
T PHA02988         11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI   83 (283)
T ss_pred             cceecCHHHc-----CCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence            3445555555     2222357999999999999984  78899999976432   235678899999999999999999


Q ss_pred             eeEEee----CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc
Q 038118          104 LGWCHE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF  179 (376)
Q Consensus       104 ~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~  179 (376)
                      ++++.+    ....++||||+++|+|.+++.. .+.+++...+.++.+++.+|.+||.  ..+++||||||+||++++++
T Consensus        84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~  160 (283)
T PHA02988         84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENY  160 (283)
T ss_pred             eeeEEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCC
Confidence            999876    4578999999999999998854 4568899999999999999999994  35889999999999999999


Q ss_pred             eEEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHH
Q 038118          180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       180 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~  257 (376)
                      .+||+|||++.......    ....|+..|+|||++.+  ..++.++|||||||++|+|++|..||...+..+....+..
T Consensus       161 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~  236 (283)
T PHA02988        161 KLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN  236 (283)
T ss_pred             cEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            99999999987543221    23357889999999876  6789999999999999999999999987654443322211


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                             .+.     .+.+    +......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       237 -------~~~-----~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        237 -------KNN-----SLKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -------cCC-----CCCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                   000     0111    11234468889999999999999999999998864

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=330.80  Aligned_cols=253  Identities=25%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999987532   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC-
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  196 (376)
                      ||+++++|.+++... +.+++..++.++.||+.||.|||   +.|++||||||+|||++.++.++|+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999988654 67899999999999999999999   7999999999999999999999999999987654332 


Q ss_pred             ---------------------------CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccch
Q 038118          197 ---------------------------GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKE  249 (376)
Q Consensus       197 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~  249 (376)
                                                 ........||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                       01223456899999999999999999999999999999999999999876644


Q ss_pred             hhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-hHHHHHH
Q 038118          250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS-IRQVIHV  312 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~~vl~~  312 (376)
                      .....+..|..      ...  + +. ...    ....+.+++.+|+. ||.+||+ +.++++.
T Consensus       237 ~~~~~i~~~~~------~~~--~-p~-~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ETYNKIINWKE------SLR--F-PP-DPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHhccCC------ccc--C-CC-CCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            43333322110      000  0 00 011    23457788888997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=332.38  Aligned_cols=257  Identities=26%  Similarity=0.404  Sum_probs=219.7

Q ss_pred             CCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCC-CCCcc
Q 038118           26 AGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLR-HRNLV  101 (376)
Q Consensus        26 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~  101 (376)
                      .++..++..+.....++|++.++||+|.||+|+++..+++++.+|||.+++.   .++..+..+.|.+++.... ||+++
T Consensus       353 ~~~~~~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~  432 (694)
T KOG0694|consen  353 SGPPEFPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLV  432 (694)
T ss_pred             CCcccCCCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEe
Confidence            3444444444556678999999999999999999999999999999999876   4556778888999998886 99999


Q ss_pred             ceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceE
Q 038118          102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA  181 (376)
Q Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~  181 (376)
                      .++..|....++|+||||+.||++..  ..+.+.+++..+..++..|+.||.|||   ++||++||||.+|||||.+|.+
T Consensus       433 ~L~~~fQT~~~l~fvmey~~Ggdm~~--~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~  507 (694)
T KOG0694|consen  433 NLFSCFQTKEHLFFVMEYVAGGDLMH--HIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHV  507 (694)
T ss_pred             ecccccccCCeEEEEEEecCCCcEEE--EEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcE
Confidence            99999999999999999999999433  235578999999999999999999999   8999999999999999999999


Q ss_pred             EEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH
Q 038118          182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      ||+|||+++. +...+..+.++.||+.|+|||++.+..|+.+.|.|+|||+||+||.|+.||.+.+.++....|..    
T Consensus       508 kiADFGlcKe-~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----  582 (694)
T KOG0694|consen  508 KIADFGLCKE-GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----  582 (694)
T ss_pred             Eecccccccc-cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----
Confidence            9999999974 23345567889999999999999999999999999999999999999999999998888777654    


Q ss_pred             HhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                                .++.....++.    +.+.++.++|.+||++|...
T Consensus       583 ----------d~~~yP~~ls~----ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 ----------DEVRYPRFLSK----EAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----------CCCCCCCcccH----HHHHHHHHHhccCcccccCC
Confidence                      23334344443    46677778999999999866

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.1e-43  Score=330.09  Aligned_cols=252  Identities=21%  Similarity=0.311  Sum_probs=199.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++|+||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999986532   223456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999998854 456889999999999999999999   79999999999999999999999999999753210000


Q ss_pred             ------------------------------------------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHH
Q 038118          198 ------------------------------------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE  235 (376)
Q Consensus       198 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~  235 (376)
                                                                .......||+.|+|||++.+..++.++|||||||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      00123468999999999999899999999999999999


Q ss_pred             HHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC---ChHHHHH
Q 038118          236 IACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP---SIRQVIH  311 (376)
Q Consensus       236 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---s~~~vl~  311 (376)
                      |++|..||......+....+..|..      .    +.......+.    ..+.+++.+|+ .+|.+|+   ++.++++
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~------~----~~~~~~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWET------T----LHIPSQAKLS----REASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCc------c----ccCCCCCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999987664443332222100      0    0000111222    33555666655 5999999   8899885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-42  Score=319.58  Aligned_cols=262  Identities=27%  Similarity=0.398  Sum_probs=203.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC----------------CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccc
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE----------------TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQ  102 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~  102 (376)
                      .++|++.++||+|+||.||+|.+..                ++..||+|.+... .......|.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998643                3457999998765 3444567899999999999999999


Q ss_pred             eeeEEeeCCeEEEEEecCCCCChhhhhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 038118          103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKEN------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVV  164 (376)
Q Consensus       103 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~  164 (376)
                      +++++.+.+..++||||+++++|.+++....                  ..+++..++.++.||+.||.|||   +.||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999998874421                  23677888999999999999999   78999


Q ss_pred             eecccCCCeeecCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh--CCC
Q 038118          165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC--GRK  241 (376)
Q Consensus       165 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt--g~~  241 (376)
                      ||||||+|||++.++.+||+|||++.......... .....++..|+|||++.++.++.++|||||||++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999987543222111 122335778999999988889999999999999999987  567


Q ss_pred             CCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       242 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ||..............+.    ......  ..    ..........+.+++.+||+.||.+|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~----~~~~~~--~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFF----RDQGRQ--VY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHh----hhcccc--cc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            887655443322222111    111000  00    0001122345788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-43  Score=321.73  Aligned_cols=239  Identities=23%  Similarity=0.305  Sum_probs=195.8

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ||+|+||.||+|.+..+++.||+|++...   .......+.+|+.++..++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999998643   233456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeecc
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG  205 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  205 (376)
                      .+++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++....... .......|
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g  155 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG  155 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence            998854 456899999999999999999999   7999999999999999999999999999987532211 22334568


Q ss_pred             CCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHH
Q 038118          206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQM  285 (376)
Q Consensus       206 t~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (376)
                      |..|+|||++.+..++.++|||||||++|+|++|..||...........+..        ..      ..+    .....
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~--------~~------~~~----~~~~~  217 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ--------EP------LRF----PDGFD  217 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc--------CC------CCC----CCcCC
Confidence            9999999999998999999999999999999999999986554333222111        00      111    11223


Q ss_pred             HHHHHHHHHccCCCCCCCCCh---HHHH
Q 038118          286 ECLMIVGLWCAHPDENLRPSI---RQVI  310 (376)
Q Consensus       286 ~~l~~li~~cl~~~p~~RPs~---~~vl  310 (376)
                      ..+.+++.+||+.||.+||++   .+++
T Consensus       218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            457788899999999999864   5555

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-42  Score=319.91  Aligned_cols=243  Identities=27%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.||+|+||.||++.+..++..||+|++...   .......+..|+.+++.++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999753   2334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeee
Q 038118          124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL  203 (376)
Q Consensus       124 sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  203 (376)
                      +|..++.. .+.+++..++.++.||+.||.|||+  ..||+||||||+|||++.++.+||+|||++...... .......
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~  156 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTF  156 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccccc
Confidence            99887744 4568999999999999999999993  279999999999999999999999999998643211 1222345


Q ss_pred             ccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       204 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      .|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..        .      ...+...+   
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~--------~------~~~~p~~~---  219 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------E------EIRFPRTL---  219 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------C------CCCCCCCC---
Confidence            689999999999988999999999999999999999999976654333222211        0      01111222   


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          284 QMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                       ...+.+++.+||+.||++|+     ++.++++
T Consensus       220 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         220 -SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence             34577889999999999996     8999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-42  Score=321.92  Aligned_cols=238  Identities=24%  Similarity=0.316  Sum_probs=189.9

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHH-HHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEV-TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|. .+++.++|+||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532   22234455554 467889999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|...+.. ...+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++...... ......
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST  155 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence            999887743 456888899999999999999999   799999999999999999999999999998643211 112234


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        ..      ..+    ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--------~~------~~~----~~  217 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH--------KP------LQL----PG  217 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------CC------CCC----CC
Confidence            5689999999999988899999999999999999999999987653332222111        10      011    11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIR  307 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~  307 (376)
                      .....+.+++.+||+.||.+||++.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCHHHHHHHHHHccCCHhhcCCCC
Confidence            2234578889999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=327.52  Aligned_cols=252  Identities=22%  Similarity=0.298  Sum_probs=200.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...   .......+.+|+++++.+.||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4789999999999999999999999999999998653   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.. .+.+++..+..++.|++.||.|||   +.||+||||||+|||++.++.++|+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999999998854 456889999999999999999999   79999999999999999999999999999853211000


Q ss_pred             c----------------------------------------------ceeeeccCCCCCchhhhccCCCCCCCceeechh
Q 038118          198 S----------------------------------------------QTTVLAGTMGYMAPECATTGRASKESDVYSFGI  231 (376)
Q Consensus       198 ~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~  231 (376)
                      .                                              ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                              001245899999999999889999999999999


Q ss_pred             hHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCC---CChHH
Q 038118          232 VALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLR---PSIRQ  308 (376)
Q Consensus       232 il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~~  308 (376)
                      ++|+|++|..||......+....+..|..      . ...  +   ..  ......+.+++.+||+ +|.+|   +++.+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~------~-~~~--p---~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRE------T-LYF--P---DD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCC------c-cCC--C---CC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999987654443333322100      0 000  0   00  0122346778888997 66665   59999


Q ss_pred             HHH
Q 038118          309 VIH  311 (376)
Q Consensus       309 vl~  311 (376)
                      ++.
T Consensus       302 ~l~  304 (377)
T cd05629         302 IKS  304 (377)
T ss_pred             Hhc
Confidence            885

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8e-43  Score=329.32  Aligned_cols=262  Identities=20%  Similarity=0.250  Sum_probs=207.9

Q ss_pred             CHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEe
Q 038118           32 TYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      .+.++....++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++.+.
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3667777789999999999999999999999999999999998642   2233456788999999999999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                      .+...|+||||+++++|.+++..  ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999999988843  35788889999999999999999   79999999999999999999999999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccC----CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTG----RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG  264 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      +...............||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+.......+..       
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------  261 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN-------  261 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc-------
Confidence            976543322223345699999999998654    378899999999999999999999987654333222211       


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCC--CCChHHHHHH
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL--RPSIRQVIHV  312 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~~  312 (376)
                      .......       .........+.+++..||..++.+  |+++.++++.
T Consensus       262 ~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1000000       001123345677888899854443  7899999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-42  Score=328.16  Aligned_cols=260  Identities=20%  Similarity=0.264  Sum_probs=205.5

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      ..+....++|++.+.||+|+||.||++.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++..+
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34455568999999999999999999999999999999998642   222345678899999999999999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      +.+|+||||+++|+|.+++..  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            999999999999999998843  35788999999999999999999   7999999999999999999999999999997


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccC----CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTG----RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ..............||+.|+|||++.+.    .++.++|||||||++|+|++|..||...+.......+..       ..
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~-------~~  263 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD-------HK  263 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CC
Confidence            6543322223355699999999998654    378899999999999999999999987654333222221       00


Q ss_pred             ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCC--CCChHHHHHH
Q 038118          267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL--RPSIRQVIHV  312 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~~  312 (376)
                      ..     ..+..  .......+.+++..||+.++.+  |+++.++++.
T Consensus       264 ~~-----~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NS-----LNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cc-----cCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00     00101  1122344677778888765544  8899999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-42  Score=322.75  Aligned_cols=242  Identities=26%  Similarity=0.353  Sum_probs=199.1

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.||+|+||.||++.+..++..||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999753   2334567888999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeee
Q 038118          124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL  203 (376)
Q Consensus       124 sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  203 (376)
                      +|...+.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... .......
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~  155 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTF  155 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccc
Confidence            99887744 456899999999999999999999   799999999999999999999999999998643211 1122345


Q ss_pred             ccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       204 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        .      +..+...    
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------~------~~~~p~~----  217 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------E------DIKFPRT----  217 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--------C------CccCCCC----
Confidence            689999999999988999999999999999999999999976554332221110        0      1111122    


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          284 QMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ....+.+++.+||+.||++|+     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            234577888999999999997     8899885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2e-42  Score=321.08  Aligned_cols=238  Identities=24%  Similarity=0.314  Sum_probs=191.4

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHH-HHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVT-IISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532   222344555544 56789999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... ......
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST  155 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence            999888854 457899999999999999999999   799999999999999999999999999998643211 122334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        ..      ..+...+  
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------~~------~~~~~~~--  219 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--------KP------LRLKPNI--  219 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------CC------CCCCCCC--
Confidence            5689999999999998999999999999999999999999987654333222211        10      1111222  


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIR  307 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~  307 (376)
                        ...+.+++.+||+.||.+||++.
T Consensus       220 --~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         220 --SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CHHHHHHHHHHhhcCHHhCCCCC
Confidence              34577888899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-43  Score=325.38  Aligned_cols=247  Identities=26%  Similarity=0.334  Sum_probs=203.6

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCC-eEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETS-SYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..++|++.+.||+|+||.||+|.+..++ ..||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3567999999999999999999976654 68999998643   2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus       108 lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999998854 456899999999999999999999   79999999999999999999999999999976432


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        +.      .
T Consensus       184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--------~~------~  245 (340)
T PTZ00426        184 ----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--------GI------I  245 (340)
T ss_pred             ----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--------CC------C
Confidence                22345689999999999988899999999999999999999999987654333222211        11      0


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      .+...+    ...+.+++.+||+.||.+|+     +++++++
T Consensus       246 ~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 YFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            111222    23467888899999999995     8888875

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.1e-43  Score=329.54  Aligned_cols=257  Identities=26%  Similarity=0.371  Sum_probs=202.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEE-----cCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||.||+|.+     ..++..||||++... .....+.+.+|+.++..+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999975     345678999998754 233456788999999999 79999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC-----------------------------------------------------------
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-----------------------------------------------------------  133 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------  133 (376)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999988885421                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          134 ---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       134 ---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                                     ..+++..++.++.||+.||.|||   +++++||||||+|||++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           24678889999999999999999   799999999999999999999999999998755332211


Q ss_pred             c-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          199 Q-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       199 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      . .....++..|+|||++.+..++.++|||||||++|+|++ |..||.............       ..+..  ...+. 
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~~~~--~~~~~-  340 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI-------KEGYR--MLSPE-  340 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH-------HhCcc--CCCCC-
Confidence            1 112234567999999998899999999999999999998 899997654332211111       11110  00111 


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                            .....+.+++.+||+.||++||++.+|++.|+.
T Consensus       341 ------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 ------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                  112457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-43  Score=329.16  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=202.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||.|+||.||+|.+..+++.||||++...   .......+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4799999999999999999999999999999999753   2334466788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999999998854 456899999999999999999999   79999999999999999999999999999865421110


Q ss_pred             c-------------------------------------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCC
Q 038118          198 S-------------------------------------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR  240 (376)
Q Consensus       198 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~  240 (376)
                      .                                     ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                     011235899999999999889999999999999999999999


Q ss_pred             CCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC---hHHHHH
Q 038118          241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS---IRQVIH  311 (376)
Q Consensus       241 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~~vl~  311 (376)
                      .||...........+..|.      ... . + +   ..  ......+.+++.+|+. +|.+|++   +.++++
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~------~~~-~-~-~---~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQETYRKIINWK------ETL-Q-F-P---DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCC------Ccc-C-C-C---CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9998766444333322210      000 0 0 0   00  0122346677778886 8999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.7e-43  Score=330.36  Aligned_cols=256  Identities=21%  Similarity=0.256  Sum_probs=205.4

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      ....++|++.+.||+|+||.||+|.+..++..||+|++...   .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            34567899999999999999999999999999999998642   223345578899999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |+||||+++|+|.+++..  ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999988843  35788889999999999999999   7999999999999999999999999999987654


Q ss_pred             cCCCcceeeeccCCCCCchhhhccC----CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTG----RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ...........||+.|+|||++.+.    .++.++|||||||++|+|++|..||...........+..       .....
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-------~~~~~  266 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD-------HKNSL  266 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc-------CCCcC
Confidence            3222223345689999999988653    478899999999999999999999987654333222211       00000


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL--RPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~  311 (376)
                           .+..  .......+.+++.+||+.+|.+  |+++.++++
T Consensus       267 -----~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         267 -----TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             -----CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                 0001  1112345778889999999988  999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-42  Score=312.00  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=208.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..+|.+.+.||+|++|.||+|.+..++..|++|.+..... ....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            4568899999999999999999999999999999875533 356788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++.... ..+++..++.++.|++.+|.|||   +++++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999999886533 45899999999999999999999   799999999999999999999999999998765432221


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+..        .     ..+   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--------~-----~~~---  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------G-----YRM---  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------C-----CCC---
Confidence            1112234567999999988889999999999999999998 9999976554333222111        0     011   


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .........+.+++.+||+.+|++||++.++++.|+.
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence             1112223557889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-43  Score=295.85  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=215.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|.||.||+|+.++++-.||+|++.+..   ....+++.+|+++-..|+||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467889999999999999999999999999999997653   23346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      +||..+|+|+..|.. ..+.+++...+.++.|++.||.|+|   .++++||||||+|+|++..+.+|++|||.+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999864 3456899999999999999999999   8999999999999999999999999999987533  


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       .....+..||..|.+||...+..++...|+|++|++.||++.|..||......+....+...              +- 
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------------~~-  239 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------------DL-  239 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--------------cc-
Confidence             34456677999999999999999999999999999999999999999988766666665541              11 


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                         .++........++|.+|+..+|.+|.+..+++..
T Consensus       240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               1122334457889999999999999999999863

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.6e-42  Score=320.61  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=199.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccC----ChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG----SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  113 (376)
                      +|++.+.||+|+||.||++.+.   .++..||+|++...    .....+.+..|+.+++.++ |+||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999999864   46889999998643    2233456788999999995 89999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++.. ...+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999999988854 456899999999999999999999   7999999999999999999999999999987543


Q ss_pred             cCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ...........||..|+|||++.+. .++.++|||||||++|+|++|..||...........+.....          ..
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------~~  226 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL----------KC  226 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh----------cC
Confidence            3333333345689999999998765 478899999999999999999999975433222211111100          01


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ++.+...    ....+.+++.+||+.||++||     ++.++++
T Consensus       227 ~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 DPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1222222    234567888899999999999     6777774

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=328.23  Aligned_cols=241  Identities=27%  Similarity=0.471  Sum_probs=199.3

Q ss_pred             cCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCC
Q 038118           45 DDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS  124 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s  124 (376)
                      -.+-||.|+.|.||+|+..  ++.||||+++.-.       ..++.-|++|+|+||+.|.++|.....+|||||||..|.
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3467999999999999987  5779999885332       247888999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeec
Q 038118          125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA  204 (376)
Q Consensus       125 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  204 (376)
                      |...| +.+..+....+..|..+||.++.|||   .+.|||||||.-||||..+..|||+|||.++.....  .....+.
T Consensus       199 L~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa  272 (904)
T KOG4721|consen  199 LYEVL-KAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA  272 (904)
T ss_pred             HHHHH-hccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence            99988 45567888889999999999999999   899999999999999999999999999999865433  3455678


Q ss_pred             cCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHH
Q 038118          205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ  284 (376)
Q Consensus       205 gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (376)
                      ||..|||||++++.+.+.|.|||||||+|||||||..||...+...+.       |. .+...        +.-..+..+
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------wG-VGsNs--------L~LpvPstc  336 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------WG-VGSNS--------LHLPVPSTC  336 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------Ee-ccCCc--------ccccCcccC
Confidence            999999999999999999999999999999999999999765432221       10 01111        111222333


Q ss_pred             HHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          285 MECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       285 ~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      .+-+..|++.||+..|+.||++++|+..|.-.
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            44567788899999999999999999888643

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-42  Score=318.58  Aligned_cols=256  Identities=22%  Similarity=0.268  Sum_probs=200.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.++..++|+||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999999999999999998642   2233456888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.+....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999998665667899999999999999999999   89999999999999999999999999999875543332


Q ss_pred             cceeeeccCCCCCchhhhcc-----CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          198 SQTTVLAGTMGYMAPECATT-----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......||+.|+|||++..     ..++.++|||||||++|+|++|..||......+....+..       ..... .+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~-------~~~~~-~~  229 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HKEHF-QF  229 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc-------CCCcc-cC
Confidence            23333468999999999863     4578899999999999999999999976554333222211       00000 01


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCC--CCCCCCChHHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHP--DENLRPSIRQVIHV  312 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPs~~~vl~~  312 (376)
                      .+ ....    ....+.+++.+||..  ++..|+++.++++.
T Consensus       230 ~~-~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PP-DVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CC-ccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11 1111    223456666666654  44448899999853

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.8e-42  Score=314.01  Aligned_cols=256  Identities=28%  Similarity=0.446  Sum_probs=208.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC-----eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS-----SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.+...+     ..|++|.+... .......|.+|+.++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            357899999999999999999986654     67999998754 334456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC
Q 038118          114 LLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN  178 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~  178 (376)
                      +++|||+++++|.+++....               ..+++..++.++.|++.||.|||   +++++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence            99999999999999885431               45788899999999999999999   7999999999999999999


Q ss_pred             ceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHH
Q 038118          179 FNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLV  256 (376)
Q Consensus       179 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~  256 (376)
                      +.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875432221 11223345788999999988889999999999999999998 999998765544322221


Q ss_pred             HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .        +..         ..........+.+++.+||+.||.+||++.+|++.|..
T Consensus       241 ~--------~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         241 S--------RQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             c--------CCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1        111         11122334568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-42  Score=324.74  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=196.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|+..+.||.|+||.||+|.+..+++.||||++.... ......+.+|+++++.++|+||+++++++...+.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            55677889999999999999999999999999986543 33456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|...     ....+..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....... ..
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  224 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP  224 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence            999998543     23567788899999999999999   7999999999999999999999999999987653221 11


Q ss_pred             eeeeccCCCCCchhhhcc-----CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          200 TTVLAGTMGYMAPECATT-----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .....|+..|+|||++..     ...+.++|||||||++|+|++|+.||......+....+.....     .     ..+
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-----~-----~~~  294 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-----S-----QPP  294 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----c-----CCC
Confidence            233468999999998743     2345689999999999999999999974433322221111000     0     001


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .    ........+.+++.+||+.||++|||+.+|++
T Consensus       295 ~----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        295 E----APATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             C----CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1    11223345788999999999999999999996

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2e-42  Score=310.40  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=203.6

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      ++|++.+.||+|+||.||++.++. +..+++|.+..... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            568899999999999999998865 45799998865432 2467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++++|.+++......+++..++.++.+++.+|.|||   +++++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            999999988665567899999999999999999999   79999999999999999999999999999875432222122


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+..        +.  ....+..   
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~--------~~--~~~~~~~---  225 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR--------GF--RLYRPKL---  225 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------CC--CCCCCCC---
Confidence            22234568999999988889999999999999999999 8999976654333222211        11  0011111   


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                          ....+.+++.+||+.+|++||++.++++.|
T Consensus       226 ----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                124578899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-43  Score=342.13  Aligned_cols=262  Identities=29%  Similarity=0.461  Sum_probs=220.2

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEee
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHE  109 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  109 (376)
                      .+....+....+.||+|.||+||+|+..+     ....||||.++..... ..++|++|++++..|+|||||+++|+|.+
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            34445566778899999999999998653     3468999999877544 67899999999999999999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKEN-------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD  176 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~  176 (376)
                      ++.+|+|+|||..|+|.++|....             ..++..+.+.++.|||.||.||-   ++.+|||||...|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence            999999999999999999985421             13788899999999999999999   89999999999999999


Q ss_pred             CCceEEEeeCCCccccccCCCccee-eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHH
Q 038118          177 LNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVY  254 (376)
Q Consensus       177 ~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~  254 (376)
                      ++..|||+|||+++..-..+..... ...-+.+|||||.+..++++.+||||||||+|||+++ |..|+.+..+++....
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            9999999999999865333222221 2234679999999999999999999999999999987 9999999998888776


Q ss_pred             HHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          255 LVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      +.+        +++         -..+..+...+..|+..||+.+|.+||+++||...|....
T Consensus       718 i~~--------g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  718 IRA--------GQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHc--------CCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            654        322         2234455567899999999999999999999999998644

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-42  Score=328.41  Aligned_cols=257  Identities=26%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC-----eEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS-----SYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||.||+|.+...+     ..||+|.+... .......+.+|+.+++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            458899999999999999999875433     47999999754 333456788999999999 79999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC-----------------------------------------------------------
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-----------------------------------------------------------  133 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-----------------------------------------------------------  133 (376)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998874321                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc-eee
Q 038118          134 ----------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ-TTV  202 (376)
Q Consensus       134 ----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  202 (376)
                                ..+++..+++++.||+.||.|||   ++|++||||||+|||+++++.++|+|||++.......... ...
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      24678889999999999999999   7999999999999999999999999999987543221111 112


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||..............       .+     ..+.....  
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~-------~~-----~~~~~~~~--  339 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK-------RG-----YQMSRPDF--  339 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH-------cc-----cCccCCCC--
Confidence            234567999999988899999999999999999997 9999976543322111111       11     00111111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        ....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       340 --~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         340 --APPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             --CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              12457888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-43  Score=311.09  Aligned_cols=252  Identities=25%  Similarity=0.296  Sum_probs=212.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .+.|++.+.||.|.-|+||++...+++..+|+|++.+.   .++.+.+.+.|-++|..+.||.++.+|..|+.+...|++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            46678889999999999999999999999999999875   344456778899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc-
Q 038118          117 YEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-  194 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-  194 (376)
                      ||||+||+|..+..++ ++.+++..+..++.+++-||+|||   ..|||+|||||+||||.++|.+.|+||.++..+.. 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999888654 467999999999999999999999   89999999999999999999999999988753210 


Q ss_pred             --------------------------------C-C---------------------CcceeeeccCCCCCchhhhccCCC
Q 038118          195 --------------------------------A-K---------------------GSQTTVLAGTMGYMAPECATTGRA  220 (376)
Q Consensus       195 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  220 (376)
                                                      . .                     +.....++||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011223579999999999999999


Q ss_pred             CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCC
Q 038118          221 SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE  300 (376)
Q Consensus       221 ~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p  300 (376)
                      +.+.|.|+||+++||||.|..||.+.++.+....+...              +..+..  .+.....+.+||.+.|.+||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--------------~l~Fp~--~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--------------PLKFPE--EPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--------------CCcCCC--CCcchhHHHHHHHHHhccCh
Confidence            99999999999999999999999999988887666531              011111  12455678999999999999


Q ss_pred             CCCCC----hHHHH
Q 038118          301 NLRPS----IRQVI  310 (376)
Q Consensus       301 ~~RPs----~~~vl  310 (376)
                      .+|..    +.||-
T Consensus       377 ~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIK  390 (459)
T ss_pred             hhhhccccchHHhh
Confidence            99998    55654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-42  Score=336.73  Aligned_cols=251  Identities=21%  Similarity=0.272  Sum_probs=206.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCC-CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRET-SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..|.+.+.||+|+||.||+|....+ +..|++|.+..........+..|+.+|+.++||||+++++++...+..|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3499999999999999999998877 788999988766666566788899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          120 MPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       120 ~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      +++|+|.+++..   ....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999887753   2346889999999999999999999   7999999999999999999999999999997654322


Q ss_pred             C-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 G-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..        +..    .+ 
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--------~~~----~~-  290 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--------GKY----DP-  290 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCC----CC-
Confidence            2 123345689999999999988999999999999999999999999976554333222111        110    00 


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .    .......+.+++.+||+.||++||++.+++.
T Consensus       291 ~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 F----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             C----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1    1112345788899999999999999999874

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-42  Score=312.75  Aligned_cols=255  Identities=28%  Similarity=0.465  Sum_probs=210.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ...+|++.+.||.|+||.||+|.+.. +..+++|.+..........+..|+.+++.++|+||+++++++......++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            45679999999999999999999988 78899999987766566788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++... ...+++..++.++.||+.||.|||   ++|++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999998653 356899999999999999999999   79999999999999999999999999999876533211


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      . .....++..|++||++.+..++.++||||||+++|+|++ |..||......+....+..        +         .
T Consensus       160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--------~---------~  221 (261)
T cd05148         160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA--------G---------Y  221 (261)
T ss_pred             c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh--------C---------C
Confidence            1 123335678999999988889999999999999999998 8999976653333222211        0         0


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...........+.+++.+||+.||.+|||+.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            011112223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=296.80  Aligned_cols=263  Identities=22%  Similarity=0.264  Sum_probs=212.8

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----  110 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  110 (376)
                      +....++|++.++||+|||+.||++..-.++..+|+|++.....+..+..++|++..++++|||+++++++...+     
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            345678999999999999999999999999999999999988888889999999999999999999999876433     


Q ss_pred             CeEEEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCCeeecCCceEEEee
Q 038118          111 KELLLVYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                      ...|++++|+..|+|.+.+..   .+..+++.+++.|+.+|++||.+||   +..  +.||||||.|||+.+.+.++|.|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEe
Confidence            358999999999999998754   3457999999999999999999999   566  99999999999999999999999


Q ss_pred             CCCccccccCCC--------cceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHH
Q 038118          186 FGLARLVEHAKG--------SQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY  254 (376)
Q Consensus       186 fg~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~  254 (376)
                      ||.++...-.-.        ........|..|.|||.+.   +...+.++|||||||+||.|+.|..||+..-..     
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-----  247 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-----  247 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----
Confidence            999875421111        1123345788999999885   345789999999999999999999999643211     


Q ss_pred             HHHHHHHHhcCCccc-cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          255 LVQWVWDLYGNGKLL-EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                                .+.+. ....+.+.-.-.....+.+..++.+||+.||.+||++.+++..+...
T Consensus       248 ----------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 ----------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ----------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                      11111 11222222222333667899999999999999999999999887643

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.6e-42  Score=315.46  Aligned_cols=241  Identities=23%  Similarity=0.358  Sum_probs=193.4

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++...   .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999998753   222344556677777654 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++.. ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++....... .....
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~  155 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST  155 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence            999888854 456899999999999999999999   7999999999999999999999999999987532221 22334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||...+.......+..       .       .+.+...   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------~-------~~~~~~~---  218 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------D-------RPHFPRW---  218 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------C-------CCCCCCC---
Confidence            5689999999999988899999999999999999999999987654333222211       0       0111112   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChH-HHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIR-QVI  310 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~-~vl  310 (376)
                       ....+.+++.+||+.||.+||++. +++
T Consensus       219 -~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         219 -ISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             234467888899999999999875 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.9e-42  Score=317.60  Aligned_cols=245  Identities=27%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHH---HhCCCCCccceeeEEeeCCeEEEE
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTII---SRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      |++.+.||+|+||.||+|.+..+++.||||++....   ....+.+..|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999999999999999997532   22345566676655   466799999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|...+.  ...+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|||++...... 
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-  154 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence            99999999987773  346899999999999999999999   799999999999999999999999999998643211 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ........|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+..        ..      ...
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--------~~------~~~  220 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--------DE------VRY  220 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC------CCC
Confidence            1223345689999999999988999999999999999999999999987654443322221        10      111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ...    ....+.+++.+||+.||.+||     ++.++++
T Consensus       221 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         221 PRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            112    234567889999999999999     4666664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.3e-42  Score=316.84  Aligned_cols=267  Identities=21%  Similarity=0.253  Sum_probs=201.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4789999999999999999999999999999999875432 223457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+. ++|.+++....+.+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++....... .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence            995 5777777666667899999999999999999999   7999999999999999999999999999986543221 1


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC-----cccccc
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG-----KLLEAV  272 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  272 (376)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......................     ......
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            2233457899999998865 4578899999999999999999999986543211111110000000000     000000


Q ss_pred             CCcCCCCCc----H------HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFD----E------QQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~----~------~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+.......    .      .....+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000000    0      01234678999999999999999999984

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=325.82  Aligned_cols=245  Identities=30%  Similarity=0.454  Sum_probs=210.8

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhh
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS  127 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~  127 (376)
                      +||+|.||+||.|++..++..+|||.+........+-+..|+.+.++|+|.|||+++|.+.+++++-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999999999999999988777777889999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCCCccccccCCCcceeeec
Q 038118          128 HLFKENNLL--TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEHAKGSQTTVLA  204 (376)
Q Consensus       128 ~l~~~~~~~--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~  204 (376)
                      ++...-+++  ++..+-.+..||++||.|||   .+.|||||||-+|||+.. .|.+||+|||.++.+... +..+.++.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT  737 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence            998777777  78888899999999999999   899999999999999965 688999999999876433 33556778


Q ss_pred             cCCCCCchhhhccC--CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          205 GTMGYMAPECATTG--RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       205 gt~~y~aPE~~~~~--~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ||..|||||++..+  .|+.++|||||||++.||.||++||..............       -        -.....++.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-------m--------yKvHP~iPe  802 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-------M--------YKVHPPIPE  802 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-------c--------eecCCCCcH
Confidence            99999999999765  589999999999999999999999976554333221111       1        112345566


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........+|++|+.++|.+||++.++|+
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            77778889999999999999999999985

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.3e-42  Score=320.80  Aligned_cols=203  Identities=28%  Similarity=0.401  Sum_probs=178.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.++||.|+||.||++.+..++..+++|.+... .......+.+|+++++.++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            57899999999999999999999999999999988764 33445678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++.. .+.+++..+..++.+++.+|.|||+  ..+++|+||||+|||++.++.+||+|||++......   
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          84 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            9999999998854 4568899999999999999999994  357999999999999999999999999998654221   


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccc
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAK  248 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~  248 (376)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~  207 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA  207 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence            12234588999999999988899999999999999999999999976543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.3e-42  Score=326.94  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=198.0

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .|++.++||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++++++|+||+++++.+.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6889999999999999999999999999999987532   3345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC--
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK--  196 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  196 (376)
                      |+++|+|.+++.+ .+.+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999998854 356889999999999999999999   7999999999999999999999999999975321000  


Q ss_pred             --------------------------------------------CcceeeeccCCCCCchhhhccCCCCCCCceeechhh
Q 038118          197 --------------------------------------------GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIV  232 (376)
Q Consensus       197 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~i  232 (376)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC---hHHH
Q 038118          233 ALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS---IRQV  309 (376)
Q Consensus       233 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~~v  309 (376)
                      +|+|++|..||...+..+....+..+..      .. . + +. ...+.    ..+.+++.+|+ .+|.+|++   +.++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~------~~-~-~-p~-~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQT------SL-H-I-PP-QAKLS----PEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCC------Cc-C-C-CC-cccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            9999999999987654443333322100      00 0 0 00 11222    33455555554 49999997   7777


Q ss_pred             HH
Q 038118          310 IH  311 (376)
Q Consensus       310 l~  311 (376)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=319.99  Aligned_cols=254  Identities=25%  Similarity=0.331  Sum_probs=218.5

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh---hHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ---GIKEYASEVTIISRLR-HRNLVQLLGWCHEKKE  112 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  112 (376)
                      ......|++.+.||.|.||.||+++.+.+|+.+|+|.+.+....   ....+.+|+++|+++. ||||+.++++|+....
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            44567899999999999999999999999999999999865332   3467899999999999 9999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC----ceEEEeeCCC
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN----FNAKIGDFGL  188 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~  188 (376)
                      +++|||++.||.|.+.+...  .+++..+..++.||+.++.|||   +.|++||||||+|+|+...    +.+|++|||+
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999999776  3999999999999999999999   8999999999999999643    4799999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      +.....  ........||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.......+..        +. 
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~--------~~-  254 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR--------GD-  254 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc--------CC-
Confidence            987765  4566778899999999999999999999999999999999999999998876555544332        11 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           ..+....-+.....+.+++..|+..||.+|+|+.++|+
T Consensus       255 -----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  255 -----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                 12222223334556788888999999999999999997

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-42  Score=324.55  Aligned_cols=211  Identities=26%  Similarity=0.367  Sum_probs=181.6

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+..|+.++..++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999999999999999999753   2233456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++|+|.+++.+ .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999999998854 457899999999999999999999   89999999999999999999999999999875422110


Q ss_pred             ----------------------------------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCC
Q 038118          198 ----------------------------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       198 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf  243 (376)
                                                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              0012346899999999999889999999999999999999999999


Q ss_pred             CCccchhhHHHH
Q 038118          244 SLTAKEEVQVYL  255 (376)
Q Consensus       244 ~~~~~~~~~~~~  255 (376)
                      ......+....+
T Consensus       237 ~~~~~~~~~~~i  248 (363)
T cd05628         237 CSETPQETYKKV  248 (363)
T ss_pred             CCCCHHHHHHHH
Confidence            876654443333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-42  Score=308.65  Aligned_cols=256  Identities=29%  Similarity=0.472  Sum_probs=208.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+..+   ...|++|.+... .......|.+|+.+++.++|+||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            46799999999999999999998643   457999998754 33445678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++....+.+++..++.++.|++.+|.|||   +++++|+||+|.||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999998766668899999999999999999999   799999999999999999999999999999876422


Q ss_pred             CCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          196 KGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       196 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+..        ....    
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--------~~~~----  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED--------GYRL----  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc--------CCCC----
Confidence            2111 112234578999999988889999999999999999998 9999976554433222211        1000    


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      +     ........+.+++.+||+.+|++||++.+|++.|..
T Consensus       228 ~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         228 P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            0     011223457899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-42  Score=300.70  Aligned_cols=268  Identities=22%  Similarity=0.242  Sum_probs=211.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhH-HHHHHHHHHHHhCCCCCccceeeEEee--CCeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGI-KEYASEVTIISRLRHRNLVQLLGWCHE--KKELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~  114 (376)
                      ..+.|+...+|++|.||.||+|+++.++..||+|+++.... .+. -.-++|+.+|.+.+|||||.+-.+...  -+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            35678888999999999999999999999999999986532 111 134689999999999999999988764  45799


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||||||++ +|..++..-..++...++.-+..|+++|+.|||   .+.|+|||||++|+|+.+.|.+||+|||+|+.++.
T Consensus       154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            99999976 788888777778999999999999999999999   89999999999999999999999999999998765


Q ss_pred             CCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC-------C
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN-------G  266 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~  266 (376)
                      .. ...+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++.|.+....+....|.+......+.       -
T Consensus       230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            42 234556678999999998775 59999999999999999999999999988777766666543221111       0


Q ss_pred             c------cccccCCcCCCCCcHH-HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 K------LLEAVDPRLCRDFDEQ-QMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 ~------~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .      ........+...+... ..+.-.+++..+|..||.+|-|+++-|+
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            0      0000001111111111 3355678888999999999999999884

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.9e-42  Score=318.72  Aligned_cols=243  Identities=23%  Similarity=0.265  Sum_probs=193.5

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHH-HHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVT-IISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+|+.||+|++...   .......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999999999999999998753   2223344555554 56778999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|...+. ..+.+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++...... ......
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (325)
T cd05604          81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT  155 (325)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence            99988774 3457899999999999999999999   799999999999999999999999999998643211 112334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        ..      ..+...   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--------~~------~~~~~~---  218 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--------KP------LVLRPG---  218 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------CC------ccCCCC---
Confidence            5689999999999998999999999999999999999999987654433222211        10      111112   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                       ....+.+++.+||+.+|.+||++.+.++.
T Consensus       219 -~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         219 -ASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             -CCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence             22346778889999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=326.91  Aligned_cols=267  Identities=29%  Similarity=0.404  Sum_probs=220.3

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCe---E-EEEEEccc---CChhhHHHHHHHHHHHHhCCCCCccce
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSS---Y-IAVKRVSK---GSKQGIKEYASEVTIISRLRHRNLVQL  103 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~---~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~  103 (376)
                      +.-..++...++.++.++||+|+||.||+|.....+.   . ||+|....   ........|.+|++++++++||||+++
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            3445566677888888999999999999998765322   3 89999885   346778899999999999999999999


Q ss_pred             eeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEE
Q 038118          104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI  183 (376)
Q Consensus       104 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl  183 (376)
                      ||+...+..+++|||+|.||+|.++|.+..+.++......++.+.+.||+|||   +++++||||-..|+|++.++.+||
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEe
Confidence            99999999999999999999999999887778999999999999999999999   899999999999999999999999


Q ss_pred             eeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHH
Q 038118          184 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      +|||+++...... .......-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....+....+..     
T Consensus       304 SDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~-----  377 (474)
T KOG0194|consen  304 SDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK-----  377 (474)
T ss_pred             CccccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh-----
Confidence            9999987532110 01111234679999999999999999999999999999998 8999998887766555432     


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                                 ...+...+......+..++..||..+|++||+|.++.+.|+...
T Consensus       378 -----------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  378 -----------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             -----------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence                       11112222234455677777999999999999999999887644

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-42  Score=324.88  Aligned_cols=261  Identities=20%  Similarity=0.187  Sum_probs=198.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|....      ..+.+|+++++.++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3689999999999999999999999999999996532      3467899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +. ++|..++.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..........
T Consensus       165 ~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        165 YK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             CC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            85 678777744 356889999999999999999999   7899999999999999999999999999987543322233


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccch-------hhHHHHHHHHHHHhcCCc-----
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKE-------EVQVYLVQWVWDLYGNGK-----  267 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~-----  267 (376)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......       .....+............     
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            34456999999999999889999999999999999999999876432210       111111110000000000     


Q ss_pred             -cc---------cccCCcCCCCC--cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 -LL---------EAVDPRLCRDF--DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 -~~---------~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ..         ....+......  .......+.+++.+||+.||.+|||+.++++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00         00000000000  0123456888999999999999999999994

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=320.12  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=210.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-C-----CCccceeeEEeeCCeEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-H-----RNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~l  115 (376)
                      +|++.+.||+|.||.|.+|.+.+|++.||||+++.. +....+-..|+.+|..|+ |     -|+|+++++|...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            899999999999999999999999999999999755 444567788999999997 4     379999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc--eEEEeeCCCcccc
Q 038118          116 VYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF--NAKIGDFGLARLV  192 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~  192 (376)
                      |+|++ ..+|++++..+. ..++...+..++.||+.+|.+||   +.+|||+||||+||||.+.+  .+||+|||.+++.
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99998 559999997654 45899999999999999999999   89999999999999997654  5999999999865


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------H----
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------D----  261 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~----  261 (376)
                      ...    ..+..-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.+.-+....|.....       +    
T Consensus       342 ~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            322    2245568899999999999999999999999999999999999999887777666654321       0    


Q ss_pred             ---HhcC-Ccc--------------------------ccccCC----cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChH
Q 038118          262 ---LYGN-GKL--------------------------LEAVDP----RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIR  307 (376)
Q Consensus       262 ---~~~~-~~~--------------------------~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  307 (376)
                         ++.. ...                          ....-|    .+...........+++++++||..||.+|+|..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence               0000 000                          000001    001111223446689999999999999999999


Q ss_pred             HHHH
Q 038118          308 QVIH  311 (376)
Q Consensus       308 ~vl~  311 (376)
                      +.++
T Consensus       498 qal~  501 (586)
T KOG0667|consen  498 QALN  501 (586)
T ss_pred             HHhc
Confidence            9985

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.1e-42  Score=319.16  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=198.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCC-CccceeeEEeeCCeEEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHR-NLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~  117 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+..|..++..+.|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            588999999999999999999999999999998753   233456788899999999764 6888999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++...... .
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-G  155 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-C
Confidence            99999999888854 456889999999999999999999   799999999999999999999999999998643211 1


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+..        .      ...+.
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--------~------~~~~~  221 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--------H------NVSYP  221 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------C------CCCCC
Confidence            223445689999999999988899999999999999999999999987654443322221        0      01111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                      ..    ....+.+++.+||..||.+|++.
T Consensus       222 ~~----~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 KS----LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence            22    23457788899999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-41  Score=315.09  Aligned_cols=244  Identities=24%  Similarity=0.300  Sum_probs=193.4

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHH-HHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEV-TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|. .+++.++|+||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999987532   12223444444 457788999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|.+.+.. .+.+.+..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....... .....
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~  155 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST  155 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence            999888854 456788888899999999999999   7999999999999999999999999999986432211 12334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        ..      ..+..    
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--------~~------~~~~~----  217 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--------KP------LQLKP----  217 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------CC------cCCCC----
Confidence            5689999999999998999999999999999999999999986654433222211        00      01111    


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      .....+.+++.+||+.||.+||++.+.+..+
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            2234577888899999999999987554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=300.62  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=215.6

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..+.|++.+.||+|.|+.||++.+..+|+.+++|++...  .....+.+.+|+++-+.|+||||+++++.+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            357889999999999999999999999999999988754  334567889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC---ceEEEeeCCCccccc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGLARLVE  193 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~  193 (376)
                      +|++.|+.|...+..+ ...++..+-..++||+++|.|.|   .++|+|||+||+|+++-..   .-+||+|||++..++
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999998877654 45788888899999999999999   8999999999999999543   349999999998776


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                        .+.......||+.|||||+++..+|+..+|||+.|+|||-||.|.+||.+.+...+...|.+...+          ++
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd----------~~  232 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD----------YP  232 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC----------CC
Confidence              455667788999999999999999999999999999999999999999987777776666542221          22


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.....+    .+...+|+.+||..||.+|.|+.|.|.
T Consensus       233 ~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 SPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CcccCcC----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2222333    345778899999999999999999873

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2e-41  Score=315.37  Aligned_cols=255  Identities=22%  Similarity=0.275  Sum_probs=202.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...   .......+.+|..++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999999999999999998642   2223455788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||++||+|.+++......+++..+..++.|++.+|.|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999765667899999999999999999999   79999999999999999999999999999876543322


Q ss_pred             cceeeeccCCCCCchhhhcc-----CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          198 SQTTVLAGTMGYMAPECATT-----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......|+..|+|||++.+     +.++.++|||||||++|+|++|+.||...+..+....+..       .... ..+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-------~~~~-~~~  229 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HEER-FQF  229 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-------CCCc-ccC
Confidence            22334568999999999875     4678899999999999999999999976654333222211       0000 001


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENL--RPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~  311 (376)
                       +....    .....+.+++.+|+..++++  |++++++++
T Consensus       230 -p~~~~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         230 -PSHIT----DVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             -CCccc----cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence             11111    12345777788888866544  468888874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.1e-42  Score=307.25  Aligned_cols=255  Identities=26%  Similarity=0.453  Sum_probs=206.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.++||+|+||.||+|.+.. +..|++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            35789999999999999999999765 56699998865433 35788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++... ...+++..++.++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999988653 356888899999999999999999   79999999999999999999999999999976543222


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..        ..     ....
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~--------~~-----~~~~  225 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR--------GY-----RMPR  225 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc--------CC-----CCCC
Confidence            22222335678999999988889999999999999999998 9999976554433222211        10     0011


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..    .....+.+++.+||..+|++||++.++++.|+.
T Consensus       226 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 ME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11    123457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.3e-41  Score=313.32  Aligned_cols=256  Identities=21%  Similarity=0.279  Sum_probs=200.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||++.++.+++.||+|++...   .......+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4789999999999999999999999999999998642   2223345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++|+|.+++.+....+++..+..++.||+.+|.|||   +.+|+||||||+|||++.++.++|+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999765667899999999999999999999   79999999999999999999999999999865432222


Q ss_pred             cceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          198 SQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......||..|+|||++.     ...++.++|||||||++|+|++|+.||...........+..       ..... .+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-------~~~~~-~~  229 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------HKERF-QF  229 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-------CCccc-cC
Confidence            2233456899999999886     34678999999999999999999999987654433322221       10000 00


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCC--CCCChHHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDEN--LRPSIRQVIHV  312 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPs~~~vl~~  312 (376)
                       +.....    ....+.+++.+|+..++.  .|+++.++++.
T Consensus       230 -p~~~~~----~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 -PAQVTD----VSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -CCcccc----CCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             111112    234466677777755444  47899998853

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-41  Score=304.93  Aligned_cols=248  Identities=28%  Similarity=0.438  Sum_probs=200.0

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      +.||+|+||.||+|.+..++..|++|.+... .......+.+|+++++.++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4799999999999999988999999988654 344456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce-eeec
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT-TVLA  204 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~  204 (376)
                      .+++......+++..++.++.|++.+|.|||   +++++||||+|+||+++.++.++|+|||++........... ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9988665567899999999999999999999   79999999999999999999999999999865432111110 1112


Q ss_pred             cCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          205 GTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       205 gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      .+..|+|||.+.++.++.++|||||||++|+|++ |..||...........+..        .     ...    .....
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~--------~-----~~~----~~~~~  220 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ--------G-----VRL----PCPEL  220 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------C-----CCC----CCccc
Confidence            2456999999988889999999999999999997 8999976543332221111        0     001    11112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          284 QMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-41  Score=315.29  Aligned_cols=239  Identities=23%  Similarity=0.291  Sum_probs=194.2

Q ss_pred             CccccCCCeeEEEEEE---cCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           47 QKLGQGGFGGVYKGFF---RETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~---~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      +.||+|+||.||++.+   ..++..||+|++....  ......+..|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999886   3568899999997532  2234457789999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      +++|.+++.+ ...+++..++.++.||+.||.|||   +.+++||||||+|||++.++.++|+|||++...... .....
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~  156 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAY  156 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCcee
Confidence            9999988854 456899999999999999999999   799999999999999999999999999998754322 12233


Q ss_pred             eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ...|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..        ..      ..+...  
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~--------~~------~~~p~~--  220 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--------AK------LGMPQF--  220 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc--------CC------CCCCCC--
Confidence            45689999999999888899999999999999999999999987654333222211        10      011112  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCChHH
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSIRQ  308 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~~~  308 (376)
                        ....+.+++.+||+.||++||++.+
T Consensus       221 --~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 --LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              2345778889999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-42  Score=307.69  Aligned_cols=255  Identities=30%  Similarity=0.430  Sum_probs=206.3

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|++|.||+|.+.. +..|++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            35779999999999999999999765 56799999875432 35678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++.... ..+++..+..++.|++.+|.+||   ++|++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999886543 46899999999999999999999   79999999999999999999999999999876542211


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ........+..|+|||++.+..++.++||||||+++|+|++ |+.||...........+..       ...         
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~---------  222 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-------GYR---------  222 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCC---------
Confidence            11111223457999999988889999999999999999999 9999976654333222211       000         


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       ..........+.+++.+|++.+|++||++.+|++.|+.
T Consensus       223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             01111233568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.6e-42  Score=316.23  Aligned_cols=242  Identities=22%  Similarity=0.303  Sum_probs=197.0

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|++..+++.||+|++...   .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999998753   233345677888888866 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|...+.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++...... ......
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~  155 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTT  155 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccc
Confidence            999888754 456889999999999999999999   799999999999999999999999999998643221 122334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        ..      ......   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--------~~------~~~p~~---  218 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--------DD------VLYPVW---  218 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--------CC------CCCCCC---
Confidence            5689999999999988999999999999999999999999987665443332221        10      011111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-------ChHHHHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRP-------SIRQVIH  311 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RP-------s~~~vl~  311 (376)
                       ....+.+++..||+.||++||       ++.++++
T Consensus       219 -~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         219 -LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             224577888999999999999       7777774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-41  Score=309.78  Aligned_cols=255  Identities=29%  Similarity=0.480  Sum_probs=206.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|.+.+.||+|+||.||+|.+..     ++..|++|.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4678999999999999999998753     3578999998765433 457899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          114 LLVYEYMPNGSLDSHLFKEN-------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ++||||+++++|.+++....             ..+++..+..++.||+.++.+||   ++|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999885432             34788899999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  258 (376)
                      ++|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.  
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence            99999999865422111 11122335678999999999999999999999999999998 999997665443322221  


Q ss_pred             HHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                            .+...         .........+.+++.+||+.||++||++.+|++.|+
T Consensus       239 ------~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 ------QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ------cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                  11110         111123345788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=310.71  Aligned_cols=251  Identities=26%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +|++.+.||+|+||.||++.+..++..||+|++....   ......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            5888999999999999999999899999999987542   2223457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++... ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999998877543 346899999999999999999999   7999999999999999999999999999987643221 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                       ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.....    .          ..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~----~----------~~  221 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK----E----------DQ  221 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh----h----------cc
Confidence             12234588999999999888899999999999999999999999986543322211111110    0          00


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ..+.......+.+++.+||+.||.+||     +++++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            111223345578899999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=306.08  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=204.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-----hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-----KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++|++.+.||+|++|.||.|.+..+++.|++|.+....     ......+.+|+.+++.++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999999999999986432     2234578899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+||+++++|.+.+.. .+.+++..+..++.|++.+|.+||   +.|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            9999999999888854 456889999999999999999999   799999999999999999999999999998754322


Q ss_pred             CCcce--eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          196 KGSQT--TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       196 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .....  ....++..|+|||++.+..++.++||||||+++|+|++|+.||..............       .        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~--------  222 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-------Q--------  222 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------c--------
Confidence            11111  234477899999999988899999999999999999999999976543222111110       0        


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                       .....+.......+.+++..||..+|.+|||+.++++.
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             00111122233457888899999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-41  Score=303.17  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=207.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||+|++|.||+|.+..++..|++|.+...  .......+.+|+.+++.++|+|++++++++.+.+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999999999999999998643  344567788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++... ...+++..++.++.+++.+|.|||   +.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999988664 467899999999999999999999   79999999999999999999999999999876543222 


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.        .+         ...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~---------~~~  219 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII--------RG---------VFP  219 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------cC---------CCC
Confidence            1233457889999999998889999999999999999999999997665333221111        01         011


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+.......+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            111133456888999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-42  Score=306.35  Aligned_cols=252  Identities=27%  Similarity=0.434  Sum_probs=203.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..+|++.+.||+|+||.||+|.+.. +..+++|.+..... ....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            3568899999999999999998864 56799999865432 235688899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++......+++..++.++.||+.+|.|||   +.+++||||+|+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999998765667899999999999999999999   7999999999999999999999999999987543221111


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.        ..     ....   
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--------~~-----~~~~---  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS--------AG-----YRLY---  221 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH--------cC-----CcCC---
Confidence            111223457999999988889999999999999999998 899997655433322211        01     0001   


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                       ........+.+++.+||..+|++|||+.++++.|
T Consensus       222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             1112344688899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.4e-42  Score=320.10  Aligned_cols=265  Identities=21%  Similarity=0.282  Sum_probs=198.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----CeEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KELL  114 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~  114 (376)
                      +|++.+.||+|+||.||+|.+..++..||||.+...  .......+.+|+.+++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588999999999999999999999999999998743  233345788999999999999999999987543     3589


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+. ++|.+++. ....+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 58888774 3456899999999999999999999   79999999999999999999999999999875422


Q ss_pred             CCCc--ceeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------HHh
Q 038118          195 AKGS--QTTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------DLY  263 (376)
Q Consensus       195 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~  263 (376)
                      ....  ......|+..|+|||++.+  ..++.++|||||||++|+|++|+.||...........+.....       ...
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2111  1233468999999999865  5789999999999999999999999976553322221111100       000


Q ss_pred             cCC---ccccccCCcCCCCCc---HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNG---KLLEAVDPRLCRDFD---EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~---~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...   .....+.......+.   +.....+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000   000000000000000   012244678999999999999999999995

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.7e-42  Score=312.62  Aligned_cols=264  Identities=23%  Similarity=0.292  Sum_probs=198.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcC-CCeEEEEEEcccCC--hhhHHHHHHHHHHHHhC---CCCCccceeeEEe-----e
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRE-TSSYIAVKRVSKGS--KQGIKEYASEVTIISRL---RHRNLVQLLGWCH-----E  109 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~  109 (376)
                      .+|++.+.||+|+||.||+|.+.. ++..||+|.+....  ......+.+|+.+++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 46889999886532  22234556677776665   6999999999885     3


Q ss_pred             CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                      ...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 5888887543 345899999999999999999999   79999999999999999999999999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      +......  .......|+..|+|||++.+..++.++|||||||++|+|++|..||......+....+....... .....
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~-~~~~~  233 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GEEDW  233 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Chhhc
Confidence            8765332  22334558999999999988889999999999999999999999998876555544443321100 00000


Q ss_pred             c-------cccCCcCC---CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 L-------EAVDPRLC---RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~-------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .       ..+.+...   ....+.....+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0       00000000   0011122345678999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-41  Score=315.81  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=195.7

Q ss_pred             CccccCCCeeEEEEEEc---CCCeEEEEEEcccC----ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           47 QKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG----SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +.||+|+||.||++.+.   .+++.||+|++...    .......+..|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999864   46788999998753    223345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+.+.. .+.+.+..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... ...
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  156 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTV  156 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCc
Confidence            999999988854 456788888899999999999999   799999999999999999999999999998643221 112


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..        +.      ..+...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--------~~------~~~~~~  222 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--------GK------LNLPPY  222 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------CC------CCCCCC
Confidence            2335689999999999888899999999999999999999999987654332222211        11      111122


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      +    ...+.+++.+||+.||++||     ++.++++
T Consensus       223 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         223 L----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             C----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            2    24577889999999999999     7888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.9e-42  Score=306.30  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=204.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||.|.+.+ +..+++|.+..... ....+.+|+.+++.++||||+++++++......++||||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            3678999999999999999998865 44599998875433 246788999999999999999999999998999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +.+++|.+++......+++..++.++.||+.||.|||   +.+++|+||+|.||+++.++.+||+|||.+..........
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999988665557899999999999999999999   7999999999999999999999999999987543322111


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      .....++..|++||++.+..++.++|||||||++|+|++ |..||...........+.+        +..     +....
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~~~  224 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ--------GLR-----LYRPH  224 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc--------CCC-----CCCCC
Confidence            122235568999999988889999999999999999998 9999976654433222211        100     00011


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                          .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       225 ----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 ----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                12356788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-41  Score=314.71  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=205.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..+|++.+.||+|+||.||+|.+..++.    .||+|.+... .....+.+.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            4679999999999999999999866554    4899998754 344567788999999999999999999998764 578


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +|+||+++|+|.+++......+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999999776667899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.        .+...  .
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~--------~~~~~--~  231 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--------KGERL--P  231 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh--------CCCCC--C
Confidence            22211 112224568999999998899999999999999999997 999998655433221111        11100  0


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .+   ..    ....+..++.+||+.+|.+||++.+++..|....
T Consensus       232 ~~---~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         232 QP---PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CC---CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            01   11    1234778889999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-41  Score=309.75  Aligned_cols=257  Identities=29%  Similarity=0.481  Sum_probs=207.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEE-----cCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|.+.+.||+|+||.||++.+     ..++..+++|.+..........+.+|+.+++.++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46899999999999999999985     3345679999998776666778999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEE
Q 038118          115 LVYEYMPNGSLDSHLFKEN------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK  182 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k  182 (376)
                      +||||+++++|.+++....            ..+++..++.++.||+.+|.|||   ++|++||||||+||+++.++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999885432            24899999999999999999999   79999999999999999999999


Q ss_pred             EeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHH
Q 038118          183 IGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       183 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      |+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..   
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~---  237 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---  237 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence            999999875432211 11122234678999999998889999999999999999998 9999976654333222211   


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                           +...     .....    ....+.+++.+||+.||.+|||+.+|+..|+..
T Consensus       238 -----~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         238 -----GRVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             -----CCcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                 1110     11111    224578899999999999999999999888753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.4e-42  Score=316.10  Aligned_cols=237  Identities=23%  Similarity=0.343  Sum_probs=193.8

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++...   .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999998753   223355677888888876 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++.. .+.+++..++.++.||+.||.|||   +++++||||||+|||++.++.++|+|||++...... ......
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTST  155 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccc
Confidence            999887754 456899999999999999999999   799999999999999999999999999998643211 122334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        ..      ......   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--------~~------~~~~~~---  218 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--------DE------VVYPTW---  218 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------CC------CCCCCC---
Confidence            5689999999999988899999999999999999999999987664443322211        10      011111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCh
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                       ....+.+++.+||+.||.+||++
T Consensus       219 -~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 -LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCHHHHHHHHHHcccCHHHCCCC
Confidence             22457888899999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-41  Score=315.82  Aligned_cols=242  Identities=24%  Similarity=0.322  Sum_probs=197.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      +|++.+.||+|+||.||+|.+..++..||+|++....   ......+..|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5888999999999999999999999999999987542   22344567788888777 4889999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++|+|...+.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... .
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-G  155 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-C
Confidence            99999999888744 456889999999999999999999   799999999999999999999999999998643211 1


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..        ..      ..+.
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------~~------~~~p  221 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------HN------VAYP  221 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC------CCCC
Confidence            123345689999999999999999999999999999999999999987664443332221        10      1111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                      .    .....+.+++.+||+.||.+|++.
T Consensus       222 ~----~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 K----SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             C----cCCHHHHHHHHHHcccCHHhcCCC
Confidence            1    223457888999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.4e-41  Score=310.46  Aligned_cols=241  Identities=23%  Similarity=0.325  Sum_probs=194.5

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..++..||+|.+....   ......+..|..++..+ .|+||+++++++...+..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999987532   22345566788887754 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++.. ...+++..+..++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++...... ......
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST  155 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence            999888854 456889999999999999999999   799999999999999999999999999998642211 122344


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        .      .+.+...   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--------~------~~~~~~~---  218 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--------D------TPHYPRW---  218 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------C------CCCCCCC---
Confidence            5689999999999998999999999999999999999999986654333222211        0      1111122   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChH-HHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIR-QVI  310 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~-~vl  310 (376)
                       ....+.+++.+||+.||++||++. +++
T Consensus       219 -~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 -ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             224577888999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-41  Score=324.79  Aligned_cols=194  Identities=23%  Similarity=0.270  Sum_probs=169.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..+|.+.+.||+|+||.||+|.+..+++.|+||...      ...+.+|+++|++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            346999999999999999999999999999999643      23456899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc-
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS-  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  198 (376)
                      +. ++|..++......+++..++.++.||+.+|.|||   ++||+||||||+|||++.++.++|+|||+++........ 
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6888888666667999999999999999999999   799999999999999999999999999999765332211 


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf  243 (376)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..++
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            122356899999999999989999999999999999999987654

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-41  Score=317.27  Aligned_cols=193  Identities=24%  Similarity=0.316  Sum_probs=168.3

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ...+|++.+.||+|+||.||+|.+..++..||+|+.....      ...|+.+++.++|+||+++++++......++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3468999999999999999999999999999999864332      2468999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ++. ++|.+++......+++..++.++.||+.||.|||   +.||+||||||+|||++.++.++|+|||++......  .
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~  211 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P  211 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence            995 5788888776778999999999999999999999   789999999999999999999999999998743221  1


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf  243 (376)
                      ......||..|+|||++.+..++.++|||||||++|+|+++..++
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            223455899999999999889999999999999999999865443

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-41  Score=304.11  Aligned_cols=253  Identities=31%  Similarity=0.476  Sum_probs=203.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.++||+|+||.||+|.+..++ .|++|.+..... ....+.+|+++++.++|+||+++++++.+ ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            467999999999999999999987654 599999875433 23578899999999999999999998754 567999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++... ...+++..++.++.|++.+|.+||   +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999988653 345789999999999999999999   799999999999999999999999999999765433322


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......++..|+|||+..+..++.++|||||||++|+|++ |..||...........+..        .         ..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~--------~---------~~  221 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------G---------YR  221 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc--------C---------CC
Confidence            2223345678999999988889999999999999999999 8889976654333221110        0         00


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..........+.+++.+|++.||++||++.++++.|+.
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            11122334567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=314.26  Aligned_cols=242  Identities=24%  Similarity=0.334  Sum_probs=197.7

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..++..||+|++...   .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999753   223355677888999888 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|...+.. .+.+++..+..++.||+.||.|||   +++++||||||+||+++.++.++|+|||++..... .......
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~  155 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-GGVTTST  155 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-CCCcccc
Confidence            999887754 457899999999999999999999   79999999999999999999999999999864221 1122234


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..        ..      ......   
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~--------~~------~~~~~~---  218 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE--------DE------VRYPRW---  218 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------CC------CCCCCc---
Confidence            4589999999999999999999999999999999999999986654333222211        10      111111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSI-----RQVIH  311 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  311 (376)
                       ....+.+++.+||+.||.+||++     .++++
T Consensus       219 -~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         219 -LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             23457889999999999999999     88874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-41  Score=315.80  Aligned_cols=257  Identities=27%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhC-CCCCccceeeEEee-CC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGS-KQGIKEYASEVTIISRL-RHRNLVQLLGWCHE-KK  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~  111 (376)
                      .++|++.+.||.|+||.||+|.+.+     +++.||+|++.... ......+.+|+.++.++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            4689999999999999999997543     35789999987542 33456788899999999 79999999998764 46


Q ss_pred             eEEEEEecCCCCChhhhhhhcC----------------------------------------------------------
Q 038118          112 ELLLVYEYMPNGSLDSHLFKEN----------------------------------------------------------  133 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------  133 (376)
                      .++++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7899999999999998874321                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCC
Q 038118          134 --NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYM  210 (376)
Q Consensus       134 --~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~  210 (376)
                        ..+++..+..++.||+.+|.|||   ++||+||||||+||+++.++.++|+|||++..+..... .......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              25788999999999999999999   79999999999999999999999999999976532211 1122334567899


Q ss_pred             chhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHH
Q 038118          211 APECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM  289 (376)
Q Consensus       211 aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (376)
                      |||++.+..++.++|||||||++|+|++ |..||......+......       ..+..     .    .........+.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~-----~----~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-------KEGTR-----M----RAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH-------hccCC-----C----CCCccCCHHHH
Confidence            9999999999999999999999999998 999997643322211110       11110     0    01112234578


Q ss_pred             HHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          290 IVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       290 ~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      +++.+||+.+|++||++.+|++.|+.
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            89999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-41  Score=321.45  Aligned_cols=259  Identities=26%  Similarity=0.345  Sum_probs=204.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCC-----CeEEEEEEcccCC-hhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCC
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRET-----SSYIAVKRVSKGS-KQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKK  111 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~  111 (376)
                      ..++|++.++||.|+||.||+|.+...     +..||||++.... ....+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            367899999999999999999987543     3469999997543 333567899999999996 999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhhcC----------------------------------------------------------
Q 038118          112 ELLLVYEYMPNGSLDSHLFKEN----------------------------------------------------------  133 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------  133 (376)
                      ..|+||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999988875421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec
Q 038118          134 -------------------------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD  176 (376)
Q Consensus       134 -------------------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~  176 (376)
                                                           ..+++..++.++.||+.||.|||   +.+++||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                 23677888899999999999999   79999999999999999


Q ss_pred             CCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHH
Q 038118          177 LNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVY  254 (376)
Q Consensus       177 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~  254 (376)
                      .++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            999999999999875432211 11222346778999999988889999999999999999997 9999976432222111


Q ss_pred             HHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          255 LVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ..       ..+.     ...    ........+.+++.+||+.+|++||++.+|.+.|+..
T Consensus       352 ~~-------~~~~-----~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         352 KI-------KSGY-----RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HH-------hcCC-----CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            11       0110     011    1112334578899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-41  Score=320.70  Aligned_cols=263  Identities=21%  Similarity=0.252  Sum_probs=202.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----eEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-----ELL  114 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  114 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999989999999998653  3334567889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+. ++|...+. ....+++..++.++.||+.||.|||   +.|++||||||+|||++.++.+||+|||++.....
T Consensus        81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 46777663 3457899999999999999999999   79999999999999999999999999999976543


Q ss_pred             CCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------------
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------------  260 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------------  260 (376)
                      ..........++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.+...             
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            322223334578899999998764 478999999999999999999999987665444333322100             


Q ss_pred             --H-HhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 --D-LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        . ............ . ...+.......+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         236 ARAHILRGPHKPPSLP-V-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHhCCCCCCchH-H-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence              0 000000000000 0 00111122345788999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.9e-42  Score=333.03  Aligned_cols=257  Identities=22%  Similarity=0.255  Sum_probs=207.4

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-  111 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-  111 (376)
                      +.....++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++..++|+|+++++..+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            3444567999999999999999999999999999999998754  3444567889999999999999999988765332 


Q ss_pred             -------eEEEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceE
Q 038118          112 -------ELLLVYEYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA  181 (376)
Q Consensus       112 -------~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~  181 (376)
                             .+++||||+++|+|.+++...   ...+++..++.++.|++.+|.|||   +.+|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence                   478999999999999988542   346899999999999999999999   7999999999999999999999


Q ss_pred             EEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH
Q 038118          182 KIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      ||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..   
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~---  259 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA---  259 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---
Confidence            9999999876533211 122345689999999999988999999999999999999999999987654333222111   


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           +.    . ..+    .......+..++.+||+.||.+||++.++++
T Consensus       260 -----~~----~-~~~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        260 -----GR----Y-DPL----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -----CC----C-CCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                 11    0 011    1223345788899999999999999999985

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-41  Score=312.00  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=195.1

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999987541   22345566778888764 899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++.. ...+++..+..++.||+.||.|||   +++++||||||+|||++.++.++|+|||++...... ......
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCT  155 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceee
Confidence            999988854 456889999999999999999999   799999999999999999999999999998643211 122334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||......+....+..        .      .+.+...   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--------~------~~~~~~~---  218 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--------D------NPCYPRW---  218 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------C------CCCCCcc---
Confidence            5689999999999988999999999999999999999999987654433222211        0      0111111   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChH-HHHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIR-QVIH  311 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~-~vl~  311 (376)
                       ....+.+++.+||+.||++||++. ++++
T Consensus       219 -~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         219 -LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             224467888999999999999997 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5e-41  Score=301.06  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +|++.+.||.|+||.||++.+..++..|++|.+... .....+.+..|+.+++.++|+|++++++.+...+.+|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            588899999999999999999999999999998643 3445677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          121 PNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       121 ~~~sL~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      ++++|.+++.. ....+++..++.++.||+.+|.+||   ++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence            99999888754 3345789999999999999999999   7999999999999999999999999999987553221 12


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..        +..         ..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~---------~~  219 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------GSY---------KP  219 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--------CCC---------CC
Confidence            2335588899999999888899999999999999999999999976543322211111        110         01


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ........+.+++.+||+.||++||++.+|+..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            111223457888999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.5e-41  Score=303.35  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=207.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||.|+||.||+|++..++..|++|.+...   .......+.+|+.+++.++|||++++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999999999999999987642   3444567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||+++++|.+++..   ....+++..++.++.||+.||.|||   +++++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999887743   3345789999999999999999999   79999999999999999999999999999876532


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........  +...    .....     .+
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--~~~~----~~~~~-----~~  226 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--LCQK----IEQCD-----YP  226 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--HHHH----HhcCC-----CC
Confidence            211 122345788999999998888999999999999999999999998654321111  1110    00000     01


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .   .........+.+++.+||+.+|++||++.+|++.|+.
T Consensus       227 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         227 P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             C---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            1   1112334568889999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.8e-41  Score=307.16  Aligned_cols=245  Identities=26%  Similarity=0.348  Sum_probs=195.7

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ||+|+||+||++.+..+++.||+|.+....   ......+..|+.+++.++|+||+++++++......|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999999999999999987542   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          126 DSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       126 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ...+..   ....+++..++.++.||+.||.|||   +++|+||||||+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            877643   3356899999999999999999999   79999999999999999999999999999875433221 2233


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+....   . .        ..  ..+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~-~--------~~--~~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI---L-N--------DS--VTYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh---c-c--------cC--CCCcc
Confidence            468999999999999999999999999999999999999997654322111111100   0 0        00  01112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      .....+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2345578888999999999999     6677774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-41  Score=307.91  Aligned_cols=256  Identities=28%  Similarity=0.453  Sum_probs=203.3

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      ..++|++.+.||+|+||.||+|.+.+     ++..||+|.+... .......+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            56889999999999999999998753     3567999988643 23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEE
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN---------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI  183 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl  183 (376)
                      .++||||+++++|.+++....         ..+++..++.++.|++.+|.|||   +.+++|+||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999885422         23567888899999999999999   789999999999999999999999


Q ss_pred             eeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHH
Q 038118          184 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      +|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~----  236 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME----  236 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence            9999986543221111 112234678999999998889999999999999999999 7899976654433222111    


Q ss_pred             HhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                          ...     +..    .......+.+++.+||+.||++|||+.++++.|+
T Consensus       237 ----~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 ----GGL-----LDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ----CCc-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                110     011    1122345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.4e-41  Score=308.42  Aligned_cols=261  Identities=28%  Similarity=0.419  Sum_probs=209.1

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCC-----CeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEE
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRET-----SSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWC  107 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  107 (376)
                      ++....++|++.+.||+|+||.||++.+...     ...+++|.+... .......+.+|+.+++.+ +|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4455667899999999999999999998643     378999998754 334456788999999999 799999999999


Q ss_pred             eeCCeEEEEEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCC
Q 038118          108 HEKKELLLVYEYMPNGSLDSHLFKE---------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN  172 (376)
Q Consensus       108 ~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  172 (376)
                      ...+..++||||+++++|..++...               ...+++..++.++.||+.||.|||   +.+++||||||.|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceee
Confidence            9999999999999999999888532               346889999999999999999999   7999999999999


Q ss_pred             eeecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchh
Q 038118          173 IMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEE  250 (376)
Q Consensus       173 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~  250 (376)
                      ||++.++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99999999999999999765432211 1122234568999999988889999999999999999997 999997665443


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ....+..        +..     .    .........+.+++.+||+.||++|||+.+|++.|+.
T Consensus       243 ~~~~~~~--------~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         243 LFKLLKE--------GYR-----M----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             HHHHHHc--------CCc-----C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence            3222211        110     0    1111223457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-41  Score=313.37  Aligned_cols=250  Identities=21%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++...   .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999753   233455688899999988 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++.. .+.+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||++..... .......
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~  155 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST  155 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcccc
Confidence            999887744 457899999999999999999999   79999999999999999999999999999864211 1122334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhh-HHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV-QVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||......+. ......+.........      ..+...+ 
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~~-  228 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPRSL-  228 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCCCC-
Confidence            5689999999999998999999999999999999999999964322110 0001111111111111      1111222 


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC------hHHHHH
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPS------IRQVIH  311 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs------~~~vl~  311 (376)
                         ...+.+++.+||+.||.+|++      +.++++
T Consensus       229 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         229 ---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence               345788899999999999997      567763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.8e-41  Score=306.01  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=206.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +.|++.+.||.|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++|+|++++++.+..++..|+||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            67999999999999999999999999999999998877777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++++|..++.+....+++..++.++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||++...... ....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  167 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR  167 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence            999998887665667899999999999999999999   799999999999999999999999999998653222 1122


Q ss_pred             eeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          201 TVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ....++..|+|||++.     ...++.++|||||||++|+|++|..||...........+.        ...     .+.
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--------~~~-----~~~  234 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--------KSE-----PPT  234 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh--------cCC-----Ccc
Confidence            3445788999999874     3446789999999999999999999997654322211111        000     011


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..  ........+.+++.+||..+|++||++.++++
T Consensus       235 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 LS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            10  11122345778899999999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-41  Score=308.67  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=208.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|.+.+.||+|+||.||+|.+..     ++..+++|.+........+.+.+|+.+++.++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            3568899999999999999998643     45679999988776666678999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc
Q 038118          115 LVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF  179 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~  179 (376)
                      +||||+++++|.+++....               ..+++..++.++.||+.+|.|||   +++++||||||.||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            9999999999999885432               34788999999999999999999   79999999999999999999


Q ss_pred             eEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHH
Q 038118          180 NAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       180 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  257 (376)
                      .++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+. 
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-  239 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-  239 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-
Confidence            9999999998754322211 1122345778999999998889999999999999999998 999997665433222111 


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                             .+....         ........+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       240 -------~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         240 -------QGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             -------CCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                   111111         11112345788999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-41  Score=319.68  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=199.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+..|+.++..++|+||+++++.+...+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4789999999999999999999999999999998743   2334567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.+ .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++........
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999999998854 456899999999999999999999   89999999999999999999999999999864421110


Q ss_pred             ----------------------------------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCC
Q 038118          198 ----------------------------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       198 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf  243 (376)
                                                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                              0012346899999999999999999999999999999999999999


Q ss_pred             CCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC---hHHHHH
Q 038118          244 SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS---IRQVIH  311 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~~vl~  311 (376)
                      ...........+..+.      ..  ..+.+.  ..+    ...+.+++.+|+ .||.+|++   +.++++
T Consensus       237 ~~~~~~~~~~~i~~~~------~~--~~~p~~--~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         237 CSETPQETYRKVMNWK------ET--LVFPPE--VPI----SEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCHHHHHHHHHcCC------Cc--eecCCC--CCC----CHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            8766544433332210      00  001111  012    234566666665 49999985   566653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=338.19  Aligned_cols=257  Identities=31%  Similarity=0.474  Sum_probs=213.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC-----eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS-----SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      ....+....||+|.||.||.|+.....     ..||+|.+... +......|.+|+.++..+.||||++++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            456677889999999999999876532     34999999865 556678899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          114 LLVYEYMPNGSLDSHLFKE------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      +|++|||+||+|..+|.+.      ...+....++.++.+||+|+.||+   ++++|||||...|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999776      567899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccccCCCcce-eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          188 LARLVEHAKGSQT-TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       188 ~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      +++.+-....... ..-.-+..|||||.+..+.++.|+|||||||++||++| |..||...++.++.....       +.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~-------~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL-------EG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-------hC
Confidence            9984432222221 11234579999999999999999999999999999998 999999887666544222       12


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      +   +.-.|..|       ...+.+++..||+.+|++||++..|++.+...
T Consensus       921 g---RL~~P~~C-------P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  921 G---RLDPPSYC-------PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             C---ccCCCCCC-------ChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            2   12223333       34578899999999999999999999877653

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.4e-41  Score=302.54  Aligned_cols=256  Identities=29%  Similarity=0.463  Sum_probs=206.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ..+|++.+.||+|+||.||+|.+..+   +..+++|.+.... ......+.+|+.+++.++||||+++++++..++..|+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46889999999999999999988643   3479999987542 3445688999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.|++.+|.+||   +++++||||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999998766667899999999999999999999   799999999999999999999999999998765432


Q ss_pred             CCccee--eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          196 KGSQTT--VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       196 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ......  ...++..|++||++.+..++.++|||||||++|++++ |..||......+....+.+        +.  .  
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~--------~~--~--  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE--------GY--R--  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC--------CC--c--
Confidence            221111  1123467999999998889999999999999999886 9999976554333222211        10  0  


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       ...    .......+.+++.+|++.+|.+||++.++++.|..
T Consensus       228 -~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 -LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             -CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence             001    11223457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=310.71  Aligned_cols=254  Identities=21%  Similarity=0.306  Sum_probs=220.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhh--HHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG--IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .+=|.+.+.||+|.|.+|-+|++--+|.+||||++.+..-+.  ...+.+|++.++.++|||||++|.+...+..+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            466899999999999999999999999999999998764332  356889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee-cCCceEEEeeCCCccccccCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |+=++|.|+++|.+...-+.+..+.+++.||+.|+.|.|   +..+|||||||+||.+ .+-|-+||.|||++..+.  .
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--P  171 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC--C
Confidence            999999999999998888999999999999999999999   7889999999999765 556889999999997543  3


Q ss_pred             CcceeeeccCCCCCchhhhccCCCC-CCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      +....+..|+..|.|||.+.+..|+ ++.||||||||||.|++|+.||...+..+....|.++.                
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK----------------  235 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK----------------  235 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc----------------
Confidence            4556777899999999999988776 56899999999999999999999888888777766532                


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HhccC
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNSE  316 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~~~  316 (376)
                        ...+........+||..||..||.+|.+.++|..  ||...
T Consensus       236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence              2334455667889999999999999999999984  55543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-42  Score=309.62  Aligned_cols=249  Identities=33%  Similarity=0.550  Sum_probs=195.7

Q ss_pred             cCCccccCCCeeEEEEEEc----CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           45 DDQKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +.+.||.|.||.||+|.+.    ..+..|+||.+... .......|.+|++.+++++||||+++++++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999998    44678999999654 344578899999999999999999999999988889999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++|+|.+++... ...+++..++.|+.||+.||.|||   +++++|++|++.|||++.++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999776 567899999999999999999999   789999999999999999999999999999765221111


Q ss_pred             -ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          199 -QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       199 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       ..........|+|||.+.+..++.++||||||+++|||++ |..||......+....+.        .+..     ...
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~--------~~~~-----~~~  226 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK--------QGQR-----LPI  226 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH--------TTEE-----TTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccc-----cee
Confidence             1122336678999999998889999999999999999999 789987765444332221        1111     111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                          .......+..++..||..||++||++.+|++.|
T Consensus       227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                112234577889999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.3e-41  Score=311.24  Aligned_cols=245  Identities=22%  Similarity=0.332  Sum_probs=192.0

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++...   .......+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999753   333455677899888877 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|...+.. .+.+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++...... ......
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTST  155 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccc
Confidence            999887743 457899999999999999999999   799999999999999999999999999998643211 122234


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhh-HHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV-QVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||........ ......+.........      ..+..   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p~---  226 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIPR---  226 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCCC---
Confidence            5689999999999998999999999999999999999999963221110 0001111111111111      11112   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                       .....+.+++.+||+.||++||++
T Consensus       227 -~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 -SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -CCCHHHHHHHHHHhcCCHHHcCCC
Confidence             223457788999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3e-41  Score=304.55  Aligned_cols=256  Identities=24%  Similarity=0.353  Sum_probs=204.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            46799999999999999999999999999999999766555556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++.. ...+++..+..++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||++........ .
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~  162 (267)
T cd06646          88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K  162 (267)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence            999999988854 456899999999999999999999   79999999999999999999999999999875532211 1


Q ss_pred             eeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          200 TTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .....++..|+|||.+.   ...++.++|||||||++|+|++|..||...........+.        ..    .+.+..
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--------~~----~~~~~~  230 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--------KS----NFQPPK  230 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--------cC----CCCCCC
Confidence            22345788999999874   3457889999999999999999999986443221111000        00    000000


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      ... .......+.+++.+||+.+|++||++++|++.|
T Consensus       231 ~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 LKD-KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             Ccc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000 112335688899999999999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.8e-41  Score=305.43  Aligned_cols=255  Identities=26%  Similarity=0.429  Sum_probs=203.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEc----CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++|++.+.||+|+||.||+|.+.    .++..|++|.+... .......+.+|+.+++.++|+||+++++++......|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            57889999999999999999863    35678999999753 34445678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc
Q 038118          116 VYEYMPNGSLDSHLFKE----------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF  179 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~----------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~  179 (376)
                      ||||+++++|.+++...                ...+++..++.++.|++.+|.|||   +++++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            99999999999987432                124788889999999999999999   79999999999999999999


Q ss_pred             eEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHH
Q 038118          180 NAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       180 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  257 (376)
                      .+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999975432211 11222335678999999988889999999999999999998 9999976553332222111


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                              ...     ......    ....+.+++.+||+.||.+||++.+|++.|..
T Consensus       242 --------~~~-----~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 --------RQL-----LPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --------CCc-----CCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                    110     011112    23457888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.8e-41  Score=302.66  Aligned_cols=255  Identities=28%  Similarity=0.488  Sum_probs=205.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCe---EEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .+|++.+.||+|+||.||+|.+..++.   .|++|.+... .......|..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            568899999999999999999876654   6999998765 444567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++....+.+++..++.++.|++.+|.|||   ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999988766667899999999999999999999   7999999999999999999999999999987653322


Q ss_pred             Ccce-e-eec--cCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          197 GSQT-T-VLA--GTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       197 ~~~~-~-~~~--gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .... . ...  .+..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+..       ...    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-------~~~----  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------DYR----  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-------CCc----
Confidence            2111 1 111  1347999999998889999999999999999886 9999976553332222110       000    


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        ..    ........+.+++.+||+.+|++||++.+|+..|+.
T Consensus       230 --~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         230 --LP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence              00    111223457888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4e-41  Score=306.46  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=203.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCC-----CeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRET-----SSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .+|++.+.||.|+||.||+|.+..+     +..||+|++..... .....+..|+.++..++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4678889999999999999987543     57899999975533 33466889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc
Q 038118          115 LVYEYMPNGSLDSHLFKE---------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF  179 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~  179 (376)
                      +++||+.+++|.+++...               ...+++..++.++.|++.||.|||   +.|++||||||.||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999887422               234788889999999999999999   79999999999999999999


Q ss_pred             eEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHH
Q 038118          180 NAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       180 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  257 (376)
                      .+||+|||++......... ......+++.|+|||++.++.++.++|||||||++|+|++ |..||......+....+..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999998754322211 1122335678999999988889999999999999999998 8889876654433222221


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                              +..         ..........+.+++..||+.+|++||++.+|+..|+.
T Consensus       242 --------~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 --------RQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --------CCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                    111         01112233457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.2e-41  Score=301.38  Aligned_cols=253  Identities=31%  Similarity=0.464  Sum_probs=203.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.++||+|+||.||+|.+.. +..|++|.+..... ....+.+|+.+++.++|+|++++++++.. ...+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            4689999999999999999998765 55699999876433 23578899999999999999999998854 568999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++... ...+++..++.++.+++.+|.|||   +.+++|+||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999988653 345899999999999999999999   789999999999999999999999999999765332222


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..        .         ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--------~---------~~  221 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER--------G---------YR  221 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------C---------CC
Confidence            2222335668999999988889999999999999999999 8999976554333222211        0         00


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..........+.+++.+|+..+|++|||+.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11112233568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.5e-41  Score=302.16  Aligned_cols=256  Identities=27%  Similarity=0.478  Sum_probs=207.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe---EEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|+..+.||+|+||.||+|.+..++.   .+++|.+... .....+.+..|+++++.++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4578899999999999999999875543   7999998765 34445678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.+++.|+.|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999998766677899999999999999999999   799999999999999999999999999998765432


Q ss_pred             CCcceee--eccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          196 KGSQTTV--LAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       196 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......  ...+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        ..  .  
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~--------~~--~--  228 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND--------GF--R--  228 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc--------CC--C--
Confidence            2221111  122457999999988889999999999999999997 9999976554333222211        10  0  


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .+     ........+.+++.+||+.+|++||++.+|++.|+.
T Consensus       229 ~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         229 LP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            00     011223457889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-40  Score=303.35  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=204.5

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      |++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++|+|++++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            67788999999999999999999999999999877666678899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++......+++..++.++.|++.+|.|||   +.|++||||+|+||+++.++.++|+|||++....... .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~  162 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS  162 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence            9998887665667899999999999999999999   7999999999999999999999999999986542211 12233


Q ss_pred             eccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          203 LAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       203 ~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ..++..|+|||++.     +..++.++|||||||++|+|++|..||...........+..        ..     .+.+.
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------~~-----~~~~~  229 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------SE-----PPTLA  229 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh--------cC-----CCCCC
Confidence            45888999999873     34577899999999999999999999976543332222111        00     00100


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ........+.+++.+||+.||.+||++.++++
T Consensus       230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11122356788999999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-41  Score=305.28  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=208.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||.|+||.||+|.+..++..|++|.+..........+..|+.+++.++|+||+++++++..+...|+||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            36799999999999999999999988999999999877776778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++......+++..++.++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QK  159 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cc
Confidence            9999999988766677999999999999999999999   7999999999999999999999999999886543221 22


Q ss_pred             eeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          200 TTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .....++..|++||++.     ...++.++||||||+++|+|++|..||...........+.        ....     +
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~-----~  226 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL--------KSEP-----P  226 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh--------cCCC-----C
Confidence            23455889999999874     3446789999999999999999999997654332221111        0100     1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+.  ........+.+++..||+.+|.+||++.+|++
T Consensus       227 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         227 TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            110  11122345778889999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.6e-41  Score=304.16  Aligned_cols=256  Identities=28%  Similarity=0.428  Sum_probs=204.3

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      ..++|.+.+.||+|++|.||+|.+..     ++..|++|.+.... ......|..|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35779999999999999999999987     77889999887543 3344678999999999999999999999999889


Q ss_pred             EEEEEecCCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc---eEEE
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF---NAKI  183 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl  183 (376)
                      .++||||+++++|.+++....      ..+++..++.++.||+.+|.|||   +++++||||+|+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999885533      25889999999999999999999   78999999999999998765   5999


Q ss_pred             eeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHH
Q 038118          184 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      +|||++.......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||...........+..    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~----  236 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG----  236 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence            9999987652221111 112223567999999988889999999999999999997 9999987654433222111    


Q ss_pred             HhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                         ...      ......    ....+.+++.+||+.+|++||++.+|++.|.
T Consensus       237 ---~~~------~~~~~~----~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 ---GGR------LDPPKG----CPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---CCc------CCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence               110      011111    2345788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.6e-41  Score=326.93  Aligned_cols=263  Identities=21%  Similarity=0.275  Sum_probs=196.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--------
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--------  110 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------  110 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....    ....+|+.+++.++|+||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3468999999999999999999999999999999886442    2235799999999999999999876432        


Q ss_pred             CeEEEEEecCCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeC
Q 038118          111 KELLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDF  186 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Df  186 (376)
                      ..+++||||+++ +|.+++.   .....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            257799999975 6666553   24567899999999999999999999   79999999999999998665 6999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh--
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY--  263 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--  263 (376)
                      |+++......  ......|++.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.+......  
T Consensus       216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9997653222  22334689999999988654 689999999999999999999999987765444433332211000  


Q ss_pred             ----cCCcccc-----ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 ----GNGKLLE-----AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ----~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          .......     .....+...++......+.+++.+||+.||.+|||+.++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                0000000     00000011111122346788999999999999999999984

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6e-41  Score=308.44  Aligned_cols=254  Identities=30%  Similarity=0.433  Sum_probs=201.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe--EEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS--YIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+..++.  .+++|.+... .......+.+|+.++.++ +|+||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            4688999999999999999999877664  4677776643 344456788999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          116 VYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ||||+++++|.+++....               ..+++..++.++.||+.||.|||   ++|++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999885432               35789999999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWV  259 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  259 (376)
                      ++|+|||++......  .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.   
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---  237 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---  237 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh---
Confidence            999999998632211  11111224567999999988889999999999999999998 999997655433222111   


Q ss_pred             HHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          260 WDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           ...     ....    .......+.+++.+||+.+|++||++.++++.|..
T Consensus       238 -----~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         238 -----QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             -----cCC-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 000     0001    11123357889999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8e-41  Score=304.11  Aligned_cols=255  Identities=27%  Similarity=0.444  Sum_probs=205.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..+|.+.++||+|+||.||++...     .++..+++|.+..........+.+|+++++.++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            467889999999999999999743     346689999988777666788999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          115 LVYEYMPNGSLDSHLFKEN--------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ++|||+++++|.+++....              ..+++..++.++.||+.|+.|||   +.|++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            9999999999999885432              24788999999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  258 (376)
                      ++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. 
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-  239 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ-  239 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc-
Confidence            999999998654321111 1112234678999999998889999999999999999998 9999976544333222111 


Q ss_pred             HHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                             +..     .....    .....+.+++.+||+.||.+||++.+|++.|.
T Consensus       240 -------~~~-----~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         240 -------GRE-----LERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -------Ccc-----CCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                   100     01111    12345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-41  Score=310.94  Aligned_cols=241  Identities=25%  Similarity=0.329  Sum_probs=188.7

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC---CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL---RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      ||+|+||.||+|.+..++..||+|++....   ......+..|..++..+   .||||+++++++......|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999986432   22233455666666655   699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|...+.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++....... .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~  155 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT  155 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence            999888754 456899999999999999999999   7999999999999999999999999999986432211 12234


Q ss_pred             eccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          203 LAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ..||..|+|||++.+. .++.++|||||||++|+|++|..||......+....+..        +.      ..+...  
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~--------~~------~~~~~~--  219 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF--------GK------VRFPKN--  219 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------CC------CCCCCc--
Confidence            5689999999998754 478999999999999999999999977654333222110        11      011111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC----ChHHHHH
Q 038118          282 EQQMECLMIVGLWCAHPDENLRP----SIRQVIH  311 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RP----s~~~vl~  311 (376)
                       .....+.+++.+||+.||.+||    ++.++++
T Consensus       220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             1234567888999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=313.92  Aligned_cols=245  Identities=27%  Similarity=0.379  Sum_probs=207.7

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .|...+.||.|+||.||.|++..+...||||++...   ..+-++.+.+|+.+|+++.|||++.+.++|..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            466678999999999999999999999999999865   34446789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ||- |+-.+++.-..+++-+..+..|+.+.+.||.|||   +.+.||||||.+|||+++.|.|||+|||.+.+..     
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----  177 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----  177 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC-----
Confidence            995 4777777777788999999999999999999999   8999999999999999999999999999986543     


Q ss_pred             ceeeeccCCCCCchhhh---ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          199 QTTVLAGTMGYMAPECA---TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ....++||++|||||++   ..+.|+-|+||||||++-.+|.-.++|+-..+......-|.+             +-.|.
T Consensus       178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-------------NesPt  244 (948)
T KOG0577|consen  178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NESPT  244 (948)
T ss_pred             chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-------------cCCCC
Confidence            34457799999999988   457899999999999999999999999876665444433332             11232


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.   ...-...++.++-.||++-|.+|||.++++.
T Consensus       245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            22   2334456788888999999999999999885

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-40  Score=296.98  Aligned_cols=247  Identities=28%  Similarity=0.434  Sum_probs=198.8

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      +.||+|+||.||+|... ++..|++|.+.... ......+.+|+++++.++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47899999999999865 47789999987653 33345788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeecc
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG  205 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  205 (376)
                      .+++......+.+..++.++.+++.+|.|||   ++|++||||+|+||+++.++.++|+|||++...............+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9988665667889999999999999999999   7999999999999999999999999999986543222111122234


Q ss_pred             CCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHH
Q 038118          206 TMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ  284 (376)
Q Consensus       206 t~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (376)
                      +..|+|||++.+..++.++||||||+++|+|++ |..||...........+.        ...     ....    ....
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~--------~~~-----~~~~----~~~~  219 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE--------KGY-----RMSC----PQKC  219 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH--------cCC-----CCCC----CCCC
Confidence            567999999988889999999999999999998 999997654333222111        110     0011    1122


Q ss_pred             HHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          285 MECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       285 ~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ...+.+++.+|+..+|++||++.++++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            346788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.6e-41  Score=307.73  Aligned_cols=253  Identities=28%  Similarity=0.432  Sum_probs=201.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCe--EEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSS--YIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999999877654  4688887643 344456789999999999 699999999999999999999


Q ss_pred             EecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceE
Q 038118          117 YEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA  181 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~  181 (376)
                      |||+++++|.+++....               ..+++..++.++.||+.||.|||   +.|++||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999885432               35788999999999999999999   7999999999999999999999


Q ss_pred             EEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHH
Q 038118          182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      ||+|||++......  ........+..|+|||++.+..++.++|||||||++|+|++ |..||...........+..   
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~---  233 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---  233 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---
Confidence            99999998632211  11111123457999999988889999999999999999997 9999976654332221110   


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           +     +....    .......+.+++.+||+.+|.+||++.++++.|..
T Consensus       234 -----~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         234 -----G-----YRMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             -----C-----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 0     00111    11223457889999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7e-41  Score=306.97  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=206.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..+|++.+.||+|++|.||+|.+..++..|++|.+..........+.+|+.+++.+.|+|++++++.+......|+||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            46899999999999999999999999999999999876555567788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++..  ..+++..++.++.|++.+|.|||   +.|++||||+|+||+++.++.++|+|||++........ .
T Consensus        99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~  172 (296)
T cd06654          99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (296)
T ss_pred             cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence            999999998843  45788999999999999999999   79999999999999999999999999999875432211 1


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|..||............       .....      +.+  .
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~-------~~~~~------~~~--~  237 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGT------PEL--Q  237 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH-------hcCCC------CCC--C
Confidence            22345888999999998888999999999999999999999999765432211100       00000      000  1


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........+.+++.+||+.+|++||++.+|++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            11233456788999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-41  Score=312.09  Aligned_cols=266  Identities=21%  Similarity=0.297  Sum_probs=204.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||+|+||.||+|++..++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999999999999999987543 22234677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++ +|.+++......++...+..++.||+.||.|||   ++||+||||||+||+++.++.+||+|||++........ .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  160 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T  160 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence            975 787877666667899999999999999999999   79999999999999999999999999999875432221 1


Q ss_pred             eeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------HHhcCCccccc
Q 038118          200 TTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------DLYGNGKLLEA  271 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  271 (376)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....       ...........
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            223457889999998865 4578999999999999999999999987665444333322110       00000000000


Q ss_pred             cC-CcCC----CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VD-PRLC----RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~-~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+ +...    ..........+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00 0000    0001122345778999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=299.39  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=209.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      ++|++.+.||.|+||.||+|.+..++..+++|.+........+.+.+|+.+++.++|+||+++++++.....+|++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            67999999999999999999999889999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++++|.+++......+++..++.++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~  158 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKR  158 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hcc
Confidence            999999988666577999999999999999999999   7999999999999999999999999999987543221 122


Q ss_pred             eeeccCCCCCchhhhccC---CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          201 TVLAGTMGYMAPECATTG---RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ....++..|+|||.+.+.   .++.++|||||||++|+|++|..||...........+..        ..    +.+.. 
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--------~~----~~~~~-  225 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--------SN----FPPPK-  225 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------cc----CCCcc-
Confidence            334578899999998776   788999999999999999999999976543322211110        00    00000 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..........+.+++.+||..+|.+|||+.+|+.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1112334566889999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.5e-41  Score=303.49  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=202.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|++.+.||.|+||.||+|.+..++.    .+++|.+.... ......+..|+..+..+.||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            3578889999999999999999976665    47888876442 3345678888999999999999999998754 5578


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +++||+++++|.+++....+.+++..++.++.||+.||.|||   +++++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999999776778999999999999999999999   79999999999999999999999999999975432


Q ss_pred             CCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .... ......++..|++||++.++.++.++|||||||++|+|++ |..||...........+        ..+...  .
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~--~  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL--------EKGERL--A  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCcC--C
Confidence            2111 1223346778999999988889999999999999999998 99999765433221111        111111  1


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .+..       ....+..++.+||..||.+|||+.++++.|....
T Consensus       232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111       1234677888999999999999999999886533

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-40  Score=300.70  Aligned_cols=257  Identities=25%  Similarity=0.365  Sum_probs=207.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||.|++|.||+|.+..++..++||.+...   .......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5789999999999999999999988999999987653   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||+++++|.+++..   ....+++..++.++.||+.+|.|||   ++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999988753   2456899999999999999999999   79999999999999999999999999999875533


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ... ......++..|+|||++.+..++.++||||||+++|+|++|..||........ .....          ......+
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----------~~~~~~~  226 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKK----------IEQCDYP  226 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhhh----------hhcCCCC
Confidence            221 12234588899999999888899999999999999999999999965432211 11000          0000011


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...   .......+.+++.+||+.||++|||+.+|++.++.
T Consensus       227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            111   12244568889999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-40  Score=299.59  Aligned_cols=253  Identities=31%  Similarity=0.472  Sum_probs=202.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||.|++|.||+|.+..++ .+++|.+..... ..+.+.+|+++++.++|+|++++++++.. +..++||||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            467999999999999999999987654 589998865432 34678899999999999999999998854 568999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +.+++|.+++.... ..+++..+..++.|++.||.|||   +.|++|+||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999999886533 45789999999999999999999   789999999999999999999999999999765332222


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......++..|+|||...+..++.++||||||+++|+|++ |..||......+....+..        .     ..+   
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------~-----~~~---  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER--------G-----YRM---  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------C-----CCC---
Confidence            2222335678999999988889999999999999999999 9999986654333221111        0     001   


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .........+.+++.+||..||++||++.+|++.|+.
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             1112334568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=301.91  Aligned_cols=273  Identities=22%  Similarity=0.281  Sum_probs=213.2

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcc--cCChhhHHHHHHHHHHHHhCCCCCccceeeEEee--
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--  109 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--  109 (376)
                      .+.......|...+.||.|+||.|+.|.+..+|..||||++.  .......++-.+|+.+|+.++|+||+.+++++..  
T Consensus        15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            345556677888899999999999999999999999999998  4456667888999999999999999999998864  


Q ss_pred             ---CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          110 ---KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       110 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                         -+.+|+|+|+| +..|...+ +.+..+.+..+..++.||++||.|+|   +.+++||||||.|+|++.+..+||+||
T Consensus        95 ~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccc
Confidence               35789999999 55777666 45556899999999999999999999   899999999999999999999999999


Q ss_pred             CCccccccC-CCcceeeeccCCCCCchhhhc-cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH---
Q 038118          187 GLARLVEHA-KGSQTTVLAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD---  261 (376)
Q Consensus       187 g~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---  261 (376)
                      |+++..... .....+..+.|..|.|||.+. ...|+.+.||||.|||+.||++|+..|.+.+..+....+......   
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            999876432 122345666789999999774 457999999999999999999999999988766655554432211   


Q ss_pred             ----HhcCCc---cccccCCcCCCC---CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 ----LYGNGK---LLEAVDPRLCRD---FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 ----~~~~~~---~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ..+...   ....+...-...   .-+.......+++.+||..||.+|+|++|.|+
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                011000   001111111111   11123345688889999999999999999985

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.1e-41  Score=305.91  Aligned_cols=264  Identities=23%  Similarity=0.300  Sum_probs=197.9

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhC---CCCCccceeeEEee-----CC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRL---RHRNLVQLLGWCHE-----KK  111 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~  111 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+.+++.+   .||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999999999999999987532  11223455667666655   69999999998864     34


Q ss_pred             eEEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ..++|||++.+ +|..++.... ..+++..++.++.||+.||.|||   +.|++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            68999999975 7877775433 45899999999999999999999   7999999999999999999999999999987


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc-----C
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG-----N  265 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-----~  265 (376)
                      ......  ......++..|+|||++.+..++.++|||||||++|+|++|..||......+....+.........     .
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            653221  122345788999999998888999999999999999999999999776554443333332110000     0


Q ss_pred             Cccc-cccCCc---CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 GKLL-EAVDPR---LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 ~~~~-~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .... ....+.   ......+.....+.+++.+||+.||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000 000000   001111223455788999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-40  Score=302.91  Aligned_cols=247  Identities=26%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ||+|+||.||++.+..+|+.||+|.+....   ......+..|+++++.++||||+++++++......|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999999999999986432   12234456799999999999999999999999999999999999999


Q ss_pred             hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeec
Q 038118          126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA  204 (376)
Q Consensus       126 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  204 (376)
                      .+++.... ..+++..++.++.||+.||.|||   +.|++||||||+||+++.++.++|+|||++......  .......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence            88775433 35888999999999999999999   799999999999999999999999999998755322  1223345


Q ss_pred             cCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHH
Q 038118          205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ  284 (376)
Q Consensus       205 gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (376)
                      |+..|+|||++.+..++.++|||||||++|+|++|..||...........+..   ... ...    +.  .   .....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~-~~~----~~--~---~~~~~  222 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR---RTL-EDE----VK--F---EHQNF  222 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---Hhh-ccc----cc--c---ccccC
Confidence            88999999999888899999999999999999999999975432211111111   000 000    00  0   01122


Q ss_pred             HHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          285 MECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       285 ~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      ...+.+++.+||+.||++||+++++++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            34578899999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-41  Score=303.76  Aligned_cols=256  Identities=27%  Similarity=0.446  Sum_probs=206.3

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCC-----eEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETS-----SYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      ..++|++.+.||.|+||.||+|.+....     ..|++|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            3578999999999999999999986543     789999987553 3445678899999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEE
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN---------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI  183 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl  183 (376)
                      .++||||+++++|.+++....         ..+++..++.++.||+.||.|||   +.+++||||+|+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence            999999999999999885422         24678889999999999999999   799999999999999999999999


Q ss_pred             eeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHH
Q 038118          184 GDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      +|||++........ .......++..|+|||.+.++.++.++|||||||++|+|++ |..||...+.......+.     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-----  235 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-----  235 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-----
Confidence            99999875533221 11223346778999999988889999999999999999998 999997655443322211     


Q ss_pred             HhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                         .+..     ......    ....+.+++.+||+.+|++|||+.+|++.|+
T Consensus       236 ---~~~~-----~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 ---DGGH-----LDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---cCCC-----CCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence               1111     111111    2356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-41  Score=303.39  Aligned_cols=253  Identities=31%  Similarity=0.454  Sum_probs=204.9

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHH--HHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK--EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      |++.+.||+|+||+||++.+..+++.||+|++.........  ...+|+.+++.++|+||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            67889999999999999999999999999999887544332  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      .+++|.+++. ....++...++.++.||+.+|.+||   +.+++|+||||+||+++.++.++|+|||.+.... ......
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF  155 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred             cccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999886 4567899999999999999999999   7999999999999999999999999999987531 122233


Q ss_pred             eeeccCCCCCchhhhc-cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          201 TVLAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ....++..|+|||++. +..++.++||||||+++|+|++|..||...........+..........         ..  .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~--~  224 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---------SS--Q  224 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---------HT--T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---------cc--c
Confidence            4456888999999998 7889999999999999999999999998763223322222211111000         00  0


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........+.+++.+||+.||++||++.++++
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00001167899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-40  Score=304.07  Aligned_cols=262  Identities=27%  Similarity=0.388  Sum_probs=206.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC----------------eEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccc
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS----------------SYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQ  102 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~  102 (376)
                      .++|++.+.||+|+||.||+|.+..++                ..|++|.+.... ......+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            468999999999999999999876543                568999987653 445678899999999999999999


Q ss_pred             eeeEEeeCCeEEEEEecCCCCChhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCC
Q 038118          103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKEN----------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN  172 (376)
Q Consensus       103 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  172 (376)
                      +++++..++..++|||++.+++|.+++....          ..+++..++.++.|++.||.|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999885433          26899999999999999999999   7999999999999


Q ss_pred             eeecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh--CCCCCCCccch
Q 038118          173 IMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC--GRKPISLTAKE  249 (376)
Q Consensus       173 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt--g~~pf~~~~~~  249 (376)
                      |+++.++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            99999999999999998754322211 1223345678999999988889999999999999999998  67888765433


Q ss_pred             hhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ........    ..........      ..........+.+++.+||+.||.+|||+.+|++.|+
T Consensus       241 ~~~~~~~~----~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVIENAGH----FFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHh----cccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            33222211    1111110000      1111122356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.9e-41  Score=337.74  Aligned_cols=262  Identities=23%  Similarity=0.355  Sum_probs=203.7

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--C
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--K  110 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~  110 (376)
                      ..+...++|++.+.||.|+||.||+|.+..++..|++|.+...  .......|..|+.++++++||||++++++|..  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            3445568999999999999999999999999999999998753  33445678999999999999999999998854  4


Q ss_pred             CeEEEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC----CCceEeecccCCCeeecC------
Q 038118          111 KELLLVYEYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGW----EQCVVHRDIKSSNIMLDL------  177 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~----~~~i~H~dlkp~Nill~~------  177 (376)
                      ..+||||||+++++|.++|...   ...+++..++.|+.||+.||.|||...    ..+|+||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5789999999999999988542   356999999999999999999999421    146999999999999964      


Q ss_pred             -----------CceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCC
Q 038118          178 -----------NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPIS  244 (376)
Q Consensus       178 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~  244 (376)
                                 .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++||||||||||+|++|..||.
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       2348999999997653221  2234468999999999854  458899999999999999999999997


Q ss_pred             CccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH--HHhcc
Q 038118          245 LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI--HVLNS  315 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl--~~L~~  315 (376)
                      ............       ...       +.+..   ......+.+||..||+.+|.+||++.+++  .++..
T Consensus       245 ~~~~~~qli~~l-------k~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        245 KANNFSQLISEL-------KRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             cCCcHHHHHHHH-------hcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            544322111111       011       11100   01124578899999999999999999998  45543

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.5e-41  Score=310.44  Aligned_cols=242  Identities=23%  Similarity=0.318  Sum_probs=196.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      +|+..+.||+|+||.||+|.+..+++.||+|++...   .....+.+..|..++..+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            478889999999999999999999999999998753   2233456778899998886 577888999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|..++.. ...+++..++.++.||+.||.|||   ++|++||||||+|||++.++.++|+|||++...... .
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-G  155 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-C
Confidence            99999999888744 456899999999999999999999   799999999999999999999999999998643221 1


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||..|+|||++.+..++.++|||||||++|+|++|..||...........+..        ..      ..+.
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--------~~------~~~p  221 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--------HN------VSYP  221 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC------CCCC
Confidence            122334589999999999988899999999999999999999999987654333222221        10      1111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                      ..    ....+.+++.+||+.+|.+|++.
T Consensus       222 ~~----~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         222 KS----LSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             cc----CCHHHHHHHHHHcccCHhhCCCC
Confidence            12    23456788899999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-40  Score=297.56  Aligned_cols=247  Identities=27%  Similarity=0.424  Sum_probs=197.3

Q ss_pred             ccccCCCeeEEEEEEc--CCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCC
Q 038118           48 KLGQGGFGGVYKGFFR--ETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS  124 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s  124 (376)
                      .||+|+||.||+|.+.  .++..||+|++.... ....+.+.+|+.+++.++|+||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999875  446679999987653 3345678999999999999999999998864 57899999999999


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce--ee
Q 038118          125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT--TV  202 (376)
Q Consensus       125 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~  202 (376)
                      |.+++......+++..++.++.||+.+|.|||   ++|++||||||+||+++.++.+||+|||++...........  ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99988666667899999999999999999999   79999999999999999999999999999875433222111  11


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +..         ....
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------~~~---------~~~~  220 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ--------GKR---------LDCP  220 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC--------CCC---------CCCC
Confidence            223568999999988889999999999999999996 9999976654433222211        110         1111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ......+.+++.+||..+|++||++.+|++.|+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            2234567789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-40  Score=302.86  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=205.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..+|++.++||.|+||.||+|.+..++.    .||+|.+... .......+.+|+.++..+.|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            4688999999999999999999876665    4899998754 34445678899999999999999999999875 4578


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +++||+++|+|.+++......+++..++.++.||+.||.|||   +++++||||||+|||+++++.+||+|||++.....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999998766667899999999999999999999   79999999999999999999999999999876543


Q ss_pred             CCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.        .+..    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--------~~~~----  229 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE--------KGER----  229 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--------CCCc----
Confidence            22211 111234678999999988889999999999999999998 999997655433222111        1110    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                       ...    .......+.+++.+||+.||++||++.++++.|....
T Consensus       230 -~~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         230 -LPQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             -CCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence             001    1122345778899999999999999999998887544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=297.30  Aligned_cols=248  Identities=33%  Similarity=0.503  Sum_probs=205.0

Q ss_pred             CccccCCCeeEEEEEEcCC---CeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRET---SSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+...   +..|++|.+...... ....+.+|+..++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   888999999866433 367889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          123 GSLDSHLFKE--------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       123 ~sL~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ++|.+++...        ...+++..++.++.|++.||.+||   +++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998665        477999999999999999999999   79999999999999999999999999999976543


Q ss_pred             CCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ... .......++..|+|||.+....++.++||||||+++|+|++ |..||......+....+..        +.     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------~~-----  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------GY-----  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------CC-----
Confidence            321 11233446889999999988889999999999999999999 6999987654433222221        11     


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                          ...........+.+++.+||+.+|++|||+.++++.|+
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                01111222456888999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-40  Score=299.70  Aligned_cols=254  Identities=29%  Similarity=0.450  Sum_probs=204.5

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.++||+|+||.||+|.... +..|++|.+...... ...+.+|+.+++.++|+|++++++++. .+..+++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            35789999999999999999998755 677999998755432 467889999999999999999999874 456899999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+.+++|.+++... ...+++..++.++.|++.+|.|||   +.|++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999987543 346889999999999999999999   79999999999999999999999999999876542222


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......++..|+|||++....++.++||||||+++|+|++ |..||...+..+....+..        ...     ...
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~  224 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER--------GYR-----MPR  224 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc--------CCC-----CCC
Confidence            22223345678999999988889999999999999999998 9999986654433222211        100     111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..    .....+.+++.+||..+|++||++++++..|+.
T Consensus       225 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11    123458889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-41  Score=300.51  Aligned_cols=255  Identities=32%  Similarity=0.489  Sum_probs=206.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||.|+||.||+|.+++ +..|++|.+..... ....+.+|+.+++.++|+|++++++++......++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            45789999999999999999999865 56799999875433 34678899999999999999999999999899999999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++.... ..+++..+..++.+|+.++.|||   +++++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999886543 46899999999999999999999   78999999999999999999999999999876543211


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+..        .     .....
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~--------~-----~~~~~  225 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER--------G-----YRMPR  225 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------C-----CCCCC
Confidence            11222234568999999998889999999999999999998 9999976554332222111        0     00001


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..    .....+.+++.+||+.+|++||+++++++.|+.
T Consensus       226 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 PP----NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11    113457889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=304.85  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=203.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC--------------CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCcccee
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET--------------SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLL  104 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~  104 (376)
                      .++|++.+.||+|+||.||++.+.++              ...|++|.+... .......|.+|+++++.++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            46899999999999999999987543              345899998764 344456789999999999999999999


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCe
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKEN-----------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI  173 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  173 (376)
                      +++...+..++||||+++++|.+++....           ..+++..++.++.|++.||.|||   +.+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999885421           23678889999999999999999   79999999999999


Q ss_pred             eecCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh--CCCCCCCccchh
Q 038118          174 MLDLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC--GRKPISLTAKEE  250 (376)
Q Consensus       174 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt--g~~pf~~~~~~~  250 (376)
                      +++.++.+||+|||++.......... .....++..|+|||++.++.++.++|||||||++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999987543222111 112234678999999988889999999999999999988  667887655433


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      .......    ........      ............+.+++.+||+.||++||++.+|++.|.
T Consensus       241 ~~~~~~~----~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGE----FFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHH----hhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            3222211    11100000      000011112346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-40  Score=298.06  Aligned_cols=250  Identities=29%  Similarity=0.399  Sum_probs=207.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      ++|++.+.||.|+||.||+|.+..++..|++|.+.....  ...+.+|+++++.++|+|++++++++......|+++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            689999999999999999999998889999999875533  678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++++|.+++......+++..++.++.|++.+|.|||   ..+++|+||+|.||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence            999999998766678899999999999999999999   78999999999999999999999999999876543321 22


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ....++..|+|||++.+..++.++||||||+++|+|++|..||...........+.        .     ...+.  ...
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------~-----~~~~~--~~~  221 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------N-----KPPPT--LSD  221 (256)
T ss_pred             ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--------c-----CCCCC--CCc
Confidence            33447889999999988889999999999999999999999997654322111100        0     00000  111


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+.+++.+||+.||++|||+.+|++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            2223356788999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3e-40  Score=304.52  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=204.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||+|+||.||++.+..++..+++|.+... .......+.+|++++++++||||+++++++..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4689999999999999999999999999999998754 333456688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++.+. +.+++..+..++.||+.+|.|||+  ..+++|+||+|+|||++.++.++|+|||++......   .
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~  154 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  154 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence            9999999988543 668999999999999999999994  368999999999999999999999999998644221   1


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc------------
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK------------  267 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------  267 (376)
                      .....++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+............            
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            22345788999999998888999999999999999999999999755432221111100000000000            


Q ss_pred             -----------cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          268 -----------LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       268 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                                 ......+.+..   ......+.+++.+||..+|++|||+.+|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       00000011100   0123457899999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-40  Score=303.75  Aligned_cols=255  Identities=27%  Similarity=0.394  Sum_probs=202.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            57889999999999999998753     23568999887543 3445678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCC
Q 038118          116 VYEYMPNGSLDSHLFKE-----------------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN  172 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  172 (376)
                      |+||+.+++|.+++...                       ...+++..++.++.|++.+|.|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            99999999999887432                       134788899999999999999999   7999999999999


Q ss_pred             eeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchh
Q 038118          173 IMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEE  250 (376)
Q Consensus       173 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~  250 (376)
                      ||+++++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999875432211 11122335678999999988889999999999999999998 999997655333


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ....+.        ...         ...........+..++.+||+.+|++||++.++++.|+..
T Consensus       238 ~~~~~~--------~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         238 LFNLLK--------TGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             HHHHHh--------CCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            222111        110         0111112234578899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.6e-40  Score=296.89  Aligned_cols=246  Identities=27%  Similarity=0.413  Sum_probs=196.3

Q ss_pred             ccccCCCeeEEEEEE--cCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           48 KLGQGGFGGVYKGFF--RETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      .||+|+||.||+|.+  ..++..+++|++....  ....+.+..|+.+++.+.|+||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999975  4567889999986542  3345678999999999999999999998854 5679999999999


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc--ee
Q 038118          124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ--TT  201 (376)
Q Consensus       124 sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~  201 (376)
                      +|.+++.. ...+++..++.++.|++.+|.+||   ++|++||||||.||+++.++.++|+|||++..........  ..
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            99988854 456899999999999999999999   7999999999999999999999999999997654332211  11


Q ss_pred             eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ...++..|+|||.+....++.++|||||||++|+|++ |..||......+....+.        .+..     +..    
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~--------~~~~-----~~~----  219 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE--------SGER-----MEC----  219 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------CCCC-----CCC----
Confidence            2223578999999988889999999999999999998 999998665433322221        1111     111    


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .......+.+++.+||+.||++||++.+|.+.|..
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            11233457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=300.89  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=205.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||.|++|.||+|.+..++..|++|.+.... ......+.+|+++++.++|+|++++++++.++...|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47899999999999999999999999999999987553 34456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++...  .+++..++.++.|++.+|.+||   +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence            9999999988543  7899999999999999999999   7999999999999999999999999999997664332 12


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|+|||++.+..++.++||||||+++|+|++|..||...........+..        .     ..+.+...
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------~-----~~~~~~~~  221 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK--------N-----NPPSLEGN  221 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh--------c-----CCCCCccc
Confidence            2334578899999999988899999999999999999999999976543222111110        0     11111111


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .....+.+++.+||..+|++|||++++++
T Consensus       222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               03345788889999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-41  Score=305.35  Aligned_cols=263  Identities=27%  Similarity=0.411  Sum_probs=203.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEE----cCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFF----RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELL  114 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~  114 (376)
                      .+|++.+.||+|+||.||++..    ..++..|++|.+........+.+.+|+++++.++|+||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5789999999999999999974    45688999999987777667889999999999999999999998743  35689


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.|++.||.|||   ++|++||||||+||+++.++.++|+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999998666667899999999999999999999   79999999999999999999999999999976533


Q ss_pred             CCCcce--eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH--------HHHHHHHHHhc
Q 038118          195 AKGSQT--TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV--------YLVQWVWDLYG  264 (376)
Q Consensus       195 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~--------~~~~~~~~~~~  264 (376)
                      ......  ....++..|+|||++.+..++.++|||||||++|+|++|..++......-...        ...........
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            221111  11123446999999988889999999999999999999887754332110000        00000000000


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..         ............+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       241 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         241 NN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             cC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            00         0001111223458889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-40  Score=298.43  Aligned_cols=252  Identities=28%  Similarity=0.501  Sum_probs=204.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..+|++.+.||.|+||.||+|.+.. +..+++|.+...... ...|.+|++++++++|+|++++++++......++||||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            4578899999999999999998864 567999988754332 35788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +.+++|.+++......+++..++.++.+++.++.+||   +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999988665667899999999999999999999   7899999999999999999999999999987543222211


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      .....++..|+|||++.++.++.++||||||+++|+|++ |..||...........+.        .+  .....+..  
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--------~~--~~~~~~~~--  225 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN--------AG--FRLYKPRL--  225 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh--------CC--CCCCCCCC--
Confidence            222234568999999988889999999999999999998 999997655333222211        11  01111111  


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                           ....+.+++.+||+.+|++|||+.++++.|
T Consensus       226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 235688899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.1e-40  Score=296.26  Aligned_cols=258  Identities=26%  Similarity=0.385  Sum_probs=208.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+...   .......+.+|+.+++.++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            6899999999999999999999989999999988642   2333567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||+++++|..++..   ....+++..++.++.+++.+|.|||   +.|++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999988753   2345899999999999999999999   79999999999999999999999999999875432


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .. .......++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......     ...+..     +
T Consensus       159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-----~~~~~~-----~  226 (267)
T cd08224         159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK-----IEKCDY-----P  226 (267)
T ss_pred             CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhh-----hhcCCC-----C
Confidence            22 1223345888999999998888999999999999999999999999654311 1110000     000100     0


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ..   ........+.+++.+||..+|++|||+.+|++.|...
T Consensus       227 ~~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 PL---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11   1113445678899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=297.98  Aligned_cols=253  Identities=26%  Similarity=0.442  Sum_probs=200.4

Q ss_pred             CCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe-----
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE-----  112 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  112 (376)
                      |.+.+.||+|+||.||.|.+..+   +..||+|.+...  .......+.+|+..++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67889999999999999987643   478999998754  33445678999999999999999999998865543     


Q ss_pred             -EEEEEecCCCCChhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          113 -LLLVYEYMPNGSLDSHLFKE-----NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       113 -~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                       .++||||+++++|..++...     ...+++..++.++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999998887432     236889999999999999999999   799999999999999999999999999


Q ss_pred             CCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhc
Q 038118          187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYG  264 (376)
Q Consensus       187 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      |++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.        
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~--------  229 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR--------  229 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------
Confidence            998755322211 1122234678999999988889999999999999999999 899997655433322211        


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .+..     ....    ......+.+++.+||+.||++|||+.+|++.|..
T Consensus       230 ~~~~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         230 HGNR-----LKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             cCCC-----CCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1111     1111    1233467888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.7e-40  Score=295.69  Aligned_cols=248  Identities=28%  Similarity=0.408  Sum_probs=201.1

Q ss_pred             CccccCCCeeEEEEEEcC-CC--eEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRE-TS--SYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|++|.||+|.+.. ++  ..|++|.+..... ...+.+.+|+..+++++|+||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999999865 33  3699999987655 567789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc--c
Q 038118          123 GSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS--Q  199 (376)
Q Consensus       123 ~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~  199 (376)
                      ++|.+.+.... ..+++..++.++.|++.||.|||   +++++|+||+|+||+++.++.+||+|||++.........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999986654 57899999999999999999999   799999999999999999999999999998765432211  1


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..       ....     .    
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~-----~----  220 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-------EGER-----L----  220 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------cCCc-----C----
Confidence            112346778999999988889999999999999999998 9999976554433222211       0000     0    


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      .........+.+++.+||+.+|.+||++.+|++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            011122345888999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-40  Score=303.99  Aligned_cols=259  Identities=27%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEE-----cCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKGS-KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      ...++|.+.+.||+|+||.||+|.+     ..++..||+|.+.... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            3346799999999999999999985     2345689999987543 34456789999999999 799999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      +..++||||+.+++|.+++.... ..+++..++.++.+|+.+|.|||   +++++|+||||+||+++.++.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999886533 34899999999999999999999   799999999999999999999999999998


Q ss_pred             cccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          190 RLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       190 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..............       .+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~-------~~~  261 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK-------EGY  261 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH-------cCC
Confidence            754322211 1112335678999999998889999999999999999998 9999976543322111110       110


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           ....    .......+.+++.+||..+|++|||+.+|++.|..
T Consensus       262 -----~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 -----RMAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             -----cCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                 0001    11123457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.1e-41  Score=314.48  Aligned_cols=265  Identities=22%  Similarity=0.238  Sum_probs=200.4

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  110 (376)
                      ...++|++.+.||+|+||.||++.+..++..||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3468999999999999999999999999999999998643  333456788999999999999999999998644     


Q ss_pred             -CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 -KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                       ...|+||||+++ +|...+.   ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             357999999976 5555552   24788889999999999999999   799999999999999999999999999998


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHH-----------
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW-----------  258 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-----------  258 (376)
                      ......  .......||..|+|||++.+..++.++|||||||++|+|++|..||...+.......+...           
T Consensus       171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            653221  1223345789999999999889999999999999999999999999866543322211110           


Q ss_pred             ----HHHHhcCCcccccc-----CCcC----CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          259 ----VWDLYGNGKLLEAV-----DPRL----CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       259 ----~~~~~~~~~~~~~~-----~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ..............     -+.+    ...........+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                00011000000000     0000    00011112345788999999999999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.2e-41  Score=297.05  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=208.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hh-HHHHHHHHHHHHhCCCCC-ccceeeEEeeCC-----
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QG-IKEYASEVTIISRLRHRN-LVQLLGWCHEKK-----  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~-----  111 (376)
                      ...|...++||+|.||+||+|+...+|+.||+|+++.... ++ -....+|+.+|+.|+|+| |+.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3456777889999999999999999999999999987644 22 234578999999999999 999999998776     


Q ss_pred             -eEEEEEecCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          112 -ELLLVYEYMPNGSLDSHLFKEN---NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       112 -~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                       .+++||||++ ..|..++....   ..++...+..+++||+.||+|||   +++|+||||||+||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             8999999984 48888886544   35777889999999999999999   8999999999999999999999999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      +++....... ..+...+|..|.|||++.+. .|+...||||+|||+.||++++..|.+....+....+...........
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9986542222 24445578889999999887 699999999999999999999999999887666655554432221111


Q ss_pred             c--cc--cccCCcCCC-----CCcH---HHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          267 K--LL--EAVDPRLCR-----DFDE---QQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       267 ~--~~--~~~~~~~~~-----~~~~---~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      .  +.  .........     .+..   .......+++.+||+.+|..|.|+...+..
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0  00  000111111     1111   111357888999999999999999999863

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-40  Score=301.94  Aligned_cols=251  Identities=26%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .|+..+.||.|+||+||+|.+..+++.||+|.+....   ......+.+|+++++.++|+|++++++.+..++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4777889999999999999999999999999987542   2223457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+.+++|.+++... ...+++..+..++.|++.+|.|||   +.+|+||||||+||++++++.++|+|||++......  
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--  155 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--
Confidence            99999998877543 346899999999999999999999   799999999999999999999999999998654322  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+....    ...      .... 
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~----~~~------~~~~-  224 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV----LET------EEVY-  224 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh----hcc------cccc-
Confidence            12233458999999999988889999999999999999999999997654332222211100    000      0111 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                         .......+.+++..||+.||++||+     +.+++.
T Consensus       225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence               1222345678889999999999999     667664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.6e-40  Score=300.59  Aligned_cols=251  Identities=26%  Similarity=0.361  Sum_probs=199.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||+|+||.||+|.+..++..|++|.+... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4688899999999999999999999999999998754 344456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|..+     ..+++..+..++.|++.+|.|||   +.|++|+||||+||+++.++.++|+|||++......   .
T Consensus        81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~  149 (279)
T cd06619          81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I  149 (279)
T ss_pred             CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence            999998543     24678889999999999999999   799999999999999999999999999998754321   2


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|..||.................. .....     .+.+.  
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~--  221 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDED-----PPVLP--  221 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccC-----CCCCC--
Confidence            23346889999999999888999999999999999999999999653322111111110000 00000     01111  


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .......+.+++.+||+.+|++||+++++++
T Consensus       222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             1112245788899999999999999999985

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-40  Score=302.59  Aligned_cols=251  Identities=26%  Similarity=0.341  Sum_probs=201.1

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +|+..+.||+|+||.||++.+..+++.||+|.+....   ......+..|+.+++.++|++++.+++.+...+..|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4778889999999999999999999999999987542   2223457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+.+++|.+++... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            99999998887543 245889999999999999999999   7999999999999999999999999999986543211 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                       ......|+..|+|||++.+..++.++|||||||++|+|++|..||..................          ......
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------~~~~~~  225 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------VQEEYS  225 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----------hhhhcC
Confidence             122345899999999999888999999999999999999999999765432211111111000          001111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      .    .....+.+++..||+.||.+|||     +.++++
T Consensus       226 ~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 E----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             c----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1    22345778889999999999999     788885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.9e-40  Score=298.84  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=199.4

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCe--EEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC------Ce
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSS--YIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK------KE  112 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~  112 (376)
                      |.+.+.||+|+||.||+|.+..++.  .||+|.+...  .....+.+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4577899999999999999877664  6899988754  345567889999999999999999999987432      25


Q ss_pred             EEEEEecCCCCChhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          113 LLLVYEYMPNGSLDSHLFK-----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      .++||||+.+++|.+++..     ....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            7899999999999887642     2235789999999999999999999   7999999999999999999999999999


Q ss_pred             CccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          188 LARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       188 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ++.......... .....++..|++||++.+..++.++|||||||++|+|++ |..||...........+.        .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--------~  229 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR--------Q  229 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--------c
Confidence            987653322111 122235678999999998889999999999999999999 899997654433222211        1


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      +...     ....    .....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       230 ~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         230 GNRL-----KQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCC-----CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1111     0111    223457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-41  Score=299.47  Aligned_cols=261  Identities=24%  Similarity=0.289  Sum_probs=205.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----eEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-----ELLL  115 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l  115 (376)
                      -.|+..+++|.|.||.||+|....++..||||++....+-    -.+|+++|+.+.||||+++.-+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3577788999999999999999999999999998765432    136999999999999999988875422     4578


Q ss_pred             EEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCCccc
Q 038118          116 VYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARL  191 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~  191 (376)
                      ||||++. +|.+.+..   .+..++...+.-+..||++||.|||   +.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999976 78887753   3567888888889999999999999   7999999999999999987 8999999999987


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC-----
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN-----  265 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----  265 (376)
                      +.....  ......|..|.|||.+.+. .|+.+.||||.||++.||+.|++.|.+.+..+....+.+.......+     
T Consensus       176 L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  176 LVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            754333  3444468899999998775 59999999999999999999999999988777777666654321111     


Q ss_pred             -CccccccCCcCC-----CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 -GKLLEAVDPRLC-----RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 -~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ....+...|.+.     .-+.......+++++.++|+.+|.+|.++.+++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence             111111111111     1133344466888999999999999999999884

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-40  Score=314.30  Aligned_cols=264  Identities=20%  Similarity=0.235  Sum_probs=201.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC------
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK------  110 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  110 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.++|+||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            468999999999999999999999999999999998753  333456788899999999999999999987543      


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ...|+||||+++ +|...+.   ..+++..++.++.|++.||.|||   ++||+||||||+|||++.++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            457999999965 6666553   24788889999999999999999   7999999999999999999999999999997


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH-----------
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV-----------  259 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-----------  259 (376)
                      ......  ......++..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....           
T Consensus       175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            543221  2233458999999999999899999999999999999999999998766444332222100           


Q ss_pred             ----HHHhcCCc-cc----cccCCcC----CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          260 ----WDLYGNGK-LL----EAVDPRL----CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       260 ----~~~~~~~~-~~----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          .....+.. ..    ..+.+..    ...........+.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                00000000 00    0000000    00111112345788999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-40  Score=297.96  Aligned_cols=249  Identities=25%  Similarity=0.431  Sum_probs=202.1

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh---------hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---------QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      +|.+...||.|++|.||+|.+..++..|++|.+.....         ...+.+.+|+.++++++|+||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            58889999999999999999988899999998865321         123568899999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .++||||+++++|.+++.. .+.+++..+..++.|++.+|.|||   +.|++||||+|+||+++.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999988854 456889999999999999999999   799999999999999999999999999998765


Q ss_pred             ccCCC-----cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          193 EHAKG-----SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       193 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .....     .......|+..|+|||.+.+..++.++|||||||++|+|++|..||...........+.        .  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~--  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG--------E--  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh--------c--
Confidence            42111     11122447889999999988889999999999999999999999997654322111110        0  


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ...+.+    .......+..++.+||+.||.+||++.+|++
T Consensus       227 ---~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 ---NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               111122    2223456788889999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-40  Score=300.23  Aligned_cols=256  Identities=27%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..++|.+.+.||+|+||.||+|.+...   ...|++|...... ....+.+.+|+.+++.+.|+||+++++++.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            356789999999999999999987543   3468999887654 4556789999999999999999999998875 4578


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.+++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999999999765556899999999999999999999   79999999999999999999999999999876543


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..........++..|+|||.+....++.++||||||+++|+|++ |..||......+....+.        .+..     
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--------~~~~-----  226 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE--------NGER-----  226 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------cCCc-----
Confidence            32111122234568999999988889999999999999999986 999997765443322221        1110     


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .....    .....+.+++.+|+..+|++|||+.++++.|..
T Consensus       227 ~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         227 LPMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            01111    223457888899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.8e-40  Score=294.70  Aligned_cols=251  Identities=33%  Similarity=0.519  Sum_probs=204.6

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCC----eEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETS----SYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      +++.+.||.|+||.||++.+...+    ..|++|.+...... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467889999999999999998766    88999999765433 5678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          118 EYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      ||+++++|.+++...... +++..++.++.|++.+|.+||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999988654444 899999999999999999999   7999999999999999999999999999997654332


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+..        ....      
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~--------~~~~------  223 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK--------GYRL------  223 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--------CCCC------
Confidence            222212336789999999988889999999999999999998 8889876543333222211        1110      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                         .........+.+++.+|+..+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               11111344578899999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-40  Score=299.42  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=203.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||.|+||.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35788889999999999999999999999999999876555566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++.. .+.+++..++.++.|++.+|.|||   +.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06645          88 CGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK  162 (267)
T ss_pred             cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence            999999998744 457899999999999999999999   7899999999999999999999999999986543221 12


Q ss_pred             eeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          200 TTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||.............        ...    ..+..
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--------~~~----~~~~~  230 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--------KSN----FQPPK  230 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--------ccC----CCCCc
Confidence            23346889999999874   4568899999999999999999999986543222111110        000    00110


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ... .......+.+++.+||+.+|++||++.+|++
T Consensus       231 ~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000 0012245788899999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.8e-41  Score=306.70  Aligned_cols=267  Identities=22%  Similarity=0.277  Sum_probs=204.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            467999999999999999999999999999999987542 2233467789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |++ ++|..++......+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            997 5888888666667899999999999999999999   79999999999999999999999999999875432221 


Q ss_pred             ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH--------hcCCccc
Q 038118          199 QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL--------YGNGKLL  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~  269 (376)
                      ......++..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.......        .......
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            12233468899999988654 47889999999999999999999998766544333222211000        0000000


Q ss_pred             cccCCcCCC----CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCR----DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..-.+....    .........+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000011100    011122345788999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.2e-40  Score=295.26  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=203.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee-CCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE-KKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e  118 (376)
                      +|++.+.||.|++|.||++.+..+++.|++|.+...  .....+.+.+|+++++.++|+|++++++.+.. +..+|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            589999999999999999999998999999998653  33445678899999999999999999988764 457899999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++... ...+++..++.++.+++.++.+||   +.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999888653 346899999999999999999999   7999999999999999999999999999987653322 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......+++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..        +..     +.  
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------~~~-----~~--  221 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------GKL-----PP--  221 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------cCC-----CC--
Confidence            223344578899999999988899999999999999999999999976543222111111        111     11  


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ........+.+++.+|++.+|++||++.++++
T Consensus       222 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         222 --MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              12233356888999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.7e-40  Score=307.28  Aligned_cols=244  Identities=22%  Similarity=0.307  Sum_probs=192.0

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..+++.||+|++...   .......+..|+.++.++ +|+||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999754   223456688899999888 599999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|..++.. .+.+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||++...... ......
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~  155 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST  155 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence            999887743 456899999999999999999999   799999999999999999999999999998642211 122334


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||.......... ...+.........      ..+...   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~------~~~p~~---  225 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKP------IRIPRF---  225 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCC------CCCCCC---
Confidence            568999999999999999999999999999999999999996432211100 0001111111110      111112   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCh
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                       ....+.+++.+||+.||.+|+++
T Consensus       226 -~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         226 -LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCHHHHHHHHHHhccCHHHcCCC
Confidence             22446788889999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-40  Score=313.36  Aligned_cols=265  Identities=21%  Similarity=0.233  Sum_probs=201.6

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  110 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++.++|+||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4568999999999999999999999999999999998753  333456788899999999999999999988643     


Q ss_pred             -CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 -KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                       ...|+||||+++ +|...+.   ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357999999976 5555553   24788889999999999999999   799999999999999999999999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHH-----------
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW-----------  258 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-----------  258 (376)
                      ......  .......||..|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...           
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            754322  1223345899999999999888999999999999999999999999866533322211110           


Q ss_pred             ----HHHHhcCC-ccccccCCcC--------CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          259 ----VWDLYGNG-KLLEAVDPRL--------CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       259 ----~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ........ .......+..        ...........+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                00000000 0000000000        00111122356789999999999999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.5e-40  Score=297.84  Aligned_cols=257  Identities=27%  Similarity=0.431  Sum_probs=205.0

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++.+.+.+.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            34455666667799999999999999999999999999987766667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCCCcccc
Q 038118          116 VYEYMPNGSLDSHLFKENNLL--TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLV  192 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~  192 (376)
                      |+||+++++|.+++......+  ++..+..++.||+.+|.|||   +.+|+||||+|.||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999886654555  78888899999999999999   799999999999999976 678999999998654


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCC--CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .... .......++..|+|||++.+..  ++.++||||||+++|+|++|..||..............    ..       
T Consensus       160 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----~~-------  227 (268)
T cd06624         160 AGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----MF-------  227 (268)
T ss_pred             ccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh----hh-------
Confidence            3221 1222335788999999986543  78899999999999999999999965432211111000    00       


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+.    +.......+..++.+||+.+|.+|||+.+|++
T Consensus       228 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 KIHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ccCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00111    22223455788899999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-40  Score=294.03  Aligned_cols=247  Identities=30%  Similarity=0.463  Sum_probs=200.5

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ++||.|+||.||+|.+.. ++.|++|.+..... .....+.+|++++++++|+||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999988 88999999876533 3556889999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce-eeec
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT-TVLA  204 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~  204 (376)
                      .+++......++...++.++.+++.+|.|||   +++++||||+|+||+++.++.++|+|||++........... ....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9988665667889999999999999999999   79999999999999999999999999999875432111111 1122


Q ss_pred             cCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          205 GTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       205 gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      ++..|+|||.+.++.++.++|||||||++|+|++ |..||...........+..        ..         .......
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~--------~~---------~~~~~~~  219 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES--------GY---------RMPAPQL  219 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc--------CC---------CCCCCcc
Confidence            3567999999988889999999999999999999 8899976654332222110        00         0011112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          284 QMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ....+.+++.+||..+|++|||+.+|++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3346888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-42  Score=324.72  Aligned_cols=260  Identities=28%  Similarity=0.464  Sum_probs=224.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC---eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS---SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .....+.+.||.|.||.||.|+.+..+   ..||||.++.. ..+....|+.|+.++.+++||||+++.++........|
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            456778899999999999999987655   57999999877 44556789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+|||++|+|+.+|.++.+.+..-++..+++.|+.+|.||-   ..++|||||...|||++.+..+|++|||+++.+.+.
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999999888888999999999999999999999   799999999999999999999999999999987655


Q ss_pred             CCcceeeecc--CCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          196 KGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       196 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .....++..|  +.+|.|||.+...+++.+|||||+|+++||.++ |+.||-..++.+....+.+               
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~---------------  849 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ---------------  849 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh---------------
Confidence            4333333323  569999999999999999999999999999876 9999988887776555443               


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPL  319 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~~  319 (376)
                        .++-..+.++...|..|+++||++|-.+||.+.+|+..|......
T Consensus       850 --gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  850 --GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             --ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence              222233445667799999999999999999999999988765543

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-40  Score=302.89  Aligned_cols=266  Identities=21%  Similarity=0.243  Sum_probs=206.9

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||.|++|.||+|.+..++..|++|++....  ......+.+|+.+++.++|+|++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999999889999999987653  33456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      + +++|.+++......+++..++.++.||+.+|.|||   +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 99999988766677999999999999999999999   7999999999999999999999999999987654332222


Q ss_pred             eeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH-------HHHhcC-Ccccc
Q 038118          200 TTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV-------WDLYGN-GKLLE  270 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-------~~~~~~-~~~~~  270 (376)
                      .....++..|+|||.+.+. .++.++|||||||++|+|++|..+|...........+....       +..... .....
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            3344588899999988654 46899999999999999999988887655433322222110       000000 00000


Q ss_pred             ccCCcC----CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRL----CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+..    ...........+.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000000    00111122367889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-40  Score=300.48  Aligned_cols=252  Identities=26%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||+|+||.||++.+..++..|++|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            4689999999999999999999989999999988754 334456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKE--NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      +++++|..++...  ...+++..+..++.+|+.+|.|||+  +.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999998887543  2368999999999999999999994  369999999999999999999999999998654221  


Q ss_pred             cceeeeccCCCCCchhhhccC------CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          198 SQTTVLAGTMGYMAPECATTG------RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                       ......++..|+|||.+.+.      .++.++|||||||++|+|++|..||...........+....     .+.    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~----  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV-----DGD----  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh-----hcC----
Confidence             12233478899999988544      34789999999999999999999997544322221111100     000    


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .+    .+.......+..++.+||+.+|++||++.+++.
T Consensus       227 -~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 -PP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -CC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence             11    122234456788899999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-40  Score=300.88  Aligned_cols=255  Identities=30%  Similarity=0.455  Sum_probs=203.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||.|+||.||+|.+.+     ++..|++|.+.... ......+.+|+.+++.+.|+||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4679999999999999999998753     57789999987653 34456788999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCC
Q 038118          114 LLVYEYMPNGSLDSHLFKEN---------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN  172 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~---------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  172 (376)
                      ++||||+++++|.+++....                     ..+++..++.++.||+.+|.|||   .++++||||+|.|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999885321                     24678889999999999999999   7999999999999


Q ss_pred             eeecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchh
Q 038118          173 IMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEE  250 (376)
Q Consensus       173 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~  250 (376)
                      |+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998654322111 1112234567999999988889999999999999999997 888987655443


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ....+.        .+...         .........+.+++.+||+.+|.+|||+.||++.|+
T Consensus       241 ~~~~~~--------~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYYVR--------DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHh--------cCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            322111        11111         011122345888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6e-40  Score=300.74  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC----------------CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccc
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE----------------TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQ  102 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~  102 (376)
                      .++|++.+.||+|+||.||++.+..                ++..|++|.+... .......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3679999999999999999986532                3457999998754 3444568899999999999999999


Q ss_pred             eeeEEeeCCeEEEEEecCCCCChhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCC
Q 038118          103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKEN----------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN  172 (376)
Q Consensus       103 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  172 (376)
                      +++++...+..++||||+++++|.+++....          ..+++..++.++.||+.||.|||   +.|++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            9999999999999999999999998885432          23667889999999999999999   7899999999999


Q ss_pred             eeecCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh--CCCCCCCccch
Q 038118          173 IMLDLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC--GRKPISLTAKE  249 (376)
Q Consensus       173 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt--g~~pf~~~~~~  249 (376)
                      ||++.++.++|+|||++..+....... .....++..|++||+..++.++.++|||||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999987543221111 112234678999999888889999999999999999998  77888765443


Q ss_pred             hhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      +.......+.    ........+ +.     .......+.+++.+||+.||.+||++.+|++.|.
T Consensus       241 ~~~~~~~~~~----~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEFF----RDQGRQVYL-PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHH----hhccccccC-CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            3322211111    000000000 00     1112256788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=295.17  Aligned_cols=249  Identities=31%  Similarity=0.453  Sum_probs=205.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||.|++|.||+|...  ++.|++|.+..... ..+++.+|+.+++.++|+||+++++++......++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            568999999999999999999876  67899999976654 467889999999999999999999999989999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++.... ..+++..++.++.|++.+|.|||   ..+++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999886543 36899999999999999999999   7999999999999999999999999999987552211  


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                        .....+..|+|||++....++.++||||||+++|+|++ |..||......+....+.        .+..     ... 
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--------~~~~-----~~~-  220 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE--------KGYR-----MEA-  220 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh--------cCCC-----CCC-
Confidence              12234668999999988889999999999999999997 999997665443322111        1100     111 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                         .......+.+++.+||..+|++||++.+++..|..
T Consensus       221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               11223567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.9e-40  Score=296.23  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=203.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+.. +..+++|.+..... ....+.+|+++++.++|+|++++++++.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            45789999999999999999998765 45699998875432 35678899999999999999999999887 77899999


Q ss_pred             cCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++... ...+++..++.++.|++.+|.|||   +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999988653 345788889999999999999999   79999999999999999999999999999875533222


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......++..|+|||++....++.++|+|||||++|+|++ |..||...........+.        .+..     ...
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~--------~~~~-----~~~  224 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE--------RGYR-----MPR  224 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh--------CCCC-----CCC
Confidence            22222335678999999988889999999999999999998 999998665433322211        1100     011


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                          .......+.+++.+|++.+|++||++.++++.|+.
T Consensus       225 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                11223457888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6e-40  Score=294.16  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|+..+.||.|+||.||.+.+..++..+++|.+...  .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999999999999999999999998754  344567788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++... ...+++..+..++.|++.+|.|||   +.+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999988654 356899999999999999999999   78999999999999999999999999999876533221 


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+..        +..    .+    
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------~~~----~~----  220 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------GNY----TP----  220 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--------CCC----CC----
Confidence            22344588999999999888889999999999999999999999976554332222211        111    01    


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                       ........+..++.+||..+|++||++.++++.
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             112233457888899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-40  Score=294.08  Aligned_cols=248  Identities=30%  Similarity=0.463  Sum_probs=197.6

Q ss_pred             CccccCCCeeEEEEEEcCCC---eEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETS---SYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      ++||+|+||.||+|.+...+   ..+++|.+..... .....+.+|+++++.+.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876544   7899999876543 34567899999999999999999999876 4568999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce--
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT--  200 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--  200 (376)
                      ++|.+++... ..+++..++.++.|++.+|.|||   ..+++|+||||+||+++.++.++|+|||++...........  
T Consensus        80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            9999988554 37899999999999999999999   78999999999999999999999999999876543322111  


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..        ...     ...   
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~---  219 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES--------GER-----LPR---  219 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc--------CCc-----CCC---
Confidence            11223467999999988889999999999999999998 9999976554333222211        110     001   


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                       .......+.+++.+||..+|++||++.+|++.|...
T Consensus       220 -~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         220 -PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             111234578899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-40  Score=299.26  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=201.0

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC------
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK------  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------  110 (376)
                      ...+.|++.+.||.|+||.||+|.+..+++.|++|.+..... ....+..|+.+++.+ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356789999999999999999999999999999999875543 345778899999998 699999999998753      


Q ss_pred             CeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      ...|+||||+.+++|.+++... ...+++..+..++.|++.+|.|||   +++++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            4689999999999999988653 346899999999999999999999   789999999999999999999999999998


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG  264 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ....... .......|+..|+|||++.     +..++.++|||||||++|+|++|..||...........+.       .
T Consensus       159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-------~  230 (272)
T cd06637         159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------R  230 (272)
T ss_pred             eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-------c
Confidence            7543222 1233456889999999885     3457889999999999999999999996543222111110       0


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..      .....   .......+.+++.+||..+|.+|||+.++++
T Consensus       231 ~~------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NP------APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CC------CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00      00110   1112345788999999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-40  Score=302.94  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=207.0

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEc-------CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFR-------ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCH  108 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  108 (376)
                      ...++|.+.+.||+|+||.||+|.+.       ..+..|++|.+... .......+.+|+.+++.+ +|+||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            45788999999999999999999753       23457999988754 334457789999999999 7999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCe
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI  173 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  173 (376)
                      .....++||||+.+++|.+++....               ..+++..++.++.||+.||.|||   ++|++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence            9999999999999999999886532               24678889999999999999999   79999999999999


Q ss_pred             eecCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhh
Q 038118          174 MLDLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEV  251 (376)
Q Consensus       174 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~  251 (376)
                      +++.++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999997654322211 222335678999999988889999999999999999998 8889876654433


Q ss_pred             HHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ...+.        ....         ..........+..++.+||+.+|++||++.+|++.|....
T Consensus       249 ~~~~~--------~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         249 FKLLK--------EGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHHH--------cCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            22221        1110         0111123355788899999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.5e-40  Score=303.55  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=204.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcC-------CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRE-------TSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHE  109 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  109 (376)
                      ..++|.+.+.||+|+||.||+|.+.+       ....+++|.+... .......+..|+.+++.+ +|+||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            34788999999999999999998642       3457999998754 344466788999999999 59999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                      .+..++||||+++++|.+++....               ..+++..+..++.||+.||.|||   ++|++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence            999999999999999999885432               35788899999999999999999   799999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhH
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQ  252 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~  252 (376)
                      ++.++.+||+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997553222111 111223467999999988889999999999999999999 89999766544433


Q ss_pred             HHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ..+..        +..     .    .........+.+++.+||..+|++|||+.++++.|...
T Consensus       247 ~~~~~--------~~~-----~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         247 KLLRE--------GHR-----M----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHHHc--------CCC-----C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            32221        110     0    11112234577899999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-40  Score=299.26  Aligned_cols=241  Identities=28%  Similarity=0.459  Sum_probs=193.1

Q ss_pred             CccccCCCeeEEEEEEcCCCe-------EEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           47 QKLGQGGFGGVYKGFFRETSS-------YIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +.||.|+||.||+|.+...+.       .|++|.+........+.+.+|+.+++.++|||++++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999999865443       4888888766555667889999999999999999999999998999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce--------EEEeeCCCccc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN--------AKIGDFGLARL  191 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--------~kl~Dfg~~~~  191 (376)
                      +++++|..++......+++..++.++.||+.+|.|||   +++++||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999998766667899999999999999999999   799999999999999987764        69999998864


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCC-CCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGR-KPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ...     .....++..|+|||++.+. .++.++|||||||++|+|++|. .||............        ...   
T Consensus       158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--------~~~---  221 (258)
T cd05078         158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--------EDR---  221 (258)
T ss_pred             cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--------Hcc---
Confidence            321     1234578899999998764 5789999999999999999984 666544332211110        000   


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                          ..+..    .....+.+++.+||+.||++|||+++|++.|+
T Consensus       222 ----~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ----HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                11111    12245788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=313.86  Aligned_cols=260  Identities=26%  Similarity=0.395  Sum_probs=223.7

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      +.++--..+.+..++||.|-||.||.|.|++....||||.++..... ++.|++|+.+++.++|||+|+++++|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            55666667778889999999999999999999999999999766554 68999999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          114 LLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      |||+|||..|+|.++|...+ ..++...++.++.||..|+.||.   .+++|||||...|+|+.++..+|++|||+++++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            99999999999999997644 35778888899999999999999   899999999999999999999999999999987


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .............+..|.|||-+....++.|+|||+|||+|||+.| |..||.+.+.......+.               
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE---------------  480 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE---------------  480 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh---------------
Confidence            6555555555556789999999999999999999999999999987 899998877554443332               


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                        ..++.+-+..+...+.+|++.||+.+|.+||++.|+.+.++
T Consensus       481 --kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  481 --KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             --ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence              22333334445566888999999999999999999998775

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.2e-40  Score=302.75  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=206.0

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||.|+||.||+|.+..+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            35889999999999999999999998899999999986655555778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++.+  ..+++..+..++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            9999999998843  45788999999999999999999   79999999999999999999999999999875432221 


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......++..|+|||.+.+..++.++|||||||++|+|++|..||...........+.       ..+      .+..  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-------~~~------~~~~--  235 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNG------TPEL--  235 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-------cCC------CCCC--
Confidence            1223457889999999988889999999999999999999999997544221110000       000      0000  


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .........+.+++.+||+.+|++||++.+|++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111223345778899999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.3e-40  Score=301.31  Aligned_cols=260  Identities=27%  Similarity=0.434  Sum_probs=204.9

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK  111 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  111 (376)
                      ...++|++.+.||+|+||.||+|.++.     .+..||+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            456899999999999999999997652     35579999886543 333456788999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEE
Q 038118          112 ELLLVYEYMPNGSLDSHLFKEN---------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK  182 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k  182 (376)
                      ..++||||+++++|.+++....         ..+....+..++.||+.||.|||   +++++||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999985421         23466778899999999999999   79999999999999999999999


Q ss_pred             EeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHH
Q 038118          183 IGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       183 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      |+|||++.......... .....++..|+|||.+.++.++.++|||||||++|+|++ |..||......+....+..   
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---  236 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---  236 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence            99999987543221111 112234678999999988889999999999999999998 7889976554443222211   


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                           +...     ....    .....+.+++.+||+.||++|||+.++++.|....
T Consensus       237 -----~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         237 -----GGYL-----DQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             -----CCCC-----CCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                 1100     1111    12346888999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-40  Score=309.28  Aligned_cols=266  Identities=20%  Similarity=0.280  Sum_probs=200.6

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--  110 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--  110 (376)
                      ......++|++.+.||.|+||.||+|.+..++..||+|++....  ......+.+|+.+++.++|+||+++++++...  
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878           9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            33445789999999999999999999999999999999987542  22345677899999999999999999887543  


Q ss_pred             ----CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          111 ----KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       111 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                          ...|++++++ +++|..++.  ...+++..++.++.||+.||.|||   ++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence                4578999987 778877663  346899999999999999999999   799999999999999999999999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH----
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD----  261 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----  261 (376)
                      |++.....    ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+......    
T Consensus       163 g~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         163 GLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             ccceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99875432    2233458999999999876 46889999999999999999999999765543332222211100    


Q ss_pred             ---HhcCC---ccccccCCcCCCC----CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 ---LYGNG---KLLEAVDPRLCRD----FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 ---~~~~~---~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .....   .....+ +.....    ........+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         239 VLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               00000   000000 000000    00011234678999999999999999999995

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.7e-41  Score=324.63  Aligned_cols=268  Identities=21%  Similarity=0.280  Sum_probs=197.6

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC------CCccceeeEEe
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH------RNLVQLLGWCH  108 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~  108 (376)
                      ++....++|++.++||+|+||.||+|.+..+++.||||++..... ....+..|+.+++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            344456899999999999999999999999999999999965322 23445667777776654      45888888887


Q ss_pred             eC-CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc--------
Q 038118          109 EK-KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF--------  179 (376)
Q Consensus       109 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~--------  179 (376)
                      .. ..+|+|||++ +++|.+++.+ .+.+++..+..++.||+.||.|||.  +.||+||||||+|||++.++        
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccc
Confidence            54 5789999988 6788887754 3578999999999999999999993  25999999999999998765        


Q ss_pred             --------eEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhh
Q 038118          180 --------NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV  251 (376)
Q Consensus       180 --------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~  251 (376)
                              .+||+|||.+....    .......||..|+|||++.+..++.++|||||||++|+|++|+.||......+.
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             cccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                    49999999875322    123345689999999999999999999999999999999999999987665444


Q ss_pred             HHHHHHHHHH----------------Hhc-CCccccccCCcCC----C--CC-cHHHHHHHHHHHHHccCCCCCCCCChH
Q 038118          252 QVYLVQWVWD----------------LYG-NGKLLEAVDPRLC----R--DF-DEQQMECLMIVGLWCAHPDENLRPSIR  307 (376)
Q Consensus       252 ~~~~~~~~~~----------------~~~-~~~~~~~~~~~~~----~--~~-~~~~~~~l~~li~~cl~~~p~~RPs~~  307 (376)
                      ...+......                .+. .+.+....++...    .  .. .......+.+|+.+||+.||++|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            3333221100                000 0000000000000    0  00 000124577899999999999999999


Q ss_pred             HHHH
Q 038118          308 QVIH  311 (376)
Q Consensus       308 ~vl~  311 (376)
                      |+++
T Consensus       434 e~L~  437 (467)
T PTZ00284        434 QMTT  437 (467)
T ss_pred             HHhc
Confidence            9996

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.3e-40  Score=304.10  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=204.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-------CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-------TSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      .++|.+.+.||+|+||.||+|.+.+       ++..+|+|.+... .......+..|+.+++.+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4789999999999999999998743       2356999999754 234456788899999999 799999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee
Q 038118          111 KELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML  175 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill  175 (376)
                      +..|+||||+++++|.+++....               ..+++..++.++.|++.+|.|||   +.|++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999986532               24788899999999999999999   7999999999999999


Q ss_pred             cCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHH
Q 038118          176 DLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQV  253 (376)
Q Consensus       176 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~  253 (376)
                      +.++.++|+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            999999999999987543221111 111224568999999988889999999999999999998 889997655433322


Q ss_pred             HHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          254 YLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      .+..        ..         ...........+.+++.+||..+|++||++.+|++.|...
T Consensus       254 ~~~~--------~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         254 LLKE--------GH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHc--------CC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            2211        11         0111122334677889999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-40  Score=305.97  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=207.3

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCC-------CeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceee
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRET-------SSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLG  105 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~-------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  105 (376)
                      +++....+|++.+.||+|+||.||+|.+...       +..|++|.+... .......+.+|+.+++++ +|+||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            3444557899999999999999999986432       236899988754 334467889999999999 7999999999


Q ss_pred             EEeeCCeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccC
Q 038118          106 WCHEKKELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS  170 (376)
Q Consensus       106 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp  170 (376)
                      ++...+..+++|||+++++|.+++....               ..+++..++.++.||+.||.|||   ++|++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecccccc
Confidence            9999999999999999999999886432               24778888999999999999999   79999999999


Q ss_pred             CCeeecCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccc
Q 038118          171 SNIMLDLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAK  248 (376)
Q Consensus       171 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~  248 (376)
                      +||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999987553322111 112223567999999998889999999999999999998 8899976654


Q ss_pred             hhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          249 EEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .+....+..        +..     .    .........+.+++.+||+.+|++||++.++++.|....
T Consensus       243 ~~~~~~~~~--------~~~-----~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 EELFKLLKE--------GHR-----M----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHHHHc--------CCC-----C----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            443222211        110     0    111122345788899999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.8e-40  Score=295.60  Aligned_cols=241  Identities=26%  Similarity=0.439  Sum_probs=192.5

Q ss_pred             CccccCCCeeEEEEEEcCC------------CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           47 QKLGQGGFGGVYKGFFRET------------SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      +.||+|+||.||+|+....            ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999986432            3368999887766666678899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce-------EEEeeCC
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN-------AKIGDFG  187 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-------~kl~Dfg  187 (376)
                      +||||+++++|..++......+++..++.++.||+.||.|||   +++++||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999998888666667899999999999999999999   799999999999999987664       8999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhc-cCCCCCCCceeechhhHHHHH-hCCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ++.....     .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+....        .. 
T Consensus       158 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--------~~-  223 (262)
T cd05077         158 IPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--------YE-  223 (262)
T ss_pred             CCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--------Hh-
Confidence            9864321     12234778899999886 456899999999999999997 58888875442222110        00 


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ..      ......    ....+.+++.+||+.||++||++.+|++.|+
T Consensus       224 ~~------~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQ------CMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cC------ccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00      001111    1245788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-40  Score=300.67  Aligned_cols=269  Identities=28%  Similarity=0.409  Sum_probs=200.5

Q ss_pred             hCC-CcCCccccCCCeeEEEEEE----cCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--Ce
Q 038118           41 NDF-NDDQKLGQGGFGGVYKGFF----RETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KE  112 (376)
Q Consensus        41 ~~y-~~~~~lg~G~~g~vy~a~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~  112 (376)
                      ++| ++.+.||+|+||+||++..    ..++..|++|.+.... ......+.+|+++++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8999999999999988653    3467789999987643 33456788999999999999999999987653  46


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .++||||+++++|.+++..  ..+++..++.++.|++.+|.|||   +++++||||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            8999999999999998854  35899999999999999999999   799999999999999999999999999998765


Q ss_pred             ccCCCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          193 EHAKGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       193 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .......  .....++..|+|||.+.+..++.++||||||+++|+|++|..||........  .+...............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhcccccccchhhhhh
Confidence            3322111  1112345679999999888899999999999999999999999865432110  00000000000000001


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      .++..............+.+++..||+.+|++|||+.+|++.|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111111111222345688899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.4e-40  Score=313.22  Aligned_cols=262  Identities=25%  Similarity=0.360  Sum_probs=205.0

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCC-CCCccceeeEEe
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGS-KQGIKEYASEVTIISRLR-HRNLVQLLGWCH  108 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~  108 (376)
                      +....++|.+.++||+|+||.||+|++.+     ++..||+|++.... ....+.+.+|+.+|..+. |+||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34445678899999999999999999643     45689999997653 333457889999999997 999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcC-------------------------------------------------------
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKEN-------------------------------------------------------  133 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------------------------  133 (376)
                      ..+..++||||+++|+|.+++....                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999885421                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCC
Q 038118          134 ------------------------------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS  171 (376)
Q Consensus       134 ------------------------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~  171 (376)
                                                                ..+++..++.++.||+.||.|||   +.+++||||||.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence                                                      13566778889999999999999   799999999999


Q ss_pred             CeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccch
Q 038118          172 NIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKE  249 (376)
Q Consensus       172 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~  249 (376)
                      |||+++++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999875432211 11222346788999999988889999999999999999998 89999765433


Q ss_pred             hhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      +.......       .+.     .+..    .......+.+++.+||..+|..||++.+|++.|+..
T Consensus       349 ~~~~~~~~-------~~~-----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 EQFYNAIK-------RGY-----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHHHH-------cCC-----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            32111110       110     0111    111234678889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-39  Score=295.72  Aligned_cols=248  Identities=24%  Similarity=0.381  Sum_probs=206.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ..|+..+.||.|+||.||+|.+..++..|++|.+.... ......+.+|+.+++.+.|+||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            46788899999999999999999989999999987543 44567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++..  ..+++..+..++.|++.+|.+||   +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06640          84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence            999999988843  46888999999999999999999   7999999999999999999999999999986553222 12


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+                 .......
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------~~~~~~~  220 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----------------PKNNPPT  220 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----------------hcCCCCC
Confidence            22345788999999998888999999999999999999999999765433221111                 0111122


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            33345567889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.6e-40  Score=302.20  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=204.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      .+|++.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++|+|++++++++......|+|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46999999999999999999999999999999997665445677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++++|..++..  ..+++..++.++.+++.+|.+||   +.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  172 (296)
T cd06655          99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR  172 (296)
T ss_pred             CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence            99999988743  35899999999999999999999   79999999999999999999999999999875432211 12


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ....++..|+|||.+.+..++.++|||||||++|+|++|..||...........+..       .. .     +.+  ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~-------~~-~-----~~~--~~  237 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------NG-T-----PEL--QN  237 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------cC-C-----ccc--CC
Confidence            234578899999999888899999999999999999999999976553222111110       00 0     000  00


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+.+++.+||..||.+||++.+|+.
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1122345778899999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.3e-40  Score=330.70  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=201.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.++||+|+||.||+|.+..+++.||+|++...   .....+++.+|+++++.++||||+++++++.+.+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            6899999999999999999999999999999998753   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          118 EYMPNGSLDSHLFKE----------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       118 e~~~~~sL~~~l~~~----------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      ||++|++|.+++...          ...++...++.++.||+.||.|||   ++||+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999887531          123456778899999999999999   7999999999999999999999999999


Q ss_pred             CccccccCCC-----------------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchh
Q 038118          188 LARLVEHAKG-----------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEE  250 (376)
Q Consensus       188 ~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~  250 (376)
                      ++........                 .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521110                 00112458999999999999999999999999999999999999997643221


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHhcc
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-SIRQVIHVLNS  315 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~L~~  315 (376)
                      ....  .         ..   .++.... ........+.+++.+||+.||++|| +++++++.|+.
T Consensus       239 i~~~--~---------~i---~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 ISYR--D---------VI---LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hhhh--h---------hc---cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1100  0         00   0000000 0012234577888999999999997 45556665543

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.5e-39  Score=293.39  Aligned_cols=250  Identities=27%  Similarity=0.447  Sum_probs=197.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKEL  113 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~  113 (376)
                      .+|++.+.||+|+||.||+|.+..++..|++|.+...     .......+.+|+.+++.++|+||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4789999999999999999999999999999988643     22345678899999999999999999998865  4678


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++++||+++++|.+.+.. ...+++...+.++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            999999999999988854 345889999999999999999999   7999999999999999999999999999987543


Q ss_pred             cCC--CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          194 HAK--GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       194 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ...  ........++..|+|||++.+..++.++|||||||++|+|++|..||...........+.       ..     .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-------~~-----~  225 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-------TQ-----P  225 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-------cC-----C
Confidence            211  111223457889999999988889999999999999999999999997553222111110       00     0


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+.+    .......+..++ .||..+|++||++++|++
T Consensus       226 ~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11121    222233455555 588899999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-39  Score=297.11  Aligned_cols=262  Identities=26%  Similarity=0.397  Sum_probs=202.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEE----cCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFF----RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KEL  113 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  113 (376)
                      ..|++.+.||+|+||.||++.+    ..++..|++|.+... .......+.+|+++++.++|+|++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578999999999999999985    356788999998754 344456789999999999999999999998775  578


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++......+++..++.++.||+.+|.|||   ++|++||||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999988665557899999999999999999999   7999999999999999999999999999987654


Q ss_pred             cCCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhh--------HHHHHHHHHHHh
Q 038118          194 HAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV--------QVYLVQWVWDLY  263 (376)
Q Consensus       194 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~--------~~~~~~~~~~~~  263 (376)
                      .....  ......++..|+|||++.+..++.++|||||||++|+|+++..|+........        ........ ...
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHH
Confidence            32211  11223466789999999888899999999999999999998766432111000        00000000 011


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..+..         ..........+.+++.+||+.||++||++.++++.|+.
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            11110         00111234568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-40  Score=302.28  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+.....   ...+.+..|+++++.++|+||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            478999999999999999999999999999999976432   24567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          118 EYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      ||+.+++|.+++... ...+++..++.++.||+.+|.|||   +.|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999988643 356899999999999999999999   7999999999999999999999999999986543211


Q ss_pred             Cc----------------------------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccc
Q 038118          197 GS----------------------------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAK  248 (376)
Q Consensus       197 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~  248 (376)
                      ..                            ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            01123578899999999888899999999999999999999999976654


Q ss_pred             hhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC----hHHHHH
Q 038118          249 EEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS----IRQVIH  311 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~~vl~  311 (376)
                      ......+..        ..      ...  .........+.+++.+||..||++|||    +.+++.
T Consensus       238 ~~~~~~~~~--------~~------~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DETFSNILK--------KE------VTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHHHHhc--------CC------ccC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            333222110        00      000  001113456888999999999999999    777775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-39  Score=292.70  Aligned_cols=248  Identities=31%  Similarity=0.449  Sum_probs=199.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEe-eCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH-EKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e  118 (376)
                      -++|++.+.||+|+||.||++...  +..|++|.+.....  .+.+.+|+.+++.++|+|++++++++. .....++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            368999999999999999999876  66789998865432  467889999999999999999999764 5567899999


Q ss_pred             cCCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++++|.+++..... .+++..++.++.||+.+|.+||   ++|++||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            9999999998865443 4889999999999999999999   7999999999999999999999999999986532211 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                         ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +.     .+..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~--------~~-----~~~~  220 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------GY-----KMDA  220 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--------CC-----CCCC
Confidence               12234568999999988889999999999999999997 9999976543332222111        10     0111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                          .......+.+++.+||+.+|++|||+.++++.|..
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 ----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                11223457888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-40  Score=298.37  Aligned_cols=240  Identities=26%  Similarity=0.390  Sum_probs=191.0

Q ss_pred             ccccCCCeeEEEEEEcC------------------------CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccce
Q 038118           48 KLGQGGFGGVYKGFFRE------------------------TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQL  103 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~  103 (376)
                      .||+|+||.||+|....                        ....|++|.+..........|.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998532                        124689999876655556778899999999999999999


Q ss_pred             eeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc----
Q 038118          104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF----  179 (376)
Q Consensus       104 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----  179 (376)
                      ++++.+....++||||+++++|..++....+.+++..+..++.||+.||.|||   +++|+||||||.||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999998888666677899999999999999999999   79999999999999997643    


Q ss_pred             ---eEEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHH-hCCCCCCCccchhhHHH
Q 038118          180 ---NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVY  254 (376)
Q Consensus       180 ---~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~ll-tg~~pf~~~~~~~~~~~  254 (376)
                         .++++|||++.....     .....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||......+....
T Consensus       159 ~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             ccceeeecCCcccccccc-----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence               389999998753321     112346788999998865 56899999999999999995 79999976544332111


Q ss_pred             HHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          255 LVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ..        ..       ..+....    ...+.+++.+||+.+|++|||+.+|++.|.
T Consensus       234 ~~--------~~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         234 YE--------KK-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH--------hc-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            10        00       0111111    134788899999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=295.06  Aligned_cols=247  Identities=30%  Similarity=0.440  Sum_probs=195.5

Q ss_pred             CccccCCCeeEEEEEEcCCCe--EEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSS--YIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+..++.  .+++|.+... .......+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999987765  4688888743 344556788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          123 GSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       123 ~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      ++|.+++....               ..+++..++.++.|++.||.|||   +.|++||||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999885432               24788999999999999999999   7999999999999999999999999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      ++......  ........+..|+|||++....++.++|||||||++|+|++ |..||......+....+.        .+
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--------~~  227 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--------QG  227 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh--------CC
Confidence            98532211  11111223567999999988889999999999999999997 999997654333222111        01


Q ss_pred             ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .         ...........+.+++.+||..+|.+|||+.+++..|..
T Consensus       228 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         228 Y---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             C---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            0         001111123457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.6e-40  Score=300.32  Aligned_cols=265  Identities=22%  Similarity=0.281  Sum_probs=199.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||.|++|.||+|++..++..|++|.+....  ......+.+|+.+++.++|+||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5889999999999999999999999999999986542  22345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKE--NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      +. ++|.+++...  ...+++..++.++.||+.||.|||   +++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 5787777442  256899999999999999999999   7999999999999999999999999999987543221 


Q ss_pred             cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH----HhcCC----cc
Q 038118          198 SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD----LYGNG----KL  268 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----~~~~~----~~  268 (376)
                      .......++..|+|||++.+. .++.++|||||||++|+|++|..||..................    .+...    ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            112233468899999988654 4788999999999999999999999865433222211111000    00000    00


Q ss_pred             ccccC---CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVD---PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....   ..............+.+++.+||+.||++|||+.+|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000   00000001112345678999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.8e-40  Score=297.47  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=203.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ++|++.+.||.|+||.||+|++..     ....|++|.+...... ....+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            678999999999999999999754     3467999988765433 4577899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          115 LVYEYMPNGSLDSHLFKEN--------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                      +||||+++++|.+++....        ..+++..++.++.||+.+|.|||   +.+++||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999886433        15899999999999999999999   799999999999999999999999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      |++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||...........+.        .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~--------~  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------A  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--------c
Confidence            9986432222222222345678999999988888999999999999999998 888996544332211111        1


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      +....        .........+.+++.+||+.+|.+||++.+++..|.
T Consensus       234 ~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11110        011122346888999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.4e-40  Score=298.30  Aligned_cols=266  Identities=22%  Similarity=0.301  Sum_probs=203.6

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++....  ....+.+.+|+.+++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47999999999999999999999999999999886542  2233567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |++++.|..++ .....+++..++.++.||+.+|.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99998887665 34456899999999999999999999   79999999999999999999999999999976543221 


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH-------HhcCCccc-
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD-------LYGNGKLL-  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~-  269 (376)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......       ........ 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            1223347789999999876 45789999999999999999999999876544333222221110       00000000 


Q ss_pred             --cccCCcCCCC---CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 --EAVDPRLCRD---FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 --~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ...++.....   ........+.+++.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              0000000000   00122356788999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.4e-40  Score=297.63  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=204.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcC----CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEee-CCe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRE----TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE-KKE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~  112 (376)
                      ..++|++.+.||+|+||.||+|.+..    ++..|++|.+... .......+.+|+.+++.++|+|++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            46889999999999999999999876    3578999988754 34446778899999999999999999998766 567


Q ss_pred             EEEEEecCCCCChhhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEee
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                      .+++++|+++++|.+++....       ..+++..++.++.||+.||.|||   +.+++|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999885432       45889999999999999999999   79999999999999999999999999


Q ss_pred             CCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHh
Q 038118          186 FGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       186 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ||+++.+...... ......++..|+|||++.+..++.++|||||||++|++++ |..||......+....+.       
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-------  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------
Confidence            9998754322111 1112335678999999988889999999999999999998 999997654433222111       


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .+.     ......    .....+.+++.+||..||++|||+.++++.|..
T Consensus       234 -~~~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         234 -DGY-----RLAQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             -cCC-----CCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence             110     000111    123457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=295.47  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=206.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|++.+.||+|+||.||+|.+..++.    .|++|.+.... ......+.+|+.+++.++|+|++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            4678999999999999999999876554    58999887553 4445678899999999999999999999887 7889


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.||+.||.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999776667999999999999999999999   79999999999999999999999999999976542


Q ss_pred             CCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..... .....++..|++||.+....++.++|+||||+++|+|++ |..||......+....+..        +..    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------~~~----  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------GER----  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC--------CCC----
Confidence            22111 111223568999999988889999999999999999998 9999987654443222211        110    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                       ......    ....+..++.+||..+|..||++.++++.|...
T Consensus       230 -~~~~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 -LPQPPI----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -CCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             000111    113467788899999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-39  Score=293.19  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=198.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKEL  113 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~  113 (376)
                      .+|++.+.||+|+||.||.|.+..++..|++|.+...     .....+.+.+|+.+++.+.|+||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5789999999999999999999999999999988532     22345678899999999999999999998866  3578


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++... ..+++...+.++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            8999999999999888543 56788889999999999999999   7999999999999999999999999999987543


Q ss_pred             cCCC--cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          194 HAKG--SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       194 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ....  .......++..|+|||++.+..++.++|||||||++|+|++|..||...........+.       ..      
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~------  224 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-------TQ------  224 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-------cC------
Confidence            2111  11223457889999999988889999999999999999999999997543222111100       00      


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .............+.+++.+|+. +|++||++++|++
T Consensus       225 ---~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 ---PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               01112233344556777788884 8999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-41  Score=284.99  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=209.2

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--------hhhHHHHHHHHHHHHhCC-CCCccceee
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--------KQGIKEYASEVTIISRLR-HRNLVQLLG  105 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~-h~~i~~~~~  105 (376)
                      +-...-..|.-.+.||.|+.+.|.++.++.++..+++|++....        ....+.-.+|+.+|+++. ||+|+++.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            33445678889999999999999999999999999999986431        122344567999999996 999999999


Q ss_pred             EEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEee
Q 038118          106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       106 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                      +++.+..+++|+|.|+.|.|++++. ..-.++++...++++|+.+++.|||   .++||||||||+|||++++.+++|+|
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence            9999999999999999999999994 4456899999999999999999999   79999999999999999999999999


Q ss_pred             CCCccccccCCCcceeeeccCCCCCchhhhcc------CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH
Q 038118          186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATT------GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV  259 (376)
Q Consensus       186 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  259 (376)
                      ||+++.+.  .+.......||++|+|||.+..      ..|+...|+|++|+|+|.||.|.+||--....-....+....
T Consensus       167 FGFa~~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk  244 (411)
T KOG0599|consen  167 FGFACQLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK  244 (411)
T ss_pred             cceeeccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence            99998654  3445566789999999998843      357888999999999999999999997544333333333211


Q ss_pred             HHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          260 WDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+         -.|.+     .+......++|.+||+.||.+|.|++|.|+
T Consensus       245 yqF---------~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  245 YQF---------RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccc---------CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            111         11221     133445788999999999999999999884

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-39  Score=293.45  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=203.0

Q ss_pred             CCCcCCccccCCCeeEEEEEEcC-CCeEEEEEEcccC----------ChhhHHHHHHHHHHHHh-CCCCCccceeeEEee
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRE-TSSYIAVKRVSKG----------SKQGIKEYASEVTIISR-LRHRNLVQLLGWCHE  109 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~-~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~  109 (376)
                      +|++.+.||+|+||.||+|.+.. ++..+++|.+...          .......+..|+.++.. ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999987 6788999987532          22334567788888865 789999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          110 KKELLLVYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.+|.+||+  ..+++|+||+|.||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999887733   34568999999999999999999993  378999999999999999999999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      |++.......  ......++..|++||.+.+..++.++||||||+++|+|++|..||...........+..        .
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------~  228 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE--------A  228 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--------c
Confidence            9987644322  23345588899999999988899999999999999999999999976543332222111        1


Q ss_pred             ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ...    +..    .......+.+++.+||+.||++||++.+|..++.
T Consensus       229 ~~~----~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYE----PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCC----cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            100    100    1112345788999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=316.41  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=211.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +-|+++..||.|+||.||+|..+.++...|.|++.......++.|+-|+.+|....||+|+++++.|..++.+||+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34567779999999999999999999999999999888888999999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      .||-++..+..-+..+.+.++..+++|++.||.|||   +++|+|||||.+|||++-+|.++|+|||.+.... ......
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkR  187 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKR  187 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch-hHHhhh
Confidence            999998888888889999999999999999999999   8999999999999999999999999999985321 122335


Q ss_pred             eeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          201 TVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ..+.||++|||||++.     ..+|+.++||||||++|.+|..+.+|-...+...+...+..      .+       .|.
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK------Se-------PPT  254 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------SE-------PPT  254 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh------cC-------CCc
Confidence            6788999999999874     46799999999999999999999999876554444333221      11       122


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +..  +..-...+.+++.+||.+||+.||++.++++
T Consensus       255 Llq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 LLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            211  1112234677888899999999999999885

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-39  Score=292.87  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=204.1

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC------hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS------KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      +|+..+.||+|++|.||+|.+..++..|++|.+....      ....+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5888899999999999999999999999999987532      2245678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCcccccc
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVEH  194 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~  194 (376)
                      ||||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++|++|+||+|.||+++.++ .++|+|||++.....
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            9999999999988854 457889999999999999999999   79999999999999998776 599999999876533


Q ss_pred             CCCc---ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          195 AKGS---QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       195 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ....   ......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+.....           
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  225 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-----------  225 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-----------
Confidence            2111   11234578899999999888899999999999999999999999975443222222111000           


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ..............+.+++.+||+.+|.+||++.+++.
T Consensus       226 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 --ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              01112233344456888999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-39  Score=291.25  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=203.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||+|++|.||+|.+..++..+++|.+...  .......+.+|+++++.++|+|++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588999999999999999999999999999998754  234467789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~  197 (376)
                      +++++|.+++.... ..+++..++.++.+++.+|.|||   ++|++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999986543 45899999999999999999999   7999999999999999865 458999999997654322 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..        ...     ..+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~--------~~~-----~~~~  222 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--------GTF-----APIS  222 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------cCC-----CCCC
Confidence             22234578899999999888889999999999999999999999976554332211110        000     1111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .    .....+..++.+||+.+|++|||+.++++
T Consensus       223 ~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 D----RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1    22345788899999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.5e-40  Score=297.55  Aligned_cols=260  Identities=26%  Similarity=0.393  Sum_probs=205.9

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHE  109 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  109 (376)
                      .+..++....+.|++.+.||.|+||.||+|.+..+++.|++|++..... ....+..|+.+++.+ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            4667777778999999999999999999999999999999999866543 345688899999998 69999999999853


Q ss_pred             ------CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEE
Q 038118          110 ------KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK  182 (376)
Q Consensus       110 ------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k  182 (376)
                            ....|++|||+++++|.+++... ...+++..++.++.||+.+|.|||   +.+++|+||+|+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  46789999999999999888553 345888889999999999999999   79999999999999999999999


Q ss_pred             EeeCCCccccccCCCcceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHH
Q 038118          183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       183 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~  257 (376)
                      |+|||++........ ......|+..|+|||++.     +..++.++|||||||++|+|++|..||...........+. 
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-  239 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-  239 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-
Confidence            999999875432211 223345888999999875     3457889999999999999999999996543222111110 


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                                  ....+.+   ........+.+++.+||+.||.+||++.+|++
T Consensus       240 ------------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         240 ------------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                        0000111   11123346888999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-39  Score=291.75  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=204.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||.|+||.+|.+.+..+++.|++|.+...  .......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588999999999999999999999999999998643  233456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +.+++|.+.+.... ..+++..++.++.|++.+|.|||   +++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999886533 35789999999999999999999   79999999999999999999999999999875432211 


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......|+..|+|||++.+...+.++|+|||||++|+|++|..||......+....+..        +..     +..  
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------~~~-----~~~--  221 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------GSY-----PPV--  221 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--------CCC-----CCC--
Confidence            12234578899999999888899999999999999999999999976543332211110        100     111  


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        .......+.+++.+||+.+|.+||++.+|++
T Consensus       222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 --SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              1223345788999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-39  Score=291.84  Aligned_cols=248  Identities=30%  Similarity=0.479  Sum_probs=202.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-----hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-----KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      +|+..+.||+|++|.||+|.+..++..|++|.+....     .+..+.+.+|+.+++.++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5788899999999999999999889999999986543     34567789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      +||+++++|.+++.+ ...+++..++.++.||+.+|.+||   +.|++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999988854 346889999999999999999999   7999999999999999999999999999987643322


Q ss_pred             CcceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                        ......++..|++||.+.... ++.++|+|||||++|+|++|..||...........+.       .....     +.
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~-----~~  222 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG-------RSKEL-----PP  222 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH-------hcccC-----CC
Confidence              223445788999999987766 8999999999999999999999997654222111110       00000     11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +    .......+.+++.+||+.+|++||++.+++.
T Consensus       223 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1    1122355778899999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-39  Score=293.63  Aligned_cols=250  Identities=30%  Similarity=0.496  Sum_probs=200.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC------hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS------KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      +|++.+.||.|+||.||+|.+. +++.+++|.+....      ......+.+|+++++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999874 57889999886432      2234568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+||+++++|.+++.+ ...+++..++.++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          80 FMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999998854 346789999999999999999999   789999999999999999999999999998754211


Q ss_pred             C-----CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          196 K-----GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       196 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .     ........++..|+|||++.+..++.++|||||||++|+|++|..||...........+..        .   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~---~  224 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA--------H---R  224 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh--------c---c
Confidence            1     1112234578899999999988899999999999999999999999976543222111110        0   0


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+.+..    .....+..++.+||+.+|.+||++.++++
T Consensus       225 ~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01112222    23345788899999999999999999984

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.1e-40  Score=305.69  Aligned_cols=257  Identities=27%  Similarity=0.383  Sum_probs=198.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhC-CCCCccceeeEEee-CC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGS-KQGIKEYASEVTIISRL-RHRNLVQLLGWCHE-KK  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~  111 (376)
                      .++|++.+.||.|+||.||+|.+.     .+++.||||.+.... ......+.+|+.++..+ +|+||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            468999999999999999999853     456789999997543 33456788999999999 68999999998765 45


Q ss_pred             eEEEEEecCCCCChhhhhhhcC----------------------------------------------------------
Q 038118          112 ELLLVYEYMPNGSLDSHLFKEN----------------------------------------------------------  133 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------  133 (376)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6899999999999998875421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-cceeeec
Q 038118          134 --------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLA  204 (376)
Q Consensus       134 --------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~  204 (376)
                              ..+++..+..++.||+.||.|||   +++++||||||.||+++.++.++|+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    23577788899999999999999   79999999999999999999999999999875422111 1112233


Q ss_pred             cCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          205 GTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       205 gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      ++..|+|||++.+..++.++||||||+++|+|++ |..||............       ...+...     ......   
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~~-----~~~~~~---  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------LKEGTRM-----RAPDYT---  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-------HhccCCC-----CCCCCC---
Confidence            5678999999988889999999999999999997 99999764322211110       0111110     011111   


Q ss_pred             HHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          284 QMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       ...+.+++..||+.||.+|||+.+|++.|..
T Consensus       308 -~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         308 -TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             -CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             2347788889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.4e-40  Score=298.08  Aligned_cols=248  Identities=26%  Similarity=0.426  Sum_probs=202.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +.|+..+.||.|+||.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++++...+..|+||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45667788999999999999999889999999987543 44456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++.  ...+++..++.++.||+.++.|||   +++++|+||+|+||++++++.++|+|||++....... ..
T Consensus        84 ~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06642          84 LGGGSALDLLK--PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             cCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence            99999988874  346889999999999999999999   7999999999999999999999999999987553321 12


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|+|||++.+..++.++|||||||++|+|++|..||...........+.        .     ...+.    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~--------~-----~~~~~----  220 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP--------K-----NSPPT----  220 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh--------c-----CCCCC----
Confidence            223457889999999998889999999999999999999999987543222211110        0     01111    


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........+.+++.+||+.+|++||++.+|++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            12223455788999999999999999999996

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=300.25  Aligned_cols=267  Identities=23%  Similarity=0.281  Sum_probs=205.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+...  .......+.+|+++++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            4789999999999999999999999999999998754  23345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |++++.+..+. .....+++..++.++.+|+.+|.|||   ..+++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            99886665544 44456899999999999999999999   789999999999999999999999999998765443322


Q ss_pred             ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh--------cCCccc
Q 038118          199 QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY--------GNGKLL  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~  269 (376)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|..||......+....+........        .+....
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            33345578899999999887 789999999999999999999999976543332222111110000        000000


Q ss_pred             c--ccCCcC----CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 E--AVDPRL----CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~--~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .  ..+...    ...+.......+.+++.+||..+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0  000000    00111122466889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-39  Score=291.83  Aligned_cols=252  Identities=32%  Similarity=0.484  Sum_probs=203.6

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||+|+||.||+|.+..+++.|++|.+.....  ...+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            68899999999999999999998899999999876543  3677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++.. ...+++..++.++.+++.+|.|||   +.+++|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999998854 345788999999999999999999   7999999999999999999999999999987654332221


Q ss_pred             e---eeeccCCCCCchhhhccCC---CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          200 T---TVLAGTMGYMAPECATTGR---ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       200 ~---~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .   ....++..|++||++.+..   .+.++||||||+++|+|++|..||..............      . ..     .
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~------~-~~-----~  224 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG------A-GH-----K  224 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh------c-CC-----C
Confidence            1   1345788999999988766   88999999999999999999999975432211111110      0 00     1


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+...  ......+.+++.+||+.+|++||++.+++.
T Consensus       225 ~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111  112345678899999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.5e-39  Score=291.69  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=206.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||.|+||.||+|.+..++..+++|++.... ......+.+|+..++.++|+|++++++.+......++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47999999999999999999998889999999987542 33567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKE--NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      +++++|.+++...  ...+++..++.++.|++.+|.+||   +.|++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999988653  246899999999999999999999   79999999999999999999999999999876543222


Q ss_pred             c---ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          198 S---QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       198 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .   ......|+..|++||++... .++.++|+|||||++|+|++|+.||..............       .      ..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-------~------~~  224 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------N------DP  224 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc-------C------CC
Confidence            1   12334588899999998776 789999999999999999999999976543322111111       0      01


Q ss_pred             CcCCCCC-cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDF-DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+.... .......+.+++.+||+.||++||++.+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1111111 1233456788999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-39  Score=298.13  Aligned_cols=245  Identities=29%  Similarity=0.378  Sum_probs=203.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||.|++|.||++.+..+++.|++|.+...   .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4789999999999999999999999999999998653   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++... ..+++..++.++.||+.+|.|||   +.|++|+||+|.||+++.++.++|+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999988554 67899999999999999999999   799999999999999999999999999998765332  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                        .....++..|+|||.+.+...+.++||||||+++|+|++|..||...........+..        +.      ..+.
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~------~~~~  218 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------GK------VRFP  218 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------CC------ccCC
Confidence              2234578899999999888889999999999999999999999976553222221111        10      1111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ..+    ...+.+++.+||+.||.+|+     +++++++
T Consensus       219 ~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         219 SFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            122    34577888999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-39  Score=291.41  Aligned_cols=252  Identities=27%  Similarity=0.416  Sum_probs=205.9

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVY  117 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~  117 (376)
                      +|++.+.||.|+||.||+|.+..++..|++|.+...  .....+.+..|+++++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            588999999999999999999999999999998653  34445678899999999999999999998753  45789999


Q ss_pred             ecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          118 EYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGW--EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       118 e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      ||+++++|.+++...   ...+++..++.++.||+.+|.+||..+  +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999888543   467899999999999999999999443  578999999999999999999999999998765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++|..||...........+.        .+.     
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~-----  226 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------EGK-----  226 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh--------cCC-----
Confidence            43322 1233458899999999988889999999999999999999999998765332222111        111     


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ...+.......+.+++.+||+.+|++||++.+|++
T Consensus       227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                11222234456888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.7e-40  Score=303.60  Aligned_cols=264  Identities=17%  Similarity=0.228  Sum_probs=196.6

Q ss_pred             cCCccccC--CCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           45 DDQKLGQG--GFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        45 ~~~~lg~G--~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +.++||+|  +|++||++.++.+++.||+|.+...  .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7899999999999999999999754  2334556778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-c
Q 038118          121 PNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-S  198 (376)
Q Consensus       121 ~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  198 (376)
                      ++++|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.++++||+.......... .
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999988643 345899999999999999999999   79999999999999999999999999986543211100 0


Q ss_pred             -----ceeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH-HhcC-----
Q 038118          199 -----QTTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD-LYGN-----  265 (376)
Q Consensus       199 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~-----  265 (376)
                           ......++..|+|||++.+  ..++.++|||||||++|+|++|..||.................. ....     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 0112245678999999875  45889999999999999999999999765432221111100000 0000     


Q ss_pred             -----CccccccCC-----------------cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 -----GKLLEAVDP-----------------RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 -----~~~~~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           .......+.                 .............+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                 000000000                 0001112223456788999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-39  Score=296.59  Aligned_cols=258  Identities=28%  Similarity=0.376  Sum_probs=206.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||++.+..++..|++|++.... ....+.+.+|+++++.++|+||+++++++.....+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            468899999999999999999999999999999887543 3445778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++.. .+.+++..+..++.+++.+|.|||+  ..+++||||+|+||++++++.++|+|||++......   
T Consensus        84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          84 FMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             cCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            9999999887744 4568999999999999999999994  368999999999999999999999999998643221   


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchh----hHHHHHHHHHHHhcCCccccccCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEE----VQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......    ....+..+........      .+
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  231 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PP  231 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CC
Confidence            1123458899999999988889999999999999999999999997654321    1111111111111100      01


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      .+..   ......+.+++.+||+.||++|||+.++++.
T Consensus       232 ~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         232 RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111   1233457889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.4e-40  Score=298.79  Aligned_cols=262  Identities=25%  Similarity=0.420  Sum_probs=205.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcC----CCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRE----TSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHE--KKEL  113 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~  113 (376)
                      +.|++.+.||+|+||.||+|.+..    ++..||+|.+...... ....|.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            578888999999999999998653    4788999999866443 56789999999999999999999999877  5689


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++......+++..++.++.|++.+|.|||   ++|++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999766657899999999999999999999   7999999999999999999999999999997654


Q ss_pred             cCCCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH--------HHHHHHHHHHh
Q 038118          194 HAKGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ--------VYLVQWVWDLY  263 (376)
Q Consensus       194 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~--------~~~~~~~~~~~  263 (376)
                      ......  .....++..|++||.+.+..++.++||||||+++|+|++|..||.........        ...... ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL-LELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH-HHHH
Confidence            221111  11223456799999998888999999999999999999999998654322111        000000 0111


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ....         ...........+.+++.+||+.+|++|||+.+|+++|..
T Consensus       240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            1110         011111223568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-39  Score=293.09  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=201.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC----------hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----------KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK  111 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  111 (376)
                      +|.+.+.||.|+||.||+|.+..+++.|++|.+....          ....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5788899999999999999998889999999886421          112346788999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..++||||+++++|.+++... +.+++..+..++.||+.+|.|||   +++++||||+|+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999988554 57889999999999999999999   79999999999999999999999999999875


Q ss_pred             cccCCC-cceeeeccCCCCCchhhhccCC--CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          192 VEHAKG-SQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ...... .......++..|+|||.+....  ++.++|+||||+++|+|++|..||...........+       . ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~-~~~~  229 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL-------G-NKRS  229 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh-------h-cccc
Confidence            432211 1123345788999999987654  789999999999999999999999654322211110       0 0111


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+.    ..........+.+++.+||..+|++||++.+|++
T Consensus       230 ~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 APPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11111    1222233456788889999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.4e-39  Score=290.32  Aligned_cols=252  Identities=29%  Similarity=0.401  Sum_probs=191.7

Q ss_pred             CccccCCCeeEEEEEEcC--CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.||+|+||.||+|.+..  ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998653  45679999887653 333457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc-
Q 038118          124 SLDSHLFKEN----NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS-  198 (376)
Q Consensus       124 sL~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  198 (376)
                      +|.+++....    ...++..+..++.|++.+|.|||   +.+++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999885422    24567778889999999999999   799999999999999999999999999998643222111 


Q ss_pred             ceeeeccCCCCCchhhhccC-------CCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          199 QTTVLAGTMGYMAPECATTG-------RASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ......++..|+|||++.+.       .++.++||||||+++|+|++ |..||......+.......        .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------EQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh--------cccCC
Confidence            11223467889999988642       35789999999999999996 9999976554433222111        11112


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ..++.+.....    ..+.+++..|+ .+|++|||+.+|+..|.
T Consensus       230 ~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKLPLS----DRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCCCCC----hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22233322222    23566777898 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=294.11  Aligned_cols=254  Identities=27%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCC-----
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKK-----  111 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-----  111 (376)
                      ...++|++.+.||.|++|.||+|.+..+++.+++|++...... ...+.+|+.+++.+ .|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            3468999999999999999999999988999999998765443 46789999999999 6999999999997544     


Q ss_pred             -eEEEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          112 -ELLLVYEYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       112 -~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                       .+++||||+++++|.+++...   ...+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             589999999999998887542   357899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhcc-----CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATT-----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++....... .......++..|+|||++..     ..++.++|||||||++|+|++|..||...........+.      
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------  231 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP------  231 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh------
Confidence            986543222 12233457889999998753     346788999999999999999999997543222211111      


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ..     ..+.+.  ........+.+++.+||..||++|||+.+|++
T Consensus       232 --~~-----~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 --RN-----PPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --cc-----CCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              00     011111  11223456888999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-39  Score=292.97  Aligned_cols=254  Identities=27%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||.|++|.||++.+..+++.|++|.+.... ......+.+|+++++.++|+||+++++++......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999999999999999987653 34456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE-QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++......+++..++.++.|++.+|.|||   + .+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999988665578899999999999999999999   7 9999999999999999999999999999865432211 


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|..||........  ............      ..+.+..
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~------~~~~~~~  226 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQYIVNE------PPPRLPS  226 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHHHHhcC------CCCCCCh
Confidence              115578899999999888999999999999999999999999965421100  001111101000      0111111


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .   .....+.+++..||..||++|||+.+++.
T Consensus       227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             h---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1   13455788999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.9e-40  Score=298.28  Aligned_cols=262  Identities=22%  Similarity=0.311  Sum_probs=205.1

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEe-
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCH-  108 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-  108 (376)
                      +..+.+....++|++.+.||+|+||.||+|.+..++..+++|++..... ....+..|+.+++.+ +|+||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            4456777788999999999999999999999999999999998865322 235678899999999 6999999999874 


Q ss_pred             ----eCCeEEEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceE
Q 038118          109 ----EKKELLLVYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA  181 (376)
Q Consensus       109 ----~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~  181 (376)
                          .+...++||||+++++|.+++..   ....+++..++.++.|++.+|.|||   +.+++||||+|+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                34578999999999999887642   3356888999999999999999999   7999999999999999999999


Q ss_pred             EEeeCCCccccccCCCcceeeeccCCCCCchhhhcc-----CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHH
Q 038118          182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV  256 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~  256 (376)
                      +|+|||++....... .......|+..|+|||++..     ..++.++|||||||++|+|++|..||.............
T Consensus       164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~  242 (286)
T cd06638         164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP  242 (286)
T ss_pred             EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence            999999987553221 12233458899999998753     447889999999999999999999997654322111100


Q ss_pred             HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                              ........++.       .....+..++.+||+.||++|||+.+|++.
T Consensus       243 --------~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         243 --------RNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             --------ccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                    00000111111       112357888999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-39  Score=309.76  Aligned_cols=261  Identities=21%  Similarity=0.257  Sum_probs=199.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC--CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ..+|++.+.||.|+||.||++...+  ++..|++|.+....     ...+|+.+++.++|+||+++++++......|+||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4679999999999999999997643  46789999886542     3457999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |++. ++|.+++ .....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.++|+|||++........
T Consensus       166 e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9985 5777777 44567899999999999999999999   79999999999999999999999999999876543222


Q ss_pred             -cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc---------
Q 038118          198 -SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK---------  267 (376)
Q Consensus       198 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------  267 (376)
                       .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+....... ....         
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~-~~~~~~~~~~~~~  319 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQNGST  319 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh-ccCccccCCccch
Confidence             22234568999999999998899999999999999999999999997654332222111111100 0000         


Q ss_pred             --------cccccCCcCC-CC-C-cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 --------LLEAVDPRLC-RD-F-DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 --------~~~~~~~~~~-~~-~-~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                              ......+... .. + .......+..++.+||+.||++|||+.+++.
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                    0000000000 00 0 0011235678889999999999999999985

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-39  Score=290.32  Aligned_cols=239  Identities=29%  Similarity=0.476  Sum_probs=192.9

Q ss_pred             CccccCCCeeEEEEEEcCCC----------eEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           47 QKLGQGGFGGVYKGFFRETS----------SYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      +.||+|+||.||+|.+..++          ..+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999998766          45888887655443 6788999999999999999999999988 778999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-------eEEEeeCCCc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-------NAKIGDFGLA  189 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-------~~kl~Dfg~~  189 (376)
                      |||+++++|.+++......+++..+..++.||+.||.|||   +++++||||||+||+++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999998765557899999999999999999999   79999999999999999887       7999999998


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccC--CCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTG--RASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      .....     .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.............        ..
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--------~~  222 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--------DQ  222 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--------cC
Confidence            75432     2223467789999998776  78999999999999999999 578886554222111100        00


Q ss_pred             ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ..       .....    ...+.+++.+||..+|.+|||+.+|++.|+
T Consensus       223 ~~-------~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 HR-------LPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC-------CCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00       00000    156788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.5e-40  Score=299.59  Aligned_cols=264  Identities=23%  Similarity=0.285  Sum_probs=199.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||.|+||.||+|.+..+|..|++|.+....  ......+.+|+.+++.++|+|++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5889999999999999999999999999999987542  22234677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++ +|.+++....+.+++..++.++.||+.||.|||   +.+++||||+|+||+++.++.++|+|||++........ .
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            974 777777665677999999999999999999999   79999999999999999999999999999875432211 1


Q ss_pred             eeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCC-ccchhhHHHHHHHH-------HHHhcCCcccc
Q 038118          200 TTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISL-TAKEEVQVYLVQWV-------WDLYGNGKLLE  270 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~-~~~~~~~~~~~~~~-------~~~~~~~~~~~  270 (376)
                      .....++..|+|||++.+. .++.++|||||||++|+|++|..||.. .+.......+....       +..........
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            2233468899999988764 468999999999999999999888643 33222222221110       00000000000


Q ss_pred             ccCCcCC-----CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLC-----RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      . -+...     ....+.....+.+++.+||+.||.+|||+++++.
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 P-YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             c-cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0 00000     0111223456788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.8e-39  Score=298.54  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=202.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|+..+.||+|+||.||+|.+..++.    .|++|.+.... ......+.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            4678899999999999999999877665    57888887543 33345688999999999999999999998654 467


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +++||+++|+|.+++......+++..++.++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999998766667899999999999999999999   79999999999999999999999999999976532


Q ss_pred             CCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.        .+...   
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~--------~~~~~---  230 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--------KGERL---  230 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------CCCCC---
Confidence            2211 1122334678999999988889999999999999999997 999997654333221111        11100   


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                        ....    .....+..++..||..+|++||++.++++.|...
T Consensus       231 --~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         231 --PQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             --CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0011    1223577888999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-39  Score=298.88  Aligned_cols=256  Identities=21%  Similarity=0.262  Sum_probs=204.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||++.+..+++.|++|.+....   ......+.+|+.+++.++|+||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47899999999999999999999999999999987653   233457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||++|++|.+++.. .+.+++..+..++.|++.||.|||   +.+++||||+|.||+++.++.++|+|||++........
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999998854 456899999999999999999999   79999999999999999999999999998863211000


Q ss_pred             --------------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          198 --------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       198 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                                    .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+.......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~------  230 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS------  230 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------
Confidence                          001123467899999999888899999999999999999999999976554333222111      


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        ...   ..+....    .....+..++.+||+.+|++||+...+.+.|+.
T Consensus       231 --~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 --DDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --ccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              000   0011111    223457889999999999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-39  Score=290.46  Aligned_cols=249  Identities=29%  Similarity=0.450  Sum_probs=193.4

Q ss_pred             CccccCCCeeEEEEEEcC---CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEe-eCCeEEEEEecCC
Q 038118           47 QKLGQGGFGGVYKGFFRE---TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCH-EKKELLLVYEYMP  121 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~  121 (376)
                      +.||+|+||.||+|.+..   ....|++|.+... .......+.+|+.+++.++|||++++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   3467999988643 3445678889999999999999999999775 4566899999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC---c
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG---S  198 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~  198 (376)
                      +++|.+++........+..+..++.||+.||.|||   +.+++||||||+|||++.++.+||+|||++........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999998665556778888899999999999999   79999999999999999999999999999875432111   1


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhC-CCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG-RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......++..|+|||.+.+..++.++|||||||++|+|++| ..||......+....+.        .+.     .+...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~--------~~~-----~~~~~  224 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL--------QGR-----RLLQP  224 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh--------cCC-----CCCCC
Confidence            11123356789999999888899999999999999999994 66776544322211111        110     01111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .    .....+.+++..||+.+|++||++.+|++.|+.
T Consensus       225 ~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         225 E----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             C----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1    122457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-39  Score=296.87  Aligned_cols=267  Identities=20%  Similarity=0.235  Sum_probs=204.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l  115 (376)
                      .++|++.+.||.|+||.||+|.+..+++.+++|.+.....  .....+.+|+.+++.++||||+++++++...  ...|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999999999999999975432  2234567899999999999999999998877  89999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+.+ +|.+++......+++..++.++.||+.||.|||   +++++|+||+|+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9999975 888887665567899999999999999999999   789999999999999999999999999998765432


Q ss_pred             CCcceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------HHh----
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------DLY----  263 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~----  263 (376)
                      . .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+.....       ...    
T Consensus       160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            2 1222344788999999887543 68899999999999999999999987655443333322110       000    


Q ss_pred             --cCCccccccCCcCCCCCcHH-HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 --GNGKLLEAVDPRLCRDFDEQ-QMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 --~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ............+...+... ....+.+++..||+.+|++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              00000000011111111111 2455788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-39  Score=292.49  Aligned_cols=248  Identities=31%  Similarity=0.462  Sum_probs=197.5

Q ss_pred             CccccCCCeeEEEEEEcCCC------eEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           47 QKLGQGGFGGVYKGFFRETS------SYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +.||.|+||.||+|.+....      ..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999986543      679999886543 23456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-----eEEEeeCCC
Q 038118          120 MPNGSLDSHLFKE------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-----NAKIGDFGL  188 (376)
Q Consensus       120 ~~~~sL~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-----~~kl~Dfg~  188 (376)
                      +++++|.+++...      ...+++..++.++.||+.+|.|||   +.+++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999988542      234788999999999999999999   78999999999999999887     899999999


Q ss_pred             ccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          189 ARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       189 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      +......... ......++..|+|||++.++.++.++|||||||++|+|++ |..||......+....+.        .+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~--------~~  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT--------AG  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh--------cC
Confidence            8654322111 1122335678999999998899999999999999999998 999997655433322211        01


Q ss_pred             ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      .         ...........+.+++.+||..+|.+||++.+|++.|.
T Consensus       230 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 G---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             C---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0         00111223456788999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-39  Score=297.31  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=202.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +.|.....||.|+||.||++.+..++..|+||.+..........+.+|+..++.++|+|++++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            44445578999999999999999889999999987665555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++++|.+++..  +.+++..++.++.||+.+|.|||   +++++||||+|+||++++++.++|+|||++....... ...
T Consensus       102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  175 (292)
T cd06658         102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR  175 (292)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence            99999887733  45889999999999999999999   7899999999999999999999999999986543222 122


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+..             .+.+.+..  
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------~~~~~~~~--  240 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-------------NLPPRVKD--  240 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------cCCCcccc--
Confidence            334588999999999888899999999999999999999999976543322111111             01111111  


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+..++.+||..||.+|||++++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1112335777888999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.5e-39  Score=296.85  Aligned_cols=265  Identities=22%  Similarity=0.264  Sum_probs=203.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-----hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-----GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+......     ....+..|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588889999999999999999988999999999765322     345577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+ +++|.+++......+++..++.++.||+.||.|||   ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999988654447899999999999999999999   7999999999999999999999999999987654322


Q ss_pred             CcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh-----cCCcccc
Q 038118          197 GSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY-----GNGKLLE  270 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  270 (376)
                      . ......++..|+|||.+.+ ..++.++|||||||++|+|++|..+|......+....+........     .......
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            1 2223346778999998854 4578899999999999999999888876654433322222110000     0000000


Q ss_pred             ccCCcC-----CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRL-----CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......     ...........+.+++.+||+.+|++|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000     01111223456888999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-39  Score=296.48  Aligned_cols=262  Identities=25%  Similarity=0.326  Sum_probs=206.6

Q ss_pred             ccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 038118           30 RFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCH  108 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  108 (376)
                      .+++.++....++|++.+.||+|+||.||+|.+..+++.+++|.+..... ....+.+|+.+++.+ +|+|++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            35567777788999999999999999999999999999999999865432 235677899999999 7999999999986


Q ss_pred             eC-----CeEEEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          109 EK-----KELLLVYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       109 ~~-----~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ..     ...++||||+++++|.+++..   ....+++..++.++.|++.+|.+||   +.+++|+||+|+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence            53     368999999999999987743   3457899999999999999999999   789999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC-----CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-----RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL  255 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~  255 (376)
                      ++|+|||++........ ......|+..|+|||++...     .++.++|||||||++|+|++|..||...........+
T Consensus       167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            99999999875432221 11234578899999987543     3688999999999999999999999765432221111


Q ss_pred             HHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .        ....     +.+.  ........+.+++.+||+.+|++||++.++++
T Consensus       246 ~--------~~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 P--------RNPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             h--------cCCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1        0100     1110  01123345888999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-39  Score=289.55  Aligned_cols=253  Identities=27%  Similarity=0.390  Sum_probs=207.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||.|++|.||+|.+..+++.|++|++..... .....+.+|+..+..++|+|++++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368899999999999999999999999999999877643 4467889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE-QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++++|.+++... ..+++..++.++.|++.++.+||   + .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-  155 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-  155 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence            9999999988544 67899999999999999999999   7 9999999999999999999999999999876543222 


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|..||.............. ..   ..      ..+.+..
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~---~~------~~~~~~~  225 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-IC---DG------PPPSLPA  225 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-Hh---cC------CCCCCCc
Confidence            12234578899999999888899999999999999999999999976643121111111 11   00      1111111


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .   .....+.+++.+||..+|++||++.++++
T Consensus       226 ~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         226 E---EFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             c---cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            1   03456888899999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-39  Score=298.43  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=200.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      .|.....||.|+||.||+|.+..++..|++|.+........+.+.+|+.+++.+.|||++++++++..++..|+||||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            34455689999999999999998899999999876544445678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      +++|..++..  ..+++..++.++.|++.+|.+||   +.+++||||+|+||+++.++.++|+|||++....... ....
T Consensus       102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~  175 (297)
T cd06659         102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK  175 (297)
T ss_pred             CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence            9999887633  46889999999999999999999   7999999999999999999999999999986543221 1223


Q ss_pred             eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ...++..|+|||++.+..++.++|||||||++|+|++|..||...........+.        ...     .+..  ...
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--------~~~-----~~~~--~~~  240 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--------DSP-----PPKL--KNA  240 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------ccC-----CCCc--ccc
Confidence            3558899999999988889999999999999999999999997554322221111        000     0000  001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......+.+++.+||+.+|++||++.+|++
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            112345778889999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.5e-39  Score=285.46  Aligned_cols=250  Identities=30%  Similarity=0.452  Sum_probs=207.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      .|++.+.||.|++|.||++.+..++..+++|++..........+.+|+.+++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            47889999999999999999998899999999987665556789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      +++|.+++......+++..++.++.|++.+|.+||   ..+++||||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            99999988665567899999999999999999999   79999999999999999999999999999876543321  23


Q ss_pred             eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ...++..|++||.+.+...+.++||||||+++|+|++|..||...+..........        ...     +.+...  
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~~~~--  220 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------NGP-----PGLRNP--  220 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------cCC-----CCcCcc--
Confidence            45588899999999888899999999999999999999999976542222111110        000     111111  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......+.+++.+||+.||++|||+.++++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111345888999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.7e-40  Score=299.69  Aligned_cols=266  Identities=24%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|+||.||+|.+..+++.|++|.+....  ....+.+.+|+++++.++|+||+++++++...+..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47899999999999999999999889999999886542  2234568889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|..+.. ....+++..++.++.||+.+|.|||   +.+++|+||+|+||++++++.++|+|||++....... .
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~  155 (286)
T cd07846          81 FVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E  155 (286)
T ss_pred             cCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence            999988877653 3445899999999999999999999   7899999999999999999999999999987543322 2


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc-------CCcc-c
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG-------NGKL-L  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~-~  269 (376)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+..+......       .... .
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2233457889999998865 34788999999999999999999999765543322222221111000       0000 0


Q ss_pred             cccCCcCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCR-----DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....+....     ...+.....+.+++.+||+.+|++||++.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000     001123456888999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.5e-39  Score=289.03  Aligned_cols=247  Identities=28%  Similarity=0.436  Sum_probs=198.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||.|+||.||++..  ++..|++|.+.....  ...+.+|+.+++.++|+|++++++++... ..++||||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            46799999999999999999875  467799999865432  35788999999999999999999998764 47999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +.+++|.+++.... ..+++..++.++.|++.||.|||   +.|++||||+|+||+++.++.++|+|||++......   
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999999886543 35889999999999999999999   799999999999999999999999999998653221   


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                       ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+.        .+..     ... 
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--------~~~~-----~~~-  218 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE--------KGYR-----MEP-  218 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh--------CCCC-----CCC-
Confidence             111224568999999988889999999999999999997 999997665433322111        1110     011 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                         .......+.+++.+||+.+|+.||++.+|+..|+.
T Consensus       219 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               11233557889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-39  Score=294.95  Aligned_cols=258  Identities=25%  Similarity=0.386  Sum_probs=207.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|.+.+.||+|+||.||++.+..++..|++|.+........+.+.+|+.+++.++|||++++++++...+..|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            47999999999999999999999888899999998765555567788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++.+  ..+++..+..++.|++.+|.|||   +.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence            999999998843  35788899999999999999999   79999999999999999999999999998865432221 2


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|++||.+.+..++.++||||||+++|+|++|..||...+.......+.       ..+      .+..  .
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-------~~~------~~~~--~  236 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNG------TPEL--Q  236 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------cCC------CCCC--C
Confidence            223457889999999988889999999999999999999999997654322111000       000      0111  1


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HhccCCC
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNSEAP  318 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~~~~~  318 (376)
                      ........+.+++..||+.+|++||++.+++.  ++....+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            11223345788999999999999999999995  3443333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.6e-39  Score=291.91  Aligned_cols=254  Identities=27%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ...+.|++...||.|++|.||+|.+..++..|++|.+..... ....+.+|+++++.++|+|++++++.+......|+|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456778999999999999999999998899999999986654 4567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++......+++..++.++.+++.+|.+||   +.|++|+||+|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999998665447899999999999999999999   79999999999999999999999999998865432211


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                       ......++..|++||.+.+..++.++||||||+++|+|++|..||...........+..        ...     +...
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~~  237 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--------KGI-----PPLK  237 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------cCC-----CCCc
Confidence             22334578899999999888899999999999999999999999976543322211110        000     0000


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ........+.+++.+||+.+|..||++.+|++
T Consensus       238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              01113356788999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.5e-39  Score=300.77  Aligned_cols=265  Identities=21%  Similarity=0.236  Sum_probs=201.9

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  110 (376)
                      ...++|++.+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4568999999999999999999999999999999998643  333445677899999999999999999988643     


Q ss_pred             -CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 -KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                       ...|+||||+.+ +|.+.+...   ++...+..++.|++.||.|||   +.|++||||||+||+++.++.++|+|||++
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             357999999965 777766432   788999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH----------
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV----------  259 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~----------  259 (376)
                      .......  ......++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+....          
T Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            7643321  1223457889999999999899999999999999999999999997665433222221100          


Q ss_pred             -----HHHhcCCc------cccccCC----cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          260 -----WDLYGNGK------LLEAVDP----RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       260 -----~~~~~~~~------~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           ........      .......    .............+.+++.+||+.||++|||+.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00000000      0000000    0000111123455788999999999999999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.9e-39  Score=291.75  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=203.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      .|...+.||.|++|.||++.+..++..+++|.+........+.+.+|+.+++.+.|+|++++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            45666799999999999999988899999999876655556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      +++|.+++..  ..+++..++.++.|++.+|.+||   ++|++||||+|+||+++.++.++|+|||++........ ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  173 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK  173 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence            9999988854  56889999999999999999999   79999999999999999999999999998765432211 223


Q ss_pred             eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ...|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..        ..     .+....  .
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~--------~~-----~~~~~~--~  238 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD--------NL-----PPKLKN--L  238 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh--------cC-----CCCCcc--c
Confidence            34588999999999888899999999999999999999999976543222211111        00     011111  1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            112346888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=295.68  Aligned_cols=265  Identities=23%  Similarity=0.305  Sum_probs=199.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||.|++|.||+|.+..++..|++|.+...... ....+.+|+++++.++|+||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            47899999999999999999999988999999998754321 22456789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+.+ +|.+++......+++..++.++.||+.||.|||   +.+++||||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            9975 898888666667899999999999999999999   79999999999999999999999999999865322111 


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccc-hhhHHHHHHHHHH----Hh----cCCcc
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAK-EEVQVYLVQWVWD----LY----GNGKL  268 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~----~~----~~~~~  268 (376)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++|..||..... .+....+.+....    .+    .....
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1122346788999998865 4578999999999999999999999975542 1111111110000    00    00000


Q ss_pred             cc----ccC-CcCC---CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LE----AVD-PRLC---RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~----~~~-~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..    ... ..+.   ....  ....+.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLD--RIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCC--CchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00    000 0000   0000  1145678899999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-38  Score=287.97  Aligned_cols=252  Identities=26%  Similarity=0.402  Sum_probs=188.7

Q ss_pred             CccccCCCeeEEEEEEcC--CCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.||+|+||.||+|....  ....+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543  34578999876543 334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc-
Q 038118          124 SLDSHLFKEN----NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS-  198 (376)
Q Consensus       124 sL~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  198 (376)
                      +|.+++....    ...++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999886533    23467778899999999999999   799999999999999999999999999998643211111 


Q ss_pred             ceeeeccCCCCCchhhhcc-------CCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          199 QTTVLAGTMGYMAPECATT-------GRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ......++..|+|||++..       ..++.++|||||||++|+|++ |..||......+.......        .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~--------~~~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR--------EQDIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh--------ccCcc
Confidence            1122235677999998743       346789999999999999999 7889876554433222111        11111


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ...+.+...+.    ..+..++..|+ .||++|||+++|++.|.
T Consensus       230 ~~~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            12222222222    34555666787 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-42  Score=292.92  Aligned_cols=248  Identities=26%  Similarity=0.383  Sum_probs=208.6

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      |.++.+||+|+||.||+|.++.+|..+|||.+.....  ++.+.+|+.++++...+++|++|+.+.....+|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            3467799999999999999999999999999976643  68899999999999999999999999998999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      |++.+.+..+++++.+..+..+++..+.+|+|||   ...-+|||||..|||+..+|..||+|||.+..+.+.-. ...+
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNT  188 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNT  188 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCc
Confidence            9999999888999999999999999999999999   57889999999999999999999999999976533222 2345


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..||+.|||||++..-.|+.++||||||++..||..|++||...........+.             ....|.+.  .+.
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------------T~PPPTF~--KPE  253 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------------TKPPPTFK--KPE  253 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------------CCCCCCCC--ChH
Confidence            669999999999999999999999999999999999999997654332221111             11111111  122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .-...+.+++..||-++|++|-|+.++++
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            23356788999999999999999999886

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-38  Score=293.60  Aligned_cols=246  Identities=29%  Similarity=0.396  Sum_probs=199.6

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|.+..+++.|++|.+...   .......+.+|+.+++.++|||++++++++...+..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            5689999999999999999999988999999998643   2334467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+. +++.+.+......+++..+..++.||+.+|.|||   +.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9997 4676766555567899999999999999999999   799999999999999999999999999998654322  


Q ss_pred             cceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          198 SQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                         ....++..|+|||++.   ...++.++||||||+++|+|++|..||...........+..       . .     .+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-------~-~-----~~  232 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------N-D-----SP  232 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------C-C-----CC
Confidence               2345788999999874   35688899999999999999999999976543332111110       0 0     01


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+.   .......+.+++.+||+.+|++||++.+|+.
T Consensus       233 ~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         233 TLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             CCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            111   1123456888999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.9e-39  Score=290.14  Aligned_cols=248  Identities=26%  Similarity=0.298  Sum_probs=203.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +|++.+.||.|+||.||+|.+..++..|++|.+....   ....+.+.+|++++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999999899999999997542   2446788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+.+++|.+++... ..+++..+..++.||+.+|.|||   .++++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999888554 57899999999999999999999   7899999999999999999999999999987543321  


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......... +..    ....  .    .+    
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~----~~~~--~----~~----  219 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRA----KQET--A----DV----  219 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH-HHH----Hhcc--c----cc----
Confidence            2234457889999999988889999999999999999999999998665421111 111    0000  0    01    


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCCh--HHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSI--RQVI  310 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~--~~vl  310 (376)
                      .........+.+++.+||+.||.+||++  .+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1111223567888999999999999999  6665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-40  Score=301.85  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEccc--CChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  114 (376)
                      ..+..|++.++||.||.+.||++...+.+. ||+|++..  .+...+.-|..|+.+|.+|+ |.+|+.+++|-..++.+|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            346789999999999999999998876544 66666543  35667788999999999997 999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      |||||= ...|...|.+....++...+..+..||+.++.++|   ..||||.||||.|+|+- .|.+||+|||++..+..
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            999983 55888888776666665688899999999999999   89999999999999885 46999999999987643


Q ss_pred             CC-CcceeeeccCCCCCchhhhccC-----------CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          195 AK-GSQTTVLAGTMGYMAPECATTG-----------RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       195 ~~-~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      .. .-......||+.||+||.+...           ..+.++||||||||||+|+.|+.||....+.  ..         
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--~a---------  580 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--IA---------  580 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--HH---------
Confidence            32 2345667899999999988432           2568999999999999999999999643211  11         


Q ss_pred             hcCCccccccCCcCCCCCcHHH-HHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQ-MECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ++..+.+|...-+++.-- ...+++++..||+.||.+||++.+||+
T Consensus       581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                112233342211111100 112888999999999999999999995

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-39  Score=290.90  Aligned_cols=248  Identities=26%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .|++.+.||.|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++   |+|++++++++......|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            578889999999999999999999999999998754 3344567888999999996   999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++..  ..+++..++.++.|++.+|.|||   +.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            99999999988743  37899999999999999999999   7999999999999999999999999999987654332 


Q ss_pred             cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......|+..|+|||.+.++ .++.++|||||||++|+|++|..||...........+             .....+.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------------~~~~~~~~  222 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------------PKSKPPRL  222 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------------ccCCCCCC
Confidence            222334588899999988654 4688999999999999999999999765432211100             00011112


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...   .....+.+++.+||+.||++||++.+++.
T Consensus       223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111   13345788889999999999999999985

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-38  Score=285.34  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=207.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|.+.+.||.|++|.||++.+..++..|++|++....  ......+.+|+++++.++|+|++++++.+......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888999999999999999999999999999997653  24566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          120 MPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       120 ~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      +++++|.+++...   ...+++..++.++.+++.+|.+||   +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999988664   367899999999999999999999   7899999999999999999999999999987654332


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       .......|+..|+|||.+.+..++.++||||||+++|+|++|..||..............        ...     +.+
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~  223 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--------GQY-----PPI  223 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc--------CCC-----CCC
Confidence             122334578899999999888899999999999999999999999976553332222111        110     111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          .......+.+++.+||..+|++|||+.++++
T Consensus       224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1123355788899999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.2e-38  Score=293.22  Aligned_cols=249  Identities=26%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ..|+..+.||+|+||.||+|.+..++..|++|.+...   .......+.+|+++++.++|+|++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3467788999999999999999988999999998743   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+.+ +|.+.+......+++..+..++.+|+.+|.|||   +.+++||||+|+||+++.++.++|+|||++.....   
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            99975 777777666677899999999999999999999   79999999999999999999999999999864332   


Q ss_pred             cceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          198 SQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                        .....++..|+|||++.   .+.++.++|||||||++|+|++|..||...........+..       ...      +
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------~~~------~  242 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NES------P  242 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------ccC------C
Confidence              22345788999999873   45688999999999999999999999876543332222111       000      0


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      .   .........+.+++.+||+.+|.+||++.+|++.+.
T Consensus       243 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         243 T---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             C---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            0   111123345788999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-38  Score=288.38  Aligned_cols=248  Identities=26%  Similarity=0.423  Sum_probs=202.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +-|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.++..++|+||+++++++..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34678889999999999999998889999999986542 34456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++.  ...+++..+..++.+++.++.+||   +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06641          84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence            99999998874  346889999999999999999999   7999999999999999999999999999986543221 11


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|+|||.+.+...+.++|+|||||++|+|++|..||...........+.        ...     .+.+   
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------~~~-----~~~~---  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP--------KNN-----PPTL---  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh--------cCC-----CCCC---
Confidence            223457889999999988888999999999999999999999997544322111110        000     0111   


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .......+.+++.+||+.+|.+||++.++++
T Consensus       222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         222 -EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             -CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             1223345788899999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-38  Score=294.79  Aligned_cols=196  Identities=22%  Similarity=0.349  Sum_probs=159.7

Q ss_pred             CCccccCCCeeEEEEEEc--CCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEEEEEecCC
Q 038118           46 DQKLGQGGFGGVYKGFFR--ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMP  121 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~  121 (376)
                      .++||+|+||.||+|.+.  .+++.||+|.+.....  ...+.+|+.+++.++||||+++++++..  +...|+||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999965  4678899999865432  2456789999999999999999998854  457899999985


Q ss_pred             CCChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee----cCCceEEEeeCCCc
Q 038118          122 NGSLDSHLFKE--------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLA  189 (376)
Q Consensus       122 ~~sL~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~  189 (376)
                      + +|..++...        ...+++..+..++.||+.||.|||   ++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 776665321        125889999999999999999999   7999999999999999    45678999999999


Q ss_pred             cccccCCC--cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCcc
Q 038118          190 RLVEHAKG--SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTA  247 (376)
Q Consensus       190 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~  247 (376)
                      ........  .......||..|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            76543211  122345689999999998764 58899999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-38  Score=294.26  Aligned_cols=267  Identities=23%  Similarity=0.275  Sum_probs=202.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l  115 (376)
                      .++|++.+.||.|+||.||+|.+..++..||+|.+.....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4789999999999999999999999999999999875422  2223466799999999999999999998755  56899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+.+ +|.+++......+++..++.++.||+.+|.|||   +.|++||||+|+||+++.++.++|+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999965 787877655567899999999999999999999   799999999999999999999999999998765432


Q ss_pred             CCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH-------hcCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL-------YGNGK  267 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~  267 (376)
                      .. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.+.....       .....
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            21 1222335778999998865 457899999999999999999999998766554444333321100       00000


Q ss_pred             ccccc--CCcCCCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAV--DPRLCRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~--~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....  ........   .......+.+++.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000  00000000   0112445678999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-39  Score=292.22  Aligned_cols=265  Identities=25%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEEEEEe
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYE  118 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e  118 (376)
                      |++.+.||.|++|.||+|.+..++..+++|.+....  ......+.+|+++++.++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999999999999998663  33446788999999999999999999999887  89999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++ +|..++......+++..++.++.||+.||.+||   ..+++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9975 888888665567899999999999999999999   789999999999999999999999999998766443322


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC--cc-----cc
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG--KL-----LE  270 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~  270 (376)
                      ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...........  ..     ..
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            2233456788999997765 3578999999999999999999999987664433332222111000000  00     00


Q ss_pred             cc------CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AV------DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..      ...+...+.......+.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00      000000001112456788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.8e-39  Score=286.91  Aligned_cols=249  Identities=23%  Similarity=0.376  Sum_probs=201.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||.|+||.||+|.++.++..|++|.+....  ....+.+.+|+.+++.++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5888999999999999999999999999999986542  23345778999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~  197 (376)
                      +++++|.+++.... ..+++..++.++.|++.+|.|||   +.+++|+||+|.||++++++ .++|+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence            99999999886543 35789999999999999999999   79999999999999999886 46999999987654322 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.        ....         
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~---------  219 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--------QGYF---------  219 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh--------cccC---------
Confidence            12223458889999999988889999999999999999999999997654322211111        0110         


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..........+.+++.+||+.+|++|||+.+|++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0111122345788899999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-38  Score=289.96  Aligned_cols=262  Identities=23%  Similarity=0.228  Sum_probs=198.4

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCC-CCCccceeeEEeeC--CeEEEEEe
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLR-HRNLVQLLGWCHEK--KELLLVYE  118 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e  118 (376)
                      |++.+.||+|+||.||+|.+..++..|++|.+..... .......+|+..+.++. |+|++++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6788999999999999999999999999999875421 12234457888888886 99999999999887  88999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+.+ +|.+.+......+++..++.++.||+.||.|||   +.+++||||+|+||+++. +.++|+|||++........ 
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            9974 777877665567899999999999999999999   799999999999999999 9999999999876533221 


Q ss_pred             ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------HHhcCCcccc
Q 038118          199 QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------DLYGNGKLLE  270 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~  270 (376)
                       .....++..|+|||++.. +.++.++|||||||++|+|++|..||...+..+....+.....       ..........
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence             223457889999997644 5578899999999999999999999987654433222221110       0000000000


Q ss_pred             ccCCcCC----CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLC----RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+...    ..........+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000    0111234567899999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.2e-38  Score=285.08  Aligned_cols=243  Identities=24%  Similarity=0.305  Sum_probs=196.7

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ||.|++|.||+|.+..++..|++|++....   ....+.+.+|+.+++.++|+||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999999999999999987542   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeecc
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG  205 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  205 (376)
                      .+++.+ ...+++..+..++.||+.+|.|||   +++++|+||+|.||+++.++.++|+|||++.......  ......+
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            998854 346899999999999999999999   7999999999999999999999999999987654322  2223457


Q ss_pred             CCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHH
Q 038118          206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQM  285 (376)
Q Consensus       206 t~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (376)
                      +..|++||.+.+..++.++|+||||+++|+|++|..||.......... ...    .. .+.        ....+.....
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~----~~-~~~--------~~~~~~~~~~  220 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-YND----IL-KGN--------GKLEFPNYID  220 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH-HHH----Hh-ccC--------CCCCCCcccC
Confidence            889999999988889999999999999999999999997665211110 110    00 000        0011111124


Q ss_pred             HHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          286 ECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       286 ~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ..+..++.+||+.+|++||+     ++|+++
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            56888999999999999999     788875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.3e-38  Score=288.08  Aligned_cols=250  Identities=28%  Similarity=0.353  Sum_probs=192.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHH-HHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTI-ISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|+||.||+|.+..+|..||+|.+.... ......+..|+.. ++.+.|+|++++++++..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47899999999999999999999999999999987642 2223445556554 666789999999999999999999999


Q ss_pred             cCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          119 YMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQ-CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       119 ~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      |++ ++|.+++..   ....+++..++.++.||+.+|.|||   ++ +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 577666643   3356899999999999999999999   55 999999999999999999999999999875432


Q ss_pred             CCCcceeeeccCCCCCchhhhcc----CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          195 AKGSQTTVLAGTMGYMAPECATT----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ..  ......++..|+|||++.+    ..++.++|+|||||++|+|++|..||......  ...+.....     +    
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~-----~----  223 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVE-----E----  223 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHh-----c----
Confidence            11  1223457889999998854    44688999999999999999999999643211  111111100     0    


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ..+.+.   .......+..++.+||..+|++||++.+|++
T Consensus       224 -~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 -PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             011111   1123355788999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-38  Score=290.27  Aligned_cols=265  Identities=23%  Similarity=0.327  Sum_probs=202.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +|++.+.||.|++|.||+|++..++..|++|.+..... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58899999999999999999999999999999876532 23456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          121 PNGSLDSHLFKEN--NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       121 ~~~sL~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ++ +|.+++....  ..+++..+..++.||+.+|.|||   +.|++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 7877775433  46899999999999999999999   78999999999999999999999999999875432211 


Q ss_pred             ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc----CCccccccC
Q 038118          199 QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG----NGKLLEAVD  273 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  273 (376)
                      ......++..|++||++.+. .++.++|||||||++|+|++|..||...+..+....+.........    .......+.
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            11223467899999988654 5688999999999999999999999876654443333221100000    000000000


Q ss_pred             CcCC-------CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLC-------RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....       ..+.+.....+.+++.+|++.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000       0111122355788999999999999999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-38  Score=289.49  Aligned_cols=268  Identities=21%  Similarity=0.206  Sum_probs=198.6

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      +.++|++.+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            35789999999999999999999999899999999875432 22346678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+. ++|.+.+......+++..+..++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 6776766555566788888999999999999999   78999999999999999999999999999875432211


Q ss_pred             cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhh-HHHHHHHHH--------HHhcCCc
Q 038118          198 SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEV-QVYLVQWVW--------DLYGNGK  267 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~--------~~~~~~~  267 (376)
                       ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ...+.....        .......
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             12223468899999988754 478899999999999999999999975543211 111100000        0000000


Q ss_pred             cccccCCcC-CCCC---c--HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRL-CRDF---D--EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~-~~~~---~--~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......+.. ....   .  ......+.+++.+|++.||.+|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000 0000   0  001245678889999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-38  Score=288.85  Aligned_cols=258  Identities=26%  Similarity=0.319  Sum_probs=202.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~  117 (376)
                      ++|+..+.||.|++|.||++.+..++..|++|.+.... ......+.+|+++++.++|+||+++++++..  .+.+|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999999999999999987543 3445678999999999999999999998864  34789999


Q ss_pred             ecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||+++++|.+++..   ....+++..+..++.||+.+|.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887643   3456889999999999999999999   79999999999999999999999999999865432


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchh-hHHHHHHHHHHHhcCCccccccC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEE-VQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..   .....++..|++||.+.+..++.++|||||||++|+|++|..||....... .......+...    .... .+.
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~-~~~  229 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNP-ELK  229 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCch-hhc
Confidence            11   123447889999999988889999999999999999999999997653210 11111111111    0000 000


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...  .........+.+++.+||+.+|.+|||+.+|++
T Consensus       230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            000  001123456889999999999999999999996

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.7e-39  Score=292.34  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=199.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||.|++|.||+|.+..++..|+||.+....  ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4889999999999999999999999999999987542  22335788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +. ++|..++... ...+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 5787777543 356899999999999999999999   78999999999999999999999999999875432211 


Q ss_pred             ceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh-------c-----C
Q 038118          199 QTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY-------G-----N  265 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-------~-----~  265 (376)
                      ......++..|+|||++.+.. ++.++|||||||++|+|+||..||...........+........       .     .
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            122334678899999886644 58889999999999999999999976654332222221110000       0     0


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..........+ ..........+.+++.+||+.||.+|||+++++.
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000000 0001112345678899999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=275.71  Aligned_cols=253  Identities=27%  Similarity=0.392  Sum_probs=201.0

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++.++...||.|..|.||+++.+.+|...|||.+... ..+..++++..+.++.+-. +|+||+.+++|..+...++.
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            345566778899999999999999999999999999875 5556677888887766654 89999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      ||.|. ..+..++..-.+++++..+-++...++.||.||..  +++|+|||+||+|||+|+.|++||||||++..+-+. 
T Consensus       170 MelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-  245 (391)
T KOG0983|consen  170 MELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-  245 (391)
T ss_pred             HHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence            99883 34556666666789999999999999999999998  789999999999999999999999999998765322 


Q ss_pred             CcceeeeccCCCCCchhhhcc---CCCCCCCceeechhhHHHHHhCCCCCCCccch-hhHHHHHHHHHHHhcCCcccccc
Q 038118          197 GSQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKPISLTAKE-EVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                       ...+...|-+.|||||.+.-   ..|+.++||||||++++||.||+.||.+-+.+ +....+.+             ..
T Consensus       246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-------------~e  311 (391)
T KOG0983|consen  246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-------------EE  311 (391)
T ss_pred             -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-------------cC
Confidence             22344568899999998853   46899999999999999999999999874422 12222211             11


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .|.+....  .+...+.+++..||++|+.+||...++++
T Consensus       312 PP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  312 PPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            23333221  13344677777899999999999999985

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=284.38  Aligned_cols=250  Identities=25%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KEL  113 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  113 (376)
                      .+|++.+.||+|+||.||+|.+..++..|++|.+...     .......+.+|+.+++.++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4789999999999999999999999999999987532     233456788999999999999999999998653  568


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++++||+++++|.+++.. .+.+++..++.++.||+.+|.|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            999999999999988854 345889999999999999999999   7999999999999999999999999999987543


Q ss_pred             cCC--CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          194 HAK--GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       194 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ...  ........++..|+|||++.+..++.++|+|||||++|+|++|..||.........   .+...           
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~-----------  223 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIAT-----------  223 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHHc-----------
Confidence            211  11122345788999999998888999999999999999999999999755322211   11100           


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ......+.......+.+++..||+ +|.+||++.+++.
T Consensus       224 --~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         224 --QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              011112233344567888889999 5799999998874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.3e-38  Score=283.25  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=188.8

Q ss_pred             CccccCCCeeEEEEEEcCC--CeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRET--SSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.||+|+||.||+|.....  ...+++|.+.... ......+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            4699999999999975432  3456777766543 344568899999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-cc
Q 038118          124 SLDSHLFKEN---NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQ  199 (376)
Q Consensus       124 sL~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  199 (376)
                      +|.+++.+..   ...+...++.++.||+.||.|||   +.+++||||||+|||++.++.++|+|||++........ ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999886532   34667778899999999999999   79999999999999999999999999999753211111 11


Q ss_pred             eeeeccCCCCCchhhhcc-------CCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          200 TTVLAGTMGYMAPECATT-------GRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .....++..|+|||++..       ..++.++|||||||++|+|++ |..||......+....+..        +.....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~--------~~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK--------DQQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--------hccccc
Confidence            223457889999998743       235789999999999999997 5778865543332222111        111222


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      .++.+...+..    .+.+++..|| .+|++||++.+|++.|.
T Consensus       230 ~~~~~~~~~~~----~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELPYSE----RWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCCCcH----HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33444333333    4566777788 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=282.20  Aligned_cols=248  Identities=30%  Similarity=0.474  Sum_probs=205.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||+|++|.||++.+..+++.|++|.+.....  .....+.+|+++++.++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58899999999999999999998899999999976643  4567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++... ..+++..++.++.|++.+|.+||   +.|++||||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999888544 67899999999999999999999   899999999999999999999999999999766433221 


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....++..|+|||...+..++.++|||+||+++|+|++|..||.............        ...     .+.+   
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~--------~~~-----~~~~---  219 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV--------QDD-----HPPL---  219 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh--------ccC-----CCCC---
Confidence            233457889999999988888999999999999999999999997544221111110        000     0111   


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .......+..++.+||..+|++||++.+++.
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             1222356788899999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.8e-38  Score=283.01  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=205.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|++.+.||.|++|.||++.+..++..+++|.+...  .......+.+|+++++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            588999999999999999999999999999998754  233456778899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          120 MPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       120 ~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      +++++|.+++.+.   ...+++..++.++.+++.||.+||   +.|++|+||+|.||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999887552   356889999999999999999999   799999999999999999999999999998765433 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                        ......++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......+.        .+.         
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--------~~~---------  217 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--------RGK---------  217 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------cCC---------
Confidence              1222447889999999988889999999999999999999999997665433222111        111         


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...........+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11222244456889999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=307.12  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=206.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEcC---CCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRE---TSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      +.++.++||+|.||.|++|.|..   +...||||.+...... ....|++|+..+..|+|+|++++|++..+ ....|||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34466799999999999999974   3357999999876443 67889999999999999999999999988 6788999


Q ss_pred             ecCCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          118 EYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |++++|+|.+.|.+ ....+....+..++.||+.||.||.   .+++|||||...|+||-....+||+|||+.+.++...
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999977 4456788888999999999999999   8999999999999999999999999999998775433


Q ss_pred             Ccce--eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          197 GSQT--TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       197 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ....  ....-...|+|||.++...++.++|||+|||+||||++ |+.||.+-....+...                 +|
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~-----------------iD  329 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN-----------------ID  329 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh-----------------cc
Confidence            2211  11223568999999999999999999999999999998 8999987764443322                 22


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..-+-...+.+.+.+.++++.||.++|++|||+..|.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            22223334556678999999999999999999999973

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=290.08  Aligned_cols=264  Identities=22%  Similarity=0.236  Sum_probs=199.5

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      |++.+.||.|++|.||+|.+..+|..|++|++....  ......+.+|+.+++.++|+|++++++++...+..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999999999999999987543  223456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          121 PNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       121 ~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      + ++|.+++.... ..+++..++.++.|++.+|.|||   +++++||||+|+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence            5 58888875433 36899999999999999999999   78999999999999999999999999999875432211 1


Q ss_pred             eeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc--------CCcccc
Q 038118          200 TTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG--------NGKLLE  270 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  270 (376)
                      .....++..|+|||++.+. .++.++||||||+++|+|++|..||...........+.+.......        ......
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            1223467899999987654 4688999999999999999999999766543332222221100000        000000


Q ss_pred             ---ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 ---AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .................+.+++.+||+.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               00000000111122345788999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-40  Score=305.42  Aligned_cols=246  Identities=26%  Similarity=0.389  Sum_probs=198.3

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEccc----CChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC--eEEEE
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK----GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK--ELLLV  116 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv  116 (376)
                      .+....||+|.|-+||+|.+..+|..||.-.++.    ......++|..|+.+|+.|+|+||++||+++.+..  .+.+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            3556689999999999999999999988766543    24555789999999999999999999999998765  48899


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~  195 (376)
                      +|++..|+|..++.+ .+.++.+.+..|++||++||.|||.. ...|+|||||.+||||+.+ |.|||+|+|+|+.....
T Consensus       122 TEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999999854 56788999999999999999999975 6789999999999999764 78999999999876543


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCC-ccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL-TAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                         ......|||.|||||++. ..|+...||||||++++||+|+.+||.- .+...++..+..        |.....+  
T Consensus       200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--------GiKP~sl--  265 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--------GIKPAAL--  265 (632)
T ss_pred             ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--------CCCHHHh--
Confidence               334477999999999877 7799999999999999999999999953 232333222221        1111111  


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ....   -.++..+|.+||.. ..+|||+.|+|.
T Consensus       266 ---~kV~---dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  266 ---SKVK---DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---hccC---CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence               1111   13478889999999 999999999994

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=298.49  Aligned_cols=262  Identities=27%  Similarity=0.393  Sum_probs=211.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .+...+.++||+|-||.|.++...+ +.+||||.++.... ...+.|.+|+.+|.+|+||||+.++++|..++.+++|+|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            4677889999999999999999876 78999999987644 445889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKENNLL-TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |++.|.|.+++..+..+. ......+++.||+.+|+||.   +.++|||||.+.|+|++.++++||+|||+++.+-....
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999997664433 55666789999999999999   89999999999999999999999999999985433322


Q ss_pred             cce-eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh--CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          198 SQT-TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC--GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       198 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ... ...+-+.+|||+|.+..++++.++|||+||+++||+++  .+.||....+++......    .+.......     
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~----~~~~~~~~~-----  763 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG----EFFRDQGRQ-----  763 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh----hhcCCCCcc-----
Confidence            222 23345789999999999999999999999999999865  778998776555433222    222221111     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .....+.-+...+.+++++||..+-.+||++++|...|.+
T Consensus       764 -~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  764 -VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             -eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence             1111222333557789999999999999999999987764

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3e-38  Score=286.72  Aligned_cols=244  Identities=26%  Similarity=0.340  Sum_probs=194.5

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ||+|+||+||+|.+..+++.|++|.+....   ......+..|+.+++.++|||++++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999999999999987542   22345667899999999999999999999999999999999999999


Q ss_pred             hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeec
Q 038118          126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA  204 (376)
Q Consensus       126 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  204 (376)
                      .+++.... ..+++..++.++.|++.+|.|||   +.|++||||+|+||+++.++.++|+|||++.....  ........
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence            98886543 36899999999999999999999   79999999999999999999999999999875433  12222345


Q ss_pred             cCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHH
Q 038118          205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ  284 (376)
Q Consensus       205 gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (376)
                      ++..|+|||++.+..++.++||||||+++|+|++|..||...........+....        .  ....    ......
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~--~~~~----~~~~~~  221 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--------L--EMAV----EYPDKF  221 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--------c--cccc----cCCccC
Confidence            7789999999988889999999999999999999999997654322211111100        0  0001    111222


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          285 MECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       285 ~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ...+.+++.+||+.||.+||     ++.+++.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            44578889999999999999     5555663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.2e-38  Score=284.89  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=198.0

Q ss_pred             CCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC------
Q 038118           43 FNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK------  111 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  111 (376)
                      |++.+.||+|+||.||+|.+.   .+++.|+||++...  .....+.+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678889999999999999864   35789999998754  3444667889999999999999999999886432      


Q ss_pred             eEEEEEecCCCCChhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          112 ELLLVYEYMPNGSLDSHLFKE-----NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                      ..+++++|+.+++|..++...     ...++...++.++.||+.+|.|||   +.+++||||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999998776432     124788899999999999999999   799999999999999999999999999


Q ss_pred             CCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhc
Q 038118          187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYG  264 (376)
Q Consensus       187 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      |++......... ......++..|++||.+....++.++|||||||++|+|++ |..||......+....+..       
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-------  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence            998755322111 1122234578999999988889999999999999999999 8999976654332222111       


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       ...     .....    .....+.+++.+||+.+|++||++.+|++.|+.
T Consensus       231 -~~~-----~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 -GNR-----LKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             -CCc-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence             100     00111    123468889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-38  Score=291.13  Aligned_cols=266  Identities=22%  Similarity=0.273  Sum_probs=198.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+....  ......+.+|+.+++.++|+||+++++++......|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999999999999999986542  2234567889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCCCccccccCC
Q 038118          119 YMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |+++ +|.+.+.... ..+++..++.++.||+.||.|||   +++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9964 7777664433 33678888899999999999999   789999999999999985 5579999999987543221


Q ss_pred             CcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC-----ccc-
Q 038118          197 GSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG-----KLL-  269 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~-  269 (376)
                       .......++..|+|||++.+. .++.++|||||||++|+|++|..||......+....+...........     .+. 
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             112233467899999988664 578899999999999999999999987654433322221110000000     000 


Q ss_pred             -cccCCcCCC----CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 -EAVDPRLCR----DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 -~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ...-+....    ...+.....+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000000000    011122345788999999999999999999985

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.3e-38  Score=289.96  Aligned_cols=266  Identities=21%  Similarity=0.229  Sum_probs=197.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe-----
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKE-----  112 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----  112 (376)
                      ++|++.+.||.|+||.||+|.+..++..|++|.+....  ......+.+|+.+++.+. |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47899999999999999999999999999999886542  223456788999999995 6999999999877665     


Q ss_pred             EEEEEecCCCCChhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCC
Q 038118          113 LLLVYEYMPNGSLDSHLFKE----NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFG  187 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg  187 (376)
                      .|+||||+++ +|.+++...    ...+++..++.++.||+.||.|||   +++++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 787777543    245899999999999999999999   799999999999999998 8899999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC-
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN-  265 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  265 (376)
                      ++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......... 
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9875432211 1122346788999998865 457899999999999999999999998765443332222211000000 


Q ss_pred             ----Ccccc-----ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 ----GKLLE-----AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 ----~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          .....     ...+.......+.....+.+++.+||..||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                00000     00000000011123455788999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=298.47  Aligned_cols=259  Identities=24%  Similarity=0.383  Sum_probs=220.2

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcC----CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEee
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRE----TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE  109 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  109 (376)
                      ..+......+..++||.|-||.||.|....    ..-.||||..+.+ ..+..+.|+.|+.+++.+.||||++++|+|.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            344556667788999999999999998643    2447999999874 45557889999999999999999999999987


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      . ..|||||+++.|.|..++..+...++...+..++.||+.+|.|||   +..+|||||...|||+....-+||+|||++
T Consensus       463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchh
Confidence            5 579999999999999999888888999999999999999999999   899999999999999999999999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      +.+.+..........-+..|||||.++-..++.++|||-|||++||++. |..||.+..+.+....+.            
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE------------  606 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE------------  606 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec------------
Confidence            9887766655555556789999999998999999999999999999976 999999887766644332            


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                           ..-+...++.+...|..++.+||..+|.+||.+.+|...|.
T Consensus       607 -----nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  607 -----NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             -----CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence                 22233444555667889999999999999999999886654

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.6e-38  Score=288.69  Aligned_cols=254  Identities=29%  Similarity=0.398  Sum_probs=196.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|+..+.||+|+||.||++.+..++..|++|.+.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666789999999999999999999999999987543 334567889999999996 9999999999999899999999


Q ss_pred             cCCCCChhhhh---h-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          119 YMPNGSLDSHL---F-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       119 ~~~~~sL~~~l---~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      |+.. ++.++.   . .....+++..+..++.+++.||.|||+  +.+++||||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 544432   2 233578999999999999999999994  35999999999999999999999999999865432


Q ss_pred             CCCcceeeeccCCCCCchhhhccC---CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTG---RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ..  ......|+..|+|||++.+.   .++.++|||||||++|+|++|..||.....  ....+..    ..      ..
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~----~~------~~  226 (288)
T cd06616         161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQ----VV------KG  226 (288)
T ss_pred             CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhh----hc------CC
Confidence            21  12233578899999998766   688999999999999999999999975431  1111111    00      00


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+.+...........+.+++.+||+.+|.+|||+.+|+.
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1122222222234456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-38  Score=284.09  Aligned_cols=246  Identities=26%  Similarity=0.379  Sum_probs=197.9

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ||.|+||.||++.+..+++.+++|.+.....   .....+.+|+++++.++|+|++++++.+......|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999899999999875533   4566788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-------c
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-------S  198 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~  198 (376)
                      .+++.+. +.+++..++.++.||+.+|.|||   ..+++|+||+|+||+++.++.++|+|||++........       .
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            9888553 47899999999999999999999   79999999999999999999999999999865432211       1


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......++..|++||...+...+.++||||||+++|+|++|..||...........+..        +..    .  ...
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~----~--~~~  222 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--------GKI----E--WPE  222 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------CCc----C--CCc
Confidence            22334578899999999888899999999999999999999999976654333222111        100    0  000


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ..  .....+..++.+||+.+|.+|||+..+.+.|+
T Consensus       223 ~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            00  02355788899999999999999955555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.9e-38  Score=280.86  Aligned_cols=251  Identities=28%  Similarity=0.429  Sum_probs=206.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLLVY  117 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~  117 (376)
                      +|...+.||+|++|.||+|.+..++..|++|++....  ......+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999999889999999987654  24567889999999999999999999999988  8999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++.... .+++..++.++.+++.+|.|||   +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999886543 7899999999999999999999   79999999999999999999999999999876543322


Q ss_pred             c-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 S-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      . ......++..|++||.+.+...+.++||||||+++|+|++|..||.......  .....    ...         ...
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~~---------~~~  221 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYK----IGS---------SGE  221 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHh----ccc---------cCC
Confidence            1 1233457889999999988889999999999999999999999997655111  11111    000         011


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+.......+.+++.+|++.||++||++.+++.
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11222223466888999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-38  Score=282.30  Aligned_cols=244  Identities=23%  Similarity=0.295  Sum_probs=191.1

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhHHHHHHHHHH-HHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGIKEYASEVTI-ISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||.|+||.||+|.+..+++.||+|.+.....   .....+..|..+ .....|+|++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            579999999999999999899999999875432   222334445444 4455899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      ++|.+++.. ...+++..+..++.||+.||.|||   +.+++|+||+|.||+++.++.++|+|||++.....     ...
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            999988854 456899999999999999999999   79999999999999999999999999999865322     223


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..++..|++||.+.+..++.++||||||+++|+|++|..||...+.......+..        ...      ........
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~------~~~~~~~~  218 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS--------RRI------NWPEEVKE  218 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------ccc------CCCCcccc
Confidence            4578899999999888889999999999999999999999976554332222111        000      00111111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       283 ~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      .....+.+++.+||+.+|++||++.++.+.|
T Consensus       219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            2335578899999999999999776555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.7e-38  Score=289.88  Aligned_cols=195  Identities=23%  Similarity=0.356  Sum_probs=159.0

Q ss_pred             CccccCCCeeEEEEEEcC--CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEe--eCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH--EKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~  122 (376)
                      .+||+|+||.||+|.+..  ++..||+|.+.....  ...+.+|+.+++.++||||+++++++.  .+...++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999999654  567899998865432  345778999999999999999999885  35678999999865


Q ss_pred             CChhhhhhh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee----cCCceEEEeeCCCcc
Q 038118          123 GSLDSHLFK--------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLAR  190 (376)
Q Consensus       123 ~sL~~~l~~--------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~~  190 (376)
                       +|.+++..        ....+++..++.++.||+.||.|||   +.+++||||||+|||+    +.++.+||+|||++.
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             66666532        1235788999999999999999999   7999999999999999    556789999999997


Q ss_pred             ccccCCC--cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCcc
Q 038118          191 LVEHAKG--SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTA  247 (376)
Q Consensus       191 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~  247 (376)
                      .......  .......+|..|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            6543221  122344678999999998764 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-38  Score=311.16  Aligned_cols=269  Identities=19%  Similarity=0.258  Sum_probs=187.5

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCe-EEEEE------------------EcccCChhhHHHHHHHHHHHHhCCC
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSS-YIAVK------------------RVSKGSKQGIKEYASEVTIISRLRH   97 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~-~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h   97 (376)
                      ....++|++.+.||+|+||.||++.++.... .++.|                  .+. ........+.+|+.+|+.++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            4456899999999999999999987653221 11111                  111 122234568899999999999


Q ss_pred             CCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCe
Q 038118           98 RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN----NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI  173 (376)
Q Consensus        98 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  173 (376)
                      +||+++++++...+..|+|++++. ++|..++....    .......+..++.||+.||.|||   ++||+||||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence            999999999999999999999985 46666653321    22345667789999999999999   79999999999999


Q ss_pred             eecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCC-CCCccchhhH
Q 038118          174 MLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP-ISLTAKEEVQ  252 (376)
Q Consensus       174 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~p-f~~~~~~~~~  252 (376)
                      |++.++.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|+|++|..+ +........ 
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~-  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG-  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH-
Confidence            999999999999999976644333333345689999999999999999999999999999999998754 433221111 


Q ss_pred             HHHHHHHHHHh--cCC------ccccccCCc----CCCCCcH-----HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          253 VYLVQWVWDLY--GNG------KLLEAVDPR----LCRDFDE-----QQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       253 ~~~~~~~~~~~--~~~------~~~~~~~~~----~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+........  ...      .....++..    ....+..     .....+.+++.+||+.||.+|||+.|+++
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11111110000  000      000000000    0000000     01123566788999999999999999985

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=288.15  Aligned_cols=264  Identities=22%  Similarity=0.237  Sum_probs=205.0

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      |++.+.||.|++|.||+|.+..+++.+++|.+.....  .....+..|+++++.++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            6788999999999999999998999999999875532  24567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++ +|...+......+++..++.++.||+.+|.+||   ..+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            75 887877665568899999999999999999999   7999999999999999999999999999987654332 112


Q ss_pred             eeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc--CCcccc-------
Q 038118          201 TVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG--NGKLLE-------  270 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------  270 (376)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+.........  ......       
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            234577899999998776 7899999999999999999999999776654433222211000000  000000       


Q ss_pred             -c--cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 -A--VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 -~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .  ................+.+++.+||+.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             0  0000001122234567889999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-37  Score=287.65  Aligned_cols=247  Identities=28%  Similarity=0.384  Sum_probs=198.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ..|...+.||.|+||.||+|.+..++..|++|.+...   .......+.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4477788999999999999999988999999998642   3334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+. +++.+.+......+++..++.++.|++.+|.|||   +.+++||||+|.||+++.++.++|+|||++.....   
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---  167 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence            9996 5777777555667899999999999999999999   79999999999999999999999999999865432   


Q ss_pred             cceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          198 SQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                        .....++..|+|||.+.   ...++.++|||||||++|+|++|..||...........+..        ..     .+
T Consensus       168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------~~-----~~  232 (308)
T cd06634         168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NE-----SP  232 (308)
T ss_pred             --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh--------cC-----CC
Confidence              12345788999999874   34578899999999999999999999865543222111110        00     01


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ...   .......+.+++.+||+.+|++||++.+|+..
T Consensus       233 ~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         233 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            111   11233557889999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.5e-38  Score=289.72  Aligned_cols=270  Identities=24%  Similarity=0.286  Sum_probs=202.9

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC---
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK---  111 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---  111 (376)
                      +...++|++.+.||.|+||.||+|.+..+++.|++|.+....  ......+.+|+++++.++|||++++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345688999999999999999999999989999999987542  223356778999999999999999999887654   


Q ss_pred             -------eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          112 -------ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       112 -------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                             .+++|+||+++ ++...+......+++..++.++.||+.||.|||   +.||+|+||+|+||++++++.+||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence                   79999999976 676776555557899999999999999999999   7899999999999999999999999


Q ss_pred             eCCCccccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       185 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      |||++...............++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+........
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9999876543322222223457789999988653 478899999999999999999999976554333222222111000


Q ss_pred             c-------CCccccccCC------cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 G-------NGKLLEAVDP------RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~-------~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .       ........++      ..... .......+.+++..||+.||.+||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0       0000000000      00000 0012356788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.1e-38  Score=286.85  Aligned_cols=245  Identities=24%  Similarity=0.313  Sum_probs=199.0

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ..+||+|+||.||++.+..++..|++|.+..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            35799999999999999999999999998765555567789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeecc
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG  205 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  205 (376)
                      .+++.  ...+++..++.++.|++.+|.|||   +.|++|+||+|.||+++.++.++|+|||++....... .......+
T Consensus       105 ~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  178 (292)
T cd06657         105 TDIVT--HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG  178 (292)
T ss_pred             HHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence            88763  345789999999999999999999   7899999999999999999999999999886543221 12233457


Q ss_pred             CCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHH
Q 038118          206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQM  285 (376)
Q Consensus       206 t~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (376)
                      +..|++||.+.+..++.++|+||||+++|+|++|..||...........+..             .+.+.+. . .....
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-------------~~~~~~~-~-~~~~~  243 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-------------NLPPKLK-N-LHKVS  243 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------hCCcccC-C-cccCC
Confidence            8899999999888889999999999999999999999976543322221111             0001100 0 01123


Q ss_pred             HHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          286 ECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       286 ~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            34678888999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.6e-37  Score=287.01  Aligned_cols=244  Identities=27%  Similarity=0.387  Sum_probs=196.7

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      |...+.||+|+||.||+|.+..++..|++|.+...   .......+.+|+.+++.++|+|++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66778899999999999999999999999998753   233446788899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +. +++.+.+......+++..++.++.||+.+|.|||   +.|++|+||+|+||+++.++.++|+|||++....     .
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence            96 4777777666667899999999999999999999   7899999999999999999999999999985432     1


Q ss_pred             eeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          200 TTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...........+..        ...     +..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------~~~-----~~~  240 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NDS-----PTL  240 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------cCC-----CCC
Confidence            22345788999999874   45688899999999999999999999876543222211110        000     111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .   .......+.+++.+||+.+|.+||++.++++
T Consensus       241 ~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         241 Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             C---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1   1112235788899999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=290.85  Aligned_cols=265  Identities=19%  Similarity=0.238  Sum_probs=197.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcC--CCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELL  114 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~  114 (376)
                      +|++.++||+|+||.||+|.+..  ++..||+|.+....   ......+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58899999999999999999988  78999999998732   33446778899999999999999999999887  8899


Q ss_pred             EEEecCCCCChhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC----CceEEEeeC
Q 038118          115 LVYEYMPNGSLDSHLFKE----NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL----NFNAKIGDF  186 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~----~~~~kl~Df  186 (376)
                      +||||+++ +|.+.+...    ...+++..++.++.||+.+|.|||   +.+++||||+|+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 565655321    236889999999999999999999   799999999999999999    899999999


Q ss_pred             CCccccccCCC--cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhh------HHHHHH
Q 038118          187 GLARLVEHAKG--SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEV------QVYLVQ  257 (376)
Q Consensus       187 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~------~~~~~~  257 (376)
                      |++........  .......++..|+|||++.+. .++.++|||||||++|+|++|..||........      ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99876543222  112234578899999988764 578999999999999999999999976544320      001111


Q ss_pred             HHHHHhcC------------Ccccc---cc-CCcCC-CCCcH------HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          258 WVWDLYGN------------GKLLE---AV-DPRLC-RDFDE------QQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       258 ~~~~~~~~------------~~~~~---~~-~~~~~-~~~~~------~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ... ....            .....   .. ..... .....      .....+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000 0000            00000   00 00000 00000      12245788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-39  Score=298.32  Aligned_cols=248  Identities=24%  Similarity=0.313  Sum_probs=208.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .+.|.+...||+|.|++|.+|++..++..||||.+.+.  .....+.+.+|++++..|+||||++++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            47899999999999999999999999999999999875  3334456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+.+|.+++++.+.+ .+.+..+..++.|+..+++|+|   .++|+|||||++||||+.+.++||+|||++.++.  ..
T Consensus       135 eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--YG  208 (596)
T ss_pred             EeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--cc
Confidence            9999999999997655 4555888999999999999999   8999999999999999999999999999998875  33


Q ss_pred             cceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ....+..|++.|.|||++.+..+ ++.+|+||||+++|.|+.|.+||++.+-.+.......                ..+
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------------gk~  272 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------------GKY  272 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------------eee
Confidence            45567789999999999988764 7889999999999999999999998764443222111                011


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        .++.-....+.++++++|-.+|.+|+++.++.+
T Consensus       273 --rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  273 --RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             --cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence              111112233567788899999999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-37  Score=328.98  Aligned_cols=269  Identities=26%  Similarity=0.446  Sum_probs=212.4

Q ss_pred             ccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee
Q 038118           30 RFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE  109 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  109 (376)
                      .++++++.   ..|.....||+|+||.||+|.+..++..||+|.+......    ...|++.+++++||||+++++++.+
T Consensus       682 ~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~  754 (968)
T PLN00113        682 SITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS  754 (968)
T ss_pred             hhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence            34444443   5678889999999999999999888999999998654321    1346889999999999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      .+..|+||||+++|+|.+++.    .+++..+..++.+|+.||.|||..++.+++||||||+||+++.++..++. |+..
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence            999999999999999999884    37899999999999999999996556799999999999999998887775 5554


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      .....     .....++..|+|||++.+..++.++|||||||++|||++|+.||.....  ....+..|...........
T Consensus       830 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  902 (968)
T PLN00113        830 GLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLD  902 (968)
T ss_pred             ccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchh
Confidence            32211     1122578899999999988999999999999999999999999954321  1222444444444444444


Q ss_pred             cccCCcCCC--CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          270 EAVDPRLCR--DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       270 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ..+++.+..  .........+.+++.+||+.||++|||+++|++.|+...
T Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            455555533  234456667889999999999999999999999998654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=296.45  Aligned_cols=268  Identities=19%  Similarity=0.246  Sum_probs=198.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  112 (376)
                      .+++|++.+.||+|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            357899999999999999999999999999999998643 233456788899999999999999999987644     35


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .|+|+||+.+ +|.+.+.  .+.+++..++.++.|++.||.+||   +.|++||||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          83 VYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            8999999965 7766663  356899999999999999999999   799999999999999999999999999998754


Q ss_pred             ccCCCc--ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc-----
Q 038118          193 EHAKGS--QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG-----  264 (376)
Q Consensus       193 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-----  264 (376)
                      ......  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.........     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            322111  1123457889999998754 46889999999999999999999999765432222111110000000     


Q ss_pred             --C---CccccccCCcCCCC---CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          265 --N---GKLLEAVDPRLCRD---FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       265 --~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                        .   ......+.......   ..+.....+.+++.+||+.+|.+|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0   00000000000000   011123557899999999999999999999963

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.1e-38  Score=288.19  Aligned_cols=270  Identities=23%  Similarity=0.303  Sum_probs=199.1

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC----
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK----  111 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  111 (376)
                      ...++|++.+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+.+++.++||||+++++++....    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            34578999999999999999999999999999999886432  222345678999999999999999999886543    


Q ss_pred             ----eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          112 ----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       112 ----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                          ..++||||+.+ +|.+.+......+++..++.++.||+.||.|||   +.|++|+||+|+||+++.++.++|+|||
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence                45999999965 777777665557899999999999999999999   7899999999999999999999999999


Q ss_pred             CccccccCCCc---ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH-
Q 038118          188 LARLVEHAKGS---QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL-  262 (376)
Q Consensus       188 ~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-  262 (376)
                      ++.........   ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+....... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            98765332211   11234467889999988654 36889999999999999999999997665433322222211000 


Q ss_pred             ---hcCC---ccccc--cCCcCCCCCcH-----HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 ---YGNG---KLLEA--VDPRLCRDFDE-----QQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ---~~~~---~~~~~--~~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         +...   .....  +..........     .....+.+++.+||..||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence               0000   00000  00000000000     01234678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=274.95  Aligned_cols=262  Identities=23%  Similarity=0.303  Sum_probs=203.1

Q ss_pred             HhhCCCcC-CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEee----CCe
Q 038118           39 ATNDFNDD-QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHE----KKE  112 (376)
Q Consensus        39 ~~~~y~~~-~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~~  112 (376)
                      .+++|++. ++||-|-.|.|..+.++.+|+++|+|++....+     ..+|+++.-..+ |+|||.++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-----ARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-----HHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35667766 569999999999999999999999999876533     357888877775 9999999998854    467


Q ss_pred             EEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC---ceEEEeeCCC
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGL  188 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~  188 (376)
                      +.+|||+++||.|+..+..++ ..+++.++..|+.||+.|+.|||   +.+|.||||||+|+|+...   -.+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            889999999999999986544 46999999999999999999999   8999999999999999754   4599999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ++.....  ....+...|+.|.|||++....|+...|+||+||++|-||+|.+||.......+..-+...    ...+. 
T Consensus       211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r----I~~gq-  283 (400)
T KOG0604|consen  211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR----IRTGQ-  283 (400)
T ss_pred             ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH----hhccC-
Confidence            9865432  2344456799999999999999999999999999999999999999765432221111110    00010 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HhccCCCCC
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNSEAPLP  320 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~~~~~~~  320 (376)
                      .+..+++     =....+...++|+.+|..+|.+|.|+++++.  ++......|
T Consensus       284 y~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp  332 (400)
T KOG0604|consen  284 YEFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP  332 (400)
T ss_pred             ccCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence            0011111     1244566788899999999999999999984  555444333

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3e-38  Score=294.51  Aligned_cols=267  Identities=19%  Similarity=0.269  Sum_probs=201.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEee----CCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHE----KKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~  113 (376)
                      .++|++.+.||.|++|.||+|.+..++..|++|++....  ......+.+|+.+++.++|+||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999999999999999987542  2345677889999999999999999998753    3578


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+. ++|.+++.. ...+++..++.++.||+.||.|||   .++++||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 588777743 456899999999999999999999   7999999999999999999999999999987553


Q ss_pred             cCCCc---ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH-------H
Q 038118          194 HAKGS---QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD-------L  262 (376)
Q Consensus       194 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------~  262 (376)
                      .....   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+......       .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211   1223468889999998765 45889999999999999999999999765543322211110000       0


Q ss_pred             hcCCcccc---ccCCcC---CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNGKLLE---AVDPRL---CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~~~~---~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........   ......   ...........+.+++.+||+.+|++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00000000   000000   00111223466889999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-38  Score=295.82  Aligned_cols=265  Identities=23%  Similarity=0.251  Sum_probs=204.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----eEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-----ELL  114 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  114 (376)
                      +|++.+.||.|++|.||+|.+..++..|++|.+....  ....+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999999889999999987643  344567889999999999999999999987765     789


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+.+ +|.+.+.. ...+++..++.++.+|+.+|.+||   +.|++||||||.||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999974 78777744 447899999999999999999999   79999999999999999999999999999976543


Q ss_pred             CCC--cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh-------c
Q 038118          195 AKG--SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY-------G  264 (376)
Q Consensus       195 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-------~  264 (376)
                      ...  .......++..|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+........       .
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            321  122334578899999999887 789999999999999999999999987765443333322110000       0


Q ss_pred             CCcccccc---CCc---CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          265 NGKLLEAV---DPR---LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       265 ~~~~~~~~---~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+   ...   -...........+.+++.+||+.+|.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            00000000   000   000011123456788999999999999999999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.5e-38  Score=292.14  Aligned_cols=267  Identities=24%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC--CeE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK--KEL  113 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~  113 (376)
                      ..++|++.+.||.|+||.||+|.+..++..+++|.+...  .......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            457899999999999999999999988999999988542  233345677899999999 999999999998643  468


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |+||||+.+ +|..++...  .+++..++.++.||+.+|.|||   +.|++|+||+|+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            999999974 888777443  7788899999999999999999   7999999999999999999999999999987653


Q ss_pred             cCCC----cceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH------
Q 038118          194 HAKG----SQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL------  262 (376)
Q Consensus       194 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~------  262 (376)
                      ....    .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+.......      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            3221    12233458889999998754 457889999999999999999999997665443322222111000      


Q ss_pred             -hc---CCccccccC---CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 -YG---NGKLLEAVD---PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 -~~---~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ..   .......+.   ........+.....+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence             00   000000000   00000111113456888999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=325.33  Aligned_cols=251  Identities=30%  Similarity=0.429  Sum_probs=205.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++.-..+||.|.||.||.|.+..+|...|+|.+...  .......+.+|..+|..++|||+|+++++=.+++..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            566678999999999999999999999999988654  344566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC--
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG--  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  197 (376)
                      |++|+|.+.+ ..++..++.....+..|++.|+.|||   +.|||||||||.|||++.+|.+|++|||.+..+.....  
T Consensus      1316 C~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1316 CEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             hccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            9999999888 44455666666678899999999999   89999999999999999999999999999987644321  


Q ss_pred             -cceeeeccCCCCCchhhhccC---CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          198 -SQTTVLAGTMGYMAPECATTG---RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       198 -~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                       .......||+.|||||++.+.   ....++|||||||++.||+||+.||...+++=...+.+       +.++.     
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-------~~gh~----- 1459 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-------AAGHK----- 1459 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-------hccCC-----
Confidence             122346799999999999654   46778999999999999999999998766433222211       11221     


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                          +.++......-.+++..||+.||.+|.++.|+++.
T Consensus      1460 ----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                22333455667888999999999999999998864

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.7e-38  Score=285.35  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=203.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ++|.+.+.||.|++|.||+|.+..++..|++|++...   .......+..|+.+++++. |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4789999999999999999999999999999998753   2333467888999999998 99999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      ||++++++|.+++.+ .+.+++..++.++.|++.+|.+||   +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            999999999998854 347999999999999999999999   7999999999999999999999999999987654322


Q ss_pred             C-------------------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHH
Q 038118          197 G-------------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       197 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~  257 (376)
                      .                   .......++..|++||++.+..++.++||||||+++++|++|..||...........+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence            1                   122234578899999999888899999999999999999999999986653222111110


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh----HHHHH
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI----RQVIH  311 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~~vl~  311 (376)
                                    ....    +.......+.+++.+||+.+|.+||++    +++++
T Consensus       237 --------------~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         237 --------------LEYS----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --------------cCCC----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                          0011    111223457888999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-37  Score=282.67  Aligned_cols=243  Identities=24%  Similarity=0.304  Sum_probs=187.8

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHH---hCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIIS---RLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      .||+|+||.||++.+..+++.||+|.+....   ......+.+|..+++   ...|+|++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999886532   111223344444433   4479999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      +++|.+++.. .+.+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++......   ...
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~  153 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH  153 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Ccc
Confidence            9999888754 456899999999999999999999   799999999999999999999999999998644322   112


Q ss_pred             eeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          202 VLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ...|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... +....          .....    .+
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~----------~~~~~----~~  218 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT----------LTVNV----EL  218 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHh----------hcCCc----CC
Confidence            3458999999998864 558899999999999999999999997554322211 11100          00111    12


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRP-----SIRQVIHV  312 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~~  312 (376)
                      .......+.+++.+||+.||.+||     ++.++++.
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            223345678888999999999999     59998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.6e-37  Score=279.09  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=197.4

Q ss_pred             CHHHHHHHhhCCCcCCcc--ccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 038118           32 TYKELAQATNDFNDDQKL--GQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCH  108 (376)
Q Consensus        32 ~~~~~~~~~~~y~~~~~l--g~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  108 (376)
                      +..+.....++|++.+.+  |.|+||.||++....++..+++|.+........     |+.....+ .|+|++++++.+.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            345556667888998887  999999999999999999999999865422111     22222222 6999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCC
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFG  187 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg  187 (376)
                      ..+..|+||||+++++|.+++... ..+++..++.++.||+.+|.|||   +.|++||||+|+||+++.++ .++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999999988554 47899999999999999999999   78999999999999999998 99999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ++......     ....++..|+|||++.+..++.++||||||+++|+|++|..||..........  ..+.....    
T Consensus       156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~----  224 (267)
T PHA03390        156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ESLLKRQQ----  224 (267)
T ss_pred             cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HHHHHhhc----
Confidence            98754322     22347889999999998889999999999999999999999998554332211  11111110    


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-hHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS-IRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~~vl~  311 (376)
                        .  ..    .........+.+++.+||+.+|.+||+ ++++++
T Consensus       225 --~--~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 --K--KL----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --c--cC----CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence              0  00    111133455788889999999999996 699874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=277.73  Aligned_cols=241  Identities=27%  Similarity=0.357  Sum_probs=204.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|...++||+|.||+|-+++.+.+++.+|+|++++.   .++....-+.|-++|+..+||.+..+.-.|...+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            5677889999999999999999999999999999875   4455666778999999999999999988899999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||..||.|+-++. +.+.+++.....+...|+.||.|||   +++||.||||.+|+|+|.+|.+||+|||+++. +-..+
T Consensus       248 eyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE-~I~~g  322 (516)
T KOG0690|consen  248 EYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE-EIKYG  322 (516)
T ss_pred             EEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh-ccccc
Confidence            9999999988884 4567888888899999999999999   89999999999999999999999999999973 22334


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ....++.||+.|+|||++....|+.+.|.|.+|+++|||++|++||...+++.+...|...              +-.+.
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--------------d~kFP  388 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--------------DLKFP  388 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------------hccCC
Confidence            4567788999999999999999999999999999999999999999988776665554321              11222


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCC
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRP  304 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RP  304 (376)
                      +.+.+    ....|+...|.+||.+|.
T Consensus       389 r~ls~----eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  389 RTLSP----EAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCH----HHHHHHHHHhhcChHhhc
Confidence            33333    345566678999999996

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.2e-37  Score=287.87  Aligned_cols=262  Identities=19%  Similarity=0.249  Sum_probs=194.4

Q ss_pred             CccccC--CCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQG--GFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G--~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      ..||.|  +||+||+|.+..+++.||+|++...  .....+.+.+|+.+++.++||||++++++|...+..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999999999999999998753  334457788999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc--
Q 038118          123 GSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ--  199 (376)
Q Consensus       123 ~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  199 (376)
                      ++|.+++.... ..+++..+..++.||+.||.|||   +++++||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99998876532 35889999999999999999999   7999999999999999999999999997653221111100  


Q ss_pred             ----eeeeccCCCCCchhhhccC--CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------------
Q 038118          200 ----TTVLAGTMGYMAPECATTG--RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------------  260 (376)
Q Consensus       200 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------------  260 (376)
                          .....++..|++||++.+.  .++.++|||||||++|+|++|..||.................             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                0112245679999998764  478999999999999999999999976543322211110000             


Q ss_pred             HHhcC-----------Cccc-----cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 DLYGN-----------GKLL-----EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ~~~~~-----------~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....           ....     ...+..+...........+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00000           0000     000011111222345567899999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.7e-38  Score=293.50  Aligned_cols=266  Identities=21%  Similarity=0.258  Sum_probs=201.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  112 (376)
                      .++|.+.+.||.|+||.||+|.+..++..|+||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46899999999999999999999999999999998753  233345677899999999999999999987644     35


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .|+|+||+. ++|.+++.. .+.+++..++.++.||+.||.|||   +++++||||+|+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            899999995 678777743 457899999999999999999999   799999999999999999999999999998765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH-------Hhc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD-------LYG  264 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------~~~  264 (376)
                      .... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+......       ...
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            3321 12233457889999998765 46889999999999999999999999766543322222211100       000


Q ss_pred             CCccc-------cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          265 NGKLL-------EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       265 ~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      .....       ....+.. ....+.....+.+++.+||+.+|++|||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             chhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000       0000000 00111234567899999999999999999999953

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-38  Score=283.78  Aligned_cols=264  Identities=23%  Similarity=0.283  Sum_probs=204.1

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      |+..+.||+|++|.||+|.+..+++.|++|.+....  ......+..|+.+++.++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            677889999999999999999999999999998653  333467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      + ++|.+++......+++..++.++.+++.+|.+||   +++++||||+|+||++++++.++|+|||++........ ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            7 4899988665467999999999999999999999   78999999999999999999999999999876543221 22


Q ss_pred             eeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------HHhcCC----cc
Q 038118          201 TVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------DLYGNG----KL  268 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~~~~----~~  268 (376)
                      ....++..|+|||.+.+. .++.++|||||||++|+|++|..||......+....+.....       .....-    ..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            233457789999998766 789999999999999999999999987664443332222110       000000    00


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .............+.....+.+++..||+.||++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000111122456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=287.30  Aligned_cols=250  Identities=25%  Similarity=0.320  Sum_probs=204.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ..+.|+.-++||+||||.||-+....||+.+|.|.+.+.   .+......+.|-.+|.+++.++||.+--.|+..+.+|+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            346788889999999999999999999999999998765   23344556789999999999999999989999999999


Q ss_pred             EEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          116 VYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      |+..|.||+|.-+|.+.+ .-+++..+..++.+|+-+|++||   +.+||+|||||+|||+|+.|+++|+|+|++..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999988775543 45899999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                        +......+||.+|||||++++..|+...|.|||||+||+|+.|+.||...........+.+...              
T Consensus       340 --g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--------------  403 (591)
T KOG0986|consen  340 --GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--------------  403 (591)
T ss_pred             --CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--------------
Confidence              3334445799999999999999999999999999999999999999976543322222211110              


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIR  307 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  307 (376)
                      .....++....+....+....|++||.+|...+
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            011223445555677777789999999997554

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-37  Score=287.56  Aligned_cols=273  Identities=21%  Similarity=0.267  Sum_probs=205.0

Q ss_pred             cccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeE
Q 038118           29 KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGW  106 (376)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~  106 (376)
                      +.....++....++|++.+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++++++|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            44556778888899999999999999999999999999999999987542  2334667889999999999999999998


Q ss_pred             EeeC------CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          107 CHEK------KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       107 ~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      +...      ...|++++++ +++|.+.+..  ..+++..++.++.||+.||.|||   +.+++||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCC
Confidence            8543      3478888886 7788776632  45899999999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV  259 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  259 (376)
                      ++|+|||++.....    ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus       159 ~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         159 LKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             EEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999875422    2223457889999998866 467889999999999999999999997655433322222111


Q ss_pred             H-------HHhcCC---ccccccCCcC---CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          260 W-------DLYGNG---KLLEAVDPRL---CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       260 ~-------~~~~~~---~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .       ......   .....+....   ..+........+.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0       000000   0000000000   00000012345788999999999999999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=279.99  Aligned_cols=263  Identities=24%  Similarity=0.290  Sum_probs=198.6

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhC---CCCCccceeeEEeeCCe-----
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRL---RHRNLVQLLGWCHEKKE-----  112 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----  112 (376)
                      |++.+.||.|+||.||+|.++.++..|++|.+....  ......+.+|+.+++++   .|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678889999999999999999889999999997432  22234566777777666   59999999999987776     


Q ss_pred             EEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      .+++|||+.+ +|.+++.... ..+++..++.++.|++.||.+||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            9999999975 7888775533 35899999999999999999999   78999999999999999999999999999876


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC--C-cc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN--G-KL  268 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~-~~  268 (376)
                      ......  .....++..|+|||++.+..++.++|||||||++|+|++|..||......+....+..........  . ..
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            533211  122346889999999998889999999999999999999999998766544433332211000000  0 00


Q ss_pred             ---ccccCCcC---CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 ---LEAVDPRL---CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ---~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ........   ...........+.+++.+||+.||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               00000000   01122234466788999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4e-37  Score=281.80  Aligned_cols=258  Identities=18%  Similarity=0.227  Sum_probs=186.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccCChhhH-----------HHHHHHHHHHHhCCCCCcccee
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKGSKQGI-----------KEYASEVTIISRLRHRNLVQLL  104 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~  104 (376)
                      ..++|++.++||+|+||.||+|.+..+   +..+++|+.........           .....+...+..+.|+++++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            357899999999999999999998877   56677776443221110           1122334455667899999999


Q ss_pred             eEEeeCC----eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          105 GWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       105 ~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      +.+....    ..+++++++.. ++.+.+. .....++..++.++.|++.||.|||   +.+++||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence            8765443    44778887643 5555553 3344678888999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCC------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHH
Q 038118          181 AKIGDFGLARLVEHAKG------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY  254 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~  254 (376)
                      ++|+|||+++.......      .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999999976532111      112234589999999999999999999999999999999999999987643222111


Q ss_pred             H--HHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHh
Q 038118          255 L--VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL  313 (376)
Q Consensus       255 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L  313 (376)
                      .  .++.... ..+..    .   ..    .....+.+++..|++.+|++||++.+|++.+
T Consensus       245 ~~~~~~~~~~-~~~~~----~---~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFIKRL-HEGKI----K---IK----NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHHHHh-hhhhh----c---cC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1  1111111 11110    0   01    1135577888899999999999999999876

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.3e-37  Score=281.65  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             CCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccCC----hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKGS----KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  113 (376)
                      +|++.+.||.|+||.||.|.+.   .+|..||+|++....    ....+.+.+|+.+++.+ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4888999999999999999874   368889999987532    22345678899999999 589999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |+||||+++++|.+++.. ...+++..+..++.||+.+|.|||   +.|++||||+|+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            999999999999998854 356888999999999999999999   7999999999999999999999999999987654


Q ss_pred             cCCCcceeeeccCCCCCchhhhccC--CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTG--RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ...........|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...........+...   ....      
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~------  227 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---ILKS------  227 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH---hhcc------
Confidence            3322223345588899999988653  4678999999999999999999999754322221111111   1000      


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                       .+..    .......+..++.+||+.||.+||     ++.+++.
T Consensus       228 -~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -EPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -CCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             1111    122334577888999999999997     6677764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.7e-38  Score=288.84  Aligned_cols=268  Identities=24%  Similarity=0.241  Sum_probs=199.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh--hHHHHHHHHHHHHhCCCCCccceeeEEeeC-------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ--GIKEYASEVTIISRLRHRNLVQLLGWCHEK-------  110 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------  110 (376)
                      .++|++.+.||.|+||.||+|.+..++..|++|.+......  ....+.+|+++++.++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            58999999999999999999999999999999998654221  224567899999999999999999887543       


Q ss_pred             -CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 -KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                       ..+++||||+.+ +|...+......+++..++.++.||+.+|.|||   +.|++|+||+|+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             357999999865 676666555567999999999999999999999   799999999999999999999999999998


Q ss_pred             cccccCCCc----------ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHH
Q 038118          190 RLVEHAKGS----------QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       190 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  258 (376)
                      .........          ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            754322111          11233567889999987654 5789999999999999999999999866554433332221


Q ss_pred             HHHHhc-----CCccccc----cCCcCCCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          259 VWDLYG-----NGKLLEA----VDPRLCRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       259 ~~~~~~-----~~~~~~~----~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......     ...+...    .........   .......+.+++.+||+.||.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            100000     0000000    000000000   0112245788999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-37  Score=279.52  Aligned_cols=263  Identities=23%  Similarity=0.249  Sum_probs=199.7

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEecC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      |++.+.||.|++|.||+|.+..+++.|++|.+..... .......+|+..++.++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6788999999999999999998899999999875432 22234557999999999 999999999999999999999999


Q ss_pred             CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          121 PNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       121 ~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                       +++|.+.+.... ..+++..++.++.|++.+|.|||   +++++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence             778888876543 46899999999999999999999   7999999999999999999999999999987553221  1


Q ss_pred             eeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH---------HhcCCccc
Q 038118          200 TTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD---------LYGNGKLL  269 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~~~  269 (376)
                      .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||......+....+..+...         ........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            223457889999998754 45789999999999999999999999776544433222221100         00000000


Q ss_pred             cccCCcCCC---CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCR---DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+......   .........+.+++.+||+.+|++|||+++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000   001111356889999999999999999999985

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.4e-37  Score=281.35  Aligned_cols=256  Identities=22%  Similarity=0.303  Sum_probs=199.4

Q ss_pred             CCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccCC----hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKGS----KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  113 (376)
                      +|++.+.||.|++|.||++.+.   .++..|++|.+....    ......+..|+.++..+ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999999864   356789999986432    22345678899999999 499999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++.. ...+++..++.++.|++.+|.|||   ..+++||||+|.||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999999988854 356889999999999999999999   7999999999999999999999999999987543


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCC--CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ...........|+..|++||.+.+..  .+.++||||||+++|+|++|..||...........+....   ...      
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~------  227 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI---LKS------  227 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH---Hcc------
Confidence            32222223345788999999987654  7889999999999999999999996433221111111111   000      


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .+.....    ....+.+++.+||+.||++|||+.++.+.|+.
T Consensus       228 -~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -KPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -CCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             1111122    22457788899999999999999888777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=290.21  Aligned_cols=267  Identities=21%  Similarity=0.214  Sum_probs=199.7

Q ss_pred             hhCCCc-CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhh--------------HHHHHHHHHHHHhCCCCCcccee
Q 038118           40 TNDFND-DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG--------------IKEYASEVTIISRLRHRNLVQLL  104 (376)
Q Consensus        40 ~~~y~~-~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~  104 (376)
                      .++|.. .+.||.|+||.||+|.+..+++.||+|.+.......              ...+.+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            467764 577999999999999999999999999986542211              12467899999999999999999


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                      +++...+..++||||+. ++|.+++. ....+++.....++.||+.+|.+||   +.|++|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 58888774 3456899999999999999999999   7999999999999999999999999


Q ss_pred             eCCCccccccCC-------------CcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchh
Q 038118          185 DFGLARLVEHAK-------------GSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEE  250 (376)
Q Consensus       185 Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~  250 (376)
                      |||++.......             ........++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999987543110             1111223467889999988764 46889999999999999999999998776544


Q ss_pred             hHHHHHHHHHHHhcC-------CccccccCCcCC---CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          251 VQVYLVQWVWDLYGN-------GKLLEAVDPRLC---RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....+..........       ............   ..........+.+++.+||+.+|++|||+.+++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            433332211100000       000000000000   0011122345778999999999999999999995

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=315.77  Aligned_cols=275  Identities=25%  Similarity=0.288  Sum_probs=225.1

Q ss_pred             chhhhhcCCCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHh
Q 038118           18 IDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISR   94 (376)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~   94 (376)
                      ...++-+..-|..-.++++.-..++|.+.+.||+|+||.|..++.+.+++.||+|++.+.   .+....-|..|-.+|..
T Consensus        52 ~i~~fl~~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~  131 (1317)
T KOG0612|consen   52 NIAEFLNRYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVF  131 (1317)
T ss_pred             hHHHHHHHhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHc
Confidence            345566666677777888999999999999999999999999999999999999999863   23334567788888887


Q ss_pred             CCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118           95 LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus        95 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                      -..+=|+.++-.|.++.++|+||||++||.|..++.+.. .+++..+..++..|+-||..||   +.|+|||||||+|||
T Consensus       132 ~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvL  207 (1317)
T KOG0612|consen  132 GNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVL  207 (1317)
T ss_pred             CCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeE
Confidence            788889999999999999999999999999999986655 8999999999999999999999   899999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhc----c-CCCCCCCceeechhhHHHHHhCCCCCCCccch
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT----T-GRASKESDVYSFGIVALEIACGRKPISLTAKE  249 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~  249 (376)
                      +|..|++||+|||.+..++....-.....+|||.|++||++.    + +.|+..+|.||+||++|||+.|..||...+--
T Consensus       208 ld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv  287 (1317)
T KOG0612|consen  208 LDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV  287 (1317)
T ss_pred             ecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH
Confidence            999999999999999877765555667778999999999884    2 56899999999999999999999999988877


Q ss_pred             hhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC---hHHHHH
Q 038118          250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS---IRQVIH  311 (376)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~~vl~  311 (376)
                      +.+..|.+....+       ..  |   .  .....+...+||.+.+. +|+.|..   ++++-.
T Consensus       288 eTY~KIm~hk~~l-------~F--P---~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  288 ETYGKIMNHKESL-------SF--P---D--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HHHHHHhchhhhc-------CC--C---c--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            7777766531110       00  0   0  11234445666665443 6788887   777664

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.7e-37  Score=281.58  Aligned_cols=254  Identities=28%  Similarity=0.409  Sum_probs=196.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++|++.+.||.|++|.||+|.+..++..|+||.+.... ......+..|+.++.... |+||+++++++......|+|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            4577899999999999999999999989999999997543 233455667777676665 99999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+. ++|..++......+++..+..++.+|+.+|.|||+  ..+++||||+|+||+++.++.++|+|||++.......
T Consensus        93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            99985 46777665555678999999999999999999994  3699999999999999999999999999987543221


Q ss_pred             CcceeeeccCCCCCchhhhccCC----CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGR----ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .  .....++..|+|||.+.+..    ++.++||||||+++|+|++|..||...... . ..+...    .... .    
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~-~~~~~~----~~~~-~----  236 (296)
T cd06618         170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-F-EVLTKI----LQEE-P----  236 (296)
T ss_pred             c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-H-HHHHHH----hcCC-C----
Confidence            1  12234778999999986543    788999999999999999999999653221 1 111110    0010 0    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       +.+..  .......+.+++.+||..||++||++.++++
T Consensus       237 -~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         237 -PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             -CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             01100  0022345788999999999999999999985

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.8e-37  Score=277.26  Aligned_cols=242  Identities=25%  Similarity=0.285  Sum_probs=187.6

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhHHHHHHHHH---HHHhCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGIKEYASEVT---IISRLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      .||+|+||.||+|.+..+++.||+|.+.....   .....+..|..   .++...|++|+++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999875421   11122334433   4444579999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      |++|..++.. .+.+++..++.++.|++.+|.|||   +.+++||||+|+||+++.++.++|+|||++......   ...
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~  153 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH  153 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCc
Confidence            9999887743 457899999999999999999999   799999999999999999999999999998654321   112


Q ss_pred             eeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          202 VLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ...|+..|+|||++.++ .++.++|||||||++|+|++|..||..............     .      ....+.+... 
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~------~~~~~~~~~~-  221 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----T------LTMAVELPDS-  221 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----h------hccCCCCCCc-
Confidence            34588999999998754 588999999999999999999999976532221111000     0      0011122222 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                         ....+.+++.+||..+|.+||     ++.++++
T Consensus       222 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         222 ---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               234578888899999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-37  Score=291.07  Aligned_cols=266  Identities=24%  Similarity=0.290  Sum_probs=197.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC---------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK---------  110 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---------  110 (376)
                      .++|++.+.||.|+||.||+|.+..++..|++|.+........+.+.+|+++++.++|+||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            47899999999999999999999999999999999776656667788999999999999999999776543         


Q ss_pred             -----CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEe
Q 038118          111 -----KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIG  184 (376)
Q Consensus       111 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~  184 (376)
                           ...|+||||++ ++|.+++.  ...+++..++.++.||+.||.|||   +.|++||||||+||+++. ++.++|+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35799999997 48877763  346889999999999999999999   799999999999999974 5578999


Q ss_pred             eCCCccccccCCCc--ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH--
Q 038118          185 DFGLARLVEHAKGS--QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV--  259 (376)
Q Consensus       185 Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~--  259 (376)
                      |||++.........  ......++..|+|||.+.. ..++.++|||||||++|+|++|..||...........+..-.  
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998754322111  1122346889999997654 467889999999999999999999997665433222211100  


Q ss_pred             ------HHHhcC-Cc-cc-cccCCc-CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          260 ------WDLYGN-GK-LL-EAVDPR-LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       260 ------~~~~~~-~~-~~-~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                            ...... .. .. ....+. ............+.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                  000000 00 00 000000 000001122345778999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-37  Score=290.07  Aligned_cols=266  Identities=20%  Similarity=0.295  Sum_probs=201.3

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-  111 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-  111 (376)
                      .++...++|++.+.||+|+||.||+|.+..++..||||.+...  .......+.+|+.+++.++|+||+++++++..+. 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            4555678999999999999999999999999999999998643  2333456889999999999999999999987543 


Q ss_pred             -----eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          112 -----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       112 -----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                           ..++||||+ +++|..++.  ...+++..++.++.||+.||.|||   +.||+||||+|+||+++.++.++|+||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence                 468999998 778877764  346899999999999999999999   799999999999999999999999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-----
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-----  260 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-----  260 (376)
                      |++......    .....++..|++||.+.+ ..++.++|+|||||++|+|++|..||...........+.....     
T Consensus       163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            998754321    223356889999998875 3578999999999999999999999986654333222211100     


Q ss_pred             --HHhcCC---ccccccCCcCC----CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 --DLYGNG---KLLEAVDPRLC----RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 --~~~~~~---~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ......   .....+ +...    ..........+.+++.+|++.||++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         239 FVQKLQSEDAKNYVKKL-PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHhhcchhHHHHHHhc-cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              000000   000000 0000    0011122334788999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=274.92  Aligned_cols=250  Identities=23%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      +.||+|+++.|-.+....+|..||||++.+.......+..+|++++.+.+ |+||+.++++|+++..+|||||.+.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            57999999999999999999999999999886666778899999999997 99999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce---EEEeeCCCccccccC------C
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLVEHA------K  196 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~------~  196 (376)
                      ..+|.+ .+.+++..+.++...|+.||.|||   .+||.||||||+|||..+...   +|||||.++.-....      .
T Consensus       164 LshI~~-~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  164 LSHIQK-RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHH-hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            999954 567899999999999999999999   899999999999999976544   899999887533211      1


Q ss_pred             CcceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH--------HHHHHHHHHh
Q 038118          197 GSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV--------YLVQWVWDLY  263 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~--------~~~~~~~~~~  263 (376)
                      .....+..|+..|||||++.     ...|+.+.|.||||||||-||+|.+||.+....+..-        .-...+.. .
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes-I  318 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES-I  318 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH-H
Confidence            22344567899999999763     2358899999999999999999999998776544311        11111111 1


Q ss_pred             cCCccccccCCcCCCCCcHHH----HHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQ----MECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      -++          .-+++...    .....+++...|..|+.+|.++.+++.
T Consensus       319 QEG----------kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  319 QEG----------KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             hcc----------CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111          12233322    244566777788899999999999885

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.2e-37  Score=287.76  Aligned_cols=267  Identities=24%  Similarity=0.291  Sum_probs=201.0

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee-CC
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE-KK  111 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~  111 (376)
                      ++..+.++|++.+.||.|+||.||+|.+..++..|++|++...  .....+.+..|+.+++.++|||++++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3455688999999999999999999999999999999988643  22335677889999999999999999998865 56


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..|+|+||+ +++|..++.  ...+++..+..++.||+.+|.|||   +.+++||||+|.||+++.++.++|+|||++..
T Consensus        84 ~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             cEEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            789999998 568877763  345788888899999999999999   79999999999999999999999999999875


Q ss_pred             cccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH--------H
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD--------L  262 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--------~  262 (376)
                      ....    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.+....        .
T Consensus       158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            4321    123346789999998765 56899999999999999999999999766543322222221100        0


Q ss_pred             hcCC--ccccccC---CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNG--KLLEAVD---PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~--~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....  .....+.   +.......+.....+.+++.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000  0000000   00000000112356788999999999999999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.6e-37  Score=275.61  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=196.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      +|.+.+.||+|+||.||++.+..++..+++|.+...     .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            588999999999999999999877666666665431     122234567799999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          117 YEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |||+++++|.+.+..   ....+++..++.++.|++.+|.|||   +.|++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999887753   3456899999999999999999999   799999999999999975 569999999987653


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.        .+     ..
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~--------~~-----~~  222 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV--------EG-----PT  222 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--------cC-----CC
Confidence            221 12223457889999999988888999999999999999999999997544222211110        00     11


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.    ........+.+++.+||+.+|++||++.++++
T Consensus       223 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11    22334456788999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-36  Score=280.02  Aligned_cols=256  Identities=21%  Similarity=0.251  Sum_probs=189.4

Q ss_pred             CCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhh
Q 038118           53 GFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF  130 (376)
Q Consensus        53 ~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  130 (376)
                      ++|.||.++...+++.||+|++...  .......+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455666666668999999998754  44556789999999999999999999999999999999999999999999886


Q ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC------cceeee
Q 038118          131 KE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG------SQTTVL  203 (376)
Q Consensus       131 ~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~  203 (376)
                      .. ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||.+........      ......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence            53 345889999999999999999999   79999999999999999999999999998864422111      111233


Q ss_pred             ccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHH-HHHHHHHHhc-------CCcccc---
Q 038118          204 AGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY-LVQWVWDLYG-------NGKLLE---  270 (376)
Q Consensus       204 ~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~---  270 (376)
                      .++..|+|||++..  ..++.++|||||||++|+|++|..||........... +.........       ......   
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            46778999999865  3578999999999999999999999976543221110 0000000000       000000   


Q ss_pred             -ccCCc----CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 -AVDPR----LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 -~~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ..++.    ............+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence             00000    111222334456888999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-37  Score=288.86  Aligned_cols=265  Identities=21%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe--
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE--  112 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--  112 (376)
                      ....++|++.+.||.|++|.||+|.+..++..|++|++...  .......+.+|+.+++.+.|+|++++++++.....  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            34578999999999999999999999999999999998653  23344667889999999999999999988766544  


Q ss_pred             ----EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          113 ----LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       113 ----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                          .++|+||+ +++|.+++..  ..+++..++.++.||+.+|.|||   +.|++||||+|+||+++.++.++|+|||+
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence                89999998 6688887743  46899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH------
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD------  261 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~------  261 (376)
                      +......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+......      
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            8754322    223357888999998865 36789999999999999999999999766543332222221000      


Q ss_pred             -HhcCC---ccccccCCcCCCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 -LYGNG---KLLEAVDPRLCRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 -~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .....   .....+.......+   .......+.+++.+||+.||++|||+.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence             00000   00000000000000   0112456889999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-37  Score=286.81  Aligned_cols=263  Identities=21%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  110 (376)
                      ...++|.+.+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            3358999999999999999999999989999999998653  222345678999999999999999999998654     


Q ss_pred             -CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 -KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                       ..+++|+||+.. +|...+   ...+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             CceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence             346999999854 665543   235889999999999999999999   789999999999999999999999999998


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH-------HH
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV-------WD  261 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-------~~  261 (376)
                      ......    .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....       ..
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            754221    123346788999998876 458899999999999999999999998655333222211100       00


Q ss_pred             HhcCCccccccC--CcC-CCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 LYGNGKLLEAVD--PRL-CRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 ~~~~~~~~~~~~--~~~-~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..........+.  +.. ...+   .+.....+.+++.+||+.||.+||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000000000000  000 0000   0112345778999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=270.86  Aligned_cols=239  Identities=28%  Similarity=0.370  Sum_probs=194.9

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      ||.|+||.||++.+..+++.|++|.+.....   .....+..|+.+++.++|+|++++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999998899999999876432   2456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeecc
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG  205 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  205 (376)
                      .+++... ..+++..++.++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  155 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG  155 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence            9988543 46899999999999999999999   7999999999999999999999999999987653321 12334457


Q ss_pred             CCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHH
Q 038118          206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQM  285 (376)
Q Consensus       206 t~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (376)
                      +..|++||.+.+...+.++|+||||+++|+|++|..||...........+..        .      ...+    .....
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~------~~~~----~~~~~  217 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--------D------PLRF----PEFLS  217 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--------C------CCCC----CCCCC
Confidence            8899999999888889999999999999999999999976553222111110        0      0111    11123


Q ss_pred             HHHHHHHHHccCCCCCCCCCh---HHHH
Q 038118          286 ECLMIVGLWCAHPDENLRPSI---RQVI  310 (376)
Q Consensus       286 ~~l~~li~~cl~~~p~~RPs~---~~vl  310 (376)
                      ..+.+++.+||..||++||++   ++++
T Consensus       218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~  245 (250)
T cd05123         218 PEARDLISGLLQKDPTKRLGSGGAEEIK  245 (250)
T ss_pred             HHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence            557888999999999999999   5554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.4e-37  Score=306.87  Aligned_cols=256  Identities=28%  Similarity=0.429  Sum_probs=195.8

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEee------
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE------  109 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------  109 (376)
                      -....+|+..+.||+||||.||+++++-+|+.||||++... .......+.+|+..|.+|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            45667888899999999999999999999999999999866 45556788999999999999999997751100      


Q ss_pred             --------------------------------------------------------------------------------
Q 038118          110 --------------------------------------------------------------------------------  109 (376)
Q Consensus       110 --------------------------------------------------------------------------------  109 (376)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 038118          110 -------------------------K--------KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ  156 (376)
Q Consensus       110 -------------------------~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh  156 (376)
                                               +        ..+||-||||+..++.+++..+...-....+|+++++|+.||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                     0        1368889999987777766443322257889999999999999999


Q ss_pred             hCCCCceEeecccCCCeeecCCceEEEeeCCCccccc--------------c---CCCcceeeeccCCCCCchhhhccCC
Q 038118          157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE--------------H---AKGSQTTVLAGTMGYMAPECATTGR  219 (376)
Q Consensus       157 ~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~--------------~---~~~~~~~~~~gt~~y~aPE~~~~~~  219 (376)
                         ++|++||||||.|||+++++.|||+|||+++...              .   ......+...||.-|+|||++.+..
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence               7999999999999999999999999999998621              0   1111345678999999999987654


Q ss_pred             ---CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHcc
Q 038118          220 ---ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA  296 (376)
Q Consensus       220 ---~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  296 (376)
                         |+.|+|+||||+||+||+.   ||...-  +-...+.+     .+.+.+...      .++.......-..+|.||+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~-----LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTN-----LRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHh-----cccCCCCCC------cccccccchHHHHHHHHHh
Confidence               9999999999999999985   565332  11111111     122222211      2333344445678999999


Q ss_pred             CCCCCCCCChHHHHH
Q 038118          297 HPDENLRPSIRQVIH  311 (376)
Q Consensus       297 ~~~p~~RPs~~~vl~  311 (376)
                      ++||.+|||+.|+|.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999984

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=275.30  Aligned_cols=262  Identities=21%  Similarity=0.280  Sum_probs=206.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC--CCC----ccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR--HRN----LVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~----i~~~~~~~~~~~~~  113 (376)
                      .++|.+...||+|.||.|-.+.+..++..||||+++...+. .+.-+-|+++|+++.  .|+    ++.+.++|.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            78999999999999999999999999999999999765443 344566999999994  232    67778889999999


Q ss_pred             EEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---------------
Q 038118          114 LLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---------------  177 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---------------  177 (376)
                      |||+|.+ |.++++++..+ ..+++...+..++.|+++++++||   +.+++|-||||+|||+.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999998 66899999663 357899999999999999999999   899999999999999832               


Q ss_pred             -----CceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH
Q 038118          178 -----NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ  252 (376)
Q Consensus       178 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~  252 (376)
                           +..++|+|||.+++...    .....+.|..|.|||++.+-+++.++||||+||||+||++|...|....+.+..
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                 24589999999986432    235566899999999999999999999999999999999999999988876655


Q ss_pred             HHHHHHHHH-------------HhcCCccccccCCcC----------C------CCCcHHHHHHHHHHHHHccCCCCCCC
Q 038118          253 VYLVQWVWD-------------LYGNGKLLEAVDPRL----------C------RDFDEQQMECLMIVGLWCAHPDENLR  303 (376)
Q Consensus       253 ~~~~~~~~~-------------~~~~~~~~~~~~~~~----------~------~~~~~~~~~~l~~li~~cl~~~p~~R  303 (376)
                      ..+.....+             +...+ ...+.+...          +      ..........|.+|+.+||..||.+|
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            444333221             11111 011000000          0      11122344569999999999999999


Q ss_pred             CChHHHHH
Q 038118          304 PSIRQVIH  311 (376)
Q Consensus       304 Ps~~~vl~  311 (376)
                      +|+.|++.
T Consensus       398 iTl~EAL~  405 (415)
T KOG0671|consen  398 ITLREALS  405 (415)
T ss_pred             ccHHHHhc
Confidence            99999985

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-36  Score=282.62  Aligned_cols=265  Identities=23%  Similarity=0.256  Sum_probs=195.3

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCC--CeEEEEEEcccC--ChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeC----Ce
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRET--SSYIAVKRVSKG--SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEK----KE  112 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~----~~  112 (376)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+...  .....+.+.+|+.+++.+. |+||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588899999999999999999887  889999998753  2223567788999999994 99999999875432    45


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .+++++++. ++|.+.+. ....+++..++.++.||+.||.|||   +.|++||||||+|||++.++.++|+|||++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 58887774 4557899999999999999999999   799999999999999999999999999998754


Q ss_pred             ccCCC---cceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH-------
Q 038118          193 EHAKG---SQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD-------  261 (376)
Q Consensus       193 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~-------  261 (376)
                      .....   .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......       
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            32211   11223468899999998765 46889999999999999999999999765543332222211100       


Q ss_pred             HhcCCcc---cccc---CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 LYGNGKL---LEAV---DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 ~~~~~~~---~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......   ....   ...............+.+++.+||+.||.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000   0000   000000001112345788999999999999999999983

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.5e-36  Score=302.22  Aligned_cols=147  Identities=27%  Similarity=0.420  Sum_probs=133.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.++||+|+||.||+|.+..+++.||||++...   .......+..|+.++..++|+||++++.++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            47899999999999999999999999999999998753   233456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      |||+.+++|.+++.. .+.+++..++.++.||+.||.|||   .++|+||||||+|||++.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998854 456889999999999999999999   7899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=291.32  Aligned_cols=202  Identities=34%  Similarity=0.489  Sum_probs=174.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC------CeE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK------KEL  113 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~  113 (376)
                      ..|...+.||+|+||.||+|+++.+|+.||||.+... .....+...+|+++|++|+|+|||+++++=+..      ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            4456678999999999999999999999999999864 344567788999999999999999999876543      356


Q ss_pred             EEEEecCCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC--c--eEEEeeCC
Q 038118          114 LLVYEYMPNGSLDSHLFKE--NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--F--NAKIGDFG  187 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~--~--~~kl~Dfg  187 (376)
                      .+|||||.||+|...+.+.  ..-+++...+.++..+..||.|||   ++||+||||||.||++-..  |  .-||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            8999999999999999653  345999999999999999999999   8999999999999998432  3  47999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCcc
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTA  247 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~  247 (376)
                      .|+.++.  +.....++||..|++||++.. +.|+..+|.|||||++|+.+||..||....
T Consensus       170 ~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  170 AARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9987654  346778899999999999984 789999999999999999999999996543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=288.40  Aligned_cols=241  Identities=25%  Similarity=0.272  Sum_probs=197.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ....|++...+|.|+|+.|-.+.+..+++..++|++.....    +-.+|+.++... +|+|++++++.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            46789999999999999999999999999999999987622    234577665555 6999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee-cCCceEEEeeCCCccccccCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |.+.|+.+.+.+....  .....+..|+.+|+.++.|||   .+|++||||||+|||+ +..++++|+|||.+...... 
T Consensus       396 e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999998888775432  223677789999999999999   7999999999999999 58899999999999765433 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                         .....-|..|.|||++....++.++|+||||++||+||+|+.||........   +...                ..
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~----------------i~  527 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTR----------------IQ  527 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHh----------------hc
Confidence               2233457899999999999999999999999999999999999987765411   1110                00


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+.........+|+.+||+.||.+||++.++..
T Consensus       528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            12222445566788999999999999999999984

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=265.05  Aligned_cols=255  Identities=27%  Similarity=0.343  Sum_probs=197.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++++-...||.|.||+|++-.++.+|+..|||.++... ....++++.|.....+- ++||||++||.+..++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            33445578999999999999999999999999998764 35667888888876655 58999999999999999999999


Q ss_pred             cCCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          119 YMPNGSLDSHLFK----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       119 ~~~~~sL~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +|+- +|..+...    ....+++..+-.+....+.||.||..  +..|+|||+||+|||++..|.+||||||++..+..
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            9954 66443321    34568999888999999999999997  78999999999999999999999999999865432


Q ss_pred             CCCcceeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGSQTTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      +  ...+...|-..|||||.+..  ..|+.+|||||||++|||+.||..|+...+.  ....+.+.+     .+.....+
T Consensus       221 S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv-----~gdpp~l~  291 (361)
T KOG1006|consen  221 S--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVV-----IGDPPILL  291 (361)
T ss_pred             H--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHH-----cCCCCeec
Confidence            2  12344558889999998853  3589999999999999999999999976543  222222211     12111111


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+.-+    ......+..++.-||.+|...||...+++.
T Consensus       292 ~~~~~----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 FDKEC----VHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             Ccccc----cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11111    223455788888999999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-37  Score=272.71  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=203.6

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKE  112 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  112 (376)
                      .....+|+....||+|+||.|.+|..+++.+.+|||++++.   ..+..+--+.|-++|.... -|.+++++..|..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            34467899999999999999999999999999999999764   1222233345666666554 6789999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|+||||+.||.|--.+ ++-+.+.+..+..++..|+-+|-+||   ++||++||||.+||+++.+|.+||+|||+++. 
T Consensus       425 LyFVMEyvnGGDLMyhi-QQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE-  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI-QQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-  499 (683)
T ss_pred             eeeEEEEecCchhhhHH-HHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccc-
Confidence            99999999999997777 44567788888899999999999999   89999999999999999999999999999973 


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      +......+.++.||+.|+|||.+..++|+..+|.||+|++|||||.|++||++.+..++...|...              
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--------------  565 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--------------  565 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--------------
Confidence            223334456788999999999999999999999999999999999999999999887777666541              


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS  305 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  305 (376)
                        .  -.++.....+.+.+....|.+.|.+|..
T Consensus       566 --n--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 --N--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --c--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence              1  1233344556777778889999999953

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=277.57  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=198.2

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCC
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      .+.||+|-||+||-|.++++|+.||||++.+-  ..+....+.+|+.+|+.+.||.||.+...|+..+..++|||.+.|-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            36899999999999999999999999999764  3344577889999999999999999999999999999999999665


Q ss_pred             ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC---ceEEEeeCCCccccccCCCcce
Q 038118          124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       124 sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      -|.-.+....+.+++.....++.||+-||.|||   -++|+|.||||+|||+...   -++||||||++++++....  .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--R  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--R  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--h
Confidence            554445556788999999999999999999999   7999999999999999654   4699999999998865433  3


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ...+||+.|+|||+++++.|...-|+||.|+|+|.-|+|..||....  ++...|.+...          ...+.-+.++
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaF----------MyPp~PW~ei  791 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAF----------MYPPNPWSEI  791 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcccc----------ccCCCchhhc
Confidence            45669999999999999999999999999999999999999996542  33333332111          1122233333


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      .    ...+++|...|+..-++|.|...-+
T Consensus       792 s----~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  792 S----PEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             C----HHHHHHHHHHHHHHHHHhcchHhhc
Confidence            3    3456777778888888898887655

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=268.99  Aligned_cols=275  Identities=26%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             hhcCCCCcccCHHHHHHH--------------hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hh-----
Q 038118           22 FEKGAGPKRFTYKELAQA--------------TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQ-----   80 (376)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~--------------~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~-----   80 (376)
                      .|+....+..-+.|+..+              .++|-+.++||+|||+.||+|++...++.||+|+-..+.  ++     
T Consensus       430 lERLErvrnlHiRELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeN  509 (775)
T KOG1151|consen  430 LERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKEN  509 (775)
T ss_pred             HHHHHHHHHHHHHHHHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhh
Confidence            344444555556666543              457888899999999999999999999999999865432  11     


Q ss_pred             hHHHHHHHHHHHHhCCCCCccceeeEEe-eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038118           81 GIKEYASEVTIISRLRHRNLVQLLGWCH-EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW  159 (376)
Q Consensus        81 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~  159 (376)
                      -.+...+|..+.+.|.||.||++|++|. +.+.+|-|+|||+|..|+-+| +..+.+++..+..|+.||+.||.||... 
T Consensus       510 YhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEi-  587 (775)
T KOG1151|consen  510 YHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEI-  587 (775)
T ss_pred             HHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhcc-
Confidence            1234668999999999999999999996 456789999999999997666 6677899999999999999999999976 


Q ss_pred             CCceEeecccCCCeeecC---CceEEEeeCCCccccccCCCcc------eeeeccCCCCCchhhhccC----CCCCCCce
Q 038118          160 EQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQ------TTVLAGTMGYMAPECATTG----RASKESDV  226 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~----~~~~~sDv  226 (376)
                      +..|+|-||||.|||+-+   .|.+||+|||++++++......      +....||..|++||.+--+    ..+.|.||
T Consensus       588 kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV  667 (775)
T KOG1151|consen  588 KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV  667 (775)
T ss_pred             CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee
Confidence            788999999999999954   4779999999999886543321      2335689999999987433    46889999


Q ss_pred             eechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          227 YSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       227 wslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                      ||.|||+|..+.|+.||.......   .|...       ..+...-  .+.-...+........+|.+||+..-++|...
T Consensus       668 WSvGVIFyQClYGrKPFGhnqsQQ---dILqe-------NTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV  735 (775)
T KOG1151|consen  668 WSVGVIFYQCLYGRKPFGHNQSQQ---DILQE-------NTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDV  735 (775)
T ss_pred             EeeehhhhhhhccCCCCCCchhHH---HHHhh-------hchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhH
Confidence            999999999999999997654221   12211       1110000  01111122334456778999999999999776


Q ss_pred             HHHH
Q 038118          307 RQVI  310 (376)
Q Consensus       307 ~~vl  310 (376)
                      .++.
T Consensus       736 ~qLA  739 (775)
T KOG1151|consen  736 QQLA  739 (775)
T ss_pred             HHHc
Confidence            6654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-35  Score=263.30  Aligned_cols=220  Identities=21%  Similarity=0.166  Sum_probs=177.0

Q ss_pred             CCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhh
Q 038118           52 GGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK  131 (376)
Q Consensus        52 G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~  131 (376)
                      |.+|.||++.+..+++.|++|.+.....     +..|...+....|||++++++++.+.+..++||||+++++|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8999999999999999999999976532     23455555566799999999999999999999999999999998854


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCc
Q 038118          132 ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA  211 (376)
Q Consensus       132 ~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a  211 (376)
                      . ..+++..+..++.|++.+|.|||   +.+++||||||+||+++.++.++|+|||.+......    .....++..|+|
T Consensus        79 ~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a  150 (237)
T cd05576          79 F-LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA  150 (237)
T ss_pred             h-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence            3 45899999999999999999999   799999999999999999999999999987644321    122335678999


Q ss_pred             hhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHH
Q 038118          212 PECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV  291 (376)
Q Consensus       212 PE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  291 (376)
                      ||.+.+..++.++||||+|+++|+|++|..||........              .    ...    ..++......+..+
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~----~~~----~~~~~~~~~~~~~l  208 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------T----HTT----LNIPEWVSEEARSL  208 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------c----ccc----cCCcccCCHHHHHH
Confidence            9999888889999999999999999999988754321100              0    000    01112233457889


Q ss_pred             HHHccCCCCCCCCCh
Q 038118          292 GLWCAHPDENLRPSI  306 (376)
Q Consensus       292 i~~cl~~~p~~RPs~  306 (376)
                      +.+||+.||++||++
T Consensus       209 i~~~l~~dp~~R~~~  223 (237)
T cd05576         209 LQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHccCCHHHhcCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=285.49  Aligned_cols=264  Identities=25%  Similarity=0.371  Sum_probs=214.8

Q ss_pred             CcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeE
Q 038118           28 PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGW  106 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~  106 (376)
                      .....++.+..-.+.|++.+.+|.|.+|.||+++..++++..|+|+....... .+.+..|.++|+.+. |||++.++++
T Consensus         6 ~~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen    6 LMDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             ccccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEE
Confidence            34455566666778899999999999999999999999999999988765433 356778999999985 9999999999


Q ss_pred             Eee-----CCeEEEEEecCCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          107 CHE-----KKELLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       107 ~~~-----~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      +..     ++.+|||||||.||+..+++.. .+..+.|..+..|++.++.+|.+||   .+.++|||||-.|||++.++.
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCc
Confidence            853     5789999999999999998864 2567999999999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC-----CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-----RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL  255 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~  255 (376)
                      |||+|||++..+....+ ...+..||+.|||||++...     .|+.++|+||||++..||.-|.+|+...........+
T Consensus       162 VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I  240 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  240 (953)
T ss_pred             EEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence            99999999977654433 33456699999999998543     4778999999999999999999999766543332211


Q ss_pred             HHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                                   .++..|.+.  -...-.+.+.++|..||.+|-.+||++.++++
T Consensus       241 -------------pRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  241 -------------PRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -------------CCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                         122222222  23344567889999999999999999998874

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=263.18  Aligned_cols=265  Identities=26%  Similarity=0.362  Sum_probs=200.7

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHh--CCCCCccceeeEEeeC----
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR--LRHRNLVQLLGWCHEK----  110 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----  110 (376)
                      .-...+..+.+.||+|.||.||+|.|+  |..||||+|...+.   +.+.+|.++.+.  |+|+||+.|++.-..+    
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            344578889999999999999999999  56799999976543   456677777765  5899999999876433    


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEeecccCCCeeecCCceEEEee
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE-----GWEQCVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-----~~~~~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                      .++|||++|.+.|||+++|..  ..++....++++..++.||++||.     +.+..|.|||||..||||..+|.+.|+|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            368999999999999999954  578889999999999999999996     3467799999999999999999999999


Q ss_pred             CCCccccccCCCc---ceeeeccCCCCCchhhhccCC------CCCCCceeechhhHHHHHhC----------CCCCCCc
Q 038118          186 FGLARLVEHAKGS---QTTVLAGTMGYMAPECATTGR------ASKESDVYSFGIVALEIACG----------RKPISLT  246 (376)
Q Consensus       186 fg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~~lltg----------~~pf~~~  246 (376)
                      +|++.........   .....+||.+|||||++....      --..+||||||.++||++-.          ++||...
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            9999755433221   123457999999999986542      23468999999999998752          2577554


Q ss_pred             cchhhHH-HHHHHHHHHhcCCccccccCCcCC-CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          247 AKEEVQV-YLVQWVWDLYGNGKLLEAVDPRLC-RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       247 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      -+.+... .+...        --.+.+.|.+. ...+...+..+.+++..||..||.-|-|+-.|-+.|...
T Consensus       440 Vp~DPs~eeMrkV--------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  440 VPSDPSFEEMRKV--------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CCCCCCHHHHhcc--------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            3333211 11110        01111223322 233457788899999999999999999998888776543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-36  Score=269.92  Aligned_cols=264  Identities=29%  Similarity=0.372  Sum_probs=196.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHh--CCCCCccceeeEEeeCC----eE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR--LRHRNLVQLLGWCHEKK----EL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~  113 (376)
                      -...++.+.+|+|.||.||+|...  ++.||||++....   .+.|..|-.+...  ++|+||++|+++-....    .+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            345567789999999999999987  4889999997554   4567777777665  47999999998876544    89


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE------GWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      +||++|.+.|+|.++|..  ..++|....+++..+++||+|||.      .++..|+|||||..||||..+++..|+|||
T Consensus       284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999944  568999999999999999999996      456789999999999999999999999999


Q ss_pred             CccccccCCC-cceeeeccCCCCCchhhhccCC------CCCCCceeechhhHHHHHhCCCCCCCccchhh---------
Q 038118          188 LARLVEHAKG-SQTTVLAGTMGYMAPECATTGR------ASKESDVYSFGIVALEIACGRKPISLTAKEEV---------  251 (376)
Q Consensus       188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~~lltg~~pf~~~~~~~~---------  251 (376)
                      ++..+..... ......+||.+|||||++.+..      .-.+.||||+|.+||||++...-+......+.         
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9987653222 2334478999999999986542      12368999999999999986533321110000         


Q ss_pred             ----HHHHHHHHHHHhcCCccccccCCcCCCC-CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCC
Q 038118          252 ----QVYLVQWVWDLYGNGKLLEAVDPRLCRD-FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP  318 (376)
Q Consensus       252 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~  318 (376)
                          ...+...+.    .++.    .|.+... .....+..+.+.+..||+.|++.|.|+.=+-+++.....
T Consensus       442 ~hPt~e~mq~~VV----~kK~----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  442 NHPTLEEMQELVV----RKKQ----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CCCCHHHHHHHHH----hhcc----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence                011111111    1111    1222211 122455678888999999999999999988887765443

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=236.96  Aligned_cols=265  Identities=23%  Similarity=0.277  Sum_probs=205.0

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +|.-.++||+|.||+||+|++..+++.||+|.++..+.  ..-....+|+-+|+.++|.||++++++...++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45556789999999999999999999999999986532  2234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      |.. .|..+...-++.++...+..++.|++++|.|.|   +.++.||||||.|+|+..+|.+||+|||+++.++-... .
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr-c  157 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C  157 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence            954 777777777788999999999999999999999   89999999999999999999999999999987654322 2


Q ss_pred             eeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCC--ccccccCCc
Q 038118          200 TTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNG--KLLEAVDPR  275 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  275 (376)
                      ....+-|..|.+|.++.+.. |+...|+||.|||+.|+.. |++.|.+.+..+....+........++.  .+....|..
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            22334588999999998765 8899999999999999986 8888988876666555544332222111  111111211


Q ss_pred             CCC---------CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCR---------DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...         .+.+.....-++++...|.-+|.+|.+++..++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111         122223333466666778889999999988775

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=277.65  Aligned_cols=249  Identities=21%  Similarity=0.261  Sum_probs=211.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..+++....||-||||.|=++..+.....+|+|++++.   ..+..+.+..|-+++...+.|.||++|..|.+..++|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            45667778899999999999998876666899988764   455567788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      ||-|-||.|+..+ +..+.+++.....++.++++|+.|||   .+||++|||||+|++++.+|-+||.|||+++.+..  
T Consensus       499 mEaClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--  572 (732)
T KOG0614|consen  499 MEACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--  572 (732)
T ss_pred             HHhhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence            9999999999988 44567888888999999999999999   89999999999999999999999999999987753  


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      +..+.++.||+.|.|||++.+...+.++|.|+||+++||||+|.+||.+.+.......|......               
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------------  637 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------------  637 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------------
Confidence            44567788999999999999999999999999999999999999999998877666655542211               


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVI  310 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl  310 (376)
                       -.++....+...+++++.+..+|.+|..     +.+|-
T Consensus       638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk  675 (732)
T KOG0614|consen  638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIK  675 (732)
T ss_pred             -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHH
Confidence             1233444456778888888999999985     55555

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.5e-34  Score=254.48  Aligned_cols=239  Identities=27%  Similarity=0.345  Sum_probs=193.7

Q ss_pred             CCeeEEEEEEcCCCeEEEEEEcccCChhh-HHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhh
Q 038118           53 GFGGVYKGFFRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK  131 (376)
Q Consensus        53 ~~g~vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~  131 (376)
                      +||.||+|.+.+++..+++|++....... ...+.+|++.++.++|+|++++++++......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999889999999998765444 67899999999999999999999999999999999999999999998854


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCc
Q 038118          132 ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA  211 (376)
Q Consensus       132 ~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a  211 (376)
                      .. .++...++.++.+++.++.+||   +.+++|+||+|.||+++.++.++|+|||.+.......  ......++..|++
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            33 3889999999999999999999   7899999999999999999999999999997654332  2334457889999


Q ss_pred             hhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHH
Q 038118          212 PECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV  291 (376)
Q Consensus       212 PE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  291 (376)
                      ||.+.+..++.++|||+||+++|+|++|..||........   +.....    ......       ..........+..+
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~---~~~~~~----~~~~~~-------~~~~~~~~~~~~~~  220 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE---LFKKIG----KPKPPF-------PPPEWKISPEAKDL  220 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHh----ccCCCC-------ccccccCCHHHHHH
Confidence            9999888889999999999999999999999976322211   111110    110000       00000033467889


Q ss_pred             HHHccCCCCCCCCChHHHHH
Q 038118          292 GLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       292 i~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+|+..+|++||++.++++
T Consensus       221 i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      221 IRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHccCCchhccCHHHHhh
Confidence            99999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=286.65  Aligned_cols=261  Identities=29%  Similarity=0.404  Sum_probs=208.9

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcC-------CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCC-CCCccceee
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRE-------TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLR-HRNLVQLLG  105 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~  105 (376)
                      .++...++..+.+.||+|.||.|++|....       ....||||.+... .....+.+..|+.+++.+. |+||+.+++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            455556666777899999999999997432       1457999998764 3355678999999999995 999999999


Q ss_pred             EEeeCCeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccC
Q 038118          106 WCHEKKELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS  170 (376)
Q Consensus       106 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp  170 (376)
                      +|...+..++|+||+..|+|..++...+               ..+....++.++.||+.|++||+   +..++||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence            9999999999999999999999997655               34888999999999999999999   79999999999


Q ss_pred             CCeeecCCceEEEeeCCCccccccCCCcceeeec--cCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCcc
Q 038118          171 SNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA--GTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTA  247 (376)
Q Consensus       171 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~  247 (376)
                      .|||+..+..+||+|||+++..............  -+..|||||.+....++.++||||||++|||+++ |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999854333222222222  2457999999999999999999999999999998 889998743


Q ss_pred             -chhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          248 -KEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       248 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       ..+...        ....+..         ...+..+...+..+++.||+.+|++||++.++.+.+..
T Consensus       527 ~~~~l~~--------~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 PTEELLE--------FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             cHHHHHH--------HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence             222211        1222322         12222334567788999999999999999999998876

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=259.79  Aligned_cols=288  Identities=22%  Similarity=0.292  Sum_probs=217.1

Q ss_pred             cccchhhhhcCCCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHh
Q 038118           15 NEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR   94 (376)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~   94 (376)
                      .+..+-+++++.|.+..-+.+.+. .++|-+.++||+|.|++||+|.+..+.+.||+|+.+...- -.+.-+.|+.+|++
T Consensus        53 ~eqE~~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~  130 (590)
T KOG1290|consen   53 EEQEDPEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQ  130 (590)
T ss_pred             ccccChhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHH
Confidence            455667788899999998887774 4899999999999999999999999999999999865432 23456789999999


Q ss_pred             CC-----C---CCccceeeEEee----CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 038118           95 LR-----H---RNLVQLLGWCHE----KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQ  161 (376)
Q Consensus        95 l~-----h---~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~  161 (376)
                      ++     |   ..||++++.|..    +.++|||+|++ |-+|..+|... .+-++...+..|++||+.||.|||.  +.
T Consensus       131 v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ec  207 (590)
T KOG1290|consen  131 VREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--EC  207 (590)
T ss_pred             HHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hc
Confidence            84     2   359999999975    45899999998 66787877653 4569999999999999999999998  79


Q ss_pred             ceEeecccCCCeeecCC---------------------------------------------------------------
Q 038118          162 CVVHRDIKSSNIMLDLN---------------------------------------------------------------  178 (376)
Q Consensus       162 ~i~H~dlkp~Nill~~~---------------------------------------------------------------  178 (376)
                      ||+|.||||+|||+..+                                                               
T Consensus       208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~  287 (590)
T KOG1290|consen  208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS  287 (590)
T ss_pred             CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence            99999999999999100                                                               


Q ss_pred             --------------------------------------------------------------------------------
Q 038118          179 --------------------------------------------------------------------------------  178 (376)
Q Consensus       179 --------------------------------------------------------------------------------  178 (376)
                                                                                                      
T Consensus       288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s  367 (590)
T KOG1290|consen  288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS  367 (590)
T ss_pred             hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence                                                                                            


Q ss_pred             -----------------------ceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHH
Q 038118          179 -----------------------FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE  235 (376)
Q Consensus       179 -----------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~  235 (376)
                                             -.+||+|||-++-+    ....+....|..|.|||++.+..|+..+||||++|++||
T Consensus       368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FE  443 (590)
T KOG1290|consen  368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWV----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFE  443 (590)
T ss_pred             cCCccccccccccCCCCCCCccceeEEEeeccchhhh----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHH
Confidence                                   01455555555422    222333445778999999999999999999999999999


Q ss_pred             HHhCCCCCCCcc------chhhHHHHHHHHH--------------HHh-cCCccccccCCcC---------CCCCcHHHH
Q 038118          236 IACGRKPISLTA------KEEVQVYLVQWVW--------------DLY-GNGKLLEAVDPRL---------CRDFDEQQM  285 (376)
Q Consensus       236 lltg~~pf~~~~------~~~~~~~~~~~~~--------------~~~-~~~~~~~~~~~~~---------~~~~~~~~~  285 (376)
                      |+||...|....      .++....|.....              .++ +.+.+..+-.-..         ...+..+..
T Consensus       444 LaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A  523 (590)
T KOG1290|consen  444 LATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDA  523 (590)
T ss_pred             hhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHH
Confidence            999999996443      2333333333221              111 1122221111111         124566777


Q ss_pred             HHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          286 ECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       286 ~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+.+++.-||+.+|++|||+.+.++
T Consensus       524 ~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  524 QQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHHHHHHHHhcCccccccHHHHhc
Confidence            88999999999999999999999984

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=280.50  Aligned_cols=251  Identities=29%  Similarity=0.443  Sum_probs=205.4

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .+..++||+|+||+||+|.|-..|.    +||+|++... ..+....+++|+-++..|.|||++++++++.... +-||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            4556899999999999999865443    6888888654 4555678999999999999999999999997765 78999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      +|+++|+|.+++..++..+.....+.|+.||++||.|||   +++++||||-..||||..-..+|+.|||+++.......
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999888888999999999999999999999   89999999999999999999999999999987643322


Q ss_pred             cc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          198 SQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       198 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      .- .....-.+.|||-|.+....++.++|||||||++||++| |..|+.+...+++...+..        +....  -|.
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~--------geRLs--qPp  923 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK--------GERLS--QPP  923 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc--------cccCC--CCC
Confidence            21 122223568999999999999999999999999999988 9999998887766544332        22211  122


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      +       ....+.-++.+||..|+..||+++++...+.
T Consensus       924 i-------CtiDVy~~mvkCwmid~~~rp~fkel~~~fs  955 (1177)
T KOG1025|consen  924 I-------CTIDVYMVMVKCWMIDADSRPTFKELAEEFS  955 (1177)
T ss_pred             C-------ccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence            2       2234566777899999999999999886554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.1e-34  Score=281.50  Aligned_cols=262  Identities=20%  Similarity=0.199  Sum_probs=170.5

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCC----CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeE------Ee
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRET----SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW------CH  108 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~  108 (376)
                      ..++|++.+.||+|+||.||+|++..+    +..||+|++......  +.+..+  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567999999999999999999999988    899999987643221  111111  1122222222222111      24


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKENNL-------------------LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIK  169 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlk  169 (376)
                      .....++|+||+.+++|.+++......                   .....+..++.||+.+|.|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            566899999999999999887543211                   123345679999999999999   7999999999


Q ss_pred             CCCeeecC-CceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC----------------------CCCCCCce
Q 038118          170 SSNIMLDL-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG----------------------RASKESDV  226 (376)
Q Consensus       170 p~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv  226 (376)
                      |+|||++. ++.+||+|||+++..............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999976543333333456689999999966322                      23456799


Q ss_pred             eechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC------CcHHHHHHHHHHHHHccCCCC
Q 038118          227 YSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD------FDEQQMECLMIVGLWCAHPDE  300 (376)
Q Consensus       227 wslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p  300 (376)
                      |||||++|+|+++..++.... ......+...-...   ......+.+....+      ..........+|+.+||+.||
T Consensus       363 wSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDL---VAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcH---HHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999776654221 00000010000000   00000011110000      000111234578999999999


Q ss_pred             CCCCChHHHHH
Q 038118          301 NLRPSIRQVIH  311 (376)
Q Consensus       301 ~~RPs~~~vl~  311 (376)
                      ++|||+.++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999995

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-34  Score=269.42  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...-|..++.||-|+||+|.++....|...||+|.+++.+   +........|-.+|..-..+-||++|-.|.+.+.+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            3445666788999999999999999999999999998753   3344567789999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc--
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE--  193 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~--  193 (376)
                      ||+|++||.+-.+|.+ -+.+++..+..++..+.-|+++.|   +.|+|||||||+|||||.+|.+||+|||+++-+.  
T Consensus       707 VMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             EEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999988855 457899999999999999999999   8999999999999999999999999999986321  


Q ss_pred             -------cCCCcc--------------------------------eeeeccCCCCCchhhhccCCCCCCCceeechhhHH
Q 038118          194 -------HAKGSQ--------------------------------TTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL  234 (376)
Q Consensus       194 -------~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~  234 (376)
                             ..+...                                ...++||+.|+|||++....++..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   000000                                01256999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 038118          235 EIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP  304 (376)
Q Consensus       235 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  304 (376)
                      +|+.|+.||-..+..+.+..+.+|..          .++-..+..+.+++...+.+|   |.  +++.|.
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~~----------~l~~~~~~~ls~e~~~li~kL---c~--sad~RL  917 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWRN----------FLHIPYQGNLSKEALDLIQKL---CC--SADSRL  917 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehhh----------ccccccccccCHHHHHHHHHH---hc--Chhhhh
Confidence            99999999998888888877777643          233344566666655554443   44  344454

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=253.19  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=199.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      -.+|.+...||+|+|++|.+++..++.+.+|+|++++.   ..+.+...+.|-.+..+- +||.+|.++.+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46789999999999999999999999999999999753   344455566777777777 49999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |.||++||.|--++ +++++++++.+..+...|+-||.|||   +.||+.||||.+|||++..|.+||+|+|+++. +..
T Consensus       329 vieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke-~l~  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GLG  403 (593)
T ss_pred             EEEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc-CCC
Confidence            99999999997666 45667999999999999999999999   89999999999999999999999999999974 233


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      .+..+.++.||+.|+|||.+++..|+...|.|+||++++||+.|+.||+............++.....-++.+      +
T Consensus       404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------r  477 (593)
T KOG0695|consen  404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------R  477 (593)
T ss_pred             CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------c
Confidence            4445667889999999999999999999999999999999999999996443322222223333222222111      1


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCC
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRP  304 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP  304 (376)
                      +.+.+    ......++..-|.+||.+|.
T Consensus       478 iprsl----svkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 IPRSL----SVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cccee----ehhhHHHHHHhhcCCcHHhc
Confidence            11222    22244556678899999985

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-34  Score=249.06  Aligned_cols=204  Identities=24%  Similarity=0.352  Sum_probs=168.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEee-CCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHE-KKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~  112 (376)
                      -..|++.++||+|.||.||+|...++..    .+|+|.+.....  ..-....+|+.+++.++|+|++.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4579999999999999999997655433    689999875421  122445689999999999999999999876 889


Q ss_pred             EEEEEecCCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC----ceEEEe
Q 038118          113 LLLVYEYMPNGSLDSHLFK----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN----FNAKIG  184 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~  184 (376)
                      +++++||.+. .|+..|.-    ..+.++...+..++.||+.++.|||   ++=|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999876 67776643    2356899999999999999999999   7889999999999999877    899999


Q ss_pred             eCCCccccccCCCc--ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCcc
Q 038118          185 DFGLARLVEHAKGS--QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTA  247 (376)
Q Consensus       185 Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~  247 (376)
                      |||+++.+...-..  .....+-|..|.|||.+.+. .|+.+.|||+.|||+.||++-++.|.+..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99999987543222  23345568899999998775 58999999999999999999998886543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.3e-33  Score=266.09  Aligned_cols=261  Identities=20%  Similarity=0.280  Sum_probs=177.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc----------------CCCeEEEEEEcccCChhhHHHHH--------------HHH
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR----------------ETSSYIAVKRVSKGSKQGIKEYA--------------SEV   89 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~----------------~~~~~vavK~~~~~~~~~~~~~~--------------~e~   89 (376)
                      .++|++.++||+|+||.||+|.+.                ..++.||||.+........+.|.              .|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            678999999999999999999752                23467999998754433333333              466


Q ss_pred             HHHHhCCCCCc-----cceeeEEee--------CCeEEEEEecCCCCChhhhhhhcC-----------------------
Q 038118           90 TIISRLRHRNL-----VQLLGWCHE--------KKELLLVYEYMPNGSLDSHLFKEN-----------------------  133 (376)
Q Consensus        90 ~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~-----------------------  133 (376)
                      .++.+++|.++     ++++++|..        .+..++||||+++++|.+++....                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766554     667777643        356899999999999998875321                       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchh
Q 038118          134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE  213 (376)
Q Consensus       134 ~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE  213 (376)
                      ..+++..++.++.|++.+|.|||   +.+|+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            12356678889999999999999   789999999999999999999999999998654322222222233578999999


Q ss_pred             hhccCC----------------------CCCCCceeechhhHHHHHhCCC-CCCCccchhhHHHHHHH---HHHHhcCCc
Q 038118          214 CATTGR----------------------ASKESDVYSFGIVALEIACGRK-PISLTAKEEVQVYLVQW---VWDLYGNGK  267 (376)
Q Consensus       214 ~~~~~~----------------------~~~~sDvwslG~il~~lltg~~-pf~~~~~~~~~~~~~~~---~~~~~~~~~  267 (376)
                      .+....                      ...+.||||+||++|+|++|.. ||.....-.........   .|.......
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            875322                      1234799999999999999885 76532211110000000   111111111


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCC---CCCCChHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE---NLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~~vl~  311 (376)
                          ++-.    ..........+++.+||..+|   .+|+|+.|+++
T Consensus       461 ----~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 ----YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ----CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                1111    112223456777788888765   78999999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-35  Score=247.47  Aligned_cols=268  Identities=22%  Similarity=0.330  Sum_probs=203.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-Chhh-HHHHHHHHHHHHhCCCCCccceeeEEe--------e
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQG-IKEYASEVTIISRLRHRNLVQLLGWCH--------E  109 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~--------~  109 (376)
                      .+.|+-..++|+|.||.||+|+.+++++.|++|++-.. .+++ -..-.+|+.+|..|+|+|++.++.+|.        .
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            46677788999999999999999999999999876542 1221 123468999999999999999988774        2


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      ...+|+||.+|++ .|..++......++...+.+++.++..+|.|+|   ...|+|||+|+.|+||+.+|.+||+|||++
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            3468999999976 677777666567899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccCCC---cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc-
Q 038118          190 RLVEHAKG---SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG-  264 (376)
Q Consensus       190 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-  264 (376)
                      +.+.....   ...+..+-|..|.+||.+.+. .++++.|||..|||+.+|.||.+-+.+.+.......|......... 
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            76533222   223344458899999988664 6999999999999999999999999988877666666554322111 


Q ss_pred             ------CCccccccCCc-CCCC---CcHHHHH------HHHHHHHHccCCCCCCCCChHHHHH
Q 038118          265 ------NGKLLEAVDPR-LCRD---FDEQQME------CLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       265 ------~~~~~~~~~~~-~~~~---~~~~~~~------~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                            +-.+...+... +...   ..++..+      ...+++..++..||.+|+.+.+++.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                  11111111100 1110   1111122      4677888899999999999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-34  Score=232.05  Aligned_cols=209  Identities=29%  Similarity=0.407  Sum_probs=173.5

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKK  111 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  111 (376)
                      ..++...+.+.-...||+|++|.|-+-++..+|...|+|.+... ..+..++.++|+.+...- .+|++|.||+......
T Consensus        39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            33555567777788999999999999999999999999999765 344456677788776554 5999999999998999


Q ss_pred             eEEEEEecCCCCChhhhh---hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          112 ELLLVYEYMPNGSLDSHL---FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l---~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                      ..++.||.|+. +|..+.   .+.++.+++..+-+++..+.+||.|||+  +..++|||+||+|||++.+|++|+||||.
T Consensus       119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccc
Confidence            99999999854 665543   3467889999999999999999999998  78999999999999999999999999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhcc----CCCCCCCceeechhhHHHHHhCCCCCCCcc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATT----GRASKESDVYSFGIVALEIACGRKPISLTA  247 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~~lltg~~pf~~~~  247 (376)
                      +..+.++-  ..+...|-..|+|||.+..    ..|+.|+||||||+++.||.+++.||....
T Consensus       196 sG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  196 SGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            97653321  1223458889999998743    368999999999999999999999997543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.1e-33  Score=258.59  Aligned_cols=273  Identities=21%  Similarity=0.193  Sum_probs=213.6

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC------CCcccee
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH------RNLVQLL  104 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~  104 (376)
                      |.+...+..-++|.+....|+|-|++|..|.+..-|..||||+|..+.. -.+.-+.|+++|++|+.      -++++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3444455557999999999999999999999999899999999987633 23456789999999963      4789999


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eE
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKENN--LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NA  181 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~  181 (376)
                      ..|...+++|||||.+ ..+|.++|.+-+.  -+....+..++.|+.-||..|.   ..||+|.||||+||||.+.. .+
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence            9999999999999987 5689998876543  3677888999999999999999   79999999999999998764 58


Q ss_pred             EEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH
Q 038118          182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      ||||||.|.+....   ..+...-+..|.|||++.|..|+...|+||.||+||||.||+..|.+.++.++..........
T Consensus       577 KLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  577 KLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            99999999765433   223333456899999999999999999999999999999999999999988877655543211


Q ss_pred             Hh----cCC---------------------------ccccccCCc------C-----CCCCcHHHHHHHHHHHHHccCCC
Q 038118          262 LY----GNG---------------------------KLLEAVDPR------L-----CRDFDEQQMECLMIVGLWCAHPD  299 (376)
Q Consensus       262 ~~----~~~---------------------------~~~~~~~~~------~-----~~~~~~~~~~~l~~li~~cl~~~  299 (376)
                      +.    ..+                           .+...+.|.      +     ..+-.......+.+|+-.||..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            10    000                           000111110      0     11223355677889999999999


Q ss_pred             CCCCCChHHHHH
Q 038118          300 ENLRPSIRQVIH  311 (376)
Q Consensus       300 p~~RPs~~~vl~  311 (376)
                      |++|.|..+.|.
T Consensus       734 P~KRit~nqAL~  745 (752)
T KOG0670|consen  734 PEKRITVNQALK  745 (752)
T ss_pred             hhhcCCHHHHhc
Confidence            999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=242.13  Aligned_cols=268  Identities=23%  Similarity=0.287  Sum_probs=199.0

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----CeEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KELL  114 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~  114 (376)
                      +.+-.+-||.|+||+||.+++..+|+.|++|++..-.  --..+++.+|+.+|.-++|.|++..+++..-.     ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4556788999999999999999999999999987542  22346788999999999999999988876533     2467


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +|+|++. ..|...+. ....++...+.-+.+||+++|.|||   +.+|.||||||.|+|++.|-.+||||||+++..+.
T Consensus       134 V~TELmQ-SDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHH-hhhhheec-cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            8888873 36665554 3456788888889999999999999   89999999999999999999999999999987654


Q ss_pred             CCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH-------hcCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL-------YGNG  266 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------~~~~  266 (376)
                      ......+..+-|.+|.|||.+.+. .|+.+.||||.|||+.||+..+..|...+.-+....+.+.....       .-++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            444445555678899999999875 58999999999999999999999998777655555554432110       0001


Q ss_pred             c----cccccC-CcCC--CCC--cHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          267 K----LLEAVD-PRLC--RDF--DEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       267 ~----~~~~~~-~~~~--~~~--~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      .    +..... |.+.  ..+  ..........+.+.++.+||+.|.+.++.+..+-
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            0    000000 1110  000  0112233455666799999999999999886543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=5.9e-31  Score=227.36  Aligned_cols=211  Identities=33%  Similarity=0.531  Sum_probs=183.7

Q ss_pred             cccCCCeeEEEEEEcCCCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhh
Q 038118           49 LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS  127 (376)
Q Consensus        49 lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~  127 (376)
                      ||+|++|.||++....+++.+++|++...... ....+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999988999999999876442 35678999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCCCccccccCCCcceeeeccC
Q 038118          128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEHAKGSQTTVLAGT  206 (376)
Q Consensus       128 ~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt  206 (376)
                      ++......++...++.++.+++.++.+||   +.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            88654356889999999999999999999   789999999999999999 89999999999876543221 12334478


Q ss_pred             CCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHH
Q 038118          207 MGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQM  285 (376)
Q Consensus       207 ~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (376)
                      ..|++||..... ..+.+.|+|+||+++++|                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            899999998877 788999999999999998                                                 


Q ss_pred             HHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          286 ECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       286 ~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ..+.+++..|++.+|++||++.++++.
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            236778888999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=253.92  Aligned_cols=199  Identities=26%  Similarity=0.381  Sum_probs=172.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhH-----HHHHHHHHHHHhCC---CCCccceeeEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGI-----KEYASEVTIISRLR---HRNLVQLLGWCH  108 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~-----~~~~~e~~~l~~l~---h~~i~~~~~~~~  108 (376)
                      ...|+..+.||.|+||.|++|.++.+...|+||.+.+...   .+.     -..-.|+++|..|+   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            4679999999999999999999999999999999876421   111     12346999999997   999999999999


Q ss_pred             eCCeEEEEEecC-CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          109 EKKELLLVYEYM-PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       109 ~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      +++++||+||.. +|-.|++++ .....+.+..+..|++|++.++++||   .+||+|||||-+||.++.+|-+||+|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            999999999986 355788888 44567999999999999999999999   8999999999999999999999999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCC
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISL  245 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~  245 (376)
                      .+....   ......++||..|.|||++.+..| +..-|||+||++||.++...-||..
T Consensus       716 saa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            987543   345667889999999999998775 6678999999999999999988853

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=263.06  Aligned_cols=243  Identities=26%  Similarity=0.400  Sum_probs=184.9

Q ss_pred             CCcCCccccCCCee-EEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEecC
Q 038118           43 FNDDQKLGQGGFGG-VYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        43 y~~~~~lg~G~~g~-vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      |.-.+.+|.|..|+ ||+|...  ++.||||.+-....   ....+|+..|+.-. ||||+++++.-.++...||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            33446788998764 6999987  67899998865433   34568999999885 999999999989999999999999


Q ss_pred             CCCChhhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---C--ceEEEeeCCCcccc
Q 038118          121 PNGSLDSHLFKENN---LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N--FNAKIGDFGLARLV  192 (376)
Q Consensus       121 ~~~sL~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~--~~~kl~Dfg~~~~~  192 (376)
                       ..+|.+++.....   .......+.+..|++.||++||   +.+||||||||+||||+.   +  ..++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             4599998865311   1111445788999999999999   799999999999999976   2  46899999999987


Q ss_pred             ccCCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhC-CCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          193 EHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG-RKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       193 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ......  ......||.+|+|||++....-+.+.|||||||++|+.++| .+||...-..+  ..|..      ++..+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~------~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT------GNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc------Ccccee
Confidence            544332  23456799999999999988888899999999999999985 89997654322  22221      111111


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      . +.     .....   ...+||.+|+.++|..||++.+|+.
T Consensus       734 ~-L~-----~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 H-LE-----PLPDC---EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             e-ec-----cCchH---HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1 11     11111   5788999999999999999999984

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=237.43  Aligned_cols=263  Identities=25%  Similarity=0.306  Sum_probs=209.8

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCC-----eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeE
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETS-----SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGW  106 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~  106 (376)
                      .+++.....+++....+-+|.||.||.|.|....     +.|-+|.+... +.-....++.|.-++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4677778889999999999999999999876532     34556666543 44456678899999999999999999998


Q ss_pred             Eee-CCeEEEEEecCCCCChhhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC
Q 038118          107 CHE-KKELLLVYEYMPNGSLDSHLFK-------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN  178 (376)
Q Consensus       107 ~~~-~~~~~lv~e~~~~~sL~~~l~~-------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~  178 (376)
                      +.+ ....++++.+..-|+|..++..       ..+.+...++..++.|++.|+.|||   +.|++|.||...|.+|++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence            765 4578889999988999998862       1234677788899999999999999   8999999999999999999


Q ss_pred             ceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHH
Q 038118          179 FNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLV  256 (376)
Q Consensus       179 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~  256 (376)
                      .++||+|-.+++.+-..+. .-......+..||+||.+.+..|+.++||||||+++|||+| |+.|+...+..+...++.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            9999999998875422222 12233345779999999999999999999999999999998 999998887777766554


Q ss_pred             HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      +        +...         ..+.++..+|..++.-||...|++||+++++..-|.+
T Consensus       513 d--------GyRl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  513 D--------GYRL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             c--------ccee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            3        2211         1122344567778888999999999999999987753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.3e-30  Score=226.85  Aligned_cols=200  Identities=32%  Similarity=0.498  Sum_probs=174.7

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      |.+.+.||.|++|.||++....+++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            56788999999999999999988899999999876554 56788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      +++|.+++......+++..++.++.+++.++.+||   ..+++|+||+|.||+++.++.++|+|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            99999988654333789999999999999999999   789999999999999999999999999998765433211223


Q ss_pred             eeccCCCCCchhhh-ccCCCCCCCceeechhhHHHHHhCCCCCCC
Q 038118          202 VLAGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKPISL  245 (376)
Q Consensus       202 ~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~~lltg~~pf~~  245 (376)
                      ...++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34577899999988 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=254.23  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=204.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+++|.|.+|.||+|++..+++..|+|+++......+.-+++|+-+++..+|+||+.+++.+...+.+|+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            46899999999999999999999999999999999987777778888999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      |.||+|.+.. .-.+++.+.++...++..+++|.|||   +.|-+|||||-.||++++.|.+||.|||.+..+...- ..
T Consensus        94 cgggslQdiy-~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K  168 (829)
T KOG0576|consen   94 CGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK  168 (829)
T ss_pred             cCCCccccee-eecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence            9999997755 44578999999999999999999999   8999999999999999999999999999986554322 23


Q ss_pred             eeeeccCCCCCchhhh---ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          200 TTVLAGTMGYMAPECA---TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ...+.||++|||||+.   +.+.|..++|||++|++..|+-.-+.|.-..........+.       ..     ..+|.-
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-------kS-----~~qpp~  236 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-------KS-----GFQPPT  236 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-------cc-----CCCCCc
Confidence            4557799999999976   56789999999999999999988777643222222111111       01     111111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      ..+ ...-...+.++++.||.++|.+||+++.+|
T Consensus       237 lkD-k~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  237 LKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             ccC-CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            111 112234577888899999999999998765

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.5e-31  Score=221.88  Aligned_cols=259  Identities=19%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeC--CeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEK--KELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l  115 (376)
                      ..++|++.+++|+|.++.||.|....+.++++||+++....   +.+.+|+.+|+-|. ||||++++++..+.  ....+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            46899999999999999999999988899999999976543   56788999999998 99999999998754  56889


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCcccccc
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVEH  194 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~  194 (376)
                      |+|++.+..+..+.    ..+....+..++.+++.||.|+|   +.||+|||+||.|++++... .++|+|+|++.+...
T Consensus       113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            99999887664433    34677788899999999999999   89999999999999998764 599999999987643


Q ss_pred             CCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCC-CCccchhhHHHHHHHHH-----HHhcCCc
Q 038118          195 AKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPI-SLTAKEEVQVYLVQWVW-----DLYGNGK  267 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~-----~~~~~~~  267 (376)
                      .  ......+.+..|..||.+-. ..|+..-|+|||||++..|+..+.|| .+.++.+....+.....     .+..  +
T Consensus       186 ~--~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~--K  261 (338)
T KOG0668|consen  186 G--KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN--K  261 (338)
T ss_pred             C--ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH--H
Confidence            2  23333446778999998754 45788899999999999999988886 55566665555544321     1111  1


Q ss_pred             cccccCCcCCC----------------CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRLCR----------------DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~----------------~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..-.+||.+..                +-..-......+++...|..|-++|+|+.|.+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            11112222211                001111245677888899999999999999763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-30  Score=217.91  Aligned_cols=252  Identities=22%  Similarity=0.342  Sum_probs=187.2

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeE-EeeCCeEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGW-CHEKKELLL  115 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~l  115 (376)
                      ...+.|++.+.||+|.||.+-+++++++...+++|.+..... ..+.|.+|...--.|. |.||+.-|+. |+..+.+++
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            346889999999999999999999999999999999876543 3678999988766675 8899988764 677788999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC--CceEEEeeCCCccccc
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--NFNAKIGDFGLARLVE  193 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~  193 (376)
                      +|||++.|+|.+.+..  .-+.+.....++.|++.|+.|+|   ++++||||||.+||||-.  ..++||||||+.+..+
T Consensus       100 ~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999999887744  34677788899999999999999   899999999999999943  3479999999987543


Q ss_pred             cCCCcceeeeccCCCCCchhhhccC-----CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTG-----RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ..    .....-+..|.+||+....     ...+.+|||.||+++|..|||..||......+.  ..  |.+..+..+..
T Consensus       175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~--~Y--~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK--PY--WEWEQWLKRKN  246 (378)
T ss_pred             ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc--hH--HHHHHHhcccC
Confidence            22    2222345689999966322     346789999999999999999999974432222  11  12222222222


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV  309 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~v  309 (376)
                      ..  -|.....+...    ++.+..+-|.+++++|=-+.++
T Consensus       247 ~~--~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  247 PA--LPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             cc--CchhhcccCHH----HHHHHHHhcCCcccccchhHHH
Confidence            21  13333444444    4455556899999999444443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-31  Score=227.25  Aligned_cols=262  Identities=21%  Similarity=0.231  Sum_probs=201.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC------C
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK------K  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~  111 (376)
                      ..+|...+.+|.|.- .|..|.+.-+++.|++|+....  .....++..+|..++..+.|+|+++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            468888899999988 8889999999999999988643  222346677899999999999999999998644      3


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..|+|||++.. +|...+.   -.++-..+..++.|++.|+.+||   +.||+||||||+||++..+..+||.|||++..
T Consensus        95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            57999999954 7777765   34677788899999999999999   89999999999999999999999999999975


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-----------
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-----------  260 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-----------  260 (376)
                      .+..  ...+..+.+..|.|||++-+..+...+||||+||++.||++|...|.+...-+....+.....           
T Consensus       168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            3322  345566778899999999988899999999999999999999999987766555444433211           


Q ss_pred             ----HHhcCCc------ccccc-CCcCCC--CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 ----DLYGNGK------LLEAV-DPRLCR--DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ----~~~~~~~------~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          .+.+...      ..+.+ |..+..  +.++.....+.+++.+||-.||++|.++.++|+
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                1111100      00001 111111  111223345788888999999999999999996

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=3.1e-29  Score=225.07  Aligned_cols=204  Identities=26%  Similarity=0.404  Sum_probs=169.1

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcC---CCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEee
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRE---TSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHE  109 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  109 (376)
                      ..+....+.|.++++||.|.|+.||++++..   .+..||+|.+.....  -.++..|+++|..+. +.||+++.+++..
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3466677889999999999999999999877   788999999875432  246789999999996 8999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCC
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGL  188 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~  188 (376)
                      ++..++|+||+++....++...    ++...+..+++.++.||.++|   .+||+||||||+|+|.+.. +.-.|+|||+
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechh
Confidence            9999999999999888777633    567888899999999999999   8999999999999999764 5688999999


Q ss_pred             cccccc--------C-------C----------------------------CcceeeeccCCCCCchhhhccC-CCCCCC
Q 038118          189 ARLVEH--------A-------K----------------------------GSQTTVLAGTMGYMAPECATTG-RASKES  224 (376)
Q Consensus       189 ~~~~~~--------~-------~----------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~s  224 (376)
                      +...+.        .       .                            ........||++|.|||++... ..+.+.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            862100        0       0                            0001124599999999998654 478899


Q ss_pred             ceeechhhHHHHHhCCCCCCCc
Q 038118          225 DVYSFGIVALEIACGRKPISLT  246 (376)
Q Consensus       225 DvwslG~il~~lltg~~pf~~~  246 (376)
                      ||||.|+|+..++++..||-..
T Consensus       260 Diws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             ceeeccceeehhhccccccccC
Confidence            9999999999999999998544

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.5e-28  Score=253.31  Aligned_cols=194  Identities=18%  Similarity=0.258  Sum_probs=136.3

Q ss_pred             CCC-CCccceeeEE-------eeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 038118           95 LRH-RNLVQLLGWC-------HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR  166 (376)
Q Consensus        95 l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~  166 (376)
                      ++| .||..++++|       .+...+++++|++ +++|.+++......+++..++.++.||+.||.|||   ++||+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            344 4677777766       2334678888987 66999999665667999999999999999999999   8999999


Q ss_pred             cccCCCeeecCCce-------------------EEEeeCCCccccccCCC---------------cceeeeccCCCCCch
Q 038118          167 DIKSSNIMLDLNFN-------------------AKIGDFGLARLVEHAKG---------------SQTTVLAGTMGYMAP  212 (376)
Q Consensus       167 dlkp~Nill~~~~~-------------------~kl~Dfg~~~~~~~~~~---------------~~~~~~~gt~~y~aP  212 (376)
                      ||||+||||+..+.                   +|++|||+++.......               .......||+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999965444                   45555555542110000               001123578889999


Q ss_pred             hhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHH
Q 038118          213 ECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVG  292 (376)
Q Consensus       213 E~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  292 (376)
                      |++.+..++.++|||||||+||||++|..|+.....  .   +......         .+.+....     .......++
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~---~~~~~~~---------~~~~~~~~-----~~~~~~~~~  245 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--T---MSSLRHR---------VLPPQILL-----NWPKEASFC  245 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--H---HHHHHHh---------hcChhhhh-----cCHHHHHHH
Confidence            999999999999999999999999999888653211  1   1111000         01111101     112345677


Q ss_pred             HHccCCCCCCCCChHHHHH
Q 038118          293 LWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       293 ~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+||+++|.+||++.+|++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            8899999999999999985

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=7.7e-27  Score=197.21  Aligned_cols=165  Identities=21%  Similarity=0.138  Sum_probs=124.7

Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      |+|.+++......+++..++.++.||+.||.|||   +.+      ||+|||++.++.+++  ||++.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6888888766677999999999999999999999   455      999999999999999  99987654321      


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcH
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE  282 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||........  .+..+......       .++.. .....
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~-------~~~~~-~~~~~  133 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPA-------DDPRD-RSNLE  133 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhcc-------CCccc-cccHH
Confidence            2478999999999999999999999999999999999999965432111  11111111100       00110 01112


Q ss_pred             HHHH--HHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          283 QQME--CLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       283 ~~~~--~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ....  .+.+++.+||..+|.+||++.++++.+.
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            2222  5899999999999999999999998664

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3.1e-26  Score=211.90  Aligned_cols=173  Identities=18%  Similarity=0.181  Sum_probs=135.1

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcC-CCeEEEEEEcccC-----ChhhHHHHHHHHHHHHhCCCCCcccee
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRE-TSSYIAVKRVSKG-----SKQGIKEYASEVTIISRLRHRNLVQLL  104 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~  104 (376)
                      ++.++.....++|++.+.||+|+||+||+|.+.. ++..||||++...     .......|.+|+++|+.++|+|++..+
T Consensus         8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188          8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            4556677788999999999999999999999876 6777899986533     223356789999999999999988533


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc-cCCCeeecCCceEEE
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI-KSSNIMLDLNFNAKI  183 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl-kp~Nill~~~~~~kl  183 (376)
                      ..   .+..|+||||++|++|.. + ...   .   ...++.+++.+|.|||   +.||+|||| ||+|||++.++.++|
T Consensus        88 ~~---~~~~~LVmE~~~G~~L~~-~-~~~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         88 LA---TGKDGLVRGWTEGVPLHL-A-RPH---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             EE---cCCcEEEEEccCCCCHHH-h-Ccc---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEE
Confidence            22   245799999999999863 2 111   1   1467889999999999   799999999 999999999999999


Q ss_pred             eeCCCccccccCCCc-------ceeeeccCCCCCchhhhcc
Q 038118          184 GDFGLARLVEHAKGS-------QTTVLAGTMGYMAPECATT  217 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~  217 (376)
                      +|||++..+......       ......++..|++||.+..
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999999865432211       1234567888999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-25  Score=207.17  Aligned_cols=257  Identities=19%  Similarity=0.251  Sum_probs=192.6

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCC-eEEEEEEcccCChhhHHHHHHHHHHHHhCCC----CCccceeeEE-eeCCeEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETS-SYIAVKRVSKGSKQGIKEYASEVTIISRLRH----RNLVQLLGWC-HEKKELLL  115 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~l  115 (376)
                      +|.+.+.||+|+||.||.+.+..++ ..+|+|............+..|..++..+..    .++..+++.. ......|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999988764 5788887765433222266778888888863    6899999998 57788999


Q ss_pred             EEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-----ceEEEeeCCCc
Q 038118          116 VYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-----FNAKIGDFGLA  189 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg~~  189 (376)
                      ||+.+ |.+|.++..... +.++...++.++.|++.+|.+||   +.|++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99997 889988775444 78999999999999999999999   8999999999999999765     46999999999


Q ss_pred             cccc--cCCC-----c-c-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH
Q 038118          190 RLVE--HAKG-----S-Q-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       190 ~~~~--~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      +...  ...+     . . .....||..|+++..+.+...+.+.|+||++.++.+|+.|..||...........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8322  1111     1 1 2345699999999999999999999999999999999999999976654333222222111


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ....        ..  .....+.   .+..+...+-..+...+|....+...|..
T Consensus       255 ~~~~--------~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  255 KLLT--------DR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             hhcc--------cc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            1110        00  1112222   23333333445788899999998877654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.7e-25  Score=185.29  Aligned_cols=209  Identities=22%  Similarity=0.294  Sum_probs=178.0

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC-CCccceeeEEeeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-RNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .+++|.++++||.|+||.+|.|....+|..||||+-+....  ..++..|..+.+.|++ ..|+.+..++.+..+-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            46899999999999999999999999999999998765433  3467789999999984 78999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~  194 (376)
                      +++ |.+|.+++.--.+.++...++-++.|++.-++|+|   .++++||||||+|+|..-   ...+.|+|||+++...+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 88998888666677899999999999999999999   899999999999999843   35699999999987643


Q ss_pred             CCC------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH
Q 038118          195 AKG------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV  253 (376)
Q Consensus       195 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~  253 (376)
                      ...      .......||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||.+.......+
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence            322      22345679999999988887788999999999999999999999998876544433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=6.1e-25  Score=191.87  Aligned_cols=238  Identities=21%  Similarity=0.285  Sum_probs=191.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +-.|++.++||+|.||+++.|++--+++.||||.-...+.  ..++..|.+..+.|. .++|+.+|-+..++.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            5679999999999999999999999999999997655443  467888999999986 7999999988888888899999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-----ceEEEeeCCCccccc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-----FNAKIGDFGLARLVE  193 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfg~~~~~~  193 (376)
                      ++ |.+|.+++.--++.++.+.+..++.|++.-++++|   ++.+|.|||||+|+||...     ..+-++|||+++...
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            98 88999988777889999999999999999999999   8999999999999999643     348999999998764


Q ss_pred             cCCC------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          194 HAKG------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       194 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      +...      .......||.+||+-....+...+.+.|+-|||-++++.|-|.+||.+.........     +...++.+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-----YeKIGe~K  255 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-----YEKIGETK  255 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-----HHHhcccc
Confidence            4333      234556799999999999999999999999999999999999999987654433222     22233333


Q ss_pred             cccccCCcCCCCCcHHHHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLM  289 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~  289 (376)
                      ....+ ..+|..++.++...|.
T Consensus       256 r~T~i-~~Lc~g~P~efa~Yl~  276 (449)
T KOG1165|consen  256 RSTPI-EVLCEGFPEEFATYLR  276 (449)
T ss_pred             ccCCH-HHHHhcCHHHHHHHHH
Confidence            33332 2345556555544443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8e-26  Score=192.42  Aligned_cols=248  Identities=21%  Similarity=0.347  Sum_probs=190.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEccc--CChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +.+++..+|.+...|..|+|+|.+++  +++|++..  .....-+.|..|.-.|+.+.||||+.+++.|.....+.+|..
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence            34556678999999999999999866  45566543  344445789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe--eCCCccccccC
Q 038118          119 YMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG--DFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~  195 (376)
                      |++.|+|+..++.... ..+..++.+++..|++++.|||+. +.-|.---|....+++|++.+.+|+  |--++.     
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-----  341 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----  341 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-----
Confidence            9999999999976543 367778899999999999999964 3445555688899999999877664  433221     


Q ss_pred             CCcceeeeccCCCCCchhhhccCCC---CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRA---SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                         +.....-.+.|++||.++..+-   -.++|+|||++++|||.|...||......+....+.-               
T Consensus       342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------------  403 (448)
T KOG0195|consen  342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------------  403 (448)
T ss_pred             ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------------
Confidence               1112234689999999977653   3578999999999999999999998887776554431               


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       ..++..+++....-+.+++.-|+..||.+||.+..|+-.|+.
T Consensus       404 -eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  404 -EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             -ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence             122233334444457778888999999999999998877653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=4.7e-23  Score=189.93  Aligned_cols=258  Identities=29%  Similarity=0.399  Sum_probs=196.0

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh---hHHHHHHHHHHHHhCCCC-CccceeeEEeeCCeEEEEEe
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ---GIKEYASEVTIISRLRHR-NLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e  118 (376)
                      |++.+.||.|+||.||.+.+.   ..+++|.+......   ....+.+|+..+..+.|+ +++++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788899999999999999998   66899988765322   467899999999999988 79999999987777899999


Q ss_pred             cCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCccccccC
Q 038118          119 YMPNGSLDSHLFKEN--NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  195 (376)
                      ++.++++.+++....  ..+.......+..|++.++.++|   ..+++|||+||+||+++..+ .++++|||++......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999986664433  26899999999999999999999   78999999999999999988 7999999998754332


Q ss_pred             CCc-----ceeeeccCCCCCchhhhcc---CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          196 KGS-----QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       196 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ...     ......|+..|++||.+.+   .......|+|++|++++++++|..||......................  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            221     2355679999999999987   578889999999999999999999987665310011111111100000  


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .................+.+++..|+..+|..|.+..+...
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence               00001111111222345777888899999999999988765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=5.8e-24  Score=183.42  Aligned_cols=172  Identities=13%  Similarity=0.114  Sum_probs=131.9

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh---hHHH------HHHHHHHHHhCCCCCccceeeEEe
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ---GIKE------YASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~---~~~~------~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      ...++|++.+.||.|+||.||++...  +..+++|++......   ....      +.+|++.+.++.|++|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34689999999999999999997653  557999999754322   2222      578999999999999999988865


Q ss_pred             eC--------CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          109 EK--------KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       109 ~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ..        ...++||||++|.+|.+..     .+++    ....+++.++..+|   ..|++|||++|+||+++.+| 
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence            33        3589999999999997763     1222    24568999999999   89999999999999999988 


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA  237 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~ll  237 (376)
                      ++|+|||...........             ...+....+..++|+|+||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999987643211110             01233345668999999999987654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.2e-24  Score=213.94  Aligned_cols=254  Identities=24%  Similarity=0.246  Sum_probs=187.5

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEEEEcc----c-CChhh-HHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS----K-GSKQG-IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~----~-~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .....+|.|.+|.|+.+........+..|.+.    . ..... ...+..|+.+-..|.|+|++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            56678999999988888776655555555543    1 11111 122666777888899999988877776666666669


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |||++ .|+.++... ..+....+..++.|++.|+.|+|   ..|+.|||+|++|+++..+|.+||+|||.+........
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 998888543 46777888899999999999999   89999999999999999999999999999876544333


Q ss_pred             ---cceeeeccCCCCCchhhhccCCCCC-CCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          198 ---SQTTVLAGTMGYMAPECATTGRASK-ESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       198 ---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                         .......|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||......+....-.+        ......+ 
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--------~~~~~~~-  546 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--------YSDQRNI-  546 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------ccccccc-
Confidence               2345677999999999999888765 48999999999999999999976654433210000        0000000 


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..-...+..........++.+||+.||.+|-|+++|++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00011222334455677888999999999999999994

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=2.9e-24  Score=212.36  Aligned_cols=261  Identities=20%  Similarity=0.188  Sum_probs=187.5

Q ss_pred             CcccCHHHHHHHhh-CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHH---HHHHHHHHHHhCCCCCccc
Q 038118           28 PKRFTYKELAQATN-DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIK---EYASEVTIISRLRHRNLVQ  102 (376)
Q Consensus        28 ~~~~~~~~~~~~~~-~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~---~~~~e~~~l~~l~h~~i~~  102 (376)
                      .+..+.+.+..... .|...+.||++.|=+|.+|++.+ |. |+||++-+.. .-.++   +...|++ ...+++||+++
T Consensus         9 sQi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lP   85 (1431)
T KOG1240|consen    9 SQISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLP   85 (1431)
T ss_pred             cccchHHHHhhcCccceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccc
Confidence            34445555554444 78888999999999999999886 44 8889887653 22233   3344444 55668999999


Q ss_pred             eeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEE
Q 038118          103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK  182 (376)
Q Consensus       103 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~k  182 (376)
                      +.-+.+.+...|||-+|+.+ +|++.+ ..+..+...+...|+.||+.||...|   +.||+|||||.+||||+.-+-+.
T Consensus        86 fqk~~~t~kAAylvRqyvkh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~  160 (1431)
T KOG1240|consen   86 FQKVLVTDKAAYLVRQYVKH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLY  160 (1431)
T ss_pred             hHHHHHhhHHHHHHHHHHhh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhh
Confidence            98888888888999999855 888888 34456777778889999999999999   89999999999999999988899


Q ss_pred             EeeCCCcccc--ccCCCccee----eeccCCCCCchhhhccC----------C-CCCCCceeechhhHHHHHh-CCCCCC
Q 038118          183 IGDFGLARLV--EHAKGSQTT----VLAGTMGYMAPECATTG----------R-ASKESDVYSFGIVALEIAC-GRKPIS  244 (376)
Q Consensus       183 l~Dfg~~~~~--~~~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~il~~llt-g~~pf~  244 (376)
                      |+||..-+..  .+.+.....    +...-.+|+|||.+...          . .+++.||||+||++.||++ |++||.
T Consensus       161 LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  161 LTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             hhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            9999876543  222222222    22234589999987431          1 5678999999999999987 799997


Q ss_pred             CccchhhHHHHHHHHHHHhcCC--ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          245 LTAKEEVQVYLVQWVWDLYGNG--KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...-       ..+     +.+  ...+.+-..+.+       ..++.+++.|++.||..|.+++++|+.-.+
T Consensus       241 LSQL-------~aY-----r~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  241 LSQL-------LAY-----RSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHHH-------HhH-----hccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            4431       110     111  000000000100       137888999999999999999999987544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.2e-22  Score=173.14  Aligned_cols=139  Identities=15%  Similarity=0.085  Sum_probs=108.3

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh--h-------H-----------------HHHHHHHHHHHhCCCCC
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ--G-------I-----------------KEYASEVTIISRLRHRN   99 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~   99 (376)
                      ...||+|+||.||+|.+. +|+.||||+++.....  .       .                 .....|++.+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999987 7999999999754211  0       0                 12235999999998877


Q ss_pred             ccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeecccCCCeeecCC
Q 038118          100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL-QEGWEQCVVHRDIKSSNIMLDLN  178 (376)
Q Consensus       100 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~dlkp~Nill~~~  178 (376)
                      +.....+...  ..+|||||++|+++...... ...++...+..++.|++.+|.++ |   ..||+||||||+||+++ +
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence            6433322222  23899999998877554323 35688899999999999999999 6   78999999999999998 4


Q ss_pred             ceEEEeeCCCcccc
Q 038118          179 FNAKIGDFGLARLV  192 (376)
Q Consensus       179 ~~~kl~Dfg~~~~~  192 (376)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2e-21  Score=166.10  Aligned_cols=141  Identities=18%  Similarity=0.122  Sum_probs=110.9

Q ss_pred             cCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh--------------------------hHHHHHHHHHHHHhCCCC
Q 038118           45 DDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ--------------------------GIKEYASEVTIISRLRHR   98 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~   98 (376)
                      +...||+|++|.||+|.+. +|+.||||+++.....                          ....+..|+..+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 7999999998764211                          012235789999999998


Q ss_pred             CccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceEeecccCCCeeecC
Q 038118           99 NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE-QCVVHRDIKSSNIMLDL  177 (376)
Q Consensus        99 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~i~H~dlkp~Nill~~  177 (376)
                      ++.....+....  .++||||++|+++...... ...++......++.|++.++.++|   . .||+||||||+||+++ 
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-  152 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence            875444333332  4899999998865443222 345778888999999999999999   6 9999999999999998 


Q ss_pred             CceEEEeeCCCccccc
Q 038118          178 NFNAKIGDFGLARLVE  193 (376)
Q Consensus       178 ~~~~kl~Dfg~~~~~~  193 (376)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=4.3e-22  Score=176.92  Aligned_cols=233  Identities=18%  Similarity=0.217  Sum_probs=150.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCC----------CCccceeeEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRH----------RNLVQLLGWC  107 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~  107 (376)
                      ..+.....||.|+++.||.+++..+++.++||++....   ...++++.+|.-....+.+          -.++.-++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            34556788999999999999999999999999986432   3346677777766555432          1122112211


Q ss_pred             ---------eeC---C-----eEEEEEecCCCCChhhhhh---hcCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 038118          108 ---------HEK---K-----ELLLVYEYMPNGSLDSHLF---KENN---LLTWEFRFKIAQDLASGLLYLQEGWEQCVV  164 (376)
Q Consensus       108 ---------~~~---~-----~~~lv~e~~~~~sL~~~l~---~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~  164 (376)
                               ...   .     ..+++|+-+ .++|.+++.   ....   .+.....+.+..|+++.+++||   ..|++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceE
Confidence                     111   1     236677776 457766542   2222   2334455667789999999999   79999


Q ss_pred             eecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc--------CCCCCCCceeechhhHHHH
Q 038118          165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--------GRASKESDVYSFGIVALEI  236 (376)
Q Consensus       165 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~il~~l  236 (376)
                      |+||+|+|+|++.+|.++|+||+.....+.    .......+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999987754322    1221345678999997643        2467889999999999999


Q ss_pred             HhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCC
Q 038118          237 ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLR  303 (376)
Q Consensus       237 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  303 (376)
                      .+|..||..........                     .....+. +..+.+..||..+|+.||++|
T Consensus       244 WC~~lPf~~~~~~~~~~---------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPE---------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSG---------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCcccccc---------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999998664322210                     0122333 666778889999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=7.7e-21  Score=160.65  Aligned_cols=186  Identities=15%  Similarity=0.046  Sum_probs=137.7

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh----hHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEe
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ----GIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      -+...|++|+||+||.+..  .+.+++.+.+......    ....+.+|+++|++|. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997765  4677777776554321    1225789999999996 5789999886    34699999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc-cCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI-KSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+.|.+|...+..        ....++.|++.+|.++|   .+||+|||| ||.|||++.++.++|+|||++........
T Consensus        79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             eecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9999988654311        11357889999999999   799999999 79999999999999999999985443221


Q ss_pred             c----c--------eeeeccCCCCCchhhhccC-CCC-CCCceeechhhHHHHHhCCCCCCCc
Q 038118          198 S----Q--------TTVLAGTMGYMAPECATTG-RAS-KESDVYSFGIVALEIACGRKPISLT  246 (376)
Q Consensus       198 ~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslG~il~~lltg~~pf~~~  246 (376)
                      .    .        ..-...++.|+.|+...-- ..+ ...+.++.|+-+|.++|+..++-.+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            0    0        0012257788888854322 122 4568889999999999999887544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2e-21  Score=195.41  Aligned_cols=256  Identities=17%  Similarity=0.211  Sum_probs=188.1

Q ss_pred             CcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC---CCCcccee
Q 038118           28 PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR---HRNLVQLL  104 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~  104 (376)
                      |+.=+..+++..+..|.|.+.||+|+||.||+|...+ |+.||||+-........   .--.+++.+|+   -+-|..+.
T Consensus       685 ~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~  760 (974)
T KOG1166|consen  685 PKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHIS  760 (974)
T ss_pred             cccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHH
Confidence            4444456677778999999999999999999999988 99999998776554321   11122222332   34566677


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-------
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-------  177 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-------  177 (376)
                      ..+.-.+..+||+||.+.|+|.+++. ..+.+++..+..++.|++..+..||   ..+||||||||+|++|..       
T Consensus       761 ~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  761 SAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             HHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCc
Confidence            77777788899999999999999985 6678999999999999999999999   799999999999999943       


Q ss_pred             CceEEEeeCCCccccccC-CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHH
Q 038118          178 NFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV  256 (376)
Q Consensus       178 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~  256 (376)
                      +..++|+|||.+..+... ++.......+|-.+-.+|...|..++...|.|.|+.+++.||.|+.--.            
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~------------  904 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV------------  904 (974)
T ss_pred             ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh------------
Confidence            345999999998755332 2335566678899999999999999999999999999999999874320            


Q ss_pred             HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                             .++. ...++..+.+-+..+.|..+..+   +|..|-..=|.+.++...++
T Consensus       905 -------~~g~-~~~~~~~~~Ry~~~~~W~~~F~~---lLN~~~~~~p~l~~lr~~~~  951 (974)
T KOG1166|consen  905 -------KNGS-SWMVKTNFPRYWKRDMWNKFFDL---LLNPDCDTLPNLQELRTELE  951 (974)
T ss_pred             -------cCCc-ceeccccchhhhhHHHHHHHHHH---HhCcCcccchhHHHHHHHHH
Confidence                   0111 11122334444455566555554   44455555566666665554

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-20  Score=178.13  Aligned_cols=215  Identities=27%  Similarity=0.378  Sum_probs=162.1

Q ss_pred             HHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCC
Q 038118           92 ISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS  171 (376)
Q Consensus        92 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~  171 (376)
                      |+.+.|.|+.+|++.+.++...++|.+||..|+|.+.+......+++.....+.+.|+.+|.|||+  +.-..|+.++..
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence            457889999999999999999999999999999999998877889999999999999999999996  455599999999


Q ss_pred             CeeecCCceEEEeeCCCccccccCC-CcceeeeccCCCCCchhhhccCC-------CCCCCceeechhhHHHHHhCCCCC
Q 038118          172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGR-------ASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       172 Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslG~il~~lltg~~pf  243 (376)
                      |.+++....+||+|||+..+..... ........-..-|.|||.++...       .+.+.||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987653210 01111122345799999887631       467799999999999999999999


Q ss_pred             CCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          244 SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...........+...+..     .....+.|.+....  .....+..++..||..+|.+||++.+|-..++.
T Consensus       159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             ccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            765433322222222211     01111122222111  333468888899999999999999999877764

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=6.4e-20  Score=157.81  Aligned_cols=137  Identities=18%  Similarity=0.196  Sum_probs=108.2

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-----CCCCccceeeEEeeCC---e-E
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-----RHRNLVQLLGWCHEKK---E-L  113 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~  113 (376)
                      +.-.+.||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     .||||++++++++.+.   . +
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            45567999999999995  6666665 69988765444557789999999999     5799999999998863   4 3


Q ss_pred             EEEEec--CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEeecccCCCeeecCC----ceEEEeeC
Q 038118          114 LLVYEY--MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL-LYLQEGWEQCVVHRDIKSSNIMLDLN----FNAKIGDF  186 (376)
Q Consensus       114 ~lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~Df  186 (376)
                      .+|+||  +.+++|.+++.+.  .+++.  ..++.+++.++ .|||   +++|+||||||+|||++..    +.++|+||
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            478999  5579999999542  35555  35677777777 9999   8999999999999999743    37999995


Q ss_pred             CCc
Q 038118          187 GLA  189 (376)
Q Consensus       187 g~~  189 (376)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=8.5e-22  Score=185.96  Aligned_cols=226  Identities=23%  Similarity=0.254  Sum_probs=175.9

Q ss_pred             ccccCCCeeEEEEEE---cCCCeEEEEEEcccCChh--hHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEecCC
Q 038118           48 KLGQGGFGGVYKGFF---RETSSYIAVKRVSKGSKQ--GIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~---~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      .+|.|.||.|+++.-   ...+..+++|+..+....  .......|..++...+ ||.+++++-.+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999988653   234667888887654211  1114556888888887 9999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCccee
Q 038118          122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT  201 (376)
Q Consensus       122 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  201 (376)
                      ||.|...+.+. ....+.....+...++-++.++|   +.+++|||+|++||+++.+|.+++.|||+++..-.....   
T Consensus        81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence            99998877443 34556666667778999999999   899999999999999999999999999999764222111   


Q ss_pred             eeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCc
Q 038118          202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD  281 (376)
Q Consensus       202 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                        .||..|||||+++  .....+|.||||++.++|+||..||..    +....|.                  ...-..+
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il------------------~~~~~~p  207 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL------------------KAELEMP  207 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh------------------hhccCCc
Confidence              6899999999988  567889999999999999999999986    2222221                  1123345


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          282 EQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       282 ~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                      ......+..++..++..+|..|.-.
T Consensus       208 ~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  208 RELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            5566667777888888999999765

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=3.9e-20  Score=162.95  Aligned_cols=155  Identities=19%  Similarity=0.215  Sum_probs=120.2

Q ss_pred             cccCHHHHHHHhhCCCcCCccccCCCeeEEEEE-EcCCCeEEEEEEcccCChh------------------------hHH
Q 038118           29 KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGF-FRETSSYIAVKRVSKGSKQ------------------------GIK   83 (376)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~-~~~~~~~vavK~~~~~~~~------------------------~~~   83 (376)
                      .......+...+.-|.+.+.||.|++|.||+|. +..+|..||+|++......                        ...
T Consensus        16 ~~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (237)
T smart00090       16 TRLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRL   95 (237)
T ss_pred             HHHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHH
Confidence            355566677777779999999999999999999 6678999999998754210                        112


Q ss_pred             HHHHHHHHHHhCCCCC--ccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 038118           84 EYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ  161 (376)
Q Consensus        84 ~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~  161 (376)
                      .+..|+..+..+.+..  +++++++    ...++||||++|.+|...... ........+..++.||+.++.+||   ..
T Consensus        96 ~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~  167 (237)
T smart00090       96 WAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLY---KE  167 (237)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHH---hc
Confidence            3568999999997532  3444432    234899999999887665422 234556667789999999999999   78


Q ss_pred             c-eEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          162 C-VVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       162 ~-i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      | ++||||||+||+++ ++.++|+|||.+...
T Consensus       168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            8 99999999999999 789999999998643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=1.5e-20  Score=186.02  Aligned_cols=213  Identities=24%  Similarity=0.284  Sum_probs=152.2

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .....+|+.++.+..|++|.||.++++.+.+.+|+| +.++.-- .+.      +|.....|.++               
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-lRn------ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-LRN------ILTFAGNPFVV---------------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-hhc------cccccCCccee---------------
Confidence            345678999999999999999999999999999994 4333211 010      22222333333               


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                            |+-...+ +.-+.++...        +.+++|||   +.||+|||+||+|++|+.-|.+|++|||+++......
T Consensus       136 ------gDc~tll-k~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ------GDCATLL-KNIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ------chhhhhc-ccCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                  2222222 3334444433        67899999   8999999999999999999999999999986532111


Q ss_pred             C--------------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          197 G--------------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       197 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      .              .......||+.|+|||++..+.|+...|.|++|+|+|+.+-|+.||.+.+.+++...........
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence            1              11234579999999999999999999999999999999999999999998888766554421111


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS  305 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs  305 (376)
                                     .+-......+..+++..+|+.+|..|--
T Consensus       278 ---------------pE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  278 ---------------PEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             ---------------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                           1112222334677888899999999963

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2e-18  Score=150.16  Aligned_cols=134  Identities=19%  Similarity=0.280  Sum_probs=110.8

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--------hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--------QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +.||+|++|.||+|.+.  +..|++|+......        .....+.+|+.++..+.|+++.....++......++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEeeC--CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            57999999999999883  56788997654321        112357789999999999998777777777778899999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      |++|++|.+.+....    . ....++.+++.+|.+||   ..+++|+|++|.||+++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999988874322    1 67789999999999999   79999999999999999 78899999999863

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2e-18  Score=148.64  Aligned_cols=147  Identities=15%  Similarity=0.136  Sum_probs=113.2

Q ss_pred             CHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh----------------------hHHHHHHHH
Q 038118           32 TYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ----------------------GIKEYASEV   89 (376)
Q Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~   89 (376)
                      ...++......|.+.+.||.|+||.||++.+. +|+.|+||++......                      ....+..|+
T Consensus         6 ~~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   84 (198)
T cd05144           6 ALHTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF   84 (198)
T ss_pred             HHHHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence            34555555556999999999999999999875 6889999987643210                      011356788


Q ss_pred             HHHHhCCCCC--ccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 038118           90 TIISRLRHRN--LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD  167 (376)
Q Consensus        90 ~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d  167 (376)
                      .++..+.|++  ++..++    ....++||||++|++|......       .....++.+++.++.++|   ..|++|||
T Consensus        85 ~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~D  150 (198)
T cd05144          85 AALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGD  150 (198)
T ss_pred             HHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCC
Confidence            8898887774  444443    2345899999999988664321       234578899999999999   79999999


Q ss_pred             ccCCCeeecCCceEEEeeCCCccccc
Q 038118          168 IKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       168 lkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |+|+||+++.++.++|+|||++....
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.5e-18  Score=155.51  Aligned_cols=191  Identities=24%  Similarity=0.259  Sum_probs=133.5

Q ss_pred             CCCCccceeeEEee---------------------------CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHH
Q 038118           96 RHRNLVQLLGWCHE---------------------------KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDL  148 (376)
Q Consensus        96 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i  148 (376)
                      +||||+.+.++|.+                           ...+|+||..++. +|..++..+.  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999887632                           2468999998855 8888886543  4555566689999


Q ss_pred             HHHHHHHHhCCCCceEeecccCCCeee--cCCc--eEEEeeCCCccccccC-----CCcceeeeccCCCCCchhhhccCC
Q 038118          149 ASGLLYLQEGWEQCVVHRDIKSSNIML--DLNF--NAKIGDFGLARLVEHA-----KGSQTTVLAGTMGYMAPECATTGR  219 (376)
Q Consensus       149 ~~~l~~Lh~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~  219 (376)
                      ++++.|||   ++||.|||+|.+|||+  ++++  .+.|+|||.+-..+..     ..+......|...-||||+....+
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   8999999999999998  3333  4788999987533221     111122345788999999875322


Q ss_pred             ------CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHH
Q 038118          220 ------ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGL  293 (376)
Q Consensus       220 ------~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  293 (376)
                            .-.|+|.|+.|.+.||+++..-||..........            ....+.--|.+....    ...+.+++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------r~Yqe~qLPalp~~v----pp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------RTYQESQLPALPSRV----PPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------hhhhhhhCCCCcccC----ChHHHHHHH
Confidence                  2358999999999999999999997633211111            111111123333333    344677788


Q ss_pred             HccCCCCCCCCChHH
Q 038118          294 WCAHPDENLRPSIRQ  308 (376)
Q Consensus       294 ~cl~~~p~~RPs~~~  308 (376)
                      ..|+.||.+|++..-
T Consensus       492 ~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNI  506 (598)
T ss_pred             HHhcCCccccCCccH
Confidence            899999999998653

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.1e-19  Score=168.58  Aligned_cols=243  Identities=21%  Similarity=0.266  Sum_probs=157.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceee-------EEe--
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG-------WCH--  108 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-------~~~--  108 (376)
                      ..+.+.+..+..+++.++...-..+   ...+.-+......-.......+++..+....|.+..-+.+       .+.  
T Consensus       244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~  323 (516)
T KOG1033|consen  244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN  323 (516)
T ss_pred             ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence            3345556666666666665543332   2222333222222122233334444444444333222222       111  


Q ss_pred             ---eCCeEEEEEecCCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEE
Q 038118          109 ---EKKELLLVYEYMPNGSLDSHLFKE--NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI  183 (376)
Q Consensus       109 ---~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl  183 (376)
                         ...++||.|++|...+|.+++..+  ....+....+.++.|++.++.|      ++.+|+|+||.||++..+..+||
T Consensus       324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhh
Confidence               123589999999999999999533  2356778888999999999987      68999999999999999999999


Q ss_pred             eeCCCccccccCC-----CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHH
Q 038118          184 GDFGLARLVEHAK-----GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       184 ~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  257 (376)
                      .|||+.+......     ....+...||..||+||++.+..|+.|+|||+||+||+||+. -...|......        
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~--------  469 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL--------  469 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh--------
Confidence            9999987654433     234566789999999999999999999999999999999987 33333211100        


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV  309 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~v  309 (376)
                         .-.+    ...++|....+.+.     -..++.+++.+.|.+||++.++
T Consensus       470 ---~d~r----~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 ---TDIR----DGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ---hhhh----cCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence               0001    11223333333333     2467778999999999955443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=9.3e-18  Score=144.57  Aligned_cols=130  Identities=20%  Similarity=0.298  Sum_probs=104.3

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCC--------hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--------KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .||+|++|.||+|.+.  +..|++|......        .....++.+|++++..+.|+++....-++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            4899999999999964  5678889854321        11135677899999999988765555555566677999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ++|++|.+.+.....        .++.+++.+|.+||   ..|++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887643211        78999999999999   79999999999999999 78999999999854

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1e-17  Score=165.40  Aligned_cols=137  Identities=18%  Similarity=0.251  Sum_probs=110.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--C------hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--S------KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  111 (376)
                      ...|...+.||+|+||.||+|.+....  +++|+....  .      .....++.+|+++++.++|++++....++....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            345567889999999999999887644  333332111  1      112356889999999999999988777777777


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..++||||++|++|.+++.         ....++.+++.+|.+||   +.+++||||||+||++ .++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            7899999999999988774         34578999999999999   7999999999999999 577899999999864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=1.2e-16  Score=130.67  Aligned_cols=135  Identities=22%  Similarity=0.148  Sum_probs=113.7

Q ss_pred             cCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC--CCccceeeEEeeCCeEEEEEecCCC
Q 038118           45 DDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH--RNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.+.||.|.++.||++...+  ..+++|.+.....  ...+..|+..++.++|  .++++++.++...+..+++|||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            45789999999999999865  5689999866543  4578889999999976  5899999988888889999999998


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      +.+..+        +......++.+++.++.+||..+..+++|+|++|.||++++.+.++++|||.+..
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            877543        4455667899999999999965446899999999999999989999999999853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.70  E-value=1.2e-16  Score=136.18  Aligned_cols=136  Identities=21%  Similarity=0.227  Sum_probs=96.9

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh--hHHH----------------------HHHHHHHHHhCCCCC--
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ--GIKE----------------------YASEVTIISRLRHRN--   99 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~~--   99 (376)
                      .+.||+|+||.||+|.+. +++.||||++......  ....                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999987 6889999998754211  1111                      134556666654432  


Q ss_pred             ccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceEeecccCCCeeecCC
Q 038118          100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE-QCVVHRDIKSSNIMLDLN  178 (376)
Q Consensus       100 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~i~H~dlkp~Nill~~~  178 (376)
                      +.+.++.    ...++||||++++.+......... . ......++.+++.++.++|   . .+++|+||+|+||+++ +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            4444443    235899999998544321111111 1 1556789999999999999   6 9999999999999999 8


Q ss_pred             ceEEEeeCCCcccc
Q 038118          179 FNAKIGDFGLARLV  192 (376)
Q Consensus       179 ~~~kl~Dfg~~~~~  192 (376)
                      +.++|+|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            89999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=8.9e-18  Score=165.63  Aligned_cols=256  Identities=24%  Similarity=0.302  Sum_probs=190.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-CCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-TSSYIAVKRVSKGS--KQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...|.+.+.||.|.|+.|-...... ....+++|.+....  .....+...|..+-..+. |.|++++++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4678889999999999999887743 34567777665543  333445556777777787 9999999999999999999


Q ss_pred             EEecCCCCChhhhh-hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCccccc
Q 038118          116 VYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVE  193 (376)
Q Consensus       116 v~e~~~~~sL~~~l-~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  193 (376)
                      ++++..|+++.+.+ .......+....-.++.|+..++.|+|.  ..++.|+|++|+|.+++..+ .+++.|||++....
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999888 4443355666677899999999999995  58999999999999999999 99999999998765


Q ss_pred             c--CCCcceeeecc-CCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          194 H--AKGSQTTVLAG-TMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       194 ~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      .  ..........| ++.|+|||...+ .......|+||.|+++..+++|..|+...........  .|.     ..+  
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~--~~~-----~~~--  247 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS--SWK-----SNK--  247 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce--eec-----ccc--
Confidence            4  22222344567 999999998877 4567889999999999999999999976654432110  000     000  


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      ..........+.    .....+..+++..+|..|.+.+++-
T Consensus       248 ~~~~~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 GRFTQLPWNSIS----DQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccccCccccCC----hhhhhcccccccCCchhcccccccc
Confidence            000011112222    2345566678889999999998875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=1.1e-15  Score=134.82  Aligned_cols=134  Identities=17%  Similarity=0.165  Sum_probs=102.4

Q ss_pred             Cccc-cCCCeeEEEEEEcCCCeEEEEEEcccCC-------------hhhHHHHHHHHHHHHhCCCCCc--cceeeEEeeC
Q 038118           47 QKLG-QGGFGGVYKGFFRETSSYIAVKRVSKGS-------------KQGIKEYASEVTIISRLRHRNL--VQLLGWCHEK  110 (376)
Q Consensus        47 ~~lg-~G~~g~vy~a~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~  110 (376)
                      ..|| .||.|+||.+...  +..++||.+....             .....++.+|+.++..|.|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 8899999998875  5668999875321             1123467889999999998775  6666664332


Q ss_pred             -C---eEEEEEecCCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEee
Q 038118          111 -K---ELLLVYEYMPN-GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       111 -~---~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                       .   ..++|||+++| .+|.+++..  ..++..    .+.+|+.+|.+||   ..||+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 688777643  334443    3568999999999   79999999999999999988999999


Q ss_pred             CCCccc
Q 038118          186 FGLARL  191 (376)
Q Consensus       186 fg~~~~  191 (376)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=1.1e-16  Score=140.47  Aligned_cols=237  Identities=24%  Similarity=0.332  Sum_probs=159.0

Q ss_pred             CCeeEEEEEEcCCCeEEEEEEcccCC----hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----CeEEEEEecCCCC
Q 038118           53 GFGGVYKGFFRETSSYIAVKRVSKGS----KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KELLLVYEYMPNG  123 (376)
Q Consensus        53 ~~g~vy~a~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~  123 (376)
                      +.-.||++.++..|..|+...++...    +........-+..|-++-|.||++++.|+.+.     ....+++||+..|
T Consensus        78 gid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssg  157 (458)
T KOG1266|consen   78 GIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG  157 (458)
T ss_pred             chHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence            34567888888877766544333221    11112223334455666799999999998654     3578999999999


Q ss_pred             Chhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc---cccCCC
Q 038118          124 SLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL---VEHAKG  197 (376)
Q Consensus       124 sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~---~~~~~~  197 (376)
                      ++..+|.+   ....+......+|+.||+.||.|||.+ ...|+|+++..+.|++..+|-+|+.---....   ......
T Consensus       158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~  236 (458)
T KOG1266|consen  158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE  236 (458)
T ss_pred             hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhH
Confidence            99999865   345688888899999999999999987 78899999999999999998888753221111   011111


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCC-ccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL-TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......+.++|.+||.-.....+.++|||+||+...+|.-|..--.. ...-.....+.+..          ..+...+
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i----------~~len~l  306 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI----------IGLENGL  306 (458)
T ss_pred             hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe----------eeccCcc
Confidence            122334467899999976666678899999999999999888755322 22222222221110          0111111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .           +.++..|++..|..||++++++.
T Consensus       307 q-----------r~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  307 Q-----------RGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             c-----------cCcCcccccCCCCCCcchhhhhc
Confidence            1           22344599999999999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=3.9e-15  Score=141.04  Aligned_cols=249  Identities=24%  Similarity=0.287  Sum_probs=185.0

Q ss_pred             hhCCCcCCcccc--CCCeeEEEEEE--cCCCeEEEEEEccc--CChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQ--GGFGGVYKGFF--RETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~--G~~g~vy~a~~--~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  112 (376)
                      ...+.+.+.+|.  |.+|.||.+..  ...+..+++|.-..  .....-..=.+|+...+++. |+|.++.+..++..+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            356778899999  99999999998  78888999997432  22222222245666677775 9999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCC
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS----GLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFG  187 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~----~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg  187 (376)
                      .++-+|+|. .+|..+.+.....++...++..+.+...    ||.++|   ..+++|-|++|.||+...+ ...+++|||
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcc
Confidence            999999984 6887887777777899999999999999    999999   8999999999999999999 789999999


Q ss_pred             CccccccCCCcc----eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          188 LARLVEHAKGSQ----TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       188 ~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +...+....-..    .....|...|++||..+ +.++..+|+|+||.++.+..+|..++.......       |  ...
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W--~~~  338 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------W--SQL  338 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-------c--ccc
Confidence            988765443211    12235788999999765 678999999999999999988876654321110       0  000


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      +...    +...++..    ....+..++..+++.+|..|++...+.
T Consensus       339 r~~~----ip~e~~~~----~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  339 RQGY----IPLEFCEG----GSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cccc----CchhhhcC----cchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            0000    11222222    223344577789999999999988765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.52  E-value=8.3e-14  Score=133.42  Aligned_cols=170  Identities=18%  Similarity=0.193  Sum_probs=131.3

Q ss_pred             EEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCH
Q 038118           59 KGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTW  138 (376)
Q Consensus        59 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~  138 (376)
                      .|..+.++.+|.|+..............+-+..|+.++||||+++++.++.++..|||+|.+  ..|..++....    .
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~  103 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----K  103 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----H
Confidence            46667778889999887765555566778899999999999999999999999999999987  45656664432    5


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC
Q 038118          139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG  218 (376)
Q Consensus       139 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  218 (376)
                      ..+..-+.||+.||.|||+  ..+++|++|.-..|+|+..|.+||++|.++........ .......-..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            5566788999999999997  78999999999999999999999999998754332221 11111223356677754322


Q ss_pred             CCCCCCceeechhhHHHHHhC
Q 038118          219 RASKESDVYSFGIVALEIACG  239 (376)
Q Consensus       219 ~~~~~sDvwslG~il~~lltg  239 (376)
                      .  -..|.|.|||++++++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  346999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.3e-13  Score=132.19  Aligned_cols=139  Identities=20%  Similarity=0.193  Sum_probs=95.8

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHH----------------------------------------HHH
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK----------------------------------------EYA   86 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~   86 (376)
                      +.||.|++|.||+|+.. +|+.||||+..........                                        +|.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999976 4789999998764211110                                        244


Q ss_pred             HHHHHHHhCC----CCCccceeeEEe-eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 038118           87 SEVTIISRLR----HRNLVQLLGWCH-EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS-GLLYLQEGWE  160 (376)
Q Consensus        87 ~e~~~l~~l~----h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~-~l~~Lh~~~~  160 (376)
                      .|+..+..+.    +.+-+.+-.++. .....++||||++|++|.+..........   ...++..++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence            4565555552    333333333332 23456999999999999876643211122   2345555555 356777   7


Q ss_pred             CceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       161 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .|++|+|++|.||+++.++.++|+|||++..+
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            99999999999999999999999999998654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=5.8e-13  Score=129.23  Aligned_cols=142  Identities=17%  Similarity=0.178  Sum_probs=95.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhh------------------------------H----H--
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG------------------------------I----K--   83 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~------------------------------~----~--   83 (376)
                      ...|.. +.||.|++|.||+|+...+|+.||||+++......                              .    +  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            455776 78999999999999998889999999997652111                              0    1  


Q ss_pred             ----HHHHHHHHHHhCC----CCCccceeeEEee-CCeEEEEEecCCCCChhhhhh-hcCC----CCCHHHHHHHHHHHH
Q 038118           84 ----EYASEVTIISRLR----HRNLVQLLGWCHE-KKELLLVYEYMPNGSLDSHLF-KENN----LLTWEFRFKIAQDLA  149 (376)
Q Consensus        84 ----~~~~e~~~l~~l~----h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~-~~~~----~~~~~~~~~~~~~i~  149 (376)
                          +|.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.+.+... ...+    .+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                1334555555442    3333444343322 345689999999999976421 1111    12222222233332 


Q ss_pred             HHHHHHHhCCCCceEeecccCCCeeecCCc----eEEEeeCCCcccc
Q 038118          150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNF----NAKIGDFGLARLV  192 (376)
Q Consensus       150 ~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~~~~  192 (376)
                            .   ..|++|+|+||+||+++.++    .++++|||+...+
T Consensus       277 ------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        277 ------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             ------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                  3   58999999999999999988    9999999998755

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=5.2e-13  Score=111.76  Aligned_cols=130  Identities=15%  Similarity=0.111  Sum_probs=94.8

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecCCCCC
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL-VQLLGWCHEKKELLLVYEYMPNGS  124 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~s  124 (376)
                      .+.|+.|.++.||++...  +..|++|........ ...+..|+.+++.+.+.++ ++++.+..  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            357889999999999875  677999987654321 2346789999998875554 45555433  33589999999988


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW--EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       125 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      +....      .   ....+..+++++|..||...  ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus        78 l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            75420      1   11245678999999999421  12369999999999999 6689999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=2.9e-12  Score=108.50  Aligned_cols=140  Identities=16%  Similarity=0.081  Sum_probs=100.7

Q ss_pred             CCccccCCCeeEEEEEEcC------CCeEEEEEEcccCC----------------------hhhHHHHH----HHHHHHH
Q 038118           46 DQKLGQGGFGGVYKGFFRE------TSSYIAVKRVSKGS----------------------KQGIKEYA----SEVTIIS   93 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~   93 (376)
                      ...||.|--+.||.|....      .+..+|||+++...                      ......+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998654      35789999875321                      01122233    7999999


Q ss_pred             hCCC--CCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeecccC
Q 038118           94 RLRH--RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL-QEGWEQCVVHRDIKS  170 (376)
Q Consensus        94 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~dlkp  170 (376)
                      ++..  -+++..+++    ..-+|||||+.+..+.....+. ..++......+..+++.+|..| |   ..|++|+||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            9863  466777764    4458999999765442222121 2344555667888999999988 7   78999999999


Q ss_pred             CCeeecCCceEEEeeCCCcccccc
Q 038118          171 SNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       171 ~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      .||++++ +.+.|+|||.+....+
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeCCC
Confidence            9999974 6799999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=4.2e-11  Score=104.67  Aligned_cols=141  Identities=21%  Similarity=0.234  Sum_probs=107.9

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCC--CCccceeeEEeeC---CeEEEEEecC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRH--RNLVQLLGWCHEK---KELLLVYEYM  120 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~  120 (376)
                      +.|+.|..+.||++...+ |..+++|....... .....+..|+++++.+.+  .++++++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998754 57799998765432 134578899999999975  4467788777654   3678999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW-----------------------------------------  159 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-----------------------------------------  159 (376)
                      +|.++...+..  ..++......++.+++++|..||+..                                         
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99888765421  34566667777888888888887421                                         


Q ss_pred             ------------CCceEeecccCCCeeecC--CceEEEeeCCCcc
Q 038118          160 ------------EQCVVHRDIKSSNIMLDL--NFNAKIGDFGLAR  190 (376)
Q Consensus       160 ------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~  190 (376)
                                  ...++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        255899999999999998  5678999999885

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=4.6e-12  Score=120.34  Aligned_cols=247  Identities=21%  Similarity=0.224  Sum_probs=170.7

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEc-CCCeEEEEEEcccCChhhHHH--HHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFR-ETSSYIAVKRVSKGSKQGIKE--YASEVTIISRLR-HRNLVQLLGWCHEKKE  112 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  112 (376)
                      -....+|..+..||.|.|+.|+....+ .++..|++|.+.........+  -..|+.+...+. |.+++..+..+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            344578889999999999999998766 677889999876553222222  235666666664 8888888888877778


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCCccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARL  191 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~  191 (376)
                      .|+=-|||+++++...+ .-...+.+...+++..|++.++.++|   +..++|+|++|.||++..+ +..++.|||..+.
T Consensus       341 ~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            88999999999876655 22335677888899999999999999   8999999999999999886 6788999998863


Q ss_pred             cccCCCcceeeeccCCCCC--chhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          192 VEHAKGSQTTVLAGTMGYM--APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      +.-    ........-++.  ++.......+..+.|+++||..+++.++|...-.....-.                .+.
T Consensus       417 ~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------------~i~  476 (524)
T KOG0601|consen  417 LAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------------TIR  476 (524)
T ss_pred             cce----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce----------------eee
Confidence            211    111122233444  5555555678899999999999999999875432211000                000


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ...-+.....     ...+..+...+..+++..||.+.++...
T Consensus       477 ~~~~p~~~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  477 SGDTPNLPGL-----KLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             cccccCCCch-----HHhhhhhhhhhcCCccccchhhhhhccc
Confidence            0011111111     1334445556888999999998887643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=5.3e-11  Score=97.61  Aligned_cols=131  Identities=21%  Similarity=0.242  Sum_probs=96.8

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC---Chh-----hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQ-----GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..+++|+-+.+|.+.+.  |..+++|.-..+   .+.     ...+-.+|++++.++.--.|..-+=+..+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46789999999999775  444667754322   111     12345579999999875555443444556666789999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      |++|..|.+.+...        ...++..+-..+.-||   ..||+|+||.++||++...+ +.++|||++.+
T Consensus        80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998888554        1356777777778899   89999999999999998764 99999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.29  E-value=4.5e-11  Score=97.61  Aligned_cols=141  Identities=18%  Similarity=0.180  Sum_probs=102.8

Q ss_pred             cCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--------ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           45 DDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--------SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ....+-+|+-+.|+++.+.  |+.++||.-...        ..-..++-.+|++.|.++.--.|.--.-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999999987  566777754322        112234567899999988654443333345555566799


Q ss_pred             EecCCC-CChhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce---EEEeeCCCcc
Q 038118          117 YEYMPN-GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLAR  190 (376)
Q Consensus       117 ~e~~~~-~sL~~~l~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~  190 (376)
                      |||++| .++.+++...... ........++..|-+.+.-||   .++++|+||..+||++..++.   +.|+|||++.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            999988 4677777654333 333334678899999999999   899999999999999976654   5899999985

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.23  E-value=1.1e-10  Score=109.14  Aligned_cols=169  Identities=19%  Similarity=0.286  Sum_probs=130.3

Q ss_pred             CCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEe----eCCeEEEEEecCCC-CChhh
Q 038118           53 GFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH----EKKELLLVYEYMPN-GSLDS  127 (376)
Q Consensus        53 ~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~sL~~  127 (376)
                      -..+.|+++.+.+|..|++|++.............-++.++++.|.|+|+|.++|.    .+..+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            45788999999999999999994332222223345688999999999999998886    34578999999986 57766


Q ss_pred             hhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          128 HLFK--------------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       128 ~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      +...              .+...++..+|.++.|+..||.++|   +.|+.-+-|.+.+|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5432              2345788999999999999999999   8999999999999999998899999888876543


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP  242 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~p  242 (376)
                      ....             +|  +.   -..+-|.=-||.+++.|.||..-
T Consensus       445 ~d~~-------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT-------------EP--LE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC-------------cc--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            3220             11  11   12346888899999999999654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.16  E-value=1.7e-11  Score=122.70  Aligned_cols=252  Identities=17%  Similarity=0.167  Sum_probs=171.7

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh---hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ---GIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      ....+.+.+.+-+-+|.++.++.+.-..++...+.|.......-   ..+....+-.++-...+|.++...--+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            34567778888899999999999887777765565554332111   112222222233233445555444445566788


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      +|+++|+.++.|...++... ..+.......+..+...+++||   ...+.|+|++|.|++...++..++.||+......
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence            99999999999988885543 4555556667777889999999   6669999999999999999999999998432211


Q ss_pred             cC----------C---------------C-----cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCC
Q 038118          194 HA----------K---------------G-----SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       194 ~~----------~---------------~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf  243 (376)
                      ..          .               .     .......+|+.|.+||...+......+|.|++|+++++.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            10          0               0     0012345899999999999999999999999999999999999999


Q ss_pred             CCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChH
Q 038118          244 SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIR  307 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~  307 (376)
                      ...........+..        +.      ..+ ..-..........++...+..+|.+|-.+.
T Consensus      1036 na~tpq~~f~ni~~--------~~------~~~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN--------RD------IPW-PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhhhhhcccc--------CC------CCC-CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            88776655443332        00      000 011111222345566677888888887766

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.12  E-value=7.8e-10  Score=93.31  Aligned_cols=125  Identities=22%  Similarity=0.237  Sum_probs=78.6

Q ss_pred             eEEEEEEcCCCeEEEEEEcccCC--------------h------------hhHHHHHHHHHHHHhCCCC--CccceeeEE
Q 038118           56 GVYKGFFRETSSYIAVKRVSKGS--------------K------------QGIKEYASEVTIISRLRHR--NLVQLLGWC  107 (376)
Q Consensus        56 ~vy~a~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~  107 (376)
                      .||.|...+ |..+|||+.+...              +            .......+|++.|.++..-  ++++.+++.
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            389998755 6789999875421              0            0012356799999999865  567776553


Q ss_pred             eeCCeEEEEEecCC--CCChhhhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          108 HEKKELLLVYEYMP--NGSLDSHLFKENNLLTWEFRFKIAQDLASGL-LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       108 ~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                          .-+|||||++  |..+..+. ...  +.......++.+++..+ ..+|   ..|++|+||++.||+++++ .+.++
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence                2379999998  65554332 211  11223445666777744 4457   8999999999999999987 89999


Q ss_pred             eCCCcccc
Q 038118          185 DFGLARLV  192 (376)
Q Consensus       185 Dfg~~~~~  192 (376)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99998644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=3.9e-09  Score=94.42  Aligned_cols=138  Identities=13%  Similarity=0.061  Sum_probs=98.6

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-hHH----------HHHHHHHHHHhCCCCC--ccceeeEEee-----
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-GIK----------EYASEVTIISRLRHRN--LVQLLGWCHE-----  109 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~~--i~~~~~~~~~-----  109 (376)
                      .+-......|++....  |+.|.||........ ..+          .+.+|...+..|...+  ++..+.+.+.     
T Consensus        29 ~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444456676654  678999977543311 112          3678999998885433  4455556543     


Q ss_pred             CCeEEEEEecCCCC-Chhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-------Cce
Q 038118          110 KKELLLVYEYMPNG-SLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-------NFN  180 (376)
Q Consensus       110 ~~~~~lv~e~~~~~-sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-------~~~  180 (376)
                      ....+||||++++. +|.+++... ....+......++.+++..+.-||   ..||+|+|+++.|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999886 788877431 234556677789999999999999   899999999999999975       467


Q ss_pred             EEEeeCCCcc
Q 038118          181 AKIGDFGLAR  190 (376)
Q Consensus       181 ~kl~Dfg~~~  190 (376)
                      +.|+||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999885

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.03  E-value=2.2e-09  Score=93.32  Aligned_cols=151  Identities=17%  Similarity=0.174  Sum_probs=104.7

Q ss_pred             CcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhh----------------------HHHH
Q 038118           28 PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG----------------------IKEY   85 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~----------------------~~~~   85 (376)
                      ...+.+..+.....-+.+...||-|--+.||.|.+.. |..++||.-+....+.                      ....
T Consensus        78 yD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A  156 (304)
T COG0478          78 YDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAA  156 (304)
T ss_pred             hhHHHHHHHHHcChHHhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHH
Confidence            3455566666666667788999999999999999875 7789999754321110                      1234


Q ss_pred             HHHHHHHHhCCCC--CccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 038118           86 ASEVTIISRLRHR--NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV  163 (376)
Q Consensus        86 ~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i  163 (376)
                      .+|.+.|.+|...  .+++-+++    +.-++|||+++|..|...-.   ..-+..   .++..|+.-+..+-   ..|+
T Consensus       157 ~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~---~~en~~---~il~~il~~~~~~~---~~Gi  223 (304)
T COG0478         157 EREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL---DVENPD---EILDKILEEVRKAY---RRGI  223 (304)
T ss_pred             HHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC---cccCHH---HHHHHHHHHHHHHH---HcCc
Confidence            5799999999754  56665543    45589999999977654321   112222   33333333333333   5899


Q ss_pred             EeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          164 VHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       164 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|+|+++-||+++++|.+.++||--+...
T Consensus       224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         224 VHGDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cccCCchheEEEecCCCEEEEeCcccccC
Confidence            99999999999999999999999877644

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=3.1e-10  Score=109.68  Aligned_cols=149  Identities=19%  Similarity=0.262  Sum_probs=102.0

Q ss_pred             HHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc--------ceeeeccCCCCCchhhhccC
Q 038118          147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS--------QTTVLAGTMGYMAPECATTG  218 (376)
Q Consensus       147 ~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~  218 (376)
                      +++.|+.|+|.  +.++||++|.|++|.++.++.+||+.|+++.........        ..........|.|||++.+.
T Consensus       107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            34489999998  899999999999999999999999999988654331111        11112245689999999988


Q ss_pred             CCCCCCceeechhhHHHHH-hCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccC
Q 038118          219 RASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAH  297 (376)
Q Consensus       219 ~~~~~sDvwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  297 (376)
                      ..+.++|+||||+++|.+. .|+.-+........... ..             ..+..-...+......++.+-+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SR-------------NLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hh-------------cccccccccccccCcHHHHHHHHHHhc
Confidence            8899999999999999998 56655554432222111 10             111111112223344455666666899


Q ss_pred             CCCCCCCChHHHHH
Q 038118          298 PDENLRPSIRQVIH  311 (376)
Q Consensus       298 ~~p~~RPs~~~vl~  311 (376)
                      .++.-||++..+..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999997777653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.95  E-value=2e-08  Score=92.05  Aligned_cols=193  Identities=17%  Similarity=0.241  Sum_probs=131.6

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeE------EeeC-CeEEE
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGW------CHEK-KELLL  115 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~------~~~~-~~~~l  115 (376)
                      ....-||+|+-+.+|..-.-.+   .+.|++.........+   -+..|... .||-+..-+.+      ..++ ...-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            4567899999999997543322   3457776554432222   22223333 35543321111      1122 23678


Q ss_pred             EEecCCCCC-hhhhhh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          116 VYEYMPNGS-LDSHLF-----KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       116 v~e~~~~~s-L~~~l~-----~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      .|..+.|.. +..++.     +......|..+++.++.++.+...||   ..|.+-+|+.++|+|+.+++.+.|.|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence            888887752 222221     12235789999999999999999999   799999999999999999999999985543


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhC-CCCCCCcc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACG-RKPISLTA  247 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg-~~pf~~~~  247 (376)
                      ...  .++......+|...|.+||.-+     +...+..+|.|.||++++++|.| ++||.+..
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            322  3344555667899999999643     34567789999999999999886 99997654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.82  E-value=4.2e-08  Score=94.99  Aligned_cols=140  Identities=15%  Similarity=0.164  Sum_probs=91.8

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhH------------------------------H----------HHH
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI------------------------------K----------EYA   86 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~   86 (376)
                      .-|+.++-|.||+|+... |+.||||+.+.+-.+..                              .          ++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            679999999999999987 89999999876422211                              0          133


Q ss_pred             HHHHHHHhCC----CCCccceeeEE-eeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 038118           87 SEVTIISRLR----HRNLVQLLGWC-HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ  161 (376)
Q Consensus        87 ~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~  161 (376)
                      +|+..+.++.    ...-+++-.++ +-.....|+|||++|-.+.+.........+.+.+.....++.-  ..+=   ..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~---~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHH---hc
Confidence            4555555542    22222222332 2245568999999999888875333334454433333222221  1111   47


Q ss_pred             ceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       162 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      |++|.|.+|+||+++.+|.+.+.|||+...+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            9999999999999999999999999998654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=5.3e-08  Score=84.15  Aligned_cols=105  Identities=22%  Similarity=0.262  Sum_probs=82.4

Q ss_pred             HHHHHHHHHHHhCCCC--CccceeeEEeeCC----eEEEEEecCCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 038118           83 KEYASEVTIISRLRHR--NLVQLLGWCHEKK----ELLLVYEYMPNG-SLDSHLFKENNLLTWEFRFKIAQDLASGLLYL  155 (376)
Q Consensus        83 ~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L  155 (376)
                      ....+|...+..|...  .++..+++.+...    ..++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            3567888888888643  3556666665532    458999999884 78877754222 56667778999999999999


Q ss_pred             HhCCCCceEeecccCCCeeecCCc---eEEEeeCCCccc
Q 038118          156 QEGWEQCVVHRDIKSSNIMLDLNF---NAKIGDFGLARL  191 (376)
Q Consensus       156 h~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~  191 (376)
                      |   ..||+|+|+++.|||++.++   .+.|+||+.+..
T Consensus       135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9   89999999999999999887   799999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=1.1e-07  Score=81.15  Aligned_cols=137  Identities=12%  Similarity=0.107  Sum_probs=91.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHH---------HHHHHHHhCC---CCCccceeeE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---------SEVTIISRLR---HRNLVQLLGW  106 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~~i~~~~~~  106 (376)
                      ..++|.+.+.+.......|.+....  |..+++|..+.......+.|.         +.+..+..+.   ......++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4578888888888877777776654  677999988776544433333         2333333332   2233333333


Q ss_pred             Ee-----eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceE
Q 038118          107 CH-----EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA  181 (376)
Q Consensus       107 ~~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~  181 (376)
                      .+     -....+++|||++|..|.+...     +++    .+...+++++.-||   ..|++|+|++|+|++++++ .+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence            22     2234578999999988865431     222    24456777889999   8999999999999999865 49


Q ss_pred             EEeeCCCcc
Q 038118          182 KIGDFGLAR  190 (376)
Q Consensus       182 kl~Dfg~~~  190 (376)
                      +++||+.-.
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.77  E-value=1.4e-07  Score=80.29  Aligned_cols=151  Identities=17%  Similarity=0.147  Sum_probs=107.2

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC------hhhHHHHHHHHHHHHhCCCC--Cccceee
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS------KQGIKEYASEVTIISRLRHR--NLVQLLG  105 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~--~i~~~~~  105 (376)
                      +.+......+--.---|+||-+.|+.....+  ..+-+|.-...-      +-....|.+|+..|..|..-  .+++.. 
T Consensus        11 ~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-   87 (216)
T PRK09902         11 NHWWATEGDWVEEPNYRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-   87 (216)
T ss_pred             HHHHhCCCceecCCCcCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-
Confidence            4455444444333334569999999977654  368888765221      33457899999999999643  344444 


Q ss_pred             EEee-----CCeEEEEEecCCC-CChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC
Q 038118          106 WCHE-----KKELLLVYEYMPN-GSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN  178 (376)
Q Consensus       106 ~~~~-----~~~~~lv~e~~~~-~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~  178 (376)
                      ++..     .-..+||+|-+.+ .+|.+.+... ..+.+......++.+++.++.-||   ..|+.|+|+.+.|||++.+
T Consensus        88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~  164 (216)
T PRK09902         88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTE  164 (216)
T ss_pred             eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCC
Confidence            3321     1246899998764 4777766432 234577777889999999999999   8999999999999999876


Q ss_pred             ce--EEEeeCCCcc
Q 038118          179 FN--AKIGDFGLAR  190 (376)
Q Consensus       179 ~~--~kl~Dfg~~~  190 (376)
                      +.  +.++||.-++
T Consensus       165 g~~~v~lIDlEk~r  178 (216)
T PRK09902        165 GKAEAGFLDLEKSR  178 (216)
T ss_pred             CCeeEEEEEhhccc
Confidence            77  9999998875

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.70  E-value=4.3e-07  Score=79.53  Aligned_cols=137  Identities=15%  Similarity=0.160  Sum_probs=85.1

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC--ccceeeEEeeCCeEEEEEecCCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEYMPNGS  124 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~s  124 (376)
                      ..||+|..+.||+..    +..+++|.......  .....+|.+.++.+..-.  +++.+.+....+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            578999999999832    34578898865432  345678999999886433  5778888888888899999999963


Q ss_pred             -hhhhh--------------hh------cC--CCCCHHHHH-HHHHHH----------HH-HHHHHHh-CCCCceEeecc
Q 038118          125 -LDSHL--------------FK------EN--NLLTWEFRF-KIAQDL----------AS-GLLYLQE-GWEQCVVHRDI  168 (376)
Q Consensus       125 -L~~~l--------------~~------~~--~~~~~~~~~-~~~~~i----------~~-~l~~Lh~-~~~~~i~H~dl  168 (376)
                       +...+              ..      ..  ......... .+..++          .. ...+|.. .....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111              00      00  001111000 010000          01 1111111 11345799999


Q ss_pred             cCCCeeecCCceEEEeeCCCcc
Q 038118          169 KSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       169 kp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.62  E-value=9e-07  Score=76.51  Aligned_cols=154  Identities=19%  Similarity=0.189  Sum_probs=99.9

Q ss_pred             ccCHHHHHHHhhCCCcCCc---cccCCCeeEEEEEEcCCCeEEEEEEcccCChhh-------------------H-----
Q 038118           30 RFTYKELAQATNDFNDDQK---LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-------------------I-----   82 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~---lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~-------------------~-----   82 (376)
                      ..+.+.+.....+..+...   |+.|-.+.||+|.. +++..+|+|++.......                   .     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3456777777788777766   45566778898876 347889999986432111                   0     


Q ss_pred             HHHHHHHHHHHhCCCC--CccceeeEEeeCCeEEEEEecCCCCChhh-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038118           83 KEYASEVTIISRLRHR--NLVQLLGWCHEKKELLLVYEYMPNGSLDS-HLFKENNLLTWEFRFKIAQDLASGLLYLQEGW  159 (376)
Q Consensus        83 ~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~  159 (376)
                      ....+|+..|+++...  .+++-+.+..    -.|||||+....+-. .| +.- .+.......+..++++.+.-|-.  
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L-kDv-~~e~~e~~~~~~~~v~~~~~l~~--  184 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL-KDV-PLELEEAEGLYEDVVEYMRRLYK--  184 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc-ccC-CcCchhHHHHHHHHHHHHHHHHH--
Confidence            0123577888877533  3444444432    369999986542111 11 111 12222455667777777776662  


Q ss_pred             CCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ..++||+||+.-|||+. ++.+.++||+-+....
T Consensus       185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            48999999999999999 7799999999987544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=5.5e-07  Score=73.67  Aligned_cols=133  Identities=17%  Similarity=0.211  Sum_probs=92.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCcc-ceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV-QLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~  119 (376)
                      ...+..+.|++|.+|.||++.|.+  ..+++|+-+..++  ...+..|+++|..+.--++. .++.|..+    ++.|||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeeccC--ceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            344567899999999999999984  5789998776654  46788999999999866654 45554443    355999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccC-CCeeecCCceEEEeeCCCcccc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS-SNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp-~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +.|..|.+.-...    +...    ...+++...-|.   ..||-|+.|+- ...++-.++.+.|+||..+++.
T Consensus        94 i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          94 IDGRPLGKLEIGG----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hcCcchhhhhhcc----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            9998886644211    2222    233444444455   68999999984 4444444458999999998743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.56  E-value=1.1e-06  Score=77.95  Aligned_cols=137  Identities=15%  Similarity=0.110  Sum_probs=84.2

Q ss_pred             cccCCC-eeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEecCCCCChh
Q 038118           49 LGQGGF-GGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLD  126 (376)
Q Consensus        49 lg~G~~-g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~  126 (376)
                      |..|.+ ..||+....  +..+.+|+.....   ...+.+|+.+++.+. +-.+++++.+....+..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444544 888998754  3568888876543   345667999888885 445667788777767789999999998775


Q ss_pred             hhhh-------------------hc---CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 038118          127 SHLF-------------------KE---NNLLTWE--FRFKIAQ--------------------DLASGLLYLQE----G  158 (376)
Q Consensus       127 ~~l~-------------------~~---~~~~~~~--~~~~~~~--------------------~i~~~l~~Lh~----~  158 (376)
                      ....                   .-   .......  .......                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4310                   00   0011000  0000000                    01111122211    1


Q ss_pred             CCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       159 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ....++|+|+.|.||++++++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            13569999999999999998778899999874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=5.4e-07  Score=87.13  Aligned_cols=139  Identities=13%  Similarity=0.163  Sum_probs=90.7

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhh-------------------------------H------HHHHHHH
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-------------------------------I------KEYASEV   89 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~-------------------------------~------~~~~~e~   89 (376)
                      +-||..+.|.||+|+.+. |+.||||+-...-...                               .      -+|.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999987 8899999876542111                               0      0133455


Q ss_pred             HHHHhC----CCCC------ccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038118           90 TIISRL----RHRN------LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW  159 (376)
Q Consensus        90 ~~l~~l----~h~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~  159 (376)
                      +...++    .|-+      |++++-  .-.....|+|||++|..+.+.-.-....++...+..-+.+..     ++...
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~-----~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY-----LEQIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH-----HHHHH
Confidence            444333    3444      333332  223457899999999988776433334455554443333322     22222


Q ss_pred             CCceEeecccCCCeeecC----CceEEEeeCCCccccc
Q 038118          160 EQCVVHRDIKSSNIMLDL----NFNAKIGDFGLARLVE  193 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~----~~~~kl~Dfg~~~~~~  193 (376)
                      ..|++|+|-+|.||+++.    ++.+.+.|||+.....
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            578999999999999984    5679999999987553

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.54  E-value=1.6e-08  Score=97.07  Aligned_cols=191  Identities=18%  Similarity=0.111  Sum_probs=137.2

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeEEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN-LVQLLGWCHEKKELLLV  116 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv  116 (376)
                      ...+-|...+-+++++++.+++.+...+...+ ++.+...     ....-++++|.+++||| .+..++-++.+...+++
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            34455666678899999999998877654433 5555433     33456899999999999 66666666777889999


Q ss_pred             EecCCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          117 YEYMPNG-SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ++++.++ +.........-.+...+...+++.-++++++||   +..-+|+|    ||+..+ +..++.||+....+...
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCcc
Confidence            9999877 322222122223344445566666777888888   45568888    777765 57899999998655433


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS  244 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~  244 (376)
                      .  ......+++.++|||+.....+..+.|+|++|.-..+|.-|.+|-.
T Consensus       385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            2  2345568999999999999999999999999987778877777654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=1e-06  Score=77.36  Aligned_cols=140  Identities=19%  Similarity=0.195  Sum_probs=83.3

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCC--CccceeeEEee---CCeEEEEEecCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHR--NLVQLLGWCHE---KKELLLVYEYMP  121 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~---~~~~~lv~e~~~  121 (376)
                      +.|+.|..+.||+....+ + .+++|.....  .....+..|+.+++.+...  .+++++.+...   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-S-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-c-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            578999999999999876 4 6899987654  4456777888888888533  35677765433   345799999999


Q ss_pred             CCChhh----------------hhh---hc---CCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 038118          122 NGSLDS----------------HLF---KE---NNLLTWEF---------RFKI------------AQDLAS-GLLYLQE  157 (376)
Q Consensus       122 ~~sL~~----------------~l~---~~---~~~~~~~~---------~~~~------------~~~i~~-~l~~Lh~  157 (376)
                      |..+..                .+.   ..   ........         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987766                110   00   01111000         0000            011111 2223322


Q ss_pred             ----CCCCceEeecccCCCeeec-CCceEEEeeCCCcc
Q 038118          158 ----GWEQCVVHRDIKSSNIMLD-LNFNAKIGDFGLAR  190 (376)
Q Consensus       158 ----~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~  190 (376)
                          .....++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1257799999999999999 56666799999874

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.34  E-value=9.3e-06  Score=84.59  Aligned_cols=80  Identities=13%  Similarity=0.260  Sum_probs=58.1

Q ss_pred             CCccccCCCeeEEEEEEcCCC--eEEEEEEcccCC-hhhHHHHHHHHHHHHhCC-CCCc--cceeeEEeeC---CeEEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRETS--SYIAVKRVSKGS-KQGIKEYASEVTIISRLR-HRNL--VQLLGWCHEK---KELLLV  116 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv  116 (376)
                      .+.|+.|.+..+|+......+  ..+++|+..... ......+.+|+++++.+. |.++  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            467889999999998776533  467788765432 122356789999999996 6654  7888887654   467899


Q ss_pred             EecCCCCCh
Q 038118          117 YEYMPNGSL  125 (376)
Q Consensus       117 ~e~~~~~sL  125 (376)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.25  E-value=1.1e-05  Score=71.25  Aligned_cols=73  Identities=15%  Similarity=0.160  Sum_probs=46.4

Q ss_pred             CccccCCCe-eEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCC---CccceeeEEeeC---CeEEEEEec
Q 038118           47 QKLGQGGFG-GVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHR---NLVQLLGWCHEK---KELLLVYEY  119 (376)
Q Consensus        47 ~~lg~G~~g-~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~  119 (376)
                      +.++.||.. .||+..     ..+++|......  ....+..|++.+..+...   .++.++......   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            467777766 588752     246778655422  235788899999888632   344555443322   245889999


Q ss_pred             CCCCChh
Q 038118          120 MPNGSLD  126 (376)
Q Consensus       120 ~~~~sL~  126 (376)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.24  E-value=2.6e-05  Score=66.48  Aligned_cols=134  Identities=19%  Similarity=0.261  Sum_probs=92.1

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC----------------hhhHHHHHHHHHHHHhCC------CCCcc
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----------------KQGIKEYASEVTIISRLR------HRNLV  101 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~  101 (376)
                      +-...||.|+.-.||.--+   +...+||+.....                ....++..+|+.....+.      +.+|.
T Consensus         4 ~~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CCCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            3456899999999997433   3336888887655                122455666776666555      78899


Q ss_pred             ceeeEEeeCCeEEEEEecCCC------CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee
Q 038118          102 QLLGWCHEKKELLLVYEYMPN------GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML  175 (376)
Q Consensus       102 ~~~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill  175 (376)
                      +++|+.+.+....+|+|.+..      .+|.+++..  +.++. .+...+.++.   .+|-   ...|+.+|++|.||++
T Consensus        81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVV  151 (199)
T ss_pred             cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEE
Confidence            999999999999999998632      367777733  23454 4444444444   4555   5789999999999999


Q ss_pred             cCCc----eEEEee-CCCc
Q 038118          176 DLNF----NAKIGD-FGLA  189 (376)
Q Consensus       176 ~~~~----~~kl~D-fg~~  189 (376)
                      ....    .+.|+| ||-.
T Consensus       152 ~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EecCCCceEEEEEeCCCCc
Confidence            6532    477777 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.19  E-value=1.6e-05  Score=71.09  Aligned_cols=136  Identities=13%  Similarity=0.054  Sum_probs=78.7

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecCCCCChh
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL-VQLLGWCHEKKELLLVYEYMPNGSLD  126 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~  126 (376)
                      .+..|-...+|+...  ++..+++|..........-...+|..+++.+....+ ++++....    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            456788889998873  356788887654332211235678999998864433 44444432    26899999987654


Q ss_pred             hh----------h-------hhc---CCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCceEeecccCC
Q 038118          127 SH----------L-------FKE---NNLLTWE-FRFKIAQDL---------ASGLLYLQEG-----WEQCVVHRDIKSS  171 (376)
Q Consensus       127 ~~----------l-------~~~---~~~~~~~-~~~~~~~~i---------~~~l~~Lh~~-----~~~~i~H~dlkp~  171 (376)
                      ..          +       +..   ...+... .+..+..++         ...+..+...     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21          1       110   1111111 111111111         1112222111     1246899999999


Q ss_pred             CeeecCCceEEEeeCCCcc
Q 038118          172 NIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       172 Nill~~~~~~kl~Dfg~~~  190 (376)
                      ||++++++ +.|+||+.+.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999876 7899999885

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.11  E-value=7.7e-05  Score=70.43  Aligned_cols=76  Identities=12%  Similarity=0.096  Sum_probs=54.6

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccC-------ChhhHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEEE
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-------SKQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv  116 (376)
                      +.||.|.+..||++....+++.|+||.-...       .+-...++..|.+.|+.+.   ..++++++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            5799999999999998765467999985321       1223566777888888874   245777777643  457899


Q ss_pred             EecCCCCC
Q 038118          117 YEYMPNGS  124 (376)
Q Consensus       117 ~e~~~~~s  124 (376)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.10  E-value=4.4e-05  Score=67.30  Aligned_cols=139  Identities=19%  Similarity=0.226  Sum_probs=80.8

Q ss_pred             CccccCCCeeEEEEEEcC-CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeEEEEEecCCCCC
Q 038118           47 QKLGQGGFGGVYKGFFRE-TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN-LVQLLGWCHEKKELLLVYEYMPNGS  124 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~s  124 (376)
                      +.|..|-...+|+..... .+..|++|+....... .....+|+.+++.+...+ .++++..+. .   .+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            467778888999987553 3457889977644222 123346888888885433 445554432 2   47999999876


Q ss_pred             hhhh----------h-------hhcCCC----------CC-HHHHHHHHHH----------------------HHHHHHH
Q 038118          125 LDSH----------L-------FKENNL----------LT-WEFRFKIAQD----------------------LASGLLY  154 (376)
Q Consensus       125 L~~~----------l-------~~~~~~----------~~-~~~~~~~~~~----------------------i~~~l~~  154 (376)
                      +...          +       +.....          .. ...+..+...                      +...+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321          1       000001          11 1111122111                      1111111


Q ss_pred             H----HhC-CCCceEeecccCCCeeecC-CceEEEeeCCCcc
Q 038118          155 L----QEG-WEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLAR  190 (376)
Q Consensus       155 L----h~~-~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~  190 (376)
                      |    ... ...+++|+|+.+.||+++. ++.+.|+||..+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            1    110 1357999999999999998 5789999999874

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.08  E-value=0.00011  Score=67.24  Aligned_cols=80  Identities=10%  Similarity=0.022  Sum_probs=57.9

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC---CCccceeeEEee---CCeEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH---RNLVQLLGWCHE---KKELLL  115 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~l  115 (376)
                      ...-.+.||.|..+.||.....+ + .+.+|..+...  ....+..|+..|+.|..   -.++++++++..   .+..+|
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCC-C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            44455679999999999986543 3 36667643311  12578889999999863   368888888754   366899


Q ss_pred             EEecCCCCCh
Q 038118          116 VYEYMPNGSL  125 (376)
Q Consensus       116 v~e~~~~~sL  125 (376)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998765

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.07  E-value=2.6e-05  Score=66.15  Aligned_cols=103  Identities=25%  Similarity=0.253  Sum_probs=82.0

Q ss_pred             HHHHHHHHhCCC-CCccceeeEEeeCCeEEEEEecCCCCChhhhh--hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 038118           86 ASEVTIISRLRH-RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC  162 (376)
Q Consensus        86 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~  162 (376)
                      ..|.-+++.+++ +++++++|+|..    ++|.||...+++....  ..+-...+|..+.+++.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999986 699999999954    6788999877654211  011234689999999999999999999655466


Q ss_pred             eEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       163 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +.-.|++++|+-+++++++|++|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999887543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=98.07  E-value=0.00022  Score=66.05  Aligned_cols=156  Identities=13%  Similarity=0.125  Sum_probs=85.4

Q ss_pred             ccCHHHHHHHhhCCCc-----CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCC--Cccc
Q 038118           30 RFTYKELAQATNDFND-----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHR--NLVQ  102 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~  102 (376)
                      ..+..++...-..|.+     .+.|+.|....+|+....+ | .+++|++.....   ..+..|+..++.|...  .+++
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-G-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-C-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCc
Confidence            3455666665566755     3456677778899987553 3 588998762222   2333455555555321  2333


Q ss_pred             eee------EEeeCCeEEEEEecCCCCChhh-----------hh---hhcCC--------CCC--H-HHHHH--------
Q 038118          103 LLG------WCHEKKELLLVYEYMPNGSLDS-----------HL---FKENN--------LLT--W-EFRFK--------  143 (376)
Q Consensus       103 ~~~------~~~~~~~~~lv~e~~~~~sL~~-----------~l---~~~~~--------~~~--~-~~~~~--------  143 (376)
                      ++.      +....+..+++++|++|..+..           .+   +....        ...  + .....        
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            332      2233567899999999875421           11   11000        000  1 11100        


Q ss_pred             ----HHHH-HHHHHHHHHh----CCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          144 ----IAQD-LASGLLYLQE----GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       144 ----~~~~-i~~~l~~Lh~----~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                          ...+ +...+..+..    ....+++|+|+.+.||+++.+...-|+||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                1111 1112222221    024689999999999999876556899999885

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.00  E-value=7.1e-06  Score=73.56  Aligned_cols=152  Identities=16%  Similarity=0.126  Sum_probs=105.2

Q ss_pred             CCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh------------------hH----H
Q 038118           26 AGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ------------------GI----K   83 (376)
Q Consensus        26 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~------------------~~----~   83 (376)
                      .|...+.++.+..-..-+.+..+||-|--+-+|.+-+.. |...++|.-+.....                  |+    -
T Consensus        77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRl  155 (465)
T KOG2268|consen   77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRL  155 (465)
T ss_pred             ccchHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHH
Confidence            455667778888877788999999999999999998865 667888865432111                  00    1


Q ss_pred             HHHHHHHHHHhCCC-C-CccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 038118           84 EYASEVTIISRLRH-R-NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ  161 (376)
Q Consensus        84 ~~~~e~~~l~~l~h-~-~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~  161 (376)
                      ...+|+..++.|.. - -+++.+++    +..++|||++.|-.|...-.    ..+...+   ...+...+.-|-   ..
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d~~~l---y~~lm~~Iv~la---~~  221 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH----VEDPPTL---YDDLMGLIVRLA---NH  221 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee----cCChHHH---HHHHHHHHHHHH---Hc
Confidence            13468888888863 2 24444443    45589999999988755332    1233333   333333344444   78


Q ss_pred             ceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       162 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      |+||+|+.==||++++++.++++||--....
T Consensus       222 GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             CceecccchheeEEecCCCEEEeechHhhcc
Confidence            9999999999999999999999999765443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.96  E-value=0.00032  Score=64.10  Aligned_cols=140  Identities=16%  Similarity=0.138  Sum_probs=83.1

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC--ccceee------EEeeCCeEEEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN--LVQLLG------WCHEKKELLLVY  117 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~  117 (376)
                      .+.|..|....+|+....+  ..+++|+.....   ...+..|+.++..+.+.+  +++++.      +....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS--GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC--CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            4567778788999986543  358889876522   345666788777775332  444433      223345678999


Q ss_pred             ecCCCCChhh-----------hh---hh--cC--C------CCCHHHH----------HHHHHHHHHHHHHHHh----CC
Q 038118          118 EYMPNGSLDS-----------HL---FK--EN--N------LLTWEFR----------FKIAQDLASGLLYLQE----GW  159 (376)
Q Consensus       118 e~~~~~sL~~-----------~l---~~--~~--~------~~~~~~~----------~~~~~~i~~~l~~Lh~----~~  159 (376)
                      ++++|..+..           .+   +.  ..  .      ...+...          ......+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876532           00   10  00  0      0010000          0011112333444442    12


Q ss_pred             CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ..+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3679999999999999988777899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.85  E-value=0.00056  Score=62.92  Aligned_cols=156  Identities=15%  Similarity=0.193  Sum_probs=89.3

Q ss_pred             cCHHHHHHHhhCCCcC-----CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC--ccce
Q 038118           31 FTYKELAQATNDFNDD-----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN--LVQL  103 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~  103 (376)
                      .+.+++...-.+|.+.     +.++.|....+|+.... ++ .+++|+......  ......|++++..|....  ++++
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~   82 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKP   82 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC-CC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcc
Confidence            4556666666667553     45666767899988653 33 578898755321  233445667777664322  3444


Q ss_pred             eeE------EeeCCeEEEEEecCCCCChhh-----------h---hhhcCCC----------C-CHHHHH----------
Q 038118          104 LGW------CHEKKELLLVYEYMPNGSLDS-----------H---LFKENNL----------L-TWEFRF----------  142 (376)
Q Consensus       104 ~~~------~~~~~~~~lv~e~~~~~sL~~-----------~---l~~~~~~----------~-~~~~~~----------  142 (376)
                      +..      ....+..+++++|++|..+..           .   ++.....          . .+....          
T Consensus        83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l  162 (307)
T TIGR00938        83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL  162 (307)
T ss_pred             ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence            331      123456789999999865421           0   1110000          0 000000          


Q ss_pred             --HHHHHHHHHHHHHHh----CCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          143 --KIAQDLASGLLYLQE----GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       143 --~~~~~i~~~l~~Lh~----~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                        .....+...+.++..    ....+++|+|+++.||+++.++...|+||+.+.
T Consensus       163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              001112234444432    125789999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.83  E-value=0.00016  Score=66.42  Aligned_cols=139  Identities=22%  Similarity=0.271  Sum_probs=82.9

Q ss_pred             CccccCCCeeEEEEEEcC------CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeEEEEEec
Q 038118           47 QKLGQGGFGGVYKGFFRE------TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN-LVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~  119 (376)
                      +.|..|-...+|+.....      .++.+++|+...... .......|..++..+.... .++++.++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667777999987654      256788998765432 2345567888888886333 3455655542    368999


Q ss_pred             CCCCChhhhh-----------------hhcCCC--------CC--HHHHHHH--------------------------HH
Q 038118          120 MPNGSLDSHL-----------------FKENNL--------LT--WEFRFKI--------------------------AQ  146 (376)
Q Consensus       120 ~~~~sL~~~l-----------------~~~~~~--------~~--~~~~~~~--------------------------~~  146 (376)
                      ++|..+....                 +.....        .+  +..+..+                          ..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9887664310                 100000        00  0011111                          11


Q ss_pred             HHHHHHHHHHh------CCCCceEeecccCCCeeecCC----ceEEEeeCCCcc
Q 038118          147 DLASGLLYLQE------GWEQCVVHRDIKSSNIMLDLN----FNAKIGDFGLAR  190 (376)
Q Consensus       147 ~i~~~l~~Lh~------~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~  190 (376)
                      .+...+.+|..      .....++|+|+.+.||+++++    +.+.|+||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22222333331      125679999999999999985    789999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.81  E-value=8.1e-05  Score=76.89  Aligned_cols=197  Identities=20%  Similarity=0.135  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHhCCCCCccceeeEEeeCCeE----EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 038118           83 KEYASEVTIISRLRHRNLVQLLGWCHEKKEL----LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG  158 (376)
Q Consensus        83 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~  158 (376)
                      .....|...+.+..|+|++.++.|..+....    .+..++|..-++...+ ..-..++....+.+..++..+|.++|  
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h--  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLH--  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHH--
Confidence            3445577788888999999999887665433    3445677777776666 44567888889999999999999999  


Q ss_pred             CCCceEeecccCC---CeeecCCceEEEe--eCCCccccccCCCcceeeeccCCCCCchhhhccCCCCC--CCceeechh
Q 038118          159 WEQCVVHRDIKSS---NIMLDLNFNAKIG--DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK--ESDVYSFGI  231 (376)
Q Consensus       159 ~~~~i~H~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwslG~  231 (376)
                       +....|.-|...   +...+..+.+.++  ||+...........  .....+..+.++|.........  ..|+|.+|.
T Consensus       304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             -HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence             455555555544   4455566666666  88888765433322  2223456778888776554443  479999999


Q ss_pred             hHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          232 VALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       232 il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+..+..|..+-......                       .+-++....    ..+......|+..+.++|+++.+++.
T Consensus       381 l~~~~~~~~~i~~~~~~~-----------------------~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVP-----------------------VSLLDVLST----SELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHhhhhhcCcccccccch-----------------------hhhhccccc----hhhhhhhhhhcchhhhhccchhhhhh
Confidence            999999877553221100                       000111111    03455666799999999999999986


Q ss_pred             H
Q 038118          312 V  312 (376)
Q Consensus       312 ~  312 (376)
                      .
T Consensus       434 ~  434 (1351)
T KOG1035|consen  434 H  434 (1351)
T ss_pred             c
Confidence            4

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.80  E-value=0.00026  Score=59.98  Aligned_cols=125  Identities=22%  Similarity=0.305  Sum_probs=87.3

Q ss_pred             hCCCcCCccccCCC-eeEEEEEEcCCCeEEEEEEccc---CCh------------------hhHHHHHHHHHHHHhCC--
Q 038118           41 NDFNDDQKLGQGGF-GGVYKGFFRETSSYIAVKRVSK---GSK------------------QGIKEYASEVTIISRLR--   96 (376)
Q Consensus        41 ~~y~~~~~lg~G~~-g~vy~a~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--   96 (376)
                      .+++..+.||.|.- |.||++...  |..+|+|++..   ...                  .-..-|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 999999987  56899999332   100                  01124667887776664  


Q ss_pred             -CCCc--cceeeEEeeC------------------CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 038118           97 -HRNL--VQLLGWCHEK------------------KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL  155 (376)
Q Consensus        97 -h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L  155 (376)
                       +.++  ++.+||..-.                  ....||.||++...          .+.    ..-+.+|.+-+..+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHH
Confidence             4456  8888887211                  12467777765533          111    23455666777888


Q ss_pred             HhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       156 h~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      |   ..||+-+|+++.|..     .-+|+|||.+
T Consensus       181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---HCCeeeccCcccccc-----CCEEEecccC
Confidence            8   899999999999985     2478999864

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.75  E-value=0.00053  Score=62.59  Aligned_cols=138  Identities=20%  Similarity=0.196  Sum_probs=87.2

Q ss_pred             cCCccccCCCeeEEEEEEcCCCeEEEEEEccc--CChhhHHHHHHHHHHHHhCCC--CCccceeeEEeeCC--eEEEEEe
Q 038118           45 DDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRH--RNLVQLLGWCHEKK--ELLLVYE  118 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e  118 (376)
                      +.+.+..|-.-.+|.....  ++++++. ...  ..........+|+..++.+.-  --+...+++|.++.  ..+.||+
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            3344444544555655544  6677877 331  233345566778888887753  34556677777665  7799999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHH-HHHHHHHHHHHhC---------------------------------------
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIA-QDLASGLLYLQEG---------------------------------------  158 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~-~~i~~~l~~Lh~~---------------------------------------  158 (376)
                      |++|..+...+....  ..    .+++ ..+++.|..||+.                                       
T Consensus       106 ~veGe~~~~~~~~~~--~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         106 WVEGEVVWSALPPES--LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             EecceeccCcCCccc--ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            999864433221110  00    1122 2555555666632                                       


Q ss_pred             ----------------CCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          159 ----------------WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       159 ----------------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                                      ....++|+|+++.|++++.++-+=|.||+++..
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                            234599999999999999998899999999864

>PLN02236 choline kinase

Probab=97.55  E-value=0.00089  Score=62.57  Aligned_cols=139  Identities=17%  Similarity=0.211  Sum_probs=82.8

Q ss_pred             CccccCCCeeEEEEEEcC----CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecCC
Q 038118           47 QKLGQGGFGGVYKGFFRE----TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL-VQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      ..|..|-.-.+|++....    .+..|++|+........+ ...+|..+++.+...++ +++++.+...    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            456568888999987543    246789998866543222 23678999888865444 4556655332    5789998


Q ss_pred             CCChhhh-----------------hhhcC---C--CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 038118          122 NGSLDSH-----------------LFKEN---N--LLTWEFRFKIAQDL-----------------ASGLLYL----QE-  157 (376)
Q Consensus       122 ~~sL~~~-----------------l~~~~---~--~~~~~~~~~~~~~i-----------------~~~l~~L----h~-  157 (376)
                      +.++...                 ++...   .  ......+..+..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7766421                 01100   0  11122222333221                 1111122    11 


Q ss_pred             CCCCceEeecccCCCeeecC-CceEEEeeCCCcc
Q 038118          158 GWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLAR  190 (376)
Q Consensus       158 ~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~  190 (376)
                      .....++|+|+++.||++++ ++.+.|+||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            22457899999999999986 4679999999885

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.33  E-value=0.004  Score=56.31  Aligned_cols=31  Identities=23%  Similarity=0.443  Sum_probs=25.7

Q ss_pred             CceEeecccCCCeeecCCce-EEEeeCCCccc
Q 038118          161 QCVVHRDIKSSNIMLDLNFN-AKIGDFGLARL  191 (376)
Q Consensus       161 ~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~  191 (376)
                      ..++|+|+++.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998853

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.32  E-value=0.0043  Score=57.13  Aligned_cols=143  Identities=16%  Similarity=0.122  Sum_probs=93.7

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----C--------------------hhhHH-HHHHHHHHHHhCCC
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----S--------------------KQGIK-EYASEVTIISRLRH   97 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----~--------------------~~~~~-~~~~e~~~l~~l~h   97 (376)
                      ++...|..|--+-||.|.... |..+|||++..+     +                    +.-++ ...+|++.|.+|..
T Consensus       147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            455678889999999998655 677999987532     1                    11111 12358888888865


Q ss_pred             CCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC
Q 038118           98 RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL  177 (376)
Q Consensus        98 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~  177 (376)
                      ..|+----+..  ..-.|||+++.+.....-. -..-.+....+..+-.+++..+.-|-+  ..++||.||+=-|+|+. 
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-
Confidence            55432111111  1247999999543221111 122345556677777788887777765  78999999999999996 


Q ss_pred             CceEEEeeCCCccccc
Q 038118          178 NFNAKIGDFGLARLVE  193 (376)
Q Consensus       178 ~~~~kl~Dfg~~~~~~  193 (376)
                      +|.+.++|.+-+...+
T Consensus       300 dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             CCEEEEEEccccccCC
Confidence            4689999998876443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.30  E-value=0.0021  Score=58.22  Aligned_cols=75  Identities=16%  Similarity=0.279  Sum_probs=47.9

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEEEEecC
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +-.+.++.|....+|+..  .++..+.||+-..   .....|..|+.-|+.|.   .-.+++++++....+..+|||||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            334568989999999977  4467788997762   22356788999888884   345788899888777789999998


Q ss_pred             CCC
Q 038118          121 PNG  123 (376)
Q Consensus       121 ~~~  123 (376)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.30  E-value=0.0039  Score=58.95  Aligned_cols=74  Identities=14%  Similarity=0.122  Sum_probs=50.6

Q ss_pred             cCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----C--hhhHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEE
Q 038118           45 DDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----S--KQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~  114 (376)
                      ..+.||.|....||+..+.  +..++||.-...     .  +-...+-..|+..|+.+.   ..++++++.++.+  ..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence            3567899999999998874  345889976521     1  112334445677776664   2478888888874  457


Q ss_pred             EEEecCCC
Q 038118          115 LVYEYMPN  122 (376)
Q Consensus       115 lv~e~~~~  122 (376)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.25  E-value=0.0045  Score=57.45  Aligned_cols=73  Identities=14%  Similarity=0.182  Sum_probs=48.2

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEccc-------CChhhHHHHHHHHHHHHhCC--CC-CccceeeEEeeCCeEEEEE
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSK-------GSKQGIKEYASEVTIISRLR--HR-NLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~  117 (376)
                      .+|.|....||++....+++.|+||.-..       ..+-...+..-|...|+...  .| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999999865446799996431       12333455566788887664  34 45555543  334556999


Q ss_pred             ecCCC
Q 038118          118 EYMPN  122 (376)
Q Consensus       118 e~~~~  122 (376)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.23  E-value=0.0068  Score=55.80  Aligned_cols=31  Identities=19%  Similarity=0.239  Sum_probs=28.3

Q ss_pred             CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ..+++|+|+.++||+++.++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4589999999999999999899999999885

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.15  E-value=0.0024  Score=60.03  Aligned_cols=75  Identities=12%  Similarity=0.150  Sum_probs=49.8

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEccc------CChhhHHHHHHHHHHHHhCC--CC-CccceeeEEeeCCeEEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSK------GSKQGIKEYASEVTIISRLR--HR-NLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv  116 (376)
                      .+.||.|....||++.+...+..|+||.-..      +.+-...+..-|.+.|+.+.  .| .+++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999999854345689986431      12333556667888888764  34 45556543  33445788


Q ss_pred             EecCCC
Q 038118          117 YEYMPN  122 (376)
Q Consensus       117 ~e~~~~  122 (376)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.09  E-value=0.0044  Score=57.61  Aligned_cols=139  Identities=17%  Similarity=0.241  Sum_probs=80.0

Q ss_pred             CccccCCCeeEEEEEEcCC---CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRET---SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL-VQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.|..|=.-.+|+....+.   +..|++++....... .-...+|..+++.+..-++ +++++++. .+   +|.+|++|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            4455577788898875432   237889987654332 2234578889988875555 45666553 22   58899987


Q ss_pred             CChhhh----------h-------hhcC----C-CCCHHHHHHHHHHH----------------------HHHHHHHHhC
Q 038118          123 GSLDSH----------L-------FKEN----N-LLTWEFRFKIAQDL----------------------ASGLLYLQEG  158 (376)
Q Consensus       123 ~sL~~~----------l-------~~~~----~-~~~~~~~~~~~~~i----------------------~~~l~~Lh~~  158 (376)
                      .+|...          +       +...    . ...+..+..+..++                      ..-+..+...
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            665220          1       1101    0 11122222222221                      1111111110


Q ss_pred             -----CCCceEeecccCCCeeecC-CceEEEeeCCCcc
Q 038118          159 -----WEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLAR  190 (376)
Q Consensus       159 -----~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~  190 (376)
                           ...-++|.|+.+.||++++ ++.++++||..+.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence                 1234899999999999975 4689999999885

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.01  E-value=6.9e-05  Score=79.31  Aligned_cols=159  Identities=16%  Similarity=0.014  Sum_probs=111.5

Q ss_pred             HHHHHHHHHhCCCCCccceeeEEe--eCCeEEEEEecCCCCChhhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhC-
Q 038118           85 YASEVTIISRLRHRNLVQLLGWCH--EKKELLLVYEYMPNGSLDSHLFKENN---LLTWEFRFKIAQDLASGLLYLQEG-  158 (376)
Q Consensus        85 ~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~-  158 (376)
                      ...|...++...|+++...+.-..  +....+..++++.+|.+...+.+...   .+....+.....+......-.|.. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555666678888776655443  33456889999999999998866433   233332222222223344444432 


Q ss_pred             -CCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHH
Q 038118          159 -WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA  237 (376)
Q Consensus       159 -~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~ll  237 (376)
                       ..+-.+|+++++-|.+|..+.++++.++|+.++.. ..........+++.|+.++..+.-.++.++|+|..|+-+|.+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             13447999999999999999999999999998432 2222334456788999999988888999999999999999999


Q ss_pred             hCCCCCC
Q 038118          238 CGRKPIS  244 (376)
Q Consensus       238 tg~~pf~  244 (376)
                      .|..+|.
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            8888774

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.91  E-value=0.0032  Score=54.45  Aligned_cols=30  Identities=27%  Similarity=0.437  Sum_probs=21.7

Q ss_pred             CceEeecccCCCeee-cCCceEEEeeCCCcc
Q 038118          161 QCVVHRDIKSSNIML-DLNFNAKIGDFGLAR  190 (376)
Q Consensus       161 ~~i~H~dlkp~Nill-~~~~~~kl~Dfg~~~  190 (376)
                      ..++|.|+.+.||++ ..++.++|+||..+.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            568999999999999 888899999999885

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.61  E-value=0.11  Score=48.26  Aligned_cols=96  Identities=9%  Similarity=-0.047  Sum_probs=56.3

Q ss_pred             CcccCHHHHHHHhhCCCcC--C--ccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC--cc
Q 038118           28 PKRFTYKELAQATNDFNDD--Q--KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN--LV  101 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~--~--~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~  101 (376)
                      ...++.+.+..+-..+-+.  .  .+=.+.-..||+..... +..+++|+.+... .....+..|+..+..|....  ++
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~-~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~   85 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDED-GRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV   85 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCC-CCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            3456667777666666543  1  22234567789887644 4568999876432 23455667787777664221  12


Q ss_pred             c---eee--EEeeCCeEEEEEecCCCCCh
Q 038118          102 Q---LLG--WCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus       102 ~---~~~--~~~~~~~~~lv~e~~~~~sL  125 (376)
                      .   .-+  +...++..+.++++++|...
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            1   111  23345678889999987643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.54  E-value=0.04  Score=50.97  Aligned_cols=156  Identities=19%  Similarity=0.238  Sum_probs=86.9

Q ss_pred             ccCHHHHHHHhhCCCcCC-----ccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC-----
Q 038118           30 RFTYKELAQATNDFNDDQ-----KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN-----   99 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~-----~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-----   99 (376)
                      .+.-.++..+...|.+.-     .|.+ .-..+|+....+ |+ +++|+....  .....+..|...+..|...+     
T Consensus        10 ~~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~   84 (331)
T COG2334          10 PLTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPA   84 (331)
T ss_pred             CcChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCC
Confidence            344455555555554432     2343 456788887665 33 489988876  22355666777777774222     


Q ss_pred             -ccceeeE--EeeCC--eEEEEEecCCCCChhh-hh--------------hh--cCC---------CCCHHH--------
Q 038118          100 -LVQLLGW--CHEKK--ELLLVYEYMPNGSLDS-HL--------------FK--ENN---------LLTWEF--------  140 (376)
Q Consensus       100 -i~~~~~~--~~~~~--~~~lv~e~~~~~sL~~-~l--------------~~--~~~---------~~~~~~--------  140 (376)
                       +...-|-  ..-..  +.+-+++|++|..+.. ..              +.  ++.         ...|..        
T Consensus        85 Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~  164 (331)
T COG2334          85 PLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLR  164 (331)
T ss_pred             CccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhh
Confidence             2222111  11223  7888999999988762 11              00  000         111110        


Q ss_pred             -----HHHHHHHHHHHHHHHHh----CCCCc---eEeecccCCCeeecCCce-EEEeeCCCcc
Q 038118          141 -----RFKIAQDLASGLLYLQE----GWEQC---VVHRDIKSSNIMLDLNFN-AKIGDFGLAR  190 (376)
Q Consensus       141 -----~~~~~~~i~~~l~~Lh~----~~~~~---i~H~dlkp~Nill~~~~~-~kl~Dfg~~~  190 (376)
                           -.....++...+..+..    ....+   +||+|+.|.||+++.+.. +-++||+-+.
T Consensus       165 ~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         165 LDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                 00122223333333332    11233   999999999999999875 8899999875

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.47  E-value=0.027  Score=48.68  Aligned_cols=74  Identities=18%  Similarity=0.306  Sum_probs=52.4

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC---CCccceeeEEeeCCeEEEEEecCCCCC
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH---RNLVQLLGWCHEKKELLLVYEYMPNGS  124 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e~~~~~s  124 (376)
                      .+..|..-..|...+.  ...+-||+   +.......|..|+.-|+.|.-   -++.+++.+....++.|+|+||++-+.
T Consensus        23 ~v~gG~inea~~v~dg--~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          23 EVSGGDINEAWRLRDG--TDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             ccCCccccceeEeecC--CcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            4555555566665543  34566774   334445678889988888853   567888988899999999999998766


Q ss_pred             hh
Q 038118          125 LD  126 (376)
Q Consensus       125 L~  126 (376)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.45  E-value=0.11  Score=47.64  Aligned_cols=30  Identities=23%  Similarity=0.263  Sum_probs=26.2

Q ss_pred             CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00296 choline kinase; Provisional

Probab=96.42  E-value=0.036  Score=53.53  Aligned_cols=76  Identities=13%  Similarity=0.107  Sum_probs=49.2

Q ss_pred             cCCccccCCCeeEEEEEEcCC--------CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCcc-ceeeEEeeCCeEEE
Q 038118           45 DDQKLGQGGFGGVYKGFFRET--------SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV-QLLGWCHEKKELLL  115 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l  115 (376)
                      -.+.|..|-.-.+|++.....        ++.|.+++......... ....|..+++.+...+|. ++++.+.    -+.
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~  183 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR  183 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence            345677777888898875422        45788888766543332 345688888888654543 4565553    246


Q ss_pred             EEecCCCCCh
Q 038118          116 VYEYMPNGSL  125 (376)
Q Consensus       116 v~e~~~~~sL  125 (376)
                      |.||++|.+|
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            7899988754

>PTZ00384 choline kinase; Provisional

Probab=96.41  E-value=0.038  Score=52.35  Aligned_cols=75  Identities=15%  Similarity=0.289  Sum_probs=46.4

Q ss_pred             CccccCCCeeEEEEEEcCCC-e-----EEEEEEcccCChhhHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEec
Q 038118           47 QKLGQGGFGGVYKGFFRETS-S-----YIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL-VQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~-~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~  119 (376)
                      +.|..|-...+|++...... .     .|.+...... ....-...+|+.+++.+...++ +++++.+..    ++|.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            45666888999999764432 1     2444433222 1112233568999999976555 455666543    599999


Q ss_pred             CCCCChh
Q 038118          120 MPNGSLD  126 (376)
Q Consensus       120 ~~~~sL~  126 (376)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.36  E-value=0.0033  Score=60.20  Aligned_cols=49  Identities=24%  Similarity=0.339  Sum_probs=37.8

Q ss_pred             HHHHHHHHHHHhCCCCCccceeeEEeeC-CeEEEEEecCCCCChhhhhhhc
Q 038118           83 KEYASEVTIISRLRHRNLVQLLGWCHEK-KELLLVYEYMPNGSLDSHLFKE  132 (376)
Q Consensus        83 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~  132 (376)
                      .++...+++++.+.|+|+...+++.... ....+|||++ +.+|.+.+..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            4567788999999999999988876532 3578999998 66888877443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.17  E-value=0.02  Score=52.86  Aligned_cols=74  Identities=24%  Similarity=0.209  Sum_probs=56.6

Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                      +.-+.|++|++. |+++. .    .+...+.++..++.+-+..+.-+..  +-.+-|||+.-.||+|+ +|++.|+||-+
T Consensus       297 e~~y~yl~~kdh-gt~is-~----ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         297 ETLYLYLHFKDH-GTPIS-I----IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             CceEEEEEEecC-Cceee-e----eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence            334667888874 55552 1    2334577788888888887777775  56789999999999999 99999999999


Q ss_pred             ccc
Q 038118          189 ARL  191 (376)
Q Consensus       189 ~~~  191 (376)
                      ++.
T Consensus       368 sRl  370 (488)
T COG5072         368 SRL  370 (488)
T ss_pred             eec
Confidence            973

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.65  E-value=0.057  Score=46.43  Aligned_cols=102  Identities=15%  Similarity=0.104  Sum_probs=62.3

Q ss_pred             EEEEEcccCChh-hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHH
Q 038118           69 IAVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD  147 (376)
Q Consensus        69 vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~  147 (376)
                      ..+|+++.-.-. ....|..+.+++.++.  .|+++..  ...-.+-+|.|+|-....          ..    ..++..
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i----------~~----~N~i~a  149 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI----------NF----SNFITA  149 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc----------ch----hHHHHH
Confidence            455655543322 3345667777777663  3444441  123356788898743211          00    112221


Q ss_pred             HHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       148 i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      =+..|.-.|.. ..+.+|||..|+||+-|..|.+||.|-+..
T Consensus       150 gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  150 GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence            13456666743 678999999999999999999999997754

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.95  E-value=0.12  Score=48.51  Aligned_cols=62  Identities=23%  Similarity=0.215  Sum_probs=40.9

Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN  178 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~  178 (376)
                      ..++=+|..|-++..++....  .++.....++.-.+.|+.-+--  -.+++|.|++|.||++..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEec
Confidence            355666778888888875433  3444555555555555443332  4689999999999999544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	376
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-38
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-36
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-33
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 166/293 (56%), Gaps = 6/293 (2%)
Query: 29  KRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIK-EYAS 87
           KRF+ +EL  A+++F++   L              +  + +AVKR+ +   QG + ++ +
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERXQGGELQFQT 84
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL---LTWEFRFKI 144
           EV +IS   HRNL++L G+C    E LLVY YM NGS+ S L +       L W  R +I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA 204
           A   A GL YL +  +  ++HRD+K++NI+LD  F A +GDFGLA+L+++        + 
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLT-AKEEVQVYLVQWVWDLY 263
           GT+G++APE  +TG++S+++DV+ +G++ LE+  G++   L     +  V L+ WV  L 
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
              KL   VD  L  ++ ++++E L+ V L C       RP + +V+ +L  +
Sbjct: 265 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 98/293 (33%), Positives = 163/293 (55%), Gaps = 6/293 (2%)
Query: 29  KRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIK-EYAS 87
           KRF+ +EL  A+++F +   L              +    +AVKR+ +   QG + ++ +
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD-GXLVAVKRLKEERTQGGELQFQT 76
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL---LTWEFRFKI 144
           EV +IS   HRNL++L G+C    E LLVY YM NGS+ S L +       L W  R +I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA 204
           A   A GL YL +  +  ++HRD+K++NI+LD  F A +GDFGLA+L+++        + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLT-AKEEVQVYLVQWVWDLY 263
           G +G++APE  +TG++S+++DV+ +G++ LE+  G++   L     +  V L+ WV  L 
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
              KL   VD  L  ++ ++++E L+ V L C       RP + +V+ +L  +
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 99/285 (34%), Positives = 155/285 (54%), Gaps = 9/285 (3%)
Query: 30  RFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIKEYASEV 89
           R    +L +ATN+F D + L                 + +A+KR +  S QGI+E+ +E+
Sbjct: 28  RVPLVDLEEATNNF-DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN---NLLTWEFRFKIAQ 146
             +S  RH +LV L+G+C E+ E++L+Y+YM NG+L  HL+  +     ++WE R +I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL-VEHAKGSQTTVLAG 205
             A GL YL     + ++HRD+KS NI+LD NF  KI DFG+++   E  +     V+ G
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T+GY+ PE    GR +++SDVYSFG+V  E+ C R  I  +   E+ V L +W  + + N
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAVESHNN 262
Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
           G+L + VDP L      + +       + C       RPS+  V+
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 99/285 (34%), Positives = 155/285 (54%), Gaps = 9/285 (3%)
Query: 30  RFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIKEYASEV 89
           R    +L +ATN+F D + L                 + +A+KR +  S QGI+E+ +E+
Sbjct: 28  RVPLVDLEEATNNF-DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN---NLLTWEFRFKIAQ 146
             +S  RH +LV L+G+C E+ E++L+Y+YM NG+L  HL+  +     ++WE R +I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL-VEHAKGSQTTVLAG 205
             A GL YL     + ++HRD+KS NI+LD NF  KI DFG+++   E  +     V+ G
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T+GY+ PE    GR +++SDVYSFG+V  E+ C R  I  +   E+ V L +W  + + N
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAVESHNN 262
Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
           G+L + VDP L      + +       + C       RPS+  V+
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 156/298 (52%), Gaps = 26/298 (8%)
Query: 31  FTYKELAQATNDFND------DQKLXXXXXXXXXXXXXRETSSYIAVKRVSK----GSKQ 80
           F++ EL   TN+F++        K+               T+  +AVK+++      +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 81  GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTW 138
             +++  E+ ++++ +H NLV+LLG+  +  +L LVY YMPNGSL   L        L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
             R KIAQ  A+G+ +L E      +HRDIKS+NI+LD  F AKI DFGLAR  E  K +
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE--KFA 187
Query: 199 QTTV---LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL 255
           QT +   + GT  YMAPE A  G  + +SD+YSFG+V LEI  G   +      E Q+ L
Sbjct: 188 QTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLL 244
Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
                       + + +D ++  D D   +E +  V   C H  +N RP I++V  +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 156/298 (52%), Gaps = 26/298 (8%)
Query: 31  FTYKELAQATNDFND------DQKLXXXXXXXXXXXXXRETSSYIAVKRVSK----GSKQ 80
           F++ EL   TN+F++        K+               T+  +AVK+++      +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 72
Query: 81  GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTW 138
             +++  E+ ++++ +H NLV+LLG+  +  +L LVY YMPNGSL   L        L+W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
             R KIAQ  A+G+ +L E      +HRDIKS+NI+LD  F AKI DFGLAR  E  K +
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE--KFA 187
Query: 199 QTTV---LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL 255
           QT +   + GT  YMAPE A  G  + +SD+YSFG+V LEI  G   +      E Q+ L
Sbjct: 188 QTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLL 244
Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
                       + + +D ++  D D   +E +  V   C H  +N RP I++V  +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 153/296 (51%), Gaps = 22/296 (7%)
Query: 31  FTYKELAQATNDFND------DQKLXXXXXXXXXXXXXRETSSYIAVKRVSK----GSKQ 80
           F++ EL   TN+F++        K+               T+  +AVK+++      +++
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEE 66
Query: 81  GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL--FKENNLLTW 138
             +++  E+ ++++ +H NLV+LLG+  +  +L LVY YMPNGSL   L        L+W
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-AKG 197
             R KIAQ  A+G+ +L E      +HRDIKS+NI+LD  F AKI DFGLAR  E  A+ 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
                + GT  YMAPE A  G  + +SD+YSFG+V LEI  G   +      E Q+ L  
Sbjct: 184 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDI 240
Query: 258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
                     + + +D ++  D D   +E +  V   C H  +N RP I++V  +L
Sbjct: 241 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 90/255 (35%), Positives = 136/255 (53%), Gaps = 14/255 (5%)
Query: 66  SSYIAVKRVSK----GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           ++ +AVK+++      +++  +++  E+ + ++ +H NLV+LLG+  +  +L LVY Y P
Sbjct: 45  NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXP 104
Query: 122 NGSLDSHL--FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           NGSL   L        L+W  R KIAQ  A+G+ +L E      +HRDIKS+NI+LD  F
Sbjct: 105 NGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAF 161
Query: 180 NAKIGDFGLARLVEH-AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
            AKI DFGLAR  E  A+    + + GT  Y APE A  G  + +SD+YSFG+V LEI  
Sbjct: 162 TAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIIT 220
Query: 239 GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHP 298
           G   +      E Q+ L            + + +D +   D D   +E    V   C H 
Sbjct: 221 GLPAVD--EHREPQLLLDIKEEIEDEEKTIEDYIDKKX-NDADSTSVEAXYSVASQCLHE 277
Query: 299 DENLRPSIRQVIHVL 313
            +N RP I++V  +L
Sbjct: 278 KKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 60/163 (36%), Positives = 92/163 (56%), Gaps = 4/163 (2%)
Query: 82  IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKE--NNLLTWE 139
           + E+  EV I+ RLRH N+V  +G   +   L +V EY+  GSL   L K      L   
Sbjct: 78  VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ 199
            R  +A D+A G+ YL       +VHRD+KS N+++D  +  K+ DFGL+RL + +    
Sbjct: 138 RRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLX 195
Query: 200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           +   AGT  +MAPE      ++++SDVYSFG++  E+A  ++P
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGLAR++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 60/163 (36%), Positives = 91/163 (55%), Gaps = 4/163 (2%)
Query: 82  IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKE--NNLLTWE 139
           + E+  EV I+ RLRH N+V  +G   +   L +V EY+  GSL   L K      L   
Sbjct: 78  VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ 199
            R  +A D+A G+ YL       +VHR++KS N+++D  +  K+ DFGL+RL      S 
Sbjct: 138 RRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196
Query: 200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            +  AGT  +MAPE      ++++SDVYSFG++  E+A  ++P
Sbjct: 197 KSA-AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 70  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 128
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 129 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 185
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 186 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 245
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 246 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 283
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 284 CWQKDRNNRPKFEQIVSILD 303

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 98/184 (53%), Gaps = 5/184 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     ++  E  ++ +L H  LVQL G C E+  + LV+E+M +G L  +
Sbjct: 54  VAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 112
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L  +  L   E    +  D+  G+ YL+E    CV+HRD+ + N ++  N   K+ DFG+
Sbjct: 113 LRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM 169
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTA 247
            R V   + + +T     + + +PE  +  R S +SDV+SFG++  E+   G+ P    +
Sbjct: 170 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 229
Query: 248 KEEV 251
             EV
Sbjct: 230 NSEV 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 43  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 101
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 102 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 158
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 218
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 219 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 256
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 257 CWQKDRNNRPKFEQIVSILD 276

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V EYM N
Sbjct: 60  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 118
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 119 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 175
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 176 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 235
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 236 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 273
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 274 CWQKDRNNRPKFEQIVSILD 293

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 5/184 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +G+    +++  E  ++ +L H  LVQL G C E+  + LV+E+M +G L  +
Sbjct: 32  VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L  +  L   E    +  D+  G+ YL+E    CV+HRD+ + N ++  N   K+ DFG+
Sbjct: 91  LRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM 147
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTA 247
            R V   + + +T     + + +PE  +  R S +SDV+SFG++  E+   G+ P    +
Sbjct: 148 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207
Query: 248 KEEV 251
             EV
Sbjct: 208 NSEV 211

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 5/184 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +G+    +++  E  ++ +L H  LVQL G C E+  + LV+E+M +G L  +
Sbjct: 34  VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L  +  L   E    +  D+  G+ YL+E    CV+HRD+ + N ++  N   K+ DFG+
Sbjct: 93  LRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM 149
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTA 247
            R V   + + +T     + + +PE  +  R S +SDV+SFG++  E+   G+ P    +
Sbjct: 150 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209
Query: 248 KEEV 251
             EV
Sbjct: 210 NSEV 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 5/184 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +G+    +++  E  ++ +L H  LVQL G C E+  + LV+E+M +G L  +
Sbjct: 37  VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L  +  L   E    +  D+  G+ YL+E    CV+HRD+ + N ++  N   K+ DFG+
Sbjct: 96  LRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM 152
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTA 247
            R V   + + +T     + + +PE  +  R S +SDV+SFG++  E+   G+ P    +
Sbjct: 153 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212
Query: 248 KEEV 251
             EV
Sbjct: 213 NSEV 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 128/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V E M N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 98/184 (53%), Gaps = 5/184 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +G+    +++  E  ++ +L H  LVQL G C E+  + LV E+M +G L  +
Sbjct: 35  VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L  +  L   E    +  D+  G+ YL+E    CV+HRD+ + N ++  N   K+ DFG+
Sbjct: 94  LRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM 150
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTA 247
            R V   + + +T     + + +PE  +  R S +SDV+SFG++  E+   G+ P    +
Sbjct: 151 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210
Query: 248 KEEV 251
             EV
Sbjct: 211 NSEV 214

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 128/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V E M N
Sbjct: 72  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMEN 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 131 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 248 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 285
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 286 CWQKDRNNRPKFEQIVSILD 305

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 128/260 (49%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +E S  I   +V    KQ  +++  E +I+ +  H N+++L G   + K +++V E M N
Sbjct: 43  KEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMEN 101
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLDS L K +   T      + + +ASG+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 102 GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 158
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + +PE     + +  SDV+S+GIV  E+ + G
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 218
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AVD   RL        M+C   L  + L 
Sbjct: 219 ERP----------------YWEM-SNQDVIKAVDEGYRL-----PPPMDCPAALYQLMLD 256
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   D N RP   Q++ +L+
Sbjct: 257 CWQKDRNNRPKFEQIVSILD 276

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 130/256 (50%), Gaps = 32/256 (12%)
Query: 68  YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           ++A+K +  G +++  +++ SE +I+ +  H N++ L G   +   ++++ E+M NGSLD
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
           S L + +   T      + + +A+G+ YL    +   VHRD+ + NI+++ N   K+ DF
Sbjct: 123 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDF 179
Query: 187 GLARLVEH--AKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGRK 241
           GL+R +E   +  + T+ L G +   + APE     + +  SDV+S+GIV  E+ + G +
Sbjct: 180 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 239
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAV--DPRLCRDFD-EQQMECLMIVGLWCAHP 298
           P                 WD+  N  ++ A+  D RL    D    +  LM   L C   
Sbjct: 240 P----------------YWDM-TNQDVINAIEQDYRLPPPMDCPSALHQLM---LDCWQK 279
Query: 299 DENLRPSIRQVIHVLN 314
           D N RP   Q+++ L+
Sbjct: 280 DRNHRPKFGQIVNTLD 295

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 39/261 (14%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL--- 125
           +AVK +   S    K++  E  +++ L+H ++V+  G C E   L++V+EYM +G L   
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
Query: 126 ------DSHLFKENNL---LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
                 D+ L  E N    LT      IAQ +A+G++YL     Q  VHRD+ + N ++ 
Sbjct: 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVG 162
Query: 177 LNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
            N   KIGDFG++R V   ++ +    T+L   + +M PE     + + ESDV+S G+V 
Sbjct: 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP--IRWMPPESIMYRKFTTESDVWSLGVVL 220
Query: 234 LEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVG 292
            EI   G++P    +  EV   + Q        G++L+   PR C     Q++  LM+ G
Sbjct: 221 WEIFTYGKQPWYQLSNNEVIECITQ--------GRVLQR--PRTC----PQEVYELML-G 265
Query: 293 LWCAHPDENLRPSIRQVIHVL 313
            W   P  ++R +I+  IH L
Sbjct: 266 CWQREP--HMRKNIKG-IHTL 283

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 128/257 (49%), Gaps = 32/257 (12%)
Query: 67  SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           S +A+K +  G +++  +E+ SE +I+ +  H N+++L G       ++++ E+M NG+L
Sbjct: 45  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
           DS L   +   T      + + +ASG+ YL    E   VHRD+ + NI+++ N   K+ D
Sbjct: 105 DSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSYVHRDLAARNILVNSNLVCKVSD 161
Query: 186 FGLARLVEH--AKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGR 240
           FGL+R +E   +  ++T+ L G +   + APE     + +  SD +S+GIV  E+ + G 
Sbjct: 162 FGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGE 221
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV--DPRLCRDFD-EQQMECLMIVGLWCAH 297
           +P                 WD+  N  ++ A+  D RL    D    +  LM   L C  
Sbjct: 222 RP----------------YWDM-SNQDVINAIEQDYRLPPPPDCPTSLHQLM---LDCWQ 261
Query: 298 PDENLRPSIRQVIHVLN 314
            D N RP   QV+  L+
Sbjct: 262 KDRNARPRFPQVVSALD 278

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 125/253 (49%), Gaps = 28/253 (11%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K +  G +++  +++ SE +I+ +  H N+++L G     +  ++V EYM NGSLD+
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQE-GWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            L   +   T      + + + +G+ YL + G+    VHRD+ + N+++D N   K+ DF
Sbjct: 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDF 195
Query: 187 GLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGRKPI 243
           GL+R++E    +  T   G +   + APE       S  SDV+SFG+V  E+ A G +P 
Sbjct: 196 GLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
Query: 244 -SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL 302
            ++T ++         V      G  L A  P  C     Q M       L C H D   
Sbjct: 256 WNMTNRD---------VISSVEEGYRLPA--PMGCPHALHQLM-------LDCWHKDRAQ 297
Query: 303 RPSIRQVIHVLNS 315
           RP   Q++ VL++
Sbjct: 298 RPRFSQIVSVLDA 310

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 98/184 (53%), Gaps = 5/184 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +G+    +++  E  ++ +L H  LVQL G C E+  + LV+E+M +G L  +
Sbjct: 34  VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L  +  L   E    +  D+  G+ YL+E     V+HRD+ + N ++  N   K+ DFG+
Sbjct: 93  LRTQRGLFAAETLLGMCLDVCEGMAYLEEA---SVIHRDLAARNCLVGENQVIKVSDFGM 149
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTA 247
            R V   + + +T     + + +PE  +  R S +SDV+SFG++  E+   G+ P    +
Sbjct: 150 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209
Query: 248 KEEV 251
             EV
Sbjct: 210 NSEV 213

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 125/253 (49%), Gaps = 28/253 (11%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K +  G +++  +++ SE +I+ +  H N+++L G     +  ++V EYM NGSLD+
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQE-GWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            L   +   T      + + + +G+ YL + G+    VHRD+ + N+++D N   K+ DF
Sbjct: 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDF 195
Query: 187 GLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGRKPI 243
           GL+R++E    +  T   G +   + APE       S  SDV+SFG+V  E+ A G +P 
Sbjct: 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
Query: 244 -SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL 302
            ++T ++         V      G  L A  P  C     Q M       L C H D   
Sbjct: 256 WNMTNRD---------VISSVEEGYRLPA--PMGCPHALHQLM-------LDCWHKDRAQ 297
Query: 303 RPSIRQVIHVLNS 315
           RP   Q++ VL++
Sbjct: 298 RPRFSQIVSVLDA 310

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 127/257 (49%), Gaps = 32/257 (12%)
Query: 67  SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           S +A+K +  G +++  +E+ SE +I+ +  H N+++L G       ++++ E+M NG+L
Sbjct: 43  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
           DS L   +   T      + + +ASG+ YL    E   VHRD+ + NI+++ N   K+ D
Sbjct: 103 DSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSYVHRDLAARNILVNSNLVCKVSD 159
Query: 186 FGLARLVEH--AKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGR 240
           FGL+R +E   +  + T+ L G +   + APE     + +  SD +S+GIV  E+ + G 
Sbjct: 160 FGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGE 219
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV--DPRLCRDFD-EQQMECLMIVGLWCAH 297
           +P                 WD+  N  ++ A+  D RL    D    +  LM   L C  
Sbjct: 220 RP----------------YWDM-SNQDVINAIEQDYRLPPPPDCPTSLHQLM---LDCWQ 259
Query: 298 PDENLRPSIRQVIHVLN 314
            D N RP   QV+  L+
Sbjct: 260 KDRNARPRFPQVVSALD 276

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/182 (34%), Positives = 99/182 (54%), Gaps = 10/182 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 95
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL         +    IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 96  HHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDF 152
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE      +   S +SDVY+FGIV  E+  G+ P
Sbjct: 153 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212
Query: 243 IS 244
            S
Sbjct: 213 YS 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 129/255 (50%), Gaps = 34/255 (13%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K +  G + +  +++ SE +I+ +  H N++ L G   + K ++++ EYM NGSLD+
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L K +   T      + + + SG+ YL    +   VHRD+ + NI+++ N   K+ DFG
Sbjct: 120 FLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFG 176
Query: 188 LARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGRKPIS 244
           ++R++E    +  T   G +   + APE     + +  SDV+S+GIV  E+ + G +P  
Sbjct: 177 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-- 234
Query: 245 LTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLWCAHPD 299
                          WD+  N  +++A++   RL        M+C   L  + L C   +
Sbjct: 235 --------------YWDM-SNQDVIKAIEEGYRL-----PPPMDCPIALHQLMLDCWQKE 274
Query: 300 ENLRPSIRQVIHVLN 314
            + RP   Q++++L+
Sbjct: 275 RSDRPKFGQIVNMLD 289

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 32  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSL 89
Query: 126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 90  LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 146
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 147 DFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 206
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 207 PGMVNREV 214

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 129/256 (50%), Gaps = 32/256 (12%)
Query: 68  YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           ++A+K +  G +++  +++ SE +I+ +  H N++ L G   +   ++++ E+M NGSLD
Sbjct: 37  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
           S L + +   T      + + +A+G+ YL    +   VHR + + NI+++ N   K+ DF
Sbjct: 97  SFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRALAARNILVNSNLVCKVSDF 153
Query: 187 GLARLVEH--AKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGRK 241
           GL+R +E   +  + T+ L G +   + APE     + +  SDV+S+GIV  E+ + G +
Sbjct: 154 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 213
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAV--DPRLCRDFD-EQQMECLMIVGLWCAHP 298
           P                 WD+  N  ++ A+  D RL    D    +  LM   L C   
Sbjct: 214 P----------------YWDM-TNQDVINAIEQDYRLPPPMDCPSALHQLM---LDCWQK 253
Query: 299 DENLRPSIRQVIHVLN 314
           D N RP   Q+++ L+
Sbjct: 254 DRNHRPKFGQIVNTLD 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 127/260 (48%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           RE    I   +V    KQ  +++  E +I+ +  H N++ L G   + K +++V EYM N
Sbjct: 49  RELPVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN 107
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSLD+ L K +   T      + + +++G+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 108 GSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLS---DMGYVHRDLAARNILINSNLVCK 164
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEIAC-G 239
           + DFGL+R++E    +  T   G +   + APE     + +  SDV+S+GIV  E+   G
Sbjct: 165 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYG 224
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 W++  N  +++AV+   RL        M+C   L  + L 
Sbjct: 225 ERP----------------YWEM-TNQDVIKAVEEGYRL-----PSPMDCPAALYQLMLD 262
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   + N RP   +++++L+
Sbjct: 263 CWQKERNSRPKFDEIVNMLD 282

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 118
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 119 HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 175
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 176 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 236 YSNINNRDQIIFMV 249

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 119
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 120 HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 176
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 177 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 237 YSNINNRDQIIFMV 250

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 91
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 92  HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 148
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 209 YSNINNRDQIIFMV 222

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 96
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 97  HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 153
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 154 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 214 YSNINNRDQIIFMV 227

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 35  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 92
Query: 126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 93  LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 149
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 150 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 209
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 210 PGMVNREV 217

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 96
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 97  HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 153
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 154 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 214 YSNINNRDQIIFMV 227

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 31  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 88
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 89  LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 145
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 146 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 205
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 206 PGMVNREV 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 33  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 90
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 91  LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 147
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 148 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 207
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 208 PGMVNREV 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 129/255 (50%), Gaps = 34/255 (13%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K +  G + +  +++ SE +I+ +  H N++ L G   + K ++++ EYM NGSLD+
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L K +   T      + + + SG+ YL    +   VHRD+ + NI+++ N   K+ DFG
Sbjct: 105 FLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFG 161
Query: 188 LARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGRKPIS 244
           ++R++E    +  T   G +   + APE     + +  SDV+S+GIV  E+ + G +P  
Sbjct: 162 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-- 219
Query: 245 LTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLWCAHPD 299
                          WD+  N  +++A++   RL        M+C   L  + L C   +
Sbjct: 220 --------------YWDM-SNQDVIKAIEEGYRL-----PPPMDCPIALHQLMLDCWQKE 259
Query: 300 ENLRPSIRQVIHVLN 314
            + RP   Q++++L+
Sbjct: 260 RSDRPKFGQIVNMLD 274

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 93
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 94  HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 150
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 151 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 211 YSNINNRDQIIFMV 224

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 129/255 (50%), Gaps = 34/255 (13%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K +  G + +  +++ SE +I+ +  H N++ L G   + K ++++ EYM NGSLD+
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L K +   T      + + + SG+ YL    +   VHRD+ + NI+++ N   K+ DFG
Sbjct: 99  FLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFG 155
Query: 188 LARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACGRKPIS 244
           ++R++E    +  T   G +   + APE     + +  SDV+S+GIV  E+ + G +P  
Sbjct: 156 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-- 213
Query: 245 LTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLWCAHPD 299
                          WD+  N  +++A++   RL        M+C   L  + L C   +
Sbjct: 214 --------------YWDM-SNQDVIKAIEEGYRL-----PPPMDCPIALHQLMLDCWQKE 253
Query: 300 ENLRPSIRQVIHVLN 314
            + RP   Q++++L+
Sbjct: 254 RSDRPKFGQIVNMLD 268

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 104/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 40  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 97
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E A+ +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 155 LARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 215 TNPEVIQ 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/182 (34%), Positives = 98/182 (53%), Gaps = 10/182 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL         +    IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPEC---ATTGRASKESDVYSFGIVALEIACGRKP 242
           GLA       GS Q   L+G++ +MAPE      +   S +SDVY+FGIV  E+  G+ P
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
Query: 243 IS 244
            S
Sbjct: 225 YS 226

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 291 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 348
Query: 126 DSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 349 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 405
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 466 PGMVNREV 473

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 208 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 265
Query: 126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 322
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 383 PGMVNREV 390

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 208 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 265
Query: 126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 322
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 383 PGMVNREV 390

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ ++RH  LVQL     E+  + +V EYM  GSL
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 126/260 (48%), Gaps = 34/260 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R+ +  I   +V    KQ  +++  E +I+ +  H N+V L G     K +++V E+M N
Sbjct: 70  RDVAVAIKTLKVGYTEKQR-RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMEN 128
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G+LD+ L K +   T      + + +A+G+ YL    +   VHRD+ + NI+++ N   K
Sbjct: 129 GALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCK 185
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEI-ACG 239
           + DFGL+R++E    +  T   G +   + APE     + +  SDV+S+GIV  E+ + G
Sbjct: 186 VSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 245
Query: 240 RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLCRDFDEQQMEC---LMIVGLW 294
            +P                 WD+  N  +++A++   RL        M+C   L  + L 
Sbjct: 246 ERP----------------YWDM-SNQDVIKAIEEGYRL-----PAPMDCPAGLHQLMLD 283
Query: 295 CAHPDENLRPSIRQVIHVLN 314
           C   +   RP   Q++ +L+
Sbjct: 284 CWQKERAERPKFEQIVGILD 303

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 41  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 100
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 101 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 218 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 268
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 269 -TECWNNNVNQRPSFRDL 285

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 97/188 (51%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD+ ++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 43  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 102
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 103 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 159
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 219
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 220 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 270
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 271 -TECWNNNVNQRPSFRDL 287

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 129 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 185
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 186 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 296
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 297 -TECWNNNVNQRPSFRDL 313

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 45  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 104
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 105 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 161
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 162 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 221
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 222 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 272
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 273 -TECWNNNVNQRPSFRDL 289

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 208 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSL 265
Query: 126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 322
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 383 PGMVNREV 390

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 39  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSL 96
Query: 126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       ++  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 153
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 154 DFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 214 PGMVNREV 221

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 42  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 101
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 102 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 158
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 159 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 218
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 219 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 269
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 270 T-ECWNNNVNQRPSFRDL 286

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 38  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 265
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 266 T-ECWNNNVNQRPSFRDL 282

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 38  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 265
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 266 -TECWNNNVNQRPSFRDL 282

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 44  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 103
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 104 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 160
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 161 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 220
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 221 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 271
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 272 -TECWNNNVNQRPSFRDL 288

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 37  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 96
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 97  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 153
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 154 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 213
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 214 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 264
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 265 T-ECWNNNVNQRPSFRDL 281

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 36  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 95
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 96  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 152
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 153 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 212
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 213 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 263
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 264 T-ECWNNNVNQRPSFRDL 280

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 119
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 120 HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 176
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA       GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 177 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 237 YSNINNRDQIIFMV 250

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 97/188 (51%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  G L
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 111
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 112 HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 168
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA       GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 169 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 229 YSNINNRDQIIFMV 242

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 39  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSL 96
Query: 126 DSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       ++  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 97  LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 153
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 154 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 214 PGMVNREV 221

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+   K +L +V ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 91
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 92  HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 148
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA       GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 149 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 209 YSNINNRDQIIFMV 222

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 16/187 (8%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           RET   + +K + +  ++  + +  EV ++  L H N+++ +G  ++ K L  + EY+  
Sbjct: 32  RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G+L   +   ++   W  R   A+D+ASG+ YL       ++HRD+ S N ++  N N  
Sbjct: 92  GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVV 148
Query: 183 IGDFGLARLVEHAKG-------------SQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           + DFGLARL+   K               +   + G   +MAPE        ++ DV+SF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208
Query: 230 GIVALEI 236
           GIV  EI
Sbjct: 209 GIVLCEI 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 56  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 115
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 116 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 172
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 233 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 283
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 284 -TECWNNNVNQRPSFRDL 300

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 56  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 115
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 116 GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 172
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 233 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 283
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 284 -TECWNNNVNQRPSFRDL 300

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 128/268 (47%), Gaps = 44/268 (16%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK +   +    K++  E  +++ L+H ++V+  G C +   L++V+EYM +G L+  
Sbjct: 48  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 107
Query: 129 L---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           L                +    L       IA  +ASG++YL     Q  VHRD+ + N 
Sbjct: 108 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNC 164
Query: 174 MLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           ++  N   KIGDFG++R V   ++ +    T+L   + +M PE     + + ESDV+SFG
Sbjct: 165 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP--IRWMPPESIMYRKFTTESDVWSFG 222
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD--FDEQQMEC 287
           ++  EI   G++P    +  EV   + Q        G++LE   PR+C    +D      
Sbjct: 223 VILWEIFTYGKQPWFQLSNTEVIECITQ--------GRVLE--RPRVCPKEVYD------ 266
Query: 288 LMIVGLWCAHPDENLR-PSIRQVIHVLN 314
            +++G W   P + L    I +++H L 
Sbjct: 267 -VMLGCWQREPQQRLNIKEIYKILHALG 293

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+     +L +V ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLY 91
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL              IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 92  HHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDF 148
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GS Q   L+G++ +MAPE          S +SDVY+FGIV  E+  G+ P
Sbjct: 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 209 YSNINNRDQIIFMV 222

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 97/188 (51%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  G L
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCL 99
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 100 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 156
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 157 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 217 PGMVNREV 224

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 97/182 (53%), Gaps = 10/182 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK   V+  + Q ++ + +EV ++ + RH N++  +G+     +L +V ++    SL 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLY 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL         +    IA+  A G+ YL     + ++HRD+KS+NI L  +   KIGDF
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 187 GLARLVEHAKGS-QTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKP 242
           GLA       GS Q   L+G++ +MAPE      +   S +SDVY+FGIV  E+  G+ P
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
Query: 243 IS 244
            S
Sbjct: 225 YS 226

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 7/185 (3%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 46  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 103
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 104 LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 160
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLT 246
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P    
Sbjct: 161 LARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 220
Query: 247 AKEEV 251
              EV
Sbjct: 221 TNPEV 225

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 49  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 106
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 107 LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 163
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 164 LARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 223
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 224 TNPEVIQ 230

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 40  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 97
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 155 LARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 215 TNPEVIQ 221

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 7/185 (3%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 48  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 105
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 106 LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 162
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLT 246
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P    
Sbjct: 163 LARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 222
Query: 247 AKEEV 251
              EV
Sbjct: 223 TNPEV 227

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 42  VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 99
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 100 LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 156
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 157 LARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 216
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 217 TNPEVIQ 223

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 97/188 (51%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  ++ +LRH  LVQL     E+  + +V EYM  GSL
Sbjct: 209 TTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL 266
Query: 126 DSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L  E    L       +A  +ASG+ Y++       VHRD++++NI++  N   K+ 
Sbjct: 267 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA 323
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGL RL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 324 DFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 383
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 384 PGMVNREV 391

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ E++P 
Sbjct: 41  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPY 100
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 101 GSLREYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 218 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 268
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 269 T-ECWNNNVNQRPSFRDL 285

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 41  VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 98
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 99  LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 155
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 156 LARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 215
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 216 TNPEVIQ 222

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 40  VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 97
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 155 LARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 215 TNPEVIQ 221

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 38  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 98  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 265
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 266 -TECWNNNVNQRPSFRDL 282

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 7/185 (3%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 50  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 107
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 108 LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 164
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLT 246
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P    
Sbjct: 165 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 224
Query: 247 AKEEV 251
              EV
Sbjct: 225 TNPEV 229

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 46  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 103
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 104 LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 160
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 161 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 220
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 221 TNPEVIQ 227

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 45  VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 102
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 103 LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 159
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 160 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 219
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 220 TNPEVIQ 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 40  VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 97
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 215 TNPEVIQ 221

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 21/191 (10%)
Query: 67  SYIAVKRVSKGSKQG-------IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           S +A+K +  G  +G        +E+  EV I+S L H N+V+L G  H    +  V E+
Sbjct: 45  SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEF 102
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLN 178
           +P G L   L  + + + W  + ++  D+A G+ Y+Q      +VHRD++S NI L  L+
Sbjct: 103 VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLD 161
Query: 179 FN----AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC--ATTGRASKESDVYSFGIV 232
            N    AK+ DFGL++   H+     + L G   +MAPE   A     ++++D YSF ++
Sbjct: 162 ENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 233 ALEIACGRKPI 243
              I  G  P 
Sbjct: 218 LYTILTGEGPF 228

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 35  VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 92
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HRD++++NI++    + KI DFG
Sbjct: 93  LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFG 149
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 150 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 209
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 210 TNPEVIQ 216

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 124/258 (48%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 39  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 98
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L K    +      +    +  G+ YL     +  +HR++ + NI+++     K
Sbjct: 99  GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVK 155
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 156 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 215
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 216 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 266
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 267 -TECWNNNVNQRPSFRDL 283

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 26/258 (10%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T   +AVK++   +++ ++++  E+ I+  L+H N+V+  G C+   ++ L L+ EY+P 
Sbjct: 41  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 100
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GSL  +L      +      +    +  G+ YL     +  +HRD+ + NI+++     K
Sbjct: 101 GSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 183 IGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE----I 236
           IGDFGL +++   K        G   + + APE  T  + S  SDV+SFG+V  E    I
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217
Query: 237 ACGRKPIS-----LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV 291
              + P +     +   ++ Q+ +   +  L  NG+L     P  C D      E  MI+
Sbjct: 218 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPD------EIYMIM 268
Query: 292 GLWCAHPDENLRPSIRQV 309
              C + + N RPS R +
Sbjct: 269 T-ECWNNNVNQRPSFRDL 285

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 101/188 (53%), Gaps = 9/188 (4%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K +  G   KQ + ++  E  I+ +  H N+++L G   + K ++++ EYM NG+LD
Sbjct: 76  VAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 134
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
             L +++   +      + + +A+G+ YL        VHRD+ + NI+++ N   K+ DF
Sbjct: 135 KFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 187 GLARLVEHAKGSQTTVLAGTMG--YMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           GL+R++E    +  T   G +   + APE  +  + +  SDV+SFGIV  E+   G +P 
Sbjct: 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
Query: 244 SLTAKEEV 251
              +  EV
Sbjct: 252 WELSNHEV 259

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 69  IAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK  +V   + +  + + +EV ++ + RH N++  +G+   K  L +V ++    SL 
Sbjct: 61  VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-TKDNLAIVTQWCEGSSLY 119
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            HL  +           IA+  A G+ YL     + ++HRD+KS+NI L      KIGDF
Sbjct: 120 KHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDF 176
Query: 187 GLARLVEHAKGSQTTVL-AGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKP 242
           GLA +     GSQ      G++ +MAPE          S +SDVYS+GIV  E+  G  P
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236
Query: 243 ISLTAKEEVQVYLV 256
            S     +  +++V
Sbjct: 237 YSHINNRDQIIFMV 250

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/188 (32%), Positives = 97/188 (51%), Gaps = 7/188 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           ++ +A+K +  G+    + +  E  I+ +L+H  LVQL     E+  + +V EYM  GSL
Sbjct: 33  NTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSL 90
Query: 126 DSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L   E   L       +A  +A+G+ Y++       +HRD++S+NI++      KI 
Sbjct: 91  LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKIA 147
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLARL+E  + +        + + APE A  GR + +SDV+SFGI+  E+   GR P 
Sbjct: 148 DFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 207
Query: 244 SLTAKEEV 251
                 EV
Sbjct: 208 PGMNNREV 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    +V EYMP 
Sbjct: 54  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPY 112
Query: 123 GSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +T      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 113 GNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVV 169
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE       S +SDV++FG++  EIA 
Sbjct: 170 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226
Query: 239 -GRKP 242
            G  P
Sbjct: 227 YGMSP 231

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 78  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 137
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 138 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 194
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 195 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 255 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 297
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 298 MRPSFSELV 306

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 60  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 237 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 279
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 280 MRPSFSELV 288

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 58  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 117
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 118 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 175 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 235 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 277
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 278 MRPSFSELV 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 59  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 118
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 119 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 176 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 236 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 278
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 279 MRPSFSELV 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 21/191 (10%)
Query: 67  SYIAVKRVSKGSKQG-------IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           S +A+K +  G  +G        +E+  EV I+S L H N+V+L G  H    +  V E+
Sbjct: 45  SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEF 102
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLN 178
           +P G L   L  + + + W  + ++  D+A G+ Y+Q      +VHRD++S NI L  L+
Sbjct: 103 VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLD 161
Query: 179 FN----AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC--ATTGRASKESDVYSFGIV 232
            N    AK+ DFG ++   H+     + L G   +MAPE   A     ++++D YSF ++
Sbjct: 162 ENAPVCAKVADFGTSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 233 ALEIACGRKPI 243
              I  G  P 
Sbjct: 218 LYTILTGEGPF 228

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 52  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 111
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 112 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 168
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 169 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 229 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 271
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 272 MRPSFSELV 280

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 60  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 177 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 237 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 279
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 280 MRPSFSELV 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 55  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 115 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 171
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 232 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 274
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 275 MRPSFSELV 283

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 57  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 117 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 174 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 234 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 276
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 277 MRPSFSELV 285

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 26/249 (10%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 79  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 138
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 139 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 195
Query: 186 FGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           FGLAR +   E+      T     + +MA E   T + + +SDV+SFG++  E+   G  
Sbjct: 196 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDEN 301
           P       ++ VYL+Q        G+ L  + P  C D        L  V L C HP   
Sbjct: 256 PYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCWHPKAE 298
Query: 302 LRPSIRQVI 310
           +RPS  +++
Sbjct: 299 MRPSFSELV 307

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 103/187 (55%), Gaps = 8/187 (4%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS      + +E  ++ +L+H+ LV+L      ++ + ++ EYM NGSL   
Sbjct: 36  VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDF 93
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   + + LT      +A  +A G+ +++E   +  +HR+++++NI++    + KI DFG
Sbjct: 94  LKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNLRAANILVSDTLSCKIADFG 150
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI-SL 245
           LARL+E  + +        + + APE    G  + +SDV+SFGI+  EI   GR P   +
Sbjct: 151 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 210
Query: 246 TAKEEVQ 252
           T  E +Q
Sbjct: 211 TNPEVIQ 217

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 21/191 (10%)
Query: 67  SYIAVKRVSKGSKQG-------IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           S +A+K +  G  +G        +E+  EV I+S L H N+V+L G  H    +  V E+
Sbjct: 45  SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEF 102
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLN 178
           +P G L   L  + + + W  + ++  D+A G+ Y+Q      +VHRD++S NI L  L+
Sbjct: 103 VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLD 161
Query: 179 FN----AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC--ATTGRASKESDVYSFGIV 232
            N    AK+ DF L++   H+     + L G   +MAPE   A     ++++D YSF ++
Sbjct: 162 ENAPVCAKVADFSLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 233 ALEIACGRKPI 243
              I  G  P 
Sbjct: 218 LYTILTGEGPF 228

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 63  RETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           R++   +A+K + K    K G++ +   EV I S LRH N+++L G+ H+   + L+ EY
Sbjct: 34  RQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 93
Query: 120 MPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
            P G++   L     F E    T+        +LA+ L Y      + V+HRDIK  N++
Sbjct: 94  APLGTVYRELQKLSRFDEQRTATY------ITELANALSYCH---SKRVIHRDIKPENLL 144
Query: 175 LDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
           L  N   KI DFG +    HA  S+ T L GT+ Y+ PE        ++ D++S G++  
Sbjct: 145 LGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 201
Query: 235 EIACGRKPISLTAKEEV 251
           E   G  P      +E 
Sbjct: 202 EFLVGMPPFEAHTYQET 218

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 59  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 118
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ YL     +  VHRD+ + N MLD  F  K+ D
Sbjct: 119 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVAD 175
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 176 FGLARDMYDKEXXSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 230
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 231 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 273
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 274 HPKAEMRPSFSELV 287

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G +   L     F E    T+        +LA+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELAN 124
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 178
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 123
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 124 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 177
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 218

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 118
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 119 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 172
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 120 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 173
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 123 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 176
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRF 142
           EV I S LRH N+++L G+ H+   + L+ EY P G++   L     F E    T+    
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---- 139
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
               +LA+ L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T 
Sbjct: 140 --ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTT 191
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           L GT+ Y+ PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 240

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 35/262 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R  ++ +AVK   +     +K ++  E  I+ +  H N+V+L+G C +K+ + +V E + 
Sbjct: 136 RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G   + L  E   L  +   ++  D A+G+ YL+    +C +HRD+ + N ++      
Sbjct: 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVL 252
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMG-------YMAPECATTGRASKESDVYSFGIVAL 234
           KI DFG++R  E A G    V A + G       + APE    GR S ESDV+SFGI+  
Sbjct: 253 KISDFGMSR--EEADG----VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 235 E-IACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGL 293
           E  + G  P    + ++ + ++ +        G+L     P LC D   + ME       
Sbjct: 307 ETFSLGASPYPNLSNQQTREFVEK-------GGRL---PCPELCPDAVFRLME-----QC 351
Query: 294 WCAHPDENLRPSIRQVIHVLNS 315
           W   P +  RPS   +   L S
Sbjct: 352 WAYEPGQ--RPSFSTIYQELQS 371

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ +L     +  VHRD+ + N MLD  F  K+ D
Sbjct: 179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 291 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 333
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 334 HPKAEMRPSFSELV 347

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 125 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 178
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 61  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 120
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ +L     +  VHRD+ + N MLD  F  K+ D
Sbjct: 121 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 178 FGLARDMLDKEFDSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 232
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 233 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 275
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 276 HPKAEMRPSFSELV 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 60  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ +L     +  VHRD+ + N MLD  F  K+ D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 231
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 232 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 274
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 275 HPKAEMRPSFSELV 288

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 123 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 176
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 61  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 120
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ +L     +  VHRD+ + N MLD  F  K+ D
Sbjct: 121 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 177
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 178 FGLARDMYDKEFDSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 232
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 233 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 275
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 276 HPKAEMRPSFSELV 289

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 120 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYL 173
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 35/262 (13%)
Query: 63  RETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R  ++ +AVK   +     +K ++  E  I+ +  H N+V+L+G C +K+ + +V E + 
Sbjct: 136 RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G   + L  E   L  +   ++  D A+G+ YL+    +C +HRD+ + N ++      
Sbjct: 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVL 252
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMG-------YMAPECATTGRASKESDVYSFGIVAL 234
           KI DFG++R  E A G    V A + G       + APE    GR S ESDV+SFGI+  
Sbjct: 253 KISDFGMSR--EEADG----VXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 235 E-IACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGL 293
           E  + G  P    + ++ + ++ +        G+L     P LC D   + ME       
Sbjct: 307 ETFSLGASPYPNLSNQQTREFVEK-------GGRL---PCPELCPDAVFRLME-----QC 351
Query: 294 WCAHPDENLRPSIRQVIHVLNS 315
           W   P +  RPS   +   L S
Sbjct: 352 WAYEPGQ--RPSFSTIYQELQS 371

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 65  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 124
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ +L     +  VHRD+ + N MLD  F  K+ D
Sbjct: 125 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 181
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 182 FGLARDMYDKEFDSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 236
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 237 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 279
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 280 HPKAEMRPSFSELV 293

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRF 142
           EV I S LRH N+++L G+ H+   + L+ EY P G++   L     F E    T+    
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---- 130
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
               +LA+ L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T 
Sbjct: 131 --ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTT 182
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           L GT+ Y+ PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 183 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 231

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 60  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 119
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ +L     +  VHRD+ + N MLD  F  K+ D
Sbjct: 120 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 176
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 177 FGLARDMYDKEFDSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 231
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 232 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 274
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 275 HPKAEMRPSFSELV 288

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L+GT+ Y+
Sbjct: 121 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSC---HAPSSRRTTLSGTLDYL 174
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 125 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 178
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRF 142
           EV I S LRH N+++L G+ H+   + L+ EY P G++   L     F E    T+    
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---- 110
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
               +LA+ L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T 
Sbjct: 111 --ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTT 162
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           L GT+ Y+ PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 89/177 (50%), Gaps = 8/177 (4%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMP 121
           T   +AVK +   S    I +   E+ I+  L H N+V+  G C E     + L+ E++P
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           +GSL  +L K  N +  + + K A  +  G+ YL  G  Q  VHRD+ + N++++     
Sbjct: 109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL--GSRQ-YVHRDLAARNVLVESEHQV 165
Query: 182 KIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
           KIGDFGL + +E  K   T        + + APEC    +    SDV+SFG+   E+
Sbjct: 166 KIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 36/254 (14%)
Query: 68  YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYEYMPNGSL 125
           + AVK +++ +  G + ++ +E  I+    H N++ LLG C   +   L+V  YM +G L
Sbjct: 58  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 117
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            + +  E +  T +        +A G+ +L     +  VHRD+ + N MLD  F  K+ D
Sbjct: 118 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 174
Query: 186 FGLAR--------LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           FGLAR         V +  G++  V      +MA E   T + + +SDV+SFG++  E+ 
Sbjct: 175 FGLARDMYDKEFDSVHNKTGAKLPV-----KWMALESLQTQKFTTKSDVWSFGVLLWELM 229
Query: 238 C-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCA 296
             G  P       ++ VYL+Q        G+ L  + P  C D        L  V L C 
Sbjct: 230 TRGAPPYPDVNTFDITVYLLQ--------GRRL--LQPEYCPD-------PLYEVMLKCW 272
Query: 297 HPDENLRPSIRQVI 310
           HP   +RPS  +++
Sbjct: 273 HPKAEMRPSFSELV 286

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 69  IAVKRV---SKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           +A+K +    +  ++ +K +  EV   S+L H+N+V ++    E     LV EY+   +L
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            S   + +  L+ +        +  G+   +   +  +VHRDIK  NI++D N   KI D
Sbjct: 99  -SEYIESHGPLSVDTAINFTNQILDGI---KHAHDMRIVHRDIKPQNILIDSNKTLKIFD 154
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE-SDVYSFGIVALEIACGRKP 242
           FG+A+ +     +QT  + GT+ Y +PE A  G A+ E +D+YS GIV  E+  G  P
Sbjct: 155 FGIAKALSETSLTQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 89/177 (50%), Gaps = 8/177 (4%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMP 121
           T   +AVK +   S    I +   E+ I+  L H N+V+  G C E     + L+ E++P
Sbjct: 37  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           +GSL  +L K  N +  + + K A  +  G+ YL  G  Q  VHRD+ + N++++     
Sbjct: 97  SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL--GSRQ-YVHRDLAARNVLVESEHQV 153
Query: 182 KIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
           KIGDFGL + +E  K   T        + + APEC    +    SDV+SFG+   E+
Sbjct: 154 KIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 120 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYL 173
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 63  RETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           R++   +A+K + K    K G++ +   EV I S LRH N+++L G+ H+   + L+ EY
Sbjct: 34  RQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 93
Query: 120 MPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
            P G++   L     F E    T+        +LA+ L Y      + V+HRDIK  N++
Sbjct: 94  APLGTVYRELQKLSRFDEQRTATY------ITELANALSYCH---SKRVIHRDIKPENLL 144
Query: 175 LDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
           L  N   KI DFG +    HA  S+   L GT+ Y+ PE        ++ D++S G++  
Sbjct: 145 LGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 201
Query: 235 EIACGRKPISLTAKEEV 251
           E   G  P      +E 
Sbjct: 202 EFLVGMPPFEAHTYQET 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 33  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTY 91
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 92  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 148
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 149 KVADFGLSRLM---TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
Query: 239 -GRKP 242
            G  P
Sbjct: 206 YGMSP 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYL 173
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYL 174
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYL 173
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 33  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 91
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 92  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 148
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 149 KVADFGLSRLM---TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
Query: 239 -GRKP 242
            G  P
Sbjct: 206 YGMSP 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI +FG +    HA  S+ T L GT+ Y+
Sbjct: 123 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYL 176
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 35  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTY 93
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 239 -GRKP 242
            G  P
Sbjct: 208 YGMSP 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 36  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTY 94
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 95  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 151
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 152 KVADFGLSRLM---TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208
Query: 239 -GRKP 242
            G  P
Sbjct: 209 YGMSP 213

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYL 173
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 95/184 (51%), Gaps = 19/184 (10%)
Query: 69  IAVKRVSKGS--KQG-IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           +A+K + K +  K G ++   +EV I  +L+H ++++L  +  +   + LV E   NG +
Sbjct: 39  VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM 98
Query: 126 DSHL------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           + +L      F EN     E R  + Q + +G+LYL       ++HRD+  SN++L  N 
Sbjct: 99  NRYLKNRVKPFSEN-----EARHFMHQ-IITGMLYLHS---HGILHRDLTLSNLLLTRNM 149
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           N KI DFGLA  ++       T L GT  Y++PE AT      ESDV+S G +   +  G
Sbjct: 150 NIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 240 RKPI 243
           R P 
Sbjct: 209 RPPF 212

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYL 178
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 35  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTY 93
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 239 -GRKP 242
            G  P
Sbjct: 208 YGMSP 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 40  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 98
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 155
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 156 KVADFGLSRLM---TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 239 -GRKP 242
            G  P
Sbjct: 213 YGMSP 217

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 35  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 239 -GRKP 242
            G  P
Sbjct: 208 YGMSP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 35  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 94  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 239 -GRKP 242
            G  P
Sbjct: 208 YGMSP 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 40  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 98
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 99  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 155
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 156 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 239 -GRKP 242
            G  P
Sbjct: 213 YGMSP 217

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 99/192 (51%), Gaps = 23/192 (11%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + + S+   +++  E  +++ L+H+++V+  G C E + LL+V+EYM +G L+  
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133
Query: 129 LFKEN--------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           L                    L       +A  +A+G++YL        VHRD+ + N +
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCL 190
Query: 175 LDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGI 231
           +      KIGDFG++R +   ++ +    T+L   + +M PE     + + ESDV+SFG+
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDVWSFGV 248
Query: 232 VALEI-ACGRKP 242
           V  EI   G++P
Sbjct: 249 VLWEIFTYGKQP 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI +FG +    HA  S+ T L GT+ Y+
Sbjct: 122 ALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYL 175
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 101/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 33  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 91
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   ++      +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 92  GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 148
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 149 KVADFGLSRLM---TGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
Query: 239 -GRKP 242
            G  P
Sbjct: 206 YGMSP 210

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 100/192 (52%), Gaps = 23/192 (11%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + + S+   +++  E  +++ L+H+++V+  G C E + LL+V+EYM +G L+  
Sbjct: 45  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 104
Query: 129 LFKEN--------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           L                    L       +A  +A+G++YL  G     VHRD+ + N +
Sbjct: 105 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCL 161
Query: 175 LDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGI 231
           +      KIGDFG++R +   ++ +    T+L   + +M PE     + + ESDV+SFG+
Sbjct: 162 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDVWSFGV 219
Query: 232 VALEI-ACGRKP 242
           V  EI   G++P
Sbjct: 220 VLWEIFTYGKQP 231

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 40  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTY 98
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 155
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 156 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 239 -GRKP 242
            G  P
Sbjct: 213 YGMSP 217

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 100/192 (52%), Gaps = 23/192 (11%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + + S+   +++  E  +++ L+H+++V+  G C E + LL+V+EYM +G L+  
Sbjct: 51  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 110
Query: 129 LFKEN--------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           L                    L       +A  +A+G++YL  G     VHRD+ + N +
Sbjct: 111 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCL 167
Query: 175 LDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGI 231
           +      KIGDFG++R +   ++ +    T+L   + +M PE     + + ESDV+SFG+
Sbjct: 168 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIRWMPPESILYRKFTTESDVWSFGV 225
Query: 232 VALEI-ACGRKP 242
           V  EI   G++P
Sbjct: 226 VLWEIFTYGKQP 237

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYL 176
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G +   L     F E    T+        +LA+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELAN 124
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYL 178
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYL 173
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 40  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 98
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 155
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 156 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 239 -GRKP 242
            G  P
Sbjct: 213 YGMSP 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 40  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 98
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 99  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 155
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 156 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 239 -GRKP 242
            G  P
Sbjct: 213 YGMSP 217

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 39  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 98  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 154
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 155 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
Query: 239 -GRKP 242
            G  P
Sbjct: 212 YGMSP 216

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 48  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 106
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 107 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 163
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 164 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220
Query: 239 -GRKP 242
            G  P
Sbjct: 221 YGMSP 225

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 36  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 94
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 95  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 151
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 152 KVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208
Query: 239 -GRKP 242
            G  P
Sbjct: 209 YGMSP 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 35  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 94  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 239 -GRKP 242
            G  P
Sbjct: 208 YGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 35  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 94  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 239 -GRKP 242
            G  P
Sbjct: 208 YGMSP 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 37  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 95
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 96  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 152
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 153 KVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
Query: 239 -GRKP 242
            G  P
Sbjct: 210 YGMSP 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 37  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 95
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 96  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 152
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 153 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
Query: 239 -GRKP 242
            G  P
Sbjct: 210 YGMSP 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYL 174
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYL 176
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 12/185 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 37  KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 95
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HRD+ + N ++  N   
Sbjct: 96  GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 152
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 153 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
Query: 239 -GRKP 242
            G  P
Sbjct: 210 YGMSP 214

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 25/237 (10%)
Query: 76  KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL 135
           K  +Q  +     +  I  L H ++V+LLG C     L LV +Y+P GSL  H+ +    
Sbjct: 71  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA 129
Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA 195
           L  +        +A G+ YL+   E  +VHR++ + N++L      ++ DFG+A L+   
Sbjct: 130 LGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 186
Query: 196 KGSQTTVLAGT-MGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQV 253
                   A T + +MA E    G+ + +SDV+S+G+   E+   G +P +     EV  
Sbjct: 187 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP- 245
Query: 254 YLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
                  DL   G+ L    P++C  D     ++C MI        DEN+RP+ +++
Sbjct: 246 -------DLLEKGERL--AQPQICTIDVYMVMVKCWMI--------DENIRPTFKEL 285

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYL 175
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 25/237 (10%)
Query: 76  KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL 135
           K  +Q  +     +  I  L H ++V+LLG C     L LV +Y+P GSL  H+ +    
Sbjct: 53  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA 111
Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA 195
           L  +        +A G+ YL+   E  +VHR++ + N++L      ++ DFG+A L+   
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
Query: 196 KGSQTTVLAGT-MGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQV 253
                   A T + +MA E    G+ + +SDV+S+G+   E+   G +P +     EV  
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP- 227
Query: 254 YLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
                  DL   G+ L    P++C  D     ++C MI        DEN+RP+ +++
Sbjct: 228 -------DLLEKGERL--AQPQICTIDVYMVMVKCWMI--------DENIRPTFKEL 267

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRF 142
           EV I S LRH N+++L G+ H+   + L+ EY P G++   L     F E    T+    
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---- 113
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
               +LA+ L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   
Sbjct: 114 --ITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAA 165
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
           L GT+ Y+ PE        ++ D++S G++  E   G+ P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 47  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 106
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 107 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 163
Query: 174 MLDLNFNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +       KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 164 MVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 220
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 221 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 269
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 270 ------CWQYNPKMRPSFLEIISSIKEE 291

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGS--KQGIK-EYASEVTIISRL 95
           A  DF   + L             +++   +A+K + K    K G++ +   EV I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           RH N+++L G+ H+   + L+ EY P G++   L     F E    T+        +LA+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   L GT+ Y+
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYL 176
Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 38  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 97
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 98  GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 154
Query: 174 MLDLNFNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +       KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 155 MVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 211
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 212 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLLELMRM- 260
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 261 ------CWQYNPKMRPSFLEIISSIKEE 282

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 53  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 112
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 113 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 169
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 226
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 227 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 275
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 276 ------CWQYNPKMRPSFLEIISSIKEE 297

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 113/250 (45%), Gaps = 41/250 (16%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL----FKENNL 135
           Q I+    E  + + L+H N++ L G C ++  L LV E+   G L+  L       + L
Sbjct: 48  QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL 107
Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-------DL-NFNAKIGDFG 187
           + W      A  +A G+ YL +     ++HRD+KSSNI++       DL N   KI DFG
Sbjct: 108 VNW------AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTA 247
           LAR  E  + ++ +  AG   +MAPE       SK SDV+S+G++  E+  G  P     
Sbjct: 162 LAR--EWHRTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218
Query: 248 KEEVQVYLVQWVWDLYGNG--KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS 305
              V           YG    KL   + P  C +   + ME        C +PD + RPS
Sbjct: 219 GLAVA----------YGVAMNKLALPI-PSTCPEPFAKLMED-------CWNPDPHSRPS 260
Query: 306 IRQVIHVLNS 315
              ++  L +
Sbjct: 261 FTNILDQLTT 270

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 46  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 105
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 106 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 162
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 163 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 219
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 220 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 268
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 269 ------CWQYNPKMRPSFLEIISSIKEE 290

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 130/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++  S +   E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHRD+ + N 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNC 161
Query: 174 MLDLNFNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +       KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 162 MVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 218
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 219 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 267
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   + N+RP+  +++++L  +
Sbjct: 268 ------CWQFNPNMRPTFLEIVNLLKDD 289

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 47  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 106
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 107 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 163
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 164 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 220
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 221 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 269
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 270 ------CWQYNPKMRPSFLEIISSIKEE 291

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRF 142
           EV I S LRH N+++L G+ H+   + L+ EY P G++   L     F E    T+    
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY---- 139
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
               +LA+ L Y      + V+HRDIK  N++L      KI DFG +    HA  S+   
Sbjct: 140 --ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDD 191
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           L GT+ Y+ PE        ++ D++S G++  E   G+ P      +E 
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 240

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 44  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 103
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 104 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 160
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 161 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 217
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 218 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 266
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 267 ------CWQYNPKMRPSFLEIISSIKEE 288

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 40  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 99
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 100 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 156
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 157 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 213
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 214 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 262
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 263 ------CWQYNPKMRPSFLEIISSIKEE 284

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 75  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 134
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 135 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 191
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 192 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 248
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 249 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 297
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 298 ------CWQYNPKMRPSFLEIISSIKEE 319

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     E+  E  ++  L H  LVQL G C +++ + ++ EYM NG L ++
Sbjct: 51  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L +  +    +   ++ +D+   + YL+    +  +HRD+ + N +++     K+ DFGL
Sbjct: 110 LREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 166
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
           +R V   + + +      + +  PE     + S +SD+++FG++  EI + G+ P     
Sbjct: 167 SRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
Query: 248 KEEVQVYLVQ 257
             E   ++ Q
Sbjct: 227 NSETAEHIAQ 236

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 22/243 (9%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + +GS     E+  E   + +L H  LV+  G C ++  + +V EY+ NG L ++
Sbjct: 35  VAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L      L      ++  D+  G+ +L+       +HRD+ + N ++D +   K+ DFG+
Sbjct: 94  LRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGM 150
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
            R V   +   +      + + APE     + S +SDV++FGI+  E+ + G+ P  L  
Sbjct: 151 TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210
Query: 248 KEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIR 307
             EV + + Q        G  L    P L  D   Q M         C H     RP+ +
Sbjct: 211 NSEVVLKVSQ--------GHRL--YRPHLASDTIYQIMYS-------CWHELPEKRPTFQ 253
Query: 308 QVI 310
           Q++
Sbjct: 254 QLL 256

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 46  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 105
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 106 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 162
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 163 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 219
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 220 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 268
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 269 ------CWQYNPKMRPSFLEIISSIKEE 290

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     E+  E  ++  L H  LVQL G C +++ + ++ EYM NG L ++
Sbjct: 51  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L +  +    +   ++ +D+   + YL+    +  +HRD+ + N +++     K+ DFGL
Sbjct: 110 LREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 166
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
           +R V   + + +      + +  PE     + S +SD+++FG++  EI + G+ P     
Sbjct: 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
Query: 248 KEEVQVYLVQ 257
             E   ++ Q
Sbjct: 227 NSETAEHIAQ 236

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 98/179 (54%), Gaps = 12/179 (6%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  G+L  +
Sbjct: 248 VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 306
Query: 129 LFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L + N   ++      +A  ++S + YL+   ++  +HR++ + N ++  N   K+ DFG
Sbjct: 307 LRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 188 LARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKP 242
           L+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA  G  P
Sbjct: 364 LSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     E+  E  ++  L H  LVQL G C +++ + ++ EYM NG L ++
Sbjct: 35  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 93
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L +  +    +   ++ +D+   + YL+    +  +HRD+ + N +++     K+ DFGL
Sbjct: 94  LREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 150
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
           +R V   + + +      + +  PE     + S +SD+++FG++  EI + G+ P     
Sbjct: 151 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 210
Query: 248 KEEVQVYLVQ 257
             E   ++ Q
Sbjct: 211 NSETAEHIAQ 220

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 36/249 (14%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           I +   + G K  + E+  E  I++ + H +LV+LLG C     + LV + MP+G L  +
Sbjct: 72  IKILNETTGPKANV-EFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEY 129
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           + +  + +  +        +A G++YL+E   + +VHRD+ + N+++    + KI DFGL
Sbjct: 130 VHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGL 186
Query: 189 ARLVE------HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           ARL+E      +A G +  +      +MA EC    + + +SDV+S+G+   E+   G K
Sbjct: 187 ARLLEGDEKEYNADGGKMPI-----KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 241
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPDE 300
           P       E+         DL   G+ L    P +C  D     ++C MI        D 
Sbjct: 242 PYDGIPTREIP--------DLLEKGERLP--QPPICTIDVYMVMVKCWMI--------DA 283
Query: 301 NLRPSIRQV 309
           + RP  +++
Sbjct: 284 DSRPKFKEL 292

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     E+  E  ++  L H  LVQL G C +++ + ++ EYM NG L ++
Sbjct: 36  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L +  +    +   ++ +D+   + YL+    +  +HRD+ + N +++     K+ DFGL
Sbjct: 95  LREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 151
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
           +R V   + + +      + +  PE     + S +SD+++FG++  EI + G+ P     
Sbjct: 152 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 211
Query: 248 KEEVQVYLVQ 257
             E   ++ Q
Sbjct: 212 NSETAEHIAQ 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 49/274 (17%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-------------RNLVQLLGWCHEKKE 112
           S Y A+K++ + +++ +    SEV +++ L H             RN V+ +    +K  
Sbjct: 31  SRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
           L +  EY  NG+L   +  EN     +  +++ + +   L Y+     Q ++HRD+K  N
Sbjct: 90  LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMN 146
Query: 173 IMLDLNFNAKIGDFGLARLVEHA-------------KGSQTTVLAGTMGYMAPECAT-TG 218
           I +D + N KIGDFGLA+ V  +                  T   GT  Y+A E    TG
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
             +++ D+YS GI+  E+     P S T  E V +             K L +V      
Sbjct: 207 HYNEKIDMYSLGIIFFEMIY---PFS-TGMERVNIL------------KKLRSVSIEFPP 250
Query: 279 DFDEQQMEC-LMIVGLWCAHPDENLRPSIRQVIH 311
           DFD+ +M+    I+ L   H D N RP  R +++
Sbjct: 251 DFDDNKMKVEKKIIRLLIDH-DPNKRPGARTLLN 283

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     E+  E  ++  L H  LVQL G C +++ + ++ EYM NG L ++
Sbjct: 31  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L +  +    +   ++ +D+   + YL+    +  +HRD+ + N +++     K+ DFGL
Sbjct: 90  LREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 146
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
           +R V   + + +      + +  PE     + S +SD+++FG++  EI + G+ P     
Sbjct: 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206
Query: 248 KEEVQVYLVQ 257
             E   ++ Q
Sbjct: 207 NSETAEHIAQ 216

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 32/190 (16%)
Query: 70  AVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           A+KR+ +  SK   +++A E+ ++ +L  H N++ LLG C  +  L L  EY P+G+L  
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 128 HLFKENNL---------------LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
            L K   L               L+ +     A D+A G+ YL +   +  +HRD+ + N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 172
Query: 173 IMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGRASKESDVY 227
           I++  N+ AKI DFGL+R        Q   +  TMG     +MA E       +  SDV+
Sbjct: 173 ILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 225
Query: 228 SFGIVALEIA 237
           S+G++  EI 
Sbjct: 226 SYGVLLWEIV 235

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 36/249 (14%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           I +   + G K  + E+  E  I++ + H +LV+LLG C     + LV + MP+G L  +
Sbjct: 49  IKILNETTGPKANV-EFMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEY 106
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           + +  + +  +        +A G++YL+E   + +VHRD+ + N+++    + KI DFGL
Sbjct: 107 VHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGL 163
Query: 189 ARLVE------HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRK 241
           ARL+E      +A G +  +      +MA EC    + + +SDV+S+G+   E+   G K
Sbjct: 164 ARLLEGDEKEYNADGGKMPI-----KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 218
Query: 242 PISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPDE 300
           P       E+         DL   G+ L    P +C  D     ++C MI        D 
Sbjct: 219 PYDGIPTREIP--------DLLEKGERLP--QPPICTIDVYMVMVKCWMI--------DA 260
Query: 301 NLRPSIRQV 309
           + RP  +++
Sbjct: 261 DSRPKFKEL 269

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     E+  E  ++  L H  LVQL G C +++ + ++ EYM NG L ++
Sbjct: 42  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 100
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L +  +    +   ++ +D+   + YL+    +  +HRD+ + N +++     K+ DFGL
Sbjct: 101 LREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 157
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
           +R V   + + +      + +  PE     + S +SD+++FG++  EI + G+ P     
Sbjct: 158 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 217
Query: 248 KEEVQVYLVQ 257
             E   ++ Q
Sbjct: 218 NSETAEHIAQ 227

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 32/190 (16%)
Query: 70  AVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           A+KR+ +  SK   +++A E+ ++ +L  H N++ LLG C  +  L L  EY P+G+L  
Sbjct: 46  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 105
Query: 128 HLFKENNL---------------LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
            L K   L               L+ +     A D+A G+ YL +   +  +HRD+ + N
Sbjct: 106 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 162
Query: 173 IMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGRASKESDVY 227
           I++  N+ AKI DFGL+R        Q   +  TMG     +MA E       +  SDV+
Sbjct: 163 ILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 215
Query: 228 SFGIVALEIA 237
           S+G++  EI 
Sbjct: 216 SYGVLLWEIV 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 53  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 112
Query: 123 GSLDSHL------FKENNLL---TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L         N +L   +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 113 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 169
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 226
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 227 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 275
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 276 ------CWQYNPKMRPSFLEIISSIKEE 297

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K + +GS     E+  E  ++  L H  LVQL G C +++ + ++ EYM NG L ++
Sbjct: 36  VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L +  +    +   ++ +D+   + YL+    +  +HRD+ + N +++     K+ DFGL
Sbjct: 95  LREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 151
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTA 247
           +R V   + + +      + +  PE     + S +SD+++FG++  EI + G+ P     
Sbjct: 152 SRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 211
Query: 248 KEEVQVYLVQ 257
             E   ++ Q
Sbjct: 212 NSETAEHIAQ 221

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           S+ +AVK +  G+   ++ +  E  ++  L+H  LV+L      ++ + ++ EYM  GSL
Sbjct: 37  STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSL 95
Query: 126 DSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L   E   +        +  +A G+ Y++    +  +HRD++++N+++  +   KI 
Sbjct: 96  LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIA 152
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           DFGLAR++E  + +        + + APE    G  + +SDV+SFGI+  EI   G+ P 
Sbjct: 153 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212
Query: 244 SLTAKEEVQVYLVQ 257
                 +V   L Q
Sbjct: 213 PGRTNADVMTALSQ 226

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 6/180 (3%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +ET   +A+K+V   S   ++E   E++I+ +    ++V+  G   +  +L +V EY   
Sbjct: 51  KETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           GS+   +   N  LT +    I Q    GL YL    +   +HRDIK+ NI+L+   +AK
Sbjct: 109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAK 165
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           + DFG+A  +      +  V+ GT  +MAPE       +  +D++S GI A+E+A G+ P
Sbjct: 166 LADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/177 (35%), Positives = 98/177 (55%), Gaps = 12/177 (6%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG-WCHEKKELLLVYEYMPNGSLDS 127
           +AVK +   +    + + +E +++++LRH NLVQLLG    EK  L +V EYM  GSL  
Sbjct: 219 VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276
Query: 128 HL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
           +L  +  ++L  +   K + D+   + YL EG     VHRD+ + N+++  +  AK+ DF
Sbjct: 277 YLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAKVSDF 333
Query: 187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
           GL +  E +    T  L   + + APE     + S +SDV+SFGI+  EI + GR P
Sbjct: 334 GLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/177 (35%), Positives = 98/177 (55%), Gaps = 12/177 (6%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG-WCHEKKELLLVYEYMPNGSLDS 127
           +AVK +   +    + + +E +++++LRH NLVQLLG    EK  L +V EYM  GSL  
Sbjct: 32  VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89
Query: 128 HL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
           +L  +  ++L  +   K + D+   + YL EG     VHRD+ + N+++  +  AK+ DF
Sbjct: 90  YLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAKVSDF 146
Query: 187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
           GL +  E +    T  L   + + APE     + S +SDV+SFGI+  EI + GR P
Sbjct: 147 GLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 98/180 (54%), Gaps = 11/180 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG C  +    ++ E+M  
Sbjct: 281 KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 339
Query: 123 GSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           G+L  +L + N   +       +A  ++S + YL+   ++  +HR++ + N ++  N   
Sbjct: 340 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLV 396
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           K+ DFGL+RL+    G   T  AG    + + APE     + S +SDV++FG++  EIA 
Sbjct: 397 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AVK + K   +   +++   EV I+  L H N+V+L      +K L LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVSA----VQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G+  Y APE     +    E DV+S G++   +  G  
Sbjct: 154 IADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 242 PI 243
           P 
Sbjct: 212 PF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AVK + K   +   +++   EV I+  L H N+V+L      +K L LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVSA----VQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G+  Y APE     +    E DV+S G++   +  G  
Sbjct: 154 IADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 242 PI 243
           P 
Sbjct: 212 PF 213

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 92/163 (56%), Gaps = 10/163 (6%)
Query: 83  KEYASEVTIISRLRHRNLVQLLG-WCHEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEF 140
           + + +E +++++LRH NLVQLLG    EK  L +V EYM  GSL  +L  +  ++L  + 
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118
Query: 141 RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT 200
             K + D+   + YL EG     VHRD+ + N+++  +  AK+ DFGL +  E +    T
Sbjct: 119 LLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDT 173
Query: 201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
             L   + + APE     + S +SDV+SFGI+  EI + GR P
Sbjct: 174 GKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 43  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 102
Query: 123 GSLDSHL------FKENNLL---TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L         N +L   +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 103 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 159
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 160 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 216
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 217 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLFELMRM- 265
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 266 ------CWQYNPKMRPSFLEIISSIKEE 287

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 9/223 (4%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRN 99
           +DF    +L             R +   +A K +    K  I+ +   E+ ++       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V   G  +   E+ +  E+M  GSLD  + KE   +  E   K++  +  GL YL+E  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 134
Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTG 218
           +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT  YMAPE     
Sbjct: 135 Q--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMAPERLQGT 188
Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD 261
             S +SD++S G+  +E+A GR PI     +E++    + V D
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVD 231

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 97/185 (52%), Gaps = 7/185 (3%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK +  GS   ++ + +E  ++  L+H  LV+L      K+ + ++ E+M  GSL   
Sbjct: 42  VAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDF 99
Query: 129 L-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   E +          +  +A G+ ++++   +  +HRD++++NI++  +   KI DFG
Sbjct: 100 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFG 156
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLT 246
           LAR++E  + +        + + APE    G  + +SDV+SFGI+ +EI   GR P    
Sbjct: 157 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 216
Query: 247 AKEEV 251
           +  EV
Sbjct: 217 SNPEV 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/177 (33%), Positives = 96/177 (54%), Gaps = 12/177 (6%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG-WCHEKKELLLVYEYMPNGSLDS 127
           +AVK +   +    + + +E +++++LRH NLVQLLG    EK  L +V EYM  GSL  
Sbjct: 38  VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 95
Query: 128 HL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
           +L  +  ++L  +   K + D+   + YL+       VHRD+ + N+++  +  AK+ DF
Sbjct: 96  YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF 152
Query: 187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
           GL +  E +    T  L   + + APE       S +SDV+SFGI+  EI + GR P
Sbjct: 153 GLTK--EASSTQDTGKLP--VKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AVK + K   +   +++   EV I+  L H N+V+L      +K L LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVSA----VQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G   Y APE     +    E DV+S G++   +  G  
Sbjct: 154 IADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 242 PI 243
           P 
Sbjct: 212 PF 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 97/185 (52%), Gaps = 7/185 (3%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK +  GS   ++ + +E  ++  L+H  LV+L      K+ + ++ E+M  GSL   
Sbjct: 215 VAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDF 272
Query: 129 L-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   E +          +  +A G+ ++++   +  +HRD++++NI++  +   KI DFG
Sbjct: 273 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFG 329
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLT 246
           LAR++E  + +        + + APE    G  + +SDV+SFGI+ +EI   GR P    
Sbjct: 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
Query: 247 AKEEV 251
           +  EV
Sbjct: 390 SNPEV 394

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AVK + K   +   +++   EV I+  L H N+V+L      +K L LV EY   
Sbjct: 39  TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASG 98
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q + S + Y  + +   +VHRD+K+ N++LD + N K
Sbjct: 99  GEVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIK 154
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G+  Y APE     +    E DV+S G++   +  G  
Sbjct: 155 IADFGFSN--EFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 242 PI 243
           P 
Sbjct: 213 PF 214

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 131/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++  S +   E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHR++ + N 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNC 161
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 162 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 218
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 219 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 267
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   + N+RP+  +++++L  +
Sbjct: 268 ------CWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 131/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++  S +   E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 46  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 105
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHR++ + N 
Sbjct: 106 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNC 162
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 163 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 219
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 220 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 268
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   + N+RP+  +++++L  +
Sbjct: 269 ------CWQFNPNMRPTFLEIVNLLKDD 290

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 75  SKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL---- 129
           S+  K+G++ +   E+ I S LRH N++++  + H++K + L+ E+ P G L   L    
Sbjct: 51  SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG 110
Query: 130 -FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
            F E    T+       ++LA  L Y     E+ V+HRDIK  N+++      KI DFG 
Sbjct: 111 RFDEQRSATF------MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW 161
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAK 248
           +    HA   +   + GT+ Y+ PE        ++ D++  G++  E   G  P    + 
Sbjct: 162 S---VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 218
Query: 249 EEVQVYLV 256
            E    +V
Sbjct: 219 TETHRRIV 226

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 12/184 (6%)
Query: 65  TSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           T   +AVK +++    S   + +   E+  +   RH ++++L        ++ +V EY+ 
Sbjct: 40  TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L  ++ K   L   E R ++ Q + SG+ Y        VVHRD+K  N++LD + NA
Sbjct: 100 GGELFDYICKNGRLDEKESR-RLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNA 155
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACG 239
           KI DFGL+ ++  + G       G+  Y APE   +GR  A  E D++S G++   + CG
Sbjct: 156 KIADFGLSNMM--SDGEFLRXSCGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
Query: 240 RKPI 243
             P 
Sbjct: 213 TLPF 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AV+ + K   +   +++   EV I+  L H N+V+L      +K L LV EY   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVSA----VQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G+  Y APE     +    E DV+S G++   +  G  
Sbjct: 154 IADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 242 PI 243
           P 
Sbjct: 212 PF 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 75  SKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL---- 129
           S+  K+G++ +   E+ I S LRH N++++  + H++K + L+ E+ P G L   L    
Sbjct: 50  SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG 109
Query: 130 -FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
            F E    T+       ++LA  L Y     E+ V+HRDIK  N+++      KI DFG 
Sbjct: 110 RFDEQRSATF------MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW 160
Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAK 248
           +    HA   +   + GT+ Y+ PE        ++ D++  G++  E   G  P    + 
Sbjct: 161 S---VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
Query: 249 EEVQVYLV 256
            E    +V
Sbjct: 218 TETHRRIV 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 94/192 (48%), Gaps = 26/192 (13%)
Query: 66  SSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKK------ELLLVYE 118
           + Y+AVK      KQ  + EY  EV  +  ++H N++Q +G   EK+      +L L+  
Sbjct: 47  NEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIG--AEKRGTSVDVDLWLITA 102
Query: 119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE-------GWEQCVVHRDIKSS 171
           +   GSL    F + N+++W     IA+ +A GL YL E       G +  + HRDIKS 
Sbjct: 103 FHEKGSLSD--FLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTG-----RASKESD 225
           N++L  N  A I DFGLA   E  K +  T    GT  YMAPE           A    D
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
Query: 226 VYSFGIVALEIA 237
           +Y+ G+V  E+A
Sbjct: 221 MYAMGLVLWELA 232

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 129/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++  S +   E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHRD+ + N 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNC 161
Query: 174 MLDLNFNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +       KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 162 MVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 218
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 219 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 267
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RP+  +++++L  +
Sbjct: 268 ------CWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 129/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++  S +   E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 42  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 101
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHRD+ + N 
Sbjct: 102 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNC 158
Query: 174 MLDLNFNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +       KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 159 MVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 215
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 216 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 264
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RP+  +++++L  +
Sbjct: 265 ------CWQFNPKMRPTFLEIVNLLKDD 286

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 32/189 (16%)
Query: 70  AVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           A+KR+ +  SK   +++A E+ ++ +L  H N++ LLG C  +  L L  EY P+G+L  
Sbjct: 53  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 112
Query: 128 HLFKENNL---------------LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
            L K   L               L+ +     A D+A G+ YL    ++  +HR++ + N
Sbjct: 113 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARN 169
Query: 173 IMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGRASKESDVY 227
           I++  N+ AKI DFGL+R        Q   +  TMG     +MA E       +  SDV+
Sbjct: 170 ILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 222
Query: 228 SFGIVALEI 236
           S+G++  EI
Sbjct: 223 SYGVLLWEI 231

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +A+K V++ +    + E+ +E +++      ++V+LLG   + +  L++ E M  
Sbjct: 40  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 99
Query: 123 GSLDSHLFK-----ENNLL----TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN +    +     ++A ++A G+ YL        VHRD+ + N 
Sbjct: 100 GDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC 156
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
            +  +F  KIGDFG+ R +     + KG +  +    + +M+PE    G  +  SDV+SF
Sbjct: 157 XVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMSPESLKDGVFTTYSDVWSF 213
Query: 230 GIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EIA    +P    + E+V  ++++        G LL+   P  C D   + M   
Sbjct: 214 GVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD--KPDNCPDMLLELMRM- 262
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RPS  ++I  +  E
Sbjct: 263 ------CWQYNPKMRPSFLEIISSIKEE 284

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 130/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++  S +   E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHRD+ + N 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNC 161
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 162 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 218
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 219 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 267
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RP+  +++++L  +
Sbjct: 268 ------CWQFNPKMRPTFLEIVNLLKDD 289

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 131/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++  S +   E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 45  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 104
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHRD+ + N 
Sbjct: 105 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNC 161
Query: 174 MLDLNFNAKIGDFGLAR-LVEHA---KGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R + E A   KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 162 MVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 218
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 219 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 267
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RP+  +++++L  +
Sbjct: 268 ------CWQFNPKMRPTFLEIVNLLKDD 289

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 64  ETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           +T    A+K ++K     +  ++    E+ I+  L H  LV L     +++++ +V + +
Sbjct: 38  DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
             G L  HL +  +      +  I + L   L YLQ    Q ++HRD+K  NI+LD + +
Sbjct: 98  LGGDLRYHLQQNVHFKEETVKLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGH 153
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES---DVYSFGIVALEIA 237
             I DF +A ++   + +Q T +AGT  YMAPE  ++ + +  S   D +S G+ A E+ 
Sbjct: 154 VHITDFNIAAML--PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 238 CGRKPI----SLTAKEEVQVY 254
            GR+P     S ++KE V  +
Sbjct: 212 RGRRPYHIRSSTSSKEIVHTF 232

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AVK + K   +   +++   EV I+  L H N+V+L      +K L LV EY   
Sbjct: 31  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 90
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 91  GEVFDYLVAHGWMKEKEARAKFRQIVSA----VQYCHQKFIVHRDLKAENLLLDADMNIK 146
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G+  Y APE     +    E DV+S G++   +  G  
Sbjct: 147 IADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 204
Query: 242 PI 243
           P 
Sbjct: 205 PF 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 130/268 (48%), Gaps = 38/268 (14%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK V++ +    + E+ +E +++      ++V+LLG   + +  L+V E M +
Sbjct: 44  EAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAH 103
Query: 123 GSLDSHLFK-----ENNL----LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           G L S+L       ENN      T +   ++A ++A G+ YL     +  VHRD+ + N 
Sbjct: 104 GDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNC 160
Query: 174 MLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSF 229
           M+  +F  KIGDFG+ R +     + KG +  +    + +MAPE    G  +  SD++SF
Sbjct: 161 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PVRWMAPESLKDGVFTTSSDMWSF 217
Query: 230 GIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECL 288
           G+V  EI +   +P    + E+V  +++        +G  L+  D    R  D  +M   
Sbjct: 218 GVVLWEITSLAEQPYQGLSNEQVLKFVM--------DGGYLDQPDNCPERVTDLMRM--- 266
Query: 289 MIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                 C   +  +RP+  +++++L  +
Sbjct: 267 ------CWQFNPKMRPTFLEIVNLLKDD 288

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKE--LLLVYEYMPNGSLDSHLFK---ENNLLTWEF 140
            SEV ++  L+H N+V+      ++    L +V EY   G L S + K   E   L  EF
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 141 RFKIAQDLASGL--LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
             ++   L   L   + +      V+HRD+K +N+ LD   N K+GDFGLAR++ H    
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
             T   GT  YM+PE       +++SD++S G +  E+     P +  +++E+
Sbjct: 173 AKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AV+ + K   +   +++   EV I+  L H N+V+L      +K L LV EY   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 98  GEVFDYLVAHGRMKEKEARAKFRQIVSA----VQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G+  Y APE     +    E DV+S G++   +  G  
Sbjct: 154 IADFGFSN--EFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 242 PI 243
           P 
Sbjct: 212 PF 213

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKE--LLLVYEYMPNGSLDSHLFK---ENNLLTWEF 140
            SEV ++  L+H N+V+      ++    L +V EY   G L S + K   E   L  EF
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 141 RFKIAQDLASGL--LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
             ++   L   L   + +      V+HRD+K +N+ LD   N K+GDFGLAR++ H   S
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTS 171
Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                 GT  YM+PE       +++SD++S G +  E+     P +  +++E+
Sbjct: 172 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 7/176 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T + +AVK++        +++  E+ I+  L    +V+  G  +   + EL LV EY+P+
Sbjct: 35  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPS 94
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G L   L +    L        +  +  G+ YL  G  +CV HRD+ + NI+++   + K
Sbjct: 95  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCV-HRDLAARNILVESEAHVK 151
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           I DFGLA+L+   K        G   + + APE  +    S++SDV+SFG+V  E+
Sbjct: 152 IADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMP 121
           T   +AVK + +G    ++  +  E+ I+  L H ++V+  G C ++  K + LV EY+P
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            GSL  +L +    L     F  AQ +  G+ YL     Q  +HR + + N++LD +   
Sbjct: 96  LGSLRDYLPRHCVGLAQLLLF--AQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLV 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           KIGDFGLA+ V            G   + + APEC    +    SDV+SFG+   E+
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMP 121
           T   +AVK + +G    ++  +  E+ I+  L H ++V+  G C ++  K + LV EY+P
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            GSL  +L +    L     F  AQ +  G+ YL     Q  +HR + + N++LD +   
Sbjct: 97  LGSLRDYLPRHCVGLAQLLLF--AQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLV 151
Query: 182 KIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           KIGDFGLA+ V            G   + + APEC    +    SDV+SFG+   E+
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 29/218 (13%)
Query: 64  ETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E  + +AVK + + +   ++ ++  E  +++   + N+V+LLG C   K + L++EYM  
Sbjct: 75  EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY 134
Query: 123 GSLDSHL----------FKENNL-------------LTWEFRFKIAQDLASGLLYLQEGW 159
           G L+  L             ++L             L+   +  IA+ +A+G+ YL E  
Sbjct: 135 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-- 192
Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL-AGTMGYMAPECATTG 218
            +  VHRD+ + N ++  N   KI DFGL+R +  A   +     A  + +M PE     
Sbjct: 193 -RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251
Query: 219 RASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYL 255
           R + ESDV+++G+V  EI + G +P    A EEV  Y+
Sbjct: 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 11/184 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           R    Y A+K + K     +K+      E  ++S + H  ++++ G   + +++ ++ +Y
Sbjct: 28  RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G L S L K         +F  A ++   L YL     + +++RD+K  NI+LD N 
Sbjct: 88  IEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNG 143
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           + KI DFG A+ V       T  L GT  Y+APE  +T   +K  D +SFGI+  E+  G
Sbjct: 144 HIKITDFGFAKYVPDV----TYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
Query: 240 RKPI 243
             P 
Sbjct: 200 YTPF 203

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 49/274 (17%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-------------RNLVQLLGWCHEKKE 112
           S Y A+K++ + +++ +    SEV +++ L H             RN V+ +    +K  
Sbjct: 31  SRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
           L +  EY  N +L   +  EN     +  +++ + +   L Y+     Q ++HRD+K  N
Sbjct: 90  LFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMN 146
Query: 173 IMLDLNFNAKIGDFGLARLVEHA-------------KGSQTTVLAGTMGYMAPECAT-TG 218
           I +D + N KIGDFGLA+ V  +                  T   GT  Y+A E    TG
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
             +++ D+YS GI+  E+     P S T  E V +             K L +V      
Sbjct: 207 HYNEKIDMYSLGIIFFEMIY---PFS-TGMERVNIL------------KKLRSVSIEFPP 250
Query: 279 DFDEQQMEC-LMIVGLWCAHPDENLRPSIRQVIH 311
           DFD+ +M+    I+ L   H D N RP  R +++
Sbjct: 251 DFDDNKMKVEKKIIRLLIDH-DPNKRPGARTLLN 283

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 30/241 (12%)
Query: 39  ATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRH 97
           +++ F   +KL             + T  Y+A+K V   S++G    A  E++++  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNG---SLDSHLFK------ENNLLTWEFRFKIAQDL 148
            N+V+L    H + +L LV+E+M N     +DS          E NL+ + F++++ Q L
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-FQWQLLQGL 121
Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG--- 205
           A          E  ++HRD+K  N++++     K+GDFGLAR    A G      +    
Sbjct: 122 AFC-------HENKILHRDLKPQNLLINKRGQLKLGDFGLAR----AFGIPVNTFSSEVV 170
Query: 206 TMGYMAPECATTGRASKES-DVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
           T+ Y AP+     R    S D++S G +  E+  G KP+     +E Q+ L   ++D+ G
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEEQLKL---IFDIMG 226
Query: 265 N 265
Sbjct: 227 T 227

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 120/249 (48%), Gaps = 26/249 (10%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K++   S++  K +  E+  +SR+ H N+V+L G C     + LV EY   GSL + 
Sbjct: 34  VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNV 89
Query: 129 LFKENNLLTWEFRFKIAQDL--ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGD 185
           L     L  +     ++  L  + G+ YL     + ++HRD+K  N++L       KI D
Sbjct: 90  LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FG A  ++    +  T   G+  +MAPE       S++ DV+S+GI+  E+   RKP   
Sbjct: 150 FGTACDIQ----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-- 203
Query: 246 TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS 305
              +E+     + +W ++   +      P L ++   + +E LM     C   D + RPS
Sbjct: 204 ---DEIGGPAFRIMWAVHNGTR------PPLIKNLP-KPIESLMTR---CWSKDPSQRPS 250
Query: 306 IRQVIHVLN 314
           + +++ ++ 
Sbjct: 251 MEEIVKIMT 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 120/249 (48%), Gaps = 26/249 (10%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +A+K++   S++  K +  E+  +SR+ H N+V+L G C     + LV EY   GSL + 
Sbjct: 35  VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNV 90
Query: 129 LFKENNLLTWEFRFKIAQDL--ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGD 185
           L     L  +     ++  L  + G+ YL     + ++HRD+K  N++L       KI D
Sbjct: 91  LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 150
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FG A  ++    +  T   G+  +MAPE       S++ DV+S+GI+  E+   RKP   
Sbjct: 151 FGTACDIQ----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-- 204
Query: 246 TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS 305
              +E+     + +W ++   +      P L ++   + +E LM     C   D + RPS
Sbjct: 205 ---DEIGGPAFRIMWAVHNGTR------PPLIKNLP-KPIESLMTR---CWSKDPSQRPS 251
Query: 306 IRQVIHVLN 314
           + +++ ++ 
Sbjct: 252 MEEIVKIMT 260

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 92/183 (50%), Gaps = 12/183 (6%)
Query: 65  TSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           T   +AVK +++    S   + +   E+  +   RH ++++L        +  +V EY+ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L  ++ K   +   E R ++ Q + S + Y        VVHRD+K  N++LD + NA
Sbjct: 95  GGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNA 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACG 239
           KI DFGL+ ++   +  +T+   G+  Y APE   +GR  A  E D++S G++   + CG
Sbjct: 151 KIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 240 RKP 242
             P
Sbjct: 208 TLP 210

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 65  TSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMP 121
           T   +AVK + +    Q    +  E+ I+  L H ++++  G C +     L LV EY+P
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            GSL  +L + +  L     F  AQ +  G+ YL     Q  +HRD+ + N++LD +   
Sbjct: 119 LGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLV 173
Query: 182 KIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           KIGDFGLA+ V            G   + + APEC    +    SDV+SFG+   E+
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 9/181 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K + K   +   +++   EV I+  L H N+V+L      +K L L+ EY   
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 95
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 96  GEVFDYLVAHGRMKEKEARSKFRQIVSA----VQYCHQKRIVHRDLKAENLLLDADMNIK 151
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G +     G+  Y APE     +    E DV+S G++   +  G  
Sbjct: 152 IADFGFSN--EFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 209
Query: 242 P 242
           P
Sbjct: 210 P 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 65  TSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMP 121
           T   +AVK + +    Q    +  E+ I+  L H ++++  G C ++  K L LV EY+P
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            GSL  +L + +  L     F  AQ +  G+ YL     Q  +HR++ + N++LD +   
Sbjct: 102 LGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRLV 156
Query: 182 KIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           KIGDFGLA+ V            G   + + APEC    +    SDV+SFG+   E+
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + L             + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 128
Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 129 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLED 184
Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
               +  D +  G+V  E+ CGR P 
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 65  TSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMP 121
           T   +AVK + +    Q    +  E+ I+  L H ++++  G C ++  K L LV EY+P
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            GSL  +L + +  L     F  AQ +  G+ YL     Q  +HR++ + N++LD +   
Sbjct: 102 LGSLRDYLPRHSIGLAQLLLF--AQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRLV 156
Query: 182 KIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           KIGDFGLA+ V            G   + + APEC    +    SDV+SFG+   E+
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + L             + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
               +  D +  G+V  E+ CGR P 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 94/179 (52%), Gaps = 6/179 (3%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL 125
           S+ +AVK +  G+   ++ +  E  ++  L+H  LV+L     +++ + ++ E+M  GSL
Sbjct: 36  STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSL 94
Query: 126 DSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
              L   E   +        +  +A G+ Y++    +  +HRD++++N+++  +   KI 
Sbjct: 95  LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIA 151
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKP 242
           DFGLAR++E  + +        + + APE    G  + +S+V+SFGI+  EI   G+ P
Sbjct: 152 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 9/182 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +AVK + K   +   +++   EV I   L H N+V+L      +K L LV EY   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L         E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 98  GEVFDYLVAHGRXKEKEARAKFRQIVSA----VQYCHQKFIVHRDLKAENLLLDADXNIK 153
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G++     G   Y APE     +    E DV+S G++   +  G  
Sbjct: 154 IADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 242 PI 243
           P 
Sbjct: 212 PF 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 9/181 (4%)
Query: 65  TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K + K   +   +++   EV I+  L H N+V+L      +K L L+ EY   
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G +  +L     +   E R K  Q +++    +Q   ++ +VHRD+K+ N++LD + N K
Sbjct: 99  GEVFDYLVAHGRMKEKEARSKFRQIVSA----VQYCHQKRIVHRDLKAENLLLDADMNIK 154
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRK 241
           I DFG +   E   G +     G   Y APE     +    E DV+S G++   +  G  
Sbjct: 155 IADFGFSN--EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 242 P 242
           P
Sbjct: 213 P 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + L             + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
               +  D +  G+V  E+ CGR P 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + L             + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
               +  D +  G+V  E+ CGR P 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + L             + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 126
Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 127 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLED 182
Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
               +  D +  G+V  E+ CGR P 
Sbjct: 183 NDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 8/173 (4%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKE--LLLVYEYMPNGSLDSHLFK---ENNLLTWEF 140
            SEV ++  L+H N+V+      ++    L +V EY   G L S + K   E   L  EF
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 141 RFKIAQDLASGL--LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
             ++   L   L   + +      V+HRD+K +N+ LD   N K+GDFGLAR++ H +  
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF 172
Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                 GT  YM+PE       +++SD++S G +  E+     P +  +++E+
Sbjct: 173 AKE-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + L             + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
               +  D +  G+V  E+ CGR P 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 69  IAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +G+ K   +E   E  I+ +L +  +V+L+G C + + L+LV E    G L  
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK 98
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L  +   +      ++   ++ G+ YL+E   +  VHRD+ + N++L     AKI DFG
Sbjct: 99  FLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 188 LARLVEHAKGSQTTVLAGT--MGYMAPECATTGRASKESDVYSFGIVALE-IACGRKPIS 244
           L++ +       T   AG   + + APEC    + S  SDV+S+G+   E ++ G+KP  
Sbjct: 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215
Query: 245 LTAKEEVQVYLVQ 257
                EV  ++ Q
Sbjct: 216 KMKGPEVMAFIEQ 228

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 88/206 (42%), Gaps = 8/206 (3%)
Query: 41  NDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + L             + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 123
Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 218 GRASKESDVYSFGIVALEIACGRKPI 243
               +  D +  G+V  E+ CGR P 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 97/189 (51%), Gaps = 17/189 (8%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +ETS   A K +   S++ +++Y  E+ I++   H N+V+LL   + +  L ++ E+   
Sbjct: 59  KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 118
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G++D+ + +    LT      + +     L YL +     ++HRD+K+ NI+  L+ + K
Sbjct: 119 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIK 175
Query: 183 IGDFGLARLVEHAKGSQTT----VLAGTMGYMAPE---CATTGRASKE--SDVYSFGIVA 233
           + DFG++     AK ++T        GT  +MAPE   C T+     +  +DV+S GI  
Sbjct: 176 LADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 234 LEIACGRKP 242
           +E+A    P
Sbjct: 231 IEMAEIEPP 239

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           IA+K + +   +  +    E+ +   L+H+N+VQ LG   E   + +  E +P GSL + 
Sbjct: 50  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109
Query: 129 LFK-----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-K 182
           L       ++N  T  F  K    +  GL YL +     +VHRDIK  N++++      K
Sbjct: 110 LRSKWGPLKDNEQTIGFYTK---QILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK 163
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA--SKESDVYSFGIVALEIACGR 240
           I DFG ++ +       T    GT+ YMAPE    G     K +D++S G   +E+A G+
Sbjct: 164 ISDFGTSKRLAGINPC-TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 241 KPISLTAKEEVQVYLV 256
            P     + +  ++ V
Sbjct: 223 PPFYELGEPQAAMFKV 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 7/176 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T + +AVK++        +++  E+ I+  L    +V+  G  +   ++ L LV EY+P+
Sbjct: 39  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 98
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G L   L +    L        +  +  G+ YL  G  +CV HRD+ + NI+++   + K
Sbjct: 99  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCV-HRDLAARNILVESEAHVK 155
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           I DFGLA+L+   K        G   + + APE  +    S++SDV+SFG+V  E+
Sbjct: 156 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 5/164 (3%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E++I   L H+++V   G+  +   + +V E     SL     +   L   E R+ + Q 
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ- 147
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           +  G  YL       V+HRD+K  N+ L+ +   KIGDFGLA  VE+  G +  VL GT 
Sbjct: 148 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTP 203
Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            Y+APE  +    S E DV+S G +   +  G+ P   +  +E 
Sbjct: 204 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 7/176 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T + +AVK++        +++  E+ I+  L    +V+  G  +   ++ L LV EY+P+
Sbjct: 38  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 97
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G L   L +    L        +  +  G+ YL  G  +CV HRD+ + NI+++   + K
Sbjct: 98  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCV-HRDLAARNILVESEAHVK 154
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           I DFGLA+L+   K        G   + + APE  +    S++SDV+SFG+V  E+
Sbjct: 155 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 7/176 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLLVYEYMPN 122
           T + +AVK++        +++  E+ I+  L    +V+  G  +   ++ L LV EY+P+
Sbjct: 51  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G L   L +    L        +  +  G+ YL  G  +CV HRD+ + NI+++   + K
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCV-HRDLAARNILVESEAHVK 167
Query: 183 IGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALEI 236
           I DFGLA+L+   K        G   + + APE  +    S++SDV+SFG+V  E+
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 5/164 (3%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E++I   L H+++V   G+  +   + +V E     SL     +   L   E R+ + Q 
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ- 149
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           +  G  YL       V+HRD+K  N+ L+ +   KIGDFGLA  VE+  G +  VL GT 
Sbjct: 150 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTP 205
Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            Y+APE  +    S E DV+S G +   +  G+ P   +  +E 
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           IA+K + +   +  +    E+ +   L+H+N+VQ LG   E   + +  E +P GSL + 
Sbjct: 36  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 95
Query: 129 LFK-----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-K 182
           L       ++N  T  F  K    +  GL YL +     +VHRDIK  N++++      K
Sbjct: 96  LRSKWGPLKDNEQTIGFYTK---QILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK 149
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA--SKESDVYSFGIVALEIACGR 240
           I DFG ++ +       T    GT+ YMAPE    G     K +D++S G   +E+A G+
Sbjct: 150 ISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208
Query: 241 KPISLTAKEEVQVYLV 256
            P     + +  ++ V
Sbjct: 209 PPFYELGEPQAAMFKV 224

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 174
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 175 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 228
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL 255
             YM+PE       S +SD++S G+  +E+A GR PI     +E+++  
Sbjct: 229 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 277

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 72  KRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK 131
           K ++K   QG  E   E++ +  LRH ++++L      K E+++V EY  N   D ++ +
Sbjct: 40  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQ 96
Query: 132 ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL 191
            + +   E R +  Q + S + Y        +VHRD+K  N++LD + N KI DFGL+ +
Sbjct: 97  RDKMSEQEAR-RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNI 152
Query: 192 VEHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKP 242
           +      +T+   G+  Y APE   +G+  A  E DV+S G++   + C R P
Sbjct: 153 MTDGNFLKTS--CGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 69  IAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +G+ K   +E   E  I+ +L +  +V+L+G C + + L+LV E    G L  
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK 424
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L  +   +      ++   ++ G+ YL+E   +  VHR++ + N++L     AKI DFG
Sbjct: 425 FLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 188 LARLVEHAKGSQTTVLAG--TMGYMAPECATTGRASKESDVYSFGIVALE-IACGRKPIS 244
           L++ +       T   AG   + + APEC    + S  SDV+S+G+   E ++ G+KP  
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541
Query: 245 LTAKEEVQVYLVQ 257
                EV  ++ Q
Sbjct: 542 KMKGPEVMAFIEQ 554

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 72  KRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK 131
           K ++K   QG  E   E++ +  LRH ++++L      K E+++V EY  N   D ++ +
Sbjct: 44  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQ 100
Query: 132 ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL 191
            + +   E R +  Q + S + Y        +VHRD+K  N++LD + N KI DFGL+ +
Sbjct: 101 RDKMSEQEAR-RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNI 156
Query: 192 VEHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKP 242
           +      +T+   G+  Y APE   +G+  A  E DV+S G++   + C R P
Sbjct: 157 MTDGNFLKTS--CGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 12/183 (6%)
Query: 65  TSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           T   +AVK +++    S   + +   E+  +   RH ++++L        +  +V EY+ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L  ++ K   +   E R ++ Q + S + Y        VVHRD+K  N++LD + NA
Sbjct: 95  GGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNA 150
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACG 239
           KI DFGL+ ++   +  + +   G+  Y APE   +GR  A  E D++S G++   + CG
Sbjct: 151 KIADFGLSNMMSDGEFLRDS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 240 RKP 242
             P
Sbjct: 208 TLP 210

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 9/185 (4%)
Query: 63  RETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           + T  Y A+K + K    +K  +    +E  ++   RH  L  L         L  V EY
Sbjct: 173 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 232
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
              G L  HL +E        RF  A+ + S L YL    E+ VV+RD+K  N+MLD + 
Sbjct: 233 ANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVYRDLKLENLMLDKDG 289
Query: 180 NAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + KI DFGL +  E  K G+      GT  Y+APE        +  D +  G+V  E+ C
Sbjct: 290 HIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 347
Query: 239 GRKPI 243
           GR P 
Sbjct: 348 GRLPF 352

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 9/185 (4%)
Query: 63  RETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           + T  Y A+K + K    +K  +    +E  ++   RH  L  L         L  V EY
Sbjct: 170 KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
              G L  HL +E        RF  A+ + S L YL    E+ VV+RD+K  N+MLD + 
Sbjct: 230 ANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVYRDLKLENLMLDKDG 286
Query: 180 NAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + KI DFGL +  E  K G+      GT  Y+APE        +  D +  G+V  E+ C
Sbjct: 287 HIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
Query: 239 GRKPI 243
           GR P 
Sbjct: 345 GRLPF 349

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 9/185 (4%)
Query: 63  RETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           + T  Y A+K + K    +K  +    +E  ++   RH  L  L         L  V EY
Sbjct: 32  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 91
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
              G L  HL +E        RF  A+ + S L YL    E+ VV+RD+K  N+MLD + 
Sbjct: 92  ANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVYRDLKLENLMLDKDG 148
Query: 180 NAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + KI DFGL +  E  K G+      GT  Y+APE        +  D +  G+V  E+ C
Sbjct: 149 HIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 206
Query: 239 GRKPI 243
           GR P 
Sbjct: 207 GRLPF 211

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 5/165 (3%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           + E++I   L H+++V   G+  +   + +V E     SL     +   L   E R+ + 
Sbjct: 63  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q +  G  YL       V+HRD+K  N+ L+ +   KIGDFGLA  VE+  G +  VL G
Sbjct: 123 Q-IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCG 177
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEE 250
           T  Y+APE  +    S E DV+S G +   +  G+ P   +  +E
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 72  KRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK 131
           K ++K   QG  E   E++ +  LRH ++++L      K E+++V EY  N   D ++ +
Sbjct: 49  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQ 105
Query: 132 ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL 191
            + +   E R +  Q + S + Y        +VHRD+K  N++LD + N KI DFGL+ +
Sbjct: 106 RDKMSEQEAR-RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNI 161
Query: 192 VEHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKP 242
           +      +T+   G+  Y APE   +G+  A  E DV+S G++   + C R P
Sbjct: 162 MTDGNFLKTS--CGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 72  KRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK 131
           K ++K   QG  E   E++ +  LRH ++++L      K E+++V EY  N   D ++ +
Sbjct: 50  KVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQ 106
Query: 132 ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL 191
            + +   E R +  Q + S + Y        +VHRD+K  N++LD + N KI DFGL+ +
Sbjct: 107 RDKMSEQEAR-RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNI 162
Query: 192 VEHAKGSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKP 242
           +      +T+   G+  Y APE   +G+  A  E DV+S G++   + C R P
Sbjct: 163 MTDGNFLKTS--CGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 94/184 (51%), Gaps = 19/184 (10%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    KE   SE+ I+S L +H N+V LLG C     +L++ EY   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 127 SHLFKENNLLTWEFRFKIAQDLASG--LLYLQEGWEQCV--------VHRDIKSSNIMLD 176
           + L +++ +L  +  F IA   AS   LL+      Q +        +HRD+ + N++L 
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 177 LNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESDVYSFGIV 232
               AKIGDFGLAR + +       ++ G     + +MAPE       + +SDV+S+GI+
Sbjct: 199 NGHVAKIGDFGLARDIMN---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 233 ALEI 236
             EI
Sbjct: 256 LWEI 259

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 8/167 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 112
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV 253
             YM+PE       S +SD++S G+  +E+A GR PI     +E+++
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 9/185 (4%)
Query: 63  RETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           + T  Y A+K + K    +K  +    +E  ++   RH  L  L         L  V EY
Sbjct: 31  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 90
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
              G L  HL +E        RF  A+ + S L YL    E+ VV+RD+K  N+MLD + 
Sbjct: 91  ANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVYRDLKLENLMLDKDG 147
Query: 180 NAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + KI DFGL +  E  K G+      GT  Y+APE        +  D +  G+V  E+ C
Sbjct: 148 HIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 205
Query: 239 GRKPI 243
           GR P 
Sbjct: 206 GRLPF 210

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 8/167 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 112
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV 253
             YM+PE       S +SD++S G+  +E+A GR PI     +E+++
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 56  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 114 AKNGCLLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 169
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   ASK SD+++ G +  ++  
Sbjct: 170 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVA 229
Query: 239 GRKPI 243
           G  P 
Sbjct: 230 GLPPF 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 9/185 (4%)
Query: 63  RETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           + T  Y A+K + K    +K  +    +E  ++   RH  L  L         L  V EY
Sbjct: 30  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 89
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
              G L  HL +E        RF  A+ + S L YL    E+ VV+RD+K  N+MLD + 
Sbjct: 90  ANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS--EKNVVYRDLKLENLMLDKDG 146
Query: 180 NAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + KI DFGL +  E  K G+      GT  Y+APE        +  D +  G+V  E+ C
Sbjct: 147 HIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 204
Query: 239 GRKPI 243
           GR P 
Sbjct: 205 GRLPF 209

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 139
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 140 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 193
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL 255
             YM+PE       S +SD++S G+  +E+A GR PI     +E+++  
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 8/167 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 112
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV 253
             YM+PE       S +SD++S G+  +E+A GR PI     +E+++
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 8/167 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 112
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV 253
             YM+PE       S +SD++S G+  +E+A GR PI     +E+++
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 96/189 (50%), Gaps = 17/189 (8%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +ETS   A K +   S++ +++Y  E+ I++   H N+V+LL   + +  L ++ E+   
Sbjct: 59  KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 118
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G++D+ + +    LT      + +     L YL +     ++HRD+K+ NI+  L+ + K
Sbjct: 119 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIK 175
Query: 183 IGDFGLARLVEHAKGSQTT----VLAGTMGYMAPE---CATTGRASKE--SDVYSFGIVA 233
           + DFG++     AK ++         GT  +MAPE   C T+     +  +DV+S GI  
Sbjct: 176 LADFGVS-----AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 234 LEIACGRKP 242
           +E+A    P
Sbjct: 231 IEMAEIEPP 239

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 112
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
             YM+PE       S +SD++S G+  +E+A GR PI
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 96/189 (50%), Gaps = 17/189 (8%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +ETS   A K +   S++ +++Y  E+ I++   H N+V+LL   + +  L ++ E+   
Sbjct: 59  KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 118
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G++D+ + +    LT      + +     L YL +     ++HRD+K+ NI+  L+ + K
Sbjct: 119 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIK 175
Query: 183 IGDFGLARLVEHAKGSQTT----VLAGTMGYMAPE---CATTGRASKE--SDVYSFGIVA 233
           + DFG++     AK ++         GT  +MAPE   C T+     +  +DV+S GI  
Sbjct: 176 LADFGVS-----AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 230
Query: 234 LEIACGRKP 242
           +E+A    P
Sbjct: 231 IEMAEIEPP 239

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 98/189 (51%), Gaps = 17/189 (8%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +ET +  A K +   S++ +++Y  E+ I++   H  +V+LLG  +   +L ++ E+ P 
Sbjct: 33  KETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 92
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G++D+ + + +  LT      + + +   L +L     + ++HRD+K+ N+++ L  + +
Sbjct: 93  GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIR 149
Query: 183 IGDFGLARLVEHAKGSQTT----VLAGTMGYMAPE---CATTGRASKE--SDVYSFGIVA 233
           + DFG++     AK  +T        GT  +MAPE   C T      +  +D++S GI  
Sbjct: 150 LADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 204
Query: 234 LEIACGRKP 242
           +E+A    P
Sbjct: 205 IEMAQIEPP 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E++I   L H+++V   G+  +   + +V E     SL     +   L   E R+ + Q 
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ- 129
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           +  G  YL       V+HRD+K  N+ L+ +   KIGDFGLA  VE+  G +   L GT 
Sbjct: 130 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTP 185
Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
            Y+APE  +    S E DV+S G +   +  G+ P   +  +E 
Sbjct: 186 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 229

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 5/166 (3%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           + E++I   L H+++V   G+  +   + +V E     SL     +   L   E R+ + 
Sbjct: 65  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 124
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q +  G  YL       V+HRD+K  N+ L+ +   KIGDFGLA  VE+  G +   L G
Sbjct: 125 Q-IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCG 179
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           T  Y+APE  +    S E DV+S G +   +  G+ P   +  +E 
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 225

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 95/187 (50%), Gaps = 25/187 (13%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    KE   SE+ I+S L +H N+V LLG C     +L++ EY   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 127 SHLFKENNLLTWEFRFKIAQD-------------LASGLLYLQEGWEQCVVHRDIKSSNI 173
           + L +++ +L  +  F IA               +A G+ +L    + C+ HRD+ + N+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS--KNCI-HRDVAARNV 195
Query: 174 MLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESDVYSF 229
           +L     AKIGDFGLAR + +       ++ G     + +MAPE       + +SDV+S+
Sbjct: 196 LLTNGHVAKIGDFGLARDIMN---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 230 GIVALEI 236
           GI+  EI
Sbjct: 253 GILLWEI 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 34  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 91
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 92  AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 147
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 148 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 207
Query: 239 GRKPI 243
           G  P 
Sbjct: 208 GLPPF 212

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 5/166 (3%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           + E++I   L H+++V   G+  +   + +V E     SL     +   L   E R+ + 
Sbjct: 65  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 124
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q +  G  YL       V+HRD+K  N+ L+ +   KIGDFGLA  VE+  G +   L G
Sbjct: 125 Q-IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCG 179
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           T  Y+APE  +    S E DV+S G +   +  G+ P   +  +E 
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 225

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 17/185 (9%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           +AVK +  GS   ++ + +E  ++  L+H  LV+L      K+ + ++ E+M  GSL   
Sbjct: 209 VAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDF 266
Query: 129 L-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           L   E +          +  +A G+ ++++   +  +HRD++++NI++  +   KI DFG
Sbjct: 267 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFG 323
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLT 246
           LAR+     G++  +      + APE    G  + +SDV+SFGI+ +EI   GR P    
Sbjct: 324 LARV-----GAKFPI-----KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 373
Query: 247 AKEEV 251
           +  EV
Sbjct: 374 SNPEV 378

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 54  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 112 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 167
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 168 HIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 239 GRKPI 243
           G  P 
Sbjct: 228 GLPPF 232

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 33  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 90
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 91  AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 146
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 147 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 206
Query: 239 GRKPI 243
           G  P 
Sbjct: 207 GLPPF 211

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 61  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSY 118
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 119 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 174
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 175 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 234
Query: 239 GRKPI 243
           G  P 
Sbjct: 235 GLPPF 239

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 98/189 (51%), Gaps = 17/189 (8%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           +ET +  A K +   S++ +++Y  E+ I++   H  +V+LLG  +   +L ++ E+ P 
Sbjct: 41  KETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G++D+ + + +  LT      + + +   L +L     + ++HRD+K+ N+++ L  + +
Sbjct: 101 GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIR 157
Query: 183 IGDFGLARLVEHAKGSQTT----VLAGTMGYMAPE---CATTGRASKE--SDVYSFGIVA 233
           + DFG++     AK  +T        GT  +MAPE   C T      +  +D++S GI  
Sbjct: 158 LADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 234 LEIACGRKP 242
           +E+A    P
Sbjct: 213 IEMAQIEPP 221

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 32  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 90  AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 145
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 146 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205
Query: 239 GRKPI 243
           G  P 
Sbjct: 206 GLPPF 210

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 56  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 114 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 169
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 170 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVA 229
Query: 239 GRKPI 243
           G  P 
Sbjct: 230 GLPPF 234

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG-TMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +    + T      + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 31  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 88
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 89  AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 144
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 145 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 204
Query: 239 GRKPI 243
           G  P 
Sbjct: 205 GLPPF 209

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG-TMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +    + T      + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 131
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT
Sbjct: 132 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 185
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
             YM+PE       S +SD++S G+  +E+A GR PI
Sbjct: 186 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+L H+N+V+ +G   +     ++ E M  G L S
Sbjct: 78  VAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 137
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 194
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 195 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 251
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 252 EIFSLGYMPYPSKSNQEV 269

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 56  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 114 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 169
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 170 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229
Query: 239 GRKPI 243
           G  P 
Sbjct: 230 GLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 57  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 114
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 115 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 170
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 171 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 230
Query: 239 GRKPI 243
           G  P 
Sbjct: 231 GLPPF 235

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 54  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 112 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 167
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 168 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 239 GRKPI 243
           G  P 
Sbjct: 228 GLPPF 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 54  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 112 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 167
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 168 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 239 GRKPI 243
           G  P 
Sbjct: 228 GLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 56  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 114 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 169
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 170 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229
Query: 239 GRKPI 243
           G  P 
Sbjct: 230 GLPPF 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 54  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 112 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 167
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 168 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
Query: 239 GRKPI 243
           G  P 
Sbjct: 228 GLPPF 232

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +KE     +E  I+  +    LV+L     +   L +V EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFGLA+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IKVTDFGLAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 59  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 116
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 117 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 172
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 173 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 232
Query: 239 GRKPI 243
           G  P 
Sbjct: 233 GLPPF 237

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 56  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 114 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 169
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 170 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229
Query: 239 GRKPI 243
           G  P 
Sbjct: 230 GLPPF 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 56  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 114 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 169
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 170 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229
Query: 239 GRKPI 243
           G  P 
Sbjct: 230 GLPPF 234

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+L H+N+V+ +G   +     ++ E M  G L S
Sbjct: 64  VAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 123
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 124 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 180
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 181 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 237
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 238 EIFSLGYMPYPSKSNQEV 255

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 38  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 95
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 96  AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 151
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 152 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 211
Query: 239 GRKPI 243
           G  P 
Sbjct: 212 GLPPF 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 57  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 114
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 115 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 170
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 171 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 230
Query: 239 GRKPI 243
           G  P 
Sbjct: 231 GLPPF 235

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 53  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 110
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 111 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 166
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 167 HIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 226
Query: 239 GRKPI 243
           G  P 
Sbjct: 227 GLPPF 231

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EYM
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYM 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGDMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IKVADFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EYM
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYM 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGDMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IKVADFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 37/264 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 127 SHLFKENNLLTWEFRFK---------IAQDLASGLLYLQEGWE-----QCVVHRDIKSSN 172
            +L +       EF F           ++DL S    +  G E     +C+ HRD+ + N
Sbjct: 123 EYL-QARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI-HRDLAARN 180
Query: 173 IMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG-TMGYMAPECATTGRASKESDVYSFGI 231
           +++  +   KI DFGLAR + H    + T      + +MAPE       + +SDV+SFG+
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 232 VALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMI 290
           +  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M+
Sbjct: 241 LLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---MM 285
Query: 291 VGLWCAHPDENLRPSIRQVIHVLN 314
              W A P +  RP+ +Q++  L+
Sbjct: 286 RDCWHAVPSQ--RPTFKQLVEDLD 307

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKE-----YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           TS   A+K + K  +  IKE        E  ++SRL H   V+L     + ++L     Y
Sbjct: 53  TSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 110
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             NG L  ++ K  +      RF  A+ + S L YL     + ++HRD+K  NI+L+ + 
Sbjct: 111 AKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDM 166
Query: 180 NAKIGDFGLARLVE-HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + +I DFG A+++   +K ++     GT  Y++PE  T   A K SD+++ G +  ++  
Sbjct: 167 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 226
Query: 239 GRKPI 243
           G  P 
Sbjct: 227 GLPPF 231

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLTAR 173
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 234 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 278
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 279 MRDCWHAVPSQ--RPTFKQLVEDLD 301

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG-TMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +    + T      + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 63  RETSSY--IAVKRVSKGS--KQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY 117
           RE  S+  +A+K + K    K+G++ +   E+ I + L H N+++L  + ++++ + L+ 
Sbjct: 43  REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLIL 102
Query: 118 EYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
           EY P G L   L     F E    T      I ++LA  L+Y      + V+HRDIK  N
Sbjct: 103 EYAPRGELYKELQKSCTFDEQRTAT------IMEELADALMYCH---GKKVIHRDIKPEN 153
Query: 173 IMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
           ++L L    KI DFG +    HA   +   + GT+ Y+ PE       +++ D++  G++
Sbjct: 154 LLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVL 210
Query: 233 ALEIACGRKPISLTAKEEVQVYLVQ 257
             E+  G  P    +  E    +V+
Sbjct: 211 CYELLVGNPPFESASHNETYRRIVK 235

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 178
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 239 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 283
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 284 MRDCWHAVPSQ--RPTFKQLVEDLD 306

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 232
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 293 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 337
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 338 MRDCWHAVPSQ--RPTFKQLVEDLD 360

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK   K      KE + SE  I+  L H ++V+L+G   E+   +++ E  P G L  
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGH 97
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           +L +  N L        +  +   + YL+     CV HRDI   NI++      K+GDFG
Sbjct: 98  YLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCV-HRDIAVRNILVASPECVKLGDFG 154
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPI 243
           L+R +E     + +V    + +M+PE     R +  SDV+ F +   EI + G++P 
Sbjct: 155 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 175
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 236 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 280
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 281 MRDCWHAVPSQ--RPTFKQLVEDLD 303

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
           T   +A K +     +  +E  +E++++++L H NL+QL      K +++LV EY+  G 
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA--- 181
           L   +  E+  LT        + +  G+ ++ + +   ++H D+K  NI+  +N +A   
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILC-VNRDAKQI 228
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           KI DFGLAR   +    +  V  GT  ++APE       S  +D++S G++A  +  G  
Sbjct: 229 KIIDFGLAR--RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
Query: 242 PISLTAKEEVQVYLVQWVWDL 262
           P       E    ++   WDL
Sbjct: 287 PFLGDNDAETLNNILACRWDL 307

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK   K      KE + SE  I+  L H ++V+L+G   E+   +++ E  P G L  
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGH 101
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           +L +  N L        +  +   + YL+     CV HRDI   NI++      K+GDFG
Sbjct: 102 YLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCV-HRDIAVRNILVASPECVKLGDFG 158
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPI 243
           L+R +E     + +V    + +M+PE     R +  SDV+ F +   EI + G++P 
Sbjct: 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 78  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKS 137
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 194
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 195 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 251
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 252 EIFSLGYMPYPSKSNQEV 269

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 63  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKS 122
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 179
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 180 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 237 EIFSLGYMPYPSKSNQEV 254

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK   K      KE + SE  I+  L H ++V+L+G   E+   +++ E  P G L  
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGH 113
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           +L +  N L        +  +   + YL+     CV HRDI   NI++      K+GDFG
Sbjct: 114 YLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCV-HRDIAVRNILVASPECVKLGDFG 170
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPI 243
           L+R +E     + +V    + +M+PE     R +  SDV+ F +   EI + G++P 
Sbjct: 171 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 55  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 114
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 115 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 171
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 172 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 228
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 229 EIFSLGYMPYPSKSNQEV 246

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 63  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 122
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 179
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 180 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 237 EIFSLGYMPYPSKSNQEV 254

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 80  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 139
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 140 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 196
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 197 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 253
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 254 EIFSLGYMPYPSKSNQEV 271

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYAS---EVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           R  S ++   +V K +   +++      E  I++ + H  +V+L      + +L L+ ++
Sbjct: 52  RPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDF 111
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G L + L KE      + +F +A+ LA GL +L       +++RD+K  NI+LD   
Sbjct: 112 LRGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLDHLHS---LGIIYRDLKPENILLDEEG 167
Query: 180 NAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
           + K+ DFGL++  ++H K + +    GT+ YMAPE       S  +D +S+G++  E+  
Sbjct: 168 HIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLT 225
Query: 239 GRKPISLTAKEEVQVYLVQ 257
           G  P     ++E    +++
Sbjct: 226 GSLPFQGKDRKETMTLILK 244

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 104 VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 164 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 220
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 221 RVAKIGDFGMARDIYRAGYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 278 EIFSLGYMPYPSKSNQEV 295

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 49/274 (17%)
Query: 66  SSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-------------RNLVQLLGWCHEKKE 112
           S Y A+K++ + +++ +    SEV +++ L H             RN V+      +K  
Sbjct: 31  SRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKST 89
Query: 113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
           L +  EY  N +L   +  EN     +  +++ + +   L Y+     Q ++HR++K  N
Sbjct: 90  LFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRNLKPXN 146
Query: 173 IMLDLNFNAKIGDFGLARLVEHA-------------KGSQTTVLAGTMGYMAPECAT-TG 218
           I +D + N KIGDFGLA+ V  +                  T   GT  Y+A E    TG
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTG 206
Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
             +++ D YS GI+  E      P S T  E V +             K L +V      
Sbjct: 207 HYNEKIDXYSLGIIFFEXIY---PFS-TGXERVNIL------------KKLRSVSIEFPP 250
Query: 279 DFDEQQMEC-LMIVGLWCAHPDENLRPSIRQVIH 311
           DFD+ + +    I+ L   H D N RP  R +++
Sbjct: 251 DFDDNKXKVEKKIIRLLIDH-DPNKRPGARTLLN 283

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 81  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 140
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 141 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 197
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 198 RVAKIGDFGMARDIYRAGYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 254
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 255 EIFSLGYMPYPSKSNQEV 272

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 64  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 123
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 124 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 180
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 181 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 237
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 238 EIFSLGYMPYPSKSNQEV 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 78  VAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 137
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 194
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 195 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 251
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 252 EIFSLGYMPYPSKSNQEV 269

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 70  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 129
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 130 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 186
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+AR +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 187 RVAKIGDFGMARDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 243
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 244 EIFSLGYMPYPSKSNQEV 261

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 15/195 (7%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 90  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 149
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 150 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 206
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAG-TMGYMAPECATTGRASKESDVYSFGIVALEI- 236
             AKIGDFG+AR +  A   +    A   + +M PE    G  + ++D +SFG++  EI 
Sbjct: 207 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 266
Query: 237 ACGRKPISLTAKEEV 251
           + G  P    + +EV
Sbjct: 267 SLGYMPYPSKSNQEV 281

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 89/192 (46%), Gaps = 29/192 (15%)
Query: 68  YIAVKRVSKGSKQGIKEYASEVTIISR--LRHRNLVQLLGWCHEKK------ELLLVYEY 119
           ++AVK      KQ    + SE  I S   ++H NL+Q +    EK+      EL L+  +
Sbjct: 40  FVAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIA--AEKRGSNLEVELWLITAF 94
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE--------GWEQCVVHRDIKSS 171
              GSL  +L  + N++TW     +A+ ++ GL YL E        G +  + HRD KS 
Sbjct: 95  HDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSK 152
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTG-----RASKESD 225
           N++L  +  A + DFGLA   E  K    T    GT  YMAPE           A    D
Sbjct: 153 NVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 212
Query: 226 VYSFGIVALEIA 237
           +Y+ G+V  E+ 
Sbjct: 213 MYAMGLVLWELV 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +KE     +E  I+  +    LV+L     +   L +V EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFGLA+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGLAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   +I DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 87/170 (51%), Gaps = 8/170 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E+ ++       +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIA 115
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGT 206
           +  GL YL+E  +  ++HRD+K SNI+++     K+ DFG++ +L++           GT
Sbjct: 116 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE----FVGT 169
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
             YM+PE       S +SD++S G+  +E+A GR P    A  E+  Y+V
Sbjct: 170 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIV 219

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 74  VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH----- 128
           +S+ S +  +E   EV +++ ++H N+VQ      E   L +V +Y   G L        
Sbjct: 59  ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 129 --LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
             LF+E+ +L W  +  +A         L+   ++ ++HRDIKS NI L  +   ++GDF
Sbjct: 119 GVLFQEDQILDWFVQICLA---------LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDF 169
Query: 187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
           G+AR++ ++         GT  Y++PE       + +SD+++ G V  E+
Sbjct: 170 GIARVL-NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 127 SHL-FKENNLLTWEFR--------------FKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L  +E   L + +                  A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 179
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 284
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 285 MRDCWHAVPSQ--RPTFKQLVEDLD 307

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 124 PGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IKVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
            P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D   
Sbjct: 124 APGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQG 179
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 180 YIKVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 236 YPP--FFADQPIQIY 248

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 10/185 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T   +A+K ++K + +G +    +E+ ++ +++H N+V L         L L+ + + 
Sbjct: 40  KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 99
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM---LDLN 178
            G L   +  E    T     ++   +   + YL +     +VHRD+K  N++   LD +
Sbjct: 100 GGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDED 155
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
               I DFGL+++ +   GS  +   GT GY+APE       SK  D +S G++A  + C
Sbjct: 156 SKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 239 GRKPI 243
           G  P 
Sbjct: 214 GYPPF 218

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 127 SHL---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L                     L+ +     A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 220
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 325
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 326 MRDCWHAVPSQ--RPTFKQLVEDLD 348

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 10/185 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T   +A+K ++K + +G +    +E+ ++ +++H N+V L         L L+ + + 
Sbjct: 40  KRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 99
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM---LDLN 178
            G L   +  E    T     ++   +   + YL +     +VHRD+K  N++   LD +
Sbjct: 100 GGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDED 155
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
               I DFGL+++ +   GS  +   GT GY+APE       SK  D +S G++A  + C
Sbjct: 156 SKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 239 GRKPI 243
           G  P 
Sbjct: 214 GYPPF 218

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 127 SHL---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L                     L+ +     A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 172
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 173 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 232
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 233 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 277
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 278 MRDCWHAVPSQ--RPTFKQLVEDLD 300

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IKVADFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 127 SHL---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L                     L+ +     A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 164
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 269
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 270 MRDCWHAVPSQ--RPTFKQLVEDLD 292

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 127 SHL---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L                     L+ +     A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 171
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 172 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 231
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 232 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 276
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 277 MRDCWHAVPSQ--RPTFKQLVEDLD 299

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 127 SHL---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L                     L+ +     A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 168
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 169 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 228
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 229 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 273
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 274 MRDCWHAVPSQ--RPTFKQLVEDLD 296

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 127 SHL---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L                     L+ +     A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 179
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 284
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 285 MRDCWHAVPSQ--RPTFKQLVEDLD 307

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IKVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 10/185 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T   +A+K ++K + +G +    +E+ ++ +++H N+V L         L L+ + + 
Sbjct: 40  KRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 99
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM---LDLN 178
            G L   +  E    T     ++   +   + YL +     +VHRD+K  N++   LD +
Sbjct: 100 GGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDED 155
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
               I DFGL+++ +   GS  +   GT GY+APE       SK  D +S G++A  + C
Sbjct: 156 SKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 239 GRKPI 243
           G  P 
Sbjct: 214 GYPPF 218

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 131
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 132 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 185
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 131
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 132 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 185
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 243

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 10/185 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T   +A+K ++K + +G +    +E+ ++ +++H N+V L         L L+ + + 
Sbjct: 40  KRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 99
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM---LDLN 178
            G L   +  E    T     ++   +   + YL +     +VHRD+K  N++   LD +
Sbjct: 100 GGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDED 155
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
               I DFGL+++ +   GS  +   GT GY+APE       SK  D +S G++A  + C
Sbjct: 156 SKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 239 GRKPI 243
           G  P 
Sbjct: 214 GYPPF 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 474
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 475 LVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 528
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 586

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 473
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 474 LVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 527
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRV-SKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + S  +++ + +  SE+ ++  + +H+N++ LLG C +   L ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 127 SHL---------------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
            +L                     L+ +     A  +A G+ YL    ++C+ HRD+ + 
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCI-HRDLAAR 179
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  +   KI DFGLAR + H     +TT     + +MAPE       + +SDV+SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRMDK--PSNCT--NELYM---M 284
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 285 MRDCWHAVPSQ--RPTFKQLVEDLD 307

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 129
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 130 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 183
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 241

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 115
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 116 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENXYK 169
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++  Y   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD---SHLFKENNLLTWEFRFKI 144
           E+ ++ +L H N+++      E  EL +V E    G L     H  K+  L+     +K 
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA 204
              L S L ++     + V+HRDIK +N+ +      K+GD GL R    +K +    L 
Sbjct: 142 FVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV 197
Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
           GT  YM+PE       + +SD++S G +  E+A  + P                  +LY 
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------------MNLYS 245
Query: 265 NGKLLEAVD-PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
             K +E  D P L  D   +++  L+ +   C +PD   RP +  V  V
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDV 291

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 27/209 (12%)
Query: 64  ETSSYIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E +  +A+K +   ++  ++E +  E  + +RL+H N+V LLG   + + L +++ Y  +
Sbjct: 54  EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH 113
Query: 123 GSLDSHLFK----------------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           G L   L                  ++ L   +F   +AQ +A+G+ YL       VVH+
Sbjct: 114 GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ-IAAGMEYLS---SHHVVHK 169
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           D+ + N+++    N KI D GL R V   ++ K    ++L   + +MAPE    G+ S +
Sbjct: 170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL--PIRWMAPEAIMYGKFSID 227
Query: 224 SDVYSFGIVALEI-ACGRKPISLTAKEEV 251
           SD++S+G+V  E+ + G +P    + ++V
Sbjct: 228 SDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ +     YL       +++RD+K  N+++D   
Sbjct: 116 VPGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQG 171
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 172 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 228 YPP--FFADQPIQIY 240

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 115
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 116 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 169
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 227

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 27/209 (12%)
Query: 64  ETSSYIAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           E +  +A+K +   ++  ++E +  E  + +RL+H N+V LLG   + + L +++ Y  +
Sbjct: 37  EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH 96
Query: 123 GSLDSHLFK----------------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           G L   L                  ++ L   +F   +AQ +A+G+ YL       VVH+
Sbjct: 97  GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ-IAAGMEYLS---SHHVVHK 152
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           D+ + N+++    N KI D GL R V   ++ K    ++L   + +MAPE    G+ S +
Sbjct: 153 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP--IRWMAPEAIMYGKFSID 210
Query: 224 SDVYSFGIVALEI-ACGRKPISLTAKEEV 251
           SD++S+G+V  E+ + G +P    + ++V
Sbjct: 211 SDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 121
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 122 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 175
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +AVK + +  S+Q   ++  E  IIS+  H+N+V+ +G   +     ++ E M  G L S
Sbjct: 64  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 123
Query: 128 HLFK------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            L +      + + L       +A+D+A G  YL+E      +HRDI + N +L      
Sbjct: 124 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPG 180
Query: 179 FNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
             AKIGDFG+A+ +  A    KG    +    + +M PE    G  + ++D +SFG++  
Sbjct: 181 RVAKIGDFGMAQDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKTDTWSFGVLLW 237
Query: 235 EI-ACGRKPISLTAKEEV 251
           EI + G  P    + +EV
Sbjct: 238 EIFSLGYMPYPSKSNQEV 255

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ +     YL       +++RD+K  N+++D   
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 109
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 110 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 163
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 221

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           E  +E  ++ +L +  +V+++G C E +  +LV E    G L+ +L ++N  +  +   +
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIE 111
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   ++ G+ YL+E      VHRD+ + N++L     AKI DFGL++ +   +  +    
Sbjct: 112 LVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---RADENYYK 165
Query: 204 AGTMG-----YMAPECATTGRASKESDVYSFGIVALE-IACGRKPISLTAKEEVQVYL 255
           A T G     + APEC    + S +SDV+SFG++  E  + G+KP       EV   L
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 13/256 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           + T   +AVK++    +Q  +   +EV I+    H N+V +        EL +V E++  
Sbjct: 67  KHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEG 126
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G+L       +  +  E    +   +   L YL     Q V+HRDIKS +I+L  +   K
Sbjct: 127 GALTD--IVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIK 181
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           + DFG    V   +  +   L GT  +MAPE  +      E D++S GI+ +E+  G  P
Sbjct: 182 LSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240
Query: 243 I----SLTAKEEVQVYLVQWVWDLYGNGKLLEA-VDPRLCRDFDEQQM--ECLMIVGLWC 295
                 L A   ++  L   V DL+    +L   +D  L R+  ++    E L    L  
Sbjct: 241 YFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKL 300
Query: 296 AHPDENLRPSIRQVIH 311
           A P   + P +RQ  H
Sbjct: 301 AGPPSCIVPLMRQYRH 316

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 12/186 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA--SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           + T    AVK + K + +G KE +  +E+ ++ +++H N+V L         L LV + +
Sbjct: 44  KATGKLFAVKCIPKKALKG-KESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLV 102
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DL 177
             G L   +  E    T +    + + +   + YL       +VHRD+K  N++    D 
Sbjct: 103 SGGELFDRIV-EKGFYTEKDASTLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDE 158
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
                I DFGL+++    KG   +   GT GY+APE       SK  D +S G++A  + 
Sbjct: 159 ESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 216
Query: 238 CGRKPI 243
           CG  P 
Sbjct: 217 CGYPPF 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 69  IAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL-- 125
           +A+KR++ +  +  + E   E+  +S+  H N+V        K EL LV + +  GS+  
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 126 -----------DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
                       S +  E+ + T      I +++  GL YL +  +   +HRD+K+ NI+
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIAT------ILREVLEGLEYLHKNGQ---IHRDVKAGNIL 153
Query: 175 LDLNFNAKIGDFGLARLVEHAKGSQTT------VLAGTMGYMAPECATTGRASK-ESDVY 227
           L  + + +I DFG++  +  A G   T         GT  +MAPE     R    ++D++
Sbjct: 154 LGEDGSVQIADFGVSAFL--ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211
Query: 228 SFGIVALEIACGRKP 242
           SFGI A+E+A G  P
Sbjct: 212 SFGITAIELATGAAP 226

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    L +L     +   L +V EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYA 124
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 125 PGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 180
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 181 IKVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 236
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 237 PP--FFADQPIQIY 248

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 121/255 (47%), Gaps = 33/255 (12%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           + +K + K  +   + +    +++S+L H++LV   G C    E +LV E++  GSLD++
Sbjct: 43  VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L K  N +   ++ ++A+ LA+ + +L+E     ++H ++ + NI+L    + K G+   
Sbjct: 103 LKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 189 ARLVEHAKGSQTTVLAGT-----MGYMAPECATTGR-ASKESDVYSFGIVALEIAC-GRK 241
            +L +   G   TVL        + ++ PEC    +  +  +D +SFG    EI   G K
Sbjct: 160 IKLSD--PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
Query: 242 PIS-LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE 300
           P+S L ++ ++Q Y  +         +L   ++   C D++                PD 
Sbjct: 218 PLSALDSQRKLQFYEDRHQLPAPKAAELANLINN--CMDYE----------------PDH 259
Query: 301 NLRPSIRQVIHVLNS 315
             RPS R +I  LNS
Sbjct: 260 --RPSFRAIIRDLNS 272

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 39/265 (14%)
Query: 69  IAVKRVSK-GSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +    +++ + +  SE+ ++  + +H+N++ LLG C +   L ++  Y   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 127 SHL-----------FKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSS 171
            +L           +  N +   +  FK   DL S    L  G E    Q  +HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFK---DLVSCTYQLARGMEYLASQKCIHRDLAAR 186
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFG 230
           N+++  N   KI DFGLAR + +     +TT     + +MAPE       + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 231 IVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLM 289
           ++  EI   G  P      EE        ++ L   G  ++   P  C   +E  M   M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDK--PANCT--NELYM---M 291
Query: 290 IVGLWCAHPDENLRPSIRQVIHVLN 314
           +   W A P +  RP+ +Q++  L+
Sbjct: 292 MRDCWHAVPSQ--RPTFKQLVEDLD 314

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 89/171 (52%), Gaps = 7/171 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E  I+  + H  +V+L      + +L L+ +++  G L + L KE      + +F +A+ 
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE- 134
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGT 206
           LA  L +L       +++RD+K  NI+LD   + K+ DFGL++  ++H K + +    GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
           + YMAPE       ++ +D +SFG++  E+  G  P     ++E    +++
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 69  IAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS-LD 126
           +A+KR++ +  +  + E   E+  +S+  H N+V        K EL LV + +  GS LD
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 127 --SHLFKE----NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
              H+  +    + +L       I +++  GL YL +  +   +HRD+K+ NI+L  + +
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 154
Query: 181 AKIGDFGLARLVEHAKGSQTT------VLAGTMGYMAPECATTGRASK-ESDVYSFGIVA 233
            +I DFG++  +  A G   T         GT  +MAPE     R    ++D++SFGI A
Sbjct: 155 VQIADFGVSAFL--ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 212
Query: 234 LEIACGRKP 242
           +E+A G  P
Sbjct: 213 IELATGAAP 221

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 84  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 144 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 199
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 200 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 256 YPP--FFADQPIQIY 268

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 56  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 115
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ +     YL       +++RD+K  N+++D   
Sbjct: 116 VPGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQG 171
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 172 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 228 YPP--FFADQPIQIY 240

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 179
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 180 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 236 YPP--FFADQPIQIY 248

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E++ +  LRH ++++L        ++++V EY   G L  ++ ++  +   E R +  Q 
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQ 116
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           +   + Y        +VHRD+K  N++LD N N KI DFGL+ ++      +T+   G+ 
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSP 171
Query: 208 GYMAPECATTGR--ASKESDVYSFGIVALEIACGRKP 242
            Y APE    G+  A  E DV+S GIV   +  GR P
Sbjct: 172 NYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 50  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 109
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ +     YL       +++RD+K  N+++D    
Sbjct: 110 PGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 165
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 166 IQVTDFGFAKRVK----GRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 221
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 222 PP--FFADQPIQIY 233

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 6/180 (3%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           + +   +AVK +    +Q  +   +EV I+   +H N+V++       +EL ++ E++  
Sbjct: 67  KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G+L   + +    L  E    + + +   L YL     Q V+HRDIKS +I+L L+   K
Sbjct: 127 GALTDIVSQVR--LNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVK 181
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           + DFG    +      +   L GT  +MAPE  +    + E D++S GI+ +E+  G  P
Sbjct: 182 LSDFGFCAQISK-DVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 179
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 180 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 236 YPP--FFADQPIQIY 248

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 179
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 180 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 236 YPP--FFADQPIQIY 248

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 105 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 161 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218
Query: 246 TAKEEV 251
             K+E 
Sbjct: 219 DTKQET 224

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 125 PGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 181 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 236
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 237 PP--FFADQPIQIY 248

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    L +L     +   L +V EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYA 124
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 180
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 181 IKVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 236
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 237 PP--FFADQPIQIY 248

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL-----DSHLFKENNLLTW 138
           E  +E++++  L H N+++L     +KK   LV E+   G L     + H F E +    
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN- 150
Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGLARLVEHA 195
                I + + SG+ YL    +  +VHRDIK  NI+L+      N KI DFGL+     +
Sbjct: 151 -----IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--S 200
Query: 196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
           K  +     GT  Y+APE     + +++ DV+S G++   + CG  P 
Sbjct: 201 KDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEE 250
             K+E
Sbjct: 220 DTKQE 224

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 86/193 (44%), Gaps = 9/193 (4%)
Query: 63  RETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYE 118
           +ET    AVK + K        ++   +E  I+S  R H  L QL         L  V E
Sbjct: 45  KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104
Query: 119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN 178
           ++  G L  H+ K         RF  A ++ S L++L +   + +++RD+K  N++LD  
Sbjct: 105 FVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLHD---KGIIYRDLKLDNVLLDHE 160
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
            + K+ DFG+ +      G  T    GT  Y+APE           D ++ G++  E+ C
Sbjct: 161 GHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 239 GRKPISLTAKEEV 251
           G  P     ++++
Sbjct: 220 GHAPFEAENEDDL 232

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 105 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 161 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218
Query: 246 TAKEEV 251
             K+E 
Sbjct: 219 DTKQET 224

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 120/255 (47%), Gaps = 33/255 (12%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           + +K + K  +   + +    +++S+L H++LV   G C    E +LV E++  GSLD++
Sbjct: 43  VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTY 102
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL 188
           L K  N +   ++ ++A+ LA  + +L+E     ++H ++ + NI+L    + K G+   
Sbjct: 103 LKKNKNCINILWKLEVAKQLAWAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 189 ARLVEHAKGSQTTVLAGT-----MGYMAPECATTGR-ASKESDVYSFGIVALEIAC-GRK 241
            +L +   G   TVL        + ++ PEC    +  +  +D +SFG    EI   G K
Sbjct: 160 IKLSD--PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
Query: 242 PIS-LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDE 300
           P+S L ++ ++Q Y  +         +L   ++   C D++                PD 
Sbjct: 218 PLSALDSQRKLQFYEDRHQLPAPKAAELANLINN--CMDYE----------------PDH 259
Query: 301 NLRPSIRQVIHVLNS 315
             RPS R +I  LNS
Sbjct: 260 --RPSFRAIIRDLNS 272

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    L +L     +   L +V EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYA 124
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+M+D    
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLMIDQQGY 180
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 181 IKVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 236
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 237 PP--FFADQPIQIY 248

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 181 IQVTDFGFAKRVK----GRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 236
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 237 PP--FFADQPIQIY 248

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 89/171 (52%), Gaps = 7/171 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E  I+  + H  +V+L      + +L L+ +++  G L + L KE      + +F +A+ 
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE- 135
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGT 206
           LA  L +L       +++RD+K  NI+LD   + K+ DFGL++  ++H K + +    GT
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 190
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
           + YMAPE       ++ +D +SFG++  E+  G  P     ++E    +++
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 241

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 89/171 (52%), Gaps = 7/171 (4%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E  I+  + H  +V+L      + +L L+ +++  G L + L KE      + +F +A+ 
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE- 134
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGT 206
           LA  L +L       +++RD+K  NI+LD   + K+ DFGL++  ++H K + +    GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ 257
           + YMAPE       ++ +D +SFG++  E+  G  P     ++E    +++
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +ET ++ A+K + K     +K+     +E  I   +    LV+L     +   L +V EY
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEY 123
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
            P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 124 APGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 179
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 180 YIKVADFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 236 YPP--FFADQPIQIY 248

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 63  RETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ++T   +A+K+   S   K   K    E+ ++ +LRH NLV LL  C +KK   LV+E++
Sbjct: 47  KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106
Query: 121 PNGSLDS-HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
            +  LD   LF   N L ++   K    + +G+ +        ++HRDIK  NI++  + 
Sbjct: 107 DHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSG 161
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIAC 238
             K+ DFG AR +  A G        T  Y APE      +  K  DV++ G +  E+  
Sbjct: 162 VVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220
Query: 239 G 239
           G
Sbjct: 221 G 221

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ +    + +LLG C     + LV + MP G L  
Sbjct: 49  VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTST-VQLVTQLMPYGCLLD 107
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           H+ +    L  +        +A G+ YL++     +VHRD+ + N+++    + KI DFG
Sbjct: 108 HVRENRGRLGSQDLLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFG 164
Query: 188 LARLVE------HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LARL++      HA G +  +      +MA E     R + +SDV+S+G+   E+   G 
Sbjct: 165 LARLLDIDETEYHADGGKVPI-----KWMALESILRRRFTHQSDVWSYGVTVWELMTFGA 219
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+         DL   G+ L    P +C  D     ++C MI        D
Sbjct: 220 KPYDGIPAREIP--------DLLEKGERLP--QPPICTIDVYMIMVKCWMI--------D 261
Query: 300 ENLRPSIRQVI 310
              RP  R+++
Sbjct: 262 SECRPRFRELV 272

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 34/196 (17%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + + +    +E   SE+ ++++L  H N+V LLG C     + L++EY   G L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 127 SHL------FKEN----------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
           ++L      F E+                N+LT+E     A  +A G+ +L+  ++ CV 
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCV- 194
Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRA 220
           HRD+ + N+++      KI DFGLAR +         V+ G     + +MAPE    G  
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDI---MSDSNYVVRGNARLPVKWMAPESLFEGIY 251
Query: 221 SKESDVYSFGIVALEI 236
           + +SDV+S+GI+  EI
Sbjct: 252 TIKSDVWSYGILLWEI 267

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 181 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 236
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 237 PP--FFADQPIQIY 248

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           P G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 93/184 (50%), Gaps = 23/184 (12%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSL- 125
           +AVK +   +    KE   SE+ I+S L +H N+V LLG C     +L++ EY   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 126 -------DSHLFKENNLLTWEFR--FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
                  ++ L KE+     E R     +  +A G+ +L    + C+ HRD+ + N++L 
Sbjct: 139 NFLRRKAEADLDKEDGR-PLELRDLLHFSSQVAQGMAFLAS--KNCI-HRDVAARNVLLT 194
Query: 177 LNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESDVYSFGIV 232
               AKIGDFGLAR + +       ++ G     + +MAPE       + +SDV+S+GI+
Sbjct: 195 NGHVAKIGDFGLARDIMN---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 251
Query: 233 ALEI 236
             EI
Sbjct: 252 LWEI 255

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           ++E+ I   L + ++V   G+  +   + +V E     SL     +   +   E R+ + 
Sbjct: 90  STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q +  G+ YL       V+HRD+K  N+ L+ + + KIGDFGLA  +E   G +   L G
Sbjct: 150 QTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKTLCG 204
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T  Y+APE       S E D++S G +   +  G+ P   +  +E  + + +   + Y  
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK---NEYSV 261
Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            + +  V   L R                  H D  LRPS+ +++
Sbjct: 262 PRHINPVASALIRRM---------------LHADPTLRPSVAELL 291

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 93/184 (50%), Gaps = 23/184 (12%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSL- 125
           +AVK +   +    KE   SE+ I+S L +H N+V LLG C     +L++ EY   G L 
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 126 -------DSHLFKENNLLTWEFR--FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
                  ++ L KE+     E R     +  +A G+ +L    + C+ HRD+ + N++L 
Sbjct: 131 NFLRRKAEADLDKEDGR-PLELRDLLHFSSQVAQGMAFLAS--KNCI-HRDVAARNVLLT 186
Query: 177 LNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESDVYSFGIV 232
               AKIGDFGLAR + +       ++ G     + +MAPE       + +SDV+S+GI+
Sbjct: 187 NGHVAKIGDFGLARDIMN---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 243
Query: 233 ALEI 236
             EI
Sbjct: 244 LWEI 247

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR S+ S++G+  +E   EV+I+ ++ H N++ L      + +++L+ E +  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
            ++ +L   E    I Q L  G+ YL     + + H D+K  NIML D N    + K+ D
Sbjct: 107 AQKESLSEEEATSFIKQIL-DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  +E   G +   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 163 FGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 246 TAKEEVQVYLVQWVWDL 262
             K+E    +    +D 
Sbjct: 221 DTKQETLANITSVSYDF 237

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 100 FLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 156
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 157 LSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R T +  A K V    +   +    E+  +S LRH  LV L     +  E++++YE+M  
Sbjct: 73  RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 132
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN-- 180
           G L   +  E+N ++ +   +  + +  GL ++    E   VH D+K  NIM     +  
Sbjct: 133 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNE 189
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFGL   ++  +  + T   GT  + APE A        +D++S G+++  +  G 
Sbjct: 190 LKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 247
Query: 241 KPI 243
            P 
Sbjct: 248 SPF 250

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 114/256 (44%), Gaps = 19/256 (7%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R +   +AVK++    +Q  +   +EV I+   +H N+V++        EL +V E++  
Sbjct: 173 RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG---WEQCVVHRDIKSSNIMLDLNF 179
           G+L          +    R    Q  A  L  LQ       Q V+HRDIKS +I+L  + 
Sbjct: 233 GALTD--------IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 284
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG    V   +  +   L GT  +MAPE  +      E D++S GI+ +E+  G
Sbjct: 285 RVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343
Query: 240 RKPI----SLTAKEEVQVYLVQWVWDLYGNGKLLEA-VDPRLCRDFDEQQM--ECLMIVG 292
             P      L A + ++  L   + +L+     L+  +D  L RD  ++    E L    
Sbjct: 344 EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403
Query: 293 LWCAHPDENLRPSIRQ 308
           L  A P  ++ P +RQ
Sbjct: 404 LAKAGPPASIVPLMRQ 419

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFR--FK 143
           E  I++++  R +V L      K +L LV   M  G +  H++   E+N    E R  F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTV 202
            AQ + SGL +L +   + +++RD+K  N++LD + N +I D GLA  VE   G ++T  
Sbjct: 295 TAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
            AGT G+MAPE           D ++ G+   E+   R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R T +  A K V    +   +    E+  +S LRH  LV L     +  E++++YE+M  
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN-- 180
           G L   +  E+N ++ +   +  + +  GL ++    E   VH D+K  NIM     +  
Sbjct: 239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNE 295
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            K+ DFGL   ++  +  + T   GT  + APE A        +D++S G+++  +  G 
Sbjct: 296 LKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
Query: 241 KPI 243
            P 
Sbjct: 354 SPF 356

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFR--FK 143
           E  I++++  R +V L      K +L LV   M  G +  H++   E+N    E R  F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTV 202
            AQ + SGL +L +   + +++RD+K  N++LD + N +I D GLA  VE   G ++T  
Sbjct: 295 TAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
            AGT G+MAPE           D ++ G+   E+   R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS----LDSHLFKENNLLTWEFRFK 143
           E+T++S+     + +  G   +  +L ++ EY+  GS    L +  F E  + T      
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------ 124
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           + +++  GL YL     +  +HRDIK++N++L    + K+ DFG+A  +   +  + T  
Sbjct: 125 MLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-F 180
Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY 263
            GT  +MAPE         ++D++S GI A+E+A G  P S      V ++L+       
Sbjct: 181 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-LFLIP------ 233
Query: 264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
                 +   P L  DF +   E +      C + D + RP+ ++++
Sbjct: 234 ------KNNPPTLVGDFTKSFKEFIDA----CLNKDPSFRPTAKELL 270

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFR--FK 143
           E  I++++  R +V L      K +L LV   M  G +  H++   E+N    E R  F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTV 202
            AQ + SGL +L +   + +++RD+K  N++LD + N +I D GLA  VE   G ++T  
Sbjct: 295 TAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
            AGT G+MAPE           D ++ G+   E+   R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           +E+ ++ RL H N+++L        E+ LV E +  G L   + ++      +    + Q
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVL 203
            L   + YL E     +VHRD+K  N++      +   KI DFGL+++VEH    +T  +
Sbjct: 157 IL-EAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--V 210
Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
            GT GY APE         E D++S GI+   + CG +P 
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 12/183 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R +   +AVK++    +Q  +   +EV I+   +H N+V++        EL +V E++  
Sbjct: 96  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG---WEQCVVHRDIKSSNIMLDLNF 179
           G+L          +    R    Q  A  L  LQ       Q V+HRDIKS +I+L  + 
Sbjct: 156 GALTD--------IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 207
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG    V   +  +   L GT  +MAPE  +      E D++S GI+ +E+  G
Sbjct: 208 RVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266
Query: 240 RKP 242
             P
Sbjct: 267 EPP 269

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR +K S++G+  ++   EV+I+  ++H N++ L      K +++L+ E +  G L   L
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
             E   LT E   +  + + +G+ YL       + H D+K  NIML D N      KI D
Sbjct: 106 -AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  ++   G++   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 162 FGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 246 TAKEEV 251
             K+E 
Sbjct: 220 DTKQET 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 12/183 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R +   +AVK++    +Q  +   +EV I+   +H N+V++        EL +V E++  
Sbjct: 51  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 110
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG---WEQCVVHRDIKSSNIMLDLNF 179
           G+L          +    R    Q  A  L  LQ       Q V+HRDIKS +I+L  + 
Sbjct: 111 GALTD--------IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 162
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG    V   +  +   L GT  +MAPE  +      E D++S GI+ +E+  G
Sbjct: 163 RVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221
Query: 240 RKP 242
             P
Sbjct: 222 EPP 224

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           ++E+ I   L + ++V   G+  +   + +V E     SL     +   +   E R+ + 
Sbjct: 90  STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q +  G+ YL       V+HRD+K  N+ L+ + + KIGDFGLA  +E   G +   L G
Sbjct: 150 QTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKXLCG 204
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T  Y+APE       S E D++S G +   +  G+ P   +  +E  + + +   + Y  
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK---NEYSV 261
Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            + +  V   L R                  H D  LRPS+ +++
Sbjct: 262 PRHINPVASALIRRM---------------LHADPTLRPSVAELL 291

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 98/189 (51%), Gaps = 22/189 (11%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKK------ELLLVYEYMP 121
           I V  V+   ++ IK+   E+ ++ +   HRN+    G   +K       +L LV E+  
Sbjct: 54  IKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 122 NGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
            GS+ + L K  + N L  E+   I +++  GL +L +     V+HRDIK  N++L  N 
Sbjct: 111 AGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENA 166
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CATTGRASKE--SDVYSFGIVAL 234
             K+ DFG++  ++   G + T + GT  +MAPE   C     A+ +  SD++S GI A+
Sbjct: 167 EVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225
Query: 235 EIACGRKPI 243
           E+A G  P+
Sbjct: 226 EMAEGAPPL 234

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFR--FK 143
           E  I++++  R +V L      K +L LV   M  G +  H++   E+N    E R  F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTV 202
            AQ + SGL +L +   + +++RD+K  N++LD + N +I D GLA  VE   G ++T  
Sbjct: 295 TAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
            AGT G+MAPE           D ++ G+   E+   R P 
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 6/178 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
           T   +A+++++   +   +   +E+ ++   ++ N+V  L       EL +V EY+  GS
Sbjct: 44  TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
           L + +  E  +   +    + ++    L +L       V+HRDIKS NI+L ++ + K+ 
Sbjct: 104 L-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 158
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           DFG    +   +  ++T + GT  +MAPE  T      + D++S GI+A+E+  G  P
Sbjct: 159 DFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 12/183 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R +   +AVK++    +Q  +   +EV I+   +H N+V++        EL +V E++  
Sbjct: 46  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 105
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG---WEQCVVHRDIKSSNIMLDLNF 179
           G+L          +    R    Q  A  L  LQ       Q V+HRDIKS +I+L  + 
Sbjct: 106 GALTD--------IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 157
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG    V   +  +   L GT  +MAPE  +      E D++S GI+ +E+  G
Sbjct: 158 RVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216
Query: 240 RKP 242
             P
Sbjct: 217 EPP 219

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           +E  I+  ++H  +V L+       +L L+ EY+  G L   L +E   +     F +A+
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 147 -DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
             +A G L+     ++ +++RD+K  NIML+   + K+ DFGL +   H  G+ T    G
Sbjct: 130 ISMALGHLH-----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHTFCG 183
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS-----------LTAKEEVQVY 254
           T+ YMAPE       ++  D +S G +  ++  G  P +           L  K  +  Y
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
Query: 255 LVQWVWDL 262
           L Q   DL
Sbjct: 244 LTQEARDL 251

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 96
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 97  FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 153
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 66  SSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           S  +A+K++S   KQ  +++     EV  + +LRH N +Q  G    +    LV EY   
Sbjct: 79  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
            + D     +  L   E    +      GL YL       ++HRD+K+ NI+L      K
Sbjct: 139 SASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVK 194
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACG 239
           +GDFG A ++  A         GT  +MAPE       G+   + DV+S GI  +E+A  
Sbjct: 195 LGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
Query: 240 RKPI 243
           + P+
Sbjct: 250 KPPL 253

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 12/183 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R +   +AVK++    +Q  +   +EV I+   +H N+V++        EL +V E++  
Sbjct: 42  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG---WEQCVVHRDIKSSNIMLDLNF 179
           G+L          +    R    Q  A  L  LQ       Q V+HRDIKS +I+L  + 
Sbjct: 102 GALTD--------IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 153
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG    V   +  +   L GT  +MAPE  +      E D++S GI+ +E+  G
Sbjct: 154 RVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
Query: 240 RKP 242
             P
Sbjct: 213 EPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 12/183 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R +   +AVK++    +Q  +   +EV I+   +H N+V++        EL +V E++  
Sbjct: 53  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 112
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG---WEQCVVHRDIKSSNIMLDLNF 179
           G+L          +    R    Q  A  L  LQ       Q V+HRDIKS +I+L  + 
Sbjct: 113 GALTD--------IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 164
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             K+ DFG    V   +  +   L GT  +MAPE  +      E D++S GI+ +E+  G
Sbjct: 165 RVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223
Query: 240 RKP 242
             P
Sbjct: 224 EPP 226

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 100 FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 156
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLY 154
           L QL         L  V EY+  G L  H+     FKE + + +      A ++A GL +
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGLFF 136
Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGYMAPE 213
           LQ    + +++RD+K  N+MLD   + KI DFG+ +  E+   G  T    GT  Y+APE
Sbjct: 137 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 191
Query: 214 CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                   K  D ++FG++  E+  G+ P     ++E+
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR S+ S++G+  +E   EV+I+ ++ H N++ L      + +++L+ E +  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
            ++ +L   E    I Q L  G+ YL     + + H D+K  NIML D N    + K+ D
Sbjct: 107 AQKESLSEEEATSFIKQIL-DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  +E   G +   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 163 FGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 246 TAKEEVQVYLVQWVWDL 262
             K+E    +    +D 
Sbjct: 221 DTKQETLANITSVSYDF 237

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 101
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 102 FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 158
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 159 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 100 FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 156
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR S+ S++G+  +E   EV+I+ ++ H N++ L      + +++L+ E +  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
            ++ +L   E    I Q L  G+ YL     + + H D+K  NIML D N    + K+ D
Sbjct: 107 AQKESLSEEEATSFIKQIL-DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  +E   G +   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 163 FGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 246 TAKEEVQVYLVQWVWDL 262
             K+E    +    +D 
Sbjct: 221 DTKQETLANITSVSYDF 237

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR S+ S++G+  +E   EV+I+ ++ H N++ L      + +++L+ E +  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
            ++ +L   E    I Q L  G+ YL     + + H D+K  NIML D N    + K+ D
Sbjct: 107 AQKESLSEEEATSFIKQIL-DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  +E   G +   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 163 FGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 246 TAKEEVQVYLVQWVWDL 262
             K+E    +    +D 
Sbjct: 221 DTKQETLANITAVSYDF 237

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 102
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 103 FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 159
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 160 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 66  SSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           S  +A+K++S   KQ  +++     EV  + +LRH N +Q  G    +    LV EY   
Sbjct: 40  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
            + D     +  L   E    +      GL YL       ++HRD+K+ NI+L      K
Sbjct: 100 SASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVK 155
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACG 239
           +GDFG A ++  A         GT  +MAPE       G+   + DV+S GI  +E+A  
Sbjct: 156 LGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210
Query: 240 RKPI 243
           + P+
Sbjct: 211 KPPL 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           +E  I+  ++H  +V L+       +L L+ EY+  G L   L +E   +     F +A+
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 147 -DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
             +A G L+     ++ +++RD+K  NIML+   + K+ DFGL +   H  G+ T    G
Sbjct: 130 ISMALGHLH-----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHXFCG 183
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS-----------LTAKEEVQVY 254
           T+ YMAPE       ++  D +S G +  ++  G  P +           L  K  +  Y
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
Query: 255 LVQWVWDL 262
           L Q   DL
Sbjct: 244 LTQEARDL 251

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR S+ S++G+  +E   EV+I+ ++ H N++ L      + +++L+ E +  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
            ++ +L   E    I Q L  G+ YL     + + H D+K  NIML D N    + K+ D
Sbjct: 107 AQKESLSEEEATSFIKQIL-DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  +E   G +   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 163 FGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 246 TAKEEVQVYLVQWVWDL 262
             K+E    +    +D 
Sbjct: 221 DTKQETLANITAVSYDF 237

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           ++E+ I   L + ++V   G+  +   + +V E     SL     +   +   E R+ + 
Sbjct: 74  STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 133
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q +  G+ YL       V+HRD+K  N+ L+ + + KIGDFGLA  +E   G +   L G
Sbjct: 134 QTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCG 188
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T  Y+APE       S E D++S G +   +  G+ P   +  +E  + + +   + Y  
Sbjct: 189 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK---NEYSV 245
Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            + +  V   L R                  H D  LRPS+ +++
Sbjct: 246 PRHINPVASALIRRM---------------LHADPTLRPSVAELL 275

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 127
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 128 FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 184
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 185 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS----LDSHLFKENNLLTWEFRFK 143
           E+T++S+     + +  G   +  +L ++ EY+  GS    L+     E  + T      
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ 108
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           I +++  GL YL     +  +HRDIK++N++L  +   K+ DFG+A  +   +  + T  
Sbjct: 109 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-F 164
Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
            GT  +MAPE         ++D++S GI A+E+A G  P S
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 104
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 105 FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 161
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLY 154
           L QL         L  V EY+  G L  H+     FKE + + +      A ++A GL +
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGLFF 457
Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGYMAPE 213
           LQ    + +++RD+K  N+MLD   + KI DFG+ +  E+   G  T    GT  Y+APE
Sbjct: 458 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 512
Query: 214 CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                   K  D ++FG++  E+  G+ P     ++E+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 479
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++  N   K+GDFG
Sbjct: 480 FLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 13/193 (6%)
Query: 65  TSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
            + +I  +R+S  S++G+  +E   EV I+  +RH N++ L      K +++L+ E +  
Sbjct: 41  AAKFIKKRRLS-SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 99
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM-LDLNF-- 179
           G L   L  E   LT +   +  + +  G+ YL     + + H D+K  NIM LD N   
Sbjct: 100 GELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPN 155
Query: 180 -NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
              K+ DFG+A  +E   G++   + GT  ++APE         E+D++S G++   +  
Sbjct: 156 PRIKLIDFGIAHKIE--AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 239 GRKPISLTAKEEV 251
           G  P     K+E 
Sbjct: 214 GASPFLGETKQET 226

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 86  ASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           ++E+ I   L + ++V   G+  +   + +V E     SL     +   +   E R+ + 
Sbjct: 90  STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           Q +  G+ YL       V+HRD+K  N+ L+ + + KIGDFGLA  +E   G +   L G
Sbjct: 150 QTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCG 204
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T  Y+APE       S E D++S G +   +  G+ P   +  +E  + + +   + Y  
Sbjct: 205 TPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKK---NEYSV 261
Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            + +  V   L R                  H D  LRPS+ +++
Sbjct: 262 PRHINPVASALIRRM---------------LHADPTLRPSVAELL 291

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 10/184 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           R T    A+K + K          +E+ ++ +++H N+V L           LV + +  
Sbjct: 31  RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSG 90
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNF 179
           G L   +  E  + T +    + Q + S + YL E     +VHRD+K  N++    + N 
Sbjct: 91  GELFDRIL-ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENS 146
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
              I DFGL+++ ++  G  +T   GT GY+APE       SK  D +S G++   + CG
Sbjct: 147 KIMITDFGLSKMEQN--GIMSTA-CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
Query: 240 RKPI 243
             P 
Sbjct: 204 YPPF 207

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 34/197 (17%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           RET   +A+KRV      +G+   A  E+ ++  L+H+N+V+L    H  K+L LV+E+ 
Sbjct: 24  RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83
Query: 121 P----------NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS 170
                      NG LD  + K        F F++ + L  G  +      + V+HRD+K 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKS-------FLFQLLKGL--GFCH-----SRNVLHRDLKP 129
Query: 171 SNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGRASKES-DV 226
            N++++ N   K+ DFGLAR    A G      +    T+ Y  P+     +    S D+
Sbjct: 130 QNLLINRNGELKLADFGLAR----AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 227 YSFGIVALEIACGRKPI 243
           +S G +  E+A   +P+
Sbjct: 186 WSAGCIFAELANAARPL 202

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 65  TSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
            + +I  +R+S  S++G+  +E   EV I+  +RH N++ L      K +++L+ E +  
Sbjct: 34  AAKFIKKRRLS-SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 92
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM-LDLNF-- 179
           G L   L  E   LT +   +  + +  G+ YL     + + H D+K  NIM LD N   
Sbjct: 93  GELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPN 148
Query: 180 -NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
              K+ DFG+A  +E   G++   + GT  ++APE         E+D++S G++   +  
Sbjct: 149 PRIKLIDFGIAHKIE--AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
Query: 239 GRKPISLTAKEEVQVYLVQWVWDL 262
           G  P     K+E    +    +D 
Sbjct: 207 GASPFLGETKQETLTNISAVNYDF 230

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 6/178 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
           T   +A+++++   +   +   +E+ ++   ++ N+V  L       EL +V EY+  GS
Sbjct: 44  TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
           L + +  E  +   +    + ++    L +L       V+HRDIKS NI+L ++ + K+ 
Sbjct: 104 L-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 158
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           DFG    +   + S+ + + GT  +MAPE  T      + D++S GI+A+E+  G  P
Sbjct: 159 DFGFCAQITPEQ-SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS----LDSHLFKENNLLTWEFRFK 143
           E+T++S+     + +  G   +  +L ++ EY+  GS    L+     E  + T      
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ 128
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           I +++  GL YL     +  +HRDIK++N++L  +   K+ DFG+A  +   +  + T  
Sbjct: 129 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-F 184
Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
            GT  +MAPE         ++D++S GI A+E+A G  P S
Sbjct: 185 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 225

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 6/178 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
           T   +A+++++   +   +   +E+ ++   ++ N+V  L       EL +V EY+  GS
Sbjct: 45  TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 104
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
           L + +  E  +   +    + ++    L +L       V+HRDIKS NI+L ++ + K+ 
Sbjct: 105 L-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 159
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           DFG    +   + S+ + + GT  +MAPE  T      + D++S GI+A+E+  G  P
Sbjct: 160 DFGFCAQITPEQ-SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISR------LRHRNLVQLLGWCHEKKELLLV 116
           ++T+ + A+K + K     + +   E T++ +        H  L  +      K+ L  V
Sbjct: 39  KKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96
Query: 117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
            EY+  G L  H+   +        F  A ++  GL +L     + +V+RD+K  NI+LD
Sbjct: 97  MEYLNGGDLMYHIQSCHKFDLSRATF-YAAEIILGLQFLHS---KGIVYRDLKLDNILLD 152
Query: 177 LNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE 235
            + + KI DFG+ +  E+  G ++T    GT  Y+APE     + +   D +SFG++  E
Sbjct: 153 KDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
Query: 236 IACGRKPISLTAKEEV 251
           +  G+ P     +EE+
Sbjct: 211 MLIGQSPFHGQDEEEL 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 26/247 (10%)
Query: 70  AVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL-LLVYEYMPNGSLDS 127
           A+K +S+ ++ Q ++ +  E  ++  L H N++ L+G     + L  ++  YM +G L  
Sbjct: 53  AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ 112
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            +       T +        +A G+ YL E   Q  VHRD+ + N MLD +F  K+ DFG
Sbjct: 113 FIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFG 169
Query: 188 LARLV---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           LAR +   E+    Q       + + A E   T R + +SDV+SFG++  E+   G  P 
Sbjct: 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229
Query: 244 SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLR 303
                 ++  +L Q        G+ L    P  C D   Q M+        C   D  +R
Sbjct: 230 RHIDPFDLTHFLAQ--------GRRLP--QPEYCPDSLYQVMQ-------QCWEADPAVR 272
Query: 304 PSIRQVI 310
           P+ R ++
Sbjct: 273 PTFRVLV 279

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 6/139 (4%)
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V EY+   +L   +  E  + T +   ++  D    L +     +  ++HRD+K +NIM
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNF---SHQNGIIHRDVKPANIM 148
Query: 175 LDLNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
           +      K+ DFG+AR +  +  S  QT  + GT  Y++PE A        SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 233 ALEIACGRKPISLTAKEEV 251
             E+  G  P +  + + V
Sbjct: 209 LYEVLTGEPPFTGDSPDSV 227

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 72  KRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           KR S+ S++G+  +E   EV+I+ ++ H N++ L      + +++L+ E +  G L   L
Sbjct: 47  KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNF---NAKIGD 185
            ++ +L   E    I Q L  G+ YL     + + H D+K  NIML D N    + K+ D
Sbjct: 107 AQKESLSEEEATSFIKQIL-DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGLA  +E   G +   + GT  ++APE         E+D++S G++   +  G  P   
Sbjct: 163 FGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 246 TAKEEVQVYLVQWVWDL 262
             K+E    +    +D 
Sbjct: 221 DTKQETLANITAVSYDF 237

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           +E ++    KR    S++G+  +E   EV I+  +RH N++ L      K +++L+ E +
Sbjct: 52  KEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 111
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM-LDLNF 179
             G L   L  E   LT +   +  + +  G+ YL     + + H D+K  NIM LD N 
Sbjct: 112 SGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNV 167
Query: 180 ---NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
                K+ DFG+A  +E   G++   + GT  ++APE         E+D++S G++   +
Sbjct: 168 PNPRIKLIDFGIAHKIE--AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 225
Query: 237 ACGRKPISLTAKEEVQVYLVQWVWDL 262
             G  P     K+E    +    +D 
Sbjct: 226 LSGASPFLGETKQETLTNISAVNYDF 251

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  LAGT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 91/180 (50%), Gaps = 10/180 (5%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
           T   +A+++++   +   +   +E+ ++   ++ N+V  L       EL +V EY+  GS
Sbjct: 44  TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
           L + +  E  +   +    + ++    L +L       V+HRDIKS NI+L ++ + K+ 
Sbjct: 104 L-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 158
Query: 185 DFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           DFG    +  E +K S+   + GT  +MAPE  T      + D++S GI+A+E+  G  P
Sbjct: 159 DFGFCAQITPEQSKRSE---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISR------LRHRNLVQLLGWCHEKKELLLV 116
           ++T+ + A+K + K     + +   E T++ +        H  L  +      K+ L  V
Sbjct: 40  KKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 97
Query: 117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
            EY+  G L  H+   +        F  A ++  GL +L     + +V+RD+K  NI+LD
Sbjct: 98  MEYLNGGDLMYHIQSCHKFDLSRATF-YAAEIILGLQFLHS---KGIVYRDLKLDNILLD 153
Query: 177 LNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE 235
            + + KI DFG+ +  E+  G ++T    GT  Y+APE     + +   D +SFG++  E
Sbjct: 154 KDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 211
Query: 236 IACGRKPISLTAKEEV 251
           +  G+ P     +EE+
Sbjct: 212 MLIGQSPFHGQDEEEL 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 6/132 (4%)
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V EY+   +L   +  E  + T +   ++  D    L +     +  ++HRD+K +NIM
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNF---SHQNGIIHRDVKPANIM 148
Query: 175 LDLNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
           +      K+ DFG+AR +  +  S  QT  + GT  Y++PE A        SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 233 ALEIACGRKPIS 244
             E+  G  P +
Sbjct: 209 LYEVLTGEPPFT 220

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 6/132 (4%)
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V EY+   +L   +  E  + T +   ++  D    L +     +  ++HRD+K +NIM
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNF---SHQNGIIHRDVKPANIM 148
Query: 175 LDLNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
           +      K+ DFG+AR +  +  S  QT  + GT  Y++PE A        SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 233 ALEIACGRKPIS 244
             E+  G  P +
Sbjct: 209 LYEVLTGEPPFT 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 6/132 (4%)
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V EY+   +L   +  E  + T +   ++  D    L +     +  ++HRD+K +NIM
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNF---SHQNGIIHRDVKPANIM 148
Query: 175 LDLNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
           +      K+ DFG+AR +  +  S  QT  + GT  Y++PE A        SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 233 ALEIACGRKPIS 244
             E+  G  P +
Sbjct: 209 LYEVLTGEPPFT 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 63  RETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R   + +AVK + +  S   +++  SE  ++ ++ H ++++L G C +   LLL+ EY  
Sbjct: 50  RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 109
Query: 122 NGSLDSHLFKENNL-----------------------LTWEFRFKIAQDLASGLLYLQEG 158
            GSL   L +   +                       LT       A  ++ G+ YL   
Sbjct: 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA-- 167
Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPEC 214
            E  +VHRD+ + NI++      KI DFGL+R V     + K SQ  +    + +MA E 
Sbjct: 168 -EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI---PVKWMAIES 223
Query: 215 ATTGRASKESDVYSFGIVALEIAC 238
                 + +SDV+SFG++  EI  
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 90/178 (50%), Gaps = 6/178 (3%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
           T   +A+++++   +   +   +E+ ++   ++ N+V  L       EL +V EY+  GS
Sbjct: 45  TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 104
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG 184
           L + +  E  +   +    + ++    L +L       V+HR+IKS NI+L ++ + K+ 
Sbjct: 105 L-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIHRNIKSDNILLGMDGSVKLT 159
Query: 185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           DFG    +   +  ++T + GT  +MAPE  T      + D++S GI+A+E+  G  P
Sbjct: 160 DFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    KE   SE+ I+S L +H N+V LLG C     +L++ EY   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 127 SHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
           + L ++                  L+       +  +A G+ +L    + C+ HRD+ + 
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLAS--KNCI-HRDVAAR 195
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESDVY 227
           N++L     AKIGDFGLAR + +       ++ G     + +MAPE       + +SDV+
Sbjct: 196 NVLLTNGHVAKIGDFGLARDIMN---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 252
Query: 228 SFGIVALEI 236
           S+GI+  EI
Sbjct: 253 SYGILLWEI 261

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 6/132 (4%)
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V EY+   +L   +  E  + T +   ++  D    L +     +  ++HRD+K +NIM
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNF---SHQNGIIHRDVKPANIM 165
Query: 175 LDLNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
           +      K+ DFG+AR +  +  S  QT  + GT  Y++PE A        SDVYS G V
Sbjct: 166 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 233 ALEIACGRKPIS 244
             E+  G  P +
Sbjct: 226 LYEVLTGEPPFT 237

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISR--LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +  +R+S    + ++E     T I R    H +++ L+        + LV++ M  G L 
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF 188
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF 186
            +L ++  L   E R  I + L   + +L       +VHRD+K  NI+LD N   ++ DF
Sbjct: 189 DYLTEKVALSEKETR-SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDF 244
Query: 187 GLARLVEHAKGSQTTVLAGTMGYMAPE---CA---TTGRASKESDVYSFGIVALEIACGR 240
           G +  +E   G +   L GT GY+APE   C+   T     KE D+++ G++   +  G 
Sbjct: 245 GFSCHLE--PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302
Query: 241 KPI 243
            P 
Sbjct: 303 PPF 305

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 34/204 (16%)
Query: 63  RETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R   + +AVK + +  S   +++  SE  ++ ++ H ++++L G C +   LLL+ EY  
Sbjct: 50  RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 109
Query: 122 NGSLDSHLFKENNL-----------------------LTWEFRFKIAQDLASGLLYLQEG 158
            GSL   L +   +                       LT       A  ++ G+ YL   
Sbjct: 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA-- 167
Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPEC 214
            E  +VHRD+ + NI++      KI DFGL+R V       K SQ  +    + +MA E 
Sbjct: 168 -EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI---PVKWMAIES 223
Query: 215 ATTGRASKESDVYSFGIVALEIAC 238
                 + +SDV+SFG++  EI  
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 85/181 (46%), Gaps = 11/181 (6%)
Query: 68  YIAVKRVSKGS---KQGIKEYASEVTIISR-LRHRNLVQLLGWCHEKKELLLVYEYMPNG 123
           + AVK + K +   K+  K   SE  ++ + ++H  LV L        +L  V +Y+  G
Sbjct: 65  FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI 183
            L  HL +E   L    RF  A ++AS L YL       +V+RD+K  NI+LD   +  +
Sbjct: 125 ELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVL 180
Query: 184 GDFGLARL-VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            DFGL +  +EH   S T+   GT  Y+APE        +  D +  G V  E+  G  P
Sbjct: 181 TDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
Query: 243 I 243
Sbjct: 239 F 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A E +Q+Y
Sbjct: 235 YPP--FFADEPIQIY 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 99
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++      K+GDFG
Sbjct: 100 FLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFG 156
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 144 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 199
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+ A    T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 200 YIQVTDFGFAKRVKGA----TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 256 YPP--FFADQPIQIY 268

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 6/177 (3%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K     +   ++E +  E   + +  H ++V+L+G   E   + ++ E    G L S
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 479
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
            L      L        A  L++ L YL+    +  VHRDI + N+++      K+GDFG
Sbjct: 480 FLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFG 536
Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI 243
           L+R +E +   + +     + +MAPE     R +  SDV+ FG+   EI   G KP 
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS----LDSHLFKENNLLTWEFRFK 143
           E+T++S+     + +  G   +  +L ++ EY+  GS    L+     E  + T      
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ 123
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           I +++  GL YL     +  +HRDIK++N++L  +   K+ DFG+A  +   +  +    
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNXF 179
Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
            GT  +MAPE         ++D++S GI A+E+A G  P S
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS----LDSHLFKENNLLTWEFRFK 143
           E+T++S+     + +  G   +  +L ++ EY+  GS    L+     E  + T      
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ 108
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           I +++  GL YL     +  +HRDIK++N++L  +   K+ DFG+A  +   +  +    
Sbjct: 109 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNXF 164
Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
            GT  +MAPE         ++D++S GI A+E+A G  P S
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 84  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 144 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 199
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 200 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 256 YPP--FFADQPIQIY 268

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 58  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 117
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ +     YL       +++RD+K  N+++D   
Sbjct: 118 VAGGEMFSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQG 173
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 174 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 230 YPP--FFADQPIQIY 242

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 109
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 110 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 166
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 167 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 221
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 222 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 263
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 264 ADSRPKFRELI 274

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGXLLD 106
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 107 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 163
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 164 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 218
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 219 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 260
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 261 ADSRPKFRELI 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 107
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 108 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 164
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 165 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 220 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 261
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 262 ADSRPKFRELI 272

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLASGLLY 154
           L QL         L  V EY+  G L  H+     FKE   + +      A +++ GL +
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISIGLFF 135
Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-AKGSQTTVLAGTMGYMAPE 213
           L +   + +++RD+K  N+MLD   + KI DFG+ +  EH   G  T    GT  Y+APE
Sbjct: 136 LHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPE 190
Query: 214 CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                   K  D +++G++  E+  G+ P     ++E+
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFAEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 130
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 131 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 187
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 188 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 242
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 243 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 284
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 285 ADSRPKFRELI 295

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 106
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 107 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 163
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 164 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 218
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 219 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 260
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 261 ADSRPKFRELI 271

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ET ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY+
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
             G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D    
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
            ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G 
Sbjct: 180 IQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 241 KPISLTAKEEVQVY 254
            P    A + +Q+Y
Sbjct: 236 PP--FFADQPIQIY 247

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 108
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 109 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 165
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 166 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 221 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 262
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 263 ADSRPKFRELI 273

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFXEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGXLLD 105
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 218 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 259
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 260 ADSRPKFRELI 270

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 112
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 113 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 169
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 170 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 225 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 266
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 267 ADSRPKFRELI 277

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 34/204 (16%)
Query: 63  RETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R   + +AVK + +  S   +++  SE  ++ ++ H ++++L G C +   LLL+ EY  
Sbjct: 50  RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 109
Query: 122 NGSLDSHLFKENNL-----------------------LTWEFRFKIAQDLASGLLYLQEG 158
            GSL   L +   +                       LT       A  ++ G+ YL   
Sbjct: 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA-- 167
Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPEC 214
            E  +VHRD+ + NI++      KI DFGL+R V       K SQ  +    + +MA E 
Sbjct: 168 -EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI---PVKWMAIES 223
Query: 215 ATTGRASKESDVYSFGIVALEIAC 238
                 + +SDV+SFG++  EI  
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 53  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 111
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 112 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 168
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 169 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 223
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 224 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 265
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 266 ADSRPKFRELI 276

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 105
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 218 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 259
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 260 ADSRPKFRELI 270

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 105
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L          G+ L    P +C  D     ++C MI        D
Sbjct: 218 KPYDGIPASEISSIL--------EKGERLP--QPPICTIDVYMIMVKCWMI--------D 259
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 260 ADSRPKFRELI 270

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 108
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 109 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 165
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 166 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 221 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 262
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 263 ADSRPKFRELI 273

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 108
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 109 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 165
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 166 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 221 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 262
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 263 ADSRPKFRELI 273

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 107
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 108 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 164
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 165 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 220 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 261
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 262 ADSRPKFRELI 272

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 82/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I + L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 34/197 (17%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           RET   +A+KRV      +G+   A  E+ ++  L+H+N+V+L    H  K+L LV+E+ 
Sbjct: 24  RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83
Query: 121 P----------NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS 170
                      NG LD  + K        F F++ + L  G  +      + V+HRD+K 
Sbjct: 84  DQDLKKYFDSCNGDLDPEIVKS-------FLFQLLKGL--GFCH-----SRNVLHRDLKP 129
Query: 171 SNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGRASKES-DV 226
            N++++ N   K+ +FGLAR    A G      +    T+ Y  P+     +    S D+
Sbjct: 130 QNLLINRNGELKLANFGLAR----AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 227 YSFGIVALEIACGRKPI 243
           +S G +  E+A   +P+
Sbjct: 186 WSAGCIFAELANAGRPL 202

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 6/132 (4%)
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V EY+   +L   +  E  + T +   ++  D    L +     +  ++HRD+K +NI+
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNF---SHQNGIIHRDVKPANIL 148
Query: 175 LDLNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
           +      K+ DFG+AR +  +  S  QT  + GT  Y++PE A        SDVYS G V
Sbjct: 149 ISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 233 ALEIACGRKPIS 244
             E+  G  P +
Sbjct: 209 LYEVLTGEPPFT 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 112
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 113 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 169
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 170 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 225 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 266
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 267 ADSRPKFRELI 277

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS-LDSHLFKENNLLTWEFRFKIAQ 146
           E+T++S+     + +  G   +  +L ++ EY+  GS LD  L K   L    +   I +
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD--LLKPGPL-EETYIATILR 123
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
           ++  GL YL     +  +HRDIK++N++L    + K+ DFG+A  +   +  +     GT
Sbjct: 124 EILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNXFVGT 179
Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
             +MAPE         ++D++S GI A+E+A G  P S
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 112
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 113 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 169
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 170 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 225 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 266
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 267 ADSRPKFRELI 277

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 105
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 218 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 259
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 260 ADSRPKFRELI 270

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 65  TSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-----ELLLVY 117
           TS  +AVK  ++   S++ I+E+ SE   +    H N+++LLG C E       + +++ 
Sbjct: 61  TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 118 EYMPNGSLDSHLFKEN-----NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN 172
            +M  G L ++L           +  +   K   D+A G+ YL     +  +HRD+ + N
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARN 177
Query: 173 IMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGI 231
            ML  +    + DFGL++ +       Q  +    + ++A E       + +SDV++FG+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 232 VALEIAC-GRKPISLTAKEEVQVYLVQ 257
              EIA  G  P       E+  YL+ 
Sbjct: 238 TMWEIATRGMTPYPGVQNHEMYDYLLH 264

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  LV L      +  L  V EY+  G L  H+ ++  L     RF  A+ ++  L YL 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH 170
Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECA 215
           E   + +++RD+K  N++LD   + K+ D+G+ +  E  + G  T+   GT  Y+APE  
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEE 250
                    D ++ G++  E+  GR P  +    +
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  LV L      +  L  V EY+  G L  H+ ++  L     RF  A+ ++  L YL 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH 127
Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECA 215
           E   + +++RD+K  N++LD   + K+ D+G+ +  E  + G  T+   GT  Y+APE  
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEIL 182
Query: 216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEE 250
                    D ++ G++  E+  GR P  +    +
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 34/196 (17%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    KE   SE+ I+S L +H N+V LLG C     +L++ EY   G L 
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 127 SHLFKENNLLT--------------------WEFR--FKIAQDLASGLLYLQEGWEQCVV 164
           + L ++   +                      E R     +  +A G+ +L    + C+ 
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS--KNCI- 180
Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRA 220
           HRD+ + N++L     AKIGDFGLAR + +       ++ G     + +MAPE       
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMN---DSNYIVKGNARLPVKWMAPESIFDCVY 237
Query: 221 SKESDVYSFGIVALEI 236
           + +SDV+S+GI+  EI
Sbjct: 238 TVQSDVWSYGILLWEI 253

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 64  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 124 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 179
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 180 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 236 YPP--FFADQPIQIY 248

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLIIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 44  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 102
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 103 YVREHKDNIGSQYLLNWCVQIAEGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 159
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 160 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 214
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 215 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 256
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 257 ADSRPKFRELI 267

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 99
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 100 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 156
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 157 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L          G+ L    P +C  D     ++C MI        D
Sbjct: 212 KPYDGIPASEISSIL--------EKGERLP--QPPICTIDVYMIMVKCWMI--------D 253
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 254 ADSRPKFRELI 264

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 50  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 109
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ +     YL       +++RD+K  N+++D   
Sbjct: 110 VAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDEQG 165
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  E+A G
Sbjct: 166 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 222 YPP--FFADQPIQIY 234

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 6/164 (3%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKI-A 145
           +E  I+ ++  R +V L      K  L LV   M  G L  H++        E R    A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
            ++  GL  L     + +V+RD+K  NI+LD + + +I D GLA  V   +G       G
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVG 347
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKE 249
           T+GYMAPE     R +   D ++ G +  E+  G+ P     K+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 6/164 (3%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKI-A 145
           +E  I+ ++  R +V L      K  L LV   M  G L  H++        E R    A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
            ++  GL  L     + +V+RD+K  NI+LD + + +I D GLA  V   +G       G
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVG 347
Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKE 249
           T+GYMAPE     R +   D ++ G +  E+  G+ P     K+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  LV L      +  L  V EY+  G L  H+ ++  L     RF  A+ ++  L YL 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH 123
Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECA 215
           E   + +++RD+K  N++LD   + K+ D+G+ +  E  + G  T+   GT  Y+APE  
Sbjct: 124 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEIL 178
Query: 216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEE 250
                    D ++ G++  E+  GR P  +    +
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 27  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 87  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 142
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202
Query: 240 RKP 242
             P
Sbjct: 203 ELP 205

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  LV L      +  L  V EY+  G L  H+ ++  L     RF  A+ ++  L YL 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH 138
Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECA 215
           E   + +++RD+K  N++LD   + K+ D+G+ +  E  + G  T+   GT  Y+APE  
Sbjct: 139 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEIL 193
Query: 216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEE 250
                    D ++ G++  E+  GR P  +    +
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 29  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 89  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
Query: 240 RKP 242
             P
Sbjct: 205 ELP 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 63  RETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           R T   +AVK V  K +    +    E+ I   L H N+V+  G   E     L  EY  
Sbjct: 28  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 87
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
            G L   +  +  +   + + +    L +G++YL       + HRDIK  N++LD   N 
Sbjct: 88  GGELFDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 143
Query: 182 KIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLA +  +    +    + GT+ Y+APE         E  DV+S GIV   +  G
Sbjct: 144 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203
Query: 240 RKP 242
             P
Sbjct: 204 ELP 206

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 108
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 109 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 165
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 166 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 220
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D      +C MI        D
Sbjct: 221 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMRKCWMI--------D 262
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 263 ADSRPKFRELI 273

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 122 NGSLDSHLFKENN-----------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS 170
            G+L ++L  + N            LT E     +  +A G+ +L     +  +HRD+ +
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLAS---RKXIHRDLAA 172
Query: 171 SNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDV 226
            NI+L      KI DFGLAR +    ++ +     +    + +MAPE       + +SDV
Sbjct: 173 RNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDV 229
Query: 227 YSFGIVALEI-ACGRKP 242
           +SFG++  EI + G  P
Sbjct: 230 WSFGVLLWEIFSLGASP 246

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 116/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 57  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 115
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 116 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 172
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 173 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 227
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L          G+ L    P +C  D      +C MI        D
Sbjct: 228 KPYDGIPASEISSIL--------EKGERLP--QPPICTIDVYMIMRKCWMI--------D 269
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 270 ADSRPKFRELI 280

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 17/169 (10%)
Query: 82  IKEYASEVTIISRLRHRNLVQLLGWCHEKKE--LLLVYEYMPNGS-LDSHLFKENNLLTW 138
           I++   E+ I+ +L H N+V+L+    +  E  L +V+E +  G  ++    K  +    
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
            F F   QDL  G+ YL     Q ++HRDIK SN+++  + + KI DFG++      KGS
Sbjct: 140 RFYF---QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN---EFKGS 190
Query: 199 QTTV--LAGTMGYMAPECATTGR---ASKESDVYSFGIVALEIACGRKP 242
              +    GT  +MAPE  +  R   + K  DV++ G+       G+ P
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG 123
           T + +A+K +    ++G    A  EV+++  L+H N+V L    H +K L LV+EY+ + 
Sbjct: 26  TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DK 84
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI 183
            L  +L    N++           L  GL Y      Q V+HRD+K  N++++     K+
Sbjct: 85  DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKL 141
Query: 184 GDFGLARLVEHAKGSQTTVLAG---TMGYMAPECAT-TGRASKESDVYSFGIVALEIACG 239
            DFGLAR    AK   T        T+ Y  P+    +   S + D++  G +  E+A G
Sbjct: 142 ADFGLAR----AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197
Query: 240 RKPISLTAKEEVQVYLV 256
           R P+   +  E Q++ +
Sbjct: 198 R-PLFPGSTVEEQLHFI 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 105
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
           LA+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D      +C MI        D
Sbjct: 218 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMRKCWMI--------D 259
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 260 ADSRPKFRELI 270

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 29/199 (14%)
Query: 63  RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL------LL 115
           ++T   +A+K+  +  S +  + +  E+ I+ +L H N+V         ++L      LL
Sbjct: 37  QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 96
Query: 116 VYEYMPNGSLDSHL--------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
             EY   G L  +L         KE  + T      +  D++S L YL E     ++HRD
Sbjct: 97  AMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSDISSALRYLHENR---IIHRD 147
Query: 168 IKSSNIMLD---LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           +K  NI+L         KI D G A+  E  +G   T   GT+ Y+APE     + +   
Sbjct: 148 LKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPELLEQKKYTVTV 205
Query: 225 DVYSFGIVALEIACGRKPI 243
           D +SFG +A E   G +P 
Sbjct: 206 DYWSFGTLAFECITGFRPF 224

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+APE   +   +K  D ++ G++  ++A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 22/147 (14%)
Query: 110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ------EGWEQCV 163
           + E LLV EY PNGSL  +L    +   W    ++A  +  GL YL       + ++  +
Sbjct: 84  RMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLA------RLVEHAKGSQTTVL-AGTMGYMAPEC-- 214
            HRD+ S N+++  +    I DFGL+      RLV   +     +   GT+ YMAPE   
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201
Query: 215 -ATTGR----ASKESDVYSFGIVALEI 236
            A   R    A K+ D+Y+ G++  EI
Sbjct: 202 GAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 29/199 (14%)
Query: 63  RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL------LL 115
           ++T   +A+K+  +  S +  + +  E+ I+ +L H N+V         ++L      LL
Sbjct: 36  QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95
Query: 116 VYEYMPNGSLDSHL--------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
             EY   G L  +L         KE  + T      +  D++S L YL E     ++HRD
Sbjct: 96  AMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSDISSALRYLHENR---IIHRD 146
Query: 168 IKSSNIMLD---LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           +K  NI+L         KI D G A+  E  +G   T   GT+ Y+APE     + +   
Sbjct: 147 LKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPELLEQKKYTVTV 204
Query: 225 DVYSFGIVALEIACGRKPI 243
           D +SFG +A E   G +P 
Sbjct: 205 DYWSFGTLAFECITGFRPF 223

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 69  IAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+KR+      +GI   A  E++++  L H N+V L+   H ++ L LV+E+M      
Sbjct: 48  VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL-- 105
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC----VVHRDIKSSNIMLDLNFNAK 182
             +  EN     + + KI       L  L  G   C    ++HRD+K  N++++ +   K
Sbjct: 106 KKVLDENKTGLQDSQIKIY------LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALK 159
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACGR 240
           + DFGLAR       S T  +  T+ Y AP+    + + S   D++S G +  E+  G+
Sbjct: 160 LADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-- 87
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
            S+D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 88  -SMDLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 141
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 142 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 234 LEIACGR 240
            E+   R
Sbjct: 198 AEMVTRR 204

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 69  IAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+KR+      +GI   A  E++++  L H N+V L+   H ++ L LV+E+M      
Sbjct: 48  VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL-- 105
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC----VVHRDIKSSNIMLDLNFNAK 182
             +  EN     + + KI       L  L  G   C    ++HRD+K  N++++ +   K
Sbjct: 106 KKVLDENKTGLQDSQIKIY------LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALK 159
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACGR 240
           + DFGLAR       S T  +  T+ Y AP+    + + S   D++S G +  E+  G+
Sbjct: 160 LADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRF 142
           +E+     LRH N++  +   ++      +L LV +Y  +GSL  +L +    +T E   
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMI 142
Query: 143 KIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           K+A   ASGL +L       +G +  + HRD+KS NI++  N    I D GLA  V H  
Sbjct: 143 KLALSTASGLAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDS 199
Query: 197 GSQTTVLA-----GTMGYMAPECATTG------RASKESDVYSFGIVALEIA 237
            + T  +A     GT  YMAPE            + K +D+Y+ G+V  EIA
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 35/241 (14%)
Query: 78  SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLT 137
           S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  ++ +  + + 
Sbjct: 91  SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG 149
Query: 138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----- 192
            ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFGLA+L+     
Sbjct: 150 SQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 206
Query: 193 -EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEE 250
             HA+G +  +      +MA E       + +SDV+S+G+   E+   G KP       E
Sbjct: 207 EYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 261
Query: 251 VQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
           +   L          G+ L    P +C  D     ++C MI        D + RP  R++
Sbjct: 262 ISSIL--------EKGERLP--QPPICTIDVYMIMVKCWMI--------DADSRPKFREL 303
Query: 310 I 310
           I
Sbjct: 304 I 304

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-- 85
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
            S+D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 86  -SMDLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 139
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 140 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 234 LEIACGR 240
            E+   R
Sbjct: 196 AEMVTRR 202

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRF 142
           +E+     LRH N++  +   ++      +L LV +Y  +GSL  +L +    +T E   
Sbjct: 46  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMI 103
Query: 143 KIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           K+A   ASGL +L       +G +  + HRD+KS NI++  N    I D GLA  V H  
Sbjct: 104 KLALSTASGLAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDS 160
Query: 197 GSQTTVLA-----GTMGYMAPECATTG------RASKESDVYSFGIVALEIA 237
            + T  +A     GT  YMAPE            + K +D+Y+ G+V  EIA
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRF 142
           +E+     LRH N++  +   ++      +L LV +Y  +GSL  +L +    +T E   
Sbjct: 52  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMI 109
Query: 143 KIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           K+A   ASGL +L       +G +  + HRD+KS NI++  N    I D GLA  V H  
Sbjct: 110 KLALSTASGLAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDS 166
Query: 197 GSQTTVLA-----GTMGYMAPECATTG------RASKESDVYSFGIVALEIA 237
            + T  +A     GT  YMAPE            + K +D+Y+ G+V  EIA
Sbjct: 167 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRF 142
           +E+     LRH N++  +   ++      +L LV +Y  +GSL  +L +    +T E   
Sbjct: 49  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMI 106
Query: 143 KIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           K+A   ASGL +L       +G +  + HRD+KS NI++  N    I D GLA  V H  
Sbjct: 107 KLALSTASGLAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDS 163
Query: 197 GSQTTVLA-----GTMGYMAPECATTG------RASKESDVYSFGIVALEIA 237
            + T  +A     GT  YMAPE            + K +D+Y+ G+V  EIA
Sbjct: 164 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRF 142
           +E+     LRH N++  +   ++      +L LV +Y  +GSL  +L +    +T E   
Sbjct: 47  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMI 104
Query: 143 KIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           K+A   ASGL +L       +G +  + HRD+KS NI++  N    I D GLA  V H  
Sbjct: 105 KLALSTASGLAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDS 161
Query: 197 GSQTTVLA-----GTMGYMAPECATTG------RASKESDVYSFGIVALEIA 237
            + T  +A     GT  YMAPE            + K +D+Y+ G+V  EIA
Sbjct: 162 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRF 142
           +E+     LRH N++  +   ++      +L LV +Y  +GSL  +L +    +T E   
Sbjct: 72  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMI 129
Query: 143 KIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           K+A   ASGL +L       +G +  + HRD+KS NI++  N    I D GLA  V H  
Sbjct: 130 KLALSTASGLAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDS 186
Query: 197 GSQTTVLA-----GTMGYMAPECATTG------RASKESDVYSFGIVALEIA 237
            + T  +A     GT  YMAPE            + K +D+Y+ G+V  EIA
Sbjct: 187 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-- 87
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
            S+D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 88  -SMDLKDFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 142 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 234 LEIACGR 240
            E+   R
Sbjct: 198 AEMVTRR 204

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 18/182 (9%)
Query: 63  RETSSYIAVKRVSKG----SKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVY 117
           + T+  +A+K++  G    +K GI   A  E+ ++  L H N++ LL     K  + LV+
Sbjct: 32  KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91
Query: 118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA-SGLLYLQEGWEQCVVHRDIKSSNIMLD 176
           ++M        + K+N+L+      K    +   GL YL + W   ++HRD+K +N++LD
Sbjct: 92  DFMETDL--EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLD 146
Query: 177 LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
            N   K+ DFGLA+       +    +  T  Y APE     R      +Y  G+    +
Sbjct: 147 ENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGAR------MYGVGVDMWAV 199
Query: 237 AC 238
            C
Sbjct: 200 GC 201

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 88  EVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           EV I+ ++  H N++QL           LV++ M  G L  +L ++  L   E R KI +
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIMR 131
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
            L   +  L +     +VHRD+K  NI+LD + N K+ DFG +  ++   G +   + GT
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLRSVCGT 186
Query: 207 MGYMAP---ECATTGRA---SKESDVYSFGIVALEIACGRKPI 243
             Y+AP   EC+         KE D++S G++   +  G  P 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 107
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 108 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 164
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
            A+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 165 RAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 220 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 261
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 262 ADSRPKFRELI 272

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-- 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
            S+D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  -SMDLKDFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 141 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 234 LEIACGR 240
            E+   R
Sbjct: 197 AEMVTRR 203

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E++I+  L+H N+V+L    H KK L+LV+E+     LD  L K  ++         A+ 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAK- 103
Query: 148 LASGLLYLQEGWEQC----VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
             S LL L  G   C    V+HRD+K  N++++     KI DFGLAR         T  +
Sbjct: 104 --SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 204 AGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACG 239
             T+ Y AP+    + + S   D++S G +  E+  G
Sbjct: 162 V-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E++I+  L+H N+V+L    H KK L+LV+E+     LD  L K  ++         A+ 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAK- 103
Query: 148 LASGLLYLQEGWEQC----VVHRDIKSSNIMLDLNFNAKIGDFGLARL--VEHAKGSQTT 201
             S LL L  G   C    V+HRD+K  N++++     KI DFGLAR   +   K +   
Sbjct: 104 --SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV 161
Query: 202 VLAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACG 239
           V   T+ Y AP+    + + S   D++S G +  E+  G
Sbjct: 162 V---TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 79/159 (49%), Gaps = 18/159 (11%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           E++I+  L+H N+V+L    H KK L+LV+E+     LD  L K  ++         A+ 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAK- 103
Query: 148 LASGLLYLQEGWEQC----VVHRDIKSSNIMLDLNFNAKIGDFGLARL--VEHAKGSQTT 201
             S LL L  G   C    V+HRD+K  N++++     KI DFGLAR   +   K +   
Sbjct: 104 --SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV 161
Query: 202 VLAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACG 239
           V   T+ Y AP+    + + S   D++S G +  E+  G
Sbjct: 162 V---TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 28/193 (14%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 58  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 122 NGSLDSHLFKENN-------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
            G+L ++L  + N              LT E     +  +A G+ +L     +  +HRD+
Sbjct: 118 FGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLAS---RKXIHRDL 174
Query: 169 KSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGRASKE 223
            + NI+L      KI DFGLAR +        KG     L     +MAPE       + +
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK----WMAPETIFDRVYTIQ 230
Query: 224 SDVYSFGIVALEI 236
           SDV+SFG++  EI
Sbjct: 231 SDVWSFGVLLWEI 243

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 29/194 (14%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 57  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 116
Query: 122 NGSLDSHLFKENN--------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
            G+L ++L  + N               LT E     +  +A G+ +L     +C+ HRD
Sbjct: 117 FGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRD 173
Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGRASK 222
           + + NI+L      KI DFGLAR +        KG     L     +MAPE       + 
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK----WMAPETIFDRVYTI 229
Query: 223 ESDVYSFGIVALEI 236
           +SDV+SFG++  EI
Sbjct: 230 QSDVWSFGVLLWEI 243

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 88  EVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           EV I+ ++  H N++QL           LV++ M  G L  +L ++  L   E R KI +
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIMR 118
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
            L   +  L +     +VHRD+K  NI+LD + N K+ DFG +   +   G +   + GT
Sbjct: 119 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREVCGT 173
Query: 207 MGYMAP---ECATTGRA---SKESDVYSFGIVALEIACGRKPI 243
             Y+AP   EC+         KE D++S G++   +  G  P 
Sbjct: 174 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 116/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 109
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 110 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 166
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
            A+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 167 RAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 221
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L          G+ L    P +C  D     ++C MI        D
Sbjct: 222 KPYDGIPASEISSIL--------EKGERLP--QPPICTIDVYMIMVKCWMI--------D 263
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 264 ADSRPKFRELI 274

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 65  TSSYIAVK--RVSKGSKQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKK-----ELL 114
           +  ++A+K  RV  G +        EV ++ RL    H N+V+L+  C   +     ++ 
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 87
Query: 115 LVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           LV+E++ +  L ++L K     L  E    + +    GL +L      C+VHRD+K  NI
Sbjct: 88  LVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENI 143
Query: 174 MLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
           ++      K+ DFGLAR+  +       V+  T+ Y APE       +   D++S G + 
Sbjct: 144 LVTSGGTVKLADFGLARIYSYQMALDPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIF 201
Query: 234 LEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
            E+   RKP+     E  Q   +  ++DL G
Sbjct: 202 AEM-FRRKPLFCGNSEADQ---LGKIFDLIG 228

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 34  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 93
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 94  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 145
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 146 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEM 204
Query: 237 ACGR 240
              R
Sbjct: 205 VTRR 208

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 88  EVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           EV I+ ++  H N++QL           LV++ M  G L  +L ++  L   E R KI +
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIMR 131
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
            L   +  L +     +VHRD+K  NI+LD + N K+ DFG +  ++   G +   + GT
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGT 186
Query: 207 MGYMAP---ECATTGRA---SKESDVYSFGIVALEIACGRKPI 243
             Y+AP   EC+         KE D++S G++   +  G  P 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 24/190 (12%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 122 NGSLDSHLFKENN-----------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS 170
            G+L ++L  + N            LT E     +  +A G+ +L     +  +HRD+ +
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKXIHRDLAA 172
Query: 171 SNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDV 226
            NI+L      KI DFGLAR +    ++ +     +    + +MAPE       + +SDV
Sbjct: 173 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDV 229
Query: 227 YSFGIVALEI 236
           +SFG++  EI
Sbjct: 230 WSFGVLLWEI 239

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT  Y+AP    +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 105
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
            A+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 163 RAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 218 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 259
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 260 ADSRPKFRELI 270

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ LV   M  
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-- 128
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
           G+    L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 129 GADLYKLLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 184
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 185 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244
Query: 240 R 240
           R
Sbjct: 245 R 245

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 112
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 113 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 169
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
            A+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 170 RAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 224
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D     ++C MI        D
Sbjct: 225 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMVKCWMI--------D 266
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 267 ADSRPKFRELI 277

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 30/195 (15%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 172
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGRAS 221
           D+ + NI+L      KI DFGLAR +        KG     L     +MAPE       +
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK----WMAPETIFDRVYT 228
Query: 222 KESDVYSFGIVALEI 236
            +SDV+SFG++  EI
Sbjct: 229 IQSDVWSFGVLLWEI 243

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 28/194 (14%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 58  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 118 FGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 174
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           D+ + NI+L      KI DFGLAR +    ++ +     +    + +MAPE       + 
Sbjct: 175 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTI 231
Query: 223 ESDVYSFGIVALEI 236
           +SDV+SFG++  EI
Sbjct: 232 QSDVWSFGVLLWEI 245

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 65  TSSYIAVK--RVSKGSKQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKK-----ELL 114
           +  ++A+K  RV  G +        EV ++ RL    H N+V+L+  C   +     ++ 
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 87
Query: 115 LVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           LV+E++ +  L ++L K     L  E    + +    GL +L      C+VHRD+K  NI
Sbjct: 88  LVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENI 143
Query: 174 MLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
           ++      K+ DFGLAR+  +       V+  T+ Y APE       +   D++S G + 
Sbjct: 144 LVTSGGTVKLADFGLARIYSYQMALAPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIF 201
Query: 234 LEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
            E+   RKP+     E  Q   +  ++DL G
Sbjct: 202 AEM-FRRKPLFCGNSEADQ---LGKIFDLIG 228

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 31  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 90
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 91  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 142
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 143 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 201
Query: 237 ACGR 240
              R
Sbjct: 202 VTRR 205

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 82/169 (48%), Gaps = 7/169 (4%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK-ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
           +E  ++  +R    +  L +  + + +L L+ +Y+  G L +HL +       E +  + 
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           + +    L L+   +  +++RDIK  NI+LD N +  + DFGL++     +  +     G
Sbjct: 167 EIV----LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 206 TMGYMAPECATTGRAS--KESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
           T+ YMAP+    G +   K  D +S G++  E+  G  P ++  ++  Q
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 28/194 (14%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 172
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           D+ + NI+L      KI DFGLAR +    ++ +     +    + +MAPE       + 
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTI 229
Query: 223 ESDVYSFGIVALEI 236
           +SDV+SFG++  EI
Sbjct: 230 QSDVWSFGVLLWEI 243

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEM 197
Query: 237 ACGR 240
              R
Sbjct: 198 VTRR 201

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 28/194 (14%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 93  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 152
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 209
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           D+ + NI+L      KI DFGLAR +    ++ +     +    + +MAPE       + 
Sbjct: 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTI 266
Query: 223 ESDVYSFGIVALEI 236
           +SDV+SFG++  EI
Sbjct: 267 QSDVWSFGVLLWEI 280

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 63  RETSSYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRN---LVQLLGWCHEKKELLLVYE 118
           R+T   IAVK++ + G+K+  K    ++ ++  L+  +   +VQ  G      ++ +  E
Sbjct: 47  RKTGHVIAVKQMRRSGNKEENKRILMDLDVV--LKSHDCPYIVQCFGTFITNTDVFIAME 104
Query: 119 YMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL 177
            M  G+    L K     +      K+   +   L YL+E  +  V+HRD+K SNI+LD 
Sbjct: 105 LM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDE 160
Query: 178 NFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGRASK-----ESDVYSFGI 231
               K+ DFG++ RLV+     ++   AG   YMAPE       +K      +DV+S GI
Sbjct: 161 RGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 232 VALEIACGRKP 242
             +E+A G+ P
Sbjct: 218 SLVELATGQFP 228

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 34  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 93
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 94  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 145
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 146 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 204
Query: 237 ACGR 240
              R
Sbjct: 205 VTRR 208

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 22/191 (11%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 172
Query: 167 DIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           D+ + NI+L      KI DFGLAR + +     +       + +MAPE       + +SD
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 226 VYSFGIVALEI 236
           V+SFG++  EI
Sbjct: 233 VWSFGVLLWEI 243

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 237 ACGR 240
              R
Sbjct: 198 VTRR 201

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 33/207 (15%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYAS--EVTIISRLR-HRNLVQLLGWCH--EKKELLLVY 117
           R T   +AVK++    +       +  E+ I++ L  H N+V LL        +++ LV+
Sbjct: 31  RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90
Query: 118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL 177
           +YM     D H     N+L    +  +   L   + YL  G    ++HRD+K SNI+L+ 
Sbjct: 91  DYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNA 144
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTV--------------------LAGTMGYMAPECAT- 216
             + K+ DFGL+R   + +     +                       T  Y APE    
Sbjct: 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204
Query: 217 TGRASKESDVYSFGIVALEIACGRKPI 243
           + + +K  D++S G +  EI CG KPI
Sbjct: 205 STKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 87
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 88  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 140 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 198
Query: 237 ACGR 240
              R
Sbjct: 199 VTRR 202

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 116/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLD 107
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 108 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 164
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
            A+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 165 RAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D      +C MI        D
Sbjct: 220 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMRKCWMI--------D 261
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 262 ADSRPKFRELI 272

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 86  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 237 ACGR 240
              R
Sbjct: 197 VTRR 200

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 30/195 (15%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 106
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 163
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGRAS 221
           D+ + NI+L      KI DFGLAR +        KG     L     +MAPE       +
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK----WMAPETIFDRVYT 219
Query: 222 KESDVYSFGIVALEI 236
            +SDV+SFG++  EI
Sbjct: 220 IQSDVWSFGVLLWEI 234

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 237 ACGR 240
              R
Sbjct: 198 VTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 237 ACGR 240
              R
Sbjct: 198 VTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 86  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 237 ACGR 240
              R
Sbjct: 197 VTRR 200

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 28/194 (14%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 163
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           D+ + NI+L      KI DFGLAR +    ++ +     +    + +MAPE       + 
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTI 220
Query: 223 ESDVYSFGIVALEI 236
           +SDV+SFG++  EI
Sbjct: 221 QSDVWSFGVLLWEI 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 116/251 (46%), Gaps = 36/251 (14%)
Query: 69  IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K + +  S +  KE   E  +++ + + ++ +LLG C     + L+ + MP G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD 107
Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           ++ +  + +  ++       +A G+ YL++   + +VHRD+ + N+++    + KI DFG
Sbjct: 108 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 164
Query: 188 LARLV------EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GR 240
            A+L+       HA+G +  +      +MA E       + +SDV+S+G+   E+   G 
Sbjct: 165 RAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 219
Query: 241 KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR-DFDEQQMECLMIVGLWCAHPD 299
           KP       E+   L +        G+ L    P +C  D      +C MI        D
Sbjct: 220 KPYDGIPASEISSILEK--------GERLP--QPPICTIDVYMIMRKCWMI--------D 261
Query: 300 ENLRPSIRQVI 310
            + RP  R++I
Sbjct: 262 ADSRPKFRELI 272

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 65  TSSYIAVK--RVSKGSKQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKK-----ELL 114
           +  ++A+K  RV  G +        EV ++ RL    H N+V+L+  C   +     ++ 
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 87
Query: 115 LVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           LV+E++ +  L ++L K     L  E    + +    GL +L      C+VHRD+K  NI
Sbjct: 88  LVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENI 143
Query: 174 MLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
           ++      K+ DFGLAR+  +       V+  T+ Y APE       +   D++S G + 
Sbjct: 144 LVTSGGTVKLADFGLARIYSYQMALFPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIF 201
Query: 234 LEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
            E+   RKP+     E  Q   +  ++DL G
Sbjct: 202 AEM-FRRKPLFCGNSEADQ---LGKIFDLIG 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 30/195 (15%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 163
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGRAS 221
           D+ + NI+L      KI DFGLAR +        KG     L     +MAPE       +
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK----WMAPETIFDRVYT 219
Query: 222 KESDVYSFGIVALEI 236
            +SDV+SFG++  EI
Sbjct: 220 IQSDVWSFGVLLWEI 234

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 28/194 (14%)
Query: 65  TSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKK-ELLLVYEYMP 121
           T   +AVK + +G+     +   SE+ I+  +  H N+V LLG C +    L+++ E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 122 NGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            G+L ++L  + N                LT E     +  +A G+ +L     +C+ HR
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HR 163
Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           D+ + NI+L      KI DFGLAR +    ++ +     +    + +MAPE       + 
Sbjct: 164 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTI 220
Query: 223 ESDVYSFGIVALEI 236
           +SDV+SFG++  EI
Sbjct: 221 QSDVWSFGVLLWEI 234

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 63/115 (54%), Gaps = 10/115 (8%)
Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RL 191
           ++++  E   KI       L +L+E  +  ++HRDIK SNI+LD + N K+ DFG++ +L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 192 VEHAKGSQTTVLAGTMGYMAPE----CATTGRASKESDVYSFGIVALEIACGRKP 242
           V+    ++    AG   YMAPE     A+       SDV+S GI   E+A GR P
Sbjct: 177 VDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ 85
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 86  ---DLKTFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 237 ACGR 240
              R
Sbjct: 197 VTRR 200

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQGIKEYA-SEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 55  VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 115 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 168
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 240 R 240
           R
Sbjct: 229 R 229

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY 119
           +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
           +  G + SHL +         RF  AQ + +   YL       +++RD+K  N+++D   
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-FEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
             ++ DFG A+ V+     +T  L GT   +APE   +   +K  D ++ G++  E+A G
Sbjct: 179 YIQVTDFGFAKRVK----GRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 240 RKPISLTAKEEVQVY 254
             P    A + +Q+Y
Sbjct: 235 YPP--FFADQPIQIY 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQGI-KEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 111 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 165 IXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224
Query: 240 R 240
           R
Sbjct: 225 R 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 13/190 (6%)
Query: 70  AVKRVSKGSKQ-GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
            +K ++K   Q  +++  +E+ ++  L H N++++     +   + +V E    G L   
Sbjct: 51  VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 129 LFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-DLNFNA--K 182
           +         L+  +  ++ + + + L Y      Q VVH+D+K  NI+  D + ++  K
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIK 167
Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           I DFGLA L +      +T  AGT  YMAPE        K  D++S G+V   +  G  P
Sbjct: 168 IIDFGLAELFK--SDEHSTNAAGTALYMAPEVFKRDVTFK-CDIWSAGVVMYFLLTGCLP 224
Query: 243 ISLTAKEEVQ 252
            + T+ EEVQ
Sbjct: 225 FTGTSLEEVQ 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 63  RETSSYIAVKRV-SKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKE-------- 112
           R+T   +A+K+V  +  K+G    A  E+ I+  L+H N+V L+  C  K          
Sbjct: 40  RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 99
Query: 113 LLLVYEYMPN---GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + LV+++  +   G L + L K     T     ++ Q L +GL Y+       ++HRD+K
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMK 152
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESD 225
           ++N+++  +   K+ DFGLAR    AK SQ         T+ Y  PE     R      D
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPID 212
Query: 226 VYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
           ++  G +  E+   R PI     E+ Q+ L+
Sbjct: 213 LWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE 139
           + + ++  EV  +  L HRNL++L G       + +V E  P GSL   L K        
Sbjct: 57  EAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 115
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR--------- 190
              + A  +A G+ YL+    +  +HRD+ + N++L      KIGDFGL R         
Sbjct: 116 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 191 -LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
            + EH K            + APE   T   S  SD + FG+   E+   G++P
Sbjct: 173 VMQEHRKVP--------FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQGI-KEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 111 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224
Query: 240 R 240
           R
Sbjct: 225 R 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 63  RETSSYIAVKRV-SKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKE-------- 112
           R+T   +A+K+V  +  K+G    A  E+ I+  L+H N+V L+  C  K          
Sbjct: 40  RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 99
Query: 113 LLLVYEYMPN---GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + LV+++  +   G L + L K     T     ++ Q L +GL Y+       ++HRD+K
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMK 152
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESD 225
           ++N+++  +   K+ DFGLAR    AK SQ         T+ Y  PE     R      D
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPID 212
Query: 226 VYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
           ++  G +  E+   R PI     E+ Q+ L+
Sbjct: 213 LWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQGI-KEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 111 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 164
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224
Query: 240 R 240
           R
Sbjct: 225 R 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 63  RETSSYIAVKRV-SKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKE-------- 112
           R+T   +A+K+V  +  K+G    A  E+ I+  L+H N+V L+  C  K          
Sbjct: 39  RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98
Query: 113 LLLVYEYMPN---GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + LV+++  +   G L + L K     T     ++ Q L +GL Y+       ++HRD+K
Sbjct: 99  IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMK 151
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESD 225
           ++N+++  +   K+ DFGLAR    AK SQ         T+ Y  PE     R      D
Sbjct: 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPID 211
Query: 226 VYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
           ++  G +  E+   R PI     E+ Q+ L+
Sbjct: 212 LWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 241

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 63  RETSSYIAVKRV-SKGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKE-------- 112
           R+T   +A+K+V  +  K+G    A  E+ I+  L+H N+V L+  C  K          
Sbjct: 40  RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKAS 99
Query: 113 LLLVYEYMPN---GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + LV+++  +   G L + L K     T     ++ Q L +GL Y+       ++HRD+K
Sbjct: 100 IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMK 152
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESD 225
           ++N+++  +   K+ DFGLAR    AK SQ         T+ Y  PE     R      D
Sbjct: 153 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPID 212
Query: 226 VYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
           ++  G +  E+   R PI     E+ Q+ L+
Sbjct: 213 LWGAGCIMAEMWT-RSPIMQGNTEQHQLALI 242

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 115 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLK 168
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 240 R 240
           R
Sbjct: 229 R 229

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 89
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 90  ---DLKTFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 142 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 234 LEIACGR 240
            E+   R
Sbjct: 198 AEMVTRR 204

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 70  AVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL---- 125
           A K++ K   + +  +  E+ I+  L H N+++L     +  ++ LV E    G L    
Sbjct: 38  AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV 97
Query: 126 -DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNA 181
               +F+E++        +I +D+ S + Y  +     V HRD+K  N +      +   
Sbjct: 98  VHKRVFRESDAA------RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPL 148
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           K+ DFGLA   +  K  +T V  GT  Y++P+    G    E D +S G++   + CG  
Sbjct: 149 KLIDFGLAARFKPGKMMRTKV--GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP 205
Query: 242 PISLTAKEEVQV 253
           P S     EV +
Sbjct: 206 PFSAPTDXEVML 217

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 9/178 (5%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           +A+K++S    Q   +    E+ I+ R RH N++ +           +   Y+    +++
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET 130
Query: 128 HLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD 185
            L+K  ++  L+ +        +  GL Y+       V+HRD+K SN++++   + KI D
Sbjct: 131 DLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICD 187
Query: 186 FGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGR 240
           FGLAR+   EH      T    T  Y APE     +  +K  D++S G +  E+   R
Sbjct: 188 FGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 11/168 (6%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE 139
           + + ++  EV  +  L HRNL++L G       + +V E  P GSL   L K        
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 121
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----EHA 195
              + A  +A G+ YL+    +  +HRD+ + N++L      KIGDFGL R +    +H 
Sbjct: 122 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHX 178
Query: 196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
              +   +     + APE   T   S  SD + FG+   E+   G++P
Sbjct: 179 VMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 11/168 (6%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE 139
           + + ++  EV  +  L HRNL++L G       + +V E  P GSL   L K        
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 111
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV----EHA 195
              + A  +A G+ YL+    +  +HRD+ + N++L      KIGDFGL R +    +H 
Sbjct: 112 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHX 168
Query: 196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
              +   +     + APE   T   S  SD + FG+   E+   G++P
Sbjct: 169 VMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 111 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 164
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224
Query: 240 R 240
           R
Sbjct: 225 R 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 70  AVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL---- 125
           A K++ K   + +  +  E+ I+  L H N+++L     +  ++ LV E    G L    
Sbjct: 55  AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV 114
Query: 126 -DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNA 181
               +F+E++        +I +D+ S + Y  +     V HRD+K  N +      +   
Sbjct: 115 VHKRVFRESDAA------RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           K+ DFGLA   +  K  +T V  GT  Y++P+    G    E D +S G++   + CG  
Sbjct: 166 KLIDFGLAARFKPGKMMRTKV--GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP 222
Query: 242 PISLTAKEEVQV 253
           P S     EV +
Sbjct: 223 PFSAPTDXEVML 234

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE 139
           + + ++  EV  +  L HRNL++L G       + +V E  P GSL   L K        
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 111
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR--------- 190
              + A  +A G+ YL+    +  +HRD+ + N++L      KIGDFGL R         
Sbjct: 112 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 191 -LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
            + EH K            + APE   T   S  SD + FG+   E+   G++P
Sbjct: 169 VMQEHRKVP--------FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 56  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 115
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 116 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 169
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 170 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229
Query: 240 R 240
           R
Sbjct: 230 R 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 49  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 108
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 109 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 162
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 163 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222
Query: 240 R 240
           R
Sbjct: 223 R 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 57  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 116
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 117 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 170
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 171 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 230
Query: 240 R 240
           R
Sbjct: 231 R 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 48  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 107
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 108 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 161
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 162 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 221
Query: 240 R 240
           R
Sbjct: 222 R 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 115 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 240 R 240
           R
Sbjct: 229 R 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 49  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 108
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 109 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 162
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 163 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222
Query: 240 R 240
           R
Sbjct: 223 R 223

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE 139
           + + ++  EV  +  L HRNL++L G       + +V E  P GSL   L K        
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 121
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR--------- 190
              + A  +A G+ YL+    +  +HRD+ + N++L      KIGDFGL R         
Sbjct: 122 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 178
Query: 191 -LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
            + EH K            + APE   T   S  SD + FG+   E+   G++P
Sbjct: 179 VMQEHRKVP--------FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 112
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 113 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 166
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 167 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226
Query: 240 R 240
           R
Sbjct: 227 R 227

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE 139
           + + ++  EV  +  L HRNL++L G       + +V E  P GSL   L K        
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 111
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR--------- 190
              + A  +A G+ YL+    +  +HRD+ + N++L      KIGDFGL R         
Sbjct: 112 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 191 -LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
            + EH K            + APE   T   S  SD + FG+   E+   G++P
Sbjct: 169 VMQEHRKVP--------FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE 139
           + + ++  EV  +  L HRNL++L G       + +V E  P GSL   L K        
Sbjct: 57  EAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 115
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR--------- 190
              + A  +A G+ YL+    +  +HRD+ + N++L      KIGDFGL R         
Sbjct: 116 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 172
Query: 191 -LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKP 242
            + EH K            + APE   T   S  SD + FG+   E+   G++P
Sbjct: 173 VMQEHRKVP--------FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 59  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 118
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 119 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 172
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 173 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 232
Query: 240 R 240
           R
Sbjct: 233 R 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 111 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 164
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 165 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224
Query: 240 R 240
           R
Sbjct: 225 R 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 10/186 (5%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           I + R +  S     +   EV ++  L H N+++L  +  +K+   LV E    G L   
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGD 185
           +         +    I Q L SG+ YL +     +VHRD+K  N++L+        KI D
Sbjct: 127 IIHRMKFNEVDAAVIIKQVL-SGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVD 182
Query: 186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISL 245
           FGL+ + E+ K  +  +  GT  Y+APE     +  ++ DV+S G++   +  G  P   
Sbjct: 183 FGLSAVFENQKKMKERL--GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGG 239
Query: 246 TAKEEV 251
              +E+
Sbjct: 240 QTDQEI 245

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    +E   SE+ ++S L  H N+V LLG C      L++ EY   G L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 127 SHLFKENNLLTWE-----------------FRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + L ++ +                           +  +A G+ +L    + C+ HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLA 195
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESD 225
           + NI+L      KI DFGLAR   H K     V+ G     + +MAPE       + ESD
Sbjct: 196 ARNILLTHGRITKICDFGLAR---HIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 252
Query: 226 VYSFGIVALEI-ACGRKP 242
           V+S+GI   E+ + G  P
Sbjct: 253 VWSYGIFLWELFSLGSSP 270

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 89
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 90  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 142 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 234 LEIACGR 240
            E+   R
Sbjct: 198 AEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 88
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 89  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 141 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 234 LEIACGR 240
            E+   R
Sbjct: 197 AEMVTRR 203

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 130
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 131 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 184
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 185 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244
Query: 240 R 240
           R
Sbjct: 245 R 245

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 86  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 138 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 234 LEIACGR 240
            E+   R
Sbjct: 194 AEMVTRR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 88
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 89  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 140
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 141 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 234 LEIACGR 240
            E+   R
Sbjct: 197 AEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 139 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 234 LEIACGR 240
            E+   R
Sbjct: 195 AEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 87
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 88  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 140 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 234 LEIACGR 240
            E+   R
Sbjct: 196 AEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 29  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 88
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 89  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 140
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 141 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 234 LEIACGR 240
            E+   R
Sbjct: 197 AEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 89
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 90  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 142 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 234 LEIACGR 240
            E+   R
Sbjct: 198 AEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 31  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 90
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 91  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 142
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 143 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 198
Query: 234 LEIACGR 240
            E+   R
Sbjct: 199 AEMVTRR 205

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +VQL     + K L +V EYMP G L + +   +    W  +F  A+     +L L    
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA-KFYTAE----VVLALDAIH 191
Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-- 217
              ++HRD+K  N++LD + + K+ DFG    ++           GT  Y++PE   +  
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 218 --GRASKESDVYSFGIVALEIACGRKPI 243
             G   +E D +S G+   E+  G  P 
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 26  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 86  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 138 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 234 LEIACGR 240
            E+   R
Sbjct: 194 AEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 139 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 234 LEIACGR 240
            E+   R
Sbjct: 195 AEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  DLKD---FMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 139 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 234 LEIACGR 240
            E+   R
Sbjct: 195 AEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 87
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 88  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 139
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 140 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 234 LEIACGR 240
            E+   R
Sbjct: 196 AEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 28  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 87
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 88  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT 139
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 140 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 234 LEIACGR 240
            E+   R
Sbjct: 196 AEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 139 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 234 LEIACGR 240
            E+   R
Sbjct: 195 AEMVTRR 201

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
           H   +L  + + M  G L  HL +       + RF  A ++  GL ++   +   VV+RD
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRD 317
Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DV 226
           +K +NI+LD + + +I D GLA      K   +    GT GYMAPE    G A   S D 
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADW 374
Query: 227 YSFGIVALEIACGRKPI 243
           +S G +  ++  G  P 
Sbjct: 375 FSLGCMLFKLLRGHSPF 391

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+ ++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 139 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 197
Query: 237 ACGR 240
              R
Sbjct: 198 VTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+ ++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 26  TGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 86  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEI 236
               K+ DFGLAR       + T  +  T+ Y APE     +  S   D++S G +  E+
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 237 ACGR 240
              R
Sbjct: 197 VTRR 200

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
           H   +L  + + M  G L  HL +       + RF  A ++  GL ++   +   VV+RD
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRD 317
Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DV 226
           +K +NI+LD + + +I D GLA      K   +    GT GYMAPE    G A   S D 
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADW 374
Query: 227 YSFGIVALEIACGRKPI 243
           +S G +  ++  G  P 
Sbjct: 375 FSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
           H   +L  + + M  G L  HL +       + RF  A ++  GL ++   +   VV+RD
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRD 317
Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DV 226
           +K +NI+LD + + +I D GLA      K   +    GT GYMAPE    G A   S D 
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADW 374
Query: 227 YSFGIVALEIACGRKPI 243
           +S G +  ++  G  P 
Sbjct: 375 FSLGCMLFKLLRGHSPF 391

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 88  EVTIISRLR---HRNLVQLLGWCHEKK-----ELLLVYEYMPNGSLDSHLFKENNL-LTW 138
           EV ++ RL    H N+V+L+  C   +     ++ LV+E++ +  L ++L K     L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPA 119
Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
           E    + +    GL +L      C+VHRD+K  NI++      K+ DFGLAR+  +    
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
              V+  T+ Y APE       +   D++S G +  E+   RKP+     E  Q   +  
Sbjct: 177 TPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQ---LGK 230
Query: 259 VWDLYG 264
           ++DL G
Sbjct: 231 IFDLIG 236

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
           H   +L  + + M  G L  HL +       + RF  A ++  GL ++   +   VV+RD
Sbjct: 261 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEHMHNRF---VVYRD 316
Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DV 226
           +K +NI+LD + + +I D GLA      K   +    GT GYMAPE    G A   S D 
Sbjct: 317 LKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADW 373
Query: 227 YSFGIVALEIACGRKPI 243
           +S G +  ++  G  P 
Sbjct: 374 FSLGCMLFKLLRGHSPF 390

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 27  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 86
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 87  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 139 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 234 LEIACGR 240
            E+   R
Sbjct: 195 AEMVTRR 201

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 12/186 (6%)
Query: 63  RETSSYIAVKRVSKGSKQG--IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           R T    AVK ++K S +         EV ++ +L H N+++L     +     +V E  
Sbjct: 44  RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--- 177
             G L   + K       +   +I + + SG+ Y+ +     +VHRD+K  NI+L+    
Sbjct: 104 TGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEK 159
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           + + KI DFGL+   +     +  +  GT  Y+APE    G   ++ DV+S G++   + 
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILL 216
Query: 238 CGRKPI 243
            G  P 
Sbjct: 217 SGTPPF 222

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A++++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 55  VAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 115 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 240 R 240
           R
Sbjct: 229 R 229

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 12/186 (6%)
Query: 63  RETSSYIAVKRVSKGSKQG--IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           R T    AVK ++K S +         EV ++ +L H N+++L     +     +V E  
Sbjct: 44  RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--- 177
             G L   + K       +   +I + + SG+ Y+ +     +VHRD+K  NI+L+    
Sbjct: 104 TGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEK 159
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           + + KI DFGL+   +     +  +  GT  Y+APE    G   ++ DV+S G++   + 
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILL 216
Query: 238 CGRKPI 243
            G  P 
Sbjct: 217 SGTPPF 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 31/234 (13%)
Query: 28  PKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIK-EYA 86
           PKR  Y      ++DF     L             + T   +A+K++    K        
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK-----ELLLVYEYMPNGSLDSHLFKENNLLTWE-F 140
            E+ I+   +H N++ +             E+ ++ E M     D H      +L+ +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHI 114
Query: 141 RFKIAQDL-ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-- 197
           ++ I Q L A  +L+        V+HRD+K SN++++ N + K+ DFGLAR+++ +    
Sbjct: 115 QYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 198 -------SQTTVLAGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKPI 243
                  S  T    T  Y APE   T+ + S+  DV+S G +  E+   R+PI
Sbjct: 170 SEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 29/191 (15%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGW----CHEKKELLLVYEYMPNG 123
           +AVK  S   +Q   +E  +E+     LRH N++  +       +   +L L+  Y  +G
Sbjct: 34  VAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHG 91
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDL 177
           SL  + F +   L      ++A   A GL +L       +G +  + HRD KS N+++  
Sbjct: 92  SL--YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG-KPAIAHRDFKSRNVLVKS 148
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVL-----AGTMGYMAPEC------ATTGRASKESDV 226
           N    I D GLA  V H++GS    +      GT  YMAPE            + K +D+
Sbjct: 149 NLQCCIADLGLA--VMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDI 206
Query: 227 YSFGIVALEIA 237
           ++FG+V  EIA
Sbjct: 207 WAFGLVLWEIA 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 31/234 (13%)
Query: 28  PKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIK-EYA 86
           PKR  Y      ++DF     L             + T   +A+K++    K        
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK-----ELLLVYEYMPNGSLDSHLFKENNLLTWE-F 140
            E+ I+   +H N++ +             E+ ++ E M     D H      +L+ +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHI 114
Query: 141 RFKIAQDL-ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-- 197
           ++ I Q L A  +L+        V+HRD+K SN++++ N + K+ DFGLAR+++ +    
Sbjct: 115 QYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 198 -------SQTTVLAGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKPI 243
                  S  T    T  Y APE   T+ + S+  DV+S G +  E+   R+PI
Sbjct: 170 SEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 115 DLYK--LLKCQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 240 R 240
           R
Sbjct: 229 R 229

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 12/186 (6%)
Query: 63  RETSSYIAVKRVSKGSKQG--IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           R T    AVK ++K S +         EV ++ +L H N+++L     +     +V E  
Sbjct: 44  RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--- 177
             G L   + K       +   +I + + SG+ Y+ +     +VHRD+K  NI+L+    
Sbjct: 104 TGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEK 159
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
           + + KI DFGL+   +     +  +  GT  Y+APE    G   ++ DV+S G++   + 
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILL 216
Query: 238 CGRKPI 243
            G  P 
Sbjct: 217 SGTPPF 222

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 65  TSSYIAVKRVSKGSK-QGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T   +A+K++   ++ +G+   A  E++++  L H N+V+LL   H + +L LV+E++  
Sbjct: 30  TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ 89
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIMLDL 177
              D   F + + LT      I   L    L+ L +G   C    V+HRD+K  N++++ 
Sbjct: 90  ---DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 141
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECATTGR-ASKESDVYSFGIVA 233
               K+ DFGLAR    A G           T+ Y APE     +  S   D++S G + 
Sbjct: 142 EGAIKLADFGLAR----AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 234 LEIACGR 240
            E+   R
Sbjct: 198 AEMVTRR 204

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 113 LLLVYEYMPNGSLDSHLFKENNLLTWEF-RFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
           L LV +Y   G L + L K  + L  E  RF     LA  ++ +    +   VHRDIK  
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY----LAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-----GRASKESDV 226
           NI++D+N + ++ DFG    +      Q++V  GT  Y++PE         GR   E D 
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 227 YSFGIVALEIACGRKPISLTAKEEVQVY 254
           +S G+   E+  G  P    A+  V+ Y
Sbjct: 265 WSLGVCMYEMLYGETP--FYAESLVETY 290

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 31/234 (13%)
Query: 28  PKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSKGSKQGIK-EYA 86
           PKR  Y      ++DF     L             + T   +A+K++    K        
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKK-----ELLLVYEYMPNGSLDSHLFKENNLLTWE-F 140
            E+ I+   +H N++ +             E+ ++ E M     D H      +L+ +  
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHI 114
Query: 141 RFKIAQDL-ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA---- 195
           ++ I Q L A  +L+        V+HRD+K SN++++ N + K+ DFGLAR+++ +    
Sbjct: 115 QYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 196 ---KGSQTTVL--AGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKPI 243
               G Q+ ++    T  Y APE   T+ + S+  DV+S G +  E+   R+PI
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 7/160 (4%)
Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           +E++I+++L H  L+ L     +K E++L+ E++  G L   +  E+  ++        +
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--FNAKIGDFGLARLVEHAKGSQTTVLA 204
               GL ++ E     +VH DIK  NIM +     + KI DFGLA  +   +  + T   
Sbjct: 157 QACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--T 211
Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
            T  + APE          +D+++ G++   +  G  P +
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQL--------------LGWCHEKKELL 114
           +A+K++     Q +K    E+ II RL H N+V++              +G   E   + 
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V EYM      +++ ++  LL    R  + Q L  GL Y+       V+HRD+K +N+ 
Sbjct: 99  IVQEYMETDL--ANVLEQGPLLEEHARLFMYQ-LLRGLKYIHSA---NVLHRDLKPANLF 152
Query: 175 LDL-NFNAKIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATT-GRASKESDVYSFG 230
           ++  +   KIGDFGLAR+++     +  +  G  T  Y +P    +    +K  D+++ G
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 231 IVALEIACGR 240
            +  E+  G+
Sbjct: 213 CIFAEMLTGK 222

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 65  TSSYIAVKRVSK---GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           T    AVK +SK     K   +    EV ++ +L H N+++L  +  +K    LV E   
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            G L   +         +   +I + + SG+ Y+ +     +VHRD+K  N++L+    +
Sbjct: 110 GGELFDEIISRKRFSEVDAA-RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD 165
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
            N +I DFGL+   E +K  +  +  GT  Y+APE    G   ++ DV+S G++   +  
Sbjct: 166 ANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 222
Query: 239 GRKPIS 244
           G  P +
Sbjct: 223 GCPPFN 228

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 13/224 (5%)
Query: 27  GPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRVSK---GSKQGIK 83
           GP  F     A  ++ +   + L             + T    AVK +SK     K   +
Sbjct: 18  GPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 77
Query: 84  EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
               EV ++ +L H N+++L  +  +K    LV E    G L   +         +   +
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-R 136
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQT 200
           I + + SG+ Y+ +     +VHRD+K  N++L+    + N +I DFGL+   E +K  + 
Sbjct: 137 IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 193
Query: 201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS 244
            +  GT  Y+APE    G   ++ DV+S G++   +  G  P +
Sbjct: 194 KI--GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 10/167 (5%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           EV ++ +L H N+++L  +  +K+   LV E    G L   +         +    I + 
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQ 129
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLVEHAKGSQTTVLA 204
           + SG  YL +     +VHRD+K  N++L+        KI DFGL+   E   G +     
Sbjct: 130 VLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERL 184
Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           GT  Y+APE     +  ++ DV+S G++   + CG  P      +E+
Sbjct: 185 GTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEI 230

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 65  TSSYIAVKRVSK---GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           T    AVK +SK     K   +    EV ++ +L H N+++L  +  +K    LV E   
Sbjct: 73  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 132
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            G L   +         +   +I + + SG+ Y+ +     +VHRD+K  N++L+    +
Sbjct: 133 GGELFDEIISRKRFSEVDAA-RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKD 188
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
            N +I DFGL+   E +K  +  +  GT  Y+APE    G   ++ DV+S G++   +  
Sbjct: 189 ANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 245
Query: 239 GRKPIS 244
           G  P +
Sbjct: 246 GCPPFN 251

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 44/87 (50%), Gaps = 3/87 (3%)
Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           LL L     Q +VH D+K +NI L      K+GDFGL  LVE        V  G   YMA
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMA 224
Query: 212 PECATTGRASKESDVYSFGIVALEIAC 238
           PE    G     +DV+S G+  LE+AC
Sbjct: 225 PEL-LQGSYGTAADVFSLGLTILEVAC 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 65  TSSYIAVKRVSK---GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           T    AVK +SK     K   +    EV ++ +L H N+++L  +  +K    LV E   
Sbjct: 74  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 133
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            G L   +         +   +I + + SG+ Y+ +     +VHRD+K  N++L+    +
Sbjct: 134 GGELFDEIISRKRFSEVDAA-RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKD 189
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
            N +I DFGL+   E +K  +  +  GT  Y+APE    G   ++ DV+S G++   +  
Sbjct: 190 ANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 246
Query: 239 GRKPIS 244
           G  P +
Sbjct: 247 GCPPFN 252

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 79  KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL---DSHLFKENNL 135
           K    ++ +E+ II+ +++   +   G      E+ ++YEYM N S+   D + F  +  
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 136 LTWEFRFKIAQDLASGLL----YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL 191
            T     ++ + +   +L    Y+    E+ + HRD+K SNI++D N   K+ DFG +  
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 192 V--EHAKGSQTTVLAGTMGYMAPECAT--TGRASKESDVYSFGIVALEIACGRKPISL 245
           +  +  KGS+     GT  +M PE  +  +     + D++S GI    +     P SL
Sbjct: 202 MVDKKIKGSR-----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 115 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 168
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H           T  Y APE     +  +K  D++S G +  E+   
Sbjct: 169 ICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 240 R 240
           R
Sbjct: 229 R 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+ R RH N++ +          + K++ +V + M  
Sbjct: 56  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 115
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 116 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 169
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H           T  Y APE     +  +K  D++S G +  E+   
Sbjct: 170 ICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229
Query: 240 R 240
           R
Sbjct: 230 R 230

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 79/185 (42%), Gaps = 14/185 (7%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISR-LRHRNLVQLLGWCHEKKELLLVYEYMP 121
           ++ +  +AVK + +G K  I E      I  R LRH N+V+          L +V EY  
Sbjct: 41  KQANELVAVKYIERGEK--IDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 98
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--F 179
            G L   +         E RF   Q L SG+ Y        V HRD+K  N +LD +   
Sbjct: 99  GGELFERICNAGRFSEDEARF-FFQQLISGVSY---AHAMQVAHRDLKLENTLLDGSPAP 154
Query: 180 NAKIGDFGLARL-VEHAKGSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIA 237
             KI DFG ++  V H   SQ     GT  Y+APE         K +DV+S G+    + 
Sbjct: 155 RLKIADFGYSKASVLH---SQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 238 CGRKP 242
            G  P
Sbjct: 212 VGAYP 216

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 9/148 (6%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +VQL     + + L +V EYMP G L + +   +    W  RF  A+     +L L    
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAE----VVLALDAIH 185
Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-- 217
               +HRD+K  N++LD + + K+ DFG    +      +     GT  Y++PE   +  
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 218 --GRASKESDVYSFGIVALEIACGRKPI 243
             G   +E D +S G+   E+  G  P 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 9/148 (6%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +VQL     + + L +V EYMP G L + +   +    W  RF  A+     +L L    
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAE----VVLALDAIH 190
Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-- 217
               +HRD+K  N++LD + + K+ DFG    +      +     GT  Y++PE   +  
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 218 --GRASKESDVYSFGIVALEIACGRKPI 243
             G   +E D +S G+   E+  G  P 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 9/148 (6%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +VQL     + + L +V EYMP G L + +   +    W  RF  A+     +L L    
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAE----VVLALDAIH 190
Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-- 217
               +HRD+K  N++LD + + K+ DFG    +      +     GT  Y++PE   +  
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 218 --GRASKESDVYSFGIVALEIACGRKPI 243
             G   +E D +S G+   E+  G  P 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKXQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDXELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMP 121
           ++++   AVK +SK  +   ++   E+T +     H N+V+L    H++    LV E + 
Sbjct: 33  KKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLN 178
            G L   + K+ +    E  + I + L S + ++ +     VVHRD+K  N++    + N
Sbjct: 90  GGELFERIKKKKHFSETEASY-IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDN 145
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
              KI DFG ARL +            T+ Y APE        +  D++S G++   +  
Sbjct: 146 LEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204
Query: 239 GRKPI-----SLTAKEEVQV 253
           G+ P      SLT    V++
Sbjct: 205 GQVPFQSHDRSLTCTSAVEI 224

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 10/167 (5%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
           EV ++ +L H N+++L  +  +K+   LV E    G L   +         +    I + 
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-IMKQ 112
Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLVEHAKGSQTTVLA 204
           + SG  YL +     +VHRD+K  N++L+        KI DFGL+   E   G +     
Sbjct: 113 VLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERL 167
Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           GT  Y+APE     +  ++ DV+S G++   + CG  P      +E+
Sbjct: 168 GTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEI 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 26/170 (15%)
Query: 88  EVTIISRLRHRNLVQLLG--WCHEKKELLLVYEYMPNGS---LDSHLFKENNLLTWEFRF 142
           E+ ++ RLRH+N++QL+   +  EK+++ +V EY   G    LDS           E RF
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDS---------VPEKRF 106
Query: 143 KIAQ------DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
            + Q       L  GL YL     Q +VH+DIK  N++L      KI   G+A  +    
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 197 GSQTTVLA-GTMGYMAPECAT--TGRASKESDVYSFGIVALEIACGRKPI 243
              T   + G+  +  PE A      +  + D++S G+    I  G  P 
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNG-----SLDSHLFKENNLLTWEFRF 142
           E+ I+SR+ H N++++L     +    LV E   +G      +D H   +  L ++ FR 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
            ++   A G L L++     ++HRDIK  NI++  +F  K+ DFG A  +E  K   T  
Sbjct: 139 LVS---AVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-- 188
Query: 203 LAGTMGYMAPECAT-TGRASKESDVYSFGIVALEIACGRKPI 243
             GT+ Y APE          E +++S G+    +     P 
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 24/183 (13%)
Query: 72  KRVSKGSKQGIKEYASEVTIISRLRHRNLVQLL-GW---CHEKKELLLVYEYMPNGSLDS 127
           ++++K  +Q  KE   E   +  L+H N+V+    W      KK ++LV E   +G+L +
Sbjct: 62  RKLTKSERQRFKE---EAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKT 118
Query: 128 HL-----FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD-LNFNA 181
           +L      K   L +W       + +  GL +L       ++HRD+K  NI +     + 
Sbjct: 119 YLKRFKVXKIKVLRSW------CRQILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSV 171
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           KIGD GLA L    + S    + GT  + APE     +  +  DVY+FG   LE A    
Sbjct: 172 KIGDLGLATL---KRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEY 227
Query: 242 PIS 244
           P S
Sbjct: 228 PYS 230

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+   RH N++ +          + K++ +V + M  
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 112
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 113 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 166
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 167 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226
Query: 240 R 240
           R
Sbjct: 227 R 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKXQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQL-----LGWCHEKKELLLVYEYMPN 122
           +A+K++S    Q   +    E+ I+   RH N++ +          + K++ +V + M  
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 112
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAK 182
                 L K  +L      + + Q L  GL Y+       V+HRD+K SN++L+   + K
Sbjct: 113 DLYK--LLKTQHLSNDHICYFLYQIL-RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLK 166
Query: 183 IGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACG 239
           I DFGLAR+   +H      T    T  Y APE     +  +K  D++S G +  E+   
Sbjct: 167 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226
Query: 240 R 240
           R
Sbjct: 227 R 227

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    +E   SE+ ++S L  H N+V LLG C      L++ EY   G L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 127 SHLFKENNLLTWE-----------------FRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + L ++ +                           +  +A G+ +L    + C+ HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLA 195
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESD 225
           + NI+L      KI DFGLAR +   K     V+ G     + +MAPE       + ESD
Sbjct: 196 ARNILLTHGRITKICDFGLARDI---KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 252
Query: 226 VYSFGIVALEI-ACGRKP 242
           V+S+GI   E+ + G  P
Sbjct: 253 VWSYGIFLWELFSLGSSP 270

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    +E   SE+ ++S L  H N+V LLG C      L++ EY   G L 
Sbjct: 72  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 131
Query: 127 SHLFKENNLLTWE-----------------FRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + L ++ +                           +  +A G+ +L    + C+ HRD+ 
Sbjct: 132 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLA 188
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESD 225
           + NI+L      KI DFGLAR +   K     V+ G     + +MAPE       + ESD
Sbjct: 189 ARNILLTHGRITKICDFGLARDI---KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 245
Query: 226 VYSFGIVALEI-ACGRKP 242
           V+S+GI   E+ + G  P
Sbjct: 246 VWSYGIFLWELFSLGSSP 263

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    +E   SE+ ++S L  H N+V LLG C      L++ EY   G L 
Sbjct: 74  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 133
Query: 127 SHLFKENNLLTWE-----------------FRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + L ++ +                           +  +A G+ +L    + C+ HRD+ 
Sbjct: 134 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLA 190
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESD 225
           + NI+L      KI DFGLAR +   K     V+ G     + +MAPE       + ESD
Sbjct: 191 ARNILLTHGRITKICDFGLARDI---KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 247
Query: 226 VYSFGIVALEI-ACGRKP 242
           V+S+GI   E+ + G  P
Sbjct: 248 VWSYGIFLWELFSLGSSP 265

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNAMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 78/184 (42%), Gaps = 12/184 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISR-LRHRNLVQLLGWCHEKKELLLVYEYMP 121
           ++++  +AVK + +G K  I E      I  R LRH N+V+          L +V EY  
Sbjct: 40  KQSNELVAVKYIERGEK--IDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 97
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--F 179
            G L   +         E RF   Q L SG+ Y        V HRD+K  N +LD +   
Sbjct: 98  GGELFERICNAGRFSEDEARF-FFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAP 153
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIAC 238
             KI DFG ++       SQ     GT  Y+APE         K +DV+S G+    +  
Sbjct: 154 RLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 211
Query: 239 GRKP 242
           G  P
Sbjct: 212 GAYP 215

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 13/186 (6%)
Query: 65  TSSYIAVKRVSK---GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP 121
           T    AVK +SK     K   +    EV ++ +L H N+ +L  +  +K    LV E   
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYT 109
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---N 178
            G L   +         +   +I + + SG+ Y  +     +VHRD+K  N++L+    +
Sbjct: 110 GGELFDEIISRKRFSEVDAA-RIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKD 165
Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
            N +I DFGL+   E +K  +  +  GT  Y+APE    G   ++ DV+S G++   +  
Sbjct: 166 ANIRIIDFGLSTHFEASKKXKDKI--GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 222
Query: 239 GRKPIS 244
           G  P +
Sbjct: 223 GCPPFN 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 69  IAVKRVSKGSKQGIKE-YASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK +   +    +E   SE+ ++S L  H N+V LLG C      L++ EY   G L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 127 SHLFKENNLLTWE-----------------FRFKIAQDLASGLLYLQEGWEQCVVHRDIK 169
           + L ++ +                           +  +A G+ +L    + C+ HRD+ 
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCI-HRDLA 172
Query: 170 SSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGRASKESD 225
           + NI+L      KI DFGLAR +   K     V+ G     + +MAPE       + ESD
Sbjct: 173 ARNILLTHGRITKICDFGLARDI---KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
Query: 226 VYSFGIVALEI-ACGRKP 242
           V+S+GI   E+ + G  P
Sbjct: 230 VWSYGIFLWELFSLGSSP 247

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 25/197 (12%)
Query: 63  RETSSYIAVKRVSKG---SKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY 117
           RET    AVK V      S  G+  ++   E +I   L+H ++V+LL        L +V+
Sbjct: 46  RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLL-YLQEGWEQC----VVHRDIKSSN 172
           E+M    L   + K  +       F  ++ +AS  +  + E    C    ++HRD+K  N
Sbjct: 106 EFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPEN 160
Query: 173 IMLDLNFNA---KIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATTGRASKESDV 226
           ++L    N+   K+GDFG+A  +    G    V  G +G   +MAPE        K  DV
Sbjct: 161 VLLASKENSAPVKLGDFGVAIQL----GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDV 216
Query: 227 YSFGIVALEIACGRKPI 243
           +  G++   +  G  P 
Sbjct: 217 WGCGVILFILLSGCLPF 233

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 55  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 114
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 115 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 168
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 169 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 224
Query: 235 EIACGR 240
           E+  GR
Sbjct: 225 ELLTGR 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++SK  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 57  KTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 116
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 117 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 170
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 171 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 235 EIACGR 240
           E+  GR
Sbjct: 227 ELLTGR 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 65  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 124
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 125 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 178
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 179 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 235 EIACGR 240
           E+  GR
Sbjct: 235 ELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 41  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 101 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 154
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 155 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 235 EIACGR 240
           E+  GR
Sbjct: 211 ELLTGR 216

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 20/156 (12%)
Query: 109 EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA-----SGLLYLQEGWEQCV 163
           ++  L LV +Y   G L + L K        F  K+ +D+A       +L +    +   
Sbjct: 145 DENHLYLVMDYYVGGDLLTLLSK--------FEDKLPEDMARFYIGEMVLAIDSIHQLHY 196
Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-----G 218
           VHRDIK  N++LD+N + ++ DFG    +      Q++V  GT  Y++PE         G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY 254
           +   E D +S G+   E+  G  P    A+  V+ Y
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETP--FYAESLVETY 290

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 64  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 123
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 124 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 177
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 178 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 233
Query: 235 EIACGR 240
           E+  GR
Sbjct: 234 ELLTGR 239

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 50  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 109
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 110 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 163
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 164 NEDXELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 235 EIACGR 240
           E+  GR
Sbjct: 220 ELLTGR 225

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA-----SGLLYLQEGWEQC 162
            ++  L LV +Y   G L + L K        F  K+ +D+A       +L +    +  
Sbjct: 160 QDENHLYLVMDYYVGGDLLTLLSK--------FEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT----- 217
            VHRDIK  N++LD+N + ++ DFG    +      Q++V  GT  Y++PE         
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY 254
           G+   E D +S G+   E+  G  P    A+  V+ Y
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETP--FYAESLVETY 306

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 51  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 110
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 111 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 164
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 165 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 235 EIACGR 240
           E+  GR
Sbjct: 221 ELLTGR 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 50  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 109
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 110 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 163
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 164 NEDXELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 235 EIACGR 240
           E+  GR
Sbjct: 220 ELLTGR 225

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 20/188 (10%)
Query: 68  YIAVKRVS-KGSKQGIK-EYASEVTIISRLR---HRNLVQLLGWC-----HEKKELLLVY 117
           ++A+KRV  +  ++G+      EV ++  L    H N+V+L   C       + +L LV+
Sbjct: 39  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 98
Query: 118 EYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           E++ +  L ++L K  E  + T   +  + Q L  GL +L       VVHRD+K  NI++
Sbjct: 99  EHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDFLHS---HRVVHRDLKPQNILV 153
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE 235
             +   K+ DFGLAR+        + V+  T+ Y APE       +   D++S G +  E
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 236 IACGRKPI 243
           +   RKP+
Sbjct: 212 M-FRRKPL 218

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 76/183 (41%), Gaps = 10/183 (5%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           ++++  +AVK + +G K        E+     LRH N+V+          L +V EY   
Sbjct: 41  KQSNELVAVKYIERGEKIA-ANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 99
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--FN 180
           G L   +         E RF   Q L SG+ Y        V HRD+K  N +LD +    
Sbjct: 100 GELFERICNAGRFSEDEARF-FFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPR 155
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIACG 239
            KI DFG ++       SQ     GT  Y+APE         K +DV+S G+    +  G
Sbjct: 156 LKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213
Query: 240 RKP 242
             P
Sbjct: 214 AYP 216

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 56  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 115
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 116 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 169
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 170 NEDXELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 225
Query: 235 EIACGR 240
           E+  GR
Sbjct: 226 ELLTGR 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 64/125 (51%), Gaps = 6/125 (4%)
Query: 113 LLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
           L +  E+   G+L+  + K     L      ++ + +  G+ Y+     + ++HRD+K S
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPS 165
Query: 172 NIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGI 231
           NI L      KIGDFGL   +++    + T   GT+ YM+PE  ++    KE D+Y+ G+
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKN--DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 223
Query: 232 VALEI 236
           +  E+
Sbjct: 224 ILAEL 228

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 20/188 (10%)
Query: 68  YIAVKRVS-KGSKQGIK-EYASEVTIISRLR---HRNLVQLLGWC-----HEKKELLLVY 117
           ++A+KRV  +  ++G+      EV ++  L    H N+V+L   C       + +L LV+
Sbjct: 39  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 98
Query: 118 EYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           E++ +  L ++L K  E  + T   +  + Q L  GL +L       VVHRD+K  NI++
Sbjct: 99  EHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDFLHS---HRVVHRDLKPQNILV 153
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE 235
             +   K+ DFGLAR+        + V+  T+ Y APE       +   D++S G +  E
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 236 IACGRKPI 243
           +   RKP+
Sbjct: 212 MF-RRKPL 218

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 20/188 (10%)
Query: 68  YIAVKRVS-KGSKQGIK-EYASEVTIISRLR---HRNLVQLLGWC-----HEKKELLLVY 117
           ++A+KRV  +  ++G+      EV ++  L    H N+V+L   C       + +L LV+
Sbjct: 39  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 98
Query: 118 EYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           E++ +  L ++L K  E  + T   +  + Q L  GL +L       VVHRD+K  NI++
Sbjct: 99  EHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDFLHS---HRVVHRDLKPQNILV 153
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALE 235
             +   K+ DFGLAR+        + V+  T+ Y APE       +   D++S G +  E
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 236 IACGRKPI 243
           +   RKP+
Sbjct: 212 M-FRRKPL 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 47  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 106
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 107 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 160
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 161 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 235 EIACGR 240
           E+  GR
Sbjct: 217 ELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 42  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 101
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 102 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 155
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 156 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 235 EIACGR 240
           E+  GR
Sbjct: 212 ELLTGR 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGXVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 41  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 101 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 154
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 155 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 235 EIACGR 240
           E+  GR
Sbjct: 211 ELLTGR 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 50  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 109
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 110 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 163
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 164 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 235 EIACGR 240
           E+  GR
Sbjct: 220 ELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 44  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 103
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 104 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 157
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 158 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 213
Query: 235 EIACGR 240
           E+  GR
Sbjct: 214 ELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 52  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 112 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 165
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 166 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 235 EIACGR 240
           E+  GR
Sbjct: 222 ELLTGR 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 64  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 123
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 124 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 177
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 178 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 233
Query: 235 EIACGR 240
           E+  GR
Sbjct: 234 ELLTGR 239

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 56  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 115
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 116 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 169
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 170 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 225
Query: 235 EIACGR 240
           E+  GR
Sbjct: 226 ELLTGR 231

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 52  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 112 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 165
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 166 NEDCELKILDFGLAR---HTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 235 EIACGR 240
           E+  GR
Sbjct: 222 ELLTGR 227

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 47  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 106
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 107 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 160
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 161 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 235 EIACGR 240
           E+  GR
Sbjct: 217 ELLTGR 222

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 52  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 112 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 165
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 166 NEDCELKILDFGLAR---HTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 235 EIACGR 240
           E+  GR
Sbjct: 222 ELLTGR 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 42  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 101
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 102 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 155
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 156 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 235 EIACGR 240
           E+  GR
Sbjct: 212 ELLTGR 217

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 23/173 (13%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMPNGSLDSHLFKENN---LLTWEFRF 142
           E  ++ +L H+N+V+L     E   +  +L+ E+ P GSL + L + +N   L   EF  
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF-L 115
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA----KIGDFGLARLVEHAKGS 198
            + +D+  G+ +L+E     +VHR+IK  NIM  +  +     K+ DFG AR +E  +  
Sbjct: 116 IVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-- 170
Query: 199 QTTVLAGTMGYMAPECATTGRASKES--------DVYSFGIVALEIACGRKPI 243
           Q   L GT  Y+ P+        K+         D++S G+     A G  P 
Sbjct: 171 QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 65  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 124
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 125 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 178
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 179 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 235 EIACGR 240
           E+  GR
Sbjct: 235 ELLTGR 240

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 57  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 116
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 117 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 170
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 171 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 235 EIACGR 240
           E+  GR
Sbjct: 227 ELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 57  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 116
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 117 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 170
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 171 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 235 EIACGR 240
           E+  GR
Sbjct: 227 ELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 51  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 110
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 111 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 164
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 165 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 235 EIACGR 240
           E+  GR
Sbjct: 221 ELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 47  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 106
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 107 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 160
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 161 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 235 EIACGR 240
           E+  GR
Sbjct: 217 ELLTGR 222

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 41  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 101 VTHLM--GADLNNIVKCAKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 154
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 155 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 235 EIACGR 240
           E+  GR
Sbjct: 211 ELLTGR 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 52  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 112 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 165
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 166 NEDCELKILDFGLAR---HTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 235 EIACGR 240
           E+  GR
Sbjct: 222 ELLTGR 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 47  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 106
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 107 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 160
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 161 NEDSELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 235 EIACGR 240
           E+  GR
Sbjct: 217 ELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 51  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 110
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 111 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 164
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 165 NEDSELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 235 EIACGR 240
           E+  GR
Sbjct: 221 ELLTGR 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 68  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 127
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 128 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 181
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 182 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 237
Query: 235 EIACGR 240
           E+  GR
Sbjct: 238 ELLTGR 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 50  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 109
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 110 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 163
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 164 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 235 EIACGR 240
           E+  GR
Sbjct: 220 ELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 43  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 102
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 103 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 156
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 157 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 212
Query: 235 EIACGR 240
           E+  GR
Sbjct: 213 ELLTGR 218

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 14/180 (7%)
Query: 65  TSSYIAVKRVS-KGSKQGIKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN 122
           T+  +A+KR+  +  ++G+   A  EV+++  L+HRN+++L    H    L L++EY  N
Sbjct: 58  TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA- 181
             L  ++ K  ++     +  + Q L +G+ +      +C +HRD+K  N++L ++  + 
Sbjct: 118 -DLKKYMDKNPDVSMRVIKSFLYQ-LINGVNFCHS--RRC-LHRDLKPQNLLLSVSDASE 172
Query: 182 ----KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEI 236
               KIGDFGLAR        Q T    T+ Y  PE     R  S   D++S   +  E+
Sbjct: 173 TPVLKIGDFGLARAFG-IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEM 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 51  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 110
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 111 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 164
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 165 NEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 235 EIACGR 240
           E+  GR
Sbjct: 221 ELLTGR 226

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 29/191 (15%)
Query: 69  IAVKRVS-KGSKQGIKEYASEVTIISRLRHRNLVQLLGW----CHEKKELLLVYEYMPNG 123
           +AVK  S +  K   +E     T++  LRH N++  +       H   +L L+  Y   G
Sbjct: 34  VAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDMTSRHSSTQLWLITHYHEMG 91
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDL 177
           SL  +L  +   L      +I   +ASGL +L       +G +  + HRD+KS NI++  
Sbjct: 92  SLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKK 148
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVL-----AGTMGYMAPEC------ATTGRASKESDV 226
           N    I D GLA  V H++ +    +      GT  YMAPE            + K  D+
Sbjct: 149 NGQCCIADLGLA--VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 227 YSFGIVALEIA 237
           ++FG+V  E+A
Sbjct: 207 WAFGLVLWEVA 217

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 26/164 (15%)
Query: 95  LRHRNLVQLLGW----CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS 150
           LRH N++  +       H   +L L+  Y   GSL  +L  +   L      +I   +AS
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIAS 116
Query: 151 GLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL- 203
           GL +L       +G +  + HRD+KS NI++  N    I D GLA  V H++ +    + 
Sbjct: 117 GLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVG 173
Query: 204 ----AGTMGYMAPEC------ATTGRASKESDVYSFGIVALEIA 237
                GT  YMAPE            + K  D+++FG+V  E+A
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKSQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGL R   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDSELKILDFGLCR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 15/184 (8%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
            +  I  K++S    Q ++    E  I   L+H N+V+L     E+    L+++ +  G 
Sbjct: 51  AAKIINTKKLSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 107
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA--- 181
           L   +         +    I Q L + L   Q G    VVHRD+K  N++L         
Sbjct: 108 LFEDIVAREYYSEADASHCIQQILEAVLHCHQMG----VVHRDLKPENLLLASKLKGAAV 163
Query: 182 KIGDFGLARLVEHAKGSQTTVL--AGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           K+ DFGLA  VE   G Q      AGT GY++PE        K  D+++ G++   +  G
Sbjct: 164 KLADFGLAIEVE---GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220
Query: 240 RKPI 243
             P 
Sbjct: 221 YPPF 224

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 63  RETSSYIAVKRVSKGSKQG-IKEYA-SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           R+T   +A+K+  +      IK+ A  E+ ++ +L+H NLV LL     K+ L LV+EY 
Sbjct: 25  RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84
Query: 121 PNGSLDS----------HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS 170
            +  L            HL K    +TW+            L  +    +   +HRD+K 
Sbjct: 85  DHTVLHELDRYQRGVPEHLVKS---ITWQ-----------TLQAVNFCHKHNCIHRDVKP 130
Query: 171 SNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-TGRASKESDVYSF 229
            NI++  +   K+ DFG ARL+          +A T  Y +PE      +     DV++ 
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPVDVWAI 189
Query: 230 GIVALEIACGRKPISLTAKEEVQVYLVQ 257
           G V  E+  G  P+     +  Q+YL++
Sbjct: 190 GCVFAELLSG-VPLWPGKSDVDQLYLIR 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 26/164 (15%)
Query: 95  LRHRNLVQLLGW----CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS 150
           LRH N++  +       H   +L L+  Y   GSL  +L  +   L      +I   +AS
Sbjct: 88  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIAS 145
Query: 151 GLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL- 203
           GL +L       +G +  + HRD+KS NI++  N    I D GLA  V H++ +    + 
Sbjct: 146 GLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQLDVG 202
Query: 204 ----AGTMGYMAPEC------ATTGRASKESDVYSFGIVALEIA 237
                GT  YMAPE            + K  D+++FG+V  E+A
Sbjct: 203 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 23/173 (13%)
Query: 88  EVTIISRLRHRNLVQLLGWCHEK--KELLLVYEYMPNGSLDSHLFKENN---LLTWEFRF 142
           E  ++ +L H+N+V+L     E   +  +L+ E+ P GSL + L + +N   L   EF  
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF-L 115
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA----KIGDFGLARLVEHAKGS 198
            + +D+  G+ +L+E     +VHR+IK  NIM  +  +     K+ DFG AR +E     
Sbjct: 116 IVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDE 170
Query: 199 QTTVLAGTMGYMAPECATTGRASKES--------DVYSFGIVALEIACGRKPI 243
           Q   L GT  Y+ P+        K+         D++S G+     A G  P 
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLLVYEYM 120
           IAVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ LV   M
Sbjct: 79  IAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM 138
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
             G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ ++ +  
Sbjct: 139 --GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAVNEDCE 192
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACG 239
            KI DFGLAR   H     T  +A T  Y APE        +   D++S G +  E+  G
Sbjct: 193 LKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248
Query: 240 R 240
           R
Sbjct: 249 R 249

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H        +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H        +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFGLAR---HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 41  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 101 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 154
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR  +     +      T  Y APE         ++ D++S G +  
Sbjct: 155 NEDCELKILDFGLARHTD----DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 235 EIACGR 240
           E+  GR
Sbjct: 211 ELLTGR 216

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 19/284 (6%)
Query: 15  NEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXRETSSYIAVKRV 74
           ++Y+ D F + A P     KE+    +DF   + +             ++T    A+K +
Sbjct: 36  DKYVAD-FLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94
Query: 75  SKGS--KQG-IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK 131
           +K    K+G +  +  E  ++     R + QL     ++  L LV EY   G L + L K
Sbjct: 95  NKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK 154
Query: 132 ENNLLTWEF-RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
               +  E  RF +A+ + +     + G+    VHRDIK  NI+LD   + ++ DFG   
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCL 210
Query: 191 LVEHAKGSQTTVLAGTMGYMAPEC-------ATTGRASKESDVYSFGIVALEIACGRKPI 243
            +      ++ V  GT  Y++PE          TG    E D ++ G+ A E+  G+ P 
Sbjct: 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 244 SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMEC 287
              +  E    +V +   L  +  L++   P   RDF  Q++ C
Sbjct: 271 YADSTAETYGKIVHYKEHL--SLPLVDEGVPEEARDF-IQRLLC 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI D+GLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDYGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 75/182 (41%), Gaps = 12/182 (6%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISR-LRHRNLVQLLGWCHEKKELLLVYEYMPNG 123
           T   +AVK + +G+   I E      I  R LRH N+V+          L ++ EY   G
Sbjct: 44  TKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--FNA 181
            L   +         E RF   Q L SG+ Y        + HRD+K  N +LD +     
Sbjct: 102 ELYERICNAGRFSEDEARF-FFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRL 157
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIACGR 240
           KI DFG ++       SQ     GT  Y+APE         K +DV+S G+    +  G 
Sbjct: 158 KICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 241 KP 242
            P
Sbjct: 216 YP 217

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 17/191 (8%)
Query: 74  VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN 133
           + + ++  +K +  EV    + RH N+V  +G C     L ++       +L S +    
Sbjct: 65  IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL----A 189
            +L      +IAQ++  G+ YL     + ++H+D+KS N+  D N    I DFGL     
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180
Query: 190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRA---------SKESDVYSFGIVALEIACGR 240
            L    +  +  +  G + ++APE                SK SDV++ G +  E+    
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 241 KPISLTAKEEV 251
            P      E +
Sbjct: 241 WPFKTQPAEAI 251

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 65  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 124
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 125 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 178
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H        +A T  Y APE         ++ D++S G +  
Sbjct: 179 NEDCELKILDFGLAR---HTDDEMXGXVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 235 EIACGR 240
           E+  GR
Sbjct: 235 ELLTGR 240

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNG 123
           TS   AVK + K           EV ++ + + HRN+++L+ +  E+    LV+E M  G
Sbjct: 37  TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN--- 180
           S+ SH+ K  +    E    + QD+AS L +L     + + HRD+K  NI+ +       
Sbjct: 97  SILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSP 152
Query: 181 AKIGDFGLARLVE------HAKGSQTTVLAGTMGYMAPEC--ATTGRAS---KESDVYSF 229
            KI DFGL   ++           +     G+  YMAPE   A +  AS   K  D++S 
Sbjct: 153 VKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 230 GIVALEIACGRKPI 243
           G++   +  G  P 
Sbjct: 213 GVILYILLSGYPPF 226

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISR-LRHRNLVQLLGWCHEKKELLLVYEYMP 121
           ++++  +AVK + +G K  I E      I  R LRH N+V+          L +V EY  
Sbjct: 41  KQSNELVAVKYIERGEK--IDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 98
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--F 179
            G L   +         E RF   Q L SG+ Y        V HRD+K  N +LD +   
Sbjct: 99  GGELFERICNAGRFSEDEARF-FFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAP 154
Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIAC 238
             KI  FG ++       SQ     GT  Y+APE         K +DV+S G+    +  
Sbjct: 155 RLKICAFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212
Query: 239 GRKP 242
           G  P
Sbjct: 213 GAYP 216

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 80/185 (43%), Gaps = 14/185 (7%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISR-LRHRNLVQLLGWCHEKKELLLVYEYMP 121
           ++++  +AVK + +G K  I E      I  R LRH N+V+          L +V EY  
Sbjct: 41  KQSNELVAVKYIERGEK--IDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 98
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--F 179
            G L   +         E RF   Q L SG+ Y        V HRD+K  N +LD +   
Sbjct: 99  GGELFERICNAGRFSEDEARF-FFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAP 154
Query: 180 NAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIA 237
             KI  FG ++  V H++   T    GT  Y+APE         K +DV+S G+    + 
Sbjct: 155 RLKICAFGYSKSSVLHSQPKDTV---GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 238 CGRKP 242
            G  P
Sbjct: 212 VGAYP 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY---MPNG 123
           +A+K++S+  +  I  K    E+ ++  ++H N++ LL        L   Y++   MP  
Sbjct: 70  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM 129
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI 183
             D            + ++ + Q L  GL Y+       VVHRD+K  N+ ++ +   KI
Sbjct: 130 QTDLQKIMGMEFSEEKIQYLVYQML-KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI 185
Query: 184 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
            DFGLAR   HA    T  +  T  Y APE   +     ++ D++S G +  E+  G+
Sbjct: 186 LDFGLAR---HADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 76  KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL 135
           K S +  ++   E  I  +L+H N+V+L     E+    LV++ +  G L   +      
Sbjct: 42  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 101
Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLV 192
              +    I Q L S       G    +VHR++K  N++L         K+ DFGLA  V
Sbjct: 102 SEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 157
Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
             ++       AGT GY++PE       SK  D+++ G++   +  G  P 
Sbjct: 158 NDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T+   AVK + K  +    + + E+ I+ R  +H N++ L     + K + LV E M 
Sbjct: 49  KATNMEYAVKVIDKSKR----DPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMR 104
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM-LDLNFN 180
            G L   + ++      E  F +   +   + YL     Q VVHRD+K SNI+ +D + N
Sbjct: 105 GGELLDKILRQKFFSEREASF-VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 181 A---KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
               +I DFG A+ +    G   T    T  ++APE        +  D++S GI+   + 
Sbjct: 161 PECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 238 CGRKPIS 244
            G  P +
Sbjct: 220 AGYTPFA 226

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 76  KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL 135
           K S +  ++   E  I  +L+H N+V+L     E+    LV++ +  G L   +      
Sbjct: 43  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 102
Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLV 192
              +    I Q L S       G    +VHR++K  N++L         K+ DFGLA  V
Sbjct: 103 SEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
             ++       AGT GY++PE       SK  D+++ G++   +  G  P 
Sbjct: 159 NDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 76  KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL 135
           K S +  ++   E  I  +L+H N+V+L     E+    LV++ +  G L   +      
Sbjct: 43  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 102
Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLV 192
              +    I Q L S       G    +VHR++K  N++L         K+ DFGLA  V
Sbjct: 103 SEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
             ++       AGT GY++PE       SK  D+++ G++   +  G  P 
Sbjct: 159 NDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 67/135 (49%), Gaps = 9/135 (6%)
Query: 112 ELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS 170
           E++L+ EY   G + S    E   +++     ++ + +  G+ YL +     +VH D+K 
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKP 159
Query: 171 SNIMLDLNF---NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVY 227
            NI+L   +   + KI DFG++R + HA   +   + GT  Y+APE       +  +D++
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 228 SFGIVALEIACGRKP 242
           + GI+A  +     P
Sbjct: 218 NIGIIAYMLLTHTSP 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 68  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 127
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 128 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 181
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DFGLAR   H        +A T  Y APE         ++ D++S G +  
Sbjct: 182 NEDCELKILDFGLAR---HTDDEMXGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 237
Query: 235 EIACGR 240
           E+  GR
Sbjct: 238 ELLTGR 243

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 15/184 (8%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
            +  I  K++S    Q ++    E  I   L+H N+V+L     E+    LV++ +  G 
Sbjct: 33  AAKIINTKKLSARDHQKLER---EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA--- 181
           L   +         +    I Q L + L   Q G    VVHRD+K  N++L         
Sbjct: 90  LFEDIVAREYYSEADASHCIQQILEAVLHCHQMG----VVHRDLKPENLLLASKCKGAAV 145
Query: 182 KIGDFGLARLVEHAKGSQTTVL--AGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           K+ DFGLA  V+   G Q      AGT GY++PE        K  D+++ G++   +  G
Sbjct: 146 KLADFGLAIEVQ---GDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202
Query: 240 RKPI 243
             P 
Sbjct: 203 YPPF 206

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T+   AVK + K  +    + + E+ I+ R  +H N++ L     + K + LV E M 
Sbjct: 49  KATNMEYAVKVIDKSKR----DPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMR 104
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM-LDLNFN 180
            G L   + ++      E  F +   +   + YL     Q VVHRD+K SNI+ +D + N
Sbjct: 105 GGELLDKILRQKFFSEREASF-VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 181 A---KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIA 237
               +I DFG A+ +    G   T    T  ++APE        +  D++S GI+   + 
Sbjct: 161 PECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTML 219
Query: 238 CGRKPIS 244
            G  P +
Sbjct: 220 AGYTPFA 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY---MPNG 123
           +A+K++S+  +  I  K    E+ ++  ++H N++ LL        L   Y++   MP  
Sbjct: 52  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM 111
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI 183
             D            + ++ + Q L  GL Y+       VVHRD+K  N+ ++ +   KI
Sbjct: 112 QTDLQKIMGLKFSEEKIQYLVYQML-KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKI 167
Query: 184 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
            DFGLAR   HA    T  +  T  Y APE   +     ++ D++S G +  E+  G+
Sbjct: 168 LDFGLAR---HADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI DF LAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDFYLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 86/190 (45%), Gaps = 32/190 (16%)
Query: 87  SEVTIISRLRHRNLVQLLG--------WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTW 138
           +E+     +RH N++  +         W     +L L+ +Y  NGSL  +L  ++  L  
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWT----QLYLITDYHENGSLYDYL--KSTTLDA 133
Query: 139 EFRFKIAQDLASGLLYLQ------EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RL 191
           +   K+A    SGL +L       +G +  + HRD+KS NI++  N    I D GLA + 
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 192 VEHAKGSQT--TVLAGTMGYMAPEC--ATTGRASKES----DVYSFGIVALEIACGRKPI 243
           +              GT  YM PE    +  R   +S    D+YSFG++  E+A  R+ +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCV 250
Query: 244 SLTAKEEVQV 253
           S    EE Q+
Sbjct: 251 SGGIVEEYQL 260

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 23/190 (12%)
Query: 70  AVKRVSKGSKQGIKE-YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL--D 126
           A+KR+   +++  +E    EV  +++L H  +V+      EK     +    P   L   
Sbjct: 34  AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQ 93
Query: 127 SHLFKENNLLTW-EFRFKIAQDLASGLLYL----QEGWE----QCVVHRDIKSSNIMLDL 177
             L ++ NL  W   R  I +   S  L++     E  E    + ++HRD+K SNI   +
Sbjct: 94  MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVL-----------AGTMGYMAPECATTGRASKESDV 226
           +   K+GDFGL   ++  +  QT +             GT  YM+PE       S + D+
Sbjct: 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213
Query: 227 YSFGIVALEI 236
           +S G++  E+
Sbjct: 214 FSLGLILFEL 223

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 15/180 (8%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           I  K++S    Q ++    E  I   L+H N+V+L     E+    L+++ +  G L   
Sbjct: 44  INTKKLSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED 100
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA---KIGD 185
           +         +    I Q L + L   Q G    VVHR++K  N++L         K+ D
Sbjct: 101 IVAREYYSEADASHCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLAD 156
Query: 186 FGLARLVEHAKGSQTTVL--AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
           FGLA  VE   G Q      AGT GY++PE        K  D+++ G++   +  G  P 
Sbjct: 157 FGLAIEVE---GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI  FGLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILGFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 19/185 (10%)
Query: 65  TSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL------LLV 116
           T + +A+K++ +   S+   K    E+ ++  +RH N++ LL      + L       LV
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
             +M  G+    L K   L     +F + Q L  GL Y+       ++HRD+K  N+ ++
Sbjct: 109 MPFM--GTDLGKLMKHEKLGEDRIQFLVYQML-KGLRYIHAA---GIIHRDLKPGNLAVN 162
Query: 177 LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALE 235
            +   KI DFGLAR  +    S+      T  Y APE      R ++  D++S G +  E
Sbjct: 163 EDCELKILDFGLARQAD----SEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 236 IACGR 240
           +  G+
Sbjct: 219 MITGK 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 97  HRNLVQLLGWCHEKKELLLVYEY-MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
           H  +++LL W   ++  +LV E  +P   L  ++ ++  L     R    Q +A+    +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA----I 152
Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFN-AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 214
           Q    + VVHRDIK  NI++DL    AK+ DFG   L+        T   GT  Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFDGTRVYSPPEW 209
Query: 215 ATTGR-ASKESDVYSFGIVALEIACGRKPI 243
            +  +  +  + V+S GI+  ++ CG  P 
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 76  KGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL 135
           K S +  ++   E  I  +L+H N+V+L     E+    LV++ +  G L   +      
Sbjct: 66  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA---KIGDFGLARLV 192
              +    I Q L S       G    +VHR++K  N++L         K+ DFGLA  V
Sbjct: 126 SEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
             ++       AGT GY++PE       SK  D+++ G++   +  G  P 
Sbjct: 182 NDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI D GLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDAGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLLVYEYM 120
           +AVK++S+  +  I  +    E+ ++  L+H N++ LL          +  E+ LV   M
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
             G+  +++ K   L     +F + Q L  GL Y+       ++HRD+K SN+ ++ +  
Sbjct: 116 --GADLNNIVKSQALSDEHVQFLVYQ-LLRGLKYIHSA---GIIHRDLKPSNVAVNEDSE 169
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
            +I DFGLAR  +     + T    T  Y APE         ++ D++S G +  E+  G
Sbjct: 170 LRILDFGLARQAD----EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 240 R 240
           +
Sbjct: 226 K 226

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI D GLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDRGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 63  RETSSYIAVKRVSK-----GSKQGIK---EYASEVTIISRLRHRNLVQLLGWCHEKKELL 114
           R+T   +A+K +SK     GS +         +E+ I+ +L H  ++++  +  + ++  
Sbjct: 32  RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 90
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V E M  G L   +     L     +    Q     LL +Q   E  ++HRD+K  N++
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQYLHENGIIHRDLKPENVL 146
Query: 175 L---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC-ATTGRA--SKESDVYS 228
           L   + +   KI DFG ++++   + S    L GT  Y+APE   + G A  ++  D +S
Sbjct: 147 LSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 229 FGIVALEIACGRKPIS 244
            G++      G  P S
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 63  RETSSYIAVKRVSK-----GSKQGIK---EYASEVTIISRLRHRNLVQLLGWCHEKKELL 114
           R+T   +A+K +SK     GS +         +E+ I+ +L H  ++++  +  + ++  
Sbjct: 32  RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 90
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V E M  G L   +     L     +    Q     LL +Q   E  ++HRD+K  N++
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQYLHENGIIHRDLKPENVL 146
Query: 175 L---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC-ATTGRA--SKESDVYS 228
           L   + +   KI DFG ++++   + S    L GT  Y+APE   + G A  ++  D +S
Sbjct: 147 LSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 229 FGIVALEIACGRKPIS 244
            G++      G  P S
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 63  RETSSYIAVKRVSK-----GSKQGIK---EYASEVTIISRLRHRNLVQLLGWCHEKKELL 114
           R+T   +A+K +SK     GS +         +E+ I+ +L H  ++++  +  + ++  
Sbjct: 32  RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 90
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V E M  G L   +     L     +    Q     LL +Q   E  ++HRD+K  N++
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQYLHENGIIHRDLKPENVL 146
Query: 175 L---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC-ATTGRA--SKESDVYS 228
           L   + +   KI DFG ++++   + S    L GT  Y+APE   + G A  ++  D +S
Sbjct: 147 LSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 229 FGIVALEIACGRKPIS 244
            G++      G  P S
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL-----------AGTMGYMA 211
           ++HRD+K SNI   ++   K+GDFGL   ++  +  QT +             GT  YM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 212 PECATTGRASKESDVYSFGIVALEI 236
           PE       S + D++S G++  E+
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 19/186 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLL 115
           +T   +AVK++S+  +  I  K    E+ ++  ++H N++ LL          E  ++ L
Sbjct: 45  KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 104
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V   M  G+  +++ K   L     +F I Q L  GL Y+       ++HRD+K SN+ +
Sbjct: 105 VTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLAV 158
Query: 176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVAL 234
           + +   KI D GLAR   H     T  +A T  Y APE         ++ D++S G +  
Sbjct: 159 NEDCELKILDGGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 235 EIACGR 240
           E+  GR
Sbjct: 215 ELLTGR 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 63  RETSSYIAVKRVSK-----GSKQGIK---EYASEVTIISRLRHRNLVQLLGWCHEKKELL 114
           R+T   +A+K +SK     GS +         +E+ I+ +L H  ++++  +  + ++  
Sbjct: 31  RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 89
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V E M  G L   +     L     +    Q     LL +Q   E  ++HRD+K  N++
Sbjct: 90  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQYLHENGIIHRDLKPENVL 145
Query: 175 L---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC-ATTGRA--SKESDVYS 228
           L   + +   KI DFG ++++   + S    L GT  Y+APE   + G A  ++  D +S
Sbjct: 146 LSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 203
Query: 229 FGIVALEIACGRKPIS 244
            G++      G  P S
Sbjct: 204 LGVILFICLSGYPPFS 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 63  RETSSYIAVKRVSK-----GSKQGIK---EYASEVTIISRLRHRNLVQLLGWCHEKKELL 114
           R+T   +A+K +SK     GS +         +E+ I+ +L H  ++++  +  + ++  
Sbjct: 38  RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 96
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V E M  G L   +     L     +    Q     LL +Q   E  ++HRD+K  N++
Sbjct: 97  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQYLHENGIIHRDLKPENVL 152
Query: 175 L---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC-ATTGRA--SKESDVYS 228
           L   + +   KI DFG ++++   + S    L GT  Y+APE   + G A  ++  D +S
Sbjct: 153 LSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 210
Query: 229 FGIVALEIACGRKPIS 244
            G++      G  P S
Sbjct: 211 LGVILFICLSGYPPFS 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 19/192 (9%)
Query: 63  RETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCH------EKKELL 114
           R T   +A+K++          K    E+ I+   +H N++ +           E K + 
Sbjct: 77  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 136
Query: 115 LVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           +V + M +   D H +   +  LT E        L  GL Y+       V+HRD+K SN+
Sbjct: 137 VVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNL 190
Query: 174 MLDLNFNAKIGDFGLARLVEHAKGSQ---TTVLAGTMGYMAPECATTGRASKES-DVYSF 229
           +++ N   KIGDFG+AR +  +        T    T  Y APE   +     ++ D++S 
Sbjct: 191 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 250
Query: 230 GIVALEIACGRK 241
           G +  E+   R+
Sbjct: 251 GCIFGEMLARRQ 262

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 63  RETSSYIAVKRVSK-----GSKQGIK---EYASEVTIISRLRHRNLVQLLGWCHEKKELL 114
           R+T   +A++ +SK     GS +         +E+ I+ +L H  ++++  +  + ++  
Sbjct: 157 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 215
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V E M  G L   +     L     +    Q     LL +Q   E  ++HRD+K  N++
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQYLHENGIIHRDLKPENVL 271
Query: 175 L---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT---TGRASKESDVYS 228
           L   + +   KI DFG ++++   + S    L GT  Y+APE      T   ++  D +S
Sbjct: 272 LSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 229 FGIVALEIACGRKPIS 244
            G++      G  P S
Sbjct: 330 LGVILFICLSGYPPFS 345

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNG 123
           TS   AVK + K           EV ++ + + HRN+++L+ +  E+    LV+E M  G
Sbjct: 37  TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96
Query: 124 SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN--- 180
           S+ SH+ K  +    E    + QD+AS L +L     + + HRD+K  NI+ +       
Sbjct: 97  SILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSP 152
Query: 181 AKIGDFGLARLVE------HAKGSQTTVLAGTMGYMAPEC--ATTGRAS---KESDVYSF 229
            KI DF L   ++           +     G+  YMAPE   A +  AS   K  D++S 
Sbjct: 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 230 GIVALEIACGRKPI 243
           G++   +  G  P 
Sbjct: 213 GVILYILLSGYPPF 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 88  EVTIISRLRHRNLVQLLG-W---------------CHEKKELLLVYEYMPNGSLDSHLFK 131
           EV  +++L H N+V   G W                 + K L +  E+   G+L+  + K
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 132 ENN-LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
                L      ++ + +  G+ Y+     + +++RD+K SNI L      KIGDFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
            +++      +   GT+ YM+PE  ++    KE D+Y+ G++  E+
Sbjct: 171 SLKNDGKRXRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
           KIA  +   L +L       V+HRD+K SN++++     K+ DFG++  +  +     T+
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK--TI 212
Query: 203 LAGTMGYMAPECATTGRASK----ESDVYSFGIVALEIACGRKP 242
            AG   YMAPE        K    +SD++S GI  +E+A  R P
Sbjct: 213 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 256

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L+   + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G++  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEV-ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 63  RETSSYIAVKRVSK-----GSKQGIK---EYASEVTIISRLRHRNLVQLLGWCHEKKELL 114
           R+T   +A++ +SK     GS +         +E+ I+ +L H  ++++  +  + ++  
Sbjct: 171 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYY 229
Query: 115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM 174
           +V E M  G L   +     L     +    Q     LL +Q   E  ++HRD+K  N++
Sbjct: 230 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----MLLAVQYLHENGIIHRDLKPENVL 285
Query: 175 L---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT---TGRASKESDVYS 228
           L   + +   KI DFG ++++   + S    L GT  Y+APE      T   ++  D +S
Sbjct: 286 LSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 343
Query: 229 FGIVALEIACGRKPIS 244
            G++      G  P S
Sbjct: 344 LGVILFICLSGYPPFS 359

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L+   + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G++  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEV-ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 19/192 (9%)
Query: 63  RETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCH------EKKELL 114
           R T   +A+K++          K    E+ I+   +H N++ +           E K + 
Sbjct: 76  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135
Query: 115 LVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI 173
           +V + M +   D H +   +  LT E        L  GL Y+       V+HRD+K SN+
Sbjct: 136 VVLDLMES---DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNL 189
Query: 174 MLDLNFNAKIGDFGLARLVEHAKGSQ---TTVLAGTMGYMAPECATTGRASKES-DVYSF 229
           +++ N   KIGDFG+AR +  +        T    T  Y APE   +     ++ D++S 
Sbjct: 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249
Query: 230 GIVALEIACGRK 241
           G +  E+   R+
Sbjct: 250 GCIFGEMLARRQ 261

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 34/203 (16%)
Query: 63  RETSSYIAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKK-----ELLL 115
           + T   +A+K+V++  +  I  K    E+TI++RL+   +++L             EL +
Sbjct: 48  KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107
Query: 116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           V E + +  L   LFK    LT E    I  +L  G  ++ E     ++HRD+K +N +L
Sbjct: 108 VLE-IADSDLKK-LFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLL 162
Query: 176 DLNFNAKIGDFGLARLVEHAKGS---------------------QTTVLAGTMGYMAPEC 214
           + + + K+ DFGLAR +   K +                     Q T    T  Y APE 
Sbjct: 163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222
Query: 215 ATTGRA-SKESDVYSFGIVALEI 236
                  +K  D++S G +  E+
Sbjct: 223 ILLQENYTKSIDIWSTGCIFAEL 245

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR    +   +  V+  T  Y APE    G   KE+ D++S G +  E+ C +
Sbjct: 166 KILDFGLARTAGTSFMMEPEVV--TRYYRAPE-VILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLLVYEYM 120
           +AVK++S+  +  I  +    E+ ++  L+H N++ LL          +  E+ LV   M
Sbjct: 48  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 107
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
             G+  +++ K   L     +F + Q L  GL Y+       ++HRD+K SN+ ++ +  
Sbjct: 108 --GADLNNIVKCQALSDEHVQFLVYQ-LLRGLKYIHSA---GIIHRDLKPSNVAVNEDCE 161
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
            +I DFGLAR  +     + T    T  Y APE         ++ D++S G +  E+  G
Sbjct: 162 LRILDFGLARQAD----EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217
Query: 240 R 240
           +
Sbjct: 218 K 218

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 21/197 (10%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL----EEFQDVYLV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+   R 
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RH 221
Query: 242 PISLTAKEEVQVYLVQW 258
            I    ++    Y+ QW
Sbjct: 222 KILFPGRD----YIDQW 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 70  AVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           AVK + K +         EV  + + + ++N+++L+ +  +     LV+E +  GS+ +H
Sbjct: 42  AVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAH 101
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGD 185
           + K+ +    E   ++ +D+A+ L +L     + + HRD+K  NI+ +        KI D
Sbjct: 102 IQKQKHFNEREAS-RVVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICD 157
Query: 186 FGLARLVEHAKGS------QTTVLAGTMGYMAPECAT--TGRAS---KESDVYSFGIVAL 234
           F L   ++           + T   G+  YMAPE     T +A+   K  D++S G+V  
Sbjct: 158 FDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLY 217
Query: 235 EIACGRKPI 243
            +  G  P 
Sbjct: 218 IMLSGYPPF 226

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 101
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 102 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+ C +
Sbjct: 160 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 21/197 (10%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL----EEFQDVYLV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+   R 
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RH 221
Query: 242 PISLTAKEEVQVYLVQW 258
            I    ++    Y+ QW
Sbjct: 222 KILFPGRD----YIDQW 234

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGW------CHEKKELLLVYEYM 120
           +AVK++S+  +  I  +    E+ ++  L+H N++ LL          +  E+ LV   M
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
             G+  +++ K   L     +F + Q L  GL Y+       ++HRD+K SN+ ++ +  
Sbjct: 116 --GADLNNIVKCQALSDEHVQFLVYQ-LLRGLKYIHSA---GIIHRDLKPSNVAVNEDSE 169
Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
            +I DFGLAR  +     + T    T  Y APE         ++ D++S G +  E+  G
Sbjct: 170 LRILDFGLARQAD----EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 240 R 240
           +
Sbjct: 226 K 226

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 25/197 (12%)
Query: 63  RETSSYIAVKRVSKG---SKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY 117
           RET    AVK V      S  G+  ++   E +I   L+H ++V+LL        L +V+
Sbjct: 46  RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLL-YLQEGWEQC----VVHRDIKSSN 172
           E+M    L   + K  +       F  ++ +AS  +  + E    C    ++HRD+K   
Sbjct: 106 EFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160
Query: 173 IMLDLNFNA---KIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATTGRASKESDV 226
           ++L    N+   K+G FG+A  +    G    V  G +G   +MAPE        K  DV
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQL----GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDV 216
Query: 227 YSFGIVALEIACGRKPI 243
           +  G++   +  G  P 
Sbjct: 217 WGCGVILFILLSGCLPF 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 19/228 (8%)
Query: 27  GPKRFTYKELAQATNDFNDDQKLXXXXXXXXXXXXXR-----ETSSYIA-VKRVSKGSKQ 80
           G +   ++ +A  T  F DD +L             R      T  Y A +    K S +
Sbjct: 14  GTENLYFQXMATCTR-FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR 72
Query: 81  GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEF 140
             ++   E  I   L+H N+V+L     E+    LV++ +  G L   +         + 
Sbjct: 73  DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADA 132
Query: 141 RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA---KIGDFGLARLVEHAKG 197
              I Q L S    +    +  +VHRD+K  N++L         K+ DFGLA  V+   G
Sbjct: 133 SHCIHQILES----VNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ---G 185
Query: 198 SQTTVL--AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
            Q      AGT GY++PE        K  D+++ G++   +  G  P 
Sbjct: 186 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 112
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 113 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 170
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+ C +
Sbjct: 171 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL------LLVYEYM 120
           +AVK +     +   I+E+  E   +    H ++ +L+G     +        +++  +M
Sbjct: 54  VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 121 PNGSLDSHLFK----ENNL-LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
            +G L + L      EN   L  +   +   D+A G+ YL     +  +HRD+ + N ML
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCML 170
Query: 176 DLNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGI 231
             +    + DFGL+R +     + +G  + +    + ++A E       +  SDV++FG+
Sbjct: 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKL---PVKWLALESLADNLYTVHSDVWAFGV 227
Query: 232 VALEIAC-GRKPISLTAKEEVQVYLV 256
              EI   G+ P +     E+  YL+
Sbjct: 228 TMWEIMTRGQTPYAGIENAEIYNYLI 253

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 25/197 (12%)
Query: 63  RETSSYIAVKRVSKG---SKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY 117
           RET    AVK V      S  G+  ++   E +I   L+H ++V+LL        L +V+
Sbjct: 48  RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 107
Query: 118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLL-YLQEGWEQC----VVHRDIKSSN 172
           E+M    L   + K  +       F  ++ +AS  +  + E    C    ++HRD+K   
Sbjct: 108 EFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 162
Query: 173 IMLDLNFNA---KIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATTGRASKESDV 226
           ++L    N+   K+G FG+A  +    G    V  G +G   +MAPE        K  DV
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQL----GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDV 218
Query: 227 YSFGIVALEIACGRKPI 243
           +  G++   +  G  P 
Sbjct: 219 WGCGVILFILLSGCLPF 235

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 21/197 (10%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL----EEFQDVYLV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+   R 
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RH 221
Query: 242 PISLTAKEEVQVYLVQW 258
            I    ++    Y+ QW
Sbjct: 222 KILFPGRD----YIDQW 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 105
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L      ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 106 MELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 163
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR    +     T    T  Y APE    G   KE+ D++S G +  E+  G
Sbjct: 164 KILDFGLARTA--STNFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR    +   +  V+  T  Y APE    G   KE+ D++S G +  E+ C +
Sbjct: 166 KILDFGLARTAGTSFMMEPEVV--TRYYRAPE-VILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 99  NLVQLLGWCHEKKELLLVYEYM-PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQ 156
            +++LL W       +L+ E M P   L   + +         R  + ++LA    + + 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITE---------RGALQEELARSFFWQVL 124
Query: 157 EGWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           E    C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSP 181
Query: 212 PECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           PE     R   + + V+S GI+  ++ CG  P 
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 21/197 (10%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 100
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 101 MELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 158
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+   R 
Sbjct: 159 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RH 214
Query: 242 PISLTAKEEVQVYLVQW 258
            I    ++    Y+ QW
Sbjct: 215 KILFPGRD----YIDQW 227

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L      ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE       +   D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--CTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 101
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 102 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 160 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 214
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 215 HKILFPGRD----YIDQW 228

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 21/197 (10%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+   R 
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RH 221
Query: 242 PISLTAKEEVQVYLVQW 258
            I    ++    Y+ QW
Sbjct: 222 KILFPGRD----YIDQW 234

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 145
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 146 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 204 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 258
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 259 HKILFPGRD----YIDQW 272

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 101
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 102 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 160 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 214
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 215 HKILFPGRD----YIDQW 228

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 220
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 221 HKILFPGRD----YIDQW 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 108
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 109 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 167 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 221
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 222 HKILFPGRD----YIDQW 235

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 108
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 109 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 167 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 221
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 222 HKILFPGRD----YIDQW 235

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 100
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 101 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 159 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 213
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 214 HKILFPGRD----YIDQW 227

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 106
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 107 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 164
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 165 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 219
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 220 HKILFPGRD----YIDQW 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 220
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 221 HKILFPGRD----YIDQW 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  L 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL----EEFQDVYLV 145
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 146 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+   R
Sbjct: 204 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMV--R 258
Query: 241 KPISLTAKEEVQVYLVQW 258
             I    ++    Y+ QW
Sbjct: 259 HKILFPGRD----YIDQW 272

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 16/107 (14%)
Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV- 192
           +L+++ F+      +A G+ +L     +C+ HRD+ + NI+L  N   KI DFGLAR + 
Sbjct: 200 DLISYSFQ------VARGMEFLSS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIY 250
Query: 193 ---EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
              ++ +   T +    + +MAPE       S +SDV+S+G++  EI
Sbjct: 251 KNPDYVRKGDTRL---PLKWMAPESIFDKIYSTKSDVWSYGVLLWEI 294

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L+   + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L+   + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 10/105 (9%)
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTT 201
           KIA  +   L +L    +  V+HRD+K SN++++     K+ DFG++  LV+        
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--- 167
Query: 202 VLAGTMGYMAPECATTGRASK----ESDVYSFGIVALEIACGRKP 242
           + AG   YMAPE        K    +SD++S GI  +E+A  R P
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 73  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 124
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 181
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 39/79 (49%)
Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
            HRD+K  NI++  +  A + DFG+A      K +Q     GT+ Y APE  +   A+  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 224 SDVYSFGIVALEIACGRKP 242
           +D+Y+   V  E   G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 75  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 126
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 183
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 74  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 125
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 182
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 70  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 121
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 70  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 121
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 51  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 109
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 110 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 162
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 163 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 220 YDMVCGDIPF 229

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 51  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 109
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 110 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 162
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 163 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 220 YDMVCGDIPF 229

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 18/151 (11%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEG 158
           +++LL W       +L+ E  P    D   F          R  + ++LA    + + E 
Sbjct: 118 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLEA 169
Query: 159 WEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
              C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  PE
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPE 226
Query: 214 CATTGR-ASKESDVYSFGIVALEIACGRKPI 243
                R   + + V+S GI+  ++ CG  P 
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 75  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 126
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 183
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 52  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 110
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 111 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 163
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 164 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 221 YDMVCGDIPF 230

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 75  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 126
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 183
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 52  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 110
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 111 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 163
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 164 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 221 YDMVCGDIPF 230

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L+   + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 70  GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 121
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPI 243
           E     R   + + V+S GI+  ++ CG  P 
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 52  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 110
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 111 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 163
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 164 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 221 YDMVCGDIPF 230

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L+   + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE        +  D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 59  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 117
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 118 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 170
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 171 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 227
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 228 YDMVCGDIPF 237

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 23/188 (12%)
Query: 65  TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGS 124
            +  I  K++S    Q ++    E  I   L+H N+V+L     E+    LV++ +  G 
Sbjct: 33  AAKIINTKKLSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 89
Query: 125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC----VVHRDIKSSNIML---DL 177
           L   +            +    D +  +  + E    C    +VHRD+K  N++L     
Sbjct: 90  LFEDIVARE--------YYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSK 141
Query: 178 NFNAKIGDFGLARLVEHAKGSQTTVL--AGTMGYMAPECATTGRASKESDVYSFGIVALE 235
               K+ DFGLA  V+   G Q      AGT GY++PE        K  D+++ G++   
Sbjct: 142 GAAVKLADFGLAIEVQ---GDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYI 198
Query: 236 IACGRKPI 243
           +  G  P 
Sbjct: 199 LLVGYPPF 206

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 108 HEKKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           H K+ LL++ E M  G L S + +  +   T     +I +D+ + + +L       + HR
Sbjct: 77  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHR 133
Query: 167 DIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           D+K  N++    + +   K+ DFG A+  E  + +  T    T  Y+APE     +  K 
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCY-TPYYVAPEVLGPEKYDKS 190
Query: 224 SDVYSFGIVALEIACGRKPI 243
            D++S G++   + CG  P 
Sbjct: 191 CDMWSLGVIMYILLCGFPPF 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 108 HEKKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           H K+ LL++ E M  G L S + +  +   T     +I +D+ + + +L       + HR
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHR 152
Query: 167 DIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           D+K  N++    + +   K+ DFG A+  E  + +  T    T  Y+APE     +  K 
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCY-TPYYVAPEVLGPEKYDKS 209
Query: 224 SDVYSFGIVALEIACGRKPI 243
            D++S G++   + CG  P 
Sbjct: 210 CDMWSLGVIMYILLCGFPPF 229

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 137
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 138 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 190
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 191 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 248 YDMVCGDIPF 257

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 64  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 122
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 123 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 175
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 176 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 233 YDMVCGDIPF 242

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 23/184 (12%)
Query: 69  IAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSH 128
           I  K++S    Q ++    E  I   L+H N+V+L     E+    LV++ +  G L   
Sbjct: 37  INTKKLSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFED 93
Query: 129 LFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC----VVHRDIKSSNIML---DLNFNA 181
           +            +    D +  +  + E    C    +VHRD+K  N++L         
Sbjct: 94  IVARE--------YYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAV 145
Query: 182 KIGDFGLARLVEHAKGSQTTVL--AGTMGYMAPECATTGRASKESDVYSFGIVALEIACG 239
           K+ DFGLA  V+   G Q      AGT GY++PE        K  D+++ G++   +  G
Sbjct: 146 KLADFGLAIEVQ---GDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202
Query: 240 RKPI 243
             P 
Sbjct: 203 YPPF 206

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 18/151 (11%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEG 158
           +++LL W       +L+ E  P    D   F          R  + ++LA    + + E 
Sbjct: 103 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLEA 154
Query: 159 WEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
              C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  PE
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPE 211
Query: 214 CATTGR-ASKESDVYSFGIVALEIACGRKPI 243
                R   + + V+S GI+  ++ CG  P 
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 31/209 (14%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 137
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 138 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 190
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 191 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247
Query: 234 LEIACGRKPISLTAKEEV---QVYLVQWV 259
            ++ CG  P      EE+   QV+  Q V
Sbjct: 248 YDMVCGDIPFE--HDEEIIRGQVFFRQRV 274

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 64  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 122
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 123 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 175
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 176 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 233 YDMVCGDIPF 242

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 31/209 (14%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 71  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 129
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 130 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 183 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 234 LEIACGRKPISLTAKEEV---QVYLVQWV 259
            ++ CG  P      EE+   QV+  Q V
Sbjct: 240 YDMVCGDIPFE--HDEEIIRGQVFFRQRV 266

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 65  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 124 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 176
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 177 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 234 YDMVCGDIPF 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 65  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 124 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 176
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 177 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 234 YDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 64  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 122
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 123 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 175
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 176 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 233 YDMVCGDIPF 242

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 69  IAVKRVSK------GSKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLLVYEYM 120
           +A+K V K      G          EV ++ ++      +++LL W       +L+ E  
Sbjct: 65  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-R 123
Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC----VVHRDIKSSNIML 175
           P    D   F          R  + ++LA    + + E    C    V+HRDIK  NI++
Sbjct: 124 PEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 176
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVA 233
           DLN    K+ DFG   L+   K +  T   GT  Y  PE     R   + + V+S GI+ 
Sbjct: 177 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233
Query: 234 LEIACGRKPI 243
            ++ CG  P 
Sbjct: 234 YDMVCGDIPF 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 18/151 (11%)
Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEG 158
           +++LL W       +L+ E  P    D   F          R  + ++LA    + + E 
Sbjct: 104 VIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLEA 155
Query: 159 WEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
              C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  PE
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPE 212
Query: 214 CATTGR-ASKESDVYSFGIVALEIACGRKPI 243
                R   + + V+S GI+  ++ CG  P 
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 23/171 (13%)
Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQE 157
            +++LL W       +L+ E  P    D   F          R  + ++LA    + + E
Sbjct: 122 GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITE-------RGALQEELARSFFWQVLE 173
Query: 158 GWEQC----VVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               C    V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  P
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 230
Query: 213 ECATTGR-ASKESDVYSFGIVALEIACGRKPISLTAKEEV---QVYLVQWV 259
           E     R   + + V+S GI+  ++ CG  P      EE+   QV+  Q V
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQVFFRQRV 279

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 108
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 109 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+  G
Sbjct: 167 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSK--GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPYVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 107
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 108 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR          T    T  Y APE    G   KE+ D++S G +  E+  G
Sbjct: 166 KILDFGLARTA--GTSFMMTPEVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 91  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 147
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 205
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 206 MWSLGVIMYILLCGYPPF 223

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 92  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 148
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 206
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 207 MWSLGVIMYILLCGYPPF 224

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 143
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 201
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 202 MWSLGVIMYILLCGYPPF 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 93  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 149
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 207
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 208 MWSLGVIMYILLCGYPPF 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 22/191 (11%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T+   AVK + K  +    +   E+ I+ R  +H N++ L     + K + +V E M 
Sbjct: 44  KATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSSNIM-LD 176
            G L   + ++        +F   ++ ++ L  + +  E    Q VVHRD+K SNI+ +D
Sbjct: 100 GGELLDKILRQ--------KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151
Query: 177 LNFNA---KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
            + N    +I DFG A+ +    G   T    T  ++APE           D++S G++ 
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLL 210
Query: 234 LEIACGRKPIS 244
             +  G  P +
Sbjct: 211 YTMLTGYTPFA 221

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 86  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 142
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 200
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 201 MWSLGVIMYILLCGYPPF 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 141
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 199
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 200 MWSLGVIMYILLCGYPPF 217

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 9/137 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 187
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 226 VYSFGIVALEIACGRKP 242
           ++S G++   + CG  P
Sbjct: 246 MWSLGVIMYILLCGYPP 262

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 101 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 157
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 215
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 216 MWSLGVIMYILLCGYPPF 233

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 9/137 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 143
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 201
Query: 226 VYSFGIVALEIACGRKP 242
           ++S G++   + CG  P
Sbjct: 202 MWSLGVIMYILLCGYPP 218

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 10/108 (9%)
Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
            + LT E     +  +A G+ +L     +C+ HRD+ + NI+L      KI DFGLAR +
Sbjct: 192 KDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEKNVVKICDFGLARDI 248
Query: 193 ----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
               ++ +     +    + +MAPE       + +SDV+SFG++  EI
Sbjct: 249 YKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 10/108 (9%)
Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
            + LT E     +  +A G+ +L     +C+ HRD+ + NI+L      KI DFGLAR +
Sbjct: 194 KDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEKNVVKICDFGLARDI 250
Query: 193 ----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
               ++ +     +    + +MAPE       + +SDV+SFG++  EI
Sbjct: 251 YKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 69  IAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +A+K++S+   ++   K    E+ ++  + H+N++ LL     +K L    E   +  + 
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIV 109
Query: 127 SHLFKENNLLTWEFRFKIAQDLASGLLY-----LQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             L   N  L    + ++  +  S LLY     ++      ++HRD+K SNI++  +   
Sbjct: 110 MELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 167
Query: 182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACG 239
           KI DFGLAR               T  Y APE    G   KE+ D++S G +  E+  G
Sbjct: 168 KILDFGLARTA--GTSFMMVPFVVTRYYRAPE-VILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 9/137 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 137 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 193
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 251
Query: 226 VYSFGIVALEIACGRKP 242
           ++S G++   + CG  P
Sbjct: 252 MWSLGVIMYILLCGYPP 268

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 10/108 (9%)
Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
            + LT E     +  +A G+ +L     +C+ HRD+ + NI+L      KI DFGLAR +
Sbjct: 185 KDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEKNVVKICDFGLARDI 241
Query: 193 ----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
               ++ +     +    + +MAPE       + +SDV+SFG++  EI
Sbjct: 242 YKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 131 RKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS---INIAHRDV 187
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 226 VYSFGIVALEIACGRKPI 243
            +S G++   + CG  P 
Sbjct: 246 XWSLGVIXYILLCGYPPF 263

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 10/108 (9%)
Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
            + LT E     +  +A G+ +L     +C+ HRD+ + NI+L      KI DFGLAR +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLAS--RKCI-HRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 193 ----EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEI 236
               ++ +     +    + +MAPE       + +SDV+SFG++  EI
Sbjct: 244 YKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 70/135 (51%), Gaps = 12/135 (8%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKK-----ELLLVYEYMP 121
           +A+K+V++  +  I  K    E+TI++RL+   +++L      +      EL +V E + 
Sbjct: 56  VAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLE-IA 114
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
           +  L   LFK    LT +    I  +L  G  ++ E     ++HRD+K +N +L+ + + 
Sbjct: 115 DSDLKK-LFKTPIFLTEQHVKTILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSV 170
Query: 182 KIGDFGLARLVEHAK 196
           KI DFGLAR +   K
Sbjct: 171 KICDFGLARTINSDK 185

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 110 KKELLLVYEYMPNGSLDSHLF-KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
           +K LL+V E +  G L S +  + +   T     +I + +   + YL       + HRD+
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 141
Query: 169 KSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           K  N++      N   K+ DFG A+  E    +  T    T  Y+APE     +  K  D
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCD 199
Query: 226 VYSFGIVALEIACGRKPI 243
           ++S G++   + CG  P 
Sbjct: 200 MWSLGVIMYILLCGYPPF 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 71/141 (50%), Gaps = 12/141 (8%)
Query: 69  IAVKRVSKGSKQGI--KEYASEVTIISRLRHRNLVQLLGWCHEKK-----ELLLVYEYMP 121
           +A+K++ +  +  I  K    E+ I++RL H ++V++L     K      EL +V E   
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA- 139
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA 181
             S    LF+    LT      +  +L  G+ Y+       ++HRD+K +N +++ + + 
Sbjct: 140 -DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSV 195
Query: 182 KIGDFGLARLVEHAKGSQTTV 202
           K+ DFGLAR V++ +   + +
Sbjct: 196 KVCDFGLARTVDYPENGNSQL 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 10/105 (9%)
Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTT 201
           KIA  +   L +L    +  V+HRD+K SN++++     K  DFG++  LV+        
Sbjct: 140 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKD--- 194
Query: 202 VLAGTMGYMAPECATTGRASK----ESDVYSFGIVALEIACGRKP 242
           + AG   Y APE        K    +SD++S GI  +E+A  R P
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 64  ETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEY 119
           E     A+K V+  +   Q +  Y +E+  +++L+  +  +++L  +    + + +V E 
Sbjct: 34  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 92
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             N  L+S L K+ ++  WE +      L +     Q G    +VH D+K +N ++ ++ 
Sbjct: 93  CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLI-VDG 147
Query: 180 NAKIGDFGLARLVEHAKGSQTTVL----AGTMGYMAPECATTGRASKES----------- 224
             K+ DFG+A      +   T+V+     GT+ YM PE      +S+E+           
Sbjct: 148 MLKLIDFGIAN---QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 204
Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G +   +  G+ P
Sbjct: 205 DVWSLGCILYYMTYGKTP 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 64  ETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEY 119
           E     A+K V+  +   Q +  Y +E+  +++L+  +  +++L  +    + + +V E 
Sbjct: 50  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             N  L+S L K+ ++  WE +      L +     Q G    +VH D+K +N ++ ++ 
Sbjct: 109 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLI-VDG 163
Query: 180 NAKIGDFGLARLVEHAKGSQTTVL----AGTMGYMAPECATTGRASKES----------- 224
             K+ DFG+A      +   T+V+     GT+ YM PE      +S+E+           
Sbjct: 164 MLKLIDFGIAN---QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G +   +  G+ P
Sbjct: 221 DVWSLGCILYYMTYGKTP 238

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 64  ETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEY 119
           E     A+K V+  +   Q +  Y +E+  +++L+  +  +++L  +    + + +V E 
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             N  L+S L K+ ++  WE +      L +     Q G    +VH D+K +N ++ ++ 
Sbjct: 137 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLI-VDG 191
Query: 180 NAKIGDFGLARLVEHAKGSQTTVL----AGTMGYMAPECATTGRASKES----------- 224
             K+ DFG+A  ++      T+V+     GT+ YM PE      +S+E+           
Sbjct: 192 MLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G +   +  G+ P
Sbjct: 249 DVWSLGCILYYMTYGKTP 266

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 30/199 (15%)
Query: 64  ETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEY 119
           E     A+K V+  +   Q +  Y +E+  +++L+  +  +++L  +    + + +V E 
Sbjct: 50  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             N  L+S L K+ ++  WE +      L +     Q G    +VH D+K +N ++ ++ 
Sbjct: 109 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLI-VDG 163
Query: 180 NAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGRASKES---------- 224
             K+ DFG+A  ++       K SQ     GT+ YM PE      +S+E+          
Sbjct: 164 MLKLIDFGIANQMQPDXXXVVKDSQ----VGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 225 -DVYSFGIVALEIACGRKP 242
            DV+S G +   +  G+ P
Sbjct: 220 SDVWSLGCILYYMTYGKTP 238

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 91/198 (45%), Gaps = 28/198 (14%)
Query: 64  ETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEY 119
           E     A+K V+  +   Q +  Y +E+  +++L+  +  +++L  +    + + +V E 
Sbjct: 30  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 88
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             N  L+S L K+ ++  WE +      L +     Q G    +VH D+K +N ++ ++ 
Sbjct: 89  CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLI-VDG 143
Query: 180 NAKIGDFGLARLVEHAKGSQTTVL----AGTMGYMAPECATTGRASKES----------- 224
             K+ DFG+A      +   T+V+     GT+ YM PE      +S+E+           
Sbjct: 144 MLKLIDFGIAN---QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 200
Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G +   +  G+ P
Sbjct: 201 DVWSLGCILYYMTYGKTP 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 64  ETSS---YIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM 120
           ETSS   Y+A     KG+ Q + +   E++I++  RHRN++ L       +EL++++E++
Sbjct: 26  ETSSKKTYMAKFVKVKGTDQVLVK--KEISILNIARHRNILHLHESFESMEELVMIFEFI 83
Query: 121 PNGSLDSHLFKENNLLTWEFR----FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
               LD  +F+  N   +E            +   L +L       + H DI+  NI+  
Sbjct: 84  --SGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQ 136
Query: 177 LNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
              ++  KI +FG AR ++   G    +L     Y APE       S  +D++S G +  
Sbjct: 137 TRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194
Query: 235 EIACGRKP 242
            +  G  P
Sbjct: 195 VLLSGINP 202

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 64  ETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEY 119
           E     A+K V+  +   Q +  Y +E+  +++L+  +  +++L  +    + + +V E 
Sbjct: 31  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             N  L+S L K+ ++  WE +      L +     Q G    +VH D+K +N ++ ++ 
Sbjct: 90  CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLI-VDG 144
Query: 180 NAKIGDFGLARLVEHAKGSQTTVL----AGTMGYMAPECATTGRASKES----------- 224
             K+ DFG+A  ++      T+V+     GT+ YM PE      +S+E+           
Sbjct: 145 MLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201
Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G +   +  G+ P
Sbjct: 202 DVWSLGCILYYMTYGKTP 219

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 64  ETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLVYEY 119
           E     A+K V+  +   Q +  Y +E+  +++L+  +  +++L  +    + + +V E 
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136
Query: 120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
             N  L+S L K+ ++  WE +      L +     Q G    +VH D+K +N ++ ++ 
Sbjct: 137 CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLI-VDG 191
Query: 180 NAKIGDFGLARLVEHAKGSQTTVL----AGTMGYMAPECATTGRASKES----------- 224
             K+ DFG+A  ++      T+V+     GT+ YM PE      +S+E+           
Sbjct: 192 MLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G +   +  G+ P
Sbjct: 249 DVWSLGCILYYMTYGKTP 266

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 19/187 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH---EKKE---LLLVY 117
           ++   +A+K+V +G  +  K    E+ I+ +L H N+V+L  + +   EKK+   L LV 
Sbjct: 43  DSGELVAIKKVLQG--KAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 118 EYMPNG--SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           +Y+P     +  H  +    L   +       L   L Y+       + HRDIK  N++L
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLL 155
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVA 233
           D +    K+ DFG A+  +  +G        +  Y APE          S DV+S G V 
Sbjct: 156 DPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 234 LEIACGR 240
            E+  G+
Sbjct: 214 AELLLGQ 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 22/191 (11%)
Query: 63  RETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMP 121
           + T+   AVK + K  +    +   E+ I+ R  +H N++ L     + K + +V E   
Sbjct: 44  KATNXEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXK 99
Query: 122 NGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE----QCVVHRDIKSSNIM-LD 176
            G L   + ++        +F   ++ ++ L  + +  E    Q VVHRD+K SNI+ +D
Sbjct: 100 GGELLDKILRQ--------KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151
Query: 177 LNFNA---KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
            + N    +I DFG A+ +    G   T    T  ++APE           D++S G++ 
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLL 210
Query: 234 LEIACGRKPIS 244
                G  P +
Sbjct: 211 YTXLTGYTPFA 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 19/187 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH---EKKE---LLLVY 117
           ++   +A+K+V +G  +  K    E+ I+ +L H N+V+L  + +   EKK+   L LV 
Sbjct: 43  DSGELVAIKKVLQG--KAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 118 EYMPNG--SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           +Y+P     +  H  +    L   +       L   L Y+       + HRDIK  N++L
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLL 155
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVA 233
           D +    K+ DFG A+  +  +G        +  Y APE          S DV+S G V 
Sbjct: 156 DPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 234 LEIACGR 240
            E+  G+
Sbjct: 214 AELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 19/187 (10%)
Query: 64  ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH---EKKE---LLLVY 117
           ++   +A+K+V +G  +  K    E+ I+ +L H N+V+L  + +   EKK+   L LV 
Sbjct: 43  DSGELVAIKKVLQG--KAFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 118 EYMPNG--SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML 175
           +Y+P     +  H  +    L   +       L   L Y+       + HRDIK  N++L
Sbjct: 99  DYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLL 155
Query: 176 DLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVA 233
           D +    K+ DFG A+  +  +G        +  Y APE          S DV+S G V 
Sbjct: 156 DPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 234 LEIACGR 240
            E+  G+
Sbjct: 214 AELLLGQ 220

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 88  EVTIISRLRHRNLVQL--LGWCHEKKELLLVYEYMPNG---SLDSHLFKENNLLTWEFRF 142
           E+ ++  L+H N++ L  +   H  +++ L+++Y  +     +  H   + N    +   
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 143 KIAQDLA----SGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEH 194
            + + L      G+ YL   W   V+HRD+K +NI++          KI D G ARL   
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 195 AKGSQTTV--LAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                  +  +  T  Y APE     R  +K  D+++ G +  E+    +PI    +E++
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDI 243
Query: 252 QV 253
           + 
Sbjct: 244 KT 245

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 88  EVTIISRLRHRNLVQLLGWCH---EKKELL---LVYEYMPNG--SLDSHLFKENNLLTWE 139
           E+ I+ +L H N+V+L  + +   EKK+++   LV +Y+P     +  H  +    L   
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGS 198
           +       L   L Y+       + HRDIK  N++LD +    K+ DFG A+  +  +G 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGE 177
Query: 199 QTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGRKPI 243
                  +  Y APE          S DV+S G V  E+  G +PI
Sbjct: 178 PNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 10/107 (9%)
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--FNAKIGDFGLAR---LVEHAKGS 198
           I + + S L YL     Q + HRDIK  N +   N  F  K+ DFGL++    + + +  
Sbjct: 173 IMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 199 QTTVLAGTMGYMAPECATTGRAS--KESDVYSFGIVALEIACGRKPI 243
             T  AGT  ++APE   T   S   + D +S G++   +  G  P 
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 27/124 (21%)
Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-------------NFNAKIGDFGLAR 190
           + + +ASG+ +L       ++HRD+K  NI++               N    I DFGL +
Sbjct: 120 LLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 191 LVEHAKGSQTTVL---AGTMGYMAPE-------CATTGRASKESDVYSFGIVALEIAC-G 239
            ++  + S  T L   +GT G+ APE         T  R ++  D++S G V   I   G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 240 RKPI 243
           + P 
Sbjct: 237 KHPF 240

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 68  YIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE----KKELLLVYEYMPNG 123
           + A+KR+    +Q  +E   E  +     H N+++L+ +C      K E  L+  +   G
Sbjct: 56  FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 124 SL---DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
           +L      L  + N LT +    +   +  GL  +     +   HRD+K +NI+L     
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQ 172
Query: 181 AKIGDFG-LARLVEHAKGSQTTVLAG-------TMGYMAPECATTGR---ASKESDVYSF 229
             + D G + +   H +GS+  +          T+ Y APE  +        + +DV+S 
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 230 GIVALEIACGRKPISLTAKEEVQVYLV 256
           G V   +  G  P  +  ++   V L 
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSVALA 259

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 88  EVTIISRLRHRNLVQLLGWCH---EKKE---LLLVYEYMPNG--SLDSHLFKENNLLTWE 139
           E+ I+ +L H N+V+L  + +   EKK+   L LV +Y+P     +  H  +    L   
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGS 198
           +       L   L Y+       + HRDIK  N++LD +    K+ DFG A+  +  +G 
Sbjct: 131 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGE 185
Query: 199 QTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGRKPI 243
                  +  Y APE          S DV+S G V  E+  G +PI
Sbjct: 186 PNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 230

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 88  EVTIISRLRHRNLVQLLGWCH---EKKE---LLLVYEYMPNG--SLDSHLFKENNLLTWE 139
           E+ I+ +L H N+V+L  + +   EKK+   L LV +Y+P     +  H  +    L   
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGS 198
           +       L   L Y+       + HRDIK  N++LD +    K+ DFG A+  +  +G 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGE 177
Query: 199 QTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGR 240
                  +  Y APE          S DV+S G V  E+  G+
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 88  EVTIISRLRHRNLVQLLGWCH---EKKE---LLLVYEYMPNG--SLDSHLFKENNLLTWE 139
           E+ I+ +L H N+V+L  + +   EKK+   L LV +Y+P     +  H  +    L   
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGS 198
           +       L   L Y+       + HRDIK  N++LD +    K+ DFG A+  +  +G 
Sbjct: 136 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGE 190
Query: 199 QTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGRKPI 243
                  +  Y APE          S DV+S G V  E+  G +PI
Sbjct: 191 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 88  EVTIISRLRHRNLVQLLGWCH---EKKE---LLLVYEYMPNG--SLDSHLFKENNLLTWE 139
           E+ I+ +L H N+V+L  + +   EKK+   L LV +Y+P     +  H  +    L   
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGS 198
           +       L   L Y+       + HRDIK  N++LD +    K+ DFG A+  +  +G 
Sbjct: 142 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGE 196
Query: 199 QTTVLAGTMGYMAPECATTGRASKES-DVYSFGIVALEIACGRKPI 243
                  +  Y APE          S DV+S G V  E+  G +PI
Sbjct: 197 PNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 241
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	376
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-139
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-132
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-128
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-85
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-67
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-66
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-63
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-53
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-51
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-48
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-46
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-46
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-45
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-45
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-45
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-45
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-45
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-45
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-44
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-44
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-44
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-44
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-44
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-44
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-44
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-44
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-43
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-43
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-43
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-43
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-42
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-42
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-42
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-42
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-42
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-41
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-41
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-41
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-40
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-40
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-40
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-40
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-39
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-39
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-39
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-39
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-39
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-39
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-39
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-38
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-37
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-35
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-30
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-30
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-29
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-28
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-28
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-27
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-25
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  396 bits (1021), Expect = e-139
 Identities = 113/304 (37%), Positives = 180/304 (59%), Gaps = 7/304 (2%)

Query: 19  DDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS 78
           D E   G   KRF+ +EL  A+++F++   LG+GGFG VYKG      + +AVKR+ +  
Sbjct: 9   DPEVHLG-QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEER 66

Query: 79  KQGIK-EYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENN 134
            QG + ++ +EV +IS   HRNL++L G+C    E LLVY YM NGS+ S L    +   
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126

Query: 135 LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH 194
            L W  R +IA   A GL YL +  +  ++HRD+K++NI+LD  F A +GDFGLA+L+++
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLT-AKEEVQV 253
                TT + GT+G++APE  +TG++S+++DV+ +G++ LE+  G++   L     +  V
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 254 YLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
            L+ WV  L    KL   VD  L  ++ ++++E L+ V L C       RP + +V+ +L
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 314 NSEA 317
             + 
Sbjct: 307 EGDG 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  379 bits (975), Expect = e-132
 Identities = 108/307 (35%), Positives = 168/307 (54%), Gaps = 24/307 (7%)

Query: 25  GAGPKRFTYKELAQATNDFNDDQ------KLGQGGFGGVYKGFFRETSSYIAVKRVSKG- 77
                 F++ EL   TN+F++        K+G+GGFG VYKG+   T+  +AVK+++   
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAMV 66

Query: 78  ---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENN 134
              +++  +++  E+ ++++ +H NLV+LLG+  +  +L LVY YMPNGSL   L   + 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 135 L--LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
              L+W  R KIAQ  A+G+ +L    E   +HRDIKS+NI+LD  F AKI DFGLAR  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 193 EHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           E    +  T+ + GT  YMAPE    G  + +SD+YSFG+V LEI  G   +    + + 
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ- 241

Query: 252 QVYLVQWVWDLYGNGKLLEA-VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
              L+    ++    K +E  +D ++  D D   +E +  V   C H  +N RP I++V 
Sbjct: 242 --LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298

Query: 311 HVLNSEA 317
            +L    
Sbjct: 299 QLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  368 bits (948), Expect = e-128
 Identities = 107/289 (37%), Positives = 164/289 (56%), Gaps = 9/289 (3%)

Query: 29  KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASE 88
            R    +L +ATN+F+    +G G FG VYKG  R+ +  +A+KR +  S QGI+E+ +E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGIEEFETE 85

Query: 89  VTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL---LTWEFRFKIA 145
           +  +S  RH +LV L+G+C E+ E++L+Y+YM NG+L  HL+  +     ++WE R +I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ-TTVLA 204
              A GL YL       ++HRD+KS NI+LD NF  KI DFG+++       +  +TV+ 
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202

Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
           GT+GY+ PE    GR +++SDVYSFG+V  E+ C R  I  +   E  V L +W  + + 
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHN 261

Query: 265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           NG+L + VDP L      + +       + C       RPS+  V+  L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  261 bits (669), Expect = 1e-85
 Identities = 78/308 (25%), Positives = 117/308 (37%), Gaps = 29/308 (9%)

Query: 31  FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVT 90
              + L   +      +   +G FG V+K        Y+AVK      KQ   +   EV 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQS-WQNEYEVY 70

Query: 91  IISRLRHRNLVQLLGWC----HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
            +  ++H N++Q +G          +L L+  +   GSL   L    N+++W     IA+
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAE 128

Query: 147 DLASGLLYL-------QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS- 198
            +A GL YL       ++G +  + HRDIKS N++L  N  A I DFGLA   E  K + 
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 199 QTTVLAGTMGYMAPECA-----TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV 253
            T    GT  YMAPE           A    D+Y+ G+V  E+A           +E  +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV-DEYML 247

Query: 254 YLVQWVWDLYGNGKLLEAVDPRLCRD------FDEQQMECLMIVGLWCAHPDENLRPSIR 307
              + +        + E V  +  R            M  L      C   D   R S  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 308 QVIHVLNS 315
            V   +  
Sbjct: 308 CVGERITQ 315

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  213 bits (544), Expect = 6e-67
 Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 26/280 (9%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHR 98
            D N  +K+G G FG V++  +  +   +AVK + +     + + E+  EV I+ RLRH 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL--LTWEFRFKIAQDLASGLLYLQ 156
           N+V  +G   +   L +V EY+  GSL   L K      L    R  +A D+A G+ YL 
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL- 153

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
                 +VHR++KS N+++D  +  K+ DFGL+RL      S  +  AGT  +MAPE   
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVLR 212

Query: 217 TGRASKESDVYSFGIVALEIACGRKPIS-LTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
              ++++SDVYSFG++  E+A  ++P   L           Q V  +    K LE   PR
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKCKRLEI--PR 262

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                   Q+  ++     C   +   RPS   ++ +L  
Sbjct: 263 NL----NPQVAAII---EGCWTNEPWKRPSFATIMDLLRP 295

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  213 bits (543), Expect = 1e-66
 Identities = 73/342 (21%), Positives = 127/342 (37%), Gaps = 48/342 (14%)

Query: 31  FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVT 90
               E +   ++    + +G+G +G VYKG   E    +AVK  S  ++Q    + +E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQ---NFINEKN 57

Query: 91  I--ISRLRHRNLVQLLGWCHE-----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
           I  +  + H N+ + +          + E LLV EY PNGSL  +L    +   W    +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCR 115

Query: 144 IAQDLASGLLYL------QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG 197
           +A  +  GL YL       + ++  + HRD+ S N+++  +    I DFGL+  +   + 
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 198 SQ-------TTVLAGTMGYMAPE-------CATTGRASKESDVYSFGIVALEIACGRKPI 243
            +            GT+ YMAPE             A K+ D+Y+ G++  EI      +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 244 SLTAK-EEVQVYLVQWVWDLYGNGKLLEAVD-----PRLCRDFDEQQMECLMIVGL--WC 295
                  E Q+     V +      +   V      P+    + E  +    +      C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 296 AHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPAN 337
              D   R + +     +        L          SP A+
Sbjct: 296 WDQDAEARLTAQXAEERMAE------LMMIWERNKSVSPTAH 331

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  210 bits (536), Expect = 4e-66
 Identities = 74/289 (25%), Positives = 131/289 (45%), Gaps = 35/289 (12%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-------IKEYASEVTIIS 93
           N+   ++++G+GGFG V+KG   +  S +A+K +  G  +G        +E+  EV I+S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 94  RLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLL 153
            L H N+V+L G         +V E++P G L   L  + + + W  + ++  D+A G+ 
Sbjct: 79  NLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 154 YLQEGWEQCVVHRDIKSSNIMLD-----LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 208
           Y+ +     +VHRD++S NI L          AK+ DFGL++   H      + L G   
Sbjct: 137 YM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQ 191

Query: 209 YMAPE--CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
           +MAPE   A     ++++D YSF ++   I  G  P      +E     ++++  +   G
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKFINMIREEG 246

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                  P  C      ++  ++     C   D   RP    ++  L+ 
Sbjct: 247 LRPTI--PEDC----PPRLRNVI---ELCWSGDPKKRPHFSYIVKELSE 286

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  209 bits (535), Expect = 9e-66
 Identities = 77/301 (25%), Positives = 134/301 (44%), Gaps = 29/301 (9%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
            +   ++ +G+G FG V K  +R     +A+K++   S+   K +  E+  +SR+ H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIE--SESERKAFIVELRQLSRVNHPNI 63

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL--LTWEFRFKIAQDLASGLLYLQEG 158
           V+L G C     + LV EY   GSL + L     L   T           + G+ YL   
Sbjct: 64  VKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 159 WEQCVVHRDIKSSNIMLDLNFN-AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
             + ++HRD+K  N++L       KI DFG A  ++    +  T   G+  +MAPE    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWMAPEVFEG 177

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
              S++ DV+S+GI+  E+   RKP      +E+     + +W ++   +      P L 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTR------PPLI 226

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS-EAPLPALPPKMPVPTYFSPPA 336
           ++  +  +E LM     C   D + RPS+ +++ ++       P     +  P   S P 
Sbjct: 227 KNLPK-PIESLM---TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPP 282

Query: 337 N 337
            
Sbjct: 283 G 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  202 bits (517), Expect = 6e-63
 Identities = 72/305 (23%), Positives = 120/305 (39%), Gaps = 39/305 (12%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
           +D    + LG+G FG   K   RET   + +K + +  ++  + +  EV ++  L H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           ++ +G  ++ K L  + EY+  G+L   +   ++   W  R   A+D+ASG+ YL     
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---S 126

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE-------------HAKGSQTTVLAGTM 207
             ++HRD+ S N ++  N N  + DFGLARL+                   +   + G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK 267
            +MAPE        ++ DV+SFGIV  EI              +   L            
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR------GFL 240

Query: 268 LLEA---VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPP 324
                    P             +    + C   D   RPS  ++ H L  E     L  
Sbjct: 241 DRYCPPNCPPSFFP---------IT---VRCCDLDPEKRPSFVKLEHWL--ETLRMHLAG 286

Query: 325 KMPVP 329
            +P+ 
Sbjct: 287 HLPLG 291

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  202 bits (516), Expect = 9e-63
 Identities = 66/315 (20%), Positives = 126/315 (40%), Gaps = 44/315 (13%)

Query: 42  DFND---DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLR 96
            F      + +G+G FG VY G +      +A++ +     ++  +K +  EV    + R
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H N+V  +G C     L ++       +L S +     +L      +IAQ++  G+ YL 
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA----KGSQTTVLAGTMGYMAP 212
               + ++H+D+KS N+  D N    I DFGL  +        +  +  +  G + ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 213 E---------CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY 263
           E                SK SDV++ G +  E+     P      E + ++ +       
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQM------- 255

Query: 264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALP 323
           G G         + ++  +  + C      W    +E  RP+  +++ +L     LP   
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLFC------WAFEQEE--RPTFTKLMDMLEK---LPKRN 304

Query: 324 PKMPVPTYFSPPANM 338
            ++  P +F   A +
Sbjct: 305 RRLSHPGHFWKSAEL 319

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  200 bits (512), Expect = 2e-62
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 29/283 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHR 98
                 Q++G G FG VYKG +      +AVK ++    + Q ++ + +EV ++ + RH 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           N++  +G+     +L +V ++    SL  HL         +    IA+  A G+ YL   
Sbjct: 81  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA- 138

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT-TVLAGTMGYMAPE---C 214
             + ++HRD+KS+NI L  +   KIGDFGLA       GS     L+G++ +MAPE    
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 215 ATTGRASKESDVYSFGIVALEIACGRKPIS-LTAKEEVQVYLVQWVWDLYGNGKLLEAVD 273
             +   S +SDVY+FGIV  E+  G+ P S +  ++++ + +V       G+     +  
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IEMVG-----RGSLSPDLSKV 250

Query: 274 PRLC-RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
              C +       EC           DE  RPS  +++  +  
Sbjct: 251 RSNCPKRMKRLMAEC------LKKKRDE--RPSFPRILAEIEE 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (509), Expect = 3e-62
 Identities = 80/290 (27%), Positives = 125/290 (43%), Gaps = 40/290 (13%)

Query: 42  DFND---DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG----SKQGIKEYASEVTIISR 94
           DF +   ++ +G GGFG VY+ F+      +AVK           Q I+    E  + + 
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
           L+H N++ L G C ++  L LV E+   G L+  L  +   +  +     A  +A G+ Y
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNY 120

Query: 155 LQEGWEQCVVHRDIKSSNIMLD--------LNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
           L +     ++HRD+KSSNI++          N   KI DFGLAR       +     AG 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---TTKMSAAGA 177

Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS-LTAKEEVQVYLVQWVWDLYGN 265
             +MAPE       SK SDV+S+G++  E+  G  P   +          +   + +  N
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LAVAYGVAMN 229

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
              L    P  C     +    LM     C +PD + RPS   ++  L +
Sbjct: 230 KLALPI--PSTC----PEPFAKLM---EDCWNPDPHSRPSFTNILDQLTT 270

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  192 bits (491), Expect = 2e-59
 Identities = 55/284 (19%), Positives = 105/284 (36%), Gaps = 35/284 (12%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHR 98
              N   KL +   G ++KG ++     I VK +     S +  +++  E   +    H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 99  NLVQLLGWCHE--KKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYL 155
           N++ +LG C         L+  +MP GSL + L +  N  +      K A D+A G+ +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC- 214
               E  +    + S ++M+D +  A+I    +          Q+        ++APE  
Sbjct: 128 -HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEAL 180

Query: 215 --ATTGRASKESDVYSFGIVALEIACGRKPIS-LTAKEEVQVYLVQWVWDLYGNGKLLEA 271
                    + +D++SF ++  E+     P + L+         ++    +   G     
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALEGLRPTI 232

Query: 272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
             P          +  LM     C + D   RP    ++ +L  
Sbjct: 233 --PPGI----SPHVSKLM---KICMNEDPAKRPKFDMIVPILEK 267

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  184 bits (470), Expect = 5e-56
 Identities = 64/295 (21%), Positives = 115/295 (38%), Gaps = 35/295 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLG 105
           + +G+G +G V++G ++     +AVK  S   ++   +E  +E+     LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQGE--NVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69

Query: 106 WC----HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL-----Q 156
                 H   +L L+  Y   GSL  +L  +   L      +I   +ASGL +L      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ---TTVLAGTMGYMAPE 213
              +  + HRD+KS NI++  N    I D GLA +   +            GT  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 214 ------CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV-------QVYLVQWVW 260
                       + K  D+++FG+V  E+A       +    +             + + 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
            +    +    +  R   D     +  LM     C + + + R +  ++   L  
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  179 bits (457), Expect = 8e-54
 Identities = 71/298 (23%), Positives = 116/298 (38%), Gaps = 39/298 (13%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLL 104
            +++G+G +G V+ G +R     +AVK      +    +E  +E+     +RH N++  +
Sbjct: 42  VKQIGKGRYGEVWMGKWRGE--KVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFI 97

Query: 105 GWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL----- 155
               +      +L L+ +Y  NGSL  +L  ++  L  +   K+A    SGL +L     
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL---AGTMGYMAP 212
               +  + HRD+KS NI++  N    I D GLA                  GT  YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 213 E------CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
           E           ++   +D+YSFG++  E+A       +   EE Q+     V       
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV--EEYQLPYHDLVPSDPSYE 273

Query: 267 KLLEAV---------DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
            + E V           R   D   +QM  LM     C   +   R +  +V   L  
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (456), Expect = 2e-53
 Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 33/295 (11%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLL 104
            + +G+G FG V++G +R     +AVK  S   ++   +E  +E+     LRH N++  +
Sbjct: 47  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 102

Query: 105 GWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
              ++      +L LV +Y  +GSL  +L      +T E   K+A   ASGL +L     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 161 QC-----VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL---AGTMGYMAP 212
                  + HRD+KS NI++  N    I D GLA   + A  +         GT  YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 213 E------CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
           E            + K +D+Y+ G+V  EIA           E+ Q+     V       
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG--IHEDYQLPYYDLVPSDPSVE 278

Query: 267 KLLEAVDPRLCR-DFDEQQMECLMIVGLW-----CAHPDENLRPSIRQVIHVLNS 315
           ++ + V  +  R +   +   C  +  +      C + +   R +  ++   L+ 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  173 bits (440), Expect = 9e-51
 Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 31/276 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLG 105
           +++G+G FG V+ G  R  ++ +AVK   +        ++  E  I+ +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
            C +K+ + +V E +  G   + L  E   L  +   ++  D A+G+ YL+    +C +H
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY----MAPECATTGRAS 221
           RD+ + N ++      KI DFG++R              G         APE    GR S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAASGGLRQVPVKWTAPEALNYGRYS 293

Query: 222 KESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF 280
            ESDV+SFGI+  E    G  P    + ++ + ++ +        G  L    P LC D 
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK--------GGRLPC--PELCPDA 343

Query: 281 DEQQM-ECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
             + M +C      W   P +  RPS   +   L S
Sbjct: 344 VFRLMEQC------WAYEPGQ--RPSFSTIYQELQS 371

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  162 bits (413), Expect = 8e-48
 Identities = 71/288 (24%), Positives = 129/288 (44%), Gaps = 46/288 (15%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSY-------IAVKRVSKGSKQGIKEYASEVTIISRLRHR 98
           ++ LGQG F  ++KG  RE   Y       + +K + K  +   + +    +++S+L H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           +LV   G C    E +LV E++  GSLD++L K  N +   ++ ++A+ LA+ + +L+  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE-- 130

Query: 159 WEQCVVHRDIKSSNIMLDLNFN--------AKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            E  ++H ++ + NI+L    +         K+ D G++  V      Q  +      ++
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI-----PWV 184

Query: 211 APECATTGRA-SKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGK 267
            PEC    +  +  +D +SFG    EI   G KP  +L ++              Y +  
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---------KLQFYEDRH 235

Query: 268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
            L A  P+     +      L+     C   + + RPS R +I  LNS
Sbjct: 236 QLPA--PKAAELAN------LI---NNCMDYEPDHRPSFRAIIRDLNS 272

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  160 bits (406), Expect = 9e-47
 Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 36/274 (13%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVS--KGSKQGIKEYASEVTIISRLRHRNLVQL 103
           D ++G+G F  VYKG   ET+  +A   +   K +K   + +  E  ++  L+H N+V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 104 LG----WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
                     KK ++LV E M +G+L ++L K   ++  +      + +  GL +L    
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTR- 148

Query: 160 EQCVVHRDIKSSNIMLD-LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
              ++HRD+K  NI +     + KIGD GLA L    + S    + GT  +MAPE     
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEEK 205

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL-- 276
              +  DVY+FG+  LE+A    P S   +   Q+Y             +  A   ++  
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRR-------VTSGVKPASFDKVAI 256

Query: 277 --CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQ 308
              ++  E            C   +++ R SI+ 
Sbjct: 257 PEVKEIIEG-----------CIRQNKDERYSIKD 279

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  157 bits (399), Expect = 6e-46
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 29/273 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           ++LG G FG V  G ++     +AVK + +GS     E+  E   + +L H  LV+  G 
Sbjct: 14  KELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C ++  + +V EY+ NG L ++L      L      ++  D+  G+ +L+       +HR
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGRASKE 223
           D+ + N ++D +   K+ DFG+ R V      Q     GT     + APE     + S +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185

Query: 224 SDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE 282
           SDV++FGI+  E+   G+ P  L    EV V  V         G  L    P L  D   
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKVS-------QGHRLYR--PHLASD--- 232

Query: 283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
             +  +M     C H     RP+ +Q++  +  
Sbjct: 233 -TIYQIM---YSCWHELPEKRPTFQQLLSSIEP 261

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  157 bits (399), Expect = 7e-46
 Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 31/279 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           Q++G G FG V+ G++      +A+K + +G+    +++  E  ++ +L H  LVQL G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C E+  + LV E+M +G L  +L  +  L   E    +  D+  G+ YL+   E CV+HR
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHR 128

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGRASKE 223
           D+ + N ++  N   K+ DFG+ R V      Q T   GT     + +PE  +  R S +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 224 SDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE 282
           SDV+SFG++  E+   G+ P    +  EV V  +         G  L    PRL      
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEV-VEDIS-------TGFRLYK--PRLAST--- 232

Query: 283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS--EAPL 319
             +  +M     C       RP+  +++  L    E+ L
Sbjct: 233 -HVYQIM---NHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  159 bits (403), Expect = 7e-46
 Identities = 78/303 (25%), Positives = 138/303 (45%), Gaps = 34/303 (11%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
            + +G G FG VYKG  + +S      +A+K +  G +++   ++  E  I+ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           ++L G   + K ++++ EYM NG+LD  L +++   +      + + +A+G+ YL     
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---N 165

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY--MAPECATTG 218
              VHRD+ + NI+++ N   K+ DFGL+R++E    +  T   G +     APE  +  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 219 RASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL 276
           + +  SDV+SFGIV  E+   G +P   L+  E         V     +G  L    P  
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------VMKAINDGFRLPT--PMD 274

Query: 277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN----SEAPLPALPPKMPVPTYF 332
           C       +  LM   + C   +   RP    ++ +L+    +   L  L    P  +  
Sbjct: 275 CPS----AIYQLM---MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIR 327

Query: 333 SPP 335
            P 
Sbjct: 328 LPS 330

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  158 bits (401), Expect = 1e-45
 Identities = 67/280 (23%), Positives = 126/280 (45%), Gaps = 34/280 (12%)

Query: 46  DQKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
            + LG G FG VYKG +     +    +A+K + +  S +  KE   E  +++ + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            +LLG C     + L+ + MP G L  ++ +  + +  ++       +A G+ YL++   
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 135

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATT 217
           + +VHRD+ + N+++    + KI DFGLA+L+      +     G      +MA E    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILH 193

Query: 218 GRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
              + +SDV+S+G+   E+   G KP   + A E         +  +   G+ L    P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ--PP 242

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           +C       +  +M     C   D + RP  R++I   + 
Sbjct: 243 ICTI----DVYMIM---RKCWMIDADSRPKFRELIIEFSK 275

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  158 bits (401), Expect = 2e-45
 Identities = 76/311 (24%), Positives = 127/311 (40%), Gaps = 46/311 (14%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
           + LG G FG VY+G         +   +AVK + +  S+Q   ++  E  IIS+  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL------FKENNLLTWEFRFKIAQDLASGLLY 154
           V+ +G   +     ++ E M  G L S L        + + L       +A+D+A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 155 LQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY-- 209
           L+   E   +HRDI + N +L        AKIGDFG+AR +   + S      G      
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRK--GGCAMLP 208

Query: 210 ---MAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGN 265
              M PE    G  + ++D +SFG++  EI   G  P    + +EV  ++          
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-------- 260

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPK 325
           G  ++   P+ C       +  +M     C       RP+   ++  +      P +   
Sbjct: 261 GGRMDP--PKNCPG----PVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQDPDV-IN 310

Query: 326 MPVPTYFSPPA 336
             +P  + P  
Sbjct: 311 TALPIEYGPLV 321

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  156 bits (397), Expect = 2e-45
 Identities = 67/273 (24%), Positives = 126/273 (46%), Gaps = 29/273 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           ++LG G FG V  G +R     +A+K + +GS     E+  E  ++  L H  LVQL G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C +++ + ++ EYM NG L ++L +  +    +   ++ +D+   + YL+    +  +HR
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGRASKE 223
           D+ + N +++     K+ DFGL+R V      + T   G+     +  PE     + S +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201

Query: 224 SDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE 282
           SD+++FG++  EI   G+ P       E   ++ Q        G  L    P L  +   
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------GLRLYR--PHLASE--- 248

Query: 283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
            ++  +M     C H   + RP+ + ++  +  
Sbjct: 249 -KVYTIM---YSCWHEKADERPTFKILLSNILD 277

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (395), Expect = 3e-45
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 34/279 (12%)

Query: 46  DQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           ++ LG+G FG VY+G +         +AVK   K  +    +++ SE  I+  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +L+G   E++   ++ E  P G L  +L +  N L        +  +   + YL+     
Sbjct: 77  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 132

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTG 218
             VHRDI   NI++      K+GDFGL+R +E          + T     +M+PE     
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINFR 189

Query: 219 RASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL 276
           R +  SDV+ F +   EI   G++P   L  K+         V  +   G  L    P L
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---------VIGVLEKGDRLPK--PDL 238

Query: 277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           C       +  LM     C   D + RP   +++  L+ 
Sbjct: 239 CPP----VLYTLM---TRCWDYDPSDRPRFTELVCSLSD 270

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  155 bits (395), Expect = 4e-45
 Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 43/284 (15%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYI--AVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQ 102
           D +LG G FG V +G +R     I  A+K + +G  K   +E   E  I+ +L +  +V+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L+G C + + L+LV E    G L   L  +   +      ++   ++ G+ YL+E   + 
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KN 130

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM--GYMAPECATTGRA 220
            VHRD+ + N++L     AKI DFGL++ +       T   AG     + APEC    + 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 221 SKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLC 277
           S  SDV+S+G+   E    G+KP                 +      +++  ++   R+ 
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP-----------------YKKMKGPEVMAFIEQGKRM- 232

Query: 278 RDFDEQQMEC------LMIVGLWCAHPDENLRPSIRQVIHVLNS 315
               E   EC      LM     C       RP    V   + +
Sbjct: 233 ----ECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRA 269

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  155 bits (394), Expect = 7e-45
 Identities = 79/293 (26%), Positives = 136/293 (46%), Gaps = 46/293 (15%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
           ++LG+G FG V+          +    +AVK +   +    K++  E  +++ L+H ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFRFKIAQ 146
           +  G C +   L++V+EYM +G L+  L                +    L       IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
            +ASG++YL     Q  VHRD+ + N ++  N   KIGDFG++R V         V   T
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGHT 195

Query: 207 M---GYMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDL 262
           M    +M PE     + + ESDV+SFG++  EI   G++P    +  EV   + Q     
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ----- 250

Query: 263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
              G++LE   PR+C      ++  +M   L C   +   R +I+++  +L++
Sbjct: 251 ---GRVLER--PRVCPK----EVYDVM---LGCWQREPQQRLNIKEIYKILHA 291

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  155 bits (395), Expect = 9e-45
 Identities = 76/292 (26%), Positives = 127/292 (43%), Gaps = 49/292 (16%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
            +LG+G FG V+          +    +AVK + + S+   +++  E  +++ L+H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHL--------------FKENNLLTWEFRFKIAQD 147
           +  G C E + LL+V+EYM +G L+  L                    L       +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           +A+G++YL        VHRD+ + N ++      KIGDFG++R +     S      G  
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY----STDYYRVGGR 219

Query: 208 G-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWD 261
                 +M PE     + + ESDV+SFG+V  EI   G++P    +  E    + Q    
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ---- 275

Query: 262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
               G+ LE   PR C      ++  +M     C   +   R SI+ V   L
Sbjct: 276 ----GRELER--PRACPP----EVYAIM---RGCWQREPQQRHSIKDVHARL 314

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  155 bits (394), Expect = 1e-44
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 47/287 (16%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSY---IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           ++ +G G  G V  G  R        +A+K +  G +++  +++ SE +I+ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +L G     +  ++V EYM NGSLD+ L   +   T      + + + +G+ YL    + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DL 170

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECAT 216
             VHRD+ + N+++D N   K+ DFGL+R++E            T G     + APE   
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE---DDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 217 TGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD-- 273
               S  SDV+SFG+V  E+   G +P           Y     W++  N  ++ +V+  
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP-----------Y-----WNM-TNRDVISSVEEG 270

Query: 274 -----PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                P  C       +  LM   L C H D   RP   Q++ VL++
Sbjct: 271 YRLPAPMGCPH----ALHQLM---LDCWHKDRAQRPRFSQIVSVLDA 310

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  154 bits (392), Expect = 1e-44
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 37/281 (13%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYI--AVK--RVSKGSKQGIKEYASEVTIISRLRHRNLV 101
           D++LG G FG V KG+++        AVK  +          E  +E  ++ +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +++G C E +  +LV E    G L+ +L ++N  +  +   ++   ++ G+ YL+E    
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---S 136

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECAT 216
             VHRD+ + N++L     AKI DFGL++ +      +    A T G     + APEC  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALR---ADENYYKAQTHGKWPVKWYAPECIN 193

Query: 217 TGRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP 274
             + S +SDV+SFG++  E    G+KP   +   E         V  +   G+ +    P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLEKGERMGC--P 242

Query: 275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
             C      +M  LM     C   D   RP    V   L +
Sbjct: 243 AGCPR----EMYDLM---NLCWTYDVENRPGFAAVELRLRN 276

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  154 bits (391), Expect = 2e-44
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 33/280 (11%)

Query: 46  DQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           D+ +G+G FG VY G +    +     A+K +S+    Q ++ +  E  ++  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 102 QLLGWCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            L+G     +    ++  YM +G L   +       T +        +A G+ YL E   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE--- 142

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 215
           Q  VHRD+ + N MLD +F  K+ DFGLAR +        +V           + A E  
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRHARLPVKWTALESL 200

Query: 216 TTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP 274
            T R + +SDV+SFG++  E+   G  P       ++  +L Q        G+ L    P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ--------GRRLPQ--P 250

Query: 275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
             C D     +  +M     C   D  +RP+ R ++  + 
Sbjct: 251 EYCPD----SLYQVM---QQCWEADPAVRPTFRVLVGEVE 283

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  156 bits (397), Expect = 2e-44
 Identities = 85/334 (25%), Positives = 145/334 (43%), Gaps = 62/334 (18%)

Query: 46  DQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           D+ +G G FG V  G  +  S     +A+K +  G +++  +++  E +I+ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +L G   + K +++V EYM NGSLDS L K +   T      + + +ASG+ YL    + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DM 166

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECAT 216
             VHRD+ + NI+++ N   K+ DFGL R++E              G     + +PE   
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLE---DDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 217 TGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD-- 273
             + +  SDV+S+GIV  E+   G +P           Y     W++  N  +++AVD  
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP-----------Y-----WEM-SNQDVIKAVDEG 266

Query: 274 -----PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPV 328
                P  C       +  LM   L C   D N RP   Q++ +L+              
Sbjct: 267 YRLPPPMDCPA----ALYQLM---LDCWQKDRNNRPKFEQIVSILD-------------- 305

Query: 329 PTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTS 362
                 P +++ +  A           S  + T+
Sbjct: 306 -KLIRNPGSLKIITSAAARPSNLLLDQSNVDITT 338

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  155 bits (393), Expect = 2e-44
 Identities = 75/312 (24%), Positives = 127/312 (40%), Gaps = 38/312 (12%)

Query: 47  QKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
            +LG+G FG V    +      T + +AVK++        +++  E+ I+  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 103 LLGWCHEKKE--LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
             G  +      L LV EY+P+G L   L +    L        +  +  G+ YL     
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---S 145

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 215
           +  VHRD+ + NI+++   + KI DFGLA+L+   K           G     + APE  
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---VREPGQSPIFWYAPESL 202

Query: 216 TTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD- 273
           +    S++SDV+SFG+V  E+     K  S +A+    +   +   D+    +LLE ++ 
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER---DVPALSRLLELLEE 259

Query: 274 ------PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMP 327
                 P  C      ++  LM     C  P    RPS   +   L+    L +      
Sbjct: 260 GQRLPAPPACPA----EVHELM---KLCWAPSPQDRPSFSALGPQLDM---LWSGSRGCE 309

Query: 328 VPTYFSPPANMR 339
              + + P    
Sbjct: 310 THAFTAHPEGKH 321

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  155 bits (394), Expect = 2e-44
 Identities = 70/362 (19%), Positives = 131/362 (36%), Gaps = 36/362 (9%)

Query: 22  FEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SK 79
               +G    T     Q+   +   QK+G+G FG        E      +K ++    S 
Sbjct: 5   HHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64

Query: 80  QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-------FKE 132
           +  +E   EV +++ ++H N+VQ      E   L +V +Y   G L   +       F+E
Sbjct: 65  KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124

Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
           + +L W       Q +   L ++ +   + ++HRDIKS NI L  +   ++GDFG+AR++
Sbjct: 125 DQILDW-----FVQ-ICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ 252
                       GT  Y++PE       + +SD+++ G V  E+   +      A     
Sbjct: 176 NSTVELARAC-IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--FEAGSMKN 232

Query: 253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
           + L           K++    P +   +       +          +   RPS+  ++  
Sbjct: 233 LVL-----------KIISGSFPPVSLHYSYDLRSLVS----QLFKRNPRDRPSVNSILEK 277

Query: 313 LNSEAPLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSSAASSSASR 372
                 +        +   F      +  +   P K P    +S S   +      +A  
Sbjct: 278 GFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKY 337

Query: 373 SN 374
             
Sbjct: 338 GI 339

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  156 bits (395), Expect = 2e-44
 Identities = 75/311 (24%), Positives = 126/311 (40%), Gaps = 46/311 (14%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
           + LG G FG VY+G         +   +AVK + +  S+Q   ++  E  IIS+  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL------FKENNLLTWEFRFKIAQDLASGLLY 154
           V+ +G   +     ++ E M  G L S L        + + L       +A+D+A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 155 LQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY-- 209
           L+   E   +HRDI + N +L        AKIGDFG+AR +   +        G      
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRK--GGCAMLP 249

Query: 210 ---MAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGN 265
              M PE    G  + ++D +SFG++  EI   G  P    + +EV  ++          
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-------- 301

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPK 325
           G  ++   P+ C       +  +M     C       RP+   ++  +      P +   
Sbjct: 302 GGRMDP--PKNCPG----PVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQDPDV-IN 351

Query: 326 MPVPTYFSPPA 336
             +P  + P  
Sbjct: 352 TALPIEYGPLV 362

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  153 bits (390), Expect = 2e-44
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 33/280 (11%)

Query: 46  DQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           ++ +G+G FG VY G          + AVK +++      + ++ +E  I+    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 102 QLLGWCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            LLG C   +   L+V  YM +G L + +  E +  T +        +A G+ YL     
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS--- 146

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 215
           +  VHRD+ + N MLD  F  K+ DFGLAR +        +V   T       +MA E  
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMALESL 204

Query: 216 TTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP 274
            T + + +SDV+SFG++  E+   G  P       ++ VYL+Q        G+ L    P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLLQ--P 254

Query: 275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
             C D     +  +M   L C HP   +RPS  +++  ++
Sbjct: 255 EYCPD----PLYEVM---LKCWHPKAEMRPSFSELVSRIS 287

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  158 bits (402), Expect = 3e-44
 Identities = 69/269 (25%), Positives = 130/269 (48%), Gaps = 23/269 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
            KLG G +G VY+G +++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
           C  +    ++ E+M  G+L  +L + N   ++      +A  ++S + YL+   ++  +H
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           R++ + N ++  N   K+ DFGL+RL+     +        + + APE     + S +SD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 226 VYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ 284
           V++FG++  EIA  G  P       +V   L +           +E   P  C +    +
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------DYRMER--PEGCPE----K 447

Query: 285 MECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           +  LM     C   + + RPS  ++    
Sbjct: 448 VYELM---RACWQWNPSDRPSFAEIHQAF 473

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  155 bits (394), Expect = 3e-44
 Identities = 77/280 (27%), Positives = 128/280 (45%), Gaps = 33/280 (11%)

Query: 46  DQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           ++ +G+G FG VY G          + AVK +++      + ++ +E  I+    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 102 QLLGWCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            LLG C   +   L+V  YM +G L + +  E +  T +        +A G+ +L     
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 210

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 215
           +  VHRD+ + N MLD  F  K+ DFGLAR +        +V   T       +MA E  
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMALESL 268

Query: 216 TTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP 274
            T + + +SDV+SFG++  E+   G  P       ++ VYL+Q        G+ L    P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLLQ--P 318

Query: 275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
             C D     +  +M   L C HP   +RPS  +++  ++
Sbjct: 319 EYCPD----PLYEVM---LKCWHPKAEMRPSFSELVSRIS 351

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  154 bits (391), Expect = 4e-44
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 45/288 (15%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
           ++LGQG FG VY+G  +     E  + +A+K V++  S +   E+ +E +++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL---------FKENNLLTWEFRFKIAQDLASG 151
           V+LLG   + +  L++ E M  G L S+L                +     ++A ++A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY-- 209
           + YL        VHRD+ + N M+  +F  KIGDFG+ R +            G  G   
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYRKGGKGLLP 203

Query: 210 ---MAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGN 265
              M+PE    G  +  SDV+SFG+V  EIA    +P    + E+V  ++++        
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-------- 255

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           G LL+   P  C D     +  LM     C   +  +RPS  ++I  +
Sbjct: 256 GGLLDK--PDNCPD----MLFELM---RMCWQYNPKMRPSFLEIISSI 294

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  153 bits (388), Expect = 5e-44
 Identities = 72/289 (24%), Positives = 117/289 (40%), Gaps = 36/289 (12%)

Query: 47  QKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           + LG+G FG V    +      T   +AVK +        I +   E+ I+  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 102 QLLGWCHEKKE--LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +  G C E     + L+ E++P+GSL  +L K  N +  + + K A  +  G+ YL    
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-- 144

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPEC 214
            +  VHRD+ + N++++     KIGDFGL + +E  K   T             + APEC
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT---VKDDRDSPVFWYAPEC 200

Query: 215 ATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD 273
               +    SDV+SFG+   E+        S  A     +             +L+  + 
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT---VTRLVNTLK 257

Query: 274 -------PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                  P  C D    ++  LM     C     + R S + +I    +
Sbjct: 258 EGKRLPCPPNCPD----EVYQLM---RKCWEFQPSNRTSFQNLIEGFEA 299

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  152 bits (386), Expect = 6e-44
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 34/278 (12%)

Query: 47  QKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQ 102
           + +G+G FG V++G +      +  +A+K      S    +++  E   + +  H ++V+
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L+G    +  + ++ E    G L S L      L        A  L++ L YL+    + 
Sbjct: 81  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 136

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGR 219
            VHRDI + N+++  N   K+GDFGL+R +E    S     +       +MAPE     R
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWMAPESINFRR 193

Query: 220 ASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
            +  SDV+ FG+   EI   G KP   +   +         V     NG+ L    P  C
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIENGERLPM--PPNC 242

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                  +  LM     C   D + RP   ++   L++
Sbjct: 243 PP----TLYSLM---TKCWAYDPSRRPRFTELKAQLST 273

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  152 bits (387), Expect = 7e-44
 Identities = 71/291 (24%), Positives = 112/291 (38%), Gaps = 47/291 (16%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSY---IAVKRVSKG---SKQGIKEYASEVTIISRLRHRN 99
            +KLG G FG V +G +   S     +AVK +        + + ++  EV  +  L HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           L++L G       + +V E  P GSL   L K           + A  +A G+ YL+   
Sbjct: 83  LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY--MAPECATT 217
            +  +HRD+ + N++L      KIGDFGL R +              + +   APE   T
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 218 GRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP-- 274
              S  SD + FG+   E+   G++P                 W      ++L  +D   
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHKIDKEG 241

Query: 275 -RLCRDFDEQQMEC------LMIVGLWCAHPDENLRPSIRQVIHVLNSEAP 318
            RL      +  +C      +M   + C       RP+   +   L    P
Sbjct: 242 ERL-----PRPEDCPQDIYNVM---VQCWAHKPEDRPTFVALRDFLLEAQP 284

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  152 bits (386), Expect = 1e-43
 Identities = 74/272 (27%), Positives = 133/272 (48%), Gaps = 29/272 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
            KLG G +G VY+G +++ S  +AVK + + + + ++E+  E  ++  ++H NLVQLLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
           C  +    ++ E+M  G+L  +L + N   ++      +A  ++S + YL+   ++  +H
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGRASK 222
           RD+ + N ++  N   K+ DFGL+RL+    G   T  AG    + + APE     + S 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 223 ESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD 281
           +SDV++FG++  EIA  G  P       +V   L +           +E   P  C +  
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------DYRMER--PEGCPE-- 239

Query: 282 EQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
             ++  LM     C   + + RPS  ++    
Sbjct: 240 --KVYELM---RACWQWNPSDRPSFAEIHQAF 266

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  152 bits (386), Expect = 1e-43
 Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 36/281 (12%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRH 97
            +F  ++K+G+G F  VY+         +A+K+V        K  A    E+ ++ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL---------FKENNLLTWEFRFKIAQDL 148
            N+++      E  EL +V E    G L   +           E  +  +       Q L
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY-----FVQ-L 145

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 208
            S L ++     + V+HRDIK +N+ +      K+GD GL R       +  +++ GT  
Sbjct: 146 CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201

Query: 209 YMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL 268
           YM+PE       + +SD++S G +  E+A  + P          +             K+
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-----------KI 250

Query: 269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
            +   P L  D   +++  L+     C +PD   RP +  V
Sbjct: 251 EQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDVTYV 288

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  152 bits (385), Expect = 1e-43
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 13/203 (6%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
             LG+G +G VY G        IA+K + +   +  +    E+ +   L+H+N+VQ LG 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE---FRFKIAQDLASGLLYLQEGWEQCV 163
             E   + +  E +P GSL + L  +   L        F   Q L  GL YL    +  +
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-EGLKYLH---DNQI 143

Query: 164 VHRDIKSSNIMLD-LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CATTGR 219
           VHRDIK  N++++  +   KI DFG ++ +        T   GT+ YMAPE       G 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGY 202

Query: 220 ASKESDVYSFGIVALEIACGRKP 242
               +D++S G   +E+A G+ P
Sbjct: 203 GKA-ADIWSLGCTIIEMATGKPP 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  152 bits (385), Expect = 2e-43
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 34/288 (11%)

Query: 47  QKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           Q+LG+G FG V    +      T   +AVK++   +++ ++++  E+ I+  L+H N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 103 LLGWCHEKKE--LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
             G C+      L L+ EY+P GSL  +L K    +      +    +  G+ YL     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 163

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 215
           +  +HRD+ + NI+++     KIGDFGL +++   K           G     + APE  
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK---VKEPGESPIFWYAPESL 220

Query: 216 TTGRASKESDVYSFGIVALEIA--CGRKPISLTAKEEVQVYLVQW------VWDLYGNGK 267
           T  + S  SDV+SFG+V  E+     +          +     Q       + +L  N  
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280

Query: 268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
            L    P  C D    ++  +M     C + + N RPS R +   ++ 
Sbjct: 281 RLPR--PDGCPD----EIYMIM---TECWNNNVNQRPSFRDLALRVDQ 319

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  152 bits (385), Expect = 3e-43
 Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 46/307 (14%)

Query: 47  QKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLV 101
           + LG+G FG V +   +    +   +AVK +     +   I+E+  E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 102 QLLGWC------HEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDLAS 150
           +L+G              +++  +M +G L + L      +    L  +   +   D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-- 208
           G+ YL     +  +HRD+ + N ML  +    + DFGL+R +     S      G     
Sbjct: 149 GMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY----SGDYYRQGCASKL 201

Query: 209 ---YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYG 264
              ++A E       +  SDV++FG+   EI   G+ P +     E+  YL+        
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG------- 254

Query: 265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPP 324
            G  L+   P  C +    ++  LM     C   D   RPS   +   L +     ++  
Sbjct: 255 -GNRLKQ--PPECME----EVYDLM---YQCWSADPKQRPSFTCLRMELENILGHLSVLS 304

Query: 325 KMPVPTY 331
               P Y
Sbjct: 305 TSQDPLY 311

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (382), Expect = 4e-43
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 28/285 (9%)

Query: 47  QKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           Q+LG+G FG V    +      T   +AVK++   +++ ++++  E+ I+  L+H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 103 LLGWCHEKKE--LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
             G C+      L L+ EY+P GSL  +L K    +      +    +  G+ YL     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---T 132

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM--GYMAPECATTG 218
           +  +HRD+ + NI+++     KIGDFGL +++   K        G     + APE  T  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 219 RASKESDVYSFGIVALEIA--CGRKPISLTAKEEVQVYLVQW------VWDLYGNGKLLE 270
           + S  SDV+SFG+V  E+     +          +     Q       + +L  N   L 
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252

Query: 271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
              P  C D    ++  +M     C + + N RPS R +   ++ 
Sbjct: 253 R--PDGCPD----EIYMIM---TECWNNNVNQRPSFRDLALRVDQ 288

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  151 bits (383), Expect = 5e-43
 Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 44/292 (15%)

Query: 47  QKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
           + LG+G FG V    +      T   +AVK +      Q    +  E+ I+  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 102 QLLGWCHEKKE--LLLVYEYMPNGSLDSHL----FKENNLLTWEFRFKIAQDLASGLLYL 155
           +  G C +     L LV EY+P GSL  +L         LL +      AQ +  G+ YL
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYL 150

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YM 210
                Q  +HRD+ + N++LD +   KIGDFGLA+ V               G     + 
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VREDGDSPVFWY 204

Query: 211 APECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQW------VWDLY 263
           APEC    +    SDV+SFG+   E+        S   K    + + Q       + +L 
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
             G+ L    P  C      ++  LM     C   + + RP+   +I +L +
Sbjct: 265 ERGERLPR--PDKCPA----EVYHLM---KNCWETEASFRPTFENLIPILKT 307

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  151 bits (383), Expect = 5e-43
 Identities = 66/280 (23%), Positives = 127/280 (45%), Gaps = 34/280 (12%)

Query: 46  DQKLGQGGFGGVYKGFFR----ETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNL 100
            + LG G FG VYKG +     +    +A+K + + +  +  KE   E  +++ + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            +LLG C     + L+ + MP G L  ++ +  + +  ++       +A G+ YL++   
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 135

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATT 217
           + +VHRD+ + N+++    + KI DFGLA+L+      +     G      +MA E    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILH 193

Query: 218 GRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
              + +SDV+S+G+   E+   G KP   + A E         +  +   G+ L    P 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ--PP 242

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           +C       +  +M   + C   D + RP  R++I   + 
Sbjct: 243 ICTI----DVYMIM---VKCWMIDADSRPKFRELIIEFSK 275

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  150 bits (380), Expect = 1e-42
 Identities = 76/304 (25%), Positives = 130/304 (42%), Gaps = 43/304 (14%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYI----AVKRVSKGS-KQGIKEYASEVTIISRLRHRNL 100
            + LG G FG V+KG +      I     +K +   S +Q  +     +  I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V+LLG C     L LV +Y+P GSL  H+ +    L  +        +A G+ YL+E   
Sbjct: 78  VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE--- 133

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATT 217
             +VHR++ + N++L      ++ DFG+A L+      +  + +       +MA E    
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP--PDDKQLLYSEAKTPIKWMALESIHF 191

Query: 218 GRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
           G+ + +SDV+S+G+   E+   G +P   L   E         V DL   G+ L    P+
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------VPDLLEKGERLAQ--PQ 240

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS---------EAPLPALPPKM 326
           +C       +  +M   + C   DEN+RP+ +++ +                  + P   
Sbjct: 241 ICTI----DVYMVM---VKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIA 293

Query: 327 PVPT 330
           P P 
Sbjct: 294 PGPE 297

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  149 bits (378), Expect = 1e-42
 Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 51/296 (17%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
           ++LG+  FG VYKG        E +  +A+K +         +E+  E  + +RL+H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFRFKIA 145
           V LLG   + + L +++ Y  +G L   L                   + L       + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
             +A+G+ YL       VVH+D+ + N+++    N KI D GL R V     +       
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADYYKLL 187

Query: 206 TMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWV 259
                   +MAPE    G+ S +SD++S+G+V  E+   G +P    + ++V   +    
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN-- 245

Query: 260 WDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                  ++L    P  C       +  LM   + C +   + RP  + +   L +
Sbjct: 246 ------RQVLPC--PDDCPA----WVYALM---IECWNEFPSRRPRFKDIHSRLRA 286

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  149 bits (378), Expect = 2e-42
 Identities = 79/299 (26%), Positives = 126/299 (42%), Gaps = 49/299 (16%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN 99
            +DF +   LGQG FG V K      S Y A+K++   +++ +    SEV +++ L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 100 LVQLLG-WCHE------------KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQ 146
           +V+    W               K  L +  EY  NG+L   +  EN     +  +++ +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 147 DLASGLLYL-QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH----------- 194
            +   L Y+  +G    ++HRD+K  NI +D + N KIGDFGLA+ V             
Sbjct: 124 QILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 195 --AKGSQTTVLAGTMGYMAPE-CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
                   T   GT  Y+A E    TG  +++ D+YS GI+  E+         T  E V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS----TGMERV 235

Query: 252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            +             K L +V      DFD+ +M+    +       D N RP  R ++
Sbjct: 236 NIL------------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  149 bits (378), Expect = 2e-42
 Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 45/289 (15%)

Query: 47  QKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLV 101
           + LG+G FG V +G  +    TS  +AVK +     S++ I+E+ SE   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 102 QLLGWC-----HEKKELLLVYEYMPNGSLDSHLFK-----ENNLLTWEFRFKIAQDLASG 151
           +LLG C         + +++  +M  G L ++L           +  +   K   D+A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG--- 208
           + YL     +  +HRD+ + N ML  +    + DFGL++ +     S      G +    
Sbjct: 160 MEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY----SGDYYRQGRIAKMP 212

Query: 209 --YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGN 265
             ++A E       + +SDV++FG+   EIA  G  P       E+  YL+         
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-------- 264

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
           G  L+   P  C D    ++  +M     C   D   RP+   +   L 
Sbjct: 265 GHRLKQ--PEDCLD----ELYEIM---YSCWRTDPLDRPTFSVLRLQLE 304

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  147 bits (374), Expect = 3e-42
 Identities = 80/276 (28%), Positives = 128/276 (46%), Gaps = 41/276 (14%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           Q +G+G FG V  G +R     +AVK +   +    + + +E +++++LRH NLVQLLG 
Sbjct: 27  QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 107 C-HEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
              EK  L +V EYM  GSL  +L  +  ++L  +   K + D+   + YL+       V
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 139

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGR 219
           HRD+ + N+++  +  AK+ DFGL +     +           G     + APE     +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------DTGKLPVKWTAPEALREKK 190

Query: 220 ASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
            S +SDV+SFGI+  EI   GR P      ++V   + +        G  ++A  P  C 
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------GYKMDA--PDGCP 240

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
                 +  +M     C H D  +RPS  Q+   L 
Sbjct: 241 P----AVYEVM---KNCWHLDAAMRPSFLQLREQLE 269

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  154 bits (391), Expect = 4e-42
 Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 43/284 (15%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYI--AVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQ 102
           D +LG G FG V +G +R     I  A+K + +G  K   +E   E  I+ +L +  +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L+G C + + L+LV E    G L   L  +   +      ++   ++ G+ YL+E   + 
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KN 456

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY--MAPECATTGRA 220
            VHR++ + N++L     AKI DFGL++ +       T   AG       APEC    + 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 221 SKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP--RLC 277
           S  SDV+S+G+   E    G+KP                 +      +++  ++   R+ 
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP-----------------YKKMKGPEVMAFIEQGKRM- 558

Query: 278 RDFDEQQMEC------LMIVGLWCAHPDENLRPSIRQVIHVLNS 315
               E   EC      LM     C       RP    V   + +
Sbjct: 559 ----ECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRA 595

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  148 bits (375), Expect = 5e-42
 Identities = 68/272 (25%), Positives = 97/272 (35%), Gaps = 31/272 (11%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRL-RHR 98
            F    +LG G +G V+K   +E     AVKR        +      +EV    ++ +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR-FKIAQDLASGLLYLQE 157
             V+L     E   L L  E     SL  H       L  E + +   +D    L +L  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP-EAQVWGYLRDTLLALAHLHS 175

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              Q +VH D+K +NI L      K+GDFGL   +  A   +     G   YMAPE    
Sbjct: 176 ---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPE-LLQ 229

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
           G     +DV+S G+  LE+AC  +                  W     G L       L 
Sbjct: 230 GSYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPPEFTAGLS 278

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
            +     +  L         PD  LR +   +
Sbjct: 279 SELRSVLVMML--------EPDPKLRATAEAL 302

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  147 bits (373), Expect = 6e-42
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
            DF + + +G GGFG V+K   R       +KRV   +++  +E    V  +++L H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66

Query: 101 VQLLG----------------WCHEKKELLLVYEYMPNGSLDSHLFKENN-LLTWEFRFK 143
           V   G                   + K L +  E+   G+L+  + K     L      +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           + + +  G+ Y+     + +++RD+K SNI L      KIGDFGL   +++      +  
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182

Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            GT+ YM+PE  ++    KE D+Y+ G++  E+      
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  146 bits (371), Expect = 1e-41
 Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 31/274 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           ++LG G FG V+ G++   +  +AVK + +GS      + +E  ++ +L+H+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 76

Query: 107 CHEKKELLLVYEYMPNGSLDSHL-FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
              ++ + ++ EYM NGSL   L       LT      +A  +A G+ +++E   +  +H
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGRASK 222
           RD++++NI++    + KI DFGLARL+E    ++ T   G      + APE    G  + 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 223 ESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD 281
           +SDV+SFGI+  EI   GR P       EV   L +        G  +    P  C +  
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--------GYRMVR--PDNCPE-- 237

Query: 282 EQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
             ++  LM     C       RP+   +  VL  
Sbjct: 238 --ELYQLM---RLCWKERPEDRPTFDYLRSVLED 266

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  150 bits (381), Expect = 1e-41
 Identities = 72/274 (26%), Positives = 129/274 (47%), Gaps = 31/274 (11%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +KLG G FG V+   + + +  +AVK +  GS    + + +E  ++  L+H  LV+L   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAV 251

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
              K+ + ++ E+M  GSL   L   E +          +  +A G+ ++++   +  +H
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATTGRASK 222
           RD++++NI++  +   KI DFGLAR++E    ++ T   G      + APE    G  + 
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 223 ESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD 281
           +SDV+SFGI+ +EI   GR P    +  EV   L +        G  +    P  C +  
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER--------GYRMPR--PENCPE-- 412

Query: 282 EQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
             ++  +M   + C       RP+   +  VL+ 
Sbjct: 413 --ELYNIM---MRCWKNRPEERPTFEYIQSVLDD 441

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  150 bits (380), Expect = 2e-41
 Identities = 81/271 (29%), Positives = 126/271 (46%), Gaps = 25/271 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
            KLGQG FG V+ G +  T+  +A+K +  G+    + +  E  ++ +LRH  LVQL   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
             E+  + +V EYM  GSL   L  E    L       +A  +ASG+ Y++       VH
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD++++NI++  N   K+ DFGLARL+E  + +        + + APE A  GR + +SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 226 VYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ 284
           V+SFGI+  E+   GR P       EV   + +        G  +    P  C +     
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------GYRMPC--PPECPE----S 409

Query: 285 MECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           +  LM     C   +   RP+   +   L  
Sbjct: 410 LHDLM---CQCWRKEPEERPTFEYLQAFLED 437

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (379), Expect = 3e-41
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 33/273 (12%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           Q +G+G FG V  G +R     +AVK +   +    + + +E +++++LRH NLVQLLG 
Sbjct: 199 QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 107 C-HEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
              EK  L +V EYM  GSL  +L     ++L  +   K + D+   + YL+       V
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 311

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           HRD+ + N+++  +  AK+ DFGL +  E +    T  L   + + APE     + S +S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKS 367

Query: 225 DVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC-RDFDE 282
           DV+SFGI+  EI   GR P      ++V   + +        G  ++A  P  C     +
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------GYKMDA--PDGCPPAVYD 417

Query: 283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
               C      W        RP+  Q+   L  
Sbjct: 418 VMKNC------WHLDAAT--RPTFLQLREQLEH 442

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  145 bits (367), Expect = 4e-41
 Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 10/205 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEY-ASEVTIISRLRH 97
            DF   + LG+G FG VY    +++   +A+K + K    K G++     EV I S LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
            N+++L G+ H+   + L+ EY P G++   L K +          I + LA+ L Y   
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+ PE    
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEG 181

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
               ++ D++S G++  E   G+ P
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPP 206

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  147 bits (372), Expect = 6e-41
 Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 54/299 (18%)

Query: 46  DQKLGQGGFGGVYKG-------FFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-R 96
            + LG+G FG V             + +  +AVK +    +++ + +  SE+ ++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFR 141
           H+N++ LLG C +   L ++ EY   G+L  +L                     +T++  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT 201
                 LA G+ YL     Q  +HRD+ + N+++  N   KI DFGLAR +     +   
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN----NIDY 258

Query: 202 VLAGTMG-----YMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYL 255
               T G     +MAPE       + +SDV+SFG++  EI   G  P      EE+   L
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
            +        G  ++   P  C +    ++  +M     C H   + RP+ +Q++  L+
Sbjct: 319 KE--------GHRMDK--PANCTN----ELYMMM---RDCWHAVPSQRPTFKQLVEDLD 360

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  149 bits (378), Expect = 9e-41
 Identities = 81/271 (29%), Positives = 126/271 (46%), Gaps = 25/271 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
            KLGQG FG V+ G +  T+  +A+K +  G+    + +  E  ++ +LRH  LVQL   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
             E+  + +V EYM  GSL   L  E    L       +A  +ASG+ Y++       VH
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD++++NI++  N   K+ DFGLARL+E  + +        + + APE A  GR + +SD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 226 VYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ 284
           V+SFGI+  E+   GR P       EV   + +        G  +    P  C +     
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------GYRMPC--PPECPE----S 492

Query: 285 MECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           +  LM     C   +   RP+   +   L  
Sbjct: 493 LHDLM---CQCWRKEPEERPTFEYLQAFLED 520

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  145 bits (367), Expect = 1e-40
 Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 54/299 (18%)

Query: 46  DQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHR 98
            + LG+G FG V +          T   +AVK + +G +    +   SE+ I+  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 99  NLVQLLGWC-HEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFRF 142
           N+V LLG C      L+++ E+   G+L ++L                   + LT E   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV 202
             +  +A G+ +L     +  +HRD+ + NI+L      KI DFGLAR +          
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY----KDPDY 204

Query: 203 LAGTMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYL 255
           +          +MAPE       + +SDV+SFG++  EI   G  P   +   EE    L
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
            +        G  + A  P         +M   M   L C H + + RP+  +++  L 
Sbjct: 265 KE--------GTRMRA--PDYTTP----EMYQTM---LDCWHGEPSQRPTFSELVEHLG 306

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (364), Expect = 1e-40
 Identities = 67/286 (23%), Positives = 117/286 (40%), Gaps = 39/286 (13%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHR 98
            D+     +G G +G   K   +     +  K +  G  ++   +   SEV ++  L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 99  NLVQLLGWCHEK--KELLLVYEYMPNGSLDSHL---------FKENNLLTWEFRFKIAQD 147
           N+V+      ++    L +V EY   G L S +           E  +L       + Q 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-----MTQ- 119

Query: 148 LASGLLYL--QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           L   L     +      V+HRD+K +N+ LD   N K+GDFGLAR++ H   S      G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVG 178

Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           T  YM+PE       +++SD++S G +  E+     P   TA  + ++            
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAG---------- 226

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
            K+ E    R+   + +   E   I+     +  +  RPS+ +++ 
Sbjct: 227 -KIREGKFRRIPYRYSD---ELNEIIT-RMLNLKDYHRPSVEEILE 267

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  150 bits (380), Expect = 2e-40
 Identities = 67/275 (24%), Positives = 117/275 (42%), Gaps = 26/275 (9%)

Query: 46  DQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLV 101
            + +G+G FG V++G +      +  +A+K      S    +++  E   + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
           +L+G    +  + ++ E    G L S L      L        A  L++ L YL+    +
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---K 510

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS 221
             VHRDI + N+++  N   K+GDFGL+R +E +   + +     + +MAPE     R +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 222 KESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF 280
             SDV+ FG+   EI   G KP       +V   +          G+ L    P  C   
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------GERLPM--PPNC--- 617

Query: 281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
               +  LM     C   D + RP   ++   L++
Sbjct: 618 -PPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 648

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  144 bits (364), Expect = 2e-40
 Identities = 58/302 (19%), Positives = 104/302 (34%), Gaps = 43/302 (14%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           QKLG+GGF  V          + A+KR+    +Q  +E   E  +     H N+++L+ +
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 107 CHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRF------KIAQDLASGLLYLQ 156
           C  ++    E  L+  +   G+L + +     L              +   +  GL  + 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA--------GTMG 208
               +   HRD+K +NI+L       + D G               L          T+ 
Sbjct: 152 ---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 209 YMAPE---CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           Y APE     +     + +DV+S G V   +  G  P  +  ++   V L          
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-------Q 261

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLNSEAPLPALPP 324
            +L     PR      +      ++  +    P +  RP I  ++  +   + P P    
Sbjct: 262 NQLSIPQSPRHSSALWQ------LLNSMMTVDPHQ--RPHIPLLLSQLEALQPPAPGQHT 313

Query: 325 KM 326
             
Sbjct: 314 TQ 315

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  143 bits (362), Expect = 3e-40
 Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 48/296 (16%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRN 99
            DF   Q LG+GGFG V++   +      A+KR+   +++  +E    EV  +++L H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 100 LVQLLGWCHEKKE------------LLLVYEYMPNGSLDSHLFKENNLLTWEFRF--KIA 145
           +V+      EK              L +  +     +L   +     +   E      I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA- 204
             +A  + +L     + ++HRD+K SNI   ++   K+GDFGL   ++  +  QT +   
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 205 ----------GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY 254
                     GT  YM+PE       S + D++S G++  E+     P S T  E V+  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS-TQMERVRTL 237

Query: 255 LVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
                        +     P L       +   +         P    RP    +I
Sbjct: 238 -----------TDVRNLKFPPLFTQKYPCEYVMVQ----DMLSPSPMERPEAINII 278

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  144 bits (365), Expect = 4e-40
 Identities = 78/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNL 100
           + +G+G FG V++         E  + +AVK + +  S     ++  E  +++   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHL-----------------------FKENNLLT 137
           V+LLG C   K + L++EYM  G L+  L                             L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG 197
              +  IA+ +A+G+ YL E   +  VHRD+ + N ++  N   KI DFGL+R +  A  
Sbjct: 173 CAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD- 228

Query: 198 SQTTVLAGTMGY-----MAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEV 251
                 A          M PE     R + ESDV+++G+V  EI   G +P    A EEV
Sbjct: 229 ---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285

Query: 252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
             Y+          G +L    P  C      ++  LM     C       RPS   +  
Sbjct: 286 IYYVRD--------GNILAC--PENCPL----ELYNLM---RLCWSKLPADRPSFCSIHR 328

Query: 312 VLNS 315
           +L  
Sbjct: 329 ILQR 332

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  143 bits (362), Expect = 4e-40
 Identities = 75/305 (24%), Positives = 121/305 (39%), Gaps = 59/305 (19%)

Query: 46  DQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRN 99
            + LG+G FG V K            + +AVK + +  S   +++  SE  ++ ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----------------------FKENNLL 136
           +++L G C +   LLL+ EY   GSL   L                         +   L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           T       A  ++ G+ YL    E  +VHRD+ + NI++      KI DFGL+R V    
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY--- 201

Query: 197 GSQTTVLAGTMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEE 250
             + + +  + G     +MA E       + +SDV+SFG++  EI   G  P      E 
Sbjct: 202 -EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

Query: 251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
           +   L          G  +E   P  C +    +M  LM   L C   + + RP    + 
Sbjct: 261 LFNLLKT--------GHRMER--PDNCSE----EMYRLM---LQCWKQEPDKRPVFADIS 303

Query: 311 HVLNS 315
             L  
Sbjct: 304 KDLEK 308

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  143 bits (364), Expect = 4e-40
 Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 54/299 (18%)

Query: 46  DQKLGQGGFGGVYKG-------FFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-R 96
            + LG+G FG V             + +  +AVK +    +++ + +  SE+ ++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFR 141
           H+N++ LLG C +   L ++ EY   G+L  +L                     +T++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT 201
                 LA G+ YL     Q  +HRD+ + N+++  N   KI DFGLAR +     +   
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN----NIDY 212

Query: 202 VLAGTMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYL 255
               T G     +MAPE       + +SDV+SFG++  EI   G  P      EE+   L
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
            +        G  ++   P  C +    ++  +M     C H   + RP+ +Q++  L+
Sbjct: 273 KE--------GHRMDK--PANCTN----ELYMMM---RDCWHAVPSQRPTFKQLVEDLD 314

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  143 bits (363), Expect = 5e-40
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 24/219 (10%)

Query: 34  KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIIS 93
            E  +  +      ++G+G FG V++   ++T    AVK+V     +       E+   +
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105

Query: 94  RLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----FKENNLLTWEFRFKIAQDL 148
            L    +V L G   E   + +  E +  GSL   +       E+        + + Q L
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED-----RALYYLGQAL 160

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQTTV----L 203
             GL YL     + ++H D+K+ N++L  +   A + DFG A  ++     ++ +    +
Sbjct: 161 -EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            GT  +MAPE         + D++S   + L +  G  P
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  142 bits (361), Expect = 9e-40
 Identities = 83/294 (28%), Positives = 126/294 (42%), Gaps = 52/294 (17%)

Query: 46  DQKLGQGGFGGVYKGFFR--ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLV 101
              +G+G FG V K   +        A+KR+ +  SK   +++A E+ ++ +L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFRFKIAQ 146
            LLG C  +  L L  EY P+G+L   L                   + L+ +     A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
           D+A G+ YL    ++  +HRD+ + NI++  N+ AKI DFGL+R  E            T
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------KKT 199

Query: 207 MG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYLVQWVW 260
           MG     +MA E       +  SDV+S+G++  EI   G  P       E+   L Q   
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--- 256

Query: 261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
                G  LE   P  C D    ++  LM     C       RPS  Q++  LN
Sbjct: 257 -----GYRLEK--PLNCDD----EVYDLM---RQCWREKPYERPSFAQILVSLN 296

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  141 bits (357), Expect = 1e-39
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 10/205 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEY-ASEVTIISRLRH 97
           +DF+  + LG+G FG VY    ++    +A+K + K    K+G++     E+ I S LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
            N++++  + H++K + L+ E+ P G L   L K            + + LA  L Y   
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCH- 131

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
             E+ V+HRDIK  N+++      KI DFG +    HA   +   + GT+ Y+ PE    
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEG 186

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
               ++ D++  G++  E   G  P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  141 bits (357), Expect = 1e-39
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKE-YASEVTIISRLRHRNLVQLLG 105
           LG+G F GVY+     T   +A+K + K +  K G+ +   +EV I  +L+H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLT-WEFRFKIAQDLASGLLYLQEGWEQCVV 164
           +  +   + LV E   NG ++ +L       +  E R  + Q + +G+LYL       ++
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-IITGMLYLHS---HGIL 134

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           HRD+  SN++L  N N KI DFGLA  ++       T L GT  Y++PE AT      ES
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLES 193

Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G +   +  GR P
Sbjct: 194 DVWSLGCMFYTLLIGRPP 211

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  142 bits (360), Expect = 1e-39
 Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 51/296 (17%)

Query: 46  DQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHR 98
            + LG G FG V +         +    +AVK +         +   SE+ I+S L +H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-------------FKENNLLTWEFRFKIA 145
           N+V LLG C     +L++ EY   G L + L                N+  +       +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
             +A G+ +L     +  +HRD+ + N++L     AKIGDFGLAR +     + +  +  
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM----NDSNYIVK 223

Query: 206 TMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVYLVQW 258
                   +MAPE       + +SDV+S+GI+  EI   G  P   +    +    +   
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD- 282

Query: 259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
                  G  +    P          +  +M     C   +   RP+ +Q+   L 
Sbjct: 283 -------GYQMAQ--PAFAPK----NIYSIM---QACWALEPTHRPTFQQICSFLQ 322

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  141 bits (358), Expect = 2e-39
 Identities = 46/233 (19%), Positives = 100/233 (42%), Gaps = 23/233 (9%)

Query: 26  AGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIK 83
            G +   ++ ++     ++  +++G GG   V++    E     A+K V+      Q + 
Sbjct: 13  LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLD 71

Query: 84  EYASEVTIISRLRHRNL--VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR 141
            Y +E+  +++L+  +   ++L  +    + + +V E   N  L+S L K+   +    R
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWER 129

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQT 200
               +++   +  + +     +VH D+K +N ++  +   K+ DFG+A  +         
Sbjct: 130 KSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 185

Query: 201 TVLAGTMGYMAPE-----------CATTGRASKESDVYSFGIVALEIACGRKP 242
               GT+ YM PE             +  + S +SDV+S G +   +  G+ P
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  142 bits (360), Expect = 4e-39
 Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 54/299 (18%)

Query: 46  DQKLGQGGFGGVYKG-------FFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-R 96
            + LG+G FG V                + +AVK +    +++ + +  SE+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL---------------FKENNLLTWEFR 141
           H+N++ LLG C +   L ++ EY   G+L  +L                     L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT 201
              A  +A G+ YL     +  +HRD+ + N+++  +   KI DFGLAR +         
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH----HIDY 246

Query: 202 VLAGTMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKPISLTAKEEVQVYL 255
               T G     +MAPE       + +SDV+SFG++  EI   G  P      EE+   L
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306

Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
            +        G  ++   P  C +    ++  +M     C H   + RP+ +Q++  L+
Sbjct: 307 KE--------GHRMDK--PSNCTN----ELYMMM---RDCWHAVPSQRPTFKQLVEDLD 348

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  140 bits (356), Expect = 4e-39
 Identities = 68/299 (22%), Positives = 116/299 (38%), Gaps = 55/299 (18%)

Query: 46  DQKLGQGGFGGVYKG-----FFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHR 98
            + LG G FG V +         + +  +AVK +         +   SE+ ++S L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHL-----------------FKENNLLTWEFR 141
           N+V LLG C      L++ EY   G L + L                   +   L  E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT 201
              +  +A G+ +L     +  +HRD+ + NI+L      KI DFGLAR ++    + + 
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK----NDSN 200

Query: 202 VLAGTMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKP-ISLTAKEEVQVY 254
            +          +MAPE       + ESDV+S+GI   E+   G  P   +    +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 255 LVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           + +        G  + +  P         +M  +M     C   D   RP+ +Q++ ++
Sbjct: 261 IKE--------GFRMLS--PEHAPA----EMYDIM---KTCWDADPLKRPTFKQIVQLI 302

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  140 bits (354), Expect = 5e-39
 Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 8/197 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKE-YASEVTIISRLRHRNLVQLLG 105
           LG+GGF   ++    +T    A K V K    K   +E  + E++I   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
           +  +   + +V E     SL     +   L   E R+ + Q +  G  YL       V+H
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQYLHR---NRVIH 138

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+K  N+ L+ +   KIGDFGLA  VE+    +   L GT  Y+APE  +    S E D
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVD 197

Query: 226 VYSFGIVALEIACGRKP 242
           V+S G +   +  G+ P
Sbjct: 198 VWSIGCIMYTLLVGKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  140 bits (356), Expect = 6e-39
 Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 8/197 (4%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKE-YASEVTIISRLRHRNLVQLLG 105
           LG+GGF   ++    +T    A K V K    K   +E  + E++I   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
           +  +   + +V E     SL     +   L   E R+ + Q +  G  YL       V+H
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQYLHR---NRVIH 164

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESD 225
           RD+K  N+ L+ +   KIGDFGLA  VE+    +   L GT  Y+APE  +    S E D
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVD 223

Query: 226 VYSFGIVALEIACGRKP 242
           V+S G +   +  G+ P
Sbjct: 224 VWSIGCIMYTLLVGKPP 240

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  140 bits (356), Expect = 7e-39
 Identities = 60/353 (16%), Positives = 138/353 (39%), Gaps = 44/353 (12%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHR 98
             ++  +++G GG   V++    E     A+K V+      Q +  Y +E+  +++L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 99  NL--VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           +   ++L  +    + + +V E   N  L+S L K+   +    R    +++   +  + 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPE-- 213
           +     +VH D+K +N ++  +   K+ DFG+A  +             GT+ YM PE  
Sbjct: 126 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 214 ---------CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
                      +  + S +SDV+S G +   +  G+ P      +  +++ +     +  
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-----IDP 236

Query: 265 NGKL-LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNSEAPLPA 321
           N ++    +  +  +D  +    CL          D   R SI +++    +  +     
Sbjct: 237 NHEIEFPDIPEKDLQDVLKC---CLKR--------DPKQRISIPELLAHPYVQIQTHPVN 285

Query: 322 LPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSSAASSSASRSN 374
              K            +  +N   P+       + Y +++   + +SS+S++ 
Sbjct: 286 QMAKGTTEEMKYVLGQLVGLN--SPNSILKAAKTLYEHYSGGESHNSSSSKTF 336

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  139 bits (353), Expect = 2e-38
 Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 60/306 (19%)

Query: 46  DQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHR 98
            + LG G FG V             S  +AVK + +       +   SE+ ++++L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHL----------------------FKENNLL 136
           N+V LLG C     + L++EY   G L ++L                       ++ N+L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           T+E     A  +A G+ +L+    +  VHRD+ + N+++      KI DFGLAR +    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM--- 223

Query: 197 GSQTTVLAGTMG-----YMAPECATTGRASKESDVYSFGIVALEIA-CGRKP-ISLTAKE 249
            S +  +          +MAPE    G  + +SDV+S+GI+  EI   G  P   +    
Sbjct: 224 -SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282

Query: 250 EVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
                +          G  ++   P    +    ++  +M     C   D   RPS   +
Sbjct: 283 NFYKLIQN--------GFKMDQ--PFYATE----EIYIIM---QSCWAFDSRKRPSFPNL 325

Query: 310 IHVLNS 315
              L  
Sbjct: 326 TSFLGC 331

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  140 bits (355), Expect = 2e-38
 Identities = 45/212 (21%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNL--VQ 102
           +++G GG   V++    E     A+K V+      Q +  Y +E+  +++L+  +   ++
Sbjct: 62  KQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           L  +    + + +V E   N  L+S L K+ ++  WE +      +   +  + +     
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-MLEAVHTIHQ---HG 175

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPE-------- 213
           +VH D+K +N ++  +   K+ DFG+A  +             G + YM PE        
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 214 ---CATTGRASKESDVYSFGIVALEIACGRKP 242
                +  + S +SDV+S G +   +  G+ P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  137 bits (348), Expect = 1e-37
 Identities = 49/228 (21%), Positives = 90/228 (39%), Gaps = 33/228 (14%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS------------- 87
           ND+   + L QG F  +      + + + A+K+  K   +  +++               
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 88  ----EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRF- 142
               E+ II+ +++   +   G      E+ ++YEYM N S+         L      F 
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 143 ------KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
                  I + + +   Y+    E+ + HRD+K SNI++D N   K+ DFG +   E+  
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES---EYMV 203

Query: 197 GSQTTVLAGTMGYMAPE-CATTGR-ASKESDVYSFGIVALEIACGRKP 242
             +     GT  +M PE  +        + D++S GI    +     P
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  135 bits (342), Expect = 3e-37
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLL 104
              LGQG    V++G  ++T    A+K  +  S  + +     E  ++ +L H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 105 G--WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTW---EFRFKIAQDLASGLLYLQEGW 159
                   +  +L+ E+ P GSL + L + +N       EF   + +D+  G+ +L    
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHL---R 129

Query: 160 EQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-- 213
           E  +VHR+IK  NIM     D     K+ DFG AR +E     Q   L GT  Y+ P+  
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187

Query: 214 --CATTGRASK----ESDVYSFGIVALEIACGRKP 242
                     K      D++S G+     A G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  136 bits (343), Expect = 6e-37
 Identities = 64/263 (24%), Positives = 115/263 (43%), Gaps = 9/263 (3%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRN 99
           +DF    +LG G  G V+K   + +   +A K +  +       +   E+ ++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V   G  +   E+ +  E+M  GSLD  + K+   +  +   K++  +  GL YL+E  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLRE-- 149

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTG 218
           +  ++HRD+K SNI+++     K+ DFG++ +L++    S      GT  YM+PE     
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGT 205

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
             S +SD++S G+  +E+A GR PI     +E+++     V               R   
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 279 DFDEQQMECLMIVGLWCAHPDEN 301
            F       + I  L     +E 
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEP 288

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  139 bits (352), Expect = 1e-36
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 19/219 (8%)

Query: 38  QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEY-ASEVTIISRLR 96
           Q    +   ++LG GGFG V +   ++T   +A+K+  +      +E    E+ I+ +L 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 97  HRNLVQLL------GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLT---WEFRFKIAQD 147
           H N+V                  LL  EY   G L  +L +  N         R  +  D
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSD 129

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA---KIGDFGLARLVEHAKGSQTTVLA 204
           ++S L YL    E  ++HRD+K  NI+L         KI D G A+ ++  +G   T   
Sbjct: 130 ISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV 184

Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI 243
           GT+ Y+APE     + +   D +SFG +A E   G +P 
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  134 bits (339), Expect = 4e-36
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 24/215 (11%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEY-ASEVTIISRLRHRNLVQLL 104
              LGQG    V++G  ++T    A+K  +  S     +    E  ++ +L H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 105 GW--CHEKKELLLVYEYMPNGSLDSHLFKENNLLTW---EFRFKIAQDLASGLLYLQEGW 159
                   +  +L+ E+ P GSL + L + +N       EF   + +D+  G+ +L    
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHL---R 129

Query: 160 EQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-- 213
           E  +VHR+IK  NIM     D     K+ DFG AR +E     Q   L GT  Y+ P+  
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187

Query: 214 ------CATTGRASKESDVYSFGIVALEIACGRKP 242
                      +     D++S G+     A G  P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  131 bits (331), Expect = 1e-35
 Identities = 52/205 (25%), Positives = 103/205 (50%), Gaps = 9/205 (4%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           +    +LG G FG VYK   +ET +  A K +   S++ +++Y  E+ I++   H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           LLG  +   +L ++ E+ P G++D+ + + +  LT      + + +   L +L     + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           ++HRD+K+ N+++ L  + ++ DFG++         + + + GT  +MAPE         
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196

Query: 223 ES-----DVYSFGIVALEIACGRKP 242
                  D++S GI  +E+A    P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP 221

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  132 bits (332), Expect = 3e-35
 Identities = 34/311 (10%), Positives = 71/311 (22%), Gaps = 52/311 (16%)

Query: 35  ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTI 91
            L+Q        + L  G    V+     E     A+K  + G++    E          
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 92  ISRLRHRNLVQLLGWCH--------------------------EKKELLLVYEYM----- 120
            +RL   +  +                                     LL+         
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN 180
              S    ++             +   L      LQ    + +VH      N+ +  +  
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGR 232

Query: 181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA--SKESDVYSFGIVALEIAC 238
             +GD           G++    +  + Y   E      A  +   + +  G+    + C
Sbjct: 233 LMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 239 GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHP 298
              P  L        +    +          +++    C    +      +I        
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGT-----DSLAFGSCTPLPDFVKT--LIGRFLNFDR 341

Query: 299 DENLRPSIRQV 309
               R    + 
Sbjct: 342 RR--RLLPLEA 350

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  129 bits (327), Expect = 3e-35
 Identities = 66/302 (21%), Positives = 103/302 (34%), Gaps = 66/302 (21%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRL-R 96
           T +F++ +K+G G FG V+K   R      A+KR  K        +    EV   + L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL---------FKENNLLTWEFRFKIAQD 147
           H ++V+      E   +L+  EY   GSL   +         FKE  L            
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL------LLQ 123

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-------------------FNAKIGDFGL 188
           +  GL Y+       +VH DIK SNI +                         KIGD G 
Sbjct: 124 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPE-CATTGRASKESDVYSFGIVALEIACGRKPISLTA 247
                  + S   V  G   ++A E          ++D+++  +  +  A          
Sbjct: 181 V-----TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235

Query: 248 KEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIR 307
           +           W     G+L     PR+ +   ++  E L        HPD   RPS  
Sbjct: 236 Q-----------WHEIRQGRL-----PRIPQVLSQEFTELLK----VMIHPDPERRPSAM 275

Query: 308 QV 309
            +
Sbjct: 276 AL 277

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  129 bits (327), Expect = 4e-35
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 6/203 (2%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN 99
              +   +K+GQG  G VY      T   +A+++++   +   +   +E+ ++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V  L       EL +V EY+  GSL   +      +       + ++    L +L    
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH--- 133

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
              V+HRDIKS NI+L ++ + K+ DFG    +   +  ++T+  GT  +MAPE  T   
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKA 192

Query: 220 ASKESDVYSFGIVALEIACGRKP 242
              + D++S GI+A+E+  G  P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  130 bits (328), Expect = 6e-35
 Identities = 61/334 (18%), Positives = 107/334 (32%), Gaps = 60/334 (17%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLG 105
           + L +GGF  VY+     +    A+KR+    ++  +    EV  + +L  H N+VQ   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 106 WC--------HEKKELLLVYEYMPNGSLD-------SHLFKENNLLTWEFRFKIAQDLAS 150
                       + E LL+ E      ++             + +L      KI      
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL------KIFYQTCR 147

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA------ 204
            + ++    +  ++HRD+K  N++L      K+ DFG A  + H      +         
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 205 -----GTMGYMAPE-CATTGRA--SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
                 T  Y  PE           ++ D+++ G +   +   + P    AK  +     
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV---- 262

Query: 257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
                   NGK                    L+         +   R SI +V+H L   
Sbjct: 263 --------NGKYSIPPHDTQ-----YTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEI 306

Query: 317 APLPALPPKMPVPTYFSPPANMRAVNGAGPDKGP 350
           A    + PK P+               A   +GP
Sbjct: 307 AAARNVNPKSPITELLEQ---NGGYGSATLSRGP 337

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  129 bits (325), Expect = 1e-34
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 6/200 (3%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
            +   K+G+G  G V     + +   +AVK +    +Q  +   +EV I+   +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
           +       +EL ++ E++  G+L   +      L  E    + + +   L YL     Q 
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
           V+HRDIKS +I+L L+   K+ DFG    +      + ++  GT  +MAPE  +    + 
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSLYAT 220

Query: 223 ESDVYSFGIVALEIACGRKP 242
           E D++S GI+ +E+  G  P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  127 bits (321), Expect = 3e-34
 Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 7/204 (3%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRNL 100
            F   +K+G+G FG V+KG    T   +A+K +  + ++  I++   E+T++S+     +
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
            +  G   +  +L ++ EY+  GS    L +   L   +    I +++  GL YL     
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIAT-ILREILKGLDYLHS--- 137

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
           +  +HRDIK++N++L  +   K+ DFG+A  +   +  + T   GT  +MAPE       
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 196

Query: 221 SKESDVYSFGIVALEIACGRKPIS 244
             ++D++S GI A+E+A G  P S
Sbjct: 197 DSKADIWSLGITAIELARGEPPHS 220

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  127 bits (321), Expect = 4e-34
 Identities = 65/200 (32%), Positives = 107/200 (53%), Gaps = 6/200 (3%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ 102
           F+  +KLG+G +G VYK   +ET   +A+K+V    +  ++E   E++I+ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVK 88

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
             G   +  +L +V EY   GS+   +   N  LT +    I Q    GL YL       
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MR 145

Query: 163 VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASK 222
            +HRDIK+ NI+L+   +AK+ DFG+A  +      + TV+ GT  +MAPE       + 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204

Query: 223 ESDVYSFGIVALEIACGRKP 242
            +D++S GI A+E+A G+ P
Sbjct: 205 VADIWSLGITAIEMAEGKPP 224

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  125 bits (316), Expect = 2e-33
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRL-RHR 98
           ND  +  ++G G  G V+K  FR+T   IAVK++   G+K+  K    ++ ++ +     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
            +VQ  G      ++ +  E M     +    +    +      K+   +   L YL+E 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE- 142

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
            +  V+HRD+K SNI+LD     K+ DFG++  +   K    +   G   YMAPE     
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPP 199

Query: 219 RASKE-----SDVYSFGIVALEIACGRKPIS 244
             +K      +DV+S GI  +E+A G+ P  
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYK 230

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  124 bits (314), Expect = 3e-33
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 16/214 (7%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRL-RHR 98
           +D     +LG+G +G V K     +   +AVKR+ +  + Q  K    ++ I  R     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDS---HLFKENNLLTWEFRFKIAQDLASGLLYL 155
             V   G    + ++ +  E M + SLD     +  +   +  +   KIA  +   L +L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL-ARLVEHAKGSQTTVLAGTMGYMAPE- 213
               +  V+HRD+K SN++++     K+ DFG+   LV     ++    AG   YMAPE 
Sbjct: 126 HS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDID-AGCKPYMAPER 180

Query: 214 --CATTGRA-SKESDVYSFGIVALEIACGRKPIS 244
                  +  S +SD++S GI  +E+A  R P  
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  125 bits (315), Expect = 3e-33
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 15/214 (7%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRL-RHR 98
            D  D  ++G+G +G V K   + +   +AVKR+ S   ++  K+   ++ ++ R     
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR----FKIAQDLASGLLY 154
            +VQ  G    + +  +  E M + S D       ++L          KI       L +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE- 213
           L+E     ++HRDIK SNI+LD + N K+ DFG++  +  +         G   YMAPE 
Sbjct: 141 LKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPER 196

Query: 214 --CATTGRA-SKESDVYSFGIVALEIACGRKPIS 244
              + + +     SDV+S GI   E+A GR P  
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  124 bits (314), Expect = 6e-33
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 15/206 (7%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS---KGSKQGIKEYASEVTIISRLRHRN 99
           F+D +++G G FG VY       S  +A+K++S   K S +  ++   EV  + +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
            +Q  G    +    LV EY    + D     +  L   E    +      GL YL    
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-VTHGALQGLAYLHS-- 172

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 216
              ++HRD+K+ NI+L      K+GDFG A     +  +      GT  +MAPE      
Sbjct: 173 -HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAMD 226

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
            G+   + DV+S GI  +E+A  + P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPP 252

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  124 bits (312), Expect = 1e-32
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 18/216 (8%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHR 98
              F   + +G G +G VYKG   +T    A+K +   +    +E   E+ ++ +   HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHR 81

Query: 99  NLVQLLG------WCHEKKELLLVYEYMPNGSL-DSHLFKENNLLTWEFRFKIAQDLASG 151
           N+    G            +L LV E+   GS+ D     + N L  E+   I +++  G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           L +L +     V+HRDIK  N++L  N   K+ DFG++  ++   G + T   GT  +MA
Sbjct: 142 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMA 197

Query: 212 PECATTGRASKES-----DVYSFGIVALEIACGRKP 242
           PE          +     D++S GI A+E+A G  P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (314), Expect = 1e-32
 Identities = 47/223 (21%), Positives = 82/223 (36%), Gaps = 30/223 (13%)

Query: 40  TNDFNDDQKLGQG--GFGGVYKGFFRETSSYIAVKRVS--KGSKQGIKEYASEVTIISRL 95
              +     +G+G      V    ++ T  Y+ V+R++    S + +     E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK------IAQDLA 149
            H N+V          EL +V  +M  GS    L        +           I Q + 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICT----HFMDGMNELAIAYILQGVL 138

Query: 150 SGLLYL-QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL----- 203
             L Y+   G     VHR +K+S+I++ ++    +        +      Q  V      
Sbjct: 139 KALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 204 -AGTMGYMAPE---CATTGRASKESDVYSFGIVALEIACGRKP 242
               + +++PE       G  +K SD+YS GI A E+A G  P
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVP 236

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (301), Expect = 2e-31
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 18/218 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVS-KGSKQGIKEYASEVTIISRLRHRN 99
           +D+   + +G G    V   +       +A+KR++ +  +  + E   E+  +S+  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK--------IAQDLASG 151
           +V        K EL LV + +  GS+   + K                    I +++  G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG----LARLVEHAKGSQTTVLAGTM 207
           L YL +      +HRD+K+ NI+L  + + +I DFG    LA   +  +        GT 
Sbjct: 134 LEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 208 GYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPIS 244
            +MAPE     R    ++D++SFGI A+E+A G  P  
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (301), Expect = 2e-31
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 21/207 (10%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR----------L 95
             KLG GG   VY       +  +A+K               +   + R          L
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIK-AIF------IPPREKEETLKRFEREVHNSSQL 68

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
            H+N+V ++    E     LV EY+   +L  ++ + +  L+ +        +  G+   
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGI--- 124

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
           +   +  +VHRDIK  NI++D N   KI DFG+A+ +     +QT  + GT+ Y +PE A
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184

Query: 216 TTGRASKESDVYSFGIVALEIACGRKP 242
                 + +D+YS GIV  E+  G  P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  120 bits (303), Expect = 3e-31
 Identities = 33/241 (13%), Positives = 69/241 (28%), Gaps = 24/241 (9%)

Query: 23  EKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG 77
            +   P      E    +        LG+G F  VY+         +      +K     
Sbjct: 47  WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106

Query: 78  SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL----FKEN 133
           +          +  +        ++       +   +LV E    G+L + +        
Sbjct: 107 NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166

Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML-----------DLNFNAK 182
            ++        A  +   +  +    +  ++H DIK  N +L           DL+    
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 183 IGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRK 241
           + D G +  +    KG+  T    T G+   E  +    + + D +        +  G  
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 242 P 242
            
Sbjct: 284 M 284

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (305), Expect = 5e-31
 Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 19/212 (8%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNL 100
            F     LG G  G +        +  +AVKR+             EV ++     H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNV 80

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           ++      +++   +  E     +L  ++ +++          + Q   SGL +L     
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS--- 136

Query: 161 QCVVHRDIKSSNIML-----DLNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPE 213
             +VHRD+K  NI++          A I DFGL + +   + S +    + GT G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 214 ---CATTGRASKESDVYSFGIVALEIACGRKP 242
                     +   D++S G V   +      
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (303), Expect = 6e-31
 Identities = 45/362 (12%), Positives = 91/362 (25%), Gaps = 65/362 (17%)

Query: 35  ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG---IKEYASEVTI 91
           EL +          LGQ       +   +ET     V       +     IK+   EV  
Sbjct: 72  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 131

Query: 92  ISRLR-------------------------HRNLVQLLGW--CHEKKELLLVYEYMPN-- 122
           +  LR                          + ++++              +Y  M +  
Sbjct: 132 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 191

Query: 123 ---GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF 179
              G +       +  L    R ++   +   L  L       +VH  ++  +I+LD   
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRG 248

Query: 180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVAL 234
              +  F        +  S            A              +   D ++ G+   
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308

Query: 235 EIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLW 294
            I C   P +  A      ++ +   ++           P+  R           + G  
Sbjct: 309 WIWCADLPNTDDAALGGSEWIFRSCKNI-----------PQPVRAL---------LEGFL 348

Query: 295 CAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNS 354
               ++  R    Q +     E     L   +P+      P        +G  +     +
Sbjct: 349 RYPKED--RLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGA 406

Query: 355 SS 356
           + 
Sbjct: 407 AE 408

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  121 bits (305), Expect = 8e-31
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 17/217 (7%)

Query: 36  LAQATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSK---GSKQGIKEYASE 88
           +  +T  F+D     + LG+G FG V     + T    AVK +SK     K   +    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 89  VTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDL 148
           V ++ +L H N+++L  +  +K    LV E    G L   +       +     +I + +
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQV 135

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
            SG+ Y+    +  +VHRD+K  N++L     + N +I DFGL+   E     +     G
Sbjct: 136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIG 190

Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           T  Y+APE    G   ++ DV+S G++   +  G  P
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  118 bits (297), Expect = 1e-30
 Identities = 60/339 (17%), Positives = 112/339 (33%), Gaps = 87/339 (25%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRN 99
            DF   Q +G+GGFG V++   +      A+KR+   +++  +E    EV  +++L H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 100 LVQLLG------WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR-----------F 142
           +V+             ++E+  ++    +           +  + + R            
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 143 KIAQDLASGLLYLQ-------------------------EGW--------------EQCV 163
           ++        LY+Q                                           + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA-----------GTMGYMAP 212
           +HRD+K SNI   ++   K+GDFGL   ++  +  QT +             GT  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV 272
           E       S + D++S G++  E+         T  E V++              +    
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFS----TQMERVRII-----------TDVRNLK 290

Query: 273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
            P L      Q+    M+       P    RP    +I 
Sbjct: 291 FPLLFTQKYPQEHM--MV--QDMLSPSPTERPEATDIIE 325

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  117 bits (295), Expect = 2e-30
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 10/207 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----KQGIKEYASEVTIISRLR 96
            DF   + LG+G F  V       TS   A+K + K       + +     E  ++SRL 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLD 88

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H   V+L     + ++L     Y  NG L  ++ K  +      RF  A+ + S L YL 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEYLH 147

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV-LAGTMGYMAPECA 215
               + ++HRD+K  NI+L+ + + +I DFG A+++             GT  Y++PE  
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204

Query: 216 TTGRASKESDVYSFGIVALEIACGRKP 242
           T   A K SD+++ G +  ++  G  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (302), Expect = 3e-30
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 12/221 (5%)

Query: 27  GPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKE 84
            P  F   +    +  +   +KLG G +G V     + T    A+K + K   S     +
Sbjct: 23  TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82

Query: 85  YASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKI 144
              EV ++  L H N+++L  +  +K+   LV E    G L   +              I
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVI 141

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTT 201
            + + SG+ YL    +  +VHRD+K  N++L   + +   KI DFGL+ + E     +  
Sbjct: 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMK 196

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
              GT  Y+APE     +  ++ DV+S G++   +  G  P
Sbjct: 197 ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  118 bits (297), Expect = 4e-30
 Identities = 54/248 (21%), Positives = 104/248 (41%), Gaps = 17/248 (6%)

Query: 1   RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFND----DQKLGQGGFGG 56
           + R   DG     ++++ +D ++K      +  + +        D     ++LG G FG 
Sbjct: 13  KVRGKYDGPKINDYDKFYEDIWKK------YVPQPVEVKQGSVYDYYDILEELGSGAFGV 66

Query: 57  VYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV 116
           V++   + T      K ++           +E++I+++L H  L+ L     +K E++L+
Sbjct: 67  VHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126

Query: 117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD 176
            E++  G L   +  E+  ++        +    GL ++    E  +VH DIK  NIM +
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCE 183

Query: 177 LNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVAL 234
               +  KI DFGLA  +         V   T  + APE          +D+++ G++  
Sbjct: 184 TKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241

Query: 235 EIACGRKP 242
            +  G  P
Sbjct: 242 VLLSGLSP 249

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  118 bits (297), Expect = 2e-29
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 11/230 (4%)

Query: 19  DDEFEKGAGPKRFTYKELAQATNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRV 74
           + +       K++  + +    +   D     ++LG G FG V++   R T +  A K V
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 190

Query: 75  SKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENN 134
               +   +    E+  +S LRH  LV L     +  E++++YE+M  G L   +  E+N
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250

Query: 135 LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA--KIGDFGLARLV 192
            ++ +   +  + +  GL ++    E   VH D+K  NIM     +   K+ DFGL   +
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307

Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           +        V  GT  + APE A        +D++S G+++  +  G  P
Sbjct: 308 D--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  117 bits (295), Expect = 2e-29
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)

Query: 36  LAQATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSK-------------GS 78
           + +      +     +KLG G +G V     +   S  A+K + K               
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 79  KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTW 138
           ++  +E  +E++++  L H N+++L     +KK   LV E+   G L   +   +     
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDE 145

Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHA 195
                I + + SG+ YL    +  +VHRDIK  NI+L   +   N KI DFGL+      
Sbjct: 146 CDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-- 200

Query: 196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           K  +     GT  Y+APE     + +++ DV+S G++   + CG  P
Sbjct: 201 KDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (287), Expect = 3e-29
 Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 23/208 (11%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR----------L 95
            + +G+GG G VY+         +A+K +S+         +S+    +R          L
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSE-------TLSSDPVFRTRMQREARTAGRL 91

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
           +  ++V +  +     +L +    +    L + L +    L       I + + S L   
Sbjct: 92  QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAA 150

Query: 156 -QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 214
              G      HRD+K  NI++  +  A + DFG+A      K +Q     GT+ YMAPE 
Sbjct: 151 HAAG----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 215 ATTGRASKESDVYSFGIVALEIACGRKP 242
            +   A+  +D+Y+   V  E   G  P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  117 bits (295), Expect = 4e-29
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 14/236 (5%)

Query: 14  FNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKR 73
           F ++I+ +        +     +    NDF+  + +G+GGFG VY     +T    A+K 
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC 221

Query: 74  VSKG---SKQGIKEYASEVTI---ISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDS 127
           + K     KQG     +E  +   +S      +V +    H   +L  + + M  G L  
Sbjct: 222 LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY 281

Query: 128 HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG 187
           HL +       + RF  A+ +  GL ++     + VV+RD+K +NI+LD + + +I D G
Sbjct: 282 HLSQHGVFSEADMRFYAAE-IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKP 242
           LA   + +K  +     GT GYMAPE    G A    +D +S G +  ++  G  P
Sbjct: 338 LA--CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (285), Expect = 5e-29
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 24/215 (11%)

Query: 40  TNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL 95
           T +        + LG G F  V+    R T    A+K + K          +E+ ++ ++
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSL-----DSHLFKENNLLTWEFRFKIAQDLAS 150
           +H N+V L           LV + +  G L     +  ++ E      +    + Q + S
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK-----DAS-LVIQQVLS 117

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
            + YL    E  +VHRD+K  N++    + N    I DFGL+++ +       +   GT 
Sbjct: 118 AVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTP 171

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           GY+APE       SK  D +S G++   + CG  P
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (287), Expect = 5e-29
 Identities = 35/240 (14%), Positives = 67/240 (27%), Gaps = 54/240 (22%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG---IKEYASEVTIISRLR--------- 96
           LGQ       +   +ET     V       +     IK+   EV  +  LR         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 97  ----------------HRNLVQLLGWCHEKKELLLVYEYM-PNGSLDS------HLFKEN 133
                            + ++++     +   L   + Y     +L +           +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE 193
             L    R ++   +   L  L       +VH  ++  +I+LD      +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 194 HAKGSQTTVLAGTMGYMAPE-----------CATTGRASKESDVYSFGIVALEIACGRKP 242
             +     V + + G+  PE                  +   D ++ G+V   I C   P
Sbjct: 255 --RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  114 bits (287), Expect = 1e-28
 Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 32/239 (13%)

Query: 28  PKRFTYKELA-----QATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS 78
            K F + +L             D+    + LG G  G V   F R+T   +A++ +SK  
Sbjct: 113 NKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISK-R 171

Query: 79  KQGIKEYAS---------EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL 129
           K  I              E+ I+ +L H  ++++  +  + ++  +V E M  G L   +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV 230

Query: 130 FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDF 186
                L     +      +   + YL    E  ++HRD+K  N++L   + +   KI DF
Sbjct: 231 VGNKRLKEATCK-LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286

Query: 187 GLARLVEHAKGSQTTVLAGTMGYMAPE---CATTGRASKESDVYSFGIVALEIACGRKP 242
           G ++++   + S    L GT  Y+APE      T   ++  D +S G++      G  P
Sbjct: 287 GHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  112 bits (282), Expect = 1e-28
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 27/213 (12%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR----------L 95
            + LG GG   V+          +AVK V +       + A + +   R          L
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVK-VLR------ADLARDPSFYLRFRREAQNAAAL 69

Query: 96  RHRNLVQLL--GWCHEKKELL--LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
            H  +V +   G        L  +V EY+   +L   +      +T +   ++  D    
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQA 128

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGY 209
           L       +  ++HRD+K +NIM+      K+ DFG+AR +  +  S  QT  + GT  Y
Sbjct: 129 L---NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 210 MAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           ++PE A        SDVYS G V  E+  G  P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  113 bits (285), Expect = 1e-28
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 12/208 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           + F   + +G+G FG V      +T    A+K ++K     +  ++    E+ I+  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             LV L     +++++ +V + +  G L  HL +  +      +  I + L   L YLQ 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-LVMALDYLQN 133

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              Q ++HRD+K  NI+LD + +  I DF +A ++   + +Q T +AGT  YMAPE  ++
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGTKPYMAPEMFSS 188

Query: 218 GRA---SKESDVYSFGIVALEIACGRKP 242
            +    S   D +S G+ A E+  GR+P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  113 bits (285), Expect = 1e-28
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 13/214 (6%)

Query: 28  PKRFTYKELAQATNDFNDD------QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG 81
           P  F ++ +       N        + LG G FG V+K     T   +A K +     + 
Sbjct: 70  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 82  IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR 141
            +E  +E++++++L H NL+QL      K +++LV EY+  G L   +  E+  LT    
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA--KIGDFGLARLVEHAKGSQ 199
               + +  G+ ++    +  ++H D+K  NI+         KI DFGLAR  +     +
Sbjct: 190 ILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REK 244

Query: 200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
             V  GT  ++APE       S  +D++S G++A
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  115 bits (289), Expect = 2e-28
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 28/218 (12%)

Query: 40  TNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIIS 93
              F +       LG+G FG V K   R T    AVK ++K     +       EV ++ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 94  RLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRF------KIAQD 147
           +L H N+++L     +     +V E    G L   + K         RF      +I + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-------RFSEHDAARIIKQ 129

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLA 204
           + SG+ Y+    +  +VHRD+K  NI+L   + + + KI DFGL+   +  + ++     
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI 184

Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           GT  Y+APE    G   ++ DV+S G++   +  G  P
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  112 bits (282), Expect = 3e-28
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 18/218 (8%)

Query: 34  KELAQATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEV 89
           ++L + +  F D     + +G G +    +   + T+   AVK + K SK+   E   E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTE---EI 66

Query: 90  TIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDL 148
            I+ R  +H N++ L     + K + +V E M  G L   + ++      E    +   +
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-AVLFTI 125

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIML-DLNFNA---KIGDFGLARLVEHAKGSQTTVLA 204
              + YL     Q VVHRD+K SNI+  D + N    +I DFG A+ +    G   T   
Sbjct: 126 TKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-C 181

Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            T  ++APE           D++S G++   +  G  P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  114 bits (287), Expect = 4e-28
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 11/207 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           N F   + LG+GGFG V     R T    A K++ K     ++G     +E  I+ ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE--FRFKIAQDLASGLLYL 155
           R +V L      K  L LV   M  G L  H++        E    F  A+ +  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDL 302

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
                + +V+RD+K  NI+LD + + +I D GLA  V   +G       GT+GYMAPE  
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVV 357

Query: 216 TTGRASKESDVYSFGIVALEIACGRKP 242
              R +   D ++ G +  E+  G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (276), Expect = 5e-28
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 14/210 (6%)

Query: 40  TNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL 95
             D N     +  +G+G +G V     + T    A K++ K   + +  +  E+ I+  L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
            H N+++L     +  ++ LV E    G L   +  +      +   +I +D+ S + Y 
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122

Query: 156 QEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
               +  V HRD+K  N +      +   K+ DFGLA   +   G       GT  Y++P
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPYYVSP 177

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKP 242
           +    G    E D +S G++   + CG  P
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  110 bits (278), Expect = 8e-28
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 29/232 (12%)

Query: 25  GAGPKRFTYKELAQATNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ 80
           G       Y       +  +D    + +LG+G    VY+   + T    A+K + K    
Sbjct: 33  GTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TV 90

Query: 81  GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL-DSHLFKENNLLTWE 139
             K   +E+ ++ RL H N+++L        E+ LV E +  G L D  + K        
Sbjct: 91  DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG------- 143

Query: 140 FRF------KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLAR 190
             +         + +   + YL E     +VHRD+K  N++      +   KI DFGL++
Sbjct: 144 -YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199

Query: 191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           +VEH        + GT GY APE         E D++S GI+   + CG +P
Sbjct: 200 IVEH--QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  113 bits (284), Expect = 8e-28
 Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 27/255 (10%)

Query: 2   KRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQAT-NDFNDDQKLGQGGFGGVYKG 60
            R V        F E++D  +       ++ + E      + F D + LG+GGFG V+  
Sbjct: 147 LRAVLAHLGQAPFQEFLDSLYFLRF--LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFAC 204

Query: 61  FFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY 117
             + T    A K+++K     ++G +    E  I++++  R +V L      K +L LV 
Sbjct: 205 QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264

Query: 118 EYMPNGSLDSHL---------FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI 168
             M  G +  H+         F+E         F  AQ + SGL +L +   + +++RD+
Sbjct: 265 TIMNGGDIRYHIYNVDEDNPGFQEP-----RAIFYTAQ-IVSGLEHLHQ---RNIIYRDL 315

Query: 169 KSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTGRASKESDVY 227
           K  N++LD + N +I D GLA  VE   G   T   AGT G+MAPE           D +
Sbjct: 316 KPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373

Query: 228 SFGIVALEIACGRKP 242
           + G+   E+   R P
Sbjct: 374 ALGVTLYEMIAARGP 388

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 9e-28
 Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 31/240 (12%)

Query: 18  IDDEFEKGAGPKRFTYKELAQATNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKR 73
           +       +G +   ++         +D     +KLG G FG V+    R +     +K 
Sbjct: 1   MHHHHHHSSGRENLYFQG------TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT 54

Query: 74  VSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL-DSHLFK 131
           ++K  S+  +++  +E+ ++  L H N++++     +   + +V E    G L +  +  
Sbjct: 55  INKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA 114

Query: 132 ENNLLTWEFRF------KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAK 182
           +                ++ + + + L Y      Q VVH+D+K  NI+      +   K
Sbjct: 115 QAR----GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIK 167

Query: 183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           I DFGLA L +      +T  AGT  YMAPE       + + D++S G+V   +  G  P
Sbjct: 168 IIDFGLAELFK--SDEHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (277), Expect = 1e-27
 Identities = 53/258 (20%), Positives = 96/258 (37%), Gaps = 58/258 (22%)

Query: 40  TNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSK-----GSKQGIKEYASEVT 90
             +          +GQG +G V      +T +  A+K ++K      + + ++   +EV 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 91  IISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRF-------- 142
           ++ +L H N+ +L     +++ + LV E    G L   L    +  T +           
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 143 -------------------------------KIAQDLASGLLYLQEGWEQCVVHRDIKSS 171
                                           I + + S L YL     Q + HRDIK  
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197

Query: 172 NIML--DLNFNAKIGDFGLARLVEHAKGSQTTVL---AGTMGYMAPE-CATTGRA-SKES 224
           N +   + +F  K+ DFGL++        +   +   AGT  ++APE   TT  +   + 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257

Query: 225 DVYSFGIVALEIACGRKP 242
           D +S G++   +  G  P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  110 bits (276), Expect = 1e-27
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 18/207 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS------EVTIISRLRHR-- 98
             LG GGFG VY G     +  +A+K V K       E  +      EV ++ ++     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 99  NLVQLLGWCHEKKELLLVYEY-MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
            +++LL W       +L+ E   P   L   + +   L     R      +   + +   
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 166

Query: 158 GWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
                V+HRDIK  NI++DLN    K+ DFG   L+   K +  T   GT  Y  PE   
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 221

Query: 217 TGR-ASKESDVYSFGIVALEIACGRKP 242
             R   + + V+S GI+  ++ CG  P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 2e-27
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 26/217 (11%)

Query: 40  TNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIIS 93
              F +       LG+G FG V K   R T    AVK ++K     +       EV ++ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 94  RLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL-----DSHLFKENNLLTWEFRFKIAQDL 148
           +L H N+++L     +     +V E    G L         F E++        +I + +
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------RIIKQV 130

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
            SG+ Y+    +  +VHRD+K  NI+L   + + + KI DFGL+   +  + ++     G
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIG 185

Query: 206 TMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           T  Y+APE    G   ++ DV+S G++   +  G  P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (279), Expect = 2e-27
 Identities = 54/232 (23%), Positives = 91/232 (39%), Gaps = 38/232 (16%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRN 99
           N    ++ LG G  G V           +AVKR+             E+ +++    H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPN 70

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLD-----SHLFKENNLLTWEFRFK-IAQDLASGLL 153
           +++        + L +  E   N +L       ++  EN  L  E+    + + +ASG+ 
Sbjct: 71  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 154 YLQEGWEQCVVHRDIKSSNIMLD-------------LNFNAKIGDFGLARLVEHAKGSQT 200
           +L       ++HRD+K  NI++               N    I DFGL + ++  + S  
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 201 TVL---AGTMGYMAPE-------CATTGRASKESDVYSFGIVALEIACGRKP 242
           T L   +GT G+ APE         T  R ++  D++S G V   I    K 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  108 bits (273), Expect = 2e-27
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 26/225 (11%)

Query: 38  QATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA------- 86
            +T+ F ++    + LG+G    V +   + T    AVK +                   
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 87  --SEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK 143
              EV I+ ++  H N++QL           LV++ M  G L  +L ++  L   E R K
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-K 128

Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           I + L   +  L +     +VHRD+K  NI+LD + N K+ DFG +  ++   G +   +
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREV 183

Query: 204 AGTMGYMAPE------CATTGRASKESDVYSFGIVALEIACGRKP 242
            GT  Y+APE              KE D++S G++   +  G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  109 bits (274), Expect = 2e-27
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 11/198 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +G+G F  V       T   +A+K + K   +   +++   EV I+  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
              +K L L+ EY   G +  +L     +   E R    + + S + Y  +   + +VHR
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQ---KRIVHR 138

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR--ASKES 224
           D+K+ N++LD + N KI DFG +               G   Y APE    G+     E 
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPE-LFQGKKYDGPEV 195

Query: 225 DVYSFGIVALEIACGRKP 242
           DV+S G++   +  G  P
Sbjct: 196 DVWSLGVILYTLVSGSLP 213

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  107 bits (270), Expect = 8e-27
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 19/214 (8%)

Query: 40  TNDFNDD-------QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTII 92
            + F          + LG+G F    K   ++++   AVK +SK  +   ++   E+T +
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITAL 59

Query: 93  SRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
                H N+V+L    H++    LV E +  G L   + K+ +    E    I + L S 
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-YIMRKLVSA 118

Query: 152 LLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 208
           + ++    +  VVHRD+K  N++    + N   KI DFG ARL         T    T+ 
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLH 174

Query: 209 YMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           Y APE        +  D++S G++   +  G+ P
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  107 bits (269), Expect = 9e-27
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 22/208 (10%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS----EVTIISRLRHRNLVQLL 104
           LG+G +G V +    ET    AVK + K   + I    +    E+ ++ RLRH+N++QL+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 105 G--WCHEKKELLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLASGLLYLQEGW 159
              +  EK+++ +V EY   G  +  +     E      +      Q L  GL YL    
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQ-LIDGLEYLHS-- 127

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPECAT 216
            Q +VH+DIK  N++L      KI   G+A  +         +T+   G+  +  PE A 
Sbjct: 128 -QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEIAN 184

Query: 217 TGR--ASKESDVYSFGIVALEIACGRKP 242
                +  + D++S G+    I  G  P
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  107 bits (269), Expect = 1e-26
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 20/209 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSK------GSKQGIKEYASEVTIISRLR---- 96
             LG+GGFG V+ G        +A+K + +                 EV ++ ++     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 97  HRNLVQLLGWCHEKKELLLVYEY-MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
           H  +++LL W   ++  +LV E  +P   L  ++ ++  L     R      + + + + 
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHC 155

Query: 156 QEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 214
                + VVHRDIK  NI++DL    AK+ DFG   L+        T   GT  Y  PE 
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPEW 209

Query: 215 ATTGR-ASKESDVYSFGIVALEIACGRKP 242
            +  +  +  + V+S GI+  ++ CG  P
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  106 bits (267), Expect = 1e-26
 Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 21/205 (10%)

Query: 40  TNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIIS 93
           +  F+D+    ++LG+G F  V +   + T    A K ++    S +  ++   E  I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 94  RLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLAS 150
           +L+H N+V+L     E+    LV++ +  G     LF         +        Q +  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
            + Y        +VHR++K  N++L         K+ DFGLA  V           AGT 
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP 171

Query: 208 GYMAPECATTGRASKESDVYSFGIV 232
           GY++PE       SK  D+++ G++
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVI 196

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  106 bits (266), Expect = 1e-26
 Identities = 61/199 (30%), Positives = 89/199 (44%), Gaps = 11/199 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS-EVTIISRLRHRNLVQLLGWC 107
           LG+G +G V     R T   +AVK V         E    E+ I   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
            E     L  EY   G L   +  +  +   + +    Q L +G++YL       + HRD
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-LMAGVVYLHG---IGITHRD 130

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA---GTMGYMAPE-CATTGRASKE 223
           IK  N++LD   N KI DFGLA +  +   ++  +L    GT+ Y+APE        ++ 
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVAPELLKRREFHAEP 188

Query: 224 SDVYSFGIVALEIACGRKP 242
            DV+S GIV   +  G  P
Sbjct: 189 VDVWSCGIVLTAMLAGELP 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  107 bits (269), Expect = 1e-26
 Identities = 42/198 (21%), Positives = 79/198 (39%), Gaps = 12/198 (6%)

Query: 42  DFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH 97
           +  +     + LG+G FG V++     +      K V             E++I++  RH
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
           RN++ L       +EL++++E++    +   +      L           +   L +L  
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
                + H DI+  NI+     ++  KI +FG AR ++   G    +L     Y APE  
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVH 175

Query: 216 TTGRASKESDVYSFGIVA 233
                S  +D++S G + 
Sbjct: 176 QHDVVSTATDMWSLGTLV 193

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (269), Expect = 2e-26
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 25/223 (11%)

Query: 39  ATNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-------- 86
           A  +F         +G+G    V +   R T    AVK +   +++   E          
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 87  SEVTIISRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIA 145
            E  I+ ++  H +++ L+        + LV++ M  G L  +L ++  L   E R  I 
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-SIM 206

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
           + L   + +L       +VHRD+K  NI+LD N   ++ DFG +  +E   G +   L G
Sbjct: 207 RSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCG 261

Query: 206 TMGYMAPE------CATTGRASKESDVYSFGIVALEIACGRKP 242
           T GY+APE        T     KE D+++ G++   +  G  P
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (265), Expect = 4e-26
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 20/208 (9%)

Query: 40  TNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA------SEV 89
                D     ++LG G F  V K   + T    A K + K   +  +          EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA 149
           +I+ ++ H N++ L      + +++L+ E +  G L   L ++ +L   E    I Q + 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-IL 125

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
            G+ YL     + + H D+K  NIML        + K+ DFGLA  +E   G +   + G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFG 180

Query: 206 TMGYMAPECATTGRASKESDVYSFGIVA 233
           T  ++APE         E+D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (264), Expect = 5e-26
 Identities = 61/199 (30%), Positives = 89/199 (44%), Gaps = 11/199 (5%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS-EVTIISRLRHRNLVQLLGWC 107
           LG+G +G V     R T   +AVK V         E    E+ I   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD 167
            E     L  EY   G L   +  +  +   + +    Q L +G++YL       + HRD
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-LMAGVVYLHG---IGITHRD 130

Query: 168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLA---GTMGYMAPE-CATTGRASKE 223
           IK  N++LD   N KI DFGLA +  +   ++  +L    GT+ Y+APE        ++ 
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVAPELLKRREFHAEP 188

Query: 224 SDVYSFGIVALEIACGRKP 242
            DV+S GIV   +  G  P
Sbjct: 189 VDVWSCGIVLTAMLAGELP 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (265), Expect = 6e-26
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 20/208 (9%)

Query: 40  TNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA------SEV 89
                D     ++LG G F  V K   + T    A K + K   +  +          EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA 149
           +I+ ++ H N++ L      + +++L+ E +  G L   L ++ +L   E      + + 
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQIL 125

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHAKGSQTTVLAG 205
            G+ YL     + + H D+K  NIML        + K+ DFGLA  +E   G +   + G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFG 180

Query: 206 TMGYMAPECATTGRASKESDVYSFGIVA 233
           T  ++APE         E+D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (263), Expect = 7e-26
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 31/216 (14%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS--------EVTIISRLRH 97
            + LG G  G V   F R+T   +A+K +SK          +        E+ I+ +L H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSL-----DSHLFKENNLLTWEFRFKIAQDLASGL 152
             ++++  +  + ++  +V E M  G L      +   KE        +      +   +
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFYQMLLAV 127

Query: 153 LYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY 209
            YL    E  ++HRD+K  N++L   + +   KI DFG ++++   + S    L GT  Y
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTY 182

Query: 210 MAPE---CATTGRASKESDVYSFGIVALEIACGRKP 242
           +APE      T   ++  D +S G++      G  P
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  105 bits (264), Expect = 8e-26
 Identities = 60/244 (24%), Positives = 109/244 (44%), Gaps = 16/244 (6%)

Query: 2   KRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGF 61
           K+  +     +   +  +D  +K   P + T +      + F+  + LG G FG V    
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQ-----LDQFDRIKTLGTGSFGRVMLVK 61

Query: 62  FRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYE 118
            +E+ ++ A+K + K     +K+     +E  I+  +    LV+L     +   L +V E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN 178
           Y+  G + SHL +         RF  AQ +     YL       +++RD+K  N+++D  
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177

Query: 179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC 238
              ++ DFG A+ V+     +T  L GT   +APE   +   +K  D ++ G++  E+A 
Sbjct: 178 GYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

Query: 239 GRKP 242
           G  P
Sbjct: 234 GYPP 237

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (264), Expect = 1e-25
 Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 21/220 (9%)

Query: 25  GAGPKRFTYKELAQATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GS 78
           G        + +  A+  F+D+    ++LG+G F  V +   + T    A K ++    S
Sbjct: 9   GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68

Query: 79  KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNL 135
            +  ++   E  I  +L+H N+V+L     E+    LV++ +  G L    F        
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREF 124

Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLV 192
            +        Q +   + Y        +VHR++K  N++L         K+ DFGLA  V
Sbjct: 125 YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

Query: 193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIV 232
                      AGT GY++PE       SK  D+++ G++
Sbjct: 182 N--DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  104 bits (262), Expect = 1e-25
 Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 24/223 (10%)

Query: 40  TNDFNDD-----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR 94
           +  F D        LG+G    V       TS   AVK + K           EV ++ +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 95  LR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLL 153
            + HRN+++L+ +  E+    LV+E M  GS+ SH+ K  +    E    + QD+AS L 
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-VVVQDVASALD 125

Query: 154 YLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTV------LA 204
           +L     + + HRD+K  NI+    +     KI DF L   ++                 
Sbjct: 126 FLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 205 GTMGYMAPE-----CATTGRASKESDVYSFGIVALEIACGRKP 242
           G+  YMAPE             K  D++S G++   +  G  P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (262), Expect = 1e-25
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 18/207 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYAS------EVTIISRLRHR 98
             LG G FG V+    +E +  + VK + K    +    E         E+ I+SR+ H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGS-LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
           N++++L     +    LV E   +G  L + + +   L      +   Q L S + YL+ 
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ-LVSAVGYLRL 148

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + ++HRDIK  NI++  +F  K+ DFG A  +E  K   T    GT+ Y APE    
Sbjct: 149 ---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPE-VLM 202

Query: 218 GR--ASKESDVYSFGIVALEIACGRKP 242
           G      E +++S G+    +     P
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENP 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (263), Expect = 1e-25
 Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 29/228 (12%)

Query: 35  ELAQATNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS--- 87
           ++A     F D     + +G+G F  V +   RET    AVK V   +K       S   
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTED 72

Query: 88  ---EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL-DSHLFKENNLLTWEFRF- 142
              E +I   L+H ++V+LL        L +V+E+M    L    + + +      F + 
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA----GFVYS 128

Query: 143 -----KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEH 194
                   + +   L Y     +  ++HRD+K   ++L   + +   K+G FG+A  +  
Sbjct: 129 EAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

Query: 195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           +         GT  +MAPE        K  DV+  G++   +  G  P
Sbjct: 186 SGLVAGGR-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  107 bits (269), Expect = 1e-25
 Identities = 53/318 (16%), Positives = 96/318 (30%), Gaps = 51/318 (16%)

Query: 46  DQKLGQGGFGGVYKGF-FRETSSYIAVKRV-SKGSKQGIKEYASEVTIISRLRHRNLVQL 103
              +  GG G +Y           + +K +   G  +      +E   ++ + H ++VQ+
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 104 L-----GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL-QE 157
                    H      +V EY+   SL          L          ++   L YL   
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSI 201

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
           G    +V+ D+K  NIML      K+ D G    +     +    L GT G+ APE    
Sbjct: 202 G----LVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NSFGYLYGTPGFQAPEIVR- 250

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
              +  +D+Y+ G     +       +    + +                  +    +  
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------------DDPVLKTY 294

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIHVLNSEAPLPALPPKMPVPTYF 332
             +         ++      PD   R +       Q+  VL          P+  + T F
Sbjct: 295 DSYGR-------LL-RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIF 346

Query: 333 SPPANMRAVNGAGPDKGP 350
           SP  +   V+        
Sbjct: 347 SPSRSTFGVDLLVAHTDV 364

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  105 bits (264), Expect = 2e-25
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 15/234 (6%)

Query: 20  DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-- 77
            +F + A P     KE+    +DF   + +G+G F  V     ++T    A+K ++K   
Sbjct: 40  ADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM 99

Query: 78  -SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLL 136
             +  +  +  E  ++     R + QL     ++  L LV EY   G L + L K    +
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159

Query: 137 TWEF-RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA 195
             E  RF +A+ +   +  +        VHRDIK  NI+LD   + ++ DFG    +   
Sbjct: 160 PAEMARFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215

Query: 196 KGSQTTVLAGTMGYMAPE-------CATTGRASKESDVYSFGIVALEIACGRKP 242
              ++ V  GT  Y++PE          TG    E D ++ G+ A E+  G+ P
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (259), Expect = 2e-25
 Identities = 55/236 (23%), Positives = 99/236 (41%), Gaps = 55/236 (23%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSK-----------------------------G 77
            ++G+G +G V   +    ++Y A+K +SK                             G
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 78  SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE------KKELLLVYEYMPNGSLDSHLFK 131
             + + +   E+ I+ +L H N+V+L     E      +  L +V+E +  G +     +
Sbjct: 79  PIEQVYQ---EIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV----ME 127

Query: 132 --ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA 189
                 L+ +      QDL  G+ YL     Q ++HRDIK SN+++  + + KI DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRAS---KESDVYSFGIVALEIACGRKP 242
              + +    +    GT  +MAPE  +  R     K  DV++ G+       G+ P
Sbjct: 185 NEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (258), Expect = 2e-25
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)

Query: 42  DFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS------EVTI 91
              D     ++LG G F  V K   + T    A K + K      +   S      EV I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 92  ISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
           +  +RH N++ L      K +++L+ E +  G L   L ++ +L   E   +  + +  G
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-QFLKQILDG 120

Query: 152 LLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           + YL     + + H D+K  NIML      N   K+ DFG+A  +E   G++   + GT 
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTP 175

Query: 208 GYMAPECATTGRASKESDVYSFGIVA 233
            ++APE         E+D++S G++ 
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVIT 201

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  104 bits (262), Expect = 4e-25
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 13/232 (5%)

Query: 20  DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK 79
            E+ + A P     K++     DF   + +G+G FG V     +      A+K ++K   
Sbjct: 53  LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112

Query: 80  QGIKEYA---SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLL 136
               E A    E  ++     + +  L     +   L LV +Y   G L + L K  + L
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172

Query: 137 TWEF-RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA 195
             E  RF +A+ +   +  + +      VHRDIK  NI++D+N + ++ DFG    +   
Sbjct: 173 PEEMARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228

Query: 196 KGSQTTVLAGTMGYMAPE-----CATTGRASKESDVYSFGIVALEIACGRKP 242
              Q++V  GT  Y++PE         GR   E D +S G+   E+  G  P
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  104 bits (261), Expect = 4e-25
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 20/234 (8%)

Query: 20  DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-- 77
           D F           ++L     D+   + +G+G FG V     + T    A+K +SK   
Sbjct: 48  DNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM 107

Query: 78  -SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHL----FKE 132
             +     +  E  I++      +VQL     + + L +V EYMP G L + +      E
Sbjct: 108 IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE 167

Query: 133 NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV 192
                   RF  A+ +   L  +        +HRD+K  N++LD + + K+ DFG    +
Sbjct: 168 KWA-----RFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218

Query: 193 EHAKGSQTTVLAGTMGYMAPE----CATTGRASKESDVYSFGIVALEIACGRKP 242
                 +     GT  Y++PE        G   +E D +S G+   E+  G  P
Sbjct: 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  102 bits (257), Expect = 6e-25
 Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 35/234 (14%)

Query: 28  PKRFTYKELAQATNDFNDD-----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGI 82
                ++          DD     Q LG G  G V + F R T    A+K +        
Sbjct: 11  GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--SPKA 68

Query: 83  KEYASEVTIISRL-RHRNLVQLLGWC----HEKKELLLVYEYMPNGSLDSHLFKENNLLT 137
           ++   EV    +     ++V +L       H K+ LL++ E M  G L S + +  +   
Sbjct: 69  RQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-- 123

Query: 138 WEFRF------KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGL 188
               F      +I +D+ + + +L       + HRD+K  N++    + +   K+ DFG 
Sbjct: 124 ---AFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           A+       +  T    T  Y+APE     +  K  D++S G++   + CG  P
Sbjct: 178 AKETTQ--NALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (261), Expect = 7e-25
 Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 20/215 (9%)

Query: 40  TNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIIS 93
              F ++    ++LG+G F  V +          A   ++    S +  ++   E  I  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 94  RLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLAS 150
            L+H N+V+L     E+    L+++ +  G     LF         +        Q +  
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILE 121

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
            +L+     +  VVHR++K  N++L         K+ DFGLA  VE  + +     AGT 
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTP 177

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           GY++PE        K  D+++ G++   +  G  P
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  101 bits (253), Expect = 9e-25
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 24/205 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSK------GSKQGIKEYASEVTIISRLRHRNLVQ 102
           LG G FG V  G  + T   +AVK +++           IK    E+  +   RH ++++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR---EIQNLKLFRHPHIIK 75

Query: 103 LLGWCHE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           L    ++      +  +V EY+  G L  ++ K   +   E R    Q + S + Y    
Sbjct: 76  L----YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ-ILSAVDYCHR- 129

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATT 217
               VVHRD+K  N++LD + NAKI DFGL+ ++   +  +T+   G+  Y APE  +  
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISGR 185

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
             A  E D++S G++   + CG  P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP 210

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (254), Expect = 1e-24
 Identities = 49/223 (21%), Positives = 97/223 (43%), Gaps = 17/223 (7%)

Query: 23  EKGAGPKRFTYKELAQATNDFND-----DQKLGQGGFGGVYKGFFRETSSYIAVK--RVS 75
              +G    T     Q+  +FN+      ++LG+G F  V +   + T    A K  +  
Sbjct: 6   HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR 65

Query: 76  KGSKQGIKEYASEVTIISRLRHR-NLVQLLGWCHEKKELLLVYEYMPNGSL-DSHLFKEN 133
           +  +    E   E+ ++   +    ++ L        E++L+ EY   G +    L +  
Sbjct: 66  RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA 125

Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLAR 190
            +++     ++ + +  G+ YL    +  +VH D+K  NI+L       + KI DFG++R
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

Query: 191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVA 233
            + H    +   + GT  Y+APE       +  +D+++ GI+A
Sbjct: 183 KIGH--ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (253), Expect = 2e-24
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 40  TNDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA------SEV 89
             + +D     ++LG G F  V K   + T    A K + K   +  +          EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQ 146
           +I+  ++H N++ L      K +++L+ E +  G     LF    E   LT E   +  +
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLK 121

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLARLVEHAKGSQTTV 202
            + +G+ YL       + H D+K  NIML          KI DFGLA  ++   G++   
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKN 176

Query: 203 LAGTMGYMAPECATTGRASKESDVYSFGIVA 233
           + GT  ++APE         E+D++S G++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  101 bits (253), Expect = 2e-24
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA---SEVTIISRLRH 97
            DF   + LG G FG V+    R    Y A+K + K     +K+      E  ++S + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             ++++ G   + +++ ++ +Y+  G L S L K         +F  A+ +   L YL  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-VCLALEYLHS 124

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + +++RD+K  NI+LD N + KI DFG A+ V       T  L GT  Y+APE  +T
Sbjct: 125 ---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVST 177

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
              +K  D +SFGI+  E+  G  P
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTP 202

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (252), Expect = 2e-24
 Identities = 56/184 (30%), Positives = 90/184 (48%), Gaps = 15/184 (8%)

Query: 38  QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLR 96
            +++ F   +KLG G +  VYKG  + T  Y+A+K V   S++G    A  E++++  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPN---GSLDSHLFKENNLLTWEFRFK-IAQDLASGL 152
           H N+V+L    H + +L LV+E+M N     +DS               K     L  GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT---TVLAGTMGY 209
            +  E     ++HRD+K  N++++     K+GDFGLAR    A G      +    T+ Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR----AFGIPVNTFSSEVVTLWY 174

Query: 210 MAPE 213
            AP+
Sbjct: 175 RAPD 178

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 6/152 (3%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYAS-EVTIISRLRHR 98
             +    K+G+G +G V+K   R+T   +A+K+  +      IK+ A  E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           NLV LL     K+ L LV+EY  + ++   L +    +       I       + +  + 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
                +HRD+K  NI++  +   K+ DFG AR
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFAR 150

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 43/152 (28%), Positives = 80/152 (52%), Gaps = 6/152 (3%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYAS-EVTIISRLRHR 98
             + +   +G+G +G V K   ++T   +A+K+  +    + +K+ A  E+ ++ +LRH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           NLV LL  C +KK   LV+E++ + ++   L    N L ++   K    + +G+ +    
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
               ++HRDIK  NI++  +   K+ DFG AR
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFAR 172

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 12/177 (6%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRN 99
             +    KLG+G +  VYKG  + T + +A+K +    ++G    A  EV+++  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V L    H +K L LV+EY+    L  +L    N++           L  GL Y     
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT---TVLAGTMGYMAPE 213
              V+HRD+K  N++++     K+ DFGLAR    AK   T        T+ Y  P+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYDNEVVTLWYRPPD 170

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 58/202 (28%), Positives = 83/202 (41%), Gaps = 20/202 (9%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEY-ASEVTIISRLRHRNLVQLLGWC 107
           +G G FG       + T   +AVK + +G    I E    E+     LRH N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRF---- 81

Query: 108 HE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
            E       L ++ EY   G L   +         E RF   Q L SG+ Y        +
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ-LLSGVSYCHS---MQI 137

Query: 164 VHRDIKSSNIMLDLNF--NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATTGRA 220
            HRD+K  N +LD +     KI DFG ++        ++TV  GT  Y+APE        
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEYD 195

Query: 221 SKESDVYSFGIVALEIACGRKP 242
            K +DV+S G+    +  G  P
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYP 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 97.2 bits (243), Expect = 3e-23
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +K+G+G +G V+K   RET   +A+KRV      +G+   A  E+ ++  L+H+N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
              H  K+L LV+E+     L  +    N  L  E        L  GL +        V+
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT---TVLAGTMGYMAPECATTGRA- 220
           HRD+K  N++++ N   K+ +FGLAR    A G      +    T+ Y  P+     +  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLAR----AFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 221 SKESDVYSFGIVALEIACGRKPI 243
           S   D++S G +  E+A   +P+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 67/205 (32%), Positives = 91/205 (44%), Gaps = 7/205 (3%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISRLRH 97
           N+F   + LG+G FG V     + T  Y A+K + K       E A    E  ++   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHS 266

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
             E+ VV+RD+K  N+MLD + + KI DFGL +      G+      GT  Y+APE    
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVLED 323

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
               +  D +  G+V  E+ CGR P
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLP 348

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 51/174 (29%), Positives = 88/174 (50%), Gaps = 14/174 (8%)

Query: 26  AGPKRFTYKELAQATN--DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGI 82
            GP   +      AT+   +    KLG+G +G VYK     T+  +A+KR+     ++G+
Sbjct: 17  QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV 76

Query: 83  KEYAS-EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFR 141
              A  EV+++  L+HRN+++L    H    L L++EY  N  L  ++ K  ++     +
Sbjct: 77  PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK 135

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA-----KIGDFGLAR 190
             + Q L +G+ +         +HRD+K  N++L ++  +     KIGDFGLAR
Sbjct: 136 SFLYQ-LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 54/222 (24%), Positives = 87/222 (39%), Gaps = 34/222 (15%)

Query: 40  TNDFNDD-----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR 94
            N   DD     Q LG G  G V + F + T    A+K +    K        EV +  R
Sbjct: 56  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWR 110

Query: 95  L-RHRNLVQLLGWCHE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRF------K 143
             +  ++V+++         +K LL+V E +  G L S +    +       F      +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASE 165

Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHAKGSQT 200
           I + +   + YL       + HRD+K  N++      N   K+ DFG A+         T
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222

Query: 201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
                T  Y+APE     +  K  D++S G++   + CG  P
Sbjct: 223 PC--YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 19/160 (11%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS-----EVTIISRL 95
             +     LG+G F  VYK   + T+  +A+K++  G +   K+  +     E+ ++  L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPN---GSLDSH--LFKENNLLTWEFRFKIAQDLAS 150
            H N++ LL     K  + LV+++M       +  +  +   +++  +     +      
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY-----MLM-TLQ 123

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
           GL YL + W   ++HRD+K +N++LD N   K+ DFGLA+
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 98.7 bits (246), Expect = 6e-23
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSK------GSKQGIKEYASEVTIISRLRHRNLVQ 102
           LG G FG V  G    T   +AVK +++           I+    E+  +   RH ++++
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR---EIQNLKLFRHPHIIK 80

Query: 103 LLGWCHE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           L    ++      ++ +V EY+  G L  ++ K   L   E R    Q + SG+ Y    
Sbjct: 81  L----YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ-ILSGVDYCHR- 134

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATT 217
               VVHRD+K  N++LD + NAKI DFGL+ ++   +  +T+   G+  Y APE  +  
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEVISGR 190

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
             A  E D++S G++   + CG  P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLP 215

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 95.3 bits (238), Expect = 1e-22
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 27/157 (17%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +K+G+G +G VYK   + T   +A+K++   +  +G+   A  E++++  L H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68

Query: 105 GWCHEKKELLLVYEYM-----------PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLL 153
              H + +L LV+E++               +   L K                L  GL 
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK-----------SYLFQLLQGLA 117

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
           +        V+HRD+K  N++++     K+ DFGLAR
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 49  LGQGGFGGVYKGFFRETSSYIAVKRVSK------GSKQGIKEYASEVTIISRLRHRNLVQ 102
           LG+G FG V      +T   +A+K +S+           ++    E++ +  LRH ++++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER---EISYLKLLRHPHIIK 73

Query: 103 LLGWCHE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           L    ++      ++++V EY   G L  ++ ++  +   E R    Q +   + Y    
Sbjct: 74  L----YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQ-IICAIEYCHR- 126

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATT 217
               +VHRD+K  N++LD N N KI DFGL+ ++      +T+   G+  Y APE     
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVINGK 182

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
             A  E DV+S GIV   +  GR P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 37/196 (18%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYAS-EVTIISRLRHR 98
           + +    K+GQG FG V+K   R+T   +A+K+V   + K+G    A  E+ I+  L+H 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 99  NLVQLLGWCHEKKE--------LLLVYEYM----------PNGSLDSHLFKENNLLTWEF 140
           N+V L+  C  K          + LV+++                     K         
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--------- 127

Query: 141 RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT 200
             ++ Q L +GL Y+       ++HRD+K++N+++  +   K+ DFGLAR    AK SQ 
Sbjct: 128 --RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 201 TVLAG---TMGYMAPE 213
                   T+ Y  PE
Sbjct: 183 NRYTNRVVTLWYRPPE 198

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 68/205 (33%), Positives = 92/205 (44%), Gaps = 8/205 (3%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISRLRH 97
           NDF+  + LG+G FG V     + T  Y A+K + K       E A    E  ++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+ + S L YL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS 123

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLED 179

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
               +  D +  G+V  E+ CGR P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)

Query: 41  NDFNDDQKLGQGGFGGVY---KGFFRETSSYIAVKRVSKG---SKQGIKEYA-SEVTIIS 93
            +F   + LG G +G V+   K    +T    A+K + K     K    E+  +E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 94  RLRHRN-LVQLLGWC----HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDL 148
            +R    LV L          K  L L+ +Y+  G L +HL +       E +  + + +
Sbjct: 114 HIRQSPFLVTL--HYAFQTETK--LHLILDYINGGELFTHLSQRERFTEHEVQIYVGE-I 168

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 208
              L +L +     +++RDIK  NI+LD N +  + DFGL++     +  +     GT+ 
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225

Query: 209 YMAPECATTGRA--SKESDVYSFGIVALEIACGRKP 242
           YMAP+    G +   K  D +S G++  E+  G  P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 91.1 bits (227), Expect = 6e-21
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 41  NDFNDDQKLGQGGFGGVY---KGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRL 95
           + F   + LGQG FG V+   K    +     A+K + K +   +       E  I+  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 96  RHRNLVQLLGWC---HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL 152
            H  +V+L  +      K  L L+ +++  G L + L KE      + +F +A+ LA  L
Sbjct: 84  NHPFIVKLH-YAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALAL 139

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL-VEHAKGSQTTVLAGTMGYMA 211
            +L       +++RD+K  NI+LD   + K+ DFGL++  ++H    +     GT+ YMA
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMA 194

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKP 242
           PE       ++ +D +SFG++  E+  G  P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 18/212 (8%)

Query: 41  NDFNDDQKLGQGGFGGVY---KGFFRETSSYIAVKRVSKGS-KQGIKEYA---SEVTIIS 93
             F   + LG+GG+G V+   K     T    A+K + K    +  K+ A   +E  I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 94  RLRHRNLVQLLGWC---HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS 150
            ++H  +V L+ +      K  L L+ EY+  G L   L +E   +     F +A+ ++ 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGK--LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE-ISM 132

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
            L +L +   + +++RD+K  NIML+   + K+ DFGL +      G+ T    GT+ YM
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYM 188

Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKP 242
           APE       ++  D +S G +  ++  G  P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.5 bits (223), Expect = 1e-20
 Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 27/156 (17%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYA-SEVTIISRLRHRNLVQLL 104
           +K+G+G +G VYK          A+K++      +GI      E++I+  L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 105 GWCHEKKELLLVYEYM----------PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
              H KK L+LV+E++            G L+S   K                L +G+ Y
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----------SFLLQLLNGIAY 115

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
             +     V+HRD+K  N++++     KI DFGLAR
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 21/213 (9%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRH 97
              +     +G G +G V     + +   +A+K++S+   S+   K    E+ ++  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 98  RNLVQLL------GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
            N++ LL             +  LV  +M     D            + ++ + Q L  G
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGLKFSEEKIQYLVYQML-KG 138

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           L Y+       VVHRD+K  N+ ++ +   KI DFGLAR  +    ++ T    T  Y A
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRA 191

Query: 212 PE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
           PE   +    ++  D++S G +  E+    K +
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEML-TGKTL 223

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 9/153 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRE-TSSYIAVKRVSKGS-KQGIKEYA-SEVTIISRLRH 97
             +   +K+G+G +G VYK   ++     +A+KR+   +  +GI   A  E++++  L H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
            N+V L+   H ++ L LV+E+M    L   L +    L           L  G+ +  +
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
                ++HRD+K  N++++ +   K+ DFGLAR
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 22/214 (10%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRH 97
              + D Q +G G +G V       T + +A+K++ +   S+   K    E+ ++  +RH
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 98  RNLVQLL------GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWE-FRFKIAQDLAS 150
            N++ LL          +  +  LV  +M     D     ++  L  +  +F + Q L  
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQFLVYQML-K 139

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
           GL Y+       ++HRD+K  N+ ++ +   KI DFGLAR  +    S+ T    T  Y 
Sbjct: 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYR 192

Query: 211 APE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
           APE      R ++  D++S G +  E+    K +
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTL 225

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 24/186 (12%)

Query: 46  DQKLGQGGFGGVYKGFFRE--TSSYIAVKRVSKGSKQGIKEYAS-EVTIISRLRHRNLVQ 102
             K+G+G +G VYK   ++       A+K++      GI   A  E+ ++  L+H N++ 
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVIS 82

Query: 103 LLGWCHEKKE--LLLVYEYMPN---GSLDSHLFKENNLLTWEFRF----KIAQDLASGLL 153
           L        +  + L+++Y  +     +  H   + N    +        +   +  G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNA----KIGDFGLARLVEHAKGSQTTVLAG--TM 207
           YL   W   V+HRD+K +NI++          KI D G ARL          +     T 
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 208 GYMAPE 213
            Y APE
Sbjct: 200 WYRAPE 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 28/215 (13%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS-EVTIISRLRHRNLV 101
           + D + +G G FG VY+    ++   +A+K+V +      K + + E+ I+ +L H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110

Query: 102 QLLGWCHEKKE------LLLVYEYMP---NGSLDSHLFKENNLLTWEFRFKIAQDLASGL 152
           +L  + +   E      L LV +Y+P         +   +  L     +  + Q L   L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
            Y+       + HRDIK  N++LD +    K+ DFG A+ +   + + + +   +  Y A
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRA 224

Query: 212 PE---CATTGRASKESDVYSFGIVALEIACGRKPI 243
           PE    AT    +   DV+S G V  E+    +PI
Sbjct: 225 PELIFGAT--DYTSSIDVWSAGCVLAEL-LLGQPI 256

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 9/206 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISR-LR 96
            DFN    LG+G FG V     + T    AVK + K       +      E  +++   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
              L QL         L  V EY+  G L  H+ +          F  A+ +A GL +LQ
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQ 459

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
               + +++RD+K  N+MLD   + KI DFG+ +      G  T    GT  Y+APE   
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
                K  D ++FG++  E+  G+ P
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 44/244 (18%), Positives = 94/244 (38%), Gaps = 30/244 (12%)

Query: 1   RKRNVDDGEDNQGFNEYIDDEFEKGAGPKRFTYKELAQATNDFNDD----------QKLG 50
                   + N G    +    ++G   K+    +   +    + D            +G
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 51  QGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS----EVTIISRLRHRNLVQLL-- 104
            G +G V + + +     +A+K++ +  +  I         E+ I++RL H ++V++L  
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI--DCKRILREIAILNRLNHDHVVKVLDI 120

Query: 105 ---GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWE-FRFKIAQDLASGLLYLQEGW 159
                  +  EL +V E       D   LF+    LT    +  +   L  G+ Y+    
Sbjct: 121 VIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTLLYNLL-VGVKYVHSA- 175

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
              ++HRD+K +N +++ + + K+ DFGLAR V++ +   + +                 
Sbjct: 176 --GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 220 ASKE 223
            + +
Sbjct: 234 KNLK 237

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 48/204 (23%)

Query: 38  QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYAS----EVTII 92
            AT+ +    ++G G +G VYK     +  ++A+K V   +   G          EV ++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 93  SRLR---HRNLVQLLGWCHEKKE-----LLLVYEYM-----------PNGSLDSHLFKEN 133
            RL    H N+V+L+  C   +      + LV+E++           P   L +   K  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK-- 123

Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE 193
                     + +    GL +L       +VHRD+K  NI++      K+ DFGLAR   
Sbjct: 124 ---------DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--- 168

Query: 194 HAKGSQTT----VLAGTMGYMAPE 213
                Q      V+  T+ Y APE
Sbjct: 169 -IYSYQMALTPVVV--TLWYRAPE 189

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 29/224 (12%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN 99
            + + D + LG GG G V+     +    +A+K++     Q +K    E+ II RL H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 100 LVQLL--------------GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWEFRFKI 144
           +V++               G   E   + +V EYM     D   + ++  LL    R  +
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVLEQGPLLEEHARLFM 126

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD-LNFNAKIGDFGLARLVEHAKGSQTTVL 203
            Q L  GL Y+       V+HRD+K +N+ ++  +   KIGDFGLAR+++    S    L
Sbjct: 127 YQLL-RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PHYSHKGHL 181

Query: 204 AG---TMGYMAPE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
           +    T  Y +P    +    +K  D+++ G +  E+    K +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTL 224

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS----EVTIISRL 95
              + +   +G+G +G V   +       +A+K++S    Q    Y      E+ I+ R 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRF 82

Query: 96  RHRNLVQLL-----GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLA 149
           RH N++ +          + K++ +V + M     D + L K  +L      + + Q L 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHICYFLYQIL- 138

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV--EHAKGSQTTVLAGTM 207
            GL Y+       V+HRD+K SN++L+   + KI DFGLAR+   +H      T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 208 GYMAPE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
            Y APE    +   +K  D++S G +  E+    +PI
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPI 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 18/212 (8%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRH 97
              + + + +G G  G V   +       +A+K++S+   ++   K    E+ ++  + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 98  RNLVQLL------GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
           +N++ LL          E +++ +V E M     +     +  L      + + Q L  G
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---NLCQVIQMELDHERMSYLLYQML-CG 139

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           + +L       ++HRD+K SNI++  +   KI DFGLAR          T    T  Y A
Sbjct: 140 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 194

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKPI 243
           PE        +  D++S G +  E+      +
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMI-KGGVL 225

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 85.7 bits (213), Expect = 7e-19
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 9/206 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISR-LR 96
            DF   + LG+G FG V+   F++T+ + A+K + K       +      E  ++S    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  L  +      K+ L  V EY+  G L  H+   +        F  A+ +  GL +L 
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE-IILGLQFLH 135

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
               + +V+RD+K  NI+LD + + KI DFG+ +       ++T    GT  Y+APE   
Sbjct: 136 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYIAPEILL 191

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
             + +   D +SFG++  E+  G+ P
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 49/218 (22%), Positives = 99/218 (45%), Gaps = 18/218 (8%)

Query: 38  QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH 97
           +  + F  ++  GQG FG V  G  + T   +A+K+V +  +   +E    +  ++ L H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHH 78

Query: 98  RNLVQLLGWCH-----EKKE--LLLVYEYMP---NGSLDSHLFKENNLLTWEFRFKIAQD 147
            N+VQL  + +     ++++  L +V EY+P   +    ++  ++        +  + Q 
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ- 137

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLD-LNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
           L   +  L       V HRDIK  N++++  +   K+ DFG A+ +  ++ +   +   +
Sbjct: 138 LIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--S 194

Query: 207 MGYMAPE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
             Y APE        +   D++S G +  E+    +PI
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEM-MLGEPI 231

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 9/206 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISR-LR 96
           ++F   + LG+G FG V     +ET    AVK + K       +      E  I+S    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  L QL         L  V E++  G L  H+ K         RF  A+ + S L++L 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-IISALMFLH 141

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
           +   + +++RD+K  N++LD   + K+ DFG+ +      G  T    GT  Y+APE   
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPEILQ 197

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
                   D ++ G++  E+ CG  P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISR-LR 96
            DF+  + +G+G +  V     ++T    A+K V K      + I    +E  +  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 97  HRNLVQLLGWCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
           H  LV L   C + +  L  V EY+  G L  H+ ++  L     RF  A+ ++  L YL
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYL 126

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
            E   + +++RD+K  N++LD   + K+ D+G+ +      G  T+   GT  Y+APE  
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEIL 182

Query: 216 TTGRASKESDVYSFGIVALEIACGRKP 242
                    D ++ G++  E+  GR P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 18/212 (8%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRH 97
              + + + +G G  G V   +       +A+K++S+   ++   K    E+ ++  + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 98  RNLVQLL------GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
           +N++ LL          E +++ LV E M     +     +  L      + + Q L  G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQML-CG 176

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           + +L       ++HRD+K SNI++  +   KI DFGLAR          T    T  Y A
Sbjct: 177 IKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 231

Query: 212 PECATTGRASKESDVYSFGIVALEIACGRKPI 243
           PE        +  D++S G +  E+    K +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMV-RHKIL 262

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 31/224 (13%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS----EVTIISRL 95
           ++DF     LG+G +G V     + T   +A+K++    K     +A     E+ I+   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP---LFALRTLREIKILKHF 66

Query: 96  RHRNLVQLL-----GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLA 149
           +H N++ +             E+ ++ E M     D H +     L     ++ I Q L 
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQT---DLHRVISTQMLSDDHIQYFIYQTL- 122

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAG---- 205
             +  L       V+HRD+K SN++++ N + K+ DFGLAR+++ +    +         
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 206 -----TMGYMAPE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
                T  Y APE   T+ + S+  DV+S G +  E+   R+PI
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPI 222

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISR-LR 96
            DF+  + +G+G +  V     ++T    A++ V K      + I    +E  +  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 97  HRNLVQLLGWCHEKKE-LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
           H  LV L   C + +  L  V EY+  G L  H+ ++  L     RF  A+ ++  L YL
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYL 169

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
            E   + +++RD+K  N++LD   + K+ D+G+ +      G  T+   GT  Y+APE  
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEIL 225

Query: 216 TTGRASKESDVYSFGIVALEIACGRKP 242
                    D ++ G++  E+  GR P
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 9/206 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISR-LR 96
            DFN    LG+G FG V     + T    AVK + K       +      E  +++   +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
              L QL         L  V EY+  G L  H+ +          F  A+ +A GL +LQ
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQ 138

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
               + +++RD+K  N+MLD   + KI DFG+ +      G  T    GT  Y+APE   
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
                K  D ++FG++  E+  G+ P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 9/206 (4%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS---EVTIISR-LR 96
           +DF+  + +G+G FG V     +    + AVK + K +    KE      E  ++ + ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  LV L        +L  V +Y+  G L  HL +E   L    RF  A+ +AS L YL 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-IASALGYLH 156

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
                 +V+RD+K  NI+LD   +  + DFGL +       S T+   GT  Y+APE   
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 217 TGRASKESDVYSFGIVALEIACGRKP 242
                +  D +  G V  E+  G  P
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 16/186 (8%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRHRNL 100
           +     +G+G +G VY  + + T   +A+K+V++        K    E+TI++RL+   +
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87

Query: 101 VQLL-----GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWE-FRFKIAQDLASGLL 153
           ++L          +  EL +V E   +   D   LFK    LT E  +  +   L  G  
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKTPIFLTEEHIKTILYNLL-LGEN 143

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 213
           ++ E     ++HRD+K +N +L+ + + K+ DFGLAR +   K +             P 
Sbjct: 144 FIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 214 CATTGR 219
                +
Sbjct: 201 NKNLKK 206

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 22/214 (10%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLRH 97
              + +   +G G +G V   F  +T   +AVK++S+   S    K    E+ ++  ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 98  RNLVQLL------GWCHEKKELLLVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLAS 150
            N++ LL          E  ++ LV   M     D + + K   L     +F I Q L  
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQIL-R 143

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
           GL Y+       ++HRD+K SN+ ++ +   KI DFGLAR        + T    T  Y 
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYR 196

Query: 211 APE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
           APE        ++  D++S G +  E+    + +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTL 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 29/215 (13%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS-EVTIISRLRHRNLV 101
           + + + +G G FG V++    E+   +A+K+V +      K + + E+ I+  ++H N+V
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-----KRFKNRELQIMRIVKHPNVV 95

Query: 102 QLL------GWCHEKKELLLVYEYMPN--GSLDSHLFKENNLLTWEF-RFKIAQDLASGL 152
            L       G   ++  L LV EY+P        H  K    +     +  + Q L   L
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSL 154

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
            Y+       + HRDIK  N++LD      K+ DFG A+++   + + + +   +  Y A
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRA 209

Query: 212 PE---CATTGRASKESDVYSFGIVALEIACGRKPI 243
           PE    AT    +   D++S G V  E+    +P+
Sbjct: 210 PELIFGAT--NYTTNIDIWSTGCVMAEL-MQGQPL 241

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 54/221 (24%), Positives = 85/221 (38%), Gaps = 31/221 (14%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-----------SEVTI 91
           +   + +  G +G V  G   E    +A+KRV      G                 E+ +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 92  ISRLRHRNLVQLL-----GWCHEKKELLLVYEYMPNGSLDSH--LFKENNLLTWE-FRFK 143
           ++   H N++ L             +L LV E M     D    +  +  +++ +  ++ 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQYF 139

Query: 144 IAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVL 203
           +   L  GL  L E     VVHRD+   NI+L  N +  I DF LAR  E    +  T  
Sbjct: 140 MYHIL-LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHY 193

Query: 204 AGTMGYMAPE-CATTGRASKESDVYSFGIVALEIACGRKPI 243
                Y APE        +K  D++S G V  E+   RK +
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 17/209 (8%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HR 98
            +D+   +KLG+G +  V++      +  + VK +    K+ IK    E+ I+  LR   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGP 91

Query: 99  NLVQLLGWCH--EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           N++ L         +   LV+E++ N            L  ++ RF + + L   L Y  
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEIL-KALDYCH 147

Query: 157 EGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 215
                 ++HRD+K  N+M+D  +   ++ D+GLA       G +  V   +  +  PE  
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELL 202

Query: 216 TTGRA-SKESDVYSFGIVALEIACGRKPI 243
              +      D++S G +   +   ++P 
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 46/202 (22%)

Query: 38  QATNDFNDDQKLGQGGFGGVYKGF-FRETSSYIAVKRVSKGS-KQGIKEYA-SEVTIISR 94
           +A   +    ++G+G +G V+K    +    ++A+KRV   + ++G+      EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 95  LR---HRNLVQLLGWCH-----EKKELLLVYEYM-----------PNGSLDSHLFKENNL 135
           L    H N+V+L   C       + +L LV+E++           P   + +   K    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---- 123

Query: 136 LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA 195
                   +   L  GL +L       VVHRD+K  NI++  +   K+ DFGLAR     
Sbjct: 124 -------DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR----I 169

Query: 196 KGSQTT----VLAGTMGYMAPE 213
              Q      V+  T+ Y APE
Sbjct: 170 YSFQMALTSVVV--TLWYRAPE 189

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 35/296 (11%), Positives = 78/296 (26%), Gaps = 52/296 (17%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRV---SKGSKQGIKEYASEVTIISRLRHRNLVQ 102
               G       ++         +A+  V          ++E  S    +SR+    + +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 103 LLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL-QEGWEQ 161
           +L   H +   L+V E++  GSL      + +        +  Q LA+      + G   
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVG-AIRAMQSLAAAADAAHRAG--- 149

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRAS 221
            V       S + + ++ +  +                          M         A+
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD-------AN 180

Query: 222 KESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD 281
            + D+   G     +   R P+             +   D  G       +D  +     
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---DTAGQPIEPADIDRDIPFQIS 237

Query: 282 EQQMECLMIVGLWCAHPDENLRPS--IRQVIHVLNSEAPLPALPPKMPVPTYFSPP 335
                    V       D  +R +  +  ++    + A    +   +      + P
Sbjct: 238 A--------VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAP 285

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 37/215 (17%)

Query: 106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH 165
              E+K L  V E      L        +L+ +      +  +A G+ +L     +  +H
Sbjct: 166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY------SFQVAKGMEFLAS---RKCIH 216

Query: 166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGRA 220
           RD+ + NI+L      KI DFGLAR +          +          +MAPE       
Sbjct: 217 RDLAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGDARLPLKWMAPETIFDRVY 272

Query: 221 SKESDVYSFGIVALEIAC-GRKPI-SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
           + +SDV+SFG++  EI   G  P   +   EE    L +        G  + A  P    
Sbjct: 273 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--------GTRMRA--PDYTT 322

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
                +M   M   L C H + + RP+  +++  L
Sbjct: 323 P----EMYQTM---LDCWHGEPSQRPTFSELVEHL 350

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 8/99 (8%)

Query: 46  DQKLGQGGFGGVYKGF-----FRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRL-RHR 98
            + LG+G FG V +          T   +AVK + +G+     +   SE+ I+  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 99  NLVQLLGWC-HEKKELLLVYEYMPNGSLDSHLFKENNLL 136
           N+V LLG C      L+++ E+   G+L ++L  + N  
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 125

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 52/250 (20%), Positives = 96/250 (38%), Gaps = 60/250 (24%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS-EVTIISRLRHR 98
           +  ++  + LG G FG V + F  E+    A+K+V +        Y + E+ I+  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60

Query: 99  NLVQLL--------------------------------------GWCHEKKELLLVYEYM 120
           N+++L+                                          + K L ++ EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 121 PN--GSLDSHLFKENNLLTWEF-RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL 177
           P+    +     +    +        I Q L   + ++       + HRDIK  N++++ 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLVNS 176

Query: 178 NFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CATTGRASKESDVYSFGIVA 233
             N  K+ DFG A+ +  ++ S   +   +  Y APE    AT    +   D++S G V 
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGAT--EYTPSIDLWSIGCVF 232

Query: 234 LEIACGRKPI 243
            E+    KP+
Sbjct: 233 GEL-ILGKPL 241

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.2 bits (188), Expect = 9e-16
 Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 17/156 (10%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLL 104
            Q LG G  G V + F + T    A+K +        +    EV +  R  +  ++V+++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARR---EVELHWRASQCPHIVRIV 77

Query: 105 GWCHE----KKELLLVYEYMPNGSL-DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
                    +K LL+V E +  G L      + +   T     +I + +   + YL    
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 134

Query: 160 EQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLV 192
              + HRD+K  N++      N   K+ DFG A+  
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 37/229 (16%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK--GSKQGIKEYASEVTIISRLR-HRN 99
           +   +KLG+G +G V+K   R T   +AVK++     +    +    E+ I++ L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 100 LVQLLGWCH--EKKELLLVYEYMPNGSLDSH-LFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           +V LL        +++ LV++YM     D H + + N L     ++ + Q +   + YL 
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET---DLHAVIRANILEPVHKQYVVYQLI-KVIKYLH 126

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
            G    ++HRD+K SNI+L+   + K+ DFGL+R   + +     +              
Sbjct: 127 SG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 217 TG-----------RA----------SKESDVYSFG-IVALEIACGRKPI 243
                        RA          +K  D++S G I+  EI    KPI
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EIL-CGKPI 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 44/224 (19%), Positives = 89/224 (39%), Gaps = 46/224 (20%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR---------- 96
           +KLG G F  V+       ++++A+K + +G K   +    E+ ++ R+           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 97  -HRNLVQLLGW--------CHEKKELLLVYEYMPNGSLDSHLF---KENNL--LTWEFRF 142
              ++++LL           H    +++V+E      L  +L    K+     +   +  
Sbjct: 84  GANHILKLLDHFNHKGPNGVH----VVMVFE-----VLGENLLALIKKYEHRGIPLIYVK 134

Query: 143 KIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL------NFNAKIGDFGLARLVEHAK 196
           +I++ L  GL Y+       ++H DIK  N+++++          KI D G A   +   
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-- 190

Query: 197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR 240
              T  +  T  Y +PE          +D++S   +  E+  G 
Sbjct: 191 -HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 3e-11
 Identities = 33/210 (15%), Positives = 61/210 (29%), Gaps = 54/210 (25%)

Query: 27  GPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK------- 79
           GP  F++      T      +K+G+G FG V++     T    A+K ++           
Sbjct: 9   GPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSH 63

Query: 80  -QGIKEYASEVTIISRL---------RHRNLVQLLGWCHEK----KELLLVYEY------ 119
            +  +E   E+ I   L         R    + L      +      LL  +++      
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 120 -------------------MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
                                 G +D    +   L +      I   L + L   +    
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-TKLSSLATAKSILHQLTASLAVAEASLR 182

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLAR 190
               HRD+   N++L      K+      +
Sbjct: 183 --FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.9 bits (152), Expect = 8e-11
 Identities = 50/346 (14%), Positives = 98/346 (28%), Gaps = 88/346 (25%)

Query: 1   RKRNVDDGEDNQGFNEYID------DEFEKGAGPKRFTYKELAQATNDFNDDQKL---GQ 51
           +          + + E  D        F K    +   Y +L QA  +    + +   G 
Sbjct: 99  KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158

Query: 52  GGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK 111
            G G   K       +++A+        Q   +   ++  ++          L  C+  +
Sbjct: 159 LGSG---K-------TWVALDVCLSYKVQ--CKMDFKIFWLN----------LKNCNSPE 196

Query: 112 ELL-----LVYEYMPNG-SLDSHLFKE----NNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            +L     L+Y+  PN  S   H        +++     R   ++   + LL L      
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL------ 250

Query: 162 CVVHRDIKSSNIMLDLNFNAKI----GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
                +++++      N + KI        +   +  A  +  ++   +M     E    
Sbjct: 251 ----LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE---- 302

Query: 218 GRASKE--SDVYSFGIVAL-EIACGRKP--ISLTAKEEVQVYLVQW-VWDLYGNGKL--- 268
               K             L        P  +S+ A E ++  L  W  W      KL   
Sbjct: 303 ---VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA-ESIRDGLATWDNWKHVNCDKLTTI 358

Query: 269 ----LEAVDPRLCRD-------FDEQQ---MECLMIVGLWCAHPDE 300
               L  ++P   R        F          L +  +W      
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL--IWFDVIKS 402

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 45/211 (21%), Positives = 85/211 (40%), Gaps = 32/211 (15%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVK---RVSKGSKQGIKEYASEVTIISRLRHR---- 98
            + +G+G FG V K +  +   ++A+K      +  +Q  +    E+ I+  LR +    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDN 157

Query: 99  --NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNL--LTWEFRFKIAQDLASG 151
             N++ +L     +  + + +E      L  +L+   K+N     +     K A  +   
Sbjct: 158 TMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGY 209
           L  L    +  ++H D+K  NI+L     +  K+ DFG +           T +  +  Y
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFY 265

Query: 210 MAPECATTGRASKESDVYSFGIVALEIACGR 240
            APE     R     D++S G +  E+  G 
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 30/210 (14%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVK---RVSKGSKQGIKEYASEVTIISRLRHR----- 98
             +G+G FG V K + R    ++A+K          Q       EV ++  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMK 115

Query: 99  -NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNL--LTWEFRFKIAQDLASGL 152
             +V L      +  L LV+E      L  +L+   +  N   ++     K AQ + + L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
           L+L    E  ++H D+K  NI+L     +  KI DFG +  +          +  +  Y 
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQ-SRFYR 225

Query: 211 APECATTGRASKESDVYSFGIVALEIACGR 240
           +PE           D++S G + +E+  G 
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 38/191 (19%), Positives = 68/191 (35%), Gaps = 33/191 (17%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIA---VKRVSKGSKQGIKEY-----ASEVTIISRLRHR 98
           +K+G GGFG +Y  F        A   VK   + +     E       ++   I +   R
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 99  NLVQLLG-----WC--HEKKEL---LLVYEYMPNG-SLDSHLFKENNLLTWEFRFKIAQD 147
             +  LG          E K      +V E +  G  L   +  +N         ++   
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KISGQNGTFKKSTVLQLGIR 159

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI--GDFGLARLV------EHAKGSQ 199
           +   L Y+    E   VH DIK++N++L      ++   D+GL+         +  + + 
Sbjct: 160 MLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 200 TTVLAGTMGYM 210
                GT+ + 
Sbjct: 217 RKGHNGTIEFT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 41/177 (23%), Positives = 68/177 (38%), Gaps = 20/177 (11%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-RNLVQLL 104
            +K+G G FG +Y G        +A+K     +K        E  I   ++    +  + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIR 71

Query: 105 GWCHEKKELLLVYEYMPNG-SLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC 162
               E    ++V E +  G SL   LF   +    +F  K    LA  ++  ++    + 
Sbjct: 72  WCGAEGDYNVMVMELL--GPSL-EDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN 125

Query: 163 VVHRDIKSSNIMLDLNFNAK---IGDFGLARLV------EHAKGSQTTVLAGTMGYM 210
            +HRD+K  N ++ L        I DFGLA+        +H    +   L GT  Y 
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 36/182 (19%), Positives = 71/182 (39%), Gaps = 28/182 (15%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-RNLVQLL 104
            +++G+G FG +++G     +  +A+K   + S         E      L     +  + 
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVY 72

Query: 105 GWCHEKKELLLVYEYMPNG-SLDSHLFKENNLLTWEFRFK----IAQDLASGLLYLQEGW 159
            +  E    +LV + +  G SL   L         +F  K     A+ + + +  +    
Sbjct: 73  YFGQEGLHNVLVIDLL--GPSL-EDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH--- 123

Query: 160 EQCVVHRDIKSSNIMLDLNFNAK-----IGDFGLARL------VEHAKGSQTTVLAGTMG 208
           E+ +V+RDIK  N ++    +       + DFG+ +        +H    +   L+GT  
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 209 YM 210
           YM
Sbjct: 184 YM 185

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 29/168 (17%), Positives = 60/168 (35%), Gaps = 30/168 (17%)

Query: 47  QKLGQGGFGGVYKGFFRETSS--------YIAVKRVSKGSK----QGIKEYASEVTIISR 94
               +   G +Y+     T +          ++K  +K  +    Q   + A++   +++
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 95  LRHRNLVQLLG-----WC--HEKKELLLVYEYMPNG-SLDSHLFKENN--LLTWEFRFKI 144
            +      LL          H+ K   LV   +  G SL       +   +L+     ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSL-QSALDVSPKHVLSERSVLQV 164

Query: 145 AQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI--GDFGLAR 190
           A  L   L +L E      VH ++ + NI +D    +++    +G A 
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 42/179 (23%), Positives = 70/179 (39%), Gaps = 22/179 (12%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-RNLVQLL 104
            +K+G G FG +  G    T+ Y+A+K     S+        E     +L     + Q+ 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVY 71

Query: 105 GWCHEKKELLLVYEYMPNG-SLDSHLFKENNLLTWEFRFKIAQDLASGLLY-LQEGWEQC 162
            +    K   +V E +  G SL   LF   +     F  K    +A  L+  ++    + 
Sbjct: 72  YFGPCGKYNAMVLELL--GPSL-EDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 163 VVHRDIKSSNIMLDLNFNAK-----IGDFGLARL------VEHAKGSQTTVLAGTMGYM 210
           +++RD+K  N ++    N       I DF LA+        +H    +   L GT  YM
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 43/226 (19%), Positives = 80/226 (35%), Gaps = 36/226 (15%)

Query: 47  QKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQGIKEY-----ASEVTIISRLR 96
             +GQGGFG +Y           + +   VK     +     E      A++   I +  
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 97  HRNLVQLLG-----WC--HEKKEL---LLVYEYMPNG-SLDSHLFKENNLLTWEFRFKIA 145
               ++ LG         H+K       ++ +    G  L           + +   +++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLS 158

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI--GDFGLA------RLVEHAKG 197
             +   L Y+ E      VH DIK+SN++L+     ++   D+GLA       + +    
Sbjct: 159 LRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215

Query: 198 SQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKP 242
                  GT+ + +   A  G A S+  D+   G   ++   G  P
Sbjct: 216 DPKRCHDGTIEFTS-IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 55/262 (20%), Positives = 88/262 (33%), Gaps = 82/262 (31%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR--------HR 98
           +KLG G F  V+  +  +   ++A+K V K ++   +    E+ ++  +R          
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 99  NLVQLLGW--------CHEKKELLLVYEYMPNG-SLDSHLFK-ENNLLTWEFRFKIAQDL 148
            +VQLL           H    + +V+E +  G  L   + K     L      KI Q +
Sbjct: 102 MVVQLLDDFKISGVNGTH----ICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 149 ASGLLYLQEGWEQC-VVHRDIKSSNIMLDLN----------------------------- 178
             GL YL     +C ++H DIK  NI+L +N                             
Sbjct: 156 LQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 179 --------------------FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
                                  KI D G A  V        T    T  Y + E     
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGS 268

Query: 219 RASKESDVYSFGIVALEIACGR 240
             +  +D++S   +A E+A G 
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 18/176 (10%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLG 105
            +K+G G FG +Y G   +T+  +A+K  +  +K     Y  E  I   L+    +  + 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVR 69

Query: 106 WC-HEKKELLLVYEYMPNG-SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCV 163
           W   E    +LV + +  G SL+      +  L+ +    +A  + + + ++     +  
Sbjct: 70  WFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSF 124

Query: 164 VHRDIKSSNIMLDLNFNAK---IGDFGLARLV------EHAKGSQTTVLAGTMGYM 210
           +HRDIK  N ++ L   A    I DFGLA+        +H    +   L GT  Y 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 32/147 (21%), Positives = 57/147 (38%), Gaps = 35/147 (23%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVK---RVSKGSKQGIKEYASEVTIISRLRHR----- 98
           +K+G G FG V      +   Y AVK    + K ++        E  I+ ++++      
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNN 96

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNLLTWEFR-F------KIAQDL 148
           N+V+  G       + L++E      L   L+     NN     +  F          ++
Sbjct: 97  NIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNN-----YNGFHIEDIKLYCIEI 146

Query: 149 ASGLLYLQEGWEQCVVHRDIKSSNIML 175
              L YL+   +  + H D+K  NI+L
Sbjct: 147 LKALNYLR---KMSLTHTDLKPENILL 170

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 32/168 (19%), Positives = 62/168 (36%), Gaps = 27/168 (16%)

Query: 47  QKLGQGGFGGVYKGFFRETS-SYIAVK---RVSKGSKQGIKEYASEVTIISRLRHR---- 98
             LG+G FG V +        S +A+K    V K  +    E    + ++ +++ +    
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80

Query: 99  --NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNLLTWEFRF--KIAQDLASG 151
               V +  W +    + + +E      L  + F   KENN   +       +A  L   
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ 199
           L +L E     + H D+K  NI+   +    + +   +   +  K + 
Sbjct: 136 LRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 37/173 (21%)

Query: 47  QKLGQGGFGGVYKGFFRETSS-YIAVK---RVSKGSKQGIKEYASEVTIISRLRHR---- 98
             LG+G FG V +    +    ++AVK    V +  +        E+ ++  L       
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNS 75

Query: 99  --NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---KENNLLTWEFR-F------KIAQ 146
               VQ+L W      + +V+E      L    +   KEN      F  F      K+A 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENG-----FLPFRLDHIRKMAY 125

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ 199
            +   + +L       + H D+K  NI+   +   +  +  + R         
Sbjct: 126 QICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	376
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.8
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.57
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.47
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.34
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.92
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.84
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.8
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.74
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.68
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.67
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.63
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.54
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.25
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.18
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.62
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.71
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.18
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.73
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.69

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.5e-60  Score=437.03  Aligned_cols=250  Identities=22%  Similarity=0.357  Sum_probs=208.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+.+|+.|+||||+++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999999999999999999754  34456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+||+|.+++.... ..+++..++.++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999996543 45799999999999999999999   7999999999999999999999999999998653211 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+..        +..     +.+.
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--------~~~-----~~~~  246 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--------GSF-----PPVS  246 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------TCC-----CCCC
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc--------CCC-----CCCC
Confidence            123345799999999999999999999999999999999999999988765555444332        111     1122


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+    ...+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          247 LHY----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            223    345788999999999999999999985

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.4e-58  Score=417.61  Aligned_cols=255  Identities=29%  Similarity=0.479  Sum_probs=213.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++|.+.+.||+|+||.||+|++.     .++..||||++........+.|.+|+++|++++||||++++++|.+.+.+||
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            67889999999999999999875     3578899999988777778899999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEE
Q 038118          116 VYEYMPNGSLDSHLFKE------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI  183 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl  183 (376)
                      |||||++|+|.+++...            ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999653            246899999999999999999999   799999999999999999999999


Q ss_pred             eeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHH
Q 038118          184 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      +|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+..    
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~----  245 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ----  245 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH----
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence            9999998654332221 223458999999999999999999999999999999998 8999988765554433322    


Q ss_pred             HhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                          +..     +.....    ....+.+++.+||+.||++|||+.+|+++|+.
T Consensus       246 ----~~~-----~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          246 ----GRV-----LQRPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             ----TCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCC-----CCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                111     111122    23457889999999999999999999998875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.5e-58  Score=421.19  Aligned_cols=250  Identities=25%  Similarity=0.315  Sum_probs=212.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      ..|++.++||+|+||.||+|++..+|+.||||++........+.+.+|+.+|+.++||||++++++|.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999999999999999997654444567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      +||+|.+++.+  +.+++..+..++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++.+.... ...
T Consensus       154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~  227 (346)
T 4fih_A          154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR  227 (346)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred             CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence            99999998854  46899999999999999999999   7999999999999999999999999999998654322 234


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+..       .      ..+.+.  .
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------~------~~~~~~--~  292 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-------N------LPPRLK--N  292 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------S------SCCCCS--C
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-------C------CCCCCC--c
Confidence            456799999999999999999999999999999999999999987665444333321       0      111111  1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+.+++.+||+.||++|||+.|+++
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1123345788999999999999999999985

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-57  Score=419.78  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=209.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|.+.++||+|+||.||+|++..     ++..||||++........+.|.+|+++|++++|||||+++++|.+.+.+|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3567888999999999999998753     57899999998887777889999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          115 LVYEYMPNGSLDSHLFKEN--------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ||||||++|+|.+++....              ..+++..++.++.||+.||.|||   +++|+||||||+||||+.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            9999999999999986532              46899999999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  258 (376)
                      +||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+....+.. 
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-  275 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-  275 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH-
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence            999999999865433222 2344568999999999999999999999999999999999 9999988765554333322 


Q ss_pred             HHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                             +..     +.....+    ...+.+++.+||+.||++|||+.+|++.|+...
T Consensus       276 -------g~~-----~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          276 -------GRE-----LERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             -------TCC-----CCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------CCC-----CCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence                   111     1111222    345788999999999999999999999987643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-57  Score=410.74  Aligned_cols=259  Identities=28%  Similarity=0.474  Sum_probs=206.6

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...++|++.++||+|+||+||+|++.+   .||||+++..  .....+.|.+|+.++++++||||+++++++.+ +.+||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            345788899999999999999998764   4899998643  45567889999999999999999999998865 56899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |||||++|+|.+++......+++..++.++.||+.||.|||   +++|+||||||+||||++++.+||+|||+++.....
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            99999999999999777778999999999999999999999   799999999999999999999999999999865433


Q ss_pred             CC-cceeeeccCCCCCchhhhcc---CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          196 KG-SQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .. .......||+.|||||++.+   +.++.++|||||||++|||+||+.||...+.......+..       .+..   
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~-------~~~~---  255 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG-------RGYA---  255 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-------TTCC---
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh-------cCCC---
Confidence            22 23445679999999999864   3589999999999999999999999987654433222211       1111   


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .|.+ ..........+.+++.+||+.||++|||+.+|++.|+.
T Consensus       256 -~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          256 -SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             -CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             -CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             1111 11222334567889999999999999999999988764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.1e-58  Score=416.64  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=213.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++...   .....+.+.+|+++|+.++||||+++++++.+++.+|||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999753   223457789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC-
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA-  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  195 (376)
                      ||||+||+|.+++.+ .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++.+... 
T Consensus       111 mEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            999999999999954 457999999999999999999999   799999999999999999999999999999876432 


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      .........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+..        ..      ..
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--------~~------~~  252 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--------LE------YD  252 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TC------CC
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------CC------CC
Confidence            22334567899999999999999999999999999999999999999988765555444432        11      11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      +...+    ...+.+++.+||+.||.+|||++|++
T Consensus       253 ~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPEKF----FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence            22223    34578899999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.8e-57  Score=411.48  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=212.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++++.++||+|+||+||+|.+.     .+++.||||++... .....+.|.+|+.++++++||||++++++|.+.+.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            56778889999999999999974     35688999999754 3344578999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc
Q 038118          115 LVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF  179 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~  179 (376)
                      ||||||++|+|.++|....               ..+++..++.++.||+.||.|||   +++|+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999985432               35899999999999999999999   79999999999999999999


Q ss_pred             eEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHH
Q 038118          180 NAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       180 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  257 (376)
                      .+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..+....+. 
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-  261 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-  261 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence            999999999986543322 22334568999999999999999999999999999999998 899998876555433322 


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                             .+...     ..    +......+.+++.+||+.||++|||+.+|++.|+...
T Consensus       262 -------~~~~~-----~~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          262 -------NRQVL-----PC----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             -------TTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -------cCCCC-----CC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                   12111     11    1223345788999999999999999999999998643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.6e-57  Score=415.81  Aligned_cols=252  Identities=19%  Similarity=0.202  Sum_probs=208.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .+.|++.++||+|+||.||+|++..+|+.||||+++....     ..+|+.+++.++|||||++++++.+.+.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3568888999999999999999999999999999976432     24699999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+||+|.+++.+ .+.+++..++.++.||+.||.|||   +++|+||||||+||||+.+| .+||+|||+++.+......
T Consensus       132 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999954 457999999999999999999999   89999999999999999988 5999999999876432211


Q ss_pred             ----ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          199 ----QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       199 ----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                          ......||+.|||||++.+..++.++|||||||++|+|++|+.||...+.......+..       .....    .
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~~~~----~  276 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-------EPPPI----R  276 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-------SCCGG----G
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-------CCCCc----h
Confidence                12335699999999999999999999999999999999999999987766555444432       11000    1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .+...    ....+.+++.+||+.||.+|||+.||++.|..
T Consensus       277 ~~~~~----~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          277 EIPPS----CAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             GSCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            11222    33457888999999999999999999987653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-56  Score=422.50  Aligned_cols=250  Identities=25%  Similarity=0.320  Sum_probs=212.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +.|++.++||+|+||.||+|++..+|+.||||++........+.+.+|+.+|+.++||||++++++|.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999999998765555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      +||+|.+++..  +.+++..+..++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++.+.... ...
T Consensus       231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~  304 (423)
T 4fie_A          231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR  304 (423)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred             CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence            99999998854  45899999999999999999999   7999999999999999999999999999998664322 234


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ....||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+..       .      ..+.+..  
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------~------~~~~~~~--  369 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-------N------LPPRLKN--  369 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------S------CCCCCSC--
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-------C------CCCCCcc--
Confidence            456799999999999999999999999999999999999999987765544433322       1      1111110  


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+.+|+.+||+.||++|||+.|+++
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1112345788999999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-56  Score=400.29  Aligned_cols=250  Identities=23%  Similarity=0.349  Sum_probs=197.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++...   .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            37899999999999999999999999999999999754   233456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+ +|+|.+++.+ .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        92 mEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-  165 (275)
T ss_dssp             EECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence            9999 6799888854 467999999999999999999999   799999999999999999999999999999765432 


Q ss_pred             CcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+..        +.      ..
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~--------~~------~~  230 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--------GV------YT  230 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TC------CC
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--------CC------CC
Confidence             23345679999999999988775 5799999999999999999999987665444333322        11      11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--Hhc
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLN  314 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~  314 (376)
                      +...++    ..+.+++.+||+.||++|||+.|+++  +++
T Consensus       231 ~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          231 LPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence            222233    45788999999999999999999996  454

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-56  Score=401.77  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=200.7

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee----CCeEEEE
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE----KKELLLV  116 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv  116 (376)
                      |++.++||+|+||+||+|.+..++..||+|++...  .....+.|.+|+.++++++||||++++++|..    ...+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36777899999999999999999999999999653  44556789999999999999999999999865    3568999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCCeeecC-CceEEEeeCCCccccc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSNIMLDL-NFNAKIGDFGLARLVE  193 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~  193 (376)
                      ||||+||+|.+++.+ .+.+++..+..|+.||+.||.|||   +++  |+||||||+||||+. ++.+||+|||+++...
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999854 467899999999999999999999   677  999999999999984 7899999999997543


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                         ........||+.|||||++.+ .++.++|||||||++|+|+||+.||............       ...+...    
T Consensus       184 ---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~-------i~~~~~~----  248 (290)
T 3fpq_A          184 ---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKP----  248 (290)
T ss_dssp             ---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-------HTTTCCC----
T ss_pred             ---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH-------HHcCCCC----
Confidence               233456679999999998875 6999999999999999999999999765432221111       1111111    


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+.....    ..+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111222    34788999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.1e-56  Score=403.37  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=201.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++|++.+.||+|+||+||+|++.   .+++.||||++....  ......+.+|+.+|++++||||+++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999999999999874   467899999997542  2223467889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |||||+||+|.+++.+ .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999999855 457999999999999999999999   799999999999999999999999999999754322


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..        ..      ..
T Consensus       180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--------~~------~~  244 (304)
T 3ubd_A          180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--------AK------LG  244 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------CC
T ss_pred             C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--------CC------CC
Confidence            2 233456799999999999999999999999999999999999999988776555444432        11      11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSI-----RQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  311 (376)
                      +...++    ..+.+++.+||+.||++|||+     +|+++
T Consensus       245 ~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 MPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            222233    457889999999999999984     67764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.4e-55  Score=405.78  Aligned_cols=266  Identities=26%  Similarity=0.370  Sum_probs=216.8

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCC-----CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCC-CCccce
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRET-----SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRH-RNLVQL  103 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h-~~i~~~  103 (376)
                      +..+.++.-.++|++.+.||+|+||.||+|.+.++     ++.||||.+... .....+.|.+|+.+|.++.| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            55667777789999999999999999999998764     367999999765 34456789999999999975 899999


Q ss_pred             eeEEeeC-CeEEEEEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 038118          104 LGWCHEK-KELLLVYEYMPNGSLDSHLFKE---------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD  167 (376)
Q Consensus       104 ~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d  167 (376)
                      +++|.+. +.+|||||||++|+|.++|...               ...+++..++.++.||+.||.|||   +++|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence            9999764 5789999999999999999643               235899999999999999999999   79999999


Q ss_pred             ccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCC
Q 038118          168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISL  245 (376)
Q Consensus       168 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~  245 (376)
                      |||+|||+++++.+||+|||+++.+..... .......||+.|||||++.+..++.++|||||||++|||+| |..||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999986543322 23344568999999999999999999999999999999998 9999987


Q ss_pred             ccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          246 TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ............       .+..     +......    ...+.+++.+||+.||++|||+.+|++.|+.
T Consensus       291 ~~~~~~~~~~i~-------~g~~-----~~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          291 VKIDEEFCRRLK-------EGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCCSHHHHHHHH-------HTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHH-------cCCC-----CCCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            654332221111       1111     1111222    3457888899999999999999999998864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-53  Score=389.01  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=191.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-------  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------  111 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999999999999999997653 344567899999999999999999999987544       


Q ss_pred             -----eEEEEEecCCCCChhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          112 -----ELLLVYEYMPNGSLDSHLFKENN--LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       112 -----~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                           .+|+|||||++|+|.+++.....  ..++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence                 47999999999999999865432  3456778899999999999999   7999999999999999999999999


Q ss_pred             eCCCccccccCCCc-----------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH
Q 038118          185 DFGLARLVEHAKGS-----------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV  253 (376)
Q Consensus       185 Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~  253 (376)
                      |||+++........           ..+...||+.|||||++.+..++.++|||||||++|+|++   ||.....  ...
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence            99999876432211           1234579999999999999999999999999999999996   7764321  111


Q ss_pred             HHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          254 YLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+..     ......         ..........+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~-----~~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 TLTD-----VRNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHH-----HHTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHH-----HhcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111     011110         1111233345678999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.9e-53  Score=385.07  Aligned_cols=266  Identities=25%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC----eEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK----ELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l  115 (376)
                      .++|.+.++||+|+||.||+|+++  |+.||||++...... ...+..|+..+..++||||+++++++.+.+    .+||
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            357889999999999999999985  788999999754332 123345666667889999999999998654    6899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG-----WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      |||||++|+|.+++..  ..+++..+++++.|++.||.|||..     +..+|+||||||+||||+.++.+||+|||+++
T Consensus        79 V~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999954  4589999999999999999999942     13499999999999999999999999999998


Q ss_pred             ccccCCCc---ceeeeccCCCCCchhhhccC------CCCCCCceeechhhHHHHHhCCCCCCCccchhhH--------H
Q 038118          191 LVEHAKGS---QTTVLAGTMGYMAPECATTG------RASKESDVYSFGIVALEIACGRKPISLTAKEEVQ--------V  253 (376)
Q Consensus       191 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~--------~  253 (376)
                      ........   ......||+.|+|||++.+.      .++.++|||||||++|||+||..||.........        .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543322   22345699999999998754      3677999999999999999998776543221100        0


Q ss_pred             HHHHHHHHHhcCCccccccCCcCCCC-CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          254 YLVQWVWDLYGNGKLLEAVDPRLCRD-FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..... ......    ..++|.+... ........+.+++.+||+.||++|||+.+|++.|+.
T Consensus       237 ~~~~~-~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          237 SVEEM-RKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHH-HHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHH-HHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            00000 001111    1122222221 123456778899999999999999999999998864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=388.05  Aligned_cols=266  Identities=21%  Similarity=0.255  Sum_probs=208.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee------CCe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE------KKE  112 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~  112 (376)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+.+|+.++||||+++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999754  34445678899999999999999999998754      367


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|||||||+ |+|.+++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 578888854 567999999999999999999999   799999999999999999999999999999865


Q ss_pred             ccCC---CcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC--
Q 038118          193 EHAK---GSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG--  266 (376)
Q Consensus       193 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--  266 (376)
                      ....   ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...........  
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            3321   2234456799999999998775 579999999999999999999999998876666555544321110000  


Q ss_pred             -----c---cccccCCcCCCC---CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 -----K---LLEAVDPRLCRD---FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 -----~---~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           .   ....+.+.....   ..+.....+.+|+.+||+.||.+|||+.|+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 0   000000000000   00112245788999999999999999999985

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.9e-51  Score=404.81  Aligned_cols=253  Identities=25%  Similarity=0.333  Sum_probs=217.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++........+.+.+|+.+|+.++||||++++++|.+.+.+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            47899999999999999999999999999999999887766677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC--ceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--FNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+||+|.+++....+.+++..+..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+++.+..  .
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--~  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--K  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--T
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--C
Confidence            9999999999777778999999999999999999999   7999999999999999854  7899999999987643  2


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..        ...  .+.....
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~--------~~~--~~~~~~~  380 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--------CDW--NMDDSAF  380 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT--------TCC--CCCSGGG
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh--------CCC--CCCcccc
Confidence            334556799999999999999999999999999999999999999988776555443332        100  0111112


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..++    ..+.+|+.+||+.||.+|||+.|+++
T Consensus       381 ~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          381 SGIS----EDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2233    45778999999999999999999997

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.3e-50  Score=376.85  Aligned_cols=204  Identities=25%  Similarity=0.351  Sum_probs=173.7

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      .+....++|++.++||+|+||.||+|+++   .+++.||+|.+.....  ..++.+|+++|+.+ .||||+++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            34455789999999999999999999875   4678999999866543  35678899999998 599999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCCc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLA  189 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~  189 (376)
                      +.+|+||||++|++|.+++.    .+++..+..++.||+.||.|||   ++||+||||||+|||++.+ +.+||+|||++
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999999882    4899999999999999999999   7999999999999999876 79999999999


Q ss_pred             cccccCCC---------------------------cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCC
Q 038118          190 RLVEHAKG---------------------------SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRK  241 (376)
Q Consensus       190 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~  241 (376)
                      +.......                           .......||+.|+|||++.+. .++.++||||+||++|+|++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            75432211                           112345699999999999775 58999999999999999999999


Q ss_pred             CCCCcc
Q 038118          242 PISLTA  247 (376)
Q Consensus       242 pf~~~~  247 (376)
                      ||....
T Consensus       246 Pf~~~~  251 (361)
T 4f9c_A          246 PFYKAS  251 (361)
T ss_dssp             SSSCCS
T ss_pred             CCCCCC
Confidence            995443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-49  Score=392.68  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=202.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC------ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG------SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.+.      ..........++.+++.++||||++++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            46799999999999999999999999999999999643      111222333456777788999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |||||||+||+|..++.+ .+.+++..+..++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++...
T Consensus       268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999999965 457999999999999999999999   8999999999999999999999999999998654


Q ss_pred             cCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..   ...+..||+.|+|||++.+ ..|+.++|||||||++|+|++|..||...+..+... +......  .        
T Consensus       344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~--~--------  409 (689)
T 3v5w_A          344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--M--------  409 (689)
T ss_dssp             SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHH--C--------
T ss_pred             CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcC--C--------
Confidence            32   2345679999999999964 579999999999999999999999998765433322 1111110  0        


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ...+...++    ..+.+++.+||+.||.+|++     +++|++
T Consensus       410 ~~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            112222333    45788999999999999998     577764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.3e-49  Score=365.54  Aligned_cols=293  Identities=37%  Similarity=0.661  Sum_probs=243.9

Q ss_pred             CCCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccce
Q 038118           25 GAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQL  103 (376)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~  103 (376)
                      ......|+.+++....++|++.+.||+|+||.||+|.+. ++..||||++..... .....+.+|+.+++.++||||+++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            344678999999999999999999999999999999864 578899999976532 223368899999999999999999


Q ss_pred             eeEEeeCCeEEEEEecCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          104 LGWCHEKKELLLVYEYMPNGSLDSHLFKEN---NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       104 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ++++...+..++||||+++++|.+++....   ..+++..++.++.||+.||.|||..+..||+||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            999999999999999999999999886533   34899999999999999999999432239999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccch-hhHHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKE-EVQVYLVQWV  259 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~  259 (376)
                      +||+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........|.
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            999999999876544444455566999999999998888999999999999999999999999633211 1122334455


Q ss_pred             HHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCC
Q 038118          260 WDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~  318 (376)
                      .............+..+...........+.+++.+||+.||.+|||+.+|++.|+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            55555566666677777778888899999999999999999999999999999987543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-48  Score=361.35  Aligned_cols=283  Identities=37%  Similarity=0.681  Sum_probs=238.2

Q ss_pred             cccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEe
Q 038118           29 KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      ..++..++....++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            45566677778899999999999999999999975 57889999998776666788999999999999999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEee
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKEN---NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                      +.+..++||||+++++|.+++....   ..+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999885433   35899999999999999999999   79999999999999999999999999


Q ss_pred             CCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc
Q 038118          186 FGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG  264 (376)
Q Consensus       186 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      ||++........ .......||..|+|||++.+..++.++|||||||++|+|++|..||......+.. ....|......
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~  261 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NLAEWAVESHN  261 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-CHHHHTHHHHT
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-HHHHHhhhccc
Confidence            999976432222 1223445899999999998889999999999999999999999999765543322 22333334444


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      .+.....+++.+...........+.+++.+||+.||++|||+.+|++.|+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            5566667777777788889999999999999999999999999999988753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-47  Score=350.93  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=211.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            57899999999999999999999999999999999766555567789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++...  .+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  172 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK  172 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence            9999999988543  5899999999999999999999   7899999999999999999999999999987654322 22


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..       ...      +.  ..
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-------~~~------~~--~~  237 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------NGT------PE--LQ  237 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------HCS------CC--CS
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC------CC--CC
Confidence            3445689999999999999999999999999999999999999987654433222211       000      00  01


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11223345788999999999999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-48  Score=357.37  Aligned_cols=277  Identities=29%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             hhhhhcCCCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCC
Q 038118           19 DDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLR   96 (376)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~   96 (376)
                      .++-++.--...+....+....++|++.+.||+|+||.||+|.+.  +..||||++...  .....+.+.+|+.++++++
T Consensus        15 ~~~~~~~~~~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~   92 (309)
T 3p86_A           15 IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR   92 (309)
T ss_dssp             -----------------CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC
T ss_pred             CCCcccceeccCCCcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC
Confidence            333444444445666666677889999999999999999999874  778999998765  3445678999999999999


Q ss_pred             CCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCC
Q 038118           97 HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENN--LLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSN  172 (376)
Q Consensus        97 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~N  172 (376)
                      ||||+++++++...+..++||||+++++|.+++.....  .+++..++.++.||+.||.|||   +.|  |+||||||+|
T Consensus        93 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~N  169 (309)
T 3p86_A           93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPN  169 (309)
T ss_dssp             CTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGG
T ss_pred             CCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhh
Confidence            99999999999999999999999999999998865432  3899999999999999999999   788  9999999999


Q ss_pred             eeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH
Q 038118          173 IMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ  252 (376)
Q Consensus       173 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~  252 (376)
                      ||++.++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       170 Ill~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  248 (309)
T 3p86_A          170 LLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV  248 (309)
T ss_dssp             EEECTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             EEEeCCCcEEECCCCCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999754322 12233456899999999999999999999999999999999999999876644432


Q ss_pred             HHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ..+..       ...     ...+...+    ...+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       249 ~~~~~-------~~~-----~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          249 AAVGF-------KCK-----RLEIPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             HHHHH-------SCC-----CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHh-------cCC-----CCCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            22211       000     11122222    345788999999999999999999999887644

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.4e-48  Score=354.93  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=214.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            47899999999999999999999999999999999877777788999999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999776778999999999999999999999   7999999999999999999999999999997654322211


Q ss_pred             -------------eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH--HHHHHHHHHhc
Q 038118          200 -------------TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV--YLVQWVWDLYG  264 (376)
Q Consensus       200 -------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~--~~~~~~~~~~~  264 (376)
                                   .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........  .......    
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----  241 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----  241 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----
Confidence                         114568999999999999999999999999999999999999986543222110  0111000    


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                               ......    ....+.+++.+||+.||++|||+.+|++.|+..
T Consensus       242 ---------~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          242 ---------RYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ---------HTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------ccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     001111    113477889999999999999999999988753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.1e-47  Score=353.63  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=210.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            357899999999999999999999999999999998754  445567889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++... +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            9999999999988554 56899999999999999999999   799999999999999999999999999999765432 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCC-CCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRAS-KESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+..        +.      ..
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------~~------~~  232 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--------GK------YR  232 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------CC
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC------CC
Confidence             223445689999999999887764 789999999999999999999988765554433322        11      11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +....    ...+.+++.+||+.||.+|||++++++
T Consensus       233 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 IPFYM----STDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCTTS----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11122    234778899999999999999999985

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-47  Score=347.95  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+...   .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            47899999999999999999999999999999998543   344567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++... +.+++..++.++.||+.+|.|||   ++||+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999999988544 57899999999999999999999   7999999999999999999999999999998665443


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..||.............       .. .. .......
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-------~~-~~-~~~~~~~  236 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-------QD-SV-PNVTTDV  236 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-------SS-CC-CCHHHHS
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-------hc-cC-CCcchhc
Confidence            334445568999999999999999999999999999999999999998765433321111       01 00 0000111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHhccCC
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRP-SIRQVIHVLNSEA  317 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~L~~~~  317 (376)
                      ...    ....+..++.+||+.||.+|| ++.++.+.|....
T Consensus       237 ~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          237 RKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             CTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            222    234578889999999999999 8999999887643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=352.73  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=212.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC---eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS---SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+..++   ..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468889999999999999999997544   45999999765 44556789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++......
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999766678999999999999999999999   799999999999999999999999999999866433


Q ss_pred             CCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          196 KGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       196 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ....  .....+|..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +.     
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~--------~~-----  271 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE--------GY-----  271 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT--------TC-----
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc--------CC-----
Confidence            2221  222345778999999998899999999999999999999 9999987665444332221        10     


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ....    .......+.+++.+||+.||++|||+.+|++.|+...
T Consensus       272 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          272 RLPA----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0111    1123345788999999999999999999999988643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-47  Score=350.42  Aligned_cols=252  Identities=18%  Similarity=0.254  Sum_probs=212.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            4789999999999999999999999999999999976543 346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC--CceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--NFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      +++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.  ++.+||+|||++......  
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--  157 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence            9999999999766667999999999999999999999   799999999999999987  789999999999865432  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..        ...  ..+....
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------~~~--~~~~~~~  227 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--------AEY--TFDEEAF  227 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------TCC--CCCHHHH
T ss_pred             CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc--------CCC--CCChhhh
Confidence            234456799999999999988889999999999999999999999987765544333322        000  0000011


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..    ....+.+++.+||..||.+|||+.++++
T Consensus       228 ~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11    2345788999999999999999999996

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-46  Score=346.40  Aligned_cols=262  Identities=24%  Similarity=0.313  Sum_probs=218.0

Q ss_pred             cccCHHHHHHHhhC----------CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCC
Q 038118           29 KRFTYKELAQATND----------FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHR   98 (376)
Q Consensus        29 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~   98 (376)
                      ..|+.+++..+.+.          |...+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            46889999988875          77778999999999999999989999999999876666677889999999999999


Q ss_pred             CccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC
Q 038118           99 NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN  178 (376)
Q Consensus        99 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~  178 (376)
                      ||+++++++...+..++||||+++++|.+++.  ...+++..++.++.||+.||.|||   +.||+||||||+|||++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            99999999999999999999999999999874  346899999999999999999999   7999999999999999999


Q ss_pred             ceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHH
Q 038118          179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       179 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  258 (376)
                      +.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.. 
T Consensus       178 ~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~-  255 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-  255 (321)
T ss_dssp             CCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-
T ss_pred             CcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-
Confidence            999999999987654322 123345689999999999988999999999999999999999999987654333222211 


Q ss_pred             HHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                            .      ..+.+.  ........+.+++.+||+.||++|||+.++++
T Consensus       256 ------~------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          256 ------S------PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ------S------SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------C------CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0      011111  01122345788899999999999999999996

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.3e-47  Score=349.13  Aligned_cols=253  Identities=25%  Similarity=0.295  Sum_probs=204.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4789999999999999999999999999999999975432 234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  197 (376)
                      |+++++|.+++. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........ 
T Consensus        86 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999884 4456899999999999999999999   79999999999999999999999999999976543221 


Q ss_pred             cceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.............  .     ....        
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~-----~~~~--------  226 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--K-----EKKT--------  226 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH--H-----TTCT--------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h-----cccc--------
Confidence            12234568999999999987765 778999999999999999999997655432211111  0     0000        


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...........+.+++.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00001122345678899999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=354.88  Aligned_cols=253  Identities=20%  Similarity=0.268  Sum_probs=213.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            57899999999999999999999999999999999877666667889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC--CceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--NFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      +++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.  .+.+||+|||++......  
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--  204 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  204 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence            9999999998766667999999999999999999999   799999999999999974  467999999999865432  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..        ..  ...++...
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--------~~--~~~~~~~~  274 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR--------CD--WEFDEDAF  274 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH--------CC--CCCCSSTT
T ss_pred             cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC--CCCCcccc
Confidence            223445699999999999988999999999999999999999999987654443332221        00  01111222


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+    ...+.+++.+||+.||.+|||+.++++
T Consensus       275 ~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          275 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccC----CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            222    345788999999999999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.1e-47  Score=353.56  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=210.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh------hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ------GIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.+..+|..||+|++......      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            57899999999999999999999999999999999765321      356789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc----eEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF----NAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~  189 (376)
                      |+||||++|++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999998854 457899999999999999999999   79999999999999998877    7999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..        ... 
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------~~~-  235 (361)
T 2yab_A          167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA--------VSY-  235 (361)
T ss_dssp             EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT--------TCC-
T ss_pred             eEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------cCC-
Confidence            765432  223345699999999999988999999999999999999999999987765544333321        100 


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .+++.....    ....+.+++.+||..||.+|||+.++++
T Consensus       236 -~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 -DFDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -CCCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             001111111    2345788999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-46  Score=354.23  Aligned_cols=256  Identities=27%  Similarity=0.418  Sum_probs=211.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc-------CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR-------ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      .++|++.+.||+|+||.||+|.+.       .++..||||++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            578999999999999999999974       34568999999765 344567899999999999 899999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee
Q 038118          111 KELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML  175 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill  175 (376)
                      +.+|+||||+++|+|.+++....               ..+++..++.++.||+.||.|||   ++||+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999986543               34789999999999999999999   7999999999999999


Q ss_pred             cCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHH
Q 038118          176 DLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQV  253 (376)
Q Consensus       176 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~  253 (376)
                      +.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999976543222 12223346788999999999999999999999999999999 999998776554433


Q ss_pred             HHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          254 YLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .+.        .+..     +..    .......+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       317 ~~~--------~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          317 LLK--------EGHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             HHH--------TTCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHh--------cCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            221        1111     111    12233457889999999999999999999998875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.5e-47  Score=341.10  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=211.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            35789999999999999999999875 677999999765432 4678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++......+++..++.++.|++.||.|||   +.|++||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            99999999999777778999999999999999999999   799999999999999999999999999999765332222


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..        .     ......
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~--------~-----~~~~~~  229 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--------G-----FRLYKP  229 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--------T-----CCCCCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc--------C-----ccCCCC
Confidence            2223346778999999998999999999999999999999 9999987665444332221        1     001111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...    ...+.+++.+||+.||++|||+.++++.|+.
T Consensus       230 ~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          230 RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            112    2457888999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-46  Score=348.68  Aligned_cols=249  Identities=29%  Similarity=0.372  Sum_probs=209.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999999753   223456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||++||+|..++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||++..... .
T Consensus        84 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-D  158 (337)
T ss_dssp             EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-T
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc-C
Confidence            999999999988854 456899999999999999999999   79999999999999999999999999999975322 1


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        ..      ..+
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------~~------~~~  224 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------EE------IRF  224 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------CCC
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--------CC------CCC
Confidence            2233455689999999999998999999999999999999999999987665444333321        10      111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ...+    ...+.+++.+||+.||.+||     ++.+|++
T Consensus       225 p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 PRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            1222    34578889999999999999     8999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=346.92  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=209.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh------hHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ------GIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++......      ..+.+.+|+.+++.++||||+++++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            347799999999999999999999999999999999764321      35778999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc----eEEEeeCCC
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF----NAKIGDFGL  188 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~  188 (376)
                      .++||||+++++|.+++.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++    .+||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999998854 457899999999999999999999   79999999999999999887    799999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...      ... 
T Consensus       165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------~~~-  235 (326)
T 2y0a_A          165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------NYE-  235 (326)
T ss_dssp             CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT------CCC-
T ss_pred             CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc------CCC-
Confidence            97654322  233456999999999999889999999999999999999999999876644433322210      000 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ........    ....+.+++.+||+.||.+|||+.++++
T Consensus       236 ---~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 ---FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ---CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               00001111    2245788899999999999999999996

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-46  Score=338.31  Aligned_cols=257  Identities=26%  Similarity=0.419  Sum_probs=213.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|++...... ...+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            35789999999999999999998875 677999999765433 4678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++......+++..++.++.||+.||.|||   +.|++||||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999999776667999999999999999999999   799999999999999999999999999999765443322


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+..        +.  ....+   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------~~--~~~~~---  227 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ--------GH--RLYRP---  227 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--------TC--CCCCC---
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc--------CC--CCCCC---
Confidence            2333445678999999998889999999999999999999 9999987665443322211        11  00011   


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ..    ....+..++.+||+.||.+|||+.++++.|+...
T Consensus       228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          228 HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11    1245788899999999999999999999998654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-46  Score=352.03  Aligned_cols=261  Identities=20%  Similarity=0.301  Sum_probs=211.8

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEe
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      |.+.......++|++.+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            33344445578999999999999999999999999999999999754  3445678899999999999999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc---eEEEee
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF---NAKIGD  185 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~D  185 (376)
                      +.+..|+||||+++++|.+.+.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++   .+||+|
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEee
Confidence            99999999999999999988854 456899999999999999999999   78999999999999998654   599999


Q ss_pred             CCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       186 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        
T Consensus       175 fG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~--------  244 (362)
T 2bdw_A          175 FGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--------  244 (362)
T ss_dssp             CTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------
T ss_pred             cCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------
Confidence            99997654322  23345699999999999988999999999999999999999999987665444333222        


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +...  ......    ......+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          245 GAYD--YPSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             TCCC--CCTTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCC--CCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1000  000011    122345788999999999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=357.22  Aligned_cols=255  Identities=19%  Similarity=0.241  Sum_probs=210.4

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            35688999999999999999999999999999999997653  3345678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec---CCceEEEeeCCCcccc
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD---LNFNAKIGDFGLARLV  192 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~  192 (376)
                      ||||+.|++|.+.+.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++   .++.+||+|||++...
T Consensus        88 v~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999998865 456899999999999999999999   79999999999999998   4578999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        +..  ..
T Consensus       164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--------~~~--~~  232 (444)
T 3soa_A          164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--------GAY--DF  232 (444)
T ss_dssp             CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------TCC--CC
T ss_pred             cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--------CCC--CC
Confidence            4322 223345699999999999988999999999999999999999999987665544433322        110  00


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+    ...+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 PSPEWDTV----TPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CTTTTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CccccccC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11111222    345788899999999999999999996

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2e-46  Score=353.16  Aligned_cols=257  Identities=28%  Similarity=0.466  Sum_probs=201.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|++.   .++..||||++... .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            468999999999999999999986   45778999999765 44456789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++......
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999776678999999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          196 KGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       196 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ....  .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.        .+..    
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~--------~~~~----  268 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYR----  268 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH--------TTEE----
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------cCCC----
Confidence            2211  122235678999999999999999999999999999998 999998765444322221        1110    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                       ...    .......+.+++.+||+.||.+||++.+|++.|+..
T Consensus       269 -~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          269 -LPP----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             -CCC----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCC----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence             011    112234578899999999999999999999988754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.9e-47  Score=358.72  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=213.3

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      +....++|++.+.||+|+||.||+|.+..++..||||.+... .......|.+|+.+++.++||||+++++++...+..|
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            344567899999999999999999999988999999998765 3344567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||++.....
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999999776667999999999999999999999   79999999999999999999999999999875432


Q ss_pred             CCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.        .+..    
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~--------~~~~----  333 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE--------KGGR----  333 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH--------TTCC----
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------cCCC----
Confidence            11111 111224668999999998889999999999999999998 999998776544332221        1110    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       ...    .......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       334 -~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          334 -LPC----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             -CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence             011    11123457889999999999999999999998864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=339.99  Aligned_cols=272  Identities=23%  Similarity=0.274  Sum_probs=216.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC--eEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK--ELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            468999999999999999999999999999999997543 334567889999999999999999999998765  78999


Q ss_pred             EecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee----cCCceEEEeeCCCcc
Q 038118          117 YEYMPNGSLDSHLFKEN--NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLAR  190 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~~  190 (376)
                      |||+++++|.+++....  ..+++..++.++.||+.||.|||   ++||+||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999986533  23899999999999999999999   7999999999999999    788889999999998


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhc--------cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH-HHHHHHHH
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECAT--------TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV-YLVQWVWD  261 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~  261 (376)
                      ......  ......||..|+|||++.        +..++.++|||||||++|+|++|..||.......... .+......
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            654332  233456899999999886        4678999999999999999999999997544322222 22222111


Q ss_pred             HhcCCccccc---------c--CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          262 LYGNGKLLEA---------V--DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       262 ~~~~~~~~~~---------~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ... ......         .  .......+.......+..++.+||+.||++|||+.|+++...+..
T Consensus       243 ~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCc-ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            110 000000         0  111223456778888999999999999999999999999877654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8e-47  Score=354.10  Aligned_cols=268  Identities=26%  Similarity=0.377  Sum_probs=217.1

Q ss_pred             cccCHHHHHHHhhCCCcCCccccCCCeeEEEEE-----EcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCcc
Q 038118           29 KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGF-----FRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLV  101 (376)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~-----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~  101 (376)
                      ..+....++...++|++.+.||+|+||.||+|.     ...+++.||||++... .....+.+.+|+.++..+ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            456678888889999999999999999999999     4556789999999764 344457799999999999 789999


Q ss_pred             ceeeEEeeCC-eEEEEEecCCCCChhhhhhhcCC----------------------------------------------
Q 038118          102 QLLGWCHEKK-ELLLVYEYMPNGSLDSHLFKENN----------------------------------------------  134 (376)
Q Consensus       102 ~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------------------------------------  134 (376)
                      ++++++.+.+ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999998754 48999999999999999865432                                              


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          135 -------------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       135 -------------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                                         .+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                               2889999999999999999999   799999999999999999999999999999765332


Q ss_pred             CC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          196 KG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .. .......||..|+|||++.+..++.++|||||||++|+|++ |..||..............       .+.     .
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------~~~-----~  314 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-------EGT-----R  314 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH-------HTC-----C
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH-------cCC-----C
Confidence            22 22344567889999999999999999999999999999998 9999987654333221111       010     1


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .......    ...+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       315 ~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          315 MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            1111222    2457888999999999999999999998875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-45  Score=335.52  Aligned_cols=281  Identities=37%  Similarity=0.633  Sum_probs=228.5

Q ss_pred             CCcccCHHHHHHHhhCCCcC------CccccCCCeeEEEEEEcCCCeEEEEEEcccC----ChhhHHHHHHHHHHHHhCC
Q 038118           27 GPKRFTYKELAQATNDFNDD------QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG----SKQGIKEYASEVTIISRLR   96 (376)
Q Consensus        27 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~   96 (376)
                      ....|+..++..++++|...      +.||+|+||.||+|.+.  +..||+|++...    .....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            46789999999999999887      89999999999999874  678999998653    2344678899999999999


Q ss_pred             CCCccceeeEEeeCCeEEEEEecCCCCChhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118           97 HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus        97 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                      ||||+++++++...+..++||||+++++|.+++..  ....+++..++.++.||+.||.|||   +.|++||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEE
Confidence            99999999999999999999999999999998853  2356899999999999999999999   799999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV  253 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~  253 (376)
                      ++.++.+||+|||++......... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||..........
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            999999999999999765432222 1233468999999998864 57899999999999999999999998765544332


Q ss_pred             HHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          254 YLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      .+.....  .....+...+++.+ ..........+..++.+||+.||.+|||+.+|++.|+..
T Consensus       245 ~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          245 DIKEEIE--DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHH--TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhh--hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2222111  01112222233332 445667788899999999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.1e-46  Score=338.44  Aligned_cols=258  Identities=24%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      +...++|++.+.||+|+||.||+|.+..+   +..||+|.+... .....+.+.+|+.+++.++||||+++++++. ++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            34568999999999999999999998653   567999998764 4445677999999999999999999999985 467


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .++||||+++++|.+++......+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            89999999999999999776667999999999999999999999   799999999999999999999999999999866


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ............+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +..   
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~--------~~~---  235 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------GER---  235 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--------TCC---
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc--------CCC---
Confidence            4433333334456788999999998899999999999999999996 9999987765544332221        110   


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        ..+..    .....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       236 --~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          236 --LPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             --CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              11112    223457888999999999999999999998864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.6e-47  Score=362.01  Aligned_cols=265  Identities=22%  Similarity=0.264  Sum_probs=218.1

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh---hhHHHHHHHHHHHHhCCCCCccceeeEE
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK---QGIKEYASEVTIISRLRHRNLVQLLGWC  107 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~  107 (376)
                      +..+++....++|++.++||+|+||.||+|++..+++.||+|++.....   .....+.+|+.++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3455666667899999999999999999999999999999999975311   1223478899999999999999999999


Q ss_pred             eeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          108 HEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       108 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      .+.+.+|+||||++||+|.+++....+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999999766678999999999999999999999   7999999999999999999999999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++...............||+.|+|||++.     ...++.++|||||||++|+|++|..||...+..+....+..+....
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence            99765443333334467999999999986     4568999999999999999999999998877666555544322111


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL--RPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~  311 (376)
                               .-|.....+.    ..+.+++.+||..+|++  ||+++++++
T Consensus       301 ---------~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 ---------QFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ---------CCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ---------cCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                     0011112233    34778888999988888  999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=339.71  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=199.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--------------------------hhHHHHHHHHHHHH
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--------------------------QGIKEYASEVTIIS   93 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~   93 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999875421                          12356889999999


Q ss_pred             hCCCCCccceeeEEee--CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCC
Q 038118           94 RLRHRNLVQLLGWCHE--KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSS  171 (376)
Q Consensus        94 ~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~  171 (376)
                      .++||||+++++++.+  ....|+||||+++++|.+++  ..+.+++..++.++.||+.||.|||   ++||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  67899999999999998765  3457899999999999999999999   789999999999


Q ss_pred             CeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCC---CCCCCceeechhhHHHHHhCCCCCCCccc
Q 038118          172 NIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR---ASKESDVYSFGIVALEIACGRKPISLTAK  248 (376)
Q Consensus       172 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~~lltg~~pf~~~~~  248 (376)
                      |||++.++.+||+|||++....... .......||+.|+|||++.+..   ++.++|||||||++|+|++|..||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            9999999999999999997654322 2233456899999999987655   37789999999999999999999986654


Q ss_pred             hhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          249 EEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......+..        ..    +.......+    ...+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~--------~~----~~~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 MCLHSKIKS--------QA----LEFPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHHH--------CC----CCCCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHhc--------cc----CCCCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            332222211        10    000011122    245788999999999999999999974

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-46  Score=341.57  Aligned_cols=246  Identities=27%  Similarity=0.354  Sum_probs=208.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            478999999999999999999999999999999997542   23356788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||++|++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||++.....  
T Consensus        85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            999999999998854 456899999999999999999999   89999999999999999999999999999976432  


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        ..      ..+
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------~~------~~~  222 (318)
T 1fot_A          159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------AE------LRF  222 (318)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------CC------CCC
T ss_pred             --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CC------CCC
Confidence              22345699999999999999999999999999999999999999987665444333322        10      111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ...+    ...+.+++.+||+.||.+||     ++++|++
T Consensus       223 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            1222    34578889999999999999     8899884

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.4e-47  Score=347.13  Aligned_cols=264  Identities=26%  Similarity=0.409  Sum_probs=208.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEE----EcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGF----FRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~  113 (376)
                      .++|++.+.||+|+||.||+|+    +..+++.||||++........+.+.+|+.+++.++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            5789999999999999999998    566789999999988877777889999999999999999999999864  3568


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++......+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999776667999999999999999999999   7999999999999999999999999999998654


Q ss_pred             cCCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH--------HHHHHHHHHHh
Q 038118          194 HAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ--------VYLVQWVWDLY  263 (376)
Q Consensus       194 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~--------~~~~~~~~~~~  263 (376)
                      .....  ......++..|+|||++.+..++.++||||||+++|+|++|..||.........        ...........
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            32221  122334667799999999999999999999999999999999998654321110        00000111111


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ....         ...........+.+++.+||+.||++|||+.+|++.|+.
T Consensus       246 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          246 KNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1111         111122233568889999999999999999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=351.12  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=205.5

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  113 (376)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...   .......+..|..++..+ +||||+++++++...+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            3458999999999999999999999999999999999754   233456788899999988 699999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |+||||++|++|..++... +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999888553 56899999999999999999999   7999999999999999999999999999997432


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      . .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        ..      
T Consensus       176 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~------  240 (353)
T 3txo_A          176 C-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--------DE------  240 (353)
T ss_dssp             C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------
T ss_pred             c-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--------CC------
Confidence            2 22234456799999999999988899999999999999999999999988776555444432        10      


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh------HHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI------RQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~~vl~  311 (376)
                      ..+...+    ...+.+++.+||+.||.+||++      .+|++
T Consensus       241 ~~~p~~~----~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 VVYPTWL----HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCCTTS----CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCC----CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1111222    2457788999999999999998      77774

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-47  Score=360.12  Aligned_cols=267  Identities=23%  Similarity=0.253  Sum_probs=217.9

Q ss_pred             CcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCcccee
Q 038118           28 PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLL  104 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~  104 (376)
                      +..+.++++....++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+.+|..++..++||||++++
T Consensus        48 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            334556677777899999999999999999999999999999999997532   22234578899999999999999999


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                      +++.+.+.+|+||||++||+|.+++.+....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+
T Consensus       128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEe
Confidence            9999999999999999999999999776668999999999999999999999   7999999999999999999999999


Q ss_pred             eCCCccccccCCCcceeeeccCCCCCchhhhc-------cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHH
Q 038118          185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-------TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       185 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~  257 (376)
                      |||++...............||+.|+|||++.       ...++.++|||||||++|+|++|..||...+..+....+..
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  284 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH  284 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999765443332333457999999999987       35689999999999999999999999988776655544443


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCC---CChHHHHH
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLR---PSIRQVIH  311 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~~vl~  311 (376)
                      +....         .-+.....+    ...+.+++.+||+ +|.+|   |++++|++
T Consensus       285 ~~~~~---------~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YKEHL---------SLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHC---------CCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cccCc---------CCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            21110         001111222    3457888999999 99988   58999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-46  Score=339.49  Aligned_cols=259  Identities=24%  Similarity=0.395  Sum_probs=210.1

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .+....++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            334457889999999999999999998874 677999999765433 467889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.||+.+|.|||   ++|++||||||+||+++.++.+||+|||++.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999999999765667999999999999999999999   79999999999999999999999999999976533


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..........+|..|+|||++.+..++.++||||||+++|+|++ |..||...........+..        +     ..
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~--------~-----~~  239 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------G-----LR  239 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--------T-----CC
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc--------c-----cC
Confidence            22122223346778999999998899999999999999999998 9999987665444332221        1     00


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .......    ...+.+++.+||+.||.+|||+.++++.|..
T Consensus       240 ~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          240 LYRPHLA----SEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1111111    2457889999999999999999999998864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=348.92  Aligned_cols=247  Identities=24%  Similarity=0.307  Sum_probs=203.1

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCCCCh
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      .+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            46799999999999999999999999999887766678899999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee--cCCceEEEeeCCCccccccCCCcceeee
Q 038118          126 DSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML--DLNFNAKIGDFGLARLVEHAKGSQTTVL  203 (376)
Q Consensus       126 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  203 (376)
                      .+++......+++..++.++.||+.||.|||   +.||+||||||+|||+  +.++.+||+|||++.......  .....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~  248 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN  248 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence            9988766667999999999999999999999   7999999999999999  567899999999998654322  23344


Q ss_pred             ccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHH
Q 038118          204 AGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQ  283 (376)
Q Consensus       204 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...      ...    +.......+   
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------~~~----~~~~~~~~~---  315 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC------RWD----LEDEEFQDI---  315 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCC----SCSGGGTTS---
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------cCC----CChhhhccC---
Confidence            6899999999999888999999999999999999999999877654443333221      000    111111222   


Q ss_pred             HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          284 QMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       284 ~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ...+.+++.+||+.||.+|||+.++++
T Consensus       316 -~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          316 -SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             345788999999999999999999996

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.2e-46  Score=338.48  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=217.1

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      +...++|++.+.||+|+||.||+|.+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            3457889999999999999999999999999999999976543 357889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |||+++++|.+++... ...+++..++.++.||+.+|.|||   +.|++||||||+||+++.++.++|+|||++......
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999998653 356899999999999999999999   789999999999999999999999999999876544


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .........++..|+|||++.+..++.++||||||+++|+|++ |..||...........+..        .     ...
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~--------~-----~~~  231 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------D-----YRM  231 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT--------T-----CCC
T ss_pred             ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--------c-----CCC
Confidence            3333444557889999999999999999999999999999999 9999987665444332221        1     011


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .....    ....+.+++.+||+.||.+|||+.++++.|+.
T Consensus       232 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          232 ERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCC----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            11122    23457889999999999999999999998864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.4e-46  Score=344.72  Aligned_cols=259  Identities=19%  Similarity=0.213  Sum_probs=212.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+.+++.+ +|+||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            5789999999999999999999999999999999875532  24578899999999 89999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce-----EEEeeCCCccccc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN-----AKIGDFGLARLVE  193 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~  193 (376)
                      |+ +++|.+++....+.+++..++.++.||+.||.|||   +.||+||||||+|||++.++.     +||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 99999999766678999999999999999999999   789999999999999999887     9999999998654


Q ss_pred             cCCCc------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          194 HAKGS------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       194 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .....      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........... 
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence            33221      12456799999999999999999999999999999999999999987654444333322211111000 


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           ...++...    . .+..++..||+.||.+||++.+|++.|..
T Consensus       241 -----~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          241 -----IEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             -----HHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -----HHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence                 00011111    1 58889999999999999999999988864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.4e-46  Score=341.88  Aligned_cols=267  Identities=21%  Similarity=0.260  Sum_probs=207.0

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++|++.+.||+|+||.||+|.+.. ++.||+|++....  ......+.+|+.+++.++||||+++++++......++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            35889999999999999999999864 8899999987542  22346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++ +|.+.+......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999975 788888776677999999999999999999999   7999999999999999999999999999997654322


Q ss_pred             CcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC---------
Q 038118          197 GSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG---------  266 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  266 (376)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...........         
T Consensus       174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence             22334568999999999876 4689999999999999999999999988776665544443221100000         


Q ss_pred             ---ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 ---KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .....................+.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               000000000000001112245788999999999999999999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.8e-46  Score=345.32  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=204.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeE----EEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|++.+.||+|+||.||+|.+..++..    |++|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            47899999999999999999998877654    588887643 3345678999999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +|+|++.+++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999877788999999999999999999999   78999999999999999999999999999986643


Q ss_pred             CCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...........+..        +..    
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--------~~~----  237 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------GER----  237 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--------TCC----
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc--------CCC----
Confidence            3222 2233456789999999999999999999999999999999 9999987765544332221        110    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                       ...    .......+..++.+||+.||.+||++.+|++.|...
T Consensus       238 -~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          238 -LPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             -CCC----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             -CCC----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             011    112234578889999999999999999999988753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.1e-46  Score=364.44  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=216.5

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++...++|++.+.||+|+||.||+|.+..++..||||.+..... ..+.|.+|+.++++++||||+++++++.....+|+
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            34446788999999999999999999999899999999976543 35789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          116 VYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||||+++|+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999653 356899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..........++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..        +       
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------~-------  435 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------D-------  435 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT--------T-------
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------C-------
Confidence            22222223345678999999998899999999999999999999 9999987765544332211        1       


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                        ............+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence              011111223345788999999999999999999999998653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-46  Score=345.83  Aligned_cols=264  Identities=28%  Similarity=0.415  Sum_probs=216.2

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEE
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWC  107 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  107 (376)
                      ..+....++|++.+.||+|+||.||+|.+..     +++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3445567899999999999999999999973     4589999999765 344567899999999999999999999999


Q ss_pred             eeCCeEEEEEecCCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 038118          108 HEKKELLLVYEYMPNGSLDSHLFKEN-----------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVV  164 (376)
Q Consensus       108 ~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~  164 (376)
                      ...+..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||   ++||+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            99999999999999999999986532                       56899999999999999999999   79999


Q ss_pred             eecccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCC
Q 038118          165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKP  242 (376)
Q Consensus       165 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~p  242 (376)
                      ||||||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999976533221 22334457889999999998899999999999999999999 9999


Q ss_pred             CCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          243 ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       243 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      |......+....+.        .+..     +.....    ....+.+++.+||+.||++|||+.+|++.|+...
T Consensus       277 ~~~~~~~~~~~~~~--------~~~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          277 YYGMAHEEVIYYVR--------DGNI-----LACPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTTSCHHHHHHHHH--------TTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCChHHHHHHHh--------CCCc-----CCCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            98766544332222        1111     111122    2345788999999999999999999999998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=352.06  Aligned_cols=257  Identities=27%  Similarity=0.393  Sum_probs=209.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEE-----cCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.+     ..++..||||++... .......+.+|+.+++.++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            47899999999999999999994     456788999999754 445556789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc---eEEEe
Q 038118          114 LLVYEYMPNGSLDSHLFKEN------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF---NAKIG  184 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~  184 (376)
                      ++||||+++++|.+++....      ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999986543      35899999999999999999999   79999999999999999555   49999


Q ss_pred             eCCCccccccCC-CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHH
Q 038118          185 DFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       185 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      |||++....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..     
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~-----  301 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----  301 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----
Confidence            999997543221 122334557889999999999999999999999999999998 9999987765444332221     


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                         +..     ......    ....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       302 ---~~~-----~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          302 ---GGR-----MDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             ---TCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCC-----CCCCcc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               110     111122    234578899999999999999999999988753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-45  Score=335.44  Aligned_cols=266  Identities=21%  Similarity=0.265  Sum_probs=206.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5799999999999999999999999999999999754  33345778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++ ++.+.+....+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....... .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence            9976 666666666678999999999999999999999   7899999999999999999999999999997654322 2


Q ss_pred             ceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCC-CCccchhhHHHHHHHHHHHhcCC--cccccc--
Q 038118          199 QTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPI-SLTAKEEVQVYLVQWVWDLYGNG--KLLEAV--  272 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--  272 (376)
                      ......||..|+|||++.+.. ++.++|||||||++|+|++|..|| ......+....+...........  ......  
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            233456899999999987765 799999999999999999988775 44433333332222111100000  000000  


Q ss_pred             -------CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 -------DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 -------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                             ...............+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                   000001112233456788999999999999999999995

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-46  Score=345.64  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=199.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC----e
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK----E  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~  112 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...   .......+.+|+.+++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            57899999999999999999999999999999999764   3444567899999999999999999999987654    3


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .|+||||+++++|.+++... +.+++..++.++.||+.+|.|||   ++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            59999999999999988543 56899999999999999999999   789999999999999999999999999999765


Q ss_pred             ccCCC--cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          193 EHAKG--SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       193 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||..............       ......
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~-------~~~~~~  239 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------EDPIPP  239 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------CCCCCH
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------CCCCCc
Confidence            43222  123345689999999999999999999999999999999999999987664443222211       110000


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ......    ....+.+++.+||+.||++||+..+++.
T Consensus       240 ---~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          240 ---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             ---HHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             ---ccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence               000111    2345788899999999999998777663

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.5e-46  Score=348.90  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=205.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-----hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-----KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....     ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3578999999999999999999999999999999986421     12356789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce---EEEeeCC
Q 038118          114 LLVYEYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFG  187 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg  187 (376)
                      |+||||+++++|.+.+...   ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998877542   345899999999999999999999   799999999999999987655   9999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+..        +.
T Consensus       179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~--------~~  248 (351)
T 3c0i_A          179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIK--------GK  248 (351)
T ss_dssp             TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHH--------TC
T ss_pred             ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHc--------CC
Confidence            997654322 223345699999999999988899999999999999999999999987532 11111111        10


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .  ...+.....    ....+.+++.+||+.||++|||+.++++
T Consensus       249 ~--~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          249 Y--KMNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C--CCCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--CCCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  001111111    2245788999999999999999999985

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-45  Score=334.59  Aligned_cols=253  Identities=29%  Similarity=0.517  Sum_probs=206.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-------hHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-------GIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++......       ..+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            47899999999999999999999999999999998654221       1267889999999999999999999997665 


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCCeeecCCce-----EEEee
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSNIMLDLNFN-----AKIGD  185 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~-----~kl~D  185 (376)
                       ++||||+++++|.+.+......+++..++.++.|++.||.|||   +.|  ++||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999988777778999999999999999999999   788  999999999999988776     99999


Q ss_pred             CCCccccccCCCcceeeeccCCCCCchhhhc--cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          186 FGLARLVEHAKGSQTTVLAGTMGYMAPECAT--TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       186 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ||++....    .......||+.|+|||++.  ...++.++|||||||++|+|++|..||.............  ..   
T Consensus       173 fg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~---  243 (287)
T 4f0f_A          173 FGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM--IR---  243 (287)
T ss_dssp             CTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH--HH---
T ss_pred             CCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH--Hh---
Confidence            99987432    2344456899999999983  4457889999999999999999999997665443321111  00   


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..     ...+.+...    ....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       244 ~~-----~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 EE-----GLRPTIPED----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HS-----CCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cc-----CCCCCCCcc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            01     111222222    23457889999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-45  Score=340.88  Aligned_cols=268  Identities=26%  Similarity=0.378  Sum_probs=194.5

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3578999999999999999999999999999999997553 223467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          118 EYMPNGSLDSHLFKEN-----NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      ||++ ++|.+++....     ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 58888875432     45899999999999999999999   799999999999999999999999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC--c--
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG--K--  267 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~--  267 (376)
                      .... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...........  .  
T Consensus       159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            4322 122344689999999998764 689999999999999999999999988776555444433211100000  0  


Q ss_pred             cccccCCcC----CCCC--------cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRL----CRDF--------DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~----~~~~--------~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......+.+    ...+        .......+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000000000    0000        0012245888999999999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.4e-46  Score=345.50  Aligned_cols=246  Identities=24%  Similarity=0.308  Sum_probs=209.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999986532   23456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||++|++|.+++... +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... 
T Consensus       120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999988654 46899999999999999999999   799999999999999999999999999999765322 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        +.      ..+
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------~~------~~~  257 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--------GK------VRF  257 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------CCC
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--------CC------CCC
Confidence               2345689999999999998999999999999999999999999987665444333332        11      111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ...+    ...+.+++.+||+.||.+||+     +++|++
T Consensus       258 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 PSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            1222    345788999999999999998     888874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.4e-46  Score=347.58  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=208.3

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      ......++|++.+.||+|+||.||+|+++.+++.||||++....   ......+..|..++..+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            34556789999999999999999999999999999999997542   23356678899999877 899999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      +.+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999998854 356899999999999999999999   7999999999999999999999999999997


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        .    
T Consensus       167 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------~----  233 (345)
T 1xjd_A          167 ENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--------D----  233 (345)
T ss_dssp             CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------C----
T ss_pred             hcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--------C----
Confidence            53221 1233456799999999999998999999999999999999999999987765544433322        1    


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChH-HHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIR-QVI  310 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-~vl  310 (376)
                        .+.+...+    ...+.+++.+||+.||.+||++. +|+
T Consensus       234 --~~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 --NPFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --CCCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --CCCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              11122222    34578889999999999999998 765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-45  Score=336.16  Aligned_cols=260  Identities=17%  Similarity=0.201  Sum_probs=212.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+|+..++.+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            5789999999999999999999999999999999865432  24577899999999 69999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce-----EEEeeCCCccccc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN-----AKIGDFGLARLVE  193 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~  193 (376)
                      |+ +++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.     +||+|||++....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999776677999999999999999999999   899999999999999987776     9999999998764


Q ss_pred             cCCCc------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          194 HAKGS------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       194 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      .....      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........... 
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  241 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-  241 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-
Confidence            43221      23445689999999999998999999999999999999999999987543333222222111111000 


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           .+.+...+    ...+.+++.+||+.||++||++.+|++.|..
T Consensus       242 -----~~~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~  280 (298)
T 1csn_A          242 -----LRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK  280 (298)
T ss_dssp             -----HHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -----HHHHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence                 01111122    2457888999999999999999999998875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.2e-46  Score=336.90  Aligned_cols=265  Identities=24%  Similarity=0.309  Sum_probs=203.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++.....  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5799999999999999999998 5688999999875432  224678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++ +|.+++....+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....... .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  155 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R  155 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence            9976 888888766677999999999999999999999   7999999999999999999999999999987653221 1


Q ss_pred             ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC----ccccccC
Q 038118          199 QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG----KLLEAVD  273 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  273 (376)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...........    ......+
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            22344689999999998764 589999999999999999999999987765544433332211000000    0000011


Q ss_pred             CcCC-------CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLC-------RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+.       ..+.......+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1110       0111123345788999999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.6e-47  Score=358.63  Aligned_cols=260  Identities=20%  Similarity=0.248  Sum_probs=213.2

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEee
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHE  109 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  109 (376)
                      +.++....++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556789999999999999999999999999999999986521   1122357889999999999999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      ...+|+||||++||+|.+++..  ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            9999999999999999998854  35899999999999999999999   799999999999999999999999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCC----CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGR----ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ...............||+.|+|||++.+..    ++.++|||||||++|+|++|..||...+.......+.......   
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---  292 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL---  292 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---
Confidence            765443322334567999999999997665    7899999999999999999999998877665555444321110   


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL--RPSIRQVIH  311 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~~vl~  311 (376)
                             .-.....++    ..+.+++.+||+.+|.+  ||++++|++
T Consensus       293 -------~~p~~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          293 -------TFPDDNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             -------CCCTTCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             -------cCCCccccc----HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                   000011222    45788889999999998  999999995

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=348.68  Aligned_cols=261  Identities=26%  Similarity=0.393  Sum_probs=213.9

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcC-------CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEE
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRE-------TSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWC  107 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  107 (376)
                      +...++|++.+.||+|+||.||+|.+..       .+..||||++... .......+.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3446899999999999999999999754       3367999999765 445567899999999999 899999999999


Q ss_pred             eeCCeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCC
Q 038118          108 HEKKELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSN  172 (376)
Q Consensus       108 ~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~N  172 (376)
                      ...+..++||||+++++|.+++....               ..+++..++.++.||+.||.|||   +.||+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence            99999999999999999999986543               35899999999999999999999   7899999999999


Q ss_pred             eeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchh
Q 038118          173 IMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEE  250 (376)
Q Consensus       173 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~  250 (376)
                      ||++.++.+||+|||++........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986543222 12233446788999999999999999999999999999999 999998766444


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ....+.        .+.     .......    ....+.+++.+||+.||++|||+.+|++.|+...
T Consensus       302 ~~~~~~--------~~~-----~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          302 LFKLLK--------EGH-----RMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHHHHH--------TTC-----CCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHH--------cCC-----CCCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            332221        111     1111122    2345788999999999999999999999887643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=347.54  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=206.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999986532   23456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+.||+|..++.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... 
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999999988854 567999999999999999999999   799999999999999999999999999999865432 


Q ss_pred             CcceeeeccCCCCCchhhhcc---CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          197 GSQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                       .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.................    .       .
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~-------~  236 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T-------V  236 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C-------C
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c-------c
Confidence             23445669999999999864   4589999999999999999999999976544333222211110    0       0


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-hHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPS-IRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~~vl~  311 (376)
                      ......+    ...+.+++.+||+.||.+||+ +.+|++
T Consensus       237 ~~~p~~~----s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 VTYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCCTTS----CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cCCCCcC----CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            1111222    345788899999999999998 777764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-46  Score=345.18  Aligned_cols=263  Identities=29%  Similarity=0.363  Sum_probs=204.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC----eEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK----ELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+.  ++.||||++...... ...+..|+.+++.++||||+++++++....    .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            478999999999999999999886  688999999765433 345567999999999999999999998743    4799


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------ceEeecccCCCeeecCCceEEEee
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ----------CVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~----------~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                      ||||+++++|.+++..  ..+++..++.++.||+.||.|||   +.          +|+||||||+|||++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            9999999999999854  35899999999999999999999   67          999999999999999999999999


Q ss_pred             CCCccccccCCCc-ceeeeccCCCCCchhhhccC-----CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH----
Q 038118          186 FGLARLVEHAKGS-QTTVLAGTMGYMAPECATTG-----RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL----  255 (376)
Q Consensus       186 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~----  255 (376)
                      ||++......... ......||+.|+|||++.+.     .++.++|||||||++|+|++|..||............    
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            9999765433221 22335689999999998763     4566889999999999999999999765432211110    


Q ss_pred             -----HHHHHHHhcCCccccccCCcCCCC-CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          256 -----VQWVWDLYGNGKLLEAVDPRLCRD-FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       256 -----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           ..+.. ......    ..+.+... ........+.+++.+||+.||++|||+.+|++.|+.
T Consensus       255 ~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          255 QHPSLEDMQE-VVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             SSCCHHHHHH-HHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCchhhhhh-hhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                 00000 011111    11111111 122445668999999999999999999999998874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-45  Score=338.29  Aligned_cols=259  Identities=27%  Similarity=0.375  Sum_probs=212.9

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      ....++|++.+.||+|+||.||+|.+.     .++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            344688999999999999999999983     45688999999764 445567899999999999999999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 038118          111 KELLLVYEYMPNGSLDSHLFKEN-----------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD  167 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d  167 (376)
                      +..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||   ++|++|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccc
Confidence            99999999999999999986533                       24889999999999999999999   79999999


Q ss_pred             ccCCCeeecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCC
Q 038118          168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISL  245 (376)
Q Consensus       168 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~  245 (376)
                      |||+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999765432221 1223346788999999998889999999999999999999 9999987


Q ss_pred             ccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          246 TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .........+..        +.     .+....    .....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       256 ~~~~~~~~~~~~--------~~-----~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          256 IPPERLFNLLKT--------GH-----RMERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             CCGGGHHHHHHT--------TC-----CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHHHHhhc--------CC-----cCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            765544322221        11     011112    223457889999999999999999999998864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-45  Score=345.73  Aligned_cols=254  Identities=23%  Similarity=0.260  Sum_probs=196.5

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+|+.+++.++||||+++++++......++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            357899999999999999999999999999999999765332 3567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce--EEEeeCCCccccccCC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN--AKIGDFGLARLVEHAK  196 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~  196 (376)
                      |+++++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.  +||+|||++.....  
T Consensus        97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            9999999998854 346899999999999999999999   799999999999999987765  99999999874322  


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCC-CceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKE-SDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........+......   . ..  .+ + 
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---~-~~--~~-~-  242 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---V-KY--SI-P-  242 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT---T-CC--CC-C-
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc---C-CC--CC-C-
Confidence            122334569999999999988777655 89999999999999999999876543333222221110   0 00  00 0 


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....+    ...+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~----s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          243 DDIRI----SPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             TTSCC----CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CcCCC----CHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            00112    245788999999999999999999995

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.6e-46  Score=346.09  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=206.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeE----EEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|++.+.||+|+||.||+|.+..++..    |++|.+.... ......+.+|+.+++.++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            46899999999999999999999887765    7888775432 233456778999999999999999999986 45689


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+.+++|.+++......+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999766667899999999999999999999   78999999999999999999999999999987643


Q ss_pred             CCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..        +...  .
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------~~~~--~  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK--------GERL--A  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT--------TCBC--C
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc--------CCCC--C
Confidence            3222 2344557889999999999999999999999999999999 9999987665544332221        1100  0


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .+..       ....+..++.+||+.||.+|||+.++++.|....
T Consensus       238 ~~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          238 QPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             CCTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0111       1123567888999999999999999999987654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.9e-46  Score=332.88  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=210.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            578999999999999999999987 4678999999765432 46789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++++|.+++......+++..++.++.|++.||.|||   ++|++||||||+||+++.++.++|+|||++..........
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            9999999999777677999999999999999999999   7999999999999999999999999999987653221111


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+..        +.     ......
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~--------~~-----~~~~~~  228 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--------GF-----RLYKPR  228 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--------TC-----CCCCCT
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc--------CC-----cCCCCc
Confidence            223346778999999998899999999999999999999 8999987654443222211        10     011111


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .    ....+.+++.+||+.||++|||+.++++.|..
T Consensus       229 ~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          229 L----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1    23457889999999999999999999998864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-45  Score=342.32  Aligned_cols=261  Identities=21%  Similarity=0.258  Sum_probs=207.8

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----ChhhHHHHHHHHHHHHhCCCCCccceeeEEe
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----SKQGIKEYASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      .++....++|++.+.||+|+||.||+|.+..++..||+|++...     .....+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            45667789999999999999999999999999999999998643     3344678999999999999999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhc---------------------------------------CCCCCHHHHHHHHHHHH
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKE---------------------------------------NNLLTWEFRFKIAQDLA  149 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~---------------------------------------~~~~~~~~~~~~~~~i~  149 (376)
                      +.+..++||||+++++|.+++...                                       ...+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            999999999999999999887420                                       11246778889999999


Q ss_pred             HHHHHHHhCCCCceEeecccCCCeeecCCc--eEEEeeCCCccccccCCCc---ceeeeccCCCCCchhhhcc--CCCCC
Q 038118          150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNF--NAKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPECATT--GRASK  222 (376)
Q Consensus       150 ~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~  222 (376)
                      .||.|||   +.+|+||||||+|||++.++  .+||+|||++.........   ......||+.|+|||++.+  ..++.
T Consensus       179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999   78999999999999998776  8999999999865432221   2345568999999999865  67889


Q ss_pred             CCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCC
Q 038118          223 ESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL  302 (376)
Q Consensus       223 ~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  302 (376)
                      ++|||||||++|+|++|..||......+....+..       ....       ............+.+++.+||+.||.+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLC-------FENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHh-------cccc-------cCCcccccCCHHHHHHHHHHcCCChhH
Confidence            99999999999999999999987765544333222       1100       000001112345788999999999999


Q ss_pred             CCChHHHHH
Q 038118          303 RPSIRQVIH  311 (376)
Q Consensus       303 RPs~~~vl~  311 (376)
                      |||+.++++
T Consensus       322 Rps~~~~l~  330 (345)
T 3hko_A          322 RFDAMRALQ  330 (345)
T ss_dssp             SCCHHHHHH
T ss_pred             CCCHHHHhc
Confidence            999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.6e-46  Score=342.53  Aligned_cols=261  Identities=23%  Similarity=0.382  Sum_probs=196.6

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCe---EEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK  111 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  111 (376)
                      ....++|++.+.||+|+||.||+|.+..++.   .||||++...  .....+.+.+|+.+++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3445789999999999999999999887664   7999999764  3445678999999999999999999999998766


Q ss_pred             eE------EEEEecCCCCChhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          112 EL------LLVYEYMPNGSLDSHLFKEN-----NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       112 ~~------~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ..      ++||||+++++|.+++....     ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence            54      99999999999999885422     25899999999999999999999   789999999999999999999


Q ss_pred             EEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  258 (376)
                      +||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. 
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-  254 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-  254 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc-
Confidence            99999999976543222 12233446788999999999999999999999999999999 9999987765554333221 


Q ss_pred             HHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                             +..     .....    .....+.+++.+||+.||++|||+.++++.|+...
T Consensus       255 -------~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          255 -------GNR-----LKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             -------TCC-----CCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCC-----CCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   110     11111    22345788999999999999999999999887643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.2e-46  Score=338.05  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=207.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC-------eEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS-------SYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||.||+|.+..++       ..|++|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            478999999999999999999988766       5799999987766677889999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce--------EEEe
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN--------AKIG  184 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--------~kl~  184 (376)
                      .++||||+++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999776666999999999999999999999   799999999999999998877        9999


Q ss_pred             eCCCccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCC-CCCCCccchhhHHHHHHHHHHH
Q 038118          185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGR-KPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       185 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      |||++.....     .....|+..|+|||++.+ ..++.++|||||||++|+|++|. .||.............      
T Consensus       164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~------  232 (289)
T 4fvq_A          164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE------  232 (289)
T ss_dssp             CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------
T ss_pred             cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh------
Confidence            9999864321     223457889999999987 67899999999999999999954 5555443222211110      


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCC
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~  318 (376)
                       .....    ....        ...+.+++.+||+.||.+|||+.++++.|+....
T Consensus       233 -~~~~~----~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 -DRHQL----PAPK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -TTCCC----CCCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -ccCCC----CCCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             11111    1111        1236788899999999999999999999987653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.6e-45  Score=331.51  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=209.5

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ...++|++.+.||+|+||.||+|.+..++..|++|++........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            34678999999999999999999999999999999998765555678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee---cCCceEEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++|++||||||+||++   +.++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999988855 456899999999999999999999   7999999999999999   7888999999999976543


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .  .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+..        +...  ...
T Consensus       162 ~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~--~~~  228 (277)
T 3f3z_A          162 G--KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--------GTFT--FPE  228 (277)
T ss_dssp             T--SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCCC--CCH
T ss_pred             c--cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------CCCC--CCc
Confidence            2  22334568999999998865 489999999999999999999999987665444333221        1000  000


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....    ....+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 KDWLN----VSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhhc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00011    2345788999999999999999999984

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.2e-46  Score=344.58  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=203.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999986431   12235788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+ +|+|.+++... +.+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++...... 
T Consensus        88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            9999 67888888554 56899999999999999999999   789999999999999999999999999999765432 


Q ss_pred             CcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........                 .+...
T Consensus       162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-----------------~i~~~  223 (336)
T 3h4j_B          162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----------------KVNSC  223 (336)
T ss_dssp             -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------------CCCSS
T ss_pred             -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------------HHHcC
Confidence             22334569999999999987765 689999999999999999999997654332211                 11000


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ...++......+.+++.+||+.||.+|||+.++++
T Consensus       224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             01111222345788999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=343.02  Aligned_cols=260  Identities=28%  Similarity=0.380  Sum_probs=209.8

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEE-----cCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      ...++|++.+.||+|+||.||+|.+     ..++..||+|++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3468999999999999999999997     345678999999754 233456789999999999 899999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENN----------------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDI  168 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dl  168 (376)
                      +..++||||+++++|.+++.....                      .+++..++.++.||+.||.|||   ++||+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence            999999999999999999865432                      3789999999999999999999   799999999


Q ss_pred             cCCCeeecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCc
Q 038118          169 KSSNIMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLT  246 (376)
Q Consensus       169 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~  246 (376)
                      ||+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999999999999765433222 2233457889999999998999999999999999999998 99999876


Q ss_pred             cchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          247 AKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ...........       .+     ........    ....+..++.+||+.||.+|||+.+|++.|...
T Consensus       279 ~~~~~~~~~~~-------~~-----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          279 PVDANFYKLIQ-------NG-----FKMDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             CCSHHHHHHHH-------TT-----CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcHHHHHHHHh-------cC-----CCCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            54333222111       11     01111112    234578899999999999999999999998753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.3e-45  Score=332.63  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=207.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcC---CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRE---TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            46889999999999999999998754   3456999999765 445567899999999999999999999998754 568


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999777777999999999999999999999   79999999999999999999999999999976544


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..........++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..        +..     
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~--------~~~-----  232 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK--------GDR-----  232 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH--------TCC-----
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc--------CCC-----
Confidence            33333344456788999999998899999999999999999998 9999986665544332221        100     


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ......    ....+..++.+||+.||++|||+.++++.|+.
T Consensus       233 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          233 LPKPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence            111111    23457889999999999999999999998864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.6e-45  Score=344.04  Aligned_cols=273  Identities=24%  Similarity=0.262  Sum_probs=213.0

Q ss_pred             ccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-----CCCcccee
Q 038118           30 RFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-----HRNLVQLL  104 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~  104 (376)
                      .|+.++.....++|++.++||+|+||.||+|.+..+++.||||++... ......+..|+.+++.++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            445555556679999999999999999999999999999999999743 344567788999999996     99999999


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC------
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL------  177 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~------  177 (376)
                      +++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 889999886544 45899999999999999999999   799999999999999975      


Q ss_pred             -------------------CceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh
Q 038118          178 -------------------NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC  238 (376)
Q Consensus       178 -------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt  238 (376)
                                         ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                               788999999999754322    234568999999999999999999999999999999999


Q ss_pred             CCCCCCCccchhhHHHHHHHHHH-------HhcCCccccccC--------CcCCCCC-------------cHHHHHHHHH
Q 038118          239 GRKPISLTAKEEVQVYLVQWVWD-------LYGNGKLLEAVD--------PRLCRDF-------------DEQQMECLMI  290 (376)
Q Consensus       239 g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~--------~~~~~~~-------------~~~~~~~l~~  290 (376)
                      |..||......+....+......       ..........++        +......             .......+.+
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            99999877655544333321100       000000000000        0000000             0000145778


Q ss_pred             HHHHccCCCCCCCCChHHHHH
Q 038118          291 VGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       291 li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ++.+||+.||++|||+.++++
T Consensus       335 li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcCChhhCCCHHHHhc
Confidence            999999999999999999984

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.8e-45  Score=338.56  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=209.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh------hHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ------GIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++......      ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            357899999999999999999999999999999999764321      35678999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc----eEEEeeCCC
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF----NAKIGDFGL  188 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~  188 (376)
                      .++||||+++++|.+++.. ...+++..++.++.||+.||.|||   +.|++||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999998854 457899999999999999999999   78999999999999999888    799999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..        .. 
T Consensus       166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~--------~~-  234 (321)
T 2a2a_A          166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS--------VS-  234 (321)
T ss_dssp             CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT--------TC-
T ss_pred             ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------cc-
Confidence            97654322  22345589999999999988999999999999999999999999987654443322221        00 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ...++.....    ....+.+++.+||+.||++|||+.++++
T Consensus       235 -~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 -YDFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -CCCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -cccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0011111111    2245788999999999999999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-45  Score=343.71  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=208.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+..|..++..+ +||||+++++++...+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4588999999999999999999999999999999997542   23456788899999988 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||++||+|.+++... +.+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||++.....
T Consensus        98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999988543 56899999999999999999999   79999999999999999999999999999975321


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                       .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        ..      .
T Consensus       174 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~------~  238 (353)
T 2i0e_A          174 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------HN------V  238 (353)
T ss_dssp             -TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------C
T ss_pred             -CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------CC------C
Confidence             12233456699999999999999999999999999999999999999987765554433332        10      1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      .+...    ....+.+++.+||+.||.+||+     +.+|++
T Consensus       239 ~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11122    2345788899999999999995     477764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.4e-45  Score=330.47  Aligned_cols=247  Identities=28%  Similarity=0.411  Sum_probs=205.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            578999999999999999999999999999999986532   22346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++... ..+++..++.++.||+.+|.|||   +.||+||||||+||+++.++.++|+|||++.....  
T Consensus        88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence            9999999999888543 56899999999999999999999   89999999999999999999999999998854322  


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       .......|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+..              .....
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------~~~~~  226 (279)
T 3fdn_A          162 -SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------------VEFTF  226 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------------TCCCC
T ss_pred             -ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--------------CCCCC
Confidence             223345689999999999998999999999999999999999999987665444333321              01111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...    ....+.+++.+||+.||.+|||+.++++
T Consensus       227 ~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          227 PDF----VTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCc----CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            122    2245778899999999999999999995

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.3e-45  Score=330.63  Aligned_cols=250  Identities=30%  Similarity=0.468  Sum_probs=195.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC----hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+.  +..||||++....    ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999986  7889999987542    2335678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc---eEeecccCCCeeecC--------CceEEEe
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC---VVHRDIKSSNIMLDL--------NFNAKIG  184 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~---i~H~dlkp~Nill~~--------~~~~kl~  184 (376)
                      ||||+++++|.+++.  .+.+++..++.++.|++.||.|||   ++|   ++||||||+||+++.        ++.+||+
T Consensus        84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999988883  457899999999999999999999   566   999999999999986        6789999


Q ss_pred             eCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc
Q 038118          185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG  264 (376)
Q Consensus       185 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      |||++.......   .....|++.|+|||++.+..++.++||||||+++|+|++|..||.............        
T Consensus       159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------  227 (271)
T 3dtc_A          159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA--------  227 (271)
T ss_dssp             CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--------
T ss_pred             cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh--------
Confidence            999997543322   223468999999999999999999999999999999999999998765433322111        


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...    .....    .......+.+++.+||+.||.+|||+.++++.|+.
T Consensus       228 ~~~----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          228 MNK----LALPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             TSC----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             cCC----CCCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            011    11111    12223457889999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.8e-45  Score=346.77  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...   .......+..|..++.++ +||||+++++++...+.+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            57899999999999999999999999999999999754   223345678899999887 79999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||++||+|..++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++.... 
T Consensus       131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-  205 (396)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence            9999999999988854 456899999999999999999999   79999999999999999999999999999975321 


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhh-----HHHHHHHHHHHhcCCcccc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV-----QVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  270 (376)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|..||......+.     ...+.....    ..    
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~----~~----  277 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EK----  277 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH----HC----
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh----cc----
Confidence            22234456799999999999999999999999999999999999999964432111     111111110    01    


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh------HHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI------RQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~~vl~  311 (376)
                        ...+...+    ...+.+++.+||+.||.+||++      .+|++
T Consensus       278 --~~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          278 --QIRIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             --CCCCCTTS----CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             --ccCCCCcC----CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence              01122222    3457888999999999999996      56664

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-45  Score=336.46  Aligned_cols=261  Identities=19%  Similarity=0.185  Sum_probs=202.6

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++...+..|
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            3468999999999999999999999999999999999754   3334577899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++... +.+++..++.++.||+.+|.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus       111 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999988543 56899999999999999999999   78999999999999999999999999999876544


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ..........|+..|+|||++.+..++.++||||||+++|+|++|..||...........+.       .......    
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~~~----  255 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-------QAIPRPS----  255 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-------SCCCCGG----
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-------cCCCCcc----
Confidence            33333345568999999999998899999999999999999999999998765432211111       1110001    


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHhccCC
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRP-SIRQVIHVLNSEA  317 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~L~~~~  317 (376)
                      .....    ....+.+++.+||+.||++|| +++++++.|....
T Consensus       256 ~~~~~----~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          256 TVRPG----IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             GTSTT----CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             ccCCC----CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            11112    223577889999999999999 9999999998654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.6e-45  Score=346.81  Aligned_cols=271  Identities=17%  Similarity=0.234  Sum_probs=208.3

Q ss_pred             HHhhCCCcCCccccC--CCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           38 QATNDFNDDQKLGQG--GFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G--~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      ...++|++.+.||+|  +||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            346899999999999  9999999999999999999999754  345567788999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          114 LLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      |+||||+++++|.+++... ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||.+...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999988654 356899999999999999999999   799999999999999999999999999987643


Q ss_pred             ccCCC------cceeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc
Q 038118          193 EHAKG------SQTTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG  264 (376)
Q Consensus       193 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  264 (376)
                      .....      .......||..|+|||++.+  ..++.++|||||||++|+|++|..||...........+.........
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            21111      11122358889999999987  57899999999999999999999999876554433222111000000


Q ss_pred             CC------c-------------ccccc---CC------cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          265 NG------K-------------LLEAV---DP------RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       265 ~~------~-------------~~~~~---~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..      .             ....+   .+      .............+.+++.+||+.||++|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00      0             00000   00      0000112223456888999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4e-45  Score=341.19  Aligned_cols=246  Identities=28%  Similarity=0.399  Sum_probs=204.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .+.|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35689999999999999999999999999999999754   233456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+. |+|.+.+......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....  
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99997 5787887666778999999999999999999999   78999999999999999999999999999975432  


Q ss_pred             CcceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          197 GSQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                         .....||+.|+|||++.   +..++.++|||||||++|+|++|..||...........+..       ..      .
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~-------~~------~  270 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NE------S  270 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SC------C
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cC------C
Confidence               22346899999999884   56789999999999999999999999976654333222211       11      0


Q ss_pred             CcC-CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRL-CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.. ....    ...+.+++.+||+.||++|||+.++++
T Consensus       271 ~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          271 PALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            111 1122    245778899999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.1e-45  Score=329.74  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=209.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999999999999999998654  4445678889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce---EEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~  194 (376)
                      ||+++++|.+.+... ..+++..++.++.||+.||.|||   ++|++||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999998888554 56899999999999999999999   799999999999999987655   99999999976543


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      ..  ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+..        +.. . ...
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--------~~~-~-~~~  228 (284)
T 3kk8_A          161 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--------GAY-D-YPS  228 (284)
T ss_dssp             SC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TCC-C-CCT
T ss_pred             Cc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh--------ccc-c-CCc
Confidence            22  22345689999999999998999999999999999999999999987665444333221        100 0 001


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....+    ...+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 PEWDTV----TPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111122    245788899999999999999999995

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5e-45  Score=340.00  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=204.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...   .......+.+|..++..+ +||||+++++++...+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999754   344566788999999988 79999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++......
T Consensus        88 v~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            9999999999988854 356899999999999999999999   799999999999999999999999999999753221


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchh-----hHHHHHHHHHHHhcCCcccc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEE-----VQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  270 (376)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ....+....   . ...   
T Consensus       164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i---~-~~~---  235 (345)
T 3a8x_A          164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---L-EKQ---  235 (345)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH---H-HCC---
T ss_pred             -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH---H-cCC---
Confidence             223345579999999999999899999999999999999999999996532211     011111110   0 111   


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh------HHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI------RQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~~vl~  311 (376)
                         ..+...+    ...+.+++.+||+.||.+||++      .++++
T Consensus       236 ---~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 ---IRIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             ---CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             ---CCCCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence               1111222    3457888999999999999996      56663

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-45  Score=340.78  Aligned_cols=266  Identities=24%  Similarity=0.326  Sum_probs=214.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEE----EcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEe--eCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGF----FRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH--EKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.    +..++..||||++........+.+.+|+.+++.++|+||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4789999999999999999999    46678999999998887777788999999999999999999999886  45679


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++......+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999766667999999999999999999999   7999999999999999999999999999998654


Q ss_pred             cCCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH-------HHHHHHHhc
Q 038118          194 HAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL-------VQWVWDLYG  264 (376)
Q Consensus       194 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~-------~~~~~~~~~  264 (376)
                      .....  ......|+..|+|||++.+..++.++|||||||++|+|++|..||............       .........
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            33221  122344777899999999888999999999999999999999999755432111000       000011111


Q ss_pred             CCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .+         ............+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       259 ~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          259 EG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             cc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11         111112223355788999999999999999999999998654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=341.30  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=192.6

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999999999999999997653  23567889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEeeCCCccccccC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+++++|.+++.. .+.+++..++.++.||+.||.|||   +.||+||||||+|||++.   ++.+||+|||++......
T Consensus       129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            9999999998854 456899999999999999999999   789999999999999975   789999999999765332


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH-HHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ-VYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.        .... . ...
T Consensus       205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~--------~~~~-~-~~~  272 (349)
T 2w4o_A          205 --VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL--------NCEY-Y-FIS  272 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH--------TTCC-C-CCT
T ss_pred             --cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH--------hCCC-c-cCC
Confidence              1223456899999999999889999999999999999999999999765543311 1111        1110 0 011


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....    ....+.+++.+||+.||++|||+.++++
T Consensus       273 ~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 PWWDE----VSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhhh----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11122    2345788999999999999999999996

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-45  Score=356.83  Aligned_cols=264  Identities=26%  Similarity=0.434  Sum_probs=214.9

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      +..+.++...++|++.+.||+|+||.||+|.++. +..||||++..... ..+.|.+|+.+++.++||||+++++++. .
T Consensus       178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ccccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            3345556667889999999999999999999875 67799999976543 3678999999999999999999999987 5


Q ss_pred             CeEEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      ...++||||+++|+|.+++.... ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            67899999999999999986432 36889999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      +..............++..|+|||++....++.++|||||||++|+|++ |..||......+....+..        +. 
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--------~~-  402 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER--------GY-  402 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH--------TC-
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------CC-
Confidence            7653221111223346778999999998999999999999999999999 9999987765544333221        10 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                          ....    .......+.+++.+||+.||++|||+.+|++.|+...
T Consensus       403 ----~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          403 ----RMPR----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             ----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ----CCCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                0011    1122345788999999999999999999999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.1e-45  Score=332.46  Aligned_cols=260  Identities=28%  Similarity=0.470  Sum_probs=198.3

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...++|++.++||+|+||.||+|.+..   .||+|++...  .....+.+.+|+.+++.++|+||+++++++ .....++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            346899999999999999999998754   3999998754  445567899999999999999999999965 4566899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.||+.+|.|||   +.|++||||||+||+++.++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999999777778999999999999999999999   799999999999999999999999999999755432


Q ss_pred             C-CcceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          196 K-GSQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       196 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      . ........||..|+|||++.   +..++.++|||||||++|+|++|..||..............       .+.....
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~  246 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-------RGSLSPD  246 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH-------HTSCCCC
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc-------ccccCcc
Confidence            2 12233456899999999986   56688899999999999999999999987654433222211       1111111


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      + ..+..    .....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       247 ~-~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          247 L-SKVRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             T-TSSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             h-hhccc----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            0 11112    2335688899999999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.9e-45  Score=336.82  Aligned_cols=259  Identities=25%  Similarity=0.362  Sum_probs=211.9

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEE-----cCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKGS-KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEK  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  110 (376)
                      ...++|++.+.||+|+||.||+|.+     ..+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3457899999999999999999985     4567899999997653 34467889999999999 899999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCe
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENN-----------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI  173 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  173 (376)
                      +..++||||+++++|.+++.....                 .+++..++.++.||+.||.|||   ++|++||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence            999999999999999999865432                 4899999999999999999999   78999999999999


Q ss_pred             eecCCceEEEeeCCCccccccCCCcc-eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhh
Q 038118          174 MLDLNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEV  251 (376)
Q Consensus       174 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~  251 (376)
                      +++.++.+||+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            99999999999999997654332221 223446788999999999999999999999999999999 9999987654333


Q ss_pred             HHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ......       ..     ........    ....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       257 ~~~~~~-------~~-----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          257 FYKMIK-------EG-----FRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             HHHHHH-------HT-----CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhc-------cC-----CCCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            222111       00     01111112    23457889999999999999999999998875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.9e-45  Score=340.91  Aligned_cols=281  Identities=22%  Similarity=0.252  Sum_probs=200.2

Q ss_pred             cCCCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--hhHHHHHHHHHHHHhCCCCCcc
Q 038118           24 KGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--QGIKEYASEVTIISRLRHRNLV  101 (376)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~  101 (376)
                      .++++...+...-....++|++.+.||+|+||.||+|.+..+++.||||++.....  .....+.+|+.+++.++||||+
T Consensus        17 ~Gp~s~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   96 (329)
T 3gbz_A           17 QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNII   96 (329)
T ss_dssp             ---------------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBC
T ss_pred             cCCCcceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcc
Confidence            34445555555666677899999999999999999999999999999999975532  2345678999999999999999


Q ss_pred             ceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec-----
Q 038118          102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD-----  176 (376)
Q Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-----  176 (376)
                      ++++++...+..++||||+++ +|.+++.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++     
T Consensus        97 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~  171 (329)
T 3gbz_A           97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDAS  171 (329)
T ss_dssp             CEEEEEEETTEEEEEEECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC----
T ss_pred             eEEEEEecCCEEEEEEecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCC
Confidence            999999999999999999975 88888854 456899999999999999999999   78999999999999994     


Q ss_pred             CCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH
Q 038118          177 LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL  255 (376)
Q Consensus       177 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~  255 (376)
                      .++.+||+|||++....... .......||..|+|||++.+. .++.++|||||||++|+|++|..||......+....+
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  250 (329)
T 3gbz_A          172 ETPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI  250 (329)
T ss_dssp             -CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccceEEECcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence            45569999999997654321 223345579999999999774 4899999999999999999999999877655544433


Q ss_pred             HHHHHHHhcCCccc--------cccCCcCCCCCcH-----HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          256 VQWVWDLYGNGKLL--------EAVDPRLCRDFDE-----QQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       256 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ........ .....        ....+........     .....+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          251 FEVLGLPD-DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHCCCC-TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCc-hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            32211000 00000        0000001110000     12255788999999999999999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-45  Score=352.25  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=210.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++....   ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997542   22356788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... 
T Consensus        95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            999999999998854 457999999999999999999999   899999999999999999999999999999865432 


Q ss_pred             CcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+..        +..      .
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------~~~------~  234 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--------GIF------Y  234 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT--------TCC------C
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------CCc------C
Confidence             22334569999999999987765 6899999999999999999999987665444333221        110      1


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--Hhcc
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNS  315 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~~  315 (376)
                      ....+.    ..+.+++.+||+.||.+|||+.++++  ++..
T Consensus       235 ~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 TPQYLN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             CCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             CCccCC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            111222    35788899999999999999999995  5544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.7e-46  Score=343.26  Aligned_cols=262  Identities=27%  Similarity=0.364  Sum_probs=212.5

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCe-----EEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEE
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSS-----YIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWC  107 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~-----~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  107 (376)
                      .++...++|++.+.||+|+||.||+|.+..++.     .||+|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345557899999999999999999999977654     7999999765 344567789999999999 899999999999


Q ss_pred             eeCCeEEEEEecCCCCChhhhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118          108 HEKKELLLVYEYMPNGSLDSHLFKE-------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus       108 ~~~~~~~lv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                      ...+..++||||+++++|.+++...             ...+++..++.++.||+.||.|||   ++||+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence            9999999999999999999988643             345799999999999999999999   789999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhH
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQ  252 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~  252 (376)
                      ++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            999999999999999765433222 1223446788999999998999999999999999999998 99999876543332


Q ss_pred             HHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..+..   .    +     .........    ...+..++.+||+.||.+|||+.+|++.|+.
T Consensus       277 ~~~~~---~----~-----~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          277 YKLVK---D----G-----YQMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             HHHHH---H----T-----CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHh---c----C-----CCCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence            22211   0    1     001111111    2457889999999999999999999998864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.4e-45  Score=337.56  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=197.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccCC----hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKGS----KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|++....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            578999999999999999999985   678999999997642    2334567889999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999998854 356889999999999999999999   789999999999999999999999999998753


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..        ..     
T Consensus       172 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--------~~-----  237 (327)
T 3a62_A          172 IHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--------CK-----  237 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------TC-----
T ss_pred             ccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------CC-----
Confidence            221 1122345689999999999988999999999999999999999999987665444333322        00     


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                       ..+...+    ...+.+++.+||+.||.+||     ++.++++
T Consensus       238 -~~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 -LNLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -CCCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CCCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             1111222    34578889999999999999     7788875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.9e-45  Score=338.20  Aligned_cols=256  Identities=22%  Similarity=0.264  Sum_probs=183.6

Q ss_pred             hCCCcC---CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEE
Q 038118           41 NDFNDD---QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        41 ~~y~~~---~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ++|++.   +.||+|+||.||+|.+..+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....|+|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            456654   7899999999999999999999999999654   3456788999999997 99999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc---eEEEeeCCCccccc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF---NAKIGDFGLARLVE  193 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfg~~~~~~  193 (376)
                      |||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++   .+||+|||++....
T Consensus        85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           85 MELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             ECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999998855 467999999999999999999999   79999999999999998766   79999999997543


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.................. ...+..     
T Consensus       161 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~-----  233 (325)
T 3kn6_A          161 PD-NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF-----  233 (325)
T ss_dssp             C-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC-----
T ss_pred             CC-CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC-----
Confidence            32 22233455899999999999999999999999999999999999999765432111111111111 111110     


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .............+.+++.+||+.||.+|||+.++++
T Consensus       234 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 -SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             -CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             -CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence             0111111123356788999999999999999999984

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.5e-45  Score=353.18  Aligned_cols=260  Identities=20%  Similarity=0.260  Sum_probs=209.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC-CCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-RNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.++||+|+||.||+|.+..+++.||||++......  ..+..|+.+++.++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            57899999999999999999999999999999988755332  357889999999986 566667777788889999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee---cCCceEEEeeCCCccccccC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+ +++|.+++....+.+++..++.++.||+.||.|||   ++||+||||||+||||   +.++.+||+|||++......
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 99999999766778999999999999999999999   7999999999999999   68889999999999876443


Q ss_pred             CCc------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          196 KGS------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       196 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ...      ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+...........   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~---  236 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS---  236 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC---
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc---
Confidence            221      12356699999999999999999999999999999999999999987655443333332222111110   


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        + ..++..+    ...+.+++..||+.+|++||++.+|++.|+.
T Consensus       237 --~-~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          237 --I-EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             --H-HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             --H-HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence              0 0111222    2457889999999999999999999987754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-45  Score=341.43  Aligned_cols=268  Identities=28%  Similarity=0.436  Sum_probs=218.1

Q ss_pred             ccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccce
Q 038118           30 RFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQL  103 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~  103 (376)
                      .+..+++....++|++.+.||+|+||.||+|.+.     .++..||+|.+... .......+.+|+.+++.++||||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            4555666777899999999999999999999876     35788999999754 33445678999999999999999999


Q ss_pred             eeEEeeCCeEEEEEecCCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118          104 LGWCHEKKELLLVYEYMPNGSLDSHLFKEN---------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus       104 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                      ++++.+.+..++||||+++++|.+++....         ..+++..++.++.||+.||.|||   ++||+||||||+||+
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEE
Confidence            999999999999999999999999885422         45789999999999999999999   789999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhH
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQ  252 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~  252 (376)
                      ++.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence            99999999999999975533221 11223346788999999998999999999999999999999 89999876644433


Q ss_pred             HHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ..+.        .+..     .....    .....+.+++.+||+.||.+|||+.++++.|+...
T Consensus       251 ~~~~--------~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          251 RFVM--------EGGL-----LDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHH--------TTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHH--------cCCc-----CCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            2221        1111     11111    22345788899999999999999999999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-45  Score=337.37  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=204.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC----eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS----SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|++.+.||+|+||.||+|.+..++    ..||+|.+... .......+.+|+.+++.++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            467788899999999999999987543    46999999765 3444567899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999776678999999999999999999999   78999999999999999999999999999976543


Q ss_pred             CCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          195 AKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       195 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ....  ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.        .+..   
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~--------~~~~---  268 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------DGFR---  268 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--------TTCC---
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH--------CCCc---
Confidence            2211  1122345778999999998899999999999999999998 999997765443322221        1110   


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                        .....    .....+.+++.+||+.||.+||++.+|++.|+..
T Consensus       269 --~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          269 --LPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             --CCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              11111    2234578889999999999999999999988753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.7e-45  Score=350.02  Aligned_cols=250  Identities=30%  Similarity=0.441  Sum_probs=206.9

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC-eEEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK-ELLLV  116 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv  116 (376)
                      ...++|++.+.||+|+||.||+|.+.  +..||||++....  ..+.|.+|+.++++++||||+++++++.+.. ..|+|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            34578999999999999999999986  6789999997654  3578999999999999999999999987665 79999


Q ss_pred             EecCCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++......
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999999976544 4799999999999999999999   799999999999999999999999999999753221


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                          .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +..     .
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--------~~~-----~  405 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------GYK-----M  405 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT--------TCC-----C
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------CCC-----C
Confidence                122357889999999999999999999999999999998 9999987765554332221        110     1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                          .........+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       406 ----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          406 ----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                1112233567889999999999999999999998864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=338.86  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=205.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeE----EEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|++.+.||+|+||.||+|.+..++..    |++|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            47899999999999999999999877764    477776543 3345678999999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +|++++.+++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999877778999999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          195 AKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||...........+..        +.     
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~--------~~-----  236 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------GE-----  236 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--------TC-----
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--------CC-----
Confidence            2221 2233446778999999999999999999999999999999 9999987765554332221        11     


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .......    ....+..++.+||+.||.+|||+.+|++.|....
T Consensus       237 ~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          237 RLPQPPI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             CCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            0111112    2335788899999999999999999999887644

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=337.16  Aligned_cols=247  Identities=27%  Similarity=0.302  Sum_probs=196.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ..++|++.++||+|+||+||+|.+..+++.||||++...  .......+..|+..+..+ +|+||+++++++.+.+..|+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            357899999999999999999999999999999998653  333344555666655555 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+ +++|.+++......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999 66898888777778999999999999999999999   789999999999999999999999999998765332


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                        .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......   ..        ...+..    .+.
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~--------~~~~~~----~~~  272 (311)
T 3p1a_A          211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQ--------LRQGYL----PPE  272 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HH--------HTTTCC----CHH
T ss_pred             --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HH--------HhccCC----Ccc
Confidence              22334558999999998875 7899999999999999999997666443211   00        111111    111


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +..    .....+.+++.+||+.||++|||+.++++
T Consensus       273 ~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 FTA----GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            111    12345788999999999999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=334.06  Aligned_cols=267  Identities=22%  Similarity=0.278  Sum_probs=204.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            46899999999999999999999999999999998654  3334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|..++. ..+.+++..++.++.|++.||.|||   +.|++||||||+||+++.++.+||+|||++....... 
T Consensus        82 e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           82 EYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             ECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence            9999998887764 4566899999999999999999999   7999999999999999999999999999997654222 


Q ss_pred             cceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------HHhcCCccc
Q 038118          198 SQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------DLYGNGKLL  269 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~  269 (376)
                      .......||..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.....       ..+......
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            12234468999999999876 5689999999999999999999999988766554443332211       011111110


Q ss_pred             cc---cCCcCCCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EA---VDPRLCRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..   .++......   .......+.+++.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00   001000000   0122345788999999999999999999995

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3e-45  Score=344.65  Aligned_cols=248  Identities=25%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHH-HHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTI-ISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ......+..|..+ ++.++||||+++++++...+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            578999999999999999999999999999999997542   2334556667766 567899999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||++||+|.+++.+ .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999998854 456889999999999999999999   799999999999999999999999999999753221


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        ..      ..
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~------~~  257 (373)
T 2r5t_A          193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--------KP------LQ  257 (373)
T ss_dssp             -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--------SC------CC
T ss_pred             -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------cc------cC
Confidence             2233456799999999999999999999999999999999999999987765554443332        10      11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      +...+.    ..+.+++.+||+.||.+||++.+.+
T Consensus       258 ~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          258 LKPNIT----NSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             CCSSSC----HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             CCCCCC----HHHHHHHHHHcccCHHhCCCCCCCH
Confidence            112222    4578889999999999999985433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-45  Score=338.70  Aligned_cols=268  Identities=26%  Similarity=0.378  Sum_probs=215.8

Q ss_pred             cccCHHHHHHHhhCCCcCCccccCCCeeEEEEEE-----cCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCcc
Q 038118           29 KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFF-----RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLV  101 (376)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~  101 (376)
                      ..+....+....++|++.+.||+|+||.||+|.+     ..+++.||||++... .....+.+.+|+.++..+ +||||+
T Consensus        15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence            3566677777889999999999999999999985     346789999999765 344556789999999999 699999


Q ss_pred             ceeeEEeeCC-eEEEEEecCCCCChhhhhhhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 038118          102 QLLGWCHEKK-ELLLVYEYMPNGSLDSHLFKENN---------------LLTWEFRFKIAQDLASGLLYLQEGWEQCVVH  165 (376)
Q Consensus       102 ~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~---------------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H  165 (376)
                      ++++++...+ ..++||||+++++|.+++.....               .+++..++.++.||+.||.|||   ++||+|
T Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H  171 (316)
T 2xir_A           95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIH  171 (316)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence            9999987654 58999999999999999865433               2789999999999999999999   789999


Q ss_pred             ecccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCC
Q 038118          166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPI  243 (376)
Q Consensus       166 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf  243 (376)
                      |||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999976543222 22233457889999999999999999999999999999998 99999


Q ss_pred             CCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          244 SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..............       .+.     ........    ...+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       252 ~~~~~~~~~~~~~~-------~~~-----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          252 PGVKIDEEFCRRLK-------EGT-----RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             TTCCCSHHHHHHHH-------HTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchhHHHHHHhc-------cCc-----cCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            77654332211111       010     01111222    2457888899999999999999999998864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.8e-45  Score=351.30  Aligned_cols=262  Identities=30%  Similarity=0.442  Sum_probs=208.8

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      .+.++...++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.|.+|+.++++++||||+++++++.+ +.
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            34455567889999999999999999999986 46699999976543 24678999999999999999999999876 67


Q ss_pred             EEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      .++||||+++|+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            89999999999999999653 356899999999999999999999   79999999999999999999999999999986


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.        .+..  
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~--------~~~~--  399 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE--------RGYR--  399 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------TTCC--
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------cCCC--
Confidence            54332222333456788999999998999999999999999999999 999998766544332221        1110  


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                         .    .........+.+++.+||+.||++|||+.+|++.|+...
T Consensus       400 ---~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          400 ---M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ---C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence               1    111223346788999999999999999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.1e-45  Score=354.56  Aligned_cols=249  Identities=27%  Similarity=0.358  Sum_probs=199.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...   .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            47899999999999999999999999999999999753   333456778899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE-QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |||+++++|.+++.. .+.+++..++.++.||+.||.|||   + .||+||||||+|||++.++.+||+|||++......
T Consensus       227 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999999988854 457899999999999999999999   6 89999999999999999999999999999753221


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..      ..        ..
T Consensus       303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~--------~~  367 (446)
T 4ejn_A          303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EE--------IR  367 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC--------CC
T ss_pred             -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------CC--------CC
Confidence             2233446799999999999999999999999999999999999999987765544333321      01        11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      +...+    ...+.+++.+||+.||.+||     ++.++++
T Consensus       368 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            11222    24578889999999999999     9999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.6e-45  Score=336.56  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=199.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC------
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK------  111 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  111 (376)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3578999999999999999999999999999999997543 334578999999999999999999999986543      


Q ss_pred             ---------------------------------------------------eEEEEEecCCCCChhhhhhhcCC--CCCH
Q 038118          112 ---------------------------------------------------ELLLVYEYMPNGSLDSHLFKENN--LLTW  138 (376)
Q Consensus       112 ---------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~--~~~~  138 (376)
                                                                         ..++||||+++++|.+++.....  ...+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               38999999999999999865432  3566


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC-----------cceeeeccCC
Q 038118          139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-----------SQTTVLAGTM  207 (376)
Q Consensus       139 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~gt~  207 (376)
                      ..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            678999999999999999   79999999999999999999999999999986643321           1123346899


Q ss_pred             CCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHH
Q 038118          208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMEC  287 (376)
Q Consensus       208 ~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (376)
                      .|+|||++.+..++.++|||||||++|+|++|..|+....     ..+..     ....         ............
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~-----~~~~---------~~~~~~~~~~~~  301 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITD-----VRNL---------KFPLLFTQKYPQ  301 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHH-----HHTT---------CCCHHHHHHCHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHH-----hhcc---------CCCcccccCChh
Confidence            9999999999999999999999999999999877753211     11110     0011         011112233455


Q ss_pred             HHHHHHHccCCCCCCCCChHHHHH
Q 038118          288 LMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       288 l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+++.+||+.||++|||+.++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhh
Confidence            788999999999999999999996

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=330.09  Aligned_cols=251  Identities=26%  Similarity=0.379  Sum_probs=188.1

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            3578999999999999999999999999999999986532   1234678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.||+.||.|||   +.|++||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999776678999999999999999999999   789999999999999999999999999999765422


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      .. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.              ..+..
T Consensus       166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------~~~~~  230 (278)
T 3cok_A          166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--------------LADYE  230 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--------------SSCCC
T ss_pred             CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--------------hcccC
Confidence            21 2234568999999999998889999999999999999999999997655332211000              00111


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....    ....+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 MPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Cccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1122    2345788999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-45  Score=333.25  Aligned_cols=257  Identities=29%  Similarity=0.451  Sum_probs=209.0

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++...++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. +..++
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            34456889999999999999999999864 67799999876533 35678999999999999999999999864 56899


Q ss_pred             EEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          116 VYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||||+++++|.+++.... ..+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|||++.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            999999999999885432 36899999999999999999999   79999999999999999999999999999986643


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..........++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+..        +.     .
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--------~~-----~  228 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--------GY-----R  228 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------TC-----C
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc--------cc-----C
Confidence            32222233446788999999988889999999999999999999 9999987664443322211        10     0


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .....    .....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       229 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          229 MVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcc----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            11111    223457889999999999999999999998875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-45  Score=329.66  Aligned_cols=251  Identities=27%  Similarity=0.377  Sum_probs=202.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            478999999999999999999999999999999987542 3345788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee---cCCceEEEeeCCCcccc
Q 038118          119 YMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLV  192 (376)
Q Consensus       119 ~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~  192 (376)
                      |+++++|.+.+..   ....+++..++.++.||+.||.|||   ++||+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999988854   3467999999999999999999999   7999999999999999   45578999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ...  .......|+..|+|||++. ..++.++|||||||++|+|++|..||......+.......      .....    
T Consensus       178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------~~~~~----  244 (285)
T 3is5_A          178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------KEPNY----  244 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCC----
T ss_pred             CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------CCccc----
Confidence            432  2233456899999999876 5688999999999999999999999987664443322211      11100    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ........    ..+.+++.+||+.||++|||+.++++
T Consensus       245 -~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 -AVECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CC--CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -ccccCcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00111122    35778899999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=334.41  Aligned_cols=267  Identities=24%  Similarity=0.289  Sum_probs=202.4

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-----hhhHHHHHHHHHHHHhC---CCCCccceeeEEee
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-----KQGIKEYASEVTIISRL---RHRNLVQLLGWCHE  109 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~  109 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....     ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34689999999999999999999999999999999986422     11123456677766665   59999999999987


Q ss_pred             CC-----eEEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEE
Q 038118          110 KK-----ELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI  183 (376)
Q Consensus       110 ~~-----~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl  183 (376)
                      ..     ..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence            54     5899999997 59988886543 34899999999999999999999   799999999999999999999999


Q ss_pred             eeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          184 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+........
T Consensus       162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999997654322  22345689999999999999999999999999999999999999988776555444433221100


Q ss_pred             cCCccccc-------cCCcCCC---CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNGKLLEA-------VDPRLCR---DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~~~~~~-------~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      . ......       +.+....   .........+.+++.+||+.||++|||+.++++
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          240 E-DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             T-TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             h-hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0 000000       0000000   001122355788999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-44  Score=334.89  Aligned_cols=259  Identities=21%  Similarity=0.300  Sum_probs=209.3

Q ss_pred             HHHHHHhhCCCcC-CccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCC-CCCccceeeEEee
Q 038118           34 KELAQATNDFNDD-QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHE  109 (376)
Q Consensus        34 ~~~~~~~~~y~~~-~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  109 (376)
                      +..+...++|.+. +.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            4455667889888 8899999999999999999999999998754  2333577889999999995 6999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEee
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGD  185 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~D  185 (376)
                      .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||   ++||+||||||+|||++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999988543 367899999999999999999999   789999999999999988   78999999


Q ss_pred             CCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       186 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...      .
T Consensus       178 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------~  249 (327)
T 3lm5_A          178 FGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------N  249 (327)
T ss_dssp             GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------C
T ss_pred             CccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc------c
Confidence            99997654322  233456899999999999999999999999999999999999999876654443333220      0


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .    ........    .....+.+++.+||+.||++|||+.++++
T Consensus       250 ~----~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 V----DYSEETFS----SVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             C----CCCTTTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c----ccCchhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            0    01111112    22345788899999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-44  Score=336.72  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=210.1

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEc-------CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFR-------ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHE  109 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  109 (376)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++... .......+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3689999999999999999999985       35678999999765 344567889999999999 89999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                      .+..++||||+++++|.+++....               ..+++..++.++.||+.||.|||   ++||+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence            999999999999999999986543               24889999999999999999999   799999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhH
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQ  252 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~  252 (376)
                      ++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            999999999999999765433221 1223346788999999988889999999999999999999 99999876644433


Q ss_pred             HHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ..+..        +.     .......    ....+..++.+||+.||.+|||+.+|++.|+..
T Consensus       270 ~~~~~--------~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          270 KLLKE--------GH-----RMDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHH--------TC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhc--------CC-----CCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            22221        11     0111122    234578889999999999999999999988754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.1e-44  Score=334.70  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=209.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|.+.+.||+|+||.||++.+..+++.|++|++...   .....+.+.+|+.+++.++|+||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            47899999999999999999999999999999998654   344567789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++.. ...+++..++.++.||+.+|.|||   ++||+||||||+|||++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999988754 457899999999999999999999   7899999999999999999999999999997654222


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       .......|+..|+|||++.+..++.++|||||||++|+|++|..||......+....+..        ..      ..+
T Consensus       196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------~~------~~~  260 (335)
T 2owb_A          196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--------NE------YSI  260 (335)
T ss_dssp             -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------TC------CCC
T ss_pred             -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc--------CC------CCC
Confidence             223345689999999999988899999999999999999999999987654433222211        00      111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+    ...+.+++.+||+.||++|||+.++++
T Consensus       261 ~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 PKHI----NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1222    235778899999999999999999995

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=328.52  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=208.8

Q ss_pred             hhCCCcCC-ccccCCCeeEEEEEEc--CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQ-KLGQGGFGGVYKGFFR--ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~-~lg~G~~g~vy~a~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            46677776 8999999999999864  46788999999865 445567899999999999999999999999 5567899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.||+.||.|||   +.|++||||||+||+++.++.++|+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999766677999999999999999999999   799999999999999999999999999999765432


Q ss_pred             CCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          196 KGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       196 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ....  .....+|..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +..    
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--------~~~----  231 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------GKR----  231 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT--------TCC----
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc--------CCc----
Confidence            2211  122346788999999988889999999999999999998 9999987665443322211        110    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       +....    .....+.+++.+||+.||.+||++.+|++.|..
T Consensus       232 -~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  269 (287)
T 1u59_A          232 -MECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  269 (287)
T ss_dssp             -CCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             11112    233468889999999999999999999998875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=339.12  Aligned_cols=251  Identities=22%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCC--CCccceeeEEeeCCeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRH--RNLVQLLGWCHEKKELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~  114 (376)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.++..++|  +||+++++++...+..|
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            3578999999999999999999885 4888999998754  44556788999999999986  99999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||| +.+++|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++ ++.+||+|||++.....
T Consensus        86 lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            9999 568899998855 457899999999999999999999   78999999999999997 57899999999976543


Q ss_pred             CCCc-ceeeeccCCCCCchhhhcc-----------CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          195 AKGS-QTTVLAGTMGYMAPECATT-----------GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       195 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.........  +..    .
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~----~  233 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--LHA----I  233 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HHH----H
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH--HHH----H
Confidence            2221 2334569999999999865           67889999999999999999999999754322111  111    0


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .         ++.....+.......+.+++.+||+.||.+|||+.++++
T Consensus       234 ~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          234 I---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             H---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             h---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            0         111111111111245788899999999999999999995

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.8e-45  Score=326.52  Aligned_cols=249  Identities=20%  Similarity=0.344  Sum_probs=205.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++...  .....+.+.+|+.++++++||||+++++++...  ...++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            578999999999999999999986  778999998764  345567899999999999999999999999876  78899


Q ss_pred             EEecCCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          116 VYEYMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      ||||+++++|.+++..... .+++..++.++.||+.||.|||   +.+  ++||||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999999965443 5899999999999999999999   788  999999999999999999999998887542


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCC---CCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASK---ESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ..      ....||+.|+|||++.+..++.   ++|||||||++|+|++|..||...........+..       ..   
T Consensus       164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~---  227 (271)
T 3kmu_A          164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-------EG---  227 (271)
T ss_dssp             SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH-------SC---
T ss_pred             cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh-------cC---
Confidence            21      2235789999999998765544   79999999999999999999987664443222211       11   


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        ..+.+...+    ...+.+++.+||+.||++|||+.++++.|+.
T Consensus       228 --~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          228 --LRPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             --CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              112222222    3457888999999999999999999998875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=329.26  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=197.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|.+....  ..+.+.+|+.+++.++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            468999999999999999999986  6789999996543  35788999999999999999999998874  47999999


Q ss_pred             CCCCChhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce-EEEeeCCCccccccCC
Q 038118          120 MPNGSLDSHLFKENN--LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN-AKIGDFGLARLVEHAK  196 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~  196 (376)
                      +++++|.+++.....  .++...++.++.||+.||.|||+.+.+||+||||||+|||++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999865432  4788999999999999999999543389999999999999988886 799999998754321 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                         .....||..|+|||++.+..++.++|||||||++|+|++|..||...........     +... .+.     .+..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----~~~~-~~~-----~~~~  225 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-----WAVH-NGT-----RPPL  225 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH-----HHHH-TTC-----CCCC
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH-----HHHh-cCC-----CCCc
Confidence               2234589999999999988999999999999999999999999975543222111     0000 111     1122


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ...+    ...+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       226 ~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          226 IKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             BTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             cccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            2222    345788899999999999999999999887643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.5e-45  Score=331.83  Aligned_cols=263  Identities=26%  Similarity=0.372  Sum_probs=207.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEE----EcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC--Ce
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGF----FRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK--KE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~  112 (376)
                      .++|++.+.||+|+||.||+|.    +..+++.||+|++... .......+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4669999999999999999999    5668899999999754 333457889999999999999999999999876  67


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .++||||+++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+||+++.++.++|+|||++...
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            89999999999999999777778999999999999999999999   799999999999999999999999999999866


Q ss_pred             ccCCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhh--------HHHHHHHHHHH
Q 038118          193 EHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV--------QVYLVQWVWDL  262 (376)
Q Consensus       193 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~--------~~~~~~~~~~~  262 (376)
                      ......  ......||..|+|||++.+..++.++|||||||++|+|++|..|+........        ........ ..
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NT  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HH
Confidence            433221  12234577789999999988899999999999999999999998653321100        00000101 11


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...+.         ...........+.+++.+||+.||.+|||+.++++.|+.
T Consensus       256 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          256 LKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            11111         111122233568889999999999999999999998864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.6e-45  Score=334.34  Aligned_cols=262  Identities=24%  Similarity=0.287  Sum_probs=200.5

Q ss_pred             hhCCCcC-CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDD-QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~-~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .++|++. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..|+||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4788885 7899999999999999999999999999876655567889999999985 6999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce---EEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~  194 (376)
                      ||+++++|.+++... +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999988654 56899999999999999999999   789999999999999998776   99999999875432


Q ss_pred             CCC------cceeeeccCCCCCchhhhcc-----CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH-------HHH
Q 038118          195 AKG------SQTTVLAGTMGYMAPECATT-----GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV-------YLV  256 (376)
Q Consensus       195 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~-------~~~  256 (376)
                      ...      .......||..|+|||++.+     ..++.++|||||||++|+|++|..||......+...       ...
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            111      11223458999999999875     457899999999999999999999997654322000       000


Q ss_pred             HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .........+..  .+.......    ....+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~i~~~~~--~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKY--EFPDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCC--CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCc--ccCchhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            000000001100  000000011    2345788999999999999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-44  Score=331.68  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=208.6

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            46889999999999999999999999999999999987655445678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee---cCCceEEEeeCCCccccccC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+++++|.+++... +.+++..++.++.||+.||.|||   +.|++||||||+||++   +.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            99999999888543 46899999999999999999999   7899999999999999   77889999999998754321


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                         ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..        +..  .....
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~--------~~~--~~~~~  229 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--------GYY--EFESP  229 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------CCC--CCCTT
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--------CCC--CCCcc
Confidence               22334589999999999988899999999999999999999999987654443322221        110  01111


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--Hhcc
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNS  315 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~~  315 (376)
                      ....+    ...+.+++.+||+.||.+|||+.++++  ++..
T Consensus       230 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          230 FWDDI----SESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             TTTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence            12222    345788999999999999999999995  5544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-45  Score=332.51  Aligned_cols=260  Identities=27%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             HHHHHHhhCCCcCC-ccccCCCeeEEEEEE--cCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEe
Q 038118           34 KELAQATNDFNDDQ-KLGQGGFGGVYKGFF--RETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        34 ~~~~~~~~~y~~~~-~lg~G~~g~vy~a~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      .++....++|++.+ .||+|+||.||+|.+  ..+++.||||++....  ....+.+.+|+.+++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            44445568899988 999999999999954  5667899999997643  33357799999999999999999999999 


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                      ..+..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||   +.|++||||||+||+++.++.+||+|||+
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence            56778999999999999998854 456899999999999999999999   78999999999999999999999999999


Q ss_pred             ccccccCCCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          189 ARLVEHAKGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       189 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      +..........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+.        .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--------~  235 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE--------K  235 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------T
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--------c
Confidence            97654332221  122335688999999988889999999999999999999 999998766544322221        1


Q ss_pred             CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      +..     +....    .....+.+++.+||+.||.+||++.+|++.|+.
T Consensus       236 ~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          236 GER-----MGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             TCC-----CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCC-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            110     11112    223458889999999999999999999998874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9e-45  Score=336.02  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=205.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEE--EEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYI--AVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+..++..+  ++|.+... .....+.+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            478999999999999999999998888755  99988753 333456788999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          116 VYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ||||+++++|.+++....               ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999886543               46899999999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWV  259 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  259 (376)
                      +||+|||++......  .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.   
T Consensus       181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~---  255 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---  255 (327)
T ss_dssp             EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred             EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh---
Confidence            999999998643221  11223346889999999988889999999999999999998 999998766443322211   


Q ss_pred             HHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          260 WDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           .+     ........    ....+.+++.+||+.||.+|||+.++++.|..
T Consensus       256 -----~~-----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          256 -----QG-----YRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             -----GT-----CCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----cC-----CCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                 11     01111112    23457889999999999999999999988864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.2e-44  Score=327.27  Aligned_cols=249  Identities=25%  Similarity=0.370  Sum_probs=209.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            47899999999999999999999999999999998654   344567789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++.. .+.+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999988754 457899999999999999999999   7899999999999999999999999999997654222


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       .......|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+.        ...      ..+
T Consensus       170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------~~~------~~~  234 (294)
T 2rku_A          170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--------KNE------YSI  234 (294)
T ss_dssp             -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------TTC------CCC
T ss_pred             -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------hcc------CCC
Confidence             22334568999999999998889999999999999999999999998765443322211        111      111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....    ...+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 PKHI----NPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            1222    245788899999999999999999995

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.6e-44  Score=347.89  Aligned_cols=263  Identities=20%  Similarity=0.218  Sum_probs=202.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC------C
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK------K  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~  111 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999999999999999999754  445567888999999999999999999999654      4


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..|+||||++++ |.+.+.   ..+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            679999999764 555552   24889999999999999999999   78999999999999999999999999999976


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH----------
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD----------  261 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----------  261 (376)
                      ....  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......          
T Consensus       214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            5432  2234567899999999999999999999999999999999999999887765554444332110          


Q ss_pred             -----HhcCCc------cccccCCcCC---CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 -----LYGNGK------LLEAVDPRLC---RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 -----~~~~~~------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           ......      ....+...+.   ..........+.+++.+||+.||++|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 000000      0000000000   0011122456889999999999999999999995

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-44  Score=339.05  Aligned_cols=265  Identities=16%  Similarity=0.164  Sum_probs=203.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCC-----CeEEEEEEcccCChhhH-----------HHHHHHHHHHHhCCCCCccc
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRET-----SSYIAVKRVSKGSKQGI-----------KEYASEVTIISRLRHRNLVQ  102 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~  102 (376)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||||++........           ..+..|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            356899999999999999999998765     57899999876643211           12345666778889999999


Q ss_pred             eeeEEeeC----CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec--
Q 038118          103 LLGWCHEK----KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD--  176 (376)
Q Consensus       103 ~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--  176 (376)
                      +++++...    ...|+||||+ +++|.+++....+.+++..++.++.||+.||.|||   ++||+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            99998764    5689999999 99999999777678999999999999999999999   78999999999999999  


Q ss_pred             CCceEEEeeCCCccccccCCCc------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchh
Q 038118          177 LNFNAKIGDFGLARLVEHAKGS------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEE  250 (376)
Q Consensus       177 ~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~  250 (376)
                      .++.+||+|||++.........      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999765322111      1133459999999999999899999999999999999999999998643332


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCC-CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLC-RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...........    ......+++.+. ...    ...+..++..||+.||.+||++.+|++.|..
T Consensus       269 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          269 KYVRDSKIRYR----ENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             HHHHHHHHHHH----HCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhh----hhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            22111111000    011111111111 111    2457888899999999999999999988764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.5e-45  Score=337.73  Aligned_cols=253  Identities=21%  Similarity=0.317  Sum_probs=202.1

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......    ..+|++++.++ +||||+++++++.+....|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468899999999999999999999999999999999765432    34688888887 7999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC----ceEEEeeCCCccccc
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN----FNAKIGDFGLARLVE  193 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~~~  193 (376)
                      ||++||+|.+.+.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||+.+.    +.+||+|||++....
T Consensus        96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999998854 457899999999999999999999   7999999999999998543    359999999998654


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....     .+...  +.
T Consensus       172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-----~~~~~--~~  243 (342)
T 2qr7_A          172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-----SGKFS--LS  243 (342)
T ss_dssp             CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH-----HCCCC--CC
T ss_pred             CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc-----cCCcc--cC
Confidence            3322 2334568999999999988788999999999999999999999997643222211111111     11110  11


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......    ....+.+++.+||..||++|||+.++++
T Consensus       244 ~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 GGYWNS----VSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             STTTTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111122    2345788999999999999999999984

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-44  Score=328.05  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=205.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh------hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK------QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....      ...+.+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            4789999999999999999999999999999999875421      1357789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc----eEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF----NAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~  189 (376)
                      ++||||+++++|.+++.. ...+++..++.++.||+.||.|||   ++|++||||||+||+++.++    .++|+|||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999998854 456899999999999999999999   78999999999999998877    7999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      .......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+..        ... 
T Consensus       160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~-  228 (283)
T 3bhy_A          160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA--------VNY-  228 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--------TCC-
T ss_pred             eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh--------ccc-
Confidence            7653322  22344589999999999988999999999999999999999999987654433222211        000 


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ...+....    .....+.+++.+||+.||++|||+.++++
T Consensus       229 -~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 -DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence             00011111    12345788999999999999999999996

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.6e-45  Score=330.94  Aligned_cols=261  Identities=19%  Similarity=0.269  Sum_probs=204.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEE-eeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~  117 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            46899999999999999999999999999999998765432  23578899999999988766665554 6778899999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee---cCCceEEEeeCCCcccccc
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||+ +++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 99999998766778999999999999999999999   7999999999999999   7889999999999986644


Q ss_pred             CCCc------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          195 AKGS------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       195 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ....      ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+...........  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence            3221      22345689999999999999999999999999999999999999987554333222222111111100  


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                          .+.+...+    ...+.+++.+||+.||++|||+.+|++.|+.
T Consensus       239 ----~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          239 ----IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             ----HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             ----hhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence                00111122    2457889999999999999999999998875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.9e-45  Score=347.83  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=204.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC--------CCCccceeeEEe--
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR--------HRNLVQLLGWCH--  108 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~--  108 (376)
                      ..++|++.++||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++        |+||+++++++.  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            368999999999999999999999999999999999754 344567889999999985        778999999987  


Q ss_pred             --eCCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEeecccCCCeeecCCc-----
Q 038118          109 --EKKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQ-CVVHRDIKSSNIMLDLNF-----  179 (376)
Q Consensus       109 --~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~~-----  179 (376)
                        .....|+||||+ +++|.+.+... ...+++..++.++.||+.||.|||   ++ ||+||||||+|||++.++     
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence              456899999999 55666665443 367999999999999999999999   67 999999999999999776     


Q ss_pred             --------------------------------------------eEEEeeCCCccccccCCCcceeeeccCCCCCchhhh
Q 038118          180 --------------------------------------------NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA  215 (376)
Q Consensus       180 --------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (376)
                                                                  .+||+|||++......    .....||..|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999765432    2334589999999999


Q ss_pred             ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH--HHHHHHHhcCC--------ccc----------cccCCc
Q 038118          216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL--VQWVWDLYGNG--------KLL----------EAVDPR  275 (376)
Q Consensus       216 ~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~--~~~~~~~~~~~--------~~~----------~~~~~~  275 (376)
                      .+..++.++|||||||++|+|++|..||............  ........+..        ...          ..+...
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999999765533221111  01111111100        000          000000


Q ss_pred             C----------CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 L----------CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~----------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .          ...........+.+++.+||+.||++|||+.++++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0          01234566778999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=340.83  Aligned_cols=267  Identities=22%  Similarity=0.274  Sum_probs=210.0

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee----
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE----  109 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----  109 (376)
                      +.+....++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            3344456899999999999999999999999999999999987777777889999999999999999999999863    


Q ss_pred             CCeEEEEEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          110 KKELLLVYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                      ....++||||+++++|.+++..   ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEec
Confidence            3478999999999999998865   3567999999999999999999999   789999999999999999999999999


Q ss_pred             CCccccccCCCc--------ceeeeccCCCCCchhhhccCC---CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHH
Q 038118          187 GLARLVEHAKGS--------QTTVLAGTMGYMAPECATTGR---ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL  255 (376)
Q Consensus       187 g~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~  255 (376)
                      |++.........        ......||..|+|||++.+..   ++.++|||||||++|+|++|..||........... 
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-  257 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-  257 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-
Confidence            998654211100        012234789999999987554   68899999999999999999999964321111100 


Q ss_pred             HHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCC
Q 038118          256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP  318 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~  318 (376)
                       ...    ...     .......    .....+.+++.+||+.||.+|||+.+|++.|....+
T Consensus       258 -~~~----~~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          258 -LAV----QNQ-----LSIPQSP----RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             -HHH----HCC-------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             -HHh----hcc-----CCCCccc----cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence             000    000     0001111    223458889999999999999999999999987653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-44  Score=333.27  Aligned_cols=260  Identities=26%  Similarity=0.412  Sum_probs=202.0

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcC---CCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRE---TSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      +....++|++.+.||+|+||.||+|.+..   ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33457889999999999999999998765   5668999998754  445567899999999999999999999999765


Q ss_pred             C-----eEEEEEecCCCCChhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          111 K-----ELLLVYEYMPNGSLDSHLFK-----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       111 ~-----~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      .     ..++||||+++++|.+++..     ....+++..++.++.||+.||.|||   ++||+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence            4     45999999999999998843     3356899999999999999999999   899999999999999999999


Q ss_pred             EEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  258 (376)
                      +||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. 
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-  264 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-  264 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc-
Confidence            99999999976543221 12233456789999999999899999999999999999999 9999987765544332221 


Q ss_pred             HHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                             +.     .+....    .....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       265 -------~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          265 -------GH-----RLKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             -------TC-----CCCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CC-----CCCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                   11     011112    223457889999999999999999999998875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.3e-45  Score=331.11  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=207.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+...  .....+.+.+|+.+++.++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            57899999999999999999999999999999999754  34456779999999999999999999998754  678999


Q ss_pred             EEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc-----eEeecccCCCeeecCCceEEEeeCC
Q 038118          116 VYEYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQC-----VVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      ||||+++++|.+++...   ...+++..++.++.||+.||.|||   +.+     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999988642   345899999999999999999999   567     9999999999999999999999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ++....... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...........+..        +.
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--------~~  232 (279)
T 2w5a_A          162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--------GK  232 (279)
T ss_dssp             HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TC
T ss_pred             hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh--------cc
Confidence            987653221 112234589999999999988899999999999999999999999987664443322221        11


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .     +.+...    ....+.+++.+||+.||.+|||+.+|++.+..
T Consensus       233 ~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          233 F-----RRIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             C-----CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             c-----ccCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            1     111122    23457889999999999999999999976553

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.4e-44  Score=328.77  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=201.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            457899999999999999999999999999999998753   34556788999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          116 VYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      ||||+++++|.+++..   ....+++..++.++.||+.||.|||   +.|++||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999988854   3567899999999999999999999   799999999999999999999999999998765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.........  +...    .......   
T Consensus       187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~----~~~~~~~---  256 (310)
T 2wqm_A          187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LCKK----IEQCDYP---  256 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH--HHHH----HHTTCSC---
T ss_pred             cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH--HHHH----hhcccCC---
Confidence            3322 1223446899999999999889999999999999999999999999764322111  1110    0111110   


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP  318 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~  318 (376)
                       +.....    ....+.+++.+||+.||++|||+.+|++.|+...+
T Consensus       257 -~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          257 -PLPSDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             -CCCTTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCcccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence             111112    23457888999999999999999999998876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-44  Score=336.10  Aligned_cols=269  Identities=25%  Similarity=0.352  Sum_probs=206.8

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            3467899999999999999999999999999999998654  33345668899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|..++ .....+++..++.++.||+.||.|||   +.|++||||||+|||++.++.+||+|||++......
T Consensus       102 v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          102 VFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999998887765 34456899999999999999999999   789999999999999999999999999999765332


Q ss_pred             CCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------HHh-cCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------DLY-GNG  266 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~-~~~  266 (376)
                      . .......|+..|+|||++.+. .++.++|||||||++|+|++|..||......+....+.....       ..+ ...
T Consensus       178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            2 223345689999999998775 689999999999999999999999987765554433322110       000 000


Q ss_pred             ccccccCCcCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 KLLEAVDPRLCRDFD-----EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+.+.....     ......+.+++.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            001111111111111     122356889999999999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.8e-45  Score=337.56  Aligned_cols=244  Identities=24%  Similarity=0.330  Sum_probs=203.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh--------hhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK--------QGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....        .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            46799999999999999999999999999999999976421        1234567899999999999999999999999


Q ss_pred             CeEEEEEecCCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          111 KELLLVYEYMPNG-SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       111 ~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      +..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999998766 8888774 4557999999999999999999999   789999999999999999999999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      .......  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......                  
T Consensus       178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------------  237 (335)
T 3dls_A          178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------------  237 (335)
T ss_dssp             EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------------
T ss_pred             eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------------
Confidence            7654332  2334569999999999988776 789999999999999999999997532110                  


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV  312 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~  312 (376)
                      ...+.  ....    ....+.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~~--~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAAIH--PPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTCCC--CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhccC--CCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000  0111    22457889999999999999999999973

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.4e-44  Score=326.49  Aligned_cols=247  Identities=24%  Similarity=0.393  Sum_probs=207.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999986532   22346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++... +.+++..++.++.||+.||.|||   ++|++||||+|+||+++.++.++|+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999988554 46899999999999999999999   899999999999999999999999999998654322 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|..||......+....+..        .      +..+
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------~------~~~~  231 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--------V------DLKF  231 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--------T------CCCC
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--------c------ccCC
Confidence              22345689999999999988899999999999999999999999987654443222211        1      1111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+    ...+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          232 PPFL----SDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1222    345788999999999999999999995

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-44  Score=328.51  Aligned_cols=260  Identities=19%  Similarity=0.277  Sum_probs=207.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEE-eeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWC-HEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......  ..+.+|+.+++.++|++++..+.++ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999999999999999998765432  4678999999999988766555554 67788999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee---cCCceEEEeeCCCccccccC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+ +++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||+   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999766778999999999999999999999   7999999999999999   47889999999999866443


Q ss_pred             CCc------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          196 KGS------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       196 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ...      ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+...........   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  238 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---  238 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence            221      12345689999999999998999999999999999999999999987543322221211111111100   


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                         .+.+...++    ..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       239 ---~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          239 ---IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             ---HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             ---hHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence               001112222    457888999999999999999999998875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.4e-44  Score=338.59  Aligned_cols=264  Identities=25%  Similarity=0.327  Sum_probs=197.7

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCC--e
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKK--E  112 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~  112 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4568999999999999999999999999999999998643  4455677889999999997 999999999997544  7


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|+||||++ ++|..++..  ..+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 588887754  46899999999999999999999   799999999999999999999999999999764


Q ss_pred             ccC--------------------CCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhh
Q 038118          193 EHA--------------------KGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEV  251 (376)
Q Consensus       193 ~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~  251 (376)
                      ...                    .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            321                    0112234568999999999876 5789999999999999999999999988776555


Q ss_pred             HHHHHHHHHHHhcCCccc--cccC------------------CcCCCCCcH-------------HHHHHHHHHHHHccCC
Q 038118          252 QVYLVQWVWDLYGNGKLL--EAVD------------------PRLCRDFDE-------------QQMECLMIVGLWCAHP  298 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~--~~~~------------------~~~~~~~~~-------------~~~~~l~~li~~cl~~  298 (376)
                      ...+.....    .....  ..+.                  .........             .....+.+++.+||+.
T Consensus       240 ~~~i~~~~~----~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          240 LERIIGVID----FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHC----CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHhcC----CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            444432110    00000  0000                  000000000             1124578899999999


Q ss_pred             CCCCCCChHHHHH
Q 038118          299 DENLRPSIRQVIH  311 (376)
Q Consensus       299 ~p~~RPs~~~vl~  311 (376)
                      ||++|||+.++++
T Consensus       316 dP~~R~t~~e~l~  328 (388)
T 3oz6_A          316 NPNKRISANDALK  328 (388)
T ss_dssp             SGGGSCCHHHHTT
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-44  Score=323.32  Aligned_cols=254  Identities=25%  Similarity=0.324  Sum_probs=206.5

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            457899999999999999999999999999999998654 2334577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++. ....+++..++.++.||+.+|.|||   ++|++||||+|+||+++.++.++|+|||++........
T Consensus        85 e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999884 3456899999999999999999999   79999999999999999999999999999976532221


Q ss_pred             -cceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          198 -SQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       198 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                       .......|+..|+|||++.+..+ +.++||||||+++|+|++|..||..........  ..+.     ....  ..   
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~-----~~~~--~~---  228 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWK-----EKKT--YL---  228 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--HHHH-----TTCT--TS---
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHhh-----hccc--cc---
Confidence             11234568999999999987664 778999999999999999999997655332211  1111     1100  00   


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         .........+.+++.+||+.||.+|||+.++++
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               001122345778999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=339.10  Aligned_cols=266  Identities=19%  Similarity=0.217  Sum_probs=200.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC---CCeEEEEEEcccCChhh-----------HHHHHHHHHHHHhCCCCCccceee
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE---TSSYIAVKRVSKGSKQG-----------IKEYASEVTIISRLRHRNLVQLLG  105 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~  105 (376)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++.......           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4789999999999999999999987   78899999987653211           123667889999999999999999


Q ss_pred             EEee----CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc--
Q 038118          106 WCHE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF--  179 (376)
Q Consensus       106 ~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~--  179 (376)
                      ++..    ....|+||||+ +++|.+++.... .+++..++.++.||+.||.|||   ++||+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9987    77899999999 999999886543 7899999999999999999999   78999999999999999887  


Q ss_pred             eEEEeeCCCccccccCCC------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH
Q 038118          180 NAKIGDFGLARLVEHAKG------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV  253 (376)
Q Consensus       180 ~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~  253 (376)
                      .+||+|||++........      .......||..|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999976532211      11234568999999999999899999999999999999999999996532222111


Q ss_pred             HHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          254 YLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ....  ......  ....+......   ......+.+++.+||+.||++||++.+|++.|+...
T Consensus       271 ~~~~--~~~~~~--~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          271 QTAK--TNLLDE--LPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHH--HHHHHT--TTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHH--Hhhccc--ccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1111  000000  00000000000   012245788899999999999999999999998643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.6e-44  Score=325.62  Aligned_cols=255  Identities=24%  Similarity=0.291  Sum_probs=202.8

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC----hhhHHHHHHHHHHHHhCCCCCccceeeEE--eeCCe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----KQGIKEYASEVTIISRLRHRNLVQLLGWC--HEKKE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~  112 (376)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++....    ......+.+|+.+++.++|+||+++++++  .+...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4589999999999999999999999999999999987542    23457789999999999999999999998  45568


Q ss_pred             EEEEEecCCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          113 LLLVYEYMPNGSLDSHLFK-ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      .++||||++++ |.+++.. ....+++..++.++.||+.||.|||   ++|++||||||+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            99999999876 6666644 3457899999999999999999999   78999999999999999999999999999976


Q ss_pred             cccCC-CcceeeeccCCCCCchhhhccCC--CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          192 VEHAK-GSQTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       192 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ..... ........|+..|+|||++.+..  ++.++||||||+++|+|++|..||...........+..        +. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--------~~-  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--------GS-  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------CC-
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--------CC-
Confidence            54322 22233456899999999987644  37799999999999999999999987654433322221        11 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--Hhcc
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNS  315 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~~  315 (376)
                           ..+....    ...+.+++.+||+.||.+|||+.++++  ++..
T Consensus       230 -----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          230 -----YAIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             -----CCCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             -----CCCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence                 1111222    245778899999999999999999995  4544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=328.31  Aligned_cols=253  Identities=28%  Similarity=0.402  Sum_probs=204.2

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+....  ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34678999999999999999999999999999999997653  2467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+++++|.+++......+++..++.++.||+.||.|||   +.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            999999999998766778999999999999999999999   7999999999999999999999999999997654321 


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......|+..|+|||++.+..++.++||||||+++|+|++|..||...........+..       ...      +.. 
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~------~~~-  245 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-------NPP------PTF-  245 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SCC------CCC-
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------CCC------ccc-
Confidence            122344689999999999988899999999999999999999999976553322211111       100      000 


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .........+.+++.+||+.||.+|||+.++++
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             011112345788999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=337.85  Aligned_cols=271  Identities=21%  Similarity=0.242  Sum_probs=203.2

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-----hHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-----GIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      +....++|++.+.||+|+||.||+|.+..+++.||||++......     ..+.+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            344568999999999999999999999999999999999754221     124678999999999999999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      +..++||||+++ +|..++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999999986 888888766667899999999999999999999   7999999999999999999999999999997


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC--c
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG--K  267 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  267 (376)
                      ...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...........  .
T Consensus       161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            654322 223345689999999998654 588999999999999999999999987765544433332111000000  0


Q ss_pred             ---cccccCCcCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 ---LLEAVDPRLCRDFD-----EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ---~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ....+.........     ......+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence               00000000000000     122356888999999999999999999996

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=342.77  Aligned_cols=271  Identities=23%  Similarity=0.273  Sum_probs=212.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC--eEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK--ELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            468999999999999999999999999999999997542 234567889999999999999999999998755  78999


Q ss_pred             EecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee----cCCceEEEeeCCCcc
Q 038118          117 YEYMPNGSLDSHLFKEN--NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNAKIGDFGLAR  190 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~~  190 (376)
                      |||+++++|.+++....  ..+++..++.++.||+.||.|||   ++||+||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999986533  23899999999999999999999   7999999999999999    778889999999997


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhcc--------CCCCCCCceeechhhHHHHHhCCCCCCCccchhh-HHHHHHHHHH
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATT--------GRASKESDVYSFGIVALEIACGRKPISLTAKEEV-QVYLVQWVWD  261 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~  261 (376)
                      .....  .......||..|+|||++.+        ..++.++|||||||++|+|++|..||........ ...+......
T Consensus       165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            65332  22334568999999998865        4577899999999999999999999975443222 1122221111


Q ss_pred             HhcC----------CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          262 LYGN----------GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       262 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ....          +...-.-+......+.......+..++.+||+.||++||++.++++.+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            1000          00000001111234557788889999999999999999999999987764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.7e-44  Score=327.56  Aligned_cols=249  Identities=26%  Similarity=0.425  Sum_probs=208.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            466999999999999999999999999999999997553 3446789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++.  .+.+++..++.++.||+.||.|||   +.|++||||+|+||+++.++.++|+|||++....... .
T Consensus       101 ~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  174 (303)
T 3a7i_A          101 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I  174 (303)
T ss_dssp             CCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred             eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence            999999999884  356899999999999999999999   7899999999999999999999999999997654322 1


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|..||...........+..        .     ..+.+..
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~-----~~~~~~~  241 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK--------N-----NPPTLEG  241 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------S-----CCCCCCS
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc--------C-----CCCCCcc
Confidence            22345689999999999988899999999999999999999999986654333222111        0     0112222


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+.    ..+..++.+||+.||.+|||+.++++
T Consensus       242 ~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          242 NYS----KPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             SCC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccC----HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            232    45788899999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-44  Score=331.46  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=204.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+..++..|++|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            35789999999999999999999999999999999987766667889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++......+++..++.++.||+.||.|||   +.|++||||||+||+++.++.+||+|||++...... ..
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence            99999999988776777999999999999999999999   789999999999999999999999999987532111 01


Q ss_pred             ceeeeccCCCCCchhhh-----ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          199 QTTVLAGTMGYMAPECA-----TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ......|+..|+|||++     .+..++.++|||||||++|+|++|..||...........+..       .. ....  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~-~~~~--  242 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------SD-PPTL--  242 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SC-CCCC--
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc-------cC-Cccc--
Confidence            12334589999999988     356788999999999999999999999987654333222211       11 0000  


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           .........+.+++.+||+.||++|||+.++++
T Consensus       243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 011122345788999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.2e-44  Score=327.24  Aligned_cols=261  Identities=25%  Similarity=0.347  Sum_probs=201.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHh--CCCCCccceeeEEee----CCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR--LRHRNLVQLLGWCHE----KKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.+  +++.||||++....   ...+..|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            57899999999999999999998  47889999986543   3455667777766  789999999998654    3568


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG-----WEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                      ++||||+++++|.+++.  ...+++..++.++.||+.||.|||..     ++.+|+||||||+|||++.++.+||+|||+
T Consensus        82 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            99999999999999983  35689999999999999999999932     158999999999999999999999999999


Q ss_pred             ccccccCCCcc---eeeeccCCCCCchhhhccC------CCCCCCceeechhhHHHHHhC----------CCCCCCccch
Q 038118          189 ARLVEHAKGSQ---TTVLAGTMGYMAPECATTG------RASKESDVYSFGIVALEIACG----------RKPISLTAKE  249 (376)
Q Consensus       189 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~il~~lltg----------~~pf~~~~~~  249 (376)
                      +..........   .....||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||......
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            97654332221   2234689999999999876      345789999999999999999          8888654322


Q ss_pred             hhH-HHHHHHHHHHhcCCccccccCCcCC-CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          250 EVQ-VYLVQWVWDLYGNGKLLEAVDPRLC-RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       250 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ... ..+....   ....     ..+.+. ..........+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       240 ~~~~~~~~~~~---~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          240 DPSFEDMRKVV---CVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             SCCHHHHHHHH---TTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CcchhhhhHHH---hccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            211 1111110   0011     011111 11233566789999999999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.5e-44  Score=335.26  Aligned_cols=268  Identities=22%  Similarity=0.290  Sum_probs=207.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEee--------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHE--------  109 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------  109 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            478999999999999999999999999999999986542  2234567899999999999999999999977        


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      .+..|+||||+++ +|.+.+......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4568999999975 777777666677999999999999999999999   799999999999999999999999999999


Q ss_pred             cccccCCC---cceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          190 RLVEHAKG---SQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       190 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ........   .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..........
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            76542221   22334568999999998876 457999999999999999999999998877655554444322111000


Q ss_pred             C-------ccccccC--CcCCCCCcHHH-----HHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 G-------KLLEAVD--PRLCRDFDEQQ-----MECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 ~-------~~~~~~~--~~~~~~~~~~~-----~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .       .....+.  ...........     ...+.+++.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0       0000000  00000001111     234788999999999999999999995

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-44  Score=329.30  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEe-eCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCH-EKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~  114 (376)
                      ..+|++.+.||+|+||.||+|.+..+   ...|++|.+... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            46788999999999999999997543   346899998754 4455678999999999999999999999864 556889


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+++++|.+++......+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999776777899999999999999999999   79999999999999999999999999999976533


Q ss_pred             CCC---cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          195 AKG---SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       195 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ...   .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+..        +..  
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~--------~~~--  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRR--  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT--------TCC--
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc--------CCC--
Confidence            221   12234457788999999999999999999999999999999 6677766554444332221        110  


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                         ......    ....+.+++.+||+.||++|||+.++++.|+.
T Consensus       251 ---~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          251 ---LLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             ---CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               011111    22457889999999999999999999998875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=339.27  Aligned_cols=265  Identities=23%  Similarity=0.297  Sum_probs=201.6

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhh-HHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG-IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999999999999999997543221 12455799999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++ +|.+++......+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++....... ..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~  156 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT  156 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence            974 888888777778999999999999999999999   7999999999999999999999999999987543221 22


Q ss_pred             eeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC-----
Q 038118          200 TTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD-----  273 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  273 (376)
                      .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......... ........     
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE-ETWPGILSNEEFK  235 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT-TTSTTGGGCHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh-Hhchhhhcchhhc
Confidence            234457999999999876 56899999999999999999999999887765554444332211000 00000000     


Q ss_pred             ----CcCCCC----CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 ----PRLCRD----FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ----~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          +.....    ........+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                000000    00112245788999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-44  Score=326.89  Aligned_cols=255  Identities=27%  Similarity=0.375  Sum_probs=204.1

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCC---eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE-EEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETS---SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL-LLV  116 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv  116 (376)
                      .|++.+.||+|+||.||+|.+..++   ..||+|.+... .....+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999975544   37999998754 445567899999999999999999999999866554 999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+.+++|.+++......+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|||++.......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999776778899999999999999999999   7899999999999999999999999999997543221


Q ss_pred             ---CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCC-CCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          197 ---GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR-KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       197 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                         ........++..|+|||.+.+..++.++|||||||++|+|++|. +||......+....+..        ..     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--------~~-----  245 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ--------GR-----  245 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT--------TC-----
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc--------CC-----
Confidence               11223345788999999999989999999999999999999955 55555444333222211        11     


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      .......    ....+.+++.+||+.||.+|||+.++++.|+..
T Consensus       246 ~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          246 RLPQPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0111111    224578899999999999999999999988753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=357.20  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=203.1

Q ss_pred             CCcCC-ccccCCCeeEEEEEEc--CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           43 FNDDQ-KLGQGGFGGVYKGFFR--ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        43 y~~~~-~lg~G~~g~vy~a~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +.+.. .||+|+||.||+|.+.  .++..||||++... .....+.|.+|+.+++.++||||+++++++.. +..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33334 7999999999999875  35678999999765 33456789999999999999999999999976 56899999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++|+|.+++......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            99999999999776777999999999999999999999   799999999999999999999999999999865432221


Q ss_pred             --ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          199 --QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       199 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                        ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +..       
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~--------~~~-------  557 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------GKR-------  557 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT--------TCC-------
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--------CCC-------
Confidence              1122335689999999999999999999999999999998 9999988765554333221        111       


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        ..........+.+++.+||+.||++||++.+|++.|+.
T Consensus       558 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          558 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              11112233568889999999999999999999998875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-44  Score=339.15  Aligned_cols=252  Identities=21%  Similarity=0.285  Sum_probs=193.0

Q ss_pred             hhCCCcC-CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHH-hCCCCCccceeeEEee----CCeE
Q 038118           40 TNDFNDD-QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIIS-RLRHRNLVQLLGWCHE----KKEL  113 (376)
Q Consensus        40 ~~~y~~~-~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~  113 (376)
                      .++|.+. +.||.|+||.||+|.+..+++.||||++...     ..+.+|+.++. ..+||||+++++++..    ...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567776 6899999999999999999999999999643     34567888874 4579999999999875    5678


Q ss_pred             EEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~  189 (376)
                      |+||||++||+|.+++.... ..+++..++.++.||+.||.|||   +.||+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999986543 46899999999999999999999   799999999999999998   788999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....    .+...
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~  285 (400)
T 1nxk_A          212 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYE  285 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCC
T ss_pred             cccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCccc
Confidence            754322  223455689999999999989999999999999999999999999976543322111111000    01000


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        +.......    ....+.+++.+||+.||.+|||+.++++
T Consensus       286 --~~~~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          286 --FPNPEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             --CCTTTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCCccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              00011112    2345788999999999999999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.1e-44  Score=349.14  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=204.2

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...++|++.+.||+|+||.||+|.+..++..||+|++....  ......+.+|+.+++.++||||+++++++.+....|+
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34678999999999999999999999999999999997642  3335678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC---ceEEEeeCCCcccc
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGLARLV  192 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~  192 (376)
                      ||||+++++|.+.+... ..+++..++.++.||+.||.|||   ++||+||||||+|||++..   +.+||+|||++...
T Consensus       114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999999888554 56899999999999999999999   7999999999999999764   45999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ...  .......||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+..        +..  ..
T Consensus       190 ~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------~~~--~~  256 (494)
T 3lij_A          190 ENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--------GKY--TF  256 (494)
T ss_dssp             BTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TCC--CC
T ss_pred             CCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCC--CC
Confidence            432  2234456999999999886 5689999999999999999999999988765554433322        110  01


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +......+    ...+.+++.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          257 DSPEWKNV----SEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CSGGGTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CchhcccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11111222    245788899999999999999999984

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-43  Score=326.93  Aligned_cols=279  Identities=22%  Similarity=0.298  Sum_probs=211.3

Q ss_pred             hhhhcCCCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC--CC
Q 038118           20 DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL--RH   97 (376)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h   97 (376)
                      ++-....+...++........++|++.+.||+|+||.||+|.+.  +..||||++....   ...+..|.+++..+  +|
T Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h   90 (337)
T 3mdy_A           16 EQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRH   90 (337)
T ss_dssp             HHHHHHCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCC
T ss_pred             cccccCCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcC
Confidence            33334445556667777778899999999999999999999986  7889999986543   23445566666554  89


Q ss_pred             CCccceeeEEeeC----CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------ceEe
Q 038118           98 RNLVQLLGWCHEK----KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ--------CVVH  165 (376)
Q Consensus        98 ~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~--------~i~H  165 (376)
                      |||+++++++...    ...++||||+++++|.+++..  ..+++..++.++.|++.||.|||   +.        ||+|
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH  165 (337)
T 3mdy_A           91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAH  165 (337)
T ss_dssp             TTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEEC
T ss_pred             CCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEe
Confidence            9999999999887    789999999999999999854  36899999999999999999999   66        9999


Q ss_pred             ecccCCCeeecCCceEEEeeCCCccccccCCCcc---eeeeccCCCCCchhhhccCCCCCC------CceeechhhHHHH
Q 038118          166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ---TTVLAGTMGYMAPECATTGRASKE------SDVYSFGIVALEI  236 (376)
Q Consensus       166 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~il~~l  236 (376)
                      |||||+|||++.++.+||+|||++..........   .....||+.|+|||++.+...+.+      +|||||||++|+|
T Consensus       166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el  245 (337)
T 3mdy_A          166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV  245 (337)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence            9999999999999999999999997553322211   123468999999999987776665      9999999999999


Q ss_pred             HhC----------CCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC-CcHHHHHHHHHHHHHccCCCCCCCCC
Q 038118          237 ACG----------RKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD-FDEQQMECLMIVGLWCAHPDENLRPS  305 (376)
Q Consensus       237 ltg----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs  305 (376)
                      ++|          ..||..............   ......    ...+.+... ........+.+++.+||+.||.+|||
T Consensus       246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps  318 (337)
T 3mdy_A          246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR---EIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT  318 (337)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHH---HHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             HhccCcccccccccccHhhhcCCCCchhhhH---HHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC
Confidence            999          667654332221111111   000011    111111111 12256778999999999999999999


Q ss_pred             hHHHHHHhcc
Q 038118          306 IRQVIHVLNS  315 (376)
Q Consensus       306 ~~~vl~~L~~  315 (376)
                      +.+|++.|+.
T Consensus       319 ~~ell~~L~~  328 (337)
T 3mdy_A          319 ALRVKKTLAK  328 (337)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-44  Score=353.36  Aligned_cols=254  Identities=27%  Similarity=0.348  Sum_probs=209.1

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3567999999999999999999999999999999996532   2234668899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          116 VYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ||||++||+|.+++.... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||++.....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999886543 34899999999999999999999   78999999999999999999999999999976543


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......          ...
T Consensus       339 ~--~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----------~~~  406 (576)
T 2acx_A          339 G--QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------VPE  406 (576)
T ss_dssp             T--CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----------CCC
T ss_pred             C--ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----------ccc
Confidence            2  2234457999999999999888999999999999999999999999876433222222221111          011


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      .+...+    ...+.+++.+||+.||.+||     ++.+|++
T Consensus       407 ~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            112222    34578899999999999999     7888884

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.1e-44  Score=333.53  Aligned_cols=257  Identities=27%  Similarity=0.396  Sum_probs=204.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEE-----EcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGF-----FRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~-----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.     +..++..||||.+... .......+.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            5899999999999999999999     4556788999999754 445566789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEe
Q 038118          114 LLVYEYMPNGSLDSHLFKEN------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIG  184 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~  184 (376)
                      |+||||+++++|.+++....      ..+++..++.++.||+.||.|||   +.||+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999986543      35889999999999999999999   789999999999999984   4469999


Q ss_pred             eCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHH
Q 038118          185 DFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       185 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      |||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.      
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh------
Confidence            9999875432221 12233457889999999998899999999999999999998 999998765443322221      


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                        .+..     +.....    ....+.+++.+||+.||.+||++.+|++.|...
T Consensus       260 --~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          260 --SGGR-----MDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             --TTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cCCC-----CCCCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence              1110     111122    234578899999999999999999999988753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-44  Score=349.33  Aligned_cols=252  Identities=25%  Similarity=0.335  Sum_probs=206.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            468899999999999999999999999999999998643  222356789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec---CCceEEEeeCCCccccc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD---LNFNAKIGDFGLARLVE  193 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~  193 (376)
                      |||+.+++|.+.+... +.+++..++.++.||+.||.|||   ++||+||||||+|||++   .++.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            9999999999888554 56899999999999999999999   79999999999999995   45679999999997653


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..  .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+..        +...  .+
T Consensus       176 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------~~~~--~~  242 (486)
T 3mwu_A          176 QN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--------GKYA--FD  242 (486)
T ss_dssp             CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TCCC--SC
T ss_pred             CC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCCC--CC
Confidence            32  22344569999999999875 589999999999999999999999987765544333322        1100  00


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....    .....+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 LPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             SGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00111    22345788999999999999999999996

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9e-44  Score=334.26  Aligned_cols=258  Identities=21%  Similarity=0.315  Sum_probs=208.7

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--------hhhHHHHHHHHHHHHhC-CCCCcccee
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--------KQGIKEYASEVTIISRL-RHRNLVQLL  104 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~  104 (376)
                      .......++|++.+.||.|+||.||+|.+..+|+.||||++....        ....+.+.+|+.+++.+ .||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            444556688999999999999999999999889999999987543        12245678999999999 799999999


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                      +++......|+||||+++++|.+++.. ...+++..++.++.||+.||.|||   +.|++||||||+|||++.++.++|+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence            999999999999999999999998854 356899999999999999999999   7899999999999999999999999


Q ss_pred             eCCCccccccCCCcceeeeccCCCCCchhhhcc------CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHH
Q 038118          185 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATT------GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW  258 (376)
Q Consensus       185 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  258 (376)
                      |||++......  .......||+.|+|||++.+      ..++.++|||||||++|+|++|..||...........+.. 
T Consensus       243 DfG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~-  319 (365)
T 2y7j_A          243 DFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME-  319 (365)
T ss_dssp             CCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-
T ss_pred             ecCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-
Confidence            99998765432  22334568999999998863      3578899999999999999999999977554333222221 


Q ss_pred             HHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                             +...  .........    ...+.+++.+||+.||++|||+.++++
T Consensus       320 -------~~~~--~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          320 -------GQYQ--FSSPEWDDR----SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -------TCCC--CCHHHHSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------CCCC--CCCcccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   1000  000000111    235788999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1e-43  Score=323.31  Aligned_cols=249  Identities=26%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee----CCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE----KKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~  113 (376)
                      ...|++.+.||+|+||.||+|.+..++..|++|.+...  .....+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            34588888999999999999999999999999998754  45556789999999999999999999999875    4568


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCCeeec-CCceEEEeeCCCcc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSNIMLD-LNFNAKIGDFGLAR  190 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~  190 (376)
                      ++||||+++++|.+++.. .+.+++..++.++.||+.||.|||   +.+  ++||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999998854 356899999999999999999999   677  99999999999997 78899999999996


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ....   .......|++.|+|||++. +.++.++|||||||++|+|++|..||............       ...+....
T Consensus       181 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~~~~  249 (290)
T 1t4h_A          181 LKRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKPA  249 (290)
T ss_dssp             GCCT---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-------HTTTCCCG
T ss_pred             cccc---cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH-------HhccCCcc
Confidence            5432   2234456899999999876 45899999999999999999999999765432221111       01111111


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ......    ...+.+++.+||+.||.+|||+.++++
T Consensus       250 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 ----SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                111111    235788999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.2e-44  Score=336.67  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=207.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            57899999999999999999999999999999999865 44456788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+++++|.+++... +.+++..++.++.||+.+|.|||+  ..||+||||||+|||++.++.++|+|||++......   
T Consensus       112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            99999999988543 468999999999999999999993  248999999999999999999999999998654321   


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC--------Cc---
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN--------GK---  267 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~---  267 (376)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..........        +.   
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            2233468999999999999999999999999999999999999998766544322211000000000        00   


Q ss_pred             ------------------cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 ------------------LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                                        ......+...   .......+.+++.+||+.||++|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCC---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCC---cccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                              0000000000   1112345788999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=356.76  Aligned_cols=262  Identities=30%  Similarity=0.443  Sum_probs=212.8

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  112 (376)
                      .+.++...++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.|.+|+.+++.++|+||+++++++.+ +.
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            34455567889999999999999999999986 46699999976543 34679999999999999999999999876 67


Q ss_pred             EEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      .|+||||+++++|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            89999999999999999653 356899999999999999999999   79999999999999999999999999999976


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.        .+..  
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~--------~~~~--  482 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE--------RGYR--  482 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH--------TTCC--
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------cCCC--
Confidence            53221111223346778999999998999999999999999999999 999998766544332221        1110  


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                             ..........+.+++.+||+.||++|||+.+|++.|+...
T Consensus       483 -------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          483 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                   1111123345788999999999999999999999998654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=337.05  Aligned_cols=264  Identities=26%  Similarity=0.412  Sum_probs=209.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEE----cCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC--eE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFF----RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK--EL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~  113 (376)
                      .++|++.+.||+|+||.||+|.+    ..+++.||+|++........+.+.+|+.+++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            56799999999999999999984    5678999999998877677788999999999999999999999986544  78


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++......+++..++.++.||+.||.+||   ++|++||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999777677999999999999999999999   7999999999999999999999999999998654


Q ss_pred             cCCCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH--------HHHHHHHHHHh
Q 038118          194 HAKGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ--------VYLVQWVWDLY  263 (376)
Q Consensus       194 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~--------~~~~~~~~~~~  263 (376)
                      ......  .....++..|+|||++.+..++.++|||||||++|+|++|..||......-..        ...........
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            332211  12234667899999999888999999999999999999999998643211100        00000011111


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ..+..     ...    .......+..++.+||+.||++|||+.+|++.|+.
T Consensus       277 ~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          277 KNNGR-----LPR----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HTTCC-----CCC----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCCC-----CCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11110     111    12233458889999999999999999999998864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-44  Score=337.46  Aligned_cols=262  Identities=20%  Similarity=0.270  Sum_probs=200.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK------  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  111 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            57899999999999999999999999999999999653  3444677899999999999999999999997653      


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      .+|+||||+ +++|.+++..  ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 7899888854  46899999999999999999999   79999999999999999999999999999976


Q ss_pred             cccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH----hcC-
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL----YGN-  265 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~~~-  265 (376)
                      ...    ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......    ... 
T Consensus       178 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          178 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            432    2334568999999999877 679999999999999999999999998876555444433221100    000 


Q ss_pred             --C---cccccc---CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 --G---KLLEAV---DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 --~---~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        .   .....+   ...-...........+.+++.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence              0   000000   000000111122345788999999999999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=322.75  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=200.5

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMP  121 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  121 (376)
                      +|.....||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            34555699999999999999999999999999987766666789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCCCccccccCCCc
Q 038118          122 NGSLDSHLFKEN--NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       122 ~~sL~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++|.+++....  ..+++..++.++.||+.||.|||   +.|++||||||+||+++. ++.+||+|||++....... .
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence            999999886543  34678889999999999999999   789999999999999987 8899999999997653321 1


Q ss_pred             ceeeeccCCCCCchhhhccCC--CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          199 QTTVLAGTMGYMAPECATTGR--ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ......|+..|+|||++.+..  ++.++||||||+++|+|++|..||..............    ..       ...+.+
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~-------~~~~~~  247 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG----MF-------KVHPEI  247 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH----HH-------CCCCCC
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc----cc-------cccccc
Confidence            223456899999999987653  78999999999999999999999975443222111100    00       011222


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+    ...+.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 PESM----SAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2222    345788899999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.8e-44  Score=350.22  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=209.2

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+|+.++++++||||+++++++.+.+..|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34678999999999999999999999999999999986542   334678899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee---cCCceEEEeeCCCccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML---DLNFNAKIGDFGLARL  191 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~  191 (376)
                      +||||+.+++|.+.+.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||+   +.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999988854 456899999999999999999999   7999999999999999   5678899999999976


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+..        +...  
T Consensus       179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------~~~~--  245 (484)
T 3nyv_A          179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------GKYT--  245 (484)
T ss_dssp             BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCCC--
T ss_pred             ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--------CCCC--
Confidence            54322  2234468999999999875 689999999999999999999999987765544333322        1100  


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......    ......+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 FELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            000001    122345788999999999999999999994

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=339.98  Aligned_cols=256  Identities=29%  Similarity=0.453  Sum_probs=198.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEe-eCCeEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCH-EKKELLL  115 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l  115 (376)
                      ..|++.+.||+|+||.||+|.+..+   ...||+|.+... .....+.|.+|+.+++.++||||+++++++. .++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            3467778999999999999987543   346899998754 3445678999999999999999999999875 4568899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++......
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999999776677899999999999999999999   799999999999999999999999999999765332


Q ss_pred             CCc---ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          196 KGS---QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       196 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ...   ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +..  .
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~--------~~~--~  315 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRR--L  315 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT--------TCC--C
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc--------CCC--C
Confidence            211   1233456788999999999999999999999999999999 7888876655444332221        110  0


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ..+   ..    ....+.+++.+||+.||++|||+.+|++.|+..
T Consensus       316 ~~p---~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          316 LQP---EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CCC---TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111   11    224578889999999999999999999988753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.3e-44  Score=348.74  Aligned_cols=254  Identities=24%  Similarity=0.314  Sum_probs=206.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ......+..|+.+++.++||||+++++++.....+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            378899999999999999999999999999999997542   23356788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          117 YEYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |||++||+|..++...   ...+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999888653   346899999999999999999999   7999999999999999999999999999998654


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....   .. .      
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~---~~-~------  409 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL---EQ-A------  409 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH---HC-C------
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh---hc-c------
Confidence            3221 23345799999999999998999999999999999999999999987543222111211111   00 0      


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI-----RQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  311 (376)
                      ..+...    ....+.+++.+||+.||.+||++     .+|++
T Consensus       410 ~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 VTYPDK----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCCCTT----SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             cCCCcc----cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            111122    23457888999999999999975     56663

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-43  Score=323.43  Aligned_cols=255  Identities=22%  Similarity=0.285  Sum_probs=207.7

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---------hhhHHHHHHHHHHHHhCC-CCCccceeeE
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---------KQGIKEYASEVTIISRLR-HRNLVQLLGW  106 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~  106 (376)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++....         ....+.+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            344689999999999999999999999999999999997543         223456889999999996 9999999999


Q ss_pred             EeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       107 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                      +......++||||+++++|.+++.. ...+++..++.++.||+.||.|||   ++|++||||+|+||+++.++.+||+||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999998854 356899999999999999999999   799999999999999999999999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhc------cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECAT------TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      |++.......  ......|+..|+|||++.      ...++.++||||||+++|+|++|..||...........+..   
T Consensus       169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---  243 (298)
T 1phk_A          169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS---  243 (298)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred             cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc---
Confidence            9997654322  233456899999999885      45678899999999999999999999987654433322221   


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           +..      .............+.+++.+||+.||.+|||+.++++
T Consensus       244 -----~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 -----GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -----TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                 100      0001111123345888999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.1e-44  Score=338.20  Aligned_cols=250  Identities=21%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCC--CCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLR--HRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|.+.. ++.||||++...  .......+.+|+.+++.++  |+||+++++++...+.+|+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            4569999999999999999999876 888999998754  4455678999999999997  5999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||| +.+++|.+++.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++ ++.+||+|||++......
T Consensus       134 v~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            999 568899998865 457889999999999999999999   89999999999999995 578999999999865432


Q ss_pred             CCc-ceeeeccCCCCCchhhhcc-----------CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          196 KGS-QTTVLAGTMGYMAPECATT-----------GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       196 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      ... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||........  .+..    ..
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~~~----~~  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHA----II  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHH----HH
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--HHHH----Hh
Confidence            221 2234569999999999865           3688899999999999999999999976432211  1111    11


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      . ...    ........    ...+.+++.+||+.||.+|||+.++++
T Consensus       282 ~-~~~----~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 D-PNH----EIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             C-TTS----CCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C-ccc----cCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1 100    01111111    245788999999999999999999995

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-44  Score=328.53  Aligned_cols=258  Identities=25%  Similarity=0.355  Sum_probs=200.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-CC--eEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-TS--SYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|.+.. ++  ..||+|++...   .....+.+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            5789999999999999999998643 22  36899988754   3345678999999999999999999999998765 8


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||+++++|.+++......+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            9999999999999999776677999999999999999999999   7899999999999999999999999999997654


Q ss_pred             cCCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          194 HAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       194 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .....  ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+..       ...   
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------~~~---  242 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------EGE---  242 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------SCC---
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc-------cCC---
Confidence            33221  1223446778999999988889999999999999999999 9999987664433222211       110   


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                        ......    .....+.+++.+||..||.+|||+.++++.|....
T Consensus       243 --~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 --RLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             --CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --CCCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence              011111    22345788999999999999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=335.19  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=191.8

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEe------
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCH------  108 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~------  108 (376)
                      +.....+|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++.++. ||||+++++++.      
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3344568999999999999999999999999999999998777777788999999999996 999999999984      


Q ss_pred             --eCCeEEEEEecCCCCChhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCCeeecCCceEE
Q 038118          109 --EKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSNIMLDLNFNAK  182 (376)
Q Consensus       109 --~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~~~~~~k  182 (376)
                        ....+++||||+. |+|.+++..  ..+.+++..++.++.||+.||.|||   +.+  |+||||||+|||++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence              3456899999996 688887754  4567999999999999999999999   788  99999999999999999999


Q ss_pred             EeeCCCccccccCCCcc-----------eeeeccCCCCCchhhh---ccCCCCCCCceeechhhHHHHHhCCCCCCCccc
Q 038118          183 IGDFGLARLVEHAKGSQ-----------TTVLAGTMGYMAPECA---TTGRASKESDVYSFGIVALEIACGRKPISLTAK  248 (376)
Q Consensus       183 l~Dfg~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~  248 (376)
                      |+|||++..........           .....||+.|+|||++   .+..++.++|||||||++|+|++|..||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998654322211           1134589999999998   566788999999999999999999999975432


Q ss_pred             hhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          249 EEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .....            ....    .......    ...+..++.+||+.||.+|||+.++++.|....
T Consensus       259 ~~~~~------------~~~~----~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          259 LRIVN------------GKYS----IPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             -------------------CC----CCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhc------------Cccc----CCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            21100            0000    0001111    123678899999999999999999999887643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9e-44  Score=348.21  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=206.0

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-------------hhHHHHHHHHHHHHhCCCCCccceee
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-------------QGIKEYASEVTIISRLRHRNLVQLLG  105 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~  105 (376)
                      ..++|++.++||+|+||.||+|.+..++..||+|++.....             ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            46899999999999999999999999999999999875421             23567889999999999999999999


Q ss_pred             EEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc---eEE
Q 038118          106 WCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF---NAK  182 (376)
Q Consensus       106 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~k  182 (376)
                      ++.+....|+||||+++++|.+.+... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            999999999999999999999988554 56899999999999999999999   79999999999999998876   699


Q ss_pred             EeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       183 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      |+|||++......  .......||+.|+|||++. +.++.++|||||||++|+|++|..||......+....+..     
T Consensus       190 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-----  261 (504)
T 3q5i_A          190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-----  261 (504)
T ss_dssp             ECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----
T ss_pred             EEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----
Confidence            9999999765432  2233456999999999887 4689999999999999999999999988765554443332     


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         +...  .+......    ....+.+++.+||+.||.+|||+.++++
T Consensus       262 ---~~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          262 ---GKYY--FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ---CCCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CCCC--CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               1100  00000011    2245788999999999999999999994

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-43  Score=343.46  Aligned_cols=202  Identities=24%  Similarity=0.346  Sum_probs=160.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee-----CCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE-----KKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~  112 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.+|+.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            47899999999999999999999999999999998653  44456789999999999999999999999843     357


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|+||||+ +++|.+++. ....+++..++.++.||+.||.|||   +.||+||||||+||||+.++.+||+|||+++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            99999998 568888774 4567999999999999999999999   789999999999999999999999999999865


Q ss_pred             ccCCC--------------------------cceeeeccCCCCCchhhh-ccCCCCCCCceeechhhHHHHHh-------
Q 038118          193 EHAKG--------------------------SQTTVLAGTMGYMAPECA-TTGRASKESDVYSFGIVALEIAC-------  238 (376)
Q Consensus       193 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~~llt-------  238 (376)
                      .....                          .......||+.|+|||++ .+..++.++|||||||++|+|++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            42211                          123445689999999986 45679999999999999999999       


Q ss_pred             ----CCCCCCCc
Q 038118          239 ----GRKPISLT  246 (376)
Q Consensus       239 ----g~~pf~~~  246 (376)
                          |..+|.+.
T Consensus       287 ~~~~~~p~f~g~  298 (458)
T 3rp9_A          287 YHADRGPLFPGS  298 (458)
T ss_dssp             SGGGCCCSCC--
T ss_pred             ccccccccCCCC
Confidence                66667554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.9e-44  Score=340.69  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=198.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC------CeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK------KEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~  113 (376)
                      ..+|++.+.||+|+||.||+|++..+++.||||++.....    .+.+|+++++.++|+||+++++++...      ..+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3479999999999999999999999999999999875432    234699999999999999999988532      247


Q ss_pred             EEEEecCCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-ceEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~  189 (376)
                      ++||||+++ +|.+.+.   .....+++..++.++.||+.||.|||   ++||+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            899999976 5555443   34567999999999999999999999   8999999999999999955 67899999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-------H
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-------D  261 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-------~  261 (376)
                      +......  ......||..|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.....       .
T Consensus       205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8653322  22345689999999998765 689999999999999999999999988765554444333210       0


Q ss_pred             HhcCCccccccCCcCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 LYGNGKLLEAVDPRLCR-----DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .. ........-+.+..     .+.......+.+|+.+||+.||.+|||+.++++
T Consensus       283 ~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00 00000000011100     011122356889999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.8e-44  Score=342.08  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=194.6

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--------hhhHHHHHHHHHHHHhCCCCCccceeeEEee
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--------KQGIKEYASEVTIISRLRHRNLVQLLGWCHE  109 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  109 (376)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++....        ......+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            44689999999999999999999999999999999987531        1122357899999999999999999999854


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc---eEEEeeC
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF---NAKIGDF  186 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~---~~kl~Df  186 (376)
                       +..|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||   +++|+||||||+|||++.++   .+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             568999999999999988854 457899999999999999999999   78999999999999997654   4999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhcc---CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      |++......  .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||..............      
T Consensus       287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~------  358 (419)
T 3i6u_A          287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT------  358 (419)
T ss_dssp             STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH------
T ss_pred             ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh------
Confidence            999865432  22344568999999999853   5678899999999999999999999976543322111110      


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .+...  ..+.....    ....+.+++.+||+.||++|||+.++++
T Consensus       359 -~~~~~--~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          359 -SGKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -TTCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -cCCCC--CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             11000  00111111    2345788999999999999999999996

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6e-44  Score=322.29  Aligned_cols=248  Identities=23%  Similarity=0.353  Sum_probs=198.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999999899999999986532   23356788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++++|.+++... +.+++..++.++.||+.||.|||   ++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999988554 46899999999999999999999   7899999999999999999999999999987653321


Q ss_pred             CcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                        ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..        +.      ..
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~~------~~  229 (276)
T 2h6d_A          166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--------GV------FY  229 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------CC
T ss_pred             --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--------Cc------cc
Confidence              2234458999999999887665 6899999999999999999999987654433222211        10      01


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +...+    ...+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          230 IPEYL----NRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cchhc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11122    245788899999999999999999996

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-44  Score=330.81  Aligned_cols=263  Identities=23%  Similarity=0.383  Sum_probs=188.3

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      +....++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            3445689999999999999999999998889999999987543 334567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCC
Q 038118          115 LVYEYMPNGSLDSHLFK-------ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFG  187 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~-------~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  187 (376)
                      +||||+++++|.+++..       ....+++..++.++.||+.||.|||   +.|++||||+|+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999998853       2456899999999999999999999   7899999999999999999999999999


Q ss_pred             CccccccCCC----cceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          188 LARLVEHAKG----SQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       188 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      ++........    .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............     
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----  241 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-----  241 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT-----
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc-----
Confidence            9875532211    11234568999999999865 5689999999999999999999999987654433221110     


Q ss_pred             hcCCc-cc-cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNGK-LL-EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~-~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .... .. ...++.....+    ...+.+++.+||+.||.+|||+.++++
T Consensus       242 -~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 -NDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -SSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -cCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             0000 00 00111122222    245788899999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.3e-43  Score=330.41  Aligned_cols=263  Identities=21%  Similarity=0.239  Sum_probs=198.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK------  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  111 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999999999999999999753  3445677889999999999999999999997654      


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..|+||||+++ +|.+.+.   ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 6777763   34889999999999999999999   78999999999999999999999999999976


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHH-------------
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW-------------  258 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-------------  258 (376)
                      ....  .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...             
T Consensus       177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            5322  1233456899999999999989999999999999999999999999877654433322210             


Q ss_pred             --HHHHhcCCccc-----cccCCcC----CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          259 --VWDLYGNGKLL-----EAVDPRL----CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       259 --~~~~~~~~~~~-----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ...........     ..+-+..    ...........+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence              00000000000     0000000    00111233567899999999999999999999995

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-43  Score=322.11  Aligned_cols=245  Identities=24%  Similarity=0.345  Sum_probs=200.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            457899999999999999999999999999999998764  333456788999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC--------------
Q 038118          116 VYEYMPNGSLDSHLFKE---NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--------------  178 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~--------------  178 (376)
                      ||||+++++|.+++...   ...+++..++.++.||+.||.|||   ++||+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999988653   256899999999999999999999   7999999999999999844              


Q ss_pred             -----ceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhH
Q 038118          179 -----FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQ  252 (376)
Q Consensus       179 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~  252 (376)
                           ..++|+|||++.......     ...||..|+|||++.+. .++.++|||||||++|+|++|..++.....   .
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~  237 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W  237 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence                 479999999997654322     23489999999999766 566899999999999999999987754321   1


Q ss_pred             HHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+        ..+..     +.+...++    ..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~--------~~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 HEI--------RQGRL-----PRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHH--------HTTCC-----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH--------HcCCC-----CCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            111        11111     12222233    45788899999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-43  Score=339.78  Aligned_cols=199  Identities=27%  Similarity=0.388  Sum_probs=169.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  112 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+++.+|+.+|+.++|+||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            57899999999999999999999999999999999753  444567889999999999999999999999766     57


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .|+||||+. ++|.+++. ....+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            999999986 58988884 4567999999999999999999999   789999999999999999999999999999865


Q ss_pred             ccCCC---------------------cceeeeccCCCCCchhhh-ccCCCCCCCceeechhhHHHHHhCCCCC
Q 038118          193 EHAKG---------------------SQTTVLAGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       193 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~~lltg~~pf  243 (376)
                      .....                     .......||..|+|||++ ....++.++|||||||++|+|++|..||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            43221                     123456789999999986 5566999999999999999999854444

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=332.66  Aligned_cols=261  Identities=25%  Similarity=0.387  Sum_probs=202.6

Q ss_pred             ccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 038118           30 RFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCH  108 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  108 (376)
                      .+...++....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            34445555667899999999999999999999999999999999876533 246788999999999 7999999999997


Q ss_pred             e------CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceE
Q 038118          109 E------KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA  181 (376)
Q Consensus       109 ~------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~  181 (376)
                      .      .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||   +.|++||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCE
Confidence            6      56899999999999999998653 356899999999999999999999   7899999999999999999999


Q ss_pred             EEeeCCCccccccCCCcceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHH
Q 038118          182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV  256 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~  256 (376)
                      ||+|||++....... .......|+..|+|||++.     +..++.++|||||||++|+|++|..||...........+.
T Consensus       169 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  247 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             EEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence            999999987654321 1223446899999999986     5668899999999999999999999997655433222111


Q ss_pred             HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .       .. ...    .....+    ...+.+++.+||..||.+|||+.++++
T Consensus       248 ~-------~~-~~~----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          248 R-------NP-APR----LKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             H-------SC-CCC----CSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c-------Cc-ccc----CCcccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1       11 000    011122    245788899999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.9e-44  Score=323.41  Aligned_cols=250  Identities=30%  Similarity=0.435  Sum_probs=199.7

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-CeEEEE
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-KELLLV  116 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv  116 (376)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++....  ..+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            34689999999999999999999885  7889999997654  356789999999999999999999997554 578999


Q ss_pred             EecCCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |||+++++|.+++..... .+++..++.++.|++.+|.|||   ++|++||||||+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999998865432 3789999999999999999999   799999999999999999999999999998754322


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                          .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+.        .+     ...
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~--------~~-----~~~  233 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--------KG-----YKM  233 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT--------TT-----CCC
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------cC-----CCC
Confidence                223347889999999998899999999999999999998 999998766544332221        11     011


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ....    .....+.+++.+||+.||.+|||+.++++.|+.
T Consensus       234 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          234 DAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence            1122    223457888999999999999999999998864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.9e-44  Score=337.77  Aligned_cols=266  Identities=21%  Similarity=0.273  Sum_probs=201.3

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee------
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE------  109 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------  109 (376)
                      ++...++|++.+.||+|+||.||+|.+..+++.||||++......    ..+|+.+++.++||||+++++++..      
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            445678999999999999999999999999999999998755322    2469999999999999999999843      


Q ss_pred             --------------------------------CCeEEEEEecCCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHH
Q 038118          110 --------------------------------KKELLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLASGLLY  154 (376)
Q Consensus       110 --------------------------------~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~  154 (376)
                                                      ....++||||+++ +|.+.+.   .....+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999985 7766664   345679999999999999999999


Q ss_pred             HHhCCCCceEeecccCCCeeec-CCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhh
Q 038118          155 LQEGWEQCVVHRDIKSSNIMLD-LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIV  232 (376)
Q Consensus       155 Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~i  232 (376)
                      ||   +.||+||||||+|||++ .++.+||+|||++.......  ......||..|+|||++.+. .++.++|||||||+
T Consensus       157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99   89999999999999997 68899999999997653322  23345689999999998765 48999999999999


Q ss_pred             HHHHHhCCCCCCCccchhhHHHHHHHHHHHh------cCCccccccCCcCC-----CCCcHHHHHHHHHHHHHccCCCCC
Q 038118          233 ALEIACGRKPISLTAKEEVQVYLVQWVWDLY------GNGKLLEAVDPRLC-----RDFDEQQMECLMIVGLWCAHPDEN  301 (376)
Q Consensus       233 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~  301 (376)
                      +|+|++|..||.+....+....+........      .........-+.+.     ..+.......+.+++.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999988776555444433211000      00000000000000     001112334578899999999999


Q ss_pred             CCCChHHHHH
Q 038118          302 LRPSIRQVIH  311 (376)
Q Consensus       302 ~RPs~~~vl~  311 (376)
                      +|||+.++++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999984

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-44  Score=333.30  Aligned_cols=262  Identities=26%  Similarity=0.399  Sum_probs=204.9

Q ss_pred             hhCC-CcCCccccCCCeeEEEEEE----cCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CC
Q 038118           40 TNDF-NDDQKLGQGGFGGVYKGFF----RETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KK  111 (376)
Q Consensus        40 ~~~y-~~~~~lg~G~~g~vy~a~~----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~  111 (376)
                      .++| ++.+.||+|+||.||++.+    ..+++.||||++... .....+.+.+|+.+++.++||||+++++++.+  ..
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            3455 9999999999999988764    447889999999865 34556779999999999999999999999987  46


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      .+++||||+++++|.+++...  .+++..++.++.||+.+|.|||   +.||+||||||+||+++.++.+||+|||++..
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             eEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            889999999999999998543  4899999999999999999999   79999999999999999999999999999987


Q ss_pred             cccCCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHH-------HHHHHHHHH
Q 038118          192 VEHAKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQV-------YLVQWVWDL  262 (376)
Q Consensus       192 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~-------~~~~~~~~~  262 (376)
                      .......  ......++..|+|||++.+..++.++|||||||++|+|++|..||..........       .........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            6433221  1233457788999999998889999999999999999999999997543221100       000001111


Q ss_pred             hcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          263 YGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...+         ............+.+++.+||+.||.+|||+.++++.|+.
T Consensus       264 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          264 LERG---------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Hhcc---------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            1111         1111122233568889999999999999999999998875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=337.31  Aligned_cols=256  Identities=22%  Similarity=0.312  Sum_probs=204.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEc---CCCeEEEEEEcccCC----hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFR---ETSSYIAVKRVSKGS----KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKK  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  111 (376)
                      .++|++.+.||+|+||.||+|++.   .+++.||||++....    ......+.+|+.+++.+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            478999999999999999999984   478999999986432    12234567899999999 6999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..++||||+++++|.+++... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            999999999999999988654 46899999999999999999999   78999999999999999999999999999976


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccC--CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTG--RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      .............||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........+......   .    
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~----  281 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---S----  281 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---C----
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc---c----
Confidence            543333334445699999999999753  4788999999999999999999999765433332222221110   0    


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHHHh
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIHVL  313 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~~L  313 (376)
                         .+.....+    ...+.+++.+||+.||.+||     ++.++++..
T Consensus       282 ---~~~~~~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 ---EPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---CCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---CCCCCccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence               11222222    34577889999999999999     999998643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-43  Score=321.98  Aligned_cols=253  Identities=29%  Similarity=0.437  Sum_probs=197.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee---------
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE---------  109 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------  109 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            467899999999999999999999999999999999653 3446788999999999999999999998865         


Q ss_pred             ----CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEee
Q 038118          110 ----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGD  185 (376)
Q Consensus       110 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~D  185 (376)
                          ....|+||||+++++|.+++......+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence                45789999999999999999776667889999999999999999999   78999999999999999999999999


Q ss_pred             CCCccccccCC-------------CcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhh
Q 038118          186 FGLARLVEHAK-------------GSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEV  251 (376)
Q Consensus       186 fg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~  251 (376)
                      ||++.......             ........|+..|+|||++.+. .++.++|||||||++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            99997653211             1122345689999999998764 68999999999999999998   5543221111


Q ss_pred             HHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         +....    ...      ...+...+.......+.+++.+||+.||.+|||+.++++
T Consensus       237 ---~~~~~----~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 ---ILKKL----RSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---HHHHH----HST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---HHHhc----ccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               11100    011      111222233333455788999999999999999999996

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.8e-44  Score=323.11  Aligned_cols=252  Identities=24%  Similarity=0.312  Sum_probs=188.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4588999999999999999999999999999999997642  22233445566668888999999999999999999999


Q ss_pred             EecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          117 YEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGWEQ-CVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      |||+++ +|.+++..   ....+++..++.++.||+.||.|||   ++ |++||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 77776643   4567999999999999999999999   66 9999999999999999999999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhh----ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECA----TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ....  ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.........  +....    .... 
T Consensus       161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~----~~~~-  231 (290)
T 3fme_A          161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVV----EEPS-  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHHHH----HSCC-
T ss_pred             cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHHHh----ccCC-
Confidence            3322  22334589999999996    4567889999999999999999999999754322111  11110    1110 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           +...   .......+.+++.+||+.||++|||+.++++
T Consensus       232 -----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 -----PQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 1111   1112345788899999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.6e-44  Score=323.14  Aligned_cols=249  Identities=25%  Similarity=0.395  Sum_probs=205.2

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee--------
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--------  109 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------  109 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+.....    .+.+|+.+++.++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            346889999999999999999999998999999999976543    45689999999999999999998854        


Q ss_pred             --------CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          110 --------KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       110 --------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                              ....++||||+++++|.+++... ...+++..++.++.||+.||.|||   ++|++||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence                    45689999999999999998653 357899999999999999999999   789999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      +||+|||++.......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||....  ..   .     
T Consensus       161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~---~-----  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KF---F-----  228 (284)
T ss_dssp             EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HH---H-----
T ss_pred             EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HH---H-----
Confidence            9999999987654322  2233458999999999998889999999999999999999998874221  00   0     


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .....+        .+...++    ..+..++.+||+.||.+|||+.++++.|....
T Consensus       229 ~~~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          229 TDLRDG--------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHTT--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHhhcc--------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            011111        1112222    34678889999999999999999999887544

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-43  Score=356.95  Aligned_cols=250  Identities=24%  Similarity=0.330  Sum_probs=209.2

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  114 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+..|..++..+ +|++|+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            457899999999999999999999999999999998753   223346678899999988 6999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      |||||++||+|..++... +.+++..++.++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999988654 56899999999999999999999   79999999999999999999999999999975322


Q ss_pred             CCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          195 AKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                       .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        ..      .
T Consensus       495 -~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--------~~------~  559 (674)
T 3pfq_A          495 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------HN------V  559 (674)
T ss_dssp             -TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--------SC------C
T ss_pred             -CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------CC------C
Confidence             12234456799999999999999999999999999999999999999988765554443331        11      1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSI-----RQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~~vl~  311 (376)
                      .+...    ....+.+++.+||+.||.+||++     ++|++
T Consensus       560 ~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 AYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCCTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCCcc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            11122    23457889999999999999998     77763

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.2e-44  Score=335.45  Aligned_cols=275  Identities=22%  Similarity=0.211  Sum_probs=205.8

Q ss_pred             ccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-----------ChhhHHHHHHHHHHHHhCCCC
Q 038118           30 RFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-----------SKQGIKEYASEVTIISRLRHR   98 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~   98 (376)
                      ...+.++....++|++.+.||+|+||.||+|.+.. +..||||++...           .....+.+.+|+.+++.++||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            34568889999999999999999999999999866 889999998542           122347889999999999999


Q ss_pred             CccceeeEEee-----CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCe
Q 038118           99 NLVQLLGWCHE-----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI  173 (376)
Q Consensus        99 ~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  173 (376)
                      ||+++++++..     ....|+||||+. ++|.+.+......+++..++.++.||+.||.|||   ++||+||||||+||
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI  165 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence            99999999854     346899999997 5888888766678999999999999999999999   78999999999999


Q ss_pred             eecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhH
Q 038118          174 MLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ  252 (376)
Q Consensus       174 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~  252 (376)
                      |++.++.+||+|||++......  .......||..|+|||++.+ ..++.++|||||||++|+|++|..||......+..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999743322  22334568899999999876 67899999999999999999999999877655544


Q ss_pred             HHHHHHHHHH-------hcC-------CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          253 VYLVQWVWDL-------YGN-------GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       253 ~~~~~~~~~~-------~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+.......       ...       ......................+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            4333211100       000       0000000000000011112345788999999999999999999995

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.6e-43  Score=328.31  Aligned_cols=275  Identities=19%  Similarity=0.233  Sum_probs=209.8

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEee
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE  109 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  109 (376)
                      +.-.++....++|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   96 (364)
T 3qyz_A           17 MVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   96 (364)
T ss_dssp             BCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             EEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence            33334444567999999999999999999999999999999999754 34445788999999999999999999999965


Q ss_pred             C-----CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          110 K-----KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       110 ~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                      .     ...|+||||+.+ +|.+++..  ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A           97 PTIEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             SSTTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEE
Confidence            4     468999999974 88888744  45899999999999999999999   7999999999999999999999999


Q ss_pred             eCCCccccccCCCc--ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH
Q 038118          185 DFGLARLVEHAKGS--QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD  261 (376)
Q Consensus       185 Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  261 (376)
                      |||++.........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+......
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  250 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  250 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999765432211  1234568999999998654 45899999999999999999999999887766655444332110


Q ss_pred             HhcC----C------ccccccC-CcCC--CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 LYGN----G------KLLEAVD-PRLC--RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 ~~~~----~------~~~~~~~-~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+    .      .....+. +...  ..........+.+++.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000    0      0000000 0000  0000112245788999999999999999999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-43  Score=353.79  Aligned_cols=247  Identities=27%  Similarity=0.416  Sum_probs=199.1

Q ss_pred             CccccCCCeeEEEEEE--cCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFF--RETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~--~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      +.||+|+||.||+|.+  ..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            3799999999999965  456789999999754  33446789999999999999999999999965 558999999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC--cce
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG--SQT  200 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  200 (376)
                      ++|.+++. ..+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++.......  ...
T Consensus       454 g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999985 4567899999999999999999999   79999999999999999999999999999976543222  122


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ....+|..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +..     ...   
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~--------~~~-----~~~---  593 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------GER-----MGC---  593 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------TCC-----CCC---
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------CCC-----CCC---
Confidence            33346788999999999999999999999999999998 9999988765544333221        111     111   


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .......+.+++.+||+.||++||++.+|++.|+.
T Consensus       594 -p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 -PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             11233567889999999999999999999998864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.5e-43  Score=325.56  Aligned_cols=260  Identities=18%  Similarity=0.226  Sum_probs=201.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEee--CCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHE--KKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   .+.+.+|+.+++.++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            478999999999999999999999999999999997554   356889999999997 9999999999987  6789999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  195 (376)
                      |||+.+++|.+++.    .+++..++.++.||+.||.|||   ++||+||||||+|||++.++ .+||+|||++......
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999988773    3789999999999999999999   79999999999999999776 8999999999765432


Q ss_pred             CCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccch-hhHHHHHHHH-----HHHhcCC--
Q 038118          196 KGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKE-EVQVYLVQWV-----WDLYGNG--  266 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~-----~~~~~~~--  266 (376)
                      .  ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... +....+....     .......  
T Consensus       185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            2  2234458899999999877 66899999999999999999999999543322 1111111110     0000000  


Q ss_pred             ------------ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 ------------KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                                  .....................+.+++.+||+.||++|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                        000000001111111223456888999999999999999999995

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-43  Score=327.53  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--------hhhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--------KQGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....        ......+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999999999999999986532        12234578999999999999999999998766


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce---EEEeeCC
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGDFG  187 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg  187 (376)
                      . .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 8999999999999988853 457899999999999999999999   799999999999999987665   9999999


Q ss_pred             CccccccCCCcceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH-HHHHHHHHHHh
Q 038118          188 LARLVEHAKGSQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ-VYLVQWVWDLY  263 (376)
Q Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~  263 (376)
                      ++......  .......||..|+|||++.   ...++.++|||||||++|+|++|..||......... ..+..      
T Consensus       163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------  234 (322)
T 2ycf_A          163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS------  234 (322)
T ss_dssp             TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH------
T ss_pred             cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh------
Confidence            99765321  1223456899999999874   456889999999999999999999999765433221 11111      


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        +..  ...+.....    ....+.+++.+||+.||++|||+.++++
T Consensus       235 --~~~--~~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 --GKY--NFIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --TCC--CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --Ccc--ccCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence              100  000111111    2345788999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.1e-45  Score=343.78  Aligned_cols=241  Identities=15%  Similarity=0.153  Sum_probs=189.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHH---HHHHhCCCCCcccee-------eE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEV---TIISRLRHRNLVQLL-------GW  106 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~  106 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++...   .....+.+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999999989999999999743   344567889999   455555799999998       66


Q ss_pred             EeeCC-----------------eEEEEEecCCCCChhhhhhhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 038118          107 CHEKK-----------------ELLLVYEYMPNGSLDSHLFKENN------LLTWEFRFKIAQDLASGLLYLQEGWEQCV  163 (376)
Q Consensus       107 ~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i  163 (376)
                      +...+                 ..|+||||+ +|+|.+++.....      .+++..++.++.||+.||.|||   ++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            66553                 289999999 6799998865322      2335888899999999999999   7899


Q ss_pred             EeecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC-----------CCCCCCceeechhh
Q 038118          164 VHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-----------RASKESDVYSFGIV  232 (376)
Q Consensus       164 ~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~i  232 (376)
                      +||||||+|||++.++.+||+|||++....    .......| ..|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999997532    23344567 999999999887           79999999999999


Q ss_pred             HHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          233 ALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       233 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +|+|++|..||...........+                 .. ....++    ..+.+++.+||+.||++|||+.++++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~-----------------~~-~~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWI-----------------FR-SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGG-----------------GS-SCCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccchhhh-----------------hh-hccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999765432221110                 01 112222    45788899999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.6e-43  Score=331.12  Aligned_cols=262  Identities=22%  Similarity=0.281  Sum_probs=190.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC------C
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK------K  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~  111 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            58999999999999999999999999999999999753  344567788999999999999999999998654      5


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..|+|+|++ +++|.+++..  ..+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++..
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            689999998 6788887743  56899999999999999999999   79999999999999999999999999999975


Q ss_pred             cccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH----hcC-
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL----YGN-  265 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~~~-  265 (376)
                      ...    ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......    ... 
T Consensus       182 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          182 TAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            432    2334568999999999876 678999999999999999999999998877655444443321100    000 


Q ss_pred             --C---ccccccCCcCCCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 --G---KLLEAVDPRLCRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 --~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        .   .....+.......+   .......+.+++.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence              0   00000000000000   0011245788999999999999999999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-42  Score=322.61  Aligned_cols=282  Identities=24%  Similarity=0.314  Sum_probs=217.0

Q ss_pred             hhhhcCCCCcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHh--CCC
Q 038118           20 DEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR--LRH   97 (376)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h   97 (376)
                      +...........+........++|++.+.||+|+||.||+|.+.  ++.||||++....   ...+.+|++++..  ++|
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h   95 (342)
T 1b6c_B           21 YDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRH   95 (342)
T ss_dssp             HHTCCTTCCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCC
T ss_pred             eeccccCCCCCCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh---HHHHHHHHHHHHHhhcCC
Confidence            33334444556667777778899999999999999999999984  7899999986442   4567788888887  689


Q ss_pred             CCccceeeEEeeCC----eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEeecc
Q 038118           98 RNLVQLLGWCHEKK----ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG-----WEQCVVHRDI  168 (376)
Q Consensus        98 ~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dl  168 (376)
                      |||+++++++....    ..++||||+++++|.+++..  ..+++..++.++.||+.||.|||..     ++.+|+||||
T Consensus        96 ~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl  173 (342)
T 1b6c_B           96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL  173 (342)
T ss_dssp             TTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred             CcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence            99999999998775    89999999999999999854  3689999999999999999999931     1479999999


Q ss_pred             cCCCeeecCCceEEEeeCCCccccccCCCc---ceeeeccCCCCCchhhhccCC------CCCCCceeechhhHHHHHhC
Q 038118          169 KSSNIMLDLNFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPECATTGR------ASKESDVYSFGIVALEIACG  239 (376)
Q Consensus       169 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~~lltg  239 (376)
                      ||+|||++.++.+||+|||++.........   ......||..|+|||++.+..      ++.++|||||||++|+|++|
T Consensus       174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999999999999999766443322   123346899999999987653      33689999999999999999


Q ss_pred             ----------CCCCCCccchhhH-HHHHHHHHHHhcCCccccccCCcCCCC-CcHHHHHHHHHHHHHccCCCCCCCCChH
Q 038118          240 ----------RKPISLTAKEEVQ-VYLVQWVWDLYGNGKLLEAVDPRLCRD-FDEQQMECLMIVGLWCAHPDENLRPSIR  307 (376)
Q Consensus       240 ----------~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~  307 (376)
                                ..||......... ..+..    .....    .+.+.+... ........+.+++.+||+.||++|||+.
T Consensus       254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  325 (342)
T 1b6c_B          254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRK----VVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  325 (342)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHHHH----HHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cCcCCcccccccCccccCcCcccHHHHHH----HHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence                      7888654322211 11111    00111    111222111 1235667899999999999999999999


Q ss_pred             HHHHHhccC
Q 038118          308 QVIHVLNSE  316 (376)
Q Consensus       308 ~vl~~L~~~  316 (376)
                      +|++.|+..
T Consensus       326 ~i~~~L~~i  334 (342)
T 1b6c_B          326 RIKKTLSQL  334 (342)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999988753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6e-43  Score=328.70  Aligned_cols=255  Identities=15%  Similarity=0.124  Sum_probs=203.6

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEE-----EcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC---CCCcccee
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGF-----FRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR---HRNLVQLL  104 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~  104 (376)
                      ..++....++|++.+.||+|+||.||+|.     +..+++.||||++.....   ..+..|+++++.++   |+||++++
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            34445556889999999999999999994     667788999999976653   45677777777776   89999999


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFK----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---  177 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---  177 (376)
                      +++...+..|+||||+++|+|.+++..    ....+++..++.++.||+.||.|||   ++||+||||||+|||++.   
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGT
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEeccccc
Confidence            999999999999999999999999864    3567999999999999999999999   799999999999999998   


Q ss_pred             --------CceEEEeeCCCccccccC-CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccc
Q 038118          178 --------NFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAK  248 (376)
Q Consensus       178 --------~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~  248 (376)
                              ++.+||+|||++...... .........||..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999765422 22334556799999999999999999999999999999999999999965432


Q ss_pred             hhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHhcc
Q 038118          249 EEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-SIRQVIHVLNS  315 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~L~~  315 (376)
                      ...                   .+...+.....   ...+.+++..||+.+|.+|+ ++.++.+.|+.
T Consensus       291 ~~~-------------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          291 GEC-------------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             TEE-------------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             Cce-------------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence            111                   01111112122   33456677789999999984 67777666653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-43  Score=354.94  Aligned_cols=260  Identities=25%  Similarity=0.360  Sum_probs=209.7

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      ......++|++.+.||+|+||.||+|.+..+   +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            3444568899999999999999999998643   567999998764 44445789999999999999999999999854 


Q ss_pred             CeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          111 KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      +..|+||||+++++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            5689999999999999999766667999999999999999999999   7899999999999999999999999999998


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ..............+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..        +.. 
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~--------~~~-  610 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------GER-  610 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH--------TCC-
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--------CCC-
Confidence            764433333334456789999999998899999999999999999997 9999987765544333221        110 


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                          ..+...    ....+.+++.+||..||.+|||+.+|++.|+.
T Consensus       611 ----~~~~~~----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          611 ----LPMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             ----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCcc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                111122    23457889999999999999999999998864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=330.54  Aligned_cols=260  Identities=17%  Similarity=0.145  Sum_probs=202.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC--------CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccc---------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET--------SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQ---------  102 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------  102 (376)
                      .++|++.+.||+|+||.||+|.+..+        ++.||+|++...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            57999999999999999999999874        789999998754     35778999999999998887         


Q ss_pred             ------eeeEEee-CCeEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118          103 ------LLGWCHE-KKELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus       103 ------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                            +++++.. ....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||   ++||+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  6777776 77899999999 99999999654 367999999999999999999999   789999999999999


Q ss_pred             ecCCc--eEEEeeCCCccccccCCCc------ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCc
Q 038118          175 LDLNF--NAKIGDFGLARLVEHAKGS------QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLT  246 (376)
Q Consensus       175 l~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~  246 (376)
                      ++.++  .+||+|||++.........      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999765322111      113346899999999999989999999999999999999999999876


Q ss_pred             cchhhHHHHHHHHHHHhcCCccccccCCcC-CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          247 AKEEVQVYLVQWVWDLYGNGKLLEAVDPRL-CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ......  +...........  ....+... ...+    ...+.+++.+||+.||.+|||+.+|++.|...
T Consensus       272 ~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          272 LPNTED--IMKQKQKFVDKP--GPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TTCHHH--HHHHHHHHHHSC--CCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CcCHHH--HHHHHHhccCCh--hhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            422111  111111111111  00111000 0112    24578889999999999999999999988753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.7e-43  Score=331.81  Aligned_cols=203  Identities=22%  Similarity=0.343  Sum_probs=157.3

Q ss_pred             HhhCCCc-CCccccCCCeeEEEEEEc--CCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 038118           39 ATNDFND-DQKLGQGGFGGVYKGFFR--ETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKEL  113 (376)
Q Consensus        39 ~~~~y~~-~~~lg~G~~g~vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~  113 (376)
                      ..+.|++ .++||+|+||.||+|.+.  .+++.||||++.....  ...+.+|+.+|+.++||||+++++++..  ....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3456777 457999999999999976  5688999999975532  2467889999999999999999999954  6789


Q ss_pred             EEEEecCCCCChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee----cCCceE
Q 038118          114 LLVYEYMPNGSLDSHLFKE--------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML----DLNFNA  181 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----~~~~~~  181 (376)
                      |+||||+.+ +|.+++...        ...+++..++.++.||+.||.|||   ++||+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999965 777766421        124899999999999999999999   7999999999999999    677899


Q ss_pred             EEeeCCCccccccCCC--cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCcc
Q 038118          182 KIGDFGLARLVEHAKG--SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTA  247 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~  247 (376)
                      ||+|||++........  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999986543221  223445689999999999874 58999999999999999999999997654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.5e-43  Score=334.02  Aligned_cols=208  Identities=21%  Similarity=0.300  Sum_probs=179.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC------CCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL------RHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~  113 (376)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            56899999999999999999999999999999999754 33456677888888877      567999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce--EEEeeCCCcc
Q 038118          114 LLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN--AKIGDFGLAR  190 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~  190 (376)
                      ++||||+. ++|.+++.... ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.  +||+|||++.
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 58888886544 45899999999999999999999   789999999999999999887  9999999997


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHH
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV  256 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~  256 (376)
                      ....    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus       251 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~  312 (429)
T 3kvw_A          251 YEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI  312 (429)
T ss_dssp             ETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5432    2234568999999999999899999999999999999999999998877655544443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=322.46  Aligned_cols=266  Identities=22%  Similarity=0.282  Sum_probs=199.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEe-----------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCH-----------  108 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----------  108 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            578999999999999999999999999999999998877777788999999999999999999999873           


Q ss_pred             ---eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec-CCceEEEe
Q 038118          109 ---EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD-LNFNAKIG  184 (376)
Q Consensus       109 ---~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~  184 (376)
                         +....++||||++ ++|.+++.  .+.+++..++.++.||+.||.|||   ++||+||||||+||+++ .++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               4468899999997 58988884  356899999999999999999999   79999999999999997 56799999


Q ss_pred             eCCCccccccCCC--cceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH--
Q 038118          185 DFGLARLVEHAKG--SQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV--  259 (376)
Q Consensus       185 Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~--  259 (376)
                      |||++........  .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+....  
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999976532211  12233457889999998865 678999999999999999999999998776544333322110  


Q ss_pred             ------HHHhcCCc--cccccC-CcC-CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          260 ------WDLYGNGK--LLEAVD-PRL-CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       260 ------~~~~~~~~--~~~~~~-~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                            ......-.  ...... +.. ...........+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                  00000000  000000 000 00000112355888999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.1e-43  Score=328.89  Aligned_cols=267  Identities=19%  Similarity=0.258  Sum_probs=203.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KE  112 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  112 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            357899999999999999999999999999999999754 344456788999999999999999999988654     67


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .++||||+. ++|.+++..  +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...
T Consensus        89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            899999997 588888754  46899999999999999999999   799999999999999999999999999999765


Q ss_pred             ccCCCc---------ceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH
Q 038118          193 EHAKGS---------QTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL  262 (376)
Q Consensus       193 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  262 (376)
                      ......         ......||..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            432111         1223468999999998764 678999999999999999999999998776544433332211100


Q ss_pred             hcCCccccccC----------CcCCC----CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          263 YGNGKLLEAVD----------PRLCR----DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       263 ~~~~~~~~~~~----------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...........          +....    .........+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000000          00000    000122345788999999999999999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.7e-43  Score=317.95  Aligned_cols=255  Identities=24%  Similarity=0.330  Sum_probs=206.7

Q ss_pred             HHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           36 LAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++...+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            344568999999999999999999999999999999998653  233467889999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC---ceEEEeeCCCcc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGLAR  190 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~  190 (376)
                      ++||||+++++|.+.+... ..+++..++.++.||+.||.|||   ++|++||||+|+||+++.+   +.+||+|||++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999998888543 46899999999999999999999   7899999999999999764   469999999987


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ......  ......|+..|+|||++.+ .++.++||||||+++|+|++|..||......+....+..        +... 
T Consensus       173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~-  240 (287)
T 2wei_A          173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--------GKYA-  240 (287)
T ss_dssp             TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCCC-
T ss_pred             eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------CCCC-
Confidence            653322  2223457889999998875 489999999999999999999999987664443322221        1110 


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .+......+    ...+.+++.+||+.||++|||+.++++
T Consensus       241 -~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 -FDLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -CCSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence             000111122    345788999999999999999999996

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.5e-43  Score=327.93  Aligned_cols=256  Identities=20%  Similarity=0.285  Sum_probs=203.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-----------------hHHHHHHHHHHHHhCCCCCccc
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-----------------GIKEYASEVTIISRLRHRNLVQ  102 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~i~~  102 (376)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++......                 ....+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            57999999999999999999999  6899999998753211                 1278899999999999999999


Q ss_pred             eeeEEeeCCeEEEEEecCCCCChhhh------hhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceEeecccCCCee
Q 038118          103 LLGWCHEKKELLLVYEYMPNGSLDSH------LFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWE-QCVVHRDIKSSNIM  174 (376)
Q Consensus       103 ~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~-~~i~H~dlkp~Nil  174 (376)
                      +++++.+.+..++||||+++++|.++      +... ...+++..++.++.||+.||.|||   + +|++||||+|+||+
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence            99999999999999999999999988      5432 567999999999999999999999   6 99999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccC-CCCC-CCceeechhhHHHHHhCCCCCCCccc-hhh
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-RASK-ESDVYSFGIVALEIACGRKPISLTAK-EEV  251 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~il~~lltg~~pf~~~~~-~~~  251 (376)
                      ++.++.++|+|||++......   ......|+..|+|||++.+. .++. ++|||||||++|+|++|..||..... .+.
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            999999999999999765322   33445689999999999877 5665 99999999999999999999987654 222


Q ss_pred             HHHHHHHHHHHhcCCccccccC---------CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          252 QVYLVQWVWDLYGNGKLLEAVD---------PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...+.        .+......+         ..............+.+++.+||+.||.+|||+.++++
T Consensus       262 ~~~i~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIR--------TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHT--------SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHh--------ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22111        111100000         00000001223356788999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-43  Score=333.77  Aligned_cols=255  Identities=12%  Similarity=0.061  Sum_probs=184.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhC--CCCCcccee-------eEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRL--RHRNLVQLL-------GWC  107 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~  107 (376)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345899999999999999999999999999999998753   23455677885544444  699977754       555


Q ss_pred             eeC-----------------CeEEEEEecCCCCChhhhhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCceE
Q 038118          108 HEK-----------------KELLLVYEYMPNGSLDSHLFKENNLLTWEFR------FKIAQDLASGLLYLQEGWEQCVV  164 (376)
Q Consensus       108 ~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~------~~~~~~i~~~l~~Lh~~~~~~i~  164 (376)
                      ...                 ..+|+||||++ ++|.+++......+....+      +.++.||+.||.|||   ++||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            433                 34899999998 8999999765445555556      678899999999999   79999


Q ss_pred             eecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCC
Q 038118          165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKP  242 (376)
Q Consensus       165 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~p  242 (376)
                      ||||||+|||++.++.+||+|||++.....    ......+++.|+|||++.+  ..++.++|||||||++|+|++|..|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999975432    2224457799999999987  6789999999999999999999999


Q ss_pred             CCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          243 ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       243 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      |..........         +........................+.+++.+||+.||++|||+.++++
T Consensus       293 f~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          293 FGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            98764321100         0000000000111111111123456788999999999999999999974

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.7e-42  Score=320.22  Aligned_cols=263  Identities=21%  Similarity=0.260  Sum_probs=206.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEE-cCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCC------CccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFF-RETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHR------NLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||.||+|.+ ..+++.||+|++... ......+.+|+.+++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            57899999999999999999998 557899999999754 34456788999999988655      49999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC--------------
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--------------  177 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--------------  177 (376)
                      .++||||+ +++|.+++.... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999886544 36889999999999999999999   789999999999999987              


Q ss_pred             -----CceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH
Q 038118          178 -----NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ  252 (376)
Q Consensus       178 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~  252 (376)
                           ++.+||+|||++......    .....||..|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 567999999999754322    23346899999999999889999999999999999999999999877655544


Q ss_pred             HHHHHHHHH-------HhcCCccccc------------------cCCc-CCCCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          253 VYLVQWVWD-------LYGNGKLLEA------------------VDPR-LCRDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       253 ~~~~~~~~~-------~~~~~~~~~~------------------~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                      ..+......       ..........                  ..+. -...........+.+++.+||+.||.+|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            333221110       0000000000                  0000 0001123445678899999999999999999


Q ss_pred             HHHHH
Q 038118          307 RQVIH  311 (376)
Q Consensus       307 ~~vl~  311 (376)
                      .++++
T Consensus       324 ~ell~  328 (339)
T 1z57_A          324 REALK  328 (339)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99984

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-42  Score=325.30  Aligned_cols=261  Identities=21%  Similarity=0.271  Sum_probs=201.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE----
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL----  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----  113 (376)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            57899999999999999999999999999999999764  344467888999999999999999999999877654    


Q ss_pred             --EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          114 --LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       114 --~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                        |+||||+. ++|.+.+   ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..
T Consensus       121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 5777666   334899999999999999999999   78999999999999999999999999999975


Q ss_pred             cccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH----hcC-
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL----YGN-  265 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~~~-  265 (376)
                      ...    ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.......    ... 
T Consensus       194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            432    2334568999999999877 678999999999999999999999998776555444433211000    000 


Q ss_pred             -C----ccccccCCcCCCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 -G----KLLEAVDPRLCRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 -~----~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .    .....+.......+   .......+.+++.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             0    00000000000000   0112356888999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-41  Score=321.65  Aligned_cols=272  Identities=21%  Similarity=0.247  Sum_probs=209.9

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CC-----CccceeeE
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HR-----NLVQLLGW  106 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~  106 (376)
                      ++......++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.++ |+     ++++++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            344444568999999999999999999999999999999999754 334567788999988885 54     49999999


Q ss_pred             EeeCCeEEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec--CCceEEE
Q 038118          107 CHEKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD--LNFNAKI  183 (376)
Q Consensus       107 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--~~~~~kl  183 (376)
                      +...+..|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||. ++.||+||||||+|||++  .++.+||
T Consensus       125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999999965 9988886544 568999999999999999999993 147999999999999995  4778999


Q ss_pred             eeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH--
Q 038118          184 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD--  261 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~--  261 (376)
                      +|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......  
T Consensus       203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999765322    23456899999999999999999999999999999999999999887665554444332110  


Q ss_pred             --HhcC-Ccc---cccc-----------------CCcC---------------------CCCCcHHHHHHHHHHHHHccC
Q 038118          262 --LYGN-GKL---LEAV-----------------DPRL---------------------CRDFDEQQMECLMIVGLWCAH  297 (376)
Q Consensus       262 --~~~~-~~~---~~~~-----------------~~~~---------------------~~~~~~~~~~~l~~li~~cl~  297 (376)
                        .... ...   ...+                 .+..                     ...........+.+++.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence              0000 000   0000                 0000                     001122333568899999999


Q ss_pred             CCCCCCCChHHHHH
Q 038118          298 PDENLRPSIRQVIH  311 (376)
Q Consensus       298 ~~p~~RPs~~~vl~  311 (376)
                      .||++|||+.++++
T Consensus       359 ~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          359 YDPKTRIQPYYALQ  372 (382)
T ss_dssp             SCTTTSCCHHHHTT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=330.02  Aligned_cols=264  Identities=22%  Similarity=0.350  Sum_probs=205.7

Q ss_pred             CHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEee
Q 038118           32 TYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHE  109 (376)
Q Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  109 (376)
                      ..+++....++|++.+.||+|+||.||+|.+.+   .|++|++....  ....+.+.+|+.+++.++|+||+++++++..
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            345555567899999999999999999999865   38999987542  2234567789999999999999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      .+..++||||+++++|.+++......+++..++.++.||+.||.|||   +.|++||||||+||+++ ++.++|+|||++
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence            99999999999999999999766667999999999999999999999   78999999999999998 679999999998


Q ss_pred             cccccCC----CcceeeeccCCCCCchhhhcc---------CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHH
Q 038118          190 RLVEHAK----GSQTTVLAGTMGYMAPECATT---------GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV  256 (376)
Q Consensus       190 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~  256 (376)
                      .......    ........|+..|+|||++.+         ..++.++|||||||++|+|++|..||...........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            6543211    112233458899999999864         357889999999999999999999998766443322221


Q ss_pred             HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCCC
Q 038118          257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAP  318 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~~  318 (376)
                              .+.......    ..    ....+.+++.+||..||.+|||+.+|++.|+....
T Consensus       257 --------~~~~~~~~~----~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          257 --------TGMKPNLSQ----IG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             --------TTCCCCCCC----SS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             --------cCCCCCCCc----CC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                    111111110    11    12347788999999999999999999999987553

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-42  Score=320.42  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=181.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHH-HHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVT-IISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... .......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            47899999999999999999999999999999999765 3334455566665 777789999999999999999999999


Q ss_pred             ecCCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          118 EYMPNGSLDSHLFK----ENNLLTWEFRFKIAQDLASGLLYLQEGWEQ-CVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       118 e~~~~~sL~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      ||+++ +|.+++..    ....+++..++.++.|++.||.|||   +. |++||||||+|||++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99976 77666642    2567899999999999999999999   67 9999999999999999999999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhh----ccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECA----TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ....  ......|+..|+|||++    .+..++.++|||||||++|+|++|..||........  .+          ...
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----------~~~  242 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL----------TQV  242 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CCC
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH----------HHH
Confidence            3321  22334589999999998    456689999999999999999999999976432110  00          001


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .....+.+...........+.+++.+||+.||++|||+.+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111111111111123345788999999999999999999984

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-42  Score=321.59  Aligned_cols=266  Identities=23%  Similarity=0.272  Sum_probs=202.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEc-CCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhC---CCCCccceeeEEe----
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFR-ETSSYIAVKRVSKGS--KQGIKEYASEVTIISRL---RHRNLVQLLGWCH----  108 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~----  108 (376)
                      ..++|++.+.||+|+||.||+|.+. .+++.||+|++....  ......+.+|+.+++.+   .||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4588999999999999999999995 678999999986432  11123455677766665   8999999999987    


Q ss_pred             -eCCeEEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeC
Q 038118          109 -EKKELLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDF  186 (376)
Q Consensus       109 -~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  186 (376)
                       .....++||||+. ++|.+++.... ..+++..++.++.||+.||.|||   ++|++||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999997 59988886543 45899999999999999999999   789999999999999999999999999


Q ss_pred             CCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC
Q 038118          187 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG  266 (376)
Q Consensus       187 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  266 (376)
                      |++......  .......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+........ ..
T Consensus       165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~  241 (326)
T 1blx_A          165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG-EE  241 (326)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-GG
T ss_pred             cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC-cc
Confidence            999765322  123345689999999999988999999999999999999999999987765544433332111000 00


Q ss_pred             cccc-------cc---CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 KLLE-------AV---DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 ~~~~-------~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....       ..   .......+.......+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000       00   000001111223345788999999999999999999994

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.9e-42  Score=320.65  Aligned_cols=273  Identities=18%  Similarity=0.168  Sum_probs=197.0

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC--
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK--  111 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--  111 (376)
                      .......++|++.+.||+|+||.||+|.+..++..||||++..... ....+.++++.+..++||||+++++++....  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            5567778999999999999999999999999999999999865432 2345677888899999999999999986533  


Q ss_pred             -----eEEEEEecCCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEE
Q 038118          112 -----ELLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAK  182 (376)
Q Consensus       112 -----~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~k  182 (376)
                           ..++||||+++ +|...+.   .....+++..++.++.||+.||.|||. +++||+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 38999999987 4444332   345678999999999999999999993 3589999999999999997 89999


Q ss_pred             EeeCCCccccccCCCcceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH-
Q 038118          183 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW-  260 (376)
Q Consensus       183 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-  260 (376)
                      |+|||++.......  ......||..|+|||++.+.. ++.++|||||||++|+|++|..||...........+..... 
T Consensus       173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            99999997654322  223445899999999986654 89999999999999999999999988766555444433210 


Q ss_pred             ------HHhcCC-ccccccCC------cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 ------DLYGNG-KLLEAVDP------RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ------~~~~~~-~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                            ...... ......+.      .............+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000 00000000      0001111123467889999999999999999999995

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=328.94  Aligned_cols=266  Identities=24%  Similarity=0.351  Sum_probs=193.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHH--HHhCCCCCccceeeEEee-----CC
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTI--ISRLRHRNLVQLLGWCHE-----KK  111 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~  111 (376)
                      ..++|++.+.||+|+||.||+|.+  +++.||||++.....   ..+..|.++  +..++|+||+++++.+..     ..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            357899999999999999999987  478999999975433   334444444  455899999999986542     33


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------ceEeecccCCCeeecCCceEE
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ---------CVVHRDIKSSNIMLDLNFNAK  182 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~---------~i~H~dlkp~Nill~~~~~~k  182 (376)
                      .+++||||+++++|.+++...  ..++..++.++.||+.||.|||   +.         ||+||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence            679999999999999998543  3588899999999999999999   67         999999999999999999999


Q ss_pred             EeeCCCccccccCCC-------cceeeeccCCCCCchhhhcc-------CCCCCCCceeechhhHHHHHhCCCCCCCccc
Q 038118          183 IGDFGLARLVEHAKG-------SQTTVLAGTMGYMAPECATT-------GRASKESDVYSFGIVALEIACGRKPISLTAK  248 (376)
Q Consensus       183 l~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~~lltg~~pf~~~~~  248 (376)
                      |+|||++........       .......||..|+|||++.+       ..++.++|||||||++|+|++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999976543211       11224468999999999876       3456789999999999999999776533221


Q ss_pred             -hhhHHHHH---------HHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          249 -EEVQVYLV---------QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       249 -~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                       ........         ...............+....  .........+.+++.+||+.||++|||+.++++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence             11110000         00000111111111111111  11223556789999999999999999999999988753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=317.25  Aligned_cols=260  Identities=20%  Similarity=0.254  Sum_probs=201.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe-----
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE-----  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  112 (376)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            47899999999999999999999999999999999754  34445778999999999999999999999987653     


Q ss_pred             -EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          113 -LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       113 -~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                       .|+||||+. ++|.+++.   ..+++..++.++.||+.||.|||   ++||+||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             599999997 57877663   34899999999999999999999   78999999999999999999999999999975


Q ss_pred             cccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH----HhcC-
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD----LYGN-  265 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----~~~~-  265 (376)
                      ...    ......||..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......    .... 
T Consensus       176 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          176 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             CCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            432    2234568999999999876 67899999999999999999999999877654443333221100    0000 


Q ss_pred             -C--------ccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 -G--------KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 -~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .        .......+.+ ..........+.+++.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0        0000000000 1111233456888999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.3e-43  Score=330.94  Aligned_cols=262  Identities=21%  Similarity=0.250  Sum_probs=196.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC------eE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK------EL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~  113 (376)
                      ..+|++.+.||+|+||.||+|.+..++. ||+|++......    ..+|+.+++.++||||+++++++....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4679999999999999999999988766 888887654321    236999999999999999999985433      38


Q ss_pred             EEEEecCCCCChhhhh--hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec-CCceEEEeeCCCcc
Q 038118          114 LLVYEYMPNGSLDSHL--FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD-LNFNAKIGDFGLAR  190 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~  190 (376)
                      ++||||++++.+....  ......+++..++.++.||+.||.|||   ++||+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            8999999875443322  123567999999999999999999999   79999999999999999 78999999999997


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH------h
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL------Y  263 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~------~  263 (376)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......      .
T Consensus       191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            653322  23345689999999998765 58999999999999999999999998877655544443321100      0


Q ss_pred             cCCccccccCCcCCC-----CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNGKLLEAVDPRLCR-----DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .........-+....     .+.......+.+++.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            000000000011100     011123346889999999999999999999995

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.4e-42  Score=322.29  Aligned_cols=263  Identities=18%  Similarity=0.240  Sum_probs=201.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-----------CCCccceeeEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-----------HRNLVQLLGWCH  108 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~  108 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            47899999999999999999999999999999999754 333567888999998886           789999999987


Q ss_pred             eCC----eEEEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEeecccCCCeeec------
Q 038118          109 EKK----ELLLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQ-CVVHRDIKSSNIMLD------  176 (376)
Q Consensus       109 ~~~----~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~------  176 (376)
                      ..+    ..++|||++ +++|.+++... ...+++..++.++.||+.||.|||   ++ ||+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 88999988653 345899999999999999999999   66 999999999999994      


Q ss_pred             CCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhh-----
Q 038118          177 LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV-----  251 (376)
Q Consensus       177 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~-----  251 (376)
                      ..+.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||........     
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            4458999999999765432    2234589999999999999999999999999999999999999976542211     


Q ss_pred             -HHHHHHHHH--------------HHhcCCccccccCCc----------CCCCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          252 -QVYLVQWVW--------------DLYGNGKLLEAVDPR----------LCRDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       252 -~~~~~~~~~--------------~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                       ...+.....              ...........+...          ....+.......+.+++.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence             111111100              000000000000000          0113456677889999999999999999999


Q ss_pred             HHHHH
Q 038118          307 RQVIH  311 (376)
Q Consensus       307 ~~vl~  311 (376)
                      .++++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99996

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9e-42  Score=318.83  Aligned_cols=263  Identities=19%  Similarity=0.248  Sum_probs=203.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC-eEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC------ccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS-SYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN------LVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++... ......+.+|+.+++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            589999999999999999999998776 78999999754 334567888999999987655      8999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee----------------
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML----------------  175 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill----------------  175 (376)
                      .++||||+ +++|.+.+.... ..+++..++.++.||+.||.|||   ++||+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 556666665443 57999999999999999999999   8999999999999999                


Q ss_pred             ---cCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH
Q 038118          176 ---DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ  252 (376)
Q Consensus       176 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~  252 (376)
                         +.++.+||+|||++......    .....||..|+|||++.+..++.++|||||||++|+|++|..||......+..
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence               56788999999999754322    23346899999999999989999999999999999999999999877655444


Q ss_pred             HHHHHHHHHH-------hcCCcccc------------------ccCC-cCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh
Q 038118          253 VYLVQWVWDL-------YGNGKLLE------------------AVDP-RLCRDFDEQQMECLMIVGLWCAHPDENLRPSI  306 (376)
Q Consensus       253 ~~~~~~~~~~-------~~~~~~~~------------------~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~  306 (376)
                      ..+.......       ........                  ...+ .............+.+++.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            3333221100       00000000                  0000 00001122334578899999999999999999


Q ss_pred             HHHHH
Q 038118          307 RQVIH  311 (376)
Q Consensus       307 ~~vl~  311 (376)
                      .++++
T Consensus       329 ~e~l~  333 (355)
T 2eu9_A          329 AEALL  333 (355)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.4e-43  Score=321.12  Aligned_cols=262  Identities=21%  Similarity=0.326  Sum_probs=199.5

Q ss_pred             CcccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCC--CCCccce
Q 038118           28 PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLR--HRNLVQL  103 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~  103 (376)
                      ++.+....+....++|++.+.||+|+||.||+|.+.. ++.||+|++...  .......+.+|+.++..++  |+||+++
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence            4455556666678899999999999999999999865 788999998754  4455678899999999997  5999999


Q ss_pred             eeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEE
Q 038118          104 LGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI  183 (376)
Q Consensus       104 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl  183 (376)
                      ++++...+..++||| +.+++|.+++.. .+.+++..++.++.||+.||.|||   ++|++||||||+|||+++ +.+||
T Consensus        94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A           94 YDYEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             EEEEECSSEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEE
T ss_pred             EEEeecCCEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEE
Confidence            999999999999999 568899998854 457899999999999999999999   789999999999999965 89999


Q ss_pred             eeCCCccccccCCCc-ceeeeccCCCCCchhhhcc-----------CCCCCCCceeechhhHHHHHhCCCCCCCccchhh
Q 038118          184 GDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATT-----------GRASKESDVYSFGIVALEIACGRKPISLTAKEEV  251 (376)
Q Consensus       184 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~  251 (376)
                      +|||++......... ......|++.|+|||++.+           ..++.++|||||||++|+|++|..||........
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  247 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence            999999765432221 2234568999999999865           4678899999999999999999999976432211


Q ss_pred             HHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .  +..    ...         +.....+.......+.+++.+||+.||.+|||+.++++
T Consensus       248 ~--~~~----~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          248 K--LHA----IID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             H--HHH----HHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H--HHH----HHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            1  111    111         11111111111245788899999999999999999995

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.3e-42  Score=315.30  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=182.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhh-HHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQG-IKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ... .+.+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            578999999999999999999999999999999997653 222 334455566788889999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ-CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      ||+ ++.+..+.......+++..++.++.||+.||.|||   ++ |++||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55555555445677999999999999999999999   54 99999999999999999999999999987553322


Q ss_pred             CcceeeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccch-hhHHHHHHHHHHHhcCCcccc
Q 038118          197 GSQTTVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKE-EVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  270 (376)
                        ......|+..|+|||++.     ...++.++|||||||++|+|++|..||...... .....+..       ...   
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------~~~---  247 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-------EEP---  247 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-------SCC---
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-------cCC---
Confidence              223445899999999984     456888999999999999999999999764322 11111111       110   


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         +.+..  .......+.+++.+||+.||.+|||+.+|++
T Consensus       248 ---~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 ---PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ---CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               11110  0012235788899999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=319.81  Aligned_cols=247  Identities=23%  Similarity=0.377  Sum_probs=192.1

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh------hhHHHHHHHHHHHHhC----CCCCccce
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK------QGIKEYASEVTIISRL----RHRNLVQL  103 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~  103 (376)
                      ++.....++|++.+.||+|+||.||+|.+..+++.||||++.....      .....+.+|+.++.++    +|+||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            4456667899999999999999999999999999999999975432      1223456799999988    89999999


Q ss_pred             eeEEeeCCeEEEEEec-CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec-CCceE
Q 038118          104 LGWCHEKKELLLVYEY-MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD-LNFNA  181 (376)
Q Consensus       104 ~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~~~~  181 (376)
                      ++++...+..++|||+ +.+++|.+++.. .+.+++..++.++.||+.||.|||   ++|++||||||+||+++ .++.+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeE
Confidence            9999999999999999 789999998865 346899999999999999999999   78999999999999999 88999


Q ss_pred             EEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH
Q 038118          182 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW  260 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  260 (376)
                      ||+|||++......   ......|+..|+|||++.+..+ +.++|||||||++|+|++|..||.....      +..   
T Consensus       180 kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~---  247 (312)
T 2iwi_A          180 KLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE---  247 (312)
T ss_dssp             EECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH---
T ss_pred             EEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh---
Confidence            99999999765432   2234558999999999877665 4589999999999999999999975321      100   


Q ss_pred             HHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ..        ..+...+    ...+.+++.+||+.||++|||+.++++
T Consensus       248 ---~~--------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          248 ---AE--------LHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---TC--------CCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---hc--------cCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00        1111222    345788899999999999999999997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.4e-42  Score=319.22  Aligned_cols=257  Identities=22%  Similarity=0.288  Sum_probs=176.6

Q ss_pred             HhhCCCcCC-ccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee----CCeE
Q 038118           39 ATNDFNDDQ-KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE----KKEL  113 (376)
Q Consensus        39 ~~~~y~~~~-~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~  113 (376)
                      ..++|.+.+ .||+|+||.||+|.+..+++.||||++.....    ...+....++.+.|+||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            467899965 69999999999999999999999999965422    12223344667789999999999876    4568


Q ss_pred             EEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC---ceEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN---FNAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~  189 (376)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.+   +.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999986543 46999999999999999999999   7899999999999999764   45999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      .....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.................    ...  
T Consensus       179 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~~--  249 (336)
T 3fhr_A          179 KETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR----LGQ--  249 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eeccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh----ccc--
Confidence            75432   122345579999999999888899999999999999999999999976553332111111000    000  


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH--Hhcc
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNS  315 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~--~L~~  315 (376)
                      ..........    ....+.+++.+||+.||.+|||+.++++  ++..
T Consensus       250 ~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          250 YGFPNPEWSE----VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -CCCTTTSTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccCchhhcc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            0001111112    2345788899999999999999999996  5544

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.5e-43  Score=321.86  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=201.3

Q ss_pred             cccCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh------hHHHHHHHHHHHHhCC--CCCc
Q 038118           29 KRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ------GIKEYASEVTIISRLR--HRNL  100 (376)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i  100 (376)
                      ...+.++.....++|++.+.||+|+||.||+|.+..+++.||||++......      ....+.+|+.+++.++  |+||
T Consensus        31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            4455667777789999999999999999999999999999999998754211      1245667999999996  5999


Q ss_pred             cceeeEEeeCCeEEEEEecCCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec-CC
Q 038118          101 VQLLGWCHEKKELLLVYEYMPN-GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD-LN  178 (376)
Q Consensus       101 ~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~-~~  178 (376)
                      +++++++...+..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||   +.||+||||||+|||++ ++
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCC
Confidence            9999999999999999999976 899988854 457899999999999999999999   79999999999999999 78


Q ss_pred             ceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHH
Q 038118          179 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ  257 (376)
Q Consensus       179 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~  257 (376)
                      +.+||+|||++......   ......||..|+|||++.+..+ +.++|||||||++|+|++|..||.....      +..
T Consensus       187 ~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~  257 (320)
T 3a99_A          187 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR  257 (320)
T ss_dssp             TEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH
T ss_pred             CCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc
Confidence            89999999999765432   2233458999999999887665 6889999999999999999999975321      000


Q ss_pred             HHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          258 WVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                              ..      ......+.    ..+.+++.+||+.||++|||+.+|++
T Consensus       258 --------~~------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 --------GQ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --------CC------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------cc------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    00      01112222    45788899999999999999999996

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.2e-41  Score=305.52  Aligned_cols=230  Identities=14%  Similarity=0.101  Sum_probs=185.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+..+..++||||+++++++...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            478999999999999999999999999999999997652   44557899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||++|++|.+++..  + .....+..++.||+.||.|||   ++||+||||||+|||++.++.+||++++.        
T Consensus       110 ~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~--------  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPAT--------  175 (286)
T ss_dssp             EECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence            999999999999843  2 355568889999999999999   79999999999999999999999985433        


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                                   ++       .++.++|||||||++|+|++|+.||...+........             ...+....
T Consensus       176 -------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------------~~~~~~~~  222 (286)
T 3uqc_A          176 -------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------------ERDTAGQP  222 (286)
T ss_dssp             -------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------CBCTTSCB
T ss_pred             -------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------HHHhccCC
Confidence                         23       2688999999999999999999999876532211000             00000000


Q ss_pred             C--CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          277 C--RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       277 ~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      .  ..........+.+++.+||+.||++| |+.++++.|....
T Consensus       223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            0  00111223457889999999999999 9999999998644

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-40  Score=317.61  Aligned_cols=249  Identities=22%  Similarity=0.255  Sum_probs=185.2

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecC
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      .|.+.+.||+|+||+||.+. ..+|+.||||++....   ...+.+|+.+++.+ +||||+++++++.+.+..|+||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            34456789999999998754 4568899999986543   35678899999876 7999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC-------------ceE
Q 038118          121 PNGSLDSHLFKENNL------LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN-------------FNA  181 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~------~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~-------------~~~  181 (376)
                      . ++|.+++......      ..+..++.++.||+.||.|||   ++||+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 5999988553321      122345679999999999999   7999999999999999754             489


Q ss_pred             EEeeCCCccccccCCCc---ceeeeccCCCCCchhhhcc-------CCCCCCCceeechhhHHHHHh-CCCCCCCccchh
Q 038118          182 KIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPECATT-------GRASKESDVYSFGIVALEIAC-GRKPISLTAKEE  250 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~  250 (376)
                      ||+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876433221   1234569999999999865       568999999999999999999 999997544322


Q ss_pred             hHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          251 VQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .  .+..      .....     +.............+.+++.+||+.||.+|||+.+|++
T Consensus       248 ~--~i~~------~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S--NIIR------GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H--HHHH------TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--HHhc------CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1  1111      00000     11112224456678899999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.5e-41  Score=335.16  Aligned_cols=268  Identities=24%  Similarity=0.261  Sum_probs=200.8

Q ss_pred             HHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEee------C
Q 038118           38 QATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE------K  110 (376)
Q Consensus        38 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~  110 (376)
                      ...++|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|+.+++.++||||+++++++..      .
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3458999999999999999999999999999999998764 45556789999999999999999999998765      6


Q ss_pred             CeEEEEEecCCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce---EEEee
Q 038118          111 KELLLVYEYMPNGSLDSHLFKEN--NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN---AKIGD  185 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~---~kl~D  185 (376)
                      +..++||||+++++|.+++....  ..+++..++.++.||+.||.|||   +.||+||||||+||+++.++.   ++|+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            77899999999999999886533  25888999999999999999999   799999999999999997664   99999


Q ss_pred             CCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHH-HHHHH-HHHh
Q 038118          186 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVY-LVQWV-WDLY  263 (376)
Q Consensus       186 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~-~~~~~-~~~~  263 (376)
                      ||++.......  ......||..|+|||++.+..++.++|||||||++|+|++|..||........... +.... ....
T Consensus       168 FG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          168 LGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             ccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            99998654322  23345689999999999999999999999999999999999999976432111000 00000 0000


Q ss_pred             cCCccccc----cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          264 GNGKLLEA----VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       264 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      ........    -.......+.......+.+++.+||..||++|||+.+++
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            00000000    001112234445667889999999999999999997743

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=319.90  Aligned_cols=249  Identities=21%  Similarity=0.291  Sum_probs=187.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..+|++.+.||+|+||.||.. ...+++.||||++......   .+.+|+.+|+.+ +||||+++++++.+....|+|||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            456889999999999997643 3345788999998754322   346799999999 79999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-----CceEEEeeCCCccccc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-----NFNAKIGDFGLARLVE  193 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~  193 (376)
                      |+. ++|.+++...........++.++.||+.||.|||   ++||+||||||+|||++.     ...+||+|||++....
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            996 5999988766555566667789999999999999   799999999999999953     2358899999997654


Q ss_pred             cCCC--cceeeeccCCCCCchhhhc---cCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          194 HAKG--SQTTVLAGTMGYMAPECAT---TGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       194 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ....  .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||...........        .....
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--------~~~~~  246 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------LGACS  246 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--------TTCCC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--------hccCC
Confidence            3221  2234456999999999987   4567889999999999999999 9999965443222111        00100


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       ...      ..........+.+++.+||+.||.+|||+.+|++
T Consensus       247 -~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 -LDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -CTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -ccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             000      1111233455788999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-40  Score=335.29  Aligned_cols=238  Identities=20%  Similarity=0.271  Sum_probs=193.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcC-CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCe-----
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRE-TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKE-----  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  112 (376)
                      .++|++.+.||+|+||.||+|.+.. +++.||||++... .......+.+|+.++..++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4899999999999999999999976 6899999998654 44556678999999999999999999999987655     


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .|+||||++|++|.+.+..   .+++..++.++.||+.+|.|||   ++||+||||||+|||++.+ .+||+|||++...
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            7999999999999887633   6899999999999999999999   7999999999999999885 8999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ...     ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........                     
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------  284 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------  284 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------------
T ss_pred             ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------------
Confidence            432     3456899999999987654 8899999999999999999988864321110                     


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCCh-HHHHHHhc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSI-RQVIHVLN  314 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-~~vl~~L~  314 (376)
                       +  ...........+..++.+||+.||.+||+. +++.+.|.
T Consensus       285 -~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 -P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             -C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence             0  011111233568889999999999999964 44544443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8e-39  Score=292.37  Aligned_cols=227  Identities=21%  Similarity=0.315  Sum_probs=179.8

Q ss_pred             hhCCCcC-CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHH-HhCCCCCccceeeEEee----CCeE
Q 038118           40 TNDFNDD-QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTII-SRLRHRNLVQLLGWCHE----KKEL  113 (376)
Q Consensus        40 ~~~y~~~-~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~  113 (376)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4677777 7799999999999999999999999999643     3466788887 56689999999999987    6789


Q ss_pred             EEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~  189 (376)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||.|||   ++||+||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999987643 46999999999999999999999   799999999999999998   788999999998


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ....                       +..++.++|||||||++|+|++|..||..........             ...
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------------~~~  211 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------------GMK  211 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------------CSC
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------------HHH
Confidence            5421                       2346788999999999999999999997654222100             000


Q ss_pred             cccCCcCCCCCc----HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRDFD----EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+.... ..+.    ......+.+++.+||+.||.+|||+.++++
T Consensus       212 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000000 0111    122356888999999999999999999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-40  Score=318.21  Aligned_cols=239  Identities=16%  Similarity=0.141  Sum_probs=180.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCC-CCcc---------c-----
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRH-RNLV---------Q-----  102 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~---------~-----  102 (376)
                      .+|...+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.+++.++| .|..         .     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45778889999999999999999999999999987432   2335778999999999987 2211         1     


Q ss_pred             -------eeeEEee-----CCeEEEEEecCCCCChhhhhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 038118          103 -------LLGWCHE-----KKELLLVYEYMPNGSLDSHLF------KENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVV  164 (376)
Q Consensus       103 -------~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~------~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~  164 (376)
                             +..++..     ....+++|+++ +++|.+++.      .....+++..++.++.||+.||.|||   ++||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                   1111111     12457777765 678888773      22445788889999999999999999   79999


Q ss_pred             eecccCCCeeecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhh----------ccCCCCCCCceeechhhHH
Q 038118          165 HRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA----------TTGRASKESDVYSFGIVAL  234 (376)
Q Consensus       165 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslG~il~  234 (376)
                      ||||||+|||++.++.+||+|||+++....    ......| +.|+|||++          .+..++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999999875432    2344557 999999998          4455788999999999999


Q ss_pred             HHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          235 EIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       235 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      +|++|+.||...........+                +.  ....++    ..+.+++.+||+.||++||++.+++
T Consensus       309 elltg~~Pf~~~~~~~~~~~~----------------~~--~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEWI----------------FR--SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGGG----------------GS--SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHCCCCCCCcchhhhHHHH----------------Hh--hcccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999866533221111                00  011222    4588899999999999999987765

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.1e-39  Score=299.13  Aligned_cols=243  Identities=17%  Similarity=0.179  Sum_probs=186.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--------hhhHHHHHHHHHHHHhCC---------CCCccc
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--------KQGIKEYASEVTIISRLR---------HRNLVQ  102 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~  102 (376)
                      .++|++.+.||+|+||.||+|++  +++.||||++....        ....+.+.+|+.+++.++         |+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            57899999999999999999998  47999999997642        223467888999988885         777777


Q ss_pred             eeeEEe------------------------------eCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHH
Q 038118          103 LLGWCH------------------------------EKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL  152 (376)
Q Consensus       103 ~~~~~~------------------------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l  152 (376)
                      +.+++.                              ..+..|+||||+++|++.+.+.+  +.+++..++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            776642                              26789999999999977776633  5689999999999999999


Q ss_pred             HHHHhCCCCceEeecccCCCeeecCCc--------------------eEEEeeCCCccccccCCCcceeeeccCCCCCch
Q 038118          153 LYLQEGWEQCVVHRDIKSSNIMLDLNF--------------------NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP  212 (376)
Q Consensus       153 ~~Lh~~~~~~i~H~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  212 (376)
                      .|||.  ++||+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+||
T Consensus       175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            99993  37999999999999999887                    8999999999865421      34699999999


Q ss_pred             hhhccCCCCCCCceeechhh-HHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHH
Q 038118          213 ECATTGRASKESDVYSFGIV-ALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIV  291 (376)
Q Consensus       213 E~~~~~~~~~~sDvwslG~i-l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  291 (376)
                      |++.+.. +.++||||||++ .+++++|..||.......   .+..   .......    ................+.++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~~~---~~~~~~~----~~~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YLTD---KMLKQMT----FKTKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HHHH---HHHHTCC----CSSCCCSHHHHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh---HHHH---hhhhhhc----cCcccchhhhhhcCHHHHHH
Confidence            9998766 889999998777 777889999985321100   0111   0000000    01111122334567789999


Q ss_pred             HHHccCCCCCCCCChHHHH
Q 038118          292 GLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       292 i~~cl~~~p~~RPs~~~vl  310 (376)
                      +.+||+.|     |+.+++
T Consensus       316 i~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHGGGSS-----SHHHHH
T ss_pred             HHHHhccC-----CHHHHH
Confidence            99999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.4e-32  Score=268.67  Aligned_cols=186  Identities=18%  Similarity=0.093  Sum_probs=131.0

Q ss_pred             ccccCCCeeEEEEEEcCCCeEEEEEEcccCC----------hhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEE
Q 038118           48 KLGQGGFGGVYKGFFRETSSYIAVKRVSKGS----------KQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        48 ~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      .+..|++|.+..++..-.|+.|++|++....          ....++|.+|+++|+++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3455666666665555567789999986531          22346799999999999 599999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||++|++|.++|.. .+.++..   +++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++......
T Consensus       321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            999999999999954 4566664   57899999999999   7999999999999999999999999999997654322


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP  242 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~p  242 (376)
                       .......||+.|+|||++.+ .+..++|+|++|+++++|.++..+
T Consensus       394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence             23345679999999999875 467789999999998887665544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=5.1e-28  Score=237.52  Aligned_cols=184  Identities=14%  Similarity=0.142  Sum_probs=141.6

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---h-----hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---K-----QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ...+.||+|+||.||+|...  +..+++|......   .     ...+++.+|++++++++||||+++..++...+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            34568999999999999544  5678888765431   1     123458999999999999999966666667777899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++++|.+++..         ++.++.||+.+|.|||   +++|+||||||+|||++.  .+||+|||+++.....
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999998854         4589999999999999   799999999999999998  9999999999876432


Q ss_pred             CCcc------eeeeccCCCCCchhhhcc--CCCCCCCceeechhhHHHHHhCCCCC
Q 038118          196 KGSQ------TTVLAGTMGYMAPECATT--GRASKESDVYSFGIVALEIACGRKPI  243 (376)
Q Consensus       196 ~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~~lltg~~pf  243 (376)
                      ....      .....||+.|+|||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1111      134579999999999976  56788899999988888777666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.1e-25  Score=203.25  Aligned_cols=155  Identities=14%  Similarity=0.102  Sum_probs=124.1

Q ss_pred             CHHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh------------------hhHHHHHHHHHHHH
Q 038118           32 TYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK------------------QGIKEYASEVTIIS   93 (376)
Q Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~   93 (376)
                      .+..+......|.+.+.||+|+||.||+|.+ .+|+.||+|++.....                  .....+.+|+.+++
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~  159 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ  159 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence            3445555566677779999999999999999 7799999999965321                  13456889999999


Q ss_pred             hCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCe
Q 038118           94 RLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNI  173 (376)
Q Consensus        94 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Ni  173 (376)
                      .++  | +++++++.. +..|+||||++|++|.+ +..       .....++.||+.+|.|||   +.||+||||||+||
T Consensus       160 ~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NI  224 (282)
T 1zar_A          160 KLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNV  224 (282)
T ss_dssp             HTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred             hcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHE
Confidence            999  5 666666544 55699999999999987 421       124479999999999999   79999999999999


Q ss_pred             eecCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhcc
Q 038118          174 MLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT  217 (376)
Q Consensus       174 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  217 (376)
                      |++ ++.+||+|||++.              .+..+.|||++..
T Consensus       225 Ll~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSV--------------EVGEEGWREILER  253 (282)
T ss_dssp             EEE-TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred             EEE-CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence            999 9999999999986              2446789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=2.7e-21  Score=172.34  Aligned_cols=140  Identities=18%  Similarity=0.065  Sum_probs=106.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeE--EEEEEcccCChh------------------------hHHHHHHHHHHHHh
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSY--IAVKRVSKGSKQ------------------------GIKEYASEVTIISR   94 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~   94 (376)
                      .-|++.+.||+|+||.||+|.+..+|..  ||||++......                        ....+.+|+..|..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999999667888  999987543111                        11357889999999


Q ss_pred             CCCCCc--cceeeEEeeCCeEEEEEecCCC-C----ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 038118           95 LRHRNL--VQLLGWCHEKKELLLVYEYMPN-G----SLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD  167 (376)
Q Consensus        95 l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d  167 (376)
                      +.|+++  +.++.+    ...+|||||+.+ |    +|.+....    .++..+..++.||+.+|.+||.  +.||+|||
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrD  196 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHAD  196 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence            988754  444432    356899999942 3    55554322    2244567899999999999994  47999999


Q ss_pred             ccCCCeeecCCceEEEeeCCCcccc
Q 038118          168 IKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       168 lkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      |||+|||++.  .++|+|||++...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  8999999999643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=1.4e-18  Score=161.31  Aligned_cols=148  Identities=12%  Similarity=0.072  Sum_probs=104.9

Q ss_pred             HHHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh------------------hhH----HHHHHHHH
Q 038118           33 YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK------------------QGI----KEYASEVT   90 (376)
Q Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~------------------~~~----~~~~~e~~   90 (376)
                      +..+.....-|++.+.||.|+||.||+|.+. +|+.||||+++....                  ...    ....+|..
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            3455555555999999999999999999985 488999998753210                  000    01235677


Q ss_pred             HHHhCCCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccC
Q 038118           91 IISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS  170 (376)
Q Consensus        91 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp  170 (376)
                      .|.++.+.++.-..-+...  ..+|||||++|++|..+..     .+  ....++.||+.+|.+||   +.|||||||||
T Consensus       166 nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~-----~~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp  233 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS-----VP--DPASLYADLIALILRLA---KHGLIHGDFNE  233 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC-----CS--CHHHHHHHHHHHHHHHH---HTTEECSCCST
T ss_pred             HHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc-----cH--HHHHHHHHHHHHHHHHH---HCCCcCCCCCH
Confidence            7777755443221111122  2379999999988865431     11  23467899999999999   78999999999


Q ss_pred             CCeeecCCc----------eEEEeeCCCccccc
Q 038118          171 SNIMLDLNF----------NAKIGDFGLARLVE  193 (376)
Q Consensus       171 ~Nill~~~~----------~~kl~Dfg~~~~~~  193 (376)
                      .|||+++++          .+.|+||+-+....
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            999998877          38999999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=7.6e-14  Score=124.17  Aligned_cols=148  Identities=15%  Similarity=0.037  Sum_probs=115.6

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeE
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  113 (376)
                      .+.....+|++...++.|+.+.||++...  +..+++|+...........+.+|+.+++.+. +..++++++++...+..
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            44566788999999999999999999754  5679999987532122245788999999885 67788999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW----------------------------------  159 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~----------------------------------  159 (376)
                      |+|||+++|.+|.+.+..      ......++.+++.+|..||...                                  
T Consensus        86 ~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999999998765311      1123367888999999999610                                  


Q ss_pred             ----------------------CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 ----------------------EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 ----------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                                            ...++|+|+++.||++++++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  1569999999999999876556799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=4e-12  Score=112.55  Aligned_cols=139  Identities=18%  Similarity=0.093  Sum_probs=100.3

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC--ccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN--LVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv  116 (376)
                      ...+|.+....+.|..+.||++.. .+|..+++|+.....   ...+..|+.+++.+.+.+  +++++.+....+..++|
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            344566544444566699999965 446679999876542   245678999998886444  56788888888889999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW-------------------------------------  159 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-------------------------------------  159 (376)
                      |||++|.+|.  . ..   ...   ..++.+++..|..||...                                     
T Consensus        94 ~e~i~G~~l~--~-~~---~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           94 LGEVPGQDLL--S-SH---LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EECCSSEETT--T-SC---CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEecCCcccC--c-Cc---CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            9999998883  2 11   111   256777778888888531                                     


Q ss_pred             ------------------CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 ------------------EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 ------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                                        ..+++|+|++|.||++++++.+.|+||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                              1239999999999999877667799999974

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=5.5e-11  Score=110.63  Aligned_cols=142  Identities=13%  Similarity=0.161  Sum_probs=106.1

Q ss_pred             cCCccccCCCeeEEEEEEcCCCeEEEEEEcc--cCC-hhhHHHHHHHHHHHHhCC--CCCccceeeEEeeC---CeEEEE
Q 038118           45 DDQKLGQGGFGGVYKGFFRETSSYIAVKRVS--KGS-KQGIKEYASEVTIISRLR--HRNLVQLLGWCHEK---KELLLV  116 (376)
Q Consensus        45 ~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv  116 (376)
                      ..+.|+.|.++.||+....  +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4567999999999998865  3568888776  332 122356788999999997  45688899988776   458999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW-------------------------------------  159 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-------------------------------------  159 (376)
                      |||++|..+.+..   ...++......++.+++..|..||...                                     
T Consensus       120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999998875422   123567778889999999999999631                                     


Q ss_pred             ------------------CCceEeecccCCCeeecCCce--EEEeeCCCccc
Q 038118          160 ------------------EQCVVHRDIKSSNIMLDLNFN--AKIGDFGLARL  191 (376)
Q Consensus       160 ------------------~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~  191 (376)
                                        ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999997753  68999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=2.6e-11  Score=110.21  Aligned_cols=184  Identities=20%  Similarity=0.170  Sum_probs=121.1

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCC--ccceeeEEeeCC---eEEEEEec
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRN--LVQLLGWCHEKK---ELLLVYEY  119 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~  119 (376)
                      .+.++.|.+..||+..     ..+++|+....  .....+.+|+..|+.+. +..  +++++.......   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863     34888876432  34567889999998884 332  445555443333   45899999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW----------------------------------------  159 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~----------------------------------------  159 (376)
                      ++|.+|.....   ..++......++.+++..+..||...                                        
T Consensus        98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99988865432   23566667778888888888888510                                        


Q ss_pred             ---------------CCceEeecccCCCeeecC--CceEEEeeCCCccccccCCCcceeeeccCCCC---Cchhhhcc--
Q 038118          160 ---------------EQCVVHRDIKSSNIMLDL--NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY---MAPECATT--  217 (376)
Q Consensus       160 ---------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~--  217 (376)
                                     ...++|+|+++.||+++.  .+.+.|+||+.+......  ...   .....+   ..|+....  
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl---~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDF---ISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHH---HTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHH---HHHHhhccccCHHHHHHHH
Confidence                           145899999999999998  556889999988642110  000   001111   23332211  


Q ss_pred             ---CCC---------CCCCceeechhhHHHHHhCCCCCC
Q 038118          218 ---GRA---------SKESDVYSFGIVALEIACGRKPIS  244 (376)
Q Consensus       218 ---~~~---------~~~sDvwslG~il~~lltg~~pf~  244 (376)
                         +..         ....+.|+++.++|.+.+|..+|.
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence               000         122589999999999999988864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.80  E-value=6.5e-08  Score=85.91  Aligned_cols=146  Identities=16%  Similarity=0.113  Sum_probs=104.1

Q ss_pred             HHHHhhCCCcCCccccCCCe-eEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeE
Q 038118           36 LAQATNDFNDDQKLGQGGFG-GVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        36 ~~~~~~~y~~~~~lg~G~~g-~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  113 (376)
                      +......|+.. .+..|..+ .||+......+..+++|+-...   ....+.+|+..|+.+. +-.+.+++.++.+.+..
T Consensus        20 l~~~l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~   95 (272)
T 4gkh_A           20 LDADLYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA   95 (272)
T ss_dssp             HHHHHTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HhccccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence            34444455543 44455555 6899887777778999986543   3456788999998885 33478889999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW----------------------------------  159 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~----------------------------------  159 (376)
                      ++|||+++|.++.+.....     ......+..+++..|..||...                                  
T Consensus        96 ~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           96 WLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            9999999998876654321     1122346666777777777420                                  


Q ss_pred             ---------------------CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 ---------------------EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 ---------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                                           ...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                 1137999999999999987777799999985

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=1.8e-07  Score=84.75  Aligned_cols=135  Identities=19%  Similarity=0.197  Sum_probs=92.6

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCC---CccceeeEEe-eCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHR---NLVQLLGWCH-EKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~  122 (376)
                      +.++.|....||+.     +..+++|+..  .......+..|+.+|+.+.+.   .+++++.+.. ..+..++|||+++|
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            46788888899987     3458888742  233456788999999999753   3566777664 45567899999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG--------------------------------------------  158 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------------------------------------------  158 (376)
                      ..+......   .++......++.+++..|..||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            887653211   123344444455555555555432                                            


Q ss_pred             -------------CCCceEeecccCCCeeecC---Cce-EEEeeCCCccc
Q 038118          159 -------------WEQCVVHRDIKSSNIMLDL---NFN-AKIGDFGLARL  191 (376)
Q Consensus       159 -------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfg~~~~  191 (376)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1346799999999999987   455 48999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.48  E-value=2.3e-07  Score=85.90  Aligned_cols=80  Identities=5%  Similarity=-0.037  Sum_probs=54.9

Q ss_pred             Ccc-ccCCCeeEEEEEEc---C---CCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCC-C--CCccceeeEEeeC---
Q 038118           47 QKL-GQGGFGGVYKGFFR---E---TSSYIAVKRVSKGS---KQGIKEYASEVTIISRLR-H--RNLVQLLGWCHEK---  110 (376)
Q Consensus        47 ~~l-g~G~~g~vy~a~~~---~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---  110 (376)
                      +.| +.|....+|+....   .   ++..+++|+.....   ......+..|+.+++.+. +  -.+++++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88888999988654   1   15678889765432   001235677888888875 2  3577888887655   


Q ss_pred             CeEEEEEecCCCCChh
Q 038118          111 KELLLVYEYMPNGSLD  126 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~  126 (376)
                      +..++|||+++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3578999999987764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.47  E-value=9.3e-07  Score=83.05  Aligned_cols=76  Identities=16%  Similarity=0.164  Sum_probs=49.6

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-------hhHHHHHHHHHHHHhCCC--C-CccceeeEEeeCCeEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-------QGIKEYASEVTIISRLRH--R-NLVQLLGWCHEKKELLL  115 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~l  115 (376)
                      .+.||.|.++.||++....++..++||.......       ....++..|+++++.+..  + .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4579999999999997665567899998653221       123456778888887742  3 34566654  3445689


Q ss_pred             EEecCCCC
Q 038118          116 VYEYMPNG  123 (376)
Q Consensus       116 v~e~~~~~  123 (376)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.34  E-value=7.4e-06  Score=74.95  Aligned_cols=152  Identities=15%  Similarity=0.157  Sum_probs=83.8

Q ss_pred             HHHHHHHh-hCCCc----CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC--CCCccceee
Q 038118           33 YKELAQAT-NDFND----DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR--HRNLVQLLG  105 (376)
Q Consensus        33 ~~~~~~~~-~~y~~----~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~  105 (376)
                      ..++.... ..|.+    .+.|+.|..+.||+....+ + .+++|+.... .   ..+..|+.+++.|.  .-.+++++.
T Consensus        19 ~~~l~~~l~~~~~~~~~~~~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~   92 (346)
T 2q83_A           19 LTELAENVLQGWDVQAEKIDVIQGNQMALVWKVHTDS-G-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILP   92 (346)
T ss_dssp             HHHHHHHHGGGSCCCCCEEEECC----CEEEEEEETT-E-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCC
T ss_pred             HHHHHHHHHHHcCCceEEeeeccccccCcEEEEEeCC-C-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceee
Confidence            34444433 55543    2346567789999987643 3 4899988753 2   22334455555443  112333332


Q ss_pred             ------EEeeCCeEEEEEecCCCCChh--------------hhhhh--cCC--C---------CCHHH------------
Q 038118          106 ------WCHEKKELLLVYEYMPNGSLD--------------SHLFK--ENN--L---------LTWEF------------  140 (376)
Q Consensus       106 ------~~~~~~~~~lv~e~~~~~sL~--------------~~l~~--~~~--~---------~~~~~------------  140 (376)
                            +....+..++||+|++|..+.              ..++.  ...  +         ..+..            
T Consensus        93 ~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  172 (346)
T 2q83_A           93 NKKGSLYSKHGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETW  172 (346)
T ss_dssp             CTTSCSCEEETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHH
T ss_pred             cCCCCEEEEECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHH
Confidence                  223467789999999986542              01111  000  0         11111            


Q ss_pred             -------------------HHHHHHHHHHHHHHHHh----------CCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          141 -------------------RFKIAQDLASGLLYLQE----------GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       141 -------------------~~~~~~~i~~~l~~Lh~----------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                                         +..+...+..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          173 KLMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHhccCCcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                               00111123334555542          125789999999999999888899999999874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=7.2e-05  Score=67.62  Aligned_cols=75  Identities=15%  Similarity=0.123  Sum_probs=59.7

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEEEEecCCC
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR---HRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      .+.|+.|.+..+|+....  +..+++|+....   ....+..|+..|+.|.   ...+++++.+....+..++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456899999999998753  566888987643   2466888999998884   35688899988888899999999998


Q ss_pred             CCh
Q 038118          123 GSL  125 (376)
Q Consensus       123 ~sL  125 (376)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.02  E-value=2.5e-05  Score=69.81  Aligned_cols=81  Identities=14%  Similarity=0.164  Sum_probs=58.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC---CCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH---RNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv  116 (376)
                      +....-.+.+|.|..+.||+.+..+ |+.|.+|+...........|..|+..|+.|..   -.+++++.+.    ..++|
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            4455667789999999999998754 77899998765544334567889999998852   2355666542    23789


Q ss_pred             EecCCCCCh
Q 038118          117 YEYMPNGSL  125 (376)
Q Consensus       117 ~e~~~~~sL  125 (376)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.92  E-value=4.2e-05  Score=72.33  Aligned_cols=31  Identities=16%  Similarity=0.342  Sum_probs=28.0

Q ss_pred             CCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ...++|+|+++.||+++.++ +.|+||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            68899999999999998876 99999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.84  E-value=6.8e-05  Score=69.67  Aligned_cols=139  Identities=15%  Similarity=0.153  Sum_probs=83.6

Q ss_pred             CccccCCCeeEEEEEEcC-------CCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEe
Q 038118           47 QKLGQGGFGGVYKGFFRE-------TSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +.|..|-...+|++....       ++..+++++..... .....+.+|..+++.|. +.-.+++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            567778889999988742       34678999864322 23455668999998885 3334667766654    29999


Q ss_pred             cCCCCChhhh----------h-------hhc----CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 038118          119 YMPNGSLDSH----------L-------FKE----NNLLT--WEFRFKIAQDLAS-------------------GLLYLQ  156 (376)
Q Consensus       119 ~~~~~sL~~~----------l-------~~~----~~~~~--~~~~~~~~~~i~~-------------------~l~~Lh  156 (376)
                      |++|.+|...          +       +..    .+...  +..+.+|..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665321          0       111    11111  3445555544322                   122222


Q ss_pred             ----h-CCCCceEeecccCCCeeecCC----ceEEEeeCCCcc
Q 038118          157 ----E-GWEQCVVHRDIKSSNIMLDLN----FNAKIGDFGLAR  190 (376)
Q Consensus       157 ----~-~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~  190 (376)
                          . .....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                1 123579999999999999876    689999999885

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.80  E-value=0.00022  Score=64.52  Aligned_cols=157  Identities=12%  Similarity=0.141  Sum_probs=88.8

Q ss_pred             ccCHHHHHHHhhCCCcC-----CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC--ccc
Q 038118           30 RFTYKELAQATNDFNDD-----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN--LVQ  102 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~-----~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~  102 (376)
                      .++.+++.....+|.+.     +.|+.|....+|+....+ + .+++|+......  ...+..|+.+++.|...+  +++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCc
Confidence            46777888877778763     346668888999987653 3 588998875311  123445677666664212  233


Q ss_pred             eee------EEeeCCeEEEEEecCCCCChhh--------------hhhhc--C--CC----CC---HHHHHH--------
Q 038118          103 LLG------WCHEKKELLLVYEYMPNGSLDS--------------HLFKE--N--NL----LT---WEFRFK--------  143 (376)
Q Consensus       103 ~~~------~~~~~~~~~lv~e~~~~~sL~~--------------~l~~~--~--~~----~~---~~~~~~--------  143 (376)
                      ++.      +....+..+++|+|++|..+..              .++..  .  ..    ..   +...+.        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            332      1223467799999999865421              01111  0  00    11   111000        


Q ss_pred             ----HHHHHHHHHHHHHhC----CCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          144 ----IAQDLASGLLYLQEG----WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       144 ----~~~~i~~~l~~Lh~~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                          +...+...+..++..    ...+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                001133344444421    14579999999999999887666899999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.74  E-value=0.0001  Score=70.32  Aligned_cols=74  Identities=14%  Similarity=0.046  Sum_probs=48.6

Q ss_pred             CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecCCCCCh
Q 038118           47 QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL-VQLLGWCHEKKELLLVYEYMPNGSL  125 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL  125 (376)
                      +.|+.|-...+|++.....+..+++|+........ -....|+.+++.|...++ +++++++.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            46788888999999876545778899875432111 112578999998875444 56777663  2  259999988554

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.68  E-value=0.0001  Score=69.83  Aligned_cols=74  Identities=16%  Similarity=0.172  Sum_probs=50.0

Q ss_pred             CCccccCCCeeEEEEEEcC-------CCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeEEEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRE-------TSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN-LVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~  117 (376)
                      .+.|+.|....+|++....       .+..+++|+......  ...+..|+.+++.|...+ .+++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567888889999998753       246789998844211  134557998888886333 3667766543    3899


Q ss_pred             ecCCCCCh
Q 038118          118 EYMPNGSL  125 (376)
Q Consensus       118 e~~~~~sL  125 (376)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.67  E-value=0.00032  Score=63.89  Aligned_cols=139  Identities=15%  Similarity=0.076  Sum_probs=71.1

Q ss_pred             CccccCCCee-EEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC--CCccceeeEEeeCCeEEEEEecCCCC
Q 038118           47 QKLGQGGFGG-VYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH--RNLVQLLGWCHEKKELLLVYEYMPNG  123 (376)
Q Consensus        47 ~~lg~G~~g~-vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~  123 (376)
                      +.|+.|+... +|+.... ++..+++|.......   ..+..|+.+++.+..  -.+++++.+....+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            4566665554 6666542 245677776554321   223446666666642  23566776644443  7899999776


Q ss_pred             Chhhhhhhc-------------------------CCCCCHHHHH-------HHH-------------HHHHHHHHHHH--
Q 038118          124 SLDSHLFKE-------------------------NNLLTWEFRF-------KIA-------------QDLASGLLYLQ--  156 (376)
Q Consensus       124 sL~~~l~~~-------------------------~~~~~~~~~~-------~~~-------------~~i~~~l~~Lh--  156 (376)
                      .+.+.+...                         ..........       .+.             ..+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            654322110                         0111111110       000             01111222221  


Q ss_pred             -hCCCCceEeecccCCCeeecCC----ceEEEeeCCCccc
Q 038118          157 -EGWEQCVVHRDIKSSNIMLDLN----FNAKIGDFGLARL  191 (376)
Q Consensus       157 -~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfg~~~~  191 (376)
                       ......++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1125689999999999999874    6799999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.64  E-value=6.4e-05  Score=67.59  Aligned_cols=71  Identities=13%  Similarity=0.119  Sum_probs=45.0

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecC-CCC
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL-VQLLGWCHEKKELLLVYEYM-PNG  123 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~~~  123 (376)
                      .+.|+.|....+|+.      ..+++|+........ .....|+..++.+...++ ++++.++  .+.-++|+||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            678999999999998      338888876542221 123468887777753233 4666543  33347899999 665


Q ss_pred             Ch
Q 038118          124 SL  125 (376)
Q Consensus       124 sL  125 (376)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            55

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.63  E-value=0.0007  Score=61.36  Aligned_cols=158  Identities=11%  Similarity=0.070  Sum_probs=89.5

Q ss_pred             CcccCHHHHHHHhhCCCcC-----CccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCC--Cc
Q 038118           28 PKRFTYKELAQATNDFNDD-----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHR--NL  100 (376)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i  100 (376)
                      ...++.+++......|.+.     ..|+ |....||+....+ |+.+++|....... ....+..|..+++.+...  .+
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~v   84 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDED-RRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPV   84 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTT-CCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSB
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCC-CCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCee
Confidence            4456666676666666542     2466 7888999876543 55689999864321 234556677777776422  23


Q ss_pred             cceeeE-----EeeCCeEEEEEecCCCCChhh-----------h---hhh--c------CCCCCHHHH----HHH-----
Q 038118          101 VQLLGW-----CHEKKELLLVYEYMPNGSLDS-----------H---LFK--E------NNLLTWEFR----FKI-----  144 (376)
Q Consensus       101 ~~~~~~-----~~~~~~~~lv~e~~~~~sL~~-----------~---l~~--~------~~~~~~~~~----~~~-----  144 (376)
                      ++++..     ....+..++||++++|..+..           .   ++.  .      .........    ..+     
T Consensus        85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  164 (328)
T 1zyl_A           85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT  164 (328)
T ss_dssp             CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred             cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence            444332     233567789999998854321           0   111  0      001111110    000     


Q ss_pred             ----------HHHHHHHHHHHHh----CCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          145 ----------AQDLASGLLYLQE----GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       145 ----------~~~i~~~l~~Lh~----~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                                ...+...+..+..    .....++|+|+++.||+++ + .+.|+||+.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                      1111112222221    1256789999999999998 4 89999998875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.54  E-value=0.00012  Score=61.54  Aligned_cols=103  Identities=15%  Similarity=0.039  Sum_probs=67.3

Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcceee
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTV  202 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  202 (376)
                      -+|.+.|...+.++++.++|.++.|.+..|.-+-.  +..-..+=+.|..|++..+|.|-+.+ ..+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            37888888888999999999999999998876521  11112334457889999998887764 2110            


Q ss_pred             eccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCC
Q 038118          203 LAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP  242 (376)
Q Consensus       203 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~p  242 (376)
                       .....+.+||... ...+.+.=|||||++||..+--..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             0123566888653 3456778899999999998864333

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.40  E-value=0.00048  Score=63.74  Aligned_cols=75  Identities=13%  Similarity=0.115  Sum_probs=45.5

Q ss_pred             CCccccCCCeeEEEEEEcCC--------CeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeEEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRET--------SSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN-LVQLLGWCHEKKELLLV  116 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv  116 (376)
                      .+.|+.|....+|+....+.        +..+++|+....... ......|..+++.+...+ .+++++.+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            34677888899999986531        257888887654322 122356888888775333 45666544  2  2689


Q ss_pred             EecCCCCCh
Q 038118          117 YEYMPNGSL  125 (376)
Q Consensus       117 ~e~~~~~sL  125 (376)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.18  E-value=0.0033  Score=57.39  Aligned_cols=31  Identities=19%  Similarity=0.273  Sum_probs=27.8

Q ss_pred             CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 ~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            4679999999999999988889999998875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.62  E-value=0.0067  Score=57.01  Aligned_cols=75  Identities=9%  Similarity=0.044  Sum_probs=49.2

Q ss_pred             CCccccCCCeeEEEEEEcCC-------CeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRET-------SSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      .+.|..|-...+|+......       +..+++++....... .-...+|..+++.+. +.-.+++++.+.  +  ++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence            35677788899999987631       467899987554322 122356888888775 333456665432  2  7899


Q ss_pred             ecCCCCCh
Q 038118          118 EYMPNGSL  125 (376)
Q Consensus       118 e~~~~~sL  125 (376)
                      ||++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.71  E-value=0.034  Score=51.85  Aligned_cols=30  Identities=23%  Similarity=0.345  Sum_probs=25.4

Q ss_pred             ceEeecccCCCeee------cCCceEEEeeCCCccc
Q 038118          162 CVVHRDIKSSNIML------DLNFNAKIGDFGLARL  191 (376)
Q Consensus       162 ~i~H~dlkp~Nill------~~~~~~kl~Dfg~~~~  191 (376)
                      .++|+|+.+.||++      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4456799999999863

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.18  E-value=0.033  Score=52.97  Aligned_cols=62  Identities=5%  Similarity=0.039  Sum_probs=18.4

Q ss_pred             CcCCccccCCCeeEEEEEEcCCCeEEEE------EEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEe
Q 038118           44 NDDQKLGQGGFGGVYKGFFRETSSYIAV------KRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        44 ~~~~~lg~G~~g~vy~a~~~~~~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      .+.+.||   ||.||+|.+......||+      |.....  ..+....|.+|..+.+.++|+|+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4456676   999999999875567888      665543  2333456888999999999999999988764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.73  E-value=1.1  Score=37.55  Aligned_cols=116  Identities=5%  Similarity=0.006  Sum_probs=76.2

Q ss_pred             CCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee
Q 038118           96 RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML  175 (376)
Q Consensus        96 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill  175 (376)
                      .||+++.. .+-..++.+.+.++.-+.+.=+..+    +..+....++++.+|+....+++     .-+|--|+|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEE
Confidence            57888766 5666777777766654322212223    34678888999999988775444     45788899999999


Q ss_pred             cCCceEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCC
Q 038118          176 DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPIS  244 (376)
Q Consensus       176 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~  244 (376)
                      +.++.+++.-.|+-..+.             |.=+..|.+          .-.+=|++..+++++..|.
T Consensus       113 ~~~~~p~i~~RGik~~l~-------------P~~~~ee~f----------L~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD-------------PLPVSEAEF----------LTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTTBS-------------CCCCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccCCC-------------CCCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            999999998877643210             000112211          2244578888899988874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.69  E-value=2.1  Score=35.92  Aligned_cols=84  Identities=12%  Similarity=-0.001  Sum_probs=59.4

Q ss_pred             CCCCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeee
Q 038118           96 RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIML  175 (376)
Q Consensus        96 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill  175 (376)
                      .||++  -..+-.+++.+.+.++.-+++.=+..+    +.++....++++.+|+....    .+...-+|--|+|+||++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~----~~~~~r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVK----HHSARRLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHS----SCCSSSEECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHH----HhhhCceeEEEeCceEEE
Confidence            47777  334446777777777765443323333    34678888899998876654    113466888899999999


Q ss_pred             cCCceEEEeeCCCc
Q 038118          176 DLNFNAKIGDFGLA  189 (376)
Q Consensus       176 ~~~~~~kl~Dfg~~  189 (376)
                      +.++.+++.-.|+-
T Consensus       118 ~~~~~p~i~hRGi~  131 (219)
T 4ano_A          118 NRALEPFFLHVGVK  131 (219)
T ss_dssp             CTTCCEEESCCEET
T ss_pred             eCCCcEEEEEcCCc
Confidence            99999999988875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	376
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-72
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-70
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-69
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-67
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-65
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-64
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-64
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-63
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-57
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-56
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-50
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-48
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-45
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-37
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 1e-72
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 25/279 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIKEYASEVTIISRLRHR 98
                 Q++G G FG VYKG +      +AVK   V+  + Q ++ + +EV ++ + RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           N++  +G+    + L +V ++    SL  HL              IA+  A G+ YL   
Sbjct: 65  NILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL--- 120

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATT 217
             + ++HRD+KS+NI L  +   KIGDFGLA +     GS Q   L+G++ +MAPE    
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 218 ---GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP 274
                 S +SDVY+FGIV  E+  G+ P S        +     +  + G G L     P
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYS-------NINNRDQIIFMVGRGYL----SP 229

Query: 275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
            L +           ++   C     + RP   Q++  +
Sbjct: 230 DLSKVRSNCPKAMKRLM-AECLKKKRDERPLFPQILASI 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  221 bits (563), Expect = 2e-70
 Identities = 75/302 (24%), Positives = 139/302 (46%), Gaps = 38/302 (12%)

Query: 31  FTYKELAQATNDFND---------DQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG- 77
           FT+++  +A  +F           +Q +G G FG V  G  +       ++A+K +  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 78  SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLT 137
           +++  +++ SE +I+ +  H N++ L G   +   ++++ E+M NGSLDS L + +   T
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG 197
                 + + +A+G+ YL    +   VHRD+ + NI+++ N   K+ DFGL+R +E    
Sbjct: 127 VIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 198 SQTTVLA----GTMGYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQ 252
             T   A      + + APE     + +  SDV+S+GIV  E+ + G +P          
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233

Query: 253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV 312
                  +    N  ++ A++              L  + L C   D N RP   Q+++ 
Sbjct: 234 -------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 313 LN 314
           L+
Sbjct: 287 LD 288

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 1e-69
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 21/273 (7%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
           ++    Q++G G FG V+ G++      +A+K + +      +++  E  ++ +L H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKL 62

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           VQL G C E+  + LV+E+M +G L  +L  +  L   E    +  D+  G+ YL    E
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EE 119

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
            CV+HRD+ + N ++  N   K+ DFG+ R V   + + +T     + + +PE  +  R 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 221 SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF 280
           S +SDV+SFG++  E+    K           V  +   + LY          PRL    
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---------KPRLAST- 229

Query: 281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
                    I+   C       RP+  +++  L
Sbjct: 230 -----HVYQIM-NHCWKERPEDRPAFSRLLRQL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 5e-69
 Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 7/264 (2%)

Query: 39  ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRH 97
             +DF    +LG G  G V+K   + +   +A K +    K  I+     E+ ++     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             +V   G  +   E+ +  E+M  GSLD  L K+   +  +   K++  +  GL YL+E
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
             +  ++HRD+K SNI+++     K+ DFG++  +     S      GT  YM+PE    
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQG 177

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
              S +SD++S G+  +E+A GR PI     +E+++     V               R  
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 278 RDFDEQQMECLMIVGLWCAHPDEN 301
             +       + I  L     +E 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEP 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 2e-67
 Identities = 64/276 (23%), Positives = 128/276 (46%), Gaps = 24/276 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
            D    ++LG G FG V  G +R     +A+K + +GS     E+  E  ++  L H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           VQL G C +++ + ++ EYM NG L ++L +  +    +   ++ +D+   + YL     
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ES 118

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA 220
           +  +HRD+ + N +++     K+ DFGL+R V   + + +      + +  PE     + 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 221 SKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD 279
           S +SD+++FG++  EI + G+ P                 ++ + N +  E +   L   
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMP-----------------YERFTNSETAEHIAQGLRLY 221

Query: 280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLN 314
                 E +  +   C H   + RP+ + ++ ++L+
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  208 bits (531), Expect = 6e-66
 Identities = 67/289 (23%), Positives = 130/289 (44%), Gaps = 21/289 (7%)

Query: 28  PKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS 87
           P    Y +      D     KLG G +G VY+G +++ S  +AVK + + + + ++E+  
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62

Query: 88  EVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQ 146
           E  ++  ++H NLVQLLG C  +    ++ E+M  G+L  +L + N   ++      +A 
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 147 DLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGT 206
            ++S + YL    ++  +HRD+ + N ++  N   K+ DFGL+RL+     +        
Sbjct: 123 QISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 207 MGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
           + + APE     + S +SDV++FG++  EIA                      +      
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----------------YPGIDLS 223

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           ++ E ++     +  E   E +  +   C   + + RPS  ++     +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 8e-65
 Identities = 68/274 (24%), Positives = 127/274 (46%), Gaps = 23/274 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
                 ++LG G FG V+ G++    + +AVK + +GS      + +E  ++ +L+H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRL 70

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGW 159
           V+L     ++  + ++ EYM NGSL   L   + + LT      +A  +A G+ ++    
Sbjct: 71  VRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---E 126

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
           E+  +HRD++++NI++    + KI DFGLARL+E  + +        + + APE    G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 220 ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD 279
            + +SDV+SFGI+  EI    +                  +    N ++++ ++      
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP----------------YPGMTNPEVIQNLERGYRMV 230

Query: 280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
             +   E L  +   C       RP+   +  VL
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-64
 Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 27/278 (9%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRN 99
           D+     +G G +G   K   +     +  K +  GS  +   +   SEV ++  L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 100 LVQLLGWCHEKKE--LLLVYEYMPNGSLDSHLF---KENNLLTWEFRFKIAQDLASGLLY 154
           +V+      ++    L +V EY   G L S +    KE   L  EF  ++   L   L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 155 L--QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
              +      V+HRD+K +N+ LD   N K+GDFGLAR++ H   S      GT  YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV 272
           E       +++SD++S G +  E+     P   TA  + ++            GK+ E  
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELA-----------GKIREGK 230

Query: 273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
             R+   + ++  E +        +  +  RPS+ +++
Sbjct: 231 FRRIPYRYSDELNEIIT----RMLNLKDYHRPSVEEIL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 5e-64
 Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 31/299 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
                + KLGQG FG V+ G +  T+  +A+K +        + +  E  ++ +LRH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKL 74

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEGW 159
           VQL      ++ + +V EYM  GSL   L  E    L       +A  +ASG+ Y++   
Sbjct: 75  VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
               VHRD++++NI++  N   K+ DFGLARL+E  + +        + + APE A  GR
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 220 ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD 279
            + +SDV+SFGI+  E+    +                  +    N ++L+ V+      
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVP----------------YPGMVNREVLDQVERGYRMP 234

Query: 280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPPANM 338
              +  E L  +   C   +   RP+   +   L  E    +  P+      + P  N+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL--EDYFTSTEPQ------YQPGENL 285

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 9e-64
 Identities = 66/287 (22%), Positives = 130/287 (45%), Gaps = 26/287 (9%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKGSKQG-IKEYASEVTIISRL 95
           +     + +G G FG VYKG  + +S      +A+K +  G  +    ++  E  I+ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 96  RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYL 155
            H N+++L G   + K ++++ EYM NG+LD  L +++   +      + + +A+G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY- 125

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH--AKGSQTTVLAGTMGYMAPE 213
                   VHRD+ + NI+++ N   K+ DFGL+R++E        T+     + + APE
Sbjct: 126 --LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 214 CATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD 273
             +  + +  SDV+SFGIV  E+    +                  W+L  N ++++A++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELS-NHEVMKAIN 227

Query: 274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLP 320
                         +  + + C   +   RP    ++ +L+     P
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  205 bits (522), Expect = 9e-64
 Identities = 71/319 (22%), Positives = 129/319 (40%), Gaps = 22/319 (6%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
           + ++  ++LG G FG V++   R T +  A K V    +   +    E+  +S LRH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V L     +  E++++YE+M  G L   +  E+N ++ +   +  + +  GL ++    E
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HE 142

Query: 161 QCVVHRDIKSSNIMLDLNFN--AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
              VH D+K  NIM     +   K+ DFGL   ++  +  + T   GT  + APE A   
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK 200

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
                +D++S G+++  +  G  P      +E    +    W++          D     
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM----------DDSAFS 250

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLNSEAPLPALPPKMPVPTYFSPPAN 337
              E   + +          D N R +I Q + H   +    P    ++P   Y     +
Sbjct: 251 GISEDGKDFIR----KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

Query: 338 MRAVNGAGPDKGPNKNSSS 356
           ++    A P+  P     S
Sbjct: 307 IKTKYDAWPEPLPPLGRIS 325

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-63
 Identities = 67/291 (23%), Positives = 118/291 (40%), Gaps = 27/291 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           + +G+G FG V++G  +     +AVK  S   ++     A E+     LRH N++  +  
Sbjct: 9   ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 65

Query: 107 CHEK----KELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC 162
            ++      +L LV +Y  +GSL  +L +    +T E   K+A   ASGL +L       
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 163 -----VVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPEC 214
                + HRD+KS NI++  N    I D GLA   + A  +         GT  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 215 ATT------GRASKESDVYSFGIVALEIACGRKPISLTAKEE---VQVYLVQWVWDLYGN 265
                      + K +D+Y+ G+V  EIA       +    +     +       +    
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 266 GKLLEAVDPRL-CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
               + + P +  R    + +  +  +   C + +   R +  ++   L+ 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 65/289 (22%), Positives = 126/289 (43%), Gaps = 28/289 (9%)

Query: 34  KELAQATNDFN-DDQKLGQGGFGGVYKGFFRETSS--YIAVKRVSKGSKQG-IKEYASEV 89
           K+L    ++    D +LG G FG V +G +R       +A+K + +G+++   +E   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 90  TIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLA 149
            I+ +L +  +V+L+G C + + L+LV E    G L   L  +   +      ++   ++
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 150 SGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV--EHAKGSQTTVLAGTM 207
            G+ YL    E+  VHRD+ + N++L     AKI DFGL++ +  + +  +  +     +
Sbjct: 120 MGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNG 266
            + APEC    + S  SDV+S+G+   E  + G+KP                 +      
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-----------------YKKMKGP 219

Query: 267 KLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           +++  ++     +   +    L  +   C       RP    V   + +
Sbjct: 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 6e-62
 Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 24/270 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
            +LG G FG VYK   +ETS   A K +   S++ +++Y  E+ I++   H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
            + +  L ++ E+   G++D+ + +    LT      + +     L YL    +  ++HR
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 167 DIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA-----S 221
           D+K+ NI+  L+ + K+ DFG++         +     GT  +MAPE      +      
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 222 KESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFD 281
            ++DV+S GI  +E+A    P        V + + +                    +DF 
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW----SSNFKDF- 248

Query: 282 EQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
                   +      + D   R +  Q++ 
Sbjct: 249 --------LKKCLEKNVDA--RWTTSQLLQ 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-61
 Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 27/280 (9%)

Query: 44  NDDQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKGSKQG-IKEYASEVTIISRLRHRN 99
           + ++ +G+G FG VY G   +      + AVK +++ +  G + ++ +E  I+    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 100 LVQLLGWCHE-KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           ++ LLG C   +   L+V  YM +G L + +  E +  T +        +A G+   +  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFL 146

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ---TTVLAGTMGYMAPECA 215
             +  VHRD+ + N MLD  F  K+ DFGLAR +   +       T     + +MA E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
            T + + +SDV+SFG++  E+     P          V        L    +LL    P 
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPP------YPDVNTFDITVYLLQGRRLL---QPE 257

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
            C        + L  V L C HP   +RPS  +++  +++
Sbjct: 258 YC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 3e-61
 Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 28/273 (10%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQL 103
           D ++G+G F  VYKG   ET+  +A   +     +K   + +  E  ++  L+H N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 104 LGWCHE----KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
                     KK ++LV E M +G+L ++L K   ++  +      + +  GL +L    
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 160 EQCVVHRDIKSSNIML-DLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
              ++HRD+K  NI +     + KIGD GLA L      S    + GT  +MAPE     
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY-EE 187

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
           +  +  DVY+FG+  LE+A    P S   +   Q+Y            ++   V P    
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYR-----------RVTSGVKPASFD 235

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
                +++ ++     C   +++ R SI+ +++
Sbjct: 236 KVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-61
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 29/275 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNL 100
            +    Q +G+G FG V  G      + +AVK +   +    + + +E +++++LRH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62

Query: 101 VQLLGWCHEKKE-LLLVYEYMPNGSLDSHLFKENN-LLTWEFRFKIAQDLASGLLYLQEG 158
           VQLLG   E+K  L +V EYM  GSL  +L      +L  +   K + D+   + YL   
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--- 119

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
                VHRD+ + N+++  +  AK+ DFGL +       S        + + APE     
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREK 175

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
           + S +SDV+SFGI+  EI    +                  +       ++  V+     
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVP----------------YPRIPLKDVVPRVEKGYKM 219

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           D  +     +  V   C H D  +RPS  Q+   L
Sbjct: 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-61
 Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 28/273 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
            DF   + LG+G FG VY    +++   +A+K + K          +   EV I S LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
            N+++L G+ H+   + L+ EY P G++   L K +     +       +LA+ L Y   
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC-- 122

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + V+HRDIK  N++L      KI DFG +    HA  S+ T L GT+ Y+ PE    
Sbjct: 123 -HSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEG 178

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
               ++ D++S G++  E   G+ P    A    + Y            K +  V+    
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETY------------KRISRVEFTFP 224

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
               E   + +          + + RP +R+V+
Sbjct: 225 DFVTEGARDLIS----RLLKHNPSQRPMLREVL 253

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 5e-61
 Identities = 66/291 (22%), Positives = 125/291 (42%), Gaps = 25/291 (8%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN 99
              +   +K+GQG  G VY      T   +A+++++   +   +   +E+ ++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V  L       EL +V EY+  GSL   + +            + ++    L +L    
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH--- 133

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGR 219
              V+HRDIKS NI+L ++ + K+ DFG    +   + S+ + + GT  +MAPE  T   
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 220 ASKESDVYSFGIVALEIACGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
              + D++S GI+A+E+  G  P ++      + +       +L    KL       + R
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-----SAIFR 247

Query: 279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH--VLNSEAPLPALPPKMP 327
           DF         +        ++  R S ++++    L    PL +L P + 
Sbjct: 248 DF---------LNRCLDMDVEK--RGSAKELLQHQFLKIAKPLSSLTPLIA 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 6e-61
 Identities = 66/274 (24%), Positives = 106/274 (38%), Gaps = 31/274 (11%)

Query: 43  FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG---IKEYASEVTIISRLRHRN 99
           F+D +++G G FG VY       S  +A+K++S   KQ     ++   EV  + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
            +Q  G    +    LV EY    + D         L       +      GL YL    
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLH--- 132

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 216
              ++HRD+K+ NI+L      K+GDFG A ++     +      GT  +MAPE      
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMD 187

Query: 217 TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL 276
            G+   + DV+S GI  +E+A  + P  L     +                + +   P L
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALY-----------HIAQNESPAL 234

Query: 277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
                 +     +     C       RP+   ++
Sbjct: 235 QSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 62/301 (20%), Positives = 124/301 (41%), Gaps = 26/301 (8%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSY----IAVKRVSKG-SKQGIKEYASEVTIISRLR 96
           +F   + LG G FG VYKG +          +A+K + +  S +  KE   E  +++ + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           + ++ +LLG C     + L+ + MP G L  ++ +  + +  ++       +A G+ YL 
Sbjct: 70  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL- 127

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECA 215
              ++ +VHRD+ + N+++    + KI DFGLA+L+    K          + +MA E  
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
                + +SDV+S+G+   E+                       +D     ++   ++  
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISSILEKG 229

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEAPLPALPPKMPVPTYFSPP 335
                       + ++ + C   D + RP  R++I   +  A  P     +        P
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289

Query: 336 A 336
           +
Sbjct: 290 S 290

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 4e-60
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 40/293 (13%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSY--IAVKRVSK-GSKQGIKEYASEVTIISRL-R 96
           ND      +G+G FG V K   ++       A+KR+ +  SK   +++A E+ ++ +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL---------------LTWEFR 141
           H N++ LLG C  +  L L  EY P+G+L   L K   L               L+ +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 142 FKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTT 201
              A D+A G+ YL    ++  +HRD+ + NI++  N+ AKI DFGL+R  E     + T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKT 184

Query: 202 VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD 261
           +    + +MA E       +  SDV+S+G++  EI                       + 
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------YC 228

Query: 262 LYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
                +L E +      +      + +  +   C       RPS  Q++  LN
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 7e-60
 Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 29/278 (10%)

Query: 45  DDQKLGQGGFGGVYKGFFRETSS--YIAVKRVSKGSKQG--IKEYASEVTIISRLRHRNL 100
           +D++LG G FG V KG+++       +AVK +   +       E  +E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 101 VQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWE 160
           V+++G C E +  +LV E    G L+ +L +  ++   +   ++   ++ G+ YL    E
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYL---EE 125

Query: 161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTG 218
              VHRD+ + N++L     AKI DFGL++ +  +       T     + + APEC    
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 219 RASKESDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
           + S +SDV+SFG++  E  + G+KP                 +      ++   ++    
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP-----------------YRGMKGSEVTAMLEKGER 228

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                     +  +   C   D   RP    V   L +
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-58
 Identities = 68/272 (25%), Positives = 105/272 (38%), Gaps = 22/272 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHRN 99
            D++  Q LG+G +G V     R T   +AVK V         E    E+ I   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V+  G   E     L  EY   G L   +  +   +      +    L +G++YL    
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYL---H 120

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECATTG 218
              + HRDIK  N++LD   N KI DFGLA +   + +      + GT+ Y+APE     
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 219 R-ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
              ++  DV+S GIV   +  G +       +  Q Y        Y N    + +D    
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSA-P 236

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQV 309
                       +  +   +P    R +I  +
Sbjct: 237 LAL---------LHKILVENPSA--RITIPDI 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 6e-58
 Identities = 74/311 (23%), Positives = 125/311 (40%), Gaps = 49/311 (15%)

Query: 33  YKELAQATNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSK-GSKQGIKEYA 86
              L    N+    + +G+G FG V++         E  + +AVK + +  S     ++ 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 87  SEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL----------- 135
            E  +++   + N+V+LLG C   K + L++EYM  G L+  L   +             
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 136 ------------LTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKI 183
                       L+   +  IA+ +A+G+ YL    E+  VHRD+ + N ++  N   KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKI 181

Query: 184 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            DFGL+R +  A   +     A  + +M PE     R + ESDV+++G+V  EI      
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 243 ISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENL 302
                  E  +Y V+       +G +L            E     L  +   C       
Sbjct: 242 PYYGMAHEEVIYYVR-------DGNILA---------CPENCPLELYNLMRLCWSKLPAD 285

Query: 303 RPSIRQVIHVL 313
           RPS   +  +L
Sbjct: 286 RPSFCSIHRIL 296

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 7e-58
 Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 43/301 (14%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQG-IKEYASEVTIISR 94
           N  +  + LG G FG V +         + +  +AVK +   +     +   SE+ ++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 95  L-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNL-----------------L 136
           L  H N+V LLG C      L++ EY   G L + L ++ +                  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
             E     +  +A G+ +L     +  +HRD+ + NI+L      KI DFGLAR +++  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 197 GS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL 255
                      + +MAPE       + ESDV+S+GI   E+                   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                 +  + K  + +         E     +  +   C   D   RP+ +Q++ ++  
Sbjct: 247 --PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 316 E 316
           +
Sbjct: 305 Q 305

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 4e-57
 Identities = 68/282 (24%), Positives = 105/282 (37%), Gaps = 29/282 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSS---YIAVKRVSK---GSKQGIKEYASEVTIISR 94
            D    +KLG G FG V +G +   S     +AVK +        + + ++  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
           L HRNL++L G       + +V E  P GSL   L K           + A  +A G+ Y
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE--HAKGSQTTVLAGTMGYMAP 212
           L     +  +HRD+ + N++L      KIGDFGL R +                  + AP
Sbjct: 127 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV 272
           E   T   S  SD + FG+   E+    +                  W      ++L  +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKI 227

Query: 273 DPRLCR-DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVL 313
           D    R    E   + +  V + C       RP+   +   L
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-57
 Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 57/334 (17%)

Query: 15  NEYIDDEFEKGAGPKRFTYKELAQ-ATNDFNDDQKLGQGGFGGVYKGFFRETSS-----Y 68
           NEY   +       + + Y    +    +    + LG G FG V        S       
Sbjct: 16  NEYFYVD------FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69

Query: 69  IAVKRVSKGSKQG-IKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLD 126
           +AVK + + +     +   SE+ ++++L  H N+V LLG C     + L++EY   G L 
Sbjct: 70  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129

Query: 127 SHLFKEN----------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVV 164
           ++L  +                       N+LT+E     A  +A G+ +L+    +  V
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV 186

Query: 165 HRDIKSSNIMLDLNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGRASKE 223
           HRD+ + N+++      KI DFGLAR ++  +           + +MAPE    G  + +
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246

Query: 224 SDVYSFGIVALEI-ACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDE 282
           SDV+S+GI+  EI + G  P                   +  +    + +      D   
Sbjct: 247 SDVWSYGILLWEIFSLGVNPY----------------PGIPVDANFYKLIQNGFKMDQPF 290

Query: 283 QQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
              E + I+   C   D   RPS   +   L  +
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  187 bits (475), Expect = 8e-57
 Identities = 67/356 (18%), Positives = 135/356 (37%), Gaps = 31/356 (8%)

Query: 14  FNEYIDDEFEKGAGPKRFTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKR 73
           ++++ +D ++K   P+    K+     + ++  ++LG G FG V++   + T      K 
Sbjct: 4   YDKFYEDIWKK-YVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 61

Query: 74  VSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN 133
           ++           +E++I+++L H  L+ L     +K E++L+ E++  G L   +  E+
Sbjct: 62  INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121

Query: 134 NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA--KIGDFGLARL 191
             ++        +    GL ++    E  +VH DIK  NIM +    +  KI DFGLA  
Sbjct: 122 YKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178

Query: 192 VEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEV 251
           +         V   T  + APE          +D+++ G++   +  G  P +     E 
Sbjct: 179 LNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236

Query: 252 QVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
              + +       + +  E     +  +  +       I  L    P +  R ++     
Sbjct: 237 LQNVKR------CDWEFDEDAFSSVSPEAKD------FIKNLLQKEPRK--RLTVHD--- 279

Query: 312 VLNSE---APLPALPPKMPVPTYFSPPANMRAVNGAGPDKGPNKNSSSYSNFTSSS 364
            L           L  ++P   Y      ++      P   P       +NF+S  
Sbjct: 280 ALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPA--PQPAIGRIANFSSLR 333

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 65/301 (21%), Positives = 118/301 (39%), Gaps = 37/301 (12%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHR 98
           DF   + LG+G F  V       TS   A+K + K     +  +     E  ++SRL H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
             V+L     + ++L     Y  NG L  ++ K  +      RF  A+     +  L+  
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----IVSALEYL 124

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH-AKGSQTTVLAGTMGYMAPECATT 217
             + ++HRD+K  NI+L+ + + +I DFG A+++   +K ++     GT  Y++PE  T 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
             A K SD+++ G +  ++  G  P     +  +   +++            E   P+  
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LEYDFPEKFFPK-A 237

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHV-----------LNSEAPLPALPPKM 326
           RD          +  L      +  R    ++              +  E      PPK+
Sbjct: 238 RDL---------VEKLLVLDATK--RLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 286

Query: 327 P 327
            
Sbjct: 287 T 287

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-56
 Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 24/279 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSY---IAVKRVSKGSKQGIKE-YASEVTIISRLR 96
                 + +G+G FG V++G +    +    +A+K     +   ++E +  E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H ++V+L+G   E   + ++ E    G L S L      L        A  L++ L YL 
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL- 124

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
               +  VHRDI + N+++  N   K+GDFGL+R +E +   + +     + +MAPE   
Sbjct: 125 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 217 TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL 276
             R +  SDV+ FG+   EI           K    +  ++    L     +     P L
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PMPPNCPPTL 238

Query: 277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
                      LM     C   D + RP   ++   L++
Sbjct: 239 YS---------LM---TKCWAYDPSRRPRFTELKAQLST 265

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 58/283 (20%), Positives = 115/283 (40%), Gaps = 24/283 (8%)

Query: 33  YKELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTI 91
           +K+     + ++    LG G F  V     + T   +A+K ++K + +G +    +E+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 92  ISRLRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
           + +++H N+V L         L L+ + +  G L   +  E    T     ++   +   
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDA 119

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 208
           + YL    +  +VHRD+K  N++      +    I DFGL+++ +   GS  +   GT G
Sbjct: 120 VKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPG 174

Query: 209 YMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL 268
           Y+APE       SK  D +S G++A  + CG  P       ++   +++         + 
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK------AEYEF 228

Query: 269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
                  +     +       I  L    P++  R +  Q + 
Sbjct: 229 DSPYWDDISDSAKD------FIRHLMEKDPEK--RFTCEQALQ 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 35/292 (11%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISR 94
                 ++LGQG FG VY+G  +     E  + +A+K V++  S +   E+ +E +++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---------KENNLLTWEFRFKIA 145
               ++V+LLG   + +  L++ E M  G L S+L                +     ++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 146 QDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAKGSQTTVLA 204
            ++A G+ YL        VHRD+ + N M+  +F  KIGDFG+ R + E     +     
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 205 GTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG 264
             + +M+PE    G  +  SDV+SFG+V  EIA   +                  +    
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----------------YQGLS 240

Query: 265 NGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE 316
           N ++L  V      D  +   + L  +   C   +  +RPS  ++I  +  E
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-53
 Identities = 56/331 (16%), Positives = 111/331 (33%), Gaps = 27/331 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           + LG+G FG V++     +      K V             E++I++  RHRN++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
               +EL++++E++    +   +      L           +   L +L       + H 
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHF 126

Query: 167 DIKSSNIMLDLNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKES 224
           DI+  NI+     ++  KI +FG AR ++   G    +L     Y APE       S  +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 225 DVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQ 284
           D++S G +   +  G  P      +++   ++             E     +  +  +  
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMN------AEYTFDEEAFKEISIEAMD-- 236

Query: 285 MECLMIVGLWCAHPDENLRPSIRQVI-HVL---NSEAPLPALPPKMPVPTYFSPPANMRA 340
                +  L         R +  + + H       E     +   +    Y+      + 
Sbjct: 237 ----FVDRLLVKERKS--RMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTL-IKKD 289

Query: 341 VNGAGPDKGPNKNSSSYSNFTSSSAASSSAS 371
           +N        +   +  S    S A    AS
Sbjct: 290 LNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 64/299 (21%), Positives = 121/299 (40%), Gaps = 44/299 (14%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETS-------SYIAVKRVSKG-SKQGIKEYASEVTII 92
           +     + LG+G FG V                + +AVK +    +++ + +  SE+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 93  SRL-RHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLF---------------KENNLL 136
             + +H+N++ LLG C +   L ++ EY   G+L  +L                     L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 137 TWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK 196
           + +     A  +A G+ YL     +  +HRD+ + N+++  +   KI DFGLAR + H  
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 197 GSQTT-VLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYL 255
             + T      + +MAPE       + +SDV+SFG++  EI                   
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP------------ 237

Query: 256 VQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN 314
               +      +L + +      D        L ++   C H   + RP+ +Q++  L+
Sbjct: 238 ----YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (424), Expect = 3e-50
 Identities = 61/284 (21%), Positives = 106/284 (37%), Gaps = 28/284 (9%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLR 96
           ++ +   + LG GG   V+          +AVK +             +  E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 97  HRNLVQLLGWCHEKKE----LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL 152
           H  +V +      +        +V EY+   +L   +  E  + T +   ++  D    L
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQAL 124

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYM 210
            +     +  ++HRD+K +NIM+      K+ DFG+AR +       +QT  + GT  Y+
Sbjct: 125 NFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE 270
           +PE A        SDVYS G V  E+  G  P   T    V V        +  +     
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAY----QHVREDPIPPS 235

Query: 271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-SIRQVIHVL 313
           A    L  D D       +++     +P+   R  +  ++   L
Sbjct: 236 ARHEGLSADLDA------VVLKALAKNPEN--RYQTAAEMRADL 271

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  167 bits (424), Expect = 4e-50
 Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 36/285 (12%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---------KQGIKEYASEVTII 92
           ++   + LG+G    V +   + T    AVK +             ++  +    EV I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 93  SRLR-HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
            ++  H N++QL           LV++ M  G L  +L  E   L+ +   KI + L   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEV 122

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
           +  L    +  +VHRD+K  NI+LD + N K+ DFG +  ++   G +   + GT  Y+A
Sbjct: 123 ICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLA 177

Query: 212 PECATTGRA------SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN 265
           PE              KE D++S G++   +  G  P     ++++ +  +     + GN
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMI----MSGN 231

Query: 266 GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            +              +      ++       P +  R +  + +
Sbjct: 232 YQFGSPEWDDYSDTVKD------LVSRFLVVQPQK--RYTAEEAL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 4e-50
 Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 27/274 (9%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISR-LR 96
            DF   + LG+G FG V+   F++T+ + A+K + K        ++    E  ++S    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQ 156
           H  L  +      K+ L  V EY+  G L  H+ +  +          A ++  GL +L 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL- 119

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
               + +V+RD+K  NI+LD + + KI DFG+ +          T   GT  Y+APE   
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILL 176

Query: 217 TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL 276
             + +   D +SFG++  E+  G+ P     +EE+      +      N      ++   
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDNPFYPRWLEKE- 229

Query: 277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
            +D          +V L+   P++  R  +R  I
Sbjct: 230 AKDL---------LVKLFVREPEK--RLGVRGDI 252

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 4e-49
 Identities = 63/301 (20%), Positives = 113/301 (37%), Gaps = 24/301 (7%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-----SEVTIISRLRHRNLV 101
             LG+G F  VYK   + T+  +A+K++  G +   K+        E+ ++  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 102 QLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQ 161
            LL     K  + LV+++M        +   + +LT             GL YL    + 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQH 119

Query: 162 CVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRA- 220
            ++HRD+K +N++LD N   K+ DFGLA+       + T     T  Y APE     R  
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGARMY 178

Query: 221 SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW-----------VWDLYGNGKLL 269
               D+++ G +  E+      +   +  +    + +            +  L       
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLNSEAPLPALPPKMPV 328
                 L   F     + L ++       +   R +  Q +     S  P P    ++P 
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLI-QGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297

Query: 329 P 329
           P
Sbjct: 298 P 298

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  166 bits (420), Expect = 1e-48
 Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 29/275 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLR- 96
           NDF+  + +G+GGFG VY     +T    A+K + K     KQG     +E  ++S +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 97  --HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
                +V +    H   +L  + + M  G L  HL +       + RF  A ++  GL +
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122

Query: 155 LQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 214
           +     + VV+RD+K +NI+LD + + +I D GLA         +     GT GYMAPE 
Sbjct: 123 M---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASVGTHGYMAPEV 176

Query: 215 ATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD 273
              G A    +D +S G +  ++  G  P      ++        +       +L ++  
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPDSFS 233

Query: 274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQ 308
           P   R           + GL     +   R     
Sbjct: 234 PE-LRSL---------LEGLLQRDVNR--RLGCLG 256

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-48
 Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 42/299 (14%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKGSKQG-IKEYASEVTIISR 94
           +     + LG+G FG V +          T   +AVK + +G+     +   SE+ I+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 95  -LRHRNLVQLLGWCHEKKE-LLLVYEYMPNGSLDSHLFKENN---------------LLT 137
              H N+V LLG C +    L+++ E+   G+L ++L  + N                LT
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 138 WEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV-EHAK 196
            E     +  +A G+ +L     +  +HRD+ + NI+L      KI DFGLAR + +   
Sbjct: 133 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLV 256
             +       + +MAPE       + +SDV+SFG++  EI           K      + 
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------ID 243

Query: 257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           +        G  + A       D+   +M   M   L C H + + RP+  +++  L +
Sbjct: 244 EEFCRRLKEGTRMRAP------DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 293

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 7e-48
 Identities = 65/297 (21%), Positives = 106/297 (35%), Gaps = 41/297 (13%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSK------GSKQGIKEYASEVTIISR 94
           + +     LG GGFG VY G     +  +A+K V K      G          EV ++ +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 95  LR--HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL 152
           +      +++LL W       +L+ E             E   L  E        +   +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 211
            +        V+HRDIK  NI++DLN    K+ DFG   L++    +  T   GT  Y  
Sbjct: 124 RHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSP 177

Query: 212 PECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE 270
           PE     R   + + V+S GI+  ++ CG  P      EE+    V +   +        
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRV-------- 227

Query: 271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLNSEAPLPALPPKM 326
                 C+           I       P +  RP+  ++  H    +  LP    ++
Sbjct: 228 ---SSECQHL---------IRWCLALRPSD--RPTFEEIQNHPWMQDVLLPQETAEI 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (409), Expect = 2e-47
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
            DF   + LG G FG V+    R    Y A+K + K      + ++    E  ++S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             ++++ G   + +++ ++ +Y+  G L S L K         +F  A+      L L+ 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----VCLALEY 119

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + +++RD+K  NI+LD N + KI DFG A+ V       T  L GT  Y+APE  +T
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVST 175

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
              +K  D +SFGI+  E+  G  P
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-47
 Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 30/281 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYAS------EVTIISR 94
           + ++  ++LG G F  V K   + T    A K + K   +  +   S      EV+I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 95  LRHRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLY 154
           ++H N++ L      K +++L+ E +  G L   L ++ + LT E   +  + + +G   
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNG--- 125

Query: 155 LQEGWEQCVVHRDIKSSNIMLD----LNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 210
           +       + H D+K  NIML          KI DFGLA  ++   G++   + GT  ++
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFV 183

Query: 211 APECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE 270
           APE         E+D++S G++   +  G  P     K+E    +    ++     +   
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF--EDEYFS 241

Query: 271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
                L +DF         I  L    P +  R +I+  + 
Sbjct: 242 NTSA-LAKDF---------IRRLLVKDPKK--RMTIQDSLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-46
 Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 21/298 (7%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRN 99
           +F   +K+G+G +G VYK   + T   +A+K++     ++        E++++  L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 100 LVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW 159
           +V+LL   H + +L LV+E++               +           L  GL +     
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---H 119

Query: 160 EQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATTG 218
              V+HRD+K  N++++     K+ DFGLAR          T    T+ Y APE      
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 219 RASKESDVYSFGIVALEIACGRKPIS-------LTAKEEVQVYLVQWVWDLYGNGKLLEA 271
             S   D++S G +  E+   R           L           + VW    +    + 
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 272 VDPRLCRDFDEQQMECLMIVGL----WCAHPDENLRPSIRQVIH---VLNSEAPLPAL 322
             P+  R    + +  L   G        H D N R S +  +      +   P+P L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (391), Expect = 4e-45
 Identities = 49/278 (17%), Positives = 96/278 (34%), Gaps = 24/278 (8%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +K+G G FG +Y G        +A+K     +K    +   E  I   ++    +  + W
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
           C  + +  ++   +   SL+      +   + +    +A  + S + Y+     +  +HR
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHR 127

Query: 167 DIKSSNIM---LDLNFNAKIGDFGLARLVEHAKGSQ------TTVLAGTMGYMAPECATT 217
           D+K  N +           I DFGLA+    A+  Q         L GT  Y +      
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
              S+  D+ S G V +    G  P         +    +       + K +      LC
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------SEKKMSTPIEVLC 241

Query: 278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           + +  +    L     +C     + +P    +  +  +
Sbjct: 242 KGYPSEFATYLN----FCRSLRFDDKPDYSYLRQLFRN 275

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 6e-45
 Identities = 63/318 (19%), Positives = 120/318 (37%), Gaps = 31/318 (9%)

Query: 40  TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYA-SEVTIISRLRHR 98
              + +   +G+G +G V   +       +A+K++S    Q   +    E+ I+ R RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFK--ENNLLTWEFRFKIAQDLASGLLYLQ 156
           N++ +           +   Y+    + + L+K  +   L+ +        +  GL Y+ 
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI- 125

Query: 157 EGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYMAPEC 214
                 V+HRD+K SN++L+   + KI DFGLAR+   +H      T    T  Y APE 
Sbjct: 126 --HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 215 ATTGRA-SKESDVYSFGIVALEIACGRKP-----------------ISLTAKEEVQVYLV 256
               +  +K  D++S G +  E+   R                    S + ++   +  +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 257 QWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLNS 315
           +    L       +    RL  + D + ++ L          + + R  + Q + H    
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLD----KMLTFNPHKRIEVEQALAHPYLE 299

Query: 316 EAPLPALPPKMPVPTYFS 333
           +   P+  P    P  F 
Sbjct: 300 QYYDPSDEPIAEAPFKFD 317

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 6e-45
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 8/205 (3%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           NDF+  + LG+G FG V     + T  Y A+K + K    +K  +    +E  ++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             L  L         L  V EY   G L  HL +E        RF  A+     +  L+ 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE----IVSALEY 120

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
              + VV+RDIK  N+MLD + + KI DFGL +    + G+      GT  Y+APE    
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED 179

Query: 218 GRASKESDVYSFGIVALEIACGRKP 242
               +  D +  G+V  E+ CGR P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 7e-45
 Identities = 63/316 (19%), Positives = 117/316 (37%), Gaps = 33/316 (10%)

Query: 42  DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV 101
            + D + +G G FG VY+    ++   +A+K+V +  +   +    E+ I+ +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76

Query: 102 QLLGWCHEKKE------LLLVYEYMPNGSLDS--HLFKENNLLTWEFRFKIAQDLASGLL 153
           +L  + +   E      L LV +Y+P        H  +    L   +       L   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 154 YLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
           Y+       + HRDIK  N++LD +    K+ DFG A+ +   + + + +   +  Y AP
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI--CSRYYRAP 191

Query: 213 -ECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ-----------WVW 260
                    +   DV+S G V  E+  G+      +  +  V +++            + 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 261 DLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI-HVLNSEA-- 317
             Y   K  +       + F  +     + +           R +  +   H    E   
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

Query: 318 PLPALPPKMPVPTYFS 333
           P   LP     P  F+
Sbjct: 312 PNVKLPNGRDTPALFN 327

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-44
 Identities = 68/310 (21%), Positives = 123/310 (39%), Gaps = 33/310 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQG--IKEYASEVTIISRLRHR 98
           + +    K+GQG FG V+K   R+T   +A+K+V   +++         E+ I+  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 99  NLVQLLGWCHEKKE--------LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLAS 150
           N+V L+  C  K          + LV+++  +                E +  + Q L +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-VMQMLLN 128

Query: 151 GLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS---QTTVLAGTM 207
           GL Y+       ++HRD+K++N+++  +   K+ DFGLAR    AK S   + T    T+
Sbjct: 129 GLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 208 GYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPIS-------LTAKEEVQVYLVQWV 259
            Y  PE     R      D++  G +  E+      +        L    ++   +   V
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 260 WDLYGNGKLLEAVD-----PRLCRDFDEQQMECLMIVGL--WCAHPDENLRPSIRQVI-H 311
           W    N +L E ++      R  +D  +  +     + L       D   R      + H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 312 VLNSEAPLPA 321
                 P+P+
Sbjct: 306 DFFWSDPMPS 315

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-43
 Identities = 61/292 (20%), Positives = 109/292 (37%), Gaps = 25/292 (8%)

Query: 39  ATNDFNDDQKLGQGGFGGVYKGFFRETSS-YIAVKRVSK--GSKQGIKEYASEVTIISRL 95
           A   +    ++G+G +G V+K    +    ++A+KRV    G +        EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 96  ---RHRNLVQLLGWCHEKKE-----LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQD 147
               H N+V+L   C   +      L LV+E++               +  E    +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 148 LASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 207
           L  GL +L       VVHRD+K  NI++  +   K+ DFGLAR+        + V   T+
Sbjct: 125 LLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTL 179

Query: 208 GYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQ---------W 258
            Y APE       +   D++S G +  E+   +     ++  +    ++          W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 259 VWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
             D+    +   +   +    F     E    + L C   +   R S    +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-43
 Identities = 55/275 (20%), Positives = 101/275 (36%), Gaps = 29/275 (10%)

Query: 46  DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRL-RHRNLVQLL 104
            Q LG G  G V + F + T    A+K +         +   EV +  R  +  ++V+++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 71

Query: 105 GWCH----EKKELLLVYEYMPNGSLDSHLFKENNL-LTWEFRFKIAQDLASGLLYLQEGW 159
                    +K LL+V E +  G L S +    +   T     +I + +   + YL    
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---H 128

Query: 160 EQCVVHRDIKSSNIMLDLNFN---AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 216
              + HRD+K  N++          K+ DFG A+         T     T  Y+APE   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLG 186

Query: 217 TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL 276
             +  K  D++S G++   + CG  P    +   + +          G  +        +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFY--SNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH 311
             +         +I  L    P +  R +I + ++
Sbjct: 245 SEEVKM------LIRNLLKTEPTQ--RMTITEFMN 271

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 60/283 (21%), Positives = 114/283 (40%), Gaps = 18/283 (6%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRV--SKGSKQGIKEYASEVTIISRLRHR 98
             ++  +K+G+G +G VYK          A+K++   K  +        E++I+  L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           N+V+L    H KK L+LV+E++           E  L +   +  + Q L +G+ Y    
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ-LLNGIAYC--- 116

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
            ++ V+HRD+K  N++++     KI DFGLAR         T  +             + 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW-----------VWDLYGNGK 267
           + S   D++S G +  E+  G       ++ +  + + +            V +L     
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI 310
                +P     F +   E  + +       D N R + +Q +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (366), Expect = 2e-41
 Identities = 42/280 (15%), Positives = 100/280 (35%), Gaps = 26/280 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +++G+G FG +++G     +  +A+K   +  +    +   E      L     +  + +
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 107 CHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHR 166
             ++    ++   +   SL+  L       + +     A+ + + +  +    E+ +V+R
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYR 125

Query: 167 DIKSSNIMLDLNFN-----AKIGDFGLARLV------EHAKGSQTTVLAGTMGYMAPECA 215
           DIK  N ++    +       + DFG+ +        +H    +   L+GT  YM+    
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 216 TTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR 275
                S+  D+ + G V +    G  P         +    +      G  K    +   
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-----GEKKQSTPL-RE 239

Query: 276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS 315
           LC  F E+  + +     +  +   +  P    +  + + 
Sbjct: 240 LCAGFPEEFYKYMH----YARNLAFDATPDYDYLQGLFSK 275

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-40
 Identities = 54/285 (18%), Positives = 104/285 (36%), Gaps = 18/285 (6%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHR 98
             +   +K+G+G +G V+K   RET   +A+KRV      +        E+ ++  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 99  NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG 158
           N+V+L    H  K+L LV+E+             N  L  E        L  GL +    
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFC--- 117

Query: 159 WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 218
             + V+HRD+K  N++++ N   K+ +FGLAR         +  +               
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 219 RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR 278
             S   D++S G +  E+A   +P+      + Q+  +  +       +          +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 279 DFDEQQMECLMIVGL------------WCAHPDENLRPSIRQVIH 311
            +        ++  +                 +   R S  + + 
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 4e-39
 Identities = 59/275 (21%), Positives = 112/275 (40%), Gaps = 30/275 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRH 97
           + F+  + LG G FG V     +E+ ++ A+K + K      + I+   +E  I+  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 98  RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQE 157
             LV+L     +   L +V EY+  G + SHL +     +       A  +     YL  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYL-- 157

Query: 158 GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 217
                +++RD+K  N+++D     ++ DFG A+ V+     +T  L GT   +APE   +
Sbjct: 158 -HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILS 212

Query: 218 GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC 277
              +K  D ++ G++  E+A G  P    A + +Q+Y       +    +        L 
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP--FFADQPIQIYEKIVSGKV----RFPSHFSSDLK 266

Query: 278 RDFDEQQMECLMIVGLWCAHPDE---NLRPSIRQV 309
                      ++  L      +   NL+  +  +
Sbjct: 267 D----------LLRNLLQVDLTKRFGNLKNGVNDI 291

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 23/225 (10%)

Query: 31  FTYKELAQATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKE 84
           F  +E+ +   +        Q +G G +G V       T + +A+K++ +   S+   K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 85  YASEVTIISRLRHRNLVQLLGWCHEKK------ELLLVYEYMPNGSLDSHLFKENNLLTW 138
              E+ ++  +RH N++ LL      +      +  LV  +M  G+    L K    L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120

Query: 139 EFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS 198
           +    +   +  GL Y+       ++HRD+K  N+ ++ +   KI DFGLAR       S
Sbjct: 121 DRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173

Query: 199 QTTVLAGTMGYMAPECA-TTGRASKESDVYSFGIVALEIACGRKP 242
           + T    T  Y APE      R ++  D++S G +  E+  G+  
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-37
 Identities = 56/278 (20%), Positives = 112/278 (40%), Gaps = 28/278 (10%)

Query: 41  NDFNDDQKLGQGGFGGVYKG---FFRETSSYIAVKRVSKGS----KQGIKEYASEVTIIS 93
            +F   + LG G +G V+        +T    A+K + K +     +  +   +E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 94  RLRHR-NLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL 152
            +R    LV L      + +L L+ +Y+  G L +HL +       E +  + +     +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----IV 139

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
           L L+   +  +++RDIK  NI+LD N +  + DFGL++     +  +     GT+ YMAP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 213 ECATTGRA--SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE 270
           +    G +   K  D +S G++  E+  G  P ++  ++  Q  + + +           
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------- 251

Query: 271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQ 308
             +P   ++      + +          D   R     
Sbjct: 252 --EPPYPQEMSALAKDLIQ----RLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  132 bits (332), Expect = 3e-36
 Identities = 47/241 (19%), Positives = 93/241 (38%), Gaps = 20/241 (8%)

Query: 27  GPKRFTYKELAQATNDFND---DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIK 83
             + + Y+       + +D    +KLG+G +  V++      +  + VK +    K+ IK
Sbjct: 18  PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK 77

Query: 84  EYASEVTIISRLR-HRNLVQLLGWCHE--KKELLLVYEYMPNGSLDSHLFKENNLLTWEF 140
               E+ I+  LR   N++ L     +   +   LV+E++ N             LT   
Sbjct: 78  R---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYD 130

Query: 141 RFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLARLVEHAKGSQ 199
                 ++   L Y        ++HRD+K  N+M+D  +   ++ D+GLA       G +
Sbjct: 131 IRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQE 185

Query: 200 TTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQW 258
             V   +  +  PE     +      D++S G +   +   ++P         Q+  +  
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

Query: 259 V 259
           V
Sbjct: 246 V 246

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-34
 Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 17/210 (8%)

Query: 41  NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHR 98
             + + + +G G  G V   +       +A+K++S+   ++   K    E+ ++  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 99  NLVQLLGWCHEKK------ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGL 152
           N++ LL     +K      ++ LV E M          +       E    +   +  G+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132

Query: 153 LYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 212
            +L       ++HRD+K SNI++  +   KI DFGLAR          T    T  Y AP
Sbjct: 133 KHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 187

Query: 213 ECATTGRASKESDVYSFGIVALEIACGRKP 242
           E        +  D++S G +  E+   +  
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 19/223 (8%)

Query: 31  FTYKELAQATNDFNDD----QKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKE 84
           F  +EL +   +  +       +G G +G V   F  +T   +AVK++S+   S    K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 85  YASEVTIISRLRHRNLVQLLGWCHEKKEL-----LLVYEYMPNGSLDSHLFKENNLLTWE 139
              E+ ++  ++H N++ LL      + L     + +  ++    L+ ++ K   L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-NIVKCQKLTDDH 122

Query: 140 FRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ 199
            +F I Q +  GL Y+       ++HRD+K SN+ ++ +   KI DFGLAR  +      
Sbjct: 123 VQFLIYQ-ILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EM 175

Query: 200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP 242
           T  +A                ++  D++S G +  E+  GR  
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (289), Expect = 7e-30
 Identities = 36/213 (16%), Positives = 79/213 (37%), Gaps = 20/213 (9%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGW 106
           +KLG G F  V+       ++++A+K V    K   +    E+ ++ R+   +  +    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 107 CHE---------------KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASG 151
                                +++V+E +    L      E+  +   +  +I++ L  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 152 LLYLQEGWEQCVVHRDIKSSNIMLDLN-FNAKIGDFGLARLVEHAKGSQTTVLA-GTMGY 209
           L Y+       ++H DIK  N+++++      +    +A L       +    +  T  Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 210 MAPECATTGRASKESDVYSFGIVALEIACGRKP 242
            +PE          +D++S   +  E+  G   
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.0 bits (199), Expect = 1e-18
 Identities = 26/159 (16%), Positives = 52/159 (32%), Gaps = 21/159 (13%)

Query: 47  QKLGQGGFGGVYKGFFRETSSYIAVK--RVSKGSKQGIK--------EYASEVTIISRLR 96
           + +G+G    V+  +  E      VK  +V   S + +K         ++      +R  
Sbjct: 6   KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 97  HRNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFK-IAQDLASGLLYL 155
            R L +L G    K      Y +  N  L   +  +            +   +   +   
Sbjct: 65  FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 156 QEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH 194
              + + +VH D+   N+++       I DF  +  V  
Sbjct: 120 ---YHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	376
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.93
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.32
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.09
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.24

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-56  Score=399.79  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999999999999997655445678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      +||+|.+++.+  +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus       100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR  173 (293)
T ss_dssp             TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred             CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence            99999987744  46899999999999999999999   7999999999999999999999999999998654322 233


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDF  280 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (376)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..       ...      +.+  ..
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-------~~~------~~~--~~  238 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------NGT------PEL--QN  238 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------HCS------CCC--SS
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh-------CCC------CCC--CC
Confidence            455699999999999999999999999999999999999999987664443322221       010      000  11


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          281 DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       281 ~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .......+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1223345788999999999999999999985

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=397.67  Aligned_cols=253  Identities=25%  Similarity=0.298  Sum_probs=206.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC-hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS-KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999999999999999999997653 2334678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ||++|+|.+++. ..+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++........
T Consensus        84 y~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999884 4567999999999999999999999   799999999999999999999999999999876433222


Q ss_pred             -ceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          199 -QTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       199 -~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..............       ....        
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------~~~~--------  224 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------EKKT--------  224 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-------TTCT--------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cCCC--------
Confidence             2345679999999999988775 6789999999999999999999976654332221111       1100        


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ...........+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00111122345778899999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-56  Score=395.83  Aligned_cols=246  Identities=27%  Similarity=0.411  Sum_probs=210.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999998643   2233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |||++|+|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....   
T Consensus        86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---  158 (263)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred             eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence            99999999998854 456899999999999999999999   79999999999999999999999999999976432   


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+        .      ...+.
T Consensus       159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--------~------~~~~p  224 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------V------EFTFP  224 (263)
T ss_dssp             CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--------T------CCCCC
T ss_pred             CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc--------C------CCCCC
Confidence            233456799999999999999999999999999999999999999987765544333221        1      11122


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+    ...+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~----s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DFV----TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            222    345788999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-56  Score=403.17  Aligned_cols=262  Identities=24%  Similarity=0.372  Sum_probs=216.9

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      ++++...++|++.+.||+|+||+||+|++..+++.||||++..... ..++|.+|+++|++++||||+++++++.+.+..
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3445557899999999999999999999999999999999976543 357899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          114 LLVYEYMPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      ++||||+++|+|.+++... ...+++..++.++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999988653 457899999999999999999999   789999999999999999999999999999876


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCC-CCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI-SLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ............|++.|+|||++.+..++.++|||||||++|+|++|..|| ...+.......+.        .+     
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~--------~~-----  232 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------KD-----  232 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH--------TT-----
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh--------cC-----
Confidence            544444444456889999999999999999999999999999999976665 4333222221111        11     


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ..+.....    ....+.+++.+||+.||++|||+.+|++.|+..
T Consensus       233 ~~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         233 YRMERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCcc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11112222    334588899999999999999999999988753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=400.07  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=213.0

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      +.|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+++|++++||||+++++++.+.+.+|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999999999999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      ++|+|.+++.+..+.+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence            999999988777778999999999999999999999   7999999999999999999999999999997543211 122


Q ss_pred             eeeccCCCCCchhhhc-----cCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          201 TVLAGTMGYMAPECAT-----TGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ....||+.|+|||++.     +..++.++|||||||++|+|++|+.||...+..+....+..        ...     +.
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~--------~~~-----~~  234 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK--------SEP-----PT  234 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH--------SCC-----CC
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------CCC-----CC
Confidence            3456999999999984     45678999999999999999999999987765554433322        100     01


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +  .........+.+++.+||+.||++|||+.|+++
T Consensus       235 ~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1  111223356788999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.5e-55  Score=402.60  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=216.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            47899999999999999999999999999999999887777678899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC--CceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL--NFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+||+|.+++....+.+++..++.++.||+.||.|||   ++||+||||||+|||++.  ++.+||+|||+++.....  
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--  179 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  179 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence            9999999998776778999999999999999999999   799999999999999964  578999999999865432  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...      ...    +.....
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------~~~----~~~~~~  249 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------DWN----MDDSAF  249 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCC----SCCGGG
T ss_pred             cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCC----CCcccc
Confidence            3345567999999999999999999999999999999999999999877655544433320      100    111111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ......+.+++.+||+.||++|||+.|+++
T Consensus       250 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         250 ----SGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                122345788999999999999999999997

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=390.27  Aligned_cols=254  Identities=28%  Similarity=0.484  Sum_probs=201.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.|.+|++++++++||||+++++++...+..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3578899999999999999999875 67899999976543 346799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++|+|.+++......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999998777778999999999999999999999   7999999999999999999999999999998765444444


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      .....||..|+|||++.+..++.++|||||||++|||+| |.+||...+..+....+..        +.  ....|.   
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~--------~~--~~~~p~---  225 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--------GF--RLYKPR---  225 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH--------TC--CCCCCT---
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh--------cC--CCCCcc---
Confidence            445668999999999999999999999999999999999 5666665554443332221        10  011111   


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .    ....+.+++.+||+.||++|||+++|++.|+.
T Consensus       226 ~----~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         226 L----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c----cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            1    22457889999999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=393.57  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=199.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--KKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||+|.+...  .....+.+.+|++++++++||||+++++++.+  .+.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36899999999999999999999999999999998765  34456778999999999999999999999864  456899


Q ss_pred             EEecCCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          116 VYEYMPNGSLDSHLFK---ENNLLTWEFRFKIAQDLASGLLYLQEGW--EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      |||||++|+|.+++.+   ....+++..++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999998854   3567999999999999999999999521  1349999999999999999999999999998


Q ss_pred             ccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          191 LVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..        +..  
T Consensus       163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--------~~~--  231 (269)
T d2java1         163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--------GKF--  231 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------TCC--
T ss_pred             ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc--------CCC--
Confidence            764322 223456799999999999999999999999999999999999999987765554333322        111  


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         +.+...+    ...+.+++.+||+.||++|||+.|+++
T Consensus       232 ---~~~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 ---RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               1111222    345788999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-54  Score=402.30  Aligned_cols=253  Identities=20%  Similarity=0.271  Sum_probs=216.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++..........+.+|+.+|++++||||++++++|.+++.+|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999999999999999999877666667889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec--CCceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD--LNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+||+|.+.+......+++..++.++.||+.||.|||   ++||+||||||+||||+  .++.+||+|||++......  
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--  182 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  182 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence            9999999988776778999999999999999999999   79999999999999997  5689999999999876432  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..      ....    +.....
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~------~~~~----~~~~~~  252 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR------CDWE----FDEDAF  252 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH------CCCC----CCSSTT
T ss_pred             CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCC----CCcccc
Confidence            334556799999999999999999999999999999999999999987765554433332      0100    111122


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       253 ~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         253 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222    345788999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.8e-55  Score=396.29  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=202.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe---EEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS---YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||+||+|++..+++   .||||.+... .....+.|.+|+++|++++||||+++++++.+.+.+++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3667888999999999999999876554   6899988754 45556789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      |||||++|+|.+++....+.+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++.....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999988777778999999999999999999999   799999999999999999999999999999876433


Q ss_pred             CCc----ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          196 KGS----QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       196 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ...    ......||+.|+|||++.++.++.++|||||||++|||+| |..||......+....+..        +.   
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~--------~~---  250 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--------DY---  250 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--------TC---
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------CC---
Confidence            221    1223457899999999999999999999999999999998 8999987765444332221        11   


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        .+..    .......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       251 --~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         251 --RLPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             --CCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              0111    12233557889999999999999999999998864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-55  Score=391.82  Aligned_cols=258  Identities=30%  Similarity=0.505  Sum_probs=204.7

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ..++|++.+.||+|+||.||+|++++   .||||++...  .....+.|.+|+.++++++||||+++++++.+ +.+++|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            35789999999999999999998753   4999998754  44557889999999999999999999998755 568999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++|+|.+++......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999999777778999999999999999999999   7999999999999999999999999999998764332


Q ss_pred             C-cceeeeccCCCCCchhhhcc---CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          197 G-SQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       197 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      . .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||...+..........   .    +..    
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~---~----~~~----  227 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---R----GYL----  227 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---H----TSC----
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh---c----CCC----
Confidence            2 23345679999999999864   3478999999999999999999999987654433222211   1    110    


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .+.+ ..........+.+++.+||+.||++|||+.+|++.|+.
T Consensus       228 ~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         228 SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            0110 11112223467889999999999999999999998874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=384.46  Aligned_cols=254  Identities=25%  Similarity=0.423  Sum_probs=217.2

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.++||+|+||+||+|+++ ++..||||++...... .+.|.+|+.++++++||||+++++++.+++.+++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            368999999999999999999986 5788999999865433 46899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ  199 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  199 (376)
                      +++|+|..++......+++..+++++.||++||.|||   ++||+||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            9999999998777778999999999999999999999   7999999999999999999999999999998765544444


Q ss_pred             eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCC
Q 038118          200 TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCR  278 (376)
Q Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (376)
                      .....||..|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+..        +..  ...|    
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~--------~~~--~~~p----  223 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------GLR--LYRP----  223 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT--------TCC--CCCC----
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh--------CCC--CCCc----
Confidence            445668999999999999999999999999999999998 8999988876655443321        111  1111    


Q ss_pred             CCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          279 DFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       279 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                         ......+.+++.+||+.||++|||+++|++.|.+
T Consensus       224 ---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence               1223468899999999999999999999998854

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=395.66  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=207.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||+||+|.+..+++.||||++...   .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            6799999999999999999999999999999998743   2233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC-
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK-  196 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  196 (376)
                      ||++||+|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||+++++.+||+|||+++.+.... 
T Consensus        88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999999988754 457999999999999999999999   7999999999999999999999999999998764332 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..        ..      ..+
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------~~------~~~  229 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--------LE------YDF  229 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--------TC------CCC
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc--------CC------CCC
Confidence            2234456799999999999999999999999999999999999999987765544333321        11      112


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVI  310 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl  310 (376)
                      ...+    ...+.+++.+||+.||++|||++|++
T Consensus       230 p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         230 PEKF----FPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CTTC----CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CccC----CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            2223    34578899999999999999999974

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-54  Score=394.46  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=196.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh-hhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK-QGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      .+.|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4679999999999999999999999999999999976532 234567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeec---CCceEEEeeCCCccccccC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLD---LNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||+||+|.+++.. .+.+++..+..++.||+.||.|||   ++||+||||||+|||+.   +++.+||+|||+++.....
T Consensus        88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999998854 567999999999999999999999   79999999999999995   4788999999999765432


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCc
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPR  275 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..        ...  .+...
T Consensus       164 --~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------~~~--~~~~~  231 (307)
T d1a06a_         164 --SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--------AEY--EFDSP  231 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT--------TCC--CCCTT
T ss_pred             --CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc--------cCC--CCCCc
Confidence              223445699999999999999999999999999999999999999987665544333322        110  01111


Q ss_pred             CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          276 LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ....    ....+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         232 YWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1222    2345788999999999999999999997

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-54  Score=382.26  Aligned_cols=246  Identities=27%  Similarity=0.411  Sum_probs=199.8

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee----CCeEEEE
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE----KKELLLV  116 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv  116 (376)
                      |++.++||+|+||+||+|++..+++.||+|.+...  .....+.|.+|+++|++++||||+++++++..    ...+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            36777899999999999999999999999998754  44556789999999999999999999999865    4568999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeecccCCCeeec-CCceEEEeeCCCccccc
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQC--VVHRDIKSSNIMLD-LNFNAKIGDFGLARLVE  193 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~  193 (376)
                      |||+++|+|.+++.+ ...+++..++.++.||+.||.|||   +++  |+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999998854 457899999999999999999999   677  99999999999996 57899999999997543


Q ss_pred             cCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      .   .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.............       ..+...    
T Consensus       167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i-------~~~~~~----  231 (270)
T d1t4ha_         167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-------TSGVKP----  231 (270)
T ss_dssp             T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-------TTTCCC----
T ss_pred             C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH-------HcCCCC----
Confidence            2   23445679999999998875 59999999999999999999999997654332211110       111111    


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      +.+....    ...+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1111222    234788999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=395.97  Aligned_cols=264  Identities=24%  Similarity=0.327  Sum_probs=207.9

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++... .......+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            357899999999999999999999999999999999765 3344567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||++||+|.+++.+. +.+++..++.++.||+.||.|||+  .+||+||||||+|||++.++.+||+|||+++.....  
T Consensus        84 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             ECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999988654 568999999999999999999994  258999999999999999999999999999865322  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhc-C-------Cc--
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYG-N-------GK--  267 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~-------~~--  267 (376)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+................. .       ..  
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence             233457999999999999999999999999999999999999999776543322111100000000 0       00  


Q ss_pred             c-------------------ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          268 L-------------------LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       268 ~-------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .                   .....+.+..   ......+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0                   0000000100   011245788999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-54  Score=386.12  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=209.1

Q ss_pred             hCCCcCCc-cccCCCeeEEEEEEcC--CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           41 NDFNDDQK-LGQGGFGGVYKGFFRE--TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        41 ~~y~~~~~-lg~G~~g~vy~a~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ++|.+... ||+|+||.||+|.++.  ++..||||++... .....+.|.+|+++|++++||||+++++++.. +.+|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            56667674 9999999999998754  4568999999754 45556789999999999999999999999865 468999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++|+|.+++......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999988776778999999999999999999999   7999999999999999999999999999998764432


Q ss_pred             Cc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          197 GS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       197 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..  ......||+.|+|||++.++.++.++|||||||++|||+| |..||......+....+.        .+..     
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~--------~~~~-----  230 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--------QGKR-----  230 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH--------TTCC-----
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH--------cCCC-----
Confidence            22  1223458899999999999999999999999999999998 999998776554433322        1211     


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      +.....    ....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       231 ~~~p~~----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 MECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             CCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            112222    23457889999999999999999999988864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-54  Score=390.92  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=205.3

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      +.|+..+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999999999999999997643   344567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |||.+|+|..++ ...+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....   
T Consensus        95 E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            999999886555 44567999999999999999999999   79999999999999999999999999999975432   


Q ss_pred             cceeeeccCCCCCchhhhcc---CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          198 SQTTVLAGTMGYMAPECATT---GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                        .....||+.|+|||++.+   +.++.++|||||||++|+|++|..||......+....+..        +..     +
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~--------~~~-----~  232 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NES-----P  232 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------SCC-----C
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------CCC-----C
Confidence              234569999999999864   4588999999999999999999999987654443332221        110     1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .+..   ......+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1111   112345788999999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-54  Score=388.46  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=210.3

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC------hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS------KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....      ....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            468999999999999999999999999999999986532      22357899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc----eEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF----NAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~  189 (376)
                      |+|||||++|+|.+++... +.+++..++.++.||+.||.|||   +++|+||||||+|||++.++    .+||+|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            9999999999999988553 57999999999999999999999   79999999999999998876    4999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..        ..  
T Consensus       165 ~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------~~--  232 (293)
T d1jksa_         165 HKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--------VN--  232 (293)
T ss_dssp             EECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--------TC--
T ss_pred             hhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh--------cC--
Confidence            865432  233445689999999999999999999999999999999999999987765544333321        10  


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                          ..............+.+++.+||+.||++|||++++++
T Consensus       233 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000011112345788999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=388.52  Aligned_cols=254  Identities=28%  Similarity=0.442  Sum_probs=206.4

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ..++|++.+.||+|+||.||+|.+++ +..||||++..... ..+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            35789999999999999999999864 67899999976543 34679999999999999999999998865 56799999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++|+|.+++.... ..+++..++.++.||+.||.|||   +++|+||||||+||||++++.+||+|||+++.......
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            999999998775433 35899999999999999999999   79999999999999999999999999999987654433


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCC-CCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR-KPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      .......||+.|+|||++.++.++.++|||||||++|||+||. +||......+....+.        .+.     .+..
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~--------~~~-----~~~~  231 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE--------RGY-----RMVR  231 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------TTC-----CCCC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------hcC-----CCCC
Confidence            3344456899999999999889999999999999999999965 5555544333322221        111     1111


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...    ....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       232 p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         232 PDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            122    23457889999999999999999999998863

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=392.73  Aligned_cols=256  Identities=29%  Similarity=0.386  Sum_probs=208.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC-----eEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS-----SYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  112 (376)
                      .++|++.+.||+|+||+||+|++..++     ..||+|.+... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            478999999999999999999987654     36999998654 333456789999999998 89999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccC
Q 038118          113 LLLVYEYMPNGSLDSHLFKEN----------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKS  170 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp  170 (376)
                      +|+|||||++|+|.+++....                      ..+++..++.++.||+.||.|||   +++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            999999999999999986543                      34789999999999999999999   79999999999


Q ss_pred             CCeeecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccc
Q 038118          171 SNIMLDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAK  248 (376)
Q Consensus       171 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~  248 (376)
                      +|||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999865443322 2334568999999999999999999999999999999997 8999987655


Q ss_pred             hhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          249 EEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                      ......+..       .+.     .+..    +......+.+++.+||+.||++|||+++|++.|.
T Consensus       273 ~~~~~~~~~-------~~~-----~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFYKLIQ-------NGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHHHHHH-------TTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHh-------cCC-----CCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            443332221       111     1111    1222346888999999999999999999999985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=381.75  Aligned_cols=256  Identities=25%  Similarity=0.439  Sum_probs=202.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCC----eEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETS----SYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  114 (376)
                      .++|+..++||+|+||.||+|.++.++    ..||||++... .......|.+|+.++++++||||+++++++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            357888999999999999999987654    47999998754 4444567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      +||||+.++++.+.+....+.+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++....
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999988777788999999999999999999999   79999999999999999999999999999987543


Q ss_pred             CCCc--ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCC-CCCccchhhHHHHHHHHHHHhcCCccccc
Q 038118          195 AKGS--QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKP-ISLTAKEEVQVYLVQWVWDLYGNGKLLEA  271 (376)
Q Consensus       195 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ....  ......||+.|+|||++.++.++.++|||||||++|||++|..| +......+....+.        .+.    
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~--------~~~----  230 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------DGF----  230 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--------TTC----
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh--------ccC----
Confidence            2221  22334589999999999999999999999999999999996555 44443333222111        111    


Q ss_pred             cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          272 VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                       .+....    .....+.+++.+||+.||++|||+.+|++.|+.
T Consensus       231 -~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         231 -RLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             -CCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CCCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence             111112    233558889999999999999999999998875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-53  Score=379.59  Aligned_cols=246  Identities=27%  Similarity=0.407  Sum_probs=199.0

Q ss_pred             CccccCCCeeEEEEEEc--CCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecCCC
Q 038118           47 QKLGQGGFGGVYKGFFR--ETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYMPN  122 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~--~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  122 (376)
                      ++||+|+||.||+|.+.  ++++.||||++...  .....+.|.+|+.++++++||||+++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999865  35678999999653  33445689999999999999999999999965 457899999999


Q ss_pred             CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcc--e
Q 038118          123 GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQ--T  200 (376)
Q Consensus       123 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~  200 (376)
                      |+|.+++. ....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.........  .
T Consensus        92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999885 4567999999999999999999999   7999999999999999999999999999998664333222  2


Q ss_pred             eeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCC
Q 038118          201 TVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRD  279 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.        .+..     +.....
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~--------~~~~-----~~~p~~  234 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE--------KGER-----MGCPAG  234 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------TTCC-----CCCCTT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH--------cCCC-----CCCCcc
Confidence            33568999999999999999999999999999999998 899998776544433222        1111     111122


Q ss_pred             CcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhc
Q 038118          280 FDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLN  314 (376)
Q Consensus       280 ~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~  314 (376)
                          ....+.+++.+||+.||++|||+.+|++.|+
T Consensus       235 ----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         235 ----CPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             ----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence                2345788999999999999999999988775

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=378.13  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.+.||+|+||.||+|++..+   +..||||.+... .....+.|.+|+.++++++||||+++++++. ++.+|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            47899999999999999999998654   457999998754 4444677999999999999999999999996 467899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999988777778999999999999999999999   799999999999999999999999999999876554


Q ss_pred             CCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDP  274 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .........||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..        +..     +
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~--------~~~-----~  228 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------GER-----L  228 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--------TCC-----C
T ss_pred             cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------CCC-----C
Confidence            4444555668999999999999999999999999999999998 8999988776655433321        111     1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          275 RLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       275 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      .....    ....+.+++.+||..||++|||+.+|++.|+.
T Consensus       229 ~~~~~----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         229 PMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCC----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            12222    23458889999999999999999999988763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=386.62  Aligned_cols=249  Identities=29%  Similarity=0.376  Sum_probs=211.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      -++|++.+.||+|+||.||+|++..+++.||||++...   .....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999999999999999999753   233467788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||++||+|.+++.+ .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus        84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-  158 (337)
T d1o6la_          84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence            999999999998854 456899999999999999999999   799999999999999999999999999999865322 


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..        +      ...+
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--------~------~~~~  224 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------E------EIRF  224 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------C------CCCC
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--------C------CCCC
Confidence            2234456799999999999999999999999999999999999999988776554433322        1      1122


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ...++    ..+.+++.+||++||.+|++     +.++++
T Consensus       225 p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            22333    35788999999999999995     788875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-52  Score=382.13  Aligned_cols=245  Identities=27%  Similarity=0.365  Sum_probs=208.9

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            6799999999999999999999999999999998743   2234577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||++||+|..++. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus        84 E~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999988774 4566888999999999999999999   899999999999999999999999999999865432  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..        +.      ..+.
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------~~------~~~p  221 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------AE------LRFP  221 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------CC------CCCC
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--------CC------CCCC
Confidence              3345699999999999999999999999999999999999999987765554443332        11      1111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ..++    ..+.+++.+||+.||.+|+     |++++++
T Consensus       222 ~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            2223    4577889999999999996     8999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-52  Score=377.32  Aligned_cols=257  Identities=22%  Similarity=0.283  Sum_probs=204.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC----e
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK----E  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~  112 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++...   .......|.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            47899999999999999999999999999999999754   3445667999999999999999999999987643    4


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|+||||++|++|..++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++..+|+|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            8999999999999888754 457899999999999999999999   799999999999999999999999999998754


Q ss_pred             ccCCC--cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          193 EHAKG--SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       193 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|+||..||...+..+....+..       ......
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-------~~~~~~  234 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------EDPIPP  234 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------CCCCCG
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh-------cCCCCC
Confidence            33222  234456799999999999999999999999999999999999999987665443322221       111100


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHhc
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRP-SIRQVIHVLN  314 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~~vl~~L~  314 (376)
                         ......+    ...+.+++.+||+.||.+|| |++++++.|.
T Consensus       235 ---~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         235 ---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             ---GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence               0111222    24578899999999999999 8999987764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=383.81  Aligned_cols=252  Identities=19%  Similarity=0.254  Sum_probs=213.1

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...... ...+.+|+.+|+.++||||+++++++.+++.+|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            47899999999999999999999999999999999876543 35688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCC--ceEEEeeCCCccccccCCC
Q 038118          120 MPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLN--FNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       120 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+|++|.+++......+++..++.++.||+.||.|||   ++||+||||||+|||++.+  ..+||+|||++.....  .
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--G  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--T
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc--C
Confidence            9999999999766667999999999999999999999   7999999999999999854  4799999999976533  2


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+...      ...    ++....
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~------~~~----~~~~~~  227 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------EYT----FDEEAF  227 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCC----CCHHHH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCC----CChhhc
Confidence            3345567899999999999999999999999999999999999999887765554444320      000    001111


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       228 ~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         228 KEI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112    245788999999999999999999996

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=378.79  Aligned_cols=255  Identities=30%  Similarity=0.435  Sum_probs=201.5

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEY  119 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  119 (376)
                      .++|++.+.||+|+||.||+|+++.+ ..||||++..... ..+.|.+|+.++++++|+||+++++++.+ +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            57899999999999999999999875 5699999975533 34679999999999999999999999855 567999999


Q ss_pred             CCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          120 MPNGSLDSHLFKE-NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       120 ~~~~sL~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      +++|+|..++... ...+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++........
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            9999998887643 356899999999999999999999   789999999999999999999999999999876544444


Q ss_pred             ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCC-CCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          199 QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPI-SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                      ......||+.|+|||++.++.++.++|||||||++|+|++|..|+ ......+....+.        .+     ..+...
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~--------~~-----~~~~~~  236 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE--------RG-----YRMPCP  236 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------TT-----CCCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH--------hc-----CCCCCC
Confidence            444566899999999999999999999999999999999965554 4443333322221        11     111122


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                      ..    ..+.+.+++.+||+.||++|||+.+|+++|....
T Consensus       237 ~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         237 PE----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             cc----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            22    2345788999999999999999999999998644

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.7e-52  Score=370.84  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=209.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---------hhhHHHHHHHHHHHHhCC-CCCccceeeEEee
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---------KQGIKEYASEVTIISRLR-HRNLVQLLGWCHE  109 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  109 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++....         ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999987542         122346889999999997 9999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      ++.+||||||+++|+|.+++.. .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999999999965 457999999999999999999999   799999999999999999999999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhcc------CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHh
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATT------GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLY  263 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  263 (376)
                      +......  ......||..|+|||.+.+      ..++.++||||+||++|+|++|+.||...+.......+..      
T Consensus       158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~------  229 (277)
T d1phka_         158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS------  229 (277)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred             eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh------
Confidence            8764322  2344569999999998853      3468899999999999999999999988765554433332      


Q ss_pred             cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          264 GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        +..      .............+.+++.+||+.||++|||+.||++
T Consensus       230 --~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         230 --GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              110      1111112223356888999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=379.55  Aligned_cols=254  Identities=25%  Similarity=0.419  Sum_probs=205.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCe----EEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSS----YIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  115 (376)
                      ++|++.++||+|+||+||+|.+..+|+    +||+|.+... .....+.|.+|+.++++++||||++++++|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999987765    6889988654 344567899999999999999999999999865 5678


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccC
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  195 (376)
                      ++|++.+++|.+.+......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            88999999999988887888999999999999999999999   789999999999999999999999999999876443


Q ss_pred             CCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccC
Q 038118          196 KGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVD  273 (376)
Q Consensus       196 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ... ......||+.|+|||++.++.++.++|||||||++|||+| |..||...+..+....+..        +..     
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~--------~~~-----  231 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------GER-----  231 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH--------TCC-----
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--------CCC-----
Confidence            322 2334568999999999999999999999999999999998 8999987766554433322        110     


Q ss_pred             CcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          274 PRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       274 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      +....    .....+.+++.+||+.||.+|||+.+|++.|..
T Consensus       232 ~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         232 LPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             CCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCc----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence            11111    223457889999999999999999999987754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-51  Score=382.48  Aligned_cols=245  Identities=24%  Similarity=0.314  Sum_probs=209.1

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVY  117 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  117 (376)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++...   .....+.+.+|+.+|+.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6899999999999999999999999999999998643   2233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          118 EYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       118 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      ||+.+|+|..++.+. +.+++..++.++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+++.....  
T Consensus       121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999999988554 56899999999999999999999   799999999999999999999999999999865432  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLC  277 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (376)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..        +.      ....
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------~~------~~~p  258 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--------GK------VRFP  258 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CC------CCCC
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--------CC------CCCC
Confidence              2345699999999999999999999999999999999999999987665444333322        10      1112


Q ss_pred             CCCcHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 038118          278 RDFDEQQMECLMIVGLWCAHPDENLRP-----SIRQVIH  311 (376)
Q Consensus       278 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~~vl~  311 (376)
                      ..++    ..+.+++.+||+.||.+|+     |++++++
T Consensus       259 ~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            2223    4578889999999999994     8999985

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=373.66  Aligned_cols=256  Identities=26%  Similarity=0.364  Sum_probs=201.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC---CeEEEEEEcccC---ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET---SSYIAVKRVSKG---SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~---~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|++...   ...||||++...   .....+.|.+|+.+|++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            36799999999999999999987543   347899988753   33446789999999999999999999999976 467


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      ++||||++++++.+.+....+.+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            8999999999999988777778999999999999999999999   7999999999999999999999999999998764


Q ss_pred             cCCCcc--eeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCcccc
Q 038118          194 HAKGSQ--TTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLE  270 (376)
Q Consensus       194 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (376)
                      ......  .....|+..|+|||++.+..++.++|||||||++|||+| |..||...+..+....+..       .+.   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~-------~~~---  232 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------EGE---  232 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------SCC---
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh-------CCC---
Confidence            432221  223457889999999999999999999999999999998 8999987765554333221       111   


Q ss_pred             ccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          271 AVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                        .+.....+    ...+.+++.+||+.||++|||+.+|++.|..
T Consensus       233 --~~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         233 --RLPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             --CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence              11111222    3457889999999999999999999998864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.7e-51  Score=380.64  Aligned_cols=250  Identities=25%  Similarity=0.299  Sum_probs=201.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC---hhhHHHH---HHHHHHHHhCCCCCccceeeEEeeCCeE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS---KQGIKEY---ASEVTIISRLRHRNLVQLLGWCHEKKEL  113 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~  113 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ......+   ..++.+++.++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999999999999999986431   1112223   3457777888899999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccc
Q 038118          114 LLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVE  193 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  193 (376)
                      |+||||++||+|.+++.+ ...+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++...
T Consensus        83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999998855 456899999999999999999999   7999999999999999999999999999998654


Q ss_pred             cCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc
Q 038118          194 HAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV  272 (376)
Q Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ..   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.......     ..      ..
T Consensus       159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-----~~------~~  224 (364)
T d1omwa3         159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TL------TM  224 (364)
T ss_dssp             SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-----SS------SC
T ss_pred             CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cc------cC
Confidence            32   2334569999999999865 4689999999999999999999999987654433221111     00      01


Q ss_pred             CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          273 DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                      ...+...++    ..+.+++.+||+.||.+|||     ++++++
T Consensus       225 ~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            111222233    45788999999999999999     688874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=377.09  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=207.2

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC---ChhhHHHHHHHHHHHH-hCCCCCccceeeEEeeCCeEEEE
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG---SKQGIKEYASEVTIIS-RLRHRNLVQLLGWCHEKKELLLV  116 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv  116 (376)
                      ++|++.+.||+|+||+||+|++..+++.||||++...   .....+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6799999999999999999999999999999999753   1233456667777665 68999999999999999999999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAK  196 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  196 (376)
                      |||+++|+|.+++.. ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            999999999998854 456899999999999999999999   7999999999999999999999999999997654322


Q ss_pred             CcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          197 GSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..        +      .+.+
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--------~------~~~~  222 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--------D------NPFY  222 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------C------CCCC
T ss_pred             -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------C------CCCC
Confidence             233445799999999999999999999999999999999999999988775554443322        1      1222


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChH-HHHH
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIR-QVIH  311 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-~vl~  311 (376)
                      ...++    ..+.+++.+||+.||.+|||+. +|++
T Consensus       223 p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 PRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            22233    4578899999999999999996 6763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-51  Score=374.21  Aligned_cols=262  Identities=28%  Similarity=0.412  Sum_probs=213.5

Q ss_pred             HHHHHhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEe
Q 038118           35 ELAQATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCH  108 (376)
Q Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  108 (376)
                      +++.-.++|++.+.||+|+||.||+|++.+     ++..||||++... .....++|.+|+.+|++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344446789999999999999999999864     4578999999765 3444677999999999999999999999999


Q ss_pred             eCCeEEEEEecCCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 038118          109 EKKELLLVYEYMPNGSLDSHLFKEN-----------------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVH  165 (376)
Q Consensus       109 ~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H  165 (376)
                      ..+..++||||+++|+|.+++....                       ..+++..++.++.||+.||.|||   +++++|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence            9999999999999999999885422                       24788999999999999999999   799999


Q ss_pred             ecccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCC-CCC
Q 038118          166 RDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR-KPI  243 (376)
Q Consensus       166 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~-~pf  243 (376)
                      |||||+|||++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. .||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999976533222 2234456889999999999999999999999999999999985 678


Q ss_pred             CCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          244 SLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ......+....+.        ++..     +.....++    ..+.+|+.+||+.||++|||+.+|+++|+..
T Consensus       244 ~~~~~~e~~~~v~--------~~~~-----~~~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         244 YGMAHEEVIYYVR--------DGNI-----LACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTSCHHHHHHHHH--------TTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCHHHHHHHHH--------cCCC-----CCCCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            7766555433322        1221     11222233    4578899999999999999999999998753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=373.47  Aligned_cols=260  Identities=20%  Similarity=0.212  Sum_probs=200.6

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccCChh-----hHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecC
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQ-----GIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYEYM  120 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  120 (376)
                      .++||+|+||+||+|++..+|+.||||++......     ..+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            46899999999999999999999999999754322     1246889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCcce
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGSQT  200 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  200 (376)
                      .++.+.... .....+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~  157 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY  157 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence            887765444 55667899999999999999999999   79999999999999999999999999999976543322 23


Q ss_pred             eeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcccccc------C
Q 038118          201 TVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAV------D  273 (376)
Q Consensus       201 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  273 (376)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......... ......      .
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~-~~~~~~~~~~~~~  236 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE-QWPDMCSLPDYVT  236 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT-TSSSTTSSTTCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh-hccchhccchhhh
Confidence            345689999999988654 57999999999999999999999998877666554444322111000 000000      0


Q ss_pred             CcCCCCCc-----HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          274 PRLCRDFD-----EQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       274 ~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      -.......     ......+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000000     112346888999999999999999999996

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=370.91  Aligned_cols=267  Identities=22%  Similarity=0.247  Sum_probs=205.7

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.++||+|+||+||+|++..+++.||||++....  ......+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999999999999999996542  2335678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      |+.++.+..........+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence            99765554444445667999999999999999999999   7999999999999999999999999999997654322 2


Q ss_pred             ceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCC--------ccc
Q 038118          199 QTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNG--------KLL  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~  269 (376)
                      ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+...........        ...
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            233456999999999876655 57899999999999999999999987765554443332211100000        000


Q ss_pred             cccCCcCCCC---CcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRD---FDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..........   ........+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0000000000   00112245788999999999999999999996

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=365.15  Aligned_cols=248  Identities=31%  Similarity=0.446  Sum_probs=199.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee-CCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE-KKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e  118 (376)
                      -++|++.+.||+|+||.||+|.++  |..||||+++...  ..+.|.+|+.++++++||||+++++++.+ .+.+|+|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            467888999999999999999985  6789999997653  34678999999999999999999999865 466899999


Q ss_pred             cCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCC
Q 038118          119 YMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG  197 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  197 (376)
                      |+++|+|.+++.+.. ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            999999999986543 35899999999999999999999   799999999999999999999999999999754322  


Q ss_pred             cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          198 SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                        .....++..|+|||++.++.++.++|||||||++|||+| |..||...+..+....+.        .+     ..+.+
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~--------~~-----~~~~~  221 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--------KG-----YKMDA  221 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT--------TT-----CCCCC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH--------cC-----CCCCC
Confidence              233457899999999999999999999999999999998 788888776555443332        11     11222


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ...    ....+.+++.+||+.||.+|||+.+|+++|+.
T Consensus       222 ~~~----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         222 PDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Ccc----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            222    23467889999999999999999999998864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-51  Score=374.74  Aligned_cols=252  Identities=21%  Similarity=0.267  Sum_probs=200.9

Q ss_pred             hhCCCcCC-ccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHh-CCCCCccceeeEEee----CCeE
Q 038118           40 TNDFNDDQ-KLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISR-LRHRNLVQLLGWCHE----KKEL  113 (376)
Q Consensus        40 ~~~y~~~~-~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~  113 (376)
                      .++|.+.+ .||+|+||.||+|++..+++.||||++...     ..+.+|+.++.+ .+||||++++++|.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898875 599999999999999999999999998643     356789988654 579999999999875    4678


Q ss_pred             EEEEecCCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEeeCCCc
Q 038118          114 LLVYEYMPNGSLDSHLFKEN-NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLA  189 (376)
Q Consensus       114 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~  189 (376)
                      |+|||||+||+|.+++.+.. ..+++..++.++.||+.||.|||   ++||+||||||+|||++.   .+.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999996543 56999999999999999999999   799999999999999986   457999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      +......  ......||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+.......+..        ..  
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~--------~i--  229 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------RI--  229 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------CC--
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH--------HH--
Confidence            8654322  33455699999999999999999999999999999999999999976654333221111        00  


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ......+...........+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000011111112234566889999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=370.98  Aligned_cols=255  Identities=30%  Similarity=0.410  Sum_probs=206.0

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCe--EEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSS--YIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  115 (376)
                      .++|++.++||+|+||.||+|+++.++.  .||||.+... .....+.|.+|+.+|.++ +||||+++++++.+.+.+++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            3789999999999999999999988776  4778887643 344566899999999999 69999999999999999999


Q ss_pred             EEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCce
Q 038118          116 VYEYMPNGSLDSHLFKE---------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFN  180 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~  180 (376)
                      ||||+++|+|.+++...               ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence            99999999999988543               357899999999999999999999   799999999999999999999


Q ss_pred             EEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCC-CCCCCccchhhHHHHHHHH
Q 038118          181 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGR-KPISLTAKEEVQVYLVQWV  259 (376)
Q Consensus       181 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~  259 (376)
                      +||+|||+++.......  .....||..|+|||.+.++.++.++|||||||++|+|++|. .||...+..+....+..  
T Consensus       166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~--  241 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--  241 (309)
T ss_dssp             EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG--
T ss_pred             eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--
Confidence            99999999975432222  22345899999999999999999999999999999999965 67876664444322211  


Q ss_pred             HHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          260 WDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                            +.     .+....    .....+.+++.+||+.||++|||+++|++.|+..
T Consensus       242 ------~~-----~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         242 ------GY-----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             ------TC-----CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------cC-----CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  11     111212    2335688899999999999999999999887653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=371.22  Aligned_cols=266  Identities=26%  Similarity=0.365  Sum_probs=203.1

Q ss_pred             cCHHHHHHHhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CCCCccce
Q 038118           31 FTYKELAQATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RHRNLVQL  103 (376)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~  103 (376)
                      +..+.++...++|++.++||+|+||.||+|.+..     +++.||||++... .....+.+.+|...+.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            3455665556899999999999999999999754     3468999999754 344566788888888777 58899999


Q ss_pred             eeEEeeC-CeEEEEEecCCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 038118          104 LGWCHEK-KELLLVYEYMPNGSLDSHLFKE---------------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRD  167 (376)
Q Consensus       104 ~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~d  167 (376)
                      ++++.+. ..+++|||||++|+|.+++...               ...+++..++.++.||+.||.|||   +++|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCc
Confidence            9988654 5689999999999999998643               235889999999999999999999   79999999


Q ss_pred             ccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhC-CCCCCC
Q 038118          168 IKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG-RKPISL  245 (376)
Q Consensus       168 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg-~~pf~~  245 (376)
                      |||+||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++| ..||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999976543322 223345689999999999999999999999999999999986 567876


Q ss_pred             ccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          246 TAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ............       .+.     .+......    ...+.+++.+||+.||++|||+.+|++.|+.
T Consensus       240 ~~~~~~~~~~~~-------~~~-----~~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         240 VKIDEEFCRRLK-------EGT-----RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             CCCSHHHHHHHH-------HTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHh-------cCC-----CCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            554333222111       111     11222222    3457889999999999999999999998864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=368.51  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=207.6

Q ss_pred             HhhCCCcCCccccCCCeeEEEEEEcCCC-------eEEEEEEcccCC-hhhHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 038118           39 ATNDFNDDQKLGQGGFGGVYKGFFRETS-------SYIAVKRVSKGS-KQGIKEYASEVTIISRL-RHRNLVQLLGWCHE  109 (376)
Q Consensus        39 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~-------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  109 (376)
                      -.++|++.+.||+|+||.||+|++..++       ..||||++.... ......+.+|+..+.++ +||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3578999999999999999999976554       479999997653 44567888999999888 79999999999999


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCee
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKEN---------------NLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIM  174 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nil  174 (376)
                      ++..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||   +++|+||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccccee
Confidence            999999999999999999986442               45899999999999999999999   799999999999999


Q ss_pred             ecCCceEEEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-CCCCCCCccchhhH
Q 038118          175 LDLNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-GRKPISLTAKEEVQ  252 (376)
Q Consensus       175 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-g~~pf~~~~~~~~~  252 (376)
                      ++.++.+||+|||++......... ......|++.|+|||.+.++.++.++|||||||++|+|++ |..||.........
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            999999999999999876543322 2344568899999999999999999999999999999998 78999876654432


Q ss_pred             HHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          253 VYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                      ..+.        .+.     .+.....+    ...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       248 ~~i~--------~~~-----~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         248 KLLK--------EGH-----RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHH--------TTC-----CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH--------cCC-----CCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            2211        121     11222222    34588899999999999999999999999753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-51  Score=371.39  Aligned_cols=271  Identities=25%  Similarity=0.360  Sum_probs=218.2

Q ss_pred             CCCcccCHHH-HHHHhhCCCcCCccccCCCeeEEEEEEc-----CCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhC-CC
Q 038118           26 AGPKRFTYKE-LAQATNDFNDDQKLGQGGFGGVYKGFFR-----ETSSYIAVKRVSKG-SKQGIKEYASEVTIISRL-RH   97 (376)
Q Consensus        26 ~~~~~~~~~~-~~~~~~~y~~~~~lg~G~~g~vy~a~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h   97 (376)
                      -+|..++++. ++.-.++|++.++||+|+||.||+|++.     .+++.||||++... .......|.+|+.++..+ +|
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~H   86 (311)
T d1t46a_           7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH   86 (311)
T ss_dssp             CCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC
T ss_pred             eCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCC
Confidence            3456666544 3344689999999999999999999863     45678999999764 344556789999999999 69


Q ss_pred             CCccceeeEEeeCCeEEEEEecCCCCChhhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 038118           98 RNLVQLLGWCHEKKELLLVYEYMPNGSLDSHLFKEN-----------------NLLTWEFRFKIAQDLASGLLYLQEGWE  160 (376)
Q Consensus        98 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~~  160 (376)
                      |||+++++++.+.+..++|||||++|+|.+++....                 ..+++..++.++.||+.||.|||   +
T Consensus        87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~  163 (311)
T d1t46a_          87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---S  163 (311)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred             CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---h
Confidence            999999999999999999999999999999886432                 25889999999999999999999   7


Q ss_pred             CceEeecccCCCeeecCCceEEEeeCCCccccccCCC-cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHh-
Q 038118          161 QCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIAC-  238 (376)
Q Consensus       161 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~llt-  238 (376)
                      ++++||||||+||+++.++.++|+|||+++....... .......||+.|+|||++.++.++.++|||||||++|+|+| 
T Consensus       164 ~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~  243 (311)
T d1t46a_         164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL  243 (311)
T ss_dssp             TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhC
Confidence            9999999999999999999999999999987654332 22334568999999999999999999999999999999998 


Q ss_pred             CCCCCCCccchhhHHHHHHHHHHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          239 GRKPISLTAKEEVQVYLVQWVWDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       239 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      |.+||......+....+..       .+     ..+.....    ....+.+|+.+||+.||++|||+.+|+++|+.
T Consensus       244 g~p~~~~~~~~~~~~~~i~-------~~-----~~~~~~~~----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         244 GSSPYPGMPVDSKFYKMIK-------EG-----FRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             TCCSSTTCCSSHHHHHHHH-------HT-----CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHh-------cC-----CCCCCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            6666766554433222221       11     11111112    23458889999999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=361.97  Aligned_cols=251  Identities=29%  Similarity=0.466  Sum_probs=201.8

Q ss_pred             CCccccCCCeeEEEEEEcCCC---eEEEEEEccc-CChhhHHHHHHHHHHHHhCCCCCccceeeEEee-CCeEEEEEecC
Q 038118           46 DQKLGQGGFGGVYKGFFRETS---SYIAVKRVSK-GSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE-KKELLLVYEYM  120 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~---~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~  120 (376)
                      .++||+|+||+||+|++..++   ..||||.+.. ......++|.+|+.++++++||||+++++++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            568999999999999986543   4699999975 356667889999999999999999999999875 56899999999


Q ss_pred             CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc--
Q 038118          121 PNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS--  198 (376)
Q Consensus       121 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  198 (376)
                      ++++|.+++......+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999998777777889999999999999999999   799999999999999999999999999999865432221  


Q ss_pred             -ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccc-hhhHHHHHHHHHHHhcCCccccccCCcC
Q 038118          199 -QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAK-EEVQVYLVQWVWDLYGNGKLLEAVDPRL  276 (376)
Q Consensus       199 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                       ......||..|+|||.+.+..++.++||||||+++|||++|..||..... .+....+.        .+..  ...|  
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~--------~g~~--~~~p--  256 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QGRR--LLQP--  256 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH--------TTCC--CCCC--
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH--------cCCC--CCCc--
Confidence             22335689999999999999999999999999999999998877754332 22211111        1111  1111  


Q ss_pred             CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccC
Q 038118          277 CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSE  316 (376)
Q Consensus       277 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~  316 (376)
                       ..    ....+.+++.+||+.||++|||+.||++.|+..
T Consensus       257 -~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         257 -EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             12    234578899999999999999999999998753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=367.58  Aligned_cols=261  Identities=28%  Similarity=0.428  Sum_probs=213.9

Q ss_pred             HHHhhCCCcCCccccCCCeeEEEEEEcC-----CCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 038118           37 AQATNDFNDDQKLGQGGFGGVYKGFFRE-----TSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK  110 (376)
Q Consensus        37 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  110 (376)
                      +...++|++.+.||+|+||.||+|++.+     ++..||||++... .......|.+|+.++++++||||+++++++...
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            3445889999999999999999999863     3578999999754 444456789999999999999999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceE
Q 038118          111 KELLLVYEYMPNGSLDSHLFKE---------NNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNA  181 (376)
Q Consensus       111 ~~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~  181 (376)
                      ...++||||+++|+|.+++...         ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++++
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceE
Confidence            9999999999999999987542         134688999999999999999999   7899999999999999999999


Q ss_pred             EEeeCCCccccccCCCc-ceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhC-CCCCCCccchhhHHHHHHHH
Q 038118          182 KIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACG-RKPISLTAKEEVQVYLVQWV  259 (376)
Q Consensus       182 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~  259 (376)
                      ||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+|| ..||...+..+....+.+  
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~--  250 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--  250 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT--
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--
Confidence            99999999866433222 23334589999999999999999999999999999999998 578877665554433321  


Q ss_pred             HHHhcCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhccCC
Q 038118          260 WDLYGNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNSEA  317 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~~~  317 (376)
                            +..     +.....    ....+.+++.+||+.||++|||+.+|++.|+...
T Consensus       251 ------~~~-----~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         251 ------GGL-----LDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             ------TCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ------CCC-----CCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                  211     111122    2346888999999999999999999999998653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=365.39  Aligned_cols=267  Identities=22%  Similarity=0.241  Sum_probs=203.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCC-CeEEEEEEcccCC--hhhHHHHHHHHHHHHhC---CCCCccceeeEEee----
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRET-SSYIAVKRVSKGS--KQGIKEYASEVTIISRL---RHRNLVQLLGWCHE----  109 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----  109 (376)
                      .++|++.+.||+|+||+||+|++..+ ++.||||++....  ......+.+|+.+++.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999765 6789999986432  22223455677776655   79999999999853    


Q ss_pred             -CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCC
Q 038118          110 -KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGL  188 (376)
Q Consensus       110 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  188 (376)
                       ....+++||++.++.+..........+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             35789999999988776555556677999999999999999999999   79999999999999999999999999999


Q ss_pred             ccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC---
Q 038118          189 ARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN---  265 (376)
Q Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---  265 (376)
                      +......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..........   
T Consensus       163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            8754322  23345679999999999999999999999999999999999999998877665554444322110000   


Q ss_pred             --Cccccc----cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 --GKLLEA----VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 --~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                        ......    ........+.......+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              000000    0000001111122345778899999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=362.64  Aligned_cols=241  Identities=24%  Similarity=0.406  Sum_probs=197.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh------hhHHHHHHHHHHHHhCC--CCCccceeeEEeeCC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK------QGIKEYASEVTIISRLR--HRNLVQLLGWCHEKK  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~  111 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....      ....++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            4689999999999999999999999999999999864311      11234668999999997  899999999999999


Q ss_pred             eEEEEEecCCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-CceEEEeeCCCc
Q 038118          112 ELLLVYEYMPN-GSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-NFNAKIGDFGLA  189 (376)
Q Consensus       112 ~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~  189 (376)
                      ..|+||||+.+ +++.+++. ....+++..++.++.||+.||.|||   ++||+||||||+|||++. ++.+||+|||++
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 46666664 4467999999999999999999999   799999999999999985 479999999999


Q ss_pred             cccccCCCcceeeeccCCCCCchhhhccCCC-CCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCcc
Q 038118          190 RLVEHAKGSQTTVLAGTMGYMAPECATTGRA-SKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKL  268 (376)
Q Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  268 (376)
                      ......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....      +..        +. 
T Consensus       159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~--------~~-  220 (273)
T d1xwsa_         159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--------GQ-  220 (273)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--------CC-
T ss_pred             eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--------cc-
Confidence            765332   2344569999999999987664 6779999999999999999999975421      111        00 


Q ss_pred             ccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          269 LEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                           ..+...++    ..+.+++.+||+.||++|||++|+++
T Consensus       221 -----~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 -----VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                 11122233    45788999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.4e-49  Score=356.00  Aligned_cols=265  Identities=23%  Similarity=0.280  Sum_probs=202.6

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCC--hhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGS--KQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.++||+|+||+||+|+++ +++.||||++....  ....+.+.+|+.+|++++||||+++++++...+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 67899999997653  2335788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ++.++.+.. +....+.+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....... .
T Consensus        81 ~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~  155 (286)
T d1ob3a_          81 HLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R  155 (286)
T ss_dssp             CCSEEHHHH-HHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             eehhhhHHH-HHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence            997765544 4456678999999999999999999999   7899999999999999999999999999997654322 2


Q ss_pred             ceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC--------Cccc
Q 038118          199 QTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN--------GKLL  269 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~  269 (376)
                      ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+..........        ....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            23344589999999998654 56899999999999999999999998776555443333221110000        0000


Q ss_pred             cc---cCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          270 EA---VDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       270 ~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..   ..+.............+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   0000001111122345788999999999999999999984

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=354.40  Aligned_cols=267  Identities=25%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC----eEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK----ELLL  115 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l  115 (376)
                      ..+|.+.+.||+|+||.||+|+++  |+.||||++...... ...+..|+..+.+++||||+++++++.+.+    .+|+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            357888899999999999999974  789999998654322 122334555566789999999999997653    6899


Q ss_pred             EEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          116 VYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG-----WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       116 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ||||+++|+|.+++.+  ..+++..++.++.+++.||.|||..     +.+||+||||||+||||+.++.+||+|||++.
T Consensus        79 v~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999999954  3589999999999999999999953     34799999999999999999999999999998


Q ss_pred             ccccCCCc---ceeeeccCCCCCchhhhccCC------CCCCCceeechhhHHHHHhCCCCCCCccchhhHH-------H
Q 038118          191 LVEHAKGS---QTTVLAGTMGYMAPECATTGR------ASKESDVYSFGIVALEIACGRKPISLTAKEEVQV-------Y  254 (376)
Q Consensus       191 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~-------~  254 (376)
                      ........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..||..........       .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            76443322   233467999999999987643      5678999999999999999998875432211100       0


Q ss_pred             HHHHHHHHhcCCccccccCCcCCCCC-cHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          255 LVQWVWDLYGNGKLLEAVDPRLCRDF-DEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                      ............    .+.|.+.... .......+.+++.+||+.||++|||+.||++.|+.
T Consensus       237 ~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            000011111111    1122222211 23456678999999999999999999999988864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=350.67  Aligned_cols=268  Identities=22%  Similarity=0.281  Sum_probs=202.8

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee--------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE--------  109 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------  109 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .......+.+|+.+|++++|+|++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            58999999999999999999999999999999998644  33345678899999999999999999998854        


Q ss_pred             CCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCc
Q 038118          110 KKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLA  189 (376)
Q Consensus       110 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~  189 (376)
                      .+..|+||||+.++.+. ........+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34689999999876654 44455667899999999999999999999   799999999999999999999999999999


Q ss_pred             cccccCCC---cceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcC
Q 038118          190 RLVEHAKG---SQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGN  265 (376)
Q Consensus       190 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  265 (376)
                      ........   .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+..........
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            76543221   122334689999999998765 68999999999999999999999998776655554444432211100


Q ss_pred             C-------ccccccCC--cCCCCCcHH-----HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          266 G-------KLLEAVDP--RLCRDFDEQ-----QMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       266 ~-------~~~~~~~~--~~~~~~~~~-----~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .       .....+..  .........     ....+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0       00000000  000011111     1234678899999999999999999996

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.6e-48  Score=349.68  Aligned_cols=260  Identities=19%  Similarity=0.241  Sum_probs=201.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRN-LVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e  118 (376)
                      +++|++.+.||+|+||.||+|++..+++.||||++.....  ...+..|+++++.++|+| |+.+..++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4689999999999999999999999999999999876533  245778999999998766 5555666788889999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC---CceEEEeeCCCccccccC
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL---NFNAKIGDFGLARLVEHA  195 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~  195 (376)
                      |+ +++|...+....+.+++..+..++.|++.||.|||   ++||+||||||+|||++.   +..++|+|||+++.....
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            98 55676777666778999999999999999999999   799999999999998764   456999999999876443


Q ss_pred             CC------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          196 KG------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       196 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      ..      .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...........   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---  236 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---  236 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence            22      123455799999999999999999999999999999999999999987665444333332222111110   


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                         .+.+...++    ..+.+++..||+.||++||++.++.+.|+.
T Consensus       237 ---~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         237 ---IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ---HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ---hhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence               011122222    447788889999999999999988777653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=356.61  Aligned_cols=261  Identities=21%  Similarity=0.258  Sum_probs=198.8

Q ss_pred             CCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCccceeeEEee------CCeEEE
Q 038118           42 DFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLVQLLGWCHE------KKELLL  115 (376)
Q Consensus        42 ~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~l  115 (376)
                      +|+..++||+|+||+||+|++..+|+.||||++......    +.+|+.+|++++|+||++++++|..      ..++|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688899999999999999999999999999999765322    2469999999999999999999854      235899


Q ss_pred             EEecCCCCChhhhh--hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCcccc
Q 038118          116 VYEYMPNGSLDSHL--FKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLV  192 (376)
Q Consensus       116 v~e~~~~~sL~~~l--~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~  192 (376)
                      ||||++++.+..+.  ......+++..++.++.||+.||.|||   ++||+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            99999876443332  234567999999999999999999999   89999999999999999775 8999999999765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHH-------HHHhc
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWV-------WDLYG  264 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-------~~~~~  264 (376)
                      ....  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+....       +....
T Consensus       174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            4322  2334568999999998765 468999999999999999999999998776655544443211       00000


Q ss_pred             C----CccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          265 N----GKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       265 ~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      .    ..........+...........+.+|+.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0    0000000000011111223345788899999999999999999995

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=351.46  Aligned_cols=258  Identities=21%  Similarity=0.272  Sum_probs=197.6

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC------
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK------  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  111 (376)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...  .....+.+.+|+.+|++++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            47899999999999999999999999999999999753  4445678899999999999999999999997654      


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      .+|+||||+ +.+|...+.  ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 556666553  346899999999999999999999   79999999999999999999999999999986


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH---------
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD---------  261 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~---------  261 (376)
                      ...    ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+......         
T Consensus       171 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         171 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            543    23445689999999998764 5789999999999999999999999877654443333221100         


Q ss_pred             -------Hh-cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 -------LY-GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 -------~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                             .. .................    ...+.+|+.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNA----SPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTC----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhhhhhhccCCcccccchHHhccCC----CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   00 00000000001111122    234678899999999999999999996

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-47  Score=345.32  Aligned_cols=260  Identities=17%  Similarity=0.201  Sum_probs=208.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC-CCccceeeEEeeCCeEEEEEe
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-RNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +++|++.+.||+|+||.||+|++..+++.||||++.....  ...+.+|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            5789999999999999999999999999999998865432  2356788999999975 899999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecC-----CceEEEeeCCCccccc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDL-----NFNAKIGDFGLARLVE  193 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~  193 (376)
                      |+ +++|.+++......++...+..++.|++.+|.|||   ++||+||||||+|||++.     ++.+||+|||+++...
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            98 68998888777778999999999999999999999   899999999999999964     5689999999998764


Q ss_pred             cCCC------cceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCc
Q 038118          194 HAKG------SQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGK  267 (376)
Q Consensus       194 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  267 (376)
                      ....      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.................... .
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-P  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-C
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-C
Confidence            3222      12334679999999999999999999999999999999999999998665444333222211111100 0


Q ss_pred             cccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHHHhcc
Q 038118          268 LLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIHVLNS  315 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~~L~~  315 (376)
                           .+.+...++    ..+..++..|+..+|++||+++.+.+.|..
T Consensus       237 -----~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         237 -----LRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             -----HHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -----hHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                 011222233    347778888999999999998888776643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-47  Score=351.07  Aligned_cols=263  Identities=19%  Similarity=0.220  Sum_probs=198.9

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC-ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCC----eEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKK----ELL  114 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~  114 (376)
                      +++|++.+.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46899999999999999999999999999999999754 3445678899999999999999999999997643    234


Q ss_pred             EEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccccc
Q 038118          115 LVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEH  194 (376)
Q Consensus       115 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  194 (376)
                      ++++++.+++|.+++..  +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus        87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            44455678999998854  36899999999999999999999   79999999999999999999999999999976533


Q ss_pred             CCC--cceeeeccCCCCCchhhhcc-CCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHH----------
Q 038118          195 AKG--SQTTVLAGTMGYMAPECATT-GRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWD----------  261 (376)
Q Consensus       195 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----------  261 (376)
                      ...  .......||+.|+|||++.. ..++.++||||+||++|+|++|..||......+...........          
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            221  12344568999999998844 56789999999999999999999999876654443332221100          


Q ss_pred             ------Hh-cCCccccccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          262 ------LY-GNGKLLEAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       262 ------~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                            .. .........-......+    ...+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00 00000000000001111    235788999999999999999999996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=342.98  Aligned_cols=266  Identities=21%  Similarity=0.251  Sum_probs=205.8

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..  ......++.+|+.+|+.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999999999999999998654  33456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccccccCCCc
Q 038118          119 YMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLVEHAKGS  198 (376)
Q Consensus       119 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  198 (376)
                      ++.+++|..++ ...+.+++..++.++.|++.||.|||   ++||+||||||+|||++.++.+||+|||.+........ 
T Consensus        82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99988887665 55677899999999999999999999   79999999999999999999999999999986543322 


Q ss_pred             ceeeeccCCCCCchhhhccCC-CCCCCceeechhhHHHHHhCCCCCCCccc-hhhHHHHHHHHHHHhcCC--cccccc--
Q 038118          199 QTTVLAGTMGYMAPECATTGR-ASKESDVYSFGIVALEIACGRKPISLTAK-EEVQVYLVQWVWDLYGNG--KLLEAV--  272 (376)
Q Consensus       199 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~--  272 (376)
                      ......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... .+....+...........  ......  
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            223344778999999887654 68999999999999999999998644332 222222222111100000  000000  


Q ss_pred             -------CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          273 -------DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       273 -------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                             ...............+.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   000011112223345778899999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=354.66  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=206.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEE---cCCCeEEEEEEcccC----ChhhHHHHHHHHHHHHhCCC-CCccceeeEEeeCC
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFF---RETSSYIAVKRVSKG----SKQGIKEYASEVTIISRLRH-RNLVQLLGWCHEKK  111 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~---~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~  111 (376)
                      .++|++.+.||+|+||+||+|++   +.+|+.||||++...    .....+.+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            37799999999999999999987   446899999998643    22234567889999999976 89999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCccc
Q 038118          112 ELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARL  191 (376)
Q Consensus       112 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  191 (376)
                      ..++||||+.+++|.+++... +.+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999988544 45788899999999999999999   79999999999999999999999999999986


Q ss_pred             cccCCCcceeeeccCCCCCchhhhccC--CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHHhcCCccc
Q 038118          192 VEHAKGSQTTVLAGTMGYMAPECATTG--RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDLYGNGKLL  269 (376)
Q Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (376)
                      .............|++.|++||.+.+.  .++.++|||||||+||+|++|..||......+....+.......       
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-------  251 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------  251 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-------
Confidence            654444444556799999999998654  46889999999999999999999998776655544444322111       


Q ss_pred             cccCCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 038118          270 EAVDPRLCRDFDEQQMECLMIVGLWCAHPDENLRPS-----IRQVIH  311 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~~vl~  311 (376)
                         .+.+..    .....+.+++.+||+.||++|||     ++|+++
T Consensus       252 ---~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ---EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence               111112    23356788899999999999994     788885

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-47  Score=350.60  Aligned_cols=262  Identities=20%  Similarity=0.218  Sum_probs=196.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEee------CCe
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHE------KKE  112 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~  112 (376)
                      ++|++.++||+|+||+||+|.+..+|+.||||++...  ......++.+|+.+|++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999999999999999999754  34455678999999999999999999999953      368


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      +|+||||+.++.+ +.+   ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.++++|||++...
T Consensus        97 ~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            9999999977554 434   245899999999999999999999   799999999999999999999999999998765


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHH------------
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVW------------  260 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~------------  260 (376)
                      ...  .......+|..|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.....            
T Consensus       170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            432  233455689999999999999999999999999999999999999987664444333322110            


Q ss_pred             ---HHhcCC-c-----cccccCCcC---CCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          261 ---DLYGNG-K-----LLEAVDPRL---CRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       261 ---~~~~~~-~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                         ...... .     .........   ...........+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               000000 0     000000001   11122344567889999999999999999999995

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.1e-46  Score=343.81  Aligned_cols=260  Identities=18%  Similarity=0.238  Sum_probs=199.4

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEee--CCeEEEE
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHE--KKELLLV  116 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv  116 (376)
                      .++|++.++||+|+||+||+|++..+++.||||++....   .+++.+|+.+|+.++ ||||+++++++..  ...+++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            368999999999999999999999999999999997654   356789999999996 9999999999974  3569999


Q ss_pred             EecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc-eEEEeeCCCccccccC
Q 038118          117 YEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF-NAKIGDFGLARLVEHA  195 (376)
Q Consensus       117 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  195 (376)
                      |||+.+++|....    +.+++..++.++.||+.||.|||   ++||+||||||+|||++.++ .+||+|||++......
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999986653    46899999999999999999999   79999999999999998654 6999999999865432


Q ss_pred             CCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchh-hHHHHHHHH-----HHHhc--CC
Q 038118          196 KGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEE-VQVYLVQWV-----WDLYG--NG  266 (376)
Q Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~-----~~~~~--~~  266 (376)
                      .  ......+|..|+|||.+.+. .++.++|||||||++|+|++|..||....... ....+....     .....  ..
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            2  23445689999999998765 47999999999999999999999997654322 111111110     00000  00


Q ss_pred             cc----cccc--------CCcCCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 KL----LEAV--------DPRLCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 ~~----~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                      ..    ....        ...............+.+|+.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00    0000        000111111222345788999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-46  Score=344.04  Aligned_cols=263  Identities=21%  Similarity=0.253  Sum_probs=199.7

Q ss_pred             hhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccC--ChhhHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 038118           40 TNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG--SKQGIKEYASEVTIISRLRHRNLVQLLGWCHEK-----KE  112 (376)
Q Consensus        40 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  112 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .....+++.+|+.+|+.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999999999999999999754  344556788999999999999999999998632     34


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEeeCCCcccc
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLARLV  192 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  192 (376)
                      .++|++++.+|+|.+++.  .+.+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            466677788999999884  346999999999999999999999   799999999999999999999999999998754


Q ss_pred             ccCCCcceeeeccCCCCCchhhhccC-CCCCCCceeechhhHHHHHhCCCCCCCccchhhHHHHHHHHHHH----hcCC-
Q 038118          193 EHAKGSQTTVLAGTMGYMAPECATTG-RASKESDVYSFGIVALEIACGRKPISLTAKEEVQVYLVQWVWDL----YGNG-  266 (376)
Q Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~-  266 (376)
                      ..    ......|+..|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......    .... 
T Consensus       172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            32    23345588999999987665 46889999999999999999999998776555544443321100    0000 


Q ss_pred             -c----cccccCCcCCCCC---cHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 038118          267 -K----LLEAVDPRLCRDF---DEQQMECLMIVGLWCAHPDENLRPSIRQVIH  311 (376)
Q Consensus       267 -~----~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPs~~~vl~  311 (376)
                       .    ....+.......+   .......+.+++.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence             0    0000000000000   0012245778999999999999999999996

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.5e-41  Score=312.77  Aligned_cols=264  Identities=17%  Similarity=0.187  Sum_probs=192.5

Q ss_pred             hCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-----------CCCccceeeEEee
Q 038118           41 NDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-----------HRNLVQLLGWCHE  109 (376)
Q Consensus        41 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~  109 (376)
                      ++|++.++||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            469999999999999999999999999999999975532 3456788998888775           4789999988764


Q ss_pred             --CCeEEEEEecCCCCChhh--hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCc------
Q 038118          110 --KKELLLVYEYMPNGSLDS--HLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNF------  179 (376)
Q Consensus       110 --~~~~~lv~e~~~~~sL~~--~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~------  179 (376)
                        ....+++++++..+....  ........+++..++.++.||+.||.|||+  ..||+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence              356667777665443322  222345678999999999999999999994  48999999999999998765      


Q ss_pred             eEEEeeCCCccccccCCCcceeeeccCCCCCchhhhccCCCCCCCceeechhhHHHHHhCCCCCCCccchhhH---HHHH
Q 038118          180 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGRASKESDVYSFGIVALEIACGRKPISLTAKEEVQ---VYLV  256 (376)
Q Consensus       180 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~~lltg~~pf~~~~~~~~~---~~~~  256 (376)
                      .++++|||.+.....    ......||+.|+|||++.+..++.++|||||||++++|++|+.||.........   ..+.
T Consensus       170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            399999999875432    223456899999999999999999999999999999999999999754322111   1111


Q ss_pred             HHHHH-----------------HhcCCccccccCCc----------CCCCCcHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 038118          257 QWVWD-----------------LYGNGKLLEAVDPR----------LCRDFDEQQMECLMIVGLWCAHPDENLRPSIRQV  309 (376)
Q Consensus       257 ~~~~~-----------------~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~~v  309 (376)
                      .....                 ..........+...          ............+.+++.+||+.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            11100                 00000011111110          0123345667789999999999999999999999


Q ss_pred             HH
Q 038118          310 IH  311 (376)
Q Consensus       310 l~  311 (376)
                      |+
T Consensus       326 L~  327 (362)
T d1q8ya_         326 VN  327 (362)
T ss_dssp             HT
T ss_pred             hc
Confidence            96

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=2e-24  Score=181.69  Aligned_cols=163  Identities=15%  Similarity=0.131  Sum_probs=118.5

Q ss_pred             CCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCCh------------------hhHHHHHHHHHHHHhCCCCCcccee
Q 038118           43 FNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSK------------------QGIKEYASEVTIISRLRHRNLVQLL  104 (376)
Q Consensus        43 y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~  104 (376)
                      +.+.++||+|+||.||+|.+. +|+.||||+++....                  ........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356789999999999999985 588999998753211                  0112345688899999999999887


Q ss_pred             eEEeeCCeEEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccCCCeeecCCceEEEe
Q 038118          105 GWCHEKKELLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGWEQCVVHRDIKSSNIMLDLNFNAKIG  184 (376)
Q Consensus       105 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dlkp~Nill~~~~~~kl~  184 (376)
                      ++..    .+++|||+++..+..        ++......++.|++.+|.+||   ++||+||||||+|||++++ .++|+
T Consensus        81 ~~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             EecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            6532    379999998866533        223335578999999999999   7999999999999999965 58999


Q ss_pred             eCCCccccccCCCcceeeeccCCCCCc------hhhhccCCCCCCCceeechhh
Q 038118          185 DFGLARLVEHAKGSQTTVLAGTMGYMA------PECATTGRASKESDVYSFGIV  232 (376)
Q Consensus       185 Dfg~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwslG~i  232 (376)
                      |||.+....+.....         |..      .+. ....|+.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence            999997554322111         111      111 23457888999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.93  E-value=2.6e-09  Score=92.40  Aligned_cols=149  Identities=15%  Similarity=0.059  Sum_probs=106.3

Q ss_pred             HHHHHHhhCCCcCCccccCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 038118           34 KELAQATNDFNDDQKLGQGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKE  112 (376)
Q Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  112 (376)
                      .++......|++.+..+.+..+.||+...  ++..+++|+...........+.+|...++.+. +-.+++++.+...++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            57777788998877766666678998763  35557888876554433445678888888775 4446788888888999


Q ss_pred             EEEEEecCCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 038118          113 LLLVYEYMPNGSLDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEGW---------------------------------  159 (376)
Q Consensus       113 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~---------------------------------  159 (376)
                      .++||++++|.++........   .   ...++.+++..+..||+..                                 
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             eEEEEEecccccccccccccc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999999988765442211   1   2234555666666666320                                 


Q ss_pred             -----------------------CCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          160 -----------------------EQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       160 -----------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                                             ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                   1237999999999999987666799999885

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.32  E-value=1.6e-06  Score=73.83  Aligned_cols=130  Identities=20%  Similarity=0.119  Sum_probs=85.4

Q ss_pred             ccccCCC-eeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC--CCccceeeEEeeCCeEEEEEecCCCCC
Q 038118           48 KLGQGGF-GGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH--RNLVQLLGWCHEKKELLLVYEYMPNGS  124 (376)
Q Consensus        48 ~lg~G~~-g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~s  124 (376)
                      .+..|.. +.||+....+ +..+++|.......   ..+..|+..++.+..  -.+++++.+..+.+..++||++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3444543 6789887654 66688898765533   245667887777643  346778888888889999999999876


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 038118          125 LDSHLFKENNLLTWEFRFKIAQDLASGLLYLQEG----------------------------------------------  158 (376)
Q Consensus       125 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~----------------------------------------------  158 (376)
                      +....      ....   ..+.++...|..||..                                              
T Consensus        93 ~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          93 LLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            54311      1111   1222333344444421                                              


Q ss_pred             ---------CCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          159 ---------WEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       159 ---------~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                               ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                     12238999999999999987667799999874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.09  E-value=4.2e-06  Score=76.22  Aligned_cols=78  Identities=15%  Similarity=0.142  Sum_probs=49.4

Q ss_pred             CCccccCCCeeEEEEEEcCCCeEEEEEEcccC-------ChhhHHHHHHHHHHHHhCC-C--CCccceeeEEeeCCeEEE
Q 038118           46 DQKLGQGGFGGVYKGFFRETSSYIAVKRVSKG-------SKQGIKEYASEVTIISRLR-H--RNLVQLLGWCHEKKELLL  115 (376)
Q Consensus        46 ~~~lg~G~~g~vy~a~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l  115 (376)
                      .+.||.|....||++.+..+++.|+||.-...       ......+...|+..|+.+. +  ..+++++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            35789999999999998877888999964321       1112334456888777663 2  3466666553  445678


Q ss_pred             EEecCCCCCh
Q 038118          116 VYEYMPNGSL  125 (376)
Q Consensus       116 v~e~~~~~sL  125 (376)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00062  Score=59.66  Aligned_cols=133  Identities=14%  Similarity=0.098  Sum_probs=76.2

Q ss_pred             CeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCCCCcc-----ce--eeEEeeCCeEEEEEecCCCCChh
Q 038118           54 FGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRHRNLV-----QL--LGWCHEKKELLLVYEYMPNGSLD  126 (376)
Q Consensus        54 ~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-----~~--~~~~~~~~~~~lv~e~~~~~sL~  126 (376)
                      --.||++...+ |..|++|+.+.... ..+++..|...+..|...++.     ..  -..+...+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~d-g~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDED-RRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTT-CCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCC-CCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            35799988754 67799999876532 245677788888777532221     11  12345567889999999874431


Q ss_pred             h-----------hh---hh--------cCCCCC-------------------HH---HHHHHHHHHHHHHHHH-HhCCCC
Q 038118          127 S-----------HL---FK--------ENNLLT-------------------WE---FRFKIAQDLASGLLYL-QEGWEQ  161 (376)
Q Consensus       127 ~-----------~l---~~--------~~~~~~-------------------~~---~~~~~~~~i~~~l~~L-h~~~~~  161 (376)
                      .           .+   +.        .....+                   ..   .....+..+...+..+ ......
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            1           00   00        000111                   11   1122223233222221 111246


Q ss_pred             ceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          162 CVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       162 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      +++|+|+.+.|||++++  ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            79999999999999753  4579999885

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.32  E-value=0.00033  Score=63.28  Aligned_cols=73  Identities=15%  Similarity=0.154  Sum_probs=50.7

Q ss_pred             CccccCCCeeEEEEEEcC-------CCeEEEEEEcccCChhhHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEe
Q 038118           47 QKLGQGGFGGVYKGFFRE-------TSSYIAVKRVSKGSKQGIKEYASEVTIISRLR-HRNLVQLLGWCHEKKELLLVYE  118 (376)
Q Consensus        47 ~~lg~G~~g~vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  118 (376)
                      +.|+.|-.-.+|++....       ....|.+++.... . ......+|..+++.+. +.-.+++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            578889999999998653       2355777776532 2 2345567999988886 4334677877753    68999


Q ss_pred             cCCCCCh
Q 038118          119 YMPNGSL  125 (376)
Q Consensus       119 ~~~~~sL  125 (376)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.24  E-value=0.0024  Score=55.37  Aligned_cols=157  Identities=11%  Similarity=-0.020  Sum_probs=84.8

Q ss_pred             ccCHHHHHHHhhCCCcCCccc-----cCCCeeEEEEEEcCCCeEEEEEEcccCChhhHHHHHHHHHHHHhCCC-----CC
Q 038118           30 RFTYKELAQATNDFNDDQKLG-----QGGFGGVYKGFFRETSSYIAVKRVSKGSKQGIKEYASEVTIISRLRH-----RN   99 (376)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~lg-----~G~~g~vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~   99 (376)
                      .++.+|+.....+|.+.+...     .|---+.|+....+ | .+++|++.....  ...+..|+.++..|..     |.
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccc
Confidence            357789999999998865543     45557789988764 4 489999865421  1233445666665532     22


Q ss_pred             cccee---eEEeeCCeEEEEEecCCCCChhhhh--------------hh--cC------CCC------------------
Q 038118          100 LVQLL---GWCHEKKELLLVYEYMPNGSLDSHL--------------FK--EN------NLL------------------  136 (376)
Q Consensus       100 i~~~~---~~~~~~~~~~lv~e~~~~~sL~~~l--------------~~--~~------~~~------------------  136 (376)
                      .+...   .+.........++.++.+.......              +.  ..      ...                  
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            21110   1223345667777777654331100              00  00      000                  


Q ss_pred             CHHHHHHHHHHHHHHHHHHHh-CCCCceEeecccCCCeeecCCceEEEeeCCCcc
Q 038118          137 TWEFRFKIAQDLASGLLYLQE-GWEQCVVHRDIKSSNIMLDLNFNAKIGDFGLAR  190 (376)
Q Consensus       137 ~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~  190 (376)
                      ........+..+...+...+. ....|++|+|+.++||+++.+...-|.||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            000111112222222222221 125789999999999999988777899999985